data_1ihw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ihw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.055 -0.72 . . . . 2.0099999999999998 109.055 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.28 138.12 43.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.53 -0.731 . . . . 0.81999999999999995 109.542 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.611 HH11 ' CG ' ' A' ' 224' ' ' ARG . 1.0 OUTLIER -108.62 157.31 18.62 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.699 -1.223 . . . . 3.79 107.699 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.85 140.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.09 -1.006 . . . . 1.05 110.418 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.79 153.17 23.87 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.593 -1.262 . . . . 0.92000000000000004 107.593 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.6 p90 -156.48 152.82 27.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.699 -1.251 . . . . 1.01 110.156 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -95.32 156.4 16.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 3.3999999999999999 109.653 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -93.07 172.55 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.661 -0.866 . . . . 2.23 108.661 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.24 -13.7 46.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 2.3199999999999998 109.251 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -90.75 -14.79 31.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 4.1799999999999997 109.954 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 234' ' ' VAL . 12.1 m-20 -161.02 128.81 2.77 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.912 -1.118 . . . . 2.1600000000000001 109.553 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.13 18.0 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 121.021 1.147 . . . . 1.3899999999999999 110.882 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 232' ' ' ASP . 31.5 m -83.24 135.06 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.829 -1.169 . . . . 2.3100000000000001 109.55 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -58.9 161.24 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.71999999999999997 109.496 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 237' ' ' GLY . 42.5 tttp -121.91 161.48 22.74 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.378 -0.826 . . . . 1.96 109.883 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.21 165.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.244 -1.142 . . . . 0.55000000000000004 110.244 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.15 158.61 53.73 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.661 1.574 . . . . 0.46999999999999997 110.699 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.01 172.55 12.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.851 -0.796 . . . . 1.05 108.851 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -92.75 135.75 33.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 3.1899999999999999 110.026 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -88.14 125.37 34.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 1.0900000000000001 109.558 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.86 -74.39 0.61 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.426 -0.796 . . . . 1.1799999999999999 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.483 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 3.8 t90 -89.85 140.91 29.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.226 -0.921 . . . . 0.34000000000000002 109.846 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.26 119.7 9.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 2.79 108.791 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -104.42 0.23 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.87 -1.157 . . . . 0.28999999999999998 110.215 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.69 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -1.067 . . . . 1.5600000000000001 109.735 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 49.0 2.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.453 -1.459 . . . . 0.28999999999999998 109.453 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.55 151.28 36.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 1.0700000000000001 108.522 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.15 126.54 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 109.909 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.86 135.16 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.025 -1.102 . . . . 1.0700000000000001 108.025 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.31 179.27 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.871 . . . . 1.04 110.135 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.22 110.33 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 2.3399999999999999 108.772 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.95 -81.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.467 -1.309 . . . . 1.1799999999999999 107.467 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -78.6 -137.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.505 -1.665 . . . . 2.4700000000000002 106.505 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.3 m -97.97 54.13 1.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.899 -1.149 . . . . 1.8700000000000001 107.899 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.45 128.59 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.988 -0.745 . . . . 1.1200000000000001 108.988 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.476 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 19.0 mt -92.74 140.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.121 -0.987 . . . . 1.1499999999999999 109.604 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -138.44 168.22 20.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.406 -0.809 . . . . 2.6299999999999999 109.774 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.75 138.34 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.508 -0.745 . . . . 1.0800000000000001 109.228 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.72 131.93 18.35 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.363 -0.836 . . . . 1.0700000000000001 109.137 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.43 139.75 91.85 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 N-CA-C 109.599 -0.962 . . . . 0.48999999999999999 109.599 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.1 OUTLIER -59.96 -34.76 73.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 3.5800000000000001 109.722 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.23 -4.96 19.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 4.3600000000000003 110.988 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -119.29 17.51 13.07 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.254 -0.904 . . . . 2.5800000000000001 108.873 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.77 17.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.014 -0.736 . . . . 1.05 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.6 131.37 27.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.303 -0.873 . . . . 2.2599999999999998 109.094 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.7 mm -88.27 108.1 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 1.1799999999999999 110.215 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.01 149.0 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.091 -1.078 . . . . 1.28 108.091 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.302 -0.874 . . . . 4.1799999999999997 108.771 179.336 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.014 -0.735 . . . . 2.0099999999999998 109.014 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -135.3 138.07 43.09 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.484 -0.76 . . . . 0.81999999999999995 109.534 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' B' ' 224' ' ' ARG . 1.0 OUTLIER -108.51 157.36 18.53 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.681 -1.229 . . . . 3.7799999999999998 107.681 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.92 140.06 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.108 -0.995 . . . . 1.0600000000000001 110.375 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.74 153.14 23.88 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.621 -1.252 . . . . 0.92000000000000004 107.621 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.5 p90 -156.47 152.77 27.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.668 -1.27 . . . . 1.01 110.241 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -95.27 156.37 16.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.476 -0.765 . . . . 3.3900000000000001 109.688 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -93.13 172.46 8.29 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.65 -0.87 . . . . 2.23 108.65 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.15 -13.75 46.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 2.3300000000000001 109.183 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.71 -14.81 31.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 4.1900000000000004 109.979 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' B' ' 234' ' ' VAL . 12.0 m-20 -161.03 128.83 2.78 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.949 -1.094 . . . . 2.1600000000000001 109.521 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.28 18.16 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 120.97 1.114 . . . . 1.3999999999999999 110.81 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.524 ' H ' ' C ' ' B' ' 232' ' ' ASP . 31.7 m -83.31 135.13 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.795 -1.191 . . . . 2.3100000000000001 109.535 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -58.97 161.22 5.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.72999999999999998 109.516 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 42.5 tttp -121.92 161.47 22.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.368 -0.832 . . . . 1.96 109.879 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.26 165.5 0.02 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.277 -1.129 . . . . 0.56000000000000005 110.277 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.28 158.68 53.71 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.619 1.546 . . . . 0.46999999999999997 110.644 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.99 172.59 12.71 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.856 -0.794 . . . . 1.05 108.856 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -92.8 135.73 33.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.009 -1.057 . . . . 3.1899999999999999 110.007 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.18 125.38 34.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.642 -0.662 . . . . 1.0900000000000001 109.603 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.86 -74.49 0.6 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.442 -0.786 . . . . 1.1799999999999999 110.158 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.476 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 3.8 t90 -89.76 140.84 29.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.142 -0.974 . . . . 0.34999999999999998 109.815 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.19 119.67 9.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 2.7999999999999998 108.816 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -104.51 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.246 -1.142 . . . . 0.29999999999999999 110.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -67.63 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -1.078 . . . . 1.5600000000000001 109.686 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.83 2.74 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.514 -1.435 . . . . 0.28999999999999998 109.514 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.29 151.29 36.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -1.077 . . . . 1.0700000000000001 108.522 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.12 126.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.159 -0.963 . . . . 1.0900000000000001 109.838 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.89 135.27 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.996 -1.113 . . . . 1.0800000000000001 107.996 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.2 pt -139.4 179.14 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 1.04 110.083 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.14 110.34 5.69 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.735 -0.839 . . . . 2.3399999999999999 108.735 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 -81.83 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.484 -1.302 . . . . 1.1799999999999999 107.484 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -78.61 -137.42 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.451 -1.685 . . . . 2.4700000000000002 106.451 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 18.4 m -97.95 54.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.913 -1.143 . . . . 1.8600000000000001 107.913 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.53 128.48 7.34 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.966 -0.753 . . . . 1.1200000000000001 108.966 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.483 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.0 mt -92.68 140.04 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 1.1499999999999999 109.67 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -138.5 168.14 20.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 2.6400000000000001 109.757 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.65 138.33 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.512 -0.743 . . . . 1.0800000000000001 109.268 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.7 131.98 18.39 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.432 -0.793 . . . . 1.0800000000000001 109.134 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.44 139.65 91.44 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 109.713 -0.918 . . . . 0.48999999999999999 109.713 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.1 OUTLIER -59.89 -34.77 73.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 3.5800000000000001 109.664 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.19 -5.03 20.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.838 . . . . 4.3600000000000003 110.955 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -119.28 17.51 13.07 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.192 -0.942 . . . . 2.5800000000000001 108.848 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.34 169.7 17.34 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.094 -0.706 . . . . 1.05 109.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.51 131.35 27.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.099 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -88.2 108.09 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.897 . . . . 1.1799999999999999 110.16 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.98 149.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.107 -1.072 . . . . 1.27 108.107 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.51 151.82 21.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.854 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.946 -1.026 . . . . 2.0499999999999998 109.35 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.091 -0.707 . . . . 2.0099999999999998 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.21 142.27 45.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.81999999999999995 109.473 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.55 HH21 ' HH ' ' A' ' 226' ' ' TYR . 28.5 mtp180 -108.63 156.67 19.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.536 -1.283 . . . . 3.79 107.536 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.1 t -141.54 143.99 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.072 -1.018 . . . . 1.05 110.794 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.55 ' HH ' HH21 ' A' ' 224' ' ' ARG . 31.4 m-85 -110.96 155.87 22.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.599 -1.259 . . . . 0.92000000000000004 107.599 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.8 151.88 26.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 1.01 110.224 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 228' ' ' ARG . 9.6 mtm-85 -92.38 137.8 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 3.3999999999999999 109.67 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.11 170.7 9.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.456 -0.777 . . . . 2.23 109.485 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.3 t -86.79 -9.13 56.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 2.3199999999999998 109.513 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.39 43.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 4.1799999999999997 110.055 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.479 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 26.0 p-10 -159.19 134.23 5.67 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.905 -1.122 . . . . 2.1600000000000001 109.462 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.61 -7.96 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.027 1.152 . . . . 1.3899999999999999 111.689 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 7.0 p -84.61 164.04 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.553 -1.342 . . . . 2.3100000000000001 110.359 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.491 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 94.5 m95 -66.85 166.42 13.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.586 . . . . 0.71999999999999997 109.595 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.11 166.37 13.01 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.349 -0.844 . . . . 1.96 109.383 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.0 164.08 0.06 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.115 -1.194 . . . . 0.55000000000000004 110.115 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.15 164.4 30.4 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.543 1.496 . . . . 0.46999999999999997 110.604 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.26 8.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.855 -0.794 . . . . 1.05 108.855 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.95 139.26 33.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.206 -0.934 . . . . 3.1899999999999999 109.041 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -88.88 121.88 31.69 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 109.833 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.2 mt -110.19 -74.55 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.366 -0.834 . . . . 1.1799999999999999 109.808 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.406 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.4 t90 -91.71 145.0 24.93 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.11 -0.994 . . . . 0.34000000000000002 110.36 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.71 120.08 8.43 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.952 -0.758 . . . . 2.79 108.952 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -106.38 0.25 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.737 -1.22 . . . . 0.28999999999999998 110.453 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.86 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -1.06 . . . . 1.5600000000000001 109.871 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.69 49.1 2.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.28999999999999998 109.469 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.2 150.0 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -1.066 . . . . 1.0700000000000001 108.582 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.7 m -144.14 127.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 1.0900000000000001 109.858 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 61.0 t -90.13 136.13 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.312 -0.995 . . . . 1.0700000000000001 108.312 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.84 179.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.305 -0.872 . . . . 1.04 109.726 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' A' ' 257' ' ' ILE . 32.2 tt0 -141.8 111.94 6.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.57 -0.9 . . . . 2.3399999999999999 108.57 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -81.54 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.57 -1.27 . . . . 1.1799999999999999 107.57 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.65 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.467 -1.679 . . . . 2.4700000000000002 106.467 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.5 p -105.6 54.29 0.7 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.048 -1.033 . . . . 1.8700000000000001 108.344 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 255' ' ' SER . 63.0 m-20 -155.87 127.78 7.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.547 -0.721 . . . . 1.1200000000000001 109.22 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' A' ' 252' ' ' GLN . 79.5 mt -91.65 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.05 -1.031 . . . . 1.1499999999999999 109.355 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.23 168.91 18.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.6299999999999999 109.921 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.66 138.92 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.519 -0.738 . . . . 1.0800000000000001 109.348 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.3 t -133.4 131.46 21.51 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.569 -0.9 . . . . 1.0700000000000001 108.569 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.38 137.87 81.78 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.546 0.831 . . . . 0.48999999999999999 110.124 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.529 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.3 OUTLIER -57.14 -36.23 70.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 3.5800000000000001 109.611 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.67 -3.0 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 4.3600000000000003 110.717 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -119.37 19.5 12.73 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.154 -0.966 . . . . 2.5800000000000001 109.029 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.67 171.87 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 1.05 109.513 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -139.87 129.23 24.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 2.2599999999999998 108.996 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.65 107.29 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.206 -0.934 . . . . 1.1799999999999999 109.565 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -105.75 154.02 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.648 -0.871 . . . . 1.28 108.648 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.554 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 4.1799999999999997 109.679 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m120 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 108.98 -0.748 . . . . 2.0099999999999998 108.98 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 142.25 46.25 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.442 -0.786 . . . . 0.81999999999999995 109.541 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.55 HH21 ' HH ' ' B' ' 226' ' ' TYR . 28.4 mtp180 -108.59 156.58 19.37 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.525 -1.287 . . . . 3.7799999999999998 107.525 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.5 144.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.075 -1.016 . . . . 1.0600000000000001 110.662 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . 0.55 ' HH ' HH21 ' B' ' 224' ' ' ARG . 31.4 m-85 -111.1 155.77 22.34 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.561 -1.274 . . . . 0.92000000000000004 107.561 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.5 p90 -156.71 151.96 26.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.741 -1.225 . . . . 1.01 110.238 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.7 mtm-85 -92.49 137.96 31.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 3.3900000000000001 109.525 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.15 170.79 9.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 2.23 109.417 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 36.6 t -86.94 -8.94 56.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 2.3300000000000001 109.429 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.41 43.85 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 4.1900000000000004 110.004 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 25.8 p-10 -159.22 134.19 5.63 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.979 -1.076 . . . . 2.1600000000000001 109.429 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.64 -7.96 20.92 Favored 'Trans proline' 0 N--CA 1.483 0.896 0 C-N-CA 121.001 1.134 . . . . 1.3999999999999999 111.701 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 7.1 p -84.51 163.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.535 -1.353 . . . . 2.3100000000000001 110.362 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.487 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 94.4 m95 -66.88 166.31 13.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.81 -0.556 . . . . 0.72999999999999998 109.547 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.07 166.17 13.23 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.424 -0.797 . . . . 1.96 109.422 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.04 164.14 0.06 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.955 -1.258 . . . . 0.56000000000000005 109.955 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -67.3 164.5 30.3 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.46999999999999997 110.526 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.37 8.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.895 -0.78 . . . . 1.05 108.895 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.86 139.31 33.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.255 -0.903 . . . . 3.1899999999999999 109.007 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -89.0 122.03 31.94 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.387 -0.821 . . . . 1.0900000000000001 109.826 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.3 mt -110.25 -74.56 0.65 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.427 -0.796 . . . . 1.1799999999999999 109.82 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -91.79 145.04 24.89 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.127 -0.983 . . . . 0.34999999999999998 110.387 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -147.65 120.12 8.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.365 -0.834 . . . . 2.7999999999999998 108.896 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -106.43 0.25 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.726 -1.226 . . . . 0.29999999999999999 110.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.84 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -1.038 . . . . 1.5600000000000001 109.855 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.7 49.23 2.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.453 -1.459 . . . . 0.28999999999999998 109.453 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.06 33.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -1.06 . . . . 1.0700000000000001 108.655 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -144.29 127.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 1.0900000000000001 109.838 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.03 136.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.289 -1.004 . . . . 1.0800000000000001 108.289 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.85 179.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 1.04 109.761 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' B' ' 257' ' ' ILE . 32.1 tt0 -141.81 111.76 6.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.682 -0.859 . . . . 2.3399999999999999 108.682 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.32 -81.62 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.647 -1.242 . . . . 1.1799999999999999 107.647 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.57 -129.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.538 -1.653 . . . . 2.4700000000000002 106.538 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.5 p -105.63 54.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.344 -0.984 . . . . 1.8600000000000001 108.344 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 255' ' ' SER . 62.7 m-20 -155.87 127.69 7.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 1.1200000000000001 109.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' B' ' 252' ' ' GLN . 79.3 mt -91.66 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.143 -0.973 . . . . 1.1499999999999999 109.312 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -137.37 168.89 18.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.6400000000000001 109.839 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.72 138.74 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.493 -0.755 . . . . 1.0800000000000001 109.352 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 23.1 t -133.26 131.68 21.76 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.592 -0.892 . . . . 1.0800000000000001 108.592 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.46 137.85 81.98 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 120.566 0.844 . . . . 0.48999999999999999 110.17 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.544 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.3 OUTLIER -57.05 -36.42 70.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 3.5800000000000001 109.618 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.51 -3.19 13.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.221 -0.924 . . . . 4.3600000000000003 110.789 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -119.18 19.45 12.87 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.242 -0.911 . . . . 2.5800000000000001 109.039 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.63 171.91 13.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 1.05 109.489 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -140.01 129.17 23.73 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.405 -0.809 . . . . 2.2599999999999998 108.892 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.6 107.36 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.183 -0.948 . . . . 1.1799999999999999 109.623 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.5 mm -105.77 154.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.582 -0.896 . . . . 1.27 108.582 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.7 OUTLIER -87.61 149.13 24.5 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.349 -0.844 . . . . 4.1799999999999997 109.604 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.6 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.976 -1.011 . . . . 2.0499999999999998 109.417 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 109.474 -0.565 . . . . 2.0099999999999998 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -135.12 131.07 36.43 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.762 -0.829 . . . . 0.81999999999999995 108.762 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -102.8 153.17 20.43 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 3.79 108.362 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.53 142.71 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 1.05 110.2 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.14 158.81 18.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.491 -1.299 . . . . 0.92000000000000004 107.491 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.4 p90 -156.37 153.59 29.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 1.01 110.447 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.431 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.4 mtm-85 -95.88 147.49 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.531 -0.73 . . . . 3.3999999999999999 110.115 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 14.5 p-10 -94.32 168.49 10.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -0.786 . . . . 2.23 109.203 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.5 t -84.92 -2.77 58.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 2.3199999999999998 109.747 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -87.71 -23.79 24.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 4.1799999999999997 109.834 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 10.1 m-20 -163.15 142.39 6.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.99 . . . . 2.1600000000000001 108.895 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.95 10.23 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.226 1.284 . . . . 1.3899999999999999 110.826 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -82.75 156.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.644 -1.285 . . . . 2.3100000000000001 110.415 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.402 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 97.2 m95 -75.69 -172.55 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.476 -0.564 . . . . 0.71999999999999997 109.476 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.09 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 1.96 108.184 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.46 172.19 55.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.694 -1.362 . . . . 0.55000000000000004 109.694 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.3 156.67 65.24 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.55 1.5 . . . . 0.46999999999999997 110.166 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.02 166.23 25.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 1.05 109.093 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.42 140.5 29.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 3.1899999999999999 109.547 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.42 125.24 34.63 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.462 -0.57 . . . . 1.0900000000000001 109.462 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.9 mt -115.19 -69.97 0.82 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.84 . . . . 1.1799999999999999 109.982 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.76 143.1 26.88 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.056 -1.027 . . . . 0.34000000000000002 110.315 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.88 115.42 6.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.272 -0.892 . . . . 2.79 109.235 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.75 0.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.204 -1.158 . . . . 0.28999999999999998 110.204 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -68.68 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.277 -1.131 . . . . 1.5600000000000001 109.802 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 51.36 3.03 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.326 -1.509 . . . . 0.28999999999999998 109.326 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.28 33.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.518 -0.989 . . . . 1.0700000000000001 108.577 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.88 125.53 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 1.0900000000000001 109.682 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.34 135.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.196 -1.038 . . . . 1.0700000000000001 108.196 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.6 pt -137.66 -178.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.395 -0.816 . . . . 1.04 110.139 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.489 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.6 tt0 -143.48 111.63 6.2 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.631 -0.877 . . . . 2.3399999999999999 108.631 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.37 -77.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.509 -1.293 . . . . 1.1799999999999999 107.509 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.81 -132.27 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.944 -1.502 . . . . 2.4700000000000002 106.944 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.9 p -104.26 53.04 0.75 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.958 -1.127 . . . . 1.8700000000000001 107.958 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -156.1 127.29 7.05 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.986 -0.746 . . . . 1.1200000000000001 108.986 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.489 ' CG1' HE21 ' A' ' 252' ' ' GLN . 55.9 mt -91.23 134.72 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 1.1499999999999999 109.344 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -136.12 170.55 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.79 . . . . 2.6299999999999999 109.857 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.73 139.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0800000000000001 109.826 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.73 124.03 14.28 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.626 -0.879 . . . . 1.0700000000000001 108.626 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.75 139.37 90.06 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 N-CA-C 110.134 -0.756 . . . . 0.48999999999999999 110.134 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -61.29 -30.48 70.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 3.5800000000000001 109.407 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 263' ' ' ARG . 0.0 OUTLIER -69.83 -9.91 56.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.41 -0.806 . . . . 4.3600000000000003 110.06 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.45 22.96 11.48 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.242 -0.911 . . . . 2.5800000000000001 109.11 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 169.57 17.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.081 -0.711 . . . . 1.05 109.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -137.11 127.89 27.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 2.2599999999999998 108.783 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.44 109.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 1.1799999999999999 109.893 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -103.34 152.63 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.54 -0.911 . . . . 1.28 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 4.1799999999999997 109.353 179.903 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.208 0.528 . . . . 2.0099999999999998 109.589 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 131.02 36.45 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.783 -0.821 . . . . 0.81999999999999995 108.783 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -102.7 153.09 20.48 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.424 -0.954 . . . . 3.7799999999999998 108.424 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.52 142.69 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -0.885 . . . . 1.0600000000000001 110.156 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -111.2 158.74 18.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.496 -1.298 . . . . 0.92000000000000004 107.496 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.3 p90 -156.21 153.69 29.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.586 -1.321 . . . . 1.01 110.45 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.5 mtm-85 -95.99 147.44 23.69 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.818 . . . . 3.3900000000000001 110.094 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 14.7 p-10 -94.31 168.55 10.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.819 . . . . 2.23 109.268 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -85.02 -2.77 58.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 2.3300000000000001 109.719 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -87.69 -23.73 24.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 4.1900000000000004 109.767 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' B' ' 234' ' ' VAL . 9.9 m-20 -163.19 142.38 6.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.1600000000000001 108.825 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -62.99 10.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.179 1.252 . . . . 1.3999999999999999 110.895 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -82.69 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.657 -1.277 . . . . 2.3100000000000001 110.372 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.405 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 97.3 m95 -75.77 -172.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.501 -0.555 . . . . 0.72999999999999998 109.501 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.06 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.229 -1.026 . . . . 1.96 108.229 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.48 172.19 55.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.697 -1.361 . . . . 0.56000000000000005 109.697 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.31 156.54 65.79 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.578 1.519 . . . . 0.46999999999999997 110.205 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.49 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 1.05 109.124 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.55 140.57 29.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.092 -1.005 . . . . 3.1899999999999999 109.495 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 17.8 tp -88.55 125.26 34.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.391 -0.596 . . . . 1.0900000000000001 109.391 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.04 -70.08 0.82 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.281 -0.887 . . . . 1.1799999999999999 110.082 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -91.72 143.17 26.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.096 -1.003 . . . . 0.34999999999999998 110.269 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.92 115.39 6.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 2.7999999999999998 109.184 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.65 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.914 -1.136 . . . . 0.29999999999999999 110.301 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -68.76 -156.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 1.5600000000000001 109.774 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.72 51.38 3.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.306 -1.518 . . . . 0.28999999999999998 109.306 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.17 33.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.991 . . . . 1.0700000000000001 108.575 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.86 125.66 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 1.0900000000000001 109.598 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.42 135.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.194 -1.039 . . . . 1.0800000000000001 108.194 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.5 pt -137.7 -178.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.309 -0.869 . . . . 1.04 110.206 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.494 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.4 tt0 -143.5 111.45 6.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.682 -0.859 . . . . 2.3399999999999999 108.682 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.36 -77.39 0.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.519 -1.289 . . . . 1.1799999999999999 107.519 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.8 -132.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.905 -1.517 . . . . 2.4700000000000002 106.905 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 5.8 p -104.25 53.07 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.977 -1.12 . . . . 1.8600000000000001 107.977 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -156.1 127.23 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.963 -0.754 . . . . 1.1200000000000001 108.963 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.494 ' CG1' HE21 ' B' ' 252' ' ' GLN . 55.4 mt -91.08 134.77 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 1.1499999999999999 109.369 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -136.15 170.57 15.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 2.6400000000000001 109.845 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 8.8 t -99.76 139.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.455 -0.778 . . . . 1.0800000000000001 109.821 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.9 t -136.75 123.92 14.18 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.627 -0.879 . . . . 1.0800000000000001 108.627 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.6 139.46 90.29 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 110.006 -0.806 . . . . 0.48999999999999999 110.006 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.41 -30.51 70.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 3.5800000000000001 109.394 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.0 OUTLIER -69.78 -9.91 56.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 110.07 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.54 23.05 11.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.295 -0.878 . . . . 2.5800000000000001 109.053 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.44 169.37 17.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.1 -0.704 . . . . 1.05 109.1 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -136.96 127.89 27.5 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.752 -0.833 . . . . 2.2599999999999998 108.752 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.1 mm -88.48 109.55 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.91 . . . . 1.1799999999999999 109.919 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.39 152.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.491 -0.929 . . . . 1.27 108.491 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -93.32 137.34 32.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.388 -0.82 . . . . 4.1799999999999997 109.342 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.999 -1.001 . . . . 2.0499999999999998 109.504 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.762 -0.829 . . . . 2.0099999999999998 108.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -120.91 141.14 50.92 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.618 -0.676 . . . . 0.81999999999999995 109.924 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -113.29 157.76 21.4 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.523 -1.288 . . . . 3.79 107.523 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.19 143.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.066 -1.021 . . . . 1.05 110.627 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -112.88 157.79 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.654 -1.239 . . . . 0.92000000000000004 107.654 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 14.6 p90 -157.48 147.35 20.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.701 -1.25 . . . . 1.01 110.144 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.64 142.52 27.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.054 -1.029 . . . . 3.3999999999999999 109.425 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.41 166.55 12.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 2.23 109.369 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.3 p -85.81 -10.15 55.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.921 . . . . 2.3199999999999998 109.635 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.44 36.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.202 -0.936 . . . . 4.1799999999999997 109.44 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 234' ' ' VAL . 3.3 p30 -159.23 128.04 3.05 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.31 -0.869 . . . . 2.1600000000000001 109.105 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.62 9.22 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.805 1.004 . . . . 1.3899999999999999 110.328 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 232' ' ' ASP . 4.4 t -84.06 156.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.013 -1.055 . . . . 2.3100000000000001 109.764 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.05 169.75 16.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.71999999999999997 109.611 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.3 mmtt -119.36 157.25 28.54 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.644 -0.873 . . . . 1.96 108.644 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.12 174.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.55000000000000004 109.296 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.7 155.76 68.72 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.545 1.497 . . . . 0.46999999999999997 110.693 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.67 171.91 13.79 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.925 -0.769 . . . . 1.05 108.925 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -93.91 137.39 33.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.049 -1.032 . . . . 3.1899999999999999 109.707 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.12 121.4 31.41 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.594 -0.691 . . . . 1.0900000000000001 109.28 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.16 -68.94 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.309 -0.87 . . . . 1.1799999999999999 110.499 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -95.42 147.35 23.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.002 -1.061 . . . . 0.34000000000000002 110.353 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.3 119.42 7.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.374 -0.829 . . . . 2.79 108.963 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.0 -109.2 0.32 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.784 -1.198 . . . . 0.28999999999999998 110.397 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.88 -150.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -1.12 . . . . 1.5600000000000001 109.488 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.5 56.18 2.47 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.196 -1.562 . . . . 0.28999999999999998 109.196 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.49 146.72 22.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.364 -1.08 . . . . 1.0700000000000001 109.643 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.05 121.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.672 -0.862 . . . . 1.0900000000000001 108.672 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 59.4 t -84.73 132.16 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.375 -0.972 . . . . 1.0700000000000001 108.375 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -137.96 178.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 1.04 109.977 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.404 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.1 tt0 -142.33 110.2 5.86 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.631 -0.877 . . . . 2.3399999999999999 108.631 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -91.12 -78.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.357 -1.349 . . . . 1.1799999999999999 107.357 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.59 -131.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.762 -1.569 . . . . 2.4700000000000002 106.762 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 58.8 m -105.35 54.5 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.114 -1.069 . . . . 1.8700000000000001 108.114 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.8 m-20 -157.08 127.33 6.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 1.1200000000000001 109.312 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.424 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 79.8 mt -94.18 134.26 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 1.1499999999999999 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.22 172.53 12.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 2.6299999999999999 109.812 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.38 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 1.0800000000000001 109.404 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.62 131.75 16.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.798 . . . . 1.0700000000000001 108.909 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.49 142.98 92.36 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 N-CA-C 109.545 -0.983 . . . . 0.48999999999999999 109.545 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -55.84 -34.69 65.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 3.5800000000000001 108.641 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -65.35 -10.83 36.33 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.666 -0.697 . . . . 4.3600000000000003 110.76 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.73 17.68 12.71 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.278 -1.008 . . . . 2.5800000000000001 108.278 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.1 168.03 20.58 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.316 -0.624 . . . . 1.05 109.316 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -140.47 126.85 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.205 -0.934 . . . . 2.2599999999999998 109.171 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.3 mm -87.54 108.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.242 -0.911 . . . . 1.1799999999999999 109.486 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.18 152.92 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.524 -0.917 . . . . 1.28 108.524 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 4.1799999999999997 109.934 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 108.708 -0.849 . . . . 2.0099999999999998 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.03 141.06 51.1 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.63 -0.668 . . . . 0.81999999999999995 109.796 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -113.31 157.75 21.41 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.559 -1.274 . . . . 3.7799999999999998 107.559 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.1 143.83 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.022 -1.049 . . . . 1.0600000000000001 110.776 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.83 157.77 20.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.667 -1.235 . . . . 0.92000000000000004 107.667 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 15.0 p90 -157.4 147.38 20.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.292 . . . . 1.01 110.161 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.62 142.42 27.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.104 -0.997 . . . . 3.3900000000000001 109.502 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -92.41 166.46 12.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.408 -0.808 . . . . 2.23 109.394 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.6 p -85.68 -10.25 55.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.219 -0.925 . . . . 2.3300000000000001 109.651 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.37 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.099 -1.0 . . . . 4.1900000000000004 109.442 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 3.3 p30 -159.23 127.88 3.0 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.083 -1.011 . . . . 2.1600000000000001 109.195 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -67.56 9.34 0.34 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.74 0.96 . . . . 1.3999999999999999 110.364 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 4.4 t -84.05 156.1 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.967 -1.083 . . . . 2.3100000000000001 109.809 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -72.97 169.74 16.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.371 -0.83 . . . . 0.72999999999999998 109.666 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mmtt -119.4 157.2 28.69 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.7 -0.852 . . . . 1.96 108.7 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.14 174.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.337 -1.505 . . . . 0.56000000000000005 109.337 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -67.65 155.8 68.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.5 1.466 . . . . 0.46999999999999997 110.648 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.61 171.95 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.902 -0.777 . . . . 1.05 108.902 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -93.94 137.44 33.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.133 -0.979 . . . . 3.1899999999999999 109.684 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.22 121.39 31.47 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.542 -0.724 . . . . 1.0900000000000001 109.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.17 -68.97 0.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.235 -0.916 . . . . 1.1799999999999999 110.462 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -95.38 147.41 23.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.056 -1.027 . . . . 0.34999999999999998 110.339 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.33 119.43 7.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.802 . . . . 2.7999999999999998 109.004 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.05 -109.25 0.32 Allowed Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.738 -1.22 . . . . 0.29999999999999999 110.336 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.9 -150.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -1.137 . . . . 1.5600000000000001 109.497 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.47 56.23 2.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.274 -1.531 . . . . 0.28999999999999998 109.274 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.5 146.82 22.74 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.342 -1.093 . . . . 1.0700000000000001 109.559 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.12 121.13 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.601 -0.889 . . . . 1.0900000000000001 108.601 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 60.3 t -84.81 132.06 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 1.0800000000000001 108.416 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -137.8 178.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.454 -0.779 . . . . 1.04 110.035 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.403 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.1 tt0 -142.31 110.28 5.89 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.662 -0.866 . . . . 2.3399999999999999 108.662 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -91.26 -78.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.307 -1.368 . . . . 1.1799999999999999 107.307 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -80.53 -131.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.731 -1.581 . . . . 2.4700000000000002 106.731 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 58.8 m -105.33 54.52 0.7 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.208 -1.034 . . . . 1.8600000000000001 108.208 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.8 m-20 -157.06 127.33 6.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.474 -0.766 . . . . 1.1200000000000001 109.242 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.417 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 79.4 mt -94.11 134.2 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 1.1499999999999999 109.51 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.08 172.48 12.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.324 -0.86 . . . . 2.6400000000000001 109.843 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.35 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.459 -0.776 . . . . 1.0800000000000001 109.407 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.64 131.8 16.13 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 1.0800000000000001 108.918 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.4 142.93 92.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 N-CA-C 109.506 -0.998 . . . . 0.48999999999999999 109.506 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -55.8 -34.76 65.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.853 -1.155 . . . . 3.5800000000000001 108.717 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -65.27 -10.92 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.649 -0.705 . . . . 4.3600000000000003 110.724 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.7 17.76 12.72 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.257 -1.016 . . . . 2.5800000000000001 108.257 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.07 168.1 20.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.259 -0.645 . . . . 1.05 109.259 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -140.55 126.82 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.249 -0.907 . . . . 2.2599999999999998 109.154 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.1 mm -87.51 108.38 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.887 . . . . 1.1799999999999999 109.556 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.23 152.8 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.49 -0.93 . . . . 1.27 108.49 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -91.4 143.67 26.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 4.1799999999999997 109.94 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.966 -1.016 . . . . 2.0499999999999998 109.541 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.001 -0.74 . . . . 2.0099999999999998 109.001 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -128.18 132.77 48.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.105 -0.702 . . . . 0.81999999999999995 109.105 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.37 159.47 15.7 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.382 -0.97 . . . . 3.79 108.382 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.83 141.68 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.156 -0.965 . . . . 1.05 110.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.68 151.28 27.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.55 -1.278 . . . . 0.92000000000000004 107.55 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.0 p90 -156.43 151.21 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.651 -1.281 . . . . 1.01 110.441 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -92.72 141.68 28.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.589 -0.694 . . . . 3.3999999999999999 109.577 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 5.0 p30 -93.79 165.72 12.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.423 -0.798 . . . . 2.23 109.044 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.99 -0.06 47.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 2.3199999999999998 109.162 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 10.1 mmm180 -90.01 -20.96 22.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.387 -0.82 . . . . 4.1799999999999997 109.205 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.7 m-20 -161.03 134.05 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.777 -0.823 . . . . 2.1600000000000001 108.777 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.73 8.86 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 120.727 0.951 . . . . 1.3899999999999999 110.208 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.2 t -84.06 159.18 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.034 -1.041 . . . . 2.3100000000000001 109.921 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.09 164.88 26.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 0.71999999999999997 108.959 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 237' ' ' GLY . 32.5 tttp -120.01 158.25 27.17 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.395 -0.816 . . . . 1.96 109.652 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.61 165.83 0.03 OUTLIER Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.283 -1.127 . . . . 0.55000000000000004 110.283 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.97 163.25 36.42 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.705 1.603 . . . . 0.46999999999999997 110.452 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.17 178.45 7.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 1.05 109.187 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.09 137.19 35.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.154 -0.966 . . . . 3.1899999999999999 109.393 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.9 tp -87.88 124.64 33.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.413 -0.805 . . . . 1.0900000000000001 109.238 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.58 -74.01 0.62 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.459 -0.776 . . . . 1.1799999999999999 109.99 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.532 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.0 t90 -92.32 141.69 28.27 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.34000000000000002 109.719 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.85 116.91 7.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.906 . . . . 2.79 109.138 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.13 -105.04 0.23 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.905 -1.14 . . . . 0.28999999999999998 110.308 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -62.39 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.104 . . . . 1.5600000000000001 109.877 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 49.86 2.79 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.773 -1.331 . . . . 0.28999999999999998 109.773 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.76 154.11 39.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -1.126 . . . . 1.0700000000000001 108.696 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.06 122.79 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 1.0900000000000001 109.747 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.72 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.963 -1.125 . . . . 1.0700000000000001 107.963 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.43 174.79 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 1.04 110.033 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.4 109.4 5.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.147 -1.057 . . . . 2.3399999999999999 108.147 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.43 -79.75 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 1.1799999999999999 107.574 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.5 -128.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.636 -1.616 . . . . 2.4700000000000002 106.636 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 13.0 p -105.89 53.38 0.71 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.284 -1.006 . . . . 1.8700000000000001 108.284 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.7 m-20 -155.69 129.85 8.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 1.1200000000000001 109.487 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.418 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.6 mt -95.11 139.86 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.461 -0.774 . . . . 1.1499999999999999 110.07 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -140.32 162.87 34.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.416 -0.802 . . . . 2.6299999999999999 109.462 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.97 141.8 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.215 -0.928 . . . . 1.0800000000000001 108.857 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.83 130.77 18.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.375 -0.828 . . . . 1.0700000000000001 109.452 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.66 141.37 97.57 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.688 -0.928 . . . . 0.48999999999999999 109.688 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.26 -29.48 69.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 3.5800000000000001 109.727 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -70.04 -12.0 61.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.865 . . . . 4.3600000000000003 111.042 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.83 28.06 8.15 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.153 -0.967 . . . . 2.5800000000000001 109.273 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.09 168.87 18.81 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.801 -0.814 . . . . 1.05 108.801 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.07 126.94 19.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.224 -0.922 . . . . 2.2599999999999998 109.392 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.52 109.73 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.343 -0.848 . . . . 1.1799999999999999 109.67 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.31 149.41 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.856 . . . . 4.1799999999999997 109.806 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.032 -0.729 . . . . 2.0099999999999998 109.032 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -128.23 132.86 48.76 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.81999999999999995 109.071 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -104.45 159.43 15.74 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.417 -0.957 . . . . 3.7799999999999998 108.417 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.8 141.67 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 1.0600000000000001 110.403 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.64 151.31 27.82 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.617 -1.253 . . . . 0.92000000000000004 107.617 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.1 p90 -156.46 151.23 25.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.752 -1.218 . . . . 1.01 110.454 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -92.76 141.62 28.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.569 -0.707 . . . . 3.3900000000000001 109.595 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 4.9 p30 -93.79 165.78 12.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.441 -0.787 . . . . 2.23 109.075 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.93 -0.24 47.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 2.3300000000000001 109.182 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 10.1 mmm180 -89.93 -21.01 22.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 4.1900000000000004 109.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.7 m-20 -161.08 134.05 4.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.787 -0.82 . . . . 2.1600000000000001 108.787 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.61 8.69 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 120.765 0.977 . . . . 1.3999999999999999 110.169 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.3 t -84.01 159.17 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.009 -1.057 . . . . 2.3100000000000001 109.958 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.04 164.95 26.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.45 -0.781 . . . . 0.72999999999999998 109.146 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' B' ' 237' ' ' GLY . 32.6 tttp -120.0 158.24 27.19 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.398 -0.814 . . . . 1.96 109.607 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.55 165.76 0.02 OUTLIER Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.296 -1.122 . . . . 0.56000000000000005 110.296 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.95 163.26 36.38 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.658 1.572 . . . . 0.46999999999999997 110.583 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.2 178.38 7.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 1.05 109.235 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.02 137.1 35.57 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 3.1899999999999999 109.417 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.74 124.64 33.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.342 -0.849 . . . . 1.0900000000000001 109.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.65 -73.93 0.63 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.465 -0.772 . . . . 1.1799999999999999 109.983 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.418 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.0 t90 -92.28 141.6 28.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.2 -0.937 . . . . 0.34999999999999998 109.844 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.76 117.04 7.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 2.7999999999999998 109.047 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.17 -105.03 0.23 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.876 -1.155 . . . . 0.29999999999999999 110.241 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -62.53 -158.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 1.5600000000000001 109.819 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.56 49.85 2.78 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.859 -1.296 . . . . 0.28999999999999998 109.859 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.04 38.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -1.086 . . . . 1.0700000000000001 108.614 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.04 122.83 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 1.0900000000000001 109.752 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.71 138.42 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.93 -1.137 . . . . 1.0800000000000001 107.93 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.9 pt -141.54 174.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 1.04 109.956 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.38 109.32 5.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.235 -1.024 . . . . 2.3399999999999999 108.235 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.4 -79.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.483 -1.303 . . . . 1.1799999999999999 107.483 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.51 -128.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.592 -1.633 . . . . 2.4700000000000002 106.592 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 13.0 p -105.8 53.21 0.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.267 -1.012 . . . . 1.8600000000000001 108.267 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.6 m-20 -155.63 129.89 8.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.435 -0.79 . . . . 1.1200000000000001 109.475 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.8 mt -95.13 139.83 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.434 -0.791 . . . . 1.1499999999999999 110.076 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -140.29 162.87 34.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.417 -0.802 . . . . 2.6400000000000001 109.491 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.93 141.84 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 1.0800000000000001 108.916 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.79 130.78 18.84 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 1.0800000000000001 109.444 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.72 141.39 97.7 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 N-CA-C 109.687 -0.928 . . . . 0.48999999999999999 109.687 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.17 -29.62 69.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 3.5800000000000001 109.68 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -69.96 -12.05 61.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 4.3600000000000003 111.117 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.77 28.08 8.14 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.08 -1.012 . . . . 2.5800000000000001 109.304 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.11 168.85 18.87 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.834 -0.802 . . . . 1.05 108.834 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.02 126.89 19.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.142 -0.974 . . . . 2.2599999999999998 109.369 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.49 109.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 1.1799999999999999 109.749 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.27 149.36 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.472 -0.936 . . . . 1.27 108.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -90.3 144.86 25.44 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.358 -0.839 . . . . 4.1799999999999997 109.879 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.014 -0.993 . . . . 2.0499999999999998 109.252 179.812 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.038 -0.727 . . . . 2.0099999999999998 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.43 131.87 38.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.563 -0.711 . . . . 0.81999999999999995 109.559 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.82 19.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.604 -1.258 . . . . 3.79 107.604 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -139.93 140.54 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 1.05 110.311 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.97 154.58 20.89 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.352 -1.351 . . . . 0.92000000000000004 107.352 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.8 p90 -155.34 153.34 30.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.55 -1.344 . . . . 1.01 110.645 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -96.03 133.24 40.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.448 -0.783 . . . . 3.3999999999999999 109.323 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -95.58 177.23 5.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 2.23 109.106 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 p -88.06 -11.63 46.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 2.3199999999999998 108.932 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 231' ' ' ARG . 11.3 mpt_? -81.49 -13.37 58.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 4.1799999999999997 109.124 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 15.6 p-10 -161.32 129.78 2.96 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.17 -0.956 . . . . 2.1600000000000001 109.552 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.13 0.62 4.92 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 N-CA-C 109.574 -0.972 . . . . 1.3899999999999999 109.574 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.44 160.83 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 2.3100000000000001 110.215 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -67.46 163.35 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.523 -0.917 . . . . 0.71999999999999997 108.523 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 40.7 tttp -119.95 164.79 15.54 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.267 -0.896 . . . . 1.96 109.748 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.02 169.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.458 -1.057 . . . . 0.55000000000000004 110.458 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.15 161.02 47.53 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.985 1.79 . . . . 0.46999999999999997 110.752 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.18 175.85 9.31 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.67 -0.863 . . . . 1.05 108.67 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -94.03 139.38 31.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.954 -1.091 . . . . 3.1899999999999999 109.127 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.9 tp -89.33 125.17 35.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.898 . . . . 1.0900000000000001 109.73 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.7 mt -117.49 -77.58 0.57 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.502 -0.749 . . . . 1.1799999999999999 110.719 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -93.36 136.74 33.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.993 -1.067 . . . . 0.34000000000000002 110.458 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.5 127.2 13.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.85 . . . . 2.79 109.249 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.64 -105.33 0.24 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.549 -1.42 . . . . 0.28999999999999998 109.549 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 245' ' ' GLY . 25.5 mt-10 -60.09 -154.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 1.5600000000000001 109.149 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.0 45.97 2.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.922 -1.671 . . . . 0.28999999999999998 108.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.73 141.44 18.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.965 . . . . 1.0700000000000001 108.867 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.29 144.26 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.116 -0.99 . . . . 1.0900000000000001 108.931 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 147.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.101 -0.999 . . . . 1.0700000000000001 109.993 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.26 178.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.749 . . . . 1.04 109.488 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.531 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.4 tt0 -144.72 110.86 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.241 -1.022 . . . . 2.3399999999999999 108.241 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.94 -78.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.551 -1.277 . . . . 1.1799999999999999 107.551 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -139.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.713 -1.588 . . . . 2.4700000000000002 106.713 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 60.2 p -97.22 53.79 1.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.009 -1.108 . . . . 1.8700000000000001 108.009 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 2.6 m-20 -155.14 126.22 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.949 -0.76 . . . . 1.1200000000000001 108.949 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.531 ' CG1' HE21 ' A' ' 252' ' ' GLN . 41.3 mt -92.43 135.46 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 1.1499999999999999 109.488 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.85 169.93 16.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.426 -0.797 . . . . 2.6299999999999999 109.562 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.15 139.99 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 1.0800000000000001 109.532 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.6 126.75 18.27 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.826 -0.805 . . . . 1.0700000000000001 108.826 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.06 141.89 96.56 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 N-CA-C 110.039 -0.793 . . . . 0.48999999999999999 110.039 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.48 -34.09 66.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.315 -0.866 . . . . 3.5800000000000001 109.138 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -70.12 -8.2 47.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 4.3600000000000003 110.496 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.48 22.29 11.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.293 -0.879 . . . . 2.5800000000000001 109.113 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.16 33.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.54 -0.725 . . . . 1.05 109.067 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -139.06 132.01 29.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.309 -0.87 . . . . 2.2599999999999998 108.957 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.5 107.36 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.372 -0.83 . . . . 1.1799999999999999 109.579 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 36.8 mm -103.79 160.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.466 -0.771 . . . . 1.28 109.275 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.407 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.768 . . . . 4.1799999999999997 109.405 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.056 -0.72 . . . . 2.0099999999999998 109.056 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.46 131.87 38.6 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.561 -0.712 . . . . 0.81999999999999995 109.454 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.9 19.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.572 -1.27 . . . . 3.7799999999999998 107.572 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -140.13 140.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.239 -0.913 . . . . 1.0600000000000001 110.236 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.17 154.55 21.03 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.317 -1.364 . . . . 0.92000000000000004 107.317 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.9 p90 -155.3 153.35 30.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.599 -1.313 . . . . 1.01 110.701 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -95.96 133.26 40.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.447 -0.783 . . . . 3.3900000000000001 109.34 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -95.6 177.27 5.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 2.23 109.102 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 4.5 p -88.17 -11.69 46.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.077 -1.014 . . . . 2.3300000000000001 108.857 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' B' ' 231' ' ' ARG . 11.3 mpt_? -81.32 -13.54 58.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 4.1900000000000004 109.131 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 16.0 p-10 -161.24 129.57 2.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.196 -0.94 . . . . 2.1600000000000001 109.555 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.9 0.45 4.99 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 N-CA-C 109.586 -0.967 . . . . 1.3999999999999999 109.586 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.44 160.81 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 2.3100000000000001 110.255 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -67.38 163.46 20.72 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.521 -0.918 . . . . 0.72999999999999998 108.521 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 237' ' ' GLY . 40.9 tttp -119.94 164.65 15.75 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.306 -0.871 . . . . 1.96 109.705 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.14 169.53 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.447 -1.061 . . . . 0.56000000000000005 110.447 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.29 161.08 47.3 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.893 1.729 . . . . 0.46999999999999997 110.695 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 175.88 9.28 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.676 -0.861 . . . . 1.05 108.676 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -93.85 139.4 30.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.017 -1.052 . . . . 3.1899999999999999 109.224 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.8 tp -89.46 125.15 35.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.182 -0.949 . . . . 1.0900000000000001 109.724 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 23.5 mt -117.53 -77.53 0.57 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.486 -0.759 . . . . 1.1799999999999999 110.747 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -93.4 136.66 33.46 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.16 -0.962 . . . . 0.34999999999999998 110.408 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.33 127.27 13.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.228 -0.92 . . . . 2.7999999999999998 109.274 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.66 -105.39 0.24 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.601 -1.4 . . . . 0.29999999999999999 109.601 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 245' ' ' GLY . 25.6 mt-10 -60.03 -154.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -1.108 . . . . 1.5600000000000001 109.121 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 45.93 2.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.961 -1.656 . . . . 0.28999999999999998 108.961 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.5 19.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.969 . . . . 1.0700000000000001 108.88 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.46 144.1 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -0.997 . . . . 1.0900000000000001 108.925 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.46 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 1.0800000000000001 110.008 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.27 178.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 1.04 109.507 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.532 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -144.56 110.76 5.5 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 2.3399999999999999 108.31 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -88.91 -78.89 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.525 -1.287 . . . . 1.1799999999999999 107.525 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' B' ' 254' ' ' ASN . 1.0 OUTLIER -81.82 -139.01 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.812 -1.551 . . . . 2.4700000000000002 106.812 177.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 60.2 p -97.17 53.78 1.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.005 -1.109 . . . . 1.8600000000000001 108.005 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' B' ' 255' ' ' SER . 2.6 m-20 -155.14 126.15 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.983 -0.747 . . . . 1.1200000000000001 108.983 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CG1' HE21 ' B' ' 252' ' ' GLN . 41.1 mt -92.33 135.48 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 1.1499999999999999 109.508 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.93 169.88 17.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.586 -0.696 . . . . 2.6400000000000001 109.485 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.17 140.07 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.419 -0.801 . . . . 1.0800000000000001 109.466 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.64 126.86 18.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.73 -0.841 . . . . 1.0800000000000001 108.73 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.22 141.97 97.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 110.035 -0.794 . . . . 0.48999999999999999 110.035 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -56.47 -34.13 66.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.257 -0.902 . . . . 3.5800000000000001 109.153 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.99 -8.29 47.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.43 -0.793 . . . . 4.3600000000000003 110.514 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.3 22.12 11.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.285 -0.884 . . . . 2.5800000000000001 109.137 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.63 163.21 33.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.089 -0.708 . . . . 1.05 109.089 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -139.16 131.98 29.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.281 -0.887 . . . . 2.2599999999999998 108.92 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.48 107.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 1.1799999999999999 109.487 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 37.1 mm -103.84 160.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 1.27 109.16 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.2 OUTLIER -93.74 141.54 28.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.487 -0.758 . . . . 4.1799999999999997 109.438 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.01 -1.056 . . . . 2.0499999999999998 109.389 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.3 m-20 . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.441 -0.577 . . . . 2.0099999999999998 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -133.38 153.2 51.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.446 -0.783 . . . . 0.81999999999999995 109.024 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -117.55 149.81 40.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.737 -1.208 . . . . 3.79 107.737 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.02 139.98 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.864 . . . . 1.05 110.085 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -109.22 154.45 22.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.499 -1.297 . . . . 0.92000000000000004 107.499 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 16.3 p90 -157.01 160.24 38.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.613 -1.304 . . . . 1.01 110.399 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -93.2 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 3.3999999999999999 109.844 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.72 171.88 8.71 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.833 -0.802 . . . . 2.23 108.833 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.9 p -89.45 -9.54 49.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 2.3199999999999998 109.458 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -87.04 -16.81 34.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 4.1799999999999997 109.632 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -162.5 134.1 3.91 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 2.1600000000000001 108.782 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.84 12.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 120.988 1.125 . . . . 1.3899999999999999 110.98 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 8.6 p -84.64 161.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.699 -1.251 . . . . 2.3100000000000001 110.029 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.401 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 98.0 m95 -75.57 163.34 27.46 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.019 -0.734 . . . . 0.71999999999999997 109.019 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.42 -162.51 0.92 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.299 -0.875 . . . . 1.96 108.764 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.19 176.51 51.62 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.639 -1.385 . . . . 0.55000000000000004 109.639 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -68.96 157.7 60.84 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.675 1.583 . . . . 0.46999999999999997 110.528 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.96 170.29 16.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.746 -0.835 . . . . 1.05 108.746 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.58 142.44 27.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 3.1899999999999999 109.702 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.27 119.32 30.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.73 -0.606 . . . . 1.0900000000000001 109.926 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -109.71 -72.63 0.71 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.331 -0.856 . . . . 1.1799999999999999 109.814 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.14 146.15 23.95 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.153 -0.967 . . . . 0.34000000000000002 110.463 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -147.28 120.83 9.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.443 -0.785 . . . . 2.79 108.917 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -107.08 0.27 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.794 -1.194 . . . . 0.28999999999999998 110.477 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -69.22 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 1.5600000000000001 110.126 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.32 46.17 2.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.369 -1.493 . . . . 0.28999999999999998 109.369 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.15 33.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.495 -1.003 . . . . 1.0700000000000001 108.525 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.65 138.3 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.06 -1.025 . . . . 1.0900000000000001 109.784 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.76 139.39 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.385 -0.968 . . . . 1.0700000000000001 108.385 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.2 pt -141.53 178.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 1.04 110.059 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.36 111.18 5.73 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.779 -0.823 . . . . 2.3399999999999999 108.779 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.78 -79.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.483 -1.302 . . . . 1.1799999999999999 107.483 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -79.38 -131.33 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.914 -1.513 . . . . 2.4700000000000002 106.914 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.432 ' N ' ' ND2' ' A' ' 254' ' ' ASN . 12.7 p -105.61 54.8 0.69 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.372 -0.973 . . . . 1.8700000000000001 108.372 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -156.31 126.32 6.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 1.1200000000000001 109.034 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -92.68 135.24 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 1.1499999999999999 109.448 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.97 168.64 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 2.6299999999999999 109.662 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.98 142.26 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.324 -0.86 . . . . 1.0800000000000001 109.332 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 33.5 t -135.89 131.17 18.89 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.437 -0.789 . . . . 1.0700000000000001 109.086 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.29 146.43 96.53 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 120.72 0.947 . . . . 0.48999999999999999 110.458 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -59.25 -32.34 69.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.564 -0.902 . . . . 3.5800000000000001 108.564 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.584 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.9 mtt-85 -70.68 -9.18 56.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.935 . . . . 4.3600000000000003 110.853 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.56 21.09 12.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.176 -0.952 . . . . 2.5800000000000001 109.776 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.25 22.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.412 -0.805 . . . . 1.05 109.959 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -140.5 124.93 17.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.58 -0.896 . . . . 2.2599999999999998 108.58 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.53 112.47 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.133 -0.979 . . . . 1.1799999999999999 110.159 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.94 147.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.74 -1.207 . . . . 1.28 107.74 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 4.1799999999999997 109.767 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.413 -0.588 . . . . 2.0099999999999998 109.413 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -133.34 153.23 51.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.773 . . . . 0.81999999999999995 109.032 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -117.63 149.77 40.14 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.695 -1.224 . . . . 3.7799999999999998 107.695 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.03 139.89 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.844 . . . . 1.0600000000000001 110.062 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.19 154.43 22.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.543 -1.28 . . . . 0.92000000000000004 107.543 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 16.0 p90 -156.93 160.22 38.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.804 -1.185 . . . . 1.01 110.387 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -93.16 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.744 . . . . 3.3900000000000001 109.839 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.79 171.91 8.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 2.23 108.846 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 30.5 p -89.5 -9.56 49.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 2.3300000000000001 109.436 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.94 -16.93 34.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 4.1900000000000004 109.693 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.4 m-20 -162.41 134.0 3.91 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.93 . . . . 2.1600000000000001 108.811 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.8 12.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 120.873 1.049 . . . . 1.3999999999999999 110.957 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.522 ' H ' ' C ' ' B' ' 232' ' ' ASP . 8.6 p -84.68 161.3 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.677 -1.264 . . . . 2.3100000000000001 109.976 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.401 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 97.9 m95 -75.4 163.23 27.65 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.077 -0.712 . . . . 0.72999999999999998 109.077 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.33 -162.63 0.92 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.289 -0.882 . . . . 1.96 108.819 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.04 176.55 51.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.76 -1.336 . . . . 0.56000000000000005 109.76 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -69.12 157.6 61.02 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.74 1.627 . . . . 0.46999999999999997 110.515 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.95 170.3 16.28 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.76 -0.83 . . . . 1.05 108.76 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.56 142.51 27.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.038 -1.039 . . . . 3.1899999999999999 109.647 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.39 119.35 30.6 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.656 -0.653 . . . . 1.0900000000000001 109.797 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.65 -72.69 0.71 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.317 -0.865 . . . . 1.1799999999999999 109.851 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.17 146.17 23.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.158 -0.964 . . . . 0.34999999999999998 110.411 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -147.29 120.83 9.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.398 -0.814 . . . . 2.7999999999999998 108.866 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.79 -107.01 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.711 -1.233 . . . . 0.29999999999999999 110.439 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.33 -153.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -1.027 . . . . 1.5600000000000001 110.125 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.29 46.06 2.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.416 -1.473 . . . . 0.28999999999999998 109.416 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.07 151.18 34.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.499 -1.0 . . . . 1.0700000000000001 108.487 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.7 m -146.58 138.25 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.0900000000000001 109.785 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.73 139.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.395 -0.965 . . . . 1.0800000000000001 108.395 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.52 178.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 1.04 110.055 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.48 111.17 5.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.766 -0.828 . . . . 2.3399999999999999 108.766 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.8 -79.84 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.47 -1.308 . . . . 1.1799999999999999 107.47 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 255' ' ' SER . 0.3 OUTLIER -79.37 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.911 -1.514 . . . . 2.4700000000000002 106.911 177.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.433 ' N ' ' ND2' ' B' ' 254' ' ' ASN . 12.8 p -105.52 54.82 0.69 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.335 -0.987 . . . . 1.8600000000000001 108.335 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -156.31 126.33 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 1.1200000000000001 109.064 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.6 mt -92.68 135.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.297 -0.877 . . . . 1.1499999999999999 109.461 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -138.99 168.56 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.865 . . . . 2.6400000000000001 109.677 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.94 142.36 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.397 -0.814 . . . . 1.0800000000000001 109.283 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.92 131.17 18.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.373 -0.83 . . . . 1.0800000000000001 109.179 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.3 146.53 96.32 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 120.692 0.928 . . . . 0.48999999999999999 110.412 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -59.34 -32.29 69.96 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.61 -0.885 . . . . 3.5800000000000001 108.61 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.9 mtt-85 -70.63 -9.18 56.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.271 -0.893 . . . . 4.3600000000000003 110.812 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.47 20.91 12.34 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.243 -0.911 . . . . 2.5800000000000001 109.769 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.15 167.25 22.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.439 -0.788 . . . . 1.05 109.9 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -140.56 124.89 17.67 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.61 -0.885 . . . . 2.2599999999999998 108.61 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.46 112.37 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.235 -0.916 . . . . 1.1799999999999999 110.22 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.95 147.12 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.638 -1.245 . . . . 1.27 107.638 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.62 140.79 29.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 4.1799999999999997 109.741 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.997 -1.002 . . . . 2.0499999999999998 109.353 179.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.988 -0.745 . . . . 2.0099999999999998 108.988 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.2 135.28 40.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.389 -0.819 . . . . 0.81999999999999995 109.299 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -103.47 157.98 16.66 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.839 -1.171 . . . . 3.79 107.839 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.33 138.68 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.026 -1.046 . . . . 1.05 110.646 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -111.03 151.87 27.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.724 -1.213 . . . . 0.92000000000000004 107.724 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.0 p90 -158.3 154.65 27.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.671 -1.268 . . . . 1.01 110.376 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.05 152.24 18.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.534 -0.729 . . . . 3.3999999999999999 109.651 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.67 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 2.23 108.82 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 58.0 m -79.25 -2.83 43.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.996 . . . . 2.3199999999999998 109.333 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.89 20.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.299 -0.876 . . . . 4.1799999999999997 109.844 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.3 m-20 -162.87 144.51 7.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.1600000000000001 109.067 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.08 15.75 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.061 1.174 . . . . 1.3899999999999999 110.643 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.522 ' H ' ' C ' ' A' ' 232' ' ' ASP . 33.9 m -83.24 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.799 -1.188 . . . . 2.3100000000000001 110.006 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -63.97 164.84 9.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.71999999999999997 109.358 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.2 tttp -119.41 158.07 26.93 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.38 -0.825 . . . . 1.96 108.893 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.01 165.38 0.02 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.281 -1.127 . . . . 0.55000000000000004 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.2 157.67 58.66 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.552 1.501 . . . . 0.46999999999999997 110.289 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.32 169.02 18.53 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.927 -0.768 . . . . 1.05 108.927 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.22 142.72 26.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 3.1899999999999999 109.334 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.0 tp -87.6 128.44 35.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.491 -0.756 . . . . 1.0900000000000001 110.179 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.0 -76.15 0.58 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.36 -0.837 . . . . 1.1799999999999999 109.749 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -93.07 142.6 27.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.154 -0.966 . . . . 0.34000000000000002 110.121 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.66 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.285 -0.884 . . . . 2.79 108.744 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.35 -107.32 0.28 Allowed Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.792 -1.194 . . . . 0.28999999999999998 110.184 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.8 -150.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 1.5600000000000001 109.644 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 49.98 3.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.354 -1.498 . . . . 0.28999999999999998 109.354 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.94 150.15 33.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.389 -1.065 . . . . 1.0700000000000001 108.822 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.52 129.66 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 1.0900000000000001 109.758 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 95.4 t -93.41 134.18 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.45 -0.944 . . . . 1.0700000000000001 108.45 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.98 178.63 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 1.04 109.583 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.484 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.2 tt0 -144.84 111.24 5.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.39 -0.819 . . . . 2.3399999999999999 109.029 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.99 -82.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.108 -1.441 . . . . 1.1799999999999999 107.108 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -78.85 -138.82 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.733 -1.58 . . . . 2.4700000000000002 106.733 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.1 m -98.05 56.25 1.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.989 -1.07 . . . . 1.8700000000000001 108.423 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -156.15 125.75 6.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.735 . . . . 1.1200000000000001 109.038 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.484 ' CG1' HE21 ' A' ' 252' ' ' GLN . 80.6 mt -93.06 134.96 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.6 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.31 165.21 26.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.444 -0.785 . . . . 2.6299999999999999 109.746 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.85 139.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 1.0800000000000001 109.743 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.35 130.57 17.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 108.702 -0.851 . . . . 1.0700000000000001 108.702 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.61 146.88 73.64 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.613 -0.957 . . . . 0.48999999999999999 109.613 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -65.16 -32.88 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 3.5800000000000001 109.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -69.97 -4.89 22.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 4.3600000000000003 110.826 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.72 16.14 13.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.283 -0.885 . . . . 2.5800000000000001 109.051 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.8 172.29 13.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.627 -0.671 . . . . 1.05 109.426 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -139.54 129.91 25.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.408 -0.808 . . . . 2.2599999999999998 109.231 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.2 mm -88.49 106.61 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 1.1799999999999999 109.727 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.01 156.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.339 -0.851 . . . . 1.28 108.849 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.289 -0.882 . . . . 4.1799999999999997 109.219 179.406 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.999 -0.741 . . . . 2.0099999999999998 108.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -135.2 135.17 40.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.421 -0.799 . . . . 0.81999999999999995 109.329 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 84.4 mtt180 -103.3 157.94 16.67 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.834 -1.173 . . . . 3.7799999999999998 107.834 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.4 t -142.3 138.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.106 -0.996 . . . . 1.0600000000000001 110.622 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.98 151.99 27.32 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.723 -1.214 . . . . 0.92000000000000004 107.723 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.2 p90 -158.39 154.68 27.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.709 -1.244 . . . . 1.01 110.344 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.0 152.16 18.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 3.3900000000000001 109.706 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.71 13.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.372 -0.83 . . . . 2.23 108.771 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 57.7 m -79.35 -2.72 42.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 2.3300000000000001 109.263 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.82 20.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 4.1900000000000004 109.894 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.2 m-20 -162.93 144.43 7.75 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.044 -1.035 . . . . 2.1600000000000001 109.065 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.9 15.54 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.236 1.291 . . . . 1.3999999999999999 110.677 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' B' ' 232' ' ' ASP . 33.9 m -83.18 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 2.3100000000000001 110.05 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -64.04 164.77 10.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.247 -0.908 . . . . 0.72999999999999998 109.427 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.0 tttp -119.32 158.04 26.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.398 -0.814 . . . . 1.96 108.986 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.98 165.36 0.02 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.258 -1.137 . . . . 0.56000000000000005 110.258 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.23 157.65 58.84 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 121.526 1.484 . . . . 0.46999999999999997 110.225 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.35 169.05 18.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 1.05 108.96 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -93.31 142.71 27.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.064 -1.023 . . . . 3.1899999999999999 109.282 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.62 128.46 35.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.416 -0.802 . . . . 1.0900000000000001 110.232 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.03 -76.12 0.58 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.514 -0.741 . . . . 1.1799999999999999 109.711 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.01 142.57 27.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.124 -0.985 . . . . 0.34999999999999998 110.126 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.74 11.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.3 -0.875 . . . . 2.7999999999999998 108.747 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -107.33 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.771 -1.204 . . . . 0.29999999999999999 110.203 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.79 -150.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -1.041 . . . . 1.5600000000000001 109.727 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.17 49.93 3.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.319 -1.513 . . . . 0.28999999999999998 109.319 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.17 33.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -1.038 . . . . 1.0700000000000001 108.799 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 12.0 m -145.58 129.74 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.827 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 95.9 t -93.47 134.17 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.439 -0.948 . . . . 1.0800000000000001 108.439 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.2 pt -136.96 178.57 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 1.04 109.654 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.2 tt0 -144.83 111.24 5.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 2.3399999999999999 109.039 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -88.98 -81.89 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.199 -1.408 . . . . 1.1799999999999999 107.199 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -78.9 -138.9 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.674 -1.602 . . . . 2.4700000000000002 106.674 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.2 m -97.94 56.22 1.23 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.954 -1.091 . . . . 1.8600000000000001 108.494 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -156.16 125.75 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 1.1200000000000001 109.102 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' B' ' 252' ' ' GLN . 80.5 mt -93.08 134.92 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.933 . . . . 1.1499999999999999 109.617 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.26 165.32 26.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 2.6400000000000001 109.749 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.92 139.96 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.424 -0.797 . . . . 1.0800000000000001 109.696 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 83.9 t -137.43 130.57 17.07 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.645 -0.872 . . . . 1.0800000000000001 108.645 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.47 146.91 71.93 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.597 -0.963 . . . . 0.48999999999999999 109.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -65.36 -32.82 74.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 3.5800000000000001 109.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -69.93 -4.86 22.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 4.3600000000000003 110.867 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.84 16.33 13.49 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.258 -0.902 . . . . 2.5800000000000001 109.013 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.89 172.23 13.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 1.05 109.426 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -139.51 129.86 25.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 2.2599999999999998 109.288 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.44 106.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.277 -0.889 . . . . 1.1799999999999999 109.778 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.02 156.33 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.385 -0.822 . . . . 1.27 108.909 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -91.02 147.4 23.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 4.1799999999999997 109.196 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.6 m-20 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.048 -1.032 . . . . 2.0499999999999998 109.477 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.393 -0.595 . . . . 2.0099999999999998 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.54 121.7 20.21 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.508 -0.745 . . . . 0.81999999999999995 109.213 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.17 165.29 12.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 3.79 108.294 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -143.39 143.02 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.138 -0.977 . . . . 1.05 110.676 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -113.02 148.29 35.44 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.631 -1.248 . . . . 0.92000000000000004 107.631 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.7 p90 -156.91 151.99 26.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.729 -1.232 . . . . 1.01 110.288 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -93.19 139.25 30.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 3.3999999999999999 109.456 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -94.19 166.79 11.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 2.23 109.224 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.4 p -79.76 -1.5 38.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 2.3199999999999998 109.105 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -87.24 -22.6 25.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 4.1799999999999997 109.531 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 234' ' ' VAL . 8.3 m-20 -163.07 135.05 3.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 2.1600000000000001 109.073 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.82 10.95 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 120.813 1.009 . . . . 1.3899999999999999 110.228 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 232' ' ' ASP . 25.0 t -85.63 160.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.905 -1.122 . . . . 2.3100000000000001 109.821 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -74.52 162.17 29.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.71999999999999997 108.765 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.3 tttm -119.44 153.06 35.83 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.296 -0.877 . . . . 1.96 109.385 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -41.26 163.57 0.01 OUTLIER Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.762 -0.935 . . . . 0.55000000000000004 110.762 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -66.6 159.44 50.87 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 121.638 1.559 . . . . 0.46999999999999997 110.612 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.78 177.18 8.08 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.008 -0.738 . . . . 1.05 109.008 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -94.39 136.49 34.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.029 -1.045 . . . . 3.1899999999999999 109.194 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.74 124.01 33.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 1.0900000000000001 109.619 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -113.3 -74.33 0.63 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.434 -0.791 . . . . 1.1799999999999999 110.208 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -91.26 143.26 26.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.264 -0.897 . . . . 0.34000000000000002 110.33 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.11 117.96 7.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.435 -0.791 . . . . 2.79 109.225 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.19 -108.7 0.3 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.944 -1.263 . . . . 0.28999999999999998 109.944 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -63.56 -154.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -1.145 . . . . 1.5600000000000001 109.416 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.37 52.02 3.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.603 -1.399 . . . . 0.28999999999999998 109.603 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.69 150.44 34.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.396 -1.061 . . . . 1.0700000000000001 108.967 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 122.85 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 1.0900000000000001 109.701 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 52.8 t -87.22 135.36 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.991 -1.114 . . . . 1.0700000000000001 107.991 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.63 178.33 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 1.04 110.52 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.433 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.7 tt0 -144.81 112.16 6.08 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.683 -0.858 . . . . 2.3399999999999999 108.683 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.93 -78.5 0.39 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.612 -1.255 . . . . 1.1799999999999999 107.612 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.688 HD21 ' H ' ' A' ' 255' ' ' SER . 8.7 t30 -80.53 -129.29 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.68 -1.6 . . . . 2.4700000000000002 106.68 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.688 ' H ' HD21 ' A' ' 254' ' ' ASN . 68.5 m -105.41 54.3 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.106 -1.072 . . . . 1.8700000000000001 108.106 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -156.19 128.41 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.519 -0.738 . . . . 1.1200000000000001 109.519 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.433 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -94.61 137.59 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.1499999999999999 109.488 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.32 166.65 23.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.386 -0.821 . . . . 2.6299999999999999 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.94 142.5 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 1.0800000000000001 109.112 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.2 t -139.28 129.52 14.5 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 1.0700000000000001 109.168 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.37 160.66 6.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.939 -0.831 . . . . 0.48999999999999999 109.939 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -84.8 -27.2 26.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 3.5800000000000001 110.249 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.32 -18.82 65.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.893 . . . . 4.3600000000000003 111.931 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -119.43 29.24 7.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.897 -1.127 . . . . 2.5800000000000001 109.616 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.4 164.41 25.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.517 -0.92 . . . . 1.05 108.517 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.12 124.62 19.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.248 -0.908 . . . . 2.2599999999999998 109.293 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.7 mm -88.52 110.41 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 1.1799999999999999 109.581 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.9 146.76 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.54 -0.911 . . . . 1.28 108.54 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 4.1799999999999997 109.612 179.94 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.316 -0.624 . . . . 2.0099999999999998 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -135.56 121.69 20.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.517 -0.739 . . . . 0.81999999999999995 109.158 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.16 165.2 12.17 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.339 -0.986 . . . . 3.7799999999999998 108.339 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.3 143.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 1.0600000000000001 110.702 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -113.19 148.18 35.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.604 -1.258 . . . . 0.92000000000000004 107.604 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.8 p90 -156.79 152.03 26.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.689 -1.257 . . . . 1.01 110.327 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -93.26 139.27 30.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.711 . . . . 3.3900000000000001 109.405 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -94.25 166.76 11.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.357 -0.839 . . . . 2.23 109.226 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.1 p -79.68 -1.45 38.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 2.3300000000000001 109.161 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -87.25 -22.62 25.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 4.1900000000000004 109.536 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' B' ' 234' ' ' VAL . 8.3 m-20 -163.03 135.1 3.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 2.1600000000000001 109.096 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.88 11.05 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.772 0.981 . . . . 1.3999999999999999 110.233 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' B' ' 232' ' ' ASP . 25.2 t -85.73 160.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.939 -1.1 . . . . 2.3100000000000001 109.907 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -74.34 162.17 29.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.72999999999999998 108.787 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.3 tttm -119.41 153.02 35.87 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.345 -0.847 . . . . 1.96 109.439 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.27 163.55 0.01 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.73 -0.948 . . . . 0.56000000000000005 110.73 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.53 159.39 50.92 Favored 'Trans proline' 0 N--CA 1.48 0.732 0 C-N-CA 121.654 1.569 . . . . 0.46999999999999997 110.629 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.2 8.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.985 -0.746 . . . . 1.05 108.985 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -94.28 136.51 34.5 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.08 -1.013 . . . . 3.1899999999999999 109.299 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.75 123.97 33.11 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 1.0900000000000001 109.608 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.25 -74.52 0.62 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.338 -0.851 . . . . 1.1799999999999999 110.206 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.16 143.29 26.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.197 -0.94 . . . . 0.34999999999999998 110.414 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.1 118.01 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 2.7999999999999998 109.214 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -108.71 0.3 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.962 -1.255 . . . . 0.29999999999999999 109.962 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.68 -154.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 1.5600000000000001 109.348 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.93 3.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.419 . . . . 0.28999999999999998 109.551 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.67 150.44 34.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.392 -1.063 . . . . 1.0700000000000001 108.948 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.66 122.79 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.209 -0.932 . . . . 1.0900000000000001 109.762 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 52.9 t -87.26 135.33 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.032 -1.099 . . . . 1.0800000000000001 108.032 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.58 178.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.21 -0.931 . . . . 1.04 110.606 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.434 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.6 tt0 -144.77 112.13 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.619 -0.882 . . . . 2.3399999999999999 108.619 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.05 -78.43 0.39 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.571 -1.27 . . . . 1.1799999999999999 107.571 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.689 HD21 ' H ' ' B' ' 255' ' ' SER . 8.8 t30 -80.54 -129.27 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.722 -1.584 . . . . 2.4700000000000002 106.722 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.689 ' H ' HD21 ' B' ' 254' ' ' ASN . 68.7 m -105.41 54.29 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.131 -1.063 . . . . 1.8600000000000001 108.131 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -156.12 128.43 7.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 1.1200000000000001 109.524 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.434 ' CG1' HE21 ' B' ' 252' ' ' GLN . 35.9 mt -94.56 137.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.259 -0.901 . . . . 1.1499999999999999 109.536 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.31 166.65 23.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.323 -0.86 . . . . 2.6400000000000001 109.701 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.0 142.43 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 1.0800000000000001 109.119 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 78.8 t -139.22 129.4 14.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.366 -0.834 . . . . 1.0800000000000001 109.258 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.3 160.54 6.49 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.616 0.877 . . . . 0.48999999999999999 109.962 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -84.73 -27.1 27.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 3.5800000000000001 110.313 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 4.3600000000000003 111.893 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -119.28 29.22 7.77 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.954 -1.091 . . . . 2.5800000000000001 109.727 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.34 164.47 25.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.538 -0.912 . . . . 1.05 108.538 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.2 124.59 19.22 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.319 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.6 mm -88.6 110.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 1.1799999999999999 109.56 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.88 146.64 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.546 -0.909 . . . . 1.27 108.546 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.24 141.17 28.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.649 -0.657 . . . . 4.1799999999999997 109.605 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 2.0499999999999998 109.429 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.3 m120 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.176 -0.676 . . . . 2.0099999999999998 109.176 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.85 124.41 23.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.411 -0.806 . . . . 0.81999999999999995 109.959 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -95.88 164.11 12.87 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.37 -1.345 . . . . 3.79 107.37 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.02 142.82 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.01 -1.056 . . . . 1.05 110.446 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -107.36 154.71 20.89 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.475 -1.306 . . . . 0.92000000000000004 107.475 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.0 p90 -156.04 157.24 35.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.484 -1.385 . . . . 1.01 111.112 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -101.15 146.08 27.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.464 0.65 . . . . 3.3999999999999999 109.421 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 230' ' ' SER . 37.0 t0 -98.74 -176.65 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 2.23 109.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.461 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 15.1 t -95.08 -14.14 24.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -0.808 . . . . 2.3199999999999998 109.678 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.28 -16.93 31.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.19 -0.944 . . . . 4.1799999999999997 109.857 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 234' ' ' VAL . 61.4 m-20 -160.4 128.82 2.94 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.147 -0.97 . . . . 2.1600000000000001 109.351 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.95 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 120.786 0.991 . . . . 1.3899999999999999 110.25 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 232' ' ' ASP . 5.6 m -82.32 127.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.869 -1.144 . . . . 2.3100000000000001 110.026 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.5 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.71999999999999997 109.257 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 237' ' ' GLY . 31.3 mtpt -119.85 166.46 13.26 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.425 -0.797 . . . . 1.96 109.418 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.99 170.17 0.02 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.287 -1.125 . . . . 0.55000000000000004 110.287 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -68.83 163.83 35.82 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 121.562 1.508 . . . . 0.46999999999999997 110.66 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.58 177.86 7.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 1.05 109.347 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.56 137.45 34.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.197 -0.939 . . . . 3.1899999999999999 109.39 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -88.67 123.86 33.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.565 -0.709 . . . . 1.0900000000000001 109.459 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.14 -72.66 0.68 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.289 -0.882 . . . . 1.1799999999999999 110.432 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.01 144.45 25.64 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.077 -1.014 . . . . 0.34000000000000002 110.497 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -145.7 119.37 9.17 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.767 -0.827 . . . . 2.79 108.767 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.88 -104.88 0.26 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.209 -1.156 . . . . 0.28999999999999998 110.209 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -73.04 -149.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -1.129 . . . . 1.5600000000000001 109.736 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.54 3.95 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.136 -1.586 . . . . 0.28999999999999998 109.136 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.49 150.95 34.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 1.0700000000000001 108.425 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.36 123.31 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.971 -1.08 . . . . 1.0900000000000001 109.827 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.94 133.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.399 -0.963 . . . . 1.0700000000000001 108.399 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.6 pt -138.81 178.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.348 -0.845 . . . . 1.04 109.987 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.485 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.7 tt0 -143.8 109.3 5.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.341 -0.985 . . . . 2.3399999999999999 108.341 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.1 -77.23 0.4 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.499 -1.297 . . . . 1.1799999999999999 107.499 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.87 -133.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.323 -1.732 . . . . 2.4700000000000002 106.323 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.3 t -105.03 56.48 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.071 -1.085 . . . . 1.8700000000000001 108.071 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -157.03 123.53 4.98 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.771 -0.826 . . . . 1.1200000000000001 108.771 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.485 ' CG1' HE21 ' A' ' 252' ' ' GLN . 39.2 mt -91.64 134.29 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -0.998 . . . . 1.1499999999999999 109.504 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.07 172.6 12.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.281 -0.887 . . . . 2.6299999999999999 110.014 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.13 140.6 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.547 -0.72 . . . . 1.0800000000000001 109.701 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.19 124.93 17.65 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.826 -0.805 . . . . 1.0700000000000001 108.826 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.16 139.55 90.89 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 120.584 0.856 . . . . 0.48999999999999999 110.331 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.76 -36.26 69.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 3.5800000000000001 109.758 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' A' ' 263' ' ' ARG . 2.3 tpt180 -67.12 -9.58 41.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 4.3600000000000003 110.693 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.494 ' CB ' ' NZ ' ' A' ' 264' ' ' LYS . 7.4 mtpm? -122.95 25.47 8.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.284 -0.885 . . . . 2.5800000000000001 108.859 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.33 32.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.462 -0.94 . . . . 1.05 108.462 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -139.34 132.09 29.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.116 -0.99 . . . . 2.2599999999999998 109.231 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.57 107.63 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 1.1799999999999999 109.297 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.51 157.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 1.28 109.308 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 4.1799999999999997 109.465 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 25.4 m120 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.148 -0.686 . . . . 2.0099999999999998 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.84 124.46 23.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.508 -0.745 . . . . 0.81999999999999995 109.957 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 6.0 mpt_? -95.89 164.19 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.298 -1.371 . . . . 3.7799999999999998 107.298 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 86.2 t -144.1 142.85 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.066 -1.021 . . . . 1.0600000000000001 110.408 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -107.37 154.77 20.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.384 -1.339 . . . . 0.92000000000000004 107.384 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.9 p90 -156.08 157.23 35.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.548 -1.345 . . . . 1.01 111.087 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -101.04 146.06 27.93 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.425 0.631 . . . . 3.3900000000000001 109.516 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' B' ' 230' ' ' SER . 36.9 t0 -98.64 -176.67 3.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 2.23 109.879 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' SER . . . . . 0.463 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 15.2 t -95.17 -13.88 24.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.415 -0.803 . . . . 2.3300000000000001 109.731 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.37 -16.97 31.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 4.1900000000000004 109.847 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' B' ' 234' ' ' VAL . 61.2 m-20 -160.39 128.82 2.95 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 2.1600000000000001 109.339 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.94 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.776 0.984 . . . . 1.3999999999999999 110.302 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' B' ' 232' ' ' ASP . 5.5 m -82.32 127.77 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.874 -1.141 . . . . 2.3100000000000001 110.014 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.44 0.22 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.72999999999999998 109.298 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' B' ' 237' ' ' GLY . 31.3 mtpt -119.71 166.44 13.21 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.371 -0.831 . . . . 1.96 109.431 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.15 170.3 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.303 -1.119 . . . . 0.56000000000000005 110.303 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -68.92 163.8 36.13 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.55 1.5 . . . . 0.46999999999999997 110.605 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.52 177.87 7.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 1.05 109.404 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.59 137.3 34.85 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.135 -0.978 . . . . 3.1899999999999999 109.389 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -88.51 123.87 33.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.544 -0.723 . . . . 1.0900000000000001 109.571 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.21 -72.53 0.69 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.381 -0.824 . . . . 1.1799999999999999 110.488 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.18 144.47 25.58 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.051 -1.031 . . . . 0.34999999999999998 110.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -145.69 119.41 9.2 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.818 -0.808 . . . . 2.7999999999999998 108.818 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.95 -104.92 0.26 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.148 -1.181 . . . . 0.29999999999999999 110.148 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -72.98 -149.44 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -1.143 . . . . 1.5600000000000001 109.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.61 3.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.19 -1.564 . . . . 0.28999999999999998 109.19 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.96 34.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -1.023 . . . . 1.0700000000000001 108.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.31 123.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.08 -1.012 . . . . 1.0900000000000001 109.81 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.82 133.66 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.392 -0.966 . . . . 1.0800000000000001 108.392 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.86 178.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 1.04 110.066 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.484 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.6 tt0 -143.72 109.41 5.19 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.353 -0.981 . . . . 2.3399999999999999 108.353 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.21 -77.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.538 -1.282 . . . . 1.1799999999999999 107.538 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -80.96 -133.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.323 -1.732 . . . . 2.4700000000000002 106.323 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.2 t -105.07 56.57 0.69 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.055 -1.091 . . . . 1.8600000000000001 108.055 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -157.05 123.62 5.0 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.778 -0.823 . . . . 1.1200000000000001 108.778 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.484 ' CG1' HE21 ' B' ' 252' ' ' GLN . 39.1 mt -91.66 134.31 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 1.1499999999999999 109.435 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.11 172.59 12.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.368 -0.832 . . . . 2.6400000000000001 110.05 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.13 140.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.461 -0.774 . . . . 1.0800000000000001 109.745 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.17 124.86 17.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.841 -0.8 . . . . 1.0800000000000001 108.841 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.12 139.49 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 120.588 0.859 . . . . 0.48999999999999999 110.325 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.81 -36.19 69.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 3.5800000000000001 109.751 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 2.3 tpt180 -67.17 -9.47 40.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 4.3600000000000003 110.733 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.496 ' CB ' ' NZ ' ' B' ' 264' ' ' LYS . 7.4 mtpm? -123.03 25.53 8.5 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.21 -0.931 . . . . 2.5800000000000001 108.833 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.493 -0.928 . . . . 1.05 108.493 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -139.32 131.9 28.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.113 -0.992 . . . . 2.2599999999999998 109.318 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.44 107.62 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.231 -0.918 . . . . 1.1799999999999999 109.311 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.44 157.55 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.41 -0.806 . . . . 1.27 109.269 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -91.69 137.23 32.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 109.487 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.105 -0.997 . . . . 2.0499999999999998 109.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.6 m-20 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.227 -0.657 . . . . 2.0099999999999998 109.227 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -135.66 134.08 38.83 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.81999999999999995 109.374 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.523 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.1 18.89 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.925 -1.139 . . . . 3.79 107.925 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -140.99 140.23 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.103 -0.998 . . . . 1.05 110.983 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -109.28 154.28 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.141 -1.429 . . . . 0.92000000000000004 107.141 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.9 p90 -156.53 150.12 24.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.593 -1.317 . . . . 1.01 110.55 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.7 mtm-85 -94.22 134.97 36.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.513 -0.742 . . . . 3.3999999999999999 109.463 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.36 175.24 6.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.366 -0.834 . . . . 2.23 109.591 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.2 t -85.88 -11.02 54.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 2.3199999999999998 108.874 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -88.8 -9.31 52.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 4.1799999999999997 109.414 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -158.07 128.52 3.51 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 2.1600000000000001 109.04 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.69 -11.58 29.84 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 120.815 1.01 . . . . 1.3899999999999999 110.44 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 1.5 p -84.59 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.043 . . . . 2.3100000000000001 109.42 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 92.7 m95 -64.43 169.57 4.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.445 -0.784 . . . . 0.71999999999999997 109.644 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 237' ' ' GLY . 44.9 tttp -118.95 165.35 14.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.512 -0.742 . . . . 1.96 109.223 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.22 167.37 0.02 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.119 -1.192 . . . . 0.55000000000000004 110.119 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.4 160.25 50.52 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.448 1.432 . . . . 0.46999999999999997 110.113 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.79 168.86 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.05 109.18 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.51 139.51 30.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.161 -0.962 . . . . 3.1899999999999999 109.971 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.08 122.94 32.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -0.77 . . . . 1.0900000000000001 109.428 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.66 -75.51 0.6 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.419 -0.801 . . . . 1.1799999999999999 110.355 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -89.79 143.68 26.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.067 -1.021 . . . . 0.34000000000000002 109.893 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.65 121.62 10.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.342 -0.849 . . . . 2.79 109.063 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.46 -104.93 0.23 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.812 -1.185 . . . . 0.28999999999999998 110.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.38 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -1.053 . . . . 1.5600000000000001 109.551 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 51.36 3.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.14 -1.584 . . . . 0.28999999999999998 109.14 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.37 154.02 40.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.427 -1.043 . . . . 1.0700000000000001 108.691 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -147.01 124.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.056 -1.027 . . . . 1.0900000000000001 109.82 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.82 133.61 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.721 -1.214 . . . . 1.0700000000000001 107.721 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.39 175.78 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.321 -0.862 . . . . 1.04 110.333 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -145.32 108.71 4.63 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.588 -0.893 . . . . 2.3399999999999999 108.588 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.34 -77.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.421 -1.326 . . . . 1.1799999999999999 107.421 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -80.28 -135.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.566 -1.642 . . . . 2.4700000000000002 106.566 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 10.2 p -101.58 55.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.099 -1.074 . . . . 1.8700000000000001 108.099 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 255' ' ' SER . 59.1 m-20 -156.75 123.71 5.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.143 -0.688 . . . . 1.1200000000000001 109.143 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.428 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.3 mt -93.05 135.39 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.1499999999999999 109.438 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.07 169.72 17.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.415 -0.803 . . . . 2.6299999999999999 109.709 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.86 140.97 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.383 -0.823 . . . . 1.0800000000000001 109.491 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.97 128.24 17.56 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.632 -0.877 . . . . 1.0700000000000001 108.632 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.65 148.64 72.66 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.528 -0.989 . . . . 0.48999999999999999 109.528 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -67.82 -30.3 69.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 3.5800000000000001 109.452 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.68 -8.29 53.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 4.3600000000000003 111.0 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.21 23.16 11.47 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.126 -0.983 . . . . 2.5800000000000001 109.005 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.97 168.13 20.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.579 -0.701 . . . . 1.05 109.164 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -139.64 129.59 24.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.318 -0.864 . . . . 2.2599999999999998 109.154 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.38 108.13 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.1799999999999999 109.431 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -101.83 156.21 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.661 -0.866 . . . . 1.28 108.661 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 4.1799999999999997 109.116 179.715 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 2.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.227 -0.657 . . . . 2.0099999999999998 109.227 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.63 134.09 38.89 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.487 -0.758 . . . . 0.81999999999999995 109.416 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.525 HH11 ' CG ' ' B' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.2 18.78 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.91 -1.144 . . . . 3.7799999999999998 107.91 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -141.09 140.27 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.181 -0.95 . . . . 1.0600000000000001 110.945 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -109.24 154.33 22.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.169 -1.419 . . . . 0.92000000000000004 107.169 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.9 p90 -156.63 149.94 24.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.468 -1.395 . . . . 1.01 110.666 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.6 mtm-85 -94.07 135.05 35.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.523 -0.736 . . . . 3.3900000000000001 109.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.45 175.18 6.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 2.23 109.629 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.1 t -85.79 -10.99 54.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 2.3300000000000001 108.925 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -88.84 -9.2 52.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.443 -0.785 . . . . 4.1900000000000004 109.433 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.17 128.37 3.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.1600000000000001 109.147 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.64 -11.54 29.84 Favored 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 120.865 1.043 . . . . 1.3999999999999999 110.433 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 1.5 p -84.52 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.037 . . . . 2.3100000000000001 109.429 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.479 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 92.7 m95 -64.45 169.57 4.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.72999999999999998 109.671 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 44.9 tttp -118.92 165.31 14.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.635 -0.666 . . . . 1.96 109.338 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.24 167.39 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.159 -1.176 . . . . 0.56000000000000005 110.159 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.37 160.27 50.47 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 121.419 1.412 . . . . 0.46999999999999997 110.122 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.88 168.88 18.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 1.05 109.071 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.4 139.48 30.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.227 -0.92 . . . . 3.1899999999999999 109.971 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.1 122.88 32.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.704 . . . . 1.0900000000000001 109.423 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -112.63 -75.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -0.828 . . . . 1.1799999999999999 110.44 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.428 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.1 t90 -89.77 143.66 26.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.005 . . . . 0.34999999999999998 109.889 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.75 121.64 10.63 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.315 -0.866 . . . . 2.7999999999999998 109.044 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.41 -104.95 0.23 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.11 -1.196 . . . . 0.29999999999999999 110.11 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -69.42 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -1.125 . . . . 1.5600000000000001 109.516 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.43 3.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.05 -1.62 . . . . 0.28999999999999998 109.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.11 40.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.467 -1.019 . . . . 1.0700000000000001 108.72 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.99 124.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.126 -0.984 . . . . 1.0900000000000001 109.943 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.78 133.77 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.703 -1.221 . . . . 1.0800000000000001 107.703 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.51 175.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.296 -0.878 . . . . 1.04 110.278 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -145.3 108.75 4.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.593 -0.891 . . . . 2.3399999999999999 108.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.43 -77.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.348 -1.353 . . . . 1.1799999999999999 107.348 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.25 -135.73 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.54 -1.652 . . . . 2.4700000000000002 106.54 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 10.1 p -101.63 56.06 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.964 -1.125 . . . . 1.8600000000000001 107.964 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 59.1 m-20 -156.78 123.68 5.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 1.1200000000000001 109.145 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.99 135.35 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 1.1499999999999999 109.429 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.12 169.77 17.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 2.6400000000000001 109.751 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 140.98 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.381 -0.824 . . . . 1.0800000000000001 109.496 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.96 128.3 17.61 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.672 -0.862 . . . . 1.0800000000000001 108.672 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.78 148.64 73.79 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.465 -1.013 . . . . 0.48999999999999999 109.465 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.78 -30.37 69.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 3.5800000000000001 109.489 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.58 -8.34 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.415 -0.803 . . . . 4.3600000000000003 111.016 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.14 23.15 11.5 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.176 -0.952 . . . . 2.5800000000000001 109.054 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.03 168.16 20.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.078 -0.712 . . . . 1.05 109.078 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.6 129.65 25.05 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.363 -0.836 . . . . 2.2599999999999998 109.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.34 108.09 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.4 -0.812 . . . . 1.1799999999999999 109.431 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.6 mm -101.88 156.08 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.319 -0.863 . . . . 1.27 108.683 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -94.5 135.36 36.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 4.1799999999999997 109.183 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.042 -1.036 . . . . 2.0499999999999998 109.555 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.178 -0.675 . . . . 2.0099999999999998 109.178 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.95 122.68 22.25 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.817 -0.808 . . . . 0.81999999999999995 108.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -100.99 161.16 13.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.289 -1.004 . . . . 3.79 108.289 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.6 141.91 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.324 -0.86 . . . . 1.05 110.093 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -107.21 155.21 20.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.299 -1.371 . . . . 0.92000000000000004 107.299 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.3 p90 -154.86 153.29 30.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.716 -1.24 . . . . 1.01 110.456 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -95.29 157.15 16.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.495 -0.753 . . . . 3.3999999999999999 109.978 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.55 176.46 6.28 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.9 -0.778 . . . . 2.23 108.9 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.41 -11.24 38.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -0.994 . . . . 2.3199999999999998 109.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.63 -15.41 35.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.33 -0.856 . . . . 4.1799999999999997 109.902 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.4 m-20 -161.38 132.34 3.77 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.142 -0.974 . . . . 2.1600000000000001 109.282 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.5 18.28 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.023 1.149 . . . . 1.3899999999999999 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.514 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.1 p -86.59 158.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.72 -1.238 . . . . 2.3100000000000001 109.921 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -75.5 176.25 7.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.429 -0.582 . . . . 0.71999999999999997 109.429 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -134.97 -150.6 0.39 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.234 -0.916 . . . . 1.96 109.141 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.17 174.95 49.63 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.093 -1.203 . . . . 0.55000000000000004 110.093 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.12 158.95 45.0 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.78 1.653 . . . . 0.46999999999999997 110.066 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 172.04 13.23 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 1.05 109.517 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.538 ' NZ ' HH22 ' A' ' 224' ' ' ARG . 66.7 mmtt -92.49 137.72 32.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.269 -0.895 . . . . 3.1899999999999999 109.428 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.27 124.47 34.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.498 -0.752 . . . . 1.0900000000000001 109.814 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.37 -73.71 0.63 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.377 -0.827 . . . . 1.1799999999999999 110.27 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.85 140.33 29.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.26 -0.9 . . . . 0.34000000000000002 109.956 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -147.24 115.11 6.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -0.897 . . . . 2.79 109.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -100.3 0.17 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.854 -1.165 . . . . 0.28999999999999998 110.302 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.37 -156.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.357 -1.084 . . . . 1.5600000000000001 109.888 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.21 48.16 2.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.061 -1.615 . . . . 0.28999999999999998 109.061 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 152.34 36.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.437 -1.037 . . . . 1.0700000000000001 108.999 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.58 125.2 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0900000000000001 109.413 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 50.5 t -87.85 135.02 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.109 -1.071 . . . . 1.0700000000000001 108.109 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.75 -177.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 1.04 110.062 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.474 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.4 tt0 -143.14 109.41 5.32 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.359 -0.978 . . . . 2.3399999999999999 108.359 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.62 -79.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.634 -1.247 . . . . 1.1799999999999999 107.634 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -78.99 -135.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.481 -1.674 . . . . 2.4700000000000002 106.481 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.7 m -101.02 53.72 0.84 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.167 -1.049 . . . . 1.8700000000000001 108.167 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -157.35 132.13 8.7 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.051 -0.722 . . . . 1.1200000000000001 109.051 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.474 ' CG1' HE21 ' A' ' 252' ' ' GLN . 37.3 mt -92.64 137.31 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 1.1499999999999999 109.479 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.54 169.91 16.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 2.6299999999999999 109.701 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.93 140.87 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.458 -0.777 . . . . 1.0800000000000001 109.411 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.56 134.03 21.96 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.678 -0.86 . . . . 1.0700000000000001 108.678 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.42 140.96 96.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 120.715 0.944 . . . . 0.48999999999999999 110.478 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -59.11 -38.95 80.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 3.5800000000000001 109.271 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -66.96 -7.95 26.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 4.3600000000000003 111.001 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.68 25.11 9.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.156 -0.965 . . . . 2.5800000000000001 109.169 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.53 164.28 30.57 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.212 -0.662 . . . . 1.05 109.212 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.03 126.47 20.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 2.2599999999999998 109.075 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.97 110.39 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.745 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.12 147.17 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.354 -0.98 . . . . 1.28 108.354 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 4.1799999999999997 109.763 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.159 -0.682 . . . . 2.0099999999999998 109.159 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.97 122.79 22.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.709 -0.849 . . . . 0.81999999999999995 108.709 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' B' ' 224' ' ' ARG . 0.0 OUTLIER -101.03 161.05 13.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.316 -0.994 . . . . 3.7799999999999998 108.316 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.54 142.0 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 1.0600000000000001 110.097 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.26 155.21 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.337 -1.357 . . . . 0.92000000000000004 107.337 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.7 p90 -154.84 153.26 30.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.696 -1.253 . . . . 1.01 110.491 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -95.24 157.17 16.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.751 . . . . 3.3900000000000001 109.975 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -94.52 176.48 6.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 2.23 108.962 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.44 -11.26 38.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 2.3300000000000001 109.342 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.66 -15.4 35.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.331 -0.855 . . . . 4.1900000000000004 109.857 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.7 m-20 -161.37 132.32 3.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 2.1600000000000001 109.274 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.48 18.16 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.965 1.11 . . . . 1.3999999999999999 110.838 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.2 p -86.41 158.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.774 -1.204 . . . . 2.3100000000000001 109.922 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -75.66 176.28 7.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.381 -0.6 . . . . 0.72999999999999998 109.381 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -135.0 -150.58 0.39 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.284 -0.885 . . . . 1.96 109.11 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.2 174.94 49.57 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.084 -1.207 . . . . 0.56000000000000005 110.084 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.13 158.97 44.94 Favored 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 121.777 1.651 . . . . 0.46999999999999997 110.077 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.11 172.15 13.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.392 -0.817 . . . . 1.05 109.5 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.542 ' NZ ' HH22 ' B' ' 224' ' ' ARG . 66.7 mmtt -92.52 137.7 32.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.233 -0.917 . . . . 3.1899999999999999 109.422 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.29 124.48 34.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 1.0900000000000001 109.783 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.35 -73.68 0.63 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.275 -0.891 . . . . 1.1799999999999999 110.317 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.89 140.32 29.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.295 -0.878 . . . . 0.34999999999999998 109.953 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -147.28 115.0 6.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.244 -0.91 . . . . 2.7999999999999998 109.221 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.66 -100.36 0.18 Allowed Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.782 -1.199 . . . . 0.29999999999999999 110.239 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.29 -157.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 1.5600000000000001 109.863 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 48.06 2.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.09 -1.604 . . . . 0.28999999999999998 109.09 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.27 36.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -1.067 . . . . 1.0700000000000001 109.111 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.61 125.15 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 1.0900000000000001 109.411 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.83 134.92 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.033 -1.099 . . . . 1.0800000000000001 108.033 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 9.2 pt -139.62 -177.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 1.04 110.105 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.4 tt0 -143.05 109.55 5.4 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.391 -0.966 . . . . 2.3399999999999999 108.391 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.66 -79.15 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.629 -1.248 . . . . 1.1799999999999999 107.629 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.94 -135.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.551 -1.648 . . . . 2.4700000000000002 106.551 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.9 m -100.95 53.7 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.13 -1.063 . . . . 1.8600000000000001 108.13 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -157.3 132.16 8.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.041 -0.726 . . . . 1.1200000000000001 109.041 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.1 mt -92.63 137.25 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.235 -0.916 . . . . 1.1499999999999999 109.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.49 169.81 17.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.402 -0.811 . . . . 2.6400000000000001 109.746 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.88 140.89 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.409 -0.807 . . . . 1.0800000000000001 109.458 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.49 133.99 22.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.802 -0.814 . . . . 1.0800000000000001 108.802 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.43 140.91 96.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.647 0.898 . . . . 0.48999999999999999 110.522 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.1 -38.85 80.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 3.5800000000000001 109.326 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -67.07 -7.83 25.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.997 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.75 25.08 9.93 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.151 -0.968 . . . . 2.5800000000000001 109.192 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 164.24 30.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -140.04 126.47 20.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 2.2599999999999998 109.097 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.94 110.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.267 -0.895 . . . . 1.1799999999999999 109.742 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.1 147.16 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.329 -0.989 . . . . 1.27 108.329 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -95.93 141.65 29.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.45 -0.781 . . . . 4.1799999999999997 109.758 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.02 -0.99 . . . . 2.0499999999999998 109.612 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 222' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.304 0.573 . . . . 2.0099999999999998 109.522 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.05 137.52 46.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.592 -0.693 . . . . 0.81999999999999995 109.416 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.6 OUTLIER -104.85 157.81 16.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.41 -1.33 . . . . 3.79 107.41 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.0 t -141.53 142.91 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.077 -1.014 . . . . 1.05 110.642 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -110.63 154.81 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.303 -1.369 . . . . 0.92000000000000004 107.303 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.76 151.91 26.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.534 -1.354 . . . . 1.01 110.529 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.0 mtm-85 -92.5 149.27 21.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.739 . . . . 3.3999999999999999 109.876 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 1.1 m-20 -94.38 168.04 11.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 2.23 108.698 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.9 t -84.81 -9.38 58.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 2.3199999999999998 109.084 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' A' ' 231' ' ' ARG . 3.5 mtt-85 -90.83 -15.75 29.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 4.1799999999999997 109.989 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 234' ' ' VAL . 38.0 m-20 -160.24 129.54 3.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 2.1600000000000001 108.95 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.86 11.03 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 120.831 1.021 . . . . 1.3899999999999999 110.827 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.8 p -81.62 158.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.697 -1.252 . . . . 2.3100000000000001 109.886 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -75.33 162.15 28.66 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.213 -0.662 . . . . 0.71999999999999997 109.213 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.7 tttp -118.38 158.13 25.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.462 -0.774 . . . . 1.96 109.162 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.16 171.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.551 -1.02 . . . . 0.55000000000000004 110.551 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.37 158.25 57.89 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.691 1.594 . . . . 0.46999999999999997 110.621 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.24 170.65 15.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.674 -0.861 . . . . 1.05 108.674 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -92.95 137.24 32.54 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.072 -1.017 . . . . 3.1899999999999999 109.349 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.55 120.31 30.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.708 -0.62 . . . . 1.0900000000000001 109.587 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.6 mt -111.15 -71.79 0.75 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.363 -0.836 . . . . 1.1799999999999999 110.101 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.2 t90 -91.59 142.11 27.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.206 -0.934 . . . . 0.34000000000000002 109.78 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.76 112.48 5.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.139 -0.976 . . . . 2.79 109.065 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.83 -104.17 0.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.814 -1.184 . . . . 0.28999999999999998 110.251 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 245' ' ' GLY . 30.0 mt-10 -56.67 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.477 -1.014 . . . . 1.5600000000000001 109.862 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.1 49.95 2.99 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.103 -1.599 . . . . 0.28999999999999998 109.103 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.22 157.9 43.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -1.009 . . . . 1.0700000000000001 108.569 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.38 132.44 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 1.0900000000000001 109.552 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.79 133.93 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.004 -1.11 . . . . 1.0700000000000001 108.004 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 15.3 pt -138.71 174.06 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.326 -0.859 . . . . 1.04 110.562 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -141.89 108.87 5.44 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.226 -1.027 . . . . 2.3399999999999999 108.226 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.22 -75.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.514 -1.291 . . . . 1.1799999999999999 107.514 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.25 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.615 -1.624 . . . . 2.4700000000000002 106.615 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.98 52.23 0.74 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.854 -1.165 . . . . 1.8700000000000001 107.854 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -156.35 129.0 7.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.521 -0.737 . . . . 1.1200000000000001 109.29 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.1 mt -92.62 141.52 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 1.1499999999999999 109.635 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.57 165.11 28.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 2.6299999999999999 109.668 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.9 137.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.818 . . . . 1.0800000000000001 109.404 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.72 131.53 20.21 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.361 -0.837 . . . . 1.0700000000000001 109.189 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.64 146.98 93.84 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 N-CA-C 109.702 -0.922 . . . . 0.48999999999999999 109.702 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.07 -33.07 75.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 3.5800000000000001 109.716 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -68.99 -7.05 31.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.21 -0.931 . . . . 4.3600000000000003 110.636 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -119.73 20.96 12.19 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.265 -0.897 . . . . 2.5800000000000001 109.13 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.89 23.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 1.05 109.534 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -139.42 131.01 27.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.213 -0.93 . . . . 2.2599999999999998 108.973 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.18 105.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 1.1799999999999999 109.523 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.1 mm -105.1 159.99 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.368 -0.833 . . . . 1.28 108.956 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 269' ' ' ARG . 24.7 mtm-85 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 4.1799999999999997 109.376 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . 0.579 ' N ' HD21 ' B' ' 222' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.491 -0.559 . . . . 2.0099999999999998 109.491 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -132.86 137.67 46.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.642 -0.661 . . . . 0.81999999999999995 109.401 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.6 OUTLIER -104.96 157.82 16.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.403 -1.332 . . . . 3.7799999999999998 107.403 178.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.55 143.03 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.111 -0.993 . . . . 1.0600000000000001 110.601 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.66 154.8 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.353 -1.351 . . . . 0.92000000000000004 107.353 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.7 p90 -156.77 151.98 26.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 1.01 110.513 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.0 mtm-85 -92.47 149.24 21.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 3.3900000000000001 109.927 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -94.45 167.86 11.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.682 -0.858 . . . . 2.23 108.682 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 47.5 t -84.73 -9.26 58.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 2.3300000000000001 109.139 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' B' ' 231' ' ' ARG . 3.6 mtt-85 -90.89 -15.68 29.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 4.1900000000000004 110.048 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 38.1 m-20 -160.31 129.59 3.2 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.159 -0.963 . . . . 2.1600000000000001 108.965 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.04 11.16 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 120.775 0.983 . . . . 1.3999999999999999 110.777 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.9 p -81.55 158.64 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.797 -1.189 . . . . 2.3100000000000001 110.055 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -75.53 162.07 28.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.11 -0.7 . . . . 0.72999999999999998 109.11 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.9 tttp -118.29 158.14 25.74 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.468 -0.77 . . . . 1.96 109.195 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.05 171.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.518 -1.033 . . . . 0.56000000000000005 110.518 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.26 158.19 58.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.825 1.683 . . . . 0.46999999999999997 110.667 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.23 170.81 15.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.678 -0.86 . . . . 1.05 108.678 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -93.14 137.16 32.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.022 -1.049 . . . . 3.1899999999999999 109.339 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.8 tp -89.4 120.28 30.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.621 -0.675 . . . . 1.0900000000000001 109.585 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.08 -71.9 0.74 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.314 -0.866 . . . . 1.1799999999999999 110.095 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.1 t90 -91.58 142.18 27.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.34999999999999998 109.805 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.84 112.55 5.67 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.205 -0.934 . . . . 2.7999999999999998 109.109 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.88 -104.2 0.22 Allowed Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.783 -1.198 . . . . 0.29999999999999999 110.301 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' B' ' 245' ' ' GLY . 30.3 mt-10 -56.68 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.032 . . . . 1.5600000000000001 109.846 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.14 49.98 3.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.6 . . . . 0.28999999999999998 109.101 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.18 158.0 43.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.589 -0.947 . . . . 1.0700000000000001 108.527 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.36 132.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 1.0900000000000001 109.544 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.79 133.95 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.936 -1.135 . . . . 1.0800000000000001 107.936 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.77 173.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 1.04 110.565 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -141.74 108.77 5.46 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.311 -0.996 . . . . 2.3399999999999999 108.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.23 -75.84 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.498 -1.297 . . . . 1.1799999999999999 107.498 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.23 -132.07 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.566 -1.642 . . . . 2.4700000000000002 106.566 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.94 52.06 0.75 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.952 -1.129 . . . . 1.8600000000000001 107.952 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -156.2 129.0 7.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.643 -0.661 . . . . 1.1200000000000001 109.335 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.2 mt -92.65 141.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.37 -0.831 . . . . 1.1499999999999999 109.591 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.35 165.24 27.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 2.6400000000000001 109.72 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.98 137.32 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 1.0800000000000001 109.408 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.64 131.51 20.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.42 -0.8 . . . . 1.0800000000000001 109.175 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.67 147.07 93.57 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 N-CA-C 109.734 -0.91 . . . . 0.48999999999999999 109.734 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.06 -33.14 75.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 3.5800000000000001 109.652 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.0 -7.03 31.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 4.3600000000000003 110.559 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -119.7 20.96 12.21 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.29 -0.881 . . . . 2.5800000000000001 109.134 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.62 166.81 23.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 1.05 109.524 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -139.41 130.91 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.354 -0.841 . . . . 2.2599999999999998 109.092 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.8 mm -89.12 105.93 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 1.1799999999999999 109.625 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.1 mm -105.08 160.13 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.383 -0.823 . . . . 1.27 109.026 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' B' ' 269' ' ' ARG . 24.6 mtm-85 -87.66 148.04 24.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 4.1799999999999997 109.387 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.028 -0.987 . . . . 2.0499999999999998 109.103 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.136 -0.691 . . . . 2.0099999999999998 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.6 130.29 36.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.595 -0.691 . . . . 0.81999999999999995 109.207 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 224' ' ' ARG . 0.4 OUTLIER -105.68 159.48 15.94 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.293 -1.003 . . . . 3.79 108.293 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.13 140.8 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.044 -1.035 . . . . 1.05 110.59 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.06 152.48 23.95 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.252 -1.388 . . . . 0.92000000000000004 107.252 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.8 p90 -156.57 151.5 26.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.537 -1.352 . . . . 1.01 110.615 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -95.06 143.63 26.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 3.3999999999999999 109.88 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.77 173.25 7.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.392 -0.818 . . . . 2.23 108.997 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.24 -9.99 51.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 2.3199999999999998 109.381 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.64 -13.0 43.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 4.1799999999999997 109.55 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -158.43 128.43 3.38 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 2.1600000000000001 108.707 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.32 2.04 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 120.875 1.05 . . . . 1.3899999999999999 111.404 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 14.8 p -84.57 167.04 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.565 -1.334 . . . . 2.3100000000000001 110.335 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.438 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 98.8 m95 -71.92 161.98 30.13 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.71999999999999997 108.692 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.2 tttp -118.75 161.96 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.288 -0.883 . . . . 1.96 109.257 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.6 164.83 0.02 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.302 -1.119 . . . . 0.55000000000000004 110.302 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.43 160.75 46.38 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.456 1.437 . . . . 0.46999999999999997 110.127 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.66 175.32 9.67 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.836 -0.802 . . . . 1.05 108.836 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -95.89 138.73 33.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.126 -0.984 . . . . 3.1899999999999999 109.795 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 tp -87.89 122.93 32.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.326 -0.859 . . . . 1.0900000000000001 109.259 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.38 -72.94 0.67 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.352 -0.842 . . . . 1.1799999999999999 110.326 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.528 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.7 t90 -90.07 139.95 30.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.091 -1.006 . . . . 0.34000000000000002 110.387 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.62 7.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.374 -0.829 . . . . 2.79 109.008 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.33 -99.9 0.17 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.83 -1.308 . . . . 0.28999999999999998 109.83 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.45 -155.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -1.149 . . . . 1.5600000000000001 109.65 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.81 46.47 2.35 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.417 -1.473 . . . . 0.28999999999999998 109.417 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.84 148.73 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -1.037 . . . . 1.0700000000000001 108.564 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.76 126.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.297 -0.877 . . . . 1.0900000000000001 109.697 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.19 139.42 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.156 -1.053 . . . . 1.0700000000000001 108.156 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.1 pt -141.2 178.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.04 110.408 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -143.69 111.29 5.96 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.892 -1.151 . . . . 2.3399999999999999 107.892 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.56 -78.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.851 -1.166 . . . . 1.1799999999999999 107.851 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -80.39 -128.47 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.802 -1.555 . . . . 2.4700000000000002 106.802 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 51.1 m -105.38 51.37 0.76 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.961 -1.126 . . . . 1.8700000000000001 107.961 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.16 134.4 11.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.009 -0.737 . . . . 1.1200000000000001 109.009 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.488 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 10.5 mt -93.52 144.89 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 1.1499999999999999 109.306 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.06 162.88 34.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.318 -0.864 . . . . 2.6299999999999999 110.056 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.77 131.3 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.536 -0.727 . . . . 1.0800000000000001 109.212 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.09 133.26 20.69 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.698 -0.853 . . . . 1.0700000000000001 108.698 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.8 147.46 80.75 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.521 0.814 . . . . 0.48999999999999999 109.993 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.29 -37.52 77.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 3.5800000000000001 109.359 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -70.84 1.81 5.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.72 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -118.93 12.0 12.71 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.581 -0.896 . . . . 2.5800000000000001 108.581 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.75 170.05 16.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.679 . . . . 1.05 109.657 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.47 130.11 27.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.339 -0.85 . . . . 2.2599999999999998 108.984 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.76 115.2 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.416 -0.803 . . . . 1.1799999999999999 109.749 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.9 mm -112.12 155.04 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.383 -0.823 . . . . 1.28 109.141 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.517 -0.739 . . . . 4.1799999999999997 109.278 179.761 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.128 -0.693 . . . . 2.0099999999999998 109.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -134.52 130.39 36.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.578 -0.701 . . . . 0.81999999999999995 109.145 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' B' ' 224' ' ' ARG . 0.4 OUTLIER -105.69 159.53 15.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.347 -0.983 . . . . 3.7799999999999998 108.347 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -142.28 140.72 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 1.0600000000000001 110.581 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -106.95 152.55 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.241 -1.392 . . . . 0.92000000000000004 107.241 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.8 p90 -156.71 151.47 25.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.595 -1.315 . . . . 1.01 110.562 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -95.09 143.53 26.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.641 -0.662 . . . . 3.3900000000000001 109.847 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.66 173.35 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 2.23 109.066 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.36 -9.91 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 2.3300000000000001 109.426 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.76 -12.95 43.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 4.1900000000000004 109.505 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -158.37 128.44 3.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.115 -0.991 . . . . 2.1600000000000001 108.732 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.29 1.99 2.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.948 1.099 . . . . 1.3999999999999999 111.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 14.7 p -84.5 166.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.59 -1.319 . . . . 2.3100000000000001 110.386 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.431 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 98.8 m95 -71.92 161.97 30.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.665 -0.865 . . . . 0.72999999999999998 108.665 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.79 162.0 19.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.383 -0.823 . . . . 1.96 109.211 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.65 164.82 0.02 OUTLIER Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.376 -1.089 . . . . 0.56000000000000005 110.376 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.39 160.67 46.68 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.484 1.456 . . . . 0.46999999999999997 110.179 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.54 175.53 9.49 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.791 -0.818 . . . . 1.05 108.791 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -96.02 138.78 33.15 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.167 -0.958 . . . . 3.1899999999999999 109.717 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.02 122.84 32.1 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 1.0900000000000001 109.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.1 mt -116.4 -72.79 0.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.423 -0.798 . . . . 1.1799999999999999 110.285 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.488 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.7 t90 -90.11 139.9 30.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.08 -1.013 . . . . 0.34999999999999998 110.268 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.54 7.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.285 -0.885 . . . . 2.7999999999999998 109.073 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.22 -99.76 0.17 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.901 -1.28 . . . . 0.29999999999999999 109.901 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.44 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -1.103 . . . . 1.5600000000000001 109.702 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 46.45 2.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.381 -1.488 . . . . 0.28999999999999998 109.381 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.78 148.63 34.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.443 -1.034 . . . . 1.0700000000000001 108.522 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.77 126.37 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.267 -0.896 . . . . 1.0900000000000001 109.732 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.13 139.52 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.227 -1.027 . . . . 1.0800000000000001 108.227 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.1 pt -141.24 178.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.207 -0.933 . . . . 1.04 110.464 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -143.65 111.31 5.98 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.985 -1.117 . . . . 2.3399999999999999 107.985 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.62 -78.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.783 -1.192 . . . . 1.1799999999999999 107.783 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.43 -128.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.767 -1.568 . . . . 2.4700000000000002 106.767 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 51.0 m -105.42 51.34 0.76 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.972 -1.122 . . . . 1.8600000000000001 107.972 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.09 134.43 11.51 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.053 -0.721 . . . . 1.1200000000000001 109.053 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 10.7 mt -93.48 145.01 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.183 -0.948 . . . . 1.1499999999999999 109.48 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.15 162.93 34.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 2.6400000000000001 109.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.76 131.27 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 1.0800000000000001 109.186 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.02 133.34 20.83 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.67 -0.863 . . . . 1.0800000000000001 108.67 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.7 147.47 79.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.534 0.822 . . . . 0.48999999999999999 110.027 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.47 -37.26 77.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 3.5800000000000001 109.392 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -71.01 1.96 5.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 4.3600000000000003 110.77 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -119.03 12.01 12.62 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.547 -0.909 . . . . 2.5800000000000001 108.547 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.84 169.99 16.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 1.05 109.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.43 130.13 27.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.448 -0.783 . . . . 2.2599999999999998 108.989 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.77 115.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.41 -0.806 . . . . 1.1799999999999999 109.753 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -111.95 155.03 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.44 -0.788 . . . . 1.27 109.178 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -91.46 136.24 33.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.572 -0.705 . . . . 4.1799999999999997 109.285 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.01 . . . . 2.0499999999999998 109.555 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 109.588 -0.523 . . . . 2.0099999999999998 109.588 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -136.07 135.46 39.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.525 -0.734 . . . . 0.81999999999999995 109.466 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.53 156.94 20.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.215 -1.402 . . . . 3.79 107.215 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.14 141.79 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.008 -1.058 . . . . 1.05 110.716 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.44 152.55 25.23 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.406 -1.331 . . . . 0.92000000000000004 107.406 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 17.6 p90 -155.91 158.58 38.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 1.01 110.673 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -102.02 143.72 31.51 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.425 0.631 . . . . 3.3999999999999999 109.606 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 230' ' ' SER . 10.3 t70 -97.92 173.12 7.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.455 -0.778 . . . . 2.23 109.131 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 57.3 m -86.99 -5.67 59.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 2.3199999999999998 109.406 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 231' ' ' ARG . 20.7 mtm-85 -88.59 -19.69 25.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.224 -0.923 . . . . 4.1799999999999997 109.614 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.0 m-20 -162.54 129.86 2.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 2.1600000000000001 108.813 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -65.89 5.61 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 120.779 0.986 . . . . 1.3899999999999999 110.698 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 232' ' ' ASP . 5.4 m -83.0 127.51 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.821 -1.174 . . . . 2.3100000000000001 109.993 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -48.28 164.4 0.05 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.25 -0.906 . . . . 0.71999999999999997 109.551 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.8 mtpt -118.97 167.32 11.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.842 -0.799 . . . . 1.96 108.842 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -48.04 174.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.024 -1.231 . . . . 0.55000000000000004 110.024 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.17 159.47 53.73 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.69 1.594 . . . . 0.46999999999999997 110.502 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 172.17 13.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.101 -0.704 . . . . 1.05 109.101 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.61 33.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.112 -0.992 . . . . 3.1899999999999999 109.573 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.78 125.32 34.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.52 -0.737 . . . . 1.0900000000000001 109.493 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.0 mt -116.53 -74.54 0.6 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.397 -0.815 . . . . 1.1799999999999999 110.209 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.71 141.55 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.34000000000000002 109.988 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -145.94 118.72 8.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.831 . . . . 2.79 109.103 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.32 -104.77 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.723 -1.227 . . . . 0.28999999999999998 110.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -68.85 -153.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 1.5600000000000001 109.812 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.23 50.32 2.73 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.28999999999999998 109.633 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.05 151.91 36.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -1.106 . . . . 1.0700000000000001 108.917 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.24 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.97 . . . . 1.0900000000000001 109.546 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -87.05 138.24 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.236 -1.024 . . . . 1.0700000000000001 108.236 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.92 177.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -0.922 . . . . 1.04 110.095 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -144.69 110.3 5.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.687 -0.857 . . . . 2.3399999999999999 108.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.57 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.577 -1.268 . . . . 1.1799999999999999 107.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.8 -130.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.636 -1.616 . . . . 2.4700000000000002 106.636 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 m -105.27 55.68 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.959 -1.126 . . . . 1.8700000000000001 107.959 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.939 -0.763 . . . . 1.1200000000000001 108.939 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.7 mt -92.65 139.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -0.872 . . . . 1.1499999999999999 109.524 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.21 166.97 23.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 2.6299999999999999 109.976 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.78 138.34 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.528 -0.916 . . . . 1.0800000000000001 108.528 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.11 133.1 20.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.834 . . . . 1.0700000000000001 109.35 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.43 139.12 89.35 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.798 -0.885 . . . . 0.48999999999999999 109.798 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.48 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.6 OUTLIER -58.9 -34.72 72.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 3.5800000000000001 109.424 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 263' ' ' ARG . 18.8 ttm-85 -69.36 -2.87 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 4.3600000000000003 109.731 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.46 17.09 13.8 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.335 -0.853 . . . . 2.5800000000000001 109.095 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.18 170.92 14.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 1.05 109.903 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -140.39 131.51 26.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.243 -0.91 . . . . 2.2599999999999998 109.17 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.73 107.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.139 -0.976 . . . . 1.1799999999999999 109.508 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.96 150.63 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.172 -1.047 . . . . 1.28 108.172 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.427 -0.796 . . . . 4.1799999999999997 109.127 179.633 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 109.539 -0.541 . . . . 2.0099999999999998 109.539 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -136.04 135.51 39.47 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.432 -0.793 . . . . 0.81999999999999995 109.508 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.48 156.88 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.292 -1.373 . . . . 3.7799999999999998 107.292 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 91.7 t -141.07 141.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.995 -1.066 . . . . 1.0600000000000001 110.661 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.41 152.52 25.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.353 -1.351 . . . . 0.92000000000000004 107.353 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 17.4 p90 -155.84 158.65 38.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.633 -1.292 . . . . 1.01 110.602 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -102.04 143.77 31.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.405 0.621 . . . . 3.3900000000000001 109.645 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 230' ' ' SER . 10.2 t70 -97.84 173.03 7.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.413 -0.804 . . . . 2.23 109.188 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 m -86.85 -5.73 59.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 2.3300000000000001 109.499 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.458 HH11 ' HG3' ' B' ' 231' ' ' ARG . 20.7 mtm-85 -88.47 -19.89 25.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.924 . . . . 4.1900000000000004 109.57 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.2 m-20 -162.46 129.84 2.63 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 2.1600000000000001 108.906 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.93 5.69 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 120.8 1.0 . . . . 1.3999999999999999 110.623 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' B' ' 232' ' ' ASP . 5.4 m -83.11 127.56 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.796 -1.19 . . . . 2.3100000000000001 110.014 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -48.29 164.44 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.214 -0.929 . . . . 0.72999999999999998 109.601 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.8 mtpt -119.0 167.23 11.95 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.863 -0.791 . . . . 1.96 108.863 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -48.06 174.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.997 -1.241 . . . . 0.56000000000000005 109.997 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.24 159.49 53.59 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.697 1.598 . . . . 0.46999999999999997 110.509 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.87 172.23 13.32 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.024 -0.732 . . . . 1.05 109.024 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.63 33.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.114 -0.991 . . . . 3.1899999999999999 109.535 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.89 125.44 34.94 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.516 -0.74 . . . . 1.0900000000000001 109.409 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.4 mt -116.65 -74.62 0.6 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.4 -0.812 . . . . 1.1799999999999999 110.103 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.66 141.55 28.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.34999999999999998 110.014 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -146.0 118.72 8.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.368 -0.833 . . . . 2.7999999999999998 109.147 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -104.79 0.23 Allowed Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.805 -1.188 . . . . 0.29999999999999999 110.195 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -68.83 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.297 -1.12 . . . . 1.5600000000000001 109.816 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.24 50.27 2.73 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.373 . . . . 0.28999999999999998 109.666 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.08 151.86 36.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -1.12 . . . . 1.0700000000000001 108.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.11 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.125 -0.985 . . . . 1.0900000000000001 109.586 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.97 138.16 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.244 -1.021 . . . . 1.0800000000000001 108.244 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.89 177.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 1.04 110.099 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.63 110.3 5.31 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.654 -0.869 . . . . 2.3399999999999999 108.654 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.65 -81.6 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.542 -1.281 . . . . 1.1799999999999999 107.542 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.73 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.593 -1.632 . . . . 2.4700000000000002 106.593 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.6 m -105.33 55.64 0.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.99 -1.115 . . . . 1.8600000000000001 107.99 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 1.1200000000000001 108.901 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 23.6 mt -92.57 139.15 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 1.1499999999999999 109.574 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.22 166.87 23.51 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 2.6400000000000001 110.023 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.76 138.4 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.569 -0.9 . . . . 1.0800000000000001 108.569 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.19 133.08 20.43 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 1.0800000000000001 109.312 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.38 139.16 89.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.769 -0.897 . . . . 0.48999999999999999 109.769 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' B' ' 262' ' ' ARG . 0.7 OUTLIER -58.98 -34.83 72.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 3.5800000000000001 109.351 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' B' ' 263' ' ' ARG . 18.9 ttm-85 -69.24 -2.81 11.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 4.3600000000000003 109.793 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.53 17.16 13.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.318 -0.863 . . . . 2.5800000000000001 109.116 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.3 170.86 14.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 1.05 109.943 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -140.36 131.49 26.4 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.356 -0.84 . . . . 2.2599999999999998 109.188 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.76 107.5 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.114 -0.991 . . . . 1.1799999999999999 109.51 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.8 150.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.267 -1.012 . . . . 1.27 108.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.407 ' NH1' ' HG2' ' B' ' 269' ' ' ARG . 6.0 tpt180 -90.98 145.21 24.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -0.785 . . . . 4.1799999999999997 109.086 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.029 -0.986 . . . . 2.0499999999999998 109.547 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.706 -0.85 . . . . 2.0099999999999998 108.706 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -133.89 145.21 49.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 0.81999999999999995 109.479 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -119.71 154.03 34.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.851 -1.166 . . . . 3.79 107.851 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -138.87 146.45 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.079 -1.013 . . . . 1.05 111.012 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.17 155.78 24.39 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.261 -1.385 . . . . 0.92000000000000004 107.261 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.8 p90 -157.43 150.86 23.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.578 -1.326 . . . . 1.01 110.465 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 228' ' ' ARG . 8.1 mtm-85 -93.04 146.44 23.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.476 -0.765 . . . . 3.3999999999999999 109.306 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.84 167.41 11.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -0.9 . . . . 2.23 108.917 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.7 t -83.18 -10.54 58.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 2.3199999999999998 109.24 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -89.96 -11.08 42.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 4.1799999999999997 109.622 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 234' ' ' VAL . 18.8 t0 -160.41 127.36 2.58 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 2.1600000000000001 108.768 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.63 6.83 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.721 0.948 . . . . 1.3899999999999999 110.269 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 232' ' ' ASP . 40.4 t -83.69 161.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 2.3100000000000001 109.85 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.4 ' CZ3' ' NZ ' ' A' ' 266' ' ' LYS . 99.5 m95 -74.17 161.62 29.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.803 . . . . 0.71999999999999997 109.076 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.3 tttp -118.92 160.86 21.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.383 -0.823 . . . . 1.96 109.25 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.0 167.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.6 -1.0 . . . . 0.55000000000000004 110.6 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.37 157.91 57.85 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.681 1.588 . . . . 0.46999999999999997 110.568 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.36 170.0 16.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.969 -0.752 . . . . 1.05 108.969 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 138.73 31.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.067 -1.02 . . . . 3.1899999999999999 109.745 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.98 120.46 30.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.133 -0.691 . . . . 1.0900000000000001 109.133 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.0 mt -111.12 -72.5 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.401 -0.812 . . . . 1.1799999999999999 110.282 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.26 143.94 25.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.165 -0.959 . . . . 0.34000000000000002 110.15 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.58 122.14 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.297 -0.877 . . . . 2.79 109.278 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.57 -103.78 0.21 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.081 -1.208 . . . . 0.28999999999999998 110.081 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.62 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -1.124 . . . . 1.5600000000000001 109.712 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 49.5 2.91 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.253 -1.539 . . . . 0.28999999999999998 109.253 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.71 35.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -1.035 . . . . 1.0700000000000001 108.704 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.03 124.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.991 . . . . 1.0900000000000001 109.809 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.0 137.04 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.079 -1.082 . . . . 1.0700000000000001 108.079 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.73 -179.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.861 . . . . 1.04 110.234 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.474 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -144.15 111.93 6.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.709 -0.848 . . . . 2.3399999999999999 108.709 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.36 -78.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.491 -1.3 . . . . 1.1799999999999999 107.491 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.64 -132.19 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.695 -1.594 . . . . 2.4700000000000002 106.695 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.7 m -103.66 54.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.031 -1.1 . . . . 1.8700000000000001 108.031 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.81 126.99 6.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 1.1200000000000001 109.283 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.474 ' CG1' HE21 ' A' ' 252' ' ' GLN . 26.9 mt -92.71 137.0 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 1.1499999999999999 109.286 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.49 171.86 13.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 2.6299999999999999 109.743 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.92 137.47 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.372 -0.83 . . . . 1.0800000000000001 109.359 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -136.94 125.22 14.8 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.401 -0.812 . . . . 1.0700000000000001 108.974 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.46 143.75 93.54 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.527 0.818 . . . . 0.48999999999999999 110.242 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.04 -32.54 72.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 3.5800000000000001 109.387 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -68.71 -7.69 35.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.338 -0.851 . . . . 4.3600000000000003 110.672 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -119.05 19.59 12.92 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.175 -0.953 . . . . 2.5800000000000001 109.451 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.01 168.9 18.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.52 -0.737 . . . . 1.05 109.589 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.4 ' NZ ' ' CZ3' ' A' ' 235' ' ' TRP . 29.0 mtmm -137.62 127.27 25.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 2.2599999999999998 109.049 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.4 mm -88.15 107.91 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.223 -0.923 . . . . 1.1799999999999999 110.15 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.5 mm -105.7 151.51 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.398 -0.964 . . . . 1.28 108.398 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.303 -0.873 . . . . 4.1799999999999997 109.053 179.349 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.696 -0.853 . . . . 2.0099999999999998 108.696 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.03 145.14 49.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.522 -0.736 . . . . 0.81999999999999995 109.449 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' B' ' 224' ' ' ARG . 0.3 OUTLIER -119.69 154.05 34.66 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.807 -1.183 . . . . 3.7799999999999998 107.807 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.94 146.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.116 -0.99 . . . . 1.0600000000000001 110.987 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -113.13 155.89 24.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.226 -1.398 . . . . 0.92000000000000004 107.226 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.435 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 14.1 p90 -157.43 151.02 24.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.572 -1.33 . . . . 1.01 110.42 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.1 mtm-85 -93.14 146.54 23.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 3.3900000000000001 109.291 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.89 167.38 11.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 2.23 108.931 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.8 t -83.16 -10.52 58.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 2.3300000000000001 109.278 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -90.06 -10.96 42.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 4.1900000000000004 109.592 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' B' ' 234' ' ' VAL . 18.7 t0 -160.44 127.31 2.56 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.1600000000000001 108.782 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.49 6.72 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 120.814 1.009 . . . . 1.3999999999999999 110.322 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.431 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.3 t -83.74 161.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 2.3100000000000001 109.893 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.06 161.55 29.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.72999999999999998 109.063 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.91 160.86 21.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.41 -0.806 . . . . 1.96 109.285 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.86 166.98 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.578 -1.009 . . . . 0.56000000000000005 110.578 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -66.33 157.91 57.77 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.767 1.644 . . . . 0.46999999999999997 110.543 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.42 169.97 16.78 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.99 -0.745 . . . . 1.05 108.99 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 138.79 31.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.107 -0.996 . . . . 3.1899999999999999 109.699 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.3 tp -88.97 120.52 30.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 1.0900000000000001 109.172 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.1 mt -111.23 -72.56 0.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.317 -0.864 . . . . 1.1799999999999999 110.246 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.28 143.81 26.03 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.34999999999999998 110.152 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -148.42 122.16 9.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 2.7999999999999998 109.314 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.6 -103.71 0.21 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.096 -1.202 . . . . 0.29999999999999999 110.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.61 -153.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -1.136 . . . . 1.5600000000000001 109.7 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.16 49.48 2.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.234 -1.546 . . . . 0.28999999999999998 109.234 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.75 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -1.061 . . . . 1.0700000000000001 108.781 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.98 124.49 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.182 -0.949 . . . . 1.0900000000000001 109.725 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.06 137.0 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.06 -1.089 . . . . 1.0800000000000001 108.06 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.64 -179.77 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.221 -0.924 . . . . 1.04 110.252 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.486 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -144.18 111.86 6.12 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 2.3399999999999999 108.705 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -90.21 -78.57 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.484 -1.302 . . . . 1.1799999999999999 107.484 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.66 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.641 -1.614 . . . . 2.4700000000000002 106.641 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.3 m -103.77 54.3 0.74 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.936 -1.135 . . . . 1.8600000000000001 107.936 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.85 126.9 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.529 -0.732 . . . . 1.1200000000000001 109.245 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.486 ' CG1' HE21 ' B' ' 252' ' ' GLN . 27.2 mt -92.65 137.03 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 1.1499999999999999 109.272 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -137.45 171.84 13.87 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.406 -0.809 . . . . 2.6400000000000001 109.728 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 137.51 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 109.396 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 55.1 t -136.97 125.2 14.75 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 108.931 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.48 143.72 93.69 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.48 0.787 . . . . 0.48999999999999999 110.298 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 3.5800000000000001 109.46 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -68.77 -7.63 35.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.227 -0.921 . . . . 4.3600000000000003 110.705 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -119.17 19.78 12.79 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.191 -0.943 . . . . 2.5800000000000001 109.436 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.1 168.85 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 1.05 109.559 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -137.55 127.35 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.341 -0.85 . . . . 2.2599999999999998 109.024 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.18 107.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.207 -0.933 . . . . 1.1799999999999999 110.201 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -105.59 151.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.482 -0.933 . . . . 1.27 108.482 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.13 149.36 21.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.374 -0.829 . . . . 4.1799999999999997 109.147 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.0499999999999998 109.49 179.872 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.366 0.603 . . . . 2.0099999999999998 109.421 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.73 131.23 35.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.41 -0.806 . . . . 0.81999999999999995 109.145 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.94 156.62 17.29 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.05 -1.093 . . . . 3.79 108.05 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.63 143.37 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.102 -0.999 . . . . 1.05 110.39 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 226' ' ' TYR . 22.6 m-85 -114.05 155.46 25.9 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.754 -1.202 . . . . 0.92000000000000004 107.754 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.0 p90 -156.8 150.2 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.781 -1.199 . . . . 1.01 110.353 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -96.21 152.64 18.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 3.3999999999999999 109.699 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.7 170.44 9.32 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.38 -0.97 . . . . 2.23 108.38 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.91 -12.44 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 2.3199999999999998 109.225 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.68 -11.34 40.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.369 -0.832 . . . . 4.1799999999999997 110.067 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 1.8 p30 -157.21 129.78 4.26 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.94 -1.1 . . . . 2.1600000000000001 109.922 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.18 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 120.907 1.071 . . . . 1.3899999999999999 110.659 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -82.53 142.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.779 -1.201 . . . . 2.3100000000000001 109.74 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.93 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.71999999999999997 108.981 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.36 -161.14 1.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.96 108.623 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.31 166.96 54.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.469 . . . . 0.55000000000000004 109.429 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.92 159.35 53.62 Favored 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.408 1.405 . . . . 0.46999999999999997 109.88 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.93 171.78 14.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.506 -0.746 . . . . 1.05 108.989 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.52 140.38 29.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.012 . . . . 3.1899999999999999 109.212 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.97 125.14 34.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.672 -0.642 . . . . 1.0900000000000001 109.718 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.3 -75.09 0.6 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.365 -0.834 . . . . 1.1799999999999999 110.46 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 30.1 t90 -91.7 146.29 23.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.128 -0.982 . . . . 0.34000000000000002 110.856 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.66 124.87 14.55 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.814 -0.809 . . . . 2.79 108.814 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.34 -116.13 0.54 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.087 -1.205 . . . . 0.28999999999999998 110.087 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.59 -149.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -1.07 . . . . 1.5600000000000001 109.449 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 52.92 3.43 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.312 -1.515 . . . . 0.28999999999999998 109.312 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.44 147.45 27.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.957 . . . . 1.0700000000000001 108.613 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.97 135.28 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.068 -1.02 . . . . 1.0900000000000001 109.873 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.84 140.59 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.64 -0.874 . . . . 1.0700000000000001 108.64 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.72 179.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 1.04 110.285 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.67 111.79 6.52 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.558 -0.905 . . . . 2.3399999999999999 108.558 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.03 -77.65 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.41 -1.329 . . . . 1.1799999999999999 107.41 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -81.77 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.72 -1.585 . . . . 2.4700000000000002 106.72 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.93 54.49 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.079 -1.082 . . . . 1.8700000000000001 108.079 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.41 130.43 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.492 -0.755 . . . . 1.1200000000000001 109.328 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.448 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 97.9 mt -94.4 139.22 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 1.1499999999999999 109.718 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.39 164.84 28.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 2.6299999999999999 109.536 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.02 136.5 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.572 -0.899 . . . . 1.0800000000000001 108.572 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.0 t -134.96 123.01 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 1.0700000000000001 109.597 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -53.57 144.5 51.81 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.809 1.006 . . . . 0.48999999999999999 110.839 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.54 -20.31 65.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.564 -0.71 . . . . 3.5800000000000001 109.143 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -66.98 -17.89 65.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 4.3600000000000003 111.64 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.89 28.67 5.55 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.979 -1.076 . . . . 2.5800000000000001 109.702 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.11 159.52 40.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.841 -0.8 . . . . 1.05 108.841 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.451 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 6.3 mtmp? -139.31 130.29 26.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 2.2599999999999998 109.635 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.83 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 1.1799999999999999 109.593 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.26 160.39 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.661 -0.866 . . . . 1.28 108.661 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.0 mtt-85 . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.31 -0.868 . . . . 4.1799999999999997 109.705 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 109.449 -0.574 . . . . 2.0099999999999998 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . 0.408 ' CA ' ' OD1' ' B' ' 270' ' ' ASP . 39.8 m-85 -135.71 131.16 35.27 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.112 -0.699 . . . . 0.81999999999999995 109.112 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.91 156.61 17.28 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.139 -1.06 . . . . 3.7799999999999998 108.139 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 61.6 t -141.58 143.43 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.144 -0.972 . . . . 1.0600000000000001 110.326 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 226' ' ' TYR . 22.0 m-85 -114.06 155.52 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.821 -1.178 . . . . 0.92000000000000004 107.821 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.9 p90 -156.89 150.16 24.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.802 -1.186 . . . . 1.01 110.321 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -96.2 152.5 18.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.336 -0.853 . . . . 3.3900000000000001 109.763 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.67 170.52 9.27 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.402 -0.962 . . . . 2.23 108.402 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.95 -12.44 53.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.981 -1.074 . . . . 2.3300000000000001 109.198 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.72 -11.41 39.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.316 -0.865 . . . . 4.1900000000000004 109.985 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.8 p30 -157.14 129.78 4.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.992 -1.067 . . . . 2.1600000000000001 109.985 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.13 6.76 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 120.989 1.126 . . . . 1.3999999999999999 110.627 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.57 142.69 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.762 -1.211 . . . . 2.3100000000000001 109.688 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -60.93 -172.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.72999999999999998 109.015 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.46 -161.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.214 -0.929 . . . . 1.96 108.604 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.25 166.96 54.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.433 -1.467 . . . . 0.56000000000000005 109.433 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.94 159.35 53.6 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.402 1.401 . . . . 0.46999999999999997 109.847 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.94 171.76 14.03 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 1.05 109.005 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.46 140.46 29.55 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.947 . . . . 3.1899999999999999 109.184 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.3 tp -89.07 125.16 34.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.617 -0.677 . . . . 1.0900000000000001 109.791 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.6 mt -114.32 -75.03 0.6 Allowed 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.302 -0.874 . . . . 1.1799999999999999 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 29.8 t90 -91.78 146.3 23.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.223 -0.923 . . . . 0.34999999999999998 110.887 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.62 124.86 14.57 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.89 -0.781 . . . . 2.7999999999999998 108.89 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -116.15 0.54 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.029 -1.228 . . . . 0.29999999999999999 110.029 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -67.45 -149.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.489 -1.007 . . . . 1.5600000000000001 109.595 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.25 52.99 3.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.38 -1.488 . . . . 0.28999999999999998 109.38 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.41 147.43 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.483 -1.01 . . . . 1.0700000000000001 108.626 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 135.34 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.947 -1.095 . . . . 1.0900000000000001 109.837 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.89 140.64 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 1.0800000000000001 108.6 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.82 179.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.17 -0.956 . . . . 1.04 110.211 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.57 111.8 6.56 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.577 -0.898 . . . . 2.3399999999999999 108.577 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.04 -77.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.482 -1.303 . . . . 1.1799999999999999 107.482 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -81.65 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.788 -1.56 . . . . 2.4700000000000002 106.788 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.99 54.5 0.71 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.062 -1.088 . . . . 1.8600000000000001 108.062 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.39 130.37 7.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.1200000000000001 109.347 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 97.9 mt -94.28 139.3 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 1.1499999999999999 109.669 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -139.51 164.8 28.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.468 -0.77 . . . . 2.6400000000000001 109.489 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.93 136.44 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.588 -0.893 . . . . 1.0800000000000001 108.588 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 71.8 t -134.99 122.98 15.55 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.373 -0.83 . . . . 1.0800000000000001 109.579 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -53.49 144.54 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.801 1.001 . . . . 0.48999999999999999 110.927 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.59 -20.35 65.99 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.557 -0.714 . . . . 3.5800000000000001 109.099 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.85 -18.07 65.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 4.3600000000000003 111.631 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.82 28.65 5.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.005 -1.06 . . . . 2.5800000000000001 109.68 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.04 159.6 40.3 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.803 -0.814 . . . . 1.05 108.803 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.46 ' HZ3' ' CB ' ' B' ' 266' ' ' LYS . 6.3 mtmp? -139.3 130.3 26.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.169 -0.957 . . . . 2.2599999999999998 109.675 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.86 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 1.1799999999999999 109.627 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.2 mm -105.37 160.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.644 -0.872 . . . . 1.27 108.644 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.32 26.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 4.1799999999999997 109.719 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.408 ' OD1' ' CA ' ' B' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.043 -1.035 . . . . 2.0499999999999998 108.965 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.003 -0.74 . . . . 2.0099999999999998 109.003 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.54 125.67 26.15 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.235 -0.916 . . . . 0.81999999999999995 109.788 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.02 164.46 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.756 -1.202 . . . . 3.79 107.756 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.02 141.65 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 1.05 109.972 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -108.83 151.98 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.523 -1.288 . . . . 0.92000000000000004 107.523 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.2 p90 -153.73 152.23 30.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.77 -1.206 . . . . 1.01 110.332 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -94.13 153.14 18.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 3.3999999999999999 110.245 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -92.3 171.09 9.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.2 t -87.77 -10.95 49.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.02 -1.05 . . . . 2.3199999999999998 109.548 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -90.01 -14.51 33.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 4.1799999999999997 109.611 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 234' ' ' VAL . 47.3 m-20 -161.3 130.57 3.19 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 2.1600000000000001 109.29 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -65.93 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.804 1.003 . . . . 1.3899999999999999 110.553 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 232' ' ' ASP . 21.7 m -83.48 140.37 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.846 -1.159 . . . . 2.3100000000000001 109.736 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -60.68 167.21 2.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.71999999999999997 109.516 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 237' ' ' GLY . 29.8 tttm -125.78 162.78 24.33 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.488 -0.757 . . . . 1.96 109.267 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.07 166.55 0.03 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.503 -1.039 . . . . 0.55000000000000004 110.503 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.6 159.48 53.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.782 1.655 . . . . 0.46999999999999997 110.458 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.22 5.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.05 109.164 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.95 138.95 34.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.029 -1.045 . . . . 3.1899999999999999 109.835 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.7 tp -88.77 123.7 33.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.438 -0.788 . . . . 1.0900000000000001 109.494 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.67 -74.51 0.61 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.474 -0.766 . . . . 1.1799999999999999 110.286 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.36 143.62 26.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.139 -0.975 . . . . 0.34000000000000002 110.191 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -147.53 118.53 7.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.875 . . . . 2.79 108.977 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.91 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.717 -1.23 . . . . 0.28999999999999998 110.471 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -68.65 -153.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.269 -1.136 . . . . 1.5600000000000001 109.917 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.46 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.139 -1.585 . . . . 0.28999999999999998 109.139 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.83 155.15 40.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -1.099 . . . . 1.0700000000000001 109.189 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.37 126.33 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 1.0900000000000001 109.307 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.54 137.85 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.004 -1.11 . . . . 1.0700000000000001 108.004 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 24.5 pt -141.97 179.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 1.04 110.344 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.455 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -142.17 114.04 8.03 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.654 -0.869 . . . . 2.3399999999999999 108.654 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.19 -80.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.28 -1.378 . . . . 1.1799999999999999 107.28 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 255' ' ' SER . 33.2 t30 -80.71 -130.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.572 -1.64 . . . . 2.4700000000000002 106.572 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.562 ' H ' ' ND2' ' A' ' 254' ' ' ASN . 75.4 m -104.13 53.74 0.74 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.161 -0.962 . . . . 1.8700000000000001 108.493 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.09 127.7 7.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.542 -0.723 . . . . 1.1200000000000001 109.293 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.455 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.7 mt -92.66 136.38 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.1499999999999999 109.493 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.1 172.15 13.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.234 -0.916 . . . . 2.6299999999999999 109.873 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.91 137.29 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.479 -0.763 . . . . 1.0800000000000001 109.935 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.05 130.21 19.32 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.423 -0.798 . . . . 1.0700000000000001 108.95 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.48 142.25 97.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 109.706 -0.921 . . . . 0.48999999999999999 109.706 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -63.63 -30.11 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.149 -0.97 . . . . 3.5800000000000001 109.15 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.91 -10.77 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.38 -0.825 . . . . 4.3600000000000003 109.873 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -119.48 25.44 10.06 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.382 -0.824 . . . . 2.5800000000000001 108.883 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.494 -0.754 . . . . 1.05 109.833 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 6.7 mtmp? -139.13 130.75 27.32 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 108.812 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.91 109.07 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 1.1799999999999999 110.475 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -108.74 147.8 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.131 -1.062 . . . . 1.28 108.131 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 4.1799999999999997 109.921 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.06 -0.718 . . . . 2.0099999999999998 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.51 125.59 26.06 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.239 -0.913 . . . . 0.81999999999999995 109.743 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.92 164.53 12.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.793 -1.188 . . . . 3.7799999999999998 107.793 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.1 141.63 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 1.0600000000000001 110.01 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.87 152.0 25.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.558 -1.275 . . . . 0.92000000000000004 107.558 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.2 p90 -153.7 152.2 30.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 1.01 110.336 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -94.1 153.13 18.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.541 -0.724 . . . . 3.3900000000000001 110.246 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.5 OUTLIER -92.35 171.06 9.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.438 -0.949 . . . . 2.23 108.438 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 44.3 t -87.65 -11.08 49.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.934 -1.104 . . . . 2.3300000000000001 109.562 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -89.96 -14.46 34.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 4.1900000000000004 109.67 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' B' ' 234' ' ' VAL . 47.1 m-20 -161.31 130.67 3.21 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.108 -0.995 . . . . 2.1600000000000001 109.224 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.01 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 120.828 1.018 . . . . 1.3999999999999999 110.459 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' B' ' 232' ' ' ASP . 21.6 m -83.5 140.36 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.876 -1.14 . . . . 2.3100000000000001 109.762 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -60.69 167.25 2.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.212 -0.93 . . . . 0.72999999999999998 109.609 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' B' ' 237' ' ' GLY . 29.8 tttm -125.76 162.77 24.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.76 . . . . 1.96 109.246 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.14 166.61 0.03 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.477 -1.049 . . . . 0.56000000000000005 110.477 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.66 159.54 53.11 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.691 1.594 . . . . 0.46999999999999997 110.491 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.16 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.35 -0.844 . . . . 1.05 109.158 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -98.02 139.06 34.41 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.027 -1.046 . . . . 3.1899999999999999 109.923 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -88.93 123.64 33.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.401 -0.812 . . . . 1.0900000000000001 109.504 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.66 -74.44 0.61 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.413 -0.805 . . . . 1.1799999999999999 110.298 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.34 143.61 26.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.174 -0.954 . . . . 0.34999999999999998 110.217 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -147.62 118.57 7.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.258 -0.901 . . . . 2.7999999999999998 108.816 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.95 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.679 -1.248 . . . . 0.29999999999999999 110.518 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.65 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -1.172 . . . . 1.5600000000000001 109.94 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.68 48.4 2.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.186 -1.565 . . . . 0.28999999999999998 109.186 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.18 40.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 1.0700000000000001 109.166 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 26.6 m -146.32 126.33 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 1.0900000000000001 109.296 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.59 137.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.938 -1.134 . . . . 1.0800000000000001 107.938 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 24.4 pt -141.8 179.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 1.04 110.362 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.46 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -142.35 114.08 7.98 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.637 -0.875 . . . . 2.3399999999999999 108.637 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -91.2 -80.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.188 -1.412 . . . . 1.1799999999999999 107.188 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' B' ' 255' ' ' SER . 33.1 t30 -80.72 -130.06 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.612 -1.625 . . . . 2.4700000000000002 106.612 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.571 ' H ' ' ND2' ' B' ' 254' ' ' ASN . 75.5 m -104.16 53.77 0.74 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.135 -0.978 . . . . 1.8600000000000001 108.535 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.07 127.72 8.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.506 -0.746 . . . . 1.1200000000000001 109.329 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.46 ' CG1' HE21 ' B' ' 252' ' ' GLN . 60.8 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.342 -0.849 . . . . 1.1499999999999999 109.438 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.16 172.05 13.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.246 -0.909 . . . . 2.6400000000000001 109.836 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.77 137.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 1.0800000000000001 109.948 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.11 130.2 19.26 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.884 -0.784 . . . . 1.0800000000000001 108.884 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.44 142.32 97.8 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 N-CA-C 109.739 -0.908 . . . . 0.48999999999999999 109.739 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -63.71 -30.16 71.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 3.5800000000000001 109.144 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.96 -10.63 51.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 4.3600000000000003 109.895 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -119.53 25.46 10.03 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.347 -0.846 . . . . 2.5800000000000001 108.825 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.85 161.11 39.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.577 -0.702 . . . . 1.05 109.905 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.416 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 6.7 mtmp? -139.17 130.76 27.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.327 -0.858 . . . . 2.2599999999999998 108.784 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.0 mm -87.96 109.14 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.211 -0.93 . . . . 1.1799999999999999 110.416 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.6 mm -108.83 147.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.184 -1.043 . . . . 1.27 108.184 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.565 HH11 ' CG ' ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.86 18.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.388 -0.82 . . . . 4.1799999999999997 109.938 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 117.977 -1.011 . . . . 2.0499999999999998 109.529 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.786 -0.82 . . . . 2.0099999999999998 108.786 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -117.51 135.13 54.15 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.193 -0.669 . . . . 0.81999999999999995 109.193 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -104.82 159.19 15.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.901 -1.148 . . . . 3.79 107.901 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.98 140.95 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 1.05 110.219 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.83 153.47 24.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.487 -1.301 . . . . 0.92000000000000004 107.487 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.3 p90 -156.38 151.45 26.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 1.01 110.123 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -95.76 143.26 27.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.371 -0.831 . . . . 3.3999999999999999 109.838 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.7 168.34 10.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.818 . . . . 2.23 108.989 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.86 8.82 7.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.984 . . . . 2.3199999999999998 109.297 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.63 -39.22 15.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 4.1799999999999997 109.523 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.3 p-10 -158.22 148.32 15.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.014 . . . . 2.1600000000000001 109.306 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.88 10.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.172 1.248 . . . . 1.3899999999999999 110.958 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.524 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.3 t -83.51 152.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.75 -1.219 . . . . 2.3100000000000001 109.773 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.84 165.04 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.964 -0.754 . . . . 0.71999999999999997 108.964 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.9 tttp -119.38 159.4 24.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.478 -0.764 . . . . 1.96 109.212 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.81 165.99 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.361 -1.095 . . . . 0.55000000000000004 110.361 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.92 161.61 41.6 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.525 1.483 . . . . 0.46999999999999997 110.405 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.23 173.4 11.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.862 -0.792 . . . . 1.05 108.862 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.06 137.01 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.095 -1.003 . . . . 3.1899999999999999 109.608 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.38 123.07 31.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.635 -0.665 . . . . 1.0900000000000001 109.366 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -115.76 -73.51 0.65 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.434 -0.791 . . . . 1.1799999999999999 110.091 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.2 t90 -93.55 146.59 23.69 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.281 -0.887 . . . . 0.34000000000000002 109.974 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -146.86 125.38 12.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 2.79 109.065 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -110.02 0.34 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.824 -1.179 . . . . 0.28999999999999998 110.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.87 -150.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -1.1 . . . . 1.5600000000000001 109.858 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.86 2.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.357 -1.497 . . . . 0.28999999999999998 109.357 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.1 150.7 34.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.509 -0.995 . . . . 1.0700000000000001 108.668 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.56 129.27 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 1.0900000000000001 109.759 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.5 t -89.79 137.41 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.027 -1.101 . . . . 1.0700000000000001 108.027 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.4 pt -141.22 177.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.301 -0.875 . . . . 1.04 109.929 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -144.09 110.75 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.472 -0.936 . . . . 2.3399999999999999 108.472 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.01 -79.12 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.53 -1.285 . . . . 1.1799999999999999 107.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.22 -130.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.48 -1.674 . . . . 2.4700000000000002 106.48 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.9 t -105.26 54.93 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.992 -1.114 . . . . 1.8700000000000001 107.992 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.56 125.48 5.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.166 -0.679 . . . . 1.1200000000000001 109.166 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -92.36 138.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.887 . . . . 1.1499999999999999 109.491 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -140.01 167.08 22.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.393 -0.817 . . . . 2.6299999999999999 109.684 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.82 139.0 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 1.0800000000000001 109.221 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -136.11 134.15 20.07 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 1.0700000000000001 108.916 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.65 142.86 98.83 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 N-CA-C 109.85 -0.865 . . . . 0.48999999999999999 109.85 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 262' ' ' ARG . 6.4 tpt180 -60.69 -34.39 74.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 3.5800000000000001 109.555 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -68.87 -7.1 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.241 -0.912 . . . . 4.3600000000000003 110.846 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -119.0 19.0 13.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.073 -1.017 . . . . 2.5800000000000001 108.839 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.36 168.71 19.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.897 -0.779 . . . . 1.05 108.897 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.43 129.72 23.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.977 . . . . 2.2599999999999998 109.541 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.83 106.03 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.326 -0.859 . . . . 1.1799999999999999 109.721 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.6 152.08 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.231 -0.918 . . . . 1.28 108.815 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.789 . . . . 4.1799999999999997 109.642 179.773 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . 0.422 ' O ' ' OXT' ' B' ' 270' ' ' ASP . 19.3 m-20 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.774 -0.825 . . . . 2.0099999999999998 108.774 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.35 135.24 54.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.573 -0.704 . . . . 0.81999999999999995 109.189 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -104.97 159.11 16.07 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.897 -1.149 . . . . 3.7799999999999998 107.897 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 81.1 t -140.96 140.99 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.185 -0.947 . . . . 1.0600000000000001 110.22 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.79 153.45 24.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.509 -1.293 . . . . 0.92000000000000004 107.509 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.5 p90 -156.36 151.39 26.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.68 -1.263 . . . . 1.01 110.114 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -95.78 143.26 27.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.485 -0.759 . . . . 3.3900000000000001 109.857 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.72 168.32 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 2.23 109.059 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.83 8.79 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 2.3300000000000001 109.301 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.56 -39.21 15.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 4.1900000000000004 109.497 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.3 p-10 -158.34 148.27 15.34 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.147 -0.97 . . . . 2.1600000000000001 109.294 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.85 10.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.222 1.281 . . . . 1.3999999999999999 110.854 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.3 t -83.43 152.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.788 -1.195 . . . . 2.3100000000000001 109.732 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.85 164.99 25.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.474 -0.766 . . . . 0.72999999999999998 109.015 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.8 tttp -119.31 159.4 24.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.444 -0.785 . . . . 1.96 109.241 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.9 165.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.305 -1.118 . . . . 0.56000000000000005 110.305 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.86 161.61 41.44 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.602 1.535 . . . . 0.46999999999999997 110.41 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.31 173.48 11.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.811 -0.811 . . . . 1.05 108.811 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.07 137.06 34.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.124 -0.985 . . . . 3.1899999999999999 109.559 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.56 123.09 32.08 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.7 . . . . 1.0900000000000001 109.345 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.75 -73.5 0.65 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.414 -0.804 . . . . 1.1799999999999999 109.996 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.45 146.61 23.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.91 . . . . 0.34999999999999998 109.979 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -146.9 125.46 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.295 -0.878 . . . . 2.7999999999999998 108.981 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -110.02 0.34 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.755 -1.212 . . . . 0.29999999999999999 110.288 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.85 -150.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -1.062 . . . . 1.5600000000000001 109.863 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 48.94 2.8 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.298 -1.521 . . . . 0.28999999999999998 109.298 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.19 150.64 34.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.461 -1.023 . . . . 1.0700000000000001 108.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.9 m -145.54 129.29 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 1.0900000000000001 109.699 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.73 137.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.096 -1.076 . . . . 1.0800000000000001 108.096 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.29 176.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.317 -0.864 . . . . 1.04 109.907 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -144.09 110.7 5.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.489 -0.93 . . . . 2.3399999999999999 108.489 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.99 -79.17 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.536 -1.283 . . . . 1.1799999999999999 107.536 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.12 -130.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.539 -1.652 . . . . 2.4700000000000002 106.539 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.0 t -105.28 54.86 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.985 -1.117 . . . . 1.8600000000000001 107.985 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.53 125.53 6.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.579 -0.701 . . . . 1.1200000000000001 109.156 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.2 mt -92.41 137.93 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.375 -0.828 . . . . 1.1499999999999999 109.519 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -139.9 167.22 22.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.432 -0.792 . . . . 2.6400000000000001 109.704 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -103.95 138.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.412 -0.805 . . . . 1.0800000000000001 109.203 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.03 134.13 20.16 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 1.0800000000000001 108.966 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.57 142.83 98.58 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 120.597 0.865 . . . . 0.48999999999999999 109.855 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' B' ' 262' ' ' ARG . 6.5 tpt180 -60.7 -34.32 74.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 3.5800000000000001 109.569 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -68.89 -7.19 32.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.27 -0.894 . . . . 4.3600000000000003 110.787 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -118.97 19.02 13.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.227 -0.921 . . . . 2.5800000000000001 108.79 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 168.74 19.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.849 -0.797 . . . . 1.05 108.849 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.44 129.76 23.83 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.139 -0.976 . . . . 2.2599999999999998 109.568 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.81 105.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.26 -0.9 . . . . 1.1799999999999999 109.728 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.67 152.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 1.27 108.737 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 58.7 ttt180 -90.95 146.13 24.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.361 -0.837 . . . . 4.1799999999999997 109.69 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.422 ' OXT' ' O ' ' B' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.933 -1.032 . . . . 2.0499999999999998 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.27 0.557 . . . . 2.0099999999999998 109.657 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.7 130.39 38.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.785 -0.82 . . . . 0.81999999999999995 108.785 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -99.27 150.71 21.82 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.459 -1.311 . . . . 3.79 107.459 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.06 136.47 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.205 -0.935 . . . . 1.05 110.559 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -107.97 156.96 18.64 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.737 -1.209 . . . . 0.92000000000000004 107.737 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.2 p90 -157.84 152.67 25.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.569 -1.332 . . . . 1.01 110.334 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.7 mtm-85 -93.37 144.36 25.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.44 -0.788 . . . . 3.3999999999999999 109.837 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.75 175.4 6.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.405 -0.809 . . . . 2.23 109.328 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.68 -10.75 44.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.188 -0.945 . . . . 2.3199999999999998 109.247 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -89.67 -15.23 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 4.1799999999999997 109.617 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -159.55 129.28 3.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.143 -0.973 . . . . 2.1600000000000001 109.204 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.06 8.57 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 120.8 1.0 . . . . 1.3899999999999999 111.273 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.0 p -85.66 164.15 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.552 -1.342 . . . . 2.3100000000000001 110.291 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -76.03 163.49 27.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.746 -0.596 . . . . 0.71999999999999997 109.532 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 237' ' ' GLY . 2.5 mtpp -118.44 165.16 14.24 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 108.658 -0.867 . . . . 1.96 108.658 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.06 164.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.998 -1.241 . . . . 0.55000000000000004 109.998 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.89 159.97 43.36 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.471 1.447 . . . . 0.46999999999999997 110.659 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.56 164.22 30.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.508 -0.923 . . . . 1.05 108.508 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.67 143.52 26.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.023 -1.048 . . . . 3.1899999999999999 109.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.86 128.36 36.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.45 -0.781 . . . . 1.0900000000000001 110.563 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 mt -119.16 -70.61 0.78 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.515 -0.74 . . . . 1.1799999999999999 110.137 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -91.96 137.85 32.02 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.34000000000000002 110.634 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -144.07 115.72 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.985 -0.746 . . . . 2.79 108.985 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.71 -104.08 0.22 Allowed Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.839 -1.172 . . . . 0.28999999999999998 110.293 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.97 -157.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 1.5600000000000001 109.602 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 47.67 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.037 -1.625 . . . . 0.28999999999999998 109.037 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.34 151.98 38.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.519 -0.989 . . . . 1.0700000000000001 108.769 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.78 134.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 1.0900000000000001 109.435 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -95.5 138.11 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.137 -1.06 . . . . 1.0700000000000001 108.137 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.0 176.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 1.04 109.818 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.68 109.28 5.65 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.455 -0.943 . . . . 2.3399999999999999 108.455 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.7 -77.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.37 -1.344 . . . . 1.1799999999999999 107.37 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.23 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.937 -1.505 . . . . 2.4700000000000002 106.937 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.6 m -97.97 56.06 1.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.681 -1.229 . . . . 1.8700000000000001 107.681 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.56 130.37 7.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 1.1200000000000001 109.46 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.91 135.5 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 1.1499999999999999 109.329 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -136.52 168.99 18.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 2.6299999999999999 109.683 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.99 140.08 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.344 -0.848 . . . . 1.0800000000000001 109.568 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.78 126.1 13.23 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.396 -0.815 . . . . 1.0700000000000001 109.188 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.95 140.56 86.03 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.642 0.895 . . . . 0.48999999999999999 110.237 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -58.97 -37.33 76.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 3.5800000000000001 109.533 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -69.8 -1.64 9.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 4.3600000000000003 110.242 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -118.32 17.04 13.93 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.681 -0.859 . . . . 2.5800000000000001 108.681 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.85 175.14 9.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.421 -0.8 . . . . 1.05 109.724 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.8 128.46 21.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.316 -0.865 . . . . 2.2599999999999998 109.127 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.7 mm -88.74 109.72 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.43 -0.794 . . . . 1.1799999999999999 109.86 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.42 153.61 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.692 -0.855 . . . . 1.28 108.692 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.5 mtt-85 . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.272 -0.892 . . . . 4.1799999999999997 109.883 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.281 0.562 . . . . 2.0099999999999998 109.799 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.6 130.5 38.44 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.756 -0.831 . . . . 0.81999999999999995 108.756 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -99.46 150.68 21.94 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 3.7799999999999998 107.48 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.2 t -139.05 136.64 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.254 -0.904 . . . . 1.0600000000000001 110.476 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.09 157.09 18.57 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.649 -1.241 . . . . 0.92000000000000004 107.649 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.9 152.66 25.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.656 -1.278 . . . . 1.01 110.288 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.7 mtm-85 -93.38 144.39 25.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.374 -0.828 . . . . 3.3900000000000001 109.853 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.79 175.21 6.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.382 -0.824 . . . . 2.23 109.316 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.39 -10.98 44.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.262 -0.899 . . . . 2.3300000000000001 109.259 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -89.65 -15.2 33.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 4.1900000000000004 109.702 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.2 m-20 -159.59 129.28 3.31 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.961 . . . . 2.1600000000000001 109.249 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -65.03 8.35 0.22 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 120.882 1.055 . . . . 1.3999999999999999 111.21 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.0 p -85.4 164.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.557 -1.34 . . . . 2.3100000000000001 110.19 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -76.25 163.51 26.97 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.436 -0.579 . . . . 0.72999999999999998 109.436 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' B' ' 237' ' ' GLY . 2.5 mtpp -118.53 165.15 14.27 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.644 -0.873 . . . . 1.96 108.644 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.15 164.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.184 -1.167 . . . . 0.56000000000000005 110.184 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -64.9 160.0 43.3 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.488 1.459 . . . . 0.46999999999999997 110.643 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.63 164.09 31.12 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.586 -0.894 . . . . 1.05 108.586 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.71 143.63 26.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.007 -1.058 . . . . 3.1899999999999999 109.393 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.5 tp -90.04 128.45 36.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.594 -0.691 . . . . 1.0900000000000001 110.4 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 32.8 mt -119.25 -70.55 0.78 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.573 -0.704 . . . . 1.1799999999999999 110.102 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -92.01 137.86 32.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.152 -0.968 . . . . 0.34999999999999998 110.7 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -144.05 115.83 8.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.8 . . . . 2.7999999999999998 108.929 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -104.15 0.22 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.161 -1.176 . . . . 0.29999999999999999 110.161 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.98 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 1.5600000000000001 109.615 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.63 47.49 2.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.1 -1.6 . . . . 0.28999999999999998 109.1 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.22 151.95 38.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.997 . . . . 1.0700000000000001 108.865 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.79 134.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 109.502 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 89.9 t -95.48 138.04 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.155 -1.054 . . . . 1.0800000000000001 108.155 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.85 176.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.04 109.945 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.61 109.29 5.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.54 -0.911 . . . . 2.3399999999999999 108.54 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.76 -77.35 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.304 -1.369 . . . . 1.1799999999999999 107.304 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.19 -138.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.925 -1.509 . . . . 2.4700000000000002 106.925 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.4 m -97.96 55.98 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.68 -1.23 . . . . 1.8600000000000001 107.68 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.48 130.44 7.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.61 -0.681 . . . . 1.1200000000000001 109.394 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 55.5 mt -95.8 135.61 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 1.1499999999999999 109.307 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.71 169.03 18.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 2.6400000000000001 109.574 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.93 140.02 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 1.0800000000000001 109.611 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 53.3 t -138.69 126.05 13.31 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 1.0800000000000001 109.221 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.81 140.48 85.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 120.616 0.877 . . . . 0.48999999999999999 110.225 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -58.87 -37.33 76.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 3.5800000000000001 109.449 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -69.96 -1.4 9.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.245 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.402 ' HG3' HH12 ' B' ' 228' ' ' ARG . 2.5 mptm? -118.41 16.87 13.86 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.717 -0.846 . . . . 2.5800000000000001 108.717 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.82 175.29 9.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.413 -0.804 . . . . 1.05 109.742 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.9 128.47 21.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.438 -0.789 . . . . 2.2599999999999998 109.122 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -88.78 109.57 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.501 -0.749 . . . . 1.1799999999999999 109.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -105.22 153.59 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 108.742 -0.836 . . . . 1.27 108.742 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' B' ' 269' ' ' ARG . 3.6 mtt-85 -94.57 137.05 34.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.228 -0.92 . . . . 4.1799999999999997 109.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' B' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.045 -1.034 . . . . 2.0499999999999998 109.677 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.273 -0.64 . . . . 2.0099999999999998 109.273 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.34 133.89 43.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.961 -0.755 . . . . 0.81999999999999995 108.961 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.73 158.69 17.39 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.192 -1.04 . . . . 3.79 108.192 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.98 140.04 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 1.05 110.08 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.42 155.43 20.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.72 -1.215 . . . . 0.92000000000000004 107.72 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.5 p90 -156.18 153.79 29.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 1.01 110.345 -179.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.93 141.16 29.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.76 . . . . 3.3999999999999999 109.645 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 9.7 p30 -92.32 162.67 14.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.306 -0.871 . . . . 2.23 109.002 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.3 -2.71 36.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 2.3199999999999998 109.842 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -89.91 -20.73 23.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.181 -0.949 . . . . 4.1799999999999997 109.541 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 234' ' ' VAL . 14.5 m-20 -162.1 130.96 3.03 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.978 . . . . 2.1600000000000001 108.969 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -63.57 8.44 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.751 0.968 . . . . 1.3899999999999999 110.422 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.1 m -82.77 139.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.037 -1.04 . . . . 2.3100000000000001 109.477 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -57.01 162.73 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.026 -1.046 . . . . 0.71999999999999997 109.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 237' ' ' GLY . 39.3 tttp -119.18 165.0 14.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.483 -0.761 . . . . 1.96 109.091 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.45 166.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.111 -1.196 . . . . 0.55000000000000004 110.111 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.51 162.18 43.06 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.641 1.561 . . . . 0.46999999999999997 110.405 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.53 178.47 7.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.966 -0.753 . . . . 1.05 108.966 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.94 140.93 29.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.134 -0.979 . . . . 3.1899999999999999 109.302 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.03 123.74 33.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.604 -0.685 . . . . 1.0900000000000001 109.736 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 28.0 mt -113.45 -74.69 0.62 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.436 -0.79 . . . . 1.1799999999999999 109.89 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.44 30.66 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.154 -0.966 . . . . 0.34000000000000002 109.783 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.26 116.93 8.13 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.667 -0.864 . . . . 2.79 108.667 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -100.84 0.18 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.8 -1.191 . . . . 0.28999999999999998 110.261 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.51 -157.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -1.096 . . . . 1.5600000000000001 109.842 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.09 49.51 2.92 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.163 -1.575 . . . . 0.28999999999999998 109.163 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.67 154.51 39.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -1.003 . . . . 1.0700000000000001 108.499 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.11 131.95 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.085 -1.009 . . . . 1.0900000000000001 109.862 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.6 t -93.84 135.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 1.0700000000000001 107.828 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -138.53 177.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.328 -0.858 . . . . 1.04 110.289 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.595 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.2 tt0 -145.07 111.5 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.581 -0.896 . . . . 2.3399999999999999 108.581 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.83 -78.32 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.2 -1.408 . . . . 1.1799999999999999 107.2 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -81.88 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.708 -1.59 . . . . 2.4700000000000002 106.708 177.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 t -101.7 55.82 0.82 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.038 -1.097 . . . . 1.8700000000000001 108.038 177.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -155.35 124.52 6.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.615 -0.678 . . . . 1.1200000000000001 109.183 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.595 ' CG1' HE21 ' A' ' 252' ' ' GLN . 70.8 mt -93.52 134.87 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 1.1499999999999999 109.202 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -137.42 167.81 20.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 2.6299999999999999 110.039 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 70.7 t -102.25 139.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.55 -0.719 . . . . 1.0800000000000001 109.256 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.7 t -136.73 127.97 16.64 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.878 -0.786 . . . . 1.0700000000000001 108.878 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.8 138.61 86.7 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.913 -0.841 . . . . 0.48999999999999999 109.913 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.27 -32.27 66.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 3.5800000000000001 109.428 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 263' ' ' ARG . 5.1 ttm-85 -67.29 -8.77 34.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.204 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -120.25 18.31 12.26 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.384 -0.823 . . . . 2.5800000000000001 109.187 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.26 168.6 19.4 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.65 -0.656 . . . . 1.05 109.4 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -141.6 130.99 23.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 2.2599999999999998 109.169 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.97 114.77 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 1.1799999999999999 109.946 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.66 154.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.69 -0.856 . . . . 1.28 108.69 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.572 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.4 mtt-85 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 109.218 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.294 -0.632 . . . . 2.0099999999999998 109.294 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.41 133.92 43.0 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.937 -0.764 . . . . 0.81999999999999995 108.937 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -108.67 158.66 17.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.272 -1.01 . . . . 3.7799999999999998 108.272 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.9 t -140.89 140.0 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 1.0600000000000001 110.145 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.28 155.42 19.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.69 -1.226 . . . . 0.92000000000000004 107.69 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.5 p90 -156.15 153.73 29.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.7 -1.25 . . . . 1.01 110.376 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.92 141.27 29.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.576 -0.703 . . . . 3.3900000000000001 109.578 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 9.8 p30 -92.34 162.65 14.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.284 -0.885 . . . . 2.23 109.041 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.26 -2.76 36.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 2.3300000000000001 109.812 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -89.82 -20.98 22.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.124 -0.985 . . . . 4.1900000000000004 109.548 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' B' ' 234' ' ' VAL . 14.6 m-20 -161.82 130.98 3.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 2.1600000000000001 108.98 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.51 8.37 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.712 0.941 . . . . 1.3999999999999999 110.454 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.2 m -82.73 139.48 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 2.3100000000000001 109.409 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.12 162.68 2.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.72999999999999998 109.53 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -119.19 164.99 14.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.38 -0.825 . . . . 1.96 109.089 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.54 166.59 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.56000000000000005 110.064 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.44 162.15 43.23 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.721 1.614 . . . . 0.46999999999999997 110.426 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.47 178.44 7.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.926 -0.768 . . . . 1.05 108.926 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.85 141.02 29.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.14 -0.975 . . . . 3.1899999999999999 109.368 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.01 123.7 33.57 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.568 -0.707 . . . . 1.0900000000000001 109.701 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 28.2 mt -113.47 -74.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.414 -0.804 . . . . 1.1799999999999999 109.859 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.28 30.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.264 -0.897 . . . . 0.34999999999999998 109.776 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.14 116.98 8.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.657 -0.868 . . . . 2.7999999999999998 108.657 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.83 -100.82 0.18 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.732 -1.223 . . . . 0.29999999999999999 110.225 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.46 -157.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 1.5600000000000001 109.816 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 49.81 3.01 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.09 -1.604 . . . . 0.28999999999999998 109.09 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.42 39.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -1.037 . . . . 1.0700000000000001 108.49 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.0 m -146.1 131.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0900000000000001 109.818 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.83 134.92 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.795 -1.187 . . . . 1.0800000000000001 107.795 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -138.43 177.93 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.219 -0.926 . . . . 1.04 110.319 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.606 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.1 tt0 -145.08 111.47 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.618 -0.882 . . . . 2.3399999999999999 108.618 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.8 -78.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.15 -1.426 . . . . 1.1799999999999999 107.15 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.84 -133.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.733 -1.58 . . . . 2.4700000000000002 106.733 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.3 t -101.83 55.85 0.81 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.977 -1.12 . . . . 1.8600000000000001 107.977 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -155.26 124.6 6.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 1.1200000000000001 109.168 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.606 ' CG1' HE21 ' B' ' 252' ' ' GLN . 71.2 mt -93.66 134.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.284 -0.885 . . . . 1.1499999999999999 109.123 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -137.38 167.86 20.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.337 -0.852 . . . . 2.6400000000000001 110.102 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 71.0 t -102.34 139.82 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.676 . . . . 1.0800000000000001 109.274 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.67 128.07 16.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.914 -0.773 . . . . 1.0800000000000001 108.914 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.89 138.58 86.52 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 N-CA-C 109.928 -0.835 . . . . 0.48999999999999999 109.928 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.28 -32.22 66.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 3.5800000000000001 109.443 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.471 ' HG3' HH11 ' B' ' 263' ' ' ARG . 5.2 ttm-85 -67.41 -8.76 35.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.478 -0.764 . . . . 4.3600000000000003 110.12 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -120.2 18.23 12.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.312 -0.868 . . . . 2.5800000000000001 109.162 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.23 168.44 19.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 1.05 109.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -141.51 130.9 23.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.286 -0.884 . . . . 2.2599999999999998 109.175 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.81 114.75 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.243 -0.911 . . . . 1.1799999999999999 109.917 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.67 154.49 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.713 -0.847 . . . . 1.27 108.713 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.4 mtt-85 -89.51 140.36 29.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.88 . . . . 4.1799999999999997 109.211 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.089 -0.958 . . . . 2.0499999999999998 109.382 179.892 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.119 -0.697 . . . . 2.0099999999999998 109.119 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -135.12 142.25 46.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.427 -0.796 . . . . 0.81999999999999995 109.524 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -115.64 153.8 30.63 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.238 -1.393 . . . . 3.79 107.238 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.2 t -140.74 141.91 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.099 -1.001 . . . . 1.05 110.472 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -109.22 155.0 21.61 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.256 -1.387 . . . . 0.92000000000000004 107.256 178.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.447 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.0 p90 -156.19 155.6 32.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.547 -1.346 . . . . 1.01 110.618 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -100.68 133.13 45.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.475 0.655 . . . . 3.3999999999999999 109.358 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 22.2 p-10 -92.35 171.65 8.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.001 -0.741 . . . . 2.23 109.001 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 78.9 p -87.45 -9.15 55.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 2.3199999999999998 109.661 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.32 -12.24 41.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.91 . . . . 4.1799999999999997 109.365 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -161.27 128.54 2.65 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.296 -1.001 . . . . 2.1600000000000001 108.296 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.53 -1.4 9.05 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 120.789 0.993 . . . . 1.3899999999999999 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 137.89 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.745 -1.222 . . . . 2.3100000000000001 110.005 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -50.35 166.98 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.089 -1.007 . . . . 0.71999999999999997 109.219 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 237' ' ' GLY . 1.9 mtpp -119.65 166.37 13.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.67 -0.863 . . . . 1.96 108.67 179.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.31 168.78 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.823 -1.311 . . . . 0.55000000000000004 109.823 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -66.96 158.87 54.58 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.685 1.59 . . . . 0.46999999999999997 110.618 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.0 171.02 15.14 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.061 -0.718 . . . . 1.05 109.061 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -94.1 139.14 31.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.179 -0.951 . . . . 3.1899999999999999 109.733 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.55 126.11 35.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.551 . . . . 1.0900000000000001 109.515 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.89 -72.06 0.71 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.389 -0.819 . . . . 1.1799999999999999 110.362 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.473 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.97 142.62 27.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.105 -0.997 . . . . 0.34000000000000002 110.032 -178.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -148.68 118.59 7.13 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 2.79 109.459 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.22 0.17 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.842 -1.17 . . . . 0.28999999999999998 110.21 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.6 -155.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -1.076 . . . . 1.5600000000000001 109.931 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.87 48.71 3.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.689 -1.364 . . . . 0.28999999999999998 109.689 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.88 154.96 41.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.379 -1.071 . . . . 1.0700000000000001 108.612 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.39 128.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.075 -1.015 . . . . 1.0900000000000001 109.787 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.06 132.69 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.955 -1.128 . . . . 1.0700000000000001 107.955 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.2 pt -135.64 177.68 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.911 . . . . 1.04 109.864 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -143.69 107.56 4.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.423 -0.798 . . . . 2.3399999999999999 109.016 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.93 -76.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.748 -1.575 . . . . 1.1799999999999999 106.748 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -163.32 0.55 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.999 -1.852 . . . . 2.4700000000000002 105.999 177.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.1 p -79.47 48.79 0.94 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.599 -1.313 . . . . 1.8700000000000001 108.288 178.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.31 126.7 11.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 109.175 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.503 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.9 mt -92.07 141.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 1.1499999999999999 109.846 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -139.95 167.98 20.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -0.785 . . . . 2.6299999999999999 109.796 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.19 137.45 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.358 -0.839 . . . . 1.0800000000000001 109.241 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.2 130.56 19.31 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.461 -0.774 . . . . 1.0700000000000001 109.038 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.16 137.11 80.35 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 N-CA-C 109.892 -0.849 . . . . 0.48999999999999999 109.892 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.18 -35.35 69.49 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.202 -0.936 . . . . 3.5800000000000001 109.427 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.82 -5.24 19.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.408 -0.807 . . . . 4.3600000000000003 110.257 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.9 22.46 11.93 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.472 -0.936 . . . . 2.5800000000000001 108.472 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.64 166.02 26.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 1.05 109.14 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.17 128.19 25.63 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.371 -0.831 . . . . 2.2599999999999998 109.326 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.46 110.34 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 1.1799999999999999 109.834 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.2 mm -105.31 156.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.452 -0.944 . . . . 1.28 108.452 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.06 -1.025 . . . . 4.1799999999999997 109.229 179.65 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 2.0099999999999998 109.111 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -135.04 142.21 46.31 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.419 -0.8 . . . . 0.81999999999999995 109.496 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' B' ' 224' ' ' ARG . 0.3 OUTLIER -115.65 153.84 30.56 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.239 -1.393 . . . . 3.7799999999999998 107.239 178.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.72 141.83 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.96 . . . . 1.0600000000000001 110.571 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -109.24 155.01 21.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.162 -1.421 . . . . 0.92000000000000004 107.162 178.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.1 p90 -156.12 155.69 32.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.604 -1.31 . . . . 1.01 110.63 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -100.94 132.99 46.09 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 3.3900000000000001 109.442 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 22.3 p-10 -92.21 171.63 8.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 2.23 109.029 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 80.0 p -87.52 -9.09 55.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 2.3300000000000001 109.633 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.2 -12.44 40.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.93 . . . . 4.1900000000000004 109.348 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -161.17 128.47 2.66 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.305 -0.998 . . . . 2.1600000000000001 108.305 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -70.41 -1.49 9.09 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 120.819 1.012 . . . . 1.3999999999999999 111.065 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.02 137.85 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.749 -1.22 . . . . 2.3100000000000001 109.933 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -50.49 166.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.073 -1.017 . . . . 0.72999999999999998 109.182 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' B' ' 237' ' ' GLY . 1.9 mtpp -119.68 166.23 13.47 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.587 -0.894 . . . . 1.96 108.587 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.18 168.64 0.04 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.863 -1.295 . . . . 0.56000000000000005 109.863 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.83 158.99 53.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.612 1.541 . . . . 0.46999999999999997 110.749 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.16 170.84 15.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.048 -0.723 . . . . 1.05 109.048 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -93.87 139.06 31.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.077 -1.015 . . . . 3.1899999999999999 109.77 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -89.48 126.05 35.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.749 -0.594 . . . . 1.0900000000000001 109.531 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.75 -72.03 0.71 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.48 -0.762 . . . . 1.1799999999999999 110.352 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.503 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.3 t90 -91.1 142.66 27.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.045 -1.034 . . . . 0.34999999999999998 109.988 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -148.65 118.53 7.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.239 -0.913 . . . . 2.7999999999999998 109.488 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.04 0.17 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.856 -1.164 . . . . 0.29999999999999999 110.245 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.63 -155.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.377 -1.072 . . . . 1.5600000000000001 109.974 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.94 48.59 3.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.727 -1.349 . . . . 0.28999999999999998 109.727 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.79 155.07 41.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 1.0700000000000001 108.59 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.44 128.73 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.728 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.1 132.71 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.967 -1.123 . . . . 1.0800000000000001 107.967 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 1.04 109.848 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -143.65 107.64 4.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 2.3399999999999999 109.079 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.05 -76.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.762 -1.57 . . . . 1.1799999999999999 106.762 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -163.25 0.54 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.975 -1.861 . . . . 2.4700000000000002 105.975 177.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 15.2 p -79.53 48.85 0.95 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.519 -1.363 . . . . 1.8600000000000001 108.315 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.37 126.72 11.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.533 -0.729 . . . . 1.1200000000000001 109.213 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.8 mt -92.07 141.57 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 1.1499999999999999 109.824 -179.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -140.09 167.96 20.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.344 -0.848 . . . . 2.6400000000000001 109.815 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.12 137.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.391 -0.818 . . . . 1.0800000000000001 109.279 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.17 130.58 19.35 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.455 -0.778 . . . . 1.0800000000000001 108.991 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.27 137.07 79.98 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 109.86 -0.862 . . . . 0.48999999999999999 109.86 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -57.05 -35.54 69.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 3.5800000000000001 109.433 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.81 -5.05 18.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.824 . . . . 4.3600000000000003 110.372 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.87 22.22 12.06 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.542 -0.91 . . . . 2.5800000000000001 108.542 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.4 166.16 25.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.535 -0.728 . . . . 1.05 109.133 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -138.21 128.1 25.41 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.361 -0.837 . . . . 2.2599999999999998 109.396 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.43 110.31 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 1.1799999999999999 109.888 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.3 mm -105.33 156.9 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.421 -0.955 . . . . 1.27 108.421 179.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.97 138.78 31.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.13 -0.981 . . . . 4.1799999999999997 109.253 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.068 -1.02 . . . . 2.0499999999999998 109.532 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.6 m120 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.297 -0.631 . . . . 2.0099999999999998 109.297 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.08 141.97 47.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.518 -0.739 . . . . 0.81999999999999995 109.166 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -116.96 157.71 25.29 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.558 -1.275 . . . . 3.79 107.558 178.827 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.39 145.45 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.949 -1.094 . . . . 1.05 110.55 -179.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.79 161.97 15.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.017 -1.105 . . . . 0.92000000000000004 108.017 178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.84 149.54 23.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.87 -1.144 . . . . 1.01 110.231 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.73 159.03 15.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.3999999999999999 109.881 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.9 OUTLIER -95.45 170.91 9.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.041 -0.726 . . . . 2.23 109.041 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.9 t -91.37 -15.05 29.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 2.3199999999999998 108.982 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.563 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.3 mtt-85 -90.21 -15.07 32.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.857 . . . . 4.1799999999999997 109.793 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.7 m-20 -161.19 128.8 2.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 2.1600000000000001 109.173 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.77 17.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.813 1.008 . . . . 1.3899999999999999 110.603 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 232' ' ' ASP . 32.7 m -80.9 130.93 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.785 -1.197 . . . . 2.3100000000000001 109.834 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.78 174.82 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.71999999999999997 109.398 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -122.62 -166.24 1.4 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.206 -1.035 . . . . 1.96 108.206 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.12 -179.31 51.75 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.287 -1.525 . . . . 0.55000000000000004 109.287 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.4 149.01 49.72 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.695 1.596 . . . . 0.46999999999999997 110.446 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.28 167.1 22.25 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.99 -0.744 . . . . 1.05 108.99 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -91.54 140.81 29.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.047 -1.033 . . . . 3.1899999999999999 110.081 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.03 129.85 35.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.807 -0.558 . . . . 1.0900000000000001 109.8 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.1 mt -118.03 -72.54 0.68 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.57 -0.707 . . . . 1.1799999999999999 110.42 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.405 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.24 143.23 26.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.34000000000000002 110.845 -178.04 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -143.89 112.6 6.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.839 -0.801 . . . . 2.79 108.839 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.67 -103.58 0.36 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.968 -1.253 . . . . 0.28999999999999998 109.968 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.43 -154.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -1.162 . . . . 1.5600000000000001 109.503 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.25 3.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.7 -1.76 . . . . 0.28999999999999998 108.7 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.69 35.84 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.57 -0.959 . . . . 1.0700000000000001 108.603 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.11 128.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.083 -1.011 . . . . 1.0900000000000001 109.619 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 54.1 t -92.84 128.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.212 -1.032 . . . . 1.0700000000000001 108.212 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.42 -179.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -0.793 . . . . 1.04 109.865 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.545 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.5 tt0 -142.66 109.96 5.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.278 -1.008 . . . . 2.3399999999999999 108.278 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -86.03 -81.02 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.298 -1.371 . . . . 1.1799999999999999 107.298 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.837 -1.542 . . . . 2.4700000000000002 106.837 177.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 35.0 t -100.58 53.71 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.052 -1.092 . . . . 1.8700000000000001 108.052 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.53 124.23 5.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 1.1200000000000001 109.375 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.545 ' CG1' HE21 ' A' ' 252' ' ' GLN . 22.2 mt -90.46 131.19 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.902 . . . . 1.1499999999999999 109.257 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.555 ' CB ' ' HZ1' ' A' ' 258' ' ' LYS . 0.0 OUTLIER -131.64 167.99 18.5 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.446 -0.784 . . . . 2.6299999999999999 109.74 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 142.06 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 1.0800000000000001 109.446 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.16 130.09 17.19 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.485 -0.932 . . . . 1.0700000000000001 108.485 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.19 141.99 90.18 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 N-CA-C 109.93 -0.834 . . . . 0.48999999999999999 109.93 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.94 -31.15 66.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 3.5800000000000001 109.101 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.08 -11.21 60.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.398 -0.814 . . . . 4.3600000000000003 110.325 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.09 21.91 12.11 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 2.5800000000000001 108.991 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.03 16.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.472 -0.767 . . . . 1.05 109.339 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -140.53 125.67 18.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 2.2599999999999998 109.262 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.35 113.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.234 -0.917 . . . . 1.1799999999999999 109.17 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.01 153.67 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.455 -0.778 . . . . 1.28 109.044 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 269' ' ' ARG . 18.4 mtm-85 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.468 -0.77 . . . . 4.1799999999999997 109.485 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 28.3 m120 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.36 -0.607 . . . . 2.0099999999999998 109.36 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -134.09 141.9 47.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.411 -0.806 . . . . 0.81999999999999995 109.138 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -116.83 157.7 25.16 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.566 -1.272 . . . . 3.7799999999999998 107.566 178.769 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.41 145.47 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.008 -1.057 . . . . 1.0600000000000001 110.624 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.8 162.06 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.956 -1.127 . . . . 0.92000000000000004 107.956 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.6 p90 -156.85 149.57 23.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.882 -1.136 . . . . 1.01 110.194 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -96.67 159.09 15.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 3.3900000000000001 109.945 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -95.55 170.9 9.02 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.996 -0.742 . . . . 2.23 108.996 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.5 t -91.4 -15.09 29.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 2.3300000000000001 108.827 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' B' ' 231' ' ' ARG . 2.3 mtt-85 -90.23 -14.99 32.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 4.1900000000000004 109.81 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.6 m-20 -161.15 128.9 2.76 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 2.1600000000000001 109.114 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.93 17.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.844 1.03 . . . . 1.3999999999999999 110.602 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' B' ' 232' ' ' ASP . 32.7 m -80.93 130.9 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.916 -1.115 . . . . 2.3100000000000001 109.826 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.8 174.89 0.14 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -0.936 . . . . 0.72999999999999998 109.532 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -122.66 -166.22 1.4 Allowed 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 108.157 -1.053 . . . . 1.96 108.157 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.1 -179.2 51.75 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.321 -1.512 . . . . 0.56000000000000005 109.321 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.42 149.0 49.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.803 1.669 . . . . 0.46999999999999997 110.421 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.35 167.12 22.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.944 -0.762 . . . . 1.05 108.944 179.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -91.57 140.76 29.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.0 -1.063 . . . . 3.1899999999999999 110.069 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 tp -88.92 129.77 35.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.751 -0.593 . . . . 1.0900000000000001 109.814 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.91 -72.58 0.68 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.363 -0.836 . . . . 1.1799999999999999 110.416 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -90.27 143.06 27.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.34999999999999998 110.887 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' B' ' 244' ' ' LYS . 0.9 OUTLIER -143.68 112.72 6.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.807 . . . . 2.7999999999999998 108.938 179.172 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.65 -103.58 0.36 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.896 -1.281 . . . . 0.29999999999999999 109.896 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.37 -154.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -1.119 . . . . 1.5600000000000001 109.492 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.23 3.54 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.678 -1.769 . . . . 0.28999999999999998 108.678 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.57 35.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.582 -0.952 . . . . 1.0700000000000001 108.644 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.05 128.7 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.034 -1.041 . . . . 1.0900000000000001 109.679 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.81 128.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.195 -1.039 . . . . 1.0800000000000001 108.195 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.5 pt -134.31 -179.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.377 -0.827 . . . . 1.04 109.908 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.546 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -142.7 109.82 5.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.378 -0.971 . . . . 2.3399999999999999 108.378 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -85.98 -81.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.281 -1.377 . . . . 1.1799999999999999 107.281 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.48 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.823 -1.547 . . . . 2.4700000000000002 106.823 177.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 34.9 t -100.6 53.73 0.87 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.046 -1.094 . . . . 1.8600000000000001 108.046 178.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.54 124.42 5.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.604 -0.685 . . . . 1.1200000000000001 109.327 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.546 ' CG1' HE21 ' B' ' 252' ' ' GLN . 21.9 mt -90.59 131.16 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.25 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . 0.552 ' CB ' ' HZ1' ' B' ' 258' ' ' LYS . 0.0 OUTLIER -131.63 168.0 18.48 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 2.6400000000000001 109.743 -179.613 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.64 142.11 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.457 -0.777 . . . . 1.0800000000000001 109.436 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 51.0 t -137.19 130.01 17.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.45 -0.944 . . . . 1.0800000000000001 108.45 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 141.91 90.47 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.904 -0.845 . . . . 0.48999999999999999 109.904 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.93 -31.15 66.54 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 3.5800000000000001 109.132 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -70.13 -11.09 60.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 4.3600000000000003 110.373 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.16 21.94 12.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.271 -0.893 . . . . 2.5800000000000001 108.899 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.05 16.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 1.05 109.324 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -140.59 125.67 18.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 2.2599999999999998 109.279 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.25 113.1 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -0.915 . . . . 1.1799999999999999 109.235 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.92 153.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 1.27 109.093 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' B' ' 269' ' ' ARG . 18.5 mtm-85 -95.75 135.93 36.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 4.1799999999999997 109.392 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.912 -1.042 . . . . 2.0499999999999998 109.029 179.48 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.218 0.533 . . . . 2.0099999999999998 110.143 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -135.5 125.23 25.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.438 -0.789 . . . . 0.81999999999999995 109.09 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -101.44 159.12 15.55 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.243 -1.021 . . . . 3.79 108.243 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.19 143.77 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.099 -1.001 . . . . 1.05 110.895 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.42 156.73 19.11 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.243 -1.391 . . . . 0.92000000000000004 107.243 178.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.9 p90 -157.69 152.86 25.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.549 -1.345 . . . . 1.01 110.697 -179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -99.49 135.3 41.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.622 -0.674 . . . . 3.3999999999999999 109.751 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 230' ' ' SER . 22.0 t70 -95.85 178.93 5.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.847 . . . . 2.23 109.185 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.433 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 73.9 p -91.21 -10.8 40.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.916 . . . . 2.3199999999999998 109.429 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 232' ' ' ASP . 53.6 mtp180 -84.1 -19.05 34.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.205 -0.935 . . . . 4.1799999999999997 109.481 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 231' ' ' ARG . 43.2 m-20 -159.37 129.04 3.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.323 -0.861 . . . . 2.1600000000000001 109.152 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.41 1.83 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.76 0.974 . . . . 1.3899999999999999 110.442 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.73 136.24 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.939 -1.101 . . . . 2.3100000000000001 110.218 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.28 163.62 0.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.71999999999999997 109.239 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.4 mtpt -119.85 166.74 12.89 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.459 -0.776 . . . . 1.96 109.561 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.16 166.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.457 -1.057 . . . . 0.55000000000000004 110.457 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.61 159.73 39.51 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.591 1.528 . . . . 0.46999999999999997 110.579 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.39 169.56 17.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.864 -0.791 . . . . 1.05 108.864 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -92.32 136.17 33.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.981 -1.074 . . . . 3.1899999999999999 109.537 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.2 116.84 26.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.671 -0.643 . . . . 1.0900000000000001 109.313 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.9 mt -104.82 -71.7 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.246 -0.908 . . . . 1.1799999999999999 109.838 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -94.08 146.98 23.58 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.107 -0.996 . . . . 0.34000000000000002 110.473 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.02 120.96 8.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.827 . . . . 2.79 109.017 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -108.58 0.3 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.78 -1.2 . . . . 0.28999999999999998 110.332 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.76 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 1.5600000000000001 109.69 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 47.91 2.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.994 -1.642 . . . . 0.28999999999999998 108.994 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.29 146.85 30.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.976 . . . . 1.0700000000000001 108.736 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.12 128.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.954 . . . . 1.0900000000000001 109.247 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.8 t -89.13 140.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.198 -1.038 . . . . 1.0700000000000001 108.198 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.38 179.28 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.919 . . . . 1.04 110.253 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.425 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.4 tt0 -141.23 112.16 7.2 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.562 -0.903 . . . . 2.3399999999999999 108.562 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.71 -81.08 0.29 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.549 -1.278 . . . . 1.1799999999999999 107.549 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' SER . 32.7 t-20 -80.34 -129.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.783 -1.562 . . . . 2.4700000000000002 106.783 177.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.6 t -104.19 53.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.245 -1.02 . . . . 1.8700000000000001 108.245 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.12 129.72 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.02 -0.733 . . . . 1.1200000000000001 109.02 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CG1' HE21 ' A' ' 252' ' ' GLN . 67.9 mt -92.23 139.28 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 1.1499999999999999 109.558 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.12 165.13 28.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 2.6299999999999999 109.954 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.92 138.55 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.468 -0.77 . . . . 1.0800000000000001 109.054 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -137.04 133.05 18.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.738 -0.838 . . . . 1.0700000000000001 108.738 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.38 141.14 89.56 Favored 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 120.836 1.024 . . . . 0.48999999999999999 110.512 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 3.5800000000000001 109.448 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.414 ' HG2' ' NH1' ' A' ' 263' ' ' ARG . 0.6 OUTLIER -69.45 -8.18 44.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 4.3600000000000003 110.526 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.77 20.74 12.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.127 -0.983 . . . . 2.5800000000000001 109.282 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.9 16.95 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.01 -0.737 . . . . 1.05 109.01 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -139.71 122.59 16.59 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.219 -0.926 . . . . 2.2599999999999998 108.977 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.82 107.42 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.145 -0.972 . . . . 1.1799999999999999 109.997 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.04 151.11 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.451 -0.944 . . . . 1.28 108.451 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.343 -0.848 . . . . 4.1799999999999997 109.726 179.755 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 121.175 0.512 . . . . 2.0099999999999998 110.199 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -135.5 125.25 25.44 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.435 -0.791 . . . . 0.81999999999999995 109.067 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -101.37 159.18 15.49 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.181 -1.044 . . . . 3.7799999999999998 108.181 179.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 59.1 t -142.3 143.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.123 -0.985 . . . . 1.0600000000000001 110.978 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -108.41 156.77 19.07 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.235 -1.394 . . . . 0.92000000000000004 107.235 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.7 p90 -157.64 152.9 25.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.595 -1.316 . . . . 1.01 110.649 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -99.54 135.13 41.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.601 -0.687 . . . . 3.3900000000000001 109.749 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' B' ' 230' ' ' SER . 22.1 t70 -95.68 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 2.23 109.182 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 230' ' ' SER . . . . . 0.431 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 74.2 p -91.13 -10.84 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 2.3300000000000001 109.492 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' B' ' 232' ' ' ASP . 53.5 mtp180 -84.08 -19.03 35.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 4.1900000000000004 109.505 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' B' ' 231' ' ' ARG . 43.5 m-20 -159.5 129.03 3.24 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 2.1600000000000001 109.053 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.28 1.7 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.792 0.995 . . . . 1.3999999999999999 110.442 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -84.57 136.14 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.868 -1.145 . . . . 2.3100000000000001 110.258 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -52.31 163.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.215 -0.928 . . . . 0.72999999999999998 109.311 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mtpt -119.78 166.93 12.61 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.261 -0.899 . . . . 1.96 109.511 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.35 166.55 0.02 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.358 -1.097 . . . . 0.56000000000000005 110.358 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.6 159.92 38.61 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.523 1.482 . . . . 0.46999999999999997 110.54 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.45 169.53 17.54 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.922 -0.77 . . . . 1.05 108.922 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -92.32 136.2 33.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.11 -0.994 . . . . 3.1899999999999999 109.596 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.27 116.79 26.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.644 . . . . 1.0900000000000001 109.284 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -104.71 -71.74 0.73 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.271 -0.893 . . . . 1.1799999999999999 109.872 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -94.12 146.98 23.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.179 -0.95 . . . . 0.34999999999999998 110.415 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.09 121.08 8.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.375 -0.828 . . . . 2.7999999999999998 108.931 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -108.65 0.3 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.785 -1.198 . . . . 0.29999999999999999 110.335 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.68 -151.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -1.08 . . . . 1.5600000000000001 109.761 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.18 47.98 2.7 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.918 -1.673 . . . . 0.28999999999999998 108.918 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.35 146.88 30.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.491 -1.005 . . . . 1.0700000000000001 108.745 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.2 128.06 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 1.0900000000000001 109.277 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.07 139.96 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.219 -1.03 . . . . 1.0800000000000001 108.219 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.37 179.27 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 1.04 110.299 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.427 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.4 tt0 -141.25 112.21 7.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.468 -0.938 . . . . 2.3399999999999999 108.468 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.7 -81.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.549 -1.278 . . . . 1.1799999999999999 107.549 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' B' ' 255' ' ' SER . 32.6 t-20 -80.29 -129.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.866 -1.531 . . . . 2.4700000000000002 106.866 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 8.7 t -104.32 53.27 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.106 -1.072 . . . . 1.8600000000000001 108.106 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.15 129.8 8.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 1.1200000000000001 108.982 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.427 ' CG1' HE21 ' B' ' 252' ' ' GLN . 68.1 mt -92.31 139.32 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.26 -0.9 . . . . 1.1499999999999999 109.519 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.19 165.18 28.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.333 -0.855 . . . . 2.6400000000000001 109.932 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.92 138.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.427 -0.795 . . . . 1.0800000000000001 109.065 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.05 132.98 18.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.677 -0.86 . . . . 1.0800000000000001 108.677 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.24 141.28 88.45 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.776 0.984 . . . . 0.48999999999999999 110.599 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -59.71 -32.6 70.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 3.5800000000000001 109.368 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.413 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 0.6 OUTLIER -69.35 -8.31 45.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.36 -0.838 . . . . 4.3600000000000003 110.56 -179.195 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.65 20.66 12.85 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.225 -0.922 . . . . 2.5800000000000001 109.274 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.72 17.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 1.05 109.101 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -139.53 122.57 16.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.228 -0.92 . . . . 2.2599999999999998 108.981 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.76 107.4 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.252 -0.905 . . . . 1.1799999999999999 109.977 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.06 151.23 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.39 -0.967 . . . . 1.27 108.39 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -90.69 143.66 26.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 4.1799999999999997 109.724 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.948 -1.025 . . . . 2.0499999999999998 109.484 179.655 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.532 -0.544 . . . . 2.0099999999999998 109.532 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.27 130.41 38.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.81999999999999995 109.191 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -105.57 156.32 18.35 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.456 -0.942 . . . . 3.79 108.456 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -139.1 142.86 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.361 -0.837 . . . . 1.05 110.098 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -109.22 152.07 25.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.312 -1.366 . . . . 0.92000000000000004 107.312 178.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.4 p90 -156.03 157.59 36.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.555 -1.341 . . . . 1.01 110.724 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -100.05 140.04 34.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.59 -0.694 . . . . 3.3999999999999999 109.291 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 232' ' ' ASP . 5.1 p-10 -93.33 176.78 6.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 2.23 109.467 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.6 t -89.02 -11.95 42.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 2.3199999999999998 109.508 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 20.3 mmm180 -86.88 -11.97 49.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.088 -1.008 . . . . 4.1799999999999997 109.417 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.5 ' N ' ' OD2' ' A' ' 229' ' ' ASP . 48.0 m-20 -161.95 129.52 2.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 2.1600000000000001 108.95 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.6 4.83 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.64 0.893 . . . . 1.3899999999999999 110.024 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.2 t -83.4 154.54 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.013 . . . . 2.3100000000000001 110.024 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.41 163.6 22.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.71999999999999997 109.071 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 4.9 mtpp -119.6 165.86 13.91 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.843 -0.799 . . . . 1.96 108.843 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -47.0 171.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.688 -1.365 . . . . 0.55000000000000004 109.688 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.7 160.88 46.18 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.568 1.512 . . . . 0.46999999999999997 110.522 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.07 13.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.489 -0.757 . . . . 1.05 109.053 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.49 134.67 34.45 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.165 -0.959 . . . . 3.1899999999999999 109.344 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.37 124.68 34.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.576 -0.703 . . . . 1.0900000000000001 109.225 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.83 -72.47 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.469 -0.769 . . . . 1.1799999999999999 110.496 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.463 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.8 t90 -91.14 142.56 27.61 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.187 -0.946 . . . . 0.34000000000000002 110.257 -178.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -147.07 121.14 9.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 2.79 109.607 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.65 -103.34 0.21 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.86 -1.162 . . . . 0.28999999999999998 110.366 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.95 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -1.074 . . . . 1.5600000000000001 110.111 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.73 47.95 2.56 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.25 -1.54 . . . . 0.28999999999999998 109.25 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.86 37.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -1.082 . . . . 1.0700000000000001 109.215 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.01 127.79 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.192 -0.942 . . . . 1.0900000000000001 109.514 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.18 139.16 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.336 -0.987 . . . . 1.0700000000000001 108.336 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.6 pt -141.52 177.3 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 1.04 110.086 -179.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -143.48 114.06 7.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 2.3399999999999999 108.818 179.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -90.29 -82.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.316 -1.364 . . . . 1.1799999999999999 107.316 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -80.28 -130.3 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.667 -1.605 . . . . 2.4700000000000002 106.667 177.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.4 m -104.1 54.72 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.073 -1.084 . . . . 1.8700000000000001 108.073 178.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -156.42 123.79 5.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.779 -0.823 . . . . 1.1200000000000001 108.779 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.415 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.5 mt -92.88 138.28 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 1.1499999999999999 109.702 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.85 168.59 19.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.384 -0.822 . . . . 2.6299999999999999 109.44 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.71 144.58 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.348 -0.845 . . . . 1.0800000000000001 109.367 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 94.1 t -138.54 128.63 14.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 1.0700000000000001 109.118 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.28 144.47 95.82 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 120.531 0.821 . . . . 0.48999999999999999 110.06 179.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -60.11 -39.56 86.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 3.5800000000000001 109.062 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -65.6 -7.48 15.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.344 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.82 22.44 11.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.233 -0.917 . . . . 2.5800000000000001 109.307 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.67 169.35 17.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 1.05 109.529 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -141.28 128.45 20.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 2.2599999999999998 109.254 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.4 112.85 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.101 -0.999 . . . . 1.1799999999999999 109.789 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.3 144.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.914 -1.143 . . . . 1.28 107.914 179.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 4.1799999999999997 109.282 179.695 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.55 -0.537 . . . . 2.0099999999999998 109.55 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -133.31 130.36 38.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 0.81999999999999995 109.222 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -105.43 156.44 18.19 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.515 -0.92 . . . . 3.7799999999999998 108.515 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 87.3 t -139.09 142.9 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 1.0600000000000001 110.112 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.26 152.16 25.59 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.339 -1.356 . . . . 0.92000000000000004 107.339 178.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.448 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 13.6 p90 -156.14 157.51 36.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.609 -1.307 . . . . 1.01 110.726 -178.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -99.91 140.08 34.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 3.3900000000000001 109.337 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' B' ' 232' ' ' ASP . 5.1 p-10 -93.41 176.78 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 2.23 109.401 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.7 t -88.99 -11.97 42.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 2.3300000000000001 109.509 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 20.3 mmm180 -86.71 -12.1 49.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.143 -0.973 . . . . 4.1900000000000004 109.462 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.501 ' N ' ' OD2' ' B' ' 229' ' ' ASP . 47.8 m-20 -161.92 129.57 2.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.171 -0.956 . . . . 2.1600000000000001 108.887 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.59 4.8 1.53 Allowed 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 120.755 0.97 . . . . 1.3999999999999999 109.959 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.3 t -83.44 154.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 2.3100000000000001 110.031 -179.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -68.32 163.62 22.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.72999999999999998 109.085 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' B' ' 237' ' ' GLY . 4.9 mtpp -119.7 165.91 13.89 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.771 -0.826 . . . . 1.96 108.771 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -47.07 171.01 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.728 -1.349 . . . . 0.56000000000000005 109.728 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.69 160.91 46.06 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.56 1.507 . . . . 0.46999999999999997 110.486 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.68 172.02 13.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.553 -0.717 . . . . 1.05 109.084 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.43 134.65 34.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.973 . . . . 3.1899999999999999 109.341 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.39 124.69 34.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.544 -0.722 . . . . 1.0900000000000001 109.173 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.77 -72.52 0.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.41 -0.806 . . . . 1.1799999999999999 110.609 -179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.415 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.09 142.52 27.67 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.124 -0.985 . . . . 0.34999999999999998 110.254 -178.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -147.08 121.14 9.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.206 -0.934 . . . . 2.7999999999999998 109.564 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.62 -103.29 0.21 Allowed Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.844 -1.17 . . . . 0.29999999999999999 110.337 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -71.04 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.347 -1.09 . . . . 1.5600000000000001 110.139 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.74 47.94 2.56 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.197 -1.561 . . . . 0.28999999999999998 109.197 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.91 151.81 37.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 1.0700000000000001 109.259 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.92 127.89 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 1.0900000000000001 109.525 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.21 139.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.325 -0.991 . . . . 1.0800000000000001 108.325 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.7 pt -141.61 177.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.898 . . . . 1.04 110.138 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -143.56 114.06 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.817 -0.808 . . . . 2.3399999999999999 108.817 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -90.29 -82.34 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.331 -1.359 . . . . 1.1799999999999999 107.331 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -80.23 -130.21 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.716 -1.587 . . . . 2.4700000000000002 106.716 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 64.8 m -104.24 54.71 0.73 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.983 -1.118 . . . . 1.8600000000000001 107.983 178.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -156.45 123.81 5.39 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.829 -0.804 . . . . 1.1200000000000001 108.829 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.463 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.4 mt -92.92 138.3 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.756 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.78 168.64 19.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 2.6400000000000001 109.412 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.72 144.58 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 1.0800000000000001 109.395 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.56 128.55 14.87 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 1.0800000000000001 109.14 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.21 144.54 95.37 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 110.012 -0.803 . . . . 0.48999999999999999 110.012 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -60.1 -39.7 87.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 3.5800000000000001 108.956 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -65.47 -7.51 14.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.512 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.88 22.52 11.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.247 -0.908 . . . . 2.5800000000000001 109.259 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.7 169.41 17.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.503 -0.748 . . . . 1.05 109.441 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -141.32 128.46 20.87 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.27 -0.894 . . . . 2.2599999999999998 109.24 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.35 112.97 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.188 -0.945 . . . . 1.1799999999999999 109.782 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.35 144.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 107.897 -1.149 . . . . 1.27 107.897 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -91.02 142.57 27.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 4.1799999999999997 109.205 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.993 -1.003 . . . . 2.0499999999999998 109.575 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 32.5 m120 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 2.0099999999999998 109.819 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -136.37 131.6 34.46 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.015 -0.735 . . . . 0.81999999999999995 109.015 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -105.21 158.09 16.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.353 -0.842 . . . . 3.79 109.014 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.5 t -139.05 140.76 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 1.05 109.877 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -107.51 156.33 19.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.508 -1.293 . . . . 0.92000000000000004 107.508 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.79 151.63 25.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.704 -1.247 . . . . 1.01 110.729 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -98.22 148.5 23.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.738 . . . . 3.3999999999999999 109.483 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 231' ' ' ARG . 25.0 t0 -94.89 -175.56 3.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.959 -0.756 . . . . 2.23 108.959 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.458 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 5.5 t -98.67 -14.77 19.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -0.956 . . . . 2.3199999999999998 109.982 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 229' ' ' ASP . 15.3 mtm-85 -89.72 -11.75 41.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 4.1799999999999997 109.981 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 231' ' ' ARG . 54.4 m-20 -161.01 129.02 2.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.928 -1.107 . . . . 2.1600000000000001 109.478 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.57 6.84 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.731 0.954 . . . . 1.3899999999999999 110.32 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 232' ' ' ASP . 5.3 m -80.08 128.24 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.787 -1.195 . . . . 2.3100000000000001 109.891 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.36 165.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.71999999999999997 109.532 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 237' ' ' GLY . 28.6 mttm -118.41 166.41 12.7 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.633 -0.877 . . . . 1.96 108.633 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.73 177.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.932 -1.267 . . . . 0.55000000000000004 109.932 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.86 160.28 48.25 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.663 1.575 . . . . 0.46999999999999997 110.477 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.95 12.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.667 -0.864 . . . . 1.05 108.667 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.18 139.43 31.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.073 -1.017 . . . . 3.1899999999999999 109.44 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.9 120.26 30.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 109.926 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.29 -72.91 0.68 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.427 -0.795 . . . . 1.1799999999999999 110.231 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.204 -0.935 . . . . 0.34000000000000002 110.129 -178.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.47 112.7 5.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.258 -0.901 . . . . 2.79 109.13 179.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -102.63 0.2 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.51 -1.328 . . . . 0.28999999999999998 110.658 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 248' ' ' ALA . 31.6 mt-10 -61.52 -159.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -1.081 . . . . 1.5600000000000001 110.188 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.99 44.86 1.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.028 -1.629 . . . . 0.28999999999999998 109.028 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 246' ' ' GLU . . . -148.3 152.51 37.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.445 -1.033 . . . . 1.0700000000000001 108.975 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.62 126.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 1.0900000000000001 109.325 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.38 137.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.971 -1.122 . . . . 1.0700000000000001 107.971 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 26.6 pt -140.17 -177.94 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 1.04 110.076 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -143.94 109.07 5.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.401 -0.963 . . . . 2.3399999999999999 108.401 178.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.81 -76.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.377 -1.342 . . . . 1.1799999999999999 107.377 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -79.93 -134.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.697 -1.594 . . . . 2.4700000000000002 106.697 177.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 15.3 p -103.9 54.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.981 -1.118 . . . . 1.8700000000000001 107.981 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 65.0 m-20 -157.1 130.9 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.887 -0.783 . . . . 1.1200000000000001 108.887 -179.308 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.45 135.1 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 1.1499999999999999 109.847 -179.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -137.45 176.67 8.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.445 -0.784 . . . . 2.6299999999999999 109.922 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.31 137.9 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.663 -0.648 . . . . 1.0800000000000001 109.602 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.43 131.56 19.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.378 -0.826 . . . . 1.0700000000000001 108.986 179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.24 144.29 95.9 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 120.621 0.881 . . . . 0.48999999999999999 109.946 179.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.46 -34.04 74.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 3.5800000000000001 109.55 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.4 ' HG3' ' NH1' ' A' ' 263' ' ' ARG . 35.4 mtm-85 -70.4 -5.68 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 4.3600000000000003 110.846 -178.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -119.36 21.3 12.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.386 -0.821 . . . . 2.5800000000000001 108.866 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.41 24.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.602 -0.686 . . . . 1.05 109.273 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 7.8 mtmp? -141.7 129.61 21.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 2.2599999999999998 109.135 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.86 117.36 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.951 . . . . 1.1799999999999999 109.978 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.86 150.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 108.795 -0.817 . . . . 1.28 108.795 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.404 -0.81 . . . . 4.1799999999999997 108.856 179.278 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 32.8 m120 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.128 0.489 . . . . 2.0099999999999998 109.905 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.14 131.49 34.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.572 -0.705 . . . . 0.81999999999999995 109.126 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -105.15 158.01 16.88 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.334 -0.854 . . . . 3.7799999999999998 109.011 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.95 140.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 1.0600000000000001 109.977 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -107.56 156.53 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.469 -1.308 . . . . 0.92000000000000004 107.469 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 13.4 p90 -156.9 151.63 25.74 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.584 -1.323 . . . . 1.01 110.67 -178.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -98.32 148.57 23.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.41 -0.806 . . . . 3.3900000000000001 109.466 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.485 ' OD2' ' NH1' ' B' ' 231' ' ' ARG . 25.1 t0 -94.86 -175.46 3.57 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.345 -0.847 . . . . 2.23 108.902 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 230' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 5.4 t -98.7 -14.72 19.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.238 -0.914 . . . . 2.3300000000000001 109.933 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.485 ' NH1' ' OD2' ' B' ' 229' ' ' ASP . 15.1 mtm-85 -89.96 -11.77 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 4.1900000000000004 109.934 -179.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 231' ' ' ARG . 54.1 m-20 -160.97 128.9 2.81 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.14 -0.975 . . . . 2.1600000000000001 109.494 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.4 6.83 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 120.705 0.937 . . . . 1.3999999999999999 110.3 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.43 ' H ' ' C ' ' B' ' 232' ' ' ASP . 5.3 m -80.04 128.22 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 2.3100000000000001 109.99 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.3 165.08 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.72999999999999998 109.546 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' B' ' 237' ' ' GLY . 28.7 mttm -118.44 166.34 12.79 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.711 -0.848 . . . . 1.96 108.711 179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.72 177.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.978 -1.249 . . . . 0.56000000000000005 109.978 -179.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -71.93 160.39 47.84 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.653 1.569 . . . . 0.46999999999999997 110.506 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.1 173.09 11.99 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.723 -0.843 . . . . 1.05 108.723 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -95.35 139.2 31.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.996 -1.065 . . . . 3.1899999999999999 109.464 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.81 120.16 30.82 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 1.0900000000000001 109.855 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.23 -72.83 0.68 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.37 -0.831 . . . . 1.1799999999999999 110.312 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.78 140.08 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.223 -0.923 . . . . 0.34999999999999998 110.006 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -146.58 112.68 5.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.224 -0.923 . . . . 2.7999999999999998 108.986 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.4 -102.47 0.2 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.496 -1.335 . . . . 0.29999999999999999 110.644 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' B' ' 248' ' ' ALA . 31.6 mt-10 -61.65 -159.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.358 -1.083 . . . . 1.5600000000000001 110.186 -179.009 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.11 44.88 1.92 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.957 -1.657 . . . . 0.28999999999999998 108.957 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 246' ' ' GLU . . . -148.13 152.63 37.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.46 -1.023 . . . . 1.0700000000000001 108.944 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.67 126.8 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 1.0900000000000001 109.442 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.37 137.53 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.941 -1.133 . . . . 1.0800000000000001 107.941 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 26.2 pt -140.26 -178.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 1.04 110.119 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -143.76 109.27 5.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.394 -0.965 . . . . 2.3399999999999999 108.394 178.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.97 -76.27 0.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.337 -1.357 . . . . 1.1799999999999999 107.337 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.87 -134.8 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.763 -1.569 . . . . 2.4700000000000002 106.763 177.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.406 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 15.4 p -103.93 54.41 0.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.897 -1.149 . . . . 1.8600000000000001 107.897 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.6 m-20 -156.98 131.0 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.931 -0.766 . . . . 1.1200000000000001 108.931 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.46 135.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.194 -0.941 . . . . 1.1499999999999999 109.805 -179.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -137.52 176.68 8.49 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.435 -0.79 . . . . 2.6400000000000001 109.891 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.32 137.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 1.0800000000000001 109.553 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.59 131.5 19.32 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.341 -0.849 . . . . 1.0800000000000001 108.955 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.13 144.41 95.18 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.571 0.847 . . . . 0.48999999999999999 109.913 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -61.43 -34.16 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 3.5800000000000001 109.628 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -70.47 -5.32 27.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 4.3600000000000003 110.866 -178.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -119.71 21.13 12.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.355 -0.84 . . . . 2.5800000000000001 108.799 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.77 166.49 24.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.653 . . . . 1.05 109.244 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.461 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 7.8 mtmp? -141.77 129.68 21.85 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 109.12 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.94 117.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.289 -0.882 . . . . 1.1799999999999999 109.892 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.8 mm -117.14 150.71 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.59 -0.893 . . . . 1.27 108.59 179.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.48 146.2 23.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.734 -0.839 . . . . 4.1799999999999997 108.734 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 120.975 -1.078 . . . . 2.0499999999999998 109.377 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 108.914 -0.772 . . . . 2.0099999999999998 108.914 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -112.83 141.49 46.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.526 -0.734 . . . . 0.81999999999999995 109.712 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -112.41 159.2 18.95 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.899 -1.148 . . . . 3.79 107.899 178.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.03 142.29 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.187 -0.946 . . . . 1.05 110.154 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.26 154.46 23.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.517 -1.29 . . . . 0.92000000000000004 107.517 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.6 p90 -155.74 154.8 32.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.8 -1.188 . . . . 1.01 110.199 -178.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.3 mtm-85 -91.98 153.39 19.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 3.3999999999999999 109.364 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -95.35 169.66 9.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.319 -0.863 . . . . 2.23 109.484 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 37.1 t -87.93 -8.89 55.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -0.898 . . . . 2.3199999999999998 109.381 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.66 32.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.313 -0.867 . . . . 4.1799999999999997 109.636 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.0 m-20 -162.11 133.97 4.05 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.598 -0.89 . . . . 2.1600000000000001 108.598 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.56 12.07 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.028 1.152 . . . . 1.3899999999999999 111.125 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 232' ' ' ASP . 9.1 p -83.02 163.03 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.737 -1.227 . . . . 2.3100000000000001 110.108 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.409 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 97.6 m95 -74.52 174.12 9.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.71999999999999997 108.805 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.64 -164.91 1.46 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.311 -0.868 . . . . 1.96 108.81 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.89 52.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.706 -1.358 . . . . 0.55000000000000004 109.706 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.26 159.89 48.49 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.694 1.596 . . . . 0.46999999999999997 109.896 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.37 11.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.775 . . . . 1.05 109.19 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -95.29 136.35 35.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.186 -0.946 . . . . 3.1899999999999999 109.45 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.46 121.49 29.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.662 . . . . 1.0900000000000001 109.339 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.71 -68.94 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.412 -0.805 . . . . 1.1799999999999999 110.039 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -94.19 146.96 23.63 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.18 -0.95 . . . . 0.34000000000000002 109.697 -178.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -148.92 115.81 6.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.199 -0.938 . . . . 2.79 109.076 179.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.44 0.32 Allowed Glycine 0 N--CA 1.498 2.811 0 C-N-CA 119.611 -1.28 . . . . 0.28999999999999998 110.722 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.38 -155.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 1.5600000000000001 109.489 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 50.38 2.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.007 -1.637 . . . . 0.28999999999999998 109.007 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.02 151.74 35.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 1.0700000000000001 108.57 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -145.0 132.43 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.796 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.01 134.89 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.67 -1.233 . . . . 1.0700000000000001 107.67 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.41 177.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 1.04 110.216 -178.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.51 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.0 tt0 -141.75 109.65 5.79 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.891 -1.151 . . . . 2.3399999999999999 107.891 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.28 -79.58 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.389 -1.338 . . . . 1.1799999999999999 107.389 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 255' ' ' SER . 26.9 t-20 -80.78 -129.51 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.516 -1.661 . . . . 2.4700000000000002 106.516 177.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.431 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 36.4 p -104.59 54.04 0.73 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.8700000000000001 108.04 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -156.44 126.66 6.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.753 . . . . 1.1200000000000001 109.195 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.51 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -93.3 135.06 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 1.1499999999999999 109.444 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.73 169.07 18.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.392 -0.818 . . . . 2.6299999999999999 109.879 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.71 139.2 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.549 -0.719 . . . . 1.0800000000000001 109.256 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 27.6 t -133.49 130.87 21.14 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 1.0700000000000001 108.882 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.87 141.98 96.27 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.59 0.86 . . . . 0.48999999999999999 110.192 179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.99 -36.03 67.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 3.5800000000000001 109.008 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -65.7 -9.63 29.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 4.3600000000000003 110.369 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -119.91 18.65 12.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.202 -0.936 . . . . 2.5800000000000001 109.506 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.52 163.76 31.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.384 -0.823 . . . . 1.05 110.064 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.451 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 7.0 mtmp? -143.17 132.14 22.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.335 -0.853 . . . . 2.2599999999999998 109.624 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.2 mm -89.06 113.58 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.295 -0.878 . . . . 1.1799999999999999 109.811 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.11 158.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.356 -0.84 . . . . 1.28 108.924 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.229 -0.919 . . . . 4.1799999999999997 109.145 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 108.923 -0.769 . . . . 2.0099999999999998 108.923 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -112.74 141.5 46.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.481 -0.762 . . . . 0.81999999999999995 109.684 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -112.43 159.09 19.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 107.849 -1.167 . . . . 3.7799999999999998 107.849 178.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 96.0 t -139.96 142.32 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.172 -0.955 . . . . 1.0600000000000001 110.13 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.32 154.43 23.5 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.512 -1.292 . . . . 0.92000000000000004 107.512 178.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.7 p90 -155.79 154.8 31.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.779 -1.201 . . . . 1.01 110.228 -178.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.465 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.3 mtm-85 -91.94 153.37 19.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 3.3900000000000001 109.434 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.33 169.65 9.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 2.23 109.44 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 37.5 t -87.83 -8.98 55.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.933 . . . . 2.3300000000000001 109.4 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.57 32.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 4.1900000000000004 109.641 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.1 m-20 -162.23 133.95 3.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.1600000000000001 108.596 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -64.55 12.06 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.006 1.137 . . . . 1.3999999999999999 111.111 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' B' ' 232' ' ' ASP . 9.0 p -83.01 163.05 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.777 -1.202 . . . . 2.3100000000000001 110.101 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.408 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 97.6 m95 -74.52 174.11 9.44 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.792 -0.818 . . . . 0.72999999999999998 108.792 179.4 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.72 -165.07 1.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.238 -0.914 . . . . 1.96 108.804 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.4 175.81 52.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.652 -1.379 . . . . 0.56000000000000005 109.652 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.28 159.82 48.62 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.688 1.592 . . . . 0.46999999999999997 109.892 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.26 173.5 11.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.447 -0.783 . . . . 1.05 109.175 179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -95.41 136.36 35.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 3.1899999999999999 109.385 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.44 121.41 29.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.589 -0.694 . . . . 1.0900000000000001 109.31 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.69 -68.97 0.89 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.458 -0.776 . . . . 1.1799999999999999 110.085 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -94.14 146.89 23.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.029 -1.045 . . . . 0.34999999999999998 109.778 -179.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -148.92 115.76 5.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.132 -0.98 . . . . 2.7999999999999998 109.131 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.53 0.32 Allowed Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.543 -1.313 . . . . 0.29999999999999999 110.74 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.29 -155.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 1.5600000000000001 109.573 -179.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 50.47 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.939 -1.664 . . . . 0.28999999999999998 108.939 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.06 151.85 35.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.577 -0.955 . . . . 1.0700000000000001 108.544 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.12 132.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.112 -0.992 . . . . 1.0900000000000001 109.747 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.1 134.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.24 177.94 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 1.04 110.27 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.495 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.9 tt0 -141.83 109.7 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.904 -1.147 . . . . 2.3399999999999999 107.904 178.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -88.39 -79.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.382 -1.34 . . . . 1.1799999999999999 107.382 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 255' ' ' SER . 26.8 t-20 -80.6 -129.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.614 -1.624 . . . . 2.4700000000000002 106.614 177.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.432 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 36.5 p -104.52 54.08 0.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.116 -1.068 . . . . 1.8600000000000001 108.116 177.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -156.42 126.59 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.462 -0.774 . . . . 1.1200000000000001 109.166 -179.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.495 ' CG1' HE21 ' B' ' 252' ' ' GLN . 36.4 mt -93.21 135.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 1.1499999999999999 109.394 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.78 169.07 18.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 2.6400000000000001 109.832 -179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 t -101.62 139.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.537 -0.727 . . . . 1.0800000000000001 109.219 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.4 t -133.33 130.9 21.32 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 1.0800000000000001 108.954 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.92 141.89 95.94 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.592 0.861 . . . . 0.48999999999999999 110.203 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.83 -36.2 67.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 3.5800000000000001 108.948 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -65.6 -9.6 28.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.995 . . . . 4.3600000000000003 110.461 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.98 18.67 12.44 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.191 -0.943 . . . . 2.5800000000000001 109.484 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.82 31.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 1.05 110.075 -179.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.445 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.0 mtmp? -143.2 132.11 22.82 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.326 -0.859 . . . . 2.2599999999999998 109.637 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.1 mm -89.09 113.59 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.331 -0.856 . . . . 1.1799999999999999 109.833 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.11 158.33 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.46 -0.775 . . . . 1.27 108.93 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 0.2 OUTLIER -90.62 142.68 27.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.197 -0.94 . . . . 4.1799999999999997 109.108 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' B' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.013 -0.994 . . . . 2.0499999999999998 109.412 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.427 -0.582 . . . . 2.0099999999999998 109.427 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.77 126.47 27.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.365 -0.834 . . . . 0.81999999999999995 108.845 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.1 OUTLIER -102.95 156.96 17.31 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.15 -0.968 . . . . 3.79 108.416 179.465 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.19 141.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.19 -0.943 . . . . 1.05 110.491 -179.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.41 156.41 18.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.621 -1.251 . . . . 0.92000000000000004 107.621 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.7 p90 -155.02 151.56 28.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.686 -1.259 . . . . 1.01 110.809 -179.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -99.11 141.47 31.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.613 -0.679 . . . . 3.3999999999999999 109.347 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 16.8 p30 -95.62 175.11 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 2.23 109.009 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.0 t -85.69 -6.24 59.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 2.3199999999999998 109.19 179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -88.84 -18.34 27.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.302 -0.874 . . . . 4.1799999999999997 109.688 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 234' ' ' VAL . 31.5 m-20 -161.95 129.1 2.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.978 . . . . 2.1600000000000001 109.267 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.36 8.55 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 120.653 0.902 . . . . 1.3899999999999999 110.252 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.2 t -83.58 158.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.877 -1.14 . . . . 2.3100000000000001 109.827 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -74.72 159.9 31.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.71999999999999997 109.327 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.1 mtpt -118.55 165.12 14.32 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.532 -0.914 . . . . 1.96 108.532 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.89 164.95 0.02 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.499 -1.04 . . . . 0.55000000000000004 110.499 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.88 161.84 42.3 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.728 1.619 . . . . 0.46999999999999997 110.302 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.82 178.39 7.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.456 -0.778 . . . . 1.05 109.067 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.75 138.76 33.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.221 -0.924 . . . . 3.1899999999999999 108.923 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.07 123.49 32.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.548 -0.72 . . . . 1.0900000000000001 109.751 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.3 mt -112.44 -76.13 0.6 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.444 -0.785 . . . . 1.1799999999999999 110.289 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -89.17 143.84 26.55 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.156 -0.965 . . . . 0.34000000000000002 110.29 -178.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.57 118.5 8.76 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.77 -0.826 . . . . 2.79 108.77 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -113.11 0.45 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.749 -1.215 . . . . 0.28999999999999998 110.195 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.53 -154.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -1.057 . . . . 1.5600000000000001 109.573 -179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.43 51.03 3.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.434 -1.466 . . . . 0.28999999999999998 109.434 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 153.01 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 1.0700000000000001 108.641 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.95 131.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.001 -1.062 . . . . 1.0900000000000001 109.952 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.39 138.25 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 1.0700000000000001 108.536 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 22.1 pt -140.37 178.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.874 . . . . 1.04 110.05 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.514 HE21 ' CG1' ' A' ' 257' ' ' ILE . 37.3 tt0 -141.1 110.11 6.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.495 -0.928 . . . . 2.3399999999999999 108.495 179.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.72 -79.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.402 -1.332 . . . . 1.1799999999999999 107.402 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.21 -131.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.492 -1.669 . . . . 2.4700000000000002 106.492 177.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.61 54.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.133 -1.062 . . . . 1.8700000000000001 108.133 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.25 124.91 5.9 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.925 -0.769 . . . . 1.1200000000000001 108.925 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.514 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.6 mt -90.92 136.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 1.1499999999999999 109.624 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.26 172.67 12.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.285 -0.885 . . . . 2.6299999999999999 109.911 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.15 136.96 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.502 -0.749 . . . . 1.0800000000000001 109.688 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.93 123.34 18.04 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 108.426 -0.953 . . . . 1.0700000000000001 108.426 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.23 139.12 85.45 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 109.854 -0.864 . . . . 0.48999999999999999 109.854 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.6 -33.35 66.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.157 -0.964 . . . . 3.5800000000000001 109.433 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -68.24 -6.07 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 4.3600000000000003 109.95 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.15 17.67 11.59 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.485 -0.759 . . . . 2.5800000000000001 109.429 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.71 168.31 20.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.467 -0.771 . . . . 1.05 109.263 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -141.44 131.69 24.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.28 -0.888 . . . . 2.2599999999999998 109.197 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.2 mm -88.02 110.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.325 -0.859 . . . . 1.1799999999999999 109.369 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.49 156.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.337 -0.852 . . . . 1.28 109.219 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.448 -0.783 . . . . 4.1799999999999997 109.736 -179.674 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.367 -0.605 . . . . 2.0099999999999998 109.367 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.72 126.37 27.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.81999999999999995 108.909 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.1 OUTLIER -102.86 157.0 17.27 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.144 -0.973 . . . . 3.7799999999999998 108.454 179.431 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.22 141.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.159 -0.963 . . . . 1.0600000000000001 110.526 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.34 156.35 19.0 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.648 -1.241 . . . . 0.92000000000000004 107.648 178.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.9 p90 -154.99 151.5 28.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.601 -1.312 . . . . 1.01 110.837 -179.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -98.95 141.3 31.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 3.3900000000000001 109.426 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 17.0 p30 -95.5 175.19 6.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 2.23 109.008 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 35.9 t -85.68 -6.36 59.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 2.3300000000000001 109.261 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -88.75 -18.34 28.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.233 -0.917 . . . . 4.1900000000000004 109.711 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' B' ' 234' ' ' VAL . 31.6 m-20 -161.98 129.11 2.59 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 2.1600000000000001 109.294 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -66.4 8.58 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.659 0.906 . . . . 1.3999999999999999 110.211 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.3 t -83.54 158.12 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.806 -1.184 . . . . 2.3100000000000001 109.844 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -74.85 159.83 31.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.72999999999999998 109.352 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.2 mtpt -118.47 165.18 14.21 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.544 -0.91 . . . . 1.96 108.544 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.88 164.92 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.516 -1.033 . . . . 0.56000000000000005 110.516 -179.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.92 161.88 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.639 1.559 . . . . 0.46999999999999997 110.302 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 178.38 7.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.533 -0.729 . . . . 1.05 109.156 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.86 138.75 33.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.276 -0.89 . . . . 3.1899999999999999 108.946 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -88.14 123.52 32.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.489 -0.757 . . . . 1.0900000000000001 109.678 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 31.0 mt -112.42 -76.13 0.6 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.356 -0.84 . . . . 1.1799999999999999 110.281 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.423 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -89.2 143.64 26.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.186 -0.946 . . . . 0.34999999999999998 110.308 -178.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.51 118.47 8.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.794 -0.817 . . . . 2.7999999999999998 108.794 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.23 -113.13 0.45 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.838 -1.172 . . . . 0.29999999999999999 110.209 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.55 -154.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.416 -1.049 . . . . 1.5600000000000001 109.545 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 51.12 3.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.28999999999999998 109.483 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.07 38.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -1.098 . . . . 1.0700000000000001 108.663 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 7.9 m -146.97 131.81 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 1.0900000000000001 109.973 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 94.4 t -93.41 138.19 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.537 -0.912 . . . . 1.0800000000000001 108.537 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 22.3 pt -140.31 178.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.176 -0.953 . . . . 1.04 110.111 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.498 HE21 ' CG1' ' B' ' 257' ' ' ILE . 37.4 tt0 -141.09 110.1 6.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.459 -0.941 . . . . 2.3399999999999999 108.459 179.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.75 -79.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.392 -1.336 . . . . 1.1799999999999999 107.392 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.29 -131.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.432 -1.692 . . . . 2.4700000000000002 106.432 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -104.58 54.72 0.72 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.182 -1.044 . . . . 1.8600000000000001 108.182 177.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.22 124.97 5.94 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.931 -0.766 . . . . 1.1200000000000001 108.931 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.498 ' CG1' HE21 ' B' ' 252' ' ' GLN . 61.1 mt -91.06 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.571 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.19 172.58 12.7 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.346 -0.846 . . . . 2.6400000000000001 109.96 -179.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.02 136.93 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.443 -0.786 . . . . 1.0800000000000001 109.737 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.97 123.34 18.0 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.424 -0.954 . . . . 1.0800000000000001 108.424 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.27 139.17 85.72 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.852 -0.865 . . . . 0.48999999999999999 109.852 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.594 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.69 -33.14 66.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.9 . . . . 3.5800000000000001 109.521 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.38 -6.04 22.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 4.3600000000000003 109.996 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.12 17.8 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.465 -0.772 . . . . 2.5800000000000001 109.463 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.85 168.41 19.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 1.05 109.227 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -141.47 131.61 24.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.896 . . . . 2.2599999999999998 109.232 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.3 mm -88.08 110.5 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 1.1799999999999999 109.299 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 29.3 mm -102.48 156.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.344 -0.848 . . . . 1.27 109.143 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.43 137.45 33.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 4.1799999999999997 109.724 -179.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.003 -0.998 . . . . 2.0499999999999998 109.317 179.469 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.223 0.535 . . . . 2.0099999999999998 109.716 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -134.14 145.64 49.47 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.428 -0.795 . . . . 0.81999999999999995 109.767 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -118.95 152.9 35.5 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.567 -1.271 . . . . 3.79 107.567 178.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.6 t -139.25 142.0 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.121 -0.987 . . . . 1.05 110.431 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -108.39 158.34 17.59 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.684 -1.228 . . . . 0.92000000000000004 107.684 178.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 15.8 p90 -156.64 152.38 27.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.722 -1.236 . . . . 1.01 110.509 -178.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -93.46 154.13 18.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.389 -0.819 . . . . 3.3999999999999999 109.59 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.73 170.14 9.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.349 -0.844 . . . . 2.23 109.183 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.0 t -89.66 -13.45 37.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.89 . . . . 2.3199999999999998 109.46 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 58.9 mtp180 -88.21 -14.6 38.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.16 -0.963 . . . . 4.1799999999999997 109.373 179.746 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 234' ' ' VAL . 50.1 m-20 -162.22 130.04 2.76 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 2.1600000000000001 108.718 179.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.57 19.37 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 120.759 0.973 . . . . 1.3899999999999999 110.794 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -84.47 158.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.778 -1.201 . . . . 2.3100000000000001 110.197 -179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -76.66 165.9 24.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.709 -0.62 . . . . 0.71999999999999997 109.937 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.72 -166.94 1.29 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.61 -0.885 . . . . 1.96 108.61 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.14 52.22 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.703 -1.359 . . . . 0.55000000000000004 109.703 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.64 149.56 61.46 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.671 1.58 . . . . 0.46999999999999997 109.862 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.63 169.21 17.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.87 -0.789 . . . . 1.05 108.87 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -92.75 138.73 31.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.088 -1.007 . . . . 3.1899999999999999 109.502 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.8 tp -87.84 118.82 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.677 -0.64 . . . . 1.0900000000000001 109.38 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.01 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.358 -0.839 . . . . 1.1799999999999999 110.154 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.9 146.62 23.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.324 -0.86 . . . . 0.34000000000000002 110.714 -178.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -150.29 117.01 5.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.452 -0.78 . . . . 2.79 109.14 179.127 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.87 -104.72 0.26 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.949 -1.261 . . . . 0.28999999999999998 109.949 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -67.05 -155.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -1.112 . . . . 1.5600000000000001 109.632 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.88 49.38 2.83 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.342 -1.503 . . . . 0.28999999999999998 109.342 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.94 152.2 38.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -1.091 . . . . 1.0700000000000001 108.542 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.0 m -144.21 132.67 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 1.0900000000000001 109.677 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.05 133.81 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.812 -1.181 . . . . 1.0700000000000001 107.812 178.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.14 -177.87 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 1.04 110.384 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.538 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.1 tt0 -142.35 112.17 6.84 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.345 -0.983 . . . . 2.3399999999999999 108.345 178.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.5 -84.55 0.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.596 -1.261 . . . . 1.1799999999999999 107.596 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.642 HD21 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -78.16 -127.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.486 -1.672 . . . . 2.4700000000000002 106.486 177.488 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.642 ' N ' HD21 ' A' ' 254' ' ' ASN . 9.7 p -105.05 52.98 0.73 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.135 -0.978 . . . . 1.8700000000000001 108.659 178.313 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -155.45 131.03 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 109.276 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.538 ' CG1' HE21 ' A' ' 252' ' ' GLN . 58.1 mt -93.06 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.486 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.04 165.26 26.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.377 -0.827 . . . . 2.6299999999999999 109.75 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.44 136.77 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.489 -0.757 . . . . 1.0800000000000001 108.978 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 26.7 t -134.36 132.08 20.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.435 -0.791 . . . . 1.0700000000000001 108.892 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.25 148.65 85.13 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.641 0.894 . . . . 0.48999999999999999 109.931 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.848 . . . . 3.5800000000000001 109.075 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.29 -8.62 47.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.249 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -119.24 19.17 12.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.428 -0.795 . . . . 2.5800000000000001 108.94 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.54 164.01 31.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 1.05 109.463 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 7.5 mtmp? -140.41 130.95 25.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 109.44 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.02 111.54 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.366 -0.834 . . . . 1.1799999999999999 110.101 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -109.0 157.46 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.486 -0.759 . . . . 1.28 108.975 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.845 . . . . 4.1799999999999997 109.155 179.327 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.617 -0.512 . . . . 2.0099999999999998 109.617 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -134.12 145.44 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.447 -0.783 . . . . 0.81999999999999995 109.791 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.484 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 11.0 mtp180 -118.82 152.97 35.26 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.481 -1.303 . . . . 3.7799999999999998 107.481 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.1 t -139.14 142.21 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.167 -0.958 . . . . 1.0600000000000001 110.469 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -108.56 158.29 17.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.651 -1.24 . . . . 0.92000000000000004 107.651 178.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 15.5 p90 -156.63 152.38 27.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.698 -1.251 . . . . 1.01 110.545 -178.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -93.33 153.91 18.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.243 -0.911 . . . . 3.3900000000000001 109.608 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.63 170.13 9.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.25 -0.906 . . . . 2.23 109.154 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 26.8 t -89.69 -13.37 37.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 2.3300000000000001 109.507 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 58.8 mtp180 -88.32 -14.5 38.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.138 -0.976 . . . . 4.1900000000000004 109.319 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' B' ' 234' ' ' VAL . 50.6 m-20 -162.29 129.98 2.72 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 2.1600000000000001 108.771 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.62 19.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 120.804 1.003 . . . . 1.3999999999999999 110.697 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.552 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -84.35 158.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.869 -1.144 . . . . 2.3100000000000001 110.243 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -76.65 166.18 23.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 0.72999999999999998 109.983 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.79 -166.98 1.3 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 1.96 108.689 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.07 52.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.713 -1.355 . . . . 0.56000000000000005 109.713 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.69 149.52 61.11 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.762 1.641 . . . . 0.46999999999999997 109.884 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.74 169.06 18.15 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.963 -0.754 . . . . 1.05 108.963 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.58 138.55 31.41 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.987 . . . . 3.1899999999999999 109.52 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.75 118.96 27.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.724 -0.61 . . . . 1.0900000000000001 109.414 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.25 -73.9 0.67 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.388 -0.82 . . . . 1.1799999999999999 110.103 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -92.91 146.47 23.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.323 -0.861 . . . . 0.34999999999999998 110.661 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -150.1 117.03 5.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.444 -0.785 . . . . 2.7999999999999998 109.164 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.89 -104.69 0.26 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.948 -1.261 . . . . 0.29999999999999999 109.948 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.03 -155.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -1.116 . . . . 1.5600000000000001 109.612 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.94 49.42 2.86 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.276 -1.529 . . . . 0.28999999999999998 109.276 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.42 38.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.389 -1.065 . . . . 1.0700000000000001 108.494 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 m -144.46 132.68 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.023 . . . . 1.0900000000000001 109.648 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.12 133.76 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.843 -1.169 . . . . 1.0800000000000001 107.843 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.6 pt -138.13 -177.72 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 1.04 110.292 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.542 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.1 tt0 -142.48 112.2 6.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.334 -0.987 . . . . 2.3399999999999999 108.334 178.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -89.59 -84.54 0.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.552 -1.277 . . . . 1.1799999999999999 107.552 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.643 HD21 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -78.12 -128.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.489 -1.671 . . . . 2.4700000000000002 106.489 177.561 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.643 ' N ' HD21 ' B' ' 254' ' ' ASN . 9.6 p -105.1 53.02 0.73 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.145 -0.972 . . . . 1.8600000000000001 108.586 178.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -155.32 131.06 9.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.491 -0.756 . . . . 1.1200000000000001 109.276 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.542 ' CG1' HE21 ' B' ' 252' ' ' GLN . 58.1 mt -93.05 135.98 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.142 -0.974 . . . . 1.1499999999999999 109.413 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -137.06 165.4 26.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.362 -0.836 . . . . 2.6400000000000001 109.67 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.68 137.05 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.045 -0.724 . . . . 1.0800000000000001 109.045 179.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.6 132.1 20.59 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.346 -0.846 . . . . 1.0800000000000001 108.935 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.26 148.72 84.87 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 N-CA-C 109.911 -0.842 . . . . 0.48999999999999999 109.911 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.84 73.39 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.282 -0.886 . . . . 3.5800000000000001 108.997 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.33 -8.48 46.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 4.3600000000000003 110.235 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -119.31 19.18 12.85 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.448 -0.782 . . . . 2.5800000000000001 108.986 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.91 31.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.564 -0.71 . . . . 1.05 109.447 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.5 mtmp? -140.4 130.97 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.258 -0.901 . . . . 2.2599999999999998 109.479 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.04 111.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.362 -0.836 . . . . 1.1799999999999999 110.102 -179.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.99 157.48 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.985 -0.746 . . . . 1.27 108.985 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -91.43 140.69 29.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 4.1799999999999997 109.159 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 2.0499999999999998 109.064 179.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.261 0.553 . . . . 2.0099999999999998 109.756 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.34 143.09 50.56 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.591 -0.693 . . . . 0.81999999999999995 109.594 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -108.08 157.79 17.96 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.456 -1.313 . . . . 3.79 107.456 178.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.47 141.39 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.785 -1.197 . . . . 1.05 110.954 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.39 155.86 20.73 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.674 -1.602 . . . . 0.92000000000000004 106.674 177.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -154.11 166.94 31.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.462 -1.399 . . . . 1.01 110.654 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -90.62 137.53 32.29 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.322 0.582 . . . . 3.3999999999999999 109.453 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -94.39 160.97 14.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.545 -0.722 . . . . 2.23 109.432 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.9 m -86.81 -6.51 58.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 2.3199999999999998 109.575 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -88.26 -20.36 25.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 4.1799999999999997 109.628 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.4 m-20 -162.19 140.29 6.73 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 2.1600000000000001 108.7 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.57 2.82 1.05 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.869 1.046 . . . . 1.3899999999999999 110.378 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.3 m -84.56 141.74 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.853 -1.155 . . . . 2.3100000000000001 110.141 -179.514 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CZ2' ' NH1' ' A' ' 228' ' ' ARG . 97.2 m95 -52.32 -177.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.345 -0.847 . . . . 0.71999999999999997 109.19 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.444 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 1.9 ttpp -131.77 -156.64 0.77 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.272 -0.893 . . . . 1.96 109.11 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.28 -178.6 52.46 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.59 -1.404 . . . . 0.55000000000000004 109.59 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.64 159.84 47.83 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.571 1.514 . . . . 0.46999999999999997 110.19 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.07 18.27 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.92 -0.77 . . . . 1.05 108.92 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -93.24 139.24 30.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.12 -0.987 . . . . 3.1899999999999999 109.223 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.27 117.31 28.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.419 -0.801 . . . . 1.0900000000000001 109.631 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.0 -73.61 0.68 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.291 -0.88 . . . . 1.1799999999999999 110.005 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -90.77 141.56 28.68 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.34000000000000002 110.531 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.73 113.95 5.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 2.79 109.361 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.01 -107.98 0.29 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.89 -1.284 . . . . 0.28999999999999998 109.89 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -60.05 -158.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 1.5600000000000001 109.833 -179.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.85 46.88 2.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.703 -1.359 . . . . 0.28999999999999998 109.703 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.23 148.39 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -1.106 . . . . 1.0700000000000001 108.867 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.0 m -142.19 129.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.912 . . . . 1.0900000000000001 109.744 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.25 137.72 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.203 -1.036 . . . . 1.0700000000000001 108.203 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -140.27 -179.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.192 -0.943 . . . . 1.04 110.452 -179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.6 tt0 -144.19 110.29 5.42 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.81 -0.811 . . . . 2.3399999999999999 108.81 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . 0.431 ' CG ' ' HH ' ' A' ' 227' ' ' TYR . 21.9 t70 -89.42 -78.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.378 -1.342 . . . . 1.1799999999999999 107.378 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -80.04 -134.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.445 -1.687 . . . . 2.4700000000000002 106.445 177.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.9 p -102.15 54.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.009 -1.108 . . . . 1.8700000000000001 108.009 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.48 126.43 7.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.705 . . . . 1.1200000000000001 109.337 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.451 ' CG1' HE21 ' A' ' 252' ' ' GLN . 30.1 mt -92.61 137.84 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.339 -0.85 . . . . 1.1499999999999999 109.61 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -140.73 170.63 15.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 2.6299999999999999 109.643 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.42 139.77 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 1.0800000000000001 109.605 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.19 130.22 19.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.645 -0.872 . . . . 1.0700000000000001 108.645 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.76 141.47 95.68 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 N-CA-C 109.644 -0.945 . . . . 0.48999999999999999 109.644 179.055 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.93 -34.7 73.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 3.5800000000000001 109.727 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.01 -6.44 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 4.3600000000000003 110.655 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.53 24.0 10.55 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.16 -0.962 . . . . 2.5800000000000001 109.204 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.19 164.54 28.94 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.085 -0.709 . . . . 1.05 109.085 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -137.77 131.68 31.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.247 -0.908 . . . . 2.2599999999999998 108.87 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.09 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 1.1799999999999999 109.828 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.98 157.2 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.378 -0.827 . . . . 1.28 108.964 179.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.543 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.1 mtt-85 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.158 -0.963 . . . . 4.1799999999999997 109.198 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.288 0.566 . . . . 2.0099999999999998 109.705 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -130.54 142.94 50.47 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.694 -0.629 . . . . 0.81999999999999995 109.48 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 49.9 mtt180 -108.1 157.76 17.99 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.401 -1.333 . . . . 3.7799999999999998 107.401 178.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.51 141.17 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.952 -1.092 . . . . 1.0600000000000001 110.979 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.16 155.8 20.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.907 -1.516 . . . . 0.92000000000000004 106.907 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.7 p90 -154.2 166.92 31.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.56 -1.337 . . . . 1.01 110.761 -178.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 228' ' ' ARG . 0.0 OUTLIER -90.47 137.41 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.706 -0.621 . . . . 3.3900000000000001 109.556 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -94.36 161.02 14.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.416 -0.803 . . . . 2.23 109.333 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 68.7 m -86.79 -6.61 58.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 2.3300000000000001 109.709 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.17 -20.37 25.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 4.1900000000000004 109.532 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.8 m-20 -162.29 140.11 6.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.984 . . . . 2.1600000000000001 108.804 179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.31 2.74 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 120.857 1.038 . . . . 1.3999999999999999 110.624 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.5 m -84.54 141.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.965 -1.084 . . . . 2.3100000000000001 110.111 -179.427 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.577 ' CZ2' ' NH1' ' B' ' 228' ' ' ARG . 97.0 m95 -52.2 -177.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 0.72999999999999998 109.213 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.452 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 1.9 ttpp -131.82 -156.71 0.77 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.184 -0.947 . . . . 1.96 109.057 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.12 -178.43 52.39 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.652 -1.379 . . . . 0.56000000000000005 109.652 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.81 159.78 47.6 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.543 1.495 . . . . 0.46999999999999997 110.171 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 168.98 18.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.876 -0.787 . . . . 1.05 108.876 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -93.23 139.11 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 3.1899999999999999 109.232 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.25 117.26 28.09 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.501 -0.749 . . . . 1.0900000000000001 109.575 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.99 -73.55 0.68 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.314 -0.866 . . . . 1.1799999999999999 110.034 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.73 141.53 28.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.34999999999999998 110.528 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.63 114.04 5.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 2.7999999999999998 109.255 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.24 -107.82 0.29 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.039 -1.224 . . . . 0.29999999999999999 110.039 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.22 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -1.169 . . . . 1.5600000000000001 109.704 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.61 46.77 2.02 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.753 -1.339 . . . . 0.28999999999999998 109.753 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.13 148.35 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -1.19 . . . . 1.0700000000000001 108.872 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.18 129.65 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.328 -0.857 . . . . 1.0900000000000001 109.796 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -93.31 137.71 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.229 -1.026 . . . . 1.0800000000000001 108.229 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.29 -179.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.19 -0.944 . . . . 1.04 110.507 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.449 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -144.13 110.14 5.37 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.835 -0.802 . . . . 2.3399999999999999 108.835 178.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.433 ' CG ' ' HH ' ' B' ' 227' ' ' TYR . 21.9 t70 -89.24 -79.07 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.415 -1.328 . . . . 1.1799999999999999 107.415 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.96 -134.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.485 -1.672 . . . . 2.4700000000000002 106.485 177.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -102.04 54.27 0.8 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.994 -1.113 . . . . 1.8600000000000001 107.994 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.55 126.32 6.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 1.1200000000000001 109.336 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.449 ' CG1' HE21 ' B' ' 252' ' ' GLN . 30.0 mt -92.61 137.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 1.1499999999999999 109.571 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -140.63 170.74 15.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 2.6400000000000001 109.544 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.55 139.78 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.364 -0.835 . . . . 1.0800000000000001 109.608 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.13 130.19 19.24 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 108.602 -0.888 . . . . 1.0800000000000001 108.602 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 141.5 95.92 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.589 -0.966 . . . . 0.48999999999999999 109.589 179.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.89 -34.6 73.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 3.5800000000000001 109.782 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.07 -6.44 28.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 4.3600000000000003 110.602 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.65 24.09 10.46 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.132 -0.98 . . . . 2.5800000000000001 109.294 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 164.49 29.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.892 -0.781 . . . . 1.05 108.892 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -137.7 131.85 31.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.259 -0.9 . . . . 2.2599999999999998 108.965 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.25 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.351 -0.843 . . . . 1.1799999999999999 109.632 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.25 157.32 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.796 -0.816 . . . . 1.27 108.796 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.1 mtt-85 -91.02 143.76 26.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.241 -0.912 . . . . 4.1799999999999997 109.176 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 18.3 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.03 -0.986 . . . . 2.0499999999999998 109.464 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 108.974 -0.75 . . . . 2.0099999999999998 108.974 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -135.28 126.99 29.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.516 -0.74 . . . . 0.81999999999999995 109.21 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -100.98 158.67 15.82 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.143 -1.058 . . . . 3.79 108.143 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.83 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 1.05 110.312 -179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -111.2 156.85 20.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.056 -1.091 . . . . 0.92000000000000004 108.056 178.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.8 p90 -155.49 153.26 30.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.806 -1.184 . . . . 1.01 110.377 -179.044 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.611 HH21 ' CA ' ' A' ' 233' ' ' PRO . 21.4 mtp180 -96.84 145.67 25.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 3.3999999999999999 109.801 -179.704 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.52 163.94 12.83 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.42 -0.8 . . . . 2.23 108.928 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.2 m -82.65 -3.17 55.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 2.3199999999999998 109.313 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.47 -17.26 30.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.865 . . . . 4.1799999999999997 109.442 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 234' ' ' VAL . 22.5 m-20 -162.62 133.8 3.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 2.1600000000000001 108.892 179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.611 ' CA ' HH21 ' A' ' 228' ' ' ARG . 6.8 Cg_endo -64.88 5.85 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.839 1.026 . . . . 1.3899999999999999 110.458 179.871 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.4 m -83.34 154.16 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.94 -1.1 . . . . 2.3100000000000001 109.786 -179.627 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.34 -171.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.71999999999999997 108.782 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.48 -155.74 0.62 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.975 . . . . 1.96 109.251 179.727 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.17 173.97 52.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.874 -1.291 . . . . 0.55000000000000004 109.874 -179.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.03 157.82 46.45 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.78 1.653 . . . . 0.46999999999999997 110.297 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.59 174.3 10.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 1.05 109.194 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.44 142.76 27.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 3.1899999999999999 109.463 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.23 124.48 34.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.318 -0.623 . . . . 1.0900000000000001 109.318 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.8 mt -115.88 -74.12 0.62 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.499 -0.75 . . . . 1.1799999999999999 110.207 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -92.25 142.08 27.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.284 -0.885 . . . . 0.34000000000000002 110.396 -178.522 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.89 7.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.865 . . . . 2.79 109.231 179.265 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.82 -103.87 0.21 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.982 -1.247 . . . . 0.28999999999999998 109.982 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.76 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 1.5600000000000001 109.647 -179.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.19 50.57 3.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.279 -1.529 . . . . 0.28999999999999998 109.279 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.26 152.93 36.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -1.02 . . . . 1.0700000000000001 108.811 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.47 129.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.535 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.37 139.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.509 -0.923 . . . . 1.0700000000000001 108.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.42 176.31 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.277 -0.889 . . . . 1.04 110.243 -179.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.518 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.5 tt0 -144.96 113.33 6.6 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.85 -0.796 . . . . 2.3399999999999999 108.85 178.93 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.09 -79.88 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.44 -1.319 . . . . 1.1799999999999999 107.44 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.64 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.756 -1.572 . . . . 2.4700000000000002 106.756 177.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.0 p -103.83 55.72 0.73 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.983 -1.117 . . . . 1.8700000000000001 107.983 177.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -156.0 125.5 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.079 -0.712 . . . . 1.1200000000000001 109.079 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.518 ' CG1' HE21 ' A' ' 252' ' ' GLN . 66.8 mt -91.78 136.97 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.238 -0.914 . . . . 1.1499999999999999 109.611 -179.493 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.1 166.4 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 2.6299999999999999 110.032 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.89 140.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.492 -0.755 . . . . 1.0800000000000001 109.534 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.62 127.94 16.75 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.357 -0.84 . . . . 1.0700000000000001 108.863 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.5 99.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.614 0.876 . . . . 0.48999999999999999 110.363 179.637 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -59.02 -28.88 66.82 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.447 -0.946 . . . . 3.5800000000000001 108.447 179.139 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.41 -13.58 62.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.468 -0.77 . . . . 4.3600000000000003 110.805 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -120.65 23.99 10.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.317 -0.864 . . . . 2.5800000000000001 109.644 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.97 163.07 33.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 1.05 109.634 -179.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 8.2 mtmp? -140.74 125.03 17.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.408 -0.807 . . . . 2.2599999999999998 108.969 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.08 112.11 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 110.128 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.94 150.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.487 -0.931 . . . . 1.28 108.487 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.475 -0.766 . . . . 4.1799999999999997 109.382 179.522 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' B' ' 222' ' ' ASN . 1.4 m-20 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.011 -0.737 . . . . 2.0099999999999998 109.011 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.3 127.04 29.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.81999999999999995 109.16 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -100.98 158.68 15.82 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.124 -1.065 . . . . 3.7799999999999998 108.124 179.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 1.0600000000000001 110.284 -179.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.23 156.93 20.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.061 -1.089 . . . . 0.92000000000000004 108.061 178.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.7 p90 -155.52 153.38 30.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.749 -1.219 . . . . 1.01 110.282 -178.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.625 HH21 ' CA ' ' B' ' 233' ' ' PRO . 21.5 mtp180 -97.01 145.62 25.77 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.6 -0.688 . . . . 3.3900000000000001 109.754 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.5 163.95 12.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 2.23 108.997 179.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.1 m -82.68 -3.06 55.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 2.3300000000000001 109.412 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.59 -17.21 30.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.39 -0.819 . . . . 4.1900000000000004 109.41 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' B' ' 234' ' ' VAL . 22.7 m-20 -162.62 133.71 3.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 2.1600000000000001 108.921 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . 0.625 ' CA ' HH21 ' B' ' 228' ' ' ARG . 6.8 Cg_endo -64.79 5.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 120.858 1.039 . . . . 1.3999999999999999 110.488 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.4 m -83.29 154.12 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.908 -1.12 . . . . 2.3100000000000001 109.813 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.38 -171.48 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.72999999999999998 108.759 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.45 -155.71 0.62 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.974 . . . . 1.96 109.264 179.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 174.04 52.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.914 -1.275 . . . . 0.56000000000000005 109.914 -179.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.07 157.81 46.27 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.745 1.63 . . . . 0.46999999999999997 110.297 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.65 174.24 10.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.488 -0.757 . . . . 1.05 109.163 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.34 142.62 27.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.02 . . . . 3.1899999999999999 109.475 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -89.14 124.42 34.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.624 -0.672 . . . . 1.0900000000000001 109.475 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 36.1 mt -115.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.388 -0.82 . . . . 1.1799999999999999 110.156 -179.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.5 t90 -92.26 142.08 27.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.34999999999999998 110.337 -178.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.85 7.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.309 -0.869 . . . . 2.7999999999999998 109.223 179.244 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.77 -104.01 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.956 -1.257 . . . . 0.29999999999999999 109.956 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.72 -156.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 1.5600000000000001 109.632 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 50.58 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.272 -1.531 . . . . 0.28999999999999998 109.272 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.28 152.87 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.443 -1.034 . . . . 1.0700000000000001 108.867 179.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.41 129.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.139 -0.975 . . . . 1.0900000000000001 109.525 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.39 139.65 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.084 -1.01 . . . . 1.0800000000000001 108.543 179.531 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.5 pt -139.48 176.22 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.264 -0.897 . . . . 1.04 110.206 -179.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.528 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.5 tt0 -144.95 113.46 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 2.3399999999999999 108.811 178.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -91.1 -80.05 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.345 -1.354 . . . . 1.1799999999999999 107.345 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.47 -131.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.737 -1.579 . . . . 2.4700000000000002 106.737 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 86.9 p -103.76 55.57 0.74 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.051 -1.092 . . . . 1.8600000000000001 108.051 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -155.96 125.53 6.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.023 -0.732 . . . . 1.1200000000000001 109.023 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CG1' HE21 ' B' ' 252' ' ' GLN . 67.0 mt -91.77 136.92 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 1.1499999999999999 109.611 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.14 166.41 23.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.398 -0.814 . . . . 2.6400000000000001 109.985 -179.109 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.97 140.66 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.483 -0.761 . . . . 1.0800000000000001 109.472 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.5 t -136.63 127.95 16.74 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.338 -0.852 . . . . 1.0800000000000001 108.897 179.613 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.8 144.49 99.56 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 120.621 0.881 . . . . 0.48999999999999999 110.253 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -58.91 -29.01 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.416 -0.957 . . . . 3.5800000000000001 108.416 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -70.4 -13.55 62.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.462 -0.774 . . . . 4.3600000000000003 110.76 -178.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -120.69 24.06 10.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.256 -0.902 . . . . 2.5800000000000001 109.563 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.1 33.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.436 -0.79 . . . . 1.05 109.633 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.457 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 8.1 mtmp? -140.71 125.06 17.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 2.2599999999999998 108.953 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 31.0 mm -89.04 112.1 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.285 -0.884 . . . . 1.1799999999999999 110.135 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.88 150.08 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.513 -0.921 . . . . 1.27 108.513 179.098 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -92.8 143.63 26.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.406 -0.808 . . . . 4.1799999999999997 109.316 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.044 -0.979 . . . . 2.0499999999999998 109.49 179.734 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.04 -0.726 . . . . 2.0099999999999998 109.04 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.3 146.4 49.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.567 -0.708 . . . . 0.81999999999999995 109.528 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.575 HH21 ' HH ' ' A' ' 226' ' ' TYR . 15.3 mtp180 -120.95 153.46 37.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.652 -1.24 . . . . 3.79 107.652 178.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.67 143.47 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 1.05 109.892 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.575 ' HH ' HH21 ' A' ' 224' ' ' ARG . 25.5 m-85 -109.94 157.36 19.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.117 -1.438 . . . . 0.92000000000000004 107.117 178.566 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 19.2 p90 -156.87 160.44 39.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.539 -1.35 . . . . 1.01 110.499 -179.354 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -97.72 153.78 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.648 -0.657 . . . . 3.3999999999999999 109.953 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -96.39 175.16 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.505 -0.747 . . . . 2.23 109.351 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 83.6 p -91.55 -16.78 26.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 2.3199999999999998 109.248 179.626 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -82.15 -12.55 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 4.1799999999999997 109.581 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 234' ' ' VAL . 46.1 m-20 -162.36 130.32 2.78 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 2.1600000000000001 109.281 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -65.16 12.15 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.677 0.918 . . . . 1.3899999999999999 110.041 179.201 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 232' ' ' ASP . 41.0 t -84.62 160.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.022 . . . . 2.3100000000000001 109.521 -179.746 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -75.09 168.68 19.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.735 . . . . 0.71999999999999997 109.092 179.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.95 -165.16 1.31 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.1 -1.074 . . . . 1.96 108.1 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.36 178.14 47.83 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.385 -1.388 . . . . 0.55000000000000004 109.882 -179.508 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.17 158.06 55.83 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.558 1.505 . . . . 0.46999999999999997 109.904 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.11 169.22 18.16 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.743 -0.836 . . . . 1.05 108.743 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -91.74 139.0 31.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.025 -1.047 . . . . 3.1899999999999999 109.398 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.17 123.7 33.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.654 -0.654 . . . . 1.0900000000000001 109.71 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.6 mt -113.91 -73.56 0.65 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.493 -0.755 . . . . 1.1799999999999999 109.768 -179.812 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -94.95 145.98 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.112 -0.993 . . . . 0.34000000000000002 110.321 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.27 120.05 8.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.364 -0.835 . . . . 2.79 109.121 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -116.98 0.57 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.28999999999999998 110.63 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.58 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.991 . . . . 1.5600000000000001 110.041 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.95 52.54 2.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.695 -1.362 . . . . 0.28999999999999998 109.695 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.55 146.46 21.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.961 -1.317 . . . . 1.0700000000000001 110.508 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 1.7 m -142.64 121.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.448 -0.945 . . . . 1.0900000000000001 108.448 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 58.1 t -84.42 134.46 26.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.418 -0.956 . . . . 1.0700000000000001 108.418 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -138.87 178.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.416 -0.802 . . . . 1.04 109.886 -179.117 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -140.96 109.78 6.06 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.328 -0.989 . . . . 2.3399999999999999 108.328 178.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.61 -78.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.582 -1.266 . . . . 1.1799999999999999 107.582 179.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.774 HD21 ' H ' ' A' ' 255' ' ' SER . 8.2 t30 -80.99 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.637 -1.616 . . . . 2.4700000000000002 106.637 177.56 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.774 ' H ' HD21 ' A' ' 254' ' ' ASN . 15.3 t -105.43 51.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.604 -0.887 . . . . 1.8700000000000001 108.604 178.274 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -155.94 130.46 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.841 . . . . 1.1200000000000001 109.402 -179.52 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 76.6 mt -92.5 136.92 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 1.1499999999999999 109.455 -179.669 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -140.06 170.92 14.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 2.6299999999999999 109.735 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.44 140.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.424 -0.797 . . . . 1.0800000000000001 109.632 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.58 129.89 16.63 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 109.163 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.17 148.82 91.21 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 120.825 1.017 . . . . 0.48999999999999999 109.637 179.132 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 262' ' ' ARG . 18.3 mmm-85 -56.66 -36.96 70.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.905 -1.122 . . . . 3.5800000000000001 108.685 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -63.57 -8.1 8.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.886 -0.509 . . . . 4.3600000000000003 110.537 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -122.61 14.1 10.16 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.3 -0.875 . . . . 2.5800000000000001 108.712 179.309 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 159.53 41.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 1.05 109.275 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.66 131.88 38.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.356 -0.84 . . . . 2.2599999999999998 109.005 179.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.53 108.97 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 1.1799999999999999 109.954 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.95 151.99 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.624 -0.88 . . . . 1.28 108.624 178.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.524 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 4.1799999999999997 109.087 179.311 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 31.5 m120 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.041 -0.726 . . . . 2.0099999999999998 109.041 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -134.29 146.52 50.09 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.601 -0.687 . . . . 0.81999999999999995 109.493 -179.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.577 HH21 ' HH ' ' B' ' 226' ' ' TYR . 15.3 mtp180 -121.09 153.4 37.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.628 -1.249 . . . . 3.7799999999999998 107.628 178.667 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.58 143.7 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.828 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . 0.577 ' HH ' HH21 ' B' ' 224' ' ' ARG . 25.3 m-85 -110.19 157.33 19.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.222 -1.399 . . . . 0.92000000000000004 107.222 178.475 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 19.0 p90 -156.99 160.55 39.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.442 -1.411 . . . . 1.01 110.501 -179.276 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -97.78 153.72 18.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.691 . . . . 3.3900000000000001 109.948 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -96.56 175.12 6.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.271 -0.893 . . . . 2.23 109.288 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 82.2 p -91.35 -16.57 27.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 2.3300000000000001 109.223 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -82.27 -12.6 57.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 4.1900000000000004 109.694 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' B' ' 234' ' ' VAL . 46.6 m-20 -162.27 130.16 2.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.049 -1.032 . . . . 2.1600000000000001 109.307 -179.912 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.2 12.25 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 120.664 0.909 . . . . 1.3999999999999999 109.957 179.291 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.9 t -84.84 160.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 2.3100000000000001 109.501 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -75.06 168.43 19.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 0.72999999999999998 109.108 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.71 -165.03 1.29 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.216 -1.031 . . . . 1.96 108.216 178.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.28 178.01 47.84 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.425 -1.369 . . . . 0.56000000000000005 109.841 -179.51 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.88 158.17 56.23 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.602 1.535 . . . . 0.46999999999999997 109.984 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.34 168.82 18.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.728 -0.841 . . . . 1.05 108.728 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -91.4 138.91 31.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.026 -1.046 . . . . 3.1899999999999999 109.515 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.12 123.76 33.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.645 -0.66 . . . . 1.0900000000000001 109.726 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.08 -73.71 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.507 -0.746 . . . . 1.1799999999999999 109.722 -179.827 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.425 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 6.8 t90 -94.77 146.0 24.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.34999999999999998 110.313 -179.139 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.4 120.29 8.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.332 -0.855 . . . . 2.7999999999999998 109.145 178.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.5 -116.74 0.56 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.649 -1.262 . . . . 0.29999999999999999 110.628 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -63.04 -145.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.997 . . . . 1.5600000000000001 109.998 -179.041 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.91 52.36 2.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.64 -1.384 . . . . 0.28999999999999998 109.64 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.57 146.4 20.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.994 -1.297 . . . . 1.0700000000000001 110.591 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 1.7 m -142.58 121.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.492 -0.929 . . . . 1.0900000000000001 108.492 178.714 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.39 134.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.464 -0.939 . . . . 1.0800000000000001 108.464 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.9 pt -138.92 178.75 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.327 -0.858 . . . . 1.04 109.892 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -141.0 109.7 6.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.323 -0.992 . . . . 2.3399999999999999 108.323 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.42 -78.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.619 -1.252 . . . . 1.1799999999999999 107.619 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.767 HD21 ' H ' ' B' ' 255' ' ' SER . 8.3 t30 -80.87 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.677 -1.601 . . . . 2.4700000000000002 106.677 177.626 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.767 ' H ' HD21 ' B' ' 254' ' ' ASN . 16.4 t -105.42 52.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.267 -0.896 . . . . 1.8600000000000001 108.584 178.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -156.06 130.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 1.1200000000000001 109.293 -179.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 76.7 mt -92.74 136.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 1.1499999999999999 109.413 -179.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.93 170.58 15.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.408 -0.808 . . . . 2.6400000000000001 109.694 -178.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.16 140.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 1.0800000000000001 109.654 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.2 t -137.76 129.77 16.37 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.297 -0.877 . . . . 1.0800000000000001 109.119 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.93 148.76 91.61 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 120.828 1.019 . . . . 0.48999999999999999 109.755 179.087 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' B' ' 262' ' ' ARG . 18.0 mmm-85 -56.49 -37.47 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 3.5800000000000001 108.622 179.247 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -63.12 -8.21 7.3 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.099 -0.5 . . . . 4.3600000000000003 110.492 -178.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -122.6 14.04 10.15 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.877 . . . . 2.5800000000000001 108.688 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.82 159.87 41.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 1.05 109.323 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.89 131.92 37.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 2.2599999999999998 109.021 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.64 109.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 1.1799999999999999 109.976 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -107.09 152.07 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.594 -0.891 . . . . 1.27 108.594 178.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.517 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.8 OUTLIER -90.21 147.85 23.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 4.1799999999999997 109.007 179.406 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.077 -0.964 . . . . 2.0499999999999998 109.37 179.641 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.147 -0.686 . . . . 2.0099999999999998 109.147 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -135.5 128.9 32.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.81999999999999995 109.301 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 224' ' ' ARG . 4.7 ptt-85 -109.65 162.59 14.28 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.141 -1.059 . . . . 3.79 108.141 178.461 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.214 -0.929 . . . . 1.05 110.814 -178.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -108.65 153.16 23.81 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.335 -1.357 . . . . 0.92000000000000004 107.335 178.168 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.3 p90 -157.13 151.04 24.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.516 -1.365 . . . . 1.01 110.432 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.574 HH21 ' HZ3' ' A' ' 264' ' ' LYS . 34.9 mtm180 -96.45 154.11 17.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 3.3999999999999999 109.606 179.715 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 230' ' ' SER . 11.9 t70 -95.07 166.14 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 2.23 108.804 179.27 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 2.9 t -82.13 -7.26 59.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 2.3199999999999998 109.171 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.73 -19.54 23.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 4.1799999999999997 109.967 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.63 3.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.986 . . . . 2.1600000000000001 109.173 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -64.69 15.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 120.842 1.028 . . . . 1.3899999999999999 110.679 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 232' ' ' ASP . 26.0 m -82.51 131.84 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.927 -1.108 . . . . 2.3100000000000001 109.82 -179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.9 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.71999999999999997 109.465 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 237' ' ' GLY . 49.1 tttp -136.25 158.31 44.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.275 -0.891 . . . . 1.96 109.153 179.249 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.03 164.81 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.617 -0.993 . . . . 0.55000000000000004 110.617 -179.326 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.56 159.44 50.74 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.614 1.543 . . . . 0.46999999999999997 110.378 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.43 175.32 9.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.898 -0.779 . . . . 1.05 108.898 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.34 135.67 33.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.167 -0.958 . . . . 3.1899999999999999 109.676 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.19 123.46 32.24 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.151 -0.685 . . . . 1.0900000000000001 109.151 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -115.87 -72.27 0.7 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.416 -0.803 . . . . 1.1799999999999999 110.125 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.78 137.46 32.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.221 -0.924 . . . . 0.34000000000000002 110.067 -178.843 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.1 116.95 8.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.291 -0.881 . . . . 2.79 108.89 179.284 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.64 0.19 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.927 -1.269 . . . . 0.28999999999999998 109.927 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.19 -157.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 1.5600000000000001 109.671 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 48.94 2.68 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.364 -1.494 . . . . 0.28999999999999998 109.364 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.42 152.04 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -1.112 . . . . 1.0700000000000001 108.882 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.78 124.76 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.112 -0.993 . . . . 1.0900000000000001 110.01 -179.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.0 136.51 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.179 -1.045 . . . . 1.0700000000000001 108.179 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -139.47 178.64 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.3 -0.875 . . . . 1.04 110.118 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.459 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.5 tt0 -143.53 112.42 6.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.538 -0.912 . . . . 2.3399999999999999 108.538 179.034 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.78 -79.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.765 -1.198 . . . . 1.1799999999999999 107.765 179.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.46 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.755 -1.572 . . . . 2.4700000000000002 106.755 177.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.4 m -105.0 54.29 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.074 -1.084 . . . . 1.8700000000000001 108.074 178.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -157.43 126.04 5.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.965 -0.754 . . . . 1.1200000000000001 108.965 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.459 ' CG1' HE21 ' A' ' 252' ' ' GLN . 19.5 mt -92.46 140.73 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.279 -0.888 . . . . 1.1499999999999999 109.589 -179.663 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.43 169.56 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.392 -0.818 . . . . 2.6299999999999999 109.59 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.66 139.69 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 1.0800000000000001 109.073 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.9 t -135.67 121.24 13.77 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.421 -0.8 . . . . 1.0700000000000001 108.926 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.81 136.59 75.23 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 N-CA-C 109.934 -0.833 . . . . 0.48999999999999999 109.934 179.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.3 OUTLIER -56.04 -35.64 67.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 3.5800000000000001 109.631 179.886 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.488 ' CG ' HH11 ' A' ' 263' ' ' ARG . 0.7 OUTLIER -69.34 -3.01 12.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 4.3600000000000003 110.259 -179.417 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.574 ' HZ3' HH21 ' A' ' 228' ' ' ARG . 19.3 mtpp -119.47 16.12 12.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.371 -0.831 . . . . 2.5800000000000001 109.044 179.674 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.34 170.8 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.474 -0.767 . . . . 1.05 109.329 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' A' ' 266' ' ' LYS . 6.3 mtmp? -140.79 132.12 26.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.27 -0.894 . . . . 2.2599999999999998 109.457 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.96 117.25 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.264 -0.898 . . . . 1.1799999999999999 109.922 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -116.21 148.84 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 108.476 -0.935 . . . . 4.1799999999999997 108.476 179.46 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.144 -0.687 . . . . 2.0099999999999998 109.144 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.58 128.84 31.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.492 -0.755 . . . . 0.81999999999999995 109.33 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' B' ' 224' ' ' ARG . 4.8 ptt-85 -109.64 162.51 14.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.207 -1.034 . . . . 3.7799999999999998 108.207 178.515 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.1 t -138.03 146.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.165 -0.959 . . . . 1.0600000000000001 110.839 -178.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -108.66 153.15 23.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.356 -1.35 . . . . 0.92000000000000004 107.356 178.134 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.3 p90 -157.03 151.07 24.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.557 -1.34 . . . . 1.01 110.548 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.566 HH21 ' HZ3' ' B' ' 264' ' ' LYS . 34.9 mtm180 -96.5 154.13 17.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 3.3900000000000001 109.591 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 230' ' ' SER . 11.8 t70 -95.0 166.13 12.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.818 . . . . 2.23 108.831 179.254 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 2.9 t -82.11 -7.22 59.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -0.999 . . . . 2.3300000000000001 109.209 179.803 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -90.66 -19.71 23.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.886 . . . . 4.1900000000000004 109.952 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' B' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.61 3.06 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.056 -1.028 . . . . 2.1600000000000001 109.139 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.71 15.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 120.86 1.04 . . . . 1.3999999999999999 110.605 179.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' B' ' 232' ' ' ASP . 26.4 m -82.53 131.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.829 -1.169 . . . . 2.3100000000000001 109.875 -179.656 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 0.72999999999999998 109.463 179.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 237' ' ' GLY . 49.1 tttp -136.36 158.21 44.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.296 -0.877 . . . . 1.96 109.189 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.98 164.87 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.538 -1.025 . . . . 0.56000000000000005 110.538 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.52 159.35 51.06 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.628 1.552 . . . . 0.46999999999999997 110.406 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.34 175.34 9.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.983 -0.747 . . . . 1.05 108.983 179.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.38 135.64 33.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.053 -1.03 . . . . 3.1899999999999999 109.671 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.17 123.51 32.28 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.166 -0.679 . . . . 1.0900000000000001 109.166 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.96 -72.24 0.7 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.399 -0.813 . . . . 1.1799999999999999 110.09 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -90.83 137.41 32.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.253 -0.904 . . . . 0.34999999999999998 110.08 -178.836 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.03 116.94 8.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.87 . . . . 2.7999999999999998 108.898 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.56 0.19 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.997 -1.241 . . . . 0.29999999999999999 109.997 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.22 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -1.099 . . . . 1.5600000000000001 109.606 -179.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 48.93 2.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.34 -1.504 . . . . 0.28999999999999998 109.34 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.43 152.03 37.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 1.0700000000000001 108.877 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.83 124.77 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.0900000000000001 109.982 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.94 136.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.156 -1.053 . . . . 1.0800000000000001 108.156 179.114 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.38 178.6 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 1.04 110.157 -179.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -143.48 112.45 6.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.603 -0.888 . . . . 2.3399999999999999 108.603 178.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.77 -79.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.759 -1.2 . . . . 1.1799999999999999 107.759 179.649 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.56 -130.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.654 -1.609 . . . . 2.4700000000000002 106.654 177.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 35.3 m -104.98 54.17 0.71 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.089 -1.078 . . . . 1.8600000000000001 108.089 178.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -157.39 126.0 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.024 -0.732 . . . . 1.1200000000000001 109.024 -179.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.451 ' CG1' HE21 ' B' ' 252' ' ' GLN . 19.4 mt -92.37 140.75 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.929 . . . . 1.1499999999999999 109.65 -179.673 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.48 169.53 17.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 2.6400000000000001 109.532 -179.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.6 139.61 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.1 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 75.5 t -135.58 121.24 13.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.477 -0.765 . . . . 1.0800000000000001 108.964 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.79 136.43 74.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.965 -0.821 . . . . 0.48999999999999999 109.965 179.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.3 OUTLIER -55.99 -35.59 66.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 3.5800000000000001 109.625 179.981 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.484 ' CG ' HH11 ' B' ' 263' ' ' ARG . 0.7 OUTLIER -69.33 -3.06 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 4.3600000000000003 110.232 -179.393 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.566 ' HZ3' HH21 ' B' ' 228' ' ' ARG . 19.4 mtpp -119.38 16.01 13.02 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.831 . . . . 2.5800000000000001 109.004 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.27 170.84 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.712 . . . . 1.05 109.416 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' B' ' 266' ' ' LYS . 6.4 mtmp? -140.76 132.16 26.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.211 -0.931 . . . . 2.2599999999999998 109.49 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.86 117.28 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.917 . . . . 1.1799999999999999 109.941 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -116.32 148.82 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.544 -0.909 . . . . 1.27 108.544 179.187 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 141.79 28.36 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.516 -0.92 . . . . 4.1799999999999997 108.516 179.497 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 2.0499999999999998 109.528 -179.862 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.272 -0.64 . . . . 2.0099999999999998 109.272 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -134.53 136.78 43.33 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.845 -0.798 . . . . 0.81999999999999995 108.845 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -111.55 155.18 23.7 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.129 -1.063 . . . . 3.79 108.129 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.14 141.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 1.05 110.258 -179.399 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.12 157.65 18.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.456 -1.313 . . . . 0.92000000000000004 107.456 178.582 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.47 150.12 24.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.653 -1.279 . . . . 1.01 110.28 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.412 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.1 mtm-85 -94.69 154.43 17.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.461 -0.775 . . . . 3.3999999999999999 109.66 179.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.81 166.44 11.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 2.23 108.841 179.362 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.0 t -85.83 -9.79 56.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 2.3199999999999998 109.324 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -89.3 -16.09 31.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 4.1799999999999997 109.56 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.5 m-20 -161.42 129.7 2.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.137 -0.977 . . . . 2.1600000000000001 109.063 -179.846 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.38 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 120.781 0.987 . . . . 1.3899999999999999 110.653 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 232' ' ' ASP . 11.6 m -82.69 133.41 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.73 -1.231 . . . . 2.3100000000000001 109.848 -179.747 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -53.56 -177.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.26 -0.9 . . . . 0.71999999999999997 109.124 179.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.693 ' HZ2' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -136.79 -164.78 1.63 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.256 -0.903 . . . . 1.96 108.631 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.693 ' H ' ' HZ2' ' A' ' 236' ' ' LYS . . . -73.52 172.38 50.61 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.661 -1.257 . . . . 0.55000000000000004 110.041 -179.441 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.35 158.76 55.21 Favored 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.633 1.555 . . . . 0.46999999999999997 109.955 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.02 172.77 12.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 1.05 109.193 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -94.44 138.82 31.91 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.2 -0.938 . . . . 3.1899999999999999 109.36 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.63 126.24 34.84 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.532 -0.73 . . . . 1.0900000000000001 109.467 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 24.5 mt -119.59 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.752 . . . . 1.1799999999999999 110.115 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.427 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.53 140.1 30.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.178 -0.951 . . . . 0.34000000000000002 109.946 -178.76 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -147.82 119.5 8.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.258 -0.901 . . . . 2.79 109.163 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.14 -100.75 0.18 Allowed Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.788 -1.196 . . . . 0.28999999999999998 110.28 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.33 -154.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -1.072 . . . . 1.5600000000000001 109.804 -179.323 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.9 2.82 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.28999999999999998 109.453 179.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.81 153.88 38.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -1.068 . . . . 1.0700000000000001 109.009 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.34 132.92 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 1.0900000000000001 109.825 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.5 t -94.39 139.32 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.206 -1.035 . . . . 1.0700000000000001 108.206 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.5 pt -140.62 179.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 1.04 110.073 -179.207 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.7 tt0 -142.54 115.03 8.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.469 -0.938 . . . . 2.3399999999999999 108.469 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.26 -84.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.417 -1.327 . . . . 1.1799999999999999 107.417 179.459 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.632 HD21 ' H ' ' A' ' 255' ' ' SER . 10.2 t30 -79.62 -126.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.629 -1.619 . . . . 2.4700000000000002 106.629 177.62 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.632 ' H ' HD21 ' A' ' 254' ' ' ASN . 14.2 t -105.7 53.9 0.71 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.025 -1.102 . . . . 1.8700000000000001 108.025 177.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.08 8.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.1200000000000001 109.196 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.451 ' CG1' HE21 ' A' ' 252' ' ' GLN . 48.6 mt -93.9 137.05 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.325 -0.859 . . . . 1.1499999999999999 109.587 -179.611 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.5 167.39 22.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 2.6299999999999999 109.681 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.04 143.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.381 -0.824 . . . . 1.0800000000000001 109.351 179.596 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.2 t -137.92 126.01 14.16 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.352 -0.843 . . . . 1.0700000000000001 109.047 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.82 143.4 99.2 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 N-CA-C 109.692 -0.926 . . . . 0.48999999999999999 109.692 179.444 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -54.62 -41.17 69.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 3.5800000000000001 109.293 179.606 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' A' ' 263' ' ' ARG . 29.6 mtm-85 -67.2 -2.48 5.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.85 . . . . 4.3600000000000003 110.563 -178.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.74 14.64 12.6 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.355 -0.841 . . . . 2.5800000000000001 109.112 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.28 169.06 18.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 1.05 109.832 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.21 130.07 24.61 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.446 -0.784 . . . . 2.2599999999999998 109.068 179.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.41 110.54 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.237 -0.915 . . . . 1.1799999999999999 109.515 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.42 155.27 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.372 -0.83 . . . . 4.1799999999999997 109.621 179.792 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.276 -0.639 . . . . 2.0099999999999998 109.276 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -134.51 136.88 43.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.848 -0.797 . . . . 0.81999999999999995 108.848 179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -111.63 155.22 23.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.063 -1.088 . . . . 3.7799999999999998 108.063 179.095 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.17 141.12 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.285 -0.884 . . . . 1.0600000000000001 110.185 -179.382 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.1 157.72 18.46 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.561 -1.274 . . . . 0.92000000000000004 107.561 178.455 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.7 p90 -156.51 150.09 24.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.66 -1.275 . . . . 1.01 110.332 -179.012 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.1 mtm-85 -94.72 154.44 17.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 3.3900000000000001 109.646 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.92 166.46 11.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 2.23 108.846 179.374 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.2 t -85.92 -9.67 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 2.3300000000000001 109.283 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.25 -16.2 31.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 4.1900000000000004 109.549 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.5 m-20 -161.43 129.81 2.93 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.223 -0.923 . . . . 2.1600000000000001 109.073 -179.839 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.25 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.835 1.023 . . . . 1.3999999999999999 110.594 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 232' ' ' ASP . 11.5 m -82.59 133.56 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.782 -1.199 . . . . 2.3100000000000001 109.806 -179.746 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -53.72 -177.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.09 -1.006 . . . . 0.72999999999999998 109.094 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.701 ' HZ2' ' H ' ' B' ' 237' ' ' GLY . 0.1 OUTLIER -136.74 -164.73 1.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.23 -0.919 . . . . 1.96 108.685 179.241 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.701 ' H ' ' HZ2' ' B' ' 236' ' ' LYS . . . -73.75 172.38 51.04 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.625 -1.274 . . . . 0.56000000000000005 110.053 -179.431 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.36 158.82 55.0 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.592 1.528 . . . . 0.46999999999999997 109.996 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.79 12.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 1.05 109.163 179.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -94.47 138.71 32.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.161 -0.962 . . . . 3.1899999999999999 109.406 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.4 tp -87.54 126.22 34.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.493 -0.754 . . . . 1.0900000000000001 109.485 -179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.56 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.737 . . . . 1.1799999999999999 110.181 -179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -91.48 139.99 30.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.119 -0.988 . . . . 0.34999999999999998 109.97 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -147.72 119.48 8.08 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.885 . . . . 2.7999999999999998 109.134 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.11 -100.86 0.18 Allowed Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.828 -1.177 . . . . 0.29999999999999999 110.334 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.23 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -1.063 . . . . 1.5600000000000001 109.865 -179.342 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.99 2.84 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.355 -1.498 . . . . 0.28999999999999998 109.355 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.86 153.92 38.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.113 . . . . 1.0700000000000001 109.029 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.3 132.84 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.095 -1.003 . . . . 1.0900000000000001 109.892 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.25 139.44 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.254 -1.017 . . . . 1.0800000000000001 108.254 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.4 pt -140.77 179.3 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 1.04 110.117 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.457 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.7 tt0 -142.48 114.9 8.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.507 -0.923 . . . . 2.3399999999999999 108.507 179.101 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.17 -84.57 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.43 -1.322 . . . . 1.1799999999999999 107.43 179.441 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.629 HD21 ' H ' ' B' ' 255' ' ' SER . 10.2 t30 -79.73 -125.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.589 -1.634 . . . . 2.4700000000000002 106.589 177.68 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.629 ' H ' HD21 ' B' ' 254' ' ' ASN . 14.3 t -105.79 53.91 0.7 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.995 -1.113 . . . . 1.8600000000000001 107.995 177.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.22 8.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.542 -0.724 . . . . 1.1200000000000001 109.164 -179.355 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.457 ' CG1' HE21 ' B' ' 252' ' ' GLN . 48.6 mt -94.01 137.06 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 1.1499999999999999 109.587 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -138.51 167.36 22.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.299 -0.876 . . . . 2.6400000000000001 109.711 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.96 143.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.391 -0.818 . . . . 1.0800000000000001 109.408 179.615 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.97 125.97 14.08 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.418 -0.801 . . . . 1.0800000000000001 108.973 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.77 143.34 99.05 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 N-CA-C 109.778 -0.893 . . . . 0.48999999999999999 109.778 179.322 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.405 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -54.58 -41.24 69.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 3.5800000000000001 109.324 179.64 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' B' ' 263' ' ' ARG . 29.6 mtm-85 -67.02 -2.63 5.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.248 -0.908 . . . . 4.3600000000000003 110.597 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.65 14.63 12.67 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.344 -0.847 . . . . 2.5800000000000001 109.127 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.14 169.08 18.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.313 -0.867 . . . . 1.05 109.839 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.16 130.15 24.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 2.2599999999999998 109.077 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.38 110.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.244 -0.91 . . . . 1.1799999999999999 109.595 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.38 155.28 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.737 -0.838 . . . . 1.27 108.737 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.36 140.86 29.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.313 -0.867 . . . . 4.1799999999999997 109.607 179.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.923 -1.037 . . . . 2.0499999999999998 109.405 179.702 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.067 0.46 . . . . 2.0099999999999998 109.773 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -135.86 135.26 39.62 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.803 . . . . 0.81999999999999995 109.717 179.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 224' ' ' ARG . 12.0 mtm-85 -106.17 160.62 15.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.79 -1.189 . . . . 3.79 107.79 178.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.7 141.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 1.05 110.212 -179.256 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.81 154.7 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.474 -1.306 . . . . 0.92000000000000004 107.474 178.363 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.8 p90 -157.15 152.2 26.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.643 -1.286 . . . . 1.01 110.11 -179.228 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.42 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 35.9 mtm180 -95.95 152.3 18.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.466 -0.771 . . . . 3.3999999999999999 110.067 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 1.1 m-20 -91.19 165.2 13.6 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 179.222 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 59.5 m -83.92 -13.07 54.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.994 -1.067 . . . . 2.3199999999999998 108.873 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.81 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 4.1799999999999997 109.588 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.7 p30 -156.95 128.87 3.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.954 -1.091 . . . . 2.1600000000000001 109.414 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.76 7.08 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 121.059 1.173 . . . . 1.3899999999999999 111.476 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 13.9 p -83.29 161.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.459 -1.401 . . . . 2.3100000000000001 110.208 -179.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -75.48 160.75 29.85 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.157 -0.683 . . . . 0.71999999999999997 109.157 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.3 tttp -119.12 163.82 16.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.395 -0.816 . . . . 1.96 109.069 179.408 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.94 168.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.902 -1.279 . . . . 0.55000000000000004 109.902 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.3 161.3 46.44 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.458 1.439 . . . . 0.46999999999999997 110.64 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.61 173.9 11.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.992 -0.744 . . . . 1.05 108.992 179.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.75 139.59 31.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.092 -1.005 . . . . 3.1899999999999999 109.21 179.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.18 123.85 33.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 1.0900000000000001 109.455 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.15 -75.37 0.59 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 1.1799999999999999 109.724 179.638 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.96 143.75 26.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 0.34000000000000002 110.301 -179.062 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -149.54 118.72 6.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.477 -0.764 . . . . 2.79 108.955 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -100.99 0.18 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.618 -1.277 . . . . 0.28999999999999998 110.157 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.35 -154.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -1.069 . . . . 1.5600000000000001 109.751 -179.365 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.77 45.77 2.23 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.217 -1.553 . . . . 0.28999999999999998 109.217 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.89 150.52 36.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.443 -1.034 . . . . 1.0700000000000001 108.834 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 129.34 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.204 -0.935 . . . . 1.0900000000000001 109.459 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.97 137.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.088 -1.078 . . . . 1.0700000000000001 108.088 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.0 pt -140.11 -178.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.178 -0.951 . . . . 1.04 110.549 -178.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.52 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -145.99 112.15 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 2.3399999999999999 108.632 178.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.93 -76.57 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.998 -1.482 . . . . 1.1799999999999999 106.998 179.216 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.19 -136.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.822 -1.547 . . . . 2.4700000000000002 106.822 177.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.74 55.42 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.206 -1.035 . . . . 1.8700000000000001 108.206 178.344 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -157.69 127.06 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 1.1200000000000001 109.097 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.52 ' CG1' HE21 ' A' ' 252' ' ' GLN . 38.3 mt -92.68 133.27 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.31 -0.869 . . . . 1.1499999999999999 109.567 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.25 168.27 19.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.505 -0.747 . . . . 2.6299999999999999 109.631 -179.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.48 138.48 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.439 -0.788 . . . . 1.0800000000000001 109.658 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.5 133.07 19.0 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.473 -0.936 . . . . 1.0700000000000001 108.473 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.39 140.64 95.3 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.663 0.909 . . . . 0.48999999999999999 110.143 179.587 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -57.92 -35.5 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 3.5800000000000001 109.209 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' A' ' 263' ' ' ARG . 2.4 mtt-85 -69.99 -1.95 11.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 4.3600000000000003 110.464 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.42 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 5.3 mptp? -118.7 15.54 13.59 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.738 -0.838 . . . . 2.5800000000000001 108.738 -179.672 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.17 173.34 11.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.524 -0.735 . . . . 1.05 109.445 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.55 129.04 22.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.336 -0.853 . . . . 2.2599999999999998 108.997 179.545 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.2 mm -86.57 113.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 1.1799999999999999 109.19 179.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.6 mm -112.6 148.65 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 179.364 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.6 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.554 -0.716 . . . . 4.1799999999999997 109.518 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.135 0.493 . . . . 2.0099999999999998 109.768 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -135.86 135.25 39.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.426 -0.796 . . . . 0.81999999999999995 109.665 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' B' ' 224' ' ' ARG . 11.9 mtm-85 -106.05 160.57 15.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.814 -1.18 . . . . 3.7799999999999998 107.814 178.79 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 141.48 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.206 -0.934 . . . . 1.0600000000000001 110.178 -179.24 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.75 154.75 22.49 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.447 -1.316 . . . . 0.92000000000000004 107.447 178.369 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.8 p90 -157.21 152.16 25.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.653 -1.28 . . . . 1.01 110.096 -179.247 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.407 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 35.7 mtm180 -95.86 152.39 18.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.461 -0.775 . . . . 3.3900000000000001 110.053 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -91.33 165.1 13.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 2.23 108.686 179.221 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 59.1 m -83.72 -13.19 54.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 2.3300000000000001 108.943 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.66 40.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 4.1900000000000004 109.59 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 1.6 p30 -157.12 128.8 3.88 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.115 -0.991 . . . . 2.1600000000000001 109.322 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.8 7.27 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.988 1.125 . . . . 1.3999999999999999 111.583 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 13.9 p -83.33 161.65 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.347 -1.47 . . . . 2.3100000000000001 110.241 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -75.45 160.75 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.72999999999999998 109.199 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.2 tttp -119.05 163.85 16.38 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.373 -0.829 . . . . 1.96 109.032 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.97 168.2 0.03 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.967 -1.253 . . . . 0.56000000000000005 109.967 -179.486 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -69.34 161.31 46.39 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.479 1.453 . . . . 0.46999999999999997 110.584 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.64 173.87 11.19 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.883 -0.784 . . . . 1.05 108.883 179.282 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.73 139.52 31.13 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.069 -1.019 . . . . 3.1899999999999999 109.215 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.19 123.78 33.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.433 -0.792 . . . . 1.0900000000000001 109.425 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.09 -75.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.476 -0.765 . . . . 1.1799999999999999 109.744 179.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.97 143.8 26.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 0.34999999999999998 110.274 -179.067 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -149.53 118.72 6.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.418 -0.801 . . . . 2.7999999999999998 109.044 179.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.8 -100.97 0.18 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.577 -1.297 . . . . 0.29999999999999999 110.191 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.32 -154.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -1.012 . . . . 1.5600000000000001 109.807 -179.399 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 45.83 2.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.236 -1.545 . . . . 0.28999999999999998 109.236 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.9 150.48 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -1.022 . . . . 1.0700000000000001 108.789 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.96 129.36 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.92 . . . . 1.0900000000000001 109.519 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.99 137.38 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.087 -1.079 . . . . 1.0800000000000001 108.087 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.01 -178.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.286 -0.884 . . . . 1.04 110.618 -178.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -146.07 112.09 5.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.632 -0.877 . . . . 2.3399999999999999 108.632 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.82 -76.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.063 -1.458 . . . . 1.1799999999999999 107.063 179.213 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -82.08 -136.43 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.812 -1.551 . . . . 2.4700000000000002 106.812 177.512 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.7 55.36 0.87 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.195 -1.039 . . . . 1.8600000000000001 108.195 178.345 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -157.66 126.96 5.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.581 -0.699 . . . . 1.1200000000000001 109.154 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.8 mt -92.56 133.25 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 1.1499999999999999 109.586 -179.623 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.2 168.28 19.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.427 -0.796 . . . . 2.6400000000000001 109.627 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.51 138.47 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 1.0800000000000001 109.657 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 133.14 19.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.376 -0.972 . . . . 1.0800000000000001 108.376 179.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.43 140.75 95.78 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 120.539 0.826 . . . . 0.48999999999999999 110.162 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -57.95 -35.51 71.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.114 -0.991 . . . . 3.5800000000000001 109.222 179.449 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.4 mtt-85 -70.01 -1.96 11.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 4.3600000000000003 110.462 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.407 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 5.3 mptp? -118.72 15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.367 -0.833 . . . . 2.5800000000000001 108.758 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 173.38 11.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.453 -0.78 . . . . 1.05 109.512 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.62 128.89 22.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 2.2599999999999998 109.075 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.0 mm -86.43 113.29 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.158 -0.964 . . . . 1.1799999999999999 109.233 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.71 148.61 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.471 -0.937 . . . . 1.27 108.471 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -91.33 150.01 21.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.541 -0.724 . . . . 4.1799999999999997 109.581 179.908 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.966 -1.016 . . . . 2.0499999999999998 109.219 179.704 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.057 -0.72 . . . . 2.0099999999999998 109.057 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.64 138.62 46.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.582 -0.699 . . . . 0.81999999999999995 109.381 -179.751 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -107.7 160.05 16.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.962 -1.125 . . . . 3.79 107.962 179.159 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 77.3 t -142.04 138.92 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.172 -0.955 . . . . 1.05 110.096 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -108.36 151.36 26.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.556 -1.276 . . . . 0.92000000000000004 107.556 178.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.0 p90 -155.61 152.31 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.609 -1.307 . . . . 1.01 110.529 -179.076 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 228' ' ' ARG . 8.8 mtm-85 -95.31 151.0 19.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 3.3999999999999999 109.513 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 1.8 m-20 -96.52 167.15 11.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 2.23 108.892 179.34 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.2 t -83.33 -8.92 59.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 2.3199999999999998 109.195 179.538 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -90.44 -16.17 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.352 -0.843 . . . . 4.1799999999999997 109.764 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 234' ' ' VAL . 59.2 m-20 -160.69 129.74 3.14 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.139 -0.976 . . . . 2.1600000000000001 109.232 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.39 10.91 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 120.862 1.041 . . . . 1.3899999999999999 110.41 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.0 m -83.17 135.91 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 2.3100000000000001 110.1 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.19 167.55 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.71999999999999997 109.127 179.71 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 237' ' ' GLY . 36.8 tttp -125.5 157.92 35.79 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.383 -0.823 . . . . 1.96 109.34 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.05 166.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.349 -1.1 . . . . 0.55000000000000004 110.349 -179.315 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -65.53 160.92 40.7 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.639 1.559 . . . . 0.46999999999999997 110.58 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.824 -0.806 . . . . 1.05 108.824 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.9 137.93 34.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.118 -0.989 . . . . 3.1899999999999999 109.216 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.89 125.41 35.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.563 -0.711 . . . . 1.0900000000000001 109.765 -179.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.76 -72.89 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 1.1799999999999999 109.912 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.24 28.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.234 -0.916 . . . . 0.34000000000000002 110.341 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.84 118.74 7.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 2.79 108.896 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -100.24 0.18 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.787 -1.197 . . . . 0.28999999999999998 110.151 -179.76 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.59 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 1.5600000000000001 109.569 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.46 47.98 2.47 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.575 -1.41 . . . . 0.28999999999999998 109.575 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.91 33.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -1.086 . . . . 1.0700000000000001 108.854 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.21 125.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.0900000000000001 109.489 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.99 139.52 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.368 -0.975 . . . . 1.0700000000000001 108.368 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -141.73 178.51 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.117 -0.989 . . . . 1.04 110.257 -179.121 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.499 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.1 tt0 -144.36 114.52 7.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.736 -0.839 . . . . 2.3399999999999999 108.736 179.193 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.96 -78.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.453 -1.314 . . . . 1.1799999999999999 107.453 179.241 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.57 -129.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.732 -1.581 . . . . 2.4700000000000002 106.732 177.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.206 -1.035 . . . . 1.8700000000000001 108.206 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.06 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.537 -0.727 . . . . 1.1200000000000001 109.277 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.499 ' CG1' HE21 ' A' ' 252' ' ' GLN . 33.8 mt -92.74 135.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.807 . . . . 1.1499999999999999 109.45 -179.629 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.09 14.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 2.6299999999999999 109.776 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.35 138.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.466 -0.771 . . . . 1.0800000000000001 109.475 179.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.5 t -134.9 126.9 18.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.592 -0.892 . . . . 1.0700000000000001 108.592 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 145.08 90.01 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 120.507 0.805 . . . . 0.48999999999999999 110.47 179.822 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 262' ' ' ARG . 4.5 ttt-85 -65.16 -36.82 85.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.428 -0.795 . . . . 3.5800000000000001 110.1 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -68.71 -4.91 17.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 4.3600000000000003 110.174 -179.099 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -119.52 19.54 12.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.341 -0.849 . . . . 2.5800000000000001 109.184 179.783 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.54 170.55 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.496 -0.752 . . . . 1.05 109.578 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -140.93 132.14 26.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.236 -0.915 . . . . 2.2599999999999998 109.358 179.765 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.8 mm -88.78 106.03 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.27 -0.894 . . . . 1.1799999999999999 109.593 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.47 155.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.374 -0.828 . . . . 1.28 109.208 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.801 . . . . 4.1799999999999997 109.464 179.578 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.03 -0.729 . . . . 2.0099999999999998 109.03 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.66 138.58 45.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.69 . . . . 0.81999999999999995 109.386 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.433 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 61.4 mtm180 -107.68 160.18 15.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.985 -1.117 . . . . 3.7799999999999998 107.985 179.158 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 77.2 t -142.2 138.96 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.192 -0.943 . . . . 1.0600000000000001 109.982 -179.57 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -108.42 151.31 26.21 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.474 -1.306 . . . . 0.92000000000000004 107.474 178.62 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.9 p90 -155.51 152.47 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.01 110.541 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.8 mtm-85 -95.39 151.08 19.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 3.3900000000000001 109.39 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.8 m-20 -96.61 167.17 11.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.355 -0.841 . . . . 2.23 108.89 179.316 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 43.5 t -83.26 -9.14 59.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 2.3300000000000001 109.215 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -90.27 -16.15 29.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 4.1900000000000004 109.821 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' B' ' 234' ' ' VAL . 59.1 m-20 -160.74 129.73 3.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 2.1600000000000001 109.295 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.41 11.02 0.23 Allowed 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 120.79 0.994 . . . . 1.3999999999999999 110.419 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.0 m -83.23 135.93 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.869 -1.144 . . . . 2.3100000000000001 110.06 -179.48 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.2 167.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.227 -0.92 . . . . 0.72999999999999998 109.107 179.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' B' ' 237' ' ' GLY . 36.8 tttp -125.48 157.92 35.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.373 -0.83 . . . . 1.96 109.272 179.447 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.11 166.11 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.361 -1.096 . . . . 0.56000000000000005 110.361 -179.342 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -65.47 160.89 40.68 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.617 1.545 . . . . 0.46999999999999997 110.585 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.805 . . . . 1.05 108.825 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.82 137.99 34.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.061 -1.024 . . . . 3.1899999999999999 109.254 179.901 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.93 125.49 35.38 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.564 -0.71 . . . . 1.0900000000000001 109.774 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.75 -72.93 0.66 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.45 -0.781 . . . . 1.1799999999999999 110.002 179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.16 28.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.23 -0.919 . . . . 0.34999999999999998 110.251 -178.789 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.78 118.8 7.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.377 -0.827 . . . . 2.7999999999999998 108.882 179.155 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -100.25 0.18 Allowed Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.726 -1.226 . . . . 0.29999999999999999 110.096 -179.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.52 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 1.5600000000000001 109.555 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.48 47.98 2.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.688 -1.365 . . . . 0.28999999999999998 109.688 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.83 33.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -1.093 . . . . 1.0700000000000001 108.82 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.12 125.87 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.501 179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.04 139.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.467 -0.938 . . . . 1.0800000000000001 108.467 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.1 pt -141.7 178.54 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.92 . . . . 1.04 110.265 -179.092 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . 0.506 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.1 tt0 -144.38 114.51 7.42 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.834 -0.802 . . . . 2.3399999999999999 108.834 179.106 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.96 -78.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.436 -1.32 . . . . 1.1799999999999999 107.436 179.33 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.51 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.78 -1.563 . . . . 2.4700000000000002 106.78 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 17.7 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.105 -1.072 . . . . 1.8600000000000001 108.105 178.081 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.07 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.628 -0.67 . . . . 1.1200000000000001 109.257 -179.379 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.506 ' CG1' HE21 ' B' ' 252' ' ' GLN . 34.1 mt -92.76 135.92 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.355 -0.841 . . . . 1.1499999999999999 109.436 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.02 15.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.822 . . . . 2.6400000000000001 109.806 -179.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 138.32 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.388 -0.82 . . . . 1.0800000000000001 109.542 179.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 91.1 t -134.8 126.97 18.2 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.573 -0.899 . . . . 1.0800000000000001 108.573 179.748 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.57 145.12 90.52 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 120.564 0.843 . . . . 0.48999999999999999 110.355 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' B' ' 262' ' ' ARG . 4.5 ttt-85 -65.14 -36.92 85.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.427 -0.796 . . . . 3.5800000000000001 110.109 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -68.53 -4.95 16.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.109 -0.994 . . . . 4.3600000000000003 110.325 -179.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -119.56 19.53 12.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.327 -0.858 . . . . 2.5800000000000001 109.191 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 170.62 15.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.448 -0.783 . . . . 1.05 109.584 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -140.95 132.05 26.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 2.2599999999999998 109.321 179.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.62 106.0 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.275 -0.891 . . . . 1.1799999999999999 109.627 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -105.53 155.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.447 -0.783 . . . . 1.27 109.212 179.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -91.27 147.9 22.72 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 4.1799999999999997 109.502 179.608 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.95 -1.024 . . . . 2.0499999999999998 109.414 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 222' ' ' ASN . 1.5 m-20 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 121.353 0.597 . . . . 2.0099999999999998 110.925 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.22 127.54 28.34 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.867 -0.79 . . . . 0.81999999999999995 108.867 178.443 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.94 159.05 15.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.206 -1.035 . . . . 3.79 108.206 179.227 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.7 t -143.44 144.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.2 -0.938 . . . . 1.05 110.157 -179.731 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.53 157.02 20.84 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.555 -1.276 . . . . 0.92000000000000004 107.555 178.626 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.0 p90 -157.78 149.26 21.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.258 . . . . 1.01 110.434 -178.943 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.464 ' NH1' ' CH2' ' A' ' 235' ' ' TRP . 24.0 mtm-85 -95.16 142.54 27.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.439 -0.788 . . . . 3.3999999999999999 109.266 179.259 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.88 173.06 8.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 2.23 109.068 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.8 m -86.83 -8.1 57.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 2.3199999999999998 109.527 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.46 -20.5 26.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 4.1799999999999997 109.455 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.4 m-20 -162.42 132.34 3.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 2.1600000000000001 108.95 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.35 14.64 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 120.724 0.949 . . . . 1.3899999999999999 110.293 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 232' ' ' ASP . 44.5 t -80.91 155.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.798 -1.189 . . . . 2.3100000000000001 109.577 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.464 ' CH2' ' NH1' ' A' ' 228' ' ' ARG . 98.8 m95 -75.89 160.71 29.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.71999999999999997 109.573 -179.789 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.0 mttm -119.33 159.32 24.38 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.347 -0.845 . . . . 1.96 109.027 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.38 168.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.997 -1.241 . . . . 0.55000000000000004 109.997 -179.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.74 159.09 54.3 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.585 1.523 . . . . 0.46999999999999997 110.425 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.4 174.41 10.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.799 -0.815 . . . . 1.05 108.799 179.13 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 240' ' ' LYS . 11.5 mptt -92.71 136.62 33.07 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 3.1899999999999999 109.373 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -87.07 122.9 31.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.327 -0.858 . . . . 1.0900000000000001 109.403 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -113.78 -76.67 0.58 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.421 -0.8 . . . . 1.1799999999999999 110.373 -179.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 21.3 t90 -97.35 137.86 35.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.018 -1.051 . . . . 0.34000000000000002 110.772 -178.722 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.89 132.36 17.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.857 -0.794 . . . . 2.79 108.857 178.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -99.82 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.48 -1.448 . . . . 0.28999999999999998 109.48 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.52 -149.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 1.5600000000000001 109.154 179.829 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 48.32 3.09 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.231 -1.548 . . . . 0.28999999999999998 109.231 179.66 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.61 149.15 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.971 . . . . 1.0700000000000001 109.085 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.11 135.6 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.096 -1.003 . . . . 1.0900000000000001 109.534 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 87.7 t -88.41 143.63 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 1.0700000000000001 109.318 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.79 179.81 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.362 -0.836 . . . . 1.04 109.482 179.737 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -143.99 110.8 5.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 2.3399999999999999 108.656 178.731 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -89.6 -78.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.67 -1.233 . . . . 1.1799999999999999 107.67 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.626 HD21 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -81.13 -131.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.815 -1.55 . . . . 2.4700000000000002 106.815 177.858 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 254' ' ' ASN . 14.6 m -105.24 53.36 0.72 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.079 -1.082 . . . . 1.8700000000000001 108.079 178.191 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -155.53 127.66 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.603 -0.686 . . . . 1.1200000000000001 109.157 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.481 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 72.4 mt -93.0 132.97 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 1.1499999999999999 109.861 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -134.99 170.62 15.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.449 -0.782 . . . . 2.6299999999999999 109.493 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.3 t -100.89 139.87 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.415 -0.803 . . . . 1.0800000000000001 109.498 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.75 121.56 14.99 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.441 -0.787 . . . . 1.0700000000000001 109.201 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.99 139.35 89.63 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.486 0.791 . . . . 0.48999999999999999 110.054 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -52.86 -43.1 65.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 3.5800000000000001 109.555 179.658 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.26 -3.88 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.412 -0.805 . . . . 4.3600000000000003 110.667 -178.783 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.426 ' CD ' ' NH2' ' A' ' 228' ' ' ARG . 7.2 mmmt -120.19 16.85 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.288 -0.883 . . . . 2.5800000000000001 108.882 179.852 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.96 172.27 12.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.702 . . . . 1.05 109.749 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -137.4 126.96 25.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.783 -0.821 . . . . 2.2599999999999998 108.783 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.97 107.11 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 1.1799999999999999 109.516 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.45 147.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.61 -0.885 . . . . 1.28 108.61 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.352 -0.843 . . . . 4.1799999999999997 109.367 179.682 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.5 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.315 0.579 . . . . 2.0099999999999998 110.873 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.21 127.68 28.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.437 -0.789 . . . . 0.81999999999999995 108.876 178.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.96 159.04 15.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.177 -1.045 . . . . 3.7799999999999998 108.177 179.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.53 144.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.166 -0.958 . . . . 1.0600000000000001 110.13 -179.84 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.45 157.01 20.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.626 -1.25 . . . . 0.92000000000000004 107.626 178.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.9 p90 -157.75 149.28 21.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.241 . . . . 1.01 110.487 -178.948 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . 0.465 ' NH1' ' CH2' ' B' ' 235' ' ' TRP . 24.1 mtm-85 -95.17 142.56 27.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.432 -0.792 . . . . 3.3900000000000001 109.222 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.93 173.09 8.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.314 -0.866 . . . . 2.23 109.073 179.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -86.87 -8.1 57.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 2.3300000000000001 109.509 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.44 -20.45 26.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 4.1900000000000004 109.452 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.6 m-20 -162.47 132.32 3.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 2.1600000000000001 108.976 179.911 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.38 14.69 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 120.65 0.9 . . . . 1.3999999999999999 110.321 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' B' ' 232' ' ' ASP . 44.3 t -80.94 155.09 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.836 -1.165 . . . . 2.3100000000000001 109.579 -179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.465 ' CH2' ' NH1' ' B' ' 228' ' ' ARG . 98.8 m95 -75.96 160.7 29.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.72999999999999998 109.609 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.0 mttm -119.31 159.33 24.34 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.415 -0.803 . . . . 1.96 108.917 179.574 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.27 168.81 0.03 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.971 -1.251 . . . . 0.56000000000000005 109.971 -179.714 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.76 159.11 54.19 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.592 1.528 . . . . 0.46999999999999997 110.424 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.37 174.38 10.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.835 -0.802 . . . . 1.05 108.835 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.428 ' CD ' ' N ' ' B' ' 240' ' ' LYS . 11.5 mptt -92.64 136.6 33.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.132 -0.98 . . . . 3.1899999999999999 109.416 -179.694 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.02 122.89 31.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.424 -0.797 . . . . 1.0900000000000001 109.401 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.8 -76.66 0.58 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 1.1799999999999999 110.442 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.411 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 21.5 t90 -97.48 137.9 35.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.057 -1.027 . . . . 0.34999999999999998 110.76 -178.726 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.9 132.38 17.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.407 -0.808 . . . . 2.7999999999999998 108.898 178.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -99.92 0.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.445 -1.462 . . . . 0.29999999999999999 109.445 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.51 -149.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -1.178 . . . . 1.5600000000000001 109.154 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.36 48.19 3.08 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.217 -1.553 . . . . 0.28999999999999998 109.217 179.675 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.57 149.22 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -1.014 . . . . 1.0700000000000001 108.981 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.15 135.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.142 -0.974 . . . . 1.0900000000000001 109.594 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . 0.475 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 87.6 t -88.44 143.61 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.918 . . . . 1.0800000000000001 109.339 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.73 179.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 1.04 109.61 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -144.04 110.73 5.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.701 -0.852 . . . . 2.3399999999999999 108.701 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.53 -78.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.598 -1.26 . . . . 1.1799999999999999 107.598 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.629 HD21 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -81.02 -131.13 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.875 -1.528 . . . . 2.4700000000000002 106.875 177.884 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.629 ' N ' HD21 ' B' ' 254' ' ' ASN . 14.6 m -105.25 53.35 0.72 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.055 -1.091 . . . . 1.8600000000000001 108.055 178.189 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -155.56 127.59 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.154 -0.684 . . . . 1.1200000000000001 109.154 -179.238 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 72.5 mt -92.96 132.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 1.1499999999999999 109.899 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.95 170.7 15.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 2.6400000000000001 109.456 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.06 139.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.501 179.79 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.69 121.55 15.06 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.504 -0.748 . . . . 1.0800000000000001 109.253 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.97 139.36 89.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 110.138 -0.755 . . . . 0.48999999999999999 110.138 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . 0.556 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -52.87 -43.1 65.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 3.5800000000000001 109.556 179.69 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.16 -4.0 4.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 4.3600000000000003 110.669 -178.85 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . 0.419 ' CD ' ' NH2' ' B' ' 228' ' ' ARG . 7.3 mmmt -120.09 16.81 12.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.355 -0.841 . . . . 2.5800000000000001 108.896 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.02 172.23 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 1.05 109.672 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -137.43 126.96 25.07 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.742 -0.836 . . . . 2.2599999999999998 108.742 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.96 107.33 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.168 -0.957 . . . . 1.1799999999999999 109.451 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.57 147.66 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.59 -0.893 . . . . 1.27 108.59 179.336 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.55 145.76 25.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.35 -0.844 . . . . 4.1799999999999997 109.433 179.673 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.941 -1.028 . . . . 2.0499999999999998 109.571 179.712 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.0 -0.741 . . . . 2.0099999999999998 109.0 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -133.16 132.33 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.535 -0.728 . . . . 0.81999999999999995 109.256 -179.545 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . 0.632 ' NH2' ' CD2' ' A' ' 226' ' ' TYR . 0.2 OUTLIER -105.99 163.04 13.07 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.782 -1.192 . . . . 3.79 107.782 178.715 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.487 ' C ' HH22 ' A' ' 224' ' ' ARG . 96.2 t -141.47 139.66 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.021 -1.049 . . . . 1.05 110.491 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.632 ' CD2' ' NH2' ' A' ' 224' ' ' ARG . 47.5 m-85 -104.37 154.79 19.4 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.017 -1.475 . . . . 0.92000000000000004 107.017 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.537 ' OH ' ' NZ ' ' A' ' 236' ' ' LYS . 23.7 p90 -158.71 163.39 36.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.372 -1.455 . . . . 1.01 110.983 -179.418 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -96.19 138.88 33.16 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.384 0.612 . . . . 3.3999999999999999 109.527 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.38 -177.13 4.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.406 -0.809 . . . . 2.23 109.277 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.3 p -94.55 -11.72 28.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -0.929 . . . . 2.3199999999999998 109.648 179.989 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.424 ' HE ' ' N ' ' A' ' 231' ' ' ARG . 2.9 mmp_? -79.51 -21.03 45.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.097 -1.002 . . . . 4.1799999999999997 109.7 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.99 139.31 7.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 2.1600000000000001 108.877 179.623 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.37 2.45 1.5 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 121.022 1.148 . . . . 1.3899999999999999 111.304 -179.651 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 12.2 p -82.91 163.26 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.561 -1.337 . . . . 2.3100000000000001 110.372 -179.361 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.405 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 93.5 m95 -68.41 165.63 18.4 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.957 -0.757 . . . . 0.71999999999999997 108.957 179.505 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.537 ' NZ ' ' OH ' ' A' ' 227' ' ' TYR . 5.6 ttpt -119.58 -163.17 0.96 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.226 -0.921 . . . . 1.96 109.328 -179.776 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.98 -179.05 32.25 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.699 -1.36 . . . . 0.55000000000000004 109.699 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HA ' HH21 ' A' ' 224' ' ' ARG . 10.7 Cg_endo -74.05 158.94 45.24 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.777 1.651 . . . . 0.46999999999999997 110.212 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.4 169.43 17.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 1.05 109.379 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -94.66 138.5 32.43 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.14 -0.975 . . . . 3.1899999999999999 109.608 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.63 125.86 35.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.607 -0.683 . . . . 1.0900000000000001 109.476 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.49 -72.95 0.66 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.447 -0.783 . . . . 1.1799999999999999 110.108 179.925 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -93.04 145.4 24.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.34000000000000002 110.129 -178.59 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -148.22 121.03 8.69 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.4 -0.812 . . . . 2.79 109.128 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.36 -102.41 0.2 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.734 -1.222 . . . . 0.28999999999999998 110.324 -179.881 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.09 -153.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.221 -1.164 . . . . 1.5600000000000001 109.803 -179.331 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.92 47.91 2.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.284 -1.527 . . . . 0.28999999999999998 109.284 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.46 151.98 37.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 1.0700000000000001 108.813 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.82 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.174 -0.954 . . . . 1.0900000000000001 109.629 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.1 135.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.882 -1.155 . . . . 1.0700000000000001 107.882 179.04 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -139.11 175.69 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.301 -0.874 . . . . 1.04 109.792 -179.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -143.86 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.746 -0.835 . . . . 2.3399999999999999 108.746 179.216 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.75 -82.76 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.537 -1.282 . . . . 1.1799999999999999 107.537 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 255' ' ' SER . 38.0 t-20 -78.96 -128.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.719 -1.586 . . . . 2.4700000000000002 106.719 177.636 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.465 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 10.7 p -105.84 54.49 0.69 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.147 -1.056 . . . . 1.8700000000000001 108.147 178.019 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 66.2 m-20 -155.05 123.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.55 -0.719 . . . . 1.1200000000000001 109.099 -179.39 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.413 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 13.5 mt -94.23 136.54 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 1.1499999999999999 109.58 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.52 169.8 17.09 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.6299999999999999 109.622 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.24 142.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 1.0800000000000001 109.027 179.389 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.49 131.38 19.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 1.0700000000000001 109.164 -179.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.73 141.24 97.58 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.551 -0.98 . . . . 0.48999999999999999 109.551 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -58.53 -35.63 72.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.209 -0.932 . . . . 3.5800000000000001 109.512 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.58 -4.39 18.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 4.3600000000000003 110.756 -179.157 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -118.96 21.27 12.47 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.124 -0.985 . . . . 2.5800000000000001 108.819 179.429 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.18 16.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 1.05 109.591 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -141.64 124.79 16.36 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.294 -0.879 . . . . 2.2599999999999998 109.142 179.802 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.77 101.53 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 1.1799999999999999 109.701 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.417 ' HB ' HH11 ' A' ' 224' ' ' ARG . 5.7 mm -106.38 158.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.413 -0.958 . . . . 1.28 108.413 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.03 . . . . 4.1799999999999997 109.444 179.555 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 108.999 -0.741 . . . . 2.0099999999999998 108.999 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.16 132.37 41.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 0.81999999999999995 109.205 -179.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . 0.636 ' NH2' ' CD2' ' B' ' 226' ' ' TYR . 0.2 OUTLIER -106.06 163.11 13.03 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.771 -1.196 . . . . 3.7799999999999998 107.771 178.65 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.488 ' C ' HH22 ' B' ' 224' ' ' ARG . 95.6 t -141.6 139.5 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 1.0600000000000001 110.52 -179.561 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . 0.636 ' CD2' ' NH2' ' B' ' 224' ' ' ARG . 47.3 m-85 -104.3 154.82 19.33 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.92000000000000004 106.991 178.357 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' B' ' 236' ' ' LYS . 24.0 p90 -158.68 163.36 36.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.487 -1.383 . . . . 1.01 111.027 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.05 138.85 33.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.742 -0.599 . . . . 3.3900000000000001 109.561 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.41 -177.09 4.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 2.23 109.249 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 29.1 p -94.59 -11.71 28.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.199 -0.938 . . . . 2.3300000000000001 109.604 -179.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.431 ' HE ' ' N ' ' B' ' 231' ' ' ARG . 2.9 mmp_? -79.57 -21.15 45.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 4.1900000000000004 109.606 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.87 139.36 7.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 2.1600000000000001 108.9 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.39 2.45 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.086 1.191 . . . . 1.3999999999999999 111.217 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 12.0 p -83.02 163.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.566 -1.334 . . . . 2.3100000000000001 110.368 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.411 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 93.4 m95 -68.42 165.7 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.996 -0.742 . . . . 0.72999999999999998 108.996 179.588 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' B' ' 227' ' ' TYR . 5.6 ttpt -119.63 -163.16 0.97 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.308 -0.87 . . . . 1.96 109.345 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -72.07 -179.06 32.57 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.691 -1.364 . . . . 0.56000000000000005 109.691 -179.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . 0.416 ' HA ' HH21 ' B' ' 224' ' ' ARG . 10.7 Cg_endo -74.1 159.09 44.88 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.639 1.559 . . . . 0.46999999999999997 110.234 -179.697 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 169.33 17.87 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.436 -0.79 . . . . 1.05 109.48 179.461 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -94.48 138.49 32.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.124 -0.985 . . . . 3.1899999999999999 109.786 179.74 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 tp -88.68 126.04 35.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.763 -0.586 . . . . 1.0900000000000001 109.474 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.57 -73.17 0.65 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.451 -0.78 . . . . 1.1799999999999999 110.019 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.4 t90 -92.91 145.37 24.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.311 -0.868 . . . . 0.34999999999999998 110.257 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -148.14 120.96 8.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.361 -0.837 . . . . 2.7999999999999998 109.132 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.31 -102.29 0.2 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.805 -1.188 . . . . 0.29999999999999999 110.328 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.16 -153.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -1.159 . . . . 1.5600000000000001 109.813 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 47.91 2.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.22 -1.552 . . . . 0.28999999999999998 109.22 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.53 151.99 37.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.493 -1.004 . . . . 1.0700000000000001 108.814 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.73 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 109.613 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.04 135.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.16 . . . . 1.0800000000000001 107.869 179.017 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -138.94 175.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 1.04 109.861 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.87 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.726 -0.842 . . . . 2.3399999999999999 108.726 179.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.72 -82.73 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.532 -1.284 . . . . 1.1799999999999999 107.532 179.43 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 255' ' ' SER . 38.0 t-20 -78.92 -128.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.63 -1.619 . . . . 2.4700000000000002 106.63 177.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 255' ' ' SER . . . . . 0.463 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 10.8 p -105.91 54.45 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.19 -1.041 . . . . 1.8600000000000001 108.19 178.026 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 255' ' ' SER . 66.0 m-20 -155.04 123.93 6.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.585 -0.697 . . . . 1.1200000000000001 109.167 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 13.3 mt -94.25 136.51 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 1.1499999999999999 109.565 -179.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.49 169.84 17.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.263 -0.898 . . . . 2.6400000000000001 109.604 -179.629 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.3 142.09 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.476 -0.765 . . . . 1.0800000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.49 131.47 19.41 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.436 -0.79 . . . . 1.0800000000000001 109.133 -179.992 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.71 141.24 97.53 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 N-CA-C 109.609 -0.958 . . . . 0.48999999999999999 109.609 178.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -58.61 -35.58 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.211 -0.931 . . . . 3.5800000000000001 109.516 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.53 -4.37 18.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 4.3600000000000003 110.746 -179.149 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -119.12 21.34 12.36 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.227 -0.921 . . . . 2.5800000000000001 108.887 179.454 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.74 170.16 16.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.53 -0.731 . . . . 1.05 109.658 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -141.72 124.71 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.238 -0.913 . . . . 2.2599999999999998 109.165 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.74 101.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.25 -0.906 . . . . 1.1799999999999999 109.668 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . 0.429 ' HB ' HH11 ' B' ' 224' ' ' ARG . 5.8 mm -106.44 158.13 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.373 -0.973 . . . . 1.27 108.373 179.025 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.29 152.85 21.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 4.1799999999999997 109.405 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 2.0499999999999998 109.39 179.794 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.771 -0.826 . . . . 2.0099999999999998 108.771 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -125.64 140.64 52.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.434 -0.791 . . . . 0.81999999999999995 109.788 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.99 157.78 24.08 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.796 -1.187 . . . . 3.79 107.796 178.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 239' ' ' ALA . 78.3 t -139.3 141.03 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.172 -0.955 . . . . 1.05 110.309 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -107.32 150.35 26.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.506 -1.294 . . . . 0.92000000000000004 107.506 178.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 14.5 p90 -155.78 156.44 34.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.753 -1.217 . . . . 1.01 110.03 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -93.87 150.01 20.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.49 -0.756 . . . . 3.3999999999999999 109.829 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -93.51 159.19 15.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 2.23 108.886 179.524 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 46.9 t -76.89 2.58 14.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.061 -1.024 . . . . 2.3199999999999998 109.189 179.796 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 231' ' ' ARG . 2.9 mtt-85 -90.37 -25.5 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 4.1799999999999997 109.831 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.0 m-20 -162.44 144.48 8.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.059 -1.026 . . . . 2.1600000000000001 109.271 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -64.41 11.4 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.268 1.312 . . . . 1.3899999999999999 110.706 179.834 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.6 m -84.86 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.872 -1.142 . . . . 2.3100000000000001 109.823 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -66.59 161.5 23.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.71999999999999997 109.244 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 237' ' ' GLY . 45.2 tttp -119.1 166.43 12.93 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.456 -0.777 . . . . 1.96 109.496 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.14 171.83 0.02 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.2 -1.16 . . . . 0.55000000000000004 110.2 -179.534 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.22 164.58 27.43 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.729 1.619 . . . . 0.46999999999999997 110.501 179.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -140.47 169.34 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.093 -0.706 . . . . 1.05 109.093 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -92.9 136.23 33.44 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.041 -1.037 . . . . 3.1899999999999999 109.609 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.39 125.94 34.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.595 -0.69 . . . . 1.0900000000000001 109.602 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.2 mt -118.37 -76.86 0.57 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.423 -0.798 . . . . 1.1799999999999999 110.164 179.77 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -102.99 139.3 38.73 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 0.34000000000000002 110.684 -178.529 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.22 134.68 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 2.79 109.205 179.05 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.75 -99.91 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.389 -1.484 . . . . 0.28999999999999998 109.389 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -66.99 -150.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 1.5600000000000001 108.985 179.781 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.77 48.15 2.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.951 -1.66 . . . . 0.28999999999999998 108.951 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.13 147.76 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -1.043 . . . . 1.0700000000000001 109.304 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.89 136.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.144 -0.973 . . . . 1.0900000000000001 109.165 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.2 t -89.69 145.24 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.0700000000000001 109.162 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.0 pt -143.82 178.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.245 -0.909 . . . . 1.04 109.998 -179.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -144.54 114.31 7.25 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.702 -0.851 . . . . 2.3399999999999999 108.702 179.06 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.31 -80.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.269 -1.382 . . . . 1.1799999999999999 107.269 179.188 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.23 -129.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.9 -1.518 . . . . 2.4700000000000002 106.9 177.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.1 m -104.54 54.87 0.72 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.931 -1.137 . . . . 1.8700000000000001 107.931 177.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.23 125.35 6.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 1.1200000000000001 109.126 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.8 mt -93.82 137.24 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 1.1499999999999999 109.657 -179.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -140.26 163.55 32.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.6299999999999999 109.586 -179.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.38 134.04 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.853 . . . . 1.0800000000000001 108.899 179.356 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.59 133.04 24.37 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 1.0700000000000001 108.827 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.47 140.76 94.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.669 0.913 . . . . 0.48999999999999999 110.323 179.505 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -56.04 -38.02 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 3.5800000000000001 109.881 179.662 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -68.38 -2.36 8.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.228 -0.92 . . . . 4.3600000000000003 110.705 -178.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -119.13 16.19 13.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.619 -0.882 . . . . 2.5800000000000001 108.619 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.12 170.69 15.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.688 -0.632 . . . . 1.05 109.311 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -140.01 127.37 21.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.287 -0.883 . . . . 2.2599999999999998 109.12 179.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.24 109.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 1.1799999999999999 109.47 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.46 150.04 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.748 -0.834 . . . . 1.28 108.748 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 4.1799999999999997 109.317 179.573 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 108.763 -0.829 . . . . 2.0099999999999998 108.763 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.68 140.53 52.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.464 -0.773 . . . . 0.81999999999999995 109.793 -179.452 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.89 157.7 24.1 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.87 -1.159 . . . . 3.7799999999999998 107.87 178.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 239' ' ' ALA . 79.8 t -139.22 141.07 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 1.0600000000000001 110.375 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -107.42 150.3 26.92 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.458 -1.312 . . . . 0.92000000000000004 107.458 178.146 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.4 p90 -155.7 156.45 34.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 1.01 110.046 -179.547 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -93.84 150.04 20.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.473 -0.767 . . . . 3.3900000000000001 109.832 -179.844 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -93.52 159.05 15.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 2.23 108.922 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 46.8 t -76.79 2.56 14.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.058 -1.026 . . . . 2.3300000000000001 109.204 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' B' ' 231' ' ' ARG . 2.9 mtt-85 -90.52 -25.35 20.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 4.1900000000000004 109.794 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.0 m-20 -162.52 144.43 8.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.068 -1.02 . . . . 2.1600000000000001 109.242 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -64.27 11.31 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.822 0 C-N-CA 121.302 1.335 . . . . 1.3999999999999999 110.775 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.6 m -84.82 145.22 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.132 . . . . 2.3100000000000001 109.841 -179.477 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -66.56 161.51 22.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.72999999999999998 109.387 179.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' B' ' 237' ' ' GLY . 45.2 tttp -119.07 166.39 12.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 1.96 109.504 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.15 171.75 0.02 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.202 -1.159 . . . . 0.56000000000000005 110.202 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.1 164.64 26.93 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.687 1.591 . . . . 0.46999999999999997 110.461 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 225' ' ' VAL . . . -140.52 169.3 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 1.05 109.073 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -92.9 136.28 33.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.038 -1.039 . . . . 3.1899999999999999 109.657 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.4 126.08 35.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.474 -0.766 . . . . 1.0900000000000001 109.587 -179.752 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.55 -76.78 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.58 -0.7 . . . . 1.1799999999999999 110.152 179.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -103.01 139.43 38.58 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.217 -0.927 . . . . 0.34999999999999998 110.637 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.25 134.68 18.46 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.344 -0.848 . . . . 2.7999999999999998 109.188 179.069 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.83 -99.9 0.18 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.308 -1.517 . . . . 0.29999999999999999 109.308 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.2 -149.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -1.128 . . . . 1.5600000000000001 108.96 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.72 48.1 2.88 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.952 -1.659 . . . . 0.28999999999999998 108.952 179.603 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.08 147.76 27.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -1.028 . . . . 1.0700000000000001 109.296 -179.673 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.86 136.45 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 1.0900000000000001 109.088 179.31 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.73 145.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 109.156 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -143.8 178.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.04 110.024 -179.891 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -144.57 114.41 7.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.683 -0.858 . . . . 2.3399999999999999 108.683 179.033 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.38 -80.04 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.26 -1.385 . . . . 1.1799999999999999 107.26 179.173 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.25 -129.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.837 -1.542 . . . . 2.4700000000000002 106.837 177.653 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.2 m -104.5 54.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.913 -1.143 . . . . 1.8600000000000001 107.913 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.2 125.41 6.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 1.1200000000000001 109.169 -179.251 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 31.1 mt -93.86 137.36 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.67 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -140.27 163.57 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 2.6400000000000001 109.576 -179.712 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.4 134.04 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 1.0800000000000001 108.927 179.306 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.6 133.03 24.37 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.893 -0.78 . . . . 1.0800000000000001 108.893 -179.904 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.52 140.83 94.5 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.687 0.925 . . . . 0.48999999999999999 110.234 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -56.1 -37.97 70.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.852 . . . . 3.5800000000000001 109.86 179.64 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -68.46 -2.31 8.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.299 -0.876 . . . . 4.3600000000000003 110.71 -178.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -119.1 16.14 13.25 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 2.5800000000000001 108.6 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 170.57 15.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.639 -0.663 . . . . 1.05 109.319 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -139.95 127.37 21.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.312 -0.868 . . . . 2.2599999999999998 109.111 179.874 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.14 109.06 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.1799999999999999 109.481 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.46 150.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.779 -0.823 . . . . 1.27 108.779 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -91.25 145.87 24.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.375 -0.828 . . . . 4.1799999999999997 109.395 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.991 -1.004 . . . . 2.0499999999999998 109.535 179.751 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.655 -0.868 . . . . 2.0099999999999998 108.655 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -134.3 149.56 50.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.409 -0.807 . . . . 0.81999999999999995 109.538 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -120.68 155.39 33.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.882 -1.155 . . . . 3.79 107.882 179.344 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.61 141.06 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.098 -1.001 . . . . 1.05 110.635 -179.625 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.73 155.81 22.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.281 -1.377 . . . . 0.92000000000000004 107.281 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.485 -1.384 . . . . 1.01 110.739 -179.175 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -100.52 140.02 35.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.591 -0.693 . . . . 3.3999999999999999 109.671 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.64 170.05 9.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.866 . . . . 2.23 109.376 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.3 m -84.63 -9.48 58.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 2.3199999999999998 109.137 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.42 -10.9 47.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 4.1799999999999997 109.516 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.6 p30 -158.88 133.95 5.67 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.179 -0.95 . . . . 2.1600000000000001 109.354 -179.242 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.13 -7.05 20.23 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 120.975 1.116 . . . . 1.3899999999999999 111.396 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 3.7 p -87.1 163.49 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.563 -1.336 . . . . 2.3100000000000001 110.416 -179.398 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.486 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 83.2 m95 -66.31 -175.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.646 -0.659 . . . . 0.71999999999999997 109.514 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 4.0 ttpp -130.77 -156.38 0.75 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.589 -0.893 . . . . 1.96 108.589 179.326 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.28 54.22 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.57 -1.412 . . . . 0.55000000000000004 109.57 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -71.46 154.26 60.56 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.677 1.585 . . . . 0.46999999999999997 109.975 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.78 25.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.767 . . . . 1.05 109.215 179.446 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.02 141.44 28.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 3.1899999999999999 109.846 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.63 123.93 34.65 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.829 -0.544 . . . . 1.0900000000000001 109.565 -179.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.06 -73.2 0.65 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.334 -0.854 . . . . 1.1799999999999999 111.017 -179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 243' ' ' TRP . . . . . 0.461 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 6.0 t90 -91.78 152.66 20.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.22 -0.925 . . . . 0.34000000000000002 110.807 -177.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.46 128.34 21.93 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.523 -0.917 . . . . 2.79 108.523 178.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.4 -126.83 1.23 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.521 -1.323 . . . . 0.28999999999999998 110.539 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.65 -144.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.589 -0.947 . . . . 1.5600000000000001 109.342 -179.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.33 49.24 2.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.827 -1.709 . . . . 0.28999999999999998 108.827 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.64 149.32 31.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.383 -1.069 . . . . 1.0700000000000001 109.041 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.47 134.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 1.0900000000000001 109.48 -179.826 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -91.9 140.84 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.287 -0.883 . . . . 1.0700000000000001 109.077 179.816 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.98 176.7 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.88 . . . . 1.04 109.794 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.92 112.3 6.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.851 . . . . 2.3399999999999999 109.018 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.41 -81.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.409 -1.33 . . . . 1.1799999999999999 107.409 179.28 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.02 -131.42 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.651 -1.611 . . . . 2.4700000000000002 106.651 177.585 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.5 t -104.34 57.07 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.7 -1.222 . . . . 1.8700000000000001 107.7 177.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -155.73 122.43 5.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.142 -0.688 . . . . 1.1200000000000001 109.142 -179.378 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.462 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 59.0 mt -93.05 134.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.258 -0.901 . . . . 1.1499999999999999 109.331 -179.831 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.79 172.72 12.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.449 -0.782 . . . . 2.6299999999999999 109.741 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.34 142.07 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.146 -0.687 . . . . 1.0800000000000001 109.146 179.387 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.51 126.7 15.06 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.398 -0.964 . . . . 1.0700000000000001 108.398 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.11 152.07 39.48 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 109.835 -0.871 . . . . 0.48999999999999999 109.835 179.526 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.71 -34.59 77.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 3.5800000000000001 109.742 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -70.93 -5.59 32.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.815 . . . . 4.3600000000000003 111.329 -178.914 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -118.77 20.33 12.89 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.236 -0.915 . . . . 2.5800000000000001 108.908 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.9 165.36 27.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.519 -0.738 . . . . 1.05 109.275 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.473 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 7.4 mtmp? -140.08 129.62 24.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.371 -0.831 . . . . 2.2599999999999998 108.925 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.97 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.313 -0.867 . . . . 1.1799999999999999 109.704 -179.35 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.45 150.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.055 -1.091 . . . . 1.28 108.055 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.541 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.187 -0.946 . . . . 4.1799999999999997 109.216 179.652 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.608 -0.886 . . . . 2.0099999999999998 108.608 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.23 149.54 50.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.81999999999999995 109.491 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -120.67 155.33 34.07 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.902 -1.147 . . . . 3.7799999999999998 107.902 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.53 141.14 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.146 -0.971 . . . . 1.0600000000000001 110.652 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.84 155.78 23.06 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.181 -1.414 . . . . 0.92000000000000004 107.181 178.363 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.487 -1.383 . . . . 1.01 110.808 -179.218 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -100.55 140.11 35.28 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.647 -0.658 . . . . 3.3900000000000001 109.639 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.79 170.02 9.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.313 -0.867 . . . . 2.23 109.412 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -9.62 58.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 2.3300000000000001 109.157 179.727 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.31 -10.85 48.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 4.1900000000000004 109.536 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 1.6 p30 -158.94 133.9 5.62 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.181 -0.949 . . . . 2.1600000000000001 109.335 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.99 -7.06 20.19 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 120.98 1.12 . . . . 1.3999999999999999 111.349 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 234' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 3.7 p -87.25 163.55 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.671 -1.268 . . . . 2.3100000000000001 110.398 -179.391 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 235' ' ' TRP . . . . . 0.485 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 83.2 m95 -66.34 -175.67 0.37 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.731 -0.605 . . . . 0.72999999999999998 109.521 -179.956 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 236' ' ' LYS . . . . . 0.445 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 4.0 ttpp -130.79 -156.55 0.76 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.598 -0.89 . . . . 1.96 108.598 179.378 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.8 177.2 54.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.604 -1.398 . . . . 0.56000000000000005 109.604 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.38 154.24 60.98 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.593 1.528 . . . . 0.46999999999999997 110.027 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 165.91 24.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.45 -0.782 . . . . 1.05 109.181 179.423 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.08 141.48 28.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.116 -0.99 . . . . 3.1899999999999999 109.808 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.61 123.93 34.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.814 -0.554 . . . . 1.0900000000000001 109.623 -179.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.97 -73.25 0.65 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.348 -0.845 . . . . 1.1799999999999999 111.079 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 243' ' ' TRP . . . . . 0.462 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 6.1 t90 -91.93 152.66 19.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.234 -0.916 . . . . 0.34999999999999998 110.804 -177.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.31 128.28 22.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.588 -0.894 . . . . 2.7999999999999998 108.588 179.014 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.38 -126.99 1.24 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.58 -1.295 . . . . 0.29999999999999999 110.574 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.44 -144.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.954 . . . . 1.5600000000000001 109.445 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.2 49.1 2.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.867 -1.693 . . . . 0.28999999999999998 108.867 179.376 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.4 149.44 31.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -1.068 . . . . 1.0700000000000001 109.001 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 134.76 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.246 -0.908 . . . . 1.0900000000000001 109.455 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.97 140.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.828 . . . . 1.0800000000000001 109.03 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.94 176.74 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 1.04 109.873 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -144.91 112.32 6.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.334 -0.854 . . . . 2.3399999999999999 108.992 179.379 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.54 -81.13 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.398 -1.334 . . . . 1.1799999999999999 107.398 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.98 -131.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.678 -1.601 . . . . 2.4700000000000002 106.678 177.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 41.6 t -104.35 57.06 0.71 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.697 -1.223 . . . . 1.8600000000000001 107.697 177.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -155.78 122.51 5.28 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.974 -0.75 . . . . 1.1200000000000001 108.974 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 257' ' ' ILE . . . . . 0.461 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 59.0 mt -93.05 134.62 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.153 -0.967 . . . . 1.1499999999999999 109.375 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.83 172.71 12.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.502 -0.749 . . . . 2.6400000000000001 109.721 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.33 142.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.114 -0.699 . . . . 1.0800000000000001 109.114 179.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.55 126.69 15.0 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.443 -0.947 . . . . 1.0800000000000001 108.443 179.349 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.03 152.1 38.73 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 N-CA-C 109.791 -0.888 . . . . 0.48999999999999999 109.791 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.73 -34.55 77.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.385 -0.822 . . . . 3.5800000000000001 109.684 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -71.06 -5.63 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.288 -0.883 . . . . 4.3600000000000003 111.238 -178.805 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -118.8 20.34 12.87 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.019 -1.051 . . . . 2.5800000000000001 108.922 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.91 165.33 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 1.05 109.269 179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 266' ' ' LYS . . . . . 0.474 ' HZ3' ' CB ' ' B' ' 266' ' ' LYS . 7.4 mtmp? -139.99 129.55 24.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.294 -0.879 . . . . 2.2599999999999998 108.987 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.87 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.725 -179.34 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -105.35 150.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.141 -1.059 . . . . 1.27 108.141 178.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 269' ' ' ARG . . . . . 0.543 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.09 142.24 27.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 4.1799999999999997 109.289 179.605 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.045 -0.979 . . . . 2.0499999999999998 109.197 179.608 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 52.3 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.508 -0.553 . . . . 4.1799999999999997 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 2.0 mp -83.59 104.98 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 2.5899999999999999 109.109 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -84.75 -119.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.864 . . . . 2.6000000000000001 109.182 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -96.52 102.98 14.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 2.0099999999999998 109.055 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.28 138.12 43.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.53 -0.731 . . . . 0.81999999999999995 109.542 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.611 HH11 ' CG ' ' A' ' 224' ' ' ARG . 1.0 OUTLIER -108.62 157.31 18.62 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.699 -1.223 . . . . 3.79 107.699 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.85 140.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.09 -1.006 . . . . 1.05 110.418 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.79 153.17 23.87 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.593 -1.262 . . . . 0.92000000000000004 107.593 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.6 p90 -156.48 152.82 27.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.699 -1.251 . . . . 1.01 110.156 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -95.32 156.4 16.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 3.3999999999999999 109.653 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -93.07 172.55 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.661 -0.866 . . . . 2.23 108.661 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.24 -13.7 46.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 2.3199999999999998 109.251 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -90.75 -14.79 31.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 4.1799999999999997 109.954 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 234' ' ' VAL . 12.1 m-20 -161.02 128.81 2.77 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.912 -1.118 . . . . 2.1600000000000001 109.553 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.13 18.0 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 121.021 1.147 . . . . 1.3899999999999999 110.882 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 232' ' ' ASP . 31.5 m -83.24 135.06 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.829 -1.169 . . . . 2.3100000000000001 109.55 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -58.9 161.24 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.71999999999999997 109.496 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 237' ' ' GLY . 42.5 tttp -121.91 161.48 22.74 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.378 -0.826 . . . . 1.96 109.883 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.21 165.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.244 -1.142 . . . . 0.55000000000000004 110.244 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.15 158.61 53.73 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.661 1.574 . . . . 0.46999999999999997 110.699 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.01 172.55 12.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.851 -0.796 . . . . 1.05 108.851 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -92.75 135.75 33.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 3.1899999999999999 110.026 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -88.14 125.37 34.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 1.0900000000000001 109.558 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.86 -74.39 0.61 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.426 -0.796 . . . . 1.1799999999999999 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.483 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 3.8 t90 -89.85 140.91 29.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.226 -0.921 . . . . 0.34000000000000002 109.846 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.26 119.7 9.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 2.79 108.791 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -104.42 0.23 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.87 -1.157 . . . . 0.28999999999999998 110.215 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.69 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -1.067 . . . . 1.5600000000000001 109.735 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 49.0 2.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.453 -1.459 . . . . 0.28999999999999998 109.453 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.55 151.28 36.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 1.0700000000000001 108.522 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.15 126.54 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 109.909 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.86 135.16 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.025 -1.102 . . . . 1.0700000000000001 108.025 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.31 179.27 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.871 . . . . 1.04 110.135 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.22 110.33 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 2.3399999999999999 108.772 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.95 -81.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.467 -1.309 . . . . 1.1799999999999999 107.467 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -78.6 -137.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.505 -1.665 . . . . 2.4700000000000002 106.505 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.3 m -97.97 54.13 1.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.899 -1.149 . . . . 1.8700000000000001 107.899 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.45 128.59 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.988 -0.745 . . . . 1.1200000000000001 108.988 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.476 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 19.0 mt -92.74 140.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.121 -0.987 . . . . 1.1499999999999999 109.604 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -138.44 168.22 20.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.406 -0.809 . . . . 2.6299999999999999 109.774 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.75 138.34 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.508 -0.745 . . . . 1.0800000000000001 109.228 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.72 131.93 18.35 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.363 -0.836 . . . . 1.0700000000000001 109.137 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.43 139.75 91.85 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 N-CA-C 109.599 -0.962 . . . . 0.48999999999999999 109.599 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.1 OUTLIER -59.96 -34.76 73.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 3.5800000000000001 109.722 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.23 -4.96 19.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 4.3600000000000003 110.988 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -119.29 17.51 13.07 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.254 -0.904 . . . . 2.5800000000000001 108.873 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.77 17.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.014 -0.736 . . . . 1.05 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.6 131.37 27.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.303 -0.873 . . . . 2.2599999999999998 109.094 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.7 mm -88.27 108.1 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 1.1799999999999999 110.215 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.01 149.0 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.091 -1.078 . . . . 1.28 108.091 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.47 151.85 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.302 -0.874 . . . . 4.1799999999999997 108.771 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.99 -1.005 . . . . 2.0499999999999998 109.312 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.48 -0.563 . . . . 4.1900000000000004 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' B' ' 220' ' ' ILE . 2.0 mp -83.51 105.0 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 2.5899999999999999 109.11 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -84.78 -119.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 2.5899999999999999 109.127 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -96.53 102.96 14.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.857 . . . . 2.0099999999999998 109.014 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -135.3 138.07 43.09 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.484 -0.76 . . . . 0.81999999999999995 109.534 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' B' ' 224' ' ' ARG . 1.0 OUTLIER -108.51 157.36 18.53 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.681 -1.229 . . . . 3.7799999999999998 107.681 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.92 140.06 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.108 -0.995 . . . . 1.0600000000000001 110.375 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.74 153.14 23.88 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.621 -1.252 . . . . 0.92000000000000004 107.621 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.5 p90 -156.47 152.77 27.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.668 -1.27 . . . . 1.01 110.241 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -95.27 156.37 16.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.476 -0.765 . . . . 3.3900000000000001 109.688 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -93.13 172.46 8.29 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.65 -0.87 . . . . 2.23 108.65 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.15 -13.75 46.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 2.3300000000000001 109.183 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.71 -14.81 31.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 4.1900000000000004 109.979 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' B' ' 234' ' ' VAL . 12.0 m-20 -161.03 128.83 2.78 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.949 -1.094 . . . . 2.1600000000000001 109.521 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.28 18.16 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 120.97 1.114 . . . . 1.3999999999999999 110.81 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.524 ' H ' ' C ' ' B' ' 232' ' ' ASP . 31.7 m -83.31 135.13 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.795 -1.191 . . . . 2.3100000000000001 109.535 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -58.97 161.22 5.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.72999999999999998 109.516 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 42.5 tttp -121.92 161.47 22.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.368 -0.832 . . . . 1.96 109.879 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.26 165.5 0.02 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.277 -1.129 . . . . 0.56000000000000005 110.277 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.28 158.68 53.71 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.619 1.546 . . . . 0.46999999999999997 110.644 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.99 172.59 12.71 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.856 -0.794 . . . . 1.05 108.856 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -92.8 135.73 33.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.009 -1.057 . . . . 3.1899999999999999 110.007 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.18 125.38 34.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.642 -0.662 . . . . 1.0900000000000001 109.603 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.86 -74.49 0.6 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.442 -0.786 . . . . 1.1799999999999999 110.158 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.476 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 3.8 t90 -89.76 140.84 29.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.142 -0.974 . . . . 0.34999999999999998 109.815 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.19 119.67 9.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 2.7999999999999998 108.816 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -104.51 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.246 -1.142 . . . . 0.29999999999999999 110.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -67.63 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -1.078 . . . . 1.5600000000000001 109.686 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.83 2.74 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.514 -1.435 . . . . 0.28999999999999998 109.514 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.29 151.29 36.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -1.077 . . . . 1.0700000000000001 108.522 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.12 126.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.159 -0.963 . . . . 1.0900000000000001 109.838 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.89 135.27 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.996 -1.113 . . . . 1.0800000000000001 107.996 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.2 pt -139.4 179.14 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 1.04 110.083 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.14 110.34 5.69 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.735 -0.839 . . . . 2.3399999999999999 108.735 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 -81.83 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.484 -1.302 . . . . 1.1799999999999999 107.484 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -78.61 -137.42 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.451 -1.685 . . . . 2.4700000000000002 106.451 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 18.4 m -97.95 54.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.913 -1.143 . . . . 1.8600000000000001 107.913 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.53 128.48 7.34 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.966 -0.753 . . . . 1.1200000000000001 108.966 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.483 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.0 mt -92.68 140.04 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 1.1499999999999999 109.67 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -138.5 168.14 20.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 2.6400000000000001 109.757 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.65 138.33 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.512 -0.743 . . . . 1.0800000000000001 109.268 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.7 131.98 18.39 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.432 -0.793 . . . . 1.0800000000000001 109.134 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.44 139.65 91.44 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 109.713 -0.918 . . . . 0.48999999999999999 109.713 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.1 OUTLIER -59.89 -34.77 73.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 3.5800000000000001 109.664 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.19 -5.03 20.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.838 . . . . 4.3600000000000003 110.955 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -119.28 17.51 13.07 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.192 -0.942 . . . . 2.5800000000000001 108.848 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.34 169.7 17.34 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.094 -0.706 . . . . 1.05 109.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.51 131.35 27.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.099 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -88.2 108.09 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.897 . . . . 1.1799999999999999 110.16 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.98 149.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.107 -1.072 . . . . 1.27 108.107 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.51 151.82 21.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.854 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.946 -1.026 . . . . 2.0499999999999998 109.35 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.464 -0.569 . . . . 4.1799999999999997 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 6.6 tp -83.14 137.21 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 2.5899999999999999 109.192 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.46 -146.82 0.14 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 2.6000000000000001 109.179 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.41 113.34 25.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.111 -0.993 . . . . 2.0099999999999998 109.091 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.21 142.27 45.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.81999999999999995 109.473 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.55 HH21 ' HH ' ' A' ' 226' ' ' TYR . 28.5 mtp180 -108.63 156.67 19.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.536 -1.283 . . . . 3.79 107.536 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.1 t -141.54 143.99 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.072 -1.018 . . . . 1.05 110.794 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.55 ' HH ' HH21 ' A' ' 224' ' ' ARG . 31.4 m-85 -110.96 155.87 22.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.599 -1.259 . . . . 0.92000000000000004 107.599 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.8 151.88 26.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 1.01 110.224 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 228' ' ' ARG . 9.6 mtm-85 -92.38 137.8 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 3.3999999999999999 109.67 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.11 170.7 9.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.456 -0.777 . . . . 2.23 109.485 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.3 t -86.79 -9.13 56.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 2.3199999999999998 109.513 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.39 43.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 4.1799999999999997 110.055 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.479 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 26.0 p-10 -159.19 134.23 5.67 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.905 -1.122 . . . . 2.1600000000000001 109.462 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.61 -7.96 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.027 1.152 . . . . 1.3899999999999999 111.689 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 7.0 p -84.61 164.04 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.553 -1.342 . . . . 2.3100000000000001 110.359 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.491 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 94.5 m95 -66.85 166.42 13.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.586 . . . . 0.71999999999999997 109.595 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.11 166.37 13.01 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.349 -0.844 . . . . 1.96 109.383 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.0 164.08 0.06 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.115 -1.194 . . . . 0.55000000000000004 110.115 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.15 164.4 30.4 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.543 1.496 . . . . 0.46999999999999997 110.604 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.26 8.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.855 -0.794 . . . . 1.05 108.855 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.95 139.26 33.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.206 -0.934 . . . . 3.1899999999999999 109.041 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -88.88 121.88 31.69 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.352 -0.842 . . . . 1.0900000000000001 109.833 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.2 mt -110.19 -74.55 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.366 -0.834 . . . . 1.1799999999999999 109.808 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.406 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.4 t90 -91.71 145.0 24.93 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.11 -0.994 . . . . 0.34000000000000002 110.36 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.71 120.08 8.43 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.952 -0.758 . . . . 2.79 108.952 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -106.38 0.25 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.737 -1.22 . . . . 0.28999999999999998 110.453 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.86 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -1.06 . . . . 1.5600000000000001 109.871 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.69 49.1 2.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.28999999999999998 109.469 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.2 150.0 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -1.066 . . . . 1.0700000000000001 108.582 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.7 m -144.14 127.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 1.0900000000000001 109.858 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 61.0 t -90.13 136.13 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.312 -0.995 . . . . 1.0700000000000001 108.312 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.84 179.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.305 -0.872 . . . . 1.04 109.726 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' A' ' 257' ' ' ILE . 32.2 tt0 -141.8 111.94 6.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.57 -0.9 . . . . 2.3399999999999999 108.57 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -81.54 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.57 -1.27 . . . . 1.1799999999999999 107.57 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.65 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.467 -1.679 . . . . 2.4700000000000002 106.467 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.5 p -105.6 54.29 0.7 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.048 -1.033 . . . . 1.8700000000000001 108.344 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 255' ' ' SER . 63.0 m-20 -155.87 127.78 7.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.547 -0.721 . . . . 1.1200000000000001 109.22 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' A' ' 252' ' ' GLN . 79.5 mt -91.65 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.05 -1.031 . . . . 1.1499999999999999 109.355 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.23 168.91 18.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.6299999999999999 109.921 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.66 138.92 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.519 -0.738 . . . . 1.0800000000000001 109.348 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.3 t -133.4 131.46 21.51 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.569 -0.9 . . . . 1.0700000000000001 108.569 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.38 137.87 81.78 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.546 0.831 . . . . 0.48999999999999999 110.124 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.529 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.3 OUTLIER -57.14 -36.23 70.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 3.5800000000000001 109.611 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.67 -3.0 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 4.3600000000000003 110.717 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -119.37 19.5 12.73 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.154 -0.966 . . . . 2.5800000000000001 109.029 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.67 171.87 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 1.05 109.513 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -139.87 129.23 24.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 2.2599999999999998 108.996 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.65 107.29 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.206 -0.934 . . . . 1.1799999999999999 109.565 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -105.75 154.02 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.648 -0.871 . . . . 1.28 108.648 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.554 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER -87.65 149.03 24.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 4.1799999999999997 109.679 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 7.5 m-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.025 -0.988 . . . . 2.0499999999999998 109.372 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.467 -0.568 . . . . 4.1900000000000004 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 6.6 tp -83.22 137.19 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 2.5899999999999999 109.162 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.49 -146.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.179 -0.95 . . . . 2.5899999999999999 109.217 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.51 113.33 25.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.144 -0.973 . . . . 2.0099999999999998 108.98 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 142.25 46.25 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.442 -0.786 . . . . 0.81999999999999995 109.541 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.55 HH21 ' HH ' ' B' ' 226' ' ' TYR . 28.4 mtp180 -108.59 156.58 19.37 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.525 -1.287 . . . . 3.7799999999999998 107.525 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.5 144.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.075 -1.016 . . . . 1.0600000000000001 110.662 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . 0.55 ' HH ' HH21 ' B' ' 224' ' ' ARG . 31.4 m-85 -111.1 155.77 22.34 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.561 -1.274 . . . . 0.92000000000000004 107.561 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.5 p90 -156.71 151.96 26.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.741 -1.225 . . . . 1.01 110.238 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.7 mtm-85 -92.49 137.96 31.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 3.3900000000000001 109.525 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.15 170.79 9.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 2.23 109.417 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 36.6 t -86.94 -8.94 56.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 2.3300000000000001 109.429 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.41 43.85 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 4.1900000000000004 110.004 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 25.8 p-10 -159.22 134.19 5.63 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.979 -1.076 . . . . 2.1600000000000001 109.429 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.64 -7.96 20.92 Favored 'Trans proline' 0 N--CA 1.483 0.896 0 C-N-CA 121.001 1.134 . . . . 1.3999999999999999 111.701 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 7.1 p -84.51 163.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.535 -1.353 . . . . 2.3100000000000001 110.362 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.487 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 94.4 m95 -66.88 166.31 13.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.81 -0.556 . . . . 0.72999999999999998 109.547 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.07 166.17 13.23 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.424 -0.797 . . . . 1.96 109.422 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.04 164.14 0.06 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.955 -1.258 . . . . 0.56000000000000005 109.955 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -67.3 164.5 30.3 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.46999999999999997 110.526 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.37 8.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.895 -0.78 . . . . 1.05 108.895 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.86 139.31 33.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.255 -0.903 . . . . 3.1899999999999999 109.007 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -89.0 122.03 31.94 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.387 -0.821 . . . . 1.0900000000000001 109.826 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.3 mt -110.25 -74.56 0.65 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.427 -0.796 . . . . 1.1799999999999999 109.82 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -91.79 145.04 24.89 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.127 -0.983 . . . . 0.34999999999999998 110.387 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -147.65 120.12 8.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.365 -0.834 . . . . 2.7999999999999998 108.896 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -106.43 0.25 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.726 -1.226 . . . . 0.29999999999999999 110.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.84 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -1.038 . . . . 1.5600000000000001 109.855 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.7 49.23 2.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.453 -1.459 . . . . 0.28999999999999998 109.453 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.06 33.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -1.06 . . . . 1.0700000000000001 108.655 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -144.29 127.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 1.0900000000000001 109.838 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.03 136.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.289 -1.004 . . . . 1.0800000000000001 108.289 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.85 179.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 1.04 109.761 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' B' ' 257' ' ' ILE . 32.1 tt0 -141.81 111.76 6.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.682 -0.859 . . . . 2.3399999999999999 108.682 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.32 -81.62 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.647 -1.242 . . . . 1.1799999999999999 107.647 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.57 -129.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.538 -1.653 . . . . 2.4700000000000002 106.538 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.5 p -105.63 54.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.344 -0.984 . . . . 1.8600000000000001 108.344 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 255' ' ' SER . 62.7 m-20 -155.87 127.69 7.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 1.1200000000000001 109.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' B' ' 252' ' ' GLN . 79.3 mt -91.66 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.143 -0.973 . . . . 1.1499999999999999 109.312 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -137.37 168.89 18.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.6400000000000001 109.839 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.72 138.74 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.493 -0.755 . . . . 1.0800000000000001 109.352 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 23.1 t -133.26 131.68 21.76 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.592 -0.892 . . . . 1.0800000000000001 108.592 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.46 137.85 81.98 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 120.566 0.844 . . . . 0.48999999999999999 110.17 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.544 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.3 OUTLIER -57.05 -36.42 70.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 3.5800000000000001 109.618 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.51 -3.19 13.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.221 -0.924 . . . . 4.3600000000000003 110.789 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -119.18 19.45 12.87 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.242 -0.911 . . . . 2.5800000000000001 109.039 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.63 171.91 13.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 1.05 109.489 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -140.01 129.17 23.73 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.405 -0.809 . . . . 2.2599999999999998 108.892 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.6 107.36 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.183 -0.948 . . . . 1.1799999999999999 109.623 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.5 mm -105.77 154.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.582 -0.896 . . . . 1.27 108.582 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.7 OUTLIER -87.61 149.13 24.5 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.349 -0.844 . . . . 4.1799999999999997 109.604 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.6 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.976 -1.011 . . . . 2.0499999999999998 109.417 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.364 -0.606 . . . . 4.1799999999999997 109.364 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.77 140.5 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 2.5899999999999999 108.329 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -84.14 -136.77 0.05 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 2.6000000000000001 110.023 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -96.3 108.59 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.315 -0.865 . . . . 2.0099999999999998 109.474 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -135.12 131.07 36.43 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.762 -0.829 . . . . 0.81999999999999995 108.762 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -102.8 153.17 20.43 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 3.79 108.362 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.53 142.71 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 1.05 110.2 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.14 158.81 18.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.491 -1.299 . . . . 0.92000000000000004 107.491 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.4 p90 -156.37 153.59 29.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 1.01 110.447 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.431 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.4 mtm-85 -95.88 147.49 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.531 -0.73 . . . . 3.3999999999999999 110.115 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 14.5 p-10 -94.32 168.49 10.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -0.786 . . . . 2.23 109.203 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.5 t -84.92 -2.77 58.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 2.3199999999999998 109.747 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -87.71 -23.79 24.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 4.1799999999999997 109.834 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 10.1 m-20 -163.15 142.39 6.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.99 . . . . 2.1600000000000001 108.895 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.95 10.23 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.226 1.284 . . . . 1.3899999999999999 110.826 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -82.75 156.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.644 -1.285 . . . . 2.3100000000000001 110.415 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.402 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 97.2 m95 -75.69 -172.55 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.476 -0.564 . . . . 0.71999999999999997 109.476 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.09 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 1.96 108.184 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.46 172.19 55.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.694 -1.362 . . . . 0.55000000000000004 109.694 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.3 156.67 65.24 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.55 1.5 . . . . 0.46999999999999997 110.166 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.02 166.23 25.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 1.05 109.093 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.42 140.5 29.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 3.1899999999999999 109.547 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.42 125.24 34.63 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.462 -0.57 . . . . 1.0900000000000001 109.462 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.9 mt -115.19 -69.97 0.82 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.84 . . . . 1.1799999999999999 109.982 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.76 143.1 26.88 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.056 -1.027 . . . . 0.34000000000000002 110.315 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.88 115.42 6.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.272 -0.892 . . . . 2.79 109.235 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.75 0.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.204 -1.158 . . . . 0.28999999999999998 110.204 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -68.68 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.277 -1.131 . . . . 1.5600000000000001 109.802 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 51.36 3.03 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.326 -1.509 . . . . 0.28999999999999998 109.326 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.28 33.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.518 -0.989 . . . . 1.0700000000000001 108.577 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.88 125.53 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 1.0900000000000001 109.682 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.34 135.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.196 -1.038 . . . . 1.0700000000000001 108.196 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.6 pt -137.66 -178.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.395 -0.816 . . . . 1.04 110.139 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.489 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.6 tt0 -143.48 111.63 6.2 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.631 -0.877 . . . . 2.3399999999999999 108.631 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.37 -77.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.509 -1.293 . . . . 1.1799999999999999 107.509 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.81 -132.27 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.944 -1.502 . . . . 2.4700000000000002 106.944 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.9 p -104.26 53.04 0.75 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.958 -1.127 . . . . 1.8700000000000001 107.958 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -156.1 127.29 7.05 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.986 -0.746 . . . . 1.1200000000000001 108.986 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.489 ' CG1' HE21 ' A' ' 252' ' ' GLN . 55.9 mt -91.23 134.72 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 1.1499999999999999 109.344 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -136.12 170.55 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.79 . . . . 2.6299999999999999 109.857 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.73 139.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 1.0800000000000001 109.826 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.73 124.03 14.28 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.626 -0.879 . . . . 1.0700000000000001 108.626 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.75 139.37 90.06 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 N-CA-C 110.134 -0.756 . . . . 0.48999999999999999 110.134 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -61.29 -30.48 70.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 3.5800000000000001 109.407 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 263' ' ' ARG . 0.0 OUTLIER -69.83 -9.91 56.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.41 -0.806 . . . . 4.3600000000000003 110.06 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.45 22.96 11.48 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.242 -0.911 . . . . 2.5800000000000001 109.11 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 169.57 17.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.081 -0.711 . . . . 1.05 109.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -137.11 127.89 27.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 2.2599999999999998 108.783 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.44 109.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 1.1799999999999999 109.893 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -103.34 152.63 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.54 -0.911 . . . . 1.28 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -93.4 137.38 32.75 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 4.1799999999999997 109.353 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.02 -0.99 . . . . 2.0499999999999998 109.519 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 34.4 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.425 -0.583 . . . . 4.1900000000000004 109.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.73 140.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.421 -0.955 . . . . 2.5899999999999999 108.421 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -84.24 -136.77 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.96 -1.088 . . . . 2.5899999999999999 110.011 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -96.27 108.49 20.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.349 -0.844 . . . . 2.0099999999999998 109.589 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 131.02 36.45 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.783 -0.821 . . . . 0.81999999999999995 108.783 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -102.7 153.09 20.48 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.424 -0.954 . . . . 3.7799999999999998 108.424 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.52 142.69 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -0.885 . . . . 1.0600000000000001 110.156 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -111.2 158.74 18.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.496 -1.298 . . . . 0.92000000000000004 107.496 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.3 p90 -156.21 153.69 29.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.586 -1.321 . . . . 1.01 110.45 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.5 mtm-85 -95.99 147.44 23.69 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.818 . . . . 3.3900000000000001 110.094 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 14.7 p-10 -94.31 168.55 10.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.819 . . . . 2.23 109.268 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -85.02 -2.77 58.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 2.3300000000000001 109.719 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -87.69 -23.73 24.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 4.1900000000000004 109.767 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' B' ' 234' ' ' VAL . 9.9 m-20 -163.19 142.38 6.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.1600000000000001 108.825 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -62.99 10.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.179 1.252 . . . . 1.3999999999999999 110.895 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -82.69 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.657 -1.277 . . . . 2.3100000000000001 110.372 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.405 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 97.3 m95 -75.77 -172.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.501 -0.555 . . . . 0.72999999999999998 109.501 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.06 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.229 -1.026 . . . . 1.96 108.229 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.48 172.19 55.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.697 -1.361 . . . . 0.56000000000000005 109.697 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.31 156.54 65.79 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.578 1.519 . . . . 0.46999999999999997 110.205 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.49 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 1.05 109.124 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.55 140.57 29.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.092 -1.005 . . . . 3.1899999999999999 109.495 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 17.8 tp -88.55 125.26 34.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.391 -0.596 . . . . 1.0900000000000001 109.391 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.04 -70.08 0.82 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.281 -0.887 . . . . 1.1799999999999999 110.082 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -91.72 143.17 26.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.096 -1.003 . . . . 0.34999999999999998 110.269 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.92 115.39 6.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 2.7999999999999998 109.184 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.65 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.914 -1.136 . . . . 0.29999999999999999 110.301 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -68.76 -156.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 1.5600000000000001 109.774 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.72 51.38 3.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.306 -1.518 . . . . 0.28999999999999998 109.306 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.17 33.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.991 . . . . 1.0700000000000001 108.575 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.86 125.66 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 1.0900000000000001 109.598 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.42 135.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.194 -1.039 . . . . 1.0800000000000001 108.194 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.5 pt -137.7 -178.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.309 -0.869 . . . . 1.04 110.206 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.494 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.4 tt0 -143.5 111.45 6.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.682 -0.859 . . . . 2.3399999999999999 108.682 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.36 -77.39 0.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.519 -1.289 . . . . 1.1799999999999999 107.519 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.8 -132.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.905 -1.517 . . . . 2.4700000000000002 106.905 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 5.8 p -104.25 53.07 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.977 -1.12 . . . . 1.8600000000000001 107.977 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -156.1 127.23 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.963 -0.754 . . . . 1.1200000000000001 108.963 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.494 ' CG1' HE21 ' B' ' 252' ' ' GLN . 55.4 mt -91.08 134.77 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 1.1499999999999999 109.369 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -136.15 170.57 15.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 2.6400000000000001 109.845 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 8.8 t -99.76 139.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.455 -0.778 . . . . 1.0800000000000001 109.821 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.9 t -136.75 123.92 14.18 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.627 -0.879 . . . . 1.0800000000000001 108.627 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.6 139.46 90.29 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 110.006 -0.806 . . . . 0.48999999999999999 110.006 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.41 -30.51 70.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 3.5800000000000001 109.394 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.0 OUTLIER -69.78 -9.91 56.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 110.07 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.54 23.05 11.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.295 -0.878 . . . . 2.5800000000000001 109.053 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.44 169.37 17.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.1 -0.704 . . . . 1.05 109.1 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -136.96 127.89 27.5 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.752 -0.833 . . . . 2.2599999999999998 108.752 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.1 mm -88.48 109.55 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.91 . . . . 1.1799999999999999 109.919 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.39 152.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.491 -0.929 . . . . 1.27 108.491 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -93.32 137.34 32.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.388 -0.82 . . . . 4.1799999999999997 109.342 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.999 -1.001 . . . . 2.0499999999999998 109.504 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.44 -0.578 . . . . 4.1799999999999997 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.4 tt -81.29 132.62 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 2.5899999999999999 109.38 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -89.26 -142.9 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.689 -0.856 . . . . 2.6000000000000001 108.689 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -90.51 100.07 12.98 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.008 -1.058 . . . . 2.0099999999999998 108.762 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -120.91 141.14 50.92 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.618 -0.676 . . . . 0.81999999999999995 109.924 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -113.29 157.76 21.4 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.523 -1.288 . . . . 3.79 107.523 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.19 143.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.066 -1.021 . . . . 1.05 110.627 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -112.88 157.79 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.654 -1.239 . . . . 0.92000000000000004 107.654 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 14.6 p90 -157.48 147.35 20.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.701 -1.25 . . . . 1.01 110.144 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.64 142.52 27.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.054 -1.029 . . . . 3.3999999999999999 109.425 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.41 166.55 12.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 2.23 109.369 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.3 p -85.81 -10.15 55.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.921 . . . . 2.3199999999999998 109.635 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.44 36.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.202 -0.936 . . . . 4.1799999999999997 109.44 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 234' ' ' VAL . 3.3 p30 -159.23 128.04 3.05 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.31 -0.869 . . . . 2.1600000000000001 109.105 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.62 9.22 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.805 1.004 . . . . 1.3899999999999999 110.328 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 232' ' ' ASP . 4.4 t -84.06 156.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.013 -1.055 . . . . 2.3100000000000001 109.764 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.05 169.75 16.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.71999999999999997 109.611 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.3 mmtt -119.36 157.25 28.54 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.644 -0.873 . . . . 1.96 108.644 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.12 174.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.55000000000000004 109.296 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.7 155.76 68.72 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.545 1.497 . . . . 0.46999999999999997 110.693 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.67 171.91 13.79 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.925 -0.769 . . . . 1.05 108.925 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -93.91 137.39 33.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.049 -1.032 . . . . 3.1899999999999999 109.707 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.12 121.4 31.41 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.594 -0.691 . . . . 1.0900000000000001 109.28 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.16 -68.94 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.309 -0.87 . . . . 1.1799999999999999 110.499 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -95.42 147.35 23.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.002 -1.061 . . . . 0.34000000000000002 110.353 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.3 119.42 7.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.374 -0.829 . . . . 2.79 108.963 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.0 -109.2 0.32 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.784 -1.198 . . . . 0.28999999999999998 110.397 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.88 -150.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -1.12 . . . . 1.5600000000000001 109.488 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.5 56.18 2.47 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.196 -1.562 . . . . 0.28999999999999998 109.196 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.49 146.72 22.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.364 -1.08 . . . . 1.0700000000000001 109.643 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.05 121.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.672 -0.862 . . . . 1.0900000000000001 108.672 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 59.4 t -84.73 132.16 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.375 -0.972 . . . . 1.0700000000000001 108.375 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -137.96 178.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 1.04 109.977 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.404 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.1 tt0 -142.33 110.2 5.86 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.631 -0.877 . . . . 2.3399999999999999 108.631 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -91.12 -78.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.357 -1.349 . . . . 1.1799999999999999 107.357 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.59 -131.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.762 -1.569 . . . . 2.4700000000000002 106.762 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 58.8 m -105.35 54.5 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.114 -1.069 . . . . 1.8700000000000001 108.114 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.8 m-20 -157.08 127.33 6.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 1.1200000000000001 109.312 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.424 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 79.8 mt -94.18 134.26 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 1.1499999999999999 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.22 172.53 12.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 2.6299999999999999 109.812 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.38 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 1.0800000000000001 109.404 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.62 131.75 16.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.798 . . . . 1.0700000000000001 108.909 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.49 142.98 92.36 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 N-CA-C 109.545 -0.983 . . . . 0.48999999999999999 109.545 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -55.84 -34.69 65.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 3.5800000000000001 108.641 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -65.35 -10.83 36.33 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.666 -0.697 . . . . 4.3600000000000003 110.76 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.73 17.68 12.71 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.278 -1.008 . . . . 2.5800000000000001 108.278 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.1 168.03 20.58 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.316 -0.624 . . . . 1.05 109.316 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -140.47 126.85 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.205 -0.934 . . . . 2.2599999999999998 109.171 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.3 mm -87.54 108.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.242 -0.911 . . . . 1.1799999999999999 109.486 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.18 152.92 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.524 -0.917 . . . . 1.28 108.524 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.4 ' O ' ' OD1' ' A' ' 270' ' ' ASP . 57.3 ttt180 -91.54 143.65 26.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 4.1799999999999997 109.934 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 269' ' ' ARG . 3.5 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.024 -0.989 . . . . 2.0499999999999998 109.484 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.4 -0.593 . . . . 4.1900000000000004 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 14.4 tt -81.07 132.56 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 2.5899999999999999 109.472 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -89.16 -142.73 0.14 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.74 -0.837 . . . . 2.5899999999999999 108.74 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -90.73 100.15 13.06 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.016 -1.052 . . . . 2.0099999999999998 108.708 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.03 141.06 51.1 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.63 -0.668 . . . . 0.81999999999999995 109.796 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -113.31 157.75 21.41 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.559 -1.274 . . . . 3.7799999999999998 107.559 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.1 143.83 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.022 -1.049 . . . . 1.0600000000000001 110.776 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.83 157.77 20.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.667 -1.235 . . . . 0.92000000000000004 107.667 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 15.0 p90 -157.4 147.38 20.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.292 . . . . 1.01 110.161 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.62 142.42 27.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.104 -0.997 . . . . 3.3900000000000001 109.502 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -92.41 166.46 12.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.408 -0.808 . . . . 2.23 109.394 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.6 p -85.68 -10.25 55.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.219 -0.925 . . . . 2.3300000000000001 109.651 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.37 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.099 -1.0 . . . . 4.1900000000000004 109.442 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 3.3 p30 -159.23 127.88 3.0 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.083 -1.011 . . . . 2.1600000000000001 109.195 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -67.56 9.34 0.34 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.74 0.96 . . . . 1.3999999999999999 110.364 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 4.4 t -84.05 156.1 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.967 -1.083 . . . . 2.3100000000000001 109.809 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -72.97 169.74 16.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.371 -0.83 . . . . 0.72999999999999998 109.666 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mmtt -119.4 157.2 28.69 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.7 -0.852 . . . . 1.96 108.7 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.14 174.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.337 -1.505 . . . . 0.56000000000000005 109.337 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -67.65 155.8 68.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.5 1.466 . . . . 0.46999999999999997 110.648 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.61 171.95 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.902 -0.777 . . . . 1.05 108.902 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -93.94 137.44 33.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.133 -0.979 . . . . 3.1899999999999999 109.684 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.22 121.39 31.47 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.542 -0.724 . . . . 1.0900000000000001 109.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.17 -68.97 0.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.235 -0.916 . . . . 1.1799999999999999 110.462 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -95.38 147.41 23.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.056 -1.027 . . . . 0.34999999999999998 110.339 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.33 119.43 7.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.802 . . . . 2.7999999999999998 109.004 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.05 -109.25 0.32 Allowed Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.738 -1.22 . . . . 0.29999999999999999 110.336 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.9 -150.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -1.137 . . . . 1.5600000000000001 109.497 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.47 56.23 2.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.274 -1.531 . . . . 0.28999999999999998 109.274 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.5 146.82 22.74 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.342 -1.093 . . . . 1.0700000000000001 109.559 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.12 121.13 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.601 -0.889 . . . . 1.0900000000000001 108.601 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 60.3 t -84.81 132.06 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 1.0800000000000001 108.416 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -137.8 178.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.454 -0.779 . . . . 1.04 110.035 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.403 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.1 tt0 -142.31 110.28 5.89 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.662 -0.866 . . . . 2.3399999999999999 108.662 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -91.26 -78.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.307 -1.368 . . . . 1.1799999999999999 107.307 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -80.53 -131.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.731 -1.581 . . . . 2.4700000000000002 106.731 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 58.8 m -105.33 54.52 0.7 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.208 -1.034 . . . . 1.8600000000000001 108.208 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.8 m-20 -157.06 127.33 6.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.474 -0.766 . . . . 1.1200000000000001 109.242 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.417 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 79.4 mt -94.11 134.2 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 1.1499999999999999 109.51 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.08 172.48 12.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.324 -0.86 . . . . 2.6400000000000001 109.843 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.35 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.459 -0.776 . . . . 1.0800000000000001 109.407 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.64 131.8 16.13 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 1.0800000000000001 108.918 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.4 142.93 92.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 N-CA-C 109.506 -0.998 . . . . 0.48999999999999999 109.506 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -55.8 -34.76 65.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.853 -1.155 . . . . 3.5800000000000001 108.717 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -65.27 -10.92 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.649 -0.705 . . . . 4.3600000000000003 110.724 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.7 17.76 12.72 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.257 -1.016 . . . . 2.5800000000000001 108.257 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.07 168.1 20.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.259 -0.645 . . . . 1.05 109.259 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -140.55 126.82 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.249 -0.907 . . . . 2.2599999999999998 109.154 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.1 mm -87.51 108.38 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.887 . . . . 1.1799999999999999 109.556 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.23 152.8 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.49 -0.93 . . . . 1.27 108.49 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -91.4 143.67 26.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 4.1799999999999997 109.94 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.966 -1.016 . . . . 2.0499999999999998 109.541 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 219' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.255 0.55 . . . . 4.1799999999999997 109.527 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.92 104.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -0.889 . . . . 2.5899999999999999 108.799 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -85.02 -125.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 2.6000000000000001 109.468 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -93.48 104.27 16.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.236 -0.915 . . . . 2.0099999999999998 109.001 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -128.18 132.77 48.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.105 -0.702 . . . . 0.81999999999999995 109.105 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.37 159.47 15.7 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.382 -0.97 . . . . 3.79 108.382 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.83 141.68 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.156 -0.965 . . . . 1.05 110.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.68 151.28 27.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.55 -1.278 . . . . 0.92000000000000004 107.55 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.0 p90 -156.43 151.21 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.651 -1.281 . . . . 1.01 110.441 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -92.72 141.68 28.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.589 -0.694 . . . . 3.3999999999999999 109.577 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 5.0 p30 -93.79 165.72 12.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.423 -0.798 . . . . 2.23 109.044 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.99 -0.06 47.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 2.3199999999999998 109.162 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 10.1 mmm180 -90.01 -20.96 22.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.387 -0.82 . . . . 4.1799999999999997 109.205 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.7 m-20 -161.03 134.05 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.777 -0.823 . . . . 2.1600000000000001 108.777 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.73 8.86 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 120.727 0.951 . . . . 1.3899999999999999 110.208 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.2 t -84.06 159.18 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.034 -1.041 . . . . 2.3100000000000001 109.921 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.09 164.88 26.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 0.71999999999999997 108.959 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 237' ' ' GLY . 32.5 tttp -120.01 158.25 27.17 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.395 -0.816 . . . . 1.96 109.652 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.61 165.83 0.03 OUTLIER Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.283 -1.127 . . . . 0.55000000000000004 110.283 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.97 163.25 36.42 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.705 1.603 . . . . 0.46999999999999997 110.452 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.17 178.45 7.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 1.05 109.187 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.09 137.19 35.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.154 -0.966 . . . . 3.1899999999999999 109.393 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.9 tp -87.88 124.64 33.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.413 -0.805 . . . . 1.0900000000000001 109.238 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.58 -74.01 0.62 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.459 -0.776 . . . . 1.1799999999999999 109.99 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.532 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.0 t90 -92.32 141.69 28.27 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.34000000000000002 109.719 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.85 116.91 7.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.906 . . . . 2.79 109.138 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.13 -105.04 0.23 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.905 -1.14 . . . . 0.28999999999999998 110.308 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -62.39 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.104 . . . . 1.5600000000000001 109.877 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 49.86 2.79 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.773 -1.331 . . . . 0.28999999999999998 109.773 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.76 154.11 39.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -1.126 . . . . 1.0700000000000001 108.696 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.06 122.79 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 1.0900000000000001 109.747 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.72 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.963 -1.125 . . . . 1.0700000000000001 107.963 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.43 174.79 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 1.04 110.033 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.4 109.4 5.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.147 -1.057 . . . . 2.3399999999999999 108.147 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.43 -79.75 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 1.1799999999999999 107.574 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.5 -128.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.636 -1.616 . . . . 2.4700000000000002 106.636 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 13.0 p -105.89 53.38 0.71 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.284 -1.006 . . . . 1.8700000000000001 108.284 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.7 m-20 -155.69 129.85 8.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 1.1200000000000001 109.487 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.418 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.6 mt -95.11 139.86 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.461 -0.774 . . . . 1.1499999999999999 110.07 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -140.32 162.87 34.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.416 -0.802 . . . . 2.6299999999999999 109.462 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.97 141.8 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.215 -0.928 . . . . 1.0800000000000001 108.857 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.83 130.77 18.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.375 -0.828 . . . . 1.0700000000000001 109.452 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.66 141.37 97.57 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.688 -0.928 . . . . 0.48999999999999999 109.688 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.26 -29.48 69.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 3.5800000000000001 109.727 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -70.04 -12.0 61.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.865 . . . . 4.3600000000000003 111.042 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.83 28.06 8.15 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.153 -0.967 . . . . 2.5800000000000001 109.273 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.09 168.87 18.81 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.801 -0.814 . . . . 1.05 108.801 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.07 126.94 19.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.224 -0.922 . . . . 2.2599999999999998 109.392 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.52 109.73 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.343 -0.848 . . . . 1.1799999999999999 109.67 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.31 149.41 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.394 -0.965 . . . . 1.28 108.394 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -90.41 144.91 25.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.856 . . . . 4.1799999999999997 109.806 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 2.0499999999999998 109.339 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' MET . . . . . 0.571 ' SD ' ' N ' ' B' ' 219' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.502 -0.555 . . . . 4.1900000000000004 109.502 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.98 104.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.329 -0.857 . . . . 2.5899999999999999 108.837 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.08 -125.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.988 . . . . 2.5899999999999999 109.415 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -93.54 104.26 16.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.189 -0.944 . . . . 2.0099999999999998 109.032 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -128.23 132.86 48.76 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.81999999999999995 109.071 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -104.45 159.43 15.74 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.417 -0.957 . . . . 3.7799999999999998 108.417 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.8 141.67 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 1.0600000000000001 110.403 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.64 151.31 27.82 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.617 -1.253 . . . . 0.92000000000000004 107.617 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.1 p90 -156.46 151.23 25.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.752 -1.218 . . . . 1.01 110.454 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -92.76 141.62 28.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.569 -0.707 . . . . 3.3900000000000001 109.595 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 4.9 p30 -93.79 165.78 12.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.441 -0.787 . . . . 2.23 109.075 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.93 -0.24 47.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 2.3300000000000001 109.182 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 10.1 mmm180 -89.93 -21.01 22.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 4.1900000000000004 109.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.7 m-20 -161.08 134.05 4.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.787 -0.82 . . . . 2.1600000000000001 108.787 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.61 8.69 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 120.765 0.977 . . . . 1.3999999999999999 110.169 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.3 t -84.01 159.17 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.009 -1.057 . . . . 2.3100000000000001 109.958 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.04 164.95 26.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.45 -0.781 . . . . 0.72999999999999998 109.146 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' B' ' 237' ' ' GLY . 32.6 tttp -120.0 158.24 27.19 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.398 -0.814 . . . . 1.96 109.607 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.55 165.76 0.02 OUTLIER Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.296 -1.122 . . . . 0.56000000000000005 110.296 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.95 163.26 36.38 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.658 1.572 . . . . 0.46999999999999997 110.583 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.2 178.38 7.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 1.05 109.235 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.02 137.1 35.57 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 3.1899999999999999 109.417 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.74 124.64 33.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.342 -0.849 . . . . 1.0900000000000001 109.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.65 -73.93 0.63 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.465 -0.772 . . . . 1.1799999999999999 109.983 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.418 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.0 t90 -92.28 141.6 28.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.2 -0.937 . . . . 0.34999999999999998 109.844 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.76 117.04 7.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 2.7999999999999998 109.047 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.17 -105.03 0.23 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.876 -1.155 . . . . 0.29999999999999999 110.241 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -62.53 -158.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 1.5600000000000001 109.819 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.56 49.85 2.78 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.859 -1.296 . . . . 0.28999999999999998 109.859 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.04 38.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -1.086 . . . . 1.0700000000000001 108.614 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.04 122.83 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 1.0900000000000001 109.752 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.71 138.42 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.93 -1.137 . . . . 1.0800000000000001 107.93 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.9 pt -141.54 174.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 1.04 109.956 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.38 109.32 5.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.235 -1.024 . . . . 2.3399999999999999 108.235 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.4 -79.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.483 -1.303 . . . . 1.1799999999999999 107.483 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.51 -128.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.592 -1.633 . . . . 2.4700000000000002 106.592 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 13.0 p -105.8 53.21 0.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.267 -1.012 . . . . 1.8600000000000001 108.267 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.6 m-20 -155.63 129.89 8.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.435 -0.79 . . . . 1.1200000000000001 109.475 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.8 mt -95.13 139.83 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.434 -0.791 . . . . 1.1499999999999999 110.076 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -140.29 162.87 34.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.417 -0.802 . . . . 2.6400000000000001 109.491 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.93 141.84 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 1.0800000000000001 108.916 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.79 130.78 18.84 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 1.0800000000000001 109.444 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.72 141.39 97.7 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 N-CA-C 109.687 -0.928 . . . . 0.48999999999999999 109.687 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.17 -29.62 69.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 3.5800000000000001 109.68 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -69.96 -12.05 61.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 4.3600000000000003 111.117 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.77 28.08 8.14 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.08 -1.012 . . . . 2.5800000000000001 109.304 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.11 168.85 18.87 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.834 -0.802 . . . . 1.05 108.834 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.02 126.89 19.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.142 -0.974 . . . . 2.2599999999999998 109.369 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.49 109.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 1.1799999999999999 109.749 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.27 149.36 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.472 -0.936 . . . . 1.27 108.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -90.3 144.86 25.44 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.358 -0.839 . . . . 4.1799999999999997 109.879 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.014 -0.993 . . . . 2.0499999999999998 109.252 179.812 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.31 0.576 . . . . 4.1799999999999997 109.461 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 33.5 mm -85.26 140.02 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 2.5899999999999999 109.038 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -84.14 -137.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.084 -1.01 . . . . 2.6000000000000001 109.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -91.35 98.44 11.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 2.0099999999999998 109.038 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.43 131.87 38.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.563 -0.711 . . . . 0.81999999999999995 109.559 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.82 19.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.604 -1.258 . . . . 3.79 107.604 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -139.93 140.54 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 1.05 110.311 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.97 154.58 20.89 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.352 -1.351 . . . . 0.92000000000000004 107.352 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.8 p90 -155.34 153.34 30.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.55 -1.344 . . . . 1.01 110.645 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -96.03 133.24 40.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.448 -0.783 . . . . 3.3999999999999999 109.323 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -95.58 177.23 5.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 2.23 109.106 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 p -88.06 -11.63 46.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 2.3199999999999998 108.932 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 231' ' ' ARG . 11.3 mpt_? -81.49 -13.37 58.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 4.1799999999999997 109.124 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 15.6 p-10 -161.32 129.78 2.96 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.17 -0.956 . . . . 2.1600000000000001 109.552 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.13 0.62 4.92 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 N-CA-C 109.574 -0.972 . . . . 1.3899999999999999 109.574 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.44 160.83 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 2.3100000000000001 110.215 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -67.46 163.35 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.523 -0.917 . . . . 0.71999999999999997 108.523 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 40.7 tttp -119.95 164.79 15.54 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.267 -0.896 . . . . 1.96 109.748 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.02 169.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.458 -1.057 . . . . 0.55000000000000004 110.458 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.15 161.02 47.53 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.985 1.79 . . . . 0.46999999999999997 110.752 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.18 175.85 9.31 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.67 -0.863 . . . . 1.05 108.67 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -94.03 139.38 31.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.954 -1.091 . . . . 3.1899999999999999 109.127 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.9 tp -89.33 125.17 35.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.898 . . . . 1.0900000000000001 109.73 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.7 mt -117.49 -77.58 0.57 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.502 -0.749 . . . . 1.1799999999999999 110.719 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -93.36 136.74 33.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.993 -1.067 . . . . 0.34000000000000002 110.458 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.5 127.2 13.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.85 . . . . 2.79 109.249 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.64 -105.33 0.24 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.549 -1.42 . . . . 0.28999999999999998 109.549 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 245' ' ' GLY . 25.5 mt-10 -60.09 -154.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 1.5600000000000001 109.149 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.0 45.97 2.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.922 -1.671 . . . . 0.28999999999999998 108.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.73 141.44 18.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.965 . . . . 1.0700000000000001 108.867 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.29 144.26 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.116 -0.99 . . . . 1.0900000000000001 108.931 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 147.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.101 -0.999 . . . . 1.0700000000000001 109.993 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.26 178.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.749 . . . . 1.04 109.488 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.531 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.4 tt0 -144.72 110.86 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.241 -1.022 . . . . 2.3399999999999999 108.241 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.94 -78.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.551 -1.277 . . . . 1.1799999999999999 107.551 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -139.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.713 -1.588 . . . . 2.4700000000000002 106.713 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 60.2 p -97.22 53.79 1.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.009 -1.108 . . . . 1.8700000000000001 108.009 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 2.6 m-20 -155.14 126.22 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.949 -0.76 . . . . 1.1200000000000001 108.949 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.531 ' CG1' HE21 ' A' ' 252' ' ' GLN . 41.3 mt -92.43 135.46 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 1.1499999999999999 109.488 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.85 169.93 16.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.426 -0.797 . . . . 2.6299999999999999 109.562 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.15 139.99 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 1.0800000000000001 109.532 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.6 126.75 18.27 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.826 -0.805 . . . . 1.0700000000000001 108.826 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.06 141.89 96.56 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 N-CA-C 110.039 -0.793 . . . . 0.48999999999999999 110.039 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.48 -34.09 66.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.315 -0.866 . . . . 3.5800000000000001 109.138 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -70.12 -8.2 47.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 4.3600000000000003 110.496 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.48 22.29 11.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.293 -0.879 . . . . 2.5800000000000001 109.113 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.16 33.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.54 -0.725 . . . . 1.05 109.067 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -139.06 132.01 29.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.309 -0.87 . . . . 2.2599999999999998 108.957 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.5 107.36 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.372 -0.83 . . . . 1.1799999999999999 109.579 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 36.8 mm -103.79 160.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.466 -0.771 . . . . 1.28 109.275 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.407 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -93.62 141.58 28.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.768 . . . . 4.1799999999999997 109.405 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 9.5 m-20 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 2.0499999999999998 109.446 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.219 0.533 . . . . 4.1900000000000004 109.632 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 33.5 mm -85.16 140.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 2.5899999999999999 109.019 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -84.19 -137.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 2.5899999999999999 109.642 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -91.33 98.53 11.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 2.0099999999999998 109.056 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.46 131.87 38.6 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.561 -0.712 . . . . 0.81999999999999995 109.454 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.9 19.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.572 -1.27 . . . . 3.7799999999999998 107.572 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -140.13 140.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.239 -0.913 . . . . 1.0600000000000001 110.236 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.17 154.55 21.03 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.317 -1.364 . . . . 0.92000000000000004 107.317 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.9 p90 -155.3 153.35 30.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.599 -1.313 . . . . 1.01 110.701 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -95.96 133.26 40.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.447 -0.783 . . . . 3.3900000000000001 109.34 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -95.6 177.27 5.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 2.23 109.102 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 4.5 p -88.17 -11.69 46.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.077 -1.014 . . . . 2.3300000000000001 108.857 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' B' ' 231' ' ' ARG . 11.3 mpt_? -81.32 -13.54 58.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 4.1900000000000004 109.131 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 16.0 p-10 -161.24 129.57 2.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.196 -0.94 . . . . 2.1600000000000001 109.555 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.9 0.45 4.99 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 N-CA-C 109.586 -0.967 . . . . 1.3999999999999999 109.586 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 45.1 t -85.44 160.81 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 2.3100000000000001 110.255 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -67.38 163.46 20.72 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.521 -0.918 . . . . 0.72999999999999998 108.521 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 237' ' ' GLY . 40.9 tttp -119.94 164.65 15.75 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.306 -0.871 . . . . 1.96 109.705 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.14 169.53 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.447 -1.061 . . . . 0.56000000000000005 110.447 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.29 161.08 47.3 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.893 1.729 . . . . 0.46999999999999997 110.695 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 175.88 9.28 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.676 -0.861 . . . . 1.05 108.676 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -93.85 139.4 30.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.017 -1.052 . . . . 3.1899999999999999 109.224 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.8 tp -89.46 125.15 35.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.182 -0.949 . . . . 1.0900000000000001 109.724 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 23.5 mt -117.53 -77.53 0.57 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.486 -0.759 . . . . 1.1799999999999999 110.747 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -93.4 136.66 33.46 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.16 -0.962 . . . . 0.34999999999999998 110.408 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.33 127.27 13.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.228 -0.92 . . . . 2.7999999999999998 109.274 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.66 -105.39 0.24 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.601 -1.4 . . . . 0.29999999999999999 109.601 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 245' ' ' GLY . 25.6 mt-10 -60.03 -154.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -1.108 . . . . 1.5600000000000001 109.121 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 45.93 2.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.961 -1.656 . . . . 0.28999999999999998 108.961 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.5 19.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.969 . . . . 1.0700000000000001 108.88 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.46 144.1 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -0.997 . . . . 1.0900000000000001 108.925 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.46 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 1.0800000000000001 110.008 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.27 178.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 1.04 109.507 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.532 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -144.56 110.76 5.5 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 2.3399999999999999 108.31 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -88.91 -78.89 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.525 -1.287 . . . . 1.1799999999999999 107.525 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' B' ' 254' ' ' ASN . 1.0 OUTLIER -81.82 -139.01 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.812 -1.551 . . . . 2.4700000000000002 106.812 177.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 60.2 p -97.17 53.78 1.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.005 -1.109 . . . . 1.8600000000000001 108.005 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' B' ' 255' ' ' SER . 2.6 m-20 -155.14 126.15 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.983 -0.747 . . . . 1.1200000000000001 108.983 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CG1' HE21 ' B' ' 252' ' ' GLN . 41.1 mt -92.33 135.48 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 1.1499999999999999 109.508 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.93 169.88 17.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.586 -0.696 . . . . 2.6400000000000001 109.485 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.17 140.07 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.419 -0.801 . . . . 1.0800000000000001 109.466 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.64 126.86 18.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.73 -0.841 . . . . 1.0800000000000001 108.73 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.22 141.97 97.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 110.035 -0.794 . . . . 0.48999999999999999 110.035 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -56.47 -34.13 66.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.257 -0.902 . . . . 3.5800000000000001 109.153 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.99 -8.29 47.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.43 -0.793 . . . . 4.3600000000000003 110.514 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.3 22.12 11.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.285 -0.884 . . . . 2.5800000000000001 109.137 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.63 163.21 33.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.089 -0.708 . . . . 1.05 109.089 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -139.16 131.98 29.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.281 -0.887 . . . . 2.2599999999999998 108.92 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.48 107.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 1.1799999999999999 109.487 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 37.1 mm -103.84 160.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 1.27 109.16 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.426 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.2 OUTLIER -93.74 141.54 28.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.487 -0.758 . . . . 4.1799999999999997 109.438 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.01 -1.056 . . . . 2.0499999999999998 109.389 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.46 -0.57 . . . . 4.1799999999999997 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.69 107.24 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.079 0.942 . . . . 2.5899999999999999 108.476 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -92.02 -131.85 0.12 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.594 -1.316 . . . . 2.6000000000000001 109.744 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.3 m-20 -95.37 109.85 21.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.202 -0.936 . . . . 2.0099999999999998 109.441 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -133.38 153.2 51.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.446 -0.783 . . . . 0.81999999999999995 109.024 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -117.55 149.81 40.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.737 -1.208 . . . . 3.79 107.737 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.02 139.98 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.864 . . . . 1.05 110.085 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -109.22 154.45 22.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.499 -1.297 . . . . 0.92000000000000004 107.499 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 16.3 p90 -157.01 160.24 38.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.613 -1.304 . . . . 1.01 110.399 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -93.2 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 3.3999999999999999 109.844 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.72 171.88 8.71 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.833 -0.802 . . . . 2.23 108.833 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.9 p -89.45 -9.54 49.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 2.3199999999999998 109.458 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -87.04 -16.81 34.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 4.1799999999999997 109.632 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -162.5 134.1 3.91 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 2.1600000000000001 108.782 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.84 12.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 120.988 1.125 . . . . 1.3899999999999999 110.98 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 8.6 p -84.64 161.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.699 -1.251 . . . . 2.3100000000000001 110.029 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.401 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 98.0 m95 -75.57 163.34 27.46 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.019 -0.734 . . . . 0.71999999999999997 109.019 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.42 -162.51 0.92 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.299 -0.875 . . . . 1.96 108.764 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.19 176.51 51.62 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.639 -1.385 . . . . 0.55000000000000004 109.639 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -68.96 157.7 60.84 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.675 1.583 . . . . 0.46999999999999997 110.528 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.96 170.29 16.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.746 -0.835 . . . . 1.05 108.746 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.58 142.44 27.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 3.1899999999999999 109.702 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.27 119.32 30.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.73 -0.606 . . . . 1.0900000000000001 109.926 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -109.71 -72.63 0.71 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.331 -0.856 . . . . 1.1799999999999999 109.814 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.14 146.15 23.95 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.153 -0.967 . . . . 0.34000000000000002 110.463 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -147.28 120.83 9.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.443 -0.785 . . . . 2.79 108.917 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -107.08 0.27 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.794 -1.194 . . . . 0.28999999999999998 110.477 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -69.22 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 1.5600000000000001 110.126 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.32 46.17 2.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.369 -1.493 . . . . 0.28999999999999998 109.369 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.15 33.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.495 -1.003 . . . . 1.0700000000000001 108.525 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.65 138.3 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.06 -1.025 . . . . 1.0900000000000001 109.784 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.76 139.39 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.385 -0.968 . . . . 1.0700000000000001 108.385 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.2 pt -141.53 178.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 1.04 110.059 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.36 111.18 5.73 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.779 -0.823 . . . . 2.3399999999999999 108.779 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.78 -79.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.483 -1.302 . . . . 1.1799999999999999 107.483 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -79.38 -131.33 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.914 -1.513 . . . . 2.4700000000000002 106.914 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.432 ' N ' ' ND2' ' A' ' 254' ' ' ASN . 12.7 p -105.61 54.8 0.69 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.372 -0.973 . . . . 1.8700000000000001 108.372 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -156.31 126.32 6.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 1.1200000000000001 109.034 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -92.68 135.24 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 1.1499999999999999 109.448 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.97 168.64 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 2.6299999999999999 109.662 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.98 142.26 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.324 -0.86 . . . . 1.0800000000000001 109.332 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 33.5 t -135.89 131.17 18.89 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.437 -0.789 . . . . 1.0700000000000001 109.086 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.29 146.43 96.53 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 120.72 0.947 . . . . 0.48999999999999999 110.458 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -59.25 -32.34 69.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.564 -0.902 . . . . 3.5800000000000001 108.564 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.584 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.9 mtt-85 -70.68 -9.18 56.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.935 . . . . 4.3600000000000003 110.853 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.56 21.09 12.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.176 -0.952 . . . . 2.5800000000000001 109.776 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.25 22.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.412 -0.805 . . . . 1.05 109.959 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -140.5 124.93 17.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.58 -0.896 . . . . 2.2599999999999998 108.58 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.53 112.47 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.133 -0.979 . . . . 1.1799999999999999 110.159 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.94 147.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.74 -1.207 . . . . 1.28 107.74 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.58 140.72 29.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 4.1799999999999997 109.767 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.069 -0.967 . . . . 2.0499999999999998 109.478 179.706 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 4.1900000000000004 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.7 107.19 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.49 -0.93 . . . . 2.5899999999999999 108.49 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -91.96 -131.87 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.668 -1.27 . . . . 2.5899999999999999 109.712 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -95.4 109.82 21.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 2.0099999999999998 109.413 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -133.34 153.23 51.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.773 . . . . 0.81999999999999995 109.032 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -117.63 149.77 40.14 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.695 -1.224 . . . . 3.7799999999999998 107.695 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.03 139.89 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.844 . . . . 1.0600000000000001 110.062 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.19 154.43 22.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.543 -1.28 . . . . 0.92000000000000004 107.543 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 16.0 p90 -156.93 160.22 38.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.804 -1.185 . . . . 1.01 110.387 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -93.16 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.744 . . . . 3.3900000000000001 109.839 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.79 171.91 8.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 2.23 108.846 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 30.5 p -89.5 -9.56 49.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 2.3300000000000001 109.436 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.94 -16.93 34.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 4.1900000000000004 109.693 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.4 m-20 -162.41 134.0 3.91 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.93 . . . . 2.1600000000000001 108.811 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.8 12.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 120.873 1.049 . . . . 1.3999999999999999 110.957 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.522 ' H ' ' C ' ' B' ' 232' ' ' ASP . 8.6 p -84.68 161.3 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.677 -1.264 . . . . 2.3100000000000001 109.976 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.401 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 97.9 m95 -75.4 163.23 27.65 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.077 -0.712 . . . . 0.72999999999999998 109.077 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.33 -162.63 0.92 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.289 -0.882 . . . . 1.96 108.819 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.04 176.55 51.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.76 -1.336 . . . . 0.56000000000000005 109.76 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -69.12 157.6 61.02 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.74 1.627 . . . . 0.46999999999999997 110.515 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.95 170.3 16.28 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.76 -0.83 . . . . 1.05 108.76 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.56 142.51 27.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.038 -1.039 . . . . 3.1899999999999999 109.647 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.39 119.35 30.6 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.656 -0.653 . . . . 1.0900000000000001 109.797 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.65 -72.69 0.71 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.317 -0.865 . . . . 1.1799999999999999 109.851 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.17 146.17 23.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.158 -0.964 . . . . 0.34999999999999998 110.411 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -147.29 120.83 9.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.398 -0.814 . . . . 2.7999999999999998 108.866 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.79 -107.01 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.711 -1.233 . . . . 0.29999999999999999 110.439 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.33 -153.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -1.027 . . . . 1.5600000000000001 110.125 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.29 46.06 2.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.416 -1.473 . . . . 0.28999999999999998 109.416 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.07 151.18 34.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.499 -1.0 . . . . 1.0700000000000001 108.487 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.7 m -146.58 138.25 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 1.0900000000000001 109.785 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.73 139.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.395 -0.965 . . . . 1.0800000000000001 108.395 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.52 178.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 1.04 110.055 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.48 111.17 5.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.766 -0.828 . . . . 2.3399999999999999 108.766 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.8 -79.84 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.47 -1.308 . . . . 1.1799999999999999 107.47 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 255' ' ' SER . 0.3 OUTLIER -79.37 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.911 -1.514 . . . . 2.4700000000000002 106.911 177.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.433 ' N ' ' ND2' ' B' ' 254' ' ' ASN . 12.8 p -105.52 54.82 0.69 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.335 -0.987 . . . . 1.8600000000000001 108.335 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -156.31 126.33 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 1.1200000000000001 109.064 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.6 mt -92.68 135.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.297 -0.877 . . . . 1.1499999999999999 109.461 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -138.99 168.56 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.865 . . . . 2.6400000000000001 109.677 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.94 142.36 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.397 -0.814 . . . . 1.0800000000000001 109.283 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.92 131.17 18.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.373 -0.83 . . . . 1.0800000000000001 109.179 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.3 146.53 96.32 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 120.692 0.928 . . . . 0.48999999999999999 110.412 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -59.34 -32.29 69.96 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.61 -0.885 . . . . 3.5800000000000001 108.61 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.9 mtt-85 -70.63 -9.18 56.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.271 -0.893 . . . . 4.3600000000000003 110.812 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.47 20.91 12.34 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.243 -0.911 . . . . 2.5800000000000001 109.769 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.15 167.25 22.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.439 -0.788 . . . . 1.05 109.9 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -140.56 124.89 17.67 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.61 -0.885 . . . . 2.2599999999999998 108.61 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.46 112.37 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.235 -0.916 . . . . 1.1799999999999999 110.22 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.95 147.12 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.638 -1.245 . . . . 1.27 107.638 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.62 140.79 29.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 4.1799999999999997 109.741 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.997 -1.002 . . . . 2.0499999999999998 109.353 179.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.305 0.574 . . . . 4.1799999999999997 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.88 130.13 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 2.5899999999999999 108.994 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.63 -134.41 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.063 . . . . 2.6000000000000001 109.42 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.02 113.82 25.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.851 . . . . 2.0099999999999998 108.988 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.2 135.28 40.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.389 -0.819 . . . . 0.81999999999999995 109.299 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 84.6 mtt180 -103.47 157.98 16.66 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.839 -1.171 . . . . 3.79 107.839 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.33 138.68 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.026 -1.046 . . . . 1.05 110.646 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -111.03 151.87 27.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.724 -1.213 . . . . 0.92000000000000004 107.724 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.0 p90 -158.3 154.65 27.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.671 -1.268 . . . . 1.01 110.376 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.05 152.24 18.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.534 -0.729 . . . . 3.3999999999999999 109.651 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.67 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 2.23 108.82 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 58.0 m -79.25 -2.83 43.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.996 . . . . 2.3199999999999998 109.333 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.89 20.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.299 -0.876 . . . . 4.1799999999999997 109.844 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.3 m-20 -162.87 144.51 7.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.1600000000000001 109.067 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.08 15.75 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.061 1.174 . . . . 1.3899999999999999 110.643 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.522 ' H ' ' C ' ' A' ' 232' ' ' ASP . 33.9 m -83.24 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.799 -1.188 . . . . 2.3100000000000001 110.006 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -63.97 164.84 9.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.71999999999999997 109.358 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.2 tttp -119.41 158.07 26.93 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.38 -0.825 . . . . 1.96 108.893 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.01 165.38 0.02 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.281 -1.127 . . . . 0.55000000000000004 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.2 157.67 58.66 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.552 1.501 . . . . 0.46999999999999997 110.289 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.32 169.02 18.53 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.927 -0.768 . . . . 1.05 108.927 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.22 142.72 26.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 3.1899999999999999 109.334 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.0 tp -87.6 128.44 35.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.491 -0.756 . . . . 1.0900000000000001 110.179 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.0 -76.15 0.58 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.36 -0.837 . . . . 1.1799999999999999 109.749 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -93.07 142.6 27.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.154 -0.966 . . . . 0.34000000000000002 110.121 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.66 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.285 -0.884 . . . . 2.79 108.744 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.35 -107.32 0.28 Allowed Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.792 -1.194 . . . . 0.28999999999999998 110.184 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.8 -150.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 1.5600000000000001 109.644 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 49.98 3.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.354 -1.498 . . . . 0.28999999999999998 109.354 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.94 150.15 33.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.389 -1.065 . . . . 1.0700000000000001 108.822 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.52 129.66 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 1.0900000000000001 109.758 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 95.4 t -93.41 134.18 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.45 -0.944 . . . . 1.0700000000000001 108.45 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.98 178.63 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 1.04 109.583 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.484 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.2 tt0 -144.84 111.24 5.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.39 -0.819 . . . . 2.3399999999999999 109.029 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.99 -82.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.108 -1.441 . . . . 1.1799999999999999 107.108 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -78.85 -138.82 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.733 -1.58 . . . . 2.4700000000000002 106.733 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.1 m -98.05 56.25 1.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.989 -1.07 . . . . 1.8700000000000001 108.423 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -156.15 125.75 6.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.735 . . . . 1.1200000000000001 109.038 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.484 ' CG1' HE21 ' A' ' 252' ' ' GLN . 80.6 mt -93.06 134.96 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.6 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.31 165.21 26.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.444 -0.785 . . . . 2.6299999999999999 109.746 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.85 139.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 1.0800000000000001 109.743 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.35 130.57 17.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 108.702 -0.851 . . . . 1.0700000000000001 108.702 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.61 146.88 73.64 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.613 -0.957 . . . . 0.48999999999999999 109.613 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -65.16 -32.88 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 3.5800000000000001 109.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -69.97 -4.89 22.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 4.3600000000000003 110.826 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.72 16.14 13.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.283 -0.885 . . . . 2.5800000000000001 109.051 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.8 172.29 13.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.627 -0.671 . . . . 1.05 109.426 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -139.54 129.91 25.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.408 -0.808 . . . . 2.2599999999999998 109.231 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.2 mm -88.49 106.61 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 1.1799999999999999 109.727 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.01 156.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.339 -0.851 . . . . 1.28 108.849 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -91.08 147.42 23.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.289 -0.882 . . . . 4.1799999999999997 109.219 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 5.7 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.946 -1.026 . . . . 2.0499999999999998 109.466 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.368 0.604 . . . . 4.1900000000000004 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.87 130.11 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.316 -0.865 . . . . 2.5899999999999999 109.001 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.61 -134.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.01 -1.056 . . . . 2.5899999999999999 109.394 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -94.99 113.76 25.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.348 -0.845 . . . . 2.0099999999999998 108.999 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -135.2 135.17 40.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.421 -0.799 . . . . 0.81999999999999995 109.329 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 84.4 mtt180 -103.3 157.94 16.67 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.834 -1.173 . . . . 3.7799999999999998 107.834 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.4 t -142.3 138.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.106 -0.996 . . . . 1.0600000000000001 110.622 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.98 151.99 27.32 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.723 -1.214 . . . . 0.92000000000000004 107.723 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.2 p90 -158.39 154.68 27.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.709 -1.244 . . . . 1.01 110.344 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.0 152.16 18.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 3.3900000000000001 109.706 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.71 13.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.372 -0.83 . . . . 2.23 108.771 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 57.7 m -79.35 -2.72 42.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 2.3300000000000001 109.263 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.82 20.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 4.1900000000000004 109.894 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.2 m-20 -162.93 144.43 7.75 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.044 -1.035 . . . . 2.1600000000000001 109.065 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.9 15.54 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.236 1.291 . . . . 1.3999999999999999 110.677 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' B' ' 232' ' ' ASP . 33.9 m -83.18 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 2.3100000000000001 110.05 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -64.04 164.77 10.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.247 -0.908 . . . . 0.72999999999999998 109.427 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.0 tttp -119.32 158.04 26.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.398 -0.814 . . . . 1.96 108.986 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.98 165.36 0.02 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.258 -1.137 . . . . 0.56000000000000005 110.258 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.23 157.65 58.84 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 121.526 1.484 . . . . 0.46999999999999997 110.225 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.35 169.05 18.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 1.05 108.96 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -93.31 142.71 27.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.064 -1.023 . . . . 3.1899999999999999 109.282 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.62 128.46 35.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.416 -0.802 . . . . 1.0900000000000001 110.232 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.03 -76.12 0.58 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.514 -0.741 . . . . 1.1799999999999999 109.711 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.01 142.57 27.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.124 -0.985 . . . . 0.34999999999999998 110.126 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.74 11.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.3 -0.875 . . . . 2.7999999999999998 108.747 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -107.33 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.771 -1.204 . . . . 0.29999999999999999 110.203 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.79 -150.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -1.041 . . . . 1.5600000000000001 109.727 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.17 49.93 3.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.319 -1.513 . . . . 0.28999999999999998 109.319 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.17 33.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -1.038 . . . . 1.0700000000000001 108.799 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 12.0 m -145.58 129.74 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.827 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 95.9 t -93.47 134.17 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.439 -0.948 . . . . 1.0800000000000001 108.439 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.2 pt -136.96 178.57 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 1.04 109.654 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.2 tt0 -144.83 111.24 5.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 2.3399999999999999 109.039 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -88.98 -81.89 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.199 -1.408 . . . . 1.1799999999999999 107.199 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -78.9 -138.9 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.674 -1.602 . . . . 2.4700000000000002 106.674 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.2 m -97.94 56.22 1.23 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.954 -1.091 . . . . 1.8600000000000001 108.494 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -156.16 125.75 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 1.1200000000000001 109.102 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' B' ' 252' ' ' GLN . 80.5 mt -93.08 134.92 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.933 . . . . 1.1499999999999999 109.617 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.26 165.32 26.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 2.6400000000000001 109.749 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.92 139.96 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.424 -0.797 . . . . 1.0800000000000001 109.696 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 83.9 t -137.43 130.57 17.07 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.645 -0.872 . . . . 1.0800000000000001 108.645 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.47 146.91 71.93 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.597 -0.963 . . . . 0.48999999999999999 109.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -65.36 -32.82 74.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 3.5800000000000001 109.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -69.93 -4.86 22.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 4.3600000000000003 110.867 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.84 16.33 13.49 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.258 -0.902 . . . . 2.5800000000000001 109.013 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.89 172.23 13.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 1.05 109.426 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -139.51 129.86 25.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 2.2599999999999998 109.288 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.44 106.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.277 -0.889 . . . . 1.1799999999999999 109.778 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.02 156.33 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.385 -0.822 . . . . 1.27 108.909 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -91.02 147.4 23.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 4.1799999999999997 109.196 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.6 m-20 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.048 -1.032 . . . . 2.0499999999999998 109.477 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.342 0.591 . . . . 4.1799999999999997 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.7 mp -82.45 124.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 2.5899999999999999 108.932 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -83.73 -129.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 2.6000000000000001 109.488 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.36 98.75 11.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 2.0099999999999998 109.393 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.54 121.7 20.21 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.508 -0.745 . . . . 0.81999999999999995 109.213 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.17 165.29 12.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 3.79 108.294 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -143.39 143.02 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.138 -0.977 . . . . 1.05 110.676 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -113.02 148.29 35.44 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.631 -1.248 . . . . 0.92000000000000004 107.631 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.7 p90 -156.91 151.99 26.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.729 -1.232 . . . . 1.01 110.288 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -93.19 139.25 30.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 3.3999999999999999 109.456 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -94.19 166.79 11.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 2.23 109.224 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.4 p -79.76 -1.5 38.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 2.3199999999999998 109.105 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -87.24 -22.6 25.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 4.1799999999999997 109.531 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 234' ' ' VAL . 8.3 m-20 -163.07 135.05 3.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 2.1600000000000001 109.073 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.82 10.95 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 120.813 1.009 . . . . 1.3899999999999999 110.228 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 232' ' ' ASP . 25.0 t -85.63 160.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.905 -1.122 . . . . 2.3100000000000001 109.821 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -74.52 162.17 29.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.71999999999999997 108.765 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.3 tttm -119.44 153.06 35.83 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.296 -0.877 . . . . 1.96 109.385 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -41.26 163.57 0.01 OUTLIER Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.762 -0.935 . . . . 0.55000000000000004 110.762 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -66.6 159.44 50.87 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 121.638 1.559 . . . . 0.46999999999999997 110.612 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.78 177.18 8.08 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.008 -0.738 . . . . 1.05 109.008 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -94.39 136.49 34.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.029 -1.045 . . . . 3.1899999999999999 109.194 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.74 124.01 33.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 1.0900000000000001 109.619 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -113.3 -74.33 0.63 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.434 -0.791 . . . . 1.1799999999999999 110.208 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -91.26 143.26 26.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.264 -0.897 . . . . 0.34000000000000002 110.33 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.11 117.96 7.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.435 -0.791 . . . . 2.79 109.225 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.19 -108.7 0.3 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.944 -1.263 . . . . 0.28999999999999998 109.944 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -63.56 -154.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -1.145 . . . . 1.5600000000000001 109.416 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.37 52.02 3.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.603 -1.399 . . . . 0.28999999999999998 109.603 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.69 150.44 34.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.396 -1.061 . . . . 1.0700000000000001 108.967 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 122.85 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 1.0900000000000001 109.701 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 52.8 t -87.22 135.36 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.991 -1.114 . . . . 1.0700000000000001 107.991 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.63 178.33 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 1.04 110.52 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.433 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.7 tt0 -144.81 112.16 6.08 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.683 -0.858 . . . . 2.3399999999999999 108.683 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.93 -78.5 0.39 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.612 -1.255 . . . . 1.1799999999999999 107.612 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.688 HD21 ' H ' ' A' ' 255' ' ' SER . 8.7 t30 -80.53 -129.29 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.68 -1.6 . . . . 2.4700000000000002 106.68 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.688 ' H ' HD21 ' A' ' 254' ' ' ASN . 68.5 m -105.41 54.3 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.106 -1.072 . . . . 1.8700000000000001 108.106 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -156.19 128.41 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.519 -0.738 . . . . 1.1200000000000001 109.519 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.433 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -94.61 137.59 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 1.1499999999999999 109.488 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.32 166.65 23.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.386 -0.821 . . . . 2.6299999999999999 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.94 142.5 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 1.0800000000000001 109.112 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.2 t -139.28 129.52 14.5 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 1.0700000000000001 109.168 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.37 160.66 6.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.939 -0.831 . . . . 0.48999999999999999 109.939 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -84.8 -27.2 26.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 3.5800000000000001 110.249 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.32 -18.82 65.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.893 . . . . 4.3600000000000003 111.931 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -119.43 29.24 7.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.897 -1.127 . . . . 2.5800000000000001 109.616 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.4 164.41 25.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.517 -0.92 . . . . 1.05 108.517 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.12 124.62 19.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.248 -0.908 . . . . 2.2599999999999998 109.293 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.7 mm -88.52 110.41 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 1.1799999999999999 109.581 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.9 146.76 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.54 -0.911 . . . . 1.28 108.54 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.38 141.13 29.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 4.1799999999999997 109.612 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.953 -1.022 . . . . 2.0499999999999998 109.48 179.799 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.292 0.568 . . . . 4.1900000000000004 109.504 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' B' ' 220' ' ' ILE . 1.7 mp -82.4 124.73 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 2.5899999999999999 108.891 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -83.83 -129.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -0.922 . . . . 2.5899999999999999 109.474 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.47 98.83 11.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.275 -0.891 . . . . 2.0099999999999998 109.316 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -135.56 121.69 20.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.517 -0.739 . . . . 0.81999999999999995 109.158 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.16 165.2 12.17 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.339 -0.986 . . . . 3.7799999999999998 108.339 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.3 143.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 1.0600000000000001 110.702 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -113.19 148.18 35.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.604 -1.258 . . . . 0.92000000000000004 107.604 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.8 p90 -156.79 152.03 26.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.689 -1.257 . . . . 1.01 110.327 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -93.26 139.27 30.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.711 . . . . 3.3900000000000001 109.405 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -94.25 166.76 11.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.357 -0.839 . . . . 2.23 109.226 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.1 p -79.68 -1.45 38.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 2.3300000000000001 109.161 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -87.25 -22.62 25.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 4.1900000000000004 109.536 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' B' ' 234' ' ' VAL . 8.3 m-20 -163.03 135.1 3.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 2.1600000000000001 109.096 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.88 11.05 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.772 0.981 . . . . 1.3999999999999999 110.233 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' B' ' 232' ' ' ASP . 25.2 t -85.73 160.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.939 -1.1 . . . . 2.3100000000000001 109.907 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -74.34 162.17 29.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.72999999999999998 108.787 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.3 tttm -119.41 153.02 35.87 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.345 -0.847 . . . . 1.96 109.439 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.27 163.55 0.01 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.73 -0.948 . . . . 0.56000000000000005 110.73 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.53 159.39 50.92 Favored 'Trans proline' 0 N--CA 1.48 0.732 0 C-N-CA 121.654 1.569 . . . . 0.46999999999999997 110.629 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.2 8.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.985 -0.746 . . . . 1.05 108.985 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -94.28 136.51 34.5 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.08 -1.013 . . . . 3.1899999999999999 109.299 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.75 123.97 33.11 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 1.0900000000000001 109.608 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.25 -74.52 0.62 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.338 -0.851 . . . . 1.1799999999999999 110.206 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.16 143.29 26.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.197 -0.94 . . . . 0.34999999999999998 110.414 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.1 118.01 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 2.7999999999999998 109.214 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -108.71 0.3 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.962 -1.255 . . . . 0.29999999999999999 109.962 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.68 -154.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 1.5600000000000001 109.348 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.93 3.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.419 . . . . 0.28999999999999998 109.551 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.67 150.44 34.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.392 -1.063 . . . . 1.0700000000000001 108.948 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.66 122.79 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.209 -0.932 . . . . 1.0900000000000001 109.762 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 52.9 t -87.26 135.33 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.032 -1.099 . . . . 1.0800000000000001 108.032 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.58 178.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.21 -0.931 . . . . 1.04 110.606 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.434 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.6 tt0 -144.77 112.13 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.619 -0.882 . . . . 2.3399999999999999 108.619 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.05 -78.43 0.39 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.571 -1.27 . . . . 1.1799999999999999 107.571 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.689 HD21 ' H ' ' B' ' 255' ' ' SER . 8.8 t30 -80.54 -129.27 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.722 -1.584 . . . . 2.4700000000000002 106.722 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.689 ' H ' HD21 ' B' ' 254' ' ' ASN . 68.7 m -105.41 54.29 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.131 -1.063 . . . . 1.8600000000000001 108.131 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -156.12 128.43 7.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 1.1200000000000001 109.524 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.434 ' CG1' HE21 ' B' ' 252' ' ' GLN . 35.9 mt -94.56 137.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.259 -0.901 . . . . 1.1499999999999999 109.536 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.31 166.65 23.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.323 -0.86 . . . . 2.6400000000000001 109.701 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.0 142.43 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 1.0800000000000001 109.119 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 78.8 t -139.22 129.4 14.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.366 -0.834 . . . . 1.0800000000000001 109.258 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.3 160.54 6.49 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.616 0.877 . . . . 0.48999999999999999 109.962 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -84.73 -27.1 27.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 3.5800000000000001 110.313 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 4.3600000000000003 111.893 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -119.28 29.22 7.77 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.954 -1.091 . . . . 2.5800000000000001 109.727 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.34 164.47 25.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.538 -0.912 . . . . 1.05 108.538 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.2 124.59 19.22 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.25 -0.906 . . . . 2.2599999999999998 109.319 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.6 mm -88.6 110.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 1.1799999999999999 109.56 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.88 146.64 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.546 -0.909 . . . . 1.27 108.546 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.24 141.17 28.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.649 -0.657 . . . . 4.1799999999999997 109.605 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 2.0499999999999998 109.429 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.44 -0.578 . . . . 4.1799999999999997 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.22 120.0 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.403 -0.811 . . . . 2.5899999999999999 108.928 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.33 -132.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.016 -1.053 . . . . 2.6000000000000001 109.506 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.79 108.27 19.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 2.0099999999999998 109.176 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.85 124.41 23.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.411 -0.806 . . . . 0.81999999999999995 109.959 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 6.0 mpt_? -95.88 164.11 12.87 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.37 -1.345 . . . . 3.79 107.37 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.02 142.82 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.01 -1.056 . . . . 1.05 110.446 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -107.36 154.71 20.89 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.475 -1.306 . . . . 0.92000000000000004 107.475 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.0 p90 -156.04 157.24 35.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.484 -1.385 . . . . 1.01 111.112 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -101.15 146.08 27.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.464 0.65 . . . . 3.3999999999999999 109.421 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 230' ' ' SER . 37.0 t0 -98.74 -176.65 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 2.23 109.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.461 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 15.1 t -95.08 -14.14 24.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -0.808 . . . . 2.3199999999999998 109.678 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.28 -16.93 31.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.19 -0.944 . . . . 4.1799999999999997 109.857 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 234' ' ' VAL . 61.4 m-20 -160.4 128.82 2.94 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.147 -0.97 . . . . 2.1600000000000001 109.351 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.95 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 120.786 0.991 . . . . 1.3899999999999999 110.25 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 232' ' ' ASP . 5.6 m -82.32 127.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.869 -1.144 . . . . 2.3100000000000001 110.026 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.5 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.71999999999999997 109.257 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 237' ' ' GLY . 31.3 mtpt -119.85 166.46 13.26 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.425 -0.797 . . . . 1.96 109.418 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.99 170.17 0.02 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.287 -1.125 . . . . 0.55000000000000004 110.287 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -68.83 163.83 35.82 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 121.562 1.508 . . . . 0.46999999999999997 110.66 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.58 177.86 7.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 1.05 109.347 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.56 137.45 34.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.197 -0.939 . . . . 3.1899999999999999 109.39 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -88.67 123.86 33.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.565 -0.709 . . . . 1.0900000000000001 109.459 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.14 -72.66 0.68 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.289 -0.882 . . . . 1.1799999999999999 110.432 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.01 144.45 25.64 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.077 -1.014 . . . . 0.34000000000000002 110.497 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -145.7 119.37 9.17 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.767 -0.827 . . . . 2.79 108.767 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.88 -104.88 0.26 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.209 -1.156 . . . . 0.28999999999999998 110.209 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -73.04 -149.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -1.129 . . . . 1.5600000000000001 109.736 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.54 3.95 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.136 -1.586 . . . . 0.28999999999999998 109.136 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.49 150.95 34.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 1.0700000000000001 108.425 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.36 123.31 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.971 -1.08 . . . . 1.0900000000000001 109.827 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.94 133.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.399 -0.963 . . . . 1.0700000000000001 108.399 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.6 pt -138.81 178.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.348 -0.845 . . . . 1.04 109.987 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.485 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.7 tt0 -143.8 109.3 5.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.341 -0.985 . . . . 2.3399999999999999 108.341 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.1 -77.23 0.4 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.499 -1.297 . . . . 1.1799999999999999 107.499 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.87 -133.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.323 -1.732 . . . . 2.4700000000000002 106.323 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.3 t -105.03 56.48 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.071 -1.085 . . . . 1.8700000000000001 108.071 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -157.03 123.53 4.98 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.771 -0.826 . . . . 1.1200000000000001 108.771 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.485 ' CG1' HE21 ' A' ' 252' ' ' GLN . 39.2 mt -91.64 134.29 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -0.998 . . . . 1.1499999999999999 109.504 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.07 172.6 12.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.281 -0.887 . . . . 2.6299999999999999 110.014 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.13 140.6 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.547 -0.72 . . . . 1.0800000000000001 109.701 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 58.1 t -134.19 124.93 17.65 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.826 -0.805 . . . . 1.0700000000000001 108.826 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.16 139.55 90.89 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 120.584 0.856 . . . . 0.48999999999999999 110.331 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.76 -36.26 69.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 3.5800000000000001 109.758 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' A' ' 263' ' ' ARG . 2.3 tpt180 -67.12 -9.58 41.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 4.3600000000000003 110.693 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.494 ' CB ' ' NZ ' ' A' ' 264' ' ' LYS . 7.4 mtpm? -122.95 25.47 8.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.284 -0.885 . . . . 2.5800000000000001 108.859 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.33 32.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.462 -0.94 . . . . 1.05 108.462 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -139.34 132.09 29.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.116 -0.99 . . . . 2.2599999999999998 109.231 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.57 107.63 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 1.1799999999999999 109.297 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.51 157.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 1.28 109.308 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -91.7 137.31 32.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 4.1799999999999997 109.465 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.03 -0.986 . . . . 2.0499999999999998 109.451 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.2 ptt? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.17 -0.678 . . . . 4.1900000000000004 109.17 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.3 120.13 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.288 -0.883 . . . . 2.5899999999999999 108.933 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -84.25 -133.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 2.5899999999999999 109.534 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -92.93 108.3 19.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.173 -0.955 . . . . 2.0099999999999998 109.148 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.84 124.46 23.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.508 -0.745 . . . . 0.81999999999999995 109.957 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 6.0 mpt_? -95.89 164.19 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.298 -1.371 . . . . 3.7799999999999998 107.298 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 86.2 t -144.1 142.85 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.066 -1.021 . . . . 1.0600000000000001 110.408 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -107.37 154.77 20.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.384 -1.339 . . . . 0.92000000000000004 107.384 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.496 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.9 p90 -156.08 157.23 35.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.548 -1.345 . . . . 1.01 111.087 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -101.04 146.06 27.93 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.425 0.631 . . . . 3.3900000000000001 109.516 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' B' ' 230' ' ' SER . 36.9 t0 -98.64 -176.67 3.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 2.23 109.879 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' SER . . . . . 0.463 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 15.2 t -95.17 -13.88 24.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.415 -0.803 . . . . 2.3300000000000001 109.731 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.37 -16.97 31.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 4.1900000000000004 109.847 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' B' ' 234' ' ' VAL . 61.2 m-20 -160.39 128.82 2.95 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 2.1600000000000001 109.339 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.94 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.776 0.984 . . . . 1.3999999999999999 110.302 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' B' ' 232' ' ' ASP . 5.5 m -82.32 127.77 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.874 -1.141 . . . . 2.3100000000000001 110.014 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.44 0.22 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.72999999999999998 109.298 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' B' ' 237' ' ' GLY . 31.3 mtpt -119.71 166.44 13.21 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.371 -0.831 . . . . 1.96 109.431 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.15 170.3 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.303 -1.119 . . . . 0.56000000000000005 110.303 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -68.92 163.8 36.13 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.55 1.5 . . . . 0.46999999999999997 110.605 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.52 177.87 7.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 1.05 109.404 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.59 137.3 34.85 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.135 -0.978 . . . . 3.1899999999999999 109.389 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -88.51 123.87 33.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.544 -0.723 . . . . 1.0900000000000001 109.571 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.21 -72.53 0.69 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.381 -0.824 . . . . 1.1799999999999999 110.488 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.18 144.47 25.58 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.051 -1.031 . . . . 0.34999999999999998 110.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -145.69 119.41 9.2 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.818 -0.808 . . . . 2.7999999999999998 108.818 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.95 -104.92 0.26 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.148 -1.181 . . . . 0.29999999999999999 110.148 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -72.98 -149.44 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -1.143 . . . . 1.5600000000000001 109.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.61 3.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.19 -1.564 . . . . 0.28999999999999998 109.19 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.96 34.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -1.023 . . . . 1.0700000000000001 108.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.31 123.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.08 -1.012 . . . . 1.0900000000000001 109.81 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.82 133.66 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.392 -0.966 . . . . 1.0800000000000001 108.392 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.5 pt -138.86 178.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 1.04 110.066 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.484 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.6 tt0 -143.72 109.41 5.19 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.353 -0.981 . . . . 2.3399999999999999 108.353 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.21 -77.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.538 -1.282 . . . . 1.1799999999999999 107.538 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -80.96 -133.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.323 -1.732 . . . . 2.4700000000000002 106.323 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.2 t -105.07 56.57 0.69 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.055 -1.091 . . . . 1.8600000000000001 108.055 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -157.05 123.62 5.0 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.778 -0.823 . . . . 1.1200000000000001 108.778 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.484 ' CG1' HE21 ' B' ' 252' ' ' GLN . 39.1 mt -91.66 134.31 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 1.1499999999999999 109.435 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.11 172.59 12.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.368 -0.832 . . . . 2.6400000000000001 110.05 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.13 140.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.461 -0.774 . . . . 1.0800000000000001 109.745 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.17 124.86 17.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.841 -0.8 . . . . 1.0800000000000001 108.841 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.12 139.49 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 120.588 0.859 . . . . 0.48999999999999999 110.325 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.81 -36.19 69.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 3.5800000000000001 109.751 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.409 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 2.3 tpt180 -67.17 -9.47 40.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 4.3600000000000003 110.733 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.496 ' CB ' ' NZ ' ' B' ' 264' ' ' LYS . 7.4 mtpm? -123.03 25.53 8.5 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.21 -0.931 . . . . 2.5800000000000001 108.833 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.493 -0.928 . . . . 1.05 108.493 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -139.32 131.9 28.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.113 -0.992 . . . . 2.2599999999999998 109.318 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.44 107.62 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.231 -0.918 . . . . 1.1799999999999999 109.311 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.44 157.55 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.41 -0.806 . . . . 1.27 109.269 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -91.69 137.23 32.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 109.487 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.105 -0.997 . . . . 2.0499999999999998 109.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.415 -0.587 . . . . 4.1799999999999997 109.415 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.542 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.9 mp -84.0 114.27 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 2.5899999999999999 108.958 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.49 -124.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 2.6000000000000001 109.792 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.6 m-20 -94.75 99.01 11.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 2.0099999999999998 109.227 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -135.66 134.08 38.83 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.81999999999999995 109.374 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.523 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.1 18.89 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.925 -1.139 . . . . 3.79 107.925 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -140.99 140.23 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.103 -0.998 . . . . 1.05 110.983 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -109.28 154.28 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.141 -1.429 . . . . 0.92000000000000004 107.141 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.9 p90 -156.53 150.12 24.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.593 -1.317 . . . . 1.01 110.55 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.7 mtm-85 -94.22 134.97 36.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.513 -0.742 . . . . 3.3999999999999999 109.463 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.36 175.24 6.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.366 -0.834 . . . . 2.23 109.591 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.2 t -85.88 -11.02 54.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 2.3199999999999998 108.874 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -88.8 -9.31 52.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 4.1799999999999997 109.414 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -158.07 128.52 3.51 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 2.1600000000000001 109.04 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.69 -11.58 29.84 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 120.815 1.01 . . . . 1.3899999999999999 110.44 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 1.5 p -84.59 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.043 . . . . 2.3100000000000001 109.42 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 92.7 m95 -64.43 169.57 4.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.445 -0.784 . . . . 0.71999999999999997 109.644 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 237' ' ' GLY . 44.9 tttp -118.95 165.35 14.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.512 -0.742 . . . . 1.96 109.223 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.22 167.37 0.02 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.119 -1.192 . . . . 0.55000000000000004 110.119 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.4 160.25 50.52 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.448 1.432 . . . . 0.46999999999999997 110.113 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.79 168.86 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.05 109.18 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.51 139.51 30.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.161 -0.962 . . . . 3.1899999999999999 109.971 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.08 122.94 32.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -0.77 . . . . 1.0900000000000001 109.428 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.66 -75.51 0.6 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.419 -0.801 . . . . 1.1799999999999999 110.355 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -89.79 143.68 26.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.067 -1.021 . . . . 0.34000000000000002 109.893 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.65 121.62 10.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.342 -0.849 . . . . 2.79 109.063 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.46 -104.93 0.23 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.812 -1.185 . . . . 0.28999999999999998 110.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.38 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -1.053 . . . . 1.5600000000000001 109.551 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 51.36 3.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.14 -1.584 . . . . 0.28999999999999998 109.14 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.37 154.02 40.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.427 -1.043 . . . . 1.0700000000000001 108.691 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -147.01 124.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.056 -1.027 . . . . 1.0900000000000001 109.82 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.82 133.61 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.721 -1.214 . . . . 1.0700000000000001 107.721 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.39 175.78 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.321 -0.862 . . . . 1.04 110.333 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -145.32 108.71 4.63 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.588 -0.893 . . . . 2.3399999999999999 108.588 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.34 -77.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.421 -1.326 . . . . 1.1799999999999999 107.421 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -80.28 -135.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.566 -1.642 . . . . 2.4700000000000002 106.566 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 10.2 p -101.58 55.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.099 -1.074 . . . . 1.8700000000000001 108.099 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 255' ' ' SER . 59.1 m-20 -156.75 123.71 5.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.143 -0.688 . . . . 1.1200000000000001 109.143 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.428 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.3 mt -93.05 135.39 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 1.1499999999999999 109.438 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.07 169.72 17.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.415 -0.803 . . . . 2.6299999999999999 109.709 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.86 140.97 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.383 -0.823 . . . . 1.0800000000000001 109.491 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.97 128.24 17.56 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.632 -0.877 . . . . 1.0700000000000001 108.632 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.65 148.64 72.66 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.528 -0.989 . . . . 0.48999999999999999 109.528 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -67.82 -30.3 69.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 3.5800000000000001 109.452 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.68 -8.29 53.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 4.3600000000000003 111.0 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.21 23.16 11.47 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.126 -0.983 . . . . 2.5800000000000001 109.005 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.97 168.13 20.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.579 -0.701 . . . . 1.05 109.164 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -139.64 129.59 24.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.318 -0.864 . . . . 2.2599999999999998 109.154 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.38 108.13 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 1.1799999999999999 109.431 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -101.83 156.21 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.661 -0.866 . . . . 1.28 108.661 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -94.57 135.37 36.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 4.1799999999999997 109.116 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.011 . . . . 2.0499999999999998 109.516 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.461 -0.57 . . . . 4.1900000000000004 109.461 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.548 ' N ' ' CD1' ' B' ' 220' ' ' ILE . 1.9 mp -83.91 114.3 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 2.5899999999999999 108.96 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -83.45 -125.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 2.5899999999999999 109.853 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 2.6 m-20 -94.7 98.95 11.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -0.857 . . . . 2.0099999999999998 109.227 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.63 134.09 38.89 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.487 -0.758 . . . . 0.81999999999999995 109.416 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.525 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.2 18.78 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.91 -1.144 . . . . 3.7799999999999998 107.91 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -141.09 140.27 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.181 -0.95 . . . . 1.0600000000000001 110.945 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -109.24 154.33 22.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.169 -1.419 . . . . 0.92000000000000004 107.169 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.9 p90 -156.63 149.94 24.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.468 -1.395 . . . . 1.01 110.666 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.6 mtm-85 -94.07 135.05 35.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.523 -0.736 . . . . 3.3900000000000001 109.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.45 175.18 6.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 2.23 109.629 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.1 t -85.79 -10.99 54.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 2.3300000000000001 108.925 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -88.84 -9.2 52.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.443 -0.785 . . . . 4.1900000000000004 109.433 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.17 128.37 3.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.1600000000000001 109.147 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.64 -11.54 29.84 Favored 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 120.865 1.043 . . . . 1.3999999999999999 110.433 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 1.5 p -84.52 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.037 . . . . 2.3100000000000001 109.429 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.479 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 92.7 m95 -64.45 169.57 4.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.72999999999999998 109.671 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 44.9 tttp -118.92 165.31 14.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.635 -0.666 . . . . 1.96 109.338 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.24 167.39 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.159 -1.176 . . . . 0.56000000000000005 110.159 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.37 160.27 50.47 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 121.419 1.412 . . . . 0.46999999999999997 110.122 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.88 168.88 18.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 1.05 109.071 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.4 139.48 30.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.227 -0.92 . . . . 3.1899999999999999 109.971 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.1 122.88 32.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.704 . . . . 1.0900000000000001 109.423 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -112.63 -75.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -0.828 . . . . 1.1799999999999999 110.44 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.428 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.1 t90 -89.77 143.66 26.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.005 . . . . 0.34999999999999998 109.889 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.75 121.64 10.63 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.315 -0.866 . . . . 2.7999999999999998 109.044 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.41 -104.95 0.23 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.11 -1.196 . . . . 0.29999999999999999 110.11 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -69.42 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -1.125 . . . . 1.5600000000000001 109.516 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.43 3.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.05 -1.62 . . . . 0.28999999999999998 109.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.11 40.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.467 -1.019 . . . . 1.0700000000000001 108.72 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.99 124.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.126 -0.984 . . . . 1.0900000000000001 109.943 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.78 133.77 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.703 -1.221 . . . . 1.0800000000000001 107.703 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.51 175.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.296 -0.878 . . . . 1.04 110.278 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -145.3 108.75 4.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.593 -0.891 . . . . 2.3399999999999999 108.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.43 -77.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.348 -1.353 . . . . 1.1799999999999999 107.348 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.25 -135.73 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.54 -1.652 . . . . 2.4700000000000002 106.54 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 10.1 p -101.63 56.06 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.964 -1.125 . . . . 1.8600000000000001 107.964 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 59.1 m-20 -156.78 123.68 5.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 1.1200000000000001 109.145 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.99 135.35 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 1.1499999999999999 109.429 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.12 169.77 17.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 2.6400000000000001 109.751 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 140.98 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.381 -0.824 . . . . 1.0800000000000001 109.496 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.96 128.3 17.61 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.672 -0.862 . . . . 1.0800000000000001 108.672 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.78 148.64 73.79 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.465 -1.013 . . . . 0.48999999999999999 109.465 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.78 -30.37 69.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 3.5800000000000001 109.489 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.58 -8.34 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.415 -0.803 . . . . 4.3600000000000003 111.016 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.14 23.15 11.5 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.176 -0.952 . . . . 2.5800000000000001 109.054 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.03 168.16 20.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.078 -0.712 . . . . 1.05 109.078 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.6 129.65 25.05 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.363 -0.836 . . . . 2.2599999999999998 109.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.34 108.09 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.4 -0.812 . . . . 1.1799999999999999 109.431 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.6 mm -101.88 156.08 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.319 -0.863 . . . . 1.27 108.683 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -94.5 135.36 36.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 4.1799999999999997 109.183 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.042 -1.036 . . . . 2.0499999999999998 109.555 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.269 0.557 . . . . 4.1799999999999997 109.525 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -86.11 120.18 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.364 -0.976 . . . . 2.5899999999999999 108.364 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -82.68 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 2.6000000000000001 109.808 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -92.55 99.71 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 2.0099999999999998 109.178 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.95 122.68 22.25 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.817 -0.808 . . . . 0.81999999999999995 108.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -100.99 161.16 13.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.289 -1.004 . . . . 3.79 108.289 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.6 141.91 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.324 -0.86 . . . . 1.05 110.093 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -107.21 155.21 20.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.299 -1.371 . . . . 0.92000000000000004 107.299 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.3 p90 -154.86 153.29 30.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.716 -1.24 . . . . 1.01 110.456 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -95.29 157.15 16.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.495 -0.753 . . . . 3.3999999999999999 109.978 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.55 176.46 6.28 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.9 -0.778 . . . . 2.23 108.9 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.41 -11.24 38.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -0.994 . . . . 2.3199999999999998 109.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.63 -15.41 35.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.33 -0.856 . . . . 4.1799999999999997 109.902 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.4 m-20 -161.38 132.34 3.77 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.142 -0.974 . . . . 2.1600000000000001 109.282 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.5 18.28 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.023 1.149 . . . . 1.3899999999999999 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.514 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.1 p -86.59 158.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.72 -1.238 . . . . 2.3100000000000001 109.921 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -75.5 176.25 7.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.429 -0.582 . . . . 0.71999999999999997 109.429 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -134.97 -150.6 0.39 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.234 -0.916 . . . . 1.96 109.141 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.17 174.95 49.63 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.093 -1.203 . . . . 0.55000000000000004 110.093 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.12 158.95 45.0 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.78 1.653 . . . . 0.46999999999999997 110.066 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 172.04 13.23 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 1.05 109.517 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.538 ' NZ ' HH22 ' A' ' 224' ' ' ARG . 66.7 mmtt -92.49 137.72 32.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.269 -0.895 . . . . 3.1899999999999999 109.428 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.27 124.47 34.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.498 -0.752 . . . . 1.0900000000000001 109.814 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.37 -73.71 0.63 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.377 -0.827 . . . . 1.1799999999999999 110.27 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.85 140.33 29.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.26 -0.9 . . . . 0.34000000000000002 109.956 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -147.24 115.11 6.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -0.897 . . . . 2.79 109.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -100.3 0.17 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.854 -1.165 . . . . 0.28999999999999998 110.302 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.37 -156.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.357 -1.084 . . . . 1.5600000000000001 109.888 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.21 48.16 2.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.061 -1.615 . . . . 0.28999999999999998 109.061 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 152.34 36.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.437 -1.037 . . . . 1.0700000000000001 108.999 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.58 125.2 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 1.0900000000000001 109.413 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 50.5 t -87.85 135.02 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.109 -1.071 . . . . 1.0700000000000001 108.109 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.75 -177.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 1.04 110.062 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.474 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.4 tt0 -143.14 109.41 5.32 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.359 -0.978 . . . . 2.3399999999999999 108.359 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.62 -79.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.634 -1.247 . . . . 1.1799999999999999 107.634 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -78.99 -135.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.481 -1.674 . . . . 2.4700000000000002 106.481 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.7 m -101.02 53.72 0.84 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.167 -1.049 . . . . 1.8700000000000001 108.167 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -157.35 132.13 8.7 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.051 -0.722 . . . . 1.1200000000000001 109.051 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.474 ' CG1' HE21 ' A' ' 252' ' ' GLN . 37.3 mt -92.64 137.31 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 1.1499999999999999 109.479 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.54 169.91 16.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 2.6299999999999999 109.701 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.93 140.87 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.458 -0.777 . . . . 1.0800000000000001 109.411 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.56 134.03 21.96 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.678 -0.86 . . . . 1.0700000000000001 108.678 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.42 140.96 96.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 120.715 0.944 . . . . 0.48999999999999999 110.478 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -59.11 -38.95 80.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 3.5800000000000001 109.271 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -66.96 -7.95 26.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 4.3600000000000003 111.001 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.68 25.11 9.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.156 -0.965 . . . . 2.5800000000000001 109.169 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.53 164.28 30.57 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.212 -0.662 . . . . 1.05 109.212 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.03 126.47 20.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 2.2599999999999998 109.075 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.97 110.39 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 1.1799999999999999 109.745 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.12 147.17 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.354 -0.98 . . . . 1.28 108.354 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -95.99 141.6 29.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 4.1799999999999997 109.763 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.007 -0.997 . . . . 2.0499999999999998 109.492 179.431 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 36.2 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.425 -0.583 . . . . 4.1900000000000004 109.425 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -86.12 120.15 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.455 -0.943 . . . . 2.5899999999999999 108.455 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -82.56 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.009 -1.057 . . . . 2.5899999999999999 109.868 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -92.55 99.71 12.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 2.0099999999999998 109.159 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.97 122.79 22.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.709 -0.849 . . . . 0.81999999999999995 108.709 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' B' ' 224' ' ' ARG . 0.0 OUTLIER -101.03 161.05 13.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.316 -0.994 . . . . 3.7799999999999998 108.316 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.54 142.0 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 1.0600000000000001 110.097 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.26 155.21 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.337 -1.357 . . . . 0.92000000000000004 107.337 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.7 p90 -154.84 153.26 30.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.696 -1.253 . . . . 1.01 110.491 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -95.24 157.17 16.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.751 . . . . 3.3900000000000001 109.975 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -94.52 176.48 6.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 2.23 108.962 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.44 -11.26 38.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 2.3300000000000001 109.342 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.66 -15.4 35.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.331 -0.855 . . . . 4.1900000000000004 109.857 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.7 m-20 -161.37 132.32 3.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 2.1600000000000001 109.274 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.48 18.16 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.965 1.11 . . . . 1.3999999999999999 110.838 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.2 p -86.41 158.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.774 -1.204 . . . . 2.3100000000000001 109.922 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -75.66 176.28 7.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.381 -0.6 . . . . 0.72999999999999998 109.381 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -135.0 -150.58 0.39 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.284 -0.885 . . . . 1.96 109.11 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.2 174.94 49.57 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.084 -1.207 . . . . 0.56000000000000005 110.084 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.13 158.97 44.94 Favored 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 121.777 1.651 . . . . 0.46999999999999997 110.077 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.11 172.15 13.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.392 -0.817 . . . . 1.05 109.5 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.542 ' NZ ' HH22 ' B' ' 224' ' ' ARG . 66.7 mmtt -92.52 137.7 32.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.233 -0.917 . . . . 3.1899999999999999 109.422 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.29 124.48 34.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 1.0900000000000001 109.783 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.35 -73.68 0.63 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.275 -0.891 . . . . 1.1799999999999999 110.317 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.89 140.32 29.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.295 -0.878 . . . . 0.34999999999999998 109.953 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -147.28 115.0 6.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.244 -0.91 . . . . 2.7999999999999998 109.221 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.66 -100.36 0.18 Allowed Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.782 -1.199 . . . . 0.29999999999999999 110.239 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.29 -157.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 1.5600000000000001 109.863 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 48.06 2.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.09 -1.604 . . . . 0.28999999999999998 109.09 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.27 36.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -1.067 . . . . 1.0700000000000001 109.111 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.61 125.15 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 1.0900000000000001 109.411 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.83 134.92 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.033 -1.099 . . . . 1.0800000000000001 108.033 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 9.2 pt -139.62 -177.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 1.04 110.105 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.482 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.4 tt0 -143.05 109.55 5.4 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.391 -0.966 . . . . 2.3399999999999999 108.391 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.66 -79.15 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.629 -1.248 . . . . 1.1799999999999999 107.629 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.94 -135.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.551 -1.648 . . . . 2.4700000000000002 106.551 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.9 m -100.95 53.7 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.13 -1.063 . . . . 1.8600000000000001 108.13 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -157.3 132.16 8.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.041 -0.726 . . . . 1.1200000000000001 109.041 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.482 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.1 mt -92.63 137.25 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.235 -0.916 . . . . 1.1499999999999999 109.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.49 169.81 17.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.402 -0.811 . . . . 2.6400000000000001 109.746 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.88 140.89 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.409 -0.807 . . . . 1.0800000000000001 109.458 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.49 133.99 22.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.802 -0.814 . . . . 1.0800000000000001 108.802 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.43 140.91 96.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.647 0.898 . . . . 0.48999999999999999 110.522 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.1 -38.85 80.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 3.5800000000000001 109.326 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -67.07 -7.83 25.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.997 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.75 25.08 9.93 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.151 -0.968 . . . . 2.5800000000000001 109.192 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 164.24 30.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.224 -0.658 . . . . 1.05 109.224 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -140.04 126.47 20.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 2.2599999999999998 109.097 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.94 110.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.267 -0.895 . . . . 1.1799999999999999 109.742 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.1 147.16 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.329 -0.989 . . . . 1.27 108.329 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -95.93 141.65 29.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.45 -0.781 . . . . 4.1799999999999997 109.758 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.02 -0.99 . . . . 2.0499999999999998 109.612 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.356 0.598 . . . . 4.1799999999999997 109.53 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.0 136.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.967 -1.083 . . . . 2.5899999999999999 108.204 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.12 -142.33 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.928 -1.107 . . . . 2.6000000000000001 109.779 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 222' ' ' ASN . 0.9 OUTLIER -92.22 109.65 21.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.867 . . . . 2.0099999999999998 109.522 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.05 137.52 46.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.592 -0.693 . . . . 0.81999999999999995 109.416 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.6 OUTLIER -104.85 157.81 16.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.41 -1.33 . . . . 3.79 107.41 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.0 t -141.53 142.91 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.077 -1.014 . . . . 1.05 110.642 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -110.63 154.81 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.303 -1.369 . . . . 0.92000000000000004 107.303 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.76 151.91 26.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.534 -1.354 . . . . 1.01 110.529 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.0 mtm-85 -92.5 149.27 21.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.739 . . . . 3.3999999999999999 109.876 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 1.1 m-20 -94.38 168.04 11.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 2.23 108.698 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.9 t -84.81 -9.38 58.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 2.3199999999999998 109.084 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' A' ' 231' ' ' ARG . 3.5 mtt-85 -90.83 -15.75 29.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 4.1799999999999997 109.989 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 234' ' ' VAL . 38.0 m-20 -160.24 129.54 3.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 2.1600000000000001 108.95 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.86 11.03 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 120.831 1.021 . . . . 1.3899999999999999 110.827 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.8 p -81.62 158.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.697 -1.252 . . . . 2.3100000000000001 109.886 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -75.33 162.15 28.66 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.213 -0.662 . . . . 0.71999999999999997 109.213 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.7 tttp -118.38 158.13 25.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.462 -0.774 . . . . 1.96 109.162 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.16 171.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.551 -1.02 . . . . 0.55000000000000004 110.551 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.37 158.25 57.89 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.691 1.594 . . . . 0.46999999999999997 110.621 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.24 170.65 15.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.674 -0.861 . . . . 1.05 108.674 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -92.95 137.24 32.54 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.072 -1.017 . . . . 3.1899999999999999 109.349 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.55 120.31 30.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.708 -0.62 . . . . 1.0900000000000001 109.587 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.6 mt -111.15 -71.79 0.75 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.363 -0.836 . . . . 1.1799999999999999 110.101 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.2 t90 -91.59 142.11 27.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.206 -0.934 . . . . 0.34000000000000002 109.78 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.76 112.48 5.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.139 -0.976 . . . . 2.79 109.065 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.83 -104.17 0.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.814 -1.184 . . . . 0.28999999999999998 110.251 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 245' ' ' GLY . 30.0 mt-10 -56.67 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.477 -1.014 . . . . 1.5600000000000001 109.862 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.1 49.95 2.99 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.103 -1.599 . . . . 0.28999999999999998 109.103 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.22 157.9 43.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -1.009 . . . . 1.0700000000000001 108.569 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.38 132.44 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 1.0900000000000001 109.552 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.79 133.93 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.004 -1.11 . . . . 1.0700000000000001 108.004 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 15.3 pt -138.71 174.06 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.326 -0.859 . . . . 1.04 110.562 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -141.89 108.87 5.44 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.226 -1.027 . . . . 2.3399999999999999 108.226 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.22 -75.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.514 -1.291 . . . . 1.1799999999999999 107.514 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.25 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.615 -1.624 . . . . 2.4700000000000002 106.615 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.98 52.23 0.74 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.854 -1.165 . . . . 1.8700000000000001 107.854 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -156.35 129.0 7.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.521 -0.737 . . . . 1.1200000000000001 109.29 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.1 mt -92.62 141.52 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 1.1499999999999999 109.635 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.57 165.11 28.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 2.6299999999999999 109.668 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.9 137.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.818 . . . . 1.0800000000000001 109.404 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.72 131.53 20.21 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.361 -0.837 . . . . 1.0700000000000001 109.189 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.64 146.98 93.84 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 N-CA-C 109.702 -0.922 . . . . 0.48999999999999999 109.702 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.07 -33.07 75.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 3.5800000000000001 109.716 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -68.99 -7.05 31.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.21 -0.931 . . . . 4.3600000000000003 110.636 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -119.73 20.96 12.19 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.265 -0.897 . . . . 2.5800000000000001 109.13 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.89 23.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 1.05 109.534 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -139.42 131.01 27.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.213 -0.93 . . . . 2.2599999999999998 108.973 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.18 105.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 1.1799999999999999 109.523 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.1 mm -105.1 159.99 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.368 -0.833 . . . . 1.28 108.956 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 269' ' ' ARG . 24.7 mtm-85 -87.54 148.19 25.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 4.1799999999999997 109.376 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 8.5 m-20 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.1 -1.0 . . . . 2.0499999999999998 109.067 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.326 0.584 . . . . 4.1900000000000004 109.466 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 8.4 mm -83.98 136.05 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.005 -1.059 . . . . 2.5899999999999999 108.205 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.06 -142.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.989 -1.069 . . . . 2.5899999999999999 109.726 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.579 ' N ' HD21 ' B' ' 222' ' ' ASN . 0.9 OUTLIER -92.39 109.51 20.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 2.0099999999999998 109.491 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -132.86 137.67 46.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.642 -0.661 . . . . 0.81999999999999995 109.401 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.6 OUTLIER -104.96 157.82 16.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.403 -1.332 . . . . 3.7799999999999998 107.403 178.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.55 143.03 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.111 -0.993 . . . . 1.0600000000000001 110.601 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.66 154.8 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.353 -1.351 . . . . 0.92000000000000004 107.353 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.7 p90 -156.77 151.98 26.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 1.01 110.513 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.0 mtm-85 -92.47 149.24 21.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 3.3900000000000001 109.927 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -94.45 167.86 11.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.682 -0.858 . . . . 2.23 108.682 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 47.5 t -84.73 -9.26 58.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 2.3300000000000001 109.139 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' B' ' 231' ' ' ARG . 3.6 mtt-85 -90.89 -15.68 29.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 4.1900000000000004 110.048 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 38.1 m-20 -160.31 129.59 3.2 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.159 -0.963 . . . . 2.1600000000000001 108.965 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.04 11.16 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 120.775 0.983 . . . . 1.3999999999999999 110.777 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.9 p -81.55 158.64 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.797 -1.189 . . . . 2.3100000000000001 110.055 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -75.53 162.07 28.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.11 -0.7 . . . . 0.72999999999999998 109.11 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.9 tttp -118.29 158.14 25.74 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.468 -0.77 . . . . 1.96 109.195 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.05 171.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.518 -1.033 . . . . 0.56000000000000005 110.518 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.26 158.19 58.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.825 1.683 . . . . 0.46999999999999997 110.667 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.23 170.81 15.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.678 -0.86 . . . . 1.05 108.678 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -93.14 137.16 32.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.022 -1.049 . . . . 3.1899999999999999 109.339 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.8 tp -89.4 120.28 30.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.621 -0.675 . . . . 1.0900000000000001 109.585 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.08 -71.9 0.74 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.314 -0.866 . . . . 1.1799999999999999 110.095 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.1 t90 -91.58 142.18 27.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.34999999999999998 109.805 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.84 112.55 5.67 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.205 -0.934 . . . . 2.7999999999999998 109.109 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.88 -104.2 0.22 Allowed Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.783 -1.198 . . . . 0.29999999999999999 110.301 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' B' ' 245' ' ' GLY . 30.3 mt-10 -56.68 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.032 . . . . 1.5600000000000001 109.846 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.14 49.98 3.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.6 . . . . 0.28999999999999998 109.101 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.18 158.0 43.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.589 -0.947 . . . . 1.0700000000000001 108.527 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.36 132.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 1.0900000000000001 109.544 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.79 133.95 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.936 -1.135 . . . . 1.0800000000000001 107.936 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.77 173.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 1.04 110.565 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -141.74 108.77 5.46 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.311 -0.996 . . . . 2.3399999999999999 108.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.23 -75.84 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.498 -1.297 . . . . 1.1799999999999999 107.498 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.23 -132.07 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.566 -1.642 . . . . 2.4700000000000002 106.566 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.94 52.06 0.75 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.952 -1.129 . . . . 1.8600000000000001 107.952 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -156.2 129.0 7.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.643 -0.661 . . . . 1.1200000000000001 109.335 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.2 mt -92.65 141.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.37 -0.831 . . . . 1.1499999999999999 109.591 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.35 165.24 27.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 2.6400000000000001 109.72 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.98 137.32 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 1.0800000000000001 109.408 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.64 131.51 20.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.42 -0.8 . . . . 1.0800000000000001 109.175 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.67 147.07 93.57 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 N-CA-C 109.734 -0.91 . . . . 0.48999999999999999 109.734 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.06 -33.14 75.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 3.5800000000000001 109.652 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.0 -7.03 31.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 4.3600000000000003 110.559 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -119.7 20.96 12.21 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.29 -0.881 . . . . 2.5800000000000001 109.134 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.62 166.81 23.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 1.05 109.524 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -139.41 130.91 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.354 -0.841 . . . . 2.2599999999999998 109.092 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.8 mm -89.12 105.93 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 1.1799999999999999 109.625 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.1 mm -105.08 160.13 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.383 -0.823 . . . . 1.27 109.026 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' B' ' 269' ' ' ARG . 24.6 mtm-85 -87.66 148.04 24.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 4.1799999999999997 109.387 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.028 -0.987 . . . . 2.0499999999999998 109.103 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.494 -0.558 . . . . 4.1799999999999997 109.494 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.407 ' CD1' ' H ' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.69 127.39 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.028 -1.101 . . . . 2.5899999999999999 108.028 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.35 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 2.6000000000000001 109.429 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -93.38 106.71 18.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.119 -0.988 . . . . 2.0099999999999998 109.136 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.6 130.29 36.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.595 -0.691 . . . . 0.81999999999999995 109.207 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 224' ' ' ARG . 0.4 OUTLIER -105.68 159.48 15.94 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.293 -1.003 . . . . 3.79 108.293 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.13 140.8 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.044 -1.035 . . . . 1.05 110.59 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.06 152.48 23.95 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.252 -1.388 . . . . 0.92000000000000004 107.252 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.8 p90 -156.57 151.5 26.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.537 -1.352 . . . . 1.01 110.615 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -95.06 143.63 26.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 3.3999999999999999 109.88 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.77 173.25 7.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.392 -0.818 . . . . 2.23 108.997 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.24 -9.99 51.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 2.3199999999999998 109.381 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.64 -13.0 43.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 4.1799999999999997 109.55 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -158.43 128.43 3.38 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 2.1600000000000001 108.707 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.32 2.04 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 120.875 1.05 . . . . 1.3899999999999999 111.404 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 14.8 p -84.57 167.04 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.565 -1.334 . . . . 2.3100000000000001 110.335 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.438 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 98.8 m95 -71.92 161.98 30.13 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.71999999999999997 108.692 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.2 tttp -118.75 161.96 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.288 -0.883 . . . . 1.96 109.257 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.6 164.83 0.02 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.302 -1.119 . . . . 0.55000000000000004 110.302 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.43 160.75 46.38 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.456 1.437 . . . . 0.46999999999999997 110.127 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.66 175.32 9.67 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.836 -0.802 . . . . 1.05 108.836 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -95.89 138.73 33.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.126 -0.984 . . . . 3.1899999999999999 109.795 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 tp -87.89 122.93 32.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.326 -0.859 . . . . 1.0900000000000001 109.259 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.38 -72.94 0.67 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.352 -0.842 . . . . 1.1799999999999999 110.326 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.528 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.7 t90 -90.07 139.95 30.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.091 -1.006 . . . . 0.34000000000000002 110.387 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.62 7.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.374 -0.829 . . . . 2.79 109.008 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.33 -99.9 0.17 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.83 -1.308 . . . . 0.28999999999999998 109.83 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.45 -155.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -1.149 . . . . 1.5600000000000001 109.65 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.81 46.47 2.35 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.417 -1.473 . . . . 0.28999999999999998 109.417 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.84 148.73 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -1.037 . . . . 1.0700000000000001 108.564 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.76 126.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.297 -0.877 . . . . 1.0900000000000001 109.697 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.19 139.42 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.156 -1.053 . . . . 1.0700000000000001 108.156 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.1 pt -141.2 178.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 1.04 110.408 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -143.69 111.29 5.96 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.892 -1.151 . . . . 2.3399999999999999 107.892 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.56 -78.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.851 -1.166 . . . . 1.1799999999999999 107.851 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -80.39 -128.47 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.802 -1.555 . . . . 2.4700000000000002 106.802 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 51.1 m -105.38 51.37 0.76 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.961 -1.126 . . . . 1.8700000000000001 107.961 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.16 134.4 11.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.009 -0.737 . . . . 1.1200000000000001 109.009 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.488 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 10.5 mt -93.52 144.89 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 1.1499999999999999 109.306 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.06 162.88 34.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.318 -0.864 . . . . 2.6299999999999999 110.056 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.77 131.3 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.536 -0.727 . . . . 1.0800000000000001 109.212 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.09 133.26 20.69 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.698 -0.853 . . . . 1.0700000000000001 108.698 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.8 147.46 80.75 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.521 0.814 . . . . 0.48999999999999999 109.993 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.29 -37.52 77.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 3.5800000000000001 109.359 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -70.84 1.81 5.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.72 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -118.93 12.0 12.71 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.581 -0.896 . . . . 2.5800000000000001 108.581 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.75 170.05 16.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.679 . . . . 1.05 109.657 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.47 130.11 27.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.339 -0.85 . . . . 2.2599999999999998 108.984 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.76 115.2 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.416 -0.803 . . . . 1.1799999999999999 109.749 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.9 mm -112.12 155.04 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.383 -0.823 . . . . 1.28 109.141 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -91.57 136.29 33.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.517 -0.739 . . . . 4.1799999999999997 109.278 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.979 -1.01 . . . . 2.0499999999999998 109.55 179.844 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 53.2 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.2 0.524 . . . . 4.1900000000000004 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.58 127.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.999 -1.112 . . . . 2.5899999999999999 107.999 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.38 -126.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 2.5899999999999999 109.479 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -93.31 106.65 18.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.2 -0.938 . . . . 2.0099999999999998 109.128 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -134.52 130.39 36.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.578 -0.701 . . . . 0.81999999999999995 109.145 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' B' ' 224' ' ' ARG . 0.4 OUTLIER -105.69 159.53 15.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.347 -0.983 . . . . 3.7799999999999998 108.347 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -142.28 140.72 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 1.0600000000000001 110.581 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -106.95 152.55 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.241 -1.392 . . . . 0.92000000000000004 107.241 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.8 p90 -156.71 151.47 25.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.595 -1.315 . . . . 1.01 110.562 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -95.09 143.53 26.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.641 -0.662 . . . . 3.3900000000000001 109.847 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.66 173.35 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 2.23 109.066 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.36 -9.91 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 2.3300000000000001 109.426 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.76 -12.95 43.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 4.1900000000000004 109.505 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -158.37 128.44 3.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.115 -0.991 . . . . 2.1600000000000001 108.732 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.29 1.99 2.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.948 1.099 . . . . 1.3999999999999999 111.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 14.7 p -84.5 166.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.59 -1.319 . . . . 2.3100000000000001 110.386 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.431 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 98.8 m95 -71.92 161.97 30.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.665 -0.865 . . . . 0.72999999999999998 108.665 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.79 162.0 19.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.383 -0.823 . . . . 1.96 109.211 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.65 164.82 0.02 OUTLIER Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.376 -1.089 . . . . 0.56000000000000005 110.376 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.39 160.67 46.68 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.484 1.456 . . . . 0.46999999999999997 110.179 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.54 175.53 9.49 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.791 -0.818 . . . . 1.05 108.791 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -96.02 138.78 33.15 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.167 -0.958 . . . . 3.1899999999999999 109.717 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.02 122.84 32.1 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 1.0900000000000001 109.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.1 mt -116.4 -72.79 0.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.423 -0.798 . . . . 1.1799999999999999 110.285 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.488 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.7 t90 -90.11 139.9 30.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.08 -1.013 . . . . 0.34999999999999998 110.268 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.54 7.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.285 -0.885 . . . . 2.7999999999999998 109.073 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.22 -99.76 0.17 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.901 -1.28 . . . . 0.29999999999999999 109.901 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.44 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -1.103 . . . . 1.5600000000000001 109.702 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 46.45 2.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.381 -1.488 . . . . 0.28999999999999998 109.381 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.78 148.63 34.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.443 -1.034 . . . . 1.0700000000000001 108.522 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.77 126.37 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.267 -0.896 . . . . 1.0900000000000001 109.732 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.13 139.52 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.227 -1.027 . . . . 1.0800000000000001 108.227 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.1 pt -141.24 178.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.207 -0.933 . . . . 1.04 110.464 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -143.65 111.31 5.98 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.985 -1.117 . . . . 2.3399999999999999 107.985 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.62 -78.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.783 -1.192 . . . . 1.1799999999999999 107.783 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.43 -128.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.767 -1.568 . . . . 2.4700000000000002 106.767 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 51.0 m -105.42 51.34 0.76 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.972 -1.122 . . . . 1.8600000000000001 107.972 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.09 134.43 11.51 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.053 -0.721 . . . . 1.1200000000000001 109.053 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 10.7 mt -93.48 145.01 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.183 -0.948 . . . . 1.1499999999999999 109.48 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.15 162.93 34.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 2.6400000000000001 109.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.76 131.27 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 1.0800000000000001 109.186 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.02 133.34 20.83 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.67 -0.863 . . . . 1.0800000000000001 108.67 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.7 147.47 79.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.534 0.822 . . . . 0.48999999999999999 110.027 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.47 -37.26 77.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 3.5800000000000001 109.392 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -71.01 1.96 5.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 4.3600000000000003 110.77 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -119.03 12.01 12.62 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.547 -0.909 . . . . 2.5800000000000001 108.547 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.84 169.99 16.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 1.05 109.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.43 130.13 27.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.448 -0.783 . . . . 2.2599999999999998 108.989 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.77 115.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.41 -0.806 . . . . 1.1799999999999999 109.753 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -111.95 155.03 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.44 -0.788 . . . . 1.27 109.178 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -91.46 136.24 33.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.572 -0.705 . . . . 4.1799999999999997 109.285 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.01 . . . . 2.0499999999999998 109.555 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.504 ' O ' ' CE2' ' A' ' 223' ' ' PHE . 53.1 mtt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.533 0.682 . . . . 4.1799999999999997 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 8.7 pt -83.3 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.125 0.965 . . . . 2.5899999999999999 109.268 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 219' ' ' MET . 76.4 mt-30 -78.82 -107.46 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.489 -0.56 . . . . 2.6000000000000001 109.489 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 -97.35 91.07 5.31 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 2.0099999999999998 109.588 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 219' ' ' MET . 38.1 m-85 -136.07 135.46 39.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.525 -0.734 . . . . 0.81999999999999995 109.466 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.53 156.94 20.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.215 -1.402 . . . . 3.79 107.215 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.14 141.79 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.008 -1.058 . . . . 1.05 110.716 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.44 152.55 25.23 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.406 -1.331 . . . . 0.92000000000000004 107.406 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 17.6 p90 -155.91 158.58 38.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 1.01 110.673 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -102.02 143.72 31.51 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.425 0.631 . . . . 3.3999999999999999 109.606 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 230' ' ' SER . 10.3 t70 -97.92 173.12 7.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.455 -0.778 . . . . 2.23 109.131 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 57.3 m -86.99 -5.67 59.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 2.3199999999999998 109.406 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 231' ' ' ARG . 20.7 mtm-85 -88.59 -19.69 25.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.224 -0.923 . . . . 4.1799999999999997 109.614 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.0 m-20 -162.54 129.86 2.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 2.1600000000000001 108.813 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -65.89 5.61 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 120.779 0.986 . . . . 1.3899999999999999 110.698 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 232' ' ' ASP . 5.4 m -83.0 127.51 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.821 -1.174 . . . . 2.3100000000000001 109.993 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -48.28 164.4 0.05 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.25 -0.906 . . . . 0.71999999999999997 109.551 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.8 mtpt -118.97 167.32 11.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.842 -0.799 . . . . 1.96 108.842 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -48.04 174.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.024 -1.231 . . . . 0.55000000000000004 110.024 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.17 159.47 53.73 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.69 1.594 . . . . 0.46999999999999997 110.502 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 172.17 13.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.101 -0.704 . . . . 1.05 109.101 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.61 33.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.112 -0.992 . . . . 3.1899999999999999 109.573 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.78 125.32 34.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.52 -0.737 . . . . 1.0900000000000001 109.493 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.0 mt -116.53 -74.54 0.6 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.397 -0.815 . . . . 1.1799999999999999 110.209 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.71 141.55 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.34000000000000002 109.988 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -145.94 118.72 8.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.831 . . . . 2.79 109.103 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.32 -104.77 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.723 -1.227 . . . . 0.28999999999999998 110.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -68.85 -153.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 1.5600000000000001 109.812 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.23 50.32 2.73 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.28999999999999998 109.633 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.05 151.91 36.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -1.106 . . . . 1.0700000000000001 108.917 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.24 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.97 . . . . 1.0900000000000001 109.546 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -87.05 138.24 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.236 -1.024 . . . . 1.0700000000000001 108.236 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.92 177.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -0.922 . . . . 1.04 110.095 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -144.69 110.3 5.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.687 -0.857 . . . . 2.3399999999999999 108.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.57 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.577 -1.268 . . . . 1.1799999999999999 107.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.8 -130.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.636 -1.616 . . . . 2.4700000000000002 106.636 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 m -105.27 55.68 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.959 -1.126 . . . . 1.8700000000000001 107.959 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.939 -0.763 . . . . 1.1200000000000001 108.939 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.7 mt -92.65 139.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -0.872 . . . . 1.1499999999999999 109.524 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.21 166.97 23.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 2.6299999999999999 109.976 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.78 138.34 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.528 -0.916 . . . . 1.0800000000000001 108.528 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.11 133.1 20.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.834 . . . . 1.0700000000000001 109.35 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.43 139.12 89.35 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.798 -0.885 . . . . 0.48999999999999999 109.798 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.48 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.6 OUTLIER -58.9 -34.72 72.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 3.5800000000000001 109.424 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 263' ' ' ARG . 18.8 ttm-85 -69.36 -2.87 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 4.3600000000000003 109.731 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.46 17.09 13.8 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.335 -0.853 . . . . 2.5800000000000001 109.095 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.18 170.92 14.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 1.05 109.903 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -140.39 131.51 26.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.243 -0.91 . . . . 2.2599999999999998 109.17 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.73 107.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.139 -0.976 . . . . 1.1799999999999999 109.508 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.96 150.63 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.172 -1.047 . . . . 1.28 108.172 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -90.9 145.19 24.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -0.796 . . . . 4.1799999999999997 109.127 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.914 -1.041 . . . . 2.0499999999999998 109.54 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' MET . . . . . 0.504 ' O ' ' CE2' ' B' ' 223' ' ' PHE . 53.0 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.439 0.638 . . . . 4.1900000000000004 109.432 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 8.7 pt -83.24 35.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 122.116 0.96 . . . . 2.5899999999999999 109.218 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' B' ' 219' ' ' MET . 76.6 mt-30 -78.79 -107.37 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.789 -0.569 . . . . 2.5899999999999999 109.556 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.3 m-20 -97.42 91.07 5.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.013 . . . . 2.0099999999999998 109.539 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' B' ' 219' ' ' MET . 38.2 m-85 -136.04 135.51 39.47 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.432 -0.793 . . . . 0.81999999999999995 109.508 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.48 156.88 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.292 -1.373 . . . . 3.7799999999999998 107.292 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 91.7 t -141.07 141.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.995 -1.066 . . . . 1.0600000000000001 110.661 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.41 152.52 25.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.353 -1.351 . . . . 0.92000000000000004 107.353 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 17.4 p90 -155.84 158.65 38.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.633 -1.292 . . . . 1.01 110.602 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -102.04 143.77 31.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.405 0.621 . . . . 3.3900000000000001 109.645 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 230' ' ' SER . 10.2 t70 -97.84 173.03 7.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.413 -0.804 . . . . 2.23 109.188 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 m -86.85 -5.73 59.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 2.3300000000000001 109.499 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.458 HH11 ' HG3' ' B' ' 231' ' ' ARG . 20.7 mtm-85 -88.47 -19.89 25.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.924 . . . . 4.1900000000000004 109.57 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.2 m-20 -162.46 129.84 2.63 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 2.1600000000000001 108.906 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.93 5.69 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 120.8 1.0 . . . . 1.3999999999999999 110.623 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' B' ' 232' ' ' ASP . 5.4 m -83.11 127.56 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.796 -1.19 . . . . 2.3100000000000001 110.014 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -48.29 164.44 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.214 -0.929 . . . . 0.72999999999999998 109.601 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.8 mtpt -119.0 167.23 11.95 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.863 -0.791 . . . . 1.96 108.863 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -48.06 174.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.997 -1.241 . . . . 0.56000000000000005 109.997 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.24 159.49 53.59 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.697 1.598 . . . . 0.46999999999999997 110.509 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.87 172.23 13.32 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.024 -0.732 . . . . 1.05 109.024 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.63 33.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.114 -0.991 . . . . 3.1899999999999999 109.535 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.89 125.44 34.94 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.516 -0.74 . . . . 1.0900000000000001 109.409 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.4 mt -116.65 -74.62 0.6 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.4 -0.812 . . . . 1.1799999999999999 110.103 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.66 141.55 28.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.34999999999999998 110.014 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -146.0 118.72 8.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.368 -0.833 . . . . 2.7999999999999998 109.147 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -104.79 0.23 Allowed Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.805 -1.188 . . . . 0.29999999999999999 110.195 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -68.83 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.297 -1.12 . . . . 1.5600000000000001 109.816 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.24 50.27 2.73 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.373 . . . . 0.28999999999999998 109.666 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.08 151.86 36.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -1.12 . . . . 1.0700000000000001 108.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.11 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.125 -0.985 . . . . 1.0900000000000001 109.586 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.97 138.16 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.244 -1.021 . . . . 1.0800000000000001 108.244 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.89 177.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 1.04 110.099 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.63 110.3 5.31 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.654 -0.869 . . . . 2.3399999999999999 108.654 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.65 -81.6 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.542 -1.281 . . . . 1.1799999999999999 107.542 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.73 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.593 -1.632 . . . . 2.4700000000000002 106.593 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.6 m -105.33 55.64 0.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.99 -1.115 . . . . 1.8600000000000001 107.99 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 1.1200000000000001 108.901 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 23.6 mt -92.57 139.15 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 1.1499999999999999 109.574 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.22 166.87 23.51 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 2.6400000000000001 110.023 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.76 138.4 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.569 -0.9 . . . . 1.0800000000000001 108.569 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.19 133.08 20.43 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 1.0800000000000001 109.312 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.38 139.16 89.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.769 -0.897 . . . . 0.48999999999999999 109.769 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' B' ' 262' ' ' ARG . 0.7 OUTLIER -58.98 -34.83 72.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 3.5800000000000001 109.351 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' B' ' 263' ' ' ARG . 18.9 ttm-85 -69.24 -2.81 11.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 4.3600000000000003 109.793 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.53 17.16 13.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.318 -0.863 . . . . 2.5800000000000001 109.116 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.3 170.86 14.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 1.05 109.943 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -140.36 131.49 26.4 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.356 -0.84 . . . . 2.2599999999999998 109.188 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.76 107.5 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.114 -0.991 . . . . 1.1799999999999999 109.51 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.8 150.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.267 -1.012 . . . . 1.27 108.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.407 ' NH1' ' HG2' ' B' ' 269' ' ' ARG . 6.0 tpt180 -90.98 145.21 24.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -0.785 . . . . 4.1799999999999997 109.086 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.029 -0.986 . . . . 2.0499999999999998 109.547 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.384 -0.599 . . . . 4.1799999999999997 109.384 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.3 135.34 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 2.5899999999999999 109.485 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.5 -139.81 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 2.6000000000000001 108.925 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -93.25 110.87 22.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 2.0099999999999998 108.706 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -133.89 145.21 49.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 0.81999999999999995 109.479 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -119.71 154.03 34.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.851 -1.166 . . . . 3.79 107.851 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -138.87 146.45 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.079 -1.013 . . . . 1.05 111.012 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.17 155.78 24.39 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.261 -1.385 . . . . 0.92000000000000004 107.261 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.8 p90 -157.43 150.86 23.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.578 -1.326 . . . . 1.01 110.465 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 228' ' ' ARG . 8.1 mtm-85 -93.04 146.44 23.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.476 -0.765 . . . . 3.3999999999999999 109.306 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.84 167.41 11.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -0.9 . . . . 2.23 108.917 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.7 t -83.18 -10.54 58.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 2.3199999999999998 109.24 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -89.96 -11.08 42.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 4.1799999999999997 109.622 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 234' ' ' VAL . 18.8 t0 -160.41 127.36 2.58 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 2.1600000000000001 108.768 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.63 6.83 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.721 0.948 . . . . 1.3899999999999999 110.269 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 232' ' ' ASP . 40.4 t -83.69 161.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 2.3100000000000001 109.85 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.4 ' CZ3' ' NZ ' ' A' ' 266' ' ' LYS . 99.5 m95 -74.17 161.62 29.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.803 . . . . 0.71999999999999997 109.076 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.3 tttp -118.92 160.86 21.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.383 -0.823 . . . . 1.96 109.25 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.0 167.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.6 -1.0 . . . . 0.55000000000000004 110.6 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.37 157.91 57.85 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.681 1.588 . . . . 0.46999999999999997 110.568 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.36 170.0 16.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.969 -0.752 . . . . 1.05 108.969 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.6 138.73 31.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.067 -1.02 . . . . 3.1899999999999999 109.745 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.98 120.46 30.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.133 -0.691 . . . . 1.0900000000000001 109.133 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.0 mt -111.12 -72.5 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.401 -0.812 . . . . 1.1799999999999999 110.282 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.26 143.94 25.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.165 -0.959 . . . . 0.34000000000000002 110.15 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.58 122.14 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.297 -0.877 . . . . 2.79 109.278 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.57 -103.78 0.21 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.081 -1.208 . . . . 0.28999999999999998 110.081 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.62 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -1.124 . . . . 1.5600000000000001 109.712 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 49.5 2.91 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.253 -1.539 . . . . 0.28999999999999998 109.253 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.71 35.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -1.035 . . . . 1.0700000000000001 108.704 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.03 124.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.991 . . . . 1.0900000000000001 109.809 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.0 137.04 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.079 -1.082 . . . . 1.0700000000000001 108.079 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.73 -179.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.861 . . . . 1.04 110.234 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.474 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -144.15 111.93 6.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.709 -0.848 . . . . 2.3399999999999999 108.709 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.36 -78.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.491 -1.3 . . . . 1.1799999999999999 107.491 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.64 -132.19 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.695 -1.594 . . . . 2.4700000000000002 106.695 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.7 m -103.66 54.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.031 -1.1 . . . . 1.8700000000000001 108.031 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.81 126.99 6.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 1.1200000000000001 109.283 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.474 ' CG1' HE21 ' A' ' 252' ' ' GLN . 26.9 mt -92.71 137.0 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 1.1499999999999999 109.286 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.49 171.86 13.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 2.6299999999999999 109.743 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.92 137.47 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.372 -0.83 . . . . 1.0800000000000001 109.359 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -136.94 125.22 14.8 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.401 -0.812 . . . . 1.0700000000000001 108.974 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.46 143.75 93.54 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.527 0.818 . . . . 0.48999999999999999 110.242 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.04 -32.54 72.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 3.5800000000000001 109.387 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -68.71 -7.69 35.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.338 -0.851 . . . . 4.3600000000000003 110.672 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -119.05 19.59 12.92 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.175 -0.953 . . . . 2.5800000000000001 109.451 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.01 168.9 18.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.52 -0.737 . . . . 1.05 109.589 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.4 ' NZ ' ' CZ3' ' A' ' 235' ' ' TRP . 29.0 mtmm -137.62 127.27 25.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 2.2599999999999998 109.049 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.4 mm -88.15 107.91 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.223 -0.923 . . . . 1.1799999999999999 110.15 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.5 mm -105.7 151.51 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.398 -0.964 . . . . 1.28 108.398 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.18 149.35 21.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.303 -0.873 . . . . 4.1799999999999997 109.053 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.927 -1.035 . . . . 2.0499999999999998 109.446 179.832 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.435 -0.58 . . . . 4.1900000000000004 109.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.27 135.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.145 -0.972 . . . . 2.5899999999999999 109.453 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.58 -139.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.889 . . . . 2.5899999999999999 108.834 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -93.2 110.91 22.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 2.0099999999999998 108.696 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.03 145.14 49.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.522 -0.736 . . . . 0.81999999999999995 109.449 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' B' ' 224' ' ' ARG . 0.3 OUTLIER -119.69 154.05 34.66 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.807 -1.183 . . . . 3.7799999999999998 107.807 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.94 146.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.116 -0.99 . . . . 1.0600000000000001 110.987 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -113.13 155.89 24.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.226 -1.398 . . . . 0.92000000000000004 107.226 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.435 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 14.1 p90 -157.43 151.02 24.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.572 -1.33 . . . . 1.01 110.42 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.1 mtm-85 -93.14 146.54 23.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 3.3900000000000001 109.291 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.89 167.38 11.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 2.23 108.931 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.8 t -83.16 -10.52 58.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 2.3300000000000001 109.278 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -90.06 -10.96 42.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 4.1900000000000004 109.592 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' B' ' 234' ' ' VAL . 18.7 t0 -160.44 127.31 2.56 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.1600000000000001 108.782 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.49 6.72 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 120.814 1.009 . . . . 1.3999999999999999 110.322 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.431 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.3 t -83.74 161.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 2.3100000000000001 109.893 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -74.06 161.55 29.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.72999999999999998 109.063 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.91 160.86 21.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.41 -0.806 . . . . 1.96 109.285 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.86 166.98 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.578 -1.009 . . . . 0.56000000000000005 110.578 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -66.33 157.91 57.77 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.767 1.644 . . . . 0.46999999999999997 110.543 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.42 169.97 16.78 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.99 -0.745 . . . . 1.05 108.99 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 138.79 31.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.107 -0.996 . . . . 3.1899999999999999 109.699 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.3 tp -88.97 120.52 30.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 1.0900000000000001 109.172 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.1 mt -111.23 -72.56 0.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.317 -0.864 . . . . 1.1799999999999999 110.246 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.28 143.81 26.03 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.34999999999999998 110.152 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -148.42 122.16 9.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 2.7999999999999998 109.314 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.6 -103.71 0.21 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.096 -1.202 . . . . 0.29999999999999999 110.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.61 -153.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -1.136 . . . . 1.5600000000000001 109.7 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.16 49.48 2.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.234 -1.546 . . . . 0.28999999999999998 109.234 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.75 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -1.061 . . . . 1.0700000000000001 108.781 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.98 124.49 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.182 -0.949 . . . . 1.0900000000000001 109.725 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.06 137.0 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.06 -1.089 . . . . 1.0800000000000001 108.06 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.64 -179.77 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.221 -0.924 . . . . 1.04 110.252 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.486 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -144.18 111.86 6.12 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 2.3399999999999999 108.705 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -90.21 -78.57 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.484 -1.302 . . . . 1.1799999999999999 107.484 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.66 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.641 -1.614 . . . . 2.4700000000000002 106.641 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.3 m -103.77 54.3 0.74 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.936 -1.135 . . . . 1.8600000000000001 107.936 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.85 126.9 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.529 -0.732 . . . . 1.1200000000000001 109.245 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.486 ' CG1' HE21 ' B' ' 252' ' ' GLN . 27.2 mt -92.65 137.03 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 1.1499999999999999 109.272 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -137.45 171.84 13.87 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.406 -0.809 . . . . 2.6400000000000001 109.728 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 137.51 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 109.396 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 55.1 t -136.97 125.2 14.75 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.374 -0.829 . . . . 1.0800000000000001 108.931 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.48 143.72 93.69 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.48 0.787 . . . . 0.48999999999999999 110.298 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 3.5800000000000001 109.46 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -68.77 -7.63 35.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.227 -0.921 . . . . 4.3600000000000003 110.705 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -119.17 19.78 12.79 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.191 -0.943 . . . . 2.5800000000000001 109.436 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.1 168.85 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 1.05 109.559 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -137.55 127.35 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.341 -0.85 . . . . 2.2599999999999998 109.024 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.18 107.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.207 -0.933 . . . . 1.1799999999999999 110.201 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -105.59 151.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.482 -0.933 . . . . 1.27 108.482 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.13 149.36 21.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.374 -0.829 . . . . 4.1799999999999997 109.147 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.0499999999999998 109.49 179.872 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.58 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.487 -0.56 . . . . 4.1799999999999997 109.487 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.2 pt -82.9 139.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 2.5899999999999999 109.278 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -85.11 -126.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 2.6000000000000001 109.793 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.69 116.54 28.88 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 2.0099999999999998 109.421 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.41 ' CA ' ' OD1' ' A' ' 270' ' ' ASP . 39.6 m-85 -135.73 131.23 35.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.41 -0.806 . . . . 0.81999999999999995 109.145 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.94 156.62 17.29 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.05 -1.093 . . . . 3.79 108.05 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.63 143.37 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.102 -0.999 . . . . 1.05 110.39 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 226' ' ' TYR . 22.6 m-85 -114.05 155.46 25.9 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.754 -1.202 . . . . 0.92000000000000004 107.754 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.0 p90 -156.8 150.2 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.781 -1.199 . . . . 1.01 110.353 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -96.21 152.64 18.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 3.3999999999999999 109.699 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.7 170.44 9.32 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.38 -0.97 . . . . 2.23 108.38 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.91 -12.44 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 2.3199999999999998 109.225 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.68 -11.34 40.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.369 -0.832 . . . . 4.1799999999999997 110.067 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.8 p30 -157.21 129.78 4.26 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.94 -1.1 . . . . 2.1600000000000001 109.922 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.18 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 120.907 1.071 . . . . 1.3899999999999999 110.659 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -82.53 142.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.779 -1.201 . . . . 2.3100000000000001 109.74 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.93 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.71999999999999997 108.981 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.36 -161.14 1.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.96 108.623 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.31 166.96 54.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.469 . . . . 0.55000000000000004 109.429 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.92 159.35 53.62 Favored 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.408 1.405 . . . . 0.46999999999999997 109.88 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.93 171.78 14.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.506 -0.746 . . . . 1.05 108.989 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.52 140.38 29.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.012 . . . . 3.1899999999999999 109.212 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.97 125.14 34.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.672 -0.642 . . . . 1.0900000000000001 109.718 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.3 -75.09 0.6 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.365 -0.834 . . . . 1.1799999999999999 110.46 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 30.1 t90 -91.7 146.29 23.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.128 -0.982 . . . . 0.34000000000000002 110.856 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.66 124.87 14.55 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.814 -0.809 . . . . 2.79 108.814 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.34 -116.13 0.54 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.087 -1.205 . . . . 0.28999999999999998 110.087 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.59 -149.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -1.07 . . . . 1.5600000000000001 109.449 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 52.92 3.43 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.312 -1.515 . . . . 0.28999999999999998 109.312 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.44 147.45 27.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.957 . . . . 1.0700000000000001 108.613 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.97 135.28 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.068 -1.02 . . . . 1.0900000000000001 109.873 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.84 140.59 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.64 -0.874 . . . . 1.0700000000000001 108.64 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.72 179.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 1.04 110.285 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.67 111.79 6.52 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.558 -0.905 . . . . 2.3399999999999999 108.558 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.03 -77.65 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.41 -1.329 . . . . 1.1799999999999999 107.41 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -81.77 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.72 -1.585 . . . . 2.4700000000000002 106.72 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.93 54.49 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.079 -1.082 . . . . 1.8700000000000001 108.079 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.41 130.43 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.492 -0.755 . . . . 1.1200000000000001 109.328 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.448 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 97.9 mt -94.4 139.22 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 1.1499999999999999 109.718 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.39 164.84 28.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 2.6299999999999999 109.536 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.02 136.5 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.572 -0.899 . . . . 1.0800000000000001 108.572 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.0 t -134.96 123.01 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 1.0700000000000001 109.597 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -53.57 144.5 51.81 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.809 1.006 . . . . 0.48999999999999999 110.839 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.54 -20.31 65.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.564 -0.71 . . . . 3.5800000000000001 109.143 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -66.98 -17.89 65.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 4.3600000000000003 111.64 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.89 28.67 5.55 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.979 -1.076 . . . . 2.5800000000000001 109.702 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.11 159.52 40.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.841 -0.8 . . . . 1.05 108.841 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.451 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 6.3 mtmp? -139.31 130.29 26.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 2.2599999999999998 109.635 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.83 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 1.1799999999999999 109.593 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.1 mm -105.26 160.39 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.661 -0.866 . . . . 1.28 108.661 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.27 26.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.31 -0.868 . . . . 4.1799999999999997 109.705 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.41 ' OD1' ' CA ' ' A' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.058 -1.026 . . . . 2.0499999999999998 108.977 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.422 -0.585 . . . . 4.1900000000000004 109.422 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.2 pt -83.01 139.6 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 2.5899999999999999 109.28 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -85.16 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.5899999999999999 109.782 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.69 116.58 28.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 2.0099999999999998 109.449 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . 0.408 ' CA ' ' OD1' ' B' ' 270' ' ' ASP . 39.8 m-85 -135.71 131.16 35.27 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.112 -0.699 . . . . 0.81999999999999995 109.112 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.91 156.61 17.28 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.139 -1.06 . . . . 3.7799999999999998 108.139 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 61.6 t -141.58 143.43 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.144 -0.972 . . . . 1.0600000000000001 110.326 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 226' ' ' TYR . 22.0 m-85 -114.06 155.52 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.821 -1.178 . . . . 0.92000000000000004 107.821 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.9 p90 -156.89 150.16 24.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.802 -1.186 . . . . 1.01 110.321 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -96.2 152.5 18.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.336 -0.853 . . . . 3.3900000000000001 109.763 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.67 170.52 9.27 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.402 -0.962 . . . . 2.23 108.402 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.95 -12.44 53.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.981 -1.074 . . . . 2.3300000000000001 109.198 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.72 -11.41 39.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.316 -0.865 . . . . 4.1900000000000004 109.985 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 1.8 p30 -157.14 129.78 4.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.992 -1.067 . . . . 2.1600000000000001 109.985 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.13 6.76 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 120.989 1.126 . . . . 1.3999999999999999 110.627 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.57 142.69 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.762 -1.211 . . . . 2.3100000000000001 109.688 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -60.93 -172.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.72999999999999998 109.015 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.46 -161.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.214 -0.929 . . . . 1.96 108.604 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.25 166.96 54.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.433 -1.467 . . . . 0.56000000000000005 109.433 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.94 159.35 53.6 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.402 1.401 . . . . 0.46999999999999997 109.847 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.94 171.76 14.03 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 1.05 109.005 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.46 140.46 29.55 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.947 . . . . 3.1899999999999999 109.184 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.3 tp -89.07 125.16 34.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.617 -0.677 . . . . 1.0900000000000001 109.791 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.6 mt -114.32 -75.03 0.6 Allowed 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.302 -0.874 . . . . 1.1799999999999999 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 29.8 t90 -91.78 146.3 23.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.223 -0.923 . . . . 0.34999999999999998 110.887 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.62 124.86 14.57 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.89 -0.781 . . . . 2.7999999999999998 108.89 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -116.15 0.54 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.029 -1.228 . . . . 0.29999999999999999 110.029 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -67.45 -149.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.489 -1.007 . . . . 1.5600000000000001 109.595 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.25 52.99 3.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.38 -1.488 . . . . 0.28999999999999998 109.38 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.41 147.43 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.483 -1.01 . . . . 1.0700000000000001 108.626 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 135.34 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.947 -1.095 . . . . 1.0900000000000001 109.837 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.89 140.64 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 1.0800000000000001 108.6 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.82 179.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.17 -0.956 . . . . 1.04 110.211 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.57 111.8 6.56 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.577 -0.898 . . . . 2.3399999999999999 108.577 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.04 -77.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.482 -1.303 . . . . 1.1799999999999999 107.482 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -81.65 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.788 -1.56 . . . . 2.4700000000000002 106.788 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.99 54.5 0.71 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.062 -1.088 . . . . 1.8600000000000001 108.062 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.39 130.37 7.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.1200000000000001 109.347 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 97.9 mt -94.28 139.3 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 1.1499999999999999 109.669 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -139.51 164.8 28.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.468 -0.77 . . . . 2.6400000000000001 109.489 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.93 136.44 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.588 -0.893 . . . . 1.0800000000000001 108.588 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 71.8 t -134.99 122.98 15.55 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.373 -0.83 . . . . 1.0800000000000001 109.579 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -53.49 144.54 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.801 1.001 . . . . 0.48999999999999999 110.927 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.59 -20.35 65.99 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.557 -0.714 . . . . 3.5800000000000001 109.099 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.85 -18.07 65.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 4.3600000000000003 111.631 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.82 28.65 5.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.005 -1.06 . . . . 2.5800000000000001 109.68 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.04 159.6 40.3 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.803 -0.814 . . . . 1.05 108.803 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.46 ' HZ3' ' CB ' ' B' ' 266' ' ' LYS . 6.3 mtmp? -139.3 130.3 26.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.169 -0.957 . . . . 2.2599999999999998 109.675 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.86 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 1.1799999999999999 109.627 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.2 mm -105.37 160.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.644 -0.872 . . . . 1.27 108.644 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' B' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.32 26.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 4.1799999999999997 109.719 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.408 ' OD1' ' CA ' ' B' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.043 -1.035 . . . . 2.0499999999999998 108.965 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 219' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.488 -0.56 . . . . 4.1799999999999997 109.488 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.23 129.36 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.005 . . . . 2.5899999999999999 108.731 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -97.02 -109.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.105 -0.997 . . . . 2.6000000000000001 110.001 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.82 104.03 12.93 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.003 -0.74 . . . . 2.0099999999999998 109.003 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.54 125.67 26.15 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.235 -0.916 . . . . 0.81999999999999995 109.788 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.02 164.46 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.756 -1.202 . . . . 3.79 107.756 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.02 141.65 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 1.05 109.972 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -108.83 151.98 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.523 -1.288 . . . . 0.92000000000000004 107.523 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 8.2 p90 -153.73 152.23 30.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.77 -1.206 . . . . 1.01 110.332 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -94.13 153.14 18.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 3.3999999999999999 110.245 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -92.3 171.09 9.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.2 t -87.77 -10.95 49.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.02 -1.05 . . . . 2.3199999999999998 109.548 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -90.01 -14.51 33.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 4.1799999999999997 109.611 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 234' ' ' VAL . 47.3 m-20 -161.3 130.57 3.19 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 2.1600000000000001 109.29 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -65.93 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.804 1.003 . . . . 1.3899999999999999 110.553 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 232' ' ' ASP . 21.7 m -83.48 140.37 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.846 -1.159 . . . . 2.3100000000000001 109.736 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -60.68 167.21 2.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.71999999999999997 109.516 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 237' ' ' GLY . 29.8 tttm -125.78 162.78 24.33 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.488 -0.757 . . . . 1.96 109.267 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.07 166.55 0.03 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.503 -1.039 . . . . 0.55000000000000004 110.503 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.6 159.48 53.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.782 1.655 . . . . 0.46999999999999997 110.458 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.22 5.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 1.05 109.164 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.95 138.95 34.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.029 -1.045 . . . . 3.1899999999999999 109.835 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.7 tp -88.77 123.7 33.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.438 -0.788 . . . . 1.0900000000000001 109.494 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.67 -74.51 0.61 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.474 -0.766 . . . . 1.1799999999999999 110.286 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.36 143.62 26.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.139 -0.975 . . . . 0.34000000000000002 110.191 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -147.53 118.53 7.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.875 . . . . 2.79 108.977 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.91 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.717 -1.23 . . . . 0.28999999999999998 110.471 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -68.65 -153.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.269 -1.136 . . . . 1.5600000000000001 109.917 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.46 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.139 -1.585 . . . . 0.28999999999999998 109.139 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.83 155.15 40.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -1.099 . . . . 1.0700000000000001 109.189 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.37 126.33 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 1.0900000000000001 109.307 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.54 137.85 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.004 -1.11 . . . . 1.0700000000000001 108.004 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 24.5 pt -141.97 179.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 1.04 110.344 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.455 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -142.17 114.04 8.03 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.654 -0.869 . . . . 2.3399999999999999 108.654 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.19 -80.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.28 -1.378 . . . . 1.1799999999999999 107.28 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 255' ' ' SER . 33.2 t30 -80.71 -130.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.572 -1.64 . . . . 2.4700000000000002 106.572 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.562 ' H ' ' ND2' ' A' ' 254' ' ' ASN . 75.4 m -104.13 53.74 0.74 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.161 -0.962 . . . . 1.8700000000000001 108.493 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.09 127.7 7.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.542 -0.723 . . . . 1.1200000000000001 109.293 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.455 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.7 mt -92.66 136.38 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.1499999999999999 109.493 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.1 172.15 13.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.234 -0.916 . . . . 2.6299999999999999 109.873 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.91 137.29 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.479 -0.763 . . . . 1.0800000000000001 109.935 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.05 130.21 19.32 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.423 -0.798 . . . . 1.0700000000000001 108.95 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.48 142.25 97.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 109.706 -0.921 . . . . 0.48999999999999999 109.706 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -63.63 -30.11 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.149 -0.97 . . . . 3.5800000000000001 109.15 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.91 -10.77 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.38 -0.825 . . . . 4.3600000000000003 109.873 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -119.48 25.44 10.06 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.382 -0.824 . . . . 2.5800000000000001 108.883 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.494 -0.754 . . . . 1.05 109.833 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 6.7 mtmp? -139.13 130.75 27.32 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 108.812 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.91 109.07 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 1.1799999999999999 110.475 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -108.74 147.8 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.131 -1.062 . . . . 1.28 108.131 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.77 18.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 4.1799999999999997 109.921 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.055 -0.974 . . . . 2.0499999999999998 109.623 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' B' ' 219' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.499 -0.556 . . . . 4.1900000000000004 109.499 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.14 129.37 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.192 -0.943 . . . . 2.5899999999999999 108.694 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -97.12 -109.54 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.045 -1.034 . . . . 2.5899999999999999 109.877 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.81 103.92 12.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.783 . . . . 2.0099999999999998 109.06 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.51 125.59 26.06 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.239 -0.913 . . . . 0.81999999999999995 109.743 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.92 164.53 12.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.793 -1.188 . . . . 3.7799999999999998 107.793 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.1 141.63 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 1.0600000000000001 110.01 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.87 152.0 25.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.558 -1.275 . . . . 0.92000000000000004 107.558 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.2 p90 -153.7 152.2 30.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 1.01 110.336 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -94.1 153.13 18.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.541 -0.724 . . . . 3.3900000000000001 110.246 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.5 OUTLIER -92.35 171.06 9.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.438 -0.949 . . . . 2.23 108.438 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 44.3 t -87.65 -11.08 49.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.934 -1.104 . . . . 2.3300000000000001 109.562 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -89.96 -14.46 34.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 4.1900000000000004 109.67 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' B' ' 234' ' ' VAL . 47.1 m-20 -161.31 130.67 3.21 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.108 -0.995 . . . . 2.1600000000000001 109.224 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.01 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 120.828 1.018 . . . . 1.3999999999999999 110.459 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' B' ' 232' ' ' ASP . 21.6 m -83.5 140.36 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.876 -1.14 . . . . 2.3100000000000001 109.762 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -60.69 167.25 2.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.212 -0.93 . . . . 0.72999999999999998 109.609 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' B' ' 237' ' ' GLY . 29.8 tttm -125.76 162.77 24.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.76 . . . . 1.96 109.246 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.14 166.61 0.03 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.477 -1.049 . . . . 0.56000000000000005 110.477 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.66 159.54 53.11 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.691 1.594 . . . . 0.46999999999999997 110.491 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.16 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.35 -0.844 . . . . 1.05 109.158 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -98.02 139.06 34.41 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.027 -1.046 . . . . 3.1899999999999999 109.923 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -88.93 123.64 33.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.401 -0.812 . . . . 1.0900000000000001 109.504 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.66 -74.44 0.61 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.413 -0.805 . . . . 1.1799999999999999 110.298 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.34 143.61 26.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.174 -0.954 . . . . 0.34999999999999998 110.217 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -147.62 118.57 7.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.258 -0.901 . . . . 2.7999999999999998 108.816 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.95 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.679 -1.248 . . . . 0.29999999999999999 110.518 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.65 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -1.172 . . . . 1.5600000000000001 109.94 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.68 48.4 2.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.186 -1.565 . . . . 0.28999999999999998 109.186 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.18 40.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 1.0700000000000001 109.166 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 26.6 m -146.32 126.33 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 1.0900000000000001 109.296 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.59 137.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.938 -1.134 . . . . 1.0800000000000001 107.938 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 24.4 pt -141.8 179.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 1.04 110.362 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.46 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -142.35 114.08 7.98 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.637 -0.875 . . . . 2.3399999999999999 108.637 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -91.2 -80.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.188 -1.412 . . . . 1.1799999999999999 107.188 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' B' ' 255' ' ' SER . 33.1 t30 -80.72 -130.06 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.612 -1.625 . . . . 2.4700000000000002 106.612 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.571 ' H ' ' ND2' ' B' ' 254' ' ' ASN . 75.5 m -104.16 53.77 0.74 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.135 -0.978 . . . . 1.8600000000000001 108.535 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.07 127.72 8.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.506 -0.746 . . . . 1.1200000000000001 109.329 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.46 ' CG1' HE21 ' B' ' 252' ' ' GLN . 60.8 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.342 -0.849 . . . . 1.1499999999999999 109.438 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.16 172.05 13.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.246 -0.909 . . . . 2.6400000000000001 109.836 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.77 137.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 1.0800000000000001 109.948 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.11 130.2 19.26 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.884 -0.784 . . . . 1.0800000000000001 108.884 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.44 142.32 97.8 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 N-CA-C 109.739 -0.908 . . . . 0.48999999999999999 109.739 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -63.71 -30.16 71.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 3.5800000000000001 109.144 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.96 -10.63 51.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 4.3600000000000003 109.895 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -119.53 25.46 10.03 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.347 -0.846 . . . . 2.5800000000000001 108.825 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.85 161.11 39.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.577 -0.702 . . . . 1.05 109.905 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.416 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 6.7 mtmp? -139.17 130.76 27.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.327 -0.858 . . . . 2.2599999999999998 108.784 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.0 mm -87.96 109.14 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.211 -0.93 . . . . 1.1799999999999999 110.416 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.6 mm -108.83 147.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.184 -1.043 . . . . 1.27 108.184 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.86 18.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.388 -0.82 . . . . 4.1799999999999997 109.938 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 117.977 -1.011 . . . . 2.0499999999999998 109.529 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.507 -0.553 . . . . 4.1799999999999997 109.507 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 pt -82.9 140.28 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 2.5899999999999999 109.465 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -89.06 -133.92 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 2.6000000000000001 109.794 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.423 ' O ' ' OXT' ' A' ' 270' ' ' ASP . 19.3 m-20 -92.5 98.24 11.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.885 . . . . 2.0099999999999998 108.786 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -117.51 135.13 54.15 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.193 -0.669 . . . . 0.81999999999999995 109.193 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -104.82 159.19 15.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.901 -1.148 . . . . 3.79 107.901 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.98 140.95 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 1.05 110.219 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.83 153.47 24.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.487 -1.301 . . . . 0.92000000000000004 107.487 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.3 p90 -156.38 151.45 26.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 1.01 110.123 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -95.76 143.26 27.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.371 -0.831 . . . . 3.3999999999999999 109.838 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.7 168.34 10.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.818 . . . . 2.23 108.989 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.86 8.82 7.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.984 . . . . 2.3199999999999998 109.297 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.63 -39.22 15.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 4.1799999999999997 109.523 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.3 p-10 -158.22 148.32 15.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.014 . . . . 2.1600000000000001 109.306 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.88 10.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.172 1.248 . . . . 1.3899999999999999 110.958 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.524 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.3 t -83.51 152.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.75 -1.219 . . . . 2.3100000000000001 109.773 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.84 165.04 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.964 -0.754 . . . . 0.71999999999999997 108.964 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.9 tttp -119.38 159.4 24.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.478 -0.764 . . . . 1.96 109.212 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.81 165.99 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.361 -1.095 . . . . 0.55000000000000004 110.361 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.92 161.61 41.6 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.525 1.483 . . . . 0.46999999999999997 110.405 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.23 173.4 11.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.862 -0.792 . . . . 1.05 108.862 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.06 137.01 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.095 -1.003 . . . . 3.1899999999999999 109.608 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.38 123.07 31.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.635 -0.665 . . . . 1.0900000000000001 109.366 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -115.76 -73.51 0.65 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.434 -0.791 . . . . 1.1799999999999999 110.091 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.2 t90 -93.55 146.59 23.69 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.281 -0.887 . . . . 0.34000000000000002 109.974 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -146.86 125.38 12.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 2.79 109.065 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -110.02 0.34 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.824 -1.179 . . . . 0.28999999999999998 110.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.87 -150.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -1.1 . . . . 1.5600000000000001 109.858 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.86 2.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.357 -1.497 . . . . 0.28999999999999998 109.357 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.1 150.7 34.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.509 -0.995 . . . . 1.0700000000000001 108.668 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.56 129.27 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 1.0900000000000001 109.759 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.5 t -89.79 137.41 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.027 -1.101 . . . . 1.0700000000000001 108.027 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.4 pt -141.22 177.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.301 -0.875 . . . . 1.04 109.929 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -144.09 110.75 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.472 -0.936 . . . . 2.3399999999999999 108.472 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.01 -79.12 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.53 -1.285 . . . . 1.1799999999999999 107.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.22 -130.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.48 -1.674 . . . . 2.4700000000000002 106.48 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.9 t -105.26 54.93 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.992 -1.114 . . . . 1.8700000000000001 107.992 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.56 125.48 5.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.166 -0.679 . . . . 1.1200000000000001 109.166 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -92.36 138.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.887 . . . . 1.1499999999999999 109.491 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -140.01 167.08 22.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.393 -0.817 . . . . 2.6299999999999999 109.684 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.82 139.0 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 1.0800000000000001 109.221 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -136.11 134.15 20.07 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 1.0700000000000001 108.916 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.65 142.86 98.83 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 N-CA-C 109.85 -0.865 . . . . 0.48999999999999999 109.85 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 262' ' ' ARG . 6.4 tpt180 -60.69 -34.39 74.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 3.5800000000000001 109.555 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -68.87 -7.1 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.241 -0.912 . . . . 4.3600000000000003 110.846 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -119.0 19.0 13.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.073 -1.017 . . . . 2.5800000000000001 108.839 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.36 168.71 19.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.897 -0.779 . . . . 1.05 108.897 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.43 129.72 23.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.977 . . . . 2.2599999999999998 109.541 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.83 106.03 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.326 -0.859 . . . . 1.1799999999999999 109.721 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.6 152.08 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.231 -0.918 . . . . 1.28 108.815 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.416 ' O ' ' OD1' ' A' ' 270' ' ' ASP . 58.7 ttt180 -91.03 146.19 24.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.789 . . . . 4.1799999999999997 109.642 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.423 ' OXT' ' O ' ' A' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.935 -1.031 . . . . 2.0499999999999998 109.429 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 4.1900000000000004 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 pt -82.71 140.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 2.5899999999999999 109.48 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -89.05 -133.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.5899999999999999 109.831 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.422 ' O ' ' OXT' ' B' ' 270' ' ' ASP . 19.3 m-20 -92.59 98.19 11.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 2.0099999999999998 108.774 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.35 135.24 54.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.573 -0.704 . . . . 0.81999999999999995 109.189 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -104.97 159.11 16.07 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.897 -1.149 . . . . 3.7799999999999998 107.897 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 81.1 t -140.96 140.99 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.185 -0.947 . . . . 1.0600000000000001 110.22 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.79 153.45 24.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.509 -1.293 . . . . 0.92000000000000004 107.509 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.5 p90 -156.36 151.39 26.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.68 -1.263 . . . . 1.01 110.114 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -95.78 143.26 27.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.485 -0.759 . . . . 3.3900000000000001 109.857 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.72 168.32 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 2.23 109.059 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.83 8.79 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 2.3300000000000001 109.301 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.56 -39.21 15.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 4.1900000000000004 109.497 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.3 p-10 -158.34 148.27 15.34 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.147 -0.97 . . . . 2.1600000000000001 109.294 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.85 10.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.222 1.281 . . . . 1.3999999999999999 110.854 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.3 t -83.43 152.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.788 -1.195 . . . . 2.3100000000000001 109.732 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.85 164.99 25.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.474 -0.766 . . . . 0.72999999999999998 109.015 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.8 tttp -119.31 159.4 24.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.444 -0.785 . . . . 1.96 109.241 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.9 165.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.305 -1.118 . . . . 0.56000000000000005 110.305 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.86 161.61 41.44 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.602 1.535 . . . . 0.46999999999999997 110.41 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.31 173.48 11.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.811 -0.811 . . . . 1.05 108.811 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.07 137.06 34.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.124 -0.985 . . . . 3.1899999999999999 109.559 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.56 123.09 32.08 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.7 . . . . 1.0900000000000001 109.345 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.75 -73.5 0.65 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.414 -0.804 . . . . 1.1799999999999999 109.996 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.45 146.61 23.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.91 . . . . 0.34999999999999998 109.979 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -146.9 125.46 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.295 -0.878 . . . . 2.7999999999999998 108.981 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -110.02 0.34 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.755 -1.212 . . . . 0.29999999999999999 110.288 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.85 -150.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -1.062 . . . . 1.5600000000000001 109.863 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 48.94 2.8 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.298 -1.521 . . . . 0.28999999999999998 109.298 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.19 150.64 34.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.461 -1.023 . . . . 1.0700000000000001 108.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.9 m -145.54 129.29 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 1.0900000000000001 109.699 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.73 137.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.096 -1.076 . . . . 1.0800000000000001 108.096 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.29 176.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.317 -0.864 . . . . 1.04 109.907 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -144.09 110.7 5.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.489 -0.93 . . . . 2.3399999999999999 108.489 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.99 -79.17 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.536 -1.283 . . . . 1.1799999999999999 107.536 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.12 -130.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.539 -1.652 . . . . 2.4700000000000002 106.539 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.0 t -105.28 54.86 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.985 -1.117 . . . . 1.8600000000000001 107.985 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.53 125.53 6.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.579 -0.701 . . . . 1.1200000000000001 109.156 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.2 mt -92.41 137.93 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.375 -0.828 . . . . 1.1499999999999999 109.519 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -139.9 167.22 22.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.432 -0.792 . . . . 2.6400000000000001 109.704 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -103.95 138.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.412 -0.805 . . . . 1.0800000000000001 109.203 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.03 134.13 20.16 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 1.0800000000000001 108.966 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.57 142.83 98.58 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 120.597 0.865 . . . . 0.48999999999999999 109.855 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' B' ' 262' ' ' ARG . 6.5 tpt180 -60.7 -34.32 74.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 3.5800000000000001 109.569 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -68.89 -7.19 32.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.27 -0.894 . . . . 4.3600000000000003 110.787 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -118.97 19.02 13.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.227 -0.921 . . . . 2.5800000000000001 108.79 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 168.74 19.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.849 -0.797 . . . . 1.05 108.849 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.44 129.76 23.83 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.139 -0.976 . . . . 2.2599999999999998 109.568 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.81 105.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.26 -0.9 . . . . 1.1799999999999999 109.728 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.67 152.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 1.27 108.737 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 58.7 ttt180 -90.95 146.13 24.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.361 -0.837 . . . . 4.1799999999999997 109.69 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.422 ' OXT' ' O ' ' B' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.933 -1.032 . . . . 2.0499999999999998 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.46 -0.57 . . . . 4.1799999999999997 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.41 138.54 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.898 -1.149 . . . . 2.5899999999999999 107.898 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -82.41 -141.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 2.6000000000000001 109.805 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -93.99 110.63 22.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 2.0099999999999998 109.657 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.7 130.39 38.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.785 -0.82 . . . . 0.81999999999999995 108.785 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -99.27 150.71 21.82 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.459 -1.311 . . . . 3.79 107.459 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.06 136.47 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.205 -0.935 . . . . 1.05 110.559 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -107.97 156.96 18.64 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.737 -1.209 . . . . 0.92000000000000004 107.737 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.2 p90 -157.84 152.67 25.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.569 -1.332 . . . . 1.01 110.334 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.7 mtm-85 -93.37 144.36 25.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.44 -0.788 . . . . 3.3999999999999999 109.837 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.75 175.4 6.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.405 -0.809 . . . . 2.23 109.328 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.68 -10.75 44.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.188 -0.945 . . . . 2.3199999999999998 109.247 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -89.67 -15.23 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 4.1799999999999997 109.617 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -159.55 129.28 3.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.143 -0.973 . . . . 2.1600000000000001 109.204 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.06 8.57 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 120.8 1.0 . . . . 1.3899999999999999 111.273 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.0 p -85.66 164.15 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.552 -1.342 . . . . 2.3100000000000001 110.291 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -76.03 163.49 27.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.746 -0.596 . . . . 0.71999999999999997 109.532 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 237' ' ' GLY . 2.5 mtpp -118.44 165.16 14.24 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 108.658 -0.867 . . . . 1.96 108.658 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.06 164.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.998 -1.241 . . . . 0.55000000000000004 109.998 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.89 159.97 43.36 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.471 1.447 . . . . 0.46999999999999997 110.659 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.56 164.22 30.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.508 -0.923 . . . . 1.05 108.508 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.67 143.52 26.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.023 -1.048 . . . . 3.1899999999999999 109.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.86 128.36 36.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.45 -0.781 . . . . 1.0900000000000001 110.563 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 mt -119.16 -70.61 0.78 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.515 -0.74 . . . . 1.1799999999999999 110.137 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -91.96 137.85 32.02 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.34000000000000002 110.634 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -144.07 115.72 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.985 -0.746 . . . . 2.79 108.985 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.71 -104.08 0.22 Allowed Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.839 -1.172 . . . . 0.28999999999999998 110.293 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.97 -157.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 1.5600000000000001 109.602 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 47.67 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.037 -1.625 . . . . 0.28999999999999998 109.037 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.34 151.98 38.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.519 -0.989 . . . . 1.0700000000000001 108.769 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.78 134.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 1.0900000000000001 109.435 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -95.5 138.11 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.137 -1.06 . . . . 1.0700000000000001 108.137 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.0 176.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 1.04 109.818 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.68 109.28 5.65 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.455 -0.943 . . . . 2.3399999999999999 108.455 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.7 -77.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.37 -1.344 . . . . 1.1799999999999999 107.37 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.23 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.937 -1.505 . . . . 2.4700000000000002 106.937 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.6 m -97.97 56.06 1.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.681 -1.229 . . . . 1.8700000000000001 107.681 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.56 130.37 7.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 1.1200000000000001 109.46 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.91 135.5 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 1.1499999999999999 109.329 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -136.52 168.99 18.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 2.6299999999999999 109.683 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.99 140.08 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.344 -0.848 . . . . 1.0800000000000001 109.568 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.78 126.1 13.23 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.396 -0.815 . . . . 1.0700000000000001 109.188 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.95 140.56 86.03 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.642 0.895 . . . . 0.48999999999999999 110.237 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -58.97 -37.33 76.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 3.5800000000000001 109.533 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -69.8 -1.64 9.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 4.3600000000000003 110.242 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -118.32 17.04 13.93 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.681 -0.859 . . . . 2.5800000000000001 108.681 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.85 175.14 9.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.421 -0.8 . . . . 1.05 109.724 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.8 128.46 21.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.316 -0.865 . . . . 2.2599999999999998 109.127 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.7 mm -88.74 109.72 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.43 -0.794 . . . . 1.1799999999999999 109.86 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.42 153.61 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.692 -0.855 . . . . 1.28 108.692 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.5 mtt-85 -94.78 136.98 34.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.272 -0.892 . . . . 4.1799999999999997 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.078 -1.014 . . . . 2.0499999999999998 109.626 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.564 -0.532 . . . . 4.1900000000000004 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.38 138.54 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.799 -1.186 . . . . 2.5899999999999999 107.799 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -82.26 -141.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.044 -1.035 . . . . 2.5899999999999999 109.875 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.85 110.51 22.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.406 -0.809 . . . . 2.0099999999999998 109.799 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.6 130.5 38.44 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.756 -0.831 . . . . 0.81999999999999995 108.756 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -99.46 150.68 21.94 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 3.7799999999999998 107.48 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.2 t -139.05 136.64 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.254 -0.904 . . . . 1.0600000000000001 110.476 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.09 157.09 18.57 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.649 -1.241 . . . . 0.92000000000000004 107.649 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.9 152.66 25.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.656 -1.278 . . . . 1.01 110.288 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.7 mtm-85 -93.38 144.39 25.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.374 -0.828 . . . . 3.3900000000000001 109.853 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.79 175.21 6.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.382 -0.824 . . . . 2.23 109.316 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.39 -10.98 44.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.262 -0.899 . . . . 2.3300000000000001 109.259 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -89.65 -15.2 33.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 4.1900000000000004 109.702 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.2 m-20 -159.59 129.28 3.31 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.961 . . . . 2.1600000000000001 109.249 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -65.03 8.35 0.22 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 120.882 1.055 . . . . 1.3999999999999999 111.21 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.0 p -85.4 164.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.557 -1.34 . . . . 2.3100000000000001 110.19 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -76.25 163.51 26.97 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.436 -0.579 . . . . 0.72999999999999998 109.436 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' B' ' 237' ' ' GLY . 2.5 mtpp -118.53 165.15 14.27 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.644 -0.873 . . . . 1.96 108.644 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.15 164.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.184 -1.167 . . . . 0.56000000000000005 110.184 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -64.9 160.0 43.3 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.488 1.459 . . . . 0.46999999999999997 110.643 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.63 164.09 31.12 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.586 -0.894 . . . . 1.05 108.586 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.71 143.63 26.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.007 -1.058 . . . . 3.1899999999999999 109.393 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.5 tp -90.04 128.45 36.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.594 -0.691 . . . . 1.0900000000000001 110.4 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 32.8 mt -119.25 -70.55 0.78 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.573 -0.704 . . . . 1.1799999999999999 110.102 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -92.01 137.86 32.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.152 -0.968 . . . . 0.34999999999999998 110.7 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -144.05 115.83 8.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.8 . . . . 2.7999999999999998 108.929 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -104.15 0.22 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.161 -1.176 . . . . 0.29999999999999999 110.161 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.98 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 1.5600000000000001 109.615 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.63 47.49 2.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.1 -1.6 . . . . 0.28999999999999998 109.1 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.22 151.95 38.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.997 . . . . 1.0700000000000001 108.865 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.79 134.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 109.502 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 89.9 t -95.48 138.04 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.155 -1.054 . . . . 1.0800000000000001 108.155 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.85 176.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 1.04 109.945 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.61 109.29 5.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.54 -0.911 . . . . 2.3399999999999999 108.54 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.76 -77.35 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.304 -1.369 . . . . 1.1799999999999999 107.304 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.19 -138.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.925 -1.509 . . . . 2.4700000000000002 106.925 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.4 m -97.96 55.98 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.68 -1.23 . . . . 1.8600000000000001 107.68 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.48 130.44 7.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.61 -0.681 . . . . 1.1200000000000001 109.394 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 55.5 mt -95.8 135.61 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 1.1499999999999999 109.307 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.71 169.03 18.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 2.6400000000000001 109.574 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.93 140.02 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 1.0800000000000001 109.611 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 53.3 t -138.69 126.05 13.31 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 1.0800000000000001 109.221 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.81 140.48 85.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 120.616 0.877 . . . . 0.48999999999999999 110.225 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -58.87 -37.33 76.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 3.5800000000000001 109.449 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -69.96 -1.4 9.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.245 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.402 ' HG3' HH12 ' B' ' 228' ' ' ARG . 2.5 mptm? -118.41 16.87 13.86 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.717 -0.846 . . . . 2.5800000000000001 108.717 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.82 175.29 9.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.413 -0.804 . . . . 1.05 109.742 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.9 128.47 21.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.438 -0.789 . . . . 2.2599999999999998 109.122 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -88.78 109.57 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.501 -0.749 . . . . 1.1799999999999999 109.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -105.22 153.59 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 108.742 -0.836 . . . . 1.27 108.742 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' B' ' 269' ' ' ARG . 3.6 mtt-85 -94.57 137.05 34.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.228 -0.92 . . . . 4.1799999999999997 109.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' B' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.045 -1.034 . . . . 2.0499999999999998 109.677 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 4.9 ptp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.373 -0.602 . . . . 4.1799999999999997 109.373 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.96 140.55 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 2.5899999999999999 109.25 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.8 -140.9 0.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.167 -0.958 . . . . 2.6000000000000001 109.686 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -92.75 104.62 16.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.268 -0.895 . . . . 2.0099999999999998 109.273 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.34 133.89 43.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.961 -0.755 . . . . 0.81999999999999995 108.961 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.73 158.69 17.39 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.192 -1.04 . . . . 3.79 108.192 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.98 140.04 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 1.05 110.08 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.42 155.43 20.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.72 -1.215 . . . . 0.92000000000000004 107.72 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.5 p90 -156.18 153.79 29.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 1.01 110.345 -179.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.93 141.16 29.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.76 . . . . 3.3999999999999999 109.645 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 9.7 p30 -92.32 162.67 14.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.306 -0.871 . . . . 2.23 109.002 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.3 -2.71 36.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 2.3199999999999998 109.842 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -89.91 -20.73 23.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.181 -0.949 . . . . 4.1799999999999997 109.541 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 234' ' ' VAL . 14.5 m-20 -162.1 130.96 3.03 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.978 . . . . 2.1600000000000001 108.969 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -63.57 8.44 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.751 0.968 . . . . 1.3899999999999999 110.422 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.1 m -82.77 139.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.037 -1.04 . . . . 2.3100000000000001 109.477 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -57.01 162.73 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.026 -1.046 . . . . 0.71999999999999997 109.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 237' ' ' GLY . 39.3 tttp -119.18 165.0 14.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.483 -0.761 . . . . 1.96 109.091 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.45 166.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.111 -1.196 . . . . 0.55000000000000004 110.111 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.51 162.18 43.06 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.641 1.561 . . . . 0.46999999999999997 110.405 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.53 178.47 7.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.966 -0.753 . . . . 1.05 108.966 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.94 140.93 29.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.134 -0.979 . . . . 3.1899999999999999 109.302 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.03 123.74 33.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.604 -0.685 . . . . 1.0900000000000001 109.736 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 28.0 mt -113.45 -74.69 0.62 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.436 -0.79 . . . . 1.1799999999999999 109.89 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.44 30.66 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.154 -0.966 . . . . 0.34000000000000002 109.783 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.26 116.93 8.13 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.667 -0.864 . . . . 2.79 108.667 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -100.84 0.18 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.8 -1.191 . . . . 0.28999999999999998 110.261 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.51 -157.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -1.096 . . . . 1.5600000000000001 109.842 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.09 49.51 2.92 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.163 -1.575 . . . . 0.28999999999999998 109.163 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.67 154.51 39.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -1.003 . . . . 1.0700000000000001 108.499 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.11 131.95 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.085 -1.009 . . . . 1.0900000000000001 109.862 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.6 t -93.84 135.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 1.0700000000000001 107.828 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -138.53 177.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.328 -0.858 . . . . 1.04 110.289 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.595 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.2 tt0 -145.07 111.5 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.581 -0.896 . . . . 2.3399999999999999 108.581 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.83 -78.32 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.2 -1.408 . . . . 1.1799999999999999 107.2 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -81.88 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.708 -1.59 . . . . 2.4700000000000002 106.708 177.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 t -101.7 55.82 0.82 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.038 -1.097 . . . . 1.8700000000000001 108.038 177.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -155.35 124.52 6.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.615 -0.678 . . . . 1.1200000000000001 109.183 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.595 ' CG1' HE21 ' A' ' 252' ' ' GLN . 70.8 mt -93.52 134.87 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 1.1499999999999999 109.202 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -137.42 167.81 20.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 2.6299999999999999 110.039 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 70.7 t -102.25 139.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.55 -0.719 . . . . 1.0800000000000001 109.256 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.7 t -136.73 127.97 16.64 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.878 -0.786 . . . . 1.0700000000000001 108.878 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.8 138.61 86.7 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.913 -0.841 . . . . 0.48999999999999999 109.913 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.27 -32.27 66.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 3.5800000000000001 109.428 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.467 HH11 ' HG3' ' A' ' 263' ' ' ARG . 5.1 ttm-85 -67.29 -8.77 34.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.204 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -120.25 18.31 12.26 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.384 -0.823 . . . . 2.5800000000000001 109.187 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.26 168.6 19.4 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.65 -0.656 . . . . 1.05 109.4 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -141.6 130.99 23.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 2.2599999999999998 109.169 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.97 114.77 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 1.1799999999999999 109.946 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.66 154.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.69 -0.856 . . . . 1.28 108.69 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.572 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.4 mtt-85 -89.6 140.43 29.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 109.218 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 2.0499999999999998 109.414 179.915 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 4.8 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.394 -0.595 . . . . 4.1900000000000004 109.394 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.99 140.52 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 2.5899999999999999 109.252 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -85.76 -140.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 2.5899999999999999 109.707 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -92.64 104.67 16.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 2.0099999999999998 109.294 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.41 133.92 43.0 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.937 -0.764 . . . . 0.81999999999999995 108.937 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -108.67 158.66 17.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.272 -1.01 . . . . 3.7799999999999998 108.272 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.9 t -140.89 140.0 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 1.0600000000000001 110.145 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.28 155.42 19.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.69 -1.226 . . . . 0.92000000000000004 107.69 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.5 p90 -156.15 153.73 29.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.7 -1.25 . . . . 1.01 110.376 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.92 141.27 29.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.576 -0.703 . . . . 3.3900000000000001 109.578 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 9.8 p30 -92.34 162.65 14.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.284 -0.885 . . . . 2.23 109.041 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.26 -2.76 36.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 2.3300000000000001 109.812 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -89.82 -20.98 22.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.124 -0.985 . . . . 4.1900000000000004 109.548 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' B' ' 234' ' ' VAL . 14.6 m-20 -161.82 130.98 3.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 2.1600000000000001 108.98 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.51 8.37 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.712 0.941 . . . . 1.3999999999999999 110.454 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.2 m -82.73 139.48 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 2.3100000000000001 109.409 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.12 162.68 2.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.72999999999999998 109.53 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -119.19 164.99 14.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.38 -0.825 . . . . 1.96 109.089 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.54 166.59 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.56000000000000005 110.064 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.44 162.15 43.23 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.721 1.614 . . . . 0.46999999999999997 110.426 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.47 178.44 7.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.926 -0.768 . . . . 1.05 108.926 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.85 141.02 29.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.14 -0.975 . . . . 3.1899999999999999 109.368 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.01 123.7 33.57 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.568 -0.707 . . . . 1.0900000000000001 109.701 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 28.2 mt -113.47 -74.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.414 -0.804 . . . . 1.1799999999999999 109.859 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.28 30.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.264 -0.897 . . . . 0.34999999999999998 109.776 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.14 116.98 8.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.657 -0.868 . . . . 2.7999999999999998 108.657 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.83 -100.82 0.18 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.732 -1.223 . . . . 0.29999999999999999 110.225 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.46 -157.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 1.5600000000000001 109.816 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 49.81 3.01 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.09 -1.604 . . . . 0.28999999999999998 109.09 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.42 39.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -1.037 . . . . 1.0700000000000001 108.49 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.0 m -146.1 131.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0900000000000001 109.818 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.83 134.92 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.795 -1.187 . . . . 1.0800000000000001 107.795 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -138.43 177.93 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.219 -0.926 . . . . 1.04 110.319 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.606 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.1 tt0 -145.08 111.47 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.618 -0.882 . . . . 2.3399999999999999 108.618 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.8 -78.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.15 -1.426 . . . . 1.1799999999999999 107.15 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.84 -133.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.733 -1.58 . . . . 2.4700000000000002 106.733 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.3 t -101.83 55.85 0.81 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.977 -1.12 . . . . 1.8600000000000001 107.977 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -155.26 124.6 6.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 1.1200000000000001 109.168 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.606 ' CG1' HE21 ' B' ' 252' ' ' GLN . 71.2 mt -93.66 134.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.284 -0.885 . . . . 1.1499999999999999 109.123 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -137.38 167.86 20.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.337 -0.852 . . . . 2.6400000000000001 110.102 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 71.0 t -102.34 139.82 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.676 . . . . 1.0800000000000001 109.274 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.67 128.07 16.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.914 -0.773 . . . . 1.0800000000000001 108.914 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.89 138.58 86.52 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 N-CA-C 109.928 -0.835 . . . . 0.48999999999999999 109.928 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.28 -32.22 66.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 3.5800000000000001 109.443 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.471 ' HG3' HH11 ' B' ' 263' ' ' ARG . 5.2 ttm-85 -67.41 -8.76 35.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.478 -0.764 . . . . 4.3600000000000003 110.12 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -120.2 18.23 12.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.312 -0.868 . . . . 2.5800000000000001 109.162 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.23 168.44 19.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 1.05 109.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -141.51 130.9 23.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.286 -0.884 . . . . 2.2599999999999998 109.175 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.81 114.75 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.243 -0.911 . . . . 1.1799999999999999 109.917 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.67 154.49 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.713 -0.847 . . . . 1.27 108.713 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.4 mtt-85 -89.51 140.36 29.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.88 . . . . 4.1799999999999997 109.211 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.089 -0.958 . . . . 2.0499999999999998 109.382 179.892 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 219' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.363 0.601 . . . . 4.1799999999999997 109.384 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.35 140.48 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.347 -0.846 . . . . 2.5899999999999999 109.075 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.62 -117.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 2.6000000000000001 109.883 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -98.94 111.36 23.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.906 . . . . 2.0099999999999998 109.119 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -135.12 142.25 46.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.427 -0.796 . . . . 0.81999999999999995 109.524 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -115.64 153.8 30.63 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.238 -1.393 . . . . 3.79 107.238 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.2 t -140.74 141.91 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.099 -1.001 . . . . 1.05 110.472 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -109.22 155.0 21.61 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.256 -1.387 . . . . 0.92000000000000004 107.256 178.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -156.19 155.6 32.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.547 -1.346 . . . . 1.01 110.618 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -100.68 133.13 45.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.475 0.655 . . . . 3.3999999999999999 109.358 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 22.2 p-10 -92.35 171.65 8.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.001 -0.741 . . . . 2.23 109.001 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 78.9 p -87.45 -9.15 55.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 2.3199999999999998 109.661 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.32 -12.24 41.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.91 . . . . 4.1799999999999997 109.365 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -161.27 128.54 2.65 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.296 -1.001 . . . . 2.1600000000000001 108.296 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.53 -1.4 9.05 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 120.789 0.993 . . . . 1.3899999999999999 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 137.89 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.745 -1.222 . . . . 2.3100000000000001 110.005 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -50.35 166.98 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.089 -1.007 . . . . 0.71999999999999997 109.219 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 237' ' ' GLY . 1.9 mtpp -119.65 166.37 13.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.67 -0.863 . . . . 1.96 108.67 179.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.31 168.78 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.823 -1.311 . . . . 0.55000000000000004 109.823 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -66.96 158.87 54.58 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.685 1.59 . . . . 0.46999999999999997 110.618 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.0 171.02 15.14 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.061 -0.718 . . . . 1.05 109.061 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -94.1 139.14 31.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.179 -0.951 . . . . 3.1899999999999999 109.733 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.55 126.11 35.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.551 . . . . 1.0900000000000001 109.515 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.89 -72.06 0.71 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.389 -0.819 . . . . 1.1799999999999999 110.362 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.473 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.97 142.62 27.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.105 -0.997 . . . . 0.34000000000000002 110.032 -178.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -148.68 118.59 7.13 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 2.79 109.459 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.22 0.17 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.842 -1.17 . . . . 0.28999999999999998 110.21 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.6 -155.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -1.076 . . . . 1.5600000000000001 109.931 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.87 48.71 3.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.689 -1.364 . . . . 0.28999999999999998 109.689 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.88 154.96 41.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.379 -1.071 . . . . 1.0700000000000001 108.612 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.39 128.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.075 -1.015 . . . . 1.0900000000000001 109.787 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.06 132.69 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.955 -1.128 . . . . 1.0700000000000001 107.955 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.2 pt -135.64 177.68 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.911 . . . . 1.04 109.864 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -143.69 107.56 4.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.423 -0.798 . . . . 2.3399999999999999 109.016 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.93 -76.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.748 -1.575 . . . . 1.1799999999999999 106.748 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -163.32 0.55 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.999 -1.852 . . . . 2.4700000000000002 105.999 177.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.1 p -79.47 48.79 0.94 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.599 -1.313 . . . . 1.8700000000000001 108.288 178.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.31 126.7 11.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 109.175 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.503 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.9 mt -92.07 141.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 1.1499999999999999 109.846 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -139.95 167.98 20.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -0.785 . . . . 2.6299999999999999 109.796 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.19 137.45 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.358 -0.839 . . . . 1.0800000000000001 109.241 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.2 130.56 19.31 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.461 -0.774 . . . . 1.0700000000000001 109.038 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.16 137.11 80.35 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 N-CA-C 109.892 -0.849 . . . . 0.48999999999999999 109.892 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.18 -35.35 69.49 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.202 -0.936 . . . . 3.5800000000000001 109.427 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.82 -5.24 19.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.408 -0.807 . . . . 4.3600000000000003 110.257 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.9 22.46 11.93 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.472 -0.936 . . . . 2.5800000000000001 108.472 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.64 166.02 26.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 1.05 109.14 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.17 128.19 25.63 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.371 -0.831 . . . . 2.2599999999999998 109.326 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.46 110.34 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 1.1799999999999999 109.834 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.2 mm -105.31 156.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.452 -0.944 . . . . 1.28 108.452 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.98 138.83 31.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.06 -1.025 . . . . 4.1799999999999997 109.229 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.038 -0.982 . . . . 2.0499999999999998 109.506 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 219' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' B' ' 219' ' ' MET . 3.9 mpp? . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.315 0.579 . . . . 4.1900000000000004 109.45 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.23 140.42 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.31 -0.869 . . . . 2.5899999999999999 109.109 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -85.55 -117.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 2.5899999999999999 109.964 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -98.97 111.37 23.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.302 -0.874 . . . . 2.0099999999999998 109.111 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -135.04 142.21 46.31 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.419 -0.8 . . . . 0.81999999999999995 109.496 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.3 OUTLIER -115.65 153.84 30.56 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.239 -1.393 . . . . 3.7799999999999998 107.239 178.748 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.72 141.83 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.96 . . . . 1.0600000000000001 110.571 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -109.24 155.01 21.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.162 -1.421 . . . . 0.92000000000000004 107.162 178.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.1 p90 -156.12 155.69 32.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.604 -1.31 . . . . 1.01 110.63 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -100.94 132.99 46.09 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 3.3900000000000001 109.442 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 22.3 p-10 -92.21 171.63 8.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 2.23 109.029 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 80.0 p -87.52 -9.09 55.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 2.3300000000000001 109.633 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.2 -12.44 40.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.93 . . . . 4.1900000000000004 109.348 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -161.17 128.47 2.66 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.305 -0.998 . . . . 2.1600000000000001 108.305 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -70.41 -1.49 9.09 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 120.819 1.012 . . . . 1.3999999999999999 111.065 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.02 137.85 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.749 -1.22 . . . . 2.3100000000000001 109.933 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -50.49 166.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.073 -1.017 . . . . 0.72999999999999998 109.182 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' B' ' 237' ' ' GLY . 1.9 mtpp -119.68 166.23 13.47 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.587 -0.894 . . . . 1.96 108.587 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.18 168.64 0.04 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.863 -1.295 . . . . 0.56000000000000005 109.863 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.83 158.99 53.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.612 1.541 . . . . 0.46999999999999997 110.749 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.16 170.84 15.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.048 -0.723 . . . . 1.05 109.048 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -93.87 139.06 31.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.077 -1.015 . . . . 3.1899999999999999 109.77 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -89.48 126.05 35.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.749 -0.594 . . . . 1.0900000000000001 109.531 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.75 -72.03 0.71 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.48 -0.762 . . . . 1.1799999999999999 110.352 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.503 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.3 t90 -91.1 142.66 27.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.045 -1.034 . . . . 0.34999999999999998 109.988 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -148.65 118.53 7.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.239 -0.913 . . . . 2.7999999999999998 109.488 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.04 0.17 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.856 -1.164 . . . . 0.29999999999999999 110.245 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.63 -155.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.377 -1.072 . . . . 1.5600000000000001 109.974 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.94 48.59 3.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.727 -1.349 . . . . 0.28999999999999998 109.727 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.79 155.07 41.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 1.0700000000000001 108.59 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.44 128.73 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.728 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.1 132.71 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.967 -1.123 . . . . 1.0800000000000001 107.967 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 1.04 109.848 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -143.65 107.64 4.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 2.3399999999999999 109.079 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.05 -76.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.762 -1.57 . . . . 1.1799999999999999 106.762 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -163.25 0.54 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.975 -1.861 . . . . 2.4700000000000002 105.975 177.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 15.2 p -79.53 48.85 0.95 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.519 -1.363 . . . . 1.8600000000000001 108.315 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.37 126.72 11.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.533 -0.729 . . . . 1.1200000000000001 109.213 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.8 mt -92.07 141.57 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 1.1499999999999999 109.824 -179.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -140.09 167.96 20.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.344 -0.848 . . . . 2.6400000000000001 109.815 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.12 137.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.391 -0.818 . . . . 1.0800000000000001 109.279 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.17 130.58 19.35 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.455 -0.778 . . . . 1.0800000000000001 108.991 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.27 137.07 79.98 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 109.86 -0.862 . . . . 0.48999999999999999 109.86 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -57.05 -35.54 69.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 3.5800000000000001 109.433 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.81 -5.05 18.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.824 . . . . 4.3600000000000003 110.372 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.87 22.22 12.06 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.542 -0.91 . . . . 2.5800000000000001 108.542 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.4 166.16 25.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.535 -0.728 . . . . 1.05 109.133 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -138.21 128.1 25.41 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.361 -0.837 . . . . 2.2599999999999998 109.396 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.43 110.31 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 1.1799999999999999 109.888 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.3 mm -105.33 156.9 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.421 -0.955 . . . . 1.27 108.421 179.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.97 138.78 31.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.13 -0.981 . . . . 4.1799999999999997 109.253 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.068 -1.02 . . . . 2.0499999999999998 109.532 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.245 -0.65 . . . . 4.1799999999999997 109.245 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.486 ' H ' ' CD1' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.3 113.16 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.436 -0.949 . . . . 2.5899999999999999 108.436 -179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -86.13 -126.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 2.6000000000000001 109.902 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -96.03 102.93 14.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.501 -0.75 . . . . 2.0099999999999998 109.297 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.08 141.97 47.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.518 -0.739 . . . . 0.81999999999999995 109.166 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -116.96 157.71 25.29 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.558 -1.275 . . . . 3.79 107.558 178.827 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.39 145.45 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.949 -1.094 . . . . 1.05 110.55 -179.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.79 161.97 15.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.017 -1.105 . . . . 0.92000000000000004 108.017 178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.84 149.54 23.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.87 -1.144 . . . . 1.01 110.231 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.73 159.03 15.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 3.3999999999999999 109.881 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.9 OUTLIER -95.45 170.91 9.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.041 -0.726 . . . . 2.23 109.041 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.9 t -91.37 -15.05 29.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 2.3199999999999998 108.982 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.563 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.3 mtt-85 -90.21 -15.07 32.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.857 . . . . 4.1799999999999997 109.793 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.7 m-20 -161.19 128.8 2.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 2.1600000000000001 109.173 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.77 17.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.813 1.008 . . . . 1.3899999999999999 110.603 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 232' ' ' ASP . 32.7 m -80.9 130.93 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.785 -1.197 . . . . 2.3100000000000001 109.834 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.78 174.82 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.71999999999999997 109.398 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -122.62 -166.24 1.4 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.206 -1.035 . . . . 1.96 108.206 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.12 -179.31 51.75 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.287 -1.525 . . . . 0.55000000000000004 109.287 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.4 149.01 49.72 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.695 1.596 . . . . 0.46999999999999997 110.446 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.28 167.1 22.25 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.99 -0.744 . . . . 1.05 108.99 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -91.54 140.81 29.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.047 -1.033 . . . . 3.1899999999999999 110.081 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.03 129.85 35.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.807 -0.558 . . . . 1.0900000000000001 109.8 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.1 mt -118.03 -72.54 0.68 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.57 -0.707 . . . . 1.1799999999999999 110.42 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.405 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.24 143.23 26.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.34000000000000002 110.845 -178.04 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -143.89 112.6 6.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.839 -0.801 . . . . 2.79 108.839 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.67 -103.58 0.36 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.968 -1.253 . . . . 0.28999999999999998 109.968 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.43 -154.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -1.162 . . . . 1.5600000000000001 109.503 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.25 3.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.7 -1.76 . . . . 0.28999999999999998 108.7 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.69 35.84 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.57 -0.959 . . . . 1.0700000000000001 108.603 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.11 128.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.083 -1.011 . . . . 1.0900000000000001 109.619 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 54.1 t -92.84 128.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.212 -1.032 . . . . 1.0700000000000001 108.212 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.42 -179.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -0.793 . . . . 1.04 109.865 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.545 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.5 tt0 -142.66 109.96 5.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.278 -1.008 . . . . 2.3399999999999999 108.278 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -86.03 -81.02 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.298 -1.371 . . . . 1.1799999999999999 107.298 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.837 -1.542 . . . . 2.4700000000000002 106.837 177.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 35.0 t -100.58 53.71 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.052 -1.092 . . . . 1.8700000000000001 108.052 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.53 124.23 5.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 1.1200000000000001 109.375 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.545 ' CG1' HE21 ' A' ' 252' ' ' GLN . 22.2 mt -90.46 131.19 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.902 . . . . 1.1499999999999999 109.257 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.555 ' CB ' ' HZ1' ' A' ' 258' ' ' LYS . 0.0 OUTLIER -131.64 167.99 18.5 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.446 -0.784 . . . . 2.6299999999999999 109.74 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 142.06 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 1.0800000000000001 109.446 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.16 130.09 17.19 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.485 -0.932 . . . . 1.0700000000000001 108.485 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.19 141.99 90.18 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 N-CA-C 109.93 -0.834 . . . . 0.48999999999999999 109.93 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.94 -31.15 66.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 3.5800000000000001 109.101 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.08 -11.21 60.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.398 -0.814 . . . . 4.3600000000000003 110.325 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.09 21.91 12.11 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 2.5800000000000001 108.991 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.03 16.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.472 -0.767 . . . . 1.05 109.339 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -140.53 125.67 18.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 2.2599999999999998 109.262 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.35 113.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.234 -0.917 . . . . 1.1799999999999999 109.17 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.01 153.67 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.455 -0.778 . . . . 1.28 109.044 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 269' ' ' ARG . 18.4 mtm-85 -95.7 135.88 36.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.468 -0.77 . . . . 4.1799999999999997 109.485 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 2.0499999999999998 109.14 179.5 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 4.1900000000000004 109.193 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.498 ' H ' ' CD1' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.26 113.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 2.5899999999999999 108.489 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -86.15 -126.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 2.5899999999999999 109.899 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -95.97 102.94 14.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.767 . . . . 2.0099999999999998 109.36 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -134.09 141.9 47.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.411 -0.806 . . . . 0.81999999999999995 109.138 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -116.83 157.7 25.16 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.566 -1.272 . . . . 3.7799999999999998 107.566 178.769 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.41 145.47 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.008 -1.057 . . . . 1.0600000000000001 110.624 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.8 162.06 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.956 -1.127 . . . . 0.92000000000000004 107.956 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.6 p90 -156.85 149.57 23.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.882 -1.136 . . . . 1.01 110.194 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -96.67 159.09 15.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 3.3900000000000001 109.945 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -95.55 170.9 9.02 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.996 -0.742 . . . . 2.23 108.996 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.5 t -91.4 -15.09 29.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 2.3300000000000001 108.827 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' B' ' 231' ' ' ARG . 2.3 mtt-85 -90.23 -14.99 32.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 4.1900000000000004 109.81 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.6 m-20 -161.15 128.9 2.76 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 2.1600000000000001 109.114 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.93 17.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.844 1.03 . . . . 1.3999999999999999 110.602 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' B' ' 232' ' ' ASP . 32.7 m -80.93 130.9 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.916 -1.115 . . . . 2.3100000000000001 109.826 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.8 174.89 0.14 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -0.936 . . . . 0.72999999999999998 109.532 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -122.66 -166.22 1.4 Allowed 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 108.157 -1.053 . . . . 1.96 108.157 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.1 -179.2 51.75 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.321 -1.512 . . . . 0.56000000000000005 109.321 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.42 149.0 49.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.803 1.669 . . . . 0.46999999999999997 110.421 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.35 167.12 22.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.944 -0.762 . . . . 1.05 108.944 179.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -91.57 140.76 29.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.0 -1.063 . . . . 3.1899999999999999 110.069 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 tp -88.92 129.77 35.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.751 -0.593 . . . . 1.0900000000000001 109.814 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.91 -72.58 0.68 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.363 -0.836 . . . . 1.1799999999999999 110.416 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -90.27 143.06 27.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.34999999999999998 110.887 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' B' ' 244' ' ' LYS . 0.9 OUTLIER -143.68 112.72 6.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.807 . . . . 2.7999999999999998 108.938 179.172 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.65 -103.58 0.36 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.896 -1.281 . . . . 0.29999999999999999 109.896 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.37 -154.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -1.119 . . . . 1.5600000000000001 109.492 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.23 3.54 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.678 -1.769 . . . . 0.28999999999999998 108.678 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.57 35.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.582 -0.952 . . . . 1.0700000000000001 108.644 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.05 128.7 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.034 -1.041 . . . . 1.0900000000000001 109.679 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.81 128.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.195 -1.039 . . . . 1.0800000000000001 108.195 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.5 pt -134.31 -179.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.377 -0.827 . . . . 1.04 109.908 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.546 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -142.7 109.82 5.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.378 -0.971 . . . . 2.3399999999999999 108.378 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -85.98 -81.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.281 -1.377 . . . . 1.1799999999999999 107.281 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.48 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.823 -1.547 . . . . 2.4700000000000002 106.823 177.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 34.9 t -100.6 53.73 0.87 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.046 -1.094 . . . . 1.8600000000000001 108.046 178.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.54 124.42 5.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.604 -0.685 . . . . 1.1200000000000001 109.327 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.546 ' CG1' HE21 ' B' ' 252' ' ' GLN . 21.9 mt -90.59 131.16 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.25 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . 0.552 ' CB ' ' HZ1' ' B' ' 258' ' ' LYS . 0.0 OUTLIER -131.63 168.0 18.48 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 2.6400000000000001 109.743 -179.613 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.64 142.11 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.457 -0.777 . . . . 1.0800000000000001 109.436 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 51.0 t -137.19 130.01 17.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.45 -0.944 . . . . 1.0800000000000001 108.45 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 141.91 90.47 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.904 -0.845 . . . . 0.48999999999999999 109.904 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.93 -31.15 66.54 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 3.5800000000000001 109.132 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -70.13 -11.09 60.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 4.3600000000000003 110.373 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.16 21.94 12.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.271 -0.893 . . . . 2.5800000000000001 108.899 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.05 16.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 1.05 109.324 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -140.59 125.67 18.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 2.2599999999999998 109.279 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.25 113.1 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -0.915 . . . . 1.1799999999999999 109.235 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.92 153.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 1.27 109.093 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' B' ' 269' ' ' ARG . 18.5 mtm-85 -95.75 135.93 36.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 4.1799999999999997 109.392 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.912 -1.042 . . . . 2.0499999999999998 109.029 179.48 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 219' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.325 0.583 . . . . 4.1799999999999997 109.428 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.2 tt -82.64 129.79 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 2.5899999999999999 109.383 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -87.29 -122.26 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.92 -1.112 . . . . 2.6000000000000001 109.267 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -101.25 110.51 22.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.177 -0.952 . . . . 2.0099999999999998 110.143 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -135.5 125.23 25.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.438 -0.789 . . . . 0.81999999999999995 109.09 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -101.44 159.12 15.55 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.243 -1.021 . . . . 3.79 108.243 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.19 143.77 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.099 -1.001 . . . . 1.05 110.895 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.42 156.73 19.11 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.243 -1.391 . . . . 0.92000000000000004 107.243 178.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.9 p90 -157.69 152.86 25.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.549 -1.345 . . . . 1.01 110.697 -179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -99.49 135.3 41.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.622 -0.674 . . . . 3.3999999999999999 109.751 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 230' ' ' SER . 22.0 t70 -95.85 178.93 5.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.847 . . . . 2.23 109.185 179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.433 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 73.9 p -91.21 -10.8 40.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.916 . . . . 2.3199999999999998 109.429 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 232' ' ' ASP . 53.6 mtp180 -84.1 -19.05 34.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.205 -0.935 . . . . 4.1799999999999997 109.481 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 231' ' ' ARG . 43.2 m-20 -159.37 129.04 3.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.323 -0.861 . . . . 2.1600000000000001 109.152 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.41 1.83 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.76 0.974 . . . . 1.3899999999999999 110.442 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.73 136.24 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.939 -1.101 . . . . 2.3100000000000001 110.218 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.28 163.62 0.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.71999999999999997 109.239 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.4 mtpt -119.85 166.74 12.89 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.459 -0.776 . . . . 1.96 109.561 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.16 166.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.457 -1.057 . . . . 0.55000000000000004 110.457 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.61 159.73 39.51 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.591 1.528 . . . . 0.46999999999999997 110.579 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.39 169.56 17.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.864 -0.791 . . . . 1.05 108.864 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -92.32 136.17 33.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.981 -1.074 . . . . 3.1899999999999999 109.537 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.2 116.84 26.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.671 -0.643 . . . . 1.0900000000000001 109.313 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.9 mt -104.82 -71.7 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.246 -0.908 . . . . 1.1799999999999999 109.838 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -94.08 146.98 23.58 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.107 -0.996 . . . . 0.34000000000000002 110.473 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.02 120.96 8.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.827 . . . . 2.79 109.017 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -108.58 0.3 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.78 -1.2 . . . . 0.28999999999999998 110.332 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.76 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 1.5600000000000001 109.69 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 47.91 2.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.994 -1.642 . . . . 0.28999999999999998 108.994 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.29 146.85 30.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.976 . . . . 1.0700000000000001 108.736 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.12 128.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.954 . . . . 1.0900000000000001 109.247 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.8 t -89.13 140.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.198 -1.038 . . . . 1.0700000000000001 108.198 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.38 179.28 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.919 . . . . 1.04 110.253 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.425 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.4 tt0 -141.23 112.16 7.2 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.562 -0.903 . . . . 2.3399999999999999 108.562 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.71 -81.08 0.29 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.549 -1.278 . . . . 1.1799999999999999 107.549 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' SER . 32.7 t-20 -80.34 -129.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.783 -1.562 . . . . 2.4700000000000002 106.783 177.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.6 t -104.19 53.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.245 -1.02 . . . . 1.8700000000000001 108.245 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.12 129.72 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.02 -0.733 . . . . 1.1200000000000001 109.02 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CG1' HE21 ' A' ' 252' ' ' GLN . 67.9 mt -92.23 139.28 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 1.1499999999999999 109.558 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.12 165.13 28.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 2.6299999999999999 109.954 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.92 138.55 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.468 -0.77 . . . . 1.0800000000000001 109.054 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -137.04 133.05 18.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.738 -0.838 . . . . 1.0700000000000001 108.738 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.38 141.14 89.56 Favored 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 120.836 1.024 . . . . 0.48999999999999999 110.512 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 3.5800000000000001 109.448 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.414 ' HG2' ' NH1' ' A' ' 263' ' ' ARG . 0.6 OUTLIER -69.45 -8.18 44.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 4.3600000000000003 110.526 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.77 20.74 12.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.127 -0.983 . . . . 2.5800000000000001 109.282 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.9 16.95 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.01 -0.737 . . . . 1.05 109.01 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -139.71 122.59 16.59 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.219 -0.926 . . . . 2.2599999999999998 108.977 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.82 107.42 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.145 -0.972 . . . . 1.1799999999999999 109.997 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.04 151.11 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.451 -0.944 . . . . 1.28 108.451 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -90.55 143.77 26.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.343 -0.848 . . . . 4.1799999999999997 109.726 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.053 -0.975 . . . . 2.0499999999999998 109.416 179.662 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 219' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' B' ' 219' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.416 -0.587 . . . . 4.1900000000000004 109.416 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 15.1 tt -82.83 129.87 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.308 -0.87 . . . . 2.5899999999999999 109.261 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.19 -122.53 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.96 -1.087 . . . . 2.5899999999999999 109.295 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -100.99 110.53 22.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.196 -0.94 . . . . 2.0099999999999998 110.199 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -135.5 125.25 25.44 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.435 -0.791 . . . . 0.81999999999999995 109.067 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -101.37 159.18 15.49 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.181 -1.044 . . . . 3.7799999999999998 108.181 179.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 59.1 t -142.3 143.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.123 -0.985 . . . . 1.0600000000000001 110.978 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -108.41 156.77 19.07 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.235 -1.394 . . . . 0.92000000000000004 107.235 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.7 p90 -157.64 152.9 25.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.595 -1.316 . . . . 1.01 110.649 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -99.54 135.13 41.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.601 -0.687 . . . . 3.3900000000000001 109.749 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' B' ' 230' ' ' SER . 22.1 t70 -95.68 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 2.23 109.182 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 230' ' ' SER . . . . . 0.431 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 74.2 p -91.13 -10.84 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 2.3300000000000001 109.492 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' B' ' 232' ' ' ASP . 53.5 mtp180 -84.08 -19.03 35.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 4.1900000000000004 109.505 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' B' ' 231' ' ' ARG . 43.5 m-20 -159.5 129.03 3.24 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 2.1600000000000001 109.053 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.28 1.7 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.792 0.995 . . . . 1.3999999999999999 110.442 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -84.57 136.14 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.868 -1.145 . . . . 2.3100000000000001 110.258 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -52.31 163.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.215 -0.928 . . . . 0.72999999999999998 109.311 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mtpt -119.78 166.93 12.61 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.261 -0.899 . . . . 1.96 109.511 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.35 166.55 0.02 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.358 -1.097 . . . . 0.56000000000000005 110.358 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.6 159.92 38.61 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.523 1.482 . . . . 0.46999999999999997 110.54 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.45 169.53 17.54 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.922 -0.77 . . . . 1.05 108.922 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -92.32 136.2 33.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.11 -0.994 . . . . 3.1899999999999999 109.596 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.27 116.79 26.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.644 . . . . 1.0900000000000001 109.284 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -104.71 -71.74 0.73 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.271 -0.893 . . . . 1.1799999999999999 109.872 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -94.12 146.98 23.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.179 -0.95 . . . . 0.34999999999999998 110.415 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.09 121.08 8.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.375 -0.828 . . . . 2.7999999999999998 108.931 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -108.65 0.3 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.785 -1.198 . . . . 0.29999999999999999 110.335 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.68 -151.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -1.08 . . . . 1.5600000000000001 109.761 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.18 47.98 2.7 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.918 -1.673 . . . . 0.28999999999999998 108.918 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.35 146.88 30.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.491 -1.005 . . . . 1.0700000000000001 108.745 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.2 128.06 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 1.0900000000000001 109.277 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.07 139.96 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.219 -1.03 . . . . 1.0800000000000001 108.219 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.37 179.27 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 1.04 110.299 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.427 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.4 tt0 -141.25 112.21 7.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.468 -0.938 . . . . 2.3399999999999999 108.468 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.7 -81.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.549 -1.278 . . . . 1.1799999999999999 107.549 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' B' ' 255' ' ' SER . 32.6 t-20 -80.29 -129.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.866 -1.531 . . . . 2.4700000000000002 106.866 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 8.7 t -104.32 53.27 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.106 -1.072 . . . . 1.8600000000000001 108.106 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.15 129.8 8.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 1.1200000000000001 108.982 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.427 ' CG1' HE21 ' B' ' 252' ' ' GLN . 68.1 mt -92.31 139.32 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.26 -0.9 . . . . 1.1499999999999999 109.519 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.19 165.18 28.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.333 -0.855 . . . . 2.6400000000000001 109.932 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.92 138.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.427 -0.795 . . . . 1.0800000000000001 109.065 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.05 132.98 18.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.677 -0.86 . . . . 1.0800000000000001 108.677 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.24 141.28 88.45 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.776 0.984 . . . . 0.48999999999999999 110.599 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -59.71 -32.6 70.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 3.5800000000000001 109.368 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.413 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 0.6 OUTLIER -69.35 -8.31 45.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.36 -0.838 . . . . 4.3600000000000003 110.56 -179.195 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.65 20.66 12.85 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.225 -0.922 . . . . 2.5800000000000001 109.274 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.72 17.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 1.05 109.101 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -139.53 122.57 16.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.228 -0.92 . . . . 2.2599999999999998 108.981 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.76 107.4 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.252 -0.905 . . . . 1.1799999999999999 109.977 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.06 151.23 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.39 -0.967 . . . . 1.27 108.39 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -90.69 143.66 26.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 4.1799999999999997 109.724 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.948 -1.025 . . . . 2.0499999999999998 109.484 179.655 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.396 -0.594 . . . . 4.1799999999999997 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.481 ' CD1' ' H ' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.83 109.82 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.456 -0.942 . . . . 2.5899999999999999 108.456 -179.869 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -83.13 -112.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 2.6000000000000001 109.629 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -100.31 102.01 13.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.31 -0.869 . . . . 2.0099999999999998 109.532 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.27 130.41 38.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.81999999999999995 109.191 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -105.57 156.32 18.35 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.456 -0.942 . . . . 3.79 108.456 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -139.1 142.86 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.361 -0.837 . . . . 1.05 110.098 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -109.22 152.07 25.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.312 -1.366 . . . . 0.92000000000000004 107.312 178.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.4 p90 -156.03 157.59 36.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.555 -1.341 . . . . 1.01 110.724 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -100.05 140.04 34.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.59 -0.694 . . . . 3.3999999999999999 109.291 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 232' ' ' ASP . 5.1 p-10 -93.33 176.78 6.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 2.23 109.467 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.6 t -89.02 -11.95 42.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 2.3199999999999998 109.508 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 20.3 mmm180 -86.88 -11.97 49.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.088 -1.008 . . . . 4.1799999999999997 109.417 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.5 ' N ' ' OD2' ' A' ' 229' ' ' ASP . 48.0 m-20 -161.95 129.52 2.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 2.1600000000000001 108.95 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.6 4.83 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.64 0.893 . . . . 1.3899999999999999 110.024 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.2 t -83.4 154.54 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.013 . . . . 2.3100000000000001 110.024 -179.385 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.41 163.6 22.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.71999999999999997 109.071 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 4.9 mtpp -119.6 165.86 13.91 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.843 -0.799 . . . . 1.96 108.843 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -47.0 171.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.688 -1.365 . . . . 0.55000000000000004 109.688 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.7 160.88 46.18 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.568 1.512 . . . . 0.46999999999999997 110.522 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.07 13.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.489 -0.757 . . . . 1.05 109.053 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.49 134.67 34.45 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.165 -0.959 . . . . 3.1899999999999999 109.344 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.37 124.68 34.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.576 -0.703 . . . . 1.0900000000000001 109.225 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.83 -72.47 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.469 -0.769 . . . . 1.1799999999999999 110.496 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.463 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.8 t90 -91.14 142.56 27.61 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.187 -0.946 . . . . 0.34000000000000002 110.257 -178.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -147.07 121.14 9.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 2.79 109.607 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.65 -103.34 0.21 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.86 -1.162 . . . . 0.28999999999999998 110.366 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.95 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -1.074 . . . . 1.5600000000000001 110.111 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.73 47.95 2.56 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.25 -1.54 . . . . 0.28999999999999998 109.25 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.86 37.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -1.082 . . . . 1.0700000000000001 109.215 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.01 127.79 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.192 -0.942 . . . . 1.0900000000000001 109.514 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.18 139.16 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.336 -0.987 . . . . 1.0700000000000001 108.336 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.6 pt -141.52 177.3 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 1.04 110.086 -179.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -143.48 114.06 7.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 2.3399999999999999 108.818 179.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -90.29 -82.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.316 -1.364 . . . . 1.1799999999999999 107.316 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -80.28 -130.3 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.667 -1.605 . . . . 2.4700000000000002 106.667 177.532 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.4 m -104.1 54.72 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.073 -1.084 . . . . 1.8700000000000001 108.073 178.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -156.42 123.79 5.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.779 -0.823 . . . . 1.1200000000000001 108.779 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.415 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.5 mt -92.88 138.28 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 1.1499999999999999 109.702 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.85 168.59 19.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.384 -0.822 . . . . 2.6299999999999999 109.44 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.71 144.58 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.348 -0.845 . . . . 1.0800000000000001 109.367 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 94.1 t -138.54 128.63 14.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 1.0700000000000001 109.118 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.28 144.47 95.82 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 120.531 0.821 . . . . 0.48999999999999999 110.06 179.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -60.11 -39.56 86.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 3.5800000000000001 109.062 179.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -65.6 -7.48 15.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.344 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.82 22.44 11.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.233 -0.917 . . . . 2.5800000000000001 109.307 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.67 169.35 17.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 1.05 109.529 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -141.28 128.45 20.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 2.2599999999999998 109.254 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.4 112.85 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.101 -0.999 . . . . 1.1799999999999999 109.789 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.3 144.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.914 -1.143 . . . . 1.28 107.914 179.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -91.02 142.63 27.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 4.1799999999999997 109.282 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 2.0499999999999998 109.556 -179.852 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.287 -0.635 . . . . 4.1900000000000004 109.287 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.472 ' CD1' ' H ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.72 109.85 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.427 -0.953 . . . . 2.5899999999999999 108.427 -179.873 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -83.22 -112.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 2.5899999999999999 109.566 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.31 102.06 13.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.293 -0.88 . . . . 2.0099999999999998 109.55 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -133.31 130.36 38.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 0.81999999999999995 109.222 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -105.43 156.44 18.19 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.515 -0.92 . . . . 3.7799999999999998 108.515 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 87.3 t -139.09 142.9 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 1.0600000000000001 110.112 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.26 152.16 25.59 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.339 -1.356 . . . . 0.92000000000000004 107.339 178.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.448 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 13.6 p90 -156.14 157.51 36.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.609 -1.307 . . . . 1.01 110.726 -178.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -99.91 140.08 34.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 3.3900000000000001 109.337 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' B' ' 232' ' ' ASP . 5.1 p-10 -93.41 176.78 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 2.23 109.401 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.7 t -88.99 -11.97 42.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 2.3300000000000001 109.509 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 20.3 mmm180 -86.71 -12.1 49.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.143 -0.973 . . . . 4.1900000000000004 109.462 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.501 ' N ' ' OD2' ' B' ' 229' ' ' ASP . 47.8 m-20 -161.92 129.57 2.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.171 -0.956 . . . . 2.1600000000000001 108.887 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.59 4.8 1.53 Allowed 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 120.755 0.97 . . . . 1.3999999999999999 109.959 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.3 t -83.44 154.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 2.3100000000000001 110.031 -179.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -68.32 163.62 22.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.72999999999999998 109.085 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' B' ' 237' ' ' GLY . 4.9 mtpp -119.7 165.91 13.89 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.771 -0.826 . . . . 1.96 108.771 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -47.07 171.01 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.728 -1.349 . . . . 0.56000000000000005 109.728 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.69 160.91 46.06 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.56 1.507 . . . . 0.46999999999999997 110.486 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.68 172.02 13.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.553 -0.717 . . . . 1.05 109.084 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.43 134.65 34.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.973 . . . . 3.1899999999999999 109.341 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.39 124.69 34.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.544 -0.722 . . . . 1.0900000000000001 109.173 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.77 -72.52 0.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.41 -0.806 . . . . 1.1799999999999999 110.609 -179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.415 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.09 142.52 27.67 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.124 -0.985 . . . . 0.34999999999999998 110.254 -178.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -147.08 121.14 9.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.206 -0.934 . . . . 2.7999999999999998 109.564 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.62 -103.29 0.21 Allowed Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.844 -1.17 . . . . 0.29999999999999999 110.337 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -71.04 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.347 -1.09 . . . . 1.5600000000000001 110.139 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.74 47.94 2.56 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.197 -1.561 . . . . 0.28999999999999998 109.197 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.91 151.81 37.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 1.0700000000000001 109.259 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.92 127.89 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 1.0900000000000001 109.525 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.21 139.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.325 -0.991 . . . . 1.0800000000000001 108.325 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.7 pt -141.61 177.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.898 . . . . 1.04 110.138 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -143.56 114.06 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.817 -0.808 . . . . 2.3399999999999999 108.817 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -90.29 -82.34 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.331 -1.359 . . . . 1.1799999999999999 107.331 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -80.23 -130.21 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.716 -1.587 . . . . 2.4700000000000002 106.716 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 64.8 m -104.24 54.71 0.73 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.983 -1.118 . . . . 1.8600000000000001 107.983 178.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -156.45 123.81 5.39 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.829 -0.804 . . . . 1.1200000000000001 108.829 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.463 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.4 mt -92.92 138.3 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.756 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.78 168.64 19.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 2.6400000000000001 109.412 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.72 144.58 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 1.0800000000000001 109.395 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.56 128.55 14.87 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 1.0800000000000001 109.14 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.21 144.54 95.37 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 110.012 -0.803 . . . . 0.48999999999999999 110.012 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -60.1 -39.7 87.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 3.5800000000000001 108.956 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -65.47 -7.51 14.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.512 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.88 22.52 11.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.247 -0.908 . . . . 2.5800000000000001 109.259 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.7 169.41 17.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.503 -0.748 . . . . 1.05 109.441 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -141.32 128.46 20.87 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.27 -0.894 . . . . 2.2599999999999998 109.24 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.35 112.97 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.188 -0.945 . . . . 1.1799999999999999 109.782 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.35 144.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 107.897 -1.149 . . . . 1.27 107.897 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -91.02 142.57 27.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 4.1799999999999997 109.205 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.993 -1.003 . . . . 2.0499999999999998 109.575 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.42 -0.585 . . . . 4.1799999999999997 109.42 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.534 ' H ' ' CD1' ' A' ' 220' ' ' ILE . 0.1 OUTLIER -83.35 121.13 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.657 -0.868 . . . . 2.5899999999999999 108.657 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -84.25 -117.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 2.6000000000000001 109.656 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -97.78 104.26 16.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 2.0099999999999998 109.819 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -136.37 131.6 34.46 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.015 -0.735 . . . . 0.81999999999999995 109.015 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -105.21 158.09 16.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.353 -0.842 . . . . 3.79 109.014 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.5 t -139.05 140.76 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 1.05 109.877 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -107.51 156.33 19.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.508 -1.293 . . . . 0.92000000000000004 107.508 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.79 151.63 25.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.704 -1.247 . . . . 1.01 110.729 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -98.22 148.5 23.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.738 . . . . 3.3999999999999999 109.483 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 231' ' ' ARG . 25.0 t0 -94.89 -175.56 3.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.959 -0.756 . . . . 2.23 108.959 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.458 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 5.5 t -98.67 -14.77 19.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -0.956 . . . . 2.3199999999999998 109.982 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 229' ' ' ASP . 15.3 mtm-85 -89.72 -11.75 41.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 4.1799999999999997 109.981 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 231' ' ' ARG . 54.4 m-20 -161.01 129.02 2.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.928 -1.107 . . . . 2.1600000000000001 109.478 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.57 6.84 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.731 0.954 . . . . 1.3899999999999999 110.32 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 232' ' ' ASP . 5.3 m -80.08 128.24 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.787 -1.195 . . . . 2.3100000000000001 109.891 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.36 165.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.71999999999999997 109.532 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 237' ' ' GLY . 28.6 mttm -118.41 166.41 12.7 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.633 -0.877 . . . . 1.96 108.633 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.73 177.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.932 -1.267 . . . . 0.55000000000000004 109.932 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.86 160.28 48.25 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.663 1.575 . . . . 0.46999999999999997 110.477 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.95 12.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.667 -0.864 . . . . 1.05 108.667 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.18 139.43 31.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.073 -1.017 . . . . 3.1899999999999999 109.44 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.9 120.26 30.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 1.0900000000000001 109.926 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.29 -72.91 0.68 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.427 -0.795 . . . . 1.1799999999999999 110.231 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.204 -0.935 . . . . 0.34000000000000002 110.129 -178.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.47 112.7 5.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.258 -0.901 . . . . 2.79 109.13 179.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -102.63 0.2 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.51 -1.328 . . . . 0.28999999999999998 110.658 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 248' ' ' ALA . 31.6 mt-10 -61.52 -159.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -1.081 . . . . 1.5600000000000001 110.188 -179.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.99 44.86 1.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.028 -1.629 . . . . 0.28999999999999998 109.028 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 246' ' ' GLU . . . -148.3 152.51 37.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.445 -1.033 . . . . 1.0700000000000001 108.975 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.62 126.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 1.0900000000000001 109.325 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.38 137.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.971 -1.122 . . . . 1.0700000000000001 107.971 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 26.6 pt -140.17 -177.94 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 1.04 110.076 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -143.94 109.07 5.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.401 -0.963 . . . . 2.3399999999999999 108.401 178.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.81 -76.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.377 -1.342 . . . . 1.1799999999999999 107.377 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -79.93 -134.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.697 -1.594 . . . . 2.4700000000000002 106.697 177.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 15.3 p -103.9 54.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.981 -1.118 . . . . 1.8700000000000001 107.981 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 65.0 m-20 -157.1 130.9 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.887 -0.783 . . . . 1.1200000000000001 108.887 -179.308 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.45 135.1 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 1.1499999999999999 109.847 -179.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -137.45 176.67 8.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.445 -0.784 . . . . 2.6299999999999999 109.922 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.31 137.9 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.663 -0.648 . . . . 1.0800000000000001 109.602 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.43 131.56 19.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.378 -0.826 . . . . 1.0700000000000001 108.986 179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.24 144.29 95.9 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 120.621 0.881 . . . . 0.48999999999999999 109.946 179.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.46 -34.04 74.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 3.5800000000000001 109.55 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.4 ' HG3' ' NH1' ' A' ' 263' ' ' ARG . 35.4 mtm-85 -70.4 -5.68 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 4.3600000000000003 110.846 -178.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -119.36 21.3 12.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.386 -0.821 . . . . 2.5800000000000001 108.866 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.41 24.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.602 -0.686 . . . . 1.05 109.273 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 7.8 mtmp? -141.7 129.61 21.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 2.2599999999999998 109.135 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.86 117.36 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.951 . . . . 1.1799999999999999 109.978 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.86 150.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 108.795 -0.817 . . . . 1.28 108.795 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.38 146.11 23.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.404 -0.81 . . . . 4.1799999999999997 108.856 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.495 1.799 0 O-C-N 120.956 -1.09 . . . . 2.0499999999999998 109.49 179.863 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.328 0.585 . . . . 4.1900000000000004 109.611 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.561 ' H ' ' CD1' ' B' ' 220' ' ' ILE . 0.1 OUTLIER -83.25 121.2 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.208 -0.933 . . . . 2.5899999999999999 108.782 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.4 -117.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.03 -1.044 . . . . 2.5899999999999999 109.673 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -97.6 104.01 16.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.249 -0.907 . . . . 2.0099999999999998 109.905 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.14 131.49 34.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.572 -0.705 . . . . 0.81999999999999995 109.126 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -105.15 158.01 16.88 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.334 -0.854 . . . . 3.7799999999999998 109.011 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.95 140.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 1.0600000000000001 109.977 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -107.56 156.53 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.469 -1.308 . . . . 0.92000000000000004 107.469 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 13.4 p90 -156.9 151.63 25.74 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.584 -1.323 . . . . 1.01 110.67 -178.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -98.32 148.57 23.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.41 -0.806 . . . . 3.3900000000000001 109.466 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.485 ' OD2' ' NH1' ' B' ' 231' ' ' ARG . 25.1 t0 -94.86 -175.46 3.57 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.345 -0.847 . . . . 2.23 108.902 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 230' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 5.4 t -98.7 -14.72 19.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.238 -0.914 . . . . 2.3300000000000001 109.933 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.485 ' NH1' ' OD2' ' B' ' 229' ' ' ASP . 15.1 mtm-85 -89.96 -11.77 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 4.1900000000000004 109.934 -179.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 231' ' ' ARG . 54.1 m-20 -160.97 128.9 2.81 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.14 -0.975 . . . . 2.1600000000000001 109.494 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.4 6.83 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 120.705 0.937 . . . . 1.3999999999999999 110.3 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.43 ' H ' ' C ' ' B' ' 232' ' ' ASP . 5.3 m -80.04 128.22 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 2.3100000000000001 109.99 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.3 165.08 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.72999999999999998 109.546 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' B' ' 237' ' ' GLY . 28.7 mttm -118.44 166.34 12.79 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.711 -0.848 . . . . 1.96 108.711 179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.72 177.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.978 -1.249 . . . . 0.56000000000000005 109.978 -179.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -71.93 160.39 47.84 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.653 1.569 . . . . 0.46999999999999997 110.506 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.1 173.09 11.99 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.723 -0.843 . . . . 1.05 108.723 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -95.35 139.2 31.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.996 -1.065 . . . . 3.1899999999999999 109.464 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.81 120.16 30.82 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 1.0900000000000001 109.855 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.23 -72.83 0.68 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.37 -0.831 . . . . 1.1799999999999999 110.312 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.78 140.08 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.223 -0.923 . . . . 0.34999999999999998 110.006 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -146.58 112.68 5.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.224 -0.923 . . . . 2.7999999999999998 108.986 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.4 -102.47 0.2 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.496 -1.335 . . . . 0.29999999999999999 110.644 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' B' ' 248' ' ' ALA . 31.6 mt-10 -61.65 -159.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.358 -1.083 . . . . 1.5600000000000001 110.186 -179.009 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.11 44.88 1.92 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.957 -1.657 . . . . 0.28999999999999998 108.957 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 246' ' ' GLU . . . -148.13 152.63 37.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.46 -1.023 . . . . 1.0700000000000001 108.944 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.67 126.8 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 1.0900000000000001 109.442 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.37 137.53 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.941 -1.133 . . . . 1.0800000000000001 107.941 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 26.2 pt -140.26 -178.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 1.04 110.119 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -143.76 109.27 5.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.394 -0.965 . . . . 2.3399999999999999 108.394 178.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.97 -76.27 0.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.337 -1.357 . . . . 1.1799999999999999 107.337 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.87 -134.8 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.763 -1.569 . . . . 2.4700000000000002 106.763 177.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.406 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 15.4 p -103.93 54.41 0.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.897 -1.149 . . . . 1.8600000000000001 107.897 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.6 m-20 -156.98 131.0 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.931 -0.766 . . . . 1.1200000000000001 108.931 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.46 135.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.194 -0.941 . . . . 1.1499999999999999 109.805 -179.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -137.52 176.68 8.49 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.435 -0.79 . . . . 2.6400000000000001 109.891 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.32 137.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 1.0800000000000001 109.553 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 25.9 t -135.59 131.5 19.32 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.341 -0.849 . . . . 1.0800000000000001 108.955 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.13 144.41 95.18 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.571 0.847 . . . . 0.48999999999999999 109.913 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -61.43 -34.16 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 3.5800000000000001 109.628 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -70.47 -5.32 27.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 4.3600000000000003 110.866 -178.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -119.71 21.13 12.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.355 -0.84 . . . . 2.5800000000000001 108.799 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.77 166.49 24.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.653 . . . . 1.05 109.244 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.461 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 7.8 mtmp? -141.77 129.68 21.85 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 109.12 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.94 117.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.289 -0.882 . . . . 1.1799999999999999 109.892 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.8 mm -117.14 150.71 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.59 -0.893 . . . . 1.27 108.59 179.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.48 146.2 23.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.734 -0.839 . . . . 4.1799999999999997 108.734 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 120.975 -1.078 . . . . 2.0499999999999998 109.377 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.509 -0.552 . . . . 4.1799999999999997 109.509 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -82.17 134.44 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 2.5899999999999999 109.449 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.57 -139.45 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.709 -0.849 . . . . 2.6000000000000001 108.709 179.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -95.29 93.85 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.045 -1.035 . . . . 2.0099999999999998 108.914 179.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -112.83 141.49 46.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.526 -0.734 . . . . 0.81999999999999995 109.712 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -112.41 159.2 18.95 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.899 -1.148 . . . . 3.79 107.899 178.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.03 142.29 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.187 -0.946 . . . . 1.05 110.154 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.26 154.46 23.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.517 -1.29 . . . . 0.92000000000000004 107.517 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.6 p90 -155.74 154.8 32.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.8 -1.188 . . . . 1.01 110.199 -178.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.3 mtm-85 -91.98 153.39 19.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 3.3999999999999999 109.364 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -95.35 169.66 9.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.319 -0.863 . . . . 2.23 109.484 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 37.1 t -87.93 -8.89 55.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -0.898 . . . . 2.3199999999999998 109.381 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.66 32.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.313 -0.867 . . . . 4.1799999999999997 109.636 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.0 m-20 -162.11 133.97 4.05 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.598 -0.89 . . . . 2.1600000000000001 108.598 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.56 12.07 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.028 1.152 . . . . 1.3899999999999999 111.125 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 232' ' ' ASP . 9.1 p -83.02 163.03 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.737 -1.227 . . . . 2.3100000000000001 110.108 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.409 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 97.6 m95 -74.52 174.12 9.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.71999999999999997 108.805 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.64 -164.91 1.46 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.311 -0.868 . . . . 1.96 108.81 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.89 52.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.706 -1.358 . . . . 0.55000000000000004 109.706 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.26 159.89 48.49 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.694 1.596 . . . . 0.46999999999999997 109.896 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.37 11.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.775 . . . . 1.05 109.19 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -95.29 136.35 35.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.186 -0.946 . . . . 3.1899999999999999 109.45 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.46 121.49 29.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.662 . . . . 1.0900000000000001 109.339 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.71 -68.94 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.412 -0.805 . . . . 1.1799999999999999 110.039 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -94.19 146.96 23.63 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.18 -0.95 . . . . 0.34000000000000002 109.697 -178.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -148.92 115.81 6.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.199 -0.938 . . . . 2.79 109.076 179.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.44 0.32 Allowed Glycine 0 N--CA 1.498 2.811 0 C-N-CA 119.611 -1.28 . . . . 0.28999999999999998 110.722 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.38 -155.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 1.5600000000000001 109.489 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 50.38 2.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.007 -1.637 . . . . 0.28999999999999998 109.007 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.02 151.74 35.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 1.0700000000000001 108.57 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -145.0 132.43 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.796 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.01 134.89 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.67 -1.233 . . . . 1.0700000000000001 107.67 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.41 177.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 1.04 110.216 -178.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.51 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.0 tt0 -141.75 109.65 5.79 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.891 -1.151 . . . . 2.3399999999999999 107.891 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.28 -79.58 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.389 -1.338 . . . . 1.1799999999999999 107.389 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 255' ' ' SER . 26.9 t-20 -80.78 -129.51 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.516 -1.661 . . . . 2.4700000000000002 106.516 177.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.431 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 36.4 p -104.59 54.04 0.73 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.8700000000000001 108.04 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -156.44 126.66 6.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.753 . . . . 1.1200000000000001 109.195 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.51 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -93.3 135.06 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 1.1499999999999999 109.444 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.73 169.07 18.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.392 -0.818 . . . . 2.6299999999999999 109.879 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.71 139.2 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.549 -0.719 . . . . 1.0800000000000001 109.256 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 27.6 t -133.49 130.87 21.14 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 1.0700000000000001 108.882 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.87 141.98 96.27 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.59 0.86 . . . . 0.48999999999999999 110.192 179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.99 -36.03 67.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 3.5800000000000001 109.008 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -65.7 -9.63 29.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 4.3600000000000003 110.369 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -119.91 18.65 12.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.202 -0.936 . . . . 2.5800000000000001 109.506 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.52 163.76 31.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.384 -0.823 . . . . 1.05 110.064 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.451 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 7.0 mtmp? -143.17 132.14 22.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.335 -0.853 . . . . 2.2599999999999998 109.624 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.2 mm -89.06 113.58 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.295 -0.878 . . . . 1.1799999999999999 109.811 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.11 158.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.356 -0.84 . . . . 1.28 108.924 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.43 ' O ' ' OD1' ' A' ' 270' ' ' ASP . 0.2 OUTLIER -90.74 142.62 27.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.229 -0.919 . . . . 4.1799999999999997 109.145 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.949 -1.024 . . . . 2.0499999999999998 109.425 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 18.9 mmt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.564 -0.532 . . . . 4.1900000000000004 109.564 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -82.09 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 2.5899999999999999 109.445 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.66 -139.35 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 2.5899999999999999 108.745 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -95.53 93.85 7.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.035 . . . . 2.0099999999999998 108.923 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -112.74 141.5 46.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.481 -0.762 . . . . 0.81999999999999995 109.684 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -112.43 159.09 19.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 107.849 -1.167 . . . . 3.7799999999999998 107.849 178.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 96.0 t -139.96 142.32 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.172 -0.955 . . . . 1.0600000000000001 110.13 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.32 154.43 23.5 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.512 -1.292 . . . . 0.92000000000000004 107.512 178.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.7 p90 -155.79 154.8 31.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.779 -1.201 . . . . 1.01 110.228 -178.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.465 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.3 mtm-85 -91.94 153.37 19.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 3.3900000000000001 109.434 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.33 169.65 9.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 2.23 109.44 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 37.5 t -87.83 -8.98 55.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.933 . . . . 2.3300000000000001 109.4 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.57 32.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 4.1900000000000004 109.641 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.1 m-20 -162.23 133.95 3.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.1600000000000001 108.596 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -64.55 12.06 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.006 1.137 . . . . 1.3999999999999999 111.111 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' B' ' 232' ' ' ASP . 9.0 p -83.01 163.05 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.777 -1.202 . . . . 2.3100000000000001 110.101 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.408 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 97.6 m95 -74.52 174.11 9.44 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.792 -0.818 . . . . 0.72999999999999998 108.792 179.4 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.72 -165.07 1.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.238 -0.914 . . . . 1.96 108.804 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.4 175.81 52.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.652 -1.379 . . . . 0.56000000000000005 109.652 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.28 159.82 48.62 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.688 1.592 . . . . 0.46999999999999997 109.892 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.26 173.5 11.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.447 -0.783 . . . . 1.05 109.175 179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -95.41 136.36 35.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 3.1899999999999999 109.385 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.44 121.41 29.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.589 -0.694 . . . . 1.0900000000000001 109.31 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.69 -68.97 0.89 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.458 -0.776 . . . . 1.1799999999999999 110.085 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -94.14 146.89 23.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.029 -1.045 . . . . 0.34999999999999998 109.778 -179.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -148.92 115.76 5.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.132 -0.98 . . . . 2.7999999999999998 109.131 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.53 0.32 Allowed Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.543 -1.313 . . . . 0.29999999999999999 110.74 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.29 -155.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 1.5600000000000001 109.573 -179.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 50.47 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.939 -1.664 . . . . 0.28999999999999998 108.939 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.06 151.85 35.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.577 -0.955 . . . . 1.0700000000000001 108.544 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.12 132.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.112 -0.992 . . . . 1.0900000000000001 109.747 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.1 134.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.24 177.94 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 1.04 110.27 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.495 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.9 tt0 -141.83 109.7 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.904 -1.147 . . . . 2.3399999999999999 107.904 178.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -88.39 -79.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.382 -1.34 . . . . 1.1799999999999999 107.382 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 255' ' ' SER . 26.8 t-20 -80.6 -129.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.614 -1.624 . . . . 2.4700000000000002 106.614 177.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.432 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 36.5 p -104.52 54.08 0.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.116 -1.068 . . . . 1.8600000000000001 108.116 177.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -156.42 126.59 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.462 -0.774 . . . . 1.1200000000000001 109.166 -179.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.495 ' CG1' HE21 ' B' ' 252' ' ' GLN . 36.4 mt -93.21 135.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 1.1499999999999999 109.394 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.78 169.07 18.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 2.6400000000000001 109.832 -179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 t -101.62 139.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.537 -0.727 . . . . 1.0800000000000001 109.219 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.4 t -133.33 130.9 21.32 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 1.0800000000000001 108.954 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.92 141.89 95.94 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.592 0.861 . . . . 0.48999999999999999 110.203 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.83 -36.2 67.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 3.5800000000000001 108.948 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -65.6 -9.6 28.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.995 . . . . 4.3600000000000003 110.461 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.98 18.67 12.44 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.191 -0.943 . . . . 2.5800000000000001 109.484 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.82 31.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 1.05 110.075 -179.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.445 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.0 mtmp? -143.2 132.11 22.82 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.326 -0.859 . . . . 2.2599999999999998 109.637 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.1 mm -89.09 113.59 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.331 -0.856 . . . . 1.1799999999999999 109.833 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -107.11 158.33 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.46 -0.775 . . . . 1.27 108.93 179.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 0.2 OUTLIER -90.62 142.68 27.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.197 -0.94 . . . . 4.1799999999999997 109.108 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' B' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.013 -0.994 . . . . 2.0499999999999998 109.412 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.537 -0.542 . . . . 4.1799999999999997 109.537 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 2.2 mp -83.6 99.11 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 2.5899999999999999 108.573 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -83.33 -108.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 2.6000000000000001 109.419 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -97.57 96.7 8.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.222 -0.923 . . . . 2.0099999999999998 109.427 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.77 126.47 27.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.365 -0.834 . . . . 0.81999999999999995 108.845 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.1 OUTLIER -102.95 156.96 17.31 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.15 -0.968 . . . . 3.79 108.416 179.465 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.19 141.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.19 -0.943 . . . . 1.05 110.491 -179.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.41 156.41 18.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.621 -1.251 . . . . 0.92000000000000004 107.621 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.7 p90 -155.02 151.56 28.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.686 -1.259 . . . . 1.01 110.809 -179.302 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -99.11 141.47 31.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.613 -0.679 . . . . 3.3999999999999999 109.347 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 16.8 p30 -95.62 175.11 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 2.23 109.009 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.0 t -85.69 -6.24 59.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 2.3199999999999998 109.19 179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -88.84 -18.34 27.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.302 -0.874 . . . . 4.1799999999999997 109.688 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 234' ' ' VAL . 31.5 m-20 -161.95 129.1 2.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.978 . . . . 2.1600000000000001 109.267 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.36 8.55 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 120.653 0.902 . . . . 1.3899999999999999 110.252 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.2 t -83.58 158.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.877 -1.14 . . . . 2.3100000000000001 109.827 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -74.72 159.9 31.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.71999999999999997 109.327 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.1 mtpt -118.55 165.12 14.32 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.532 -0.914 . . . . 1.96 108.532 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.89 164.95 0.02 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.499 -1.04 . . . . 0.55000000000000004 110.499 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.88 161.84 42.3 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.728 1.619 . . . . 0.46999999999999997 110.302 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.82 178.39 7.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.456 -0.778 . . . . 1.05 109.067 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.75 138.76 33.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.221 -0.924 . . . . 3.1899999999999999 108.923 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.07 123.49 32.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.548 -0.72 . . . . 1.0900000000000001 109.751 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.3 mt -112.44 -76.13 0.6 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.444 -0.785 . . . . 1.1799999999999999 110.289 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -89.17 143.84 26.55 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.156 -0.965 . . . . 0.34000000000000002 110.29 -178.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.57 118.5 8.76 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.77 -0.826 . . . . 2.79 108.77 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -113.11 0.45 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.749 -1.215 . . . . 0.28999999999999998 110.195 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.53 -154.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -1.057 . . . . 1.5600000000000001 109.573 -179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.43 51.03 3.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.434 -1.466 . . . . 0.28999999999999998 109.434 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 153.01 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 1.0700000000000001 108.641 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.95 131.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.001 -1.062 . . . . 1.0900000000000001 109.952 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.39 138.25 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 1.0700000000000001 108.536 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 22.1 pt -140.37 178.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.874 . . . . 1.04 110.05 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.514 HE21 ' CG1' ' A' ' 257' ' ' ILE . 37.3 tt0 -141.1 110.11 6.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.495 -0.928 . . . . 2.3399999999999999 108.495 179.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.72 -79.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.402 -1.332 . . . . 1.1799999999999999 107.402 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.21 -131.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.492 -1.669 . . . . 2.4700000000000002 106.492 177.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.61 54.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.133 -1.062 . . . . 1.8700000000000001 108.133 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.25 124.91 5.9 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.925 -0.769 . . . . 1.1200000000000001 108.925 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.514 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.6 mt -90.92 136.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 1.1499999999999999 109.624 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.26 172.67 12.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.285 -0.885 . . . . 2.6299999999999999 109.911 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.15 136.96 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.502 -0.749 . . . . 1.0800000000000001 109.688 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.93 123.34 18.04 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 108.426 -0.953 . . . . 1.0700000000000001 108.426 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.23 139.12 85.45 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 109.854 -0.864 . . . . 0.48999999999999999 109.854 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.6 -33.35 66.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.157 -0.964 . . . . 3.5800000000000001 109.433 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -68.24 -6.07 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 4.3600000000000003 109.95 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.15 17.67 11.59 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.485 -0.759 . . . . 2.5800000000000001 109.429 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.71 168.31 20.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.467 -0.771 . . . . 1.05 109.263 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -141.44 131.69 24.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.28 -0.888 . . . . 2.2599999999999998 109.197 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.2 mm -88.02 110.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.325 -0.859 . . . . 1.1799999999999999 109.369 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.49 156.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.337 -0.852 . . . . 1.28 109.219 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.38 137.46 33.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.448 -0.783 . . . . 4.1799999999999997 109.736 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.908 -1.044 . . . . 2.0499999999999998 109.446 179.485 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.564 -0.532 . . . . 4.1900000000000004 109.564 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' B' ' 220' ' ' ILE . 2.2 mp -83.43 99.09 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 2.5899999999999999 108.652 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -83.24 -108.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 2.5899999999999999 109.463 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.7 96.75 8.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 2.0099999999999998 109.367 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.72 126.37 27.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.81999999999999995 108.909 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.1 OUTLIER -102.86 157.0 17.27 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.144 -0.973 . . . . 3.7799999999999998 108.454 179.431 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.22 141.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.159 -0.963 . . . . 1.0600000000000001 110.526 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.34 156.35 19.0 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.648 -1.241 . . . . 0.92000000000000004 107.648 178.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.9 p90 -154.99 151.5 28.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.601 -1.312 . . . . 1.01 110.837 -179.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -98.95 141.3 31.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 3.3900000000000001 109.426 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 17.0 p30 -95.5 175.19 6.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 2.23 109.008 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 35.9 t -85.68 -6.36 59.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 2.3300000000000001 109.261 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -88.75 -18.34 28.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.233 -0.917 . . . . 4.1900000000000004 109.711 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' B' ' 234' ' ' VAL . 31.6 m-20 -161.98 129.11 2.59 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 2.1600000000000001 109.294 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -66.4 8.58 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.659 0.906 . . . . 1.3999999999999999 110.211 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.3 t -83.54 158.12 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.806 -1.184 . . . . 2.3100000000000001 109.844 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -74.85 159.83 31.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.72999999999999998 109.352 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.2 mtpt -118.47 165.18 14.21 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.544 -0.91 . . . . 1.96 108.544 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.88 164.92 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.516 -1.033 . . . . 0.56000000000000005 110.516 -179.064 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.92 161.88 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.639 1.559 . . . . 0.46999999999999997 110.302 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 178.38 7.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.533 -0.729 . . . . 1.05 109.156 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.86 138.75 33.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.276 -0.89 . . . . 3.1899999999999999 108.946 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -88.14 123.52 32.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.489 -0.757 . . . . 1.0900000000000001 109.678 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 31.0 mt -112.42 -76.13 0.6 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.356 -0.84 . . . . 1.1799999999999999 110.281 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.423 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -89.2 143.64 26.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.186 -0.946 . . . . 0.34999999999999998 110.308 -178.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.51 118.47 8.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.794 -0.817 . . . . 2.7999999999999998 108.794 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.23 -113.13 0.45 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.838 -1.172 . . . . 0.29999999999999999 110.209 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.55 -154.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.416 -1.049 . . . . 1.5600000000000001 109.545 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 51.12 3.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.28999999999999998 109.483 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.07 38.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -1.098 . . . . 1.0700000000000001 108.663 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 7.9 m -146.97 131.81 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 1.0900000000000001 109.973 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 94.4 t -93.41 138.19 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.537 -0.912 . . . . 1.0800000000000001 108.537 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 22.3 pt -140.31 178.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.176 -0.953 . . . . 1.04 110.111 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.498 HE21 ' CG1' ' B' ' 257' ' ' ILE . 37.4 tt0 -141.09 110.1 6.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.459 -0.941 . . . . 2.3399999999999999 108.459 179.204 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.75 -79.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.392 -1.336 . . . . 1.1799999999999999 107.392 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.29 -131.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.432 -1.692 . . . . 2.4700000000000002 106.432 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -104.58 54.72 0.72 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.182 -1.044 . . . . 1.8600000000000001 108.182 177.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.22 124.97 5.94 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.931 -0.766 . . . . 1.1200000000000001 108.931 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.498 ' CG1' HE21 ' B' ' 252' ' ' GLN . 61.1 mt -91.06 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.571 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.19 172.58 12.7 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.346 -0.846 . . . . 2.6400000000000001 109.96 -179.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.02 136.93 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.443 -0.786 . . . . 1.0800000000000001 109.737 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.97 123.34 18.0 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.424 -0.954 . . . . 1.0800000000000001 108.424 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.27 139.17 85.72 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.852 -0.865 . . . . 0.48999999999999999 109.852 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.594 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.69 -33.14 66.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.9 . . . . 3.5800000000000001 109.521 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.38 -6.04 22.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 4.3600000000000003 109.996 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.12 17.8 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.465 -0.772 . . . . 2.5800000000000001 109.463 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.85 168.41 19.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 1.05 109.227 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -141.47 131.61 24.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.896 . . . . 2.2599999999999998 109.232 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.3 mm -88.08 110.5 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 1.1799999999999999 109.299 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 29.3 mm -102.48 156.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.344 -0.848 . . . . 1.27 109.143 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.43 137.45 33.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 4.1799999999999997 109.724 -179.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.003 -0.998 . . . . 2.0499999999999998 109.317 179.469 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.27 -0.641 . . . . 4.1799999999999997 109.27 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.41 ' CD1' ' H ' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -84.93 107.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.218 -0.926 . . . . 2.5899999999999999 108.981 -179.539 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.02 -128.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 2.6000000000000001 109.69 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -93.57 105.32 17.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.358 -0.839 . . . . 2.0099999999999998 109.716 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -134.14 145.64 49.47 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.428 -0.795 . . . . 0.81999999999999995 109.767 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.493 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 11.2 mtp180 -118.95 152.9 35.5 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.567 -1.271 . . . . 3.79 107.567 178.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.6 t -139.25 142.0 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.121 -0.987 . . . . 1.05 110.431 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -108.39 158.34 17.59 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.684 -1.228 . . . . 0.92000000000000004 107.684 178.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 15.8 p90 -156.64 152.38 27.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.722 -1.236 . . . . 1.01 110.509 -178.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -93.46 154.13 18.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.389 -0.819 . . . . 3.3999999999999999 109.59 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.73 170.14 9.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.349 -0.844 . . . . 2.23 109.183 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.0 t -89.66 -13.45 37.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.89 . . . . 2.3199999999999998 109.46 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 58.9 mtp180 -88.21 -14.6 38.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.16 -0.963 . . . . 4.1799999999999997 109.373 179.746 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 234' ' ' VAL . 50.1 m-20 -162.22 130.04 2.76 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 2.1600000000000001 108.718 179.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.57 19.37 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 120.759 0.973 . . . . 1.3899999999999999 110.794 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -84.47 158.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.778 -1.201 . . . . 2.3100000000000001 110.197 -179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -76.66 165.9 24.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.709 -0.62 . . . . 0.71999999999999997 109.937 179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.72 -166.94 1.29 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.61 -0.885 . . . . 1.96 108.61 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.14 52.22 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.703 -1.359 . . . . 0.55000000000000004 109.703 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.64 149.56 61.46 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.671 1.58 . . . . 0.46999999999999997 109.862 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.63 169.21 17.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.87 -0.789 . . . . 1.05 108.87 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -92.75 138.73 31.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.088 -1.007 . . . . 3.1899999999999999 109.502 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.8 tp -87.84 118.82 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.677 -0.64 . . . . 1.0900000000000001 109.38 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.01 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.358 -0.839 . . . . 1.1799999999999999 110.154 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.9 146.62 23.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.324 -0.86 . . . . 0.34000000000000002 110.714 -178.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -150.29 117.01 5.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.452 -0.78 . . . . 2.79 109.14 179.127 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.87 -104.72 0.26 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.949 -1.261 . . . . 0.28999999999999998 109.949 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -67.05 -155.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -1.112 . . . . 1.5600000000000001 109.632 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.88 49.38 2.83 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.342 -1.503 . . . . 0.28999999999999998 109.342 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.94 152.2 38.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -1.091 . . . . 1.0700000000000001 108.542 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.0 m -144.21 132.67 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 1.0900000000000001 109.677 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.05 133.81 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.812 -1.181 . . . . 1.0700000000000001 107.812 178.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.14 -177.87 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 1.04 110.384 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.538 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.1 tt0 -142.35 112.17 6.84 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.345 -0.983 . . . . 2.3399999999999999 108.345 178.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.5 -84.55 0.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.596 -1.261 . . . . 1.1799999999999999 107.596 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.642 HD21 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -78.16 -127.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.486 -1.672 . . . . 2.4700000000000002 106.486 177.488 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.642 ' N ' HD21 ' A' ' 254' ' ' ASN . 9.7 p -105.05 52.98 0.73 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.135 -0.978 . . . . 1.8700000000000001 108.659 178.313 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -155.45 131.03 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 109.276 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.538 ' CG1' HE21 ' A' ' 252' ' ' GLN . 58.1 mt -93.06 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 1.1499999999999999 109.486 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.04 165.26 26.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.377 -0.827 . . . . 2.6299999999999999 109.75 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.44 136.77 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.489 -0.757 . . . . 1.0800000000000001 108.978 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 26.7 t -134.36 132.08 20.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.435 -0.791 . . . . 1.0700000000000001 108.892 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.25 148.65 85.13 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.641 0.894 . . . . 0.48999999999999999 109.931 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.848 . . . . 3.5800000000000001 109.075 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.29 -8.62 47.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.249 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -119.24 19.17 12.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.428 -0.795 . . . . 2.5800000000000001 108.94 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.54 164.01 31.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 1.05 109.463 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 7.5 mtmp? -140.41 130.95 25.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 109.44 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.02 111.54 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.366 -0.834 . . . . 1.1799999999999999 110.101 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -109.0 157.46 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.486 -0.759 . . . . 1.28 108.975 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -91.44 140.72 29.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.845 . . . . 4.1799999999999997 109.155 179.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 2.0499999999999998 109.176 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.935 -0.765 . . . . 4.1900000000000004 108.935 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.402 ' CD1' ' H ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -85.12 107.18 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.077 -1.014 . . . . 2.5899999999999999 108.919 -179.462 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -84.81 -128.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 2.5899999999999999 109.76 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -93.7 105.29 17.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 2.0099999999999998 109.617 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -134.12 145.44 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.447 -0.783 . . . . 0.81999999999999995 109.791 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.484 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 11.0 mtp180 -118.82 152.97 35.26 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.481 -1.303 . . . . 3.7799999999999998 107.481 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.1 t -139.14 142.21 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.167 -0.958 . . . . 1.0600000000000001 110.469 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -108.56 158.29 17.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.651 -1.24 . . . . 0.92000000000000004 107.651 178.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 15.5 p90 -156.63 152.38 27.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.698 -1.251 . . . . 1.01 110.545 -178.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -93.33 153.91 18.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.243 -0.911 . . . . 3.3900000000000001 109.608 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.63 170.13 9.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.25 -0.906 . . . . 2.23 109.154 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 26.8 t -89.69 -13.37 37.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 2.3300000000000001 109.507 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 58.8 mtp180 -88.32 -14.5 38.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.138 -0.976 . . . . 4.1900000000000004 109.319 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' B' ' 234' ' ' VAL . 50.6 m-20 -162.29 129.98 2.72 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 2.1600000000000001 108.771 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.62 19.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 120.804 1.003 . . . . 1.3999999999999999 110.697 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.552 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -84.35 158.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.869 -1.144 . . . . 2.3100000000000001 110.243 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -76.65 166.18 23.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 0.72999999999999998 109.983 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.79 -166.98 1.3 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 1.96 108.689 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.07 52.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.713 -1.355 . . . . 0.56000000000000005 109.713 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.69 149.52 61.11 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.762 1.641 . . . . 0.46999999999999997 109.884 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.74 169.06 18.15 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.963 -0.754 . . . . 1.05 108.963 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.58 138.55 31.41 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.987 . . . . 3.1899999999999999 109.52 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.75 118.96 27.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.724 -0.61 . . . . 1.0900000000000001 109.414 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.25 -73.9 0.67 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.388 -0.82 . . . . 1.1799999999999999 110.103 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -92.91 146.47 23.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.323 -0.861 . . . . 0.34999999999999998 110.661 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -150.1 117.03 5.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.444 -0.785 . . . . 2.7999999999999998 109.164 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.89 -104.69 0.26 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.948 -1.261 . . . . 0.29999999999999999 109.948 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.03 -155.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -1.116 . . . . 1.5600000000000001 109.612 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.94 49.42 2.86 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.276 -1.529 . . . . 0.28999999999999998 109.276 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.42 38.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.389 -1.065 . . . . 1.0700000000000001 108.494 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 m -144.46 132.68 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.023 . . . . 1.0900000000000001 109.648 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.12 133.76 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.843 -1.169 . . . . 1.0800000000000001 107.843 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.6 pt -138.13 -177.72 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 1.04 110.292 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.542 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.1 tt0 -142.48 112.2 6.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.334 -0.987 . . . . 2.3399999999999999 108.334 178.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -89.59 -84.54 0.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.552 -1.277 . . . . 1.1799999999999999 107.552 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.643 HD21 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -78.12 -128.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.489 -1.671 . . . . 2.4700000000000002 106.489 177.561 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.643 ' N ' HD21 ' B' ' 254' ' ' ASN . 9.6 p -105.1 53.02 0.73 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.145 -0.972 . . . . 1.8600000000000001 108.586 178.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -155.32 131.06 9.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.491 -0.756 . . . . 1.1200000000000001 109.276 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.542 ' CG1' HE21 ' B' ' 252' ' ' GLN . 58.1 mt -93.05 135.98 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.142 -0.974 . . . . 1.1499999999999999 109.413 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -137.06 165.4 26.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.362 -0.836 . . . . 2.6400000000000001 109.67 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.68 137.05 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.045 -0.724 . . . . 1.0800000000000001 109.045 179.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.6 132.1 20.59 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.346 -0.846 . . . . 1.0800000000000001 108.935 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.26 148.72 84.87 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 N-CA-C 109.911 -0.842 . . . . 0.48999999999999999 109.911 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.84 73.39 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.282 -0.886 . . . . 3.5800000000000001 108.997 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.33 -8.48 46.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 4.3600000000000003 110.235 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -119.31 19.18 12.85 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.448 -0.782 . . . . 2.5800000000000001 108.986 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.91 31.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.564 -0.71 . . . . 1.05 109.447 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 7.5 mtmp? -140.4 130.97 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.258 -0.901 . . . . 2.2599999999999998 109.479 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.04 111.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.362 -0.836 . . . . 1.1799999999999999 110.102 -179.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.99 157.48 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.985 -0.746 . . . . 1.27 108.985 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -91.43 140.69 29.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 4.1799999999999997 109.159 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 2.0499999999999998 109.064 179.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.275 -0.639 . . . . 4.1799999999999997 109.275 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.8 mp -84.67 136.89 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.257 -0.902 . . . . 2.5899999999999999 109.181 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -82.67 -141.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 2.6000000000000001 109.758 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -92.95 107.2 19.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 2.0099999999999998 109.756 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.34 143.09 50.56 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.591 -0.693 . . . . 0.81999999999999995 109.594 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 50.1 mtt180 -108.08 157.79 17.96 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.456 -1.313 . . . . 3.79 107.456 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.47 141.39 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.785 -1.197 . . . . 1.05 110.954 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.39 155.86 20.73 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.674 -1.602 . . . . 0.92000000000000004 106.674 177.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -154.11 166.94 31.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.462 -1.399 . . . . 1.01 110.654 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -90.62 137.53 32.29 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.322 0.582 . . . . 3.3999999999999999 109.453 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -94.39 160.97 14.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.545 -0.722 . . . . 2.23 109.432 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.9 m -86.81 -6.51 58.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 2.3199999999999998 109.575 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -88.26 -20.36 25.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 4.1799999999999997 109.628 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.4 m-20 -162.19 140.29 6.73 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 2.1600000000000001 108.7 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.57 2.82 1.05 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.869 1.046 . . . . 1.3899999999999999 110.378 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.3 m -84.56 141.74 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.853 -1.155 . . . . 2.3100000000000001 110.141 -179.514 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CZ2' ' NH1' ' A' ' 228' ' ' ARG . 97.2 m95 -52.32 -177.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.345 -0.847 . . . . 0.71999999999999997 109.19 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.444 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 1.9 ttpp -131.77 -156.64 0.77 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.272 -0.893 . . . . 1.96 109.11 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.28 -178.6 52.46 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.59 -1.404 . . . . 0.55000000000000004 109.59 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.64 159.84 47.83 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.571 1.514 . . . . 0.46999999999999997 110.19 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.07 18.27 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.92 -0.77 . . . . 1.05 108.92 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -93.24 139.24 30.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.12 -0.987 . . . . 3.1899999999999999 109.223 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.27 117.31 28.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.419 -0.801 . . . . 1.0900000000000001 109.631 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.0 -73.61 0.68 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.291 -0.88 . . . . 1.1799999999999999 110.005 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -90.77 141.56 28.68 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.34000000000000002 110.531 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.73 113.95 5.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 2.79 109.361 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.01 -107.98 0.29 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.89 -1.284 . . . . 0.28999999999999998 109.89 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -60.05 -158.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 1.5600000000000001 109.833 -179.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.85 46.88 2.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.703 -1.359 . . . . 0.28999999999999998 109.703 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.23 148.39 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -1.106 . . . . 1.0700000000000001 108.867 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.0 m -142.19 129.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.912 . . . . 1.0900000000000001 109.744 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.25 137.72 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.203 -1.036 . . . . 1.0700000000000001 108.203 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -140.27 -179.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.192 -0.943 . . . . 1.04 110.452 -179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.6 tt0 -144.19 110.29 5.42 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.81 -0.811 . . . . 2.3399999999999999 108.81 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . 0.431 ' CG ' ' HH ' ' A' ' 227' ' ' TYR . 21.9 t70 -89.42 -78.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.378 -1.342 . . . . 1.1799999999999999 107.378 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -80.04 -134.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.445 -1.687 . . . . 2.4700000000000002 106.445 177.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.9 p -102.15 54.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.009 -1.108 . . . . 1.8700000000000001 108.009 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.48 126.43 7.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.705 . . . . 1.1200000000000001 109.337 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.451 ' CG1' HE21 ' A' ' 252' ' ' GLN . 30.1 mt -92.61 137.84 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.339 -0.85 . . . . 1.1499999999999999 109.61 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -140.73 170.63 15.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 2.6299999999999999 109.643 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.42 139.77 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 1.0800000000000001 109.605 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.19 130.22 19.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.645 -0.872 . . . . 1.0700000000000001 108.645 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.76 141.47 95.68 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 N-CA-C 109.644 -0.945 . . . . 0.48999999999999999 109.644 179.055 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.93 -34.7 73.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 3.5800000000000001 109.727 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.01 -6.44 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 4.3600000000000003 110.655 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.53 24.0 10.55 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.16 -0.962 . . . . 2.5800000000000001 109.204 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.19 164.54 28.94 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.085 -0.709 . . . . 1.05 109.085 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -137.77 131.68 31.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.247 -0.908 . . . . 2.2599999999999998 108.87 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.09 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 1.1799999999999999 109.828 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.98 157.2 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.378 -0.827 . . . . 1.28 108.964 179.274 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.543 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.1 mtt-85 -90.84 143.77 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.158 -0.963 . . . . 4.1799999999999997 109.198 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 18.4 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.104 -0.951 . . . . 2.0499999999999998 109.448 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.315 -0.624 . . . . 4.1900000000000004 109.315 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' B' ' 220' ' ' ILE . 1.8 mp -84.79 137.0 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.92 . . . . 2.5899999999999999 109.253 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -82.47 -141.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 2.5899999999999999 109.789 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -93.08 107.28 19.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 2.0099999999999998 109.705 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -130.54 142.94 50.47 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.694 -0.629 . . . . 0.81999999999999995 109.48 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 49.9 mtt180 -108.1 157.76 17.99 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.401 -1.333 . . . . 3.7799999999999998 107.401 178.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.51 141.17 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.952 -1.092 . . . . 1.0600000000000001 110.979 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.16 155.8 20.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.907 -1.516 . . . . 0.92000000000000004 106.907 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.7 p90 -154.2 166.92 31.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.56 -1.337 . . . . 1.01 110.761 -178.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 228' ' ' ARG . 0.0 OUTLIER -90.47 137.41 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.706 -0.621 . . . . 3.3900000000000001 109.556 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -94.36 161.02 14.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.416 -0.803 . . . . 2.23 109.333 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 68.7 m -86.79 -6.61 58.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 2.3300000000000001 109.709 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.17 -20.37 25.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 4.1900000000000004 109.532 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.8 m-20 -162.29 140.11 6.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.984 . . . . 2.1600000000000001 108.804 179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.31 2.74 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 120.857 1.038 . . . . 1.3999999999999999 110.624 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.5 m -84.54 141.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.965 -1.084 . . . . 2.3100000000000001 110.111 -179.427 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.577 ' CZ2' ' NH1' ' B' ' 228' ' ' ARG . 97.0 m95 -52.2 -177.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 0.72999999999999998 109.213 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.452 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 1.9 ttpp -131.82 -156.71 0.77 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.184 -0.947 . . . . 1.96 109.057 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.12 -178.43 52.39 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.652 -1.379 . . . . 0.56000000000000005 109.652 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.81 159.78 47.6 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.543 1.495 . . . . 0.46999999999999997 110.171 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 168.98 18.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.876 -0.787 . . . . 1.05 108.876 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -93.23 139.11 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 3.1899999999999999 109.232 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.25 117.26 28.09 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.501 -0.749 . . . . 1.0900000000000001 109.575 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.99 -73.55 0.68 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.314 -0.866 . . . . 1.1799999999999999 110.034 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.73 141.53 28.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.34999999999999998 110.528 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.63 114.04 5.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 2.7999999999999998 109.255 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.24 -107.82 0.29 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.039 -1.224 . . . . 0.29999999999999999 110.039 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.22 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -1.169 . . . . 1.5600000000000001 109.704 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.61 46.77 2.02 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.753 -1.339 . . . . 0.28999999999999998 109.753 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.13 148.35 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -1.19 . . . . 1.0700000000000001 108.872 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.18 129.65 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.328 -0.857 . . . . 1.0900000000000001 109.796 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -93.31 137.71 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.229 -1.026 . . . . 1.0800000000000001 108.229 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.29 -179.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.19 -0.944 . . . . 1.04 110.507 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.449 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -144.13 110.14 5.37 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.835 -0.802 . . . . 2.3399999999999999 108.835 178.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.433 ' CG ' ' HH ' ' B' ' 227' ' ' TYR . 21.9 t70 -89.24 -79.07 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.415 -1.328 . . . . 1.1799999999999999 107.415 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.96 -134.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.485 -1.672 . . . . 2.4700000000000002 106.485 177.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -102.04 54.27 0.8 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.994 -1.113 . . . . 1.8600000000000001 107.994 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.55 126.32 6.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 1.1200000000000001 109.336 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.449 ' CG1' HE21 ' B' ' 252' ' ' GLN . 30.0 mt -92.61 137.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 1.1499999999999999 109.571 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -140.63 170.74 15.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 2.6400000000000001 109.544 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.55 139.78 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.364 -0.835 . . . . 1.0800000000000001 109.608 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.13 130.19 19.24 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 108.602 -0.888 . . . . 1.0800000000000001 108.602 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 141.5 95.92 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.589 -0.966 . . . . 0.48999999999999999 109.589 179.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.89 -34.6 73.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 3.5800000000000001 109.782 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.07 -6.44 28.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 4.3600000000000003 110.602 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.65 24.09 10.46 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.132 -0.98 . . . . 2.5800000000000001 109.294 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 164.49 29.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.892 -0.781 . . . . 1.05 108.892 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -137.7 131.85 31.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.259 -0.9 . . . . 2.2599999999999998 108.965 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.25 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.351 -0.843 . . . . 1.1799999999999999 109.632 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.25 157.32 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.796 -0.816 . . . . 1.27 108.796 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.1 mtt-85 -91.02 143.76 26.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.241 -0.912 . . . . 4.1799999999999997 109.176 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 18.3 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.03 -0.986 . . . . 2.0499999999999998 109.464 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.444 -0.576 . . . . 4.1799999999999997 109.444 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.02 139.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 2.5899999999999999 109.228 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.35 -116.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 2.6000000000000001 109.734 -179.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 -99.27 107.62 19.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.233 -0.917 . . . . 2.0099999999999998 108.974 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -135.28 126.99 29.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.516 -0.74 . . . . 0.81999999999999995 109.21 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -100.98 158.67 15.82 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.143 -1.058 . . . . 3.79 108.143 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.83 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 1.05 110.312 -179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -111.2 156.85 20.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.056 -1.091 . . . . 0.92000000000000004 108.056 178.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.8 p90 -155.49 153.26 30.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.806 -1.184 . . . . 1.01 110.377 -179.044 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.611 HH21 ' CA ' ' A' ' 233' ' ' PRO . 21.4 mtp180 -96.84 145.67 25.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 3.3999999999999999 109.801 -179.704 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.52 163.94 12.83 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.42 -0.8 . . . . 2.23 108.928 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.2 m -82.65 -3.17 55.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 2.3199999999999998 109.313 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.47 -17.26 30.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.865 . . . . 4.1799999999999997 109.442 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 234' ' ' VAL . 22.5 m-20 -162.62 133.8 3.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 2.1600000000000001 108.892 179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.611 ' CA ' HH21 ' A' ' 228' ' ' ARG . 6.8 Cg_endo -64.88 5.85 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.839 1.026 . . . . 1.3899999999999999 110.458 179.871 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.4 m -83.34 154.16 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.94 -1.1 . . . . 2.3100000000000001 109.786 -179.627 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.34 -171.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.71999999999999997 108.782 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.48 -155.74 0.62 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.975 . . . . 1.96 109.251 179.727 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.17 173.97 52.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.874 -1.291 . . . . 0.55000000000000004 109.874 -179.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.03 157.82 46.45 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.78 1.653 . . . . 0.46999999999999997 110.297 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.59 174.3 10.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 1.05 109.194 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.44 142.76 27.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 3.1899999999999999 109.463 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.23 124.48 34.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.318 -0.623 . . . . 1.0900000000000001 109.318 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.8 mt -115.88 -74.12 0.62 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.499 -0.75 . . . . 1.1799999999999999 110.207 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -92.25 142.08 27.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.284 -0.885 . . . . 0.34000000000000002 110.396 -178.522 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.89 7.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.865 . . . . 2.79 109.231 179.265 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.82 -103.87 0.21 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.982 -1.247 . . . . 0.28999999999999998 109.982 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.76 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 1.5600000000000001 109.647 -179.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.19 50.57 3.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.279 -1.529 . . . . 0.28999999999999998 109.279 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.26 152.93 36.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -1.02 . . . . 1.0700000000000001 108.811 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.47 129.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.535 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.37 139.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.509 -0.923 . . . . 1.0700000000000001 108.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.42 176.31 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.277 -0.889 . . . . 1.04 110.243 -179.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.518 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.5 tt0 -144.96 113.33 6.6 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.85 -0.796 . . . . 2.3399999999999999 108.85 178.93 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.09 -79.88 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.44 -1.319 . . . . 1.1799999999999999 107.44 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.64 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.756 -1.572 . . . . 2.4700000000000002 106.756 177.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.0 p -103.83 55.72 0.73 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.983 -1.117 . . . . 1.8700000000000001 107.983 177.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -156.0 125.5 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.079 -0.712 . . . . 1.1200000000000001 109.079 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.518 ' CG1' HE21 ' A' ' 252' ' ' GLN . 66.8 mt -91.78 136.97 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.238 -0.914 . . . . 1.1499999999999999 109.611 -179.493 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.1 166.4 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 2.6299999999999999 110.032 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.89 140.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.492 -0.755 . . . . 1.0800000000000001 109.534 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.62 127.94 16.75 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.357 -0.84 . . . . 1.0700000000000001 108.863 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.5 99.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.614 0.876 . . . . 0.48999999999999999 110.363 179.637 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -59.02 -28.88 66.82 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.447 -0.946 . . . . 3.5800000000000001 108.447 179.139 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.41 -13.58 62.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.468 -0.77 . . . . 4.3600000000000003 110.805 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -120.65 23.99 10.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.317 -0.864 . . . . 2.5800000000000001 109.644 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.97 163.07 33.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 1.05 109.634 -179.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 266' ' ' LYS . 8.2 mtmp? -140.74 125.03 17.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.408 -0.807 . . . . 2.2599999999999998 108.969 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.08 112.11 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.246 -0.909 . . . . 1.1799999999999999 110.128 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.94 150.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.487 -0.931 . . . . 1.28 108.487 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -92.7 143.68 26.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.475 -0.766 . . . . 4.1799999999999997 109.382 179.522 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.969 -1.015 . . . . 2.0499999999999998 109.418 179.713 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.468 -0.567 . . . . 4.1900000000000004 109.468 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.94 139.49 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.217 -0.927 . . . . 2.5899999999999999 109.251 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.29 -116.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.432 -0.793 . . . . 2.5899999999999999 109.776 -179.4 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.424 ' N ' ' OD1' ' B' ' 222' ' ' ASN . 1.4 m-20 -99.21 107.74 20.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.326 -0.859 . . . . 2.0099999999999998 109.011 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.3 127.04 29.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.81999999999999995 109.16 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -100.98 158.68 15.82 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.124 -1.065 . . . . 3.7799999999999998 108.124 179.16 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 1.0600000000000001 110.284 -179.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.23 156.93 20.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.061 -1.089 . . . . 0.92000000000000004 108.061 178.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 8.7 p90 -155.52 153.38 30.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.749 -1.219 . . . . 1.01 110.282 -178.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.625 HH21 ' CA ' ' B' ' 233' ' ' PRO . 21.5 mtp180 -97.01 145.62 25.77 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.6 -0.688 . . . . 3.3900000000000001 109.754 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.5 163.95 12.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 2.23 108.997 179.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.1 m -82.68 -3.06 55.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 2.3300000000000001 109.412 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.59 -17.21 30.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.39 -0.819 . . . . 4.1900000000000004 109.41 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' B' ' 234' ' ' VAL . 22.7 m-20 -162.62 133.71 3.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 2.1600000000000001 108.921 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.625 ' CA ' HH21 ' B' ' 228' ' ' ARG . 6.8 Cg_endo -64.79 5.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 120.858 1.039 . . . . 1.3999999999999999 110.488 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.4 m -83.29 154.12 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.908 -1.12 . . . . 2.3100000000000001 109.813 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.38 -171.48 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.72999999999999998 108.759 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.45 -155.71 0.62 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.974 . . . . 1.96 109.264 179.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 174.04 52.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.914 -1.275 . . . . 0.56000000000000005 109.914 -179.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.07 157.81 46.27 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.745 1.63 . . . . 0.46999999999999997 110.297 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.65 174.24 10.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.488 -0.757 . . . . 1.05 109.163 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.34 142.62 27.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.02 . . . . 3.1899999999999999 109.475 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -89.14 124.42 34.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.624 -0.672 . . . . 1.0900000000000001 109.475 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 36.1 mt -115.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.388 -0.82 . . . . 1.1799999999999999 110.156 -179.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.5 t90 -92.26 142.08 27.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.34999999999999998 110.337 -178.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.85 7.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.309 -0.869 . . . . 2.7999999999999998 109.223 179.244 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.77 -104.01 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.956 -1.257 . . . . 0.29999999999999999 109.956 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.72 -156.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 1.5600000000000001 109.632 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 50.58 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.272 -1.531 . . . . 0.28999999999999998 109.272 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.28 152.87 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.443 -1.034 . . . . 1.0700000000000001 108.867 179.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.41 129.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.139 -0.975 . . . . 1.0900000000000001 109.525 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.39 139.65 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.084 -1.01 . . . . 1.0800000000000001 108.543 179.531 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.5 pt -139.48 176.22 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.264 -0.897 . . . . 1.04 110.206 -179.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.528 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.5 tt0 -144.95 113.46 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 2.3399999999999999 108.811 178.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -91.1 -80.05 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.345 -1.354 . . . . 1.1799999999999999 107.345 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.47 -131.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.737 -1.579 . . . . 2.4700000000000002 106.737 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 86.9 p -103.76 55.57 0.74 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.051 -1.092 . . . . 1.8600000000000001 108.051 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -155.96 125.53 6.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.023 -0.732 . . . . 1.1200000000000001 109.023 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CG1' HE21 ' B' ' 252' ' ' GLN . 67.0 mt -91.77 136.92 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 1.1499999999999999 109.611 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.14 166.41 23.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.398 -0.814 . . . . 2.6400000000000001 109.985 -179.109 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.97 140.66 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.483 -0.761 . . . . 1.0800000000000001 109.472 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.5 t -136.63 127.95 16.74 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.338 -0.852 . . . . 1.0800000000000001 108.897 179.613 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.8 144.49 99.56 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 120.621 0.881 . . . . 0.48999999999999999 110.253 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -58.91 -29.01 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.416 -0.957 . . . . 3.5800000000000001 108.416 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -70.4 -13.55 62.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.462 -0.774 . . . . 4.3600000000000003 110.76 -178.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -120.69 24.06 10.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.256 -0.902 . . . . 2.5800000000000001 109.563 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.1 33.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.436 -0.79 . . . . 1.05 109.633 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.457 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 8.1 mtmp? -140.71 125.06 17.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 2.2599999999999998 108.953 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 31.0 mm -89.04 112.1 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.285 -0.884 . . . . 1.1799999999999999 110.135 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.88 150.08 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.513 -0.921 . . . . 1.27 108.513 179.098 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -92.8 143.63 26.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.406 -0.808 . . . . 4.1799999999999997 109.316 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.044 -0.979 . . . . 2.0499999999999998 109.49 179.734 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 57.9 mmm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.258 -0.645 . . . . 4.1799999999999997 109.258 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.96 141.14 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.892 . . . . 2.5899999999999999 109.829 -179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -87.57 -131.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 2.6000000000000001 110.12 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -92.29 106.71 18.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 2.0099999999999998 109.04 179.812 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.3 146.4 49.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.567 -0.708 . . . . 0.81999999999999995 109.528 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.575 HH21 ' HH ' ' A' ' 226' ' ' TYR . 15.3 mtp180 -120.95 153.46 37.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.652 -1.24 . . . . 3.79 107.652 178.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.67 143.47 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 1.05 109.892 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.575 ' HH ' HH21 ' A' ' 224' ' ' ARG . 25.5 m-85 -109.94 157.36 19.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.117 -1.438 . . . . 0.92000000000000004 107.117 178.566 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 19.2 p90 -156.87 160.44 39.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.539 -1.35 . . . . 1.01 110.499 -179.354 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -97.72 153.78 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.648 -0.657 . . . . 3.3999999999999999 109.953 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -96.39 175.16 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.505 -0.747 . . . . 2.23 109.351 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 83.6 p -91.55 -16.78 26.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 2.3199999999999998 109.248 179.626 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -82.15 -12.55 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 4.1799999999999997 109.581 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 234' ' ' VAL . 46.1 m-20 -162.36 130.32 2.78 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 2.1600000000000001 109.281 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -65.16 12.15 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.677 0.918 . . . . 1.3899999999999999 110.041 179.201 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 232' ' ' ASP . 41.0 t -84.62 160.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.022 . . . . 2.3100000000000001 109.521 -179.746 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -75.09 168.68 19.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.735 . . . . 0.71999999999999997 109.092 179.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.95 -165.16 1.31 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.1 -1.074 . . . . 1.96 108.1 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.36 178.14 47.83 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.385 -1.388 . . . . 0.55000000000000004 109.882 -179.508 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.17 158.06 55.83 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.558 1.505 . . . . 0.46999999999999997 109.904 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.11 169.22 18.16 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.743 -0.836 . . . . 1.05 108.743 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -91.74 139.0 31.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.025 -1.047 . . . . 3.1899999999999999 109.398 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.17 123.7 33.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.654 -0.654 . . . . 1.0900000000000001 109.71 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.6 mt -113.91 -73.56 0.65 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.493 -0.755 . . . . 1.1799999999999999 109.768 -179.812 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -94.95 145.98 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.112 -0.993 . . . . 0.34000000000000002 110.321 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.27 120.05 8.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.364 -0.835 . . . . 2.79 109.121 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -116.98 0.57 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.28999999999999998 110.63 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.58 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.991 . . . . 1.5600000000000001 110.041 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.95 52.54 2.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.695 -1.362 . . . . 0.28999999999999998 109.695 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.55 146.46 21.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.961 -1.317 . . . . 1.0700000000000001 110.508 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 1.7 m -142.64 121.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.448 -0.945 . . . . 1.0900000000000001 108.448 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 58.1 t -84.42 134.46 26.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.418 -0.956 . . . . 1.0700000000000001 108.418 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -138.87 178.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.416 -0.802 . . . . 1.04 109.886 -179.117 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -140.96 109.78 6.06 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.328 -0.989 . . . . 2.3399999999999999 108.328 178.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.61 -78.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.582 -1.266 . . . . 1.1799999999999999 107.582 179.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.774 HD21 ' H ' ' A' ' 255' ' ' SER . 8.2 t30 -80.99 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.637 -1.616 . . . . 2.4700000000000002 106.637 177.56 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.774 ' H ' HD21 ' A' ' 254' ' ' ASN . 15.3 t -105.43 51.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.604 -0.887 . . . . 1.8700000000000001 108.604 178.274 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -155.94 130.46 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.841 . . . . 1.1200000000000001 109.402 -179.52 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 76.6 mt -92.5 136.92 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 1.1499999999999999 109.455 -179.669 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -140.06 170.92 14.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 2.6299999999999999 109.735 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.44 140.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.424 -0.797 . . . . 1.0800000000000001 109.632 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.58 129.89 16.63 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 109.163 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.17 148.82 91.21 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 120.825 1.017 . . . . 0.48999999999999999 109.637 179.132 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 262' ' ' ARG . 18.3 mmm-85 -56.66 -36.96 70.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.905 -1.122 . . . . 3.5800000000000001 108.685 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -63.57 -8.1 8.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.886 -0.509 . . . . 4.3600000000000003 110.537 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -122.61 14.1 10.16 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.3 -0.875 . . . . 2.5800000000000001 108.712 179.309 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 159.53 41.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 1.05 109.275 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.66 131.88 38.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.356 -0.84 . . . . 2.2599999999999998 109.005 179.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.53 108.97 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 1.1799999999999999 109.954 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.95 151.99 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.624 -0.88 . . . . 1.28 108.624 178.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.524 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.8 OUTLIER -90.17 147.95 23.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 4.1799999999999997 109.087 179.311 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.022 -0.989 . . . . 2.0499999999999998 109.416 179.777 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 57.8 mmm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.202 -0.666 . . . . 4.1900000000000004 109.202 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 3.2 pt -84.19 141.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 2.5899999999999999 109.774 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.67 -131.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 2.5899999999999999 109.94 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -92.6 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 2.0099999999999998 109.041 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -134.29 146.52 50.09 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.601 -0.687 . . . . 0.81999999999999995 109.493 -179.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.577 HH21 ' HH ' ' B' ' 226' ' ' TYR . 15.3 mtp180 -121.09 153.4 37.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.628 -1.249 . . . . 3.7799999999999998 107.628 178.667 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.58 143.7 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.828 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . 0.577 ' HH ' HH21 ' B' ' 224' ' ' ARG . 25.3 m-85 -110.19 157.33 19.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.222 -1.399 . . . . 0.92000000000000004 107.222 178.475 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 19.0 p90 -156.99 160.55 39.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.442 -1.411 . . . . 1.01 110.501 -179.276 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -97.78 153.72 18.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.691 . . . . 3.3900000000000001 109.948 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -96.56 175.12 6.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.271 -0.893 . . . . 2.23 109.288 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 82.2 p -91.35 -16.57 27.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 2.3300000000000001 109.223 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -82.27 -12.6 57.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 4.1900000000000004 109.694 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' B' ' 234' ' ' VAL . 46.6 m-20 -162.27 130.16 2.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.049 -1.032 . . . . 2.1600000000000001 109.307 -179.912 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.2 12.25 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 120.664 0.909 . . . . 1.3999999999999999 109.957 179.291 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.9 t -84.84 160.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 2.3100000000000001 109.501 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -75.06 168.43 19.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 0.72999999999999998 109.108 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.71 -165.03 1.29 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.216 -1.031 . . . . 1.96 108.216 178.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.28 178.01 47.84 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.425 -1.369 . . . . 0.56000000000000005 109.841 -179.51 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.88 158.17 56.23 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.602 1.535 . . . . 0.46999999999999997 109.984 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.34 168.82 18.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.728 -0.841 . . . . 1.05 108.728 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -91.4 138.91 31.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.026 -1.046 . . . . 3.1899999999999999 109.515 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.12 123.76 33.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.645 -0.66 . . . . 1.0900000000000001 109.726 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.08 -73.71 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.507 -0.746 . . . . 1.1799999999999999 109.722 -179.827 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.425 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 6.8 t90 -94.77 146.0 24.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.34999999999999998 110.313 -179.139 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.4 120.29 8.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.332 -0.855 . . . . 2.7999999999999998 109.145 178.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.5 -116.74 0.56 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.649 -1.262 . . . . 0.29999999999999999 110.628 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -63.04 -145.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.997 . . . . 1.5600000000000001 109.998 -179.041 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.91 52.36 2.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.64 -1.384 . . . . 0.28999999999999998 109.64 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.57 146.4 20.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.994 -1.297 . . . . 1.0700000000000001 110.591 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 1.7 m -142.58 121.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.492 -0.929 . . . . 1.0900000000000001 108.492 178.714 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.39 134.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.464 -0.939 . . . . 1.0800000000000001 108.464 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.9 pt -138.92 178.75 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.327 -0.858 . . . . 1.04 109.892 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -141.0 109.7 6.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.323 -0.992 . . . . 2.3399999999999999 108.323 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.42 -78.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.619 -1.252 . . . . 1.1799999999999999 107.619 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.767 HD21 ' H ' ' B' ' 255' ' ' SER . 8.3 t30 -80.87 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.677 -1.601 . . . . 2.4700000000000002 106.677 177.626 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.767 ' H ' HD21 ' B' ' 254' ' ' ASN . 16.4 t -105.42 52.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.267 -0.896 . . . . 1.8600000000000001 108.584 178.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -156.06 130.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 1.1200000000000001 109.293 -179.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 76.7 mt -92.74 136.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 1.1499999999999999 109.413 -179.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.93 170.58 15.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.408 -0.808 . . . . 2.6400000000000001 109.694 -178.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.16 140.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 1.0800000000000001 109.654 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.2 t -137.76 129.77 16.37 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.297 -0.877 . . . . 1.0800000000000001 109.119 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.93 148.76 91.61 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 120.828 1.019 . . . . 0.48999999999999999 109.755 179.087 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' B' ' 262' ' ' ARG . 18.0 mmm-85 -56.49 -37.47 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 3.5800000000000001 108.622 179.247 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -63.12 -8.21 7.3 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.099 -0.5 . . . . 4.3600000000000003 110.492 -178.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -122.6 14.04 10.15 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.877 . . . . 2.5800000000000001 108.688 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.82 159.87 41.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 1.05 109.323 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.89 131.92 37.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 2.2599999999999998 109.021 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.64 109.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 1.1799999999999999 109.976 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -107.09 152.07 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.594 -0.891 . . . . 1.27 108.594 178.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.517 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.8 OUTLIER -90.21 147.85 23.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 4.1799999999999997 109.007 179.406 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.077 -0.964 . . . . 2.0499999999999998 109.37 179.641 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.381 -0.6 . . . . 4.1799999999999997 109.381 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.57 138.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.195 -0.941 . . . . 2.5899999999999999 108.643 179.801 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -88.42 -126.42 0.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.965 -1.084 . . . . 2.6000000000000001 109.772 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -94.92 99.99 11.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.276 -0.89 . . . . 2.0099999999999998 109.147 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -135.5 128.9 32.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.81999999999999995 109.301 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 224' ' ' ARG . 4.7 ptt-85 -109.65 162.59 14.28 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.141 -1.059 . . . . 3.79 108.141 178.461 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.214 -0.929 . . . . 1.05 110.814 -178.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -108.65 153.16 23.81 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.335 -1.357 . . . . 0.92000000000000004 107.335 178.168 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.3 p90 -157.13 151.04 24.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.516 -1.365 . . . . 1.01 110.432 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.574 HH21 ' HZ3' ' A' ' 264' ' ' LYS . 34.9 mtm180 -96.45 154.11 17.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 3.3999999999999999 109.606 179.715 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 230' ' ' SER . 11.9 t70 -95.07 166.14 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 2.23 108.804 179.27 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 2.9 t -82.13 -7.26 59.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 2.3199999999999998 109.171 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.73 -19.54 23.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 4.1799999999999997 109.967 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.63 3.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.986 . . . . 2.1600000000000001 109.173 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -64.69 15.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 120.842 1.028 . . . . 1.3899999999999999 110.679 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 232' ' ' ASP . 26.0 m -82.51 131.84 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.927 -1.108 . . . . 2.3100000000000001 109.82 -179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.9 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.71999999999999997 109.465 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 237' ' ' GLY . 49.1 tttp -136.25 158.31 44.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.275 -0.891 . . . . 1.96 109.153 179.249 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.03 164.81 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.617 -0.993 . . . . 0.55000000000000004 110.617 -179.326 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.56 159.44 50.74 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.614 1.543 . . . . 0.46999999999999997 110.378 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.43 175.32 9.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.898 -0.779 . . . . 1.05 108.898 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.34 135.67 33.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.167 -0.958 . . . . 3.1899999999999999 109.676 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.19 123.46 32.24 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.151 -0.685 . . . . 1.0900000000000001 109.151 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -115.87 -72.27 0.7 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.416 -0.803 . . . . 1.1799999999999999 110.125 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.78 137.46 32.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.221 -0.924 . . . . 0.34000000000000002 110.067 -178.843 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.1 116.95 8.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.291 -0.881 . . . . 2.79 108.89 179.284 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.64 0.19 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.927 -1.269 . . . . 0.28999999999999998 109.927 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.19 -157.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 1.5600000000000001 109.671 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 48.94 2.68 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.364 -1.494 . . . . 0.28999999999999998 109.364 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.42 152.04 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -1.112 . . . . 1.0700000000000001 108.882 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.78 124.76 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.112 -0.993 . . . . 1.0900000000000001 110.01 -179.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.0 136.51 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.179 -1.045 . . . . 1.0700000000000001 108.179 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -139.47 178.64 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.3 -0.875 . . . . 1.04 110.118 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.459 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.5 tt0 -143.53 112.42 6.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.538 -0.912 . . . . 2.3399999999999999 108.538 179.034 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.78 -79.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.765 -1.198 . . . . 1.1799999999999999 107.765 179.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.46 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.755 -1.572 . . . . 2.4700000000000002 106.755 177.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.4 m -105.0 54.29 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.074 -1.084 . . . . 1.8700000000000001 108.074 178.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -157.43 126.04 5.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.965 -0.754 . . . . 1.1200000000000001 108.965 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.459 ' CG1' HE21 ' A' ' 252' ' ' GLN . 19.5 mt -92.46 140.73 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.279 -0.888 . . . . 1.1499999999999999 109.589 -179.663 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.43 169.56 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.392 -0.818 . . . . 2.6299999999999999 109.59 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.66 139.69 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 1.0800000000000001 109.073 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.9 t -135.67 121.24 13.77 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.421 -0.8 . . . . 1.0700000000000001 108.926 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.81 136.59 75.23 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 N-CA-C 109.934 -0.833 . . . . 0.48999999999999999 109.934 179.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.3 OUTLIER -56.04 -35.64 67.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 3.5800000000000001 109.631 179.886 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.488 ' CG ' HH11 ' A' ' 263' ' ' ARG . 0.7 OUTLIER -69.34 -3.01 12.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 4.3600000000000003 110.259 -179.417 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.574 ' HZ3' HH21 ' A' ' 228' ' ' ARG . 19.3 mtpp -119.47 16.12 12.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.371 -0.831 . . . . 2.5800000000000001 109.044 179.674 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.34 170.8 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.474 -0.767 . . . . 1.05 109.329 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' A' ' 266' ' ' LYS . 6.3 mtmp? -140.79 132.12 26.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.27 -0.894 . . . . 2.2599999999999998 109.457 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.96 117.25 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.264 -0.898 . . . . 1.1799999999999999 109.922 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -116.21 148.84 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 141.93 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.476 -0.935 . . . . 4.1799999999999997 108.476 179.46 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 118.008 -0.996 . . . . 2.0499999999999998 109.505 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.371 -0.604 . . . . 4.1900000000000004 109.371 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.54 138.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.158 -0.963 . . . . 2.5899999999999999 108.763 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -88.34 -126.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.953 -1.092 . . . . 2.5899999999999999 109.729 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -94.92 100.06 11.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -0.899 . . . . 2.0099999999999998 109.144 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.58 128.84 31.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.492 -0.755 . . . . 0.81999999999999995 109.33 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' B' ' 224' ' ' ARG . 4.8 ptt-85 -109.64 162.51 14.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.207 -1.034 . . . . 3.7799999999999998 108.207 178.515 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.1 t -138.03 146.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.165 -0.959 . . . . 1.0600000000000001 110.839 -178.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -108.66 153.15 23.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.356 -1.35 . . . . 0.92000000000000004 107.356 178.134 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.3 p90 -157.03 151.07 24.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.557 -1.34 . . . . 1.01 110.548 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.566 HH21 ' HZ3' ' B' ' 264' ' ' LYS . 34.9 mtm180 -96.5 154.13 17.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 3.3900000000000001 109.591 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 230' ' ' SER . 11.8 t70 -95.0 166.13 12.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.818 . . . . 2.23 108.831 179.254 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 2.9 t -82.11 -7.22 59.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -0.999 . . . . 2.3300000000000001 109.209 179.803 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -90.66 -19.71 23.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.886 . . . . 4.1900000000000004 109.952 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' B' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.61 3.06 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.056 -1.028 . . . . 2.1600000000000001 109.139 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.71 15.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 120.86 1.04 . . . . 1.3999999999999999 110.605 179.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' B' ' 232' ' ' ASP . 26.4 m -82.53 131.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.829 -1.169 . . . . 2.3100000000000001 109.875 -179.656 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 0.72999999999999998 109.463 179.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 237' ' ' GLY . 49.1 tttp -136.36 158.21 44.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.296 -0.877 . . . . 1.96 109.189 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.98 164.87 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.538 -1.025 . . . . 0.56000000000000005 110.538 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.52 159.35 51.06 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.628 1.552 . . . . 0.46999999999999997 110.406 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.34 175.34 9.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.983 -0.747 . . . . 1.05 108.983 179.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.38 135.64 33.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.053 -1.03 . . . . 3.1899999999999999 109.671 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.17 123.51 32.28 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.166 -0.679 . . . . 1.0900000000000001 109.166 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.96 -72.24 0.7 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.399 -0.813 . . . . 1.1799999999999999 110.09 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -90.83 137.41 32.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.253 -0.904 . . . . 0.34999999999999998 110.08 -178.836 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.03 116.94 8.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.87 . . . . 2.7999999999999998 108.898 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.56 0.19 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.997 -1.241 . . . . 0.29999999999999999 109.997 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.22 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -1.099 . . . . 1.5600000000000001 109.606 -179.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 48.93 2.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.34 -1.504 . . . . 0.28999999999999998 109.34 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.43 152.03 37.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 1.0700000000000001 108.877 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.83 124.77 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.0900000000000001 109.982 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.94 136.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.156 -1.053 . . . . 1.0800000000000001 108.156 179.114 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.38 178.6 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 1.04 110.157 -179.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -143.48 112.45 6.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.603 -0.888 . . . . 2.3399999999999999 108.603 178.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.77 -79.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.759 -1.2 . . . . 1.1799999999999999 107.759 179.649 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.56 -130.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.654 -1.609 . . . . 2.4700000000000002 106.654 177.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 35.3 m -104.98 54.17 0.71 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.089 -1.078 . . . . 1.8600000000000001 108.089 178.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -157.39 126.0 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.024 -0.732 . . . . 1.1200000000000001 109.024 -179.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.451 ' CG1' HE21 ' B' ' 252' ' ' GLN . 19.4 mt -92.37 140.75 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.929 . . . . 1.1499999999999999 109.65 -179.673 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.48 169.53 17.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 2.6400000000000001 109.532 -179.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.6 139.61 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.1 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 75.5 t -135.58 121.24 13.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.477 -0.765 . . . . 1.0800000000000001 108.964 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.79 136.43 74.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.965 -0.821 . . . . 0.48999999999999999 109.965 179.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.3 OUTLIER -55.99 -35.59 66.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 3.5800000000000001 109.625 179.981 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.484 ' CG ' HH11 ' B' ' 263' ' ' ARG . 0.7 OUTLIER -69.33 -3.06 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 4.3600000000000003 110.232 -179.393 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.566 ' HZ3' HH21 ' B' ' 228' ' ' ARG . 19.4 mtpp -119.38 16.01 13.02 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.831 . . . . 2.5800000000000001 109.004 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.27 170.84 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.712 . . . . 1.05 109.416 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' B' ' 266' ' ' LYS . 6.4 mtmp? -140.76 132.16 26.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.211 -0.931 . . . . 2.2599999999999998 109.49 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.86 117.28 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.917 . . . . 1.1799999999999999 109.941 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -116.32 148.82 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.544 -0.909 . . . . 1.27 108.544 179.187 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 141.79 28.36 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.516 -0.92 . . . . 4.1799999999999997 108.516 179.497 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 2.0499999999999998 109.528 -179.862 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.504 -0.554 . . . . 4.1799999999999997 109.504 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.91 141.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 2.5899999999999999 109.516 -179.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -86.64 -132.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 2.6000000000000001 109.858 -179.661 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -92.26 108.3 19.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.172 -0.955 . . . . 2.0099999999999998 109.272 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -134.53 136.78 43.33 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.845 -0.798 . . . . 0.81999999999999995 108.845 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -111.55 155.18 23.7 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.129 -1.063 . . . . 3.79 108.129 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.14 141.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 1.05 110.258 -179.399 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.12 157.65 18.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.456 -1.313 . . . . 0.92000000000000004 107.456 178.582 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.47 150.12 24.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.653 -1.279 . . . . 1.01 110.28 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.412 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.1 mtm-85 -94.69 154.43 17.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.461 -0.775 . . . . 3.3999999999999999 109.66 179.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.81 166.44 11.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 2.23 108.841 179.362 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.0 t -85.83 -9.79 56.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 2.3199999999999998 109.324 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -89.3 -16.09 31.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 4.1799999999999997 109.56 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.5 m-20 -161.42 129.7 2.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.137 -0.977 . . . . 2.1600000000000001 109.063 -179.846 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.38 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 120.781 0.987 . . . . 1.3899999999999999 110.653 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 232' ' ' ASP . 11.6 m -82.69 133.41 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.73 -1.231 . . . . 2.3100000000000001 109.848 -179.747 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -53.56 -177.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.26 -0.9 . . . . 0.71999999999999997 109.124 179.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.693 ' HZ2' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -136.79 -164.78 1.63 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.256 -0.903 . . . . 1.96 108.631 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.693 ' H ' ' HZ2' ' A' ' 236' ' ' LYS . . . -73.52 172.38 50.61 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.661 -1.257 . . . . 0.55000000000000004 110.041 -179.441 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.35 158.76 55.21 Favored 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.633 1.555 . . . . 0.46999999999999997 109.955 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.02 172.77 12.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 1.05 109.193 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -94.44 138.82 31.91 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.2 -0.938 . . . . 3.1899999999999999 109.36 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.63 126.24 34.84 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.532 -0.73 . . . . 1.0900000000000001 109.467 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 24.5 mt -119.59 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.752 . . . . 1.1799999999999999 110.115 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.427 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.53 140.1 30.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.178 -0.951 . . . . 0.34000000000000002 109.946 -178.76 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -147.82 119.5 8.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.258 -0.901 . . . . 2.79 109.163 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.14 -100.75 0.18 Allowed Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.788 -1.196 . . . . 0.28999999999999998 110.28 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.33 -154.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -1.072 . . . . 1.5600000000000001 109.804 -179.323 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.9 2.82 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.28999999999999998 109.453 179.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.81 153.88 38.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -1.068 . . . . 1.0700000000000001 109.009 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.34 132.92 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 1.0900000000000001 109.825 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.5 t -94.39 139.32 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.206 -1.035 . . . . 1.0700000000000001 108.206 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.5 pt -140.62 179.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 1.04 110.073 -179.207 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.451 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.7 tt0 -142.54 115.03 8.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.469 -0.938 . . . . 2.3399999999999999 108.469 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.26 -84.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.417 -1.327 . . . . 1.1799999999999999 107.417 179.459 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.632 HD21 ' H ' ' A' ' 255' ' ' SER . 10.2 t30 -79.62 -126.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.629 -1.619 . . . . 2.4700000000000002 106.629 177.62 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.632 ' H ' HD21 ' A' ' 254' ' ' ASN . 14.2 t -105.7 53.9 0.71 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.025 -1.102 . . . . 1.8700000000000001 108.025 177.891 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.08 8.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.1200000000000001 109.196 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.451 ' CG1' HE21 ' A' ' 252' ' ' GLN . 48.6 mt -93.9 137.05 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.325 -0.859 . . . . 1.1499999999999999 109.587 -179.611 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.5 167.39 22.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 2.6299999999999999 109.681 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.04 143.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.381 -0.824 . . . . 1.0800000000000001 109.351 179.596 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.2 t -137.92 126.01 14.16 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.352 -0.843 . . . . 1.0700000000000001 109.047 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.82 143.4 99.2 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 N-CA-C 109.692 -0.926 . . . . 0.48999999999999999 109.692 179.444 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -54.62 -41.17 69.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 3.5800000000000001 109.293 179.606 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' A' ' 263' ' ' ARG . 29.6 mtm-85 -67.2 -2.48 5.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.85 . . . . 4.3600000000000003 110.563 -178.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.74 14.64 12.6 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.355 -0.841 . . . . 2.5800000000000001 109.112 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.28 169.06 18.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 1.05 109.832 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.21 130.07 24.61 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.446 -0.784 . . . . 2.2599999999999998 109.068 179.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.41 110.54 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.237 -0.915 . . . . 1.1799999999999999 109.515 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.42 155.27 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.38 140.79 29.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.372 -0.83 . . . . 4.1799999999999997 109.621 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.007 -0.997 . . . . 2.0499999999999998 109.449 179.661 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.509 -0.552 . . . . 4.1900000000000004 109.509 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.89 141.19 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 2.5899999999999999 109.542 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -86.58 -132.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 2.5899999999999999 109.864 -179.651 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -92.33 108.28 19.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 2.0099999999999998 109.276 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -134.51 136.88 43.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.848 -0.797 . . . . 0.81999999999999995 108.848 179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -111.63 155.22 23.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.063 -1.088 . . . . 3.7799999999999998 108.063 179.095 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.17 141.12 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.285 -0.884 . . . . 1.0600000000000001 110.185 -179.382 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.1 157.72 18.46 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.561 -1.274 . . . . 0.92000000000000004 107.561 178.455 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.7 p90 -156.51 150.09 24.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.66 -1.275 . . . . 1.01 110.332 -179.012 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.1 mtm-85 -94.72 154.44 17.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 3.3900000000000001 109.646 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.92 166.46 11.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 2.23 108.846 179.374 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.2 t -85.92 -9.67 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 2.3300000000000001 109.283 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.25 -16.2 31.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 4.1900000000000004 109.549 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.5 m-20 -161.43 129.81 2.93 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.223 -0.923 . . . . 2.1600000000000001 109.073 -179.839 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.25 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.835 1.023 . . . . 1.3999999999999999 110.594 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 232' ' ' ASP . 11.5 m -82.59 133.56 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.782 -1.199 . . . . 2.3100000000000001 109.806 -179.746 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -53.72 -177.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.09 -1.006 . . . . 0.72999999999999998 109.094 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.701 ' HZ2' ' H ' ' B' ' 237' ' ' GLY . 0.1 OUTLIER -136.74 -164.73 1.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.23 -0.919 . . . . 1.96 108.685 179.241 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.701 ' H ' ' HZ2' ' B' ' 236' ' ' LYS . . . -73.75 172.38 51.04 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.625 -1.274 . . . . 0.56000000000000005 110.053 -179.431 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.36 158.82 55.0 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.592 1.528 . . . . 0.46999999999999997 109.996 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.79 12.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 1.05 109.163 179.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -94.47 138.71 32.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.161 -0.962 . . . . 3.1899999999999999 109.406 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.4 tp -87.54 126.22 34.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.493 -0.754 . . . . 1.0900000000000001 109.485 -179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.56 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.737 . . . . 1.1799999999999999 110.181 -179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -91.48 139.99 30.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.119 -0.988 . . . . 0.34999999999999998 109.97 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -147.72 119.48 8.08 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.885 . . . . 2.7999999999999998 109.134 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.11 -100.86 0.18 Allowed Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.828 -1.177 . . . . 0.29999999999999999 110.334 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.23 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -1.063 . . . . 1.5600000000000001 109.865 -179.342 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.99 2.84 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.355 -1.498 . . . . 0.28999999999999998 109.355 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.86 153.92 38.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.113 . . . . 1.0700000000000001 109.029 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.3 132.84 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.095 -1.003 . . . . 1.0900000000000001 109.892 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.25 139.44 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.254 -1.017 . . . . 1.0800000000000001 108.254 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.4 pt -140.77 179.3 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 1.04 110.117 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.457 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.7 tt0 -142.48 114.9 8.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.507 -0.923 . . . . 2.3399999999999999 108.507 179.101 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.17 -84.57 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.43 -1.322 . . . . 1.1799999999999999 107.43 179.441 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.629 HD21 ' H ' ' B' ' 255' ' ' SER . 10.2 t30 -79.73 -125.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.589 -1.634 . . . . 2.4700000000000002 106.589 177.68 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.629 ' H ' HD21 ' B' ' 254' ' ' ASN . 14.3 t -105.79 53.91 0.7 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.995 -1.113 . . . . 1.8600000000000001 107.995 177.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.22 8.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.542 -0.724 . . . . 1.1200000000000001 109.164 -179.355 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.457 ' CG1' HE21 ' B' ' 252' ' ' GLN . 48.6 mt -94.01 137.06 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 1.1499999999999999 109.587 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -138.51 167.36 22.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.299 -0.876 . . . . 2.6400000000000001 109.711 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.96 143.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.391 -0.818 . . . . 1.0800000000000001 109.408 179.615 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.97 125.97 14.08 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.418 -0.801 . . . . 1.0800000000000001 108.973 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.77 143.34 99.05 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 N-CA-C 109.778 -0.893 . . . . 0.48999999999999999 109.778 179.322 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.405 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -54.58 -41.24 69.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 3.5800000000000001 109.324 179.64 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' B' ' 263' ' ' ARG . 29.6 mtm-85 -67.02 -2.63 5.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.248 -0.908 . . . . 4.3600000000000003 110.597 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.65 14.63 12.67 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.344 -0.847 . . . . 2.5800000000000001 109.127 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.14 169.08 18.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.313 -0.867 . . . . 1.05 109.839 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.16 130.15 24.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 2.2599999999999998 109.077 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.38 110.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.244 -0.91 . . . . 1.1799999999999999 109.595 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.38 155.28 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.737 -0.838 . . . . 1.27 108.737 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.36 140.86 29.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.313 -0.867 . . . . 4.1799999999999997 109.607 179.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.923 -1.037 . . . . 2.0499999999999998 109.405 179.702 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.337 -0.616 . . . . 4.1799999999999997 109.337 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 1.9 mp -83.01 109.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 2.5899999999999999 108.843 -179.925 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -83.81 -121.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 2.6000000000000001 109.435 179.853 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -96.49 100.2 11.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.262 -0.898 . . . . 2.0099999999999998 109.773 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -135.86 135.26 39.62 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.803 . . . . 0.81999999999999995 109.717 179.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' A' ' 224' ' ' ARG . 12.0 mtm-85 -106.17 160.62 15.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.79 -1.189 . . . . 3.79 107.79 178.829 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.7 141.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 1.05 110.212 -179.256 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.81 154.7 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.474 -1.306 . . . . 0.92000000000000004 107.474 178.363 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.8 p90 -157.15 152.2 26.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.643 -1.286 . . . . 1.01 110.11 -179.228 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.42 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 35.9 mtm180 -95.95 152.3 18.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.466 -0.771 . . . . 3.3999999999999999 110.067 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 1.1 m-20 -91.19 165.2 13.6 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 179.222 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 59.5 m -83.92 -13.07 54.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.994 -1.067 . . . . 2.3199999999999998 108.873 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.81 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 4.1799999999999997 109.588 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.7 p30 -156.95 128.87 3.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.954 -1.091 . . . . 2.1600000000000001 109.414 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.76 7.08 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 121.059 1.173 . . . . 1.3899999999999999 111.476 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 13.9 p -83.29 161.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.459 -1.401 . . . . 2.3100000000000001 110.208 -179.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -75.48 160.75 29.85 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.157 -0.683 . . . . 0.71999999999999997 109.157 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.3 tttp -119.12 163.82 16.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.395 -0.816 . . . . 1.96 109.069 179.408 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.94 168.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.902 -1.279 . . . . 0.55000000000000004 109.902 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.3 161.3 46.44 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.458 1.439 . . . . 0.46999999999999997 110.64 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.61 173.9 11.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.992 -0.744 . . . . 1.05 108.992 179.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.75 139.59 31.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.092 -1.005 . . . . 3.1899999999999999 109.21 179.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.18 123.85 33.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 1.0900000000000001 109.455 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.15 -75.37 0.59 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 1.1799999999999999 109.724 179.638 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.96 143.75 26.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 0.34000000000000002 110.301 -179.062 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -149.54 118.72 6.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.477 -0.764 . . . . 2.79 108.955 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -100.99 0.18 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.618 -1.277 . . . . 0.28999999999999998 110.157 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.35 -154.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -1.069 . . . . 1.5600000000000001 109.751 -179.365 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.77 45.77 2.23 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.217 -1.553 . . . . 0.28999999999999998 109.217 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.89 150.52 36.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.443 -1.034 . . . . 1.0700000000000001 108.834 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 129.34 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.204 -0.935 . . . . 1.0900000000000001 109.459 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.97 137.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.088 -1.078 . . . . 1.0700000000000001 108.088 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.0 pt -140.11 -178.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.178 -0.951 . . . . 1.04 110.549 -178.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.52 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -145.99 112.15 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 2.3399999999999999 108.632 178.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.93 -76.57 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.998 -1.482 . . . . 1.1799999999999999 106.998 179.216 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.19 -136.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.822 -1.547 . . . . 2.4700000000000002 106.822 177.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.74 55.42 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.206 -1.035 . . . . 1.8700000000000001 108.206 178.344 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -157.69 127.06 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 1.1200000000000001 109.097 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.52 ' CG1' HE21 ' A' ' 252' ' ' GLN . 38.3 mt -92.68 133.27 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.31 -0.869 . . . . 1.1499999999999999 109.567 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.25 168.27 19.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.505 -0.747 . . . . 2.6299999999999999 109.631 -179.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.48 138.48 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.439 -0.788 . . . . 1.0800000000000001 109.658 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.5 133.07 19.0 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.473 -0.936 . . . . 1.0700000000000001 108.473 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.39 140.64 95.3 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.663 0.909 . . . . 0.48999999999999999 110.143 179.587 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -57.92 -35.5 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 3.5800000000000001 109.209 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' A' ' 263' ' ' ARG . 2.4 mtt-85 -69.99 -1.95 11.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 4.3600000000000003 110.464 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.42 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 5.3 mptp? -118.7 15.54 13.59 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.738 -0.838 . . . . 2.5800000000000001 108.738 -179.672 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.17 173.34 11.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.524 -0.735 . . . . 1.05 109.445 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.55 129.04 22.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.336 -0.853 . . . . 2.2599999999999998 108.997 179.545 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.2 mm -86.57 113.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 1.1799999999999999 109.19 179.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.6 mm -112.6 148.65 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 179.364 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.6 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -91.39 149.99 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.554 -0.716 . . . . 4.1799999999999997 109.518 179.917 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.972 -1.013 . . . . 2.0499999999999998 109.24 179.647 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.271 -0.64 . . . . 4.1900000000000004 109.271 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' B' ' 220' ' ' ILE . 1.9 mp -82.97 109.47 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 2.5899999999999999 108.901 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -83.81 -122.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 2.5899999999999999 109.348 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -96.51 100.09 11.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.214 -0.928 . . . . 2.0099999999999998 109.768 -179.652 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -135.86 135.25 39.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.426 -0.796 . . . . 0.81999999999999995 109.665 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' B' ' 224' ' ' ARG . 11.9 mtm-85 -106.05 160.57 15.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.814 -1.18 . . . . 3.7799999999999998 107.814 178.79 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 141.48 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.206 -0.934 . . . . 1.0600000000000001 110.178 -179.24 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.75 154.75 22.49 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.447 -1.316 . . . . 0.92000000000000004 107.447 178.369 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 12.8 p90 -157.21 152.16 25.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.653 -1.28 . . . . 1.01 110.096 -179.247 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.407 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 35.7 mtm180 -95.86 152.39 18.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.461 -0.775 . . . . 3.3900000000000001 110.053 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -91.33 165.1 13.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 2.23 108.686 179.221 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 59.1 m -83.72 -13.19 54.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 2.3300000000000001 108.943 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.66 40.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 4.1900000000000004 109.59 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 1.6 p30 -157.12 128.8 3.88 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.115 -0.991 . . . . 2.1600000000000001 109.322 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.8 7.27 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.988 1.125 . . . . 1.3999999999999999 111.583 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 13.9 p -83.33 161.65 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.347 -1.47 . . . . 2.3100000000000001 110.241 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -75.45 160.75 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.72999999999999998 109.199 179.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.2 tttp -119.05 163.85 16.38 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.373 -0.829 . . . . 1.96 109.032 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.97 168.2 0.03 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.967 -1.253 . . . . 0.56000000000000005 109.967 -179.486 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -69.34 161.31 46.39 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.479 1.453 . . . . 0.46999999999999997 110.584 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.64 173.87 11.19 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.883 -0.784 . . . . 1.05 108.883 179.282 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.73 139.52 31.13 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.069 -1.019 . . . . 3.1899999999999999 109.215 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.19 123.78 33.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.433 -0.792 . . . . 1.0900000000000001 109.425 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.09 -75.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.476 -0.765 . . . . 1.1799999999999999 109.744 179.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.97 143.8 26.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 0.34999999999999998 110.274 -179.067 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -149.53 118.72 6.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.418 -0.801 . . . . 2.7999999999999998 109.044 179.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.8 -100.97 0.18 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.577 -1.297 . . . . 0.29999999999999999 110.191 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.32 -154.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -1.012 . . . . 1.5600000000000001 109.807 -179.399 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 45.83 2.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.236 -1.545 . . . . 0.28999999999999998 109.236 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.9 150.48 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -1.022 . . . . 1.0700000000000001 108.789 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.96 129.36 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.92 . . . . 1.0900000000000001 109.519 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.99 137.38 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.087 -1.079 . . . . 1.0800000000000001 108.087 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.01 -178.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.286 -0.884 . . . . 1.04 110.618 -178.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -146.07 112.09 5.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.632 -0.877 . . . . 2.3399999999999999 108.632 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.82 -76.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.063 -1.458 . . . . 1.1799999999999999 107.063 179.213 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -82.08 -136.43 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.812 -1.551 . . . . 2.4700000000000002 106.812 177.512 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.7 55.36 0.87 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.195 -1.039 . . . . 1.8600000000000001 108.195 178.345 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -157.66 126.96 5.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.581 -0.699 . . . . 1.1200000000000001 109.154 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.8 mt -92.56 133.25 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 1.1499999999999999 109.586 -179.623 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.2 168.28 19.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.427 -0.796 . . . . 2.6400000000000001 109.627 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.51 138.47 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 1.0800000000000001 109.657 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 133.14 19.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.376 -0.972 . . . . 1.0800000000000001 108.376 179.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.43 140.75 95.78 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 120.539 0.826 . . . . 0.48999999999999999 110.162 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -57.95 -35.51 71.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.114 -0.991 . . . . 3.5800000000000001 109.222 179.449 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.4 mtt-85 -70.01 -1.96 11.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 4.3600000000000003 110.462 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.407 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 5.3 mptp? -118.72 15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.367 -0.833 . . . . 2.5800000000000001 108.758 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 173.38 11.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.453 -0.78 . . . . 1.05 109.512 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.62 128.89 22.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 2.2599999999999998 109.075 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.0 mm -86.43 113.29 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.158 -0.964 . . . . 1.1799999999999999 109.233 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.71 148.61 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.471 -0.937 . . . . 1.27 108.471 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -91.33 150.01 21.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.541 -0.724 . . . . 4.1799999999999997 109.581 179.908 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.966 -1.016 . . . . 2.0499999999999998 109.219 179.704 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.594 -0.521 . . . . 4.1799999999999997 109.594 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.0 pt -82.62 141.23 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 2.5899999999999999 109.431 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -86.17 -135.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 2.6000000000000001 109.475 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -93.92 110.81 22.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.203 -0.936 . . . . 2.0099999999999998 109.057 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.64 138.62 46.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.582 -0.699 . . . . 0.81999999999999995 109.381 -179.751 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.435 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 61.4 mtm180 -107.7 160.05 16.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.962 -1.125 . . . . 3.79 107.962 179.159 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 77.3 t -142.04 138.92 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.172 -0.955 . . . . 1.05 110.096 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -108.36 151.36 26.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.556 -1.276 . . . . 0.92000000000000004 107.556 178.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.0 p90 -155.61 152.31 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.609 -1.307 . . . . 1.01 110.529 -179.076 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 228' ' ' ARG . 8.8 mtm-85 -95.31 151.0 19.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 3.3999999999999999 109.513 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 1.8 m-20 -96.52 167.15 11.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 2.23 108.892 179.34 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.2 t -83.33 -8.92 59.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 2.3199999999999998 109.195 179.538 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -90.44 -16.17 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.352 -0.843 . . . . 4.1799999999999997 109.764 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 234' ' ' VAL . 59.2 m-20 -160.69 129.74 3.14 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.139 -0.976 . . . . 2.1600000000000001 109.232 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.39 10.91 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 120.862 1.041 . . . . 1.3899999999999999 110.41 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.0 m -83.17 135.91 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 2.3100000000000001 110.1 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.19 167.55 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.71999999999999997 109.127 179.71 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 237' ' ' GLY . 36.8 tttp -125.5 157.92 35.79 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.383 -0.823 . . . . 1.96 109.34 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.05 166.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.349 -1.1 . . . . 0.55000000000000004 110.349 -179.315 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -65.53 160.92 40.7 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.639 1.559 . . . . 0.46999999999999997 110.58 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.824 -0.806 . . . . 1.05 108.824 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.9 137.93 34.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.118 -0.989 . . . . 3.1899999999999999 109.216 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.89 125.41 35.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.563 -0.711 . . . . 1.0900000000000001 109.765 -179.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.76 -72.89 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 1.1799999999999999 109.912 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.24 28.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.234 -0.916 . . . . 0.34000000000000002 110.341 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.84 118.74 7.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 2.79 108.896 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -100.24 0.18 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.787 -1.197 . . . . 0.28999999999999998 110.151 -179.76 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.59 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 1.5600000000000001 109.569 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.46 47.98 2.47 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.575 -1.41 . . . . 0.28999999999999998 109.575 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.91 33.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -1.086 . . . . 1.0700000000000001 108.854 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.21 125.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 1.0900000000000001 109.489 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.99 139.52 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.368 -0.975 . . . . 1.0700000000000001 108.368 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -141.73 178.51 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.117 -0.989 . . . . 1.04 110.257 -179.121 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.499 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.1 tt0 -144.36 114.52 7.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.736 -0.839 . . . . 2.3399999999999999 108.736 179.193 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.96 -78.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.453 -1.314 . . . . 1.1799999999999999 107.453 179.241 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.57 -129.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.732 -1.581 . . . . 2.4700000000000002 106.732 177.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.206 -1.035 . . . . 1.8700000000000001 108.206 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.06 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.537 -0.727 . . . . 1.1200000000000001 109.277 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.499 ' CG1' HE21 ' A' ' 252' ' ' GLN . 33.8 mt -92.74 135.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.807 . . . . 1.1499999999999999 109.45 -179.629 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.09 14.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 2.6299999999999999 109.776 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.35 138.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.466 -0.771 . . . . 1.0800000000000001 109.475 179.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.5 t -134.9 126.9 18.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.592 -0.892 . . . . 1.0700000000000001 108.592 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 145.08 90.01 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 120.507 0.805 . . . . 0.48999999999999999 110.47 179.822 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 262' ' ' ARG . 4.5 ttt-85 -65.16 -36.82 85.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.428 -0.795 . . . . 3.5800000000000001 110.1 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -68.71 -4.91 17.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 4.3600000000000003 110.174 -179.099 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -119.52 19.54 12.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.341 -0.849 . . . . 2.5800000000000001 109.184 179.783 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.54 170.55 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.496 -0.752 . . . . 1.05 109.578 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -140.93 132.14 26.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.236 -0.915 . . . . 2.2599999999999998 109.358 179.765 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.8 mm -88.78 106.03 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.27 -0.894 . . . . 1.1799999999999999 109.593 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.47 155.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.374 -0.828 . . . . 1.28 109.208 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -91.34 147.91 22.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.801 . . . . 4.1799999999999997 109.464 179.578 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.096 -1.002 . . . . 2.0499999999999998 109.424 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 9.2 ptt? . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.599 -0.519 . . . . 4.1900000000000004 109.599 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.0 pt -82.51 141.28 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 2.5899999999999999 109.446 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -86.22 -135.44 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 2.5899999999999999 109.471 -179.652 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -93.89 110.76 22.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.923 . . . . 2.0099999999999998 109.03 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.66 138.58 45.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.69 . . . . 0.81999999999999995 109.386 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.433 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 61.4 mtm180 -107.68 160.18 15.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.985 -1.117 . . . . 3.7799999999999998 107.985 179.158 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 77.2 t -142.2 138.96 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.192 -0.943 . . . . 1.0600000000000001 109.982 -179.57 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -108.42 151.31 26.21 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.474 -1.306 . . . . 0.92000000000000004 107.474 178.62 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 11.9 p90 -155.51 152.47 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.01 110.541 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.8 mtm-85 -95.39 151.08 19.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 3.3900000000000001 109.39 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.8 m-20 -96.61 167.17 11.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.355 -0.841 . . . . 2.23 108.89 179.316 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 43.5 t -83.26 -9.14 59.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 2.3300000000000001 109.215 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -90.27 -16.15 29.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 4.1900000000000004 109.821 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' B' ' 234' ' ' VAL . 59.1 m-20 -160.74 129.73 3.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 2.1600000000000001 109.295 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.41 11.02 0.23 Allowed 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 120.79 0.994 . . . . 1.3999999999999999 110.419 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.0 m -83.23 135.93 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.869 -1.144 . . . . 2.3100000000000001 110.06 -179.48 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.2 167.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.227 -0.92 . . . . 0.72999999999999998 109.107 179.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' B' ' 237' ' ' GLY . 36.8 tttp -125.48 157.92 35.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.373 -0.83 . . . . 1.96 109.272 179.447 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.11 166.11 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.361 -1.096 . . . . 0.56000000000000005 110.361 -179.342 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -65.47 160.89 40.68 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.617 1.545 . . . . 0.46999999999999997 110.585 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.805 . . . . 1.05 108.825 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.82 137.99 34.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.061 -1.024 . . . . 3.1899999999999999 109.254 179.901 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.93 125.49 35.38 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.564 -0.71 . . . . 1.0900000000000001 109.774 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.75 -72.93 0.66 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.45 -0.781 . . . . 1.1799999999999999 110.002 179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.16 28.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.23 -0.919 . . . . 0.34999999999999998 110.251 -178.789 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.78 118.8 7.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.377 -0.827 . . . . 2.7999999999999998 108.882 179.155 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -100.25 0.18 Allowed Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.726 -1.226 . . . . 0.29999999999999999 110.096 -179.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.52 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 1.5600000000000001 109.555 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.48 47.98 2.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.688 -1.365 . . . . 0.28999999999999998 109.688 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.83 33.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -1.093 . . . . 1.0700000000000001 108.82 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.12 125.87 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.501 179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.04 139.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.467 -0.938 . . . . 1.0800000000000001 108.467 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.1 pt -141.7 178.54 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.92 . . . . 1.04 110.265 -179.092 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.506 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.1 tt0 -144.38 114.51 7.42 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.834 -0.802 . . . . 2.3399999999999999 108.834 179.106 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.96 -78.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.436 -1.32 . . . . 1.1799999999999999 107.436 179.33 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.51 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.78 -1.563 . . . . 2.4700000000000002 106.78 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 17.7 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.105 -1.072 . . . . 1.8600000000000001 108.105 178.081 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.07 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.628 -0.67 . . . . 1.1200000000000001 109.257 -179.379 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.506 ' CG1' HE21 ' B' ' 252' ' ' GLN . 34.1 mt -92.76 135.92 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.355 -0.841 . . . . 1.1499999999999999 109.436 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.02 15.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.822 . . . . 2.6400000000000001 109.806 -179.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 138.32 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.388 -0.82 . . . . 1.0800000000000001 109.542 179.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 91.1 t -134.8 126.97 18.2 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.573 -0.899 . . . . 1.0800000000000001 108.573 179.748 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.57 145.12 90.52 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 120.564 0.843 . . . . 0.48999999999999999 110.355 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' B' ' 262' ' ' ARG . 4.5 ttt-85 -65.14 -36.92 85.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.427 -0.796 . . . . 3.5800000000000001 110.109 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -68.53 -4.95 16.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.109 -0.994 . . . . 4.3600000000000003 110.325 -179.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -119.56 19.53 12.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.327 -0.858 . . . . 2.5800000000000001 109.191 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 170.62 15.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.448 -0.783 . . . . 1.05 109.584 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -140.95 132.05 26.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 2.2599999999999998 109.321 179.779 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.62 106.0 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.275 -0.891 . . . . 1.1799999999999999 109.627 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -105.53 155.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.447 -0.783 . . . . 1.27 109.212 179.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -91.27 147.9 22.72 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 4.1799999999999997 109.502 179.608 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.95 -1.024 . . . . 2.0499999999999998 109.414 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.422 0.63 . . . . 4.1799999999999997 109.332 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.9 mm -83.11 122.73 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 2.5899999999999999 108.995 179.951 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.742 ' H ' HE21 ' A' ' 221' ' ' GLN . 0.0 OUTLIER -81.54 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.04 . . . . 2.6000000000000001 110.256 -179.425 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.508 ' H ' ' CG ' ' A' ' 221' ' ' GLN . 1.5 m-20 -96.96 103.79 15.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.242 -0.911 . . . . 2.0099999999999998 110.925 -178.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.22 127.54 28.34 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.867 -0.79 . . . . 0.81999999999999995 108.867 178.443 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.94 159.05 15.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.206 -1.035 . . . . 3.79 108.206 179.227 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.7 t -143.44 144.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.2 -0.938 . . . . 1.05 110.157 -179.731 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.53 157.02 20.84 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.555 -1.276 . . . . 0.92000000000000004 107.555 178.626 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.0 p90 -157.78 149.26 21.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.258 . . . . 1.01 110.434 -178.943 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.464 ' NH1' ' CH2' ' A' ' 235' ' ' TRP . 24.0 mtm-85 -95.16 142.54 27.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.439 -0.788 . . . . 3.3999999999999999 109.266 179.259 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.88 173.06 8.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 2.23 109.068 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.8 m -86.83 -8.1 57.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 2.3199999999999998 109.527 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.46 -20.5 26.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 4.1799999999999997 109.455 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.4 m-20 -162.42 132.34 3.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 2.1600000000000001 108.95 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.35 14.64 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 120.724 0.949 . . . . 1.3899999999999999 110.293 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 232' ' ' ASP . 44.5 t -80.91 155.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.798 -1.189 . . . . 2.3100000000000001 109.577 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.464 ' CH2' ' NH1' ' A' ' 228' ' ' ARG . 98.8 m95 -75.89 160.71 29.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.71999999999999997 109.573 -179.789 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.0 mttm -119.33 159.32 24.38 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.347 -0.845 . . . . 1.96 109.027 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.38 168.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.997 -1.241 . . . . 0.55000000000000004 109.997 -179.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.74 159.09 54.3 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.585 1.523 . . . . 0.46999999999999997 110.425 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.4 174.41 10.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.799 -0.815 . . . . 1.05 108.799 179.13 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 240' ' ' LYS . 11.5 mptt -92.71 136.62 33.07 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 3.1899999999999999 109.373 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -87.07 122.9 31.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.327 -0.858 . . . . 1.0900000000000001 109.403 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -113.78 -76.67 0.58 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.421 -0.8 . . . . 1.1799999999999999 110.373 -179.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 21.3 t90 -97.35 137.86 35.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.018 -1.051 . . . . 0.34000000000000002 110.772 -178.722 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.89 132.36 17.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.857 -0.794 . . . . 2.79 108.857 178.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -99.82 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.48 -1.448 . . . . 0.28999999999999998 109.48 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.52 -149.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 1.5600000000000001 109.154 179.829 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 48.32 3.09 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.231 -1.548 . . . . 0.28999999999999998 109.231 179.66 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.61 149.15 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.971 . . . . 1.0700000000000001 109.085 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.11 135.6 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.096 -1.003 . . . . 1.0900000000000001 109.534 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 87.7 t -88.41 143.63 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 1.0700000000000001 109.318 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.79 179.81 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.362 -0.836 . . . . 1.04 109.482 179.737 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -143.99 110.8 5.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 2.3399999999999999 108.656 178.731 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -89.6 -78.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.67 -1.233 . . . . 1.1799999999999999 107.67 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.626 HD21 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -81.13 -131.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.815 -1.55 . . . . 2.4700000000000002 106.815 177.858 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.626 ' N ' HD21 ' A' ' 254' ' ' ASN . 14.6 m -105.24 53.36 0.72 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.079 -1.082 . . . . 1.8700000000000001 108.079 178.191 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -155.53 127.66 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.603 -0.686 . . . . 1.1200000000000001 109.157 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.481 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 72.4 mt -93.0 132.97 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 1.1499999999999999 109.861 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -134.99 170.62 15.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.449 -0.782 . . . . 2.6299999999999999 109.493 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.3 t -100.89 139.87 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.415 -0.803 . . . . 1.0800000000000001 109.498 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.75 121.56 14.99 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.441 -0.787 . . . . 1.0700000000000001 109.201 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.99 139.35 89.63 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.486 0.791 . . . . 0.48999999999999999 110.054 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 262' ' ' ARG . 0.0 OUTLIER -52.86 -43.1 65.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 3.5800000000000001 109.555 179.658 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.26 -3.88 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.412 -0.805 . . . . 4.3600000000000003 110.667 -178.783 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.426 ' CD ' ' NH2' ' A' ' 228' ' ' ARG . 7.2 mmmt -120.19 16.85 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.288 -0.883 . . . . 2.5800000000000001 108.882 179.852 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.96 172.27 12.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.702 . . . . 1.05 109.749 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -137.4 126.96 25.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.783 -0.821 . . . . 2.2599999999999998 108.783 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.97 107.11 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 1.1799999999999999 109.516 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.45 147.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.61 -0.885 . . . . 1.28 108.61 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.65 145.8 24.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.352 -0.843 . . . . 4.1799999999999997 109.367 179.682 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.994 -1.003 . . . . 2.0499999999999998 109.594 179.746 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.34 -0.615 . . . . 4.1900000000000004 109.34 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 15.9 mm -82.99 122.78 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.388 -0.82 . . . . 2.5899999999999999 109.001 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . 0.739 ' H ' HE21 ' B' ' 221' ' ' GLN . 0.0 OUTLIER -81.63 -117.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 2.5899999999999999 110.226 -179.442 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.502 ' H ' ' CG ' ' B' ' 221' ' ' GLN . 1.5 m-20 -96.97 103.74 15.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.922 . . . . 2.0099999999999998 110.873 -178.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.21 127.68 28.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.437 -0.789 . . . . 0.81999999999999995 108.876 178.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.96 159.04 15.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.177 -1.045 . . . . 3.7799999999999998 108.177 179.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.53 144.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.166 -0.958 . . . . 1.0600000000000001 110.13 -179.84 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.45 157.01 20.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.626 -1.25 . . . . 0.92000000000000004 107.626 178.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 9.9 p90 -157.75 149.28 21.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.241 . . . . 1.01 110.487 -178.948 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.465 ' NH1' ' CH2' ' B' ' 235' ' ' TRP . 24.1 mtm-85 -95.17 142.56 27.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.432 -0.792 . . . . 3.3900000000000001 109.222 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.93 173.09 8.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.314 -0.866 . . . . 2.23 109.073 179.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -86.87 -8.1 57.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 2.3300000000000001 109.509 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.44 -20.45 26.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 4.1900000000000004 109.452 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.6 m-20 -162.47 132.32 3.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 2.1600000000000001 108.976 179.911 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.38 14.69 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 120.65 0.9 . . . . 1.3999999999999999 110.321 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' B' ' 232' ' ' ASP . 44.3 t -80.94 155.09 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.836 -1.165 . . . . 2.3100000000000001 109.579 -179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.465 ' CH2' ' NH1' ' B' ' 228' ' ' ARG . 98.8 m95 -75.96 160.7 29.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.72999999999999998 109.609 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.0 mttm -119.31 159.33 24.34 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.415 -0.803 . . . . 1.96 108.917 179.574 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.27 168.81 0.03 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.971 -1.251 . . . . 0.56000000000000005 109.971 -179.714 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.76 159.11 54.19 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.592 1.528 . . . . 0.46999999999999997 110.424 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.37 174.38 10.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.835 -0.802 . . . . 1.05 108.835 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.428 ' CD ' ' N ' ' B' ' 240' ' ' LYS . 11.5 mptt -92.64 136.6 33.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.132 -0.98 . . . . 3.1899999999999999 109.416 -179.694 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.02 122.89 31.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.424 -0.797 . . . . 1.0900000000000001 109.401 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.8 -76.66 0.58 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 1.1799999999999999 110.442 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.411 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 21.5 t90 -97.48 137.9 35.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.057 -1.027 . . . . 0.34999999999999998 110.76 -178.726 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.9 132.38 17.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.407 -0.808 . . . . 2.7999999999999998 108.898 178.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -99.92 0.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.445 -1.462 . . . . 0.29999999999999999 109.445 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.51 -149.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -1.178 . . . . 1.5600000000000001 109.154 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.36 48.19 3.08 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.217 -1.553 . . . . 0.28999999999999998 109.217 179.675 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.57 149.22 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -1.014 . . . . 1.0700000000000001 108.981 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.15 135.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.142 -0.974 . . . . 1.0900000000000001 109.594 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . 0.475 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 87.6 t -88.44 143.61 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.918 . . . . 1.0800000000000001 109.339 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.73 179.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 1.04 109.61 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -144.04 110.73 5.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.701 -0.852 . . . . 2.3399999999999999 108.701 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.53 -78.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.598 -1.26 . . . . 1.1799999999999999 107.598 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.629 HD21 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -81.02 -131.13 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.875 -1.528 . . . . 2.4700000000000002 106.875 177.884 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.629 ' N ' HD21 ' B' ' 254' ' ' ASN . 14.6 m -105.25 53.35 0.72 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.055 -1.091 . . . . 1.8600000000000001 108.055 178.189 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -155.56 127.59 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.154 -0.684 . . . . 1.1200000000000001 109.154 -179.238 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 72.5 mt -92.96 132.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 1.1499999999999999 109.899 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.95 170.7 15.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 2.6400000000000001 109.456 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.06 139.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.386 -0.821 . . . . 1.0800000000000001 109.501 179.79 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.69 121.55 15.06 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.504 -0.748 . . . . 1.0800000000000001 109.253 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.97 139.36 89.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 110.138 -0.755 . . . . 0.48999999999999999 110.138 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . 0.556 HH11 ' CG ' ' B' ' 262' ' ' ARG . 0.0 OUTLIER -52.87 -43.1 65.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 3.5800000000000001 109.556 179.69 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.16 -4.0 4.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 4.3600000000000003 110.669 -178.85 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . 0.419 ' CD ' ' NH2' ' B' ' 228' ' ' ARG . 7.3 mmmt -120.09 16.81 12.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.355 -0.841 . . . . 2.5800000000000001 108.896 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.02 172.23 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 1.05 109.672 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -137.43 126.96 25.07 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.742 -0.836 . . . . 2.2599999999999998 108.742 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.96 107.33 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.168 -0.957 . . . . 1.1799999999999999 109.451 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.57 147.66 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.59 -0.893 . . . . 1.27 108.59 179.336 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.55 145.76 25.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.35 -0.844 . . . . 4.1799999999999997 109.433 179.673 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.941 -1.028 . . . . 2.0499999999999998 109.571 179.712 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 43.0 mtt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.363 0.601 . . . . 4.1799999999999997 109.414 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt -82.73 141.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 2.5899999999999999 109.374 179.916 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -86.37 -130.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 2.6000000000000001 109.684 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.74 104.7 16.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 2.0099999999999998 109.0 179.786 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -133.16 132.33 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.535 -0.728 . . . . 0.81999999999999995 109.256 -179.545 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.632 ' NH2' ' CD2' ' A' ' 226' ' ' TYR . 0.2 OUTLIER -105.99 163.04 13.07 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.782 -1.192 . . . . 3.79 107.782 178.715 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.487 ' C ' HH22 ' A' ' 224' ' ' ARG . 96.2 t -141.47 139.66 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.021 -1.049 . . . . 1.05 110.491 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.632 ' CD2' ' NH2' ' A' ' 224' ' ' ARG . 47.5 m-85 -104.37 154.79 19.4 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.017 -1.475 . . . . 0.92000000000000004 107.017 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.537 ' OH ' ' NZ ' ' A' ' 236' ' ' LYS . 23.7 p90 -158.71 163.39 36.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.372 -1.455 . . . . 1.01 110.983 -179.418 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -96.19 138.88 33.16 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.384 0.612 . . . . 3.3999999999999999 109.527 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.38 -177.13 4.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.406 -0.809 . . . . 2.23 109.277 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.3 p -94.55 -11.72 28.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -0.929 . . . . 2.3199999999999998 109.648 179.989 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.424 ' HE ' ' N ' ' A' ' 231' ' ' ARG . 2.9 mmp_? -79.51 -21.03 45.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.097 -1.002 . . . . 4.1799999999999997 109.7 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.99 139.31 7.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 2.1600000000000001 108.877 179.623 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.37 2.45 1.5 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 121.022 1.148 . . . . 1.3899999999999999 111.304 -179.651 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 12.2 p -82.91 163.26 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.561 -1.337 . . . . 2.3100000000000001 110.372 -179.361 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.405 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 93.5 m95 -68.41 165.63 18.4 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.957 -0.757 . . . . 0.71999999999999997 108.957 179.505 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.537 ' NZ ' ' OH ' ' A' ' 227' ' ' TYR . 5.6 ttpt -119.58 -163.17 0.96 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.226 -0.921 . . . . 1.96 109.328 -179.776 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.98 -179.05 32.25 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.699 -1.36 . . . . 0.55000000000000004 109.699 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.411 ' HA ' HH21 ' A' ' 224' ' ' ARG . 10.7 Cg_endo -74.05 158.94 45.24 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.777 1.651 . . . . 0.46999999999999997 110.212 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.4 169.43 17.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 1.05 109.379 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -94.66 138.5 32.43 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.14 -0.975 . . . . 3.1899999999999999 109.608 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.63 125.86 35.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.607 -0.683 . . . . 1.0900000000000001 109.476 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.49 -72.95 0.66 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.447 -0.783 . . . . 1.1799999999999999 110.108 179.925 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -93.04 145.4 24.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.34000000000000002 110.129 -178.59 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -148.22 121.03 8.69 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.4 -0.812 . . . . 2.79 109.128 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.36 -102.41 0.2 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.734 -1.222 . . . . 0.28999999999999998 110.324 -179.881 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.09 -153.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.221 -1.164 . . . . 1.5600000000000001 109.803 -179.331 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.92 47.91 2.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.284 -1.527 . . . . 0.28999999999999998 109.284 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.46 151.98 37.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 1.0700000000000001 108.813 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.82 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.174 -0.954 . . . . 1.0900000000000001 109.629 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.1 135.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.882 -1.155 . . . . 1.0700000000000001 107.882 179.04 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -139.11 175.69 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.301 -0.874 . . . . 1.04 109.792 -179.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -143.86 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.746 -0.835 . . . . 2.3399999999999999 108.746 179.216 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.75 -82.76 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.537 -1.282 . . . . 1.1799999999999999 107.537 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 255' ' ' SER . 38.0 t-20 -78.96 -128.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.719 -1.586 . . . . 2.4700000000000002 106.719 177.636 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.465 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 10.7 p -105.84 54.49 0.69 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.147 -1.056 . . . . 1.8700000000000001 108.147 178.019 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 66.2 m-20 -155.05 123.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.55 -0.719 . . . . 1.1200000000000001 109.099 -179.39 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.413 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 13.5 mt -94.23 136.54 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 1.1499999999999999 109.58 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.52 169.8 17.09 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.6299999999999999 109.622 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.24 142.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 1.0800000000000001 109.027 179.389 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.49 131.38 19.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 1.0700000000000001 109.164 -179.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.73 141.24 97.58 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.551 -0.98 . . . . 0.48999999999999999 109.551 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -58.53 -35.63 72.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.209 -0.932 . . . . 3.5800000000000001 109.512 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.58 -4.39 18.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 4.3600000000000003 110.756 -179.157 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -118.96 21.27 12.47 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.124 -0.985 . . . . 2.5800000000000001 108.819 179.429 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.18 16.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 1.05 109.591 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -141.64 124.79 16.36 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.294 -0.879 . . . . 2.2599999999999998 109.142 179.802 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.77 101.53 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 1.1799999999999999 109.701 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.417 ' HB ' HH11 ' A' ' 224' ' ' ARG . 5.7 mm -106.38 158.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.413 -0.958 . . . . 1.28 108.413 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.27 152.89 21.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.03 . . . . 4.1799999999999997 109.444 179.555 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.984 -1.008 . . . . 2.0499999999999998 109.42 179.774 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 43.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.372 -0.603 . . . . 4.1900000000000004 109.372 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt -82.57 141.4 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 2.5899999999999999 109.465 179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -86.3 -131.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 2.5899999999999999 109.701 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -94.61 104.74 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.332 -0.855 . . . . 2.0099999999999998 108.999 179.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.16 132.37 41.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 0.81999999999999995 109.205 -179.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.636 ' NH2' ' CD2' ' B' ' 226' ' ' TYR . 0.2 OUTLIER -106.06 163.11 13.03 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.771 -1.196 . . . . 3.7799999999999998 107.771 178.65 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.488 ' C ' HH22 ' B' ' 224' ' ' ARG . 95.6 t -141.6 139.5 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 1.0600000000000001 110.52 -179.561 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . 0.636 ' CD2' ' NH2' ' B' ' 224' ' ' ARG . 47.3 m-85 -104.3 154.82 19.33 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.92000000000000004 106.991 178.357 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' B' ' 236' ' ' LYS . 24.0 p90 -158.68 163.36 36.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.487 -1.383 . . . . 1.01 111.027 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.05 138.85 33.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.742 -0.599 . . . . 3.3900000000000001 109.561 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.41 -177.09 4.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 2.23 109.249 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 29.1 p -94.59 -11.71 28.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.199 -0.938 . . . . 2.3300000000000001 109.604 -179.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.431 ' HE ' ' N ' ' B' ' 231' ' ' ARG . 2.9 mmp_? -79.57 -21.15 45.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 4.1900000000000004 109.606 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.87 139.36 7.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 2.1600000000000001 108.9 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.39 2.45 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.086 1.191 . . . . 1.3999999999999999 111.217 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 12.0 p -83.02 163.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.566 -1.334 . . . . 2.3100000000000001 110.368 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.411 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 93.4 m95 -68.42 165.7 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.996 -0.742 . . . . 0.72999999999999998 108.996 179.588 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' B' ' 227' ' ' TYR . 5.6 ttpt -119.63 -163.16 0.97 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.308 -0.87 . . . . 1.96 109.345 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -72.07 -179.06 32.57 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.691 -1.364 . . . . 0.56000000000000005 109.691 -179.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . 0.416 ' HA ' HH21 ' B' ' 224' ' ' ARG . 10.7 Cg_endo -74.1 159.09 44.88 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.639 1.559 . . . . 0.46999999999999997 110.234 -179.697 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 169.33 17.87 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.436 -0.79 . . . . 1.05 109.48 179.461 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -94.48 138.49 32.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.124 -0.985 . . . . 3.1899999999999999 109.786 179.74 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 tp -88.68 126.04 35.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.763 -0.586 . . . . 1.0900000000000001 109.474 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.57 -73.17 0.65 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.451 -0.78 . . . . 1.1799999999999999 110.019 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.4 t90 -92.91 145.37 24.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.311 -0.868 . . . . 0.34999999999999998 110.257 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -148.14 120.96 8.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.361 -0.837 . . . . 2.7999999999999998 109.132 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.31 -102.29 0.2 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.805 -1.188 . . . . 0.29999999999999999 110.328 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.16 -153.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -1.159 . . . . 1.5600000000000001 109.813 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 47.91 2.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.22 -1.552 . . . . 0.28999999999999998 109.22 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.53 151.99 37.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.493 -1.004 . . . . 1.0700000000000001 108.814 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.73 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 109.613 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.04 135.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.16 . . . . 1.0800000000000001 107.869 179.017 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -138.94 175.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 1.04 109.861 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.87 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.726 -0.842 . . . . 2.3399999999999999 108.726 179.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.72 -82.73 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.532 -1.284 . . . . 1.1799999999999999 107.532 179.43 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 255' ' ' SER . 38.0 t-20 -78.92 -128.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.63 -1.619 . . . . 2.4700000000000002 106.63 177.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.463 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 10.8 p -105.91 54.45 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.19 -1.041 . . . . 1.8600000000000001 108.19 178.026 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 255' ' ' SER . 66.0 m-20 -155.04 123.93 6.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.585 -0.697 . . . . 1.1200000000000001 109.167 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 13.3 mt -94.25 136.51 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 1.1499999999999999 109.565 -179.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.49 169.84 17.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.263 -0.898 . . . . 2.6400000000000001 109.604 -179.629 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.3 142.09 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.476 -0.765 . . . . 1.0800000000000001 108.992 179.384 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.49 131.47 19.41 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.436 -0.79 . . . . 1.0800000000000001 109.133 -179.992 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.71 141.24 97.53 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 N-CA-C 109.609 -0.958 . . . . 0.48999999999999999 109.609 178.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -58.61 -35.58 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.211 -0.931 . . . . 3.5800000000000001 109.516 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.53 -4.37 18.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 4.3600000000000003 110.746 -179.149 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -119.12 21.34 12.36 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.227 -0.921 . . . . 2.5800000000000001 108.887 179.454 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.74 170.16 16.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.53 -0.731 . . . . 1.05 109.658 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -141.72 124.71 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.238 -0.913 . . . . 2.2599999999999998 109.165 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.74 101.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.25 -0.906 . . . . 1.1799999999999999 109.668 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . 0.429 ' HB ' HH11 ' B' ' 224' ' ' ARG . 5.8 mm -106.44 158.13 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.373 -0.973 . . . . 1.27 108.373 179.025 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.29 152.85 21.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 4.1799999999999997 109.405 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 2.0499999999999998 109.39 179.794 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.413 -0.588 . . . . 4.1799999999999997 109.413 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 6.1 tp -85.46 81.9 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.087 0.946 . . . . 2.5899999999999999 109.122 179.971 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -86.03 -121.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 2.6000000000000001 108.944 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -97.03 95.61 7.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.078 -1.014 . . . . 2.0099999999999998 108.771 179.344 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -125.64 140.64 52.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.434 -0.791 . . . . 0.81999999999999995 109.788 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.99 157.78 24.08 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.796 -1.187 . . . . 3.79 107.796 178.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 239' ' ' ALA . 78.3 t -139.3 141.03 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.172 -0.955 . . . . 1.05 110.309 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -107.32 150.35 26.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.506 -1.294 . . . . 0.92000000000000004 107.506 178.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 14.5 p90 -155.78 156.44 34.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.753 -1.217 . . . . 1.01 110.03 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -93.87 150.01 20.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.49 -0.756 . . . . 3.3999999999999999 109.829 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -93.51 159.19 15.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 2.23 108.886 179.524 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 46.9 t -76.89 2.58 14.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.061 -1.024 . . . . 2.3199999999999998 109.189 179.796 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 231' ' ' ARG . 2.9 mtt-85 -90.37 -25.5 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 4.1799999999999997 109.831 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.0 m-20 -162.44 144.48 8.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.059 -1.026 . . . . 2.1600000000000001 109.271 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -64.41 11.4 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.268 1.312 . . . . 1.3899999999999999 110.706 179.834 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.6 m -84.86 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.872 -1.142 . . . . 2.3100000000000001 109.823 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -66.59 161.5 23.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.71999999999999997 109.244 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 237' ' ' GLY . 45.2 tttp -119.1 166.43 12.93 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.456 -0.777 . . . . 1.96 109.496 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.14 171.83 0.02 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.2 -1.16 . . . . 0.55000000000000004 110.2 -179.534 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.22 164.58 27.43 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.729 1.619 . . . . 0.46999999999999997 110.501 179.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -140.47 169.34 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.093 -0.706 . . . . 1.05 109.093 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -92.9 136.23 33.44 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.041 -1.037 . . . . 3.1899999999999999 109.609 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.39 125.94 34.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.595 -0.69 . . . . 1.0900000000000001 109.602 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.2 mt -118.37 -76.86 0.57 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.423 -0.798 . . . . 1.1799999999999999 110.164 179.77 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -102.99 139.3 38.73 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 0.34000000000000002 110.684 -178.529 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.22 134.68 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 2.79 109.205 179.05 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.75 -99.91 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.389 -1.484 . . . . 0.28999999999999998 109.389 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -66.99 -150.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 1.5600000000000001 108.985 179.781 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.77 48.15 2.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.951 -1.66 . . . . 0.28999999999999998 108.951 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.13 147.76 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -1.043 . . . . 1.0700000000000001 109.304 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.89 136.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.144 -0.973 . . . . 1.0900000000000001 109.165 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.2 t -89.69 145.24 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 1.0700000000000001 109.162 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.0 pt -143.82 178.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.245 -0.909 . . . . 1.04 109.998 -179.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -144.54 114.31 7.25 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.702 -0.851 . . . . 2.3399999999999999 108.702 179.06 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.31 -80.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.269 -1.382 . . . . 1.1799999999999999 107.269 179.188 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.23 -129.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.9 -1.518 . . . . 2.4700000000000002 106.9 177.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.1 m -104.54 54.87 0.72 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.931 -1.137 . . . . 1.8700000000000001 107.931 177.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.23 125.35 6.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 1.1200000000000001 109.126 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.8 mt -93.82 137.24 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 1.1499999999999999 109.657 -179.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -140.26 163.55 32.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.6299999999999999 109.586 -179.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.38 134.04 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.853 . . . . 1.0800000000000001 108.899 179.356 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.59 133.04 24.37 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 1.0700000000000001 108.827 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.47 140.76 94.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.669 0.913 . . . . 0.48999999999999999 110.323 179.505 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -56.04 -38.02 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 3.5800000000000001 109.881 179.662 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -68.38 -2.36 8.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.228 -0.92 . . . . 4.3600000000000003 110.705 -178.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -119.13 16.19 13.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.619 -0.882 . . . . 2.5800000000000001 108.619 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.12 170.69 15.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.688 -0.632 . . . . 1.05 109.311 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -140.01 127.37 21.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.287 -0.883 . . . . 2.2599999999999998 109.12 179.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.24 109.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 1.1799999999999999 109.47 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.46 150.04 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.748 -0.834 . . . . 1.28 108.748 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -91.12 145.94 24.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 4.1799999999999997 109.317 179.573 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.99 -1.005 . . . . 2.0499999999999998 109.511 179.632 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.37 0.605 . . . . 4.1900000000000004 109.453 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 6.1 tp -85.47 81.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 2.5899999999999999 109.089 179.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -86.03 -121.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 2.5899999999999999 108.893 179.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -97.04 95.67 7.95 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.129 -0.982 . . . . 2.0099999999999998 108.763 179.319 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.68 140.53 52.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.464 -0.773 . . . . 0.81999999999999995 109.793 -179.452 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.89 157.7 24.1 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.87 -1.159 . . . . 3.7799999999999998 107.87 178.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 239' ' ' ALA . 79.8 t -139.22 141.07 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 1.0600000000000001 110.375 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -107.42 150.3 26.92 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.458 -1.312 . . . . 0.92000000000000004 107.458 178.146 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.4 p90 -155.7 156.45 34.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 1.01 110.046 -179.547 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -93.84 150.04 20.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.473 -0.767 . . . . 3.3900000000000001 109.832 -179.844 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -93.52 159.05 15.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 2.23 108.922 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 46.8 t -76.79 2.56 14.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.058 -1.026 . . . . 2.3300000000000001 109.204 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' B' ' 231' ' ' ARG . 2.9 mtt-85 -90.52 -25.35 20.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 4.1900000000000004 109.794 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.0 m-20 -162.52 144.43 8.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.068 -1.02 . . . . 2.1600000000000001 109.242 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -64.27 11.31 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.822 0 C-N-CA 121.302 1.335 . . . . 1.3999999999999999 110.775 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.6 m -84.82 145.22 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.132 . . . . 2.3100000000000001 109.841 -179.477 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -66.56 161.51 22.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.72999999999999998 109.387 179.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' B' ' 237' ' ' GLY . 45.2 tttp -119.07 166.39 12.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 1.96 109.504 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.15 171.75 0.02 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.202 -1.159 . . . . 0.56000000000000005 110.202 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.1 164.64 26.93 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.687 1.591 . . . . 0.46999999999999997 110.461 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 225' ' ' VAL . . . -140.52 169.3 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 1.05 109.073 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -92.9 136.28 33.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.038 -1.039 . . . . 3.1899999999999999 109.657 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.4 126.08 35.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.474 -0.766 . . . . 1.0900000000000001 109.587 -179.752 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.55 -76.78 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.58 -0.7 . . . . 1.1799999999999999 110.152 179.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -103.01 139.43 38.58 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.217 -0.927 . . . . 0.34999999999999998 110.637 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.25 134.68 18.46 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.344 -0.848 . . . . 2.7999999999999998 109.188 179.069 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.83 -99.9 0.18 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.308 -1.517 . . . . 0.29999999999999999 109.308 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.2 -149.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -1.128 . . . . 1.5600000000000001 108.96 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.72 48.1 2.88 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.952 -1.659 . . . . 0.28999999999999998 108.952 179.603 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.08 147.76 27.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -1.028 . . . . 1.0700000000000001 109.296 -179.673 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.86 136.45 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 1.0900000000000001 109.088 179.31 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.73 145.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 109.156 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -143.8 178.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.04 110.024 -179.891 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -144.57 114.41 7.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.683 -0.858 . . . . 2.3399999999999999 108.683 179.033 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.38 -80.04 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.26 -1.385 . . . . 1.1799999999999999 107.26 179.173 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.25 -129.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.837 -1.542 . . . . 2.4700000000000002 106.837 177.653 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.2 m -104.5 54.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.913 -1.143 . . . . 1.8600000000000001 107.913 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.2 125.41 6.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 1.1200000000000001 109.169 -179.251 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 31.1 mt -93.86 137.36 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 1.1499999999999999 109.67 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -140.27 163.57 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 2.6400000000000001 109.576 -179.712 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.4 134.04 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 1.0800000000000001 108.927 179.306 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.6 133.03 24.37 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.893 -0.78 . . . . 1.0800000000000001 108.893 -179.904 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.52 140.83 94.5 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.687 0.925 . . . . 0.48999999999999999 110.234 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -56.1 -37.97 70.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.852 . . . . 3.5800000000000001 109.86 179.64 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -68.46 -2.31 8.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.299 -0.876 . . . . 4.3600000000000003 110.71 -178.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -119.1 16.14 13.25 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 2.5800000000000001 108.6 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 170.57 15.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.639 -0.663 . . . . 1.05 109.319 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -139.95 127.37 21.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.312 -0.868 . . . . 2.2599999999999998 109.111 179.874 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.14 109.06 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 1.1799999999999999 109.481 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.46 150.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.779 -0.823 . . . . 1.27 108.779 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -91.25 145.87 24.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.375 -0.828 . . . . 4.1799999999999997 109.395 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.991 -1.004 . . . . 2.0499999999999998 109.535 179.751 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 32.6 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.449 -0.574 . . . . 4.1799999999999997 109.449 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.593 ' H ' ' CD1' ' A' ' 220' ' ' ILE . 0.1 OUTLIER -80.39 136.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.072 -1.017 . . . . 2.5899999999999999 109.165 179.519 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -86.91 -135.85 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.132 -0.692 . . . . 2.6000000000000001 109.132 -179.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -92.83 116.33 28.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 2.0099999999999998 108.655 179.426 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -134.3 149.56 50.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.409 -0.807 . . . . 0.81999999999999995 109.538 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -120.68 155.39 33.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.882 -1.155 . . . . 3.79 107.882 179.344 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.61 141.06 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.098 -1.001 . . . . 1.05 110.635 -179.625 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.73 155.81 22.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.281 -1.377 . . . . 0.92000000000000004 107.281 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.485 -1.384 . . . . 1.01 110.739 -179.175 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -100.52 140.02 35.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.591 -0.693 . . . . 3.3999999999999999 109.671 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.64 170.05 9.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.866 . . . . 2.23 109.376 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.3 m -84.63 -9.48 58.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 2.3199999999999998 109.137 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.42 -10.9 47.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 4.1799999999999997 109.516 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.6 p30 -158.88 133.95 5.67 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.179 -0.95 . . . . 2.1600000000000001 109.354 -179.242 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.13 -7.05 20.23 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 120.975 1.116 . . . . 1.3899999999999999 111.396 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 3.7 p -87.1 163.49 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.563 -1.336 . . . . 2.3100000000000001 110.416 -179.398 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.486 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 83.2 m95 -66.31 -175.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.646 -0.659 . . . . 0.71999999999999997 109.514 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 4.0 ttpp -130.77 -156.38 0.75 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.589 -0.893 . . . . 1.96 108.589 179.326 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.28 54.22 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.57 -1.412 . . . . 0.55000000000000004 109.57 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -71.46 154.26 60.56 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.677 1.585 . . . . 0.46999999999999997 109.975 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.78 25.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.767 . . . . 1.05 109.215 179.446 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.02 141.44 28.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 3.1899999999999999 109.846 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.63 123.93 34.65 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.829 -0.544 . . . . 1.0900000000000001 109.565 -179.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.06 -73.2 0.65 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.334 -0.854 . . . . 1.1799999999999999 111.017 -179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.461 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 6.0 t90 -91.78 152.66 20.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.22 -0.925 . . . . 0.34000000000000002 110.807 -177.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.46 128.34 21.93 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.523 -0.917 . . . . 2.79 108.523 178.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.4 -126.83 1.23 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.521 -1.323 . . . . 0.28999999999999998 110.539 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.65 -144.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.589 -0.947 . . . . 1.5600000000000001 109.342 -179.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.33 49.24 2.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.827 -1.709 . . . . 0.28999999999999998 108.827 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.64 149.32 31.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.383 -1.069 . . . . 1.0700000000000001 109.041 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.47 134.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 1.0900000000000001 109.48 -179.826 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -91.9 140.84 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.287 -0.883 . . . . 1.0700000000000001 109.077 179.816 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.98 176.7 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.88 . . . . 1.04 109.794 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.92 112.3 6.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.851 . . . . 2.3399999999999999 109.018 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.41 -81.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.409 -1.33 . . . . 1.1799999999999999 107.409 179.28 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.02 -131.42 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.651 -1.611 . . . . 2.4700000000000002 106.651 177.585 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.5 t -104.34 57.07 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.7 -1.222 . . . . 1.8700000000000001 107.7 177.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -155.73 122.43 5.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.142 -0.688 . . . . 1.1200000000000001 109.142 -179.378 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.462 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 59.0 mt -93.05 134.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.258 -0.901 . . . . 1.1499999999999999 109.331 -179.831 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.79 172.72 12.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.449 -0.782 . . . . 2.6299999999999999 109.741 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.34 142.07 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.146 -0.687 . . . . 1.0800000000000001 109.146 179.387 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.51 126.7 15.06 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.398 -0.964 . . . . 1.0700000000000001 108.398 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.11 152.07 39.48 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 109.835 -0.871 . . . . 0.48999999999999999 109.835 179.526 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.71 -34.59 77.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 3.5800000000000001 109.742 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -70.93 -5.59 32.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.815 . . . . 4.3600000000000003 111.329 -178.914 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -118.77 20.33 12.89 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.236 -0.915 . . . . 2.5800000000000001 108.908 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.9 165.36 27.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.519 -0.738 . . . . 1.05 109.275 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.473 ' HZ3' ' CB ' ' A' ' 266' ' ' LYS . 7.4 mtmp? -140.08 129.62 24.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.371 -0.831 . . . . 2.2599999999999998 108.925 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.97 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.313 -0.867 . . . . 1.1799999999999999 109.704 -179.35 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.45 150.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.055 -1.091 . . . . 1.28 108.055 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.541 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -92.05 142.27 27.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.187 -0.946 . . . . 4.1799999999999997 109.216 179.652 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.978 . . . . 2.0499999999999998 109.21 179.531 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 32.6 mtt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.566 -0.531 . . . . 4.1900000000000004 109.566 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.589 ' H ' ' CD1' ' B' ' 220' ' ' ILE . 0.1 OUTLIER -80.38 136.69 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.217 -0.927 . . . . 2.5899999999999999 109.225 179.554 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -86.72 -135.89 0.08 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.166 -0.679 . . . . 2.5899999999999999 109.166 -179.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -92.83 116.32 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 2.0099999999999998 108.608 179.483 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.23 149.54 50.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.81999999999999995 109.491 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -120.67 155.33 34.07 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.902 -1.147 . . . . 3.7799999999999998 107.902 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.53 141.14 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.146 -0.971 . . . . 1.0600000000000001 110.652 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.84 155.78 23.06 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.181 -1.414 . . . . 0.92000000000000004 107.181 178.363 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.487 -1.383 . . . . 1.01 110.808 -179.218 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -100.55 140.11 35.28 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.647 -0.658 . . . . 3.3900000000000001 109.639 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.79 170.02 9.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.313 -0.867 . . . . 2.23 109.412 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -9.62 58.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 2.3300000000000001 109.157 179.727 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.31 -10.85 48.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 4.1900000000000004 109.536 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 1.6 p30 -158.94 133.9 5.62 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.181 -0.949 . . . . 2.1600000000000001 109.335 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.99 -7.06 20.19 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 120.98 1.12 . . . . 1.3999999999999999 111.349 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 3.7 p -87.25 163.55 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.671 -1.268 . . . . 2.3100000000000001 110.398 -179.391 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . 0.485 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 83.2 m95 -66.34 -175.67 0.37 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.731 -0.605 . . . . 0.72999999999999998 109.521 -179.956 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.445 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 4.0 ttpp -130.79 -156.55 0.76 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.598 -0.89 . . . . 1.96 108.598 179.378 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.8 177.2 54.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.604 -1.398 . . . . 0.56000000000000005 109.604 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.38 154.24 60.98 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.593 1.528 . . . . 0.46999999999999997 110.027 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 165.91 24.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.45 -0.782 . . . . 1.05 109.181 179.423 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.08 141.48 28.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.116 -0.99 . . . . 3.1899999999999999 109.808 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.61 123.93 34.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.814 -0.554 . . . . 1.0900000000000001 109.623 -179.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.97 -73.25 0.65 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.348 -0.845 . . . . 1.1799999999999999 111.079 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.462 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 6.1 t90 -91.93 152.66 19.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.234 -0.916 . . . . 0.34999999999999998 110.804 -177.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.31 128.28 22.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.588 -0.894 . . . . 2.7999999999999998 108.588 179.014 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.38 -126.99 1.24 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.58 -1.295 . . . . 0.29999999999999999 110.574 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.44 -144.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.954 . . . . 1.5600000000000001 109.445 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.2 49.1 2.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.867 -1.693 . . . . 0.28999999999999998 108.867 179.376 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.4 149.44 31.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -1.068 . . . . 1.0700000000000001 109.001 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 134.76 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.246 -0.908 . . . . 1.0900000000000001 109.455 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.97 140.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.828 . . . . 1.0800000000000001 109.03 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.94 176.74 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 1.04 109.873 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -144.91 112.32 6.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.334 -0.854 . . . . 2.3399999999999999 108.992 179.379 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.54 -81.13 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.398 -1.334 . . . . 1.1799999999999999 107.398 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.98 -131.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.678 -1.601 . . . . 2.4700000000000002 106.678 177.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 41.6 t -104.35 57.06 0.71 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.697 -1.223 . . . . 1.8600000000000001 107.697 177.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -155.78 122.51 5.28 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.974 -0.75 . . . . 1.1200000000000001 108.974 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.461 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 59.0 mt -93.05 134.62 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.153 -0.967 . . . . 1.1499999999999999 109.375 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.83 172.71 12.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.502 -0.749 . . . . 2.6400000000000001 109.721 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.33 142.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.114 -0.699 . . . . 1.0800000000000001 109.114 179.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.55 126.69 15.0 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.443 -0.947 . . . . 1.0800000000000001 108.443 179.349 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.03 152.1 38.73 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 N-CA-C 109.791 -0.888 . . . . 0.48999999999999999 109.791 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.73 -34.55 77.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.385 -0.822 . . . . 3.5800000000000001 109.684 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -71.06 -5.63 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.288 -0.883 . . . . 4.3600000000000003 111.238 -178.805 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -118.8 20.34 12.87 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.019 -1.051 . . . . 2.5800000000000001 108.922 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.91 165.33 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 1.05 109.269 179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . 0.474 ' HZ3' ' CB ' ' B' ' 266' ' ' LYS . 7.4 mtmp? -139.99 129.55 24.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.294 -0.879 . . . . 2.2599999999999998 108.987 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.87 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 1.1799999999999999 109.725 -179.34 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -105.35 150.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.141 -1.059 . . . . 1.27 108.141 178.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . 0.543 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.09 142.24 27.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 4.1799999999999997 109.289 179.605 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.045 -0.979 . . . . 2.0499999999999998 109.197 179.608 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.055 -0.72 . . . . 1.48 109.055 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.28 138.12 43.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.53 -0.731 . . . . 0.72 109.542 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.624 HH11 ' CG ' ' A' ' 224' ' ' ARG . 1.0 OUTLIER -108.62 157.31 18.62 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.699 -1.223 . . . . 3.26 107.699 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.85 140.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.09 -1.006 . . . . 0.23 110.418 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.79 153.17 23.87 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.593 -1.262 . . . . 0.58 107.593 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.6 p90 -156.48 152.82 27.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.699 -1.251 . . . . 0.44 110.156 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -95.32 156.4 16.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 2.76 109.653 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -93.07 172.55 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.661 -0.866 . . . . 2.23 108.661 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.24 -13.7 46.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 1.8 109.251 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -90.75 -14.79 31.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 3.63 109.954 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 12.1 m-20 -161.02 128.81 2.77 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.912 -1.118 . . . . 2.16 109.553 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.13 18.0 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 121.021 1.147 . . . . 1.25 110.882 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 31.5 m -83.24 135.06 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.829 -1.169 . . . . 1.75 109.55 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -58.9 161.24 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.66 109.496 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 237' ' ' GLY . 42.5 tttp -121.91 161.48 22.74 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.378 -0.826 . . . . 1.43 109.883 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.21 165.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.244 -1.142 . . . . 0.39 110.244 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.15 158.61 53.73 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.661 1.574 . . . . 0.41 110.699 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.01 172.55 12.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.851 -0.796 . . . . 0.21 108.851 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -92.75 135.75 33.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 2.72 110.026 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -88.14 125.37 34.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.29 109.558 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.86 -74.39 0.61 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.426 -0.796 . . . . 0.45 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.483 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 3.8 t90 -89.85 140.91 29.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.226 -0.921 . . . . 0.31 109.846 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.26 119.7 9.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 2.32 108.791 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -104.42 0.23 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.87 -1.157 . . . . 0.27 110.215 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.69 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -1.067 . . . . 1.39 109.735 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 49.0 2.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.55 151.28 36.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.29 108.522 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.15 126.54 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.31 109.909 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.86 135.16 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.025 -1.102 . . . . 0.29 108.025 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 257' ' ' ILE . 18.1 pt -139.31 179.27 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.871 . . . . 0.23 110.135 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -143.22 110.33 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 1.81 108.772 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.95 -81.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.467 -1.309 . . . . 1.18 107.467 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -78.6 -137.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.505 -1.665 . . . . 1.98 106.505 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.3 m -97.97 54.13 1.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.899 -1.149 . . . . 1.39 107.899 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.45 128.59 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.988 -0.745 . . . . 1.12 108.988 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.476 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 19.0 mt -92.74 140.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.121 -0.987 . . . . 0.47 109.604 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -138.44 168.22 20.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.406 -0.809 . . . . 2.11 109.774 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.75 138.34 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.508 -0.745 . . . . 0.33 109.228 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.72 131.93 18.35 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.363 -0.836 . . . . 0.34 109.137 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.43 139.75 91.85 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 N-CA-C 109.599 -0.962 . . . . 0.42 109.599 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.1 OUTLIER -59.96 -34.76 73.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 3.12 109.722 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.23 -4.96 19.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 3.82 110.988 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -119.29 17.51 13.07 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.254 -0.904 . . . . 2.08 108.873 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.77 17.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.014 -0.736 . . . . 0.32 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.6 131.37 27.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.303 -0.873 . . . . 1.79 109.094 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.7 mm -88.27 108.1 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.45 110.215 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.01 149.0 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.091 -1.078 . . . . 0.57 108.091 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.302 -0.874 . . . . 3.63 108.771 179.336 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.014 -0.735 . . . . 1.48 109.014 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -135.3 138.07 43.09 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.484 -0.76 . . . . 0.73 109.534 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 224' ' ' ARG . 1.0 OUTLIER -108.51 157.36 18.53 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.681 -1.229 . . . . 3.26 107.681 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.92 140.06 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.108 -0.995 . . . . 0.23 110.375 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.74 153.14 23.88 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.621 -1.252 . . . . 0.58 107.621 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.47 152.77 27.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.668 -1.27 . . . . 0.44 110.241 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -95.27 156.37 16.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.476 -0.765 . . . . 2.76 109.688 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -93.13 172.46 8.29 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.65 -0.87 . . . . 2.23 108.65 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.15 -13.75 46.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.81 109.183 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.71 -14.81 31.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 3.64 109.979 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' B' ' 234' ' ' VAL . 12.0 m-20 -161.03 128.83 2.78 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.949 -1.094 . . . . 2.16 109.521 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.28 18.16 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 120.97 1.114 . . . . 1.27 110.81 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' B' ' 232' ' ' ASP . 31.7 m -83.31 135.13 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.795 -1.191 . . . . 1.76 109.535 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -58.97 161.22 5.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.67 109.516 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 42.5 tttp -121.92 161.47 22.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.368 -0.832 . . . . 1.44 109.879 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.26 165.5 0.02 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.277 -1.129 . . . . 0.4 110.277 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.28 158.68 53.71 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.619 1.546 . . . . 0.41 110.644 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.99 172.59 12.71 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.856 -0.794 . . . . 0.21 108.856 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -92.8 135.73 33.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.009 -1.057 . . . . 2.72 110.007 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.18 125.38 34.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.642 -0.662 . . . . 0.3 109.603 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.86 -74.49 0.6 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.442 -0.786 . . . . 0.45 110.158 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.476 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 3.8 t90 -89.76 140.84 29.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.142 -0.974 . . . . 0.33 109.815 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.19 119.67 9.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 2.33 108.816 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -104.51 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.246 -1.142 . . . . 0.28 110.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -67.63 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -1.078 . . . . 1.4 109.686 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.83 2.74 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.514 -1.435 . . . . 0.29 109.514 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.29 151.29 36.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -1.077 . . . . 0.29 108.522 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.12 126.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.159 -0.963 . . . . 0.31 109.838 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.89 135.27 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.996 -1.113 . . . . 0.3 107.996 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 257' ' ' ILE . 18.2 pt -139.4 179.14 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.24 110.083 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -143.14 110.34 5.69 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.735 -0.839 . . . . 1.81 108.735 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 -81.83 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -78.61 -137.42 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.451 -1.685 . . . . 1.97 106.451 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 18.4 m -97.95 54.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.53 128.48 7.34 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.966 -0.753 . . . . 1.12 108.966 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.483 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.0 mt -92.68 140.04 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 0.48 109.67 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -138.5 168.14 20.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 2.13 109.757 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.65 138.33 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.512 -0.743 . . . . 0.34 109.268 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.7 131.98 18.39 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.432 -0.793 . . . . 0.34 109.134 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.44 139.65 91.44 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 109.713 -0.918 . . . . 0.42 109.713 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.1 OUTLIER -59.89 -34.77 73.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 3.11 109.664 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.19 -5.03 20.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.838 . . . . 3.82 110.955 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -119.28 17.51 13.07 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.192 -0.942 . . . . 2.08 108.848 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.34 169.7 17.34 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.094 -0.706 . . . . 0.32 109.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.51 131.35 27.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.25 -0.906 . . . . 1.79 109.099 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -88.2 108.09 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.897 . . . . 0.45 110.16 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.98 149.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.107 -1.072 . . . . 0.57 108.107 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.51 151.82 21.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 3.62 108.854 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.946 -1.026 . . . . 2.05 109.35 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.091 -0.707 . . . . 1.48 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.21 142.27 45.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.72 109.473 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -108.63 156.67 19.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.536 -1.283 . . . . 3.26 107.536 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.1 t -141.54 143.99 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.072 -1.018 . . . . 0.23 110.794 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.96 155.87 22.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.599 -1.259 . . . . 0.58 107.599 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.8 151.88 26.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.44 110.224 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.6 mtm-85 -92.38 137.8 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 2.76 109.67 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.11 170.7 9.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.456 -0.777 . . . . 2.23 109.485 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.3 t -86.79 -9.13 56.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 1.8 109.513 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.39 43.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 3.63 110.055 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.479 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 26.0 p-10 -159.19 134.23 5.67 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.905 -1.122 . . . . 2.16 109.462 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.61 -7.96 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.027 1.152 . . . . 1.25 111.689 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.0 p -84.61 164.04 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.553 -1.342 . . . . 1.75 110.359 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.612 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.5 m95 -66.85 166.42 13.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.586 . . . . 0.66 109.595 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.11 166.37 13.01 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.349 -0.844 . . . . 1.43 109.383 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.0 164.08 0.06 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.115 -1.194 . . . . 0.39 110.115 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.15 164.4 30.4 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.543 1.496 . . . . 0.41 110.604 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.26 8.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.855 -0.794 . . . . 0.21 108.855 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.95 139.26 33.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.206 -0.934 . . . . 2.72 109.041 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -88.88 121.88 31.69 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.352 -0.842 . . . . 0.29 109.833 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.2 mt -110.19 -74.55 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.366 -0.834 . . . . 0.45 109.808 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.406 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.4 t90 -91.71 145.0 24.93 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.11 -0.994 . . . . 0.31 110.36 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.71 120.08 8.43 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.952 -0.758 . . . . 2.32 108.952 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -106.38 0.25 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.737 -1.22 . . . . 0.27 110.453 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.86 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -1.06 . . . . 1.39 109.871 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.69 49.1 2.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.29 109.469 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.2 150.0 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -1.066 . . . . 0.29 108.582 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.7 m -144.14 127.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.31 109.858 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 61.0 t -90.13 136.13 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.312 -0.995 . . . . 0.29 108.312 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.84 179.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.305 -0.872 . . . . 0.23 109.726 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -141.8 111.94 6.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -81.54 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.57 -1.27 . . . . 1.18 107.57 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.65 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.467 -1.679 . . . . 1.98 106.467 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.5 p -105.6 54.29 0.7 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.048 -1.033 . . . . 1.39 108.344 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 255' ' ' SER . 63.0 m-20 -155.87 127.78 7.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.547 -0.721 . . . . 1.12 109.22 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.41 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 79.5 mt -91.65 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.05 -1.031 . . . . 0.47 109.355 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.23 168.91 18.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.921 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.66 138.92 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.519 -0.738 . . . . 0.33 109.348 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.3 t -133.4 131.46 21.51 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.38 137.87 81.78 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.546 0.831 . . . . 0.42 110.124 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -57.14 -36.23 70.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 3.12 109.611 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.67 -3.0 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 3.82 110.717 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -119.37 19.5 12.73 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.154 -0.966 . . . . 2.08 109.029 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.67 171.87 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.32 109.513 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -139.87 129.23 24.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 1.79 108.996 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.65 107.29 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.206 -0.934 . . . . 0.45 109.565 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -105.75 154.02 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.648 -0.871 . . . . 0.57 108.648 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 3.63 109.679 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m120 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 108.98 -0.748 . . . . 1.48 108.98 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 142.25 46.25 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.442 -0.786 . . . . 0.73 109.541 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 28.4 mtp180 -108.59 156.58 19.37 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.525 -1.287 . . . . 3.26 107.525 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.5 144.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.075 -1.016 . . . . 0.23 110.662 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.1 155.77 22.34 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.71 151.96 26.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.741 -1.225 . . . . 0.44 110.238 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.7 mtm-85 -92.49 137.96 31.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.76 109.525 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.15 170.79 9.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 2.23 109.417 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 36.6 t -86.94 -8.94 56.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 1.81 109.429 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.41 43.85 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 3.64 110.004 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 25.8 p-10 -159.22 134.19 5.63 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.979 -1.076 . . . . 2.16 109.429 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.64 -7.96 20.92 Favored 'Trans proline' 0 N--CA 1.483 0.896 0 C-N-CA 121.001 1.134 . . . . 1.27 111.701 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.1 p -84.51 163.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.535 -1.353 . . . . 1.76 110.362 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.4 m95 -66.88 166.31 13.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.81 -0.556 . . . . 0.67 109.547 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.07 166.17 13.23 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.424 -0.797 . . . . 1.44 109.422 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.04 164.14 0.06 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.955 -1.258 . . . . 0.4 109.955 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -67.3 164.5 30.3 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.41 110.526 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.37 8.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.895 -0.78 . . . . 0.21 108.895 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.86 139.31 33.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.255 -0.903 . . . . 2.72 109.007 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -89.0 122.03 31.94 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.387 -0.821 . . . . 0.3 109.826 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.3 mt -110.25 -74.56 0.65 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.427 -0.796 . . . . 0.45 109.82 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -91.79 145.04 24.89 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.127 -0.983 . . . . 0.33 110.387 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -147.65 120.12 8.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.365 -0.834 . . . . 2.33 108.896 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -106.43 0.25 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.84 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -1.038 . . . . 1.4 109.855 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.7 49.23 2.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.06 33.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -1.06 . . . . 0.29 108.655 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -144.29 127.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.31 109.838 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.03 136.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.289 -1.004 . . . . 0.3 108.289 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.85 179.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 0.24 109.761 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -141.81 111.76 6.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.32 -81.62 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.647 -1.242 . . . . 1.18 107.647 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.57 -129.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.538 -1.653 . . . . 1.97 106.538 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.5 p -105.63 54.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.344 -0.984 . . . . 1.38 108.344 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 256' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 255' ' ' SER . 62.7 m-20 -155.87 127.69 7.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 1.12 109.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.406 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 79.3 mt -91.66 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.143 -0.973 . . . . 0.48 109.312 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -137.37 168.89 18.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.13 109.839 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.72 138.74 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.493 -0.755 . . . . 0.34 109.352 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 23.1 t -133.26 131.68 21.76 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.46 137.85 81.98 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 120.566 0.844 . . . . 0.42 110.17 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -57.05 -36.42 70.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 3.11 109.618 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.51 -3.19 13.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.221 -0.924 . . . . 3.82 110.789 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -119.18 19.45 12.87 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.242 -0.911 . . . . 2.08 109.039 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.63 171.91 13.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.32 109.489 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -140.01 129.17 23.73 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.405 -0.809 . . . . 1.79 108.892 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.6 107.36 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.183 -0.948 . . . . 0.45 109.623 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.5 mm -105.77 154.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.582 -0.896 . . . . 0.57 108.582 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.7 OUTLIER -87.61 149.13 24.5 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.349 -0.844 . . . . 3.62 109.604 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.6 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.976 -1.011 . . . . 2.05 109.417 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 109.474 -0.565 . . . . 1.48 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -135.12 131.07 36.43 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.762 -0.829 . . . . 0.72 108.762 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -102.8 153.17 20.43 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 3.26 108.362 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.53 142.71 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 0.23 110.2 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.14 158.81 18.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.491 -1.299 . . . . 0.58 107.491 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.4 p90 -156.37 153.59 29.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.447 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.4 mtm-85 -95.88 147.49 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.531 -0.73 . . . . 2.76 110.115 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 14.5 p-10 -94.32 168.49 10.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -0.786 . . . . 2.23 109.203 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.5 t -84.92 -2.77 58.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 1.8 109.747 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -87.71 -23.79 24.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 3.63 109.834 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 234' ' ' VAL . 10.1 m-20 -163.15 142.39 6.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.99 . . . . 2.16 108.895 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.95 10.23 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.226 1.284 . . . . 1.25 110.826 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -82.75 156.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.644 -1.285 . . . . 1.75 110.415 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.488 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.2 m95 -75.69 -172.55 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.476 -0.564 . . . . 0.66 109.476 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.09 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 1.43 108.184 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.46 172.19 55.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.694 -1.362 . . . . 0.39 109.694 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.3 156.67 65.24 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.55 1.5 . . . . 0.41 110.166 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.02 166.23 25.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.21 109.093 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.42 140.5 29.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 2.72 109.547 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.42 125.24 34.63 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.462 -0.57 . . . . 0.29 109.462 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.9 mt -115.19 -69.97 0.82 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.84 . . . . 0.45 109.982 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.76 143.1 26.88 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.056 -1.027 . . . . 0.31 110.315 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.88 115.42 6.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.272 -0.892 . . . . 2.32 109.235 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.75 0.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.204 -1.158 . . . . 0.27 110.204 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -68.68 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.277 -1.131 . . . . 1.39 109.802 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 51.36 3.03 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.326 -1.509 . . . . 0.29 109.326 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.28 33.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.518 -0.989 . . . . 0.29 108.577 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.88 125.53 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.31 109.682 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.34 135.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.196 -1.038 . . . . 0.29 108.196 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.6 pt -137.66 -178.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.395 -0.816 . . . . 0.23 110.139 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -143.48 111.63 6.2 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.37 -77.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.509 -1.293 . . . . 1.18 107.509 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.81 -132.27 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.944 -1.502 . . . . 1.98 106.944 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.9 p -104.26 53.04 0.75 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.958 -1.127 . . . . 1.39 107.958 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -156.1 127.29 7.05 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.986 -0.746 . . . . 1.12 108.986 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.9 mt -91.23 134.72 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.47 109.344 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -136.12 170.55 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.79 . . . . 2.11 109.857 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.73 139.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.33 109.826 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.73 124.03 14.28 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.626 -0.879 . . . . 0.34 108.626 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.75 139.37 90.06 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 N-CA-C 110.134 -0.756 . . . . 0.42 110.134 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -61.29 -30.48 70.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 3.12 109.407 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' A' ' 263' ' ' ARG . 0.0 OUTLIER -69.83 -9.91 56.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.41 -0.806 . . . . 3.82 110.06 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.45 22.96 11.48 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.242 -0.911 . . . . 2.08 109.11 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 169.57 17.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.081 -0.711 . . . . 0.32 109.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -137.11 127.89 27.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 1.79 108.783 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.44 109.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.45 109.893 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -103.34 152.63 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 3.63 109.353 179.903 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.208 0.528 . . . . 1.48 109.589 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 131.02 36.45 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.783 -0.821 . . . . 0.73 108.783 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -102.7 153.09 20.48 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.424 -0.954 . . . . 3.26 108.424 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.52 142.69 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -0.885 . . . . 0.23 110.156 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -111.2 158.74 18.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.496 -1.298 . . . . 0.58 107.496 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.3 p90 -156.21 153.69 29.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.586 -1.321 . . . . 0.44 110.45 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' B' ' 228' ' ' ARG . 10.5 mtm-85 -95.99 147.44 23.69 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.818 . . . . 2.76 110.094 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 14.7 p-10 -94.31 168.55 10.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.819 . . . . 2.23 109.268 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -85.02 -2.77 58.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 1.81 109.719 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -87.69 -23.73 24.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 3.64 109.767 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 9.9 m-20 -163.19 142.38 6.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.16 108.825 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -62.99 10.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.179 1.252 . . . . 1.27 110.895 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.501 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.7 p -82.69 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.657 -1.277 . . . . 1.76 110.372 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.501 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.3 m95 -75.77 -172.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.501 -0.555 . . . . 0.67 109.501 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.06 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.229 -1.026 . . . . 1.44 108.229 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.48 172.19 55.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.697 -1.361 . . . . 0.4 109.697 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.31 156.54 65.79 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.578 1.519 . . . . 0.41 110.205 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.49 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.21 109.124 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.55 140.57 29.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.092 -1.005 . . . . 2.72 109.495 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 17.8 tp -88.55 125.26 34.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.04 -70.08 0.82 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.281 -0.887 . . . . 0.45 110.082 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -91.72 143.17 26.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.096 -1.003 . . . . 0.33 110.269 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.92 115.39 6.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 2.33 109.184 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.65 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.914 -1.136 . . . . 0.28 110.301 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -68.76 -156.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 1.4 109.774 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.72 51.38 3.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.306 -1.518 . . . . 0.29 109.306 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.17 33.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.991 . . . . 0.29 108.575 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.86 125.66 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.31 109.598 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.42 135.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.194 -1.039 . . . . 0.3 108.194 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.5 pt -137.7 -178.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.309 -0.869 . . . . 0.24 110.206 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -143.5 111.45 6.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.36 -77.39 0.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.519 -1.289 . . . . 1.18 107.519 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.8 -132.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.905 -1.517 . . . . 1.97 106.905 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 5.8 p -104.25 53.07 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -156.1 127.23 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.963 -0.754 . . . . 1.12 108.963 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.404 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 55.4 mt -91.08 134.77 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.48 109.369 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -136.15 170.57 15.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 2.13 109.845 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 8.8 t -99.76 139.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.455 -0.778 . . . . 0.34 109.821 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.9 t -136.75 123.92 14.18 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.6 139.46 90.29 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 110.006 -0.806 . . . . 0.42 110.006 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.41 -30.51 70.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 3.11 109.394 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.0 OUTLIER -69.78 -9.91 56.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.45 -0.781 . . . . 3.82 110.07 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.54 23.05 11.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.295 -0.878 . . . . 2.08 109.053 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.44 169.37 17.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.1 -0.704 . . . . 0.32 109.1 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -136.96 127.89 27.5 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.752 -0.833 . . . . 1.79 108.752 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.1 mm -88.48 109.55 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.91 . . . . 0.45 109.919 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.39 152.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.491 -0.929 . . . . 0.57 108.491 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -93.32 137.34 32.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.388 -0.82 . . . . 3.62 109.342 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.999 -1.001 . . . . 2.05 109.504 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.762 -0.829 . . . . 1.48 108.762 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -120.91 141.14 50.92 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.618 -0.676 . . . . 0.72 109.924 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -113.29 157.76 21.4 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.523 -1.288 . . . . 3.26 107.523 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.19 143.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.066 -1.021 . . . . 0.23 110.627 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -112.88 157.79 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.654 -1.239 . . . . 0.58 107.654 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 14.6 p90 -157.48 147.35 20.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.701 -1.25 . . . . 0.44 110.144 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.64 142.52 27.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.054 -1.029 . . . . 2.76 109.425 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.41 166.55 12.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 2.23 109.369 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.3 p -85.81 -10.15 55.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.921 . . . . 1.8 109.635 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.44 36.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.202 -0.936 . . . . 3.63 109.44 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 234' ' ' VAL . 3.3 p30 -159.23 128.04 3.05 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.31 -0.869 . . . . 2.16 109.105 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.62 9.22 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.805 1.004 . . . . 1.25 110.328 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 232' ' ' ASP . 4.4 t -84.06 156.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.013 -1.055 . . . . 1.75 109.764 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.05 169.75 16.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.66 109.611 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.3 mmtt -119.36 157.25 28.54 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.644 -0.873 . . . . 1.43 108.644 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.12 174.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.39 109.296 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.7 155.76 68.72 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.545 1.497 . . . . 0.41 110.693 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.67 171.91 13.79 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.925 -0.769 . . . . 0.21 108.925 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -93.91 137.39 33.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.049 -1.032 . . . . 2.72 109.707 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.12 121.4 31.41 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.594 -0.691 . . . . 0.29 109.28 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.16 -68.94 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.309 -0.87 . . . . 0.45 110.499 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -95.42 147.35 23.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.002 -1.061 . . . . 0.31 110.353 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.3 119.42 7.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.374 -0.829 . . . . 2.32 108.963 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.0 -109.2 0.32 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.784 -1.198 . . . . 0.27 110.397 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.88 -150.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -1.12 . . . . 1.39 109.488 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.5 56.18 2.47 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.196 -1.562 . . . . 0.29 109.196 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.49 146.72 22.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.364 -1.08 . . . . 0.29 109.643 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.05 121.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.672 -0.862 . . . . 0.31 108.672 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 59.4 t -84.73 132.16 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.375 -0.972 . . . . 0.29 108.375 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -137.96 178.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.23 109.977 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -142.33 110.2 5.86 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -91.12 -78.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.357 -1.349 . . . . 1.18 107.357 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.59 -131.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.762 -1.569 . . . . 1.98 106.762 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 58.8 m -105.35 54.5 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.114 -1.069 . . . . 1.39 108.114 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.8 m-20 -157.08 127.33 6.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 1.12 109.312 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.424 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 79.8 mt -94.18 134.26 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.47 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.22 172.53 12.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 2.11 109.812 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.38 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.33 109.404 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.62 131.75 16.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.798 . . . . 0.34 108.909 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.49 142.98 92.36 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 N-CA-C 109.545 -0.983 . . . . 0.42 109.545 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -55.84 -34.69 65.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 3.12 108.641 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -65.35 -10.83 36.33 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.666 -0.697 . . . . 3.82 110.76 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.73 17.68 12.71 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.278 -1.008 . . . . 2.08 108.278 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.1 168.03 20.58 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.316 -0.624 . . . . 0.32 109.316 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -140.47 126.85 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.205 -0.934 . . . . 1.79 109.171 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.3 mm -87.54 108.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.242 -0.911 . . . . 0.45 109.486 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.18 152.92 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.524 -0.917 . . . . 0.57 108.524 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 3.63 109.934 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 108.708 -0.849 . . . . 1.48 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.03 141.06 51.1 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.63 -0.668 . . . . 0.73 109.796 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -113.31 157.75 21.41 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.559 -1.274 . . . . 3.26 107.559 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.1 143.83 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.022 -1.049 . . . . 0.23 110.776 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.83 157.77 20.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.667 -1.235 . . . . 0.58 107.667 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.0 p90 -157.4 147.38 20.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.292 . . . . 0.44 110.161 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.62 142.42 27.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.104 -0.997 . . . . 2.76 109.502 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -92.41 166.46 12.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.408 -0.808 . . . . 2.23 109.394 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.6 p -85.68 -10.25 55.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.219 -0.925 . . . . 1.81 109.651 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.37 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.099 -1.0 . . . . 3.64 109.442 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' B' ' 234' ' ' VAL . 3.3 p30 -159.23 127.88 3.0 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.083 -1.011 . . . . 2.16 109.195 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -67.56 9.34 0.34 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.74 0.96 . . . . 1.27 110.364 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' B' ' 232' ' ' ASP . 4.4 t -84.05 156.1 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.967 -1.083 . . . . 1.76 109.809 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -72.97 169.74 16.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.371 -0.83 . . . . 0.67 109.666 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mmtt -119.4 157.2 28.69 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.7 -0.852 . . . . 1.44 108.7 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.14 174.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.337 -1.505 . . . . 0.4 109.337 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -67.65 155.8 68.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.5 1.466 . . . . 0.41 110.648 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.61 171.95 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.902 -0.777 . . . . 0.21 108.902 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -93.94 137.44 33.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.133 -0.979 . . . . 2.72 109.684 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.22 121.39 31.47 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.542 -0.724 . . . . 0.3 109.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.17 -68.97 0.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.235 -0.916 . . . . 0.45 110.462 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -95.38 147.41 23.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.056 -1.027 . . . . 0.33 110.339 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.33 119.43 7.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.802 . . . . 2.33 109.004 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.05 -109.25 0.32 Allowed Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.738 -1.22 . . . . 0.28 110.336 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.9 -150.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -1.137 . . . . 1.4 109.497 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.47 56.23 2.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.274 -1.531 . . . . 0.29 109.274 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.5 146.82 22.74 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.342 -1.093 . . . . 0.29 109.559 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.12 121.13 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.601 -0.889 . . . . 0.31 108.601 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 60.3 t -84.81 132.06 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.3 108.416 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -137.8 178.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.454 -0.779 . . . . 0.24 110.035 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -142.31 110.28 5.89 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.662 -0.866 . . . . 1.81 108.662 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -91.26 -78.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.307 -1.368 . . . . 1.18 107.307 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -80.53 -131.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.731 -1.581 . . . . 1.97 106.731 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 58.8 m -105.33 54.52 0.7 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.208 -1.034 . . . . 1.38 108.208 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.8 m-20 -157.06 127.33 6.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.474 -0.766 . . . . 1.12 109.242 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.417 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 79.4 mt -94.11 134.2 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.48 109.51 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.08 172.48 12.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.324 -0.86 . . . . 2.13 109.843 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.35 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.459 -0.776 . . . . 0.34 109.407 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.64 131.8 16.13 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 0.34 108.918 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.4 142.93 92.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 N-CA-C 109.506 -0.998 . . . . 0.42 109.506 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -55.8 -34.76 65.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.853 -1.155 . . . . 3.11 108.717 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -65.27 -10.92 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.649 -0.705 . . . . 3.82 110.724 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.7 17.76 12.72 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.257 -1.016 . . . . 2.08 108.257 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.07 168.1 20.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.259 -0.645 . . . . 0.32 109.259 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -140.55 126.82 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.249 -0.907 . . . . 1.79 109.154 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.1 mm -87.51 108.38 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.887 . . . . 0.45 109.556 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.23 152.8 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.49 -0.93 . . . . 0.57 108.49 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -91.4 143.67 26.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 3.62 109.94 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.541 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.001 -0.74 . . . . 1.48 109.001 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -128.18 132.77 48.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.105 -0.702 . . . . 0.72 109.105 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.37 159.47 15.7 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.382 -0.97 . . . . 3.26 108.382 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.83 141.68 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.156 -0.965 . . . . 0.23 110.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.68 151.28 27.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.55 -1.278 . . . . 0.58 107.55 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.0 p90 -156.43 151.21 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.651 -1.281 . . . . 0.44 110.441 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -92.72 141.68 28.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.589 -0.694 . . . . 2.76 109.577 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 5.0 p30 -93.79 165.72 12.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.423 -0.798 . . . . 2.23 109.044 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.99 -0.06 47.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 1.8 109.162 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 10.1 mmm180 -90.01 -20.96 22.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.387 -0.82 . . . . 3.63 109.205 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.7 m-20 -161.03 134.05 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.777 -0.823 . . . . 2.16 108.777 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.73 8.86 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 120.727 0.951 . . . . 1.25 110.208 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.2 t -84.06 159.18 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.034 -1.041 . . . . 1.75 109.921 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.435 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.9 m95 -75.09 164.88 26.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 0.66 108.959 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 237' ' ' GLY . 32.5 tttp -120.01 158.25 27.17 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.395 -0.816 . . . . 1.43 109.652 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.61 165.83 0.03 OUTLIER Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.283 -1.127 . . . . 0.39 110.283 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.97 163.25 36.42 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.705 1.603 . . . . 0.41 110.452 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.17 178.45 7.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.21 109.187 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.09 137.19 35.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.154 -0.966 . . . . 2.72 109.393 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.9 tp -87.88 124.64 33.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.413 -0.805 . . . . 0.29 109.238 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.58 -74.01 0.62 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.459 -0.776 . . . . 0.45 109.99 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.532 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.0 t90 -92.32 141.69 28.27 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.31 109.719 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.85 116.91 7.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.906 . . . . 2.32 109.138 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.13 -105.04 0.23 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.905 -1.14 . . . . 0.27 110.308 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -62.39 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.104 . . . . 1.39 109.877 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 49.86 2.79 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.773 -1.331 . . . . 0.29 109.773 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.76 154.11 39.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -1.126 . . . . 0.29 108.696 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.06 122.79 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.31 109.747 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.72 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.963 -1.125 . . . . 0.29 107.963 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.43 174.79 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.23 110.033 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.4 109.4 5.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.147 -1.057 . . . . 1.81 108.147 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.43 -79.75 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 1.18 107.574 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.5 -128.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 13.0 p -105.89 53.38 0.71 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.284 -1.006 . . . . 1.39 108.284 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.7 m-20 -155.69 129.85 8.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 1.12 109.487 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.418 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.6 mt -95.11 139.86 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.461 -0.774 . . . . 0.47 110.07 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -140.32 162.87 34.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.416 -0.802 . . . . 2.11 109.462 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.97 141.8 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.215 -0.928 . . . . 0.33 108.857 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.83 130.77 18.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.375 -0.828 . . . . 0.34 109.452 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.66 141.37 97.57 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.688 -0.928 . . . . 0.42 109.688 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.26 -29.48 69.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 3.12 109.727 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -70.04 -12.0 61.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.865 . . . . 3.82 111.042 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.83 28.06 8.15 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.153 -0.967 . . . . 2.08 109.273 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.09 168.87 18.81 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.801 -0.814 . . . . 0.32 108.801 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.07 126.94 19.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.224 -0.922 . . . . 1.79 109.392 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.52 109.73 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.343 -0.848 . . . . 0.45 109.67 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.31 149.41 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.394 -0.965 . . . . 0.57 108.394 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.856 . . . . 3.63 109.806 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.032 -0.729 . . . . 1.48 109.032 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -128.23 132.86 48.76 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.73 109.071 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -104.45 159.43 15.74 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.417 -0.957 . . . . 3.26 108.417 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.8 141.67 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.23 110.403 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.64 151.31 27.82 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.617 -1.253 . . . . 0.58 107.617 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.1 p90 -156.46 151.23 25.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.752 -1.218 . . . . 0.44 110.454 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -92.76 141.62 28.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.569 -0.707 . . . . 2.76 109.595 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 4.9 p30 -93.79 165.78 12.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.441 -0.787 . . . . 2.23 109.075 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.93 -0.24 47.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 1.81 109.182 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 10.1 mmm180 -89.93 -21.01 22.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 3.64 109.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.7 m-20 -161.08 134.05 4.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.787 -0.82 . . . . 2.16 108.787 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.61 8.69 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 120.765 0.977 . . . . 1.27 110.169 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.3 t -84.01 159.17 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.009 -1.057 . . . . 1.76 109.958 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.441 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.9 m95 -75.04 164.95 26.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.45 -0.781 . . . . 0.67 109.146 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' B' ' 237' ' ' GLY . 32.6 tttp -120.0 158.24 27.19 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.398 -0.814 . . . . 1.44 109.607 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.55 165.76 0.02 OUTLIER Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.296 -1.122 . . . . 0.4 110.296 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.95 163.26 36.38 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.658 1.572 . . . . 0.41 110.583 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.2 178.38 7.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.21 109.235 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.02 137.1 35.57 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 2.72 109.417 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.74 124.64 33.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.342 -0.849 . . . . 0.3 109.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.65 -73.93 0.63 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.465 -0.772 . . . . 0.45 109.983 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.418 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.0 t90 -92.28 141.6 28.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.2 -0.937 . . . . 0.33 109.844 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.76 117.04 7.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 2.33 109.047 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.17 -105.03 0.23 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.876 -1.155 . . . . 0.28 110.241 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -62.53 -158.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 1.4 109.819 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.56 49.85 2.78 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.859 -1.296 . . . . 0.29 109.859 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.04 38.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -1.086 . . . . 0.29 108.614 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.04 122.83 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.31 109.752 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.71 138.42 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.93 -1.137 . . . . 0.3 107.93 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.9 pt -141.54 174.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.24 109.956 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.38 109.32 5.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.235 -1.024 . . . . 1.81 108.235 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.4 -79.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.483 -1.303 . . . . 1.18 107.483 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.51 -128.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.592 -1.633 . . . . 1.97 106.592 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 13.0 p -105.8 53.21 0.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.267 -1.012 . . . . 1.38 108.267 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.6 m-20 -155.63 129.89 8.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.435 -0.79 . . . . 1.12 109.475 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.8 mt -95.13 139.83 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.434 -0.791 . . . . 0.48 110.076 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -140.29 162.87 34.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.417 -0.802 . . . . 2.13 109.491 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.93 141.84 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.34 108.916 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.79 130.78 18.84 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.34 109.444 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.72 141.39 97.7 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 N-CA-C 109.687 -0.928 . . . . 0.42 109.687 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.17 -29.62 69.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 3.11 109.68 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -69.96 -12.05 61.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 3.82 111.117 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.77 28.08 8.14 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.08 -1.012 . . . . 2.08 109.304 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.11 168.85 18.87 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.834 -0.802 . . . . 0.32 108.834 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.02 126.89 19.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.142 -0.974 . . . . 1.79 109.369 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.49 109.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.45 109.749 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.27 149.36 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.472 -0.936 . . . . 0.57 108.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -90.3 144.86 25.44 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.358 -0.839 . . . . 3.62 109.879 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.014 -0.993 . . . . 2.05 109.252 179.812 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.038 -0.727 . . . . 1.48 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.43 131.87 38.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.563 -0.711 . . . . 0.72 109.559 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.82 19.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.604 -1.258 . . . . 3.26 107.604 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -139.93 140.54 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 0.23 110.311 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.97 154.58 20.89 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.352 -1.351 . . . . 0.58 107.352 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.8 p90 -155.34 153.34 30.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.55 -1.344 . . . . 0.44 110.645 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -96.03 133.24 40.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.448 -0.783 . . . . 2.76 109.323 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -95.58 177.23 5.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 2.23 109.106 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 p -88.06 -11.63 46.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 1.8 108.932 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 231' ' ' ARG . 11.3 mpt_? -81.49 -13.37 58.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 3.63 109.124 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 15.6 p-10 -161.32 129.78 2.96 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.17 -0.956 . . . . 2.16 109.552 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.13 0.62 4.92 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 N-CA-C 109.574 -0.972 . . . . 1.25 109.574 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 235' ' ' TRP . 45.0 t -85.44 160.83 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 1.75 110.215 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.485 ' N ' HG12 ' A' ' 234' ' ' VAL . 98.5 m95 -67.46 163.35 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.523 -0.917 . . . . 0.66 108.523 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 40.7 tttp -119.95 164.79 15.54 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.267 -0.896 . . . . 1.43 109.748 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.02 169.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.458 -1.057 . . . . 0.39 110.458 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.15 161.02 47.53 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.985 1.79 . . . . 0.41 110.752 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.18 175.85 9.31 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.67 -0.863 . . . . 0.21 108.67 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -94.03 139.38 31.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.954 -1.091 . . . . 2.72 109.127 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.9 tp -89.33 125.17 35.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.898 . . . . 0.29 109.73 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.7 mt -117.49 -77.58 0.57 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.502 -0.749 . . . . 0.45 110.719 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -93.36 136.74 33.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.993 -1.067 . . . . 0.31 110.458 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.5 127.2 13.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.85 . . . . 2.32 109.249 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.64 -105.33 0.24 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.549 -1.42 . . . . 0.27 109.549 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 245' ' ' GLY . 25.5 mt-10 -60.09 -154.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 1.39 109.149 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.0 45.97 2.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.922 -1.671 . . . . 0.29 108.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.73 141.44 18.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.965 . . . . 0.29 108.867 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.29 144.26 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.116 -0.99 . . . . 0.31 108.931 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 147.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.101 -0.999 . . . . 0.29 109.993 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.26 178.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.749 . . . . 0.23 109.488 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -144.72 110.86 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.241 -1.022 . . . . 1.81 108.241 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.94 -78.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.551 -1.277 . . . . 1.18 107.551 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -139.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.713 -1.588 . . . . 1.98 106.713 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 60.2 p -97.22 53.79 1.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 2.6 m-20 -155.14 126.22 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.949 -0.76 . . . . 1.12 108.949 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 41.3 mt -92.43 135.46 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.47 109.488 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.85 169.93 16.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.426 -0.797 . . . . 2.11 109.562 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.15 139.99 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.33 109.532 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.6 126.75 18.27 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.06 141.89 96.56 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 N-CA-C 110.039 -0.793 . . . . 0.42 110.039 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.48 -34.09 66.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.315 -0.866 . . . . 3.12 109.138 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -70.12 -8.2 47.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 3.82 110.496 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.48 22.29 11.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.293 -0.879 . . . . 2.08 109.113 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.16 33.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.54 -0.725 . . . . 0.32 109.067 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -139.06 132.01 29.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.309 -0.87 . . . . 1.79 108.957 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.5 107.36 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.372 -0.83 . . . . 0.45 109.579 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 269' ' ' ARG . 36.8 mm -103.79 160.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.466 -0.771 . . . . 0.57 109.275 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.438 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.768 . . . . 3.63 109.405 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.056 -0.72 . . . . 1.48 109.056 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.46 131.87 38.6 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.561 -0.712 . . . . 0.73 109.454 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.9 19.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.572 -1.27 . . . . 3.26 107.572 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -140.13 140.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.239 -0.913 . . . . 0.23 110.236 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.17 154.55 21.03 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.317 -1.364 . . . . 0.58 107.317 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -155.3 153.35 30.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.599 -1.313 . . . . 0.44 110.701 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -95.96 133.26 40.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.447 -0.783 . . . . 2.76 109.34 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -95.6 177.27 5.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 2.23 109.102 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 4.5 p -88.17 -11.69 46.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.077 -1.014 . . . . 1.81 108.857 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' B' ' 231' ' ' ARG . 11.3 mpt_? -81.32 -13.54 58.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 3.64 109.131 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 16.0 p-10 -161.24 129.57 2.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.196 -0.94 . . . . 2.16 109.555 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.9 0.45 4.99 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 N-CA-C 109.586 -0.967 . . . . 1.27 109.586 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.487 HG12 ' N ' ' B' ' 235' ' ' TRP . 45.1 t -85.44 160.81 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 1.76 110.255 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.487 ' N ' HG12 ' B' ' 234' ' ' VAL . 98.4 m95 -67.38 163.46 20.72 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.521 -0.918 . . . . 0.67 108.521 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 237' ' ' GLY . 40.9 tttp -119.94 164.65 15.75 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.306 -0.871 . . . . 1.44 109.705 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.14 169.53 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.447 -1.061 . . . . 0.4 110.447 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.29 161.08 47.3 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.893 1.729 . . . . 0.41 110.695 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 175.88 9.28 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.676 -0.861 . . . . 0.21 108.676 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -93.85 139.4 30.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.017 -1.052 . . . . 2.72 109.224 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.8 tp -89.46 125.15 35.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.182 -0.949 . . . . 0.3 109.724 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 23.5 mt -117.53 -77.53 0.57 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.486 -0.759 . . . . 0.45 110.747 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -93.4 136.66 33.46 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.16 -0.962 . . . . 0.33 110.408 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.33 127.27 13.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.228 -0.92 . . . . 2.33 109.274 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.66 -105.39 0.24 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.601 -1.4 . . . . 0.28 109.601 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 245' ' ' GLY . 25.6 mt-10 -60.03 -154.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -1.108 . . . . 1.4 109.121 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 45.93 2.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.961 -1.656 . . . . 0.29 108.961 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.5 19.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.969 . . . . 0.29 108.88 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.46 144.1 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -0.997 . . . . 0.31 108.925 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.46 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.3 110.008 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.27 178.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.24 109.507 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -144.56 110.76 5.5 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 1.81 108.31 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -88.91 -78.89 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.525 -1.287 . . . . 1.18 107.525 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 254' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' B' ' 254' ' ' ASN . 1.0 OUTLIER -81.82 -139.01 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 60.2 p -97.17 53.78 1.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.005 -1.109 . . . . 1.38 108.005 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 256' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' B' ' 255' ' ' SER . 2.6 m-20 -155.14 126.15 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.983 -0.747 . . . . 1.12 108.983 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 41.1 mt -92.33 135.48 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.48 109.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.93 169.88 17.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.586 -0.696 . . . . 2.13 109.485 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.17 140.07 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.419 -0.801 . . . . 0.34 109.466 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.64 126.86 18.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.73 -0.841 . . . . 0.34 108.73 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.22 141.97 97.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 110.035 -0.794 . . . . 0.42 110.035 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -56.47 -34.13 66.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.257 -0.902 . . . . 3.11 109.153 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.99 -8.29 47.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.43 -0.793 . . . . 3.82 110.514 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.3 22.12 11.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.285 -0.884 . . . . 2.08 109.137 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.63 163.21 33.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.089 -0.708 . . . . 0.32 109.089 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -139.16 131.98 29.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.281 -0.887 . . . . 1.79 108.92 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.48 107.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.45 109.487 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.442 HG22 ' N ' ' B' ' 269' ' ' ARG . 37.1 mm -103.84 160.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.57 109.16 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.442 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -93.74 141.54 28.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.487 -0.758 . . . . 3.62 109.438 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.01 -1.056 . . . . 2.05 109.389 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.3 m-20 . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.441 -0.577 . . . . 1.48 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -133.38 153.2 51.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.446 -0.783 . . . . 0.72 109.024 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -117.55 149.81 40.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.737 -1.208 . . . . 3.26 107.737 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.02 139.98 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.864 . . . . 0.23 110.085 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -109.22 154.45 22.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.499 -1.297 . . . . 0.58 107.499 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 16.3 p90 -157.01 160.24 38.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.613 -1.304 . . . . 0.44 110.399 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -93.2 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 2.76 109.844 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.72 171.88 8.71 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.833 -0.802 . . . . 2.23 108.833 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.9 p -89.45 -9.54 49.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 1.8 109.458 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -87.04 -16.81 34.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 3.63 109.632 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -162.5 134.1 3.91 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 2.16 108.782 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.84 12.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 120.988 1.125 . . . . 1.25 110.98 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 235' ' ' TRP . 8.6 p -84.64 161.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.699 -1.251 . . . . 1.75 110.029 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.539 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.0 m95 -75.57 163.34 27.46 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.42 -162.51 0.92 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.299 -0.875 . . . . 1.43 108.764 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.19 176.51 51.62 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.639 -1.385 . . . . 0.39 109.639 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -68.96 157.7 60.84 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.675 1.583 . . . . 0.41 110.528 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.96 170.29 16.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.746 -0.835 . . . . 0.21 108.746 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.58 142.44 27.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 2.72 109.702 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.27 119.32 30.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.73 -0.606 . . . . 0.29 109.926 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -109.71 -72.63 0.71 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.331 -0.856 . . . . 0.45 109.814 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.14 146.15 23.95 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.153 -0.967 . . . . 0.31 110.463 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -147.28 120.83 9.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.443 -0.785 . . . . 2.32 108.917 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -107.08 0.27 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.794 -1.194 . . . . 0.27 110.477 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -69.22 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 1.39 110.126 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.32 46.17 2.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.369 -1.493 . . . . 0.29 109.369 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.15 33.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.495 -1.003 . . . . 0.29 108.525 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.65 138.3 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.06 -1.025 . . . . 0.31 109.784 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.76 139.39 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.385 -0.968 . . . . 0.29 108.385 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.2 pt -141.53 178.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.23 110.059 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -144.36 111.18 5.73 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.779 -0.823 . . . . 1.81 108.779 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.78 -79.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.483 -1.302 . . . . 1.18 107.483 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -79.38 -131.33 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.914 -1.513 . . . . 1.98 106.914 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.7 p -105.61 54.8 0.69 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.372 -0.973 . . . . 1.39 108.372 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -156.31 126.32 6.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 1.12 109.034 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -92.68 135.24 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.47 109.448 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.97 168.64 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 2.11 109.662 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.98 142.26 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.324 -0.86 . . . . 0.33 109.332 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 33.5 t -135.89 131.17 18.89 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.437 -0.789 . . . . 0.34 109.086 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.29 146.43 96.53 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 120.72 0.947 . . . . 0.42 110.458 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -59.25 -32.34 69.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.564 -0.902 . . . . 3.12 108.564 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.9 mtt-85 -70.68 -9.18 56.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.935 . . . . 3.82 110.853 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.56 21.09 12.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.176 -0.952 . . . . 2.08 109.776 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.25 22.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.412 -0.805 . . . . 0.32 109.959 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -140.5 124.93 17.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.58 -0.896 . . . . 1.79 108.58 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.53 112.47 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.133 -0.979 . . . . 0.45 110.159 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.94 147.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.74 -1.207 . . . . 0.57 107.74 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 3.63 109.767 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.413 -0.588 . . . . 1.48 109.413 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -133.34 153.23 51.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.773 . . . . 0.73 109.032 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -117.63 149.77 40.14 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.695 -1.224 . . . . 3.26 107.695 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.03 139.89 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.844 . . . . 0.23 110.062 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.19 154.43 22.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.543 -1.28 . . . . 0.58 107.543 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 16.0 p90 -156.93 160.22 38.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.804 -1.185 . . . . 0.44 110.387 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -93.16 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.744 . . . . 2.76 109.839 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.79 171.91 8.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 2.23 108.846 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 30.5 p -89.5 -9.56 49.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 1.81 109.436 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.94 -16.93 34.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 3.64 109.693 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.4 m-20 -162.41 134.0 3.91 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.93 . . . . 2.16 108.811 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.8 12.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 120.873 1.049 . . . . 1.27 110.957 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.532 HG22 ' N ' ' B' ' 235' ' ' TRP . 8.6 p -84.68 161.3 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.677 -1.264 . . . . 1.76 109.976 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.532 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.9 m95 -75.4 163.23 27.65 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.077 -0.712 . . . . 0.67 109.077 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.33 -162.63 0.92 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.289 -0.882 . . . . 1.44 108.819 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.04 176.55 51.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.76 -1.336 . . . . 0.4 109.76 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -69.12 157.6 61.02 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.74 1.627 . . . . 0.41 110.515 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.95 170.3 16.28 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.76 -0.83 . . . . 0.21 108.76 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.56 142.51 27.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.038 -1.039 . . . . 2.72 109.647 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.39 119.35 30.6 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.656 -0.653 . . . . 0.3 109.797 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.65 -72.69 0.71 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.317 -0.865 . . . . 0.45 109.851 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.17 146.17 23.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.158 -0.964 . . . . 0.33 110.411 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -147.29 120.83 9.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.398 -0.814 . . . . 2.33 108.866 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.79 -107.01 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.711 -1.233 . . . . 0.28 110.439 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.33 -153.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -1.027 . . . . 1.4 110.125 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.29 46.06 2.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.416 -1.473 . . . . 0.29 109.416 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.07 151.18 34.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.499 -1.0 . . . . 0.29 108.487 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.7 m -146.58 138.25 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 0.31 109.785 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.73 139.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.395 -0.965 . . . . 0.3 108.395 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.52 178.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.24 110.055 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -144.48 111.17 5.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.766 -0.828 . . . . 1.81 108.766 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.8 -79.84 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.47 -1.308 . . . . 1.18 107.47 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -79.37 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.911 -1.514 . . . . 1.97 106.911 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -105.52 54.82 0.69 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.335 -0.987 . . . . 1.38 108.335 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -156.31 126.33 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 1.12 109.064 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.6 mt -92.68 135.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.297 -0.877 . . . . 0.48 109.461 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -138.99 168.56 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.865 . . . . 2.13 109.677 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.94 142.36 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.397 -0.814 . . . . 0.34 109.283 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.92 131.17 18.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.373 -0.83 . . . . 0.34 109.179 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.3 146.53 96.32 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 120.692 0.928 . . . . 0.42 110.412 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -59.34 -32.29 69.96 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.61 -0.885 . . . . 3.11 108.61 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' B' ' 263' ' ' ARG . 2.9 mtt-85 -70.63 -9.18 56.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.271 -0.893 . . . . 3.82 110.812 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.47 20.91 12.34 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.243 -0.911 . . . . 2.08 109.769 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.15 167.25 22.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.439 -0.788 . . . . 0.32 109.9 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -140.56 124.89 17.67 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.61 -0.885 . . . . 1.79 108.61 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.46 112.37 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.235 -0.916 . . . . 0.45 110.22 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.95 147.12 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.638 -1.245 . . . . 0.57 107.638 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.62 140.79 29.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 3.62 109.741 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.997 -1.002 . . . . 2.05 109.353 179.737 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.988 -0.745 . . . . 1.48 108.988 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.2 135.28 40.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.389 -0.819 . . . . 0.72 109.299 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -103.47 157.98 16.66 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.839 -1.171 . . . . 3.26 107.839 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.33 138.68 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.026 -1.046 . . . . 0.23 110.646 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -111.03 151.87 27.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.724 -1.213 . . . . 0.58 107.724 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.0 p90 -158.3 154.65 27.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.671 -1.268 . . . . 0.44 110.376 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.05 152.24 18.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.534 -0.729 . . . . 2.76 109.651 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.67 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 2.23 108.82 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 58.0 m -79.25 -2.83 43.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.996 . . . . 1.8 109.333 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.89 20.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.299 -0.876 . . . . 3.63 109.844 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.3 m-20 -162.87 144.51 7.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.16 109.067 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.08 15.75 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.061 1.174 . . . . 1.25 110.643 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 232' ' ' ASP . 33.9 m -83.24 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.799 -1.188 . . . . 1.75 110.006 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -63.97 164.84 9.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.66 109.358 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.2 tttp -119.41 158.07 26.93 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.38 -0.825 . . . . 1.43 108.893 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.01 165.38 0.02 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.281 -1.127 . . . . 0.39 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.2 157.67 58.66 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.552 1.501 . . . . 0.41 110.289 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.32 169.02 18.53 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.927 -0.768 . . . . 0.21 108.927 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.22 142.72 26.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 2.72 109.334 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.0 tp -87.6 128.44 35.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.491 -0.756 . . . . 0.29 110.179 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.0 -76.15 0.58 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.36 -0.837 . . . . 0.45 109.749 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' A' ' 250' ' ' VAL . 5.3 t90 -93.07 142.6 27.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.154 -0.966 . . . . 0.31 110.121 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.66 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.285 -0.884 . . . . 2.32 108.744 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.35 -107.32 0.28 Allowed Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.792 -1.194 . . . . 0.27 110.184 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.8 -150.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 1.39 109.644 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 49.98 3.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.354 -1.498 . . . . 0.29 109.354 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.94 150.15 33.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.389 -1.065 . . . . 0.29 108.822 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.52 129.66 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.31 109.758 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 243' ' ' TRP . 95.4 t -93.41 134.18 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.45 -0.944 . . . . 0.29 108.45 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.98 178.63 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.23 109.583 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.84 111.24 5.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.39 -0.819 . . . . 1.81 109.029 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.99 -82.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.108 -1.441 . . . . 1.18 107.108 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -78.85 -138.82 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.733 -1.58 . . . . 1.98 106.733 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.1 m -98.05 56.25 1.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.989 -1.07 . . . . 1.39 108.423 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -156.15 125.75 6.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.735 . . . . 1.12 109.038 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.412 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 80.6 mt -93.06 134.96 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.267 -0.896 . . . . 0.47 109.6 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.31 165.21 26.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.444 -0.785 . . . . 2.11 109.746 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.85 139.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.33 109.743 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.35 130.57 17.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 108.702 -0.851 . . . . 0.34 108.702 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.61 146.88 73.64 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.613 -0.957 . . . . 0.42 109.613 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -65.16 -32.88 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 3.12 109.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -69.97 -4.89 22.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 3.82 110.826 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.72 16.14 13.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.283 -0.885 . . . . 2.08 109.051 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.8 172.29 13.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.627 -0.671 . . . . 0.32 109.426 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -139.54 129.91 25.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.408 -0.808 . . . . 1.79 109.231 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.2 mm -88.49 106.61 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.45 109.727 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.01 156.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.339 -0.851 . . . . 0.57 108.849 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.289 -0.882 . . . . 3.63 109.219 179.406 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.999 -0.741 . . . . 1.48 108.999 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -135.2 135.17 40.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.421 -0.799 . . . . 0.73 109.329 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 84.4 mtt180 -103.3 157.94 16.67 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.834 -1.173 . . . . 3.26 107.834 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.4 t -142.3 138.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.106 -0.996 . . . . 0.23 110.622 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.98 151.99 27.32 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.723 -1.214 . . . . 0.58 107.723 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.2 p90 -158.39 154.68 27.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.709 -1.244 . . . . 0.44 110.344 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.0 152.16 18.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 2.76 109.706 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.71 13.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.372 -0.83 . . . . 2.23 108.771 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 57.7 m -79.35 -2.72 42.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 1.81 109.263 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.82 20.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 3.64 109.894 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.2 m-20 -162.93 144.43 7.75 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.044 -1.035 . . . . 2.16 109.065 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.9 15.54 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.236 1.291 . . . . 1.27 110.677 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' B' ' 232' ' ' ASP . 33.9 m -83.18 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 1.76 110.05 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -64.04 164.77 10.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.247 -0.908 . . . . 0.67 109.427 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.0 tttp -119.32 158.04 26.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.398 -0.814 . . . . 1.44 108.986 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.98 165.36 0.02 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.258 -1.137 . . . . 0.4 110.258 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.23 157.65 58.84 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 121.526 1.484 . . . . 0.41 110.225 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.35 169.05 18.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.21 108.96 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -93.31 142.71 27.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.064 -1.023 . . . . 2.72 109.282 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.62 128.46 35.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.416 -0.802 . . . . 0.3 110.232 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.03 -76.12 0.58 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.514 -0.741 . . . . 0.45 109.711 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' B' ' 250' ' ' VAL . 5.3 t90 -93.01 142.57 27.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.124 -0.985 . . . . 0.33 110.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.74 11.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.3 -0.875 . . . . 2.33 108.747 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -107.33 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.771 -1.204 . . . . 0.28 110.203 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.79 -150.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -1.041 . . . . 1.4 109.727 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.17 49.93 3.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.319 -1.513 . . . . 0.29 109.319 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.17 33.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -1.038 . . . . 0.29 108.799 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 12.0 m -145.58 129.74 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.31 109.827 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' B' ' 243' ' ' TRP . 95.9 t -93.47 134.17 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.439 -0.948 . . . . 0.3 108.439 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.2 pt -136.96 178.57 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.24 109.654 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.83 111.24 5.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 1.81 109.039 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -88.98 -81.89 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.199 -1.408 . . . . 1.18 107.199 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -78.9 -138.9 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.674 -1.602 . . . . 1.97 106.674 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.2 m -97.94 56.22 1.23 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.954 -1.091 . . . . 1.38 108.494 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -156.16 125.75 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 1.12 109.102 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.41 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 80.5 mt -93.08 134.92 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.933 . . . . 0.48 109.617 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.26 165.32 26.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 2.13 109.749 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.92 139.96 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.424 -0.797 . . . . 0.34 109.696 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 83.9 t -137.43 130.57 17.07 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.47 146.91 71.93 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.597 -0.963 . . . . 0.42 109.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -65.36 -32.82 74.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 3.11 109.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -69.93 -4.86 22.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 3.82 110.867 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.84 16.33 13.49 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.258 -0.902 . . . . 2.08 109.013 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.89 172.23 13.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 0.32 109.426 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -139.51 129.86 25.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 1.79 109.288 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.44 106.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.277 -0.889 . . . . 0.45 109.778 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.02 156.33 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.385 -0.822 . . . . 0.57 108.909 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -91.02 147.4 23.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 3.62 109.196 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.6 m-20 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.048 -1.032 . . . . 2.05 109.477 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.393 -0.595 . . . . 1.48 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.54 121.7 20.21 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.508 -0.745 . . . . 0.72 109.213 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.17 165.29 12.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 3.26 108.294 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -143.39 143.02 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.138 -0.977 . . . . 0.23 110.676 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -113.02 148.29 35.44 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.631 -1.248 . . . . 0.58 107.631 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.7 p90 -156.91 151.99 26.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.729 -1.232 . . . . 0.44 110.288 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -93.19 139.25 30.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 2.76 109.456 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -94.19 166.79 11.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 2.23 109.224 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.4 p -79.76 -1.5 38.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 1.8 109.105 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -87.24 -22.6 25.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 3.63 109.531 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 234' ' ' VAL . 8.3 m-20 -163.07 135.05 3.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 2.16 109.073 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.82 10.95 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 120.813 1.009 . . . . 1.25 110.228 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 232' ' ' ASP . 25.0 t -85.63 160.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.905 -1.122 . . . . 1.75 109.821 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.461 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.2 m95 -74.52 162.17 29.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.66 108.765 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.3 tttm -119.44 153.06 35.83 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.296 -0.877 . . . . 1.43 109.385 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -41.26 163.57 0.01 OUTLIER Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.762 -0.935 . . . . 0.39 110.762 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -66.6 159.44 50.87 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 121.638 1.559 . . . . 0.41 110.612 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.78 177.18 8.08 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.008 -0.738 . . . . 0.21 109.008 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -94.39 136.49 34.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.029 -1.045 . . . . 2.72 109.194 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.74 124.01 33.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 0.29 109.619 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -113.3 -74.33 0.63 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.434 -0.791 . . . . 0.45 110.208 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -91.26 143.26 26.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.264 -0.897 . . . . 0.31 110.33 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.11 117.96 7.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.435 -0.791 . . . . 2.32 109.225 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.19 -108.7 0.3 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.944 -1.263 . . . . 0.27 109.944 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -63.56 -154.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -1.145 . . . . 1.39 109.416 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.37 52.02 3.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.603 -1.399 . . . . 0.29 109.603 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.69 150.44 34.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.396 -1.061 . . . . 0.29 108.967 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 122.85 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.31 109.701 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 52.8 t -87.22 135.36 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.991 -1.114 . . . . 0.29 107.991 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.63 178.33 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.23 110.52 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -144.81 112.16 6.08 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.93 -78.5 0.39 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.612 -1.255 . . . . 1.18 107.612 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -80.53 -129.29 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.68 -1.6 . . . . 1.98 106.68 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.5 m -105.41 54.3 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.106 -1.072 . . . . 1.39 108.106 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -156.19 128.41 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.519 -0.738 . . . . 1.12 109.519 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 36.1 mt -94.61 137.59 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 0.47 109.488 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.32 166.65 23.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.386 -0.821 . . . . 2.11 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.94 142.5 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.33 109.112 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.2 t -139.28 129.52 14.5 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 0.34 109.168 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.406 ' HG2' ' HZ3' ' A' ' 264' ' ' LYS . 7.0 Cg_exo -54.37 160.66 6.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.939 -0.831 . . . . 0.42 109.939 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -84.8 -27.2 26.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 3.12 110.249 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.32 -18.82 65.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.893 . . . . 3.82 111.931 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.406 ' HZ3' ' HG2' ' A' ' 261' ' ' PRO . 2.0 ptpp? -119.43 29.24 7.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.897 -1.127 . . . . 2.08 109.616 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.4 164.41 25.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.517 -0.92 . . . . 0.32 108.517 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.12 124.62 19.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.248 -0.908 . . . . 1.79 109.293 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.7 mm -88.52 110.41 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 0.45 109.581 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.9 146.76 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 3.63 109.612 179.94 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.316 -0.624 . . . . 1.48 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -135.56 121.69 20.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.517 -0.739 . . . . 0.73 109.158 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.16 165.2 12.17 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.339 -0.986 . . . . 3.26 108.339 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.3 143.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.23 110.702 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -113.19 148.18 35.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.604 -1.258 . . . . 0.58 107.604 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.8 p90 -156.79 152.03 26.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.689 -1.257 . . . . 0.44 110.327 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -93.26 139.27 30.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.711 . . . . 2.76 109.405 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -94.25 166.76 11.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.357 -0.839 . . . . 2.23 109.226 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.1 p -79.68 -1.45 38.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 1.81 109.161 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -87.25 -22.62 25.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.64 109.536 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 8.3 m-20 -163.03 135.1 3.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 2.16 109.096 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.88 11.05 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.772 0.981 . . . . 1.27 110.233 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.488 ' H ' ' C ' ' B' ' 232' ' ' ASP . 25.2 t -85.73 160.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.939 -1.1 . . . . 1.76 109.907 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.467 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.2 m95 -74.34 162.17 29.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.67 108.787 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.3 tttm -119.41 153.02 35.87 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.345 -0.847 . . . . 1.44 109.439 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.27 163.55 0.01 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.73 -0.948 . . . . 0.4 110.73 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.53 159.39 50.92 Favored 'Trans proline' 0 N--CA 1.48 0.732 0 C-N-CA 121.654 1.569 . . . . 0.41 110.629 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.2 8.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.985 -0.746 . . . . 0.21 108.985 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -94.28 136.51 34.5 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.08 -1.013 . . . . 2.72 109.299 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.75 123.97 33.11 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.3 109.608 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.25 -74.52 0.62 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.338 -0.851 . . . . 0.45 110.206 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.16 143.29 26.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.197 -0.94 . . . . 0.33 110.414 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.1 118.01 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 2.33 109.214 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -108.71 0.3 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.962 -1.255 . . . . 0.28 109.962 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.68 -154.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 1.4 109.348 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.93 3.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.419 . . . . 0.29 109.551 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.67 150.44 34.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.392 -1.063 . . . . 0.29 108.948 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.66 122.79 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.209 -0.932 . . . . 0.31 109.762 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 52.9 t -87.26 135.33 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.032 -1.099 . . . . 0.3 108.032 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.58 178.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.21 -0.931 . . . . 0.24 110.606 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -144.77 112.13 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.619 -0.882 . . . . 1.81 108.619 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.05 -78.43 0.39 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.571 -1.27 . . . . 1.18 107.571 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -80.54 -129.27 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.722 -1.584 . . . . 1.97 106.722 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 68.7 m -105.41 54.29 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.131 -1.063 . . . . 1.38 108.131 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -156.12 128.43 7.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 1.12 109.524 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.56 137.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.259 -0.901 . . . . 0.48 109.536 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.31 166.65 23.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.323 -0.86 . . . . 2.13 109.701 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.0 142.43 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.34 109.119 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 78.8 t -139.22 129.4 14.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.366 -0.834 . . . . 0.34 109.258 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.3 160.54 6.49 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.616 0.877 . . . . 0.42 109.962 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -84.73 -27.1 27.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 3.11 110.313 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 3.82 111.893 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.401 ' HG2' ' HZ2' ' B' ' 264' ' ' LYS . 2.0 ptpp? -119.28 29.22 7.77 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.954 -1.091 . . . . 2.08 109.727 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.34 164.47 25.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.538 -0.912 . . . . 0.32 108.538 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.2 124.59 19.22 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.25 -0.906 . . . . 1.79 109.319 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.6 mm -88.6 110.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.45 109.56 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.88 146.64 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.546 -0.909 . . . . 0.57 108.546 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.24 141.17 28.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.649 -0.657 . . . . 3.62 109.605 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 2.05 109.429 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.3 m120 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.176 -0.676 . . . . 1.48 109.176 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.85 124.41 23.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.411 -0.806 . . . . 0.72 109.959 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -95.88 164.11 12.87 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.37 -1.345 . . . . 3.26 107.37 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.02 142.82 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.01 -1.056 . . . . 0.23 110.446 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -107.36 154.71 20.89 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.475 -1.306 . . . . 0.58 107.475 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.0 p90 -156.04 157.24 35.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.484 -1.385 . . . . 0.44 111.112 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -101.15 146.08 27.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.464 0.65 . . . . 2.76 109.421 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 230' ' ' SER . 37.0 t0 -98.74 -176.65 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 2.23 109.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 15.1 t -95.08 -14.14 24.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -0.808 . . . . 1.8 109.678 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.28 -16.93 31.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.19 -0.944 . . . . 3.63 109.857 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 234' ' ' VAL . 61.4 m-20 -160.4 128.82 2.94 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.147 -0.97 . . . . 2.16 109.351 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.95 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 120.786 0.991 . . . . 1.25 110.25 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.6 m -82.32 127.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.869 -1.144 . . . . 1.75 110.026 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.5 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.66 109.257 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 237' ' ' GLY . 31.3 mtpt -119.85 166.46 13.26 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.425 -0.797 . . . . 1.43 109.418 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.99 170.17 0.02 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.287 -1.125 . . . . 0.39 110.287 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -68.83 163.83 35.82 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 121.562 1.508 . . . . 0.41 110.66 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.58 177.86 7.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.21 109.347 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.56 137.45 34.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.197 -0.939 . . . . 2.72 109.39 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.408 HD21 ' NZ ' ' A' ' 244' ' ' LYS . 19.1 tp -88.67 123.86 33.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.565 -0.709 . . . . 0.29 109.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.14 -72.66 0.68 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.289 -0.882 . . . . 0.45 110.432 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.01 144.45 25.64 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.077 -1.014 . . . . 0.31 110.497 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.408 ' NZ ' HD21 ' A' ' 241' ' ' LEU . 16.0 ttmm -145.7 119.37 9.17 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.767 -0.827 . . . . 2.32 108.767 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.88 -104.88 0.26 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.209 -1.156 . . . . 0.27 110.209 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -73.04 -149.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -1.129 . . . . 1.39 109.736 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.54 3.95 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.136 -1.586 . . . . 0.29 109.136 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.49 150.95 34.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.29 108.425 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.36 123.31 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.971 -1.08 . . . . 0.31 109.827 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.94 133.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.399 -0.963 . . . . 0.29 108.399 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 260' ' ' VAL . 10.6 pt -138.81 178.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.348 -0.845 . . . . 0.23 109.987 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -143.8 109.3 5.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.341 -0.985 . . . . 1.81 108.341 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.1 -77.23 0.4 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.499 -1.297 . . . . 1.18 107.499 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.87 -133.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.323 -1.732 . . . . 1.98 106.323 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.3 t -105.03 56.48 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.071 -1.085 . . . . 1.39 108.071 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -157.03 123.53 4.98 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.771 -0.826 . . . . 1.12 108.771 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.413 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 39.2 mt -91.64 134.29 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -0.998 . . . . 0.47 109.504 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.07 172.6 12.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.281 -0.887 . . . . 2.11 110.014 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.13 140.6 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.547 -0.72 . . . . 0.33 109.701 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 251' ' ' ILE . 58.1 t -134.19 124.93 17.65 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.16 139.55 90.89 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 120.584 0.856 . . . . 0.42 110.331 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.76 -36.26 69.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 3.12 109.758 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 263' ' ' ARG . 2.3 tpt180 -67.12 -9.58 41.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 3.82 110.693 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.545 ' HZ2' ' HB2' ' A' ' 264' ' ' LYS . 7.4 mtpm? -122.95 25.47 8.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.284 -0.885 . . . . 2.08 108.859 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.33 32.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.462 -0.94 . . . . 0.32 108.462 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -139.34 132.09 29.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.116 -0.99 . . . . 1.79 109.231 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.57 107.63 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 0.45 109.297 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.51 157.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.57 109.308 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 3.63 109.465 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 25.4 m120 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.148 -0.686 . . . . 1.48 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.84 124.46 23.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.508 -0.745 . . . . 0.73 109.957 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 6.0 mpt_? -95.89 164.19 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.298 -1.371 . . . . 3.26 107.298 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 86.2 t -144.1 142.85 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.066 -1.021 . . . . 0.23 110.408 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -107.37 154.77 20.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.384 -1.339 . . . . 0.58 107.384 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.9 p90 -156.08 157.23 35.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.548 -1.345 . . . . 0.44 111.087 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -101.04 146.06 27.93 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.425 0.631 . . . . 2.76 109.516 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' B' ' 230' ' ' SER . 36.9 t0 -98.64 -176.67 3.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 2.23 109.879 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 15.2 t -95.17 -13.88 24.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.415 -0.803 . . . . 1.81 109.731 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.37 -16.97 31.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 3.64 109.847 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 234' ' ' VAL . 61.2 m-20 -160.39 128.82 2.95 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 2.16 109.339 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.94 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.776 0.984 . . . . 1.27 110.302 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.5 m -82.32 127.77 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.874 -1.141 . . . . 1.76 110.014 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.44 0.22 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.67 109.298 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' B' ' 237' ' ' GLY . 31.3 mtpt -119.71 166.44 13.21 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.371 -0.831 . . . . 1.44 109.431 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.15 170.3 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.303 -1.119 . . . . 0.4 110.303 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -68.92 163.8 36.13 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.55 1.5 . . . . 0.41 110.605 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.52 177.87 7.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.21 109.404 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.59 137.3 34.85 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.135 -0.978 . . . . 2.72 109.389 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.404 HD21 ' NZ ' ' B' ' 244' ' ' LYS . 19.3 tp -88.51 123.87 33.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.544 -0.723 . . . . 0.3 109.571 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.21 -72.53 0.69 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.381 -0.824 . . . . 0.45 110.488 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.18 144.47 25.58 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.051 -1.031 . . . . 0.33 110.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' HD21 ' B' ' 241' ' ' LEU . 16.0 ttmm -145.69 119.41 9.2 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.818 -0.808 . . . . 2.33 108.818 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.95 -104.92 0.26 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.148 -1.181 . . . . 0.28 110.148 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -72.98 -149.44 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -1.143 . . . . 1.4 109.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.61 3.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.19 -1.564 . . . . 0.29 109.19 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.96 34.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -1.023 . . . . 0.29 108.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.31 123.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.08 -1.012 . . . . 0.31 109.81 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.82 133.66 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.392 -0.966 . . . . 0.3 108.392 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.405 HD11 HG21 ' B' ' 260' ' ' VAL . 10.5 pt -138.86 178.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.24 110.066 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -143.72 109.41 5.19 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.353 -0.981 . . . . 1.81 108.353 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.21 -77.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.538 -1.282 . . . . 1.18 107.538 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -80.96 -133.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.323 -1.732 . . . . 1.97 106.323 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.2 t -105.07 56.57 0.69 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -157.05 123.62 5.0 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.778 -0.823 . . . . 1.12 108.778 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 39.1 mt -91.66 134.31 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.48 109.435 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.11 172.59 12.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.368 -0.832 . . . . 2.13 110.05 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.13 140.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.461 -0.774 . . . . 0.34 109.745 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' VAL . . . . . 0.405 HG21 HD11 ' B' ' 251' ' ' ILE . 58.5 t -134.17 124.86 17.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.841 -0.8 . . . . 0.34 108.841 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.12 139.49 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 120.588 0.859 . . . . 0.42 110.325 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.81 -36.19 69.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 3.11 109.751 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.416 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 2.3 tpt180 -67.17 -9.47 40.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 3.82 110.733 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' B' ' 264' ' ' LYS . 7.4 mtpm? -123.03 25.53 8.5 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.21 -0.931 . . . . 2.08 108.833 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.493 -0.928 . . . . 0.32 108.493 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -139.32 131.9 28.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.113 -0.992 . . . . 1.79 109.318 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.44 107.62 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.231 -0.918 . . . . 0.45 109.311 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.44 157.55 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.41 -0.806 . . . . 0.57 109.269 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -91.69 137.23 32.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.308 -0.87 . . . . 3.62 109.487 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.105 -0.997 . . . . 2.05 109.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.6 m-20 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.227 -0.657 . . . . 1.48 109.227 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -135.66 134.08 38.83 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.72 109.374 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.1 18.89 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.925 -1.139 . . . . 3.26 107.925 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -140.99 140.23 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.103 -0.998 . . . . 0.23 110.983 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -109.28 154.28 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.141 -1.429 . . . . 0.58 107.141 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.9 p90 -156.53 150.12 24.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.593 -1.317 . . . . 0.44 110.55 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 228' ' ' ARG . 10.7 mtm-85 -94.22 134.97 36.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.513 -0.742 . . . . 2.76 109.463 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.36 175.24 6.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.366 -0.834 . . . . 2.23 109.591 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.2 t -85.88 -11.02 54.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 1.8 108.874 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -88.8 -9.31 52.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 3.63 109.414 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -158.07 128.52 3.51 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 2.16 109.04 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.69 -11.58 29.84 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 120.815 1.01 . . . . 1.25 110.44 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 1.5 p -84.59 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.043 . . . . 1.75 109.42 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 92.7 m95 -64.43 169.57 4.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.445 -0.784 . . . . 0.66 109.644 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 237' ' ' GLY . 44.9 tttp -118.95 165.35 14.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.512 -0.742 . . . . 1.43 109.223 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.22 167.37 0.02 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.119 -1.192 . . . . 0.39 110.119 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.4 160.25 50.52 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.448 1.432 . . . . 0.41 110.113 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.79 168.86 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 0.21 109.18 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.51 139.51 30.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.161 -0.962 . . . . 2.72 109.971 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.08 122.94 32.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -0.77 . . . . 0.29 109.428 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.66 -75.51 0.6 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.419 -0.801 . . . . 0.45 110.355 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -89.79 143.68 26.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.067 -1.021 . . . . 0.31 109.893 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.65 121.62 10.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.342 -0.849 . . . . 2.32 109.063 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.46 -104.93 0.23 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.812 -1.185 . . . . 0.27 110.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.38 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -1.053 . . . . 1.39 109.551 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 51.36 3.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.14 -1.584 . . . . 0.29 109.14 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.37 154.02 40.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.427 -1.043 . . . . 0.29 108.691 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -147.01 124.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.056 -1.027 . . . . 0.31 109.82 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.82 133.61 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.721 -1.214 . . . . 0.29 107.721 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.39 175.78 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.321 -0.862 . . . . 0.23 110.333 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -145.32 108.71 4.63 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.588 -0.893 . . . . 1.81 108.588 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.34 -77.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.421 -1.326 . . . . 1.18 107.421 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -80.28 -135.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.566 -1.642 . . . . 1.98 106.566 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 10.2 p -101.58 55.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.099 -1.074 . . . . 1.39 108.099 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 255' ' ' SER . 59.1 m-20 -156.75 123.71 5.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.143 -0.688 . . . . 1.12 109.143 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.428 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.3 mt -93.05 135.39 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.47 109.438 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.07 169.72 17.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.415 -0.803 . . . . 2.11 109.709 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.86 140.97 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.383 -0.823 . . . . 0.33 109.491 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.97 128.24 17.56 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.632 -0.877 . . . . 0.34 108.632 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.65 148.64 72.66 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.528 -0.989 . . . . 0.42 109.528 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -67.82 -30.3 69.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 3.12 109.452 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.68 -8.29 53.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 3.82 111.0 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.21 23.16 11.47 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.126 -0.983 . . . . 2.08 109.005 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.97 168.13 20.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.579 -0.701 . . . . 0.32 109.164 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -139.64 129.59 24.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.318 -0.864 . . . . 1.79 109.154 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.38 108.13 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 0.45 109.431 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -101.83 156.21 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 3.63 109.116 179.715 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 222' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 2.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.227 -0.657 . . . . 1.48 109.227 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.63 134.09 38.89 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.487 -0.758 . . . . 0.73 109.416 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.2 18.78 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.91 -1.144 . . . . 3.26 107.91 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -141.09 140.27 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.181 -0.95 . . . . 0.23 110.945 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -109.24 154.33 22.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.169 -1.419 . . . . 0.58 107.169 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -156.63 149.94 24.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.468 -1.395 . . . . 0.44 110.666 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.6 mtm-85 -94.07 135.05 35.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.523 -0.736 . . . . 2.76 109.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.45 175.18 6.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 2.23 109.629 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.1 t -85.79 -10.99 54.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 1.81 108.925 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -88.84 -9.2 52.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.443 -0.785 . . . . 3.64 109.433 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.17 128.37 3.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.16 109.147 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.64 -11.54 29.84 Favored 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 120.865 1.043 . . . . 1.27 110.433 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 1.5 p -84.52 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.037 . . . . 1.76 109.429 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.479 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 92.7 m95 -64.45 169.57 4.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.67 109.671 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 44.9 tttp -118.92 165.31 14.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.635 -0.666 . . . . 1.44 109.338 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.24 167.39 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.159 -1.176 . . . . 0.4 110.159 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.37 160.27 50.47 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 121.419 1.412 . . . . 0.41 110.122 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.88 168.88 18.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.21 109.071 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.4 139.48 30.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.227 -0.92 . . . . 2.72 109.971 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.1 122.88 32.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.704 . . . . 0.3 109.423 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -112.63 -75.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -0.828 . . . . 0.45 110.44 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.428 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.1 t90 -89.77 143.66 26.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.005 . . . . 0.33 109.889 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.75 121.64 10.63 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.315 -0.866 . . . . 2.33 109.044 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.41 -104.95 0.23 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.11 -1.196 . . . . 0.28 110.11 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -69.42 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -1.125 . . . . 1.4 109.516 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.43 3.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.05 -1.62 . . . . 0.29 109.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.11 40.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.467 -1.019 . . . . 0.29 108.72 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.99 124.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.126 -0.984 . . . . 0.31 109.943 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.78 133.77 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.703 -1.221 . . . . 0.3 107.703 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.51 175.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.296 -0.878 . . . . 0.24 110.278 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -145.3 108.75 4.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.593 -0.891 . . . . 1.81 108.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.43 -77.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.348 -1.353 . . . . 1.18 107.348 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.25 -135.73 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.54 -1.652 . . . . 1.97 106.54 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 10.1 p -101.63 56.06 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.964 -1.125 . . . . 1.38 107.964 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 59.1 m-20 -156.78 123.68 5.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 1.12 109.145 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.99 135.35 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.48 109.429 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.12 169.77 17.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 2.13 109.751 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 140.98 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.381 -0.824 . . . . 0.34 109.496 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.96 128.3 17.61 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.672 -0.862 . . . . 0.34 108.672 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.78 148.64 73.79 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.465 -1.013 . . . . 0.42 109.465 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.78 -30.37 69.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 3.11 109.489 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.58 -8.34 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.415 -0.803 . . . . 3.82 111.016 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.14 23.15 11.5 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.176 -0.952 . . . . 2.08 109.054 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.03 168.16 20.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.078 -0.712 . . . . 0.32 109.078 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.6 129.65 25.05 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.363 -0.836 . . . . 1.79 109.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.34 108.09 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.4 -0.812 . . . . 0.45 109.431 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.6 mm -101.88 156.08 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.319 -0.863 . . . . 0.57 108.683 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -94.5 135.36 36.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 3.62 109.183 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.042 -1.036 . . . . 2.05 109.555 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.178 -0.675 . . . . 1.48 109.178 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.95 122.68 22.25 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.817 -0.808 . . . . 0.72 108.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -100.99 161.16 13.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.289 -1.004 . . . . 3.26 108.289 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.6 141.91 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.324 -0.86 . . . . 0.23 110.093 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -107.21 155.21 20.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.299 -1.371 . . . . 0.58 107.299 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.3 p90 -154.86 153.29 30.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.716 -1.24 . . . . 0.44 110.456 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -95.29 157.15 16.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.495 -0.753 . . . . 2.76 109.978 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.55 176.46 6.28 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.9 -0.778 . . . . 2.23 108.9 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.41 -11.24 38.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -0.994 . . . . 1.8 109.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.63 -15.41 35.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.33 -0.856 . . . . 3.63 109.902 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.4 m-20 -161.38 132.34 3.77 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.142 -0.974 . . . . 2.16 109.282 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.5 18.28 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.023 1.149 . . . . 1.25 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.1 p -86.59 158.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.72 -1.238 . . . . 1.75 109.921 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.1 m95 -75.5 176.25 7.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.429 -0.582 . . . . 0.66 109.429 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -134.97 -150.6 0.39 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.234 -0.916 . . . . 1.43 109.141 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.17 174.95 49.63 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.093 -1.203 . . . . 0.39 110.093 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.12 158.95 45.0 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.78 1.653 . . . . 0.41 110.066 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 172.04 13.23 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 0.21 109.517 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.55 ' NZ ' HH22 ' A' ' 224' ' ' ARG . 66.7 mmtt -92.49 137.72 32.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.269 -0.895 . . . . 2.72 109.428 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.27 124.47 34.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.498 -0.752 . . . . 0.29 109.814 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.37 -73.71 0.63 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.377 -0.827 . . . . 0.45 110.27 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.85 140.33 29.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.26 -0.9 . . . . 0.31 109.956 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -147.24 115.11 6.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -0.897 . . . . 2.32 109.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -100.3 0.17 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.854 -1.165 . . . . 0.27 110.302 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.37 -156.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.357 -1.084 . . . . 1.39 109.888 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.21 48.16 2.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.061 -1.615 . . . . 0.29 109.061 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 152.34 36.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.437 -1.037 . . . . 0.29 108.999 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.58 125.2 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.31 109.413 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 50.5 t -87.85 135.02 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.109 -1.071 . . . . 0.29 108.109 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 260' ' ' VAL . 9.1 pt -139.75 -177.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.23 110.062 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -143.14 109.41 5.32 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.359 -0.978 . . . . 1.81 108.359 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.62 -79.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.634 -1.247 . . . . 1.18 107.634 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -78.99 -135.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.481 -1.674 . . . . 1.98 106.481 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.7 m -101.02 53.72 0.84 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.167 -1.049 . . . . 1.39 108.167 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -157.35 132.13 8.7 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.051 -0.722 . . . . 1.12 109.051 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.64 137.31 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.47 109.479 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.54 169.91 16.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 2.11 109.701 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.93 140.87 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.458 -0.777 . . . . 0.33 109.411 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 251' ' ' ILE . 43.0 t -134.56 134.03 21.96 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.678 -0.86 . . . . 0.34 108.678 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.42 140.96 96.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 120.715 0.944 . . . . 0.42 110.478 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.4 HH12 HG13 ' A' ' 267' ' ' ILE . 20.7 tpt180 -59.11 -38.95 80.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 3.12 109.271 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -66.96 -7.95 26.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 3.82 111.001 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.68 25.11 9.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.156 -0.965 . . . . 2.08 109.169 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.53 164.28 30.57 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.212 -0.662 . . . . 0.32 109.212 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.03 126.47 20.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 1.79 109.075 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ILE . . . . . 0.4 HG13 HH12 ' A' ' 262' ' ' ARG . 18.4 mm -87.97 110.39 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.45 109.745 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.12 147.17 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.354 -0.98 . . . . 0.57 108.354 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 3.63 109.763 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.159 -0.682 . . . . 1.48 109.159 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.97 122.79 22.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.709 -0.849 . . . . 0.73 108.709 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.594 HH11 ' CG ' ' B' ' 224' ' ' ARG . 0.0 OUTLIER -101.03 161.05 13.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.316 -0.994 . . . . 3.26 108.316 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.54 142.0 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 0.23 110.097 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.26 155.21 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.337 -1.357 . . . . 0.58 107.337 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -154.84 153.26 30.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.696 -1.253 . . . . 0.44 110.491 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -95.24 157.17 16.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.751 . . . . 2.76 109.975 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -94.52 176.48 6.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 2.23 108.962 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.44 -11.26 38.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 1.81 109.342 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.66 -15.4 35.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.331 -0.855 . . . . 3.64 109.857 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.7 m-20 -161.37 132.32 3.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 2.16 109.274 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.48 18.16 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.965 1.11 . . . . 1.27 110.838 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.2 p -86.41 158.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.774 -1.204 . . . . 1.76 109.922 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.498 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.66 176.28 7.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.381 -0.6 . . . . 0.67 109.381 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -135.0 -150.58 0.39 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.284 -0.885 . . . . 1.44 109.11 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.2 174.94 49.57 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.084 -1.207 . . . . 0.4 110.084 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.13 158.97 44.94 Favored 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 121.777 1.651 . . . . 0.41 110.077 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.11 172.15 13.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.392 -0.817 . . . . 0.21 109.5 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.552 ' NZ ' HH22 ' B' ' 224' ' ' ARG . 66.7 mmtt -92.52 137.7 32.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.233 -0.917 . . . . 2.72 109.422 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.29 124.48 34.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.3 109.783 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.35 -73.68 0.63 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.275 -0.891 . . . . 0.45 110.317 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.89 140.32 29.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.295 -0.878 . . . . 0.33 109.953 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -147.28 115.0 6.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.244 -0.91 . . . . 2.33 109.221 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.66 -100.36 0.18 Allowed Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.782 -1.199 . . . . 0.28 110.239 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.29 -157.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 1.4 109.863 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 48.06 2.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.27 36.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -1.067 . . . . 0.29 109.111 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.61 125.15 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.31 109.411 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.83 134.92 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.033 -1.099 . . . . 0.3 108.033 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 260' ' ' VAL . 9.2 pt -139.62 -177.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.24 110.105 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -143.05 109.55 5.4 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.391 -0.966 . . . . 1.81 108.391 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.66 -79.15 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.629 -1.248 . . . . 1.18 107.629 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.94 -135.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.551 -1.648 . . . . 1.97 106.551 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.9 m -100.95 53.7 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.13 -1.063 . . . . 1.38 108.13 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -157.3 132.16 8.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.041 -0.726 . . . . 1.12 109.041 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 37.1 mt -92.63 137.25 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.235 -0.916 . . . . 0.48 109.477 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.49 169.81 17.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.402 -0.811 . . . . 2.13 109.746 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.88 140.89 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.409 -0.807 . . . . 0.34 109.458 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 260' ' ' VAL . . . . . 0.418 HG21 HD11 ' B' ' 251' ' ' ILE . 42.8 t -134.49 133.99 22.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.802 -0.814 . . . . 0.34 108.802 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.43 140.91 96.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.647 0.898 . . . . 0.42 110.522 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.1 -38.85 80.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 3.11 109.326 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -67.07 -7.83 25.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.465 -0.772 . . . . 3.82 110.997 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.75 25.08 9.93 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.151 -0.968 . . . . 2.08 109.192 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 164.24 30.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.224 -0.658 . . . . 0.32 109.224 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -140.04 126.47 20.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 1.79 109.097 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.94 110.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.267 -0.895 . . . . 0.45 109.742 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.1 147.16 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.329 -0.989 . . . . 0.57 108.329 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -95.93 141.65 29.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.45 -0.781 . . . . 3.62 109.758 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.02 -0.99 . . . . 2.05 109.612 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 222' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.304 0.573 . . . . 1.48 109.522 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.05 137.52 46.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.592 -0.693 . . . . 0.72 109.416 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.6 OUTLIER -104.85 157.81 16.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.41 -1.33 . . . . 3.26 107.41 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.0 t -141.53 142.91 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.077 -1.014 . . . . 0.23 110.642 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -110.63 154.81 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.303 -1.369 . . . . 0.58 107.303 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.76 151.91 26.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.534 -1.354 . . . . 0.44 110.529 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 228' ' ' ARG . 2.0 mtm-85 -92.5 149.27 21.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.739 . . . . 2.76 109.876 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -94.38 168.04 11.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 2.23 108.698 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.9 t -84.81 -9.38 58.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 1.8 109.084 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 231' ' ' ARG . 3.5 mtt-85 -90.83 -15.75 29.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 3.63 109.989 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 234' ' ' VAL . 38.0 m-20 -160.24 129.54 3.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 2.16 108.95 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.86 11.03 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 120.831 1.021 . . . . 1.25 110.827 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.8 p -81.62 158.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.697 -1.252 . . . . 1.75 109.886 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.6 m95 -75.33 162.15 28.66 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.213 -0.662 . . . . 0.66 109.213 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.7 tttp -118.38 158.13 25.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.462 -0.774 . . . . 1.43 109.162 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.16 171.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.551 -1.02 . . . . 0.39 110.551 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.37 158.25 57.89 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.691 1.594 . . . . 0.41 110.621 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.24 170.65 15.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.674 -0.861 . . . . 0.21 108.674 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -92.95 137.24 32.54 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.072 -1.017 . . . . 2.72 109.349 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.55 120.31 30.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.708 -0.62 . . . . 0.29 109.587 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.6 mt -111.15 -71.79 0.75 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.363 -0.836 . . . . 0.45 110.101 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.2 t90 -91.59 142.11 27.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.206 -0.934 . . . . 0.31 109.78 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.76 112.48 5.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.139 -0.976 . . . . 2.32 109.065 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.83 -104.17 0.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.814 -1.184 . . . . 0.27 110.251 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 245' ' ' GLY . 30.0 mt-10 -56.67 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.477 -1.014 . . . . 1.39 109.862 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.1 49.95 2.99 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.103 -1.599 . . . . 0.29 109.103 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.22 157.9 43.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -1.009 . . . . 0.29 108.569 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.38 132.44 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.31 109.552 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.79 133.93 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 15.3 pt -138.71 174.06 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.326 -0.859 . . . . 0.23 110.562 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -141.89 108.87 5.44 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.226 -1.027 . . . . 1.81 108.226 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.22 -75.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.514 -1.291 . . . . 1.18 107.514 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.25 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.615 -1.624 . . . . 1.98 106.615 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.98 52.23 0.74 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.854 -1.165 . . . . 1.39 107.854 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -156.35 129.0 7.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.521 -0.737 . . . . 1.12 109.29 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.1 mt -92.62 141.52 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.47 109.635 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.57 165.11 28.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 2.11 109.668 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.9 137.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.818 . . . . 0.33 109.404 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.72 131.53 20.21 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.361 -0.837 . . . . 0.34 109.189 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.64 146.98 93.84 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 N-CA-C 109.702 -0.922 . . . . 0.42 109.702 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.07 -33.07 75.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 3.12 109.716 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -68.99 -7.05 31.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.21 -0.931 . . . . 3.82 110.636 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -119.73 20.96 12.19 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.265 -0.897 . . . . 2.08 109.13 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.89 23.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.32 109.534 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -139.42 131.01 27.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.213 -0.93 . . . . 1.79 108.973 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.18 105.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 0.45 109.523 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 269' ' ' ARG . 8.1 mm -105.1 159.99 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.368 -0.833 . . . . 0.57 108.956 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 269' ' ' ARG . 24.7 mtm-85 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 3.63 109.376 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' ASN . . . . . 0.602 ' N ' HD22 ' B' ' 222' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.491 -0.559 . . . . 1.48 109.491 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -132.86 137.67 46.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.642 -0.661 . . . . 0.73 109.401 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.6 OUTLIER -104.96 157.82 16.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.403 -1.332 . . . . 3.26 107.403 178.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.55 143.03 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.111 -0.993 . . . . 0.23 110.601 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.66 154.8 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.77 151.98 26.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.513 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.0 mtm-85 -92.47 149.24 21.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 2.76 109.927 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -94.45 167.86 11.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.682 -0.858 . . . . 2.23 108.682 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 47.5 t -84.73 -9.26 58.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 1.81 109.139 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 231' ' ' ARG . 3.6 mtt-85 -90.89 -15.68 29.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 3.64 110.048 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 38.1 m-20 -160.31 129.59 3.2 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.159 -0.963 . . . . 2.16 108.965 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.04 11.16 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 120.775 0.983 . . . . 1.27 110.777 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.493 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.9 p -81.55 158.64 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.797 -1.189 . . . . 1.76 110.055 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.493 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.6 m95 -75.53 162.07 28.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.11 -0.7 . . . . 0.67 109.11 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.9 tttp -118.29 158.14 25.74 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.468 -0.77 . . . . 1.44 109.195 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.05 171.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.518 -1.033 . . . . 0.4 110.518 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.26 158.19 58.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.825 1.683 . . . . 0.41 110.667 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.23 170.81 15.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.678 -0.86 . . . . 0.21 108.678 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -93.14 137.16 32.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.022 -1.049 . . . . 2.72 109.339 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.8 tp -89.4 120.28 30.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.621 -0.675 . . . . 0.3 109.585 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.08 -71.9 0.74 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.314 -0.866 . . . . 0.45 110.095 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.1 t90 -91.58 142.18 27.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.33 109.805 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.84 112.55 5.67 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.205 -0.934 . . . . 2.33 109.109 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.88 -104.2 0.22 Allowed Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.783 -1.198 . . . . 0.28 110.301 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' B' ' 245' ' ' GLY . 30.3 mt-10 -56.68 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.032 . . . . 1.4 109.846 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.14 49.98 3.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.6 . . . . 0.29 109.101 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.18 158.0 43.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.589 -0.947 . . . . 0.29 108.527 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.36 132.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.31 109.544 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.79 133.95 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.936 -1.135 . . . . 0.3 107.936 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.77 173.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.24 110.565 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -141.74 108.77 5.46 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.311 -0.996 . . . . 1.81 108.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.23 -75.84 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.498 -1.297 . . . . 1.18 107.498 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.23 -132.07 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.566 -1.642 . . . . 1.97 106.566 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.94 52.06 0.75 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.952 -1.129 . . . . 1.38 107.952 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -156.2 129.0 7.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.643 -0.661 . . . . 1.12 109.335 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.2 mt -92.65 141.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.37 -0.831 . . . . 0.48 109.591 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.35 165.24 27.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 2.13 109.72 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.98 137.32 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.34 109.408 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.64 131.51 20.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.42 -0.8 . . . . 0.34 109.175 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.67 147.07 93.57 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 N-CA-C 109.734 -0.91 . . . . 0.42 109.734 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.06 -33.14 75.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 3.11 109.652 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.0 -7.03 31.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 3.82 110.559 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -119.7 20.96 12.21 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.29 -0.881 . . . . 2.08 109.134 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.62 166.81 23.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.32 109.524 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -139.41 130.91 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.354 -0.841 . . . . 1.79 109.092 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.8 mm -89.12 105.93 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 0.45 109.625 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' B' ' 269' ' ' ARG . 8.1 mm -105.08 160.13 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.383 -0.823 . . . . 0.57 109.026 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' B' ' 269' ' ' ARG . 24.6 mtm-85 -87.66 148.04 24.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 3.62 109.387 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.028 -0.987 . . . . 2.05 109.103 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.136 -0.691 . . . . 1.48 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.6 130.29 36.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.595 -0.691 . . . . 0.72 109.207 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.4 OUTLIER -105.68 159.48 15.94 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.293 -1.003 . . . . 3.26 108.293 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.13 140.8 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.044 -1.035 . . . . 0.23 110.59 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.06 152.48 23.95 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.252 -1.388 . . . . 0.58 107.252 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.8 p90 -156.57 151.5 26.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.537 -1.352 . . . . 0.44 110.615 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -95.06 143.63 26.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 2.76 109.88 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.77 173.25 7.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.392 -0.818 . . . . 2.23 108.997 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.24 -9.99 51.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.8 109.381 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.64 -13.0 43.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 3.63 109.55 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -158.43 128.43 3.38 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 2.16 108.707 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.32 2.04 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 120.875 1.05 . . . . 1.25 111.404 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.623 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.8 p -84.57 167.04 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.565 -1.334 . . . . 1.75 110.335 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.623 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.8 m95 -71.92 161.98 30.13 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.66 108.692 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.2 tttp -118.75 161.96 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.288 -0.883 . . . . 1.43 109.257 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.6 164.83 0.02 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.302 -1.119 . . . . 0.39 110.302 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.43 160.75 46.38 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.456 1.437 . . . . 0.41 110.127 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.66 175.32 9.67 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.836 -0.802 . . . . 0.21 108.836 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -95.89 138.73 33.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.126 -0.984 . . . . 2.72 109.795 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 tp -87.89 122.93 32.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.326 -0.859 . . . . 0.29 109.259 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.38 -72.94 0.67 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.352 -0.842 . . . . 0.45 110.326 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.528 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.7 t90 -90.07 139.95 30.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.091 -1.006 . . . . 0.31 110.387 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.62 7.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.374 -0.829 . . . . 2.32 109.008 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.33 -99.9 0.17 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.83 -1.308 . . . . 0.27 109.83 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.45 -155.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -1.149 . . . . 1.39 109.65 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.81 46.47 2.35 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.417 -1.473 . . . . 0.29 109.417 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.84 148.73 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -1.037 . . . . 0.29 108.564 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.76 126.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.297 -0.877 . . . . 0.31 109.697 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.19 139.42 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.156 -1.053 . . . . 0.29 108.156 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 257' ' ' ILE . 11.1 pt -141.2 178.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.23 110.408 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -143.69 111.29 5.96 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.892 -1.151 . . . . 1.81 107.892 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.56 -78.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.851 -1.166 . . . . 1.18 107.851 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -80.39 -128.47 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.802 -1.555 . . . . 1.98 106.802 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 51.1 m -105.38 51.37 0.76 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.961 -1.126 . . . . 1.39 107.961 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.16 134.4 11.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.009 -0.737 . . . . 1.12 109.009 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.488 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 10.5 mt -93.52 144.89 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 0.47 109.306 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.06 162.88 34.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.318 -0.864 . . . . 2.11 110.056 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.77 131.3 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.536 -0.727 . . . . 0.33 109.212 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.09 133.26 20.69 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.698 -0.853 . . . . 0.34 108.698 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.8 147.46 80.75 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.521 0.814 . . . . 0.42 109.993 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.29 -37.52 77.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 3.12 109.359 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -70.84 1.81 5.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.791 . . . . 3.82 110.72 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -118.93 12.0 12.71 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.581 -0.896 . . . . 2.08 108.581 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.75 170.05 16.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.679 . . . . 0.32 109.657 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.47 130.11 27.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.339 -0.85 . . . . 1.79 108.984 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.76 115.2 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.416 -0.803 . . . . 0.45 109.749 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.9 mm -112.12 155.04 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.383 -0.823 . . . . 0.57 109.141 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.517 -0.739 . . . . 3.63 109.278 179.761 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.128 -0.693 . . . . 1.48 109.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -134.52 130.39 36.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.578 -0.701 . . . . 0.73 109.145 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.532 ' HG2' HH11 ' B' ' 224' ' ' ARG . 0.4 OUTLIER -105.69 159.53 15.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.347 -0.983 . . . . 3.26 108.347 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -142.28 140.72 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.23 110.581 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -106.95 152.55 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.241 -1.392 . . . . 0.58 107.241 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.8 p90 -156.71 151.47 25.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.595 -1.315 . . . . 0.44 110.562 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -95.09 143.53 26.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.641 -0.662 . . . . 2.76 109.847 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.66 173.35 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 2.23 109.066 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.36 -9.91 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.81 109.426 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.76 -12.95 43.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 3.64 109.505 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -158.37 128.44 3.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.115 -0.991 . . . . 2.16 108.732 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.29 1.99 2.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.948 1.099 . . . . 1.27 111.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.7 p -84.5 166.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.59 -1.319 . . . . 1.76 110.386 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.8 m95 -71.92 161.97 30.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.665 -0.865 . . . . 0.67 108.665 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.79 162.0 19.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.383 -0.823 . . . . 1.44 109.211 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.65 164.82 0.02 OUTLIER Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.376 -1.089 . . . . 0.4 110.376 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.39 160.67 46.68 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.484 1.456 . . . . 0.41 110.179 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.54 175.53 9.49 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.791 -0.818 . . . . 0.21 108.791 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -96.02 138.78 33.15 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.167 -0.958 . . . . 2.72 109.717 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.02 122.84 32.1 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.3 109.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.1 mt -116.4 -72.79 0.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.423 -0.798 . . . . 0.45 110.285 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.488 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.7 t90 -90.11 139.9 30.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.08 -1.013 . . . . 0.33 110.268 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.54 7.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.285 -0.885 . . . . 2.33 109.073 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.22 -99.76 0.17 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.901 -1.28 . . . . 0.28 109.901 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.44 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -1.103 . . . . 1.4 109.702 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 46.45 2.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.381 -1.488 . . . . 0.29 109.381 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.78 148.63 34.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.443 -1.034 . . . . 0.29 108.522 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.77 126.37 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.267 -0.896 . . . . 0.31 109.732 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.13 139.52 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.227 -1.027 . . . . 0.3 108.227 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.427 ' O ' HG23 ' B' ' 257' ' ' ILE . 11.1 pt -141.24 178.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.207 -0.933 . . . . 0.24 110.464 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -143.65 111.31 5.98 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.985 -1.117 . . . . 1.81 107.985 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.62 -78.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.783 -1.192 . . . . 1.18 107.783 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.43 -128.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.767 -1.568 . . . . 1.97 106.767 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 51.0 m -105.42 51.34 0.76 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.972 -1.122 . . . . 1.38 107.972 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.09 134.43 11.51 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.053 -0.721 . . . . 1.12 109.053 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 10.7 mt -93.48 145.01 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.183 -0.948 . . . . 0.48 109.48 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.15 162.93 34.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 2.13 109.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.76 131.27 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 0.34 109.186 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.02 133.34 20.83 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.67 -0.863 . . . . 0.34 108.67 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.7 147.47 79.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.534 0.822 . . . . 0.42 110.027 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.47 -37.26 77.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 3.11 109.392 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -71.01 1.96 5.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 3.82 110.77 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -119.03 12.01 12.62 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.547 -0.909 . . . . 2.08 108.547 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.84 169.99 16.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.32 109.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.43 130.13 27.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.448 -0.783 . . . . 1.79 108.989 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.77 115.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.41 -0.806 . . . . 0.45 109.753 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -111.95 155.03 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.44 -0.788 . . . . 0.57 109.178 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -91.46 136.24 33.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.572 -0.705 . . . . 3.62 109.285 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.01 . . . . 2.05 109.555 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 109.588 -0.523 . . . . 1.48 109.588 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -136.07 135.46 39.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.525 -0.734 . . . . 0.72 109.466 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.53 156.94 20.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.215 -1.402 . . . . 3.26 107.215 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.14 141.79 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.008 -1.058 . . . . 0.23 110.716 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.44 152.55 25.23 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.406 -1.331 . . . . 0.58 107.406 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 17.6 p90 -155.91 158.58 38.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.44 110.673 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -102.02 143.72 31.51 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.425 0.631 . . . . 2.76 109.606 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 230' ' ' SER . 10.3 t70 -97.92 173.12 7.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.455 -0.778 . . . . 2.23 109.131 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 57.3 m -86.99 -5.67 59.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.8 109.406 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 231' ' ' ARG . 20.7 mtm-85 -88.59 -19.69 25.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.224 -0.923 . . . . 3.63 109.614 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -162.54 129.86 2.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 2.16 108.813 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -65.89 5.61 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 120.779 0.986 . . . . 1.25 110.698 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.4 m -83.0 127.51 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.821 -1.174 . . . . 1.75 109.993 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -48.28 164.4 0.05 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.25 -0.906 . . . . 0.66 109.551 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.8 mtpt -118.97 167.32 11.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.842 -0.799 . . . . 1.43 108.842 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -48.04 174.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.024 -1.231 . . . . 0.39 110.024 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.17 159.47 53.73 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.69 1.594 . . . . 0.41 110.502 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 172.17 13.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.101 -0.704 . . . . 0.21 109.101 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.61 33.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.112 -0.992 . . . . 2.72 109.573 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.78 125.32 34.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.52 -0.737 . . . . 0.29 109.493 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.0 mt -116.53 -74.54 0.6 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.397 -0.815 . . . . 0.45 110.209 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.71 141.55 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.31 109.988 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -145.94 118.72 8.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.831 . . . . 2.32 109.103 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.32 -104.77 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.723 -1.227 . . . . 0.27 110.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -68.85 -153.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 1.39 109.812 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.23 50.32 2.73 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.29 109.633 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.05 151.91 36.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -1.106 . . . . 0.29 108.917 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.24 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.97 . . . . 0.31 109.546 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -87.05 138.24 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.236 -1.024 . . . . 0.29 108.236 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.92 177.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -0.922 . . . . 0.23 110.095 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -144.69 110.3 5.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.687 -0.857 . . . . 1.81 108.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.57 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.577 -1.268 . . . . 1.18 107.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.8 -130.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 m -105.27 55.68 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.959 -1.126 . . . . 1.39 107.959 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.939 -0.763 . . . . 1.12 108.939 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.7 mt -92.65 139.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -0.872 . . . . 0.47 109.524 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.21 166.97 23.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 2.11 109.976 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.78 138.34 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.528 -0.916 . . . . 0.33 108.528 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.11 133.1 20.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.834 . . . . 0.34 109.35 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.43 139.12 89.35 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.798 -0.885 . . . . 0.42 109.798 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 262' ' ' ARG . 0.6 OUTLIER -58.9 -34.72 72.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 3.12 109.424 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 263' ' ' ARG . 18.8 ttm-85 -69.36 -2.87 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 3.82 109.731 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.46 17.09 13.8 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.335 -0.853 . . . . 2.08 109.095 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.18 170.92 14.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 0.32 109.903 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -140.39 131.51 26.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.243 -0.91 . . . . 1.79 109.17 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.73 107.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.139 -0.976 . . . . 0.45 109.508 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.96 150.63 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.172 -1.047 . . . . 0.57 108.172 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 269' ' ' ARG . 6.0 tpt180 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.427 -0.796 . . . . 3.63 109.127 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 109.539 -0.541 . . . . 1.48 109.539 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -136.04 135.51 39.47 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.432 -0.793 . . . . 0.73 109.508 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.48 156.88 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.292 -1.373 . . . . 3.26 107.292 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 91.7 t -141.07 141.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.995 -1.066 . . . . 0.23 110.661 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.41 152.52 25.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 17.4 p90 -155.84 158.65 38.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.633 -1.292 . . . . 0.44 110.602 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -102.04 143.77 31.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.405 0.621 . . . . 2.76 109.645 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 230' ' ' SER . 10.2 t70 -97.84 173.03 7.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.413 -0.804 . . . . 2.23 109.188 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 m -86.85 -5.73 59.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 1.81 109.499 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' B' ' 231' ' ' ARG . 20.7 mtm-85 -88.47 -19.89 25.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.924 . . . . 3.64 109.57 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.2 m-20 -162.46 129.84 2.63 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 2.16 108.906 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.93 5.69 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 120.8 1.0 . . . . 1.27 110.623 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.481 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.4 m -83.11 127.56 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.796 -1.19 . . . . 1.76 110.014 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -48.29 164.44 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.214 -0.929 . . . . 0.67 109.601 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.8 mtpt -119.0 167.23 11.95 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.863 -0.791 . . . . 1.44 108.863 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -48.06 174.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.997 -1.241 . . . . 0.4 109.997 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.24 159.49 53.59 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.697 1.598 . . . . 0.41 110.509 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.87 172.23 13.32 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.024 -0.732 . . . . 0.21 109.024 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.63 33.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.114 -0.991 . . . . 2.72 109.535 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.89 125.44 34.94 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.516 -0.74 . . . . 0.3 109.409 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.4 mt -116.65 -74.62 0.6 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.4 -0.812 . . . . 0.45 110.103 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.66 141.55 28.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.33 110.014 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -146.0 118.72 8.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.368 -0.833 . . . . 2.33 109.147 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -104.79 0.23 Allowed Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.195 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -68.83 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.297 -1.12 . . . . 1.4 109.816 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.24 50.27 2.73 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.373 . . . . 0.29 109.666 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.08 151.86 36.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -1.12 . . . . 0.29 108.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.11 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.125 -0.985 . . . . 0.31 109.586 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.97 138.16 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.244 -1.021 . . . . 0.3 108.244 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.89 177.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 0.24 110.099 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -144.63 110.3 5.31 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.65 -81.6 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.542 -1.281 . . . . 1.18 107.542 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.73 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.593 -1.632 . . . . 1.97 106.593 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.6 m -105.33 55.64 0.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.99 -1.115 . . . . 1.38 107.99 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 1.12 108.901 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 23.6 mt -92.57 139.15 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.48 109.574 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.22 166.87 23.51 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 2.13 110.023 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.76 138.4 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.19 133.08 20.43 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.34 109.312 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.38 139.16 89.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.769 -0.897 . . . . 0.42 109.769 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' B' ' 262' ' ' ARG . 0.7 OUTLIER -58.98 -34.83 72.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 3.11 109.351 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' B' ' 263' ' ' ARG . 18.9 ttm-85 -69.24 -2.81 11.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 3.82 109.793 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.53 17.16 13.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.318 -0.863 . . . . 2.08 109.116 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.3 170.86 14.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.32 109.943 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -140.36 131.49 26.4 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.356 -0.84 . . . . 1.79 109.188 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.76 107.5 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.114 -0.991 . . . . 0.45 109.51 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.8 150.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.267 -1.012 . . . . 0.57 108.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' B' ' 269' ' ' ARG . 6.0 tpt180 -90.98 145.21 24.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -0.785 . . . . 3.62 109.086 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.029 -0.986 . . . . 2.05 109.547 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.706 -0.85 . . . . 1.48 108.706 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -133.89 145.21 49.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 0.72 109.479 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.3 OUTLIER -119.71 154.03 34.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.851 -1.166 . . . . 3.26 107.851 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -138.87 146.45 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.079 -1.013 . . . . 0.23 111.012 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.17 155.78 24.39 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.261 -1.385 . . . . 0.58 107.261 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.8 p90 -157.43 150.86 23.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.578 -1.326 . . . . 0.44 110.465 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 228' ' ' ARG . 8.1 mtm-85 -93.04 146.44 23.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.476 -0.765 . . . . 2.76 109.306 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.84 167.41 11.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -0.9 . . . . 2.23 108.917 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.7 t -83.18 -10.54 58.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 1.8 109.24 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -89.96 -11.08 42.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 3.63 109.622 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.415 ' OD2' ' CG2' ' A' ' 234' ' ' VAL . 18.8 t0 -160.41 127.36 2.58 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 2.16 108.768 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.63 6.83 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.721 0.948 . . . . 1.25 110.269 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 235' ' ' TRP . 40.4 t -83.69 161.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 1.75 109.85 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.5 m95 -74.17 161.62 29.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.803 . . . . 0.66 109.076 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.3 tttp -118.92 160.86 21.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.383 -0.823 . . . . 1.43 109.25 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.0 167.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.6 -1.0 . . . . 0.39 110.6 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.37 157.91 57.85 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.681 1.588 . . . . 0.41 110.568 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.36 170.0 16.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.969 -0.752 . . . . 0.21 108.969 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -93.6 138.73 31.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.067 -1.02 . . . . 2.72 109.745 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.98 120.46 30.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.133 -0.691 . . . . 0.29 109.133 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.0 mt -111.12 -72.5 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.401 -0.812 . . . . 0.45 110.282 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.26 143.94 25.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.165 -0.959 . . . . 0.31 110.15 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.58 122.14 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.297 -0.877 . . . . 2.32 109.278 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.57 -103.78 0.21 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.081 -1.208 . . . . 0.27 110.081 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.62 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -1.124 . . . . 1.39 109.712 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 49.5 2.91 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.253 -1.539 . . . . 0.29 109.253 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.71 35.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -1.035 . . . . 0.29 108.704 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.03 124.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.991 . . . . 0.31 109.809 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.0 137.04 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.079 -1.082 . . . . 0.29 108.079 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.73 -179.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.861 . . . . 0.23 110.234 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -144.15 111.93 6.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.709 -0.848 . . . . 1.81 108.709 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.36 -78.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.491 -1.3 . . . . 1.18 107.491 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.64 -132.19 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.695 -1.594 . . . . 1.98 106.695 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.7 m -103.66 54.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.031 -1.1 . . . . 1.39 108.031 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.81 126.99 6.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 1.12 109.283 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.9 mt -92.71 137.0 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.47 109.286 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.49 171.86 13.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 2.11 109.743 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.92 137.47 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.372 -0.83 . . . . 0.33 109.359 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -136.94 125.22 14.8 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.401 -0.812 . . . . 0.34 108.974 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.46 143.75 93.54 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.527 0.818 . . . . 0.42 110.242 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.04 -32.54 72.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 3.12 109.387 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -68.71 -7.69 35.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.338 -0.851 . . . . 3.82 110.672 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -119.05 19.59 12.92 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.175 -0.953 . . . . 2.08 109.451 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.01 168.9 18.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.52 -0.737 . . . . 0.32 109.589 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.4 ' NZ ' ' CZ3' ' A' ' 235' ' ' TRP . 29.0 mtmm -137.62 127.27 25.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 1.79 109.049 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.4 mm -88.15 107.91 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.223 -0.923 . . . . 0.45 110.15 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.5 mm -105.7 151.51 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.398 -0.964 . . . . 0.57 108.398 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.303 -0.873 . . . . 3.63 109.053 179.349 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.696 -0.853 . . . . 1.48 108.696 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.03 145.14 49.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.522 -0.736 . . . . 0.73 109.449 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' B' ' 224' ' ' ARG . 0.3 OUTLIER -119.69 154.05 34.66 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.807 -1.183 . . . . 3.26 107.807 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.94 146.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.116 -0.99 . . . . 0.23 110.987 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -113.13 155.89 24.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.226 -1.398 . . . . 0.58 107.226 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.1 p90 -157.43 151.02 24.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.572 -1.33 . . . . 0.44 110.42 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' B' ' 228' ' ' ARG . 8.1 mtm-85 -93.14 146.54 23.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 2.76 109.291 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.89 167.38 11.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 2.23 108.931 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.8 t -83.16 -10.52 58.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 1.81 109.278 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -90.06 -10.96 42.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 3.64 109.592 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.413 ' OD2' ' CG2' ' B' ' 234' ' ' VAL . 18.7 t0 -160.44 127.31 2.56 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.16 108.782 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.49 6.72 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 120.814 1.009 . . . . 1.27 110.322 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.494 HG12 ' N ' ' B' ' 235' ' ' TRP . 40.3 t -83.74 161.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 1.76 109.893 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.494 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -74.06 161.55 29.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.67 109.063 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.91 160.86 21.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.41 -0.806 . . . . 1.44 109.285 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.86 166.98 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.578 -1.009 . . . . 0.4 110.578 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -66.33 157.91 57.77 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.767 1.644 . . . . 0.41 110.543 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.42 169.97 16.78 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.99 -0.745 . . . . 0.21 108.99 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.499 ' HZ2' ' HB2' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -93.55 138.79 31.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.107 -0.996 . . . . 2.72 109.699 -179.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.3 tp -88.97 120.52 30.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.3 109.172 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.1 mt -111.23 -72.56 0.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.317 -0.864 . . . . 0.45 110.246 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.28 143.81 26.03 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.33 110.152 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -148.42 122.16 9.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 2.33 109.314 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.6 -103.71 0.21 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.096 -1.202 . . . . 0.28 110.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.61 -153.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -1.136 . . . . 1.4 109.7 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.16 49.48 2.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.234 -1.546 . . . . 0.29 109.234 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.75 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -1.061 . . . . 0.29 108.781 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.98 124.49 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.182 -0.949 . . . . 0.31 109.725 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.06 137.0 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.06 -1.089 . . . . 0.3 108.06 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.64 -179.77 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.221 -0.924 . . . . 0.24 110.252 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -144.18 111.86 6.12 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 1.81 108.705 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -90.21 -78.57 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.66 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.641 -1.614 . . . . 1.97 106.641 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.3 m -103.77 54.3 0.74 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.936 -1.135 . . . . 1.38 107.936 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.85 126.9 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.529 -0.732 . . . . 1.12 109.245 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.65 137.03 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.48 109.272 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -137.45 171.84 13.87 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.406 -0.809 . . . . 2.13 109.728 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 137.51 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.374 -0.829 . . . . 0.34 109.396 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 55.1 t -136.97 125.2 14.75 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.374 -0.829 . . . . 0.34 108.931 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.48 143.72 93.69 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.48 0.787 . . . . 0.42 110.298 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 3.11 109.46 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -68.77 -7.63 35.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.227 -0.921 . . . . 3.82 110.705 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -119.17 19.78 12.79 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.191 -0.943 . . . . 2.08 109.436 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.1 168.85 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.32 109.559 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -137.55 127.35 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.341 -0.85 . . . . 1.79 109.024 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.18 107.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.207 -0.933 . . . . 0.45 110.201 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -105.59 151.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.482 -0.933 . . . . 0.57 108.482 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.13 149.36 21.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.374 -0.829 . . . . 3.62 109.147 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.05 109.49 179.872 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.366 0.603 . . . . 1.48 109.421 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.73 131.23 35.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.41 -0.806 . . . . 0.72 109.145 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.94 156.62 17.29 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.05 -1.093 . . . . 3.26 108.05 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.63 143.37 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.102 -0.999 . . . . 0.23 110.39 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 226' ' ' TYR . 22.6 m-85 -114.05 155.46 25.9 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.754 -1.202 . . . . 0.58 107.754 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.0 p90 -156.8 150.2 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.781 -1.199 . . . . 0.44 110.353 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -96.21 152.64 18.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 2.76 109.699 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.7 170.44 9.32 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.38 -0.97 . . . . 2.23 108.38 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.91 -12.44 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 1.8 109.225 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.68 -11.34 40.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.369 -0.832 . . . . 3.63 110.067 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 1.8 p30 -157.21 129.78 4.26 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.94 -1.1 . . . . 2.16 109.922 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.18 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 120.907 1.071 . . . . 1.25 110.659 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -82.53 142.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.779 -1.201 . . . . 1.75 109.74 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.93 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.66 108.981 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.36 -161.14 1.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.43 108.623 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.31 166.96 54.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.469 . . . . 0.39 109.429 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.92 159.35 53.62 Favored 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.408 1.405 . . . . 0.41 109.88 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.93 171.78 14.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.506 -0.746 . . . . 0.21 108.989 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.52 140.38 29.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.012 . . . . 2.72 109.212 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.97 125.14 34.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.672 -0.642 . . . . 0.29 109.718 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.3 -75.09 0.6 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.365 -0.834 . . . . 0.45 110.46 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 30.1 t90 -91.7 146.29 23.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.128 -0.982 . . . . 0.31 110.856 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.66 124.87 14.55 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.814 -0.809 . . . . 2.32 108.814 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.34 -116.13 0.54 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.087 -1.205 . . . . 0.27 110.087 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.59 -149.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -1.07 . . . . 1.39 109.449 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 52.92 3.43 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.312 -1.515 . . . . 0.29 109.312 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.44 147.45 27.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.957 . . . . 0.29 108.613 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.97 135.28 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.068 -1.02 . . . . 0.31 109.873 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.84 140.59 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.64 -0.874 . . . . 0.29 108.64 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.72 179.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.23 110.285 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -142.67 111.79 6.52 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.558 -0.905 . . . . 1.81 108.558 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.03 -77.65 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.41 -1.329 . . . . 1.18 107.41 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -81.77 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.72 -1.585 . . . . 1.98 106.72 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.93 54.49 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.41 130.43 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.492 -0.755 . . . . 1.12 109.328 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.448 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 97.9 mt -94.4 139.22 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.47 109.718 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.39 164.84 28.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 2.11 109.536 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.02 136.5 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.572 -0.899 . . . . 0.33 108.572 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.0 t -134.96 123.01 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 0.34 109.597 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -53.57 144.5 51.81 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.809 1.006 . . . . 0.42 110.839 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.54 -20.31 65.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.564 -0.71 . . . . 3.12 109.143 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -66.98 -17.89 65.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 3.82 111.64 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.89 28.67 5.55 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.979 -1.076 . . . . 2.08 109.702 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.11 159.52 40.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.841 -0.8 . . . . 0.32 108.841 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.436 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 6.3 mtmp? -139.31 130.29 26.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 1.79 109.635 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.83 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.45 109.593 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 269' ' ' ARG . 25.1 mm -105.26 160.39 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.0 mtt-85 . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.31 -0.868 . . . . 3.63 109.705 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 109.449 -0.574 . . . . 1.48 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 223' ' ' PHE . . . . . 0.408 ' CA ' ' OD1' ' B' ' 270' ' ' ASP . 39.8 m-85 -135.71 131.16 35.27 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.112 -0.699 . . . . 0.73 109.112 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.91 156.61 17.28 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.139 -1.06 . . . . 3.26 108.139 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 61.6 t -141.58 143.43 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.144 -0.972 . . . . 0.23 110.326 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 226' ' ' TYR . 22.0 m-85 -114.06 155.52 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.821 -1.178 . . . . 0.58 107.821 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.9 p90 -156.89 150.16 24.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.802 -1.186 . . . . 0.44 110.321 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -96.2 152.5 18.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.336 -0.853 . . . . 2.76 109.763 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.67 170.52 9.27 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.402 -0.962 . . . . 2.23 108.402 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.95 -12.44 53.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.981 -1.074 . . . . 1.81 109.198 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.72 -11.41 39.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.316 -0.865 . . . . 3.64 109.985 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 1.8 p30 -157.14 129.78 4.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.992 -1.067 . . . . 2.16 109.985 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.13 6.76 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 120.989 1.126 . . . . 1.27 110.627 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.57 142.69 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.762 -1.211 . . . . 1.76 109.688 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -60.93 -172.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.67 109.015 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.46 -161.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.214 -0.929 . . . . 1.44 108.604 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.25 166.96 54.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.433 -1.467 . . . . 0.4 109.433 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.94 159.35 53.6 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.402 1.401 . . . . 0.41 109.847 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.94 171.76 14.03 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.21 109.005 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.46 140.46 29.55 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.947 . . . . 2.72 109.184 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.3 tp -89.07 125.16 34.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.617 -0.677 . . . . 0.3 109.791 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.6 mt -114.32 -75.03 0.6 Allowed 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.302 -0.874 . . . . 0.45 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 29.8 t90 -91.78 146.3 23.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.223 -0.923 . . . . 0.33 110.887 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.62 124.86 14.57 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.89 -0.781 . . . . 2.33 108.89 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -116.15 0.54 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.029 -1.228 . . . . 0.28 110.029 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -67.45 -149.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.489 -1.007 . . . . 1.4 109.595 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.25 52.99 3.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.38 -1.488 . . . . 0.29 109.38 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.41 147.43 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.483 -1.01 . . . . 0.29 108.626 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 135.34 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.947 -1.095 . . . . 0.31 109.837 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.89 140.64 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.3 108.6 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.82 179.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.17 -0.956 . . . . 0.24 110.211 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -142.57 111.8 6.56 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.577 -0.898 . . . . 1.81 108.577 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.04 -77.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.482 -1.303 . . . . 1.18 107.482 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -81.65 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.788 -1.56 . . . . 1.97 106.788 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.99 54.5 0.71 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.062 -1.088 . . . . 1.38 108.062 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.39 130.37 7.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.12 109.347 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 97.9 mt -94.28 139.3 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.48 109.669 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -139.51 164.8 28.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.468 -0.77 . . . . 2.13 109.489 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.93 136.44 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.588 -0.893 . . . . 0.34 108.588 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 71.8 t -134.99 122.98 15.55 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.373 -0.83 . . . . 0.34 109.579 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -53.49 144.54 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.801 1.001 . . . . 0.42 110.927 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.59 -20.35 65.99 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.557 -0.714 . . . . 3.11 109.099 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.85 -18.07 65.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 3.82 111.631 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.82 28.65 5.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.005 -1.06 . . . . 2.08 109.68 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.04 159.6 40.3 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.803 -0.814 . . . . 0.32 108.803 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.435 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 6.3 mtmp? -139.3 130.3 26.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.169 -0.957 . . . . 1.79 109.675 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.86 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.45 109.627 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.439 HG22 ' N ' ' B' ' 269' ' ' ARG . 25.2 mm -105.37 160.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.644 -0.872 . . . . 0.57 108.644 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.32 26.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 3.62 109.719 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.408 ' OD1' ' CA ' ' B' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.043 -1.035 . . . . 2.05 108.965 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.003 -0.74 . . . . 1.48 109.003 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.54 125.67 26.15 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.235 -0.916 . . . . 0.72 109.788 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.02 164.46 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.756 -1.202 . . . . 3.26 107.756 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.02 141.65 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 0.23 109.972 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -108.83 151.98 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.523 -1.288 . . . . 0.58 107.523 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.2 p90 -153.73 152.23 30.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.77 -1.206 . . . . 0.44 110.332 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -94.13 153.14 18.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.76 110.245 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -92.3 171.09 9.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.2 t -87.77 -10.95 49.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.02 -1.05 . . . . 1.8 109.548 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -90.01 -14.51 33.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 3.63 109.611 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 234' ' ' VAL . 47.3 m-20 -161.3 130.57 3.19 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 2.16 109.29 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -65.93 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.804 1.003 . . . . 1.25 110.553 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 232' ' ' ASP . 21.7 m -83.48 140.37 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.846 -1.159 . . . . 1.75 109.736 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -60.68 167.21 2.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.66 109.516 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 237' ' ' GLY . 29.8 tttm -125.78 162.78 24.33 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.488 -0.757 . . . . 1.43 109.267 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.07 166.55 0.03 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.503 -1.039 . . . . 0.39 110.503 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.6 159.48 53.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.782 1.655 . . . . 0.41 110.458 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.22 5.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 0.21 109.164 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.95 138.95 34.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.029 -1.045 . . . . 2.72 109.835 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.7 tp -88.77 123.7 33.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.438 -0.788 . . . . 0.29 109.494 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.67 -74.51 0.61 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.474 -0.766 . . . . 0.45 110.286 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.36 143.62 26.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.139 -0.975 . . . . 0.31 110.191 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -147.53 118.53 7.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.875 . . . . 2.32 108.977 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.91 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.717 -1.23 . . . . 0.27 110.471 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -68.65 -153.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.269 -1.136 . . . . 1.39 109.917 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.46 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.139 -1.585 . . . . 0.29 109.139 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.83 155.15 40.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -1.099 . . . . 0.29 109.189 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.37 126.33 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.31 109.307 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.54 137.85 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 24.5 pt -141.97 179.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.23 110.344 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -142.17 114.04 8.03 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.19 -80.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.28 -1.378 . . . . 1.18 107.28 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -80.71 -130.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.572 -1.64 . . . . 1.98 106.572 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.13 53.74 0.74 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.161 -0.962 . . . . 1.39 108.493 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.09 127.7 7.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.542 -0.723 . . . . 1.12 109.293 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 60.7 mt -92.66 136.38 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 0.47 109.493 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.1 172.15 13.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.234 -0.916 . . . . 2.11 109.873 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.91 137.29 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.479 -0.763 . . . . 0.33 109.935 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.05 130.21 19.32 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.423 -0.798 . . . . 0.34 108.95 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.48 142.25 97.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 109.706 -0.921 . . . . 0.42 109.706 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -63.63 -30.11 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.149 -0.97 . . . . 3.12 109.15 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.91 -10.77 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.38 -0.825 . . . . 3.82 109.873 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -119.48 25.44 10.06 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.382 -0.824 . . . . 2.08 108.883 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.494 -0.754 . . . . 0.32 109.833 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.444 ' HZ2' HD11 ' A' ' 268' ' ' ILE . 6.7 mtmp? -139.13 130.75 27.32 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.329 -0.857 . . . . 1.79 108.812 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.91 109.07 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.45 110.475 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.444 HD11 ' HZ2' ' A' ' 266' ' ' LYS . 23.5 mm -108.74 147.8 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.131 -1.062 . . . . 0.57 108.131 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 3.63 109.921 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.06 -0.718 . . . . 1.48 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.51 125.59 26.06 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.239 -0.913 . . . . 0.73 109.743 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.92 164.53 12.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.793 -1.188 . . . . 3.26 107.793 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.1 141.63 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.23 110.01 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.87 152.0 25.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.558 -1.275 . . . . 0.58 107.558 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.2 p90 -153.7 152.2 30.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 0.44 110.336 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -94.1 153.13 18.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.541 -0.724 . . . . 2.76 110.246 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.5 OUTLIER -92.35 171.06 9.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.438 -0.949 . . . . 2.23 108.438 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 44.3 t -87.65 -11.08 49.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.934 -1.104 . . . . 1.81 109.562 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -89.96 -14.46 34.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 3.64 109.67 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' B' ' 234' ' ' VAL . 47.1 m-20 -161.31 130.67 3.21 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.108 -0.995 . . . . 2.16 109.224 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.01 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 120.828 1.018 . . . . 1.27 110.459 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 232' ' ' ASP . 21.6 m -83.5 140.36 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.876 -1.14 . . . . 1.76 109.762 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -60.69 167.25 2.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.212 -0.93 . . . . 0.67 109.609 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' B' ' 237' ' ' GLY . 29.8 tttm -125.76 162.77 24.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.76 . . . . 1.44 109.246 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.14 166.61 0.03 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.477 -1.049 . . . . 0.4 110.477 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.66 159.54 53.11 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.691 1.594 . . . . 0.41 110.491 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.16 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.35 -0.844 . . . . 0.21 109.158 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -98.02 139.06 34.41 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.027 -1.046 . . . . 2.72 109.923 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -88.93 123.64 33.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.401 -0.812 . . . . 0.3 109.504 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.66 -74.44 0.61 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.413 -0.805 . . . . 0.45 110.298 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.34 143.61 26.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.174 -0.954 . . . . 0.33 110.217 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -147.62 118.57 7.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.258 -0.901 . . . . 2.33 108.816 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.95 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.679 -1.248 . . . . 0.28 110.518 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.65 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -1.172 . . . . 1.4 109.94 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.68 48.4 2.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.186 -1.565 . . . . 0.29 109.186 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.18 40.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.29 109.166 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 249' ' ' VAL . 26.6 m -146.32 126.33 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.31 109.296 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.59 137.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.938 -1.134 . . . . 0.3 107.938 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 24.4 pt -141.8 179.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.24 110.362 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -142.35 114.08 7.98 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.637 -0.875 . . . . 1.81 108.637 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -91.2 -80.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.188 -1.412 . . . . 1.18 107.188 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -80.72 -130.06 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.612 -1.625 . . . . 1.97 106.612 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.5 m -104.16 53.77 0.74 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.135 -0.978 . . . . 1.38 108.535 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.07 127.72 8.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.506 -0.746 . . . . 1.12 109.329 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 60.8 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.342 -0.849 . . . . 0.48 109.438 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.16 172.05 13.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.246 -0.909 . . . . 2.13 109.836 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.77 137.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 0.34 109.948 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.11 130.2 19.26 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.884 -0.784 . . . . 0.34 108.884 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.44 142.32 97.8 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 N-CA-C 109.739 -0.908 . . . . 0.42 109.739 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -63.71 -30.16 71.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 3.11 109.144 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.96 -10.63 51.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 3.82 109.895 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -119.53 25.46 10.03 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.347 -0.846 . . . . 2.08 108.825 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.85 161.11 39.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.577 -0.702 . . . . 0.32 109.905 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.442 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.7 mtmp? -139.17 130.76 27.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.327 -0.858 . . . . 1.79 108.784 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.0 mm -87.96 109.14 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.211 -0.93 . . . . 0.45 110.416 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.442 HD11 ' HZ1' ' B' ' 266' ' ' LYS . 23.6 mm -108.83 147.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.184 -1.043 . . . . 0.57 108.184 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.571 HH11 ' CG ' ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.86 18.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.388 -0.82 . . . . 3.62 109.938 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' B' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 117.977 -1.011 . . . . 2.05 109.529 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.786 -0.82 . . . . 1.48 108.786 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -117.51 135.13 54.15 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.193 -0.669 . . . . 0.72 109.193 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -104.82 159.19 15.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.901 -1.148 . . . . 3.26 107.901 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.98 140.95 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.23 110.219 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.83 153.47 24.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.487 -1.301 . . . . 0.58 107.487 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.3 p90 -156.38 151.45 26.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.44 110.123 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -95.76 143.26 27.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.371 -0.831 . . . . 2.76 109.838 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.7 168.34 10.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.818 . . . . 2.23 108.989 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.86 8.82 7.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.984 . . . . 1.8 109.297 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.63 -39.22 15.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 3.63 109.523 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.3 p-10 -158.22 148.32 15.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.014 . . . . 2.16 109.306 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.88 10.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.172 1.248 . . . . 1.25 110.958 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.3 t -83.51 152.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.75 -1.219 . . . . 1.75 109.773 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.84 165.04 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.964 -0.754 . . . . 0.66 108.964 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.9 tttp -119.38 159.4 24.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.478 -0.764 . . . . 1.43 109.212 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.81 165.99 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.361 -1.095 . . . . 0.39 110.361 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.92 161.61 41.6 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.525 1.483 . . . . 0.41 110.405 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.23 173.4 11.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.862 -0.792 . . . . 0.21 108.862 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.06 137.01 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.095 -1.003 . . . . 2.72 109.608 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.38 123.07 31.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.635 -0.665 . . . . 0.29 109.366 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -115.76 -73.51 0.65 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.434 -0.791 . . . . 0.45 110.091 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.2 t90 -93.55 146.59 23.69 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.281 -0.887 . . . . 0.31 109.974 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -146.86 125.38 12.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 2.32 109.065 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -110.02 0.34 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.824 -1.179 . . . . 0.27 110.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.87 -150.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -1.1 . . . . 1.39 109.858 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.86 2.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.357 -1.497 . . . . 0.29 109.357 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.1 150.7 34.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.509 -0.995 . . . . 0.29 108.668 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.56 129.27 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.31 109.759 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.5 t -89.79 137.41 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.027 -1.101 . . . . 0.29 108.027 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.4 pt -141.22 177.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.301 -0.875 . . . . 0.23 109.929 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -144.09 110.75 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.472 -0.936 . . . . 1.81 108.472 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.01 -79.12 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.53 -1.285 . . . . 1.18 107.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.22 -130.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.48 -1.674 . . . . 1.98 106.48 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.9 t -105.26 54.93 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.992 -1.114 . . . . 1.39 107.992 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.56 125.48 5.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.166 -0.679 . . . . 1.12 109.166 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -92.36 138.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.887 . . . . 0.47 109.491 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -140.01 167.08 22.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.393 -0.817 . . . . 2.11 109.684 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.82 139.0 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.33 109.221 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -136.11 134.15 20.07 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.34 108.916 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.65 142.86 98.83 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 N-CA-C 109.85 -0.865 . . . . 0.42 109.85 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.417 ' HG2' ' NH1' ' A' ' 262' ' ' ARG . 6.4 tpt180 -60.69 -34.39 74.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 3.12 109.555 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -68.87 -7.1 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.241 -0.912 . . . . 3.82 110.846 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -119.0 19.0 13.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.073 -1.017 . . . . 2.08 108.839 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.36 168.71 19.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.897 -0.779 . . . . 0.32 108.897 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.43 129.72 23.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.977 . . . . 1.79 109.541 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.83 106.03 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.326 -0.859 . . . . 0.45 109.721 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.6 152.08 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.231 -0.918 . . . . 0.57 108.815 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.789 . . . . 3.63 109.642 179.773 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 222' ' ' ASN . . . . . 0.422 ' O ' ' OXT' ' B' ' 270' ' ' ASP . 19.3 m-20 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.774 -0.825 . . . . 1.48 108.774 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.35 135.24 54.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.573 -0.704 . . . . 0.73 109.189 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -104.97 159.11 16.07 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.897 -1.149 . . . . 3.26 107.897 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 81.1 t -140.96 140.99 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.185 -0.947 . . . . 0.23 110.22 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.79 153.45 24.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.509 -1.293 . . . . 0.58 107.509 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.5 p90 -156.36 151.39 26.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.68 -1.263 . . . . 0.44 110.114 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -95.78 143.26 27.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.485 -0.759 . . . . 2.76 109.857 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.72 168.32 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 2.23 109.059 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.83 8.79 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 1.81 109.301 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.56 -39.21 15.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 3.64 109.497 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.3 p-10 -158.34 148.27 15.34 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.147 -0.97 . . . . 2.16 109.294 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.85 10.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.222 1.281 . . . . 1.27 110.854 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.3 t -83.43 152.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.788 -1.195 . . . . 1.76 109.732 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.85 164.99 25.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.474 -0.766 . . . . 0.67 109.015 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.8 tttp -119.31 159.4 24.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.444 -0.785 . . . . 1.44 109.241 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.9 165.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.305 -1.118 . . . . 0.4 110.305 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.86 161.61 41.44 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.602 1.535 . . . . 0.41 110.41 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.31 173.48 11.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.811 -0.811 . . . . 0.21 108.811 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.07 137.06 34.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.124 -0.985 . . . . 2.72 109.559 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.56 123.09 32.08 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.7 . . . . 0.3 109.345 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.75 -73.5 0.65 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.414 -0.804 . . . . 0.45 109.996 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.45 146.61 23.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.91 . . . . 0.33 109.979 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -146.9 125.46 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.295 -0.878 . . . . 2.33 108.981 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -110.02 0.34 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.755 -1.212 . . . . 0.28 110.288 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.85 -150.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -1.062 . . . . 1.4 109.863 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 48.94 2.8 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.298 -1.521 . . . . 0.29 109.298 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.19 150.64 34.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.461 -1.023 . . . . 0.29 108.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.9 m -145.54 129.29 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.31 109.699 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.73 137.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.096 -1.076 . . . . 0.3 108.096 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.29 176.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.317 -0.864 . . . . 0.24 109.907 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -144.09 110.7 5.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.489 -0.93 . . . . 1.81 108.489 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.99 -79.17 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.536 -1.283 . . . . 1.18 107.536 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.12 -130.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.539 -1.652 . . . . 1.97 106.539 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.0 t -105.28 54.86 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.985 -1.117 . . . . 1.38 107.985 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.53 125.53 6.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.579 -0.701 . . . . 1.12 109.156 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.2 mt -92.41 137.93 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.375 -0.828 . . . . 0.48 109.519 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -139.9 167.22 22.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.432 -0.792 . . . . 2.13 109.704 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -103.95 138.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.412 -0.805 . . . . 0.34 109.203 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.03 134.13 20.16 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.34 108.966 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.57 142.83 98.58 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 120.597 0.865 . . . . 0.42 109.855 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' B' ' 262' ' ' ARG . 6.5 tpt180 -60.7 -34.32 74.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 3.11 109.569 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -68.89 -7.19 32.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.27 -0.894 . . . . 3.82 110.787 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -118.97 19.02 13.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.227 -0.921 . . . . 2.08 108.79 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 168.74 19.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.849 -0.797 . . . . 0.32 108.849 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.44 129.76 23.83 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.139 -0.976 . . . . 1.79 109.568 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.81 105.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.26 -0.9 . . . . 0.45 109.728 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.67 152.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.57 108.737 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 58.7 ttt180 -90.95 146.13 24.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.361 -0.837 . . . . 3.62 109.69 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.422 ' OXT' ' O ' ' B' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.933 -1.032 . . . . 2.05 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.27 0.557 . . . . 1.48 109.657 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.7 130.39 38.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.785 -0.82 . . . . 0.72 108.785 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -99.27 150.71 21.82 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.459 -1.311 . . . . 3.26 107.459 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.06 136.47 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.205 -0.935 . . . . 0.23 110.559 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -107.97 156.96 18.64 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.737 -1.209 . . . . 0.58 107.737 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.2 p90 -157.84 152.67 25.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.569 -1.332 . . . . 0.44 110.334 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.7 mtm-85 -93.37 144.36 25.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.44 -0.788 . . . . 2.76 109.837 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.75 175.4 6.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.405 -0.809 . . . . 2.23 109.328 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.68 -10.75 44.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.188 -0.945 . . . . 1.8 109.247 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -89.67 -15.23 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 3.63 109.617 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -159.55 129.28 3.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.143 -0.973 . . . . 2.16 109.204 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.06 8.57 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 120.8 1.0 . . . . 1.25 111.273 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.0 p -85.66 164.15 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.552 -1.342 . . . . 1.75 110.291 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.562 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.9 m95 -76.03 163.49 27.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.746 -0.596 . . . . 0.66 109.532 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 237' ' ' GLY . 2.5 mtpp -118.44 165.16 14.24 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 108.658 -0.867 . . . . 1.43 108.658 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.06 164.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.998 -1.241 . . . . 0.39 109.998 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.89 159.97 43.36 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.471 1.447 . . . . 0.41 110.659 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.56 164.22 30.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.508 -0.923 . . . . 0.21 108.508 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.67 143.52 26.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.023 -1.048 . . . . 2.72 109.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.86 128.36 36.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.45 -0.781 . . . . 0.29 110.563 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 mt -119.16 -70.61 0.78 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.515 -0.74 . . . . 0.45 110.137 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -91.96 137.85 32.02 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -144.07 115.72 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.985 -0.746 . . . . 2.32 108.985 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.71 -104.08 0.22 Allowed Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.839 -1.172 . . . . 0.27 110.293 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.97 -157.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 1.39 109.602 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 47.67 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.037 -1.625 . . . . 0.29 109.037 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.34 151.98 38.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.519 -0.989 . . . . 0.29 108.769 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.78 134.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.31 109.435 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -95.5 138.11 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.137 -1.06 . . . . 0.29 108.137 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.0 176.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.23 109.818 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.68 109.28 5.65 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.455 -0.943 . . . . 1.81 108.455 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.7 -77.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.37 -1.344 . . . . 1.18 107.37 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.23 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.937 -1.505 . . . . 1.98 106.937 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.6 m -97.97 56.06 1.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.681 -1.229 . . . . 1.39 107.681 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.56 130.37 7.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 1.12 109.46 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.91 135.5 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.47 109.329 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -136.52 168.99 18.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 2.11 109.683 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.99 140.08 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.344 -0.848 . . . . 0.33 109.568 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.78 126.1 13.23 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.396 -0.815 . . . . 0.34 109.188 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.95 140.56 86.03 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.642 0.895 . . . . 0.42 110.237 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -58.97 -37.33 76.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 3.12 109.533 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -69.8 -1.64 9.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 3.82 110.242 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HG3' HH12 ' A' ' 228' ' ' ARG . 2.5 mptm? -118.32 17.04 13.93 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.681 -0.859 . . . . 2.08 108.681 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.85 175.14 9.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.421 -0.8 . . . . 0.32 109.724 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.8 128.46 21.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.316 -0.865 . . . . 1.79 109.127 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.7 mm -88.74 109.72 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.43 -0.794 . . . . 0.45 109.86 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.42 153.61 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.692 -0.855 . . . . 0.57 108.692 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.5 mtt-85 . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.272 -0.892 . . . . 3.63 109.883 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.281 0.562 . . . . 1.48 109.799 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.6 130.5 38.44 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.756 -0.831 . . . . 0.73 108.756 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 224' ' ' ARG . 20.2 mtm-85 -99.46 150.68 21.94 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 3.26 107.48 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.2 t -139.05 136.64 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.254 -0.904 . . . . 0.23 110.476 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.09 157.09 18.57 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.649 -1.241 . . . . 0.58 107.649 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.9 152.66 25.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.656 -1.278 . . . . 0.44 110.288 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.427 HH12 ' HG3' ' B' ' 264' ' ' LYS . 2.7 mtm-85 -93.38 144.39 25.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.374 -0.828 . . . . 2.76 109.853 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.79 175.21 6.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.382 -0.824 . . . . 2.23 109.316 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.39 -10.98 44.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.262 -0.899 . . . . 1.81 109.259 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -89.65 -15.2 33.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 3.64 109.702 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.2 m-20 -159.59 129.28 3.31 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.961 . . . . 2.16 109.249 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -65.03 8.35 0.22 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 120.882 1.055 . . . . 1.27 111.21 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.0 p -85.4 164.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.557 -1.34 . . . . 1.76 110.19 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.9 m95 -76.25 163.51 26.97 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' B' ' 237' ' ' GLY . 2.5 mtpp -118.53 165.15 14.27 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.644 -0.873 . . . . 1.44 108.644 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.15 164.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.184 -1.167 . . . . 0.4 110.184 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -64.9 160.0 43.3 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.488 1.459 . . . . 0.41 110.643 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.63 164.09 31.12 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.586 -0.894 . . . . 0.21 108.586 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.71 143.63 26.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.007 -1.058 . . . . 2.72 109.393 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.5 tp -90.04 128.45 36.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.594 -0.691 . . . . 0.3 110.4 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 32.8 mt -119.25 -70.55 0.78 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.573 -0.704 . . . . 0.45 110.102 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -92.01 137.86 32.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.152 -0.968 . . . . 0.33 110.7 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -144.05 115.83 8.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.8 . . . . 2.33 108.929 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -104.15 0.22 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.161 -1.176 . . . . 0.28 110.161 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.98 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 1.4 109.615 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.63 47.49 2.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.1 -1.6 . . . . 0.29 109.1 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.22 151.95 38.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.997 . . . . 0.29 108.865 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.79 134.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.31 109.502 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 89.9 t -95.48 138.04 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.155 -1.054 . . . . 0.3 108.155 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' B' ' 251' ' ' ILE . 12.8 pt -139.85 176.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.24 109.945 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.61 109.29 5.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.54 -0.911 . . . . 1.81 108.54 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.76 -77.35 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.304 -1.369 . . . . 1.18 107.304 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.19 -138.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.925 -1.509 . . . . 1.97 106.925 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.4 m -97.96 55.98 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.68 -1.23 . . . . 1.38 107.68 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.48 130.44 7.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.61 -0.681 . . . . 1.12 109.394 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 55.5 mt -95.8 135.61 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.48 109.307 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.71 169.03 18.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 2.13 109.574 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.93 140.02 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.34 109.611 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 53.3 t -138.69 126.05 13.31 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.34 109.221 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.81 140.48 85.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 120.616 0.877 . . . . 0.42 110.225 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -58.87 -37.33 76.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 3.11 109.449 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -69.96 -1.4 9.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.402 -0.811 . . . . 3.82 110.245 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.427 ' HG3' HH12 ' B' ' 228' ' ' ARG . 2.5 mptm? -118.41 16.87 13.86 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.717 -0.846 . . . . 2.08 108.717 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.82 175.29 9.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.413 -0.804 . . . . 0.32 109.742 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.9 128.47 21.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.438 -0.789 . . . . 1.79 109.122 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -88.78 109.57 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.501 -0.749 . . . . 0.45 109.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -105.22 153.59 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 108.742 -0.836 . . . . 0.57 108.742 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.586 HH11 ' CG ' ' B' ' 269' ' ' ARG . 3.6 mtt-85 -94.57 137.05 34.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.228 -0.92 . . . . 3.62 109.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' B' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.045 -1.034 . . . . 2.05 109.677 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.273 -0.64 . . . . 1.48 109.273 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.34 133.89 43.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.961 -0.755 . . . . 0.72 108.961 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.73 158.69 17.39 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.192 -1.04 . . . . 3.26 108.192 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.98 140.04 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.23 110.08 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.42 155.43 20.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.72 -1.215 . . . . 0.58 107.72 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.5 p90 -156.18 153.79 29.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.44 110.345 -179.107 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.93 141.16 29.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.76 . . . . 2.76 109.645 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 9.7 p30 -92.32 162.67 14.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.306 -0.871 . . . . 2.23 109.002 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.3 -2.71 36.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 1.8 109.842 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -89.91 -20.73 23.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.181 -0.949 . . . . 3.63 109.541 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 234' ' ' VAL . 14.5 m-20 -162.1 130.96 3.03 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.978 . . . . 2.16 108.969 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -63.57 8.44 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.751 0.968 . . . . 1.25 110.422 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.1 m -82.77 139.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.037 -1.04 . . . . 1.75 109.477 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -57.01 162.73 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.026 -1.046 . . . . 0.66 109.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 237' ' ' GLY . 39.3 tttp -119.18 165.0 14.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.483 -0.761 . . . . 1.43 109.091 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.45 166.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.111 -1.196 . . . . 0.39 110.111 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.51 162.18 43.06 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.641 1.561 . . . . 0.41 110.405 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.53 178.47 7.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.966 -0.753 . . . . 0.21 108.966 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.94 140.93 29.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.134 -0.979 . . . . 2.72 109.302 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.03 123.74 33.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.604 -0.685 . . . . 0.29 109.736 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 28.0 mt -113.45 -74.69 0.62 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.436 -0.79 . . . . 0.45 109.89 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.44 30.66 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.154 -0.966 . . . . 0.31 109.783 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.26 116.93 8.13 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.667 -0.864 . . . . 2.32 108.667 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -100.84 0.18 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.8 -1.191 . . . . 0.27 110.261 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.51 -157.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -1.096 . . . . 1.39 109.842 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.09 49.51 2.92 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.163 -1.575 . . . . 0.29 109.163 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.67 154.51 39.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -1.003 . . . . 0.29 108.499 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.11 131.95 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.085 -1.009 . . . . 0.31 109.862 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.6 t -93.84 135.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.29 107.828 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -138.53 177.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.328 -0.858 . . . . 0.23 110.289 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -145.07 111.5 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.581 -0.896 . . . . 1.81 108.581 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.83 -78.32 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.2 -1.408 . . . . 1.18 107.2 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -81.88 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.708 -1.59 . . . . 1.98 106.708 177.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 t -101.7 55.82 0.82 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.038 -1.097 . . . . 1.39 108.038 177.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -155.35 124.52 6.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.615 -0.678 . . . . 1.12 109.183 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.52 134.87 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.47 109.202 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -137.42 167.81 20.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 2.11 110.039 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 70.7 t -102.25 139.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.55 -0.719 . . . . 0.33 109.256 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.7 t -136.73 127.97 16.64 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.878 -0.786 . . . . 0.34 108.878 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.8 138.61 86.7 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.913 -0.841 . . . . 0.42 109.913 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.27 -32.27 66.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 3.12 109.428 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.485 HH11 ' HG3' ' A' ' 263' ' ' ARG . 5.1 ttm-85 -67.29 -8.77 34.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.433 -0.792 . . . . 3.82 110.204 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -120.25 18.31 12.26 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.384 -0.823 . . . . 2.08 109.187 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.26 168.6 19.4 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.65 -0.656 . . . . 0.32 109.4 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -141.6 130.99 23.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.79 109.169 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.97 114.77 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.45 109.946 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.66 154.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.69 -0.856 . . . . 0.57 108.69 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.4 mtt-85 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 3.63 109.218 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.294 -0.632 . . . . 1.48 109.294 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.41 133.92 43.0 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.937 -0.764 . . . . 0.73 108.937 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -108.67 158.66 17.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.272 -1.01 . . . . 3.26 108.272 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.9 t -140.89 140.0 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.23 110.145 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.28 155.42 19.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.69 -1.226 . . . . 0.58 107.69 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.5 p90 -156.15 153.73 29.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.7 -1.25 . . . . 0.44 110.376 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.92 141.27 29.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.576 -0.703 . . . . 2.76 109.578 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 9.8 p30 -92.34 162.65 14.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.284 -0.885 . . . . 2.23 109.041 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.26 -2.76 36.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 1.81 109.812 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -89.82 -20.98 22.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.124 -0.985 . . . . 3.64 109.548 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' B' ' 234' ' ' VAL . 14.6 m-20 -161.82 130.98 3.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 2.16 108.98 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.51 8.37 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.712 0.941 . . . . 1.27 110.454 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.2 m -82.73 139.48 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 1.76 109.409 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.12 162.68 2.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.67 109.53 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -119.19 164.99 14.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.38 -0.825 . . . . 1.44 109.089 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.54 166.59 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.4 110.064 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.44 162.15 43.23 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.721 1.614 . . . . 0.41 110.426 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.47 178.44 7.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.926 -0.768 . . . . 0.21 108.926 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.85 141.02 29.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.14 -0.975 . . . . 2.72 109.368 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.01 123.7 33.57 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.568 -0.707 . . . . 0.3 109.701 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 28.2 mt -113.47 -74.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.414 -0.804 . . . . 0.45 109.859 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.28 30.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.264 -0.897 . . . . 0.33 109.776 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.14 116.98 8.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.657 -0.868 . . . . 2.33 108.657 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.83 -100.82 0.18 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.732 -1.223 . . . . 0.28 110.225 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.46 -157.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 1.4 109.816 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 49.81 3.01 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.42 39.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -1.037 . . . . 0.29 108.49 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.0 m -146.1 131.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.31 109.818 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.83 134.92 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.795 -1.187 . . . . 0.3 107.795 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -138.43 177.93 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.219 -0.926 . . . . 0.24 110.319 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -145.08 111.47 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.618 -0.882 . . . . 1.81 108.618 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.8 -78.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.15 -1.426 . . . . 1.18 107.15 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.84 -133.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.733 -1.58 . . . . 1.97 106.733 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.3 t -101.83 55.85 0.81 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -155.26 124.6 6.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 1.12 109.168 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.66 134.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.284 -0.885 . . . . 0.48 109.123 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -137.38 167.86 20.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.337 -0.852 . . . . 2.13 110.102 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 71.0 t -102.34 139.82 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.676 . . . . 0.34 109.274 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.67 128.07 16.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.914 -0.773 . . . . 0.34 108.914 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.89 138.58 86.52 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 N-CA-C 109.928 -0.835 . . . . 0.42 109.928 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.28 -32.22 66.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 3.11 109.443 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' B' ' 263' ' ' ARG . 5.2 ttm-85 -67.41 -8.76 35.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.478 -0.764 . . . . 3.82 110.12 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -120.2 18.23 12.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.312 -0.868 . . . . 2.08 109.162 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.23 168.44 19.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 0.32 109.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -141.51 130.9 23.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.286 -0.884 . . . . 1.79 109.175 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.81 114.75 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.243 -0.911 . . . . 0.45 109.917 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.67 154.49 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.713 -0.847 . . . . 0.57 108.713 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.4 mtt-85 -89.51 140.36 29.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.88 . . . . 3.62 109.211 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.089 -0.958 . . . . 2.05 109.382 179.892 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.119 -0.697 . . . . 1.48 109.119 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -135.12 142.25 46.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.427 -0.796 . . . . 0.72 109.524 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -115.64 153.8 30.63 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.238 -1.393 . . . . 3.26 107.238 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.2 t -140.74 141.91 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.099 -1.001 . . . . 0.23 110.472 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -109.22 155.0 21.61 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.256 -1.387 . . . . 0.58 107.256 178.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.447 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.0 p90 -156.19 155.6 32.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.547 -1.346 . . . . 0.44 110.618 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -100.68 133.13 45.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.475 0.655 . . . . 2.76 109.358 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 22.2 p-10 -92.35 171.65 8.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.001 -0.741 . . . . 2.23 109.001 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 78.9 p -87.45 -9.15 55.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 1.8 109.661 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.32 -12.24 41.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.91 . . . . 3.63 109.365 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -161.27 128.54 2.65 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.296 -1.001 . . . . 2.16 108.296 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.53 -1.4 9.05 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 120.789 0.993 . . . . 1.25 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 137.89 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.745 -1.222 . . . . 1.75 110.005 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -50.35 166.98 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.089 -1.007 . . . . 0.66 109.219 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 237' ' ' GLY . 1.9 mtpp -119.65 166.37 13.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.67 -0.863 . . . . 1.43 108.67 179.278 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.31 168.78 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.823 -1.311 . . . . 0.39 109.823 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -66.96 158.87 54.58 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.685 1.59 . . . . 0.41 110.618 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.0 171.02 15.14 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.061 -0.718 . . . . 0.21 109.061 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -94.1 139.14 31.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.179 -0.951 . . . . 2.72 109.733 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.55 126.11 35.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.551 . . . . 0.29 109.515 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.89 -72.06 0.71 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.389 -0.819 . . . . 0.45 110.362 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.473 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.97 142.62 27.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.105 -0.997 . . . . 0.31 110.032 -178.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -148.68 118.59 7.13 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 2.32 109.459 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.22 0.17 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.842 -1.17 . . . . 0.27 110.21 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.6 -155.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -1.076 . . . . 1.39 109.931 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.87 48.71 3.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.689 -1.364 . . . . 0.29 109.689 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.88 154.96 41.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.379 -1.071 . . . . 0.29 108.612 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.39 128.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.075 -1.015 . . . . 0.31 109.787 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.06 132.69 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.955 -1.128 . . . . 0.29 107.955 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 251' ' ' ILE . 13.2 pt -135.64 177.68 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.911 . . . . 0.23 109.864 -179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -143.69 107.56 4.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.423 -0.798 . . . . 1.81 109.016 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.93 -76.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.748 -1.575 . . . . 1.18 106.748 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -163.32 0.55 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.999 -1.852 . . . . 1.98 105.999 177.134 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.1 p -79.47 48.79 0.94 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.599 -1.313 . . . . 1.39 108.288 178.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.31 126.7 11.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 1.12 109.175 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.503 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.9 mt -92.07 141.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.47 109.846 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -139.95 167.98 20.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -0.785 . . . . 2.11 109.796 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.19 137.45 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.358 -0.839 . . . . 0.33 109.241 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.2 130.56 19.31 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.461 -0.774 . . . . 0.34 109.038 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.16 137.11 80.35 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 N-CA-C 109.892 -0.849 . . . . 0.42 109.892 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.18 -35.35 69.49 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.202 -0.936 . . . . 3.12 109.427 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.82 -5.24 19.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.408 -0.807 . . . . 3.82 110.257 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.9 22.46 11.93 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.472 -0.936 . . . . 2.08 108.472 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.64 166.02 26.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.32 109.14 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.17 128.19 25.63 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.371 -0.831 . . . . 1.79 109.326 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.46 110.34 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.45 109.834 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.2 mm -105.31 156.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.452 -0.944 . . . . 0.57 108.452 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.06 -1.025 . . . . 3.63 109.229 179.65 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 1.48 109.111 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -135.04 142.21 46.31 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.419 -0.8 . . . . 0.73 109.496 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' B' ' 224' ' ' ARG . 0.3 OUTLIER -115.65 153.84 30.56 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.239 -1.393 . . . . 3.26 107.239 178.748 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.72 141.83 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.96 . . . . 0.23 110.571 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -109.24 155.01 21.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.162 -1.421 . . . . 0.58 107.162 178.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.1 p90 -156.12 155.69 32.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.604 -1.31 . . . . 0.44 110.63 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -100.94 132.99 46.09 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 2.76 109.442 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 22.3 p-10 -92.21 171.63 8.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 2.23 109.029 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 80.0 p -87.52 -9.09 55.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 1.81 109.633 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.2 -12.44 40.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.93 . . . . 3.64 109.348 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -161.17 128.47 2.66 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.305 -0.998 . . . . 2.16 108.305 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -70.41 -1.49 9.09 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 120.819 1.012 . . . . 1.27 111.065 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.02 137.85 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.749 -1.22 . . . . 1.76 109.933 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -50.49 166.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.073 -1.017 . . . . 0.67 109.182 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' B' ' 237' ' ' GLY . 1.9 mtpp -119.68 166.23 13.47 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.587 -0.894 . . . . 1.44 108.587 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.18 168.64 0.04 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.863 -1.295 . . . . 0.4 109.863 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.83 158.99 53.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.612 1.541 . . . . 0.41 110.749 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.16 170.84 15.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.048 -0.723 . . . . 0.21 109.048 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -93.87 139.06 31.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.077 -1.015 . . . . 2.72 109.77 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -89.48 126.05 35.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.749 -0.594 . . . . 0.3 109.531 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.75 -72.03 0.71 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.48 -0.762 . . . . 0.45 110.352 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.503 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.3 t90 -91.1 142.66 27.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.045 -1.034 . . . . 0.33 109.988 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -148.65 118.53 7.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.239 -0.913 . . . . 2.33 109.488 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.04 0.17 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.856 -1.164 . . . . 0.28 110.245 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.63 -155.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.377 -1.072 . . . . 1.4 109.974 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.94 48.59 3.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.727 -1.349 . . . . 0.29 109.727 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.79 155.07 41.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.29 108.59 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.44 128.73 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.134 -0.979 . . . . 0.31 109.728 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.1 132.71 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.967 -1.123 . . . . 0.3 107.967 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.24 109.848 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -143.65 107.64 4.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 1.81 109.079 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.05 -76.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.762 -1.57 . . . . 1.18 106.762 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -163.25 0.54 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.975 -1.861 . . . . 1.97 105.975 177.145 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 15.2 p -79.53 48.85 0.95 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.519 -1.363 . . . . 1.38 108.315 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.37 126.72 11.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.533 -0.729 . . . . 1.12 109.213 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.8 mt -92.07 141.57 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 0.48 109.824 -179.444 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -140.09 167.96 20.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.344 -0.848 . . . . 2.13 109.815 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.12 137.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.391 -0.818 . . . . 0.34 109.279 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.17 130.58 19.35 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.455 -0.778 . . . . 0.34 108.991 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.27 137.07 79.98 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 109.86 -0.862 . . . . 0.42 109.86 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -57.05 -35.54 69.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 3.11 109.433 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.81 -5.05 18.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.824 . . . . 3.82 110.372 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.87 22.22 12.06 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.542 -0.91 . . . . 2.08 108.542 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.4 166.16 25.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.535 -0.728 . . . . 0.32 109.133 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -138.21 128.1 25.41 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.361 -0.837 . . . . 1.79 109.396 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.43 110.31 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.45 109.888 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.3 mm -105.33 156.9 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.421 -0.955 . . . . 0.57 108.421 179.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.97 138.78 31.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.13 -0.981 . . . . 3.62 109.253 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.068 -1.02 . . . . 2.05 109.532 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.6 m120 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.297 -0.631 . . . . 1.48 109.297 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.08 141.97 47.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.518 -0.739 . . . . 0.72 109.166 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -116.96 157.71 25.29 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.558 -1.275 . . . . 3.26 107.558 178.827 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.39 145.45 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.949 -1.094 . . . . 0.23 110.55 -179.184 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.79 161.97 15.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.017 -1.105 . . . . 0.58 108.017 178.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.84 149.54 23.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.87 -1.144 . . . . 0.44 110.231 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.73 159.03 15.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 2.76 109.881 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.9 OUTLIER -95.45 170.91 9.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.041 -0.726 . . . . 2.23 109.041 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.9 t -91.37 -15.05 29.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 1.8 108.982 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.3 mtt-85 -90.21 -15.07 32.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.857 . . . . 3.63 109.793 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.7 m-20 -161.19 128.8 2.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 2.16 109.173 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.77 17.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.813 1.008 . . . . 1.25 110.603 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 232' ' ' ASP . 32.7 m -80.9 130.93 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.785 -1.197 . . . . 1.75 109.834 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.78 174.82 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.66 109.398 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -122.62 -166.24 1.4 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.206 -1.035 . . . . 1.43 108.206 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.12 -179.31 51.75 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.287 -1.525 . . . . 0.39 109.287 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.4 149.01 49.72 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.695 1.596 . . . . 0.41 110.446 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.28 167.1 22.25 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.99 -0.744 . . . . 0.21 108.99 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -91.54 140.81 29.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.047 -1.033 . . . . 2.72 110.081 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.03 129.85 35.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.807 -0.558 . . . . 0.29 109.8 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.1 mt -118.03 -72.54 0.68 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.57 -0.707 . . . . 0.45 110.42 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.405 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.24 143.23 26.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.31 110.845 -178.04 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -143.89 112.6 6.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.839 -0.801 . . . . 2.32 108.839 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.67 -103.58 0.36 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.968 -1.253 . . . . 0.27 109.968 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.43 -154.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -1.162 . . . . 1.39 109.503 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.25 3.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.7 -1.76 . . . . 0.29 108.7 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.69 35.84 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.57 -0.959 . . . . 0.29 108.603 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.11 128.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.083 -1.011 . . . . 0.31 109.619 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 54.1 t -92.84 128.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.212 -1.032 . . . . 0.29 108.212 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.42 -179.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -0.793 . . . . 0.23 109.865 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -142.66 109.96 5.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.278 -1.008 . . . . 1.81 108.278 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -86.03 -81.02 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.298 -1.371 . . . . 1.18 107.298 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.837 -1.542 . . . . 1.98 106.837 177.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 35.0 t -100.58 53.71 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.052 -1.092 . . . . 1.39 108.052 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.53 124.23 5.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 1.12 109.375 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 22.2 mt -90.46 131.19 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.902 . . . . 0.47 109.257 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 258' ' ' LYS . 0.0 OUTLIER -131.64 167.99 18.5 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.446 -0.784 . . . . 2.11 109.74 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 142.06 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.33 109.446 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.16 130.09 17.19 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.485 -0.932 . . . . 0.34 108.485 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.19 141.99 90.18 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 N-CA-C 109.93 -0.834 . . . . 0.42 109.93 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.94 -31.15 66.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 3.12 109.101 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.08 -11.21 60.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.398 -0.814 . . . . 3.82 110.325 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.09 21.91 12.11 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 2.08 108.991 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.03 16.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.472 -0.767 . . . . 0.32 109.339 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -140.53 125.67 18.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 1.79 109.262 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.35 113.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.234 -0.917 . . . . 0.45 109.17 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.01 153.67 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.455 -0.778 . . . . 0.57 109.044 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 269' ' ' ARG . 18.4 mtm-85 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.468 -0.77 . . . . 3.63 109.485 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 28.3 m120 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.36 -0.607 . . . . 1.48 109.36 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -134.09 141.9 47.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.411 -0.806 . . . . 0.73 109.138 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -116.83 157.7 25.16 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.566 -1.272 . . . . 3.26 107.566 178.769 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.41 145.47 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.008 -1.057 . . . . 0.23 110.624 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.8 162.06 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.956 -1.127 . . . . 0.58 107.956 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.6 p90 -156.85 149.57 23.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.882 -1.136 . . . . 0.44 110.194 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -96.67 159.09 15.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 2.76 109.945 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -95.55 170.9 9.02 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.996 -0.742 . . . . 2.23 108.996 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.5 t -91.4 -15.09 29.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 1.81 108.827 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 231' ' ' ARG . 2.3 mtt-85 -90.23 -14.99 32.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 3.64 109.81 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.6 m-20 -161.15 128.9 2.76 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 2.16 109.114 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.93 17.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.844 1.03 . . . . 1.27 110.602 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' B' ' 232' ' ' ASP . 32.7 m -80.93 130.9 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.916 -1.115 . . . . 1.76 109.826 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.8 174.89 0.14 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -0.936 . . . . 0.67 109.532 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -122.66 -166.22 1.4 Allowed 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 108.157 -1.053 . . . . 1.44 108.157 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.1 -179.2 51.75 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.321 -1.512 . . . . 0.4 109.321 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.42 149.0 49.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.803 1.669 . . . . 0.41 110.421 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.35 167.12 22.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.944 -0.762 . . . . 0.21 108.944 179.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -91.57 140.76 29.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.0 -1.063 . . . . 2.72 110.069 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 tp -88.92 129.77 35.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.751 -0.593 . . . . 0.3 109.814 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.91 -72.58 0.68 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.363 -0.836 . . . . 0.45 110.416 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -90.27 143.06 27.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.33 110.887 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' B' ' 244' ' ' LYS . 0.9 OUTLIER -143.68 112.72 6.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.807 . . . . 2.33 108.938 179.172 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.65 -103.58 0.36 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.896 -1.281 . . . . 0.28 109.896 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.37 -154.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -1.119 . . . . 1.4 109.492 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.23 3.54 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.678 -1.769 . . . . 0.29 108.678 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.57 35.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.582 -0.952 . . . . 0.29 108.644 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.05 128.7 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.034 -1.041 . . . . 0.31 109.679 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.81 128.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.195 -1.039 . . . . 0.3 108.195 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.5 pt -134.31 -179.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.377 -0.827 . . . . 0.24 109.908 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -142.7 109.82 5.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.378 -0.971 . . . . 1.81 108.378 178.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -85.98 -81.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.281 -1.377 . . . . 1.18 107.281 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.48 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.823 -1.547 . . . . 1.97 106.823 177.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 34.9 t -100.6 53.73 0.87 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.046 -1.094 . . . . 1.38 108.046 178.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.54 124.42 5.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.604 -0.685 . . . . 1.12 109.327 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.405 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 21.9 mt -90.59 131.16 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.48 109.25 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 258' ' ' LYS . . . . . 0.593 ' HZ2' ' HB2' ' B' ' 258' ' ' LYS . 0.0 OUTLIER -131.63 168.0 18.48 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 2.13 109.743 -179.613 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.64 142.11 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.457 -0.777 . . . . 0.34 109.436 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 51.0 t -137.19 130.01 17.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.45 -0.944 . . . . 0.34 108.45 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 141.91 90.47 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.904 -0.845 . . . . 0.42 109.904 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.93 -31.15 66.54 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 3.11 109.132 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -70.13 -11.09 60.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 3.82 110.373 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.16 21.94 12.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.271 -0.893 . . . . 2.08 108.899 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.05 16.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.32 109.324 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -140.59 125.67 18.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 1.79 109.279 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.25 113.1 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -0.915 . . . . 0.45 109.235 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.92 153.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.57 109.093 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' B' ' 269' ' ' ARG . 18.5 mtm-85 -95.75 135.93 36.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 3.62 109.392 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.912 -1.042 . . . . 2.05 109.029 179.48 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.218 0.533 . . . . 1.48 110.143 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -135.5 125.23 25.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.438 -0.789 . . . . 0.72 109.09 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -101.44 159.12 15.55 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.243 -1.021 . . . . 3.26 108.243 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.19 143.77 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.099 -1.001 . . . . 0.23 110.895 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.42 156.73 19.11 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.243 -1.391 . . . . 0.58 107.243 178.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.9 p90 -157.69 152.86 25.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.549 -1.345 . . . . 0.44 110.697 -179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -99.49 135.3 41.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.622 -0.674 . . . . 2.76 109.751 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -95.85 178.93 5.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.847 . . . . 2.23 109.185 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 73.9 p -91.21 -10.8 40.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.916 . . . . 1.8 109.429 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 232' ' ' ASP . 53.6 mtp180 -84.1 -19.05 34.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.205 -0.935 . . . . 3.63 109.481 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 231' ' ' ARG . 43.2 m-20 -159.37 129.04 3.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.323 -0.861 . . . . 2.16 109.152 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.41 1.83 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.76 0.974 . . . . 1.25 110.442 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.73 136.24 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.939 -1.101 . . . . 1.75 110.218 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.28 163.62 0.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.66 109.239 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.4 mtpt -119.85 166.74 12.89 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.459 -0.776 . . . . 1.43 109.561 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.16 166.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.457 -1.057 . . . . 0.39 110.457 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.61 159.73 39.51 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.591 1.528 . . . . 0.41 110.579 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.39 169.56 17.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.864 -0.791 . . . . 0.21 108.864 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -92.32 136.17 33.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.981 -1.074 . . . . 2.72 109.537 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.2 116.84 26.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.671 -0.643 . . . . 0.29 109.313 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.9 mt -104.82 -71.7 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.246 -0.908 . . . . 0.45 109.838 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -94.08 146.98 23.58 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.107 -0.996 . . . . 0.31 110.473 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.02 120.96 8.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.827 . . . . 2.32 109.017 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -108.58 0.3 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.78 -1.2 . . . . 0.27 110.332 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.76 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 1.39 109.69 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 47.91 2.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.994 -1.642 . . . . 0.29 108.994 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.29 146.85 30.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.976 . . . . 0.29 108.736 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.12 128.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.954 . . . . 0.31 109.247 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.8 t -89.13 140.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.198 -1.038 . . . . 0.29 108.198 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.38 179.28 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.919 . . . . 0.23 110.253 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -141.23 112.16 7.2 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.562 -0.903 . . . . 1.81 108.562 178.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.71 -81.08 0.29 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' SER . 32.7 t-20 -80.34 -129.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.783 -1.562 . . . . 1.98 106.783 177.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.6 t -104.19 53.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.245 -1.02 . . . . 1.39 108.245 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.12 129.72 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.02 -0.733 . . . . 1.12 109.02 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.9 mt -92.23 139.28 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.47 109.558 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.12 165.13 28.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 2.11 109.954 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.92 138.55 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.468 -0.77 . . . . 0.33 109.054 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -137.04 133.05 18.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.738 -0.838 . . . . 0.34 108.738 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.38 141.14 89.56 Favored 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 120.836 1.024 . . . . 0.42 110.512 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 3.12 109.448 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.422 ' HG2' ' NH1' ' A' ' 263' ' ' ARG . 0.6 OUTLIER -69.45 -8.18 44.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 3.82 110.526 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.77 20.74 12.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.127 -0.983 . . . . 2.08 109.282 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.9 16.95 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.01 -0.737 . . . . 0.32 109.01 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -139.71 122.59 16.59 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.219 -0.926 . . . . 1.79 108.977 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.82 107.42 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.145 -0.972 . . . . 0.45 109.997 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.04 151.11 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.451 -0.944 . . . . 0.57 108.451 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.343 -0.848 . . . . 3.63 109.726 179.755 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 121.175 0.512 . . . . 1.48 110.199 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -135.5 125.25 25.44 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.435 -0.791 . . . . 0.73 109.067 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -101.37 159.18 15.49 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.181 -1.044 . . . . 3.26 108.181 179.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 59.1 t -142.3 143.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.123 -0.985 . . . . 0.23 110.978 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -108.41 156.77 19.07 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.235 -1.394 . . . . 0.58 107.235 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.7 p90 -157.64 152.9 25.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.595 -1.316 . . . . 0.44 110.649 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -99.54 135.13 41.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.601 -0.687 . . . . 2.76 109.749 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -95.68 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 2.23 109.182 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.2 p -91.13 -10.84 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 1.81 109.492 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' B' ' 232' ' ' ASP . 53.5 mtp180 -84.08 -19.03 35.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 3.64 109.505 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' B' ' 231' ' ' ARG . 43.5 m-20 -159.5 129.03 3.24 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 2.16 109.053 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.28 1.7 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.792 0.995 . . . . 1.27 110.442 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -84.57 136.14 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.868 -1.145 . . . . 1.76 110.258 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -52.31 163.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.215 -0.928 . . . . 0.67 109.311 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mtpt -119.78 166.93 12.61 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.261 -0.899 . . . . 1.44 109.511 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.35 166.55 0.02 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.358 -1.097 . . . . 0.4 110.358 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.6 159.92 38.61 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.523 1.482 . . . . 0.41 110.54 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.45 169.53 17.54 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.922 -0.77 . . . . 0.21 108.922 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -92.32 136.2 33.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.11 -0.994 . . . . 2.72 109.596 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.27 116.79 26.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.644 . . . . 0.3 109.284 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -104.71 -71.74 0.73 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.271 -0.893 . . . . 0.45 109.872 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -94.12 146.98 23.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.179 -0.95 . . . . 0.33 110.415 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.09 121.08 8.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.375 -0.828 . . . . 2.33 108.931 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -108.65 0.3 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.785 -1.198 . . . . 0.28 110.335 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.68 -151.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -1.08 . . . . 1.4 109.761 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.18 47.98 2.7 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.918 -1.673 . . . . 0.29 108.918 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.35 146.88 30.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.491 -1.005 . . . . 0.29 108.745 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.2 128.06 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.31 109.277 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.07 139.96 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.219 -1.03 . . . . 0.3 108.219 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.37 179.27 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.24 110.299 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -141.25 112.21 7.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.468 -0.938 . . . . 1.81 108.468 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.7 -81.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' B' ' 255' ' ' SER . 32.6 t-20 -80.29 -129.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.866 -1.531 . . . . 1.97 106.866 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 8.7 t -104.32 53.27 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.106 -1.072 . . . . 1.38 108.106 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.15 129.8 8.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 1.12 108.982 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 68.1 mt -92.31 139.32 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.26 -0.9 . . . . 0.48 109.519 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.19 165.18 28.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.333 -0.855 . . . . 2.13 109.932 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.92 138.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.427 -0.795 . . . . 0.34 109.065 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.05 132.98 18.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.677 -0.86 . . . . 0.34 108.677 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.24 141.28 88.45 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.776 0.984 . . . . 0.42 110.599 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -59.71 -32.6 70.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 3.11 109.368 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.421 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 0.6 OUTLIER -69.35 -8.31 45.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.36 -0.838 . . . . 3.82 110.56 -179.195 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.65 20.66 12.85 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.225 -0.922 . . . . 2.08 109.274 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.72 17.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.32 109.101 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -139.53 122.57 16.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.228 -0.92 . . . . 1.79 108.981 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.76 107.4 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.252 -0.905 . . . . 0.45 109.977 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.06 151.23 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.39 -0.967 . . . . 0.57 108.39 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -90.69 143.66 26.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 3.62 109.724 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.948 -1.025 . . . . 2.05 109.484 179.655 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.532 -0.544 . . . . 1.48 109.532 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.27 130.41 38.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.72 109.191 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -105.57 156.32 18.35 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.456 -0.942 . . . . 3.26 108.456 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -139.1 142.86 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.361 -0.837 . . . . 0.23 110.098 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -109.22 152.07 25.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.312 -1.366 . . . . 0.58 107.312 178.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.4 p90 -156.03 157.59 36.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.555 -1.341 . . . . 0.44 110.724 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -100.05 140.04 34.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.59 -0.694 . . . . 2.76 109.291 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 232' ' ' ASP . 5.1 p-10 -93.33 176.78 6.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 2.23 109.467 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.6 t -89.02 -11.95 42.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 1.8 109.508 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 20.3 mmm180 -86.88 -11.97 49.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.088 -1.008 . . . . 3.63 109.417 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.5 ' N ' ' OD2' ' A' ' 229' ' ' ASP . 48.0 m-20 -161.95 129.52 2.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 2.16 108.95 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.6 4.83 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.64 0.893 . . . . 1.25 110.024 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.2 t -83.4 154.54 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.013 . . . . 1.75 110.024 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.41 163.6 22.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.66 109.071 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 4.9 mtpp -119.6 165.86 13.91 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.843 -0.799 . . . . 1.43 108.843 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -47.0 171.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.688 -1.365 . . . . 0.39 109.688 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.7 160.88 46.18 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.568 1.512 . . . . 0.41 110.522 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.07 13.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.489 -0.757 . . . . 0.21 109.053 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.49 134.67 34.45 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.165 -0.959 . . . . 2.72 109.344 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.37 124.68 34.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.576 -0.703 . . . . 0.29 109.225 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.83 -72.47 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.469 -0.769 . . . . 0.45 110.496 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.463 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.8 t90 -91.14 142.56 27.61 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.187 -0.946 . . . . 0.31 110.257 -178.481 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.406 ' HG3' HH22 ' A' ' 262' ' ' ARG . 8.1 ttpm? -147.07 121.14 9.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 2.32 109.607 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.65 -103.34 0.21 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.86 -1.162 . . . . 0.27 110.366 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.95 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -1.074 . . . . 1.39 110.111 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.73 47.95 2.56 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.25 -1.54 . . . . 0.29 109.25 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.86 37.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -1.082 . . . . 0.29 109.215 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.01 127.79 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.192 -0.942 . . . . 0.31 109.514 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.18 139.16 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.336 -0.987 . . . . 0.29 108.336 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 257' ' ' ILE . 19.6 pt -141.52 177.3 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.23 110.086 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -143.48 114.06 7.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 1.81 108.818 179.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -90.29 -82.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.316 -1.364 . . . . 1.18 107.316 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -80.28 -130.3 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.667 -1.605 . . . . 1.98 106.667 177.532 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.4 m -104.1 54.72 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.073 -1.084 . . . . 1.39 108.073 178.045 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -156.42 123.79 5.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.779 -0.823 . . . . 1.12 108.779 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' ILE . 11.5 mt -92.88 138.28 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.47 109.702 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.85 168.59 19.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.384 -0.822 . . . . 2.11 109.44 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.71 144.58 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.348 -0.845 . . . . 0.33 109.367 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 94.1 t -138.54 128.63 14.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 0.34 109.118 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.28 144.47 95.82 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 120.531 0.821 . . . . 0.42 110.06 179.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.406 HH22 ' HG3' ' A' ' 244' ' ' LYS . 11.9 tpp180 -60.11 -39.56 86.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 3.12 109.062 179.299 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -65.6 -7.48 15.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 3.82 110.344 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.82 22.44 11.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.233 -0.917 . . . . 2.08 109.307 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.67 169.35 17.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.32 109.529 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -141.28 128.45 20.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 1.79 109.254 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.4 112.85 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.101 -0.999 . . . . 0.45 109.789 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.3 144.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.914 -1.143 . . . . 0.57 107.914 179.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 269' ' ' ARG . 31.1 ptt180 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 3.63 109.282 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.55 -0.537 . . . . 1.48 109.55 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -133.31 130.36 38.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 0.73 109.222 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -105.43 156.44 18.19 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.515 -0.92 . . . . 3.26 108.515 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 87.3 t -139.09 142.9 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.23 110.112 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.26 152.16 25.59 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.339 -1.356 . . . . 0.58 107.339 178.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.6 p90 -156.14 157.51 36.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.609 -1.307 . . . . 0.44 110.726 -178.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -99.91 140.08 34.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 2.76 109.337 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' B' ' 232' ' ' ASP . 5.1 p-10 -93.41 176.78 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 2.23 109.401 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.7 t -88.99 -11.97 42.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 1.81 109.509 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 20.3 mmm180 -86.71 -12.1 49.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.143 -0.973 . . . . 3.64 109.462 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.501 ' N ' ' OD2' ' B' ' 229' ' ' ASP . 47.8 m-20 -161.92 129.57 2.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.171 -0.956 . . . . 2.16 108.887 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.59 4.8 1.53 Allowed 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 120.755 0.97 . . . . 1.27 109.959 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 7.3 t -83.44 154.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 1.76 110.031 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -68.32 163.62 22.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.67 109.085 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' B' ' 237' ' ' GLY . 4.9 mtpp -119.7 165.91 13.89 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -47.07 171.01 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.728 -1.349 . . . . 0.4 109.728 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.69 160.91 46.06 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.56 1.507 . . . . 0.41 110.486 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.68 172.02 13.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.553 -0.717 . . . . 0.21 109.084 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.43 134.65 34.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.973 . . . . 2.72 109.341 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.39 124.69 34.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.544 -0.722 . . . . 0.3 109.173 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.77 -72.52 0.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.41 -0.806 . . . . 0.45 110.609 -179.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.415 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.09 142.52 27.67 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.124 -0.985 . . . . 0.33 110.254 -178.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 244' ' ' LYS . . . . . 0.404 ' HG3' HH22 ' B' ' 262' ' ' ARG . 8.1 ttpm? -147.08 121.14 9.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.206 -0.934 . . . . 2.33 109.564 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.62 -103.29 0.21 Allowed Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.844 -1.17 . . . . 0.28 110.337 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -71.04 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.347 -1.09 . . . . 1.4 110.139 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.74 47.94 2.56 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.197 -1.561 . . . . 0.29 109.197 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.91 151.81 37.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.29 109.259 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.92 127.89 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.31 109.525 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.21 139.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.325 -0.991 . . . . 0.3 108.325 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 257' ' ' ILE . 19.7 pt -141.61 177.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.898 . . . . 0.24 110.138 -179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -143.56 114.06 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.817 -0.808 . . . . 1.81 108.817 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -90.29 -82.34 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.331 -1.359 . . . . 1.18 107.331 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -80.23 -130.21 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.716 -1.587 . . . . 1.97 106.716 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 64.8 m -104.24 54.71 0.73 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.983 -1.118 . . . . 1.38 107.983 178.106 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -156.45 123.81 5.39 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.829 -0.804 . . . . 1.12 108.829 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.463 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.4 mt -92.92 138.3 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.48 109.756 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.78 168.64 19.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 2.13 109.412 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.72 144.58 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 0.34 109.395 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.56 128.55 14.87 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.34 109.14 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.21 144.54 95.37 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 110.012 -0.803 . . . . 0.42 110.012 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' B' ' 244' ' ' LYS . 11.9 tpp180 -60.1 -39.7 87.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 3.11 108.956 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -65.47 -7.51 14.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 3.82 110.512 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.88 22.52 11.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.247 -0.908 . . . . 2.08 109.259 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.7 169.41 17.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.503 -0.748 . . . . 0.32 109.441 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -141.32 128.46 20.87 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.27 -0.894 . . . . 1.79 109.24 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.35 112.97 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.188 -0.945 . . . . 0.45 109.782 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.35 144.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 107.897 -1.149 . . . . 0.57 107.897 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -91.02 142.57 27.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 3.62 109.205 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.993 -1.003 . . . . 2.05 109.575 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 32.5 m120 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 1.48 109.819 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -136.37 131.6 34.46 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.015 -0.735 . . . . 0.72 109.015 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -105.21 158.09 16.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.353 -0.842 . . . . 3.26 109.014 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.5 t -139.05 140.76 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.23 109.877 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -107.51 156.33 19.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.508 -1.293 . . . . 0.58 107.508 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.79 151.63 25.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.704 -1.247 . . . . 0.44 110.729 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -98.22 148.5 23.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.738 . . . . 2.76 109.483 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 231' ' ' ARG . 25.0 t0 -94.89 -175.56 3.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.959 -0.756 . . . . 2.23 108.959 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.426 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 5.5 t -98.67 -14.77 19.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -0.956 . . . . 1.8 109.982 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 229' ' ' ASP . 15.3 mtm-85 -89.72 -11.75 41.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 3.63 109.981 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 231' ' ' ARG . 54.4 m-20 -161.01 129.02 2.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.928 -1.107 . . . . 2.16 109.478 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.57 6.84 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.731 0.954 . . . . 1.25 110.32 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.3 m -80.08 128.24 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.787 -1.195 . . . . 1.75 109.891 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.36 165.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.66 109.532 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 237' ' ' GLY . 28.6 mttm -118.41 166.41 12.7 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.633 -0.877 . . . . 1.43 108.633 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.73 177.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.932 -1.267 . . . . 0.39 109.932 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.86 160.28 48.25 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.663 1.575 . . . . 0.41 110.477 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.95 12.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.667 -0.864 . . . . 0.21 108.667 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.18 139.43 31.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.073 -1.017 . . . . 2.72 109.44 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.9 120.26 30.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 0.29 109.926 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.29 -72.91 0.68 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.427 -0.795 . . . . 0.45 110.231 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.204 -0.935 . . . . 0.31 110.129 -178.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.47 112.7 5.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.258 -0.901 . . . . 2.32 109.13 179.326 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -102.63 0.2 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.51 -1.328 . . . . 0.27 110.658 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.52 -159.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -1.081 . . . . 1.39 110.188 -179.052 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.99 44.86 1.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.028 -1.629 . . . . 0.29 109.028 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.3 152.51 37.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.445 -1.033 . . . . 0.29 108.975 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.62 126.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.31 109.325 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.38 137.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.971 -1.122 . . . . 0.29 107.971 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 260' ' ' VAL . 26.6 pt -140.17 -177.94 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.23 110.076 -179.013 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -143.94 109.07 5.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.401 -0.963 . . . . 1.81 108.401 178.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.81 -76.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.377 -1.342 . . . . 1.18 107.377 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -79.93 -134.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.697 -1.594 . . . . 1.98 106.697 177.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 15.3 p -103.9 54.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.981 -1.118 . . . . 1.39 107.981 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 65.0 m-20 -157.1 130.9 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.887 -0.783 . . . . 1.12 108.887 -179.308 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.45 135.1 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.47 109.847 -179.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -137.45 176.67 8.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.445 -0.784 . . . . 2.11 109.922 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.31 137.9 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.663 -0.648 . . . . 0.33 109.602 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 251' ' ' ILE . 25.9 t -135.43 131.56 19.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.378 -0.826 . . . . 0.34 108.986 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.24 144.29 95.9 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 120.621 0.881 . . . . 0.42 109.946 179.044 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.46 -34.04 74.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 3.12 109.55 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 263' ' ' ARG . 35.4 mtm-85 -70.4 -5.68 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 3.82 110.846 -178.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -119.36 21.3 12.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.386 -0.821 . . . . 2.08 108.866 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.41 24.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.602 -0.686 . . . . 0.32 109.273 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.465 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.8 mtmp? -141.7 129.61 21.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 1.79 109.135 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.86 117.36 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.951 . . . . 0.45 109.978 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.86 150.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 108.795 -0.817 . . . . 0.57 108.795 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.404 -0.81 . . . . 3.63 108.856 179.278 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 32.8 m120 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.128 0.489 . . . . 1.48 109.905 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.14 131.49 34.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.572 -0.705 . . . . 0.73 109.126 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -105.15 158.01 16.88 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.334 -0.854 . . . . 3.26 109.011 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.95 140.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 0.23 109.977 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -107.56 156.53 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.469 -1.308 . . . . 0.58 107.469 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.4 p90 -156.9 151.63 25.74 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.584 -1.323 . . . . 0.44 110.67 -178.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -98.32 148.57 23.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.41 -0.806 . . . . 2.76 109.466 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.485 ' OD2' ' NH1' ' B' ' 231' ' ' ARG . 25.1 t0 -94.86 -175.46 3.57 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.345 -0.847 . . . . 2.23 108.902 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 230' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 5.4 t -98.7 -14.72 19.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.238 -0.914 . . . . 1.81 109.933 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.485 ' NH1' ' OD2' ' B' ' 229' ' ' ASP . 15.1 mtm-85 -89.96 -11.77 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 3.64 109.934 -179.409 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 231' ' ' ARG . 54.1 m-20 -160.97 128.9 2.81 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.14 -0.975 . . . . 2.16 109.494 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.4 6.83 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 120.705 0.937 . . . . 1.27 110.3 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.466 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.3 m -80.04 128.22 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 1.76 109.99 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.3 165.08 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.67 109.546 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' B' ' 237' ' ' GLY . 28.7 mttm -118.44 166.34 12.79 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.711 -0.848 . . . . 1.44 108.711 179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.72 177.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.978 -1.249 . . . . 0.4 109.978 -179.343 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -71.93 160.39 47.84 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.653 1.569 . . . . 0.41 110.506 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.1 173.09 11.99 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.723 -0.843 . . . . 0.21 108.723 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -95.35 139.2 31.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.996 -1.065 . . . . 2.72 109.464 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.81 120.16 30.82 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 0.3 109.855 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.23 -72.83 0.68 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.37 -0.831 . . . . 0.45 110.312 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.78 140.08 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.223 -0.923 . . . . 0.33 110.006 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -146.58 112.68 5.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.224 -0.923 . . . . 2.33 108.986 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.4 -102.47 0.2 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.496 -1.335 . . . . 0.28 110.644 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.65 -159.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.358 -1.083 . . . . 1.4 110.186 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.11 44.88 1.92 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.957 -1.657 . . . . 0.29 108.957 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 152.63 37.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.46 -1.023 . . . . 0.29 108.944 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.67 126.8 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.31 109.442 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.37 137.53 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.941 -1.133 . . . . 0.3 107.941 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 260' ' ' VAL . 26.2 pt -140.26 -178.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.24 110.119 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -143.76 109.27 5.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.394 -0.965 . . . . 1.81 108.394 178.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.97 -76.27 0.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.337 -1.357 . . . . 1.18 107.337 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.87 -134.8 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.763 -1.569 . . . . 1.97 106.763 177.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.406 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 15.4 p -103.93 54.41 0.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.897 -1.149 . . . . 1.38 107.897 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 256' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.6 m-20 -156.98 131.0 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.46 135.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.194 -0.941 . . . . 0.48 109.805 -179.365 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -137.52 176.68 8.49 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.435 -0.79 . . . . 2.13 109.891 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.32 137.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 0.34 109.553 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 260' ' ' VAL . . . . . 0.41 HG21 HD11 ' B' ' 251' ' ' ILE . 25.9 t -135.59 131.5 19.32 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.341 -0.849 . . . . 0.34 108.955 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.13 144.41 95.18 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.571 0.847 . . . . 0.42 109.913 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -61.43 -34.16 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 3.11 109.628 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' B' ' 263' ' ' ARG . 35.2 mtm-85 -70.47 -5.32 27.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 3.82 110.866 -178.562 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -119.71 21.13 12.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.355 -0.84 . . . . 2.08 108.799 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.77 166.49 24.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.653 . . . . 0.32 109.244 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.461 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.8 mtmp? -141.77 129.68 21.85 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.329 -0.857 . . . . 1.79 109.12 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.94 117.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.289 -0.882 . . . . 0.45 109.892 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.8 mm -117.14 150.71 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.48 146.2 23.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.734 -0.839 . . . . 3.62 108.734 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 120.975 -1.078 . . . . 2.05 109.377 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 108.914 -0.772 . . . . 1.48 108.914 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -112.83 141.49 46.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.526 -0.734 . . . . 0.72 109.712 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -112.41 159.2 18.95 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.899 -1.148 . . . . 3.26 107.899 178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.03 142.29 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.187 -0.946 . . . . 0.23 110.154 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.26 154.46 23.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.517 -1.29 . . . . 0.58 107.517 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.6 p90 -155.74 154.8 32.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.8 -1.188 . . . . 0.44 110.199 -178.715 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.3 mtm-85 -91.98 153.39 19.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 2.76 109.364 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -95.35 169.66 9.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.319 -0.863 . . . . 2.23 109.484 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 37.1 t -87.93 -8.89 55.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -0.898 . . . . 1.8 109.381 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.66 32.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.313 -0.867 . . . . 3.63 109.636 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.0 m-20 -162.11 133.97 4.05 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.598 -0.89 . . . . 2.16 108.598 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.56 12.07 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.028 1.152 . . . . 1.25 111.125 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 235' ' ' TRP . 9.1 p -83.02 163.03 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.737 -1.227 . . . . 1.75 110.108 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.561 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.6 m95 -74.52 174.12 9.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.66 108.805 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.64 -164.91 1.46 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.311 -0.868 . . . . 1.43 108.81 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.89 52.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.706 -1.358 . . . . 0.39 109.706 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.26 159.89 48.49 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.694 1.596 . . . . 0.41 109.896 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.37 11.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.775 . . . . 0.21 109.19 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -95.29 136.35 35.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.186 -0.946 . . . . 2.72 109.45 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.46 121.49 29.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.662 . . . . 0.29 109.339 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.71 -68.94 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.412 -0.805 . . . . 0.45 110.039 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -94.19 146.96 23.63 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.18 -0.95 . . . . 0.31 109.697 -178.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -148.92 115.81 6.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.199 -0.938 . . . . 2.32 109.076 179.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.44 0.32 Allowed Glycine 0 N--CA 1.498 2.811 0 C-N-CA 119.611 -1.28 . . . . 0.27 110.722 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.38 -155.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 1.39 109.489 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 50.38 2.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.007 -1.637 . . . . 0.29 109.007 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.02 151.74 35.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.29 108.57 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -145.0 132.43 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 0.31 109.796 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.01 134.89 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.67 -1.233 . . . . 0.29 107.67 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.41 177.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 0.23 110.216 -178.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -141.75 109.65 5.79 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.891 -1.151 . . . . 1.81 107.891 178.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.28 -79.58 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.389 -1.338 . . . . 1.18 107.389 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 255' ' ' SER . 26.9 t-20 -80.78 -129.51 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.516 -1.661 . . . . 1.98 106.516 177.614 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.431 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 36.4 p -104.59 54.04 0.73 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.39 108.04 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -156.44 126.66 6.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.753 . . . . 1.12 109.195 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.3 135.06 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.47 109.444 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.73 169.07 18.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.392 -0.818 . . . . 2.11 109.879 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.71 139.2 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.549 -0.719 . . . . 0.33 109.256 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 27.6 t -133.49 130.87 21.14 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.34 108.882 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.87 141.98 96.27 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.59 0.86 . . . . 0.42 110.192 179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.99 -36.03 67.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 3.12 109.008 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -65.7 -9.63 29.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 3.82 110.369 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -119.91 18.65 12.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.202 -0.936 . . . . 2.08 109.506 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.52 163.76 31.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.384 -0.823 . . . . 0.32 110.064 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.451 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.0 mtmp? -143.17 132.14 22.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.335 -0.853 . . . . 1.79 109.624 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.2 mm -89.06 113.58 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.295 -0.878 . . . . 0.45 109.811 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.1 mm -107.11 158.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.356 -0.84 . . . . 0.57 108.924 179.193 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.229 -0.919 . . . . 3.63 109.145 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 108.923 -0.769 . . . . 1.48 108.923 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -112.74 141.5 46.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.481 -0.762 . . . . 0.73 109.684 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -112.43 159.09 19.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 107.849 -1.167 . . . . 3.26 107.849 178.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 96.0 t -139.96 142.32 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.172 -0.955 . . . . 0.23 110.13 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.32 154.43 23.5 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.512 -1.292 . . . . 0.58 107.512 178.54 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.7 p90 -155.79 154.8 31.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.779 -1.201 . . . . 0.44 110.228 -178.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.478 ' HG3' HH11 ' B' ' 228' ' ' ARG . 2.3 mtm-85 -91.94 153.37 19.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 2.76 109.434 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.33 169.65 9.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 2.23 109.44 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 37.5 t -87.83 -8.98 55.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.933 . . . . 1.81 109.4 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.57 32.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 3.64 109.641 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.1 m-20 -162.23 133.95 3.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.16 108.596 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -64.55 12.06 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.006 1.137 . . . . 1.27 111.111 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 9.0 p -83.01 163.05 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.777 -1.202 . . . . 1.76 110.101 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.6 m95 -74.52 174.11 9.44 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.792 -0.818 . . . . 0.67 108.792 179.4 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.72 -165.07 1.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.238 -0.914 . . . . 1.44 108.804 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.4 175.81 52.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.28 159.82 48.62 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.688 1.592 . . . . 0.41 109.892 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.26 173.5 11.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.447 -0.783 . . . . 0.21 109.175 179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -95.41 136.36 35.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 2.72 109.385 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.44 121.41 29.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.589 -0.694 . . . . 0.3 109.31 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.69 -68.97 0.89 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.458 -0.776 . . . . 0.45 110.085 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -94.14 146.89 23.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.029 -1.045 . . . . 0.33 109.778 -179.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -148.92 115.76 5.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.132 -0.98 . . . . 2.33 109.131 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.53 0.32 Allowed Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.543 -1.313 . . . . 0.28 110.74 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.29 -155.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 1.4 109.573 -179.158 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 50.47 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.939 -1.664 . . . . 0.29 108.939 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.06 151.85 35.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.577 -0.955 . . . . 0.29 108.544 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.12 132.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.112 -0.992 . . . . 0.31 109.747 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.1 134.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.3 107.754 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.24 177.94 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.24 110.27 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -141.83 109.7 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.904 -1.147 . . . . 1.81 107.904 178.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -88.39 -79.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.382 -1.34 . . . . 1.18 107.382 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 254' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 255' ' ' SER . 26.8 t-20 -80.6 -129.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.614 -1.624 . . . . 1.97 106.614 177.518 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.432 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 36.5 p -104.52 54.08 0.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.116 -1.068 . . . . 1.38 108.116 177.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -156.42 126.59 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.462 -0.774 . . . . 1.12 109.166 -179.396 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 36.4 mt -93.21 135.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.48 109.394 -179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.78 169.07 18.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 2.13 109.832 -179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 t -101.62 139.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.537 -0.727 . . . . 0.34 109.219 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.4 t -133.33 130.9 21.32 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.34 108.954 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.92 141.89 95.94 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.592 0.861 . . . . 0.42 110.203 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.83 -36.2 67.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 3.11 108.948 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -65.6 -9.6 28.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.995 . . . . 3.82 110.461 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.98 18.67 12.44 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.191 -0.943 . . . . 2.08 109.484 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.82 31.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.32 110.075 -179.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.445 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 7.0 mtmp? -143.2 132.11 22.82 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.326 -0.859 . . . . 1.79 109.637 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.1 mm -89.09 113.59 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.331 -0.856 . . . . 0.45 109.833 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.0 mm -107.11 158.33 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.46 -0.775 . . . . 0.57 108.93 179.235 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -90.62 142.68 27.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.197 -0.94 . . . . 3.62 109.108 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' B' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.013 -0.994 . . . . 2.05 109.412 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.427 -0.582 . . . . 1.48 109.427 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.77 126.47 27.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.365 -0.834 . . . . 0.72 108.845 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.1 OUTLIER -102.95 156.96 17.31 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.15 -0.968 . . . . 3.26 108.416 179.465 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.19 141.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.19 -0.943 . . . . 0.23 110.491 -179.315 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.41 156.41 18.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.621 -1.251 . . . . 0.58 107.621 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.7 p90 -155.02 151.56 28.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.686 -1.259 . . . . 0.44 110.809 -179.302 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -99.11 141.47 31.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.613 -0.679 . . . . 2.76 109.347 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 16.8 p30 -95.62 175.11 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 2.23 109.009 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.0 t -85.69 -6.24 59.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.8 109.19 179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -88.84 -18.34 27.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.302 -0.874 . . . . 3.63 109.688 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 234' ' ' VAL . 31.5 m-20 -161.95 129.1 2.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.978 . . . . 2.16 109.267 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.36 8.55 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 120.653 0.902 . . . . 1.25 110.252 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.2 t -83.58 158.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.877 -1.14 . . . . 1.75 109.827 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.401 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.5 m95 -74.72 159.9 31.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.66 109.327 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.1 mtpt -118.55 165.12 14.32 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.532 -0.914 . . . . 1.43 108.532 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.89 164.95 0.02 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.499 -1.04 . . . . 0.39 110.499 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.88 161.84 42.3 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.728 1.619 . . . . 0.41 110.302 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.82 178.39 7.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.456 -0.778 . . . . 0.21 109.067 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.75 138.76 33.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.221 -0.924 . . . . 2.72 108.923 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.07 123.49 32.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.548 -0.72 . . . . 0.29 109.751 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.3 mt -112.44 -76.13 0.6 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.444 -0.785 . . . . 0.45 110.289 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -89.17 143.84 26.55 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.156 -0.965 . . . . 0.31 110.29 -178.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.57 118.5 8.76 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.77 -0.826 . . . . 2.32 108.77 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -113.11 0.45 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.749 -1.215 . . . . 0.27 110.195 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.53 -154.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -1.057 . . . . 1.39 109.573 -179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.43 51.03 3.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.434 -1.466 . . . . 0.29 109.434 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 153.01 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.29 108.641 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.95 131.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.001 -1.062 . . . . 0.31 109.952 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.39 138.25 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.29 108.536 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 22.1 pt -140.37 178.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.874 . . . . 0.23 110.05 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -141.1 110.11 6.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.495 -0.928 . . . . 1.81 108.495 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.72 -79.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.402 -1.332 . . . . 1.18 107.402 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.21 -131.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.492 -1.669 . . . . 1.98 106.492 177.385 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.61 54.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.25 124.91 5.9 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.925 -0.769 . . . . 1.12 108.925 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.423 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 60.6 mt -90.92 136.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 0.47 109.624 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.26 172.67 12.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.285 -0.885 . . . . 2.11 109.911 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.15 136.96 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.502 -0.749 . . . . 0.33 109.688 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.93 123.34 18.04 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 108.426 -0.953 . . . . 0.34 108.426 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.23 139.12 85.45 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 109.854 -0.864 . . . . 0.42 109.854 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.6 -33.35 66.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.157 -0.964 . . . . 3.12 109.433 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -68.24 -6.07 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 3.82 109.95 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.15 17.67 11.59 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.485 -0.759 . . . . 2.08 109.429 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.71 168.31 20.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.467 -0.771 . . . . 0.32 109.263 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -141.44 131.69 24.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.28 -0.888 . . . . 1.79 109.197 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.2 mm -88.02 110.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.325 -0.859 . . . . 0.45 109.369 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.49 156.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.337 -0.852 . . . . 0.57 109.219 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.448 -0.783 . . . . 3.63 109.736 -179.674 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.367 -0.605 . . . . 1.48 109.367 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.72 126.37 27.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.73 108.909 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.1 OUTLIER -102.86 157.0 17.27 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.144 -0.973 . . . . 3.26 108.454 179.431 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.22 141.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.159 -0.963 . . . . 0.23 110.526 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.34 156.35 19.0 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.648 -1.241 . . . . 0.58 107.648 178.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -154.99 151.5 28.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.601 -1.312 . . . . 0.44 110.837 -179.353 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -98.95 141.3 31.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 2.76 109.426 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 17.0 p30 -95.5 175.19 6.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 2.23 109.008 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 35.9 t -85.68 -6.36 59.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 1.81 109.261 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -88.75 -18.34 28.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.233 -0.917 . . . . 3.64 109.711 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 31.6 m-20 -161.98 129.11 2.59 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 2.16 109.294 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -66.4 8.58 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.659 0.906 . . . . 1.27 110.211 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.3 t -83.54 158.12 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.806 -1.184 . . . . 1.76 109.844 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.402 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.5 m95 -74.85 159.83 31.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.67 109.352 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.2 mtpt -118.47 165.18 14.21 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.544 -0.91 . . . . 1.44 108.544 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.88 164.92 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.516 -1.033 . . . . 0.4 110.516 -179.064 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.92 161.88 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.639 1.559 . . . . 0.41 110.302 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 178.38 7.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.533 -0.729 . . . . 0.21 109.156 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.86 138.75 33.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.276 -0.89 . . . . 2.72 108.946 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -88.14 123.52 32.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.489 -0.757 . . . . 0.3 109.678 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 31.0 mt -112.42 -76.13 0.6 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.356 -0.84 . . . . 0.45 110.281 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.423 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -89.2 143.64 26.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.186 -0.946 . . . . 0.33 110.308 -178.739 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.51 118.47 8.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.794 -0.817 . . . . 2.33 108.794 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.23 -113.13 0.45 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.838 -1.172 . . . . 0.28 110.209 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.55 -154.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.416 -1.049 . . . . 1.4 109.545 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 51.12 3.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.29 109.483 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.07 38.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -1.098 . . . . 0.29 108.663 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 7.9 m -146.97 131.81 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.31 109.973 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 94.4 t -93.41 138.19 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.537 -0.912 . . . . 0.3 108.537 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 22.3 pt -140.31 178.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.176 -0.953 . . . . 0.24 110.111 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -141.09 110.1 6.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.459 -0.941 . . . . 1.81 108.459 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.75 -79.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.392 -1.336 . . . . 1.18 107.392 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.29 -131.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.432 -1.692 . . . . 1.97 106.432 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -104.58 54.72 0.72 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.182 -1.044 . . . . 1.38 108.182 177.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.22 124.97 5.94 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.06 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.48 109.571 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.19 172.58 12.7 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.346 -0.846 . . . . 2.13 109.96 -179.434 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.02 136.93 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.443 -0.786 . . . . 0.34 109.737 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.97 123.34 18.0 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.424 -0.954 . . . . 0.34 108.424 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.27 139.17 85.72 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.852 -0.865 . . . . 0.42 109.852 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.69 -33.14 66.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.9 . . . . 3.11 109.521 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.38 -6.04 22.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 3.82 109.996 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.12 17.8 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.465 -0.772 . . . . 2.08 109.463 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.85 168.41 19.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.32 109.227 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -141.47 131.61 24.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.896 . . . . 1.79 109.232 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.3 mm -88.08 110.5 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 0.45 109.299 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 29.3 mm -102.48 156.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.344 -0.848 . . . . 0.57 109.143 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.43 137.45 33.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 3.62 109.724 -179.709 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.003 -0.998 . . . . 2.05 109.317 179.469 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.223 0.535 . . . . 1.48 109.716 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -134.14 145.64 49.47 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.428 -0.795 . . . . 0.72 109.767 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -118.95 152.9 35.5 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.567 -1.271 . . . . 3.26 107.567 178.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.6 t -139.25 142.0 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.121 -0.987 . . . . 0.23 110.431 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -108.39 158.34 17.59 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.684 -1.228 . . . . 0.58 107.684 178.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 15.8 p90 -156.64 152.38 27.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.722 -1.236 . . . . 0.44 110.509 -178.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -93.46 154.13 18.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.389 -0.819 . . . . 2.76 109.59 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.73 170.14 9.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.349 -0.844 . . . . 2.23 109.183 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.0 t -89.66 -13.45 37.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.89 . . . . 1.8 109.46 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 58.9 mtp180 -88.21 -14.6 38.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.16 -0.963 . . . . 3.63 109.373 179.746 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 234' ' ' VAL . 50.1 m-20 -162.22 130.04 2.76 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 2.16 108.718 179.747 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.57 19.37 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 120.759 0.973 . . . . 1.25 110.794 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.7 p -84.47 158.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.778 -1.201 . . . . 1.75 110.197 -179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.518 ' N ' HG22 ' A' ' 234' ' ' VAL . 96.8 m95 -76.66 165.9 24.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.709 -0.62 . . . . 0.66 109.937 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.72 -166.94 1.29 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.61 -0.885 . . . . 1.43 108.61 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.14 52.22 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.703 -1.359 . . . . 0.39 109.703 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.64 149.56 61.46 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.671 1.58 . . . . 0.41 109.862 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.63 169.21 17.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.87 -0.789 . . . . 0.21 108.87 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -92.75 138.73 31.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.088 -1.007 . . . . 2.72 109.502 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.8 tp -87.84 118.82 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.677 -0.64 . . . . 0.29 109.38 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.01 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.358 -0.839 . . . . 0.45 110.154 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.9 146.62 23.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.324 -0.86 . . . . 0.31 110.714 -178.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -150.29 117.01 5.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.452 -0.78 . . . . 2.32 109.14 179.127 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.87 -104.72 0.26 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.949 -1.261 . . . . 0.27 109.949 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -67.05 -155.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -1.112 . . . . 1.39 109.632 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.88 49.38 2.83 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.94 152.2 38.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -1.091 . . . . 0.29 108.542 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.0 m -144.21 132.67 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.31 109.677 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.05 133.81 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.812 -1.181 . . . . 0.29 107.812 178.79 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.14 -177.87 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.23 110.384 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -142.35 112.17 6.84 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.345 -0.983 . . . . 1.81 108.345 178.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.5 -84.55 0.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.596 -1.261 . . . . 1.18 107.596 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -78.16 -127.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.486 -1.672 . . . . 1.98 106.486 177.488 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.7 p -105.05 52.98 0.73 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.135 -0.978 . . . . 1.39 108.659 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -155.45 131.03 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 1.12 109.276 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.06 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.47 109.486 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.04 165.26 26.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.377 -0.827 . . . . 2.11 109.75 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.44 136.77 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.489 -0.757 . . . . 0.33 108.978 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 26.7 t -134.36 132.08 20.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.435 -0.791 . . . . 0.34 108.892 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.25 148.65 85.13 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.641 0.894 . . . . 0.42 109.931 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.848 . . . . 3.12 109.075 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.29 -8.62 47.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -0.791 . . . . 3.82 110.249 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -119.24 19.17 12.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.428 -0.795 . . . . 2.08 108.94 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.54 164.01 31.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.32 109.463 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.5 mtmp? -140.41 130.95 25.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.329 -0.857 . . . . 1.79 109.44 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.02 111.54 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.366 -0.834 . . . . 0.45 110.101 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.0 mm -109.0 157.46 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.486 -0.759 . . . . 0.57 108.975 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 268' ' ' ILE . 83.8 mtm180 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.845 . . . . 3.63 109.155 179.327 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.617 -0.512 . . . . 1.48 109.617 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -134.12 145.44 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.447 -0.783 . . . . 0.73 109.791 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.484 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 11.0 mtp180 -118.82 152.97 35.26 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.481 -1.303 . . . . 3.26 107.481 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.1 t -139.14 142.21 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.167 -0.958 . . . . 0.23 110.469 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -108.56 158.29 17.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.651 -1.24 . . . . 0.58 107.651 178.702 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.5 p90 -156.63 152.38 27.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.698 -1.251 . . . . 0.44 110.545 -178.687 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -93.33 153.91 18.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.243 -0.911 . . . . 2.76 109.608 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.63 170.13 9.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.25 -0.906 . . . . 2.23 109.154 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 26.8 t -89.69 -13.37 37.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 1.81 109.507 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 58.8 mtp180 -88.32 -14.5 38.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.138 -0.976 . . . . 3.64 109.319 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' B' ' 234' ' ' VAL . 50.6 m-20 -162.29 129.98 2.72 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 2.16 108.771 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.62 19.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 120.804 1.003 . . . . 1.27 110.697 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -84.35 158.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.869 -1.144 . . . . 1.76 110.243 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.523 ' N ' HG22 ' B' ' 234' ' ' VAL . 96.8 m95 -76.65 166.18 23.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 0.67 109.983 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.79 -166.98 1.3 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 1.44 108.689 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.07 52.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.713 -1.355 . . . . 0.4 109.713 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.69 149.52 61.11 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.762 1.641 . . . . 0.41 109.884 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.74 169.06 18.15 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.963 -0.754 . . . . 0.21 108.963 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.58 138.55 31.41 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.987 . . . . 2.72 109.52 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.75 118.96 27.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.724 -0.61 . . . . 0.3 109.414 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.25 -73.9 0.67 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.388 -0.82 . . . . 0.45 110.103 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -92.91 146.47 23.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.323 -0.861 . . . . 0.33 110.661 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -150.1 117.03 5.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.444 -0.785 . . . . 2.33 109.164 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.89 -104.69 0.26 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.948 -1.261 . . . . 0.28 109.948 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.03 -155.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -1.116 . . . . 1.4 109.612 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.94 49.42 2.86 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.276 -1.529 . . . . 0.29 109.276 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.42 38.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.389 -1.065 . . . . 0.29 108.494 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 m -144.46 132.68 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.023 . . . . 0.31 109.648 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.12 133.76 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.843 -1.169 . . . . 0.3 107.843 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.6 pt -138.13 -177.72 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.24 110.292 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -142.48 112.2 6.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.334 -0.987 . . . . 1.81 108.334 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -89.59 -84.54 0.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.552 -1.277 . . . . 1.18 107.552 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.12 -128.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.489 -1.671 . . . . 1.97 106.489 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 9.6 p -105.1 53.02 0.73 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.145 -0.972 . . . . 1.38 108.586 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -155.32 131.06 9.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.491 -0.756 . . . . 1.12 109.276 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.05 135.98 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.142 -0.974 . . . . 0.48 109.413 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -137.06 165.4 26.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.362 -0.836 . . . . 2.13 109.67 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.68 137.05 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.045 -0.724 . . . . 0.34 109.045 179.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.6 132.1 20.59 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.346 -0.846 . . . . 0.34 108.935 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.26 148.72 84.87 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 N-CA-C 109.911 -0.842 . . . . 0.42 109.911 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.84 73.39 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.282 -0.886 . . . . 3.11 108.997 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.33 -8.48 46.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 3.82 110.235 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -119.31 19.18 12.85 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.448 -0.782 . . . . 2.08 108.986 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.91 31.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.564 -0.71 . . . . 0.32 109.447 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 7.5 mtmp? -140.4 130.97 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.258 -0.901 . . . . 1.79 109.479 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.04 111.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.362 -0.836 . . . . 0.45 110.102 -179.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.418 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.1 mm -108.99 157.48 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.985 -0.746 . . . . 0.57 108.985 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.418 ' N ' HG22 ' B' ' 268' ' ' ILE . 83.8 mtm180 -91.43 140.69 29.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 3.62 109.159 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 2.05 109.064 179.495 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.261 0.553 . . . . 1.48 109.756 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.34 143.09 50.56 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.591 -0.693 . . . . 0.72 109.594 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -108.08 157.79 17.96 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.456 -1.313 . . . . 3.26 107.456 178.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.47 141.39 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.785 -1.197 . . . . 0.23 110.954 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.39 155.86 20.73 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.674 -1.602 . . . . 0.58 106.674 177.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -154.11 166.94 31.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.462 -1.399 . . . . 0.44 110.654 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -90.62 137.53 32.29 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.322 0.582 . . . . 2.76 109.453 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -94.39 160.97 14.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.545 -0.722 . . . . 2.23 109.432 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.9 m -86.81 -6.51 58.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 1.8 109.575 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -88.26 -20.36 25.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 3.63 109.628 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.4 m-20 -162.19 140.29 6.73 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 2.16 108.7 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.57 2.82 1.05 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.869 1.046 . . . . 1.25 110.378 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 235' ' ' TRP . 7.3 m -84.56 141.74 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.853 -1.155 . . . . 1.75 110.141 -179.514 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CZ2' ' NH1' ' A' ' 228' ' ' ARG . 97.2 m95 -52.32 -177.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.345 -0.847 . . . . 0.66 109.19 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.444 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 1.9 ttpp -131.77 -156.64 0.77 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.272 -0.893 . . . . 1.43 109.11 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.28 -178.6 52.46 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.59 -1.404 . . . . 0.39 109.59 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.64 159.84 47.83 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.571 1.514 . . . . 0.41 110.19 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.07 18.27 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.92 -0.77 . . . . 0.21 108.92 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -93.24 139.24 30.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.12 -0.987 . . . . 2.72 109.223 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.27 117.31 28.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.419 -0.801 . . . . 0.29 109.631 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.0 -73.61 0.68 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.291 -0.88 . . . . 0.45 110.005 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -90.77 141.56 28.68 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.31 110.531 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.73 113.95 5.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 2.32 109.361 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.01 -107.98 0.29 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.89 -1.284 . . . . 0.27 109.89 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -60.05 -158.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 1.39 109.833 -179.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.85 46.88 2.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.703 -1.359 . . . . 0.29 109.703 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.23 148.39 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -1.106 . . . . 0.29 108.867 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.0 m -142.19 129.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.912 . . . . 0.31 109.744 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.25 137.72 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.203 -1.036 . . . . 0.29 108.203 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -140.27 -179.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.192 -0.943 . . . . 0.23 110.452 -179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -144.19 110.29 5.42 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.81 -0.811 . . . . 1.81 108.81 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.42 -78.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.378 -1.342 . . . . 1.18 107.378 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -80.04 -134.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.445 -1.687 . . . . 1.98 106.445 177.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.9 p -102.15 54.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.48 126.43 7.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.705 . . . . 1.12 109.337 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.1 mt -92.61 137.84 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.339 -0.85 . . . . 0.47 109.61 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -140.73 170.63 15.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 2.11 109.643 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.42 139.77 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.33 109.605 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.19 130.22 19.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.76 141.47 95.68 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 N-CA-C 109.644 -0.945 . . . . 0.42 109.644 179.055 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.93 -34.7 73.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 3.12 109.727 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.01 -6.44 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 3.82 110.655 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.53 24.0 10.55 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.16 -0.962 . . . . 2.08 109.204 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.19 164.54 28.94 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.085 -0.709 . . . . 0.32 109.085 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -137.77 131.68 31.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.247 -0.908 . . . . 1.79 108.87 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.09 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 0.45 109.828 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.98 157.2 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.378 -0.827 . . . . 0.57 108.964 179.274 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.1 mtt-85 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.158 -0.963 . . . . 3.63 109.198 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.288 0.566 . . . . 1.48 109.705 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -130.54 142.94 50.47 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.694 -0.629 . . . . 0.73 109.48 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 49.9 mtt180 -108.1 157.76 17.99 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.401 -1.333 . . . . 3.26 107.401 178.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.51 141.17 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.952 -1.092 . . . . 0.23 110.979 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.16 155.8 20.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.907 -1.516 . . . . 0.58 106.907 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.7 p90 -154.2 166.92 31.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.56 -1.337 . . . . 0.44 110.761 -178.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' B' ' 228' ' ' ARG . 0.0 OUTLIER -90.47 137.41 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.706 -0.621 . . . . 2.76 109.556 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -94.36 161.02 14.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.416 -0.803 . . . . 2.23 109.333 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 68.7 m -86.79 -6.61 58.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 1.81 109.709 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.17 -20.37 25.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 3.64 109.532 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -162.29 140.11 6.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.984 . . . . 2.16 108.804 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.31 2.74 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 120.857 1.038 . . . . 1.27 110.624 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' B' ' 235' ' ' TRP . 7.5 m -84.54 141.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.965 -1.084 . . . . 1.76 110.111 -179.427 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.577 ' CZ2' ' NH1' ' B' ' 228' ' ' ARG . 97.0 m95 -52.2 -177.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 0.67 109.213 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.452 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 1.9 ttpp -131.82 -156.71 0.77 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.184 -0.947 . . . . 1.44 109.057 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.12 -178.43 52.39 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.81 159.78 47.6 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.543 1.495 . . . . 0.41 110.171 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 168.98 18.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.876 -0.787 . . . . 0.21 108.876 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -93.23 139.11 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 2.72 109.232 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.25 117.26 28.09 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.501 -0.749 . . . . 0.3 109.575 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.99 -73.55 0.68 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.314 -0.866 . . . . 0.45 110.034 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.73 141.53 28.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.33 110.528 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.63 114.04 5.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 2.33 109.255 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.24 -107.82 0.29 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.039 -1.224 . . . . 0.28 110.039 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.22 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -1.169 . . . . 1.4 109.704 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.61 46.77 2.02 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.753 -1.339 . . . . 0.29 109.753 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.13 148.35 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -1.19 . . . . 0.29 108.872 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.18 129.65 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.328 -0.857 . . . . 0.31 109.796 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -93.31 137.71 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.229 -1.026 . . . . 0.3 108.229 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.29 -179.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.19 -0.944 . . . . 0.24 110.507 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -144.13 110.14 5.37 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.835 -0.802 . . . . 1.81 108.835 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.24 -79.07 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.415 -1.328 . . . . 1.18 107.415 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.96 -134.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.485 -1.672 . . . . 1.97 106.485 177.388 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -102.04 54.27 0.8 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.994 -1.113 . . . . 1.38 107.994 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.55 126.32 6.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 1.12 109.336 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 30.0 mt -92.61 137.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.48 109.571 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -140.63 170.74 15.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 2.13 109.544 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.55 139.78 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.364 -0.835 . . . . 0.34 109.608 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.13 130.19 19.24 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 108.602 -0.888 . . . . 0.34 108.602 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 141.5 95.92 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.589 -0.966 . . . . 0.42 109.589 179.037 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.89 -34.6 73.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 3.11 109.782 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.07 -6.44 28.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 3.82 110.602 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.65 24.09 10.46 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.132 -0.98 . . . . 2.08 109.294 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 164.49 29.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.892 -0.781 . . . . 0.32 108.892 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -137.7 131.85 31.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.259 -0.9 . . . . 1.79 108.965 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.25 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.351 -0.843 . . . . 0.45 109.632 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.25 157.32 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.796 -0.816 . . . . 0.57 108.796 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.1 mtt-85 -91.02 143.76 26.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.241 -0.912 . . . . 3.62 109.176 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 18.3 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.03 -0.986 . . . . 2.05 109.464 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 108.974 -0.75 . . . . 1.48 108.974 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -135.28 126.99 29.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.516 -0.74 . . . . 0.72 109.21 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -100.98 158.67 15.82 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.143 -1.058 . . . . 3.26 108.143 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.83 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.23 110.312 -179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -111.2 156.85 20.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.056 -1.091 . . . . 0.58 108.056 178.838 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.8 p90 -155.49 153.26 30.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.806 -1.184 . . . . 0.44 110.377 -179.044 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 233' ' ' PRO . 21.4 mtp180 -96.84 145.67 25.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 2.76 109.801 -179.704 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.52 163.94 12.83 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.42 -0.8 . . . . 2.23 108.928 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.2 m -82.65 -3.17 55.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 1.8 109.313 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.47 -17.26 30.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.865 . . . . 3.63 109.442 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 234' ' ' VAL . 22.5 m-20 -162.62 133.8 3.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 2.16 108.892 179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.632 ' CA ' HH21 ' A' ' 228' ' ' ARG . 6.8 Cg_endo -64.88 5.85 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.839 1.026 . . . . 1.25 110.458 179.871 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.4 m -83.34 154.16 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.94 -1.1 . . . . 1.75 109.786 -179.627 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.34 -171.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.66 108.782 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.48 -155.74 0.62 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.975 . . . . 1.43 109.251 179.727 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.17 173.97 52.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.874 -1.291 . . . . 0.39 109.874 -179.568 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.03 157.82 46.45 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.78 1.653 . . . . 0.41 110.297 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.59 174.3 10.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.21 109.194 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.44 142.76 27.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 2.72 109.463 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.23 124.48 34.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.318 -0.623 . . . . 0.29 109.318 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.8 mt -115.88 -74.12 0.62 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.499 -0.75 . . . . 0.45 110.207 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -92.25 142.08 27.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.284 -0.885 . . . . 0.31 110.396 -178.522 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.89 7.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.865 . . . . 2.32 109.231 179.265 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.82 -103.87 0.21 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.982 -1.247 . . . . 0.27 109.982 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.76 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 1.39 109.647 -179.658 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.19 50.57 3.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.279 -1.529 . . . . 0.29 109.279 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.26 152.93 36.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -1.02 . . . . 0.29 108.811 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.47 129.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 0.31 109.535 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.37 139.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.509 -0.923 . . . . 0.29 108.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.42 176.31 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.277 -0.889 . . . . 0.23 110.243 -179.234 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -144.96 113.33 6.6 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.85 -0.796 . . . . 1.81 108.85 178.93 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.09 -79.88 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.44 -1.319 . . . . 1.18 107.44 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.64 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.756 -1.572 . . . . 1.98 106.756 177.737 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.0 p -103.83 55.72 0.73 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.983 -1.117 . . . . 1.39 107.983 177.986 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -156.0 125.5 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.079 -0.712 . . . . 1.12 109.079 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 66.8 mt -91.78 136.97 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.238 -0.914 . . . . 0.47 109.611 -179.493 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.1 166.4 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 2.11 110.032 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.89 140.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.492 -0.755 . . . . 0.33 109.534 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.62 127.94 16.75 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.357 -0.84 . . . . 0.34 108.863 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.5 99.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.614 0.876 . . . . 0.42 110.363 179.637 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -59.02 -28.88 66.82 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.447 -0.946 . . . . 3.12 108.447 179.139 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.41 -13.58 62.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.468 -0.77 . . . . 3.82 110.805 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -120.65 23.99 10.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.317 -0.864 . . . . 2.08 109.644 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.97 163.07 33.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.32 109.634 -179.855 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.469 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 8.2 mtmp? -140.74 125.03 17.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.408 -0.807 . . . . 1.79 108.969 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.08 112.11 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.246 -0.909 . . . . 0.45 110.128 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.94 150.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.487 -0.931 . . . . 0.57 108.487 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.475 -0.766 . . . . 3.63 109.382 179.522 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 222' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.4 m-20 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.011 -0.737 . . . . 1.48 109.011 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.3 127.04 29.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.73 109.16 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -100.98 158.68 15.82 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.124 -1.065 . . . . 3.26 108.124 179.16 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.23 110.284 -179.396 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.23 156.93 20.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.061 -1.089 . . . . 0.58 108.061 178.791 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -155.52 153.38 30.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.749 -1.219 . . . . 0.44 110.282 -178.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.646 HH21 ' CA ' ' B' ' 233' ' ' PRO . 21.5 mtp180 -97.01 145.62 25.77 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.6 -0.688 . . . . 2.76 109.754 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.5 163.95 12.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 2.23 108.997 179.58 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.1 m -82.68 -3.06 55.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 1.81 109.412 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.59 -17.21 30.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.39 -0.819 . . . . 3.64 109.41 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' B' ' 234' ' ' VAL . 22.7 m-20 -162.62 133.71 3.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 2.16 108.921 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 233' ' ' PRO . . . . . 0.646 ' CA ' HH21 ' B' ' 228' ' ' ARG . 6.8 Cg_endo -64.79 5.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 120.858 1.039 . . . . 1.27 110.488 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.4 m -83.29 154.12 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.908 -1.12 . . . . 1.76 109.813 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.38 -171.48 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.67 108.759 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.45 -155.71 0.62 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.974 . . . . 1.44 109.264 179.759 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 174.04 52.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.914 -1.275 . . . . 0.4 109.914 -179.636 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.07 157.81 46.27 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.745 1.63 . . . . 0.41 110.297 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.65 174.24 10.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.488 -0.757 . . . . 0.21 109.163 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.34 142.62 27.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.02 . . . . 2.72 109.475 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -89.14 124.42 34.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.624 -0.672 . . . . 0.3 109.475 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 36.1 mt -115.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.388 -0.82 . . . . 0.45 110.156 -179.818 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.5 t90 -92.26 142.08 27.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.33 110.337 -178.492 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.85 7.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.309 -0.869 . . . . 2.33 109.223 179.244 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.77 -104.01 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.956 -1.257 . . . . 0.28 109.956 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.72 -156.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 1.4 109.632 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 50.58 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.272 -1.531 . . . . 0.29 109.272 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.28 152.87 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.443 -1.034 . . . . 0.29 108.867 179.94 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.41 129.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.139 -0.975 . . . . 0.31 109.525 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.39 139.65 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.084 -1.01 . . . . 0.3 108.543 179.531 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.5 pt -139.48 176.22 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.264 -0.897 . . . . 0.24 110.206 -179.131 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -144.95 113.46 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 1.81 108.811 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -91.1 -80.05 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.345 -1.354 . . . . 1.18 107.345 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.47 -131.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.737 -1.579 . . . . 1.97 106.737 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 86.9 p -103.76 55.57 0.74 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.051 -1.092 . . . . 1.38 108.051 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -155.96 125.53 6.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.023 -0.732 . . . . 1.12 109.023 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 67.0 mt -91.77 136.92 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.48 109.611 -179.489 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.14 166.41 23.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.398 -0.814 . . . . 2.13 109.985 -179.109 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.97 140.66 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.483 -0.761 . . . . 0.34 109.472 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.5 t -136.63 127.95 16.74 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.338 -0.852 . . . . 0.34 108.897 179.613 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.8 144.49 99.56 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 120.621 0.881 . . . . 0.42 110.253 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -58.91 -29.01 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.416 -0.957 . . . . 3.11 108.416 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -70.4 -13.55 62.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.462 -0.774 . . . . 3.82 110.76 -178.968 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -120.69 24.06 10.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.256 -0.902 . . . . 2.08 109.563 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.1 33.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.436 -0.79 . . . . 0.32 109.633 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 8.1 mtmp? -140.71 125.06 17.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 1.79 108.953 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 31.0 mm -89.04 112.1 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.285 -0.884 . . . . 0.45 110.135 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.88 150.08 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.513 -0.921 . . . . 0.57 108.513 179.098 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -92.8 143.63 26.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.406 -0.808 . . . . 3.62 109.316 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.044 -0.979 . . . . 2.05 109.49 179.734 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.04 -0.726 . . . . 1.48 109.04 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.3 146.4 49.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.567 -0.708 . . . . 0.72 109.528 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -120.95 153.46 37.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.652 -1.24 . . . . 3.26 107.652 178.686 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.67 143.47 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.23 109.892 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.94 157.36 19.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.117 -1.438 . . . . 0.58 107.117 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 19.2 p90 -156.87 160.44 39.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.539 -1.35 . . . . 0.44 110.499 -179.354 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -97.72 153.78 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.648 -0.657 . . . . 2.76 109.953 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -96.39 175.16 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.505 -0.747 . . . . 2.23 109.351 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 83.6 p -91.55 -16.78 26.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 1.8 109.248 179.626 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -82.15 -12.55 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 3.63 109.581 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 46.1 m-20 -162.36 130.32 2.78 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 2.16 109.281 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -65.16 12.15 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.677 0.918 . . . . 1.25 110.041 179.201 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 41.0 t -84.62 160.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.022 . . . . 1.75 109.521 -179.746 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.46 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.4 m95 -75.09 168.68 19.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.735 . . . . 0.66 109.092 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.95 -165.16 1.31 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.1 -1.074 . . . . 1.43 108.1 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.36 178.14 47.83 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.385 -1.388 . . . . 0.39 109.882 -179.508 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.17 158.06 55.83 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.558 1.505 . . . . 0.41 109.904 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.11 169.22 18.16 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.743 -0.836 . . . . 0.21 108.743 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -91.74 139.0 31.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.025 -1.047 . . . . 2.72 109.398 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.17 123.7 33.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.654 -0.654 . . . . 0.29 109.71 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.6 mt -113.91 -73.56 0.65 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.493 -0.755 . . . . 0.45 109.768 -179.812 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -94.95 145.98 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.112 -0.993 . . . . 0.31 110.321 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.27 120.05 8.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.364 -0.835 . . . . 2.32 109.121 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -116.98 0.57 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.27 110.63 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.58 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.991 . . . . 1.39 110.041 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.95 52.54 2.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.695 -1.362 . . . . 0.29 109.695 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.55 146.46 21.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.961 -1.317 . . . . 0.29 110.508 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 249' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 262' ' ' ARG . 1.7 m -142.64 121.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.448 -0.945 . . . . 0.31 108.448 178.581 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 58.1 t -84.42 134.46 26.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.418 -0.956 . . . . 0.29 108.418 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -138.87 178.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.416 -0.802 . . . . 0.23 109.886 -179.117 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -140.96 109.78 6.06 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.328 -0.989 . . . . 1.81 108.328 178.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.61 -78.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.582 -1.266 . . . . 1.18 107.582 179.925 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.99 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.637 -1.616 . . . . 1.98 106.637 177.56 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.3 t -105.43 51.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.604 -0.887 . . . . 1.39 108.604 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -155.94 130.46 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.841 . . . . 1.12 109.402 -179.52 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 76.6 mt -92.5 136.92 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.47 109.455 -179.669 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -140.06 170.92 14.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 2.11 109.735 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.44 140.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.424 -0.797 . . . . 0.33 109.632 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.58 129.89 16.63 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.244 -0.91 . . . . 0.34 109.163 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.17 148.82 91.21 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 120.825 1.017 . . . . 0.42 109.637 179.132 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HG3' HH11 ' A' ' 262' ' ' ARG . 18.3 mmm-85 -56.66 -36.96 70.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.905 -1.122 . . . . 3.12 108.685 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -63.57 -8.1 8.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.886 -0.509 . . . . 3.82 110.537 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -122.61 14.1 10.16 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.3 -0.875 . . . . 2.08 108.712 179.309 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 159.53 41.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.32 109.275 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.66 131.88 38.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.356 -0.84 . . . . 1.79 109.005 179.995 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.53 108.97 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.45 109.954 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.95 151.99 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.624 -0.88 . . . . 0.57 108.624 178.961 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 3.63 109.087 179.311 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 31.5 m120 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.041 -0.726 . . . . 1.48 109.041 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -134.29 146.52 50.09 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.601 -0.687 . . . . 0.73 109.493 -179.677 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -121.09 153.4 37.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.628 -1.249 . . . . 3.26 107.628 178.667 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.58 143.7 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.25 -0.906 . . . . 0.23 109.828 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.19 157.33 19.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.222 -1.399 . . . . 0.58 107.222 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 19.0 p90 -156.99 160.55 39.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.442 -1.411 . . . . 0.44 110.501 -179.276 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -97.78 153.72 18.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.691 . . . . 2.76 109.948 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -96.56 175.12 6.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.271 -0.893 . . . . 2.23 109.288 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 82.2 p -91.35 -16.57 27.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 1.81 109.223 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -82.27 -12.6 57.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 3.64 109.694 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' B' ' 234' ' ' VAL . 46.6 m-20 -162.27 130.16 2.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.049 -1.032 . . . . 2.16 109.307 -179.912 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.2 12.25 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 120.664 0.909 . . . . 1.27 109.957 179.291 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.9 t -84.84 160.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 1.76 109.501 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.459 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -75.06 168.43 19.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 0.67 109.108 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.71 -165.03 1.29 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.216 -1.031 . . . . 1.44 108.216 178.953 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.28 178.01 47.84 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.425 -1.369 . . . . 0.4 109.841 -179.51 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.88 158.17 56.23 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.602 1.535 . . . . 0.41 109.984 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.34 168.82 18.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.728 -0.841 . . . . 0.21 108.728 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -91.4 138.91 31.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.026 -1.046 . . . . 2.72 109.515 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.12 123.76 33.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.645 -0.66 . . . . 0.3 109.726 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.08 -73.71 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.507 -0.746 . . . . 0.45 109.722 -179.827 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.425 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 6.8 t90 -94.77 146.0 24.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.33 110.313 -179.139 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.4 120.29 8.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.332 -0.855 . . . . 2.33 109.145 178.947 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.5 -116.74 0.56 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.649 -1.262 . . . . 0.28 110.628 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -63.04 -145.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.997 . . . . 1.4 109.998 -179.041 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.91 52.36 2.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.64 -1.384 . . . . 0.29 109.64 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.57 146.4 20.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.994 -1.297 . . . . 0.29 110.591 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 249' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' B' ' 262' ' ' ARG . 1.7 m -142.58 121.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.492 -0.929 . . . . 0.31 108.492 178.714 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.39 134.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.464 -0.939 . . . . 0.3 108.464 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.9 pt -138.92 178.75 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.327 -0.858 . . . . 0.24 109.892 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -141.0 109.7 6.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.323 -0.992 . . . . 1.81 108.323 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.42 -78.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.619 -1.252 . . . . 1.18 107.619 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -80.87 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.677 -1.601 . . . . 1.97 106.677 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.4 t -105.42 52.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.267 -0.896 . . . . 1.38 108.584 178.285 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -156.06 130.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 1.12 109.293 -179.419 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 76.7 mt -92.74 136.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.48 109.413 -179.647 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.93 170.58 15.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.408 -0.808 . . . . 2.13 109.694 -178.992 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.16 140.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 0.34 109.654 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.2 t -137.76 129.77 16.37 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.297 -0.877 . . . . 0.34 109.119 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.93 148.76 91.61 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 120.828 1.019 . . . . 0.42 109.755 179.087 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' B' ' 262' ' ' ARG . 18.0 mmm-85 -56.49 -37.47 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 3.11 108.622 179.247 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -63.12 -8.21 7.3 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.099 -0.5 . . . . 3.82 110.492 -178.217 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -122.6 14.04 10.15 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.877 . . . . 2.08 108.688 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.82 159.87 41.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.32 109.323 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.89 131.92 37.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 1.79 109.021 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.64 109.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.45 109.976 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -107.09 152.07 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.594 -0.891 . . . . 0.57 108.594 178.979 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' B' ' 269' ' ' ARG . 0.8 OUTLIER -90.21 147.85 23.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 3.62 109.007 179.406 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.077 -0.964 . . . . 2.05 109.37 179.641 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.147 -0.686 . . . . 1.48 109.147 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -135.5 128.9 32.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.72 109.301 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 224' ' ' ARG . 4.7 ptt-85 -109.65 162.59 14.28 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.141 -1.059 . . . . 3.26 108.141 178.461 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.214 -0.929 . . . . 0.23 110.814 -178.395 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -108.65 153.16 23.81 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.335 -1.357 . . . . 0.58 107.335 178.168 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.3 p90 -157.13 151.04 24.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.516 -1.365 . . . . 0.44 110.432 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.55 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 34.9 mtm180 -96.45 154.11 17.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 2.76 109.606 179.715 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 230' ' ' SER . 11.9 t70 -95.07 166.14 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 2.23 108.804 179.27 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 2.9 t -82.13 -7.26 59.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 1.8 109.171 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.73 -19.54 23.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 3.63 109.967 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.63 3.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.986 . . . . 2.16 109.173 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -64.69 15.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 120.842 1.028 . . . . 1.25 110.679 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 232' ' ' ASP . 26.0 m -82.51 131.84 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.927 -1.108 . . . . 1.75 109.82 -179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.9 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.66 109.465 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 237' ' ' GLY . 49.1 tttp -136.25 158.31 44.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.275 -0.891 . . . . 1.43 109.153 179.249 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.03 164.81 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.617 -0.993 . . . . 0.39 110.617 -179.326 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.56 159.44 50.74 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.614 1.543 . . . . 0.41 110.378 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.43 175.32 9.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.898 -0.779 . . . . 0.21 108.898 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.34 135.67 33.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.167 -0.958 . . . . 2.72 109.676 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.19 123.46 32.24 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.151 -0.685 . . . . 0.29 109.151 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -115.87 -72.27 0.7 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.416 -0.803 . . . . 0.45 110.125 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.78 137.46 32.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.221 -0.924 . . . . 0.31 110.067 -178.843 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.1 116.95 8.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.291 -0.881 . . . . 2.32 108.89 179.284 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.64 0.19 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.927 -1.269 . . . . 0.27 109.927 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.19 -157.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 1.39 109.671 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 48.94 2.68 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.364 -1.494 . . . . 0.29 109.364 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.42 152.04 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -1.112 . . . . 0.29 108.882 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.78 124.76 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.112 -0.993 . . . . 0.31 110.01 -179.716 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.0 136.51 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.179 -1.045 . . . . 0.29 108.179 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -139.47 178.64 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.3 -0.875 . . . . 0.23 110.118 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -143.53 112.42 6.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.538 -0.912 . . . . 1.81 108.538 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.78 -79.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.765 -1.198 . . . . 1.18 107.765 179.596 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.46 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.755 -1.572 . . . . 1.98 106.755 177.76 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.4 m -105.0 54.29 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.074 -1.084 . . . . 1.39 108.074 178.083 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -157.43 126.04 5.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.965 -0.754 . . . . 1.12 108.965 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.5 mt -92.46 140.73 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.279 -0.888 . . . . 0.47 109.589 -179.663 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.43 169.56 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.392 -0.818 . . . . 2.11 109.59 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.66 139.69 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 0.33 109.073 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.9 t -135.67 121.24 13.77 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.421 -0.8 . . . . 0.34 108.926 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.81 136.59 75.23 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 N-CA-C 109.934 -0.833 . . . . 0.42 109.934 179.588 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -56.04 -35.64 67.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 3.12 109.631 179.886 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.503 HH11 ' CG ' ' A' ' 263' ' ' ARG . 0.7 OUTLIER -69.34 -3.01 12.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 3.82 110.259 -179.417 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.55 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 19.3 mtpp -119.47 16.12 12.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.371 -0.831 . . . . 2.08 109.044 179.674 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.34 170.8 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.474 -0.767 . . . . 0.32 109.329 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.492 ' HZ1' HD11 ' A' ' 268' ' ' ILE . 6.3 mtmp? -140.79 132.12 26.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.27 -0.894 . . . . 1.79 109.457 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.96 117.25 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.264 -0.898 . . . . 0.45 109.922 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.492 HD11 ' HZ1' ' A' ' 266' ' ' LYS . 5.7 mm -116.21 148.84 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.556 -0.905 . . . . 0.57 108.556 179.15 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 108.476 -0.935 . . . . 3.63 108.476 179.46 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.144 -0.687 . . . . 1.48 109.144 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.58 128.84 31.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.492 -0.755 . . . . 0.73 109.33 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 224' ' ' ARG . 4.8 ptt-85 -109.64 162.51 14.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.207 -1.034 . . . . 3.26 108.207 178.515 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.1 t -138.03 146.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.165 -0.959 . . . . 0.23 110.839 -178.329 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -108.66 153.15 23.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.356 -1.35 . . . . 0.58 107.356 178.134 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.3 p90 -157.03 151.07 24.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.557 -1.34 . . . . 0.44 110.548 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.569 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 34.9 mtm180 -96.5 154.13 17.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 2.76 109.591 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 230' ' ' SER . 11.8 t70 -95.0 166.13 12.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.818 . . . . 2.23 108.831 179.254 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 2.9 t -82.11 -7.22 59.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -0.999 . . . . 1.81 109.209 179.803 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -90.66 -19.71 23.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.886 . . . . 3.64 109.952 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' B' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.61 3.06 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.056 -1.028 . . . . 2.16 109.139 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.71 15.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 120.86 1.04 . . . . 1.27 110.605 179.691 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' B' ' 232' ' ' ASP . 26.4 m -82.53 131.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.829 -1.169 . . . . 1.76 109.875 -179.656 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 0.67 109.463 179.895 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 237' ' ' GLY . 49.1 tttp -136.36 158.21 44.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.296 -0.877 . . . . 1.44 109.189 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.98 164.87 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.538 -1.025 . . . . 0.4 110.538 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.52 159.35 51.06 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.628 1.552 . . . . 0.41 110.406 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.34 175.34 9.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.983 -0.747 . . . . 0.21 108.983 179.371 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.38 135.64 33.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.053 -1.03 . . . . 2.72 109.671 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.17 123.51 32.28 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.166 -0.679 . . . . 0.3 109.166 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.96 -72.24 0.7 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.399 -0.813 . . . . 0.45 110.09 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -90.83 137.41 32.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.253 -0.904 . . . . 0.33 110.08 -178.836 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.03 116.94 8.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.87 . . . . 2.33 108.898 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.56 0.19 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.997 -1.241 . . . . 0.28 109.997 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.22 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -1.099 . . . . 1.4 109.606 -179.643 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 48.93 2.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.34 -1.504 . . . . 0.29 109.34 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.43 152.03 37.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 0.29 108.877 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.83 124.77 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 0.31 109.982 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.94 136.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.156 -1.053 . . . . 0.3 108.156 179.114 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.38 178.6 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 0.24 110.157 -179.127 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -143.48 112.45 6.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.603 -0.888 . . . . 1.81 108.603 178.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.77 -79.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.759 -1.2 . . . . 1.18 107.759 179.649 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.56 -130.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.654 -1.609 . . . . 1.97 106.654 177.794 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 35.3 m -104.98 54.17 0.71 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.089 -1.078 . . . . 1.38 108.089 178.207 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -157.39 126.0 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.024 -0.732 . . . . 1.12 109.024 -179.376 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.37 140.75 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.929 . . . . 0.48 109.65 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.48 169.53 17.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 2.13 109.532 -179.598 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.6 139.61 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.34 109.1 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 75.5 t -135.58 121.24 13.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.477 -0.765 . . . . 0.34 108.964 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.79 136.43 74.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.965 -0.821 . . . . 0.42 109.965 179.557 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.55 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -55.99 -35.59 66.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 3.11 109.625 179.981 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.7 OUTLIER -69.33 -3.06 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 3.82 110.232 -179.393 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.569 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 19.4 mtpp -119.38 16.01 13.02 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.831 . . . . 2.08 109.004 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.27 170.84 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.712 . . . . 0.32 109.416 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.482 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.4 mtmp? -140.76 132.16 26.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.211 -0.931 . . . . 1.79 109.49 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.86 117.28 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.917 . . . . 0.45 109.941 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.484 HG21 ' NH2' ' B' ' 224' ' ' ARG . 5.7 mm -116.32 148.82 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.544 -0.909 . . . . 0.57 108.544 179.187 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 141.79 28.36 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.516 -0.92 . . . . 3.62 108.516 179.497 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 2.05 109.528 -179.862 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.272 -0.64 . . . . 1.48 109.272 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -134.53 136.78 43.33 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.845 -0.798 . . . . 0.72 108.845 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -111.55 155.18 23.7 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.129 -1.063 . . . . 3.26 108.129 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.14 141.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 0.23 110.258 -179.399 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.12 157.65 18.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.456 -1.313 . . . . 0.58 107.456 178.582 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 10.5 p90 -156.47 150.12 24.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.653 -1.279 . . . . 0.44 110.28 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 228' ' ' ARG . 9.1 mtm-85 -94.69 154.43 17.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.461 -0.775 . . . . 2.76 109.66 179.774 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.81 166.44 11.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 2.23 108.841 179.362 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.0 t -85.83 -9.79 56.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 1.8 109.324 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -89.3 -16.09 31.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 3.63 109.56 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.5 m-20 -161.42 129.7 2.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.137 -0.977 . . . . 2.16 109.063 -179.846 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.38 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 120.781 0.987 . . . . 1.25 110.653 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 232' ' ' ASP . 11.6 m -82.69 133.41 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.73 -1.231 . . . . 1.75 109.848 -179.747 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -53.56 -177.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.26 -0.9 . . . . 0.66 109.124 179.635 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.742 ' HZ3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -136.79 -164.78 1.63 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.256 -0.903 . . . . 1.43 108.631 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.742 ' H ' ' HZ3' ' A' ' 236' ' ' LYS . . . -73.52 172.38 50.61 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.661 -1.257 . . . . 0.39 110.041 -179.441 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.35 158.76 55.21 Favored 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.633 1.555 . . . . 0.41 109.955 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.02 172.77 12.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.21 109.193 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -94.44 138.82 31.91 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.2 -0.938 . . . . 2.72 109.36 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.63 126.24 34.84 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.532 -0.73 . . . . 0.29 109.467 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 24.5 mt -119.59 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.752 . . . . 0.45 110.115 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.427 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.53 140.1 30.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.178 -0.951 . . . . 0.31 109.946 -178.76 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -147.82 119.5 8.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.258 -0.901 . . . . 2.32 109.163 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.14 -100.75 0.18 Allowed Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.788 -1.196 . . . . 0.27 110.28 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.33 -154.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -1.072 . . . . 1.39 109.804 -179.323 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.9 2.82 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.875 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.81 153.88 38.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -1.068 . . . . 0.29 109.009 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.34 132.92 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.31 109.825 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.5 t -94.39 139.32 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.206 -1.035 . . . . 0.29 108.206 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.5 pt -140.62 179.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.23 110.073 -179.207 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -142.54 115.03 8.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.469 -0.938 . . . . 1.81 108.469 179.013 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.26 -84.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.417 -1.327 . . . . 1.18 107.417 179.459 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.62 -126.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.629 -1.619 . . . . 1.98 106.629 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.2 t -105.7 53.9 0.71 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.025 -1.102 . . . . 1.39 108.025 177.891 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.08 8.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.12 109.196 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.6 mt -93.9 137.05 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.325 -0.859 . . . . 0.47 109.587 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.5 167.39 22.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 2.11 109.681 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.04 143.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.381 -0.824 . . . . 0.33 109.351 179.596 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.2 t -137.92 126.01 14.16 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.352 -0.843 . . . . 0.34 109.047 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.82 143.4 99.2 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 N-CA-C 109.692 -0.926 . . . . 0.42 109.692 179.444 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.421 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -54.62 -41.17 69.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 3.12 109.293 179.606 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.431 HH11 ' HG3' ' A' ' 263' ' ' ARG . 29.6 mtm-85 -67.2 -2.48 5.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.85 . . . . 3.82 110.563 -178.955 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.74 14.64 12.6 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.355 -0.841 . . . . 2.08 109.112 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.28 169.06 18.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.32 109.832 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.21 130.07 24.61 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.446 -0.784 . . . . 1.79 109.068 179.629 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.41 110.54 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.237 -0.915 . . . . 0.45 109.515 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.42 155.27 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.749 -0.834 . . . . 0.57 108.749 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.372 -0.83 . . . . 3.63 109.621 179.792 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.276 -0.639 . . . . 1.48 109.276 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -134.51 136.88 43.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.848 -0.797 . . . . 0.73 108.848 179.966 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -111.63 155.22 23.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.063 -1.088 . . . . 3.26 108.063 179.095 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.17 141.12 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.285 -0.884 . . . . 0.23 110.185 -179.382 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.1 157.72 18.46 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.455 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.51 150.09 24.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.66 -1.275 . . . . 0.44 110.332 -179.012 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' B' ' 228' ' ' ARG . 9.1 mtm-85 -94.72 154.44 17.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 2.76 109.646 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.92 166.46 11.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 2.23 108.846 179.374 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.2 t -85.92 -9.67 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 1.81 109.283 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.25 -16.2 31.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 3.64 109.549 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.5 m-20 -161.43 129.81 2.93 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.223 -0.923 . . . . 2.16 109.073 -179.839 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.25 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.835 1.023 . . . . 1.27 110.594 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' B' ' 232' ' ' ASP . 11.5 m -82.59 133.56 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.782 -1.199 . . . . 1.76 109.806 -179.746 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -53.72 -177.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.09 -1.006 . . . . 0.67 109.094 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.77 ' HZ3' ' H ' ' B' ' 237' ' ' GLY . 0.1 OUTLIER -136.74 -164.73 1.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.23 -0.919 . . . . 1.44 108.685 179.241 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.77 ' H ' ' HZ3' ' B' ' 236' ' ' LYS . . . -73.75 172.38 51.04 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.625 -1.274 . . . . 0.4 110.053 -179.431 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.36 158.82 55.0 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.592 1.528 . . . . 0.41 109.996 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.79 12.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.21 109.163 179.471 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -94.47 138.71 32.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.161 -0.962 . . . . 2.72 109.406 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.4 tp -87.54 126.22 34.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.493 -0.754 . . . . 0.3 109.485 -179.829 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.56 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.737 . . . . 0.45 110.181 -179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -91.48 139.99 30.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.119 -0.988 . . . . 0.33 109.97 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -147.72 119.48 8.08 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.885 . . . . 2.33 109.134 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.11 -100.86 0.18 Allowed Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.828 -1.177 . . . . 0.28 110.334 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.23 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -1.063 . . . . 1.4 109.865 -179.342 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.99 2.84 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.355 -1.498 . . . . 0.29 109.355 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.86 153.92 38.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.113 . . . . 0.29 109.029 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.3 132.84 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.095 -1.003 . . . . 0.31 109.892 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.25 139.44 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.254 -1.017 . . . . 0.3 108.254 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.4 pt -140.77 179.3 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.24 110.117 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -142.48 114.9 8.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.507 -0.923 . . . . 1.81 108.507 179.101 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.17 -84.57 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.43 -1.322 . . . . 1.18 107.43 179.441 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.73 -125.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.589 -1.634 . . . . 1.97 106.589 177.68 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.3 t -105.79 53.91 0.7 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.995 -1.113 . . . . 1.38 107.995 177.946 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.22 8.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.542 -0.724 . . . . 1.12 109.164 -179.355 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.427 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 48.6 mt -94.01 137.06 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.48 109.587 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -138.51 167.36 22.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.299 -0.876 . . . . 2.13 109.711 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.96 143.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.391 -0.818 . . . . 0.34 109.408 179.615 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.97 125.97 14.08 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.418 -0.801 . . . . 0.34 108.973 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.77 143.34 99.05 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 N-CA-C 109.778 -0.893 . . . . 0.42 109.778 179.322 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.412 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -54.58 -41.24 69.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 3.11 109.324 179.64 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' B' ' 263' ' ' ARG . 29.6 mtm-85 -67.02 -2.63 5.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.248 -0.908 . . . . 3.82 110.597 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.65 14.63 12.67 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.344 -0.847 . . . . 2.08 109.127 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.14 169.08 18.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.313 -0.867 . . . . 0.32 109.839 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.16 130.15 24.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 1.79 109.077 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.38 110.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.244 -0.91 . . . . 0.45 109.595 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.38 155.28 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.737 -0.838 . . . . 0.57 108.737 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.36 140.86 29.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.313 -0.867 . . . . 3.62 109.607 179.831 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.923 -1.037 . . . . 2.05 109.405 179.702 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.067 0.46 . . . . 1.48 109.773 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -135.86 135.26 39.62 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.803 . . . . 0.72 109.717 179.962 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 224' ' ' ARG . 12.0 mtm-85 -106.17 160.62 15.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.79 -1.189 . . . . 3.26 107.79 178.829 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.7 141.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.23 110.212 -179.256 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.81 154.7 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.363 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.8 p90 -157.15 152.2 26.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.643 -1.286 . . . . 0.44 110.11 -179.228 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.435 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 35.9 mtm180 -95.95 152.3 18.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.466 -0.771 . . . . 2.76 110.067 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -91.19 165.2 13.6 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 179.222 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 59.5 m -83.92 -13.07 54.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.994 -1.067 . . . . 1.8 108.873 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.81 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 3.63 109.588 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.7 p30 -156.95 128.87 3.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.954 -1.091 . . . . 2.16 109.414 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.76 7.08 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 121.059 1.173 . . . . 1.25 111.476 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 235' ' ' TRP . 13.9 p -83.29 161.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.459 -1.401 . . . . 1.75 110.208 -179.523 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.535 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.2 m95 -75.48 160.75 29.85 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.157 -0.683 . . . . 0.66 109.157 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.3 tttp -119.12 163.82 16.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.395 -0.816 . . . . 1.43 109.069 179.408 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.94 168.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.902 -1.279 . . . . 0.39 109.902 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.3 161.3 46.44 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.458 1.439 . . . . 0.41 110.64 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.61 173.9 11.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.992 -0.744 . . . . 0.21 108.992 179.252 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.75 139.59 31.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.092 -1.005 . . . . 2.72 109.21 179.725 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.18 123.85 33.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 0.29 109.455 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.15 -75.37 0.59 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.45 109.724 179.638 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.96 143.75 26.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 0.31 110.301 -179.062 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -149.54 118.72 6.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.477 -0.764 . . . . 2.32 108.955 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -100.99 0.18 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.618 -1.277 . . . . 0.27 110.157 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.35 -154.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -1.069 . . . . 1.39 109.751 -179.365 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.77 45.77 2.23 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.89 150.52 36.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.443 -1.034 . . . . 0.29 108.834 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 129.34 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.204 -0.935 . . . . 0.31 109.459 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.97 137.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.088 -1.078 . . . . 0.29 108.088 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.0 pt -140.11 -178.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.178 -0.951 . . . . 0.23 110.549 -178.747 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -145.99 112.15 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.93 -76.57 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.998 -1.482 . . . . 1.18 106.998 179.216 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.19 -136.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.822 -1.547 . . . . 1.98 106.822 177.586 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.74 55.42 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.344 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -157.69 127.06 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 1.12 109.097 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.3 mt -92.68 133.27 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.31 -0.869 . . . . 0.47 109.567 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.25 168.27 19.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.505 -0.747 . . . . 2.11 109.631 -179.661 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.48 138.48 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.439 -0.788 . . . . 0.33 109.658 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.5 133.07 19.0 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.473 -0.936 . . . . 0.34 108.473 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.39 140.64 95.3 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.663 0.909 . . . . 0.42 110.143 179.587 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -57.92 -35.5 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 3.12 109.209 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 263' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.4 mtt-85 -69.99 -1.95 11.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 3.82 110.464 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.435 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 5.3 mptp? -118.7 15.54 13.59 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.738 -0.838 . . . . 2.08 108.738 -179.672 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.17 173.34 11.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.524 -0.735 . . . . 0.32 109.445 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.55 129.04 22.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.336 -0.853 . . . . 1.79 108.997 179.545 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.2 mm -86.57 113.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.45 109.19 179.773 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.6 mm -112.6 148.65 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.514 -0.921 . . . . 0.57 108.514 179.364 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.554 -0.716 . . . . 3.63 109.518 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.135 0.493 . . . . 1.48 109.768 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -135.86 135.25 39.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.426 -0.796 . . . . 0.73 109.665 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' B' ' 224' ' ' ARG . 11.9 mtm-85 -106.05 160.57 15.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.814 -1.18 . . . . 3.26 107.814 178.79 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 141.48 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.206 -0.934 . . . . 0.23 110.178 -179.24 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.75 154.75 22.49 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.447 -1.316 . . . . 0.58 107.447 178.369 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.21 152.16 25.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.653 -1.28 . . . . 0.44 110.096 -179.247 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.419 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 35.7 mtm180 -95.86 152.39 18.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.461 -0.775 . . . . 2.76 110.053 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -91.33 165.1 13.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 2.23 108.686 179.221 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 59.1 m -83.72 -13.19 54.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 1.81 108.943 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.66 40.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 3.64 109.59 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -157.12 128.8 3.88 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.115 -0.991 . . . . 2.16 109.322 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.8 7.27 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.988 1.125 . . . . 1.27 111.583 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.538 HG22 ' N ' ' B' ' 235' ' ' TRP . 13.9 p -83.33 161.65 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.347 -1.47 . . . . 1.76 110.241 -179.574 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.538 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.45 160.75 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.67 109.199 179.68 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.2 tttp -119.05 163.85 16.38 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.373 -0.829 . . . . 1.44 109.032 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.97 168.2 0.03 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.967 -1.253 . . . . 0.4 109.967 -179.486 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -69.34 161.31 46.39 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.479 1.453 . . . . 0.41 110.584 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.64 173.87 11.19 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.883 -0.784 . . . . 0.21 108.883 179.282 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.73 139.52 31.13 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.069 -1.019 . . . . 2.72 109.215 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.19 123.78 33.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.433 -0.792 . . . . 0.3 109.425 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.09 -75.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.476 -0.765 . . . . 0.45 109.744 179.655 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.97 143.8 26.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 0.33 110.274 -179.067 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -149.53 118.72 6.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.418 -0.801 . . . . 2.33 109.044 179.279 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.8 -100.97 0.18 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.577 -1.297 . . . . 0.28 110.191 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.32 -154.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -1.012 . . . . 1.4 109.807 -179.399 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 45.83 2.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.236 -1.545 . . . . 0.29 109.236 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.9 150.48 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -1.022 . . . . 0.29 108.789 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.96 129.36 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.92 . . . . 0.31 109.519 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.99 137.38 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.087 -1.079 . . . . 0.3 108.087 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.01 -178.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.286 -0.884 . . . . 0.24 110.618 -178.829 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -146.07 112.09 5.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.984 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.82 -76.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.063 -1.458 . . . . 1.18 107.063 179.213 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -82.08 -136.43 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.512 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.7 55.36 0.87 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.195 -1.039 . . . . 1.38 108.195 178.345 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -157.66 126.96 5.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.581 -0.699 . . . . 1.12 109.154 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 37.8 mt -92.56 133.25 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.48 109.586 -179.623 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.2 168.28 19.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.427 -0.796 . . . . 2.13 109.627 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.51 138.47 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 0.34 109.657 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 133.14 19.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.376 -0.972 . . . . 0.34 108.376 179.421 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.43 140.75 95.78 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 120.539 0.826 . . . . 0.42 110.162 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -57.95 -35.51 71.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.114 -0.991 . . . . 3.11 109.222 179.449 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' B' B ' 263' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.4 mtt-85 -70.01 -1.96 11.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 3.82 110.462 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.419 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 5.3 mptp? -118.72 15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.367 -0.833 . . . . 2.08 108.758 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 173.38 11.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.453 -0.78 . . . . 0.32 109.512 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.62 128.89 22.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 1.79 109.075 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.0 mm -86.43 113.29 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.158 -0.964 . . . . 0.45 109.233 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.71 148.61 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.471 -0.937 . . . . 0.57 108.471 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -91.33 150.01 21.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.541 -0.724 . . . . 3.62 109.581 179.908 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.219 179.704 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.057 -0.72 . . . . 1.48 109.057 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.64 138.62 46.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.582 -0.699 . . . . 0.72 109.381 -179.751 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -107.7 160.05 16.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.962 -1.125 . . . . 3.26 107.962 179.159 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 77.3 t -142.04 138.92 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.172 -0.955 . . . . 0.23 110.096 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -108.36 151.36 26.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.556 -1.276 . . . . 0.58 107.556 178.611 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.0 p90 -155.61 152.31 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.609 -1.307 . . . . 0.44 110.529 -179.076 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 228' ' ' ARG . 8.8 mtm-85 -95.31 151.0 19.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 2.76 109.513 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.8 m-20 -96.52 167.15 11.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 2.23 108.892 179.34 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.2 t -83.33 -8.92 59.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.8 109.195 179.538 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -90.44 -16.17 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.352 -0.843 . . . . 3.63 109.764 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 234' ' ' VAL . 59.2 m-20 -160.69 129.74 3.14 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.139 -0.976 . . . . 2.16 109.232 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.39 10.91 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 120.862 1.041 . . . . 1.25 110.41 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.0 m -83.17 135.91 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 1.75 110.1 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.19 167.55 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.66 109.127 179.71 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 237' ' ' GLY . 36.8 tttp -125.5 157.92 35.79 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.383 -0.823 . . . . 1.43 109.34 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.05 166.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.349 -1.1 . . . . 0.39 110.349 -179.315 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -65.53 160.92 40.7 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.639 1.559 . . . . 0.41 110.58 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.824 -0.806 . . . . 0.21 108.824 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.9 137.93 34.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.118 -0.989 . . . . 2.72 109.216 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.89 125.41 35.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.563 -0.711 . . . . 0.29 109.765 -179.589 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.76 -72.89 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 0.45 109.912 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.24 28.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.234 -0.916 . . . . 0.31 110.341 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.84 118.74 7.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 2.32 108.896 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -100.24 0.18 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.787 -1.197 . . . . 0.27 110.151 -179.76 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.59 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 1.39 109.569 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.46 47.98 2.47 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.575 -1.41 . . . . 0.29 109.575 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.91 33.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -1.086 . . . . 0.29 108.854 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.21 125.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 0.31 109.489 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.99 139.52 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.368 -0.975 . . . . 0.29 108.368 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 251' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 260' ' ' VAL . 27.2 pt -141.73 178.51 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.117 -0.989 . . . . 0.23 110.257 -179.121 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -144.36 114.52 7.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.736 -0.839 . . . . 1.81 108.736 179.193 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.96 -78.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.453 -1.314 . . . . 1.18 107.453 179.241 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.57 -129.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.638 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.06 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.537 -0.727 . . . . 1.12 109.277 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mt -92.74 135.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.807 . . . . 0.47 109.45 -179.629 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.09 14.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 2.11 109.776 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.35 138.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.466 -0.771 . . . . 0.33 109.475 179.802 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 251' ' ' ILE . 90.5 t -134.9 126.9 18.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.668 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 145.08 90.01 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 120.507 0.805 . . . . 0.42 110.47 179.822 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.524 ' HG2' HH11 ' A' ' 262' ' ' ARG . 4.5 ttt-85 -65.16 -36.82 85.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.428 -0.795 . . . . 3.12 110.1 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -68.71 -4.91 17.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 3.82 110.174 -179.099 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -119.52 19.54 12.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.341 -0.849 . . . . 2.08 109.184 179.783 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.54 170.55 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.496 -0.752 . . . . 0.32 109.578 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -140.93 132.14 26.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.236 -0.915 . . . . 1.79 109.358 179.765 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.8 mm -88.78 106.03 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.27 -0.894 . . . . 0.45 109.593 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.47 155.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.374 -0.828 . . . . 0.57 109.208 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.801 . . . . 3.63 109.464 179.578 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.03 -0.729 . . . . 1.48 109.03 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.66 138.58 45.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.69 . . . . 0.73 109.386 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.433 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 61.4 mtm180 -107.68 160.18 15.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.985 -1.117 . . . . 3.26 107.985 179.158 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 77.2 t -142.2 138.96 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.192 -0.943 . . . . 0.23 109.982 -179.57 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -108.42 151.31 26.21 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.62 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -155.51 152.47 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.44 110.541 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.45 ' HG3' HH11 ' B' ' 228' ' ' ARG . 8.8 mtm-85 -95.39 151.08 19.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 2.76 109.39 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 229' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.8 m-20 -96.61 167.17 11.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.355 -0.841 . . . . 2.23 108.89 179.316 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 43.5 t -83.26 -9.14 59.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 1.81 109.215 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -90.27 -16.15 29.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 3.64 109.821 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 59.1 m-20 -160.74 129.73 3.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 2.16 109.295 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.41 11.02 0.23 Allowed 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 120.79 0.994 . . . . 1.27 110.419 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.0 m -83.23 135.93 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.869 -1.144 . . . . 1.76 110.06 -179.48 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.2 167.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.227 -0.92 . . . . 0.67 109.107 179.663 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' B' ' 237' ' ' GLY . 36.8 tttp -125.48 157.92 35.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.373 -0.83 . . . . 1.44 109.272 179.447 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.11 166.11 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.361 -1.096 . . . . 0.4 110.361 -179.342 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -65.47 160.89 40.68 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.617 1.545 . . . . 0.41 110.585 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.805 . . . . 0.21 108.825 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.82 137.99 34.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.061 -1.024 . . . . 2.72 109.254 179.901 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.93 125.49 35.38 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.564 -0.71 . . . . 0.3 109.774 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.75 -72.93 0.66 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.45 -0.781 . . . . 0.45 110.002 179.872 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.16 28.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.23 -0.919 . . . . 0.33 110.251 -178.789 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.78 118.8 7.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.377 -0.827 . . . . 2.33 108.882 179.155 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -100.25 0.18 Allowed Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.096 -179.779 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.52 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 1.4 109.555 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.48 47.98 2.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.688 -1.365 . . . . 0.29 109.688 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.83 33.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -1.093 . . . . 0.29 108.82 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.12 125.87 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 0.31 109.501 179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.04 139.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.467 -0.938 . . . . 0.3 108.467 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 251' ' ' ILE . . . . . 0.427 HD11 HG21 ' B' ' 260' ' ' VAL . 27.1 pt -141.7 178.54 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.92 . . . . 0.24 110.265 -179.092 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -144.38 114.51 7.42 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.834 -0.802 . . . . 1.81 108.834 179.106 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.96 -78.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.436 -1.32 . . . . 1.18 107.436 179.33 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.51 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.78 -1.563 . . . . 1.97 106.78 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 17.7 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.105 -1.072 . . . . 1.38 108.105 178.081 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.07 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.628 -0.67 . . . . 1.12 109.257 -179.379 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 34.1 mt -92.76 135.92 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.355 -0.841 . . . . 0.48 109.436 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.02 15.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.822 . . . . 2.13 109.806 -179.432 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 138.32 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.388 -0.82 . . . . 0.34 109.542 179.795 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 260' ' ' VAL . . . . . 0.427 HG21 HD11 ' B' ' 251' ' ' ILE . 91.1 t -134.8 126.97 18.2 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.573 -0.899 . . . . 0.34 108.573 179.748 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.57 145.12 90.52 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 120.564 0.843 . . . . 0.42 110.355 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 262' ' ' ARG . 4.5 ttt-85 -65.14 -36.92 85.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.427 -0.796 . . . . 3.11 110.109 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -68.53 -4.95 16.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.109 -0.994 . . . . 3.82 110.325 -179.216 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -119.56 19.53 12.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.327 -0.858 . . . . 2.08 109.191 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 170.62 15.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.448 -0.783 . . . . 0.32 109.584 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -140.95 132.05 26.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 1.79 109.321 179.779 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.62 106.0 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.275 -0.891 . . . . 0.45 109.627 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -105.53 155.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.447 -0.783 . . . . 0.57 109.212 179.631 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -91.27 147.9 22.72 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 3.62 109.502 179.608 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 270' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.95 -1.024 . . . . 2.05 109.414 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 222' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 222' ' ' ASN . 1.5 m-20 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 121.353 0.597 . . . . 1.48 110.925 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.22 127.54 28.34 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.867 -0.79 . . . . 0.72 108.867 178.443 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.94 159.05 15.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.206 -1.035 . . . . 3.26 108.206 179.227 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.7 t -143.44 144.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.2 -0.938 . . . . 0.23 110.157 -179.731 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.53 157.02 20.84 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.555 -1.276 . . . . 0.58 107.555 178.626 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.0 p90 -157.78 149.26 21.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.258 . . . . 0.44 110.434 -178.943 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.464 ' NH1' ' CH2' ' A' ' 235' ' ' TRP . 24.0 mtm-85 -95.16 142.54 27.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.439 -0.788 . . . . 2.76 109.266 179.259 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.88 173.06 8.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 2.23 109.068 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.8 m -86.83 -8.1 57.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 1.8 109.527 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.46 -20.5 26.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 3.63 109.455 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.4 m-20 -162.42 132.34 3.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 2.16 108.95 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.35 14.64 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 120.724 0.949 . . . . 1.25 110.293 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 232' ' ' ASP . 44.5 t -80.91 155.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.798 -1.189 . . . . 1.75 109.577 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.464 ' CH2' ' NH1' ' A' ' 228' ' ' ARG . 98.8 m95 -75.89 160.71 29.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.66 109.573 -179.789 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.0 mttm -119.33 159.32 24.38 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.347 -0.845 . . . . 1.43 109.027 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.38 168.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.997 -1.241 . . . . 0.39 109.997 -179.565 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.74 159.09 54.3 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.585 1.523 . . . . 0.41 110.425 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.4 174.41 10.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.799 -0.815 . . . . 0.21 108.799 179.13 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 240' ' ' LYS . 11.5 mptt -92.71 136.62 33.07 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 2.72 109.373 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -87.07 122.9 31.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.327 -0.858 . . . . 0.29 109.403 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -113.78 -76.67 0.58 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.421 -0.8 . . . . 0.45 110.373 -179.958 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 21.3 t90 -97.35 137.86 35.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.018 -1.051 . . . . 0.31 110.772 -178.722 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.89 132.36 17.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.857 -0.794 . . . . 2.32 108.857 178.804 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -99.82 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.48 -1.448 . . . . 0.27 109.48 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.52 -149.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 1.39 109.154 179.829 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 48.32 3.09 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.231 -1.548 . . . . 0.29 109.231 179.66 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.61 149.15 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.971 . . . . 0.29 109.085 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.11 135.6 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.096 -1.003 . . . . 0.31 109.534 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 87.7 t -88.41 143.63 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.29 109.318 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.79 179.81 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.362 -0.836 . . . . 0.23 109.482 179.737 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -143.99 110.8 5.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 1.81 108.656 178.731 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -89.6 -78.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.67 -1.233 . . . . 1.18 107.67 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -81.13 -131.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.815 -1.55 . . . . 1.98 106.815 177.858 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -105.24 53.36 0.72 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.191 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -155.53 127.66 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.603 -0.686 . . . . 1.12 109.157 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.481 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 72.4 mt -93.0 132.97 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.47 109.861 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -134.99 170.62 15.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.449 -0.782 . . . . 2.11 109.493 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.3 t -100.89 139.87 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.415 -0.803 . . . . 0.33 109.498 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.75 121.56 14.99 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.441 -0.787 . . . . 0.34 109.201 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.99 139.35 89.63 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.486 0.791 . . . . 0.42 110.054 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -52.86 -43.1 65.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 3.12 109.555 179.658 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.26 -3.88 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.412 -0.805 . . . . 3.82 110.667 -178.783 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.426 ' CD ' ' NH2' ' A' ' 228' ' ' ARG . 7.2 mmmt -120.19 16.85 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.288 -0.883 . . . . 2.08 108.882 179.852 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.96 172.27 12.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.702 . . . . 0.32 109.749 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -137.4 126.96 25.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.783 -0.821 . . . . 1.79 108.783 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.97 107.11 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.45 109.516 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.45 147.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.61 -0.885 . . . . 0.57 108.61 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.352 -0.843 . . . . 3.63 109.367 179.682 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' B' B ' 222' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' B' ' 222' ' ' ASN . 1.5 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.315 0.579 . . . . 1.48 110.873 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.21 127.68 28.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.437 -0.789 . . . . 0.73 108.876 178.362 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.96 159.04 15.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.177 -1.045 . . . . 3.26 108.177 179.245 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.53 144.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.166 -0.958 . . . . 0.23 110.13 -179.84 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.45 157.01 20.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.626 -1.25 . . . . 0.58 107.626 178.6 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -157.75 149.28 21.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.241 . . . . 0.44 110.487 -178.948 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 228' ' ' ARG . . . . . 0.465 ' NH1' ' CH2' ' B' ' 235' ' ' TRP . 24.1 mtm-85 -95.17 142.56 27.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.432 -0.792 . . . . 2.76 109.222 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.93 173.09 8.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.314 -0.866 . . . . 2.23 109.073 179.856 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -86.87 -8.1 57.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 1.81 109.509 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.44 -20.45 26.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 3.64 109.452 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.6 m-20 -162.47 132.32 3.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 2.16 108.976 179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.38 14.69 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 120.65 0.9 . . . . 1.27 110.321 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' B' ' 232' ' ' ASP . 44.3 t -80.94 155.09 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.836 -1.165 . . . . 1.76 109.579 -179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.465 ' CH2' ' NH1' ' B' ' 228' ' ' ARG . 98.8 m95 -75.96 160.7 29.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.67 109.609 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.0 mttm -119.31 159.33 24.34 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.415 -0.803 . . . . 1.44 108.917 179.574 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.27 168.81 0.03 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.971 -1.251 . . . . 0.4 109.971 -179.714 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.76 159.11 54.19 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.592 1.528 . . . . 0.41 110.424 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.37 174.38 10.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.835 -0.802 . . . . 0.21 108.835 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' B' ' 240' ' ' LYS . 11.5 mptt -92.64 136.6 33.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.132 -0.98 . . . . 2.72 109.416 -179.694 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.02 122.89 31.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.424 -0.797 . . . . 0.3 109.401 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.8 -76.66 0.58 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.45 110.442 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.411 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 21.5 t90 -97.48 137.9 35.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.057 -1.027 . . . . 0.33 110.76 -178.726 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.9 132.38 17.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.407 -0.808 . . . . 2.33 108.898 178.914 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -99.92 0.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.445 -1.462 . . . . 0.28 109.445 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.51 -149.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -1.178 . . . . 1.4 109.154 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.36 48.19 3.08 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.675 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.57 149.22 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -1.014 . . . . 0.29 108.981 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.15 135.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.142 -0.974 . . . . 0.31 109.594 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 250' ' ' VAL . . . . . 0.475 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 87.6 t -88.44 143.61 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.918 . . . . 0.3 109.339 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.73 179.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 0.24 109.61 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -144.04 110.73 5.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.701 -0.852 . . . . 1.81 108.701 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.53 -78.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.598 -1.26 . . . . 1.18 107.598 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -81.02 -131.13 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.875 -1.528 . . . . 1.97 106.875 177.884 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -105.25 53.35 0.72 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.189 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -155.56 127.59 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.154 -0.684 . . . . 1.12 109.154 -179.238 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 72.5 mt -92.96 132.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.48 109.899 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.95 170.7 15.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 2.13 109.456 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.06 139.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.386 -0.821 . . . . 0.34 109.501 179.79 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.69 121.55 15.06 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.504 -0.748 . . . . 0.34 109.253 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.97 139.36 89.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 110.138 -0.755 . . . . 0.42 110.138 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 262' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -52.87 -43.1 65.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 3.11 109.556 179.69 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.16 -4.0 4.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 3.82 110.669 -178.85 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 264' ' ' LYS . . . . . 0.419 ' CD ' ' NH2' ' B' ' 228' ' ' ARG . 7.3 mmmt -120.09 16.81 12.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.355 -0.841 . . . . 2.08 108.896 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.02 172.23 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.32 109.672 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -137.43 126.96 25.07 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.742 -0.836 . . . . 1.79 108.742 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.96 107.33 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.168 -0.957 . . . . 0.45 109.451 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.57 147.66 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.336 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.55 145.76 25.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.35 -0.844 . . . . 3.62 109.433 179.673 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.941 -1.028 . . . . 2.05 109.571 179.712 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.0 -0.741 . . . . 1.48 109.0 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -133.16 132.33 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.535 -0.728 . . . . 0.72 109.256 -179.545 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 224' ' ' ARG . . . . . 0.632 ' NH2' ' CD2' ' A' ' 226' ' ' TYR . 0.2 OUTLIER -105.99 163.04 13.07 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.782 -1.192 . . . . 3.26 107.782 178.715 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.5 ' C ' HH22 ' A' ' 224' ' ' ARG . 96.2 t -141.47 139.66 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.021 -1.049 . . . . 0.23 110.491 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.632 ' CD2' ' NH2' ' A' ' 224' ' ' ARG . 47.5 m-85 -104.37 154.79 19.4 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.017 -1.475 . . . . 0.58 107.017 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.53 ' OH ' ' NZ ' ' A' ' 236' ' ' LYS . 23.7 p90 -158.71 163.39 36.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.372 -1.455 . . . . 0.44 110.983 -179.418 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -96.19 138.88 33.16 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.384 0.612 . . . . 2.76 109.527 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.38 -177.13 4.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.406 -0.809 . . . . 2.23 109.277 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.3 p -94.55 -11.72 28.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -0.929 . . . . 1.8 109.648 179.989 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 231' ' ' ARG . 2.9 mmp_? -79.51 -21.03 45.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.097 -1.002 . . . . 3.63 109.7 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.99 139.31 7.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 2.16 108.877 179.623 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.37 2.45 1.5 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 121.022 1.148 . . . . 1.25 111.304 -179.651 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.2 p -82.91 163.26 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.561 -1.337 . . . . 1.75 110.372 -179.361 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.573 ' N ' HG22 ' A' ' 234' ' ' VAL . 93.5 m95 -68.41 165.63 18.4 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.957 -0.757 . . . . 0.66 108.957 179.505 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.53 ' NZ ' ' OH ' ' A' ' 227' ' ' TYR . 5.6 ttpt -119.58 -163.17 0.96 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.226 -0.921 . . . . 1.43 109.328 -179.776 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.98 -179.05 32.25 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.699 -1.36 . . . . 0.39 109.699 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.05 158.94 45.24 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.777 1.651 . . . . 0.41 110.212 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.4 169.43 17.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.21 109.379 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -94.66 138.5 32.43 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.14 -0.975 . . . . 2.72 109.608 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.63 125.86 35.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.607 -0.683 . . . . 0.29 109.476 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.49 -72.95 0.66 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.447 -0.783 . . . . 0.45 110.108 179.925 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -93.04 145.4 24.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.31 110.129 -178.59 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -148.22 121.03 8.69 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.4 -0.812 . . . . 2.32 109.128 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.36 -102.41 0.2 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.734 -1.222 . . . . 0.27 110.324 -179.881 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.09 -153.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.221 -1.164 . . . . 1.39 109.803 -179.331 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.92 47.91 2.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.284 -1.527 . . . . 0.29 109.284 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.46 151.98 37.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.29 108.813 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.82 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.174 -0.954 . . . . 0.31 109.629 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.1 135.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.882 -1.155 . . . . 0.29 107.882 179.04 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -139.11 175.69 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.301 -0.874 . . . . 0.23 109.792 -179.02 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.86 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.746 -0.835 . . . . 1.81 108.746 179.216 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.75 -82.76 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.537 -1.282 . . . . 1.18 107.537 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 255' ' ' SER . 38.0 t-20 -78.96 -128.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.719 -1.586 . . . . 1.98 106.719 177.636 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.465 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 10.7 p -105.84 54.49 0.69 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.147 -1.056 . . . . 1.39 108.147 178.019 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 66.2 m-20 -155.05 123.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.55 -0.719 . . . . 1.12 109.099 -179.39 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.413 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 13.5 mt -94.23 136.54 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.47 109.58 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.52 169.8 17.09 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.11 109.622 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.24 142.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.33 109.027 179.389 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.49 131.38 19.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.34 109.164 -179.924 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.73 141.24 97.58 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.551 -0.98 . . . . 0.42 109.551 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -58.53 -35.63 72.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.209 -0.932 . . . . 3.12 109.512 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.58 -4.39 18.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 3.82 110.756 -179.157 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -118.96 21.27 12.47 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.124 -0.985 . . . . 2.08 108.819 179.429 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.18 16.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.32 109.591 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -141.64 124.79 16.36 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.294 -0.879 . . . . 1.79 109.142 179.802 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.77 101.53 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 0.45 109.701 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.467 ' HB ' HH11 ' A' ' 224' ' ' ARG . 5.7 mm -106.38 158.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.413 -0.958 . . . . 0.57 108.413 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.03 . . . . 3.63 109.444 179.555 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 108.999 -0.741 . . . . 1.48 108.999 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.16 132.37 41.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 0.73 109.205 -179.532 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 224' ' ' ARG . . . . . 0.636 ' NH2' ' CD2' ' B' ' 226' ' ' TYR . 0.2 OUTLIER -106.06 163.11 13.03 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.771 -1.196 . . . . 3.26 107.771 178.65 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.501 ' C ' HH22 ' B' ' 224' ' ' ARG . 95.6 t -141.6 139.5 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.23 110.52 -179.561 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 226' ' ' TYR . . . . . 0.636 ' CD2' ' NH2' ' B' ' 224' ' ' ARG . 47.3 m-85 -104.3 154.82 19.33 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.58 106.991 178.357 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' B' ' 236' ' ' LYS . 24.0 p90 -158.68 163.36 36.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.487 -1.383 . . . . 0.44 111.027 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.05 138.85 33.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.742 -0.599 . . . . 2.76 109.561 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.41 -177.09 4.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 2.23 109.249 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 29.1 p -94.59 -11.71 28.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.199 -0.938 . . . . 1.81 109.604 -179.921 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' N ' ' B' ' 231' ' ' ARG . 2.9 mmp_? -79.57 -21.15 45.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 3.64 109.606 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.87 139.36 7.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 2.16 108.9 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.39 2.45 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.086 1.191 . . . . 1.27 111.217 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.577 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.0 p -83.02 163.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.566 -1.334 . . . . 1.76 110.368 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.577 ' N ' HG22 ' B' ' 234' ' ' VAL . 93.4 m95 -68.42 165.7 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.996 -0.742 . . . . 0.67 108.996 179.588 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' B' ' 227' ' ' TYR . 5.6 ttpt -119.63 -163.16 0.97 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.308 -0.87 . . . . 1.44 109.345 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -72.07 -179.06 32.57 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.691 -1.364 . . . . 0.4 109.691 -179.694 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.1 159.09 44.88 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.639 1.559 . . . . 0.41 110.234 -179.697 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 169.33 17.87 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.436 -0.79 . . . . 0.21 109.48 179.461 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -94.48 138.49 32.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.124 -0.985 . . . . 2.72 109.786 179.74 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 tp -88.68 126.04 35.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.763 -0.586 . . . . 0.3 109.474 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.57 -73.17 0.65 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.451 -0.78 . . . . 0.45 110.019 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.4 t90 -92.91 145.37 24.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.311 -0.868 . . . . 0.33 110.257 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -148.14 120.96 8.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.361 -0.837 . . . . 2.33 109.132 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.31 -102.29 0.2 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.328 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.16 -153.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -1.159 . . . . 1.4 109.813 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 47.91 2.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.22 -1.552 . . . . 0.29 109.22 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.53 151.99 37.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.493 -1.004 . . . . 0.29 108.814 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.73 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.245 -0.909 . . . . 0.31 109.613 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.04 135.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.16 . . . . 0.3 107.869 179.017 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -138.94 175.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.24 109.861 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.87 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.726 -0.842 . . . . 1.81 108.726 179.105 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.72 -82.73 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.532 -1.284 . . . . 1.18 107.532 179.43 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 254' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 255' ' ' SER . 38.0 t-20 -78.92 -128.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.63 -1.619 . . . . 1.97 106.63 177.683 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 255' ' ' SER . . . . . 0.463 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 10.8 p -105.91 54.45 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.19 -1.041 . . . . 1.38 108.19 178.026 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 255' ' ' SER . 66.0 m-20 -155.04 123.93 6.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.585 -0.697 . . . . 1.12 109.167 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 13.3 mt -94.25 136.51 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.48 109.565 -179.686 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.49 169.84 17.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.263 -0.898 . . . . 2.13 109.604 -179.629 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.3 142.09 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.476 -0.765 . . . . 0.34 108.992 179.384 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.49 131.47 19.41 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.436 -0.79 . . . . 0.34 109.133 -179.992 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.71 141.24 97.53 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 N-CA-C 109.609 -0.958 . . . . 0.42 109.609 178.753 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -58.61 -35.58 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.211 -0.931 . . . . 3.11 109.516 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.53 -4.37 18.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 3.82 110.746 -179.149 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -119.12 21.34 12.36 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.227 -0.921 . . . . 2.08 108.887 179.454 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.74 170.16 16.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.53 -0.731 . . . . 0.32 109.658 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -141.72 124.71 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.238 -0.913 . . . . 1.79 109.165 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.74 101.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.25 -0.906 . . . . 0.45 109.668 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 268' ' ' ILE . . . . . 0.477 ' HB ' HH11 ' B' ' 224' ' ' ARG . 5.8 mm -106.44 158.13 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.373 -0.973 . . . . 0.57 108.373 179.025 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.29 152.85 21.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 3.62 109.405 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 2.05 109.39 179.794 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.771 -0.826 . . . . 1.48 108.771 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -125.64 140.64 52.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.434 -0.791 . . . . 0.72 109.788 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.99 157.78 24.08 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.796 -1.187 . . . . 3.26 107.796 178.865 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 239' ' ' ALA . 78.3 t -139.3 141.03 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.172 -0.955 . . . . 0.23 110.309 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -107.32 150.35 26.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.506 -1.294 . . . . 0.58 107.506 178.138 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 14.5 p90 -155.78 156.44 34.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.753 -1.217 . . . . 0.44 110.03 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -93.87 150.01 20.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.49 -0.756 . . . . 2.76 109.829 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -93.51 159.19 15.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 2.23 108.886 179.524 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 46.9 t -76.89 2.58 14.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.061 -1.024 . . . . 1.8 109.189 179.796 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.9 mtt-85 -90.37 -25.5 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 3.63 109.831 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.0 m-20 -162.44 144.48 8.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.059 -1.026 . . . . 2.16 109.271 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -64.41 11.4 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.268 1.312 . . . . 1.25 110.706 179.834 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.6 m -84.86 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.872 -1.142 . . . . 1.75 109.823 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -66.59 161.5 23.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.66 109.244 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 237' ' ' GLY . 45.2 tttp -119.1 166.43 12.93 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.456 -0.777 . . . . 1.43 109.496 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.14 171.83 0.02 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.2 -1.16 . . . . 0.39 110.2 -179.534 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.22 164.58 27.43 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.729 1.619 . . . . 0.41 110.501 179.997 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -140.47 169.34 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.093 -0.706 . . . . 0.21 109.093 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -92.9 136.23 33.44 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.041 -1.037 . . . . 2.72 109.609 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.39 125.94 34.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.595 -0.69 . . . . 0.29 109.602 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.2 mt -118.37 -76.86 0.57 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.423 -0.798 . . . . 0.45 110.164 179.77 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -102.99 139.3 38.73 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 0.31 110.684 -178.529 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.22 134.68 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 2.32 109.205 179.05 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.75 -99.91 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.389 -1.484 . . . . 0.27 109.389 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -66.99 -150.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 1.39 108.985 179.781 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.77 48.15 2.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.951 -1.66 . . . . 0.29 108.951 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.13 147.76 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -1.043 . . . . 0.29 109.304 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.89 136.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.144 -0.973 . . . . 0.31 109.165 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.2 t -89.69 145.24 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.29 109.162 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.0 pt -143.82 178.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.245 -0.909 . . . . 0.23 109.998 -179.887 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -144.54 114.31 7.25 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.702 -0.851 . . . . 1.81 108.702 179.06 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.31 -80.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.269 -1.382 . . . . 1.18 107.269 179.188 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.23 -129.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.9 -1.518 . . . . 1.98 106.9 177.608 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.1 m -104.54 54.87 0.72 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.931 -1.137 . . . . 1.39 107.931 177.99 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.23 125.35 6.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 1.12 109.126 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.8 mt -93.82 137.24 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 0.47 109.657 -179.613 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -140.26 163.55 32.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.586 -179.711 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.38 134.04 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.853 . . . . 0.33 108.899 179.356 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.59 133.04 24.37 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.34 108.827 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.47 140.76 94.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.669 0.913 . . . . 0.42 110.323 179.505 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -56.04 -38.02 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 3.12 109.881 179.662 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -68.38 -2.36 8.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.228 -0.92 . . . . 3.82 110.705 -178.945 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -119.13 16.19 13.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.619 -0.882 . . . . 2.08 108.619 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.12 170.69 15.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.688 -0.632 . . . . 0.32 109.311 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -140.01 127.37 21.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.287 -0.883 . . . . 1.79 109.12 179.876 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.24 109.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 0.45 109.47 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.46 150.04 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.748 -0.834 . . . . 0.57 108.748 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 3.63 109.317 179.573 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 108.763 -0.829 . . . . 1.48 108.763 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.68 140.53 52.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.464 -0.773 . . . . 0.73 109.793 -179.452 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.89 157.7 24.1 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.87 -1.159 . . . . 3.26 107.87 178.878 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 225' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 239' ' ' ALA . 79.8 t -139.22 141.07 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 0.23 110.375 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -107.42 150.3 26.92 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.458 -1.312 . . . . 0.58 107.458 178.146 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.4 p90 -155.7 156.45 34.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.44 110.046 -179.547 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -93.84 150.04 20.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.473 -0.767 . . . . 2.76 109.832 -179.844 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -93.52 159.05 15.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 2.23 108.922 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 46.8 t -76.79 2.56 14.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.058 -1.026 . . . . 1.81 109.204 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 231' ' ' ARG . . . . . 0.625 HH11 ' CG ' ' B' ' 231' ' ' ARG . 2.9 mtt-85 -90.52 -25.35 20.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 3.64 109.794 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.0 m-20 -162.52 144.43 8.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.068 -1.02 . . . . 2.16 109.242 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -64.27 11.31 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.822 0 C-N-CA 121.302 1.335 . . . . 1.27 110.775 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.6 m -84.82 145.22 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.132 . . . . 1.76 109.841 -179.477 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -66.56 161.51 22.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.67 109.387 179.814 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' B' ' 237' ' ' GLY . 45.2 tttp -119.07 166.39 12.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 1.44 109.504 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.15 171.75 0.02 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.202 -1.159 . . . . 0.4 110.202 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.1 164.64 26.93 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.687 1.591 . . . . 0.41 110.461 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 225' ' ' VAL . . . -140.52 169.3 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.21 109.073 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -92.9 136.28 33.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.038 -1.039 . . . . 2.72 109.657 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.4 126.08 35.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.474 -0.766 . . . . 0.3 109.587 -179.752 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.55 -76.78 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.58 -0.7 . . . . 0.45 110.152 179.792 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -103.01 139.43 38.58 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.217 -0.927 . . . . 0.33 110.637 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.25 134.68 18.46 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.344 -0.848 . . . . 2.33 109.188 179.069 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.83 -99.9 0.18 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.308 -1.517 . . . . 0.28 109.308 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.2 -149.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -1.128 . . . . 1.4 108.96 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.72 48.1 2.88 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.952 -1.659 . . . . 0.29 108.952 179.603 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.08 147.76 27.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -1.028 . . . . 0.29 109.296 -179.673 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.86 136.45 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.31 109.088 179.31 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.73 145.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.3 109.156 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -143.8 178.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.24 110.024 -179.891 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -144.57 114.41 7.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.033 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.38 -80.04 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.26 -1.385 . . . . 1.18 107.26 179.173 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.25 -129.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.837 -1.542 . . . . 1.97 106.837 177.653 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.2 m -104.5 54.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.2 125.41 6.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 1.12 109.169 -179.251 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 31.1 mt -93.86 137.36 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.48 109.67 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -140.27 163.57 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 2.13 109.576 -179.712 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.4 134.04 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 0.34 108.927 179.306 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.6 133.03 24.37 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.893 -0.78 . . . . 0.34 108.893 -179.904 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.52 140.83 94.5 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.687 0.925 . . . . 0.42 110.234 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -56.1 -37.97 70.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.852 . . . . 3.11 109.86 179.64 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -68.46 -2.31 8.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.299 -0.876 . . . . 3.82 110.71 -178.877 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -119.1 16.14 13.25 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 2.08 108.6 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 170.57 15.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.639 -0.663 . . . . 0.32 109.319 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -139.95 127.37 21.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.312 -0.868 . . . . 1.79 109.111 179.874 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.14 109.06 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 0.45 109.481 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.46 150.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.779 -0.823 . . . . 0.57 108.779 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -91.25 145.87 24.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.375 -0.828 . . . . 3.62 109.395 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.991 -1.004 . . . . 2.05 109.535 179.751 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.655 -0.868 . . . . 1.48 108.655 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -134.3 149.56 50.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.409 -0.807 . . . . 0.72 109.538 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -120.68 155.39 33.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.882 -1.155 . . . . 3.26 107.882 179.344 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.61 141.06 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.098 -1.001 . . . . 0.23 110.635 -179.625 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.73 155.81 22.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.281 -1.377 . . . . 0.58 107.281 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.485 -1.384 . . . . 0.44 110.739 -179.175 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -100.52 140.02 35.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.591 -0.693 . . . . 2.76 109.671 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.64 170.05 9.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.866 . . . . 2.23 109.376 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.3 m -84.63 -9.48 58.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 1.8 109.137 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.42 -10.9 47.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 3.63 109.516 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.6 p30 -158.88 133.95 5.67 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.179 -0.95 . . . . 2.16 109.354 -179.242 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.13 -7.05 20.23 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 120.975 1.116 . . . . 1.25 111.396 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.569 HG22 ' N ' ' A' ' 235' ' ' TRP . 3.7 p -87.1 163.49 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.563 -1.336 . . . . 1.75 110.416 -179.398 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.569 ' N ' HG22 ' A' ' 234' ' ' VAL . 83.2 m95 -66.31 -175.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.646 -0.659 . . . . 0.66 109.514 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 4.0 ttpp -130.77 -156.38 0.75 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.589 -0.893 . . . . 1.43 108.589 179.326 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.28 54.22 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.57 -1.412 . . . . 0.39 109.57 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -71.46 154.26 60.56 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.677 1.585 . . . . 0.41 109.975 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.78 25.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.767 . . . . 0.21 109.215 179.446 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.02 141.44 28.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 2.72 109.846 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.63 123.93 34.65 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.829 -0.544 . . . . 0.29 109.565 -179.719 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.06 -73.2 0.65 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.334 -0.854 . . . . 0.45 111.017 -179.543 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 243' ' ' TRP . . . . . 0.461 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 6.0 t90 -91.78 152.66 20.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.22 -0.925 . . . . 0.31 110.807 -177.97 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.46 128.34 21.93 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.523 -0.917 . . . . 2.32 108.523 178.934 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.4 -126.83 1.23 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.521 -1.323 . . . . 0.27 110.539 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.65 -144.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.589 -0.947 . . . . 1.39 109.342 -179.284 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.33 49.24 2.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.827 -1.709 . . . . 0.29 108.827 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.64 149.32 31.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.383 -1.069 . . . . 0.29 109.041 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.47 134.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.31 109.48 -179.826 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -91.9 140.84 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.287 -0.883 . . . . 0.29 109.077 179.816 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.98 176.7 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.88 . . . . 0.23 109.794 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -144.92 112.3 6.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.851 . . . . 1.81 109.018 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.41 -81.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.409 -1.33 . . . . 1.18 107.409 179.28 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.02 -131.42 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.651 -1.611 . . . . 1.98 106.651 177.585 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.5 t -104.34 57.07 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.7 -1.222 . . . . 1.39 107.7 177.82 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -155.73 122.43 5.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.142 -0.688 . . . . 1.12 109.142 -179.378 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.462 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 59.0 mt -93.05 134.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.258 -0.901 . . . . 0.47 109.331 -179.831 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.79 172.72 12.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.449 -0.782 . . . . 2.11 109.741 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.34 142.07 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.146 -0.687 . . . . 0.33 109.146 179.387 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.51 126.7 15.06 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.398 -0.964 . . . . 0.34 108.398 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.11 152.07 39.48 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 109.835 -0.871 . . . . 0.42 109.835 179.526 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.71 -34.59 77.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 3.12 109.742 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -70.93 -5.59 32.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.815 . . . . 3.82 111.329 -178.914 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -118.77 20.33 12.89 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.236 -0.915 . . . . 2.08 108.908 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.9 165.36 27.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.519 -0.738 . . . . 0.32 109.275 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.4 mtmp? -140.08 129.62 24.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.371 -0.831 . . . . 1.79 108.925 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.97 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.313 -0.867 . . . . 0.45 109.704 -179.35 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.45 150.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.055 -1.091 . . . . 0.57 108.055 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.187 -0.946 . . . . 3.63 109.216 179.652 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.608 -0.886 . . . . 1.48 108.608 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.23 149.54 50.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.73 109.491 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -120.67 155.33 34.07 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.902 -1.147 . . . . 3.26 107.902 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.53 141.14 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.146 -0.971 . . . . 0.23 110.652 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.84 155.78 23.06 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.181 -1.414 . . . . 0.58 107.181 178.363 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.487 -1.383 . . . . 0.44 110.808 -179.218 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -100.55 140.11 35.28 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.647 -0.658 . . . . 2.76 109.639 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.79 170.02 9.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.313 -0.867 . . . . 2.23 109.412 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -9.62 58.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 1.81 109.157 179.727 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.31 -10.85 48.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 3.64 109.536 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 232' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -158.94 133.9 5.62 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.181 -0.949 . . . . 2.16 109.335 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.99 -7.06 20.19 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 120.98 1.12 . . . . 1.27 111.349 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 234' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 235' ' ' TRP . 3.7 p -87.25 163.55 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.671 -1.268 . . . . 1.76 110.398 -179.391 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 235' ' ' TRP . . . . . 0.57 ' N ' HG22 ' B' ' 234' ' ' VAL . 83.2 m95 -66.34 -175.67 0.37 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.731 -0.605 . . . . 0.67 109.521 -179.956 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 236' ' ' LYS . . . . . 0.445 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 4.0 ttpp -130.79 -156.55 0.76 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.598 -0.89 . . . . 1.44 108.598 179.378 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.8 177.2 54.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.604 -1.398 . . . . 0.4 109.604 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.38 154.24 60.98 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.593 1.528 . . . . 0.41 110.027 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 165.91 24.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.45 -0.782 . . . . 0.21 109.181 179.423 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.08 141.48 28.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.116 -0.99 . . . . 2.72 109.808 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.61 123.93 34.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.814 -0.554 . . . . 0.3 109.623 -179.82 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.97 -73.25 0.65 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.348 -0.845 . . . . 0.45 111.079 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 243' ' ' TRP . . . . . 0.462 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 6.1 t90 -91.93 152.66 19.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.234 -0.916 . . . . 0.33 110.804 -177.943 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.31 128.28 22.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.588 -0.894 . . . . 2.33 108.588 179.014 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.38 -126.99 1.24 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.58 -1.295 . . . . 0.28 110.574 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.44 -144.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.954 . . . . 1.4 109.445 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.2 49.1 2.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.867 -1.693 . . . . 0.29 108.867 179.376 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.4 149.44 31.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -1.068 . . . . 0.29 109.001 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 134.76 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.246 -0.908 . . . . 0.31 109.455 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.97 140.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.828 . . . . 0.3 109.03 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.94 176.74 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.24 109.873 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -144.91 112.32 6.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.334 -0.854 . . . . 1.81 108.992 179.379 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.54 -81.13 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.398 -1.334 . . . . 1.18 107.398 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.98 -131.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.678 -1.601 . . . . 1.97 106.678 177.569 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 41.6 t -104.35 57.06 0.71 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.697 -1.223 . . . . 1.38 107.697 177.785 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -155.78 122.51 5.28 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.974 -0.75 . . . . 1.12 108.974 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 257' ' ' ILE . . . . . 0.461 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 59.0 mt -93.05 134.62 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.153 -0.967 . . . . 0.48 109.375 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.83 172.71 12.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.502 -0.749 . . . . 2.13 109.721 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.33 142.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.114 -0.699 . . . . 0.34 109.114 179.5 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.55 126.69 15.0 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.443 -0.947 . . . . 0.34 108.443 179.349 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.03 152.1 38.73 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 N-CA-C 109.791 -0.888 . . . . 0.42 109.791 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.73 -34.55 77.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.385 -0.822 . . . . 3.11 109.684 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -71.06 -5.63 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.288 -0.883 . . . . 3.82 111.238 -178.805 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -118.8 20.34 12.87 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.019 -1.051 . . . . 2.08 108.922 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.91 165.33 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.32 109.269 179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 266' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.4 mtmp? -139.99 129.55 24.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.294 -0.879 . . . . 1.79 108.987 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.87 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.45 109.725 -179.34 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -105.35 150.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.141 -1.059 . . . . 0.57 108.141 178.954 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 269' ' ' ARG . . . . . 0.553 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.09 142.24 27.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 3.62 109.289 179.605 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.045 -0.979 . . . . 2.05 109.197 179.608 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 52.3 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.508 -0.553 . . . . 3.82 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 220' ' ' ILE . 2.0 mp -83.59 104.98 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 2.08 109.109 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -84.75 -119.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.864 . . . . 2.17 109.182 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -96.52 102.98 14.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 1.48 109.055 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.28 138.12 43.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.53 -0.731 . . . . 0.72 109.542 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.624 HH11 ' CG ' ' A' ' 224' ' ' ARG . 1.0 OUTLIER -108.62 157.31 18.62 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.699 -1.223 . . . . 3.26 107.699 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.85 140.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.09 -1.006 . . . . 0.23 110.418 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.79 153.17 23.87 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.593 -1.262 . . . . 0.58 107.593 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.6 p90 -156.48 152.82 27.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.699 -1.251 . . . . 0.44 110.156 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -95.32 156.4 16.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 2.76 109.653 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -93.07 172.55 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.661 -0.866 . . . . 2.23 108.661 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.24 -13.7 46.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 1.8 109.251 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -90.75 -14.79 31.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 3.63 109.954 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 12.1 m-20 -161.02 128.81 2.77 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.912 -1.118 . . . . 2.16 109.553 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.13 18.0 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 121.021 1.147 . . . . 1.25 110.882 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 31.5 m -83.24 135.06 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.829 -1.169 . . . . 1.75 109.55 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -58.9 161.24 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.66 109.496 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 237' ' ' GLY . 42.5 tttp -121.91 161.48 22.74 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.378 -0.826 . . . . 1.43 109.883 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.21 165.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.244 -1.142 . . . . 0.39 110.244 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.15 158.61 53.73 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.661 1.574 . . . . 0.41 110.699 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.01 172.55 12.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.851 -0.796 . . . . 0.21 108.851 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -92.75 135.75 33.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 2.72 110.026 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -88.14 125.37 34.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.29 109.558 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.86 -74.39 0.61 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.426 -0.796 . . . . 0.45 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.483 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 3.8 t90 -89.85 140.91 29.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.226 -0.921 . . . . 0.31 109.846 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.26 119.7 9.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 2.32 108.791 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -104.42 0.23 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.87 -1.157 . . . . 0.27 110.215 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.69 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -1.067 . . . . 1.39 109.735 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 49.0 2.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.55 151.28 36.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.29 108.522 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.15 126.54 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.31 109.909 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.86 135.16 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.025 -1.102 . . . . 0.29 108.025 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 257' ' ' ILE . 18.1 pt -139.31 179.27 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.871 . . . . 0.23 110.135 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -143.22 110.33 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 1.81 108.772 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.95 -81.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.467 -1.309 . . . . 1.18 107.467 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -78.6 -137.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.505 -1.665 . . . . 1.98 106.505 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.3 m -97.97 54.13 1.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.899 -1.149 . . . . 1.39 107.899 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.45 128.59 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.988 -0.745 . . . . 1.12 108.988 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.476 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 19.0 mt -92.74 140.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.121 -0.987 . . . . 0.47 109.604 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -138.44 168.22 20.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.406 -0.809 . . . . 2.11 109.774 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.75 138.34 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.508 -0.745 . . . . 0.33 109.228 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.72 131.93 18.35 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.363 -0.836 . . . . 0.34 109.137 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.43 139.75 91.85 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 N-CA-C 109.599 -0.962 . . . . 0.42 109.599 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.1 OUTLIER -59.96 -34.76 73.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 3.12 109.722 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.23 -4.96 19.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 3.82 110.988 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -119.29 17.51 13.07 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.254 -0.904 . . . . 2.08 108.873 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.77 17.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.014 -0.736 . . . . 0.32 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.6 131.37 27.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.303 -0.873 . . . . 1.79 109.094 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.7 mm -88.27 108.1 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.45 110.215 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.01 149.0 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.091 -1.078 . . . . 0.57 108.091 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.47 151.85 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.302 -0.874 . . . . 3.63 108.771 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.99 -1.005 . . . . 2.05 109.312 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.48 -0.563 . . . . 3.83 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.734 ' N ' HD12 ' B' ' 220' ' ' ILE . 2.0 mp -83.51 105.0 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 2.08 109.11 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -84.78 -119.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 2.16 109.127 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -96.53 102.96 14.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.857 . . . . 1.48 109.014 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -135.3 138.07 43.09 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.484 -0.76 . . . . 0.73 109.534 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 224' ' ' ARG . 1.0 OUTLIER -108.51 157.36 18.53 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.681 -1.229 . . . . 3.26 107.681 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.92 140.06 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.108 -0.995 . . . . 0.23 110.375 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.74 153.14 23.88 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.621 -1.252 . . . . 0.58 107.621 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.47 152.77 27.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.668 -1.27 . . . . 0.44 110.241 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -95.27 156.37 16.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.476 -0.765 . . . . 2.76 109.688 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -93.13 172.46 8.29 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.65 -0.87 . . . . 2.23 108.65 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.15 -13.75 46.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.81 109.183 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.71 -14.81 31.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 3.64 109.979 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' B' ' 234' ' ' VAL . 12.0 m-20 -161.03 128.83 2.78 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.949 -1.094 . . . . 2.16 109.521 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.28 18.16 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 120.97 1.114 . . . . 1.27 110.81 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' B' ' 232' ' ' ASP . 31.7 m -83.31 135.13 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.795 -1.191 . . . . 1.76 109.535 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -58.97 161.22 5.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.67 109.516 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 42.5 tttp -121.92 161.47 22.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.368 -0.832 . . . . 1.44 109.879 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.26 165.5 0.02 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.277 -1.129 . . . . 0.4 110.277 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.28 158.68 53.71 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.619 1.546 . . . . 0.41 110.644 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.99 172.59 12.71 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.856 -0.794 . . . . 0.21 108.856 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -92.8 135.73 33.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.009 -1.057 . . . . 2.72 110.007 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.18 125.38 34.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.642 -0.662 . . . . 0.3 109.603 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.86 -74.49 0.6 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.442 -0.786 . . . . 0.45 110.158 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.476 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 3.8 t90 -89.76 140.84 29.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.142 -0.974 . . . . 0.33 109.815 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.19 119.67 9.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 2.33 108.816 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -104.51 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.246 -1.142 . . . . 0.28 110.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -67.63 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -1.078 . . . . 1.4 109.686 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.83 2.74 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.514 -1.435 . . . . 0.29 109.514 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.29 151.29 36.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -1.077 . . . . 0.29 108.522 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.12 126.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.159 -0.963 . . . . 0.31 109.838 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.89 135.27 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.996 -1.113 . . . . 0.3 107.996 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 257' ' ' ILE . 18.2 pt -139.4 179.14 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.24 110.083 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -143.14 110.34 5.69 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.735 -0.839 . . . . 1.81 108.735 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 -81.83 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -78.61 -137.42 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.451 -1.685 . . . . 1.97 106.451 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 18.4 m -97.95 54.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.53 128.48 7.34 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.966 -0.753 . . . . 1.12 108.966 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.483 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.0 mt -92.68 140.04 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 0.48 109.67 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -138.5 168.14 20.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 2.13 109.757 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.65 138.33 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.512 -0.743 . . . . 0.34 109.268 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.7 131.98 18.39 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.432 -0.793 . . . . 0.34 109.134 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.44 139.65 91.44 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 109.713 -0.918 . . . . 0.42 109.713 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.1 OUTLIER -59.89 -34.77 73.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 3.11 109.664 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.19 -5.03 20.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.838 . . . . 3.82 110.955 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -119.28 17.51 13.07 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.192 -0.942 . . . . 2.08 108.848 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.34 169.7 17.34 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.094 -0.706 . . . . 0.32 109.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.51 131.35 27.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.25 -0.906 . . . . 1.79 109.099 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -88.2 108.09 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.897 . . . . 0.45 110.16 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.98 149.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.107 -1.072 . . . . 0.57 108.107 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.51 151.82 21.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 3.62 108.854 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.946 -1.026 . . . . 2.05 109.35 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.464 -0.569 . . . . 3.82 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 223' ' ' PHE . 6.6 tp -83.14 137.21 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 2.08 109.192 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.46 -146.82 0.14 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 2.17 109.179 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.41 113.34 25.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.111 -0.993 . . . . 1.48 109.091 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.45 ' CD2' HD11 ' A' ' 220' ' ' ILE . 41.0 m-85 -135.21 142.27 45.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.72 109.473 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 28.5 mtp180 -108.63 156.67 19.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.536 -1.283 . . . . 3.26 107.536 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.1 t -141.54 143.99 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.072 -1.018 . . . . 0.23 110.794 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.96 155.87 22.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.599 -1.259 . . . . 0.58 107.599 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.8 151.88 26.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.44 110.224 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.6 mtm-85 -92.38 137.8 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 2.76 109.67 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.11 170.7 9.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.456 -0.777 . . . . 2.23 109.485 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.3 t -86.79 -9.13 56.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 1.8 109.513 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.39 43.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 3.63 110.055 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.479 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 26.0 p-10 -159.19 134.23 5.67 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.905 -1.122 . . . . 2.16 109.462 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.61 -7.96 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.027 1.152 . . . . 1.25 111.689 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.0 p -84.61 164.04 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.553 -1.342 . . . . 1.75 110.359 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.612 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.5 m95 -66.85 166.42 13.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.586 . . . . 0.66 109.595 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.11 166.37 13.01 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.349 -0.844 . . . . 1.43 109.383 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.0 164.08 0.06 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.115 -1.194 . . . . 0.39 110.115 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.15 164.4 30.4 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.543 1.496 . . . . 0.41 110.604 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.26 8.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.855 -0.794 . . . . 0.21 108.855 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.95 139.26 33.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.206 -0.934 . . . . 2.72 109.041 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -88.88 121.88 31.69 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.352 -0.842 . . . . 0.29 109.833 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.2 mt -110.19 -74.55 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.366 -0.834 . . . . 0.45 109.808 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.406 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.4 t90 -91.71 145.0 24.93 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.11 -0.994 . . . . 0.31 110.36 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.71 120.08 8.43 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.952 -0.758 . . . . 2.32 108.952 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -106.38 0.25 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.737 -1.22 . . . . 0.27 110.453 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.86 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -1.06 . . . . 1.39 109.871 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.69 49.1 2.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.29 109.469 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.2 150.0 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -1.066 . . . . 0.29 108.582 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.7 m -144.14 127.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.31 109.858 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 61.0 t -90.13 136.13 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.312 -0.995 . . . . 0.29 108.312 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.84 179.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.305 -0.872 . . . . 0.23 109.726 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -141.8 111.94 6.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -81.54 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.57 -1.27 . . . . 1.18 107.57 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.65 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.467 -1.679 . . . . 1.98 106.467 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.5 p -105.6 54.29 0.7 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.048 -1.033 . . . . 1.39 108.344 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 255' ' ' SER . 63.0 m-20 -155.87 127.78 7.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.547 -0.721 . . . . 1.12 109.22 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.41 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 79.5 mt -91.65 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.05 -1.031 . . . . 0.47 109.355 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.23 168.91 18.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.921 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.66 138.92 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.519 -0.738 . . . . 0.33 109.348 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.3 t -133.4 131.46 21.51 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.38 137.87 81.78 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.546 0.831 . . . . 0.42 110.124 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -57.14 -36.23 70.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 3.12 109.611 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.67 -3.0 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 3.82 110.717 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -119.37 19.5 12.73 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.154 -0.966 . . . . 2.08 109.029 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.67 171.87 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.32 109.513 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -139.87 129.23 24.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 1.79 108.996 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.65 107.29 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.206 -0.934 . . . . 0.45 109.565 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -105.75 154.02 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.648 -0.871 . . . . 0.57 108.648 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER -87.65 149.03 24.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 3.63 109.679 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 7.5 m-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.025 -0.988 . . . . 2.05 109.372 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.467 -0.568 . . . . 3.83 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' B' ' 223' ' ' PHE . 6.6 tp -83.22 137.19 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 2.08 109.162 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.49 -146.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.179 -0.95 . . . . 2.16 109.217 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.51 113.33 25.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.144 -0.973 . . . . 1.48 108.98 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' B' ' 220' ' ' ILE . 41.0 m-85 -135.08 142.25 46.25 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.442 -0.786 . . . . 0.73 109.541 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 28.4 mtp180 -108.59 156.58 19.37 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.525 -1.287 . . . . 3.26 107.525 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.5 144.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.075 -1.016 . . . . 0.23 110.662 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.1 155.77 22.34 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.71 151.96 26.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.741 -1.225 . . . . 0.44 110.238 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.7 mtm-85 -92.49 137.96 31.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.76 109.525 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.15 170.79 9.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 2.23 109.417 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 36.6 t -86.94 -8.94 56.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 1.81 109.429 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.41 43.85 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 3.64 110.004 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 25.8 p-10 -159.22 134.19 5.63 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.979 -1.076 . . . . 2.16 109.429 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.64 -7.96 20.92 Favored 'Trans proline' 0 N--CA 1.483 0.896 0 C-N-CA 121.001 1.134 . . . . 1.27 111.701 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.1 p -84.51 163.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.535 -1.353 . . . . 1.76 110.362 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.4 m95 -66.88 166.31 13.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.81 -0.556 . . . . 0.67 109.547 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.07 166.17 13.23 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.424 -0.797 . . . . 1.44 109.422 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.04 164.14 0.06 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.955 -1.258 . . . . 0.4 109.955 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -67.3 164.5 30.3 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.41 110.526 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.37 8.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.895 -0.78 . . . . 0.21 108.895 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.86 139.31 33.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.255 -0.903 . . . . 2.72 109.007 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -89.0 122.03 31.94 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.387 -0.821 . . . . 0.3 109.826 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.3 mt -110.25 -74.56 0.65 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.427 -0.796 . . . . 0.45 109.82 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -91.79 145.04 24.89 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.127 -0.983 . . . . 0.33 110.387 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -147.65 120.12 8.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.365 -0.834 . . . . 2.33 108.896 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -106.43 0.25 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.84 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -1.038 . . . . 1.4 109.855 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.7 49.23 2.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.06 33.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -1.06 . . . . 0.29 108.655 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -144.29 127.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.31 109.838 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.03 136.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.289 -1.004 . . . . 0.3 108.289 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.85 179.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 0.24 109.761 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -141.81 111.76 6.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.32 -81.62 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.647 -1.242 . . . . 1.18 107.647 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.57 -129.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.538 -1.653 . . . . 1.97 106.538 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.5 p -105.63 54.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.344 -0.984 . . . . 1.38 108.344 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 255' ' ' SER . 62.7 m-20 -155.87 127.69 7.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 1.12 109.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.406 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 79.3 mt -91.66 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.143 -0.973 . . . . 0.48 109.312 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -137.37 168.89 18.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.13 109.839 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.72 138.74 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.493 -0.755 . . . . 0.34 109.352 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 23.1 t -133.26 131.68 21.76 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.46 137.85 81.98 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 120.566 0.844 . . . . 0.42 110.17 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -57.05 -36.42 70.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 3.11 109.618 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.51 -3.19 13.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.221 -0.924 . . . . 3.82 110.789 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -119.18 19.45 12.87 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.242 -0.911 . . . . 2.08 109.039 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.63 171.91 13.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.32 109.489 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -140.01 129.17 23.73 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.405 -0.809 . . . . 1.79 108.892 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.6 107.36 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.183 -0.948 . . . . 0.45 109.623 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.5 mm -105.77 154.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.582 -0.896 . . . . 0.57 108.582 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.7 OUTLIER -87.61 149.13 24.5 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.349 -0.844 . . . . 3.62 109.604 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.6 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.976 -1.011 . . . . 2.05 109.417 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.364 -0.606 . . . . 3.82 109.364 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.77 140.5 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 2.08 108.329 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -84.14 -136.77 0.05 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 2.17 110.023 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -96.3 108.59 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.315 -0.865 . . . . 1.48 109.474 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -135.12 131.07 36.43 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.762 -0.829 . . . . 0.72 108.762 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -102.8 153.17 20.43 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 3.26 108.362 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.53 142.71 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 0.23 110.2 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.14 158.81 18.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.491 -1.299 . . . . 0.58 107.491 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.4 p90 -156.37 153.59 29.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.447 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.4 mtm-85 -95.88 147.49 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.531 -0.73 . . . . 2.76 110.115 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 14.5 p-10 -94.32 168.49 10.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -0.786 . . . . 2.23 109.203 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.5 t -84.92 -2.77 58.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 1.8 109.747 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -87.71 -23.79 24.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 3.63 109.834 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 234' ' ' VAL . 10.1 m-20 -163.15 142.39 6.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.99 . . . . 2.16 108.895 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.95 10.23 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.226 1.284 . . . . 1.25 110.826 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -82.75 156.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.644 -1.285 . . . . 1.75 110.415 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.488 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.2 m95 -75.69 -172.55 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.476 -0.564 . . . . 0.66 109.476 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.09 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 1.43 108.184 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.46 172.19 55.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.694 -1.362 . . . . 0.39 109.694 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.3 156.67 65.24 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.55 1.5 . . . . 0.41 110.166 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.02 166.23 25.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.21 109.093 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.42 140.5 29.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 2.72 109.547 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.42 125.24 34.63 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.462 -0.57 . . . . 0.29 109.462 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.9 mt -115.19 -69.97 0.82 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.84 . . . . 0.45 109.982 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.76 143.1 26.88 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.056 -1.027 . . . . 0.31 110.315 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.88 115.42 6.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.272 -0.892 . . . . 2.32 109.235 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.75 0.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.204 -1.158 . . . . 0.27 110.204 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -68.68 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.277 -1.131 . . . . 1.39 109.802 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 51.36 3.03 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.326 -1.509 . . . . 0.29 109.326 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.28 33.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.518 -0.989 . . . . 0.29 108.577 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.88 125.53 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.31 109.682 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.34 135.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.196 -1.038 . . . . 0.29 108.196 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.6 pt -137.66 -178.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.395 -0.816 . . . . 0.23 110.139 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -143.48 111.63 6.2 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.37 -77.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.509 -1.293 . . . . 1.18 107.509 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.81 -132.27 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.944 -1.502 . . . . 1.98 106.944 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.9 p -104.26 53.04 0.75 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.958 -1.127 . . . . 1.39 107.958 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -156.1 127.29 7.05 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.986 -0.746 . . . . 1.12 108.986 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.9 mt -91.23 134.72 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.47 109.344 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -136.12 170.55 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.79 . . . . 2.11 109.857 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.73 139.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.33 109.826 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.73 124.03 14.28 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.626 -0.879 . . . . 0.34 108.626 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.75 139.37 90.06 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 N-CA-C 110.134 -0.756 . . . . 0.42 110.134 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -61.29 -30.48 70.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 3.12 109.407 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' A' ' 263' ' ' ARG . 0.0 OUTLIER -69.83 -9.91 56.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.41 -0.806 . . . . 3.82 110.06 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.45 22.96 11.48 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.242 -0.911 . . . . 2.08 109.11 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 169.57 17.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.081 -0.711 . . . . 0.32 109.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -137.11 127.89 27.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 1.79 108.783 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.44 109.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.45 109.893 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -103.34 152.63 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -93.4 137.38 32.75 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 3.63 109.353 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.02 -0.99 . . . . 2.05 109.519 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 34.4 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.425 -0.583 . . . . 3.83 109.425 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.73 140.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.421 -0.955 . . . . 2.08 108.421 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -84.24 -136.77 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.96 -1.088 . . . . 2.16 110.011 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -96.27 108.49 20.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.349 -0.844 . . . . 1.48 109.589 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 131.02 36.45 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.783 -0.821 . . . . 0.73 108.783 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -102.7 153.09 20.48 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.424 -0.954 . . . . 3.26 108.424 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.52 142.69 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -0.885 . . . . 0.23 110.156 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -111.2 158.74 18.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.496 -1.298 . . . . 0.58 107.496 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.3 p90 -156.21 153.69 29.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.586 -1.321 . . . . 0.44 110.45 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' B' ' 228' ' ' ARG . 10.5 mtm-85 -95.99 147.44 23.69 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.818 . . . . 2.76 110.094 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 14.7 p-10 -94.31 168.55 10.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.819 . . . . 2.23 109.268 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -85.02 -2.77 58.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 1.81 109.719 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -87.69 -23.73 24.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 3.64 109.767 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 9.9 m-20 -163.19 142.38 6.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.16 108.825 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -62.99 10.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.179 1.252 . . . . 1.27 110.895 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.501 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.7 p -82.69 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.657 -1.277 . . . . 1.76 110.372 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.501 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.3 m95 -75.77 -172.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.501 -0.555 . . . . 0.67 109.501 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.06 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.229 -1.026 . . . . 1.44 108.229 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.48 172.19 55.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.697 -1.361 . . . . 0.4 109.697 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.31 156.54 65.79 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.578 1.519 . . . . 0.41 110.205 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.49 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.21 109.124 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.55 140.57 29.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.092 -1.005 . . . . 2.72 109.495 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 17.8 tp -88.55 125.26 34.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.04 -70.08 0.82 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.281 -0.887 . . . . 0.45 110.082 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -91.72 143.17 26.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.096 -1.003 . . . . 0.33 110.269 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.92 115.39 6.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 2.33 109.184 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.65 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.914 -1.136 . . . . 0.28 110.301 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -68.76 -156.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 1.4 109.774 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.72 51.38 3.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.306 -1.518 . . . . 0.29 109.306 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.17 33.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.991 . . . . 0.29 108.575 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.86 125.66 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.31 109.598 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.42 135.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.194 -1.039 . . . . 0.3 108.194 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.5 pt -137.7 -178.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.309 -0.869 . . . . 0.24 110.206 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -143.5 111.45 6.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.36 -77.39 0.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.519 -1.289 . . . . 1.18 107.519 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.8 -132.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.905 -1.517 . . . . 1.97 106.905 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 5.8 p -104.25 53.07 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -156.1 127.23 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.963 -0.754 . . . . 1.12 108.963 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.404 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 55.4 mt -91.08 134.77 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.48 109.369 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -136.15 170.57 15.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 2.13 109.845 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 8.8 t -99.76 139.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.455 -0.778 . . . . 0.34 109.821 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.9 t -136.75 123.92 14.18 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.6 139.46 90.29 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 110.006 -0.806 . . . . 0.42 110.006 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.41 -30.51 70.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 3.11 109.394 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.0 OUTLIER -69.78 -9.91 56.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.45 -0.781 . . . . 3.82 110.07 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.54 23.05 11.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.295 -0.878 . . . . 2.08 109.053 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.44 169.37 17.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.1 -0.704 . . . . 0.32 109.1 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -136.96 127.89 27.5 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.752 -0.833 . . . . 1.79 108.752 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.1 mm -88.48 109.55 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.91 . . . . 0.45 109.919 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.39 152.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.491 -0.929 . . . . 0.57 108.491 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -93.32 137.34 32.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.388 -0.82 . . . . 3.62 109.342 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.999 -1.001 . . . . 2.05 109.504 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.44 -0.578 . . . . 3.82 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 220' ' ' ILE . 14.4 tt -81.29 132.62 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 2.08 109.38 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -89.26 -142.9 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.689 -0.856 . . . . 2.17 108.689 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -90.51 100.07 12.98 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.008 -1.058 . . . . 1.48 108.762 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -120.91 141.14 50.92 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.618 -0.676 . . . . 0.72 109.924 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -113.29 157.76 21.4 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.523 -1.288 . . . . 3.26 107.523 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.19 143.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.066 -1.021 . . . . 0.23 110.627 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -112.88 157.79 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.654 -1.239 . . . . 0.58 107.654 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 14.6 p90 -157.48 147.35 20.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.701 -1.25 . . . . 0.44 110.144 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.64 142.52 27.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.054 -1.029 . . . . 2.76 109.425 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.41 166.55 12.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 2.23 109.369 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.3 p -85.81 -10.15 55.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.921 . . . . 1.8 109.635 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.44 36.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.202 -0.936 . . . . 3.63 109.44 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 234' ' ' VAL . 3.3 p30 -159.23 128.04 3.05 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.31 -0.869 . . . . 2.16 109.105 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.62 9.22 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.805 1.004 . . . . 1.25 110.328 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 232' ' ' ASP . 4.4 t -84.06 156.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.013 -1.055 . . . . 1.75 109.764 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.05 169.75 16.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.66 109.611 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.3 mmtt -119.36 157.25 28.54 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.644 -0.873 . . . . 1.43 108.644 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.12 174.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.39 109.296 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.7 155.76 68.72 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.545 1.497 . . . . 0.41 110.693 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.67 171.91 13.79 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.925 -0.769 . . . . 0.21 108.925 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -93.91 137.39 33.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.049 -1.032 . . . . 2.72 109.707 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.12 121.4 31.41 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.594 -0.691 . . . . 0.29 109.28 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.16 -68.94 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.309 -0.87 . . . . 0.45 110.499 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -95.42 147.35 23.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.002 -1.061 . . . . 0.31 110.353 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.3 119.42 7.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.374 -0.829 . . . . 2.32 108.963 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.0 -109.2 0.32 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.784 -1.198 . . . . 0.27 110.397 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.88 -150.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -1.12 . . . . 1.39 109.488 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.5 56.18 2.47 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.196 -1.562 . . . . 0.29 109.196 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.49 146.72 22.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.364 -1.08 . . . . 0.29 109.643 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.05 121.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.672 -0.862 . . . . 0.31 108.672 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 59.4 t -84.73 132.16 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.375 -0.972 . . . . 0.29 108.375 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -137.96 178.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.23 109.977 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -142.33 110.2 5.86 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -91.12 -78.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.357 -1.349 . . . . 1.18 107.357 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.59 -131.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.762 -1.569 . . . . 1.98 106.762 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 58.8 m -105.35 54.5 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.114 -1.069 . . . . 1.39 108.114 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.8 m-20 -157.08 127.33 6.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 1.12 109.312 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.424 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 79.8 mt -94.18 134.26 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.47 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.22 172.53 12.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 2.11 109.812 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.38 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.33 109.404 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.62 131.75 16.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.798 . . . . 0.34 108.909 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.49 142.98 92.36 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 N-CA-C 109.545 -0.983 . . . . 0.42 109.545 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -55.84 -34.69 65.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 3.12 108.641 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -65.35 -10.83 36.33 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.666 -0.697 . . . . 3.82 110.76 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.73 17.68 12.71 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.278 -1.008 . . . . 2.08 108.278 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.1 168.03 20.58 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.316 -0.624 . . . . 0.32 109.316 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -140.47 126.85 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.205 -0.934 . . . . 1.79 109.171 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.3 mm -87.54 108.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.242 -0.911 . . . . 0.45 109.486 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.18 152.92 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.524 -0.917 . . . . 0.57 108.524 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.4 ' O ' ' OD1' ' A' ' 270' ' ' ASP . 57.3 ttt180 -91.54 143.65 26.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 3.63 109.934 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 269' ' ' ARG . 3.5 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.024 -0.989 . . . . 2.05 109.484 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.4 -0.593 . . . . 3.83 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.441 ' O ' HG23 ' B' ' 220' ' ' ILE . 14.4 tt -81.07 132.56 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 2.08 109.472 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -89.16 -142.73 0.14 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.74 -0.837 . . . . 2.16 108.74 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -90.73 100.15 13.06 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.016 -1.052 . . . . 1.48 108.708 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.03 141.06 51.1 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.63 -0.668 . . . . 0.73 109.796 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -113.31 157.75 21.41 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.559 -1.274 . . . . 3.26 107.559 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.1 143.83 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.022 -1.049 . . . . 0.23 110.776 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.83 157.77 20.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.667 -1.235 . . . . 0.58 107.667 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.0 p90 -157.4 147.38 20.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.292 . . . . 0.44 110.161 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.62 142.42 27.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.104 -0.997 . . . . 2.76 109.502 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -92.41 166.46 12.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.408 -0.808 . . . . 2.23 109.394 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.6 p -85.68 -10.25 55.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.219 -0.925 . . . . 1.81 109.651 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.37 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.099 -1.0 . . . . 3.64 109.442 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' B' ' 234' ' ' VAL . 3.3 p30 -159.23 127.88 3.0 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.083 -1.011 . . . . 2.16 109.195 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -67.56 9.34 0.34 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.74 0.96 . . . . 1.27 110.364 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' B' ' 232' ' ' ASP . 4.4 t -84.05 156.1 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.967 -1.083 . . . . 1.76 109.809 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -72.97 169.74 16.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.371 -0.83 . . . . 0.67 109.666 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mmtt -119.4 157.2 28.69 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.7 -0.852 . . . . 1.44 108.7 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.14 174.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.337 -1.505 . . . . 0.4 109.337 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -67.65 155.8 68.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.5 1.466 . . . . 0.41 110.648 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.61 171.95 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.902 -0.777 . . . . 0.21 108.902 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -93.94 137.44 33.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.133 -0.979 . . . . 2.72 109.684 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.22 121.39 31.47 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.542 -0.724 . . . . 0.3 109.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.17 -68.97 0.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.235 -0.916 . . . . 0.45 110.462 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -95.38 147.41 23.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.056 -1.027 . . . . 0.33 110.339 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.33 119.43 7.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.802 . . . . 2.33 109.004 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.05 -109.25 0.32 Allowed Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.738 -1.22 . . . . 0.28 110.336 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.9 -150.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -1.137 . . . . 1.4 109.497 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.47 56.23 2.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.274 -1.531 . . . . 0.29 109.274 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.5 146.82 22.74 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.342 -1.093 . . . . 0.29 109.559 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.12 121.13 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.601 -0.889 . . . . 0.31 108.601 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 60.3 t -84.81 132.06 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.3 108.416 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -137.8 178.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.454 -0.779 . . . . 0.24 110.035 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -142.31 110.28 5.89 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.662 -0.866 . . . . 1.81 108.662 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -91.26 -78.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.307 -1.368 . . . . 1.18 107.307 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -80.53 -131.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.731 -1.581 . . . . 1.97 106.731 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 58.8 m -105.33 54.52 0.7 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.208 -1.034 . . . . 1.38 108.208 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.8 m-20 -157.06 127.33 6.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.474 -0.766 . . . . 1.12 109.242 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.417 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 79.4 mt -94.11 134.2 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.48 109.51 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.08 172.48 12.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.324 -0.86 . . . . 2.13 109.843 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.35 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.459 -0.776 . . . . 0.34 109.407 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.64 131.8 16.13 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 0.34 108.918 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.4 142.93 92.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 N-CA-C 109.506 -0.998 . . . . 0.42 109.506 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -55.8 -34.76 65.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.853 -1.155 . . . . 3.11 108.717 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -65.27 -10.92 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.649 -0.705 . . . . 3.82 110.724 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.7 17.76 12.72 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.257 -1.016 . . . . 2.08 108.257 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.07 168.1 20.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.259 -0.645 . . . . 0.32 109.259 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -140.55 126.82 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.249 -0.907 . . . . 1.79 109.154 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.1 mm -87.51 108.38 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.887 . . . . 0.45 109.556 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.23 152.8 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.49 -0.93 . . . . 0.57 108.49 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -91.4 143.67 26.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 3.62 109.94 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.541 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' A' ' 219' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.255 0.55 . . . . 3.82 109.527 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.92 104.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -0.889 . . . . 2.08 108.799 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -85.02 -125.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 2.17 109.468 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -93.48 104.27 16.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.236 -0.915 . . . . 1.48 109.001 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -128.18 132.77 48.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.105 -0.702 . . . . 0.72 109.105 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.37 159.47 15.7 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.382 -0.97 . . . . 3.26 108.382 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.83 141.68 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.156 -0.965 . . . . 0.23 110.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.68 151.28 27.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.55 -1.278 . . . . 0.58 107.55 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.0 p90 -156.43 151.21 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.651 -1.281 . . . . 0.44 110.441 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -92.72 141.68 28.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.589 -0.694 . . . . 2.76 109.577 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 5.0 p30 -93.79 165.72 12.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.423 -0.798 . . . . 2.23 109.044 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.99 -0.06 47.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 1.8 109.162 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 10.1 mmm180 -90.01 -20.96 22.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.387 -0.82 . . . . 3.63 109.205 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.7 m-20 -161.03 134.05 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.777 -0.823 . . . . 2.16 108.777 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.73 8.86 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 120.727 0.951 . . . . 1.25 110.208 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.2 t -84.06 159.18 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.034 -1.041 . . . . 1.75 109.921 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.435 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.9 m95 -75.09 164.88 26.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 0.66 108.959 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 237' ' ' GLY . 32.5 tttp -120.01 158.25 27.17 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.395 -0.816 . . . . 1.43 109.652 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.61 165.83 0.03 OUTLIER Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.283 -1.127 . . . . 0.39 110.283 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.97 163.25 36.42 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.705 1.603 . . . . 0.41 110.452 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.17 178.45 7.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.21 109.187 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.09 137.19 35.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.154 -0.966 . . . . 2.72 109.393 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.9 tp -87.88 124.64 33.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.413 -0.805 . . . . 0.29 109.238 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.58 -74.01 0.62 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.459 -0.776 . . . . 0.45 109.99 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.532 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.0 t90 -92.32 141.69 28.27 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.31 109.719 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.85 116.91 7.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.906 . . . . 2.32 109.138 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.13 -105.04 0.23 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.905 -1.14 . . . . 0.27 110.308 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -62.39 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.104 . . . . 1.39 109.877 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 49.86 2.79 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.773 -1.331 . . . . 0.29 109.773 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.76 154.11 39.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -1.126 . . . . 0.29 108.696 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.06 122.79 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.31 109.747 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.72 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.963 -1.125 . . . . 0.29 107.963 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.43 174.79 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.23 110.033 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.4 109.4 5.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.147 -1.057 . . . . 1.81 108.147 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.43 -79.75 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 1.18 107.574 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.5 -128.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 13.0 p -105.89 53.38 0.71 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.284 -1.006 . . . . 1.39 108.284 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.7 m-20 -155.69 129.85 8.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 1.12 109.487 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.418 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.6 mt -95.11 139.86 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.461 -0.774 . . . . 0.47 110.07 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -140.32 162.87 34.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.416 -0.802 . . . . 2.11 109.462 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.97 141.8 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.215 -0.928 . . . . 0.33 108.857 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.83 130.77 18.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.375 -0.828 . . . . 0.34 109.452 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.66 141.37 97.57 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.688 -0.928 . . . . 0.42 109.688 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.26 -29.48 69.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 3.12 109.727 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -70.04 -12.0 61.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.865 . . . . 3.82 111.042 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.83 28.06 8.15 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.153 -0.967 . . . . 2.08 109.273 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.09 168.87 18.81 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.801 -0.814 . . . . 0.32 108.801 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.07 126.94 19.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.224 -0.922 . . . . 1.79 109.392 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.52 109.73 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.343 -0.848 . . . . 0.45 109.67 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.31 149.41 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.394 -0.965 . . . . 0.57 108.394 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -90.41 144.91 25.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.856 . . . . 3.63 109.806 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 2.05 109.339 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 219' ' ' MET . . . . . 0.571 ' N ' ' SD ' ' B' ' 219' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.502 -0.555 . . . . 3.83 109.502 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.98 104.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.329 -0.857 . . . . 2.08 108.837 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.08 -125.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.988 . . . . 2.16 109.415 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -93.54 104.26 16.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.189 -0.944 . . . . 1.48 109.032 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -128.23 132.86 48.76 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.73 109.071 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -104.45 159.43 15.74 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.417 -0.957 . . . . 3.26 108.417 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.8 141.67 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.23 110.403 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.64 151.31 27.82 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.617 -1.253 . . . . 0.58 107.617 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.1 p90 -156.46 151.23 25.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.752 -1.218 . . . . 0.44 110.454 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -92.76 141.62 28.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.569 -0.707 . . . . 2.76 109.595 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 4.9 p30 -93.79 165.78 12.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.441 -0.787 . . . . 2.23 109.075 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.93 -0.24 47.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 1.81 109.182 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 10.1 mmm180 -89.93 -21.01 22.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 3.64 109.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.7 m-20 -161.08 134.05 4.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.787 -0.82 . . . . 2.16 108.787 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.61 8.69 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 120.765 0.977 . . . . 1.27 110.169 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.3 t -84.01 159.17 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.009 -1.057 . . . . 1.76 109.958 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.441 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.9 m95 -75.04 164.95 26.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.45 -0.781 . . . . 0.67 109.146 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' B' ' 237' ' ' GLY . 32.6 tttp -120.0 158.24 27.19 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.398 -0.814 . . . . 1.44 109.607 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.55 165.76 0.02 OUTLIER Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.296 -1.122 . . . . 0.4 110.296 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.95 163.26 36.38 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.658 1.572 . . . . 0.41 110.583 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.2 178.38 7.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.21 109.235 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.02 137.1 35.57 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 2.72 109.417 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.74 124.64 33.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.342 -0.849 . . . . 0.3 109.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.65 -73.93 0.63 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.465 -0.772 . . . . 0.45 109.983 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.418 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.0 t90 -92.28 141.6 28.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.2 -0.937 . . . . 0.33 109.844 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.76 117.04 7.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 2.33 109.047 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.17 -105.03 0.23 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.876 -1.155 . . . . 0.28 110.241 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -62.53 -158.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 1.4 109.819 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.56 49.85 2.78 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.859 -1.296 . . . . 0.29 109.859 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.04 38.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -1.086 . . . . 0.29 108.614 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.04 122.83 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.31 109.752 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.71 138.42 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.93 -1.137 . . . . 0.3 107.93 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.9 pt -141.54 174.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.24 109.956 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.38 109.32 5.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.235 -1.024 . . . . 1.81 108.235 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.4 -79.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.483 -1.303 . . . . 1.18 107.483 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.51 -128.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.592 -1.633 . . . . 1.97 106.592 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 13.0 p -105.8 53.21 0.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.267 -1.012 . . . . 1.38 108.267 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.6 m-20 -155.63 129.89 8.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.435 -0.79 . . . . 1.12 109.475 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.8 mt -95.13 139.83 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.434 -0.791 . . . . 0.48 110.076 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -140.29 162.87 34.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.417 -0.802 . . . . 2.13 109.491 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.93 141.84 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.34 108.916 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.79 130.78 18.84 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.34 109.444 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.72 141.39 97.7 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 N-CA-C 109.687 -0.928 . . . . 0.42 109.687 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.17 -29.62 69.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 3.11 109.68 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -69.96 -12.05 61.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 3.82 111.117 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.77 28.08 8.14 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.08 -1.012 . . . . 2.08 109.304 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.11 168.85 18.87 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.834 -0.802 . . . . 0.32 108.834 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.02 126.89 19.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.142 -0.974 . . . . 1.79 109.369 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.49 109.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.45 109.749 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.27 149.36 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.472 -0.936 . . . . 0.57 108.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -90.3 144.86 25.44 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.358 -0.839 . . . . 3.62 109.879 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.014 -0.993 . . . . 2.05 109.252 179.812 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.31 0.576 . . . . 3.82 109.461 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 33.5 mm -85.26 140.02 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 2.08 109.038 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -84.14 -137.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.084 -1.01 . . . . 2.17 109.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -91.35 98.44 11.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 1.48 109.038 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.43 131.87 38.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.563 -0.711 . . . . 0.72 109.559 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.82 19.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.604 -1.258 . . . . 3.26 107.604 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -139.93 140.54 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 0.23 110.311 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.97 154.58 20.89 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.352 -1.351 . . . . 0.58 107.352 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.8 p90 -155.34 153.34 30.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.55 -1.344 . . . . 0.44 110.645 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -96.03 133.24 40.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.448 -0.783 . . . . 2.76 109.323 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -95.58 177.23 5.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 2.23 109.106 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 p -88.06 -11.63 46.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 1.8 108.932 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 231' ' ' ARG . 11.3 mpt_? -81.49 -13.37 58.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 3.63 109.124 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 15.6 p-10 -161.32 129.78 2.96 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.17 -0.956 . . . . 2.16 109.552 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.13 0.62 4.92 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 N-CA-C 109.574 -0.972 . . . . 1.25 109.574 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 235' ' ' TRP . 45.0 t -85.44 160.83 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 1.75 110.215 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.485 ' N ' HG12 ' A' ' 234' ' ' VAL . 98.5 m95 -67.46 163.35 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.523 -0.917 . . . . 0.66 108.523 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 40.7 tttp -119.95 164.79 15.54 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.267 -0.896 . . . . 1.43 109.748 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.02 169.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.458 -1.057 . . . . 0.39 110.458 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.15 161.02 47.53 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.985 1.79 . . . . 0.41 110.752 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.18 175.85 9.31 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.67 -0.863 . . . . 0.21 108.67 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -94.03 139.38 31.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.954 -1.091 . . . . 2.72 109.127 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.9 tp -89.33 125.17 35.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.898 . . . . 0.29 109.73 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.7 mt -117.49 -77.58 0.57 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.502 -0.749 . . . . 0.45 110.719 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -93.36 136.74 33.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.993 -1.067 . . . . 0.31 110.458 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.5 127.2 13.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.85 . . . . 2.32 109.249 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.64 -105.33 0.24 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.549 -1.42 . . . . 0.27 109.549 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 245' ' ' GLY . 25.5 mt-10 -60.09 -154.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 1.39 109.149 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.0 45.97 2.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.922 -1.671 . . . . 0.29 108.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.73 141.44 18.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.965 . . . . 0.29 108.867 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.29 144.26 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.116 -0.99 . . . . 0.31 108.931 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 147.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.101 -0.999 . . . . 0.29 109.993 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.26 178.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.749 . . . . 0.23 109.488 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -144.72 110.86 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.241 -1.022 . . . . 1.81 108.241 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.94 -78.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.551 -1.277 . . . . 1.18 107.551 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -139.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.713 -1.588 . . . . 1.98 106.713 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 60.2 p -97.22 53.79 1.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 2.6 m-20 -155.14 126.22 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.949 -0.76 . . . . 1.12 108.949 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 41.3 mt -92.43 135.46 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.47 109.488 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.85 169.93 16.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.426 -0.797 . . . . 2.11 109.562 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.15 139.99 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.33 109.532 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.6 126.75 18.27 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.06 141.89 96.56 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 N-CA-C 110.039 -0.793 . . . . 0.42 110.039 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.48 -34.09 66.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.315 -0.866 . . . . 3.12 109.138 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -70.12 -8.2 47.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 3.82 110.496 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.48 22.29 11.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.293 -0.879 . . . . 2.08 109.113 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.16 33.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.54 -0.725 . . . . 0.32 109.067 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -139.06 132.01 29.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.309 -0.87 . . . . 1.79 108.957 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.5 107.36 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.372 -0.83 . . . . 0.45 109.579 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 269' ' ' ARG . 36.8 mm -103.79 160.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.466 -0.771 . . . . 0.57 109.275 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.438 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER -93.62 141.58 28.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.768 . . . . 3.63 109.405 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 9.5 m-20 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 2.05 109.446 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.219 0.533 . . . . 3.83 109.632 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 33.5 mm -85.16 140.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 2.08 109.019 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -84.19 -137.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 2.16 109.642 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -91.33 98.53 11.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 1.48 109.056 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.46 131.87 38.6 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.561 -0.712 . . . . 0.73 109.454 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.9 19.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.572 -1.27 . . . . 3.26 107.572 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -140.13 140.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.239 -0.913 . . . . 0.23 110.236 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.17 154.55 21.03 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.317 -1.364 . . . . 0.58 107.317 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -155.3 153.35 30.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.599 -1.313 . . . . 0.44 110.701 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -95.96 133.26 40.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.447 -0.783 . . . . 2.76 109.34 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -95.6 177.27 5.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 2.23 109.102 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 4.5 p -88.17 -11.69 46.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.077 -1.014 . . . . 1.81 108.857 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' B' ' 231' ' ' ARG . 11.3 mpt_? -81.32 -13.54 58.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 3.64 109.131 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 16.0 p-10 -161.24 129.57 2.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.196 -0.94 . . . . 2.16 109.555 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.9 0.45 4.99 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 N-CA-C 109.586 -0.967 . . . . 1.27 109.586 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.487 HG12 ' N ' ' B' ' 235' ' ' TRP . 45.1 t -85.44 160.81 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 1.76 110.255 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.487 ' N ' HG12 ' B' ' 234' ' ' VAL . 98.4 m95 -67.38 163.46 20.72 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.521 -0.918 . . . . 0.67 108.521 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 237' ' ' GLY . 40.9 tttp -119.94 164.65 15.75 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.306 -0.871 . . . . 1.44 109.705 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.14 169.53 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.447 -1.061 . . . . 0.4 110.447 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.29 161.08 47.3 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.893 1.729 . . . . 0.41 110.695 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 175.88 9.28 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.676 -0.861 . . . . 0.21 108.676 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -93.85 139.4 30.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.017 -1.052 . . . . 2.72 109.224 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.8 tp -89.46 125.15 35.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.182 -0.949 . . . . 0.3 109.724 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 23.5 mt -117.53 -77.53 0.57 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.486 -0.759 . . . . 0.45 110.747 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -93.4 136.66 33.46 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.16 -0.962 . . . . 0.33 110.408 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.33 127.27 13.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.228 -0.92 . . . . 2.33 109.274 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.66 -105.39 0.24 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.601 -1.4 . . . . 0.28 109.601 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 245' ' ' GLY . 25.6 mt-10 -60.03 -154.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -1.108 . . . . 1.4 109.121 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 45.93 2.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.961 -1.656 . . . . 0.29 108.961 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.5 19.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.969 . . . . 0.29 108.88 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.46 144.1 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -0.997 . . . . 0.31 108.925 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.46 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.3 110.008 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.27 178.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.24 109.507 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -144.56 110.76 5.5 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 1.81 108.31 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -88.91 -78.89 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.525 -1.287 . . . . 1.18 107.525 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' B' ' 254' ' ' ASN . 1.0 OUTLIER -81.82 -139.01 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 60.2 p -97.17 53.78 1.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.005 -1.109 . . . . 1.38 108.005 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' B' ' 255' ' ' SER . 2.6 m-20 -155.14 126.15 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.983 -0.747 . . . . 1.12 108.983 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 41.1 mt -92.33 135.48 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.48 109.508 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.93 169.88 17.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.586 -0.696 . . . . 2.13 109.485 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.17 140.07 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.419 -0.801 . . . . 0.34 109.466 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.64 126.86 18.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.73 -0.841 . . . . 0.34 108.73 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.22 141.97 97.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 110.035 -0.794 . . . . 0.42 110.035 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -56.47 -34.13 66.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.257 -0.902 . . . . 3.11 109.153 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.99 -8.29 47.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.43 -0.793 . . . . 3.82 110.514 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.3 22.12 11.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.285 -0.884 . . . . 2.08 109.137 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.63 163.21 33.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.089 -0.708 . . . . 0.32 109.089 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -139.16 131.98 29.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.281 -0.887 . . . . 1.79 108.92 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.48 107.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.45 109.487 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.442 HG22 ' N ' ' B' ' 269' ' ' ARG . 37.1 mm -103.84 160.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.57 109.16 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.442 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -93.74 141.54 28.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.487 -0.758 . . . . 3.62 109.438 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.01 -1.056 . . . . 2.05 109.389 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.46 -0.57 . . . . 3.82 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.69 107.24 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.079 0.942 . . . . 2.08 108.476 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -92.02 -131.85 0.12 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.594 -1.316 . . . . 2.17 109.744 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.3 m-20 -95.37 109.85 21.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.202 -0.936 . . . . 1.48 109.441 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -133.38 153.2 51.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.446 -0.783 . . . . 0.72 109.024 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -117.55 149.81 40.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.737 -1.208 . . . . 3.26 107.737 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.02 139.98 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.864 . . . . 0.23 110.085 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -109.22 154.45 22.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.499 -1.297 . . . . 0.58 107.499 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 16.3 p90 -157.01 160.24 38.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.613 -1.304 . . . . 0.44 110.399 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -93.2 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 2.76 109.844 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.72 171.88 8.71 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.833 -0.802 . . . . 2.23 108.833 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.9 p -89.45 -9.54 49.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 1.8 109.458 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -87.04 -16.81 34.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 3.63 109.632 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -162.5 134.1 3.91 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 2.16 108.782 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.84 12.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 120.988 1.125 . . . . 1.25 110.98 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 235' ' ' TRP . 8.6 p -84.64 161.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.699 -1.251 . . . . 1.75 110.029 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.539 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.0 m95 -75.57 163.34 27.46 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.42 -162.51 0.92 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.299 -0.875 . . . . 1.43 108.764 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.19 176.51 51.62 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.639 -1.385 . . . . 0.39 109.639 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -68.96 157.7 60.84 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.675 1.583 . . . . 0.41 110.528 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.96 170.29 16.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.746 -0.835 . . . . 0.21 108.746 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.58 142.44 27.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 2.72 109.702 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.27 119.32 30.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.73 -0.606 . . . . 0.29 109.926 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -109.71 -72.63 0.71 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.331 -0.856 . . . . 0.45 109.814 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.14 146.15 23.95 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.153 -0.967 . . . . 0.31 110.463 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -147.28 120.83 9.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.443 -0.785 . . . . 2.32 108.917 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -107.08 0.27 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.794 -1.194 . . . . 0.27 110.477 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -69.22 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 1.39 110.126 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.32 46.17 2.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.369 -1.493 . . . . 0.29 109.369 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.15 33.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.495 -1.003 . . . . 0.29 108.525 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.65 138.3 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.06 -1.025 . . . . 0.31 109.784 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.76 139.39 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.385 -0.968 . . . . 0.29 108.385 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.2 pt -141.53 178.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.23 110.059 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -144.36 111.18 5.73 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.779 -0.823 . . . . 1.81 108.779 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.78 -79.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.483 -1.302 . . . . 1.18 107.483 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -79.38 -131.33 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.914 -1.513 . . . . 1.98 106.914 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.7 p -105.61 54.8 0.69 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.372 -0.973 . . . . 1.39 108.372 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -156.31 126.32 6.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 1.12 109.034 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -92.68 135.24 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.47 109.448 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.97 168.64 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 2.11 109.662 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.98 142.26 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.324 -0.86 . . . . 0.33 109.332 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 33.5 t -135.89 131.17 18.89 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.437 -0.789 . . . . 0.34 109.086 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.29 146.43 96.53 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 120.72 0.947 . . . . 0.42 110.458 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -59.25 -32.34 69.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.564 -0.902 . . . . 3.12 108.564 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.9 mtt-85 -70.68 -9.18 56.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.935 . . . . 3.82 110.853 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.56 21.09 12.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.176 -0.952 . . . . 2.08 109.776 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.25 22.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.412 -0.805 . . . . 0.32 109.959 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -140.5 124.93 17.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.58 -0.896 . . . . 1.79 108.58 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.53 112.47 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.133 -0.979 . . . . 0.45 110.159 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.94 147.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.74 -1.207 . . . . 0.57 107.74 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.58 140.72 29.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 3.63 109.767 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.069 -0.967 . . . . 2.05 109.478 179.706 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 3.83 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.617 ' O ' HG23 ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.7 107.19 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.49 -0.93 . . . . 2.08 108.49 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -91.96 -131.87 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.668 -1.27 . . . . 2.16 109.712 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -95.4 109.82 21.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.48 109.413 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -133.34 153.23 51.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.773 . . . . 0.73 109.032 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -117.63 149.77 40.14 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.695 -1.224 . . . . 3.26 107.695 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.03 139.89 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.844 . . . . 0.23 110.062 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.19 154.43 22.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.543 -1.28 . . . . 0.58 107.543 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 16.0 p90 -156.93 160.22 38.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.804 -1.185 . . . . 0.44 110.387 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -93.16 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.744 . . . . 2.76 109.839 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.79 171.91 8.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 2.23 108.846 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 30.5 p -89.5 -9.56 49.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 1.81 109.436 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.94 -16.93 34.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 3.64 109.693 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.4 m-20 -162.41 134.0 3.91 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.93 . . . . 2.16 108.811 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.8 12.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 120.873 1.049 . . . . 1.27 110.957 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.532 HG22 ' N ' ' B' ' 235' ' ' TRP . 8.6 p -84.68 161.3 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.677 -1.264 . . . . 1.76 109.976 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.532 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.9 m95 -75.4 163.23 27.65 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.077 -0.712 . . . . 0.67 109.077 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.33 -162.63 0.92 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.289 -0.882 . . . . 1.44 108.819 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.04 176.55 51.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.76 -1.336 . . . . 0.4 109.76 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -69.12 157.6 61.02 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.74 1.627 . . . . 0.41 110.515 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.95 170.3 16.28 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.76 -0.83 . . . . 0.21 108.76 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.56 142.51 27.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.038 -1.039 . . . . 2.72 109.647 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.39 119.35 30.6 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.656 -0.653 . . . . 0.3 109.797 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.65 -72.69 0.71 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.317 -0.865 . . . . 0.45 109.851 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.17 146.17 23.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.158 -0.964 . . . . 0.33 110.411 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -147.29 120.83 9.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.398 -0.814 . . . . 2.33 108.866 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.79 -107.01 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.711 -1.233 . . . . 0.28 110.439 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.33 -153.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -1.027 . . . . 1.4 110.125 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.29 46.06 2.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.416 -1.473 . . . . 0.29 109.416 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.07 151.18 34.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.499 -1.0 . . . . 0.29 108.487 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.7 m -146.58 138.25 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 0.31 109.785 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.73 139.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.395 -0.965 . . . . 0.3 108.395 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.52 178.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.24 110.055 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -144.48 111.17 5.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.766 -0.828 . . . . 1.81 108.766 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.8 -79.84 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.47 -1.308 . . . . 1.18 107.47 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -79.37 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.911 -1.514 . . . . 1.97 106.911 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -105.52 54.82 0.69 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.335 -0.987 . . . . 1.38 108.335 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -156.31 126.33 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 1.12 109.064 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.6 mt -92.68 135.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.297 -0.877 . . . . 0.48 109.461 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -138.99 168.56 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.865 . . . . 2.13 109.677 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.94 142.36 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.397 -0.814 . . . . 0.34 109.283 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.92 131.17 18.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.373 -0.83 . . . . 0.34 109.179 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.3 146.53 96.32 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 120.692 0.928 . . . . 0.42 110.412 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -59.34 -32.29 69.96 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.61 -0.885 . . . . 3.11 108.61 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' B' ' 263' ' ' ARG . 2.9 mtt-85 -70.63 -9.18 56.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.271 -0.893 . . . . 3.82 110.812 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.47 20.91 12.34 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.243 -0.911 . . . . 2.08 109.769 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.15 167.25 22.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.439 -0.788 . . . . 0.32 109.9 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -140.56 124.89 17.67 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.61 -0.885 . . . . 1.79 108.61 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.46 112.37 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.235 -0.916 . . . . 0.45 110.22 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.95 147.12 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.638 -1.245 . . . . 0.57 107.638 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.62 140.79 29.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 3.62 109.741 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.997 -1.002 . . . . 2.05 109.353 179.737 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.305 0.574 . . . . 3.82 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -84.88 130.13 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 2.08 108.994 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.63 -134.41 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.063 . . . . 2.17 109.42 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.02 113.82 25.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.851 . . . . 1.48 108.988 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.2 135.28 40.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.389 -0.819 . . . . 0.72 109.299 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 84.6 mtt180 -103.47 157.98 16.66 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.839 -1.171 . . . . 3.26 107.839 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.33 138.68 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.026 -1.046 . . . . 0.23 110.646 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -111.03 151.87 27.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.724 -1.213 . . . . 0.58 107.724 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.0 p90 -158.3 154.65 27.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.671 -1.268 . . . . 0.44 110.376 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.05 152.24 18.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.534 -0.729 . . . . 2.76 109.651 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.67 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 2.23 108.82 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 58.0 m -79.25 -2.83 43.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.996 . . . . 1.8 109.333 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.89 20.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.299 -0.876 . . . . 3.63 109.844 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.3 m-20 -162.87 144.51 7.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.16 109.067 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.08 15.75 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.061 1.174 . . . . 1.25 110.643 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 232' ' ' ASP . 33.9 m -83.24 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.799 -1.188 . . . . 1.75 110.006 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -63.97 164.84 9.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.66 109.358 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.2 tttp -119.41 158.07 26.93 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.38 -0.825 . . . . 1.43 108.893 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.01 165.38 0.02 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.281 -1.127 . . . . 0.39 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.2 157.67 58.66 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.552 1.501 . . . . 0.41 110.289 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.32 169.02 18.53 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.927 -0.768 . . . . 0.21 108.927 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.22 142.72 26.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 2.72 109.334 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.0 tp -87.6 128.44 35.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.491 -0.756 . . . . 0.29 110.179 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.0 -76.15 0.58 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.36 -0.837 . . . . 0.45 109.749 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' A' ' 250' ' ' VAL . 5.3 t90 -93.07 142.6 27.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.154 -0.966 . . . . 0.31 110.121 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.66 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.285 -0.884 . . . . 2.32 108.744 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.35 -107.32 0.28 Allowed Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.792 -1.194 . . . . 0.27 110.184 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.8 -150.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 1.39 109.644 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 49.98 3.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.354 -1.498 . . . . 0.29 109.354 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.94 150.15 33.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.389 -1.065 . . . . 0.29 108.822 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.52 129.66 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.31 109.758 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 243' ' ' TRP . 95.4 t -93.41 134.18 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.45 -0.944 . . . . 0.29 108.45 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.98 178.63 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.23 109.583 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.84 111.24 5.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.39 -0.819 . . . . 1.81 109.029 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.99 -82.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.108 -1.441 . . . . 1.18 107.108 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -78.85 -138.82 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.733 -1.58 . . . . 1.98 106.733 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.1 m -98.05 56.25 1.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.989 -1.07 . . . . 1.39 108.423 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -156.15 125.75 6.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.735 . . . . 1.12 109.038 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.412 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 80.6 mt -93.06 134.96 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.267 -0.896 . . . . 0.47 109.6 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.31 165.21 26.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.444 -0.785 . . . . 2.11 109.746 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.85 139.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.33 109.743 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.35 130.57 17.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 108.702 -0.851 . . . . 0.34 108.702 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.61 146.88 73.64 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.613 -0.957 . . . . 0.42 109.613 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -65.16 -32.88 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 3.12 109.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -69.97 -4.89 22.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 3.82 110.826 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.72 16.14 13.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.283 -0.885 . . . . 2.08 109.051 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.8 172.29 13.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.627 -0.671 . . . . 0.32 109.426 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -139.54 129.91 25.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.408 -0.808 . . . . 1.79 109.231 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.2 mm -88.49 106.61 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.45 109.727 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.01 156.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.339 -0.851 . . . . 0.57 108.849 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -91.08 147.42 23.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.289 -0.882 . . . . 3.63 109.219 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 5.7 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.946 -1.026 . . . . 2.05 109.466 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.368 0.604 . . . . 3.83 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.52 ' O ' HD12 ' B' ' 220' ' ' ILE . 0.8 OUTLIER -84.87 130.11 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.316 -0.865 . . . . 2.08 109.001 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.61 -134.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.01 -1.056 . . . . 2.16 109.394 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -94.99 113.76 25.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.348 -0.845 . . . . 1.48 108.999 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -135.2 135.17 40.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.421 -0.799 . . . . 0.73 109.329 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 84.4 mtt180 -103.3 157.94 16.67 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.834 -1.173 . . . . 3.26 107.834 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.4 t -142.3 138.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.106 -0.996 . . . . 0.23 110.622 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.98 151.99 27.32 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.723 -1.214 . . . . 0.58 107.723 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.2 p90 -158.39 154.68 27.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.709 -1.244 . . . . 0.44 110.344 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.0 152.16 18.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 2.76 109.706 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.71 13.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.372 -0.83 . . . . 2.23 108.771 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 57.7 m -79.35 -2.72 42.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 1.81 109.263 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.82 20.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 3.64 109.894 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.2 m-20 -162.93 144.43 7.75 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.044 -1.035 . . . . 2.16 109.065 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.9 15.54 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.236 1.291 . . . . 1.27 110.677 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' B' ' 232' ' ' ASP . 33.9 m -83.18 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 1.76 110.05 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -64.04 164.77 10.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.247 -0.908 . . . . 0.67 109.427 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.0 tttp -119.32 158.04 26.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.398 -0.814 . . . . 1.44 108.986 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.98 165.36 0.02 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.258 -1.137 . . . . 0.4 110.258 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.23 157.65 58.84 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 121.526 1.484 . . . . 0.41 110.225 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.35 169.05 18.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.21 108.96 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -93.31 142.71 27.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.064 -1.023 . . . . 2.72 109.282 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.62 128.46 35.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.416 -0.802 . . . . 0.3 110.232 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.03 -76.12 0.58 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.514 -0.741 . . . . 0.45 109.711 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' B' ' 250' ' ' VAL . 5.3 t90 -93.01 142.57 27.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.124 -0.985 . . . . 0.33 110.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.74 11.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.3 -0.875 . . . . 2.33 108.747 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -107.33 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.771 -1.204 . . . . 0.28 110.203 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.79 -150.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -1.041 . . . . 1.4 109.727 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.17 49.93 3.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.319 -1.513 . . . . 0.29 109.319 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.17 33.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -1.038 . . . . 0.29 108.799 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 12.0 m -145.58 129.74 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.31 109.827 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' B' ' 243' ' ' TRP . 95.9 t -93.47 134.17 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.439 -0.948 . . . . 0.3 108.439 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.2 pt -136.96 178.57 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.24 109.654 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -144.83 111.24 5.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 1.81 109.039 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -88.98 -81.89 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.199 -1.408 . . . . 1.18 107.199 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -78.9 -138.9 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.674 -1.602 . . . . 1.97 106.674 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.2 m -97.94 56.22 1.23 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.954 -1.091 . . . . 1.38 108.494 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -156.16 125.75 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 1.12 109.102 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.41 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 80.5 mt -93.08 134.92 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.933 . . . . 0.48 109.617 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.26 165.32 26.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 2.13 109.749 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.92 139.96 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.424 -0.797 . . . . 0.34 109.696 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 83.9 t -137.43 130.57 17.07 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.47 146.91 71.93 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.597 -0.963 . . . . 0.42 109.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -65.36 -32.82 74.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 3.11 109.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -69.93 -4.86 22.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 3.82 110.867 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.84 16.33 13.49 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.258 -0.902 . . . . 2.08 109.013 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.89 172.23 13.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 0.32 109.426 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -139.51 129.86 25.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 1.79 109.288 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.44 106.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.277 -0.889 . . . . 0.45 109.778 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.02 156.33 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.385 -0.822 . . . . 0.57 108.909 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -91.02 147.4 23.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 3.62 109.196 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.6 m-20 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.048 -1.032 . . . . 2.05 109.477 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.342 0.591 . . . . 3.82 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.691 ' N ' HD12 ' A' ' 220' ' ' ILE . 1.7 mp -82.45 124.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 2.08 108.932 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -83.73 -129.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 2.17 109.488 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.36 98.75 11.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 1.48 109.393 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.54 121.7 20.21 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.508 -0.745 . . . . 0.72 109.213 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.17 165.29 12.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 3.26 108.294 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -143.39 143.02 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.138 -0.977 . . . . 0.23 110.676 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -113.02 148.29 35.44 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.631 -1.248 . . . . 0.58 107.631 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.7 p90 -156.91 151.99 26.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.729 -1.232 . . . . 0.44 110.288 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -93.19 139.25 30.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 2.76 109.456 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -94.19 166.79 11.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 2.23 109.224 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.4 p -79.76 -1.5 38.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 1.8 109.105 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -87.24 -22.6 25.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 3.63 109.531 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 234' ' ' VAL . 8.3 m-20 -163.07 135.05 3.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 2.16 109.073 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.82 10.95 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 120.813 1.009 . . . . 1.25 110.228 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 232' ' ' ASP . 25.0 t -85.63 160.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.905 -1.122 . . . . 1.75 109.821 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.461 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.2 m95 -74.52 162.17 29.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.66 108.765 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.3 tttm -119.44 153.06 35.83 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.296 -0.877 . . . . 1.43 109.385 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -41.26 163.57 0.01 OUTLIER Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.762 -0.935 . . . . 0.39 110.762 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -66.6 159.44 50.87 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 121.638 1.559 . . . . 0.41 110.612 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.78 177.18 8.08 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.008 -0.738 . . . . 0.21 109.008 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -94.39 136.49 34.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.029 -1.045 . . . . 2.72 109.194 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.74 124.01 33.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 0.29 109.619 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -113.3 -74.33 0.63 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.434 -0.791 . . . . 0.45 110.208 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -91.26 143.26 26.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.264 -0.897 . . . . 0.31 110.33 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.11 117.96 7.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.435 -0.791 . . . . 2.32 109.225 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.19 -108.7 0.3 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.944 -1.263 . . . . 0.27 109.944 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -63.56 -154.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -1.145 . . . . 1.39 109.416 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.37 52.02 3.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.603 -1.399 . . . . 0.29 109.603 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.69 150.44 34.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.396 -1.061 . . . . 0.29 108.967 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 122.85 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.31 109.701 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 52.8 t -87.22 135.36 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.991 -1.114 . . . . 0.29 107.991 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.63 178.33 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.23 110.52 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -144.81 112.16 6.08 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.93 -78.5 0.39 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.612 -1.255 . . . . 1.18 107.612 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -80.53 -129.29 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.68 -1.6 . . . . 1.98 106.68 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.5 m -105.41 54.3 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.106 -1.072 . . . . 1.39 108.106 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -156.19 128.41 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.519 -0.738 . . . . 1.12 109.519 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 36.1 mt -94.61 137.59 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 0.47 109.488 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.32 166.65 23.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.386 -0.821 . . . . 2.11 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.94 142.5 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.33 109.112 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.2 t -139.28 129.52 14.5 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 0.34 109.168 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.406 ' HG2' ' HZ3' ' A' ' 264' ' ' LYS . 7.0 Cg_exo -54.37 160.66 6.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.939 -0.831 . . . . 0.42 109.939 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -84.8 -27.2 26.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 3.12 110.249 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.32 -18.82 65.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.893 . . . . 3.82 111.931 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.406 ' HZ3' ' HG2' ' A' ' 261' ' ' PRO . 2.0 ptpp? -119.43 29.24 7.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.897 -1.127 . . . . 2.08 109.616 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.4 164.41 25.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.517 -0.92 . . . . 0.32 108.517 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.12 124.62 19.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.248 -0.908 . . . . 1.79 109.293 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.7 mm -88.52 110.41 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 0.45 109.581 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.9 146.76 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.38 141.13 29.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 3.63 109.612 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.953 -1.022 . . . . 2.05 109.48 179.799 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.292 0.568 . . . . 3.83 109.504 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.693 HD12 ' N ' ' B' ' 220' ' ' ILE . 1.7 mp -82.4 124.73 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 2.08 108.891 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -83.83 -129.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -0.922 . . . . 2.16 109.474 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.47 98.83 11.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.275 -0.891 . . . . 1.48 109.316 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -135.56 121.69 20.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.517 -0.739 . . . . 0.73 109.158 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.16 165.2 12.17 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.339 -0.986 . . . . 3.26 108.339 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.3 143.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.23 110.702 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -113.19 148.18 35.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.604 -1.258 . . . . 0.58 107.604 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.8 p90 -156.79 152.03 26.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.689 -1.257 . . . . 0.44 110.327 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -93.26 139.27 30.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.711 . . . . 2.76 109.405 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -94.25 166.76 11.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.357 -0.839 . . . . 2.23 109.226 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.1 p -79.68 -1.45 38.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 1.81 109.161 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -87.25 -22.62 25.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.64 109.536 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 8.3 m-20 -163.03 135.1 3.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 2.16 109.096 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.88 11.05 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.772 0.981 . . . . 1.27 110.233 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.488 ' H ' ' C ' ' B' ' 232' ' ' ASP . 25.2 t -85.73 160.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.939 -1.1 . . . . 1.76 109.907 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.467 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.2 m95 -74.34 162.17 29.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.67 108.787 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.3 tttm -119.41 153.02 35.87 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.345 -0.847 . . . . 1.44 109.439 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.27 163.55 0.01 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.73 -0.948 . . . . 0.4 110.73 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.53 159.39 50.92 Favored 'Trans proline' 0 N--CA 1.48 0.732 0 C-N-CA 121.654 1.569 . . . . 0.41 110.629 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.2 8.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.985 -0.746 . . . . 0.21 108.985 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -94.28 136.51 34.5 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.08 -1.013 . . . . 2.72 109.299 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.75 123.97 33.11 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.3 109.608 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.25 -74.52 0.62 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.338 -0.851 . . . . 0.45 110.206 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.16 143.29 26.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.197 -0.94 . . . . 0.33 110.414 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.1 118.01 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 2.33 109.214 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -108.71 0.3 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.962 -1.255 . . . . 0.28 109.962 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.68 -154.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 1.4 109.348 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.93 3.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.419 . . . . 0.29 109.551 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.67 150.44 34.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.392 -1.063 . . . . 0.29 108.948 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.66 122.79 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.209 -0.932 . . . . 0.31 109.762 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 52.9 t -87.26 135.33 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.032 -1.099 . . . . 0.3 108.032 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.58 178.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.21 -0.931 . . . . 0.24 110.606 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -144.77 112.13 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.619 -0.882 . . . . 1.81 108.619 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.05 -78.43 0.39 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.571 -1.27 . . . . 1.18 107.571 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -80.54 -129.27 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.722 -1.584 . . . . 1.97 106.722 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 68.7 m -105.41 54.29 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.131 -1.063 . . . . 1.38 108.131 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -156.12 128.43 7.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 1.12 109.524 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.56 137.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.259 -0.901 . . . . 0.48 109.536 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.31 166.65 23.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.323 -0.86 . . . . 2.13 109.701 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.0 142.43 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.34 109.119 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 78.8 t -139.22 129.4 14.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.366 -0.834 . . . . 0.34 109.258 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.3 160.54 6.49 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.616 0.877 . . . . 0.42 109.962 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -84.73 -27.1 27.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 3.11 110.313 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 3.82 111.893 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.401 ' HG2' ' HZ2' ' B' ' 264' ' ' LYS . 2.0 ptpp? -119.28 29.22 7.77 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.954 -1.091 . . . . 2.08 109.727 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.34 164.47 25.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.538 -0.912 . . . . 0.32 108.538 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.2 124.59 19.22 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.25 -0.906 . . . . 1.79 109.319 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.6 mm -88.6 110.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.45 109.56 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.88 146.64 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.546 -0.909 . . . . 0.57 108.546 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.24 141.17 28.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.649 -0.657 . . . . 3.62 109.605 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 2.05 109.429 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.44 -0.578 . . . . 3.82 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -85.22 120.0 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.403 -0.811 . . . . 2.08 108.928 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.33 -132.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.016 -1.053 . . . . 2.17 109.506 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.79 108.27 19.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 1.48 109.176 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.85 124.41 23.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.411 -0.806 . . . . 0.72 109.959 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 6.0 mpt_? -95.88 164.11 12.87 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.37 -1.345 . . . . 3.26 107.37 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.02 142.82 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.01 -1.056 . . . . 0.23 110.446 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -107.36 154.71 20.89 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.475 -1.306 . . . . 0.58 107.475 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.0 p90 -156.04 157.24 35.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.484 -1.385 . . . . 0.44 111.112 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -101.15 146.08 27.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.464 0.65 . . . . 2.76 109.421 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 230' ' ' SER . 37.0 t0 -98.74 -176.65 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 2.23 109.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 15.1 t -95.08 -14.14 24.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -0.808 . . . . 1.8 109.678 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.28 -16.93 31.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.19 -0.944 . . . . 3.63 109.857 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 234' ' ' VAL . 61.4 m-20 -160.4 128.82 2.94 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.147 -0.97 . . . . 2.16 109.351 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.95 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 120.786 0.991 . . . . 1.25 110.25 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.6 m -82.32 127.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.869 -1.144 . . . . 1.75 110.026 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.5 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.66 109.257 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 237' ' ' GLY . 31.3 mtpt -119.85 166.46 13.26 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.425 -0.797 . . . . 1.43 109.418 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.99 170.17 0.02 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.287 -1.125 . . . . 0.39 110.287 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -68.83 163.83 35.82 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 121.562 1.508 . . . . 0.41 110.66 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.58 177.86 7.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.21 109.347 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.56 137.45 34.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.197 -0.939 . . . . 2.72 109.39 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.408 HD21 ' NZ ' ' A' ' 244' ' ' LYS . 19.1 tp -88.67 123.86 33.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.565 -0.709 . . . . 0.29 109.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.14 -72.66 0.68 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.289 -0.882 . . . . 0.45 110.432 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.01 144.45 25.64 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.077 -1.014 . . . . 0.31 110.497 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.408 ' NZ ' HD21 ' A' ' 241' ' ' LEU . 16.0 ttmm -145.7 119.37 9.17 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.767 -0.827 . . . . 2.32 108.767 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.88 -104.88 0.26 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.209 -1.156 . . . . 0.27 110.209 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -73.04 -149.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -1.129 . . . . 1.39 109.736 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.54 3.95 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.136 -1.586 . . . . 0.29 109.136 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.49 150.95 34.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.29 108.425 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.36 123.31 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.971 -1.08 . . . . 0.31 109.827 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.94 133.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.399 -0.963 . . . . 0.29 108.399 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 260' ' ' VAL . 10.6 pt -138.81 178.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.348 -0.845 . . . . 0.23 109.987 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -143.8 109.3 5.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.341 -0.985 . . . . 1.81 108.341 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.1 -77.23 0.4 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.499 -1.297 . . . . 1.18 107.499 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.87 -133.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.323 -1.732 . . . . 1.98 106.323 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.3 t -105.03 56.48 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.071 -1.085 . . . . 1.39 108.071 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -157.03 123.53 4.98 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.771 -0.826 . . . . 1.12 108.771 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.413 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 39.2 mt -91.64 134.29 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -0.998 . . . . 0.47 109.504 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.07 172.6 12.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.281 -0.887 . . . . 2.11 110.014 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.13 140.6 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.547 -0.72 . . . . 0.33 109.701 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 251' ' ' ILE . 58.1 t -134.19 124.93 17.65 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.16 139.55 90.89 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 120.584 0.856 . . . . 0.42 110.331 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.76 -36.26 69.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 3.12 109.758 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 263' ' ' ARG . 2.3 tpt180 -67.12 -9.58 41.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 3.82 110.693 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.545 ' HZ2' ' HB2' ' A' ' 264' ' ' LYS . 7.4 mtpm? -122.95 25.47 8.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.284 -0.885 . . . . 2.08 108.859 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.33 32.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.462 -0.94 . . . . 0.32 108.462 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -139.34 132.09 29.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.116 -0.99 . . . . 1.79 109.231 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.57 107.63 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 0.45 109.297 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.51 157.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.57 109.308 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -91.7 137.31 32.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 3.63 109.465 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.03 -0.986 . . . . 2.05 109.451 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.2 ptt? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.17 -0.678 . . . . 3.83 109.17 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.468 ' O ' HD12 ' B' ' 220' ' ' ILE . 0.8 OUTLIER -85.3 120.13 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.288 -0.883 . . . . 2.08 108.933 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -84.25 -133.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 2.16 109.534 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -92.93 108.3 19.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.173 -0.955 . . . . 1.48 109.148 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.84 124.46 23.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.508 -0.745 . . . . 0.73 109.957 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 6.0 mpt_? -95.89 164.19 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.298 -1.371 . . . . 3.26 107.298 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 86.2 t -144.1 142.85 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.066 -1.021 . . . . 0.23 110.408 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -107.37 154.77 20.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.384 -1.339 . . . . 0.58 107.384 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.9 p90 -156.08 157.23 35.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.548 -1.345 . . . . 0.44 111.087 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -101.04 146.06 27.93 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.425 0.631 . . . . 2.76 109.516 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' B' ' 230' ' ' SER . 36.9 t0 -98.64 -176.67 3.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 2.23 109.879 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 15.2 t -95.17 -13.88 24.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.415 -0.803 . . . . 1.81 109.731 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.37 -16.97 31.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 3.64 109.847 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 234' ' ' VAL . 61.2 m-20 -160.39 128.82 2.95 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 2.16 109.339 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.94 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.776 0.984 . . . . 1.27 110.302 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.5 m -82.32 127.77 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.874 -1.141 . . . . 1.76 110.014 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.44 0.22 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.67 109.298 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' B' ' 237' ' ' GLY . 31.3 mtpt -119.71 166.44 13.21 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.371 -0.831 . . . . 1.44 109.431 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.15 170.3 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.303 -1.119 . . . . 0.4 110.303 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -68.92 163.8 36.13 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.55 1.5 . . . . 0.41 110.605 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.52 177.87 7.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.21 109.404 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.59 137.3 34.85 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.135 -0.978 . . . . 2.72 109.389 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.404 HD21 ' NZ ' ' B' ' 244' ' ' LYS . 19.3 tp -88.51 123.87 33.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.544 -0.723 . . . . 0.3 109.571 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.21 -72.53 0.69 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.381 -0.824 . . . . 0.45 110.488 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.18 144.47 25.58 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.051 -1.031 . . . . 0.33 110.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' HD21 ' B' ' 241' ' ' LEU . 16.0 ttmm -145.69 119.41 9.2 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.818 -0.808 . . . . 2.33 108.818 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.95 -104.92 0.26 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.148 -1.181 . . . . 0.28 110.148 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -72.98 -149.44 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -1.143 . . . . 1.4 109.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.61 3.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.19 -1.564 . . . . 0.29 109.19 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.96 34.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -1.023 . . . . 0.29 108.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.31 123.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.08 -1.012 . . . . 0.31 109.81 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.82 133.66 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.392 -0.966 . . . . 0.3 108.392 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.405 HD11 HG21 ' B' ' 260' ' ' VAL . 10.5 pt -138.86 178.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.24 110.066 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -143.72 109.41 5.19 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.353 -0.981 . . . . 1.81 108.353 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.21 -77.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.538 -1.282 . . . . 1.18 107.538 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -80.96 -133.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.323 -1.732 . . . . 1.97 106.323 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.2 t -105.07 56.57 0.69 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -157.05 123.62 5.0 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.778 -0.823 . . . . 1.12 108.778 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 39.1 mt -91.66 134.31 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.48 109.435 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.11 172.59 12.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.368 -0.832 . . . . 2.13 110.05 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.13 140.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.461 -0.774 . . . . 0.34 109.745 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' VAL . . . . . 0.405 HG21 HD11 ' B' ' 251' ' ' ILE . 58.5 t -134.17 124.86 17.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.841 -0.8 . . . . 0.34 108.841 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.12 139.49 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 120.588 0.859 . . . . 0.42 110.325 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.81 -36.19 69.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 3.11 109.751 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.416 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 2.3 tpt180 -67.17 -9.47 40.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 3.82 110.733 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' B' ' 264' ' ' LYS . 7.4 mtpm? -123.03 25.53 8.5 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.21 -0.931 . . . . 2.08 108.833 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.493 -0.928 . . . . 0.32 108.493 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -139.32 131.9 28.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.113 -0.992 . . . . 1.79 109.318 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.44 107.62 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.231 -0.918 . . . . 0.45 109.311 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.44 157.55 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.41 -0.806 . . . . 0.57 109.269 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -91.69 137.23 32.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.308 -0.87 . . . . 3.62 109.487 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.105 -0.997 . . . . 2.05 109.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.415 -0.587 . . . . 3.82 109.415 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 220' ' ' ILE . 1.9 mp -84.0 114.27 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 2.08 108.958 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.49 -124.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 2.17 109.792 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.6 m-20 -94.75 99.01 11.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 1.48 109.227 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -135.66 134.08 38.83 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.72 109.374 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.1 18.89 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.925 -1.139 . . . . 3.26 107.925 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -140.99 140.23 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.103 -0.998 . . . . 0.23 110.983 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -109.28 154.28 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.141 -1.429 . . . . 0.58 107.141 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.9 p90 -156.53 150.12 24.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.593 -1.317 . . . . 0.44 110.55 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 228' ' ' ARG . 10.7 mtm-85 -94.22 134.97 36.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.513 -0.742 . . . . 2.76 109.463 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.36 175.24 6.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.366 -0.834 . . . . 2.23 109.591 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.2 t -85.88 -11.02 54.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 1.8 108.874 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -88.8 -9.31 52.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 3.63 109.414 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -158.07 128.52 3.51 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 2.16 109.04 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.69 -11.58 29.84 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 120.815 1.01 . . . . 1.25 110.44 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 1.5 p -84.59 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.043 . . . . 1.75 109.42 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 92.7 m95 -64.43 169.57 4.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.445 -0.784 . . . . 0.66 109.644 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 237' ' ' GLY . 44.9 tttp -118.95 165.35 14.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.512 -0.742 . . . . 1.43 109.223 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.22 167.37 0.02 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.119 -1.192 . . . . 0.39 110.119 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.4 160.25 50.52 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.448 1.432 . . . . 0.41 110.113 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.79 168.86 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 0.21 109.18 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.51 139.51 30.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.161 -0.962 . . . . 2.72 109.971 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.08 122.94 32.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -0.77 . . . . 0.29 109.428 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.66 -75.51 0.6 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.419 -0.801 . . . . 0.45 110.355 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -89.79 143.68 26.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.067 -1.021 . . . . 0.31 109.893 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.65 121.62 10.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.342 -0.849 . . . . 2.32 109.063 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.46 -104.93 0.23 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.812 -1.185 . . . . 0.27 110.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.38 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -1.053 . . . . 1.39 109.551 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 51.36 3.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.14 -1.584 . . . . 0.29 109.14 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.37 154.02 40.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.427 -1.043 . . . . 0.29 108.691 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -147.01 124.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.056 -1.027 . . . . 0.31 109.82 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.82 133.61 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.721 -1.214 . . . . 0.29 107.721 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.39 175.78 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.321 -0.862 . . . . 0.23 110.333 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -145.32 108.71 4.63 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.588 -0.893 . . . . 1.81 108.588 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.34 -77.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.421 -1.326 . . . . 1.18 107.421 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -80.28 -135.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.566 -1.642 . . . . 1.98 106.566 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 10.2 p -101.58 55.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.099 -1.074 . . . . 1.39 108.099 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 255' ' ' SER . 59.1 m-20 -156.75 123.71 5.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.143 -0.688 . . . . 1.12 109.143 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.428 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.3 mt -93.05 135.39 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.47 109.438 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.07 169.72 17.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.415 -0.803 . . . . 2.11 109.709 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.86 140.97 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.383 -0.823 . . . . 0.33 109.491 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.97 128.24 17.56 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.632 -0.877 . . . . 0.34 108.632 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.65 148.64 72.66 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.528 -0.989 . . . . 0.42 109.528 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -67.82 -30.3 69.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 3.12 109.452 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.68 -8.29 53.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 3.82 111.0 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.21 23.16 11.47 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.126 -0.983 . . . . 2.08 109.005 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.97 168.13 20.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.579 -0.701 . . . . 0.32 109.164 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -139.64 129.59 24.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.318 -0.864 . . . . 1.79 109.154 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.38 108.13 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 0.45 109.431 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -101.83 156.21 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -94.57 135.37 36.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 3.63 109.116 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.011 . . . . 2.05 109.516 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.461 -0.57 . . . . 3.83 109.461 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.762 ' N ' HD12 ' B' ' 220' ' ' ILE . 1.9 mp -83.91 114.3 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 2.08 108.96 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -83.45 -125.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 2.16 109.853 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 2.6 m-20 -94.7 98.95 11.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -0.857 . . . . 1.48 109.227 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.63 134.09 38.89 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.487 -0.758 . . . . 0.73 109.416 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.2 18.78 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.91 -1.144 . . . . 3.26 107.91 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -141.09 140.27 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.181 -0.95 . . . . 0.23 110.945 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -109.24 154.33 22.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.169 -1.419 . . . . 0.58 107.169 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -156.63 149.94 24.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.468 -1.395 . . . . 0.44 110.666 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.6 mtm-85 -94.07 135.05 35.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.523 -0.736 . . . . 2.76 109.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.45 175.18 6.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 2.23 109.629 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.1 t -85.79 -10.99 54.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 1.81 108.925 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -88.84 -9.2 52.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.443 -0.785 . . . . 3.64 109.433 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.17 128.37 3.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.16 109.147 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.64 -11.54 29.84 Favored 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 120.865 1.043 . . . . 1.27 110.433 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 1.5 p -84.52 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.037 . . . . 1.76 109.429 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.479 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 92.7 m95 -64.45 169.57 4.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.67 109.671 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 44.9 tttp -118.92 165.31 14.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.635 -0.666 . . . . 1.44 109.338 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.24 167.39 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.159 -1.176 . . . . 0.4 110.159 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.37 160.27 50.47 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 121.419 1.412 . . . . 0.41 110.122 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.88 168.88 18.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.21 109.071 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.4 139.48 30.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.227 -0.92 . . . . 2.72 109.971 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.1 122.88 32.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.704 . . . . 0.3 109.423 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -112.63 -75.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -0.828 . . . . 0.45 110.44 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.428 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.1 t90 -89.77 143.66 26.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.005 . . . . 0.33 109.889 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.75 121.64 10.63 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.315 -0.866 . . . . 2.33 109.044 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.41 -104.95 0.23 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.11 -1.196 . . . . 0.28 110.11 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -69.42 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -1.125 . . . . 1.4 109.516 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.43 3.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.05 -1.62 . . . . 0.29 109.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.11 40.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.467 -1.019 . . . . 0.29 108.72 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.99 124.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.126 -0.984 . . . . 0.31 109.943 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.78 133.77 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.703 -1.221 . . . . 0.3 107.703 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.51 175.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.296 -0.878 . . . . 0.24 110.278 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -145.3 108.75 4.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.593 -0.891 . . . . 1.81 108.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.43 -77.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.348 -1.353 . . . . 1.18 107.348 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.25 -135.73 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.54 -1.652 . . . . 1.97 106.54 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 10.1 p -101.63 56.06 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.964 -1.125 . . . . 1.38 107.964 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 59.1 m-20 -156.78 123.68 5.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 1.12 109.145 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.99 135.35 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.48 109.429 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.12 169.77 17.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 2.13 109.751 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 140.98 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.381 -0.824 . . . . 0.34 109.496 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.96 128.3 17.61 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.672 -0.862 . . . . 0.34 108.672 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.78 148.64 73.79 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.465 -1.013 . . . . 0.42 109.465 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.78 -30.37 69.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 3.11 109.489 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.58 -8.34 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.415 -0.803 . . . . 3.82 111.016 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.14 23.15 11.5 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.176 -0.952 . . . . 2.08 109.054 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.03 168.16 20.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.078 -0.712 . . . . 0.32 109.078 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.6 129.65 25.05 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.363 -0.836 . . . . 1.79 109.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.34 108.09 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.4 -0.812 . . . . 0.45 109.431 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.6 mm -101.88 156.08 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.319 -0.863 . . . . 0.57 108.683 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -94.5 135.36 36.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 3.62 109.183 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.042 -1.036 . . . . 2.05 109.555 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.269 0.557 . . . . 3.82 109.525 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -86.11 120.18 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.364 -0.976 . . . . 2.08 108.364 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -82.68 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 2.17 109.808 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -92.55 99.71 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 1.48 109.178 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.95 122.68 22.25 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.817 -0.808 . . . . 0.72 108.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -100.99 161.16 13.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.289 -1.004 . . . . 3.26 108.289 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.6 141.91 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.324 -0.86 . . . . 0.23 110.093 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -107.21 155.21 20.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.299 -1.371 . . . . 0.58 107.299 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 8.3 p90 -154.86 153.29 30.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.716 -1.24 . . . . 0.44 110.456 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -95.29 157.15 16.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.495 -0.753 . . . . 2.76 109.978 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.55 176.46 6.28 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.9 -0.778 . . . . 2.23 108.9 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.41 -11.24 38.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -0.994 . . . . 1.8 109.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.63 -15.41 35.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.33 -0.856 . . . . 3.63 109.902 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.4 m-20 -161.38 132.34 3.77 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.142 -0.974 . . . . 2.16 109.282 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.5 18.28 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.023 1.149 . . . . 1.25 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.1 p -86.59 158.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.72 -1.238 . . . . 1.75 109.921 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.1 m95 -75.5 176.25 7.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.429 -0.582 . . . . 0.66 109.429 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -134.97 -150.6 0.39 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.234 -0.916 . . . . 1.43 109.141 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.17 174.95 49.63 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.093 -1.203 . . . . 0.39 110.093 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.12 158.95 45.0 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.78 1.653 . . . . 0.41 110.066 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 172.04 13.23 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 0.21 109.517 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.55 ' NZ ' HH22 ' A' ' 224' ' ' ARG . 66.7 mmtt -92.49 137.72 32.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.269 -0.895 . . . . 2.72 109.428 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.27 124.47 34.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.498 -0.752 . . . . 0.29 109.814 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.37 -73.71 0.63 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.377 -0.827 . . . . 0.45 110.27 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.85 140.33 29.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.26 -0.9 . . . . 0.31 109.956 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -147.24 115.11 6.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -0.897 . . . . 2.32 109.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -100.3 0.17 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.854 -1.165 . . . . 0.27 110.302 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.37 -156.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.357 -1.084 . . . . 1.39 109.888 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.21 48.16 2.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.061 -1.615 . . . . 0.29 109.061 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 152.34 36.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.437 -1.037 . . . . 0.29 108.999 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.58 125.2 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.31 109.413 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 50.5 t -87.85 135.02 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.109 -1.071 . . . . 0.29 108.109 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 260' ' ' VAL . 9.1 pt -139.75 -177.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.23 110.062 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -143.14 109.41 5.32 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.359 -0.978 . . . . 1.81 108.359 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.62 -79.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.634 -1.247 . . . . 1.18 107.634 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -78.99 -135.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.481 -1.674 . . . . 1.98 106.481 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.7 m -101.02 53.72 0.84 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.167 -1.049 . . . . 1.39 108.167 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -157.35 132.13 8.7 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.051 -0.722 . . . . 1.12 109.051 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.64 137.31 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.47 109.479 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.54 169.91 16.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 2.11 109.701 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.93 140.87 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.458 -0.777 . . . . 0.33 109.411 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 251' ' ' ILE . 43.0 t -134.56 134.03 21.96 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.678 -0.86 . . . . 0.34 108.678 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.42 140.96 96.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 120.715 0.944 . . . . 0.42 110.478 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.4 HH12 HG13 ' A' ' 267' ' ' ILE . 20.7 tpt180 -59.11 -38.95 80.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 3.12 109.271 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -66.96 -7.95 26.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 3.82 111.001 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.68 25.11 9.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.156 -0.965 . . . . 2.08 109.169 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.53 164.28 30.57 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.212 -0.662 . . . . 0.32 109.212 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.03 126.47 20.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 1.79 109.075 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.4 HG13 HH12 ' A' ' 262' ' ' ARG . 18.4 mm -87.97 110.39 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.45 109.745 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.12 147.17 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.354 -0.98 . . . . 0.57 108.354 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -95.99 141.6 29.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 3.63 109.763 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.007 -0.997 . . . . 2.05 109.492 179.431 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 36.2 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.425 -0.583 . . . . 3.83 109.425 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.406 ' N ' HD13 ' B' ' 220' ' ' ILE . 0.4 OUTLIER -86.12 120.15 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.455 -0.943 . . . . 2.08 108.455 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -82.56 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.009 -1.057 . . . . 2.16 109.868 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -92.55 99.71 12.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.48 109.159 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.97 122.79 22.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.709 -0.849 . . . . 0.73 108.709 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -101.03 161.05 13.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.316 -0.994 . . . . 3.26 108.316 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.54 142.0 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 0.23 110.097 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.26 155.21 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.337 -1.357 . . . . 0.58 107.337 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -154.84 153.26 30.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.696 -1.253 . . . . 0.44 110.491 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -95.24 157.17 16.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.751 . . . . 2.76 109.975 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -94.52 176.48 6.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 2.23 108.962 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.44 -11.26 38.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 1.81 109.342 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.66 -15.4 35.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.331 -0.855 . . . . 3.64 109.857 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.7 m-20 -161.37 132.32 3.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 2.16 109.274 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.48 18.16 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.965 1.11 . . . . 1.27 110.838 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.2 p -86.41 158.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.774 -1.204 . . . . 1.76 109.922 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.498 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.66 176.28 7.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.381 -0.6 . . . . 0.67 109.381 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -135.0 -150.58 0.39 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.284 -0.885 . . . . 1.44 109.11 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.2 174.94 49.57 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.084 -1.207 . . . . 0.4 110.084 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.13 158.97 44.94 Favored 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 121.777 1.651 . . . . 0.41 110.077 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.11 172.15 13.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.392 -0.817 . . . . 0.21 109.5 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.552 ' NZ ' HH22 ' B' ' 224' ' ' ARG . 66.7 mmtt -92.52 137.7 32.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.233 -0.917 . . . . 2.72 109.422 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.29 124.48 34.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.3 109.783 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.35 -73.68 0.63 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.275 -0.891 . . . . 0.45 110.317 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.89 140.32 29.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.295 -0.878 . . . . 0.33 109.953 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -147.28 115.0 6.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.244 -0.91 . . . . 2.33 109.221 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.66 -100.36 0.18 Allowed Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.782 -1.199 . . . . 0.28 110.239 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.29 -157.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 1.4 109.863 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 48.06 2.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.27 36.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -1.067 . . . . 0.29 109.111 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.61 125.15 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.31 109.411 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.83 134.92 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.033 -1.099 . . . . 0.3 108.033 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 260' ' ' VAL . 9.2 pt -139.62 -177.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.24 110.105 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -143.05 109.55 5.4 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.391 -0.966 . . . . 1.81 108.391 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.66 -79.15 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.629 -1.248 . . . . 1.18 107.629 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.94 -135.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.551 -1.648 . . . . 1.97 106.551 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.9 m -100.95 53.7 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.13 -1.063 . . . . 1.38 108.13 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -157.3 132.16 8.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.041 -0.726 . . . . 1.12 109.041 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 37.1 mt -92.63 137.25 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.235 -0.916 . . . . 0.48 109.477 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.49 169.81 17.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.402 -0.811 . . . . 2.13 109.746 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.88 140.89 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.409 -0.807 . . . . 0.34 109.458 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' VAL . . . . . 0.418 HG21 HD11 ' B' ' 251' ' ' ILE . 42.8 t -134.49 133.99 22.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.802 -0.814 . . . . 0.34 108.802 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.43 140.91 96.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.647 0.898 . . . . 0.42 110.522 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.1 -38.85 80.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 3.11 109.326 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -67.07 -7.83 25.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.465 -0.772 . . . . 3.82 110.997 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.75 25.08 9.93 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.151 -0.968 . . . . 2.08 109.192 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 164.24 30.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.224 -0.658 . . . . 0.32 109.224 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -140.04 126.47 20.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 1.79 109.097 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.94 110.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.267 -0.895 . . . . 0.45 109.742 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.1 147.16 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.329 -0.989 . . . . 0.57 108.329 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -95.93 141.65 29.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.45 -0.781 . . . . 3.62 109.758 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.02 -0.99 . . . . 2.05 109.612 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.356 0.598 . . . . 3.82 109.53 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.0 136.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.967 -1.083 . . . . 2.08 108.204 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.12 -142.33 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.928 -1.107 . . . . 2.17 109.779 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -92.22 109.65 21.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.867 . . . . 1.48 109.522 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.05 137.52 46.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.592 -0.693 . . . . 0.72 109.416 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.6 OUTLIER -104.85 157.81 16.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.41 -1.33 . . . . 3.26 107.41 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.0 t -141.53 142.91 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.077 -1.014 . . . . 0.23 110.642 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -110.63 154.81 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.303 -1.369 . . . . 0.58 107.303 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.76 151.91 26.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.534 -1.354 . . . . 0.44 110.529 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 228' ' ' ARG . 2.0 mtm-85 -92.5 149.27 21.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.739 . . . . 2.76 109.876 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -94.38 168.04 11.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 2.23 108.698 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.9 t -84.81 -9.38 58.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 1.8 109.084 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 231' ' ' ARG . 3.5 mtt-85 -90.83 -15.75 29.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 3.63 109.989 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 234' ' ' VAL . 38.0 m-20 -160.24 129.54 3.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 2.16 108.95 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.86 11.03 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 120.831 1.021 . . . . 1.25 110.827 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.8 p -81.62 158.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.697 -1.252 . . . . 1.75 109.886 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.6 m95 -75.33 162.15 28.66 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.213 -0.662 . . . . 0.66 109.213 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.7 tttp -118.38 158.13 25.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.462 -0.774 . . . . 1.43 109.162 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.16 171.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.551 -1.02 . . . . 0.39 110.551 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.37 158.25 57.89 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.691 1.594 . . . . 0.41 110.621 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.24 170.65 15.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.674 -0.861 . . . . 0.21 108.674 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -92.95 137.24 32.54 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.072 -1.017 . . . . 2.72 109.349 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.55 120.31 30.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.708 -0.62 . . . . 0.29 109.587 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.6 mt -111.15 -71.79 0.75 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.363 -0.836 . . . . 0.45 110.101 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.2 t90 -91.59 142.11 27.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.206 -0.934 . . . . 0.31 109.78 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.76 112.48 5.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.139 -0.976 . . . . 2.32 109.065 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.83 -104.17 0.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.814 -1.184 . . . . 0.27 110.251 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 245' ' ' GLY . 30.0 mt-10 -56.67 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.477 -1.014 . . . . 1.39 109.862 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.1 49.95 2.99 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.103 -1.599 . . . . 0.29 109.103 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.22 157.9 43.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -1.009 . . . . 0.29 108.569 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.38 132.44 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.31 109.552 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.79 133.93 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 15.3 pt -138.71 174.06 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.326 -0.859 . . . . 0.23 110.562 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -141.89 108.87 5.44 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.226 -1.027 . . . . 1.81 108.226 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.22 -75.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.514 -1.291 . . . . 1.18 107.514 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.25 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.615 -1.624 . . . . 1.98 106.615 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.98 52.23 0.74 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.854 -1.165 . . . . 1.39 107.854 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -156.35 129.0 7.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.521 -0.737 . . . . 1.12 109.29 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.1 mt -92.62 141.52 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.47 109.635 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.57 165.11 28.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 2.11 109.668 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.9 137.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.818 . . . . 0.33 109.404 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.72 131.53 20.21 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.361 -0.837 . . . . 0.34 109.189 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.64 146.98 93.84 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 N-CA-C 109.702 -0.922 . . . . 0.42 109.702 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.07 -33.07 75.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 3.12 109.716 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -68.99 -7.05 31.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.21 -0.931 . . . . 3.82 110.636 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -119.73 20.96 12.19 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.265 -0.897 . . . . 2.08 109.13 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.89 23.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.32 109.534 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -139.42 131.01 27.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.213 -0.93 . . . . 1.79 108.973 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.18 105.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 0.45 109.523 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 269' ' ' ARG . 8.1 mm -105.1 159.99 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.368 -0.833 . . . . 0.57 108.956 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 269' ' ' ARG . 24.7 mtm-85 -87.54 148.19 25.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 3.63 109.376 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 8.5 m-20 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.1 -1.0 . . . . 2.05 109.067 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.326 0.584 . . . . 3.83 109.466 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 8.4 mm -83.98 136.05 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.005 -1.059 . . . . 2.08 108.205 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.06 -142.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.989 -1.069 . . . . 2.16 109.726 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -92.39 109.51 20.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.48 109.491 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -132.86 137.67 46.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.642 -0.661 . . . . 0.73 109.401 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.6 OUTLIER -104.96 157.82 16.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.403 -1.332 . . . . 3.26 107.403 178.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.55 143.03 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.111 -0.993 . . . . 0.23 110.601 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.66 154.8 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.77 151.98 26.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.513 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.0 mtm-85 -92.47 149.24 21.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 2.76 109.927 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -94.45 167.86 11.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.682 -0.858 . . . . 2.23 108.682 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 47.5 t -84.73 -9.26 58.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 1.81 109.139 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 231' ' ' ARG . 3.6 mtt-85 -90.89 -15.68 29.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 3.64 110.048 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 38.1 m-20 -160.31 129.59 3.2 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.159 -0.963 . . . . 2.16 108.965 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.04 11.16 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 120.775 0.983 . . . . 1.27 110.777 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.493 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.9 p -81.55 158.64 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.797 -1.189 . . . . 1.76 110.055 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.493 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.6 m95 -75.53 162.07 28.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.11 -0.7 . . . . 0.67 109.11 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.9 tttp -118.29 158.14 25.74 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.468 -0.77 . . . . 1.44 109.195 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.05 171.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.518 -1.033 . . . . 0.4 110.518 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.26 158.19 58.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.825 1.683 . . . . 0.41 110.667 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.23 170.81 15.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.678 -0.86 . . . . 0.21 108.678 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -93.14 137.16 32.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.022 -1.049 . . . . 2.72 109.339 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.8 tp -89.4 120.28 30.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.621 -0.675 . . . . 0.3 109.585 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.08 -71.9 0.74 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.314 -0.866 . . . . 0.45 110.095 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.1 t90 -91.58 142.18 27.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.33 109.805 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.84 112.55 5.67 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.205 -0.934 . . . . 2.33 109.109 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.88 -104.2 0.22 Allowed Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.783 -1.198 . . . . 0.28 110.301 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' B' ' 245' ' ' GLY . 30.3 mt-10 -56.68 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.032 . . . . 1.4 109.846 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.14 49.98 3.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.6 . . . . 0.29 109.101 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.18 158.0 43.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.589 -0.947 . . . . 0.29 108.527 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.36 132.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.31 109.544 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.79 133.95 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.936 -1.135 . . . . 0.3 107.936 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.77 173.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.24 110.565 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -141.74 108.77 5.46 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.311 -0.996 . . . . 1.81 108.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.23 -75.84 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.498 -1.297 . . . . 1.18 107.498 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.23 -132.07 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.566 -1.642 . . . . 1.97 106.566 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.94 52.06 0.75 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.952 -1.129 . . . . 1.38 107.952 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -156.2 129.0 7.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.643 -0.661 . . . . 1.12 109.335 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.2 mt -92.65 141.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.37 -0.831 . . . . 0.48 109.591 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.35 165.24 27.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 2.13 109.72 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.98 137.32 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.34 109.408 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.64 131.51 20.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.42 -0.8 . . . . 0.34 109.175 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.67 147.07 93.57 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 N-CA-C 109.734 -0.91 . . . . 0.42 109.734 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.06 -33.14 75.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 3.11 109.652 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.0 -7.03 31.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 3.82 110.559 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -119.7 20.96 12.21 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.29 -0.881 . . . . 2.08 109.134 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.62 166.81 23.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.32 109.524 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -139.41 130.91 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.354 -0.841 . . . . 1.79 109.092 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.8 mm -89.12 105.93 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 0.45 109.625 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' B' ' 269' ' ' ARG . 8.1 mm -105.08 160.13 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.383 -0.823 . . . . 0.57 109.026 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' B' ' 269' ' ' ARG . 24.6 mtm-85 -87.66 148.04 24.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 3.62 109.387 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.028 -0.987 . . . . 2.05 109.103 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.494 -0.558 . . . . 3.82 109.494 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.69 127.39 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.028 -1.101 . . . . 2.08 108.028 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.35 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 2.17 109.429 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -93.38 106.71 18.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.119 -0.988 . . . . 1.48 109.136 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.6 130.29 36.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.595 -0.691 . . . . 0.72 109.207 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.4 OUTLIER -105.68 159.48 15.94 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.293 -1.003 . . . . 3.26 108.293 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.13 140.8 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.044 -1.035 . . . . 0.23 110.59 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.06 152.48 23.95 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.252 -1.388 . . . . 0.58 107.252 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.57 151.5 26.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.537 -1.352 . . . . 0.44 110.615 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -95.06 143.63 26.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 2.76 109.88 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.77 173.25 7.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.392 -0.818 . . . . 2.23 108.997 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.24 -9.99 51.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.8 109.381 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.64 -13.0 43.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 3.63 109.55 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -158.43 128.43 3.38 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 2.16 108.707 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.32 2.04 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 120.875 1.05 . . . . 1.25 111.404 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.623 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.8 p -84.57 167.04 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.565 -1.334 . . . . 1.75 110.335 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.623 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.8 m95 -71.92 161.98 30.13 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.66 108.692 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.2 tttp -118.75 161.96 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.288 -0.883 . . . . 1.43 109.257 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.6 164.83 0.02 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.302 -1.119 . . . . 0.39 110.302 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.43 160.75 46.38 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.456 1.437 . . . . 0.41 110.127 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.66 175.32 9.67 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.836 -0.802 . . . . 0.21 108.836 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -95.89 138.73 33.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.126 -0.984 . . . . 2.72 109.795 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 tp -87.89 122.93 32.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.326 -0.859 . . . . 0.29 109.259 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.38 -72.94 0.67 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.352 -0.842 . . . . 0.45 110.326 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.528 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.7 t90 -90.07 139.95 30.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.091 -1.006 . . . . 0.31 110.387 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.62 7.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.374 -0.829 . . . . 2.32 109.008 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.33 -99.9 0.17 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.83 -1.308 . . . . 0.27 109.83 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.45 -155.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -1.149 . . . . 1.39 109.65 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.81 46.47 2.35 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.417 -1.473 . . . . 0.29 109.417 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.84 148.73 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -1.037 . . . . 0.29 108.564 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.76 126.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.297 -0.877 . . . . 0.31 109.697 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.19 139.42 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.156 -1.053 . . . . 0.29 108.156 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 257' ' ' ILE . 11.1 pt -141.2 178.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.23 110.408 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -143.69 111.29 5.96 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.892 -1.151 . . . . 1.81 107.892 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.56 -78.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.851 -1.166 . . . . 1.18 107.851 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -80.39 -128.47 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.802 -1.555 . . . . 1.98 106.802 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 51.1 m -105.38 51.37 0.76 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.961 -1.126 . . . . 1.39 107.961 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.16 134.4 11.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.009 -0.737 . . . . 1.12 109.009 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.488 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 10.5 mt -93.52 144.89 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 0.47 109.306 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.06 162.88 34.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.318 -0.864 . . . . 2.11 110.056 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.77 131.3 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.536 -0.727 . . . . 0.33 109.212 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.09 133.26 20.69 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.698 -0.853 . . . . 0.34 108.698 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.8 147.46 80.75 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.521 0.814 . . . . 0.42 109.993 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.29 -37.52 77.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 3.12 109.359 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -70.84 1.81 5.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.791 . . . . 3.82 110.72 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -118.93 12.0 12.71 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.581 -0.896 . . . . 2.08 108.581 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.75 170.05 16.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.679 . . . . 0.32 109.657 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.47 130.11 27.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.339 -0.85 . . . . 1.79 108.984 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.76 115.2 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.416 -0.803 . . . . 0.45 109.749 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.9 mm -112.12 155.04 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.383 -0.823 . . . . 0.57 109.141 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -91.57 136.29 33.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.517 -0.739 . . . . 3.63 109.278 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.979 -1.01 . . . . 2.05 109.55 179.844 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 53.2 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.2 0.524 . . . . 3.83 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.521 HD13 ' N ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.58 127.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.999 -1.112 . . . . 2.08 107.999 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.38 -126.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 2.16 109.479 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -93.31 106.65 18.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.2 -0.938 . . . . 1.48 109.128 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -134.52 130.39 36.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.578 -0.701 . . . . 0.73 109.145 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.532 HH11 ' HG2' ' B' ' 224' ' ' ARG . 0.4 OUTLIER -105.69 159.53 15.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.347 -0.983 . . . . 3.26 108.347 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -142.28 140.72 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.23 110.581 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -106.95 152.55 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.241 -1.392 . . . . 0.58 107.241 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.8 p90 -156.71 151.47 25.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.595 -1.315 . . . . 0.44 110.562 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -95.09 143.53 26.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.641 -0.662 . . . . 2.76 109.847 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.66 173.35 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 2.23 109.066 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.36 -9.91 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.81 109.426 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.76 -12.95 43.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 3.64 109.505 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -158.37 128.44 3.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.115 -0.991 . . . . 2.16 108.732 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.29 1.99 2.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.948 1.099 . . . . 1.27 111.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.7 p -84.5 166.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.59 -1.319 . . . . 1.76 110.386 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.8 m95 -71.92 161.97 30.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.665 -0.865 . . . . 0.67 108.665 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.79 162.0 19.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.383 -0.823 . . . . 1.44 109.211 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.65 164.82 0.02 OUTLIER Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.376 -1.089 . . . . 0.4 110.376 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.39 160.67 46.68 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.484 1.456 . . . . 0.41 110.179 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.54 175.53 9.49 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.791 -0.818 . . . . 0.21 108.791 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -96.02 138.78 33.15 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.167 -0.958 . . . . 2.72 109.717 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.02 122.84 32.1 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.3 109.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.1 mt -116.4 -72.79 0.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.423 -0.798 . . . . 0.45 110.285 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.488 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.7 t90 -90.11 139.9 30.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.08 -1.013 . . . . 0.33 110.268 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.54 7.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.285 -0.885 . . . . 2.33 109.073 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.22 -99.76 0.17 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.901 -1.28 . . . . 0.28 109.901 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.44 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -1.103 . . . . 1.4 109.702 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 46.45 2.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.381 -1.488 . . . . 0.29 109.381 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.78 148.63 34.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.443 -1.034 . . . . 0.29 108.522 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.77 126.37 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.267 -0.896 . . . . 0.31 109.732 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.13 139.52 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.227 -1.027 . . . . 0.3 108.227 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.427 ' O ' HG23 ' B' ' 257' ' ' ILE . 11.1 pt -141.24 178.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.207 -0.933 . . . . 0.24 110.464 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -143.65 111.31 5.98 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.985 -1.117 . . . . 1.81 107.985 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.62 -78.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.783 -1.192 . . . . 1.18 107.783 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.43 -128.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.767 -1.568 . . . . 1.97 106.767 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 51.0 m -105.42 51.34 0.76 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.972 -1.122 . . . . 1.38 107.972 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.09 134.43 11.51 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.053 -0.721 . . . . 1.12 109.053 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 10.7 mt -93.48 145.01 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.183 -0.948 . . . . 0.48 109.48 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.15 162.93 34.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 2.13 109.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.76 131.27 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 0.34 109.186 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.02 133.34 20.83 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.67 -0.863 . . . . 0.34 108.67 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.7 147.47 79.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.534 0.822 . . . . 0.42 110.027 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.47 -37.26 77.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 3.11 109.392 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -71.01 1.96 5.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 3.82 110.77 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -119.03 12.01 12.62 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.547 -0.909 . . . . 2.08 108.547 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.84 169.99 16.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.32 109.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.43 130.13 27.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.448 -0.783 . . . . 1.79 108.989 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.77 115.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.41 -0.806 . . . . 0.45 109.753 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -111.95 155.03 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.44 -0.788 . . . . 0.57 109.178 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -91.46 136.24 33.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.572 -0.705 . . . . 3.62 109.285 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.01 . . . . 2.05 109.555 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.504 ' O ' ' CE2' ' A' ' 223' ' ' PHE . 53.1 mtt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.533 0.682 . . . . 3.82 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 8.7 pt -83.3 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.125 0.965 . . . . 2.08 109.268 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -78.82 -107.46 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.489 -0.56 . . . . 2.17 109.489 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 -97.35 91.07 5.31 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 1.48 109.588 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 219' ' ' MET . 38.1 m-85 -136.07 135.46 39.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.525 -0.734 . . . . 0.72 109.466 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.53 156.94 20.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.215 -1.402 . . . . 3.26 107.215 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.14 141.79 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.008 -1.058 . . . . 0.23 110.716 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.44 152.55 25.23 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.406 -1.331 . . . . 0.58 107.406 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 17.6 p90 -155.91 158.58 38.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.44 110.673 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -102.02 143.72 31.51 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.425 0.631 . . . . 2.76 109.606 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 230' ' ' SER . 10.3 t70 -97.92 173.12 7.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.455 -0.778 . . . . 2.23 109.131 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 57.3 m -86.99 -5.67 59.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.8 109.406 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 231' ' ' ARG . 20.7 mtm-85 -88.59 -19.69 25.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.224 -0.923 . . . . 3.63 109.614 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -162.54 129.86 2.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 2.16 108.813 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -65.89 5.61 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 120.779 0.986 . . . . 1.25 110.698 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.4 m -83.0 127.51 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.821 -1.174 . . . . 1.75 109.993 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -48.28 164.4 0.05 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.25 -0.906 . . . . 0.66 109.551 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.8 mtpt -118.97 167.32 11.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.842 -0.799 . . . . 1.43 108.842 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -48.04 174.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.024 -1.231 . . . . 0.39 110.024 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.17 159.47 53.73 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.69 1.594 . . . . 0.41 110.502 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 172.17 13.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.101 -0.704 . . . . 0.21 109.101 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.61 33.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.112 -0.992 . . . . 2.72 109.573 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.78 125.32 34.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.52 -0.737 . . . . 0.29 109.493 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.0 mt -116.53 -74.54 0.6 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.397 -0.815 . . . . 0.45 110.209 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.71 141.55 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.31 109.988 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -145.94 118.72 8.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.831 . . . . 2.32 109.103 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.32 -104.77 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.723 -1.227 . . . . 0.27 110.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -68.85 -153.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 1.39 109.812 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.23 50.32 2.73 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.29 109.633 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.05 151.91 36.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -1.106 . . . . 0.29 108.917 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.24 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.97 . . . . 0.31 109.546 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -87.05 138.24 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.236 -1.024 . . . . 0.29 108.236 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.92 177.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -0.922 . . . . 0.23 110.095 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -144.69 110.3 5.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.687 -0.857 . . . . 1.81 108.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.57 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.577 -1.268 . . . . 1.18 107.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.8 -130.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 m -105.27 55.68 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.959 -1.126 . . . . 1.39 107.959 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.939 -0.763 . . . . 1.12 108.939 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.7 mt -92.65 139.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -0.872 . . . . 0.47 109.524 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.21 166.97 23.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 2.11 109.976 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.78 138.34 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.528 -0.916 . . . . 0.33 108.528 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.11 133.1 20.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.834 . . . . 0.34 109.35 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.43 139.12 89.35 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.798 -0.885 . . . . 0.42 109.798 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 262' ' ' ARG . 0.6 OUTLIER -58.9 -34.72 72.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 3.12 109.424 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 263' ' ' ARG . 18.8 ttm-85 -69.36 -2.87 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 3.82 109.731 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.46 17.09 13.8 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.335 -0.853 . . . . 2.08 109.095 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.18 170.92 14.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 0.32 109.903 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -140.39 131.51 26.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.243 -0.91 . . . . 1.79 109.17 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.73 107.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.139 -0.976 . . . . 0.45 109.508 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.96 150.63 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.172 -1.047 . . . . 0.57 108.172 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 269' ' ' ARG . 6.0 tpt180 -90.9 145.19 24.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -0.796 . . . . 3.63 109.127 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.914 -1.041 . . . . 2.05 109.54 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 219' ' ' MET . . . . . 0.504 ' O ' ' CE2' ' B' ' 223' ' ' PHE . 53.0 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.439 0.638 . . . . 3.83 109.432 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 8.7 pt -83.24 35.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 122.116 0.96 . . . . 2.08 109.218 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -78.79 -107.37 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.789 -0.569 . . . . 2.16 109.556 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.3 m-20 -97.42 91.07 5.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.013 . . . . 1.48 109.539 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' B' ' 219' ' ' MET . 38.2 m-85 -136.04 135.51 39.47 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.432 -0.793 . . . . 0.73 109.508 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.48 156.88 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.292 -1.373 . . . . 3.26 107.292 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 91.7 t -141.07 141.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.995 -1.066 . . . . 0.23 110.661 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.41 152.52 25.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 17.4 p90 -155.84 158.65 38.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.633 -1.292 . . . . 0.44 110.602 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -102.04 143.77 31.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.405 0.621 . . . . 2.76 109.645 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 230' ' ' SER . 10.2 t70 -97.84 173.03 7.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.413 -0.804 . . . . 2.23 109.188 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 m -86.85 -5.73 59.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 1.81 109.499 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' B' ' 231' ' ' ARG . 20.7 mtm-85 -88.47 -19.89 25.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.924 . . . . 3.64 109.57 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.2 m-20 -162.46 129.84 2.63 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 2.16 108.906 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.93 5.69 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 120.8 1.0 . . . . 1.27 110.623 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.481 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.4 m -83.11 127.56 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.796 -1.19 . . . . 1.76 110.014 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -48.29 164.44 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.214 -0.929 . . . . 0.67 109.601 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.8 mtpt -119.0 167.23 11.95 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.863 -0.791 . . . . 1.44 108.863 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -48.06 174.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.997 -1.241 . . . . 0.4 109.997 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.24 159.49 53.59 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.697 1.598 . . . . 0.41 110.509 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.87 172.23 13.32 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.024 -0.732 . . . . 0.21 109.024 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.63 33.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.114 -0.991 . . . . 2.72 109.535 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.89 125.44 34.94 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.516 -0.74 . . . . 0.3 109.409 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.4 mt -116.65 -74.62 0.6 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.4 -0.812 . . . . 0.45 110.103 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.66 141.55 28.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.33 110.014 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -146.0 118.72 8.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.368 -0.833 . . . . 2.33 109.147 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -104.79 0.23 Allowed Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.195 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -68.83 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.297 -1.12 . . . . 1.4 109.816 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.24 50.27 2.73 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.373 . . . . 0.29 109.666 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.08 151.86 36.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -1.12 . . . . 0.29 108.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.11 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.125 -0.985 . . . . 0.31 109.586 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.97 138.16 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.244 -1.021 . . . . 0.3 108.244 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.89 177.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 0.24 110.099 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -144.63 110.3 5.31 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.65 -81.6 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.542 -1.281 . . . . 1.18 107.542 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.73 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.593 -1.632 . . . . 1.97 106.593 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.6 m -105.33 55.64 0.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.99 -1.115 . . . . 1.38 107.99 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 1.12 108.901 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 23.6 mt -92.57 139.15 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.48 109.574 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.22 166.87 23.51 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 2.13 110.023 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.76 138.4 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.19 133.08 20.43 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.34 109.312 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.38 139.16 89.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.769 -0.897 . . . . 0.42 109.769 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' B' ' 262' ' ' ARG . 0.7 OUTLIER -58.98 -34.83 72.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 3.11 109.351 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' B' ' 263' ' ' ARG . 18.9 ttm-85 -69.24 -2.81 11.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 3.82 109.793 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.53 17.16 13.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.318 -0.863 . . . . 2.08 109.116 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.3 170.86 14.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.32 109.943 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -140.36 131.49 26.4 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.356 -0.84 . . . . 1.79 109.188 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.76 107.5 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.114 -0.991 . . . . 0.45 109.51 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.8 150.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.267 -1.012 . . . . 0.57 108.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' B' ' 269' ' ' ARG . 6.0 tpt180 -90.98 145.21 24.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -0.785 . . . . 3.62 109.086 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.029 -0.986 . . . . 2.05 109.547 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.384 -0.599 . . . . 3.82 109.384 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.3 135.34 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 2.08 109.485 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.5 -139.81 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 2.17 108.925 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -93.25 110.87 22.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 1.48 108.706 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -133.89 145.21 49.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 0.72 109.479 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.3 OUTLIER -119.71 154.03 34.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.851 -1.166 . . . . 3.26 107.851 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -138.87 146.45 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.079 -1.013 . . . . 0.23 111.012 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.17 155.78 24.39 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.261 -1.385 . . . . 0.58 107.261 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.8 p90 -157.43 150.86 23.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.578 -1.326 . . . . 0.44 110.465 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 228' ' ' ARG . 8.1 mtm-85 -93.04 146.44 23.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.476 -0.765 . . . . 2.76 109.306 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.84 167.41 11.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -0.9 . . . . 2.23 108.917 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.7 t -83.18 -10.54 58.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 1.8 109.24 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -89.96 -11.08 42.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 3.63 109.622 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.415 ' OD2' ' CG2' ' A' ' 234' ' ' VAL . 18.8 t0 -160.41 127.36 2.58 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 2.16 108.768 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.63 6.83 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.721 0.948 . . . . 1.25 110.269 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 235' ' ' TRP . 40.4 t -83.69 161.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 1.75 109.85 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.5 m95 -74.17 161.62 29.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.803 . . . . 0.66 109.076 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.3 tttp -118.92 160.86 21.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.383 -0.823 . . . . 1.43 109.25 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.0 167.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.6 -1.0 . . . . 0.39 110.6 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.37 157.91 57.85 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.681 1.588 . . . . 0.41 110.568 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.36 170.0 16.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.969 -0.752 . . . . 0.21 108.969 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -93.6 138.73 31.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.067 -1.02 . . . . 2.72 109.745 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.98 120.46 30.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.133 -0.691 . . . . 0.29 109.133 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.0 mt -111.12 -72.5 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.401 -0.812 . . . . 0.45 110.282 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.26 143.94 25.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.165 -0.959 . . . . 0.31 110.15 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.58 122.14 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.297 -0.877 . . . . 2.32 109.278 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.57 -103.78 0.21 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.081 -1.208 . . . . 0.27 110.081 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.62 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -1.124 . . . . 1.39 109.712 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 49.5 2.91 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.253 -1.539 . . . . 0.29 109.253 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.71 35.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -1.035 . . . . 0.29 108.704 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.03 124.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.991 . . . . 0.31 109.809 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.0 137.04 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.079 -1.082 . . . . 0.29 108.079 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.73 -179.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.861 . . . . 0.23 110.234 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -144.15 111.93 6.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.709 -0.848 . . . . 1.81 108.709 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.36 -78.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.491 -1.3 . . . . 1.18 107.491 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.64 -132.19 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.695 -1.594 . . . . 1.98 106.695 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.7 m -103.66 54.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.031 -1.1 . . . . 1.39 108.031 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.81 126.99 6.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 1.12 109.283 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.9 mt -92.71 137.0 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.47 109.286 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.49 171.86 13.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 2.11 109.743 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.92 137.47 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.372 -0.83 . . . . 0.33 109.359 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -136.94 125.22 14.8 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.401 -0.812 . . . . 0.34 108.974 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.46 143.75 93.54 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.527 0.818 . . . . 0.42 110.242 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.04 -32.54 72.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 3.12 109.387 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -68.71 -7.69 35.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.338 -0.851 . . . . 3.82 110.672 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -119.05 19.59 12.92 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.175 -0.953 . . . . 2.08 109.451 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.01 168.9 18.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.52 -0.737 . . . . 0.32 109.589 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.4 ' NZ ' ' CZ3' ' A' ' 235' ' ' TRP . 29.0 mtmm -137.62 127.27 25.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 1.79 109.049 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.4 mm -88.15 107.91 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.223 -0.923 . . . . 0.45 110.15 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.5 mm -105.7 151.51 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.398 -0.964 . . . . 0.57 108.398 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.18 149.35 21.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.303 -0.873 . . . . 3.63 109.053 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.927 -1.035 . . . . 2.05 109.446 179.832 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.435 -0.58 . . . . 3.83 109.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.27 135.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.145 -0.972 . . . . 2.08 109.453 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.58 -139.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.889 . . . . 2.16 108.834 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -93.2 110.91 22.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 1.48 108.696 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.03 145.14 49.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.522 -0.736 . . . . 0.73 109.449 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' B' ' 224' ' ' ARG . 0.3 OUTLIER -119.69 154.05 34.66 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.807 -1.183 . . . . 3.26 107.807 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.94 146.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.116 -0.99 . . . . 0.23 110.987 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -113.13 155.89 24.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.226 -1.398 . . . . 0.58 107.226 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.1 p90 -157.43 151.02 24.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.572 -1.33 . . . . 0.44 110.42 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' B' ' 228' ' ' ARG . 8.1 mtm-85 -93.14 146.54 23.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 2.76 109.291 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.89 167.38 11.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 2.23 108.931 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.8 t -83.16 -10.52 58.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 1.81 109.278 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -90.06 -10.96 42.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 3.64 109.592 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.413 ' OD2' ' CG2' ' B' ' 234' ' ' VAL . 18.7 t0 -160.44 127.31 2.56 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.16 108.782 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.49 6.72 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 120.814 1.009 . . . . 1.27 110.322 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.494 HG12 ' N ' ' B' ' 235' ' ' TRP . 40.3 t -83.74 161.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 1.76 109.893 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.494 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -74.06 161.55 29.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.67 109.063 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.91 160.86 21.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.41 -0.806 . . . . 1.44 109.285 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.86 166.98 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.578 -1.009 . . . . 0.4 110.578 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -66.33 157.91 57.77 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.767 1.644 . . . . 0.41 110.543 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.42 169.97 16.78 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.99 -0.745 . . . . 0.21 108.99 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.499 ' HZ2' ' HB2' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -93.55 138.79 31.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.107 -0.996 . . . . 2.72 109.699 -179.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.3 tp -88.97 120.52 30.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.3 109.172 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.1 mt -111.23 -72.56 0.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.317 -0.864 . . . . 0.45 110.246 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.28 143.81 26.03 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.33 110.152 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -148.42 122.16 9.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 2.33 109.314 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.6 -103.71 0.21 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.096 -1.202 . . . . 0.28 110.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.61 -153.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -1.136 . . . . 1.4 109.7 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.16 49.48 2.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.234 -1.546 . . . . 0.29 109.234 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.75 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -1.061 . . . . 0.29 108.781 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.98 124.49 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.182 -0.949 . . . . 0.31 109.725 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.06 137.0 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.06 -1.089 . . . . 0.3 108.06 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.64 -179.77 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.221 -0.924 . . . . 0.24 110.252 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -144.18 111.86 6.12 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 1.81 108.705 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -90.21 -78.57 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.66 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.641 -1.614 . . . . 1.97 106.641 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.3 m -103.77 54.3 0.74 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.936 -1.135 . . . . 1.38 107.936 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.85 126.9 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.529 -0.732 . . . . 1.12 109.245 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.65 137.03 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.48 109.272 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -137.45 171.84 13.87 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.406 -0.809 . . . . 2.13 109.728 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 137.51 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.374 -0.829 . . . . 0.34 109.396 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 55.1 t -136.97 125.2 14.75 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.374 -0.829 . . . . 0.34 108.931 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.48 143.72 93.69 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.48 0.787 . . . . 0.42 110.298 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 3.11 109.46 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -68.77 -7.63 35.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.227 -0.921 . . . . 3.82 110.705 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -119.17 19.78 12.79 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.191 -0.943 . . . . 2.08 109.436 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.1 168.85 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.32 109.559 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -137.55 127.35 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.341 -0.85 . . . . 1.79 109.024 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.18 107.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.207 -0.933 . . . . 0.45 110.201 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -105.59 151.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.482 -0.933 . . . . 0.57 108.482 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.13 149.36 21.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.374 -0.829 . . . . 3.62 109.147 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.05 109.49 179.872 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.58 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.487 -0.56 . . . . 3.82 109.487 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.2 pt -82.9 139.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 2.08 109.278 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -85.11 -126.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 2.17 109.793 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.69 116.54 28.88 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 1.48 109.421 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.41 ' CA ' ' OD1' ' A' ' 270' ' ' ASP . 39.6 m-85 -135.73 131.23 35.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.41 -0.806 . . . . 0.72 109.145 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.94 156.62 17.29 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.05 -1.093 . . . . 3.26 108.05 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.63 143.37 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.102 -0.999 . . . . 0.23 110.39 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 226' ' ' TYR . 22.6 m-85 -114.05 155.46 25.9 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.754 -1.202 . . . . 0.58 107.754 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.0 p90 -156.8 150.2 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.781 -1.199 . . . . 0.44 110.353 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -96.21 152.64 18.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 2.76 109.699 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.7 170.44 9.32 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.38 -0.97 . . . . 2.23 108.38 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.91 -12.44 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 1.8 109.225 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.68 -11.34 40.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.369 -0.832 . . . . 3.63 110.067 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.8 p30 -157.21 129.78 4.26 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.94 -1.1 . . . . 2.16 109.922 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.18 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 120.907 1.071 . . . . 1.25 110.659 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -82.53 142.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.779 -1.201 . . . . 1.75 109.74 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.93 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.66 108.981 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.36 -161.14 1.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.43 108.623 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.31 166.96 54.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.469 . . . . 0.39 109.429 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.92 159.35 53.62 Favored 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.408 1.405 . . . . 0.41 109.88 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.93 171.78 14.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.506 -0.746 . . . . 0.21 108.989 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.52 140.38 29.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.012 . . . . 2.72 109.212 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.97 125.14 34.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.672 -0.642 . . . . 0.29 109.718 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.3 -75.09 0.6 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.365 -0.834 . . . . 0.45 110.46 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 30.1 t90 -91.7 146.29 23.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.128 -0.982 . . . . 0.31 110.856 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.66 124.87 14.55 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.814 -0.809 . . . . 2.32 108.814 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.34 -116.13 0.54 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.087 -1.205 . . . . 0.27 110.087 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.59 -149.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -1.07 . . . . 1.39 109.449 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 52.92 3.43 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.312 -1.515 . . . . 0.29 109.312 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.44 147.45 27.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.957 . . . . 0.29 108.613 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.97 135.28 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.068 -1.02 . . . . 0.31 109.873 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.84 140.59 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.64 -0.874 . . . . 0.29 108.64 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.72 179.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.23 110.285 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -142.67 111.79 6.52 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.558 -0.905 . . . . 1.81 108.558 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.03 -77.65 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.41 -1.329 . . . . 1.18 107.41 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -81.77 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.72 -1.585 . . . . 1.98 106.72 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.93 54.49 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.41 130.43 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.492 -0.755 . . . . 1.12 109.328 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.448 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 97.9 mt -94.4 139.22 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.47 109.718 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.39 164.84 28.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 2.11 109.536 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.02 136.5 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.572 -0.899 . . . . 0.33 108.572 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.0 t -134.96 123.01 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 0.34 109.597 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -53.57 144.5 51.81 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.809 1.006 . . . . 0.42 110.839 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.54 -20.31 65.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.564 -0.71 . . . . 3.12 109.143 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -66.98 -17.89 65.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 3.82 111.64 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.89 28.67 5.55 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.979 -1.076 . . . . 2.08 109.702 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.11 159.52 40.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.841 -0.8 . . . . 0.32 108.841 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.436 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 6.3 mtmp? -139.31 130.29 26.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 1.79 109.635 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.83 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.45 109.593 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 269' ' ' ARG . 25.1 mm -105.26 160.39 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.27 26.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.31 -0.868 . . . . 3.63 109.705 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.41 ' OD1' ' CA ' ' A' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.058 -1.026 . . . . 2.05 108.977 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.422 -0.585 . . . . 3.83 109.422 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.2 pt -83.01 139.6 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 2.08 109.28 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -85.16 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.16 109.782 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.69 116.58 28.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 1.48 109.449 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' PHE . . . . . 0.408 ' CA ' ' OD1' ' B' ' 270' ' ' ASP . 39.8 m-85 -135.71 131.16 35.27 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.112 -0.699 . . . . 0.73 109.112 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.91 156.61 17.28 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.139 -1.06 . . . . 3.26 108.139 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 61.6 t -141.58 143.43 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.144 -0.972 . . . . 0.23 110.326 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 226' ' ' TYR . 22.0 m-85 -114.06 155.52 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.821 -1.178 . . . . 0.58 107.821 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.9 p90 -156.89 150.16 24.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.802 -1.186 . . . . 0.44 110.321 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -96.2 152.5 18.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.336 -0.853 . . . . 2.76 109.763 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.67 170.52 9.27 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.402 -0.962 . . . . 2.23 108.402 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.95 -12.44 53.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.981 -1.074 . . . . 1.81 109.198 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.72 -11.41 39.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.316 -0.865 . . . . 3.64 109.985 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.8 p30 -157.14 129.78 4.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.992 -1.067 . . . . 2.16 109.985 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.13 6.76 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 120.989 1.126 . . . . 1.27 110.627 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.57 142.69 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.762 -1.211 . . . . 1.76 109.688 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -60.93 -172.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.67 109.015 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.46 -161.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.214 -0.929 . . . . 1.44 108.604 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.25 166.96 54.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.433 -1.467 . . . . 0.4 109.433 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.94 159.35 53.6 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.402 1.401 . . . . 0.41 109.847 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.94 171.76 14.03 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.21 109.005 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.46 140.46 29.55 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.947 . . . . 2.72 109.184 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.3 tp -89.07 125.16 34.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.617 -0.677 . . . . 0.3 109.791 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.6 mt -114.32 -75.03 0.6 Allowed 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.302 -0.874 . . . . 0.45 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 29.8 t90 -91.78 146.3 23.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.223 -0.923 . . . . 0.33 110.887 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.62 124.86 14.57 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.89 -0.781 . . . . 2.33 108.89 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -116.15 0.54 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.029 -1.228 . . . . 0.28 110.029 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -67.45 -149.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.489 -1.007 . . . . 1.4 109.595 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.25 52.99 3.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.38 -1.488 . . . . 0.29 109.38 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.41 147.43 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.483 -1.01 . . . . 0.29 108.626 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 135.34 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.947 -1.095 . . . . 0.31 109.837 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.89 140.64 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.3 108.6 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.82 179.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.17 -0.956 . . . . 0.24 110.211 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -142.57 111.8 6.56 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.577 -0.898 . . . . 1.81 108.577 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.04 -77.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.482 -1.303 . . . . 1.18 107.482 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -81.65 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.788 -1.56 . . . . 1.97 106.788 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.99 54.5 0.71 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.062 -1.088 . . . . 1.38 108.062 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.39 130.37 7.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.12 109.347 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 97.9 mt -94.28 139.3 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.48 109.669 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -139.51 164.8 28.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.468 -0.77 . . . . 2.13 109.489 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.93 136.44 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.588 -0.893 . . . . 0.34 108.588 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 71.8 t -134.99 122.98 15.55 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.373 -0.83 . . . . 0.34 109.579 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -53.49 144.54 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.801 1.001 . . . . 0.42 110.927 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.59 -20.35 65.99 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.557 -0.714 . . . . 3.11 109.099 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.85 -18.07 65.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 3.82 111.631 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.82 28.65 5.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.005 -1.06 . . . . 2.08 109.68 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.04 159.6 40.3 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.803 -0.814 . . . . 0.32 108.803 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.435 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 6.3 mtmp? -139.3 130.3 26.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.169 -0.957 . . . . 1.79 109.675 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.86 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.45 109.627 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.439 HG22 ' N ' ' B' ' 269' ' ' ARG . 25.2 mm -105.37 160.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.644 -0.872 . . . . 0.57 108.644 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.32 26.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 3.62 109.719 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.408 ' OD1' ' CA ' ' B' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.043 -1.035 . . . . 2.05 108.965 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 219' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.488 -0.56 . . . . 3.82 109.488 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.23 129.36 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.005 . . . . 2.08 108.731 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -97.02 -109.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.105 -0.997 . . . . 2.17 110.001 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.82 104.03 12.93 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.003 -0.74 . . . . 1.48 109.003 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.54 125.67 26.15 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.235 -0.916 . . . . 0.72 109.788 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.02 164.46 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.756 -1.202 . . . . 3.26 107.756 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.02 141.65 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 0.23 109.972 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -108.83 151.98 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.523 -1.288 . . . . 0.58 107.523 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 8.2 p90 -153.73 152.23 30.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.77 -1.206 . . . . 0.44 110.332 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -94.13 153.14 18.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.76 110.245 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -92.3 171.09 9.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.2 t -87.77 -10.95 49.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.02 -1.05 . . . . 1.8 109.548 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -90.01 -14.51 33.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 3.63 109.611 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 234' ' ' VAL . 47.3 m-20 -161.3 130.57 3.19 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 2.16 109.29 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -65.93 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.804 1.003 . . . . 1.25 110.553 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 232' ' ' ASP . 21.7 m -83.48 140.37 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.846 -1.159 . . . . 1.75 109.736 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -60.68 167.21 2.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.66 109.516 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 237' ' ' GLY . 29.8 tttm -125.78 162.78 24.33 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.488 -0.757 . . . . 1.43 109.267 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.07 166.55 0.03 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.503 -1.039 . . . . 0.39 110.503 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.6 159.48 53.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.782 1.655 . . . . 0.41 110.458 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.22 5.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 0.21 109.164 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.95 138.95 34.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.029 -1.045 . . . . 2.72 109.835 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.7 tp -88.77 123.7 33.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.438 -0.788 . . . . 0.29 109.494 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.67 -74.51 0.61 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.474 -0.766 . . . . 0.45 110.286 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.36 143.62 26.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.139 -0.975 . . . . 0.31 110.191 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -147.53 118.53 7.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.875 . . . . 2.32 108.977 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.91 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.717 -1.23 . . . . 0.27 110.471 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -68.65 -153.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.269 -1.136 . . . . 1.39 109.917 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.46 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.139 -1.585 . . . . 0.29 109.139 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.83 155.15 40.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -1.099 . . . . 0.29 109.189 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.37 126.33 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.31 109.307 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.54 137.85 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 24.5 pt -141.97 179.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.23 110.344 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -142.17 114.04 8.03 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.19 -80.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.28 -1.378 . . . . 1.18 107.28 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -80.71 -130.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.572 -1.64 . . . . 1.98 106.572 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.13 53.74 0.74 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.161 -0.962 . . . . 1.39 108.493 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.09 127.7 7.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.542 -0.723 . . . . 1.12 109.293 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 60.7 mt -92.66 136.38 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 0.47 109.493 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.1 172.15 13.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.234 -0.916 . . . . 2.11 109.873 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.91 137.29 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.479 -0.763 . . . . 0.33 109.935 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.05 130.21 19.32 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.423 -0.798 . . . . 0.34 108.95 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.48 142.25 97.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 109.706 -0.921 . . . . 0.42 109.706 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -63.63 -30.11 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.149 -0.97 . . . . 3.12 109.15 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.91 -10.77 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.38 -0.825 . . . . 3.82 109.873 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -119.48 25.44 10.06 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.382 -0.824 . . . . 2.08 108.883 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.494 -0.754 . . . . 0.32 109.833 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.444 ' HZ2' HD11 ' A' ' 268' ' ' ILE . 6.7 mtmp? -139.13 130.75 27.32 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.329 -0.857 . . . . 1.79 108.812 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.91 109.07 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.45 110.475 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.444 HD11 ' HZ2' ' A' ' 266' ' ' LYS . 23.5 mm -108.74 147.8 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.131 -1.062 . . . . 0.57 108.131 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.77 18.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 3.63 109.921 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.055 -0.974 . . . . 2.05 109.623 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' B' ' 219' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.499 -0.556 . . . . 3.83 109.499 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.14 129.37 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.192 -0.943 . . . . 2.08 108.694 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -97.12 -109.54 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.045 -1.034 . . . . 2.16 109.877 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.81 103.92 12.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.783 . . . . 1.48 109.06 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.51 125.59 26.06 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.239 -0.913 . . . . 0.73 109.743 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.92 164.53 12.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.793 -1.188 . . . . 3.26 107.793 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.1 141.63 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.23 110.01 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.87 152.0 25.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.558 -1.275 . . . . 0.58 107.558 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.2 p90 -153.7 152.2 30.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 0.44 110.336 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -94.1 153.13 18.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.541 -0.724 . . . . 2.76 110.246 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.5 OUTLIER -92.35 171.06 9.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.438 -0.949 . . . . 2.23 108.438 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 44.3 t -87.65 -11.08 49.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.934 -1.104 . . . . 1.81 109.562 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -89.96 -14.46 34.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 3.64 109.67 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' B' ' 234' ' ' VAL . 47.1 m-20 -161.31 130.67 3.21 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.108 -0.995 . . . . 2.16 109.224 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.01 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 120.828 1.018 . . . . 1.27 110.459 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 232' ' ' ASP . 21.6 m -83.5 140.36 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.876 -1.14 . . . . 1.76 109.762 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -60.69 167.25 2.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.212 -0.93 . . . . 0.67 109.609 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' B' ' 237' ' ' GLY . 29.8 tttm -125.76 162.77 24.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.76 . . . . 1.44 109.246 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.14 166.61 0.03 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.477 -1.049 . . . . 0.4 110.477 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.66 159.54 53.11 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.691 1.594 . . . . 0.41 110.491 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.16 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.35 -0.844 . . . . 0.21 109.158 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -98.02 139.06 34.41 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.027 -1.046 . . . . 2.72 109.923 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -88.93 123.64 33.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.401 -0.812 . . . . 0.3 109.504 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.66 -74.44 0.61 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.413 -0.805 . . . . 0.45 110.298 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.34 143.61 26.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.174 -0.954 . . . . 0.33 110.217 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -147.62 118.57 7.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.258 -0.901 . . . . 2.33 108.816 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.95 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.679 -1.248 . . . . 0.28 110.518 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.65 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -1.172 . . . . 1.4 109.94 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.68 48.4 2.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.186 -1.565 . . . . 0.29 109.186 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.18 40.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.29 109.166 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 249' ' ' VAL . 26.6 m -146.32 126.33 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.31 109.296 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.59 137.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.938 -1.134 . . . . 0.3 107.938 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 24.4 pt -141.8 179.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.24 110.362 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -142.35 114.08 7.98 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.637 -0.875 . . . . 1.81 108.637 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -91.2 -80.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.188 -1.412 . . . . 1.18 107.188 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -80.72 -130.06 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.612 -1.625 . . . . 1.97 106.612 177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.5 m -104.16 53.77 0.74 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.135 -0.978 . . . . 1.38 108.535 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.07 127.72 8.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.506 -0.746 . . . . 1.12 109.329 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 60.8 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.342 -0.849 . . . . 0.48 109.438 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.16 172.05 13.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.246 -0.909 . . . . 2.13 109.836 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.77 137.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 0.34 109.948 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.11 130.2 19.26 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.884 -0.784 . . . . 0.34 108.884 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.44 142.32 97.8 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 N-CA-C 109.739 -0.908 . . . . 0.42 109.739 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -63.71 -30.16 71.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 3.11 109.144 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.96 -10.63 51.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 3.82 109.895 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -119.53 25.46 10.03 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.347 -0.846 . . . . 2.08 108.825 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.85 161.11 39.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.577 -0.702 . . . . 0.32 109.905 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.442 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.7 mtmp? -139.17 130.76 27.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.327 -0.858 . . . . 1.79 108.784 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.0 mm -87.96 109.14 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.211 -0.93 . . . . 0.45 110.416 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.442 HD11 ' HZ1' ' B' ' 266' ' ' LYS . 23.6 mm -108.83 147.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.184 -1.043 . . . . 0.57 108.184 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.86 18.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.388 -0.82 . . . . 3.62 109.938 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 117.977 -1.011 . . . . 2.05 109.529 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.507 -0.553 . . . . 3.82 109.507 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 pt -82.9 140.28 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 2.08 109.465 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -89.06 -133.92 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 2.17 109.794 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.423 ' O ' ' OXT' ' A' ' 270' ' ' ASP . 19.3 m-20 -92.5 98.24 11.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.885 . . . . 1.48 108.786 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -117.51 135.13 54.15 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.193 -0.669 . . . . 0.72 109.193 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -104.82 159.19 15.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.901 -1.148 . . . . 3.26 107.901 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.98 140.95 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.23 110.219 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.83 153.47 24.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.487 -1.301 . . . . 0.58 107.487 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.3 p90 -156.38 151.45 26.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.44 110.123 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -95.76 143.26 27.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.371 -0.831 . . . . 2.76 109.838 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.7 168.34 10.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.818 . . . . 2.23 108.989 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.86 8.82 7.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.984 . . . . 1.8 109.297 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.63 -39.22 15.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 3.63 109.523 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.3 p-10 -158.22 148.32 15.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.014 . . . . 2.16 109.306 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.88 10.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.172 1.248 . . . . 1.25 110.958 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.3 t -83.51 152.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.75 -1.219 . . . . 1.75 109.773 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.84 165.04 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.964 -0.754 . . . . 0.66 108.964 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.9 tttp -119.38 159.4 24.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.478 -0.764 . . . . 1.43 109.212 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.81 165.99 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.361 -1.095 . . . . 0.39 110.361 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.92 161.61 41.6 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.525 1.483 . . . . 0.41 110.405 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.23 173.4 11.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.862 -0.792 . . . . 0.21 108.862 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.06 137.01 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.095 -1.003 . . . . 2.72 109.608 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.38 123.07 31.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.635 -0.665 . . . . 0.29 109.366 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -115.76 -73.51 0.65 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.434 -0.791 . . . . 0.45 110.091 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.2 t90 -93.55 146.59 23.69 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.281 -0.887 . . . . 0.31 109.974 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -146.86 125.38 12.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 2.32 109.065 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -110.02 0.34 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.824 -1.179 . . . . 0.27 110.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.87 -150.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -1.1 . . . . 1.39 109.858 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.86 2.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.357 -1.497 . . . . 0.29 109.357 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.1 150.7 34.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.509 -0.995 . . . . 0.29 108.668 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.56 129.27 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.31 109.759 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.5 t -89.79 137.41 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.027 -1.101 . . . . 0.29 108.027 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.4 pt -141.22 177.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.301 -0.875 . . . . 0.23 109.929 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -144.09 110.75 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.472 -0.936 . . . . 1.81 108.472 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.01 -79.12 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.53 -1.285 . . . . 1.18 107.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.22 -130.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.48 -1.674 . . . . 1.98 106.48 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.9 t -105.26 54.93 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.992 -1.114 . . . . 1.39 107.992 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.56 125.48 5.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.166 -0.679 . . . . 1.12 109.166 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -92.36 138.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.887 . . . . 0.47 109.491 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -140.01 167.08 22.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.393 -0.817 . . . . 2.11 109.684 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.82 139.0 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.33 109.221 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -136.11 134.15 20.07 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.34 108.916 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.65 142.86 98.83 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 N-CA-C 109.85 -0.865 . . . . 0.42 109.85 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.417 ' HG2' ' NH1' ' A' ' 262' ' ' ARG . 6.4 tpt180 -60.69 -34.39 74.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 3.12 109.555 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -68.87 -7.1 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.241 -0.912 . . . . 3.82 110.846 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -119.0 19.0 13.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.073 -1.017 . . . . 2.08 108.839 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.36 168.71 19.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.897 -0.779 . . . . 0.32 108.897 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.43 129.72 23.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.977 . . . . 1.79 109.541 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.83 106.03 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.326 -0.859 . . . . 0.45 109.721 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.6 152.08 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.231 -0.918 . . . . 0.57 108.815 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.416 ' O ' ' OD1' ' A' ' 270' ' ' ASP . 58.7 ttt180 -91.03 146.19 24.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.789 . . . . 3.63 109.642 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.423 ' OXT' ' O ' ' A' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.935 -1.031 . . . . 2.05 109.429 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 3.83 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 pt -82.71 140.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 2.08 109.48 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -89.05 -133.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.16 109.831 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.422 ' O ' ' OXT' ' B' ' 270' ' ' ASP . 19.3 m-20 -92.59 98.19 11.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 1.48 108.774 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.35 135.24 54.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.573 -0.704 . . . . 0.73 109.189 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -104.97 159.11 16.07 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.897 -1.149 . . . . 3.26 107.897 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 81.1 t -140.96 140.99 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.185 -0.947 . . . . 0.23 110.22 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.79 153.45 24.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.509 -1.293 . . . . 0.58 107.509 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.5 p90 -156.36 151.39 26.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.68 -1.263 . . . . 0.44 110.114 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -95.78 143.26 27.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.485 -0.759 . . . . 2.76 109.857 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.72 168.32 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 2.23 109.059 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.83 8.79 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 1.81 109.301 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.56 -39.21 15.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 3.64 109.497 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.3 p-10 -158.34 148.27 15.34 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.147 -0.97 . . . . 2.16 109.294 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.85 10.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.222 1.281 . . . . 1.27 110.854 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.3 t -83.43 152.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.788 -1.195 . . . . 1.76 109.732 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.85 164.99 25.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.474 -0.766 . . . . 0.67 109.015 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.8 tttp -119.31 159.4 24.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.444 -0.785 . . . . 1.44 109.241 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.9 165.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.305 -1.118 . . . . 0.4 110.305 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.86 161.61 41.44 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.602 1.535 . . . . 0.41 110.41 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.31 173.48 11.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.811 -0.811 . . . . 0.21 108.811 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.07 137.06 34.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.124 -0.985 . . . . 2.72 109.559 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.56 123.09 32.08 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.7 . . . . 0.3 109.345 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.75 -73.5 0.65 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.414 -0.804 . . . . 0.45 109.996 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.45 146.61 23.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.91 . . . . 0.33 109.979 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -146.9 125.46 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.295 -0.878 . . . . 2.33 108.981 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -110.02 0.34 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.755 -1.212 . . . . 0.28 110.288 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.85 -150.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -1.062 . . . . 1.4 109.863 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 48.94 2.8 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.298 -1.521 . . . . 0.29 109.298 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.19 150.64 34.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.461 -1.023 . . . . 0.29 108.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.9 m -145.54 129.29 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.31 109.699 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.73 137.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.096 -1.076 . . . . 0.3 108.096 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.29 176.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.317 -0.864 . . . . 0.24 109.907 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -144.09 110.7 5.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.489 -0.93 . . . . 1.81 108.489 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.99 -79.17 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.536 -1.283 . . . . 1.18 107.536 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.12 -130.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.539 -1.652 . . . . 1.97 106.539 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.0 t -105.28 54.86 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.985 -1.117 . . . . 1.38 107.985 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.53 125.53 6.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.579 -0.701 . . . . 1.12 109.156 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.2 mt -92.41 137.93 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.375 -0.828 . . . . 0.48 109.519 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -139.9 167.22 22.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.432 -0.792 . . . . 2.13 109.704 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -103.95 138.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.412 -0.805 . . . . 0.34 109.203 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.03 134.13 20.16 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.34 108.966 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.57 142.83 98.58 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 120.597 0.865 . . . . 0.42 109.855 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' B' ' 262' ' ' ARG . 6.5 tpt180 -60.7 -34.32 74.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 3.11 109.569 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -68.89 -7.19 32.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.27 -0.894 . . . . 3.82 110.787 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -118.97 19.02 13.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.227 -0.921 . . . . 2.08 108.79 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 168.74 19.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.849 -0.797 . . . . 0.32 108.849 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.44 129.76 23.83 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.139 -0.976 . . . . 1.79 109.568 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.81 105.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.26 -0.9 . . . . 0.45 109.728 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.67 152.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.57 108.737 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 58.7 ttt180 -90.95 146.13 24.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.361 -0.837 . . . . 3.62 109.69 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.422 ' OXT' ' O ' ' B' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.933 -1.032 . . . . 2.05 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.46 -0.57 . . . . 3.82 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.41 138.54 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.898 -1.149 . . . . 2.08 107.898 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -82.41 -141.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 2.17 109.805 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -93.99 110.63 22.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 1.48 109.657 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.7 130.39 38.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.785 -0.82 . . . . 0.72 108.785 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -99.27 150.71 21.82 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.459 -1.311 . . . . 3.26 107.459 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.06 136.47 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.205 -0.935 . . . . 0.23 110.559 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -107.97 156.96 18.64 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.737 -1.209 . . . . 0.58 107.737 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.2 p90 -157.84 152.67 25.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.569 -1.332 . . . . 0.44 110.334 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' A' ' 228' ' ' ARG . 2.7 mtm-85 -93.37 144.36 25.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.44 -0.788 . . . . 2.76 109.837 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.75 175.4 6.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.405 -0.809 . . . . 2.23 109.328 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.68 -10.75 44.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.188 -0.945 . . . . 1.8 109.247 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -89.67 -15.23 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 3.63 109.617 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -159.55 129.28 3.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.143 -0.973 . . . . 2.16 109.204 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.06 8.57 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 120.8 1.0 . . . . 1.25 111.273 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.0 p -85.66 164.15 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.552 -1.342 . . . . 1.75 110.291 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.562 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.9 m95 -76.03 163.49 27.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.746 -0.596 . . . . 0.66 109.532 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 237' ' ' GLY . 2.5 mtpp -118.44 165.16 14.24 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 108.658 -0.867 . . . . 1.43 108.658 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.06 164.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.998 -1.241 . . . . 0.39 109.998 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.89 159.97 43.36 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.471 1.447 . . . . 0.41 110.659 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.56 164.22 30.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.508 -0.923 . . . . 0.21 108.508 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.67 143.52 26.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.023 -1.048 . . . . 2.72 109.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.86 128.36 36.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.45 -0.781 . . . . 0.29 110.563 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 mt -119.16 -70.61 0.78 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.515 -0.74 . . . . 0.45 110.137 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -91.96 137.85 32.02 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -144.07 115.72 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.985 -0.746 . . . . 2.32 108.985 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.71 -104.08 0.22 Allowed Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.839 -1.172 . . . . 0.27 110.293 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.97 -157.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 1.39 109.602 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 47.67 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.037 -1.625 . . . . 0.29 109.037 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.34 151.98 38.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.519 -0.989 . . . . 0.29 108.769 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.78 134.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.31 109.435 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -95.5 138.11 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.137 -1.06 . . . . 0.29 108.137 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.0 176.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.23 109.818 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.68 109.28 5.65 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.455 -0.943 . . . . 1.81 108.455 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.7 -77.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.37 -1.344 . . . . 1.18 107.37 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.23 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.937 -1.505 . . . . 1.98 106.937 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.6 m -97.97 56.06 1.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.681 -1.229 . . . . 1.39 107.681 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.56 130.37 7.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 1.12 109.46 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.91 135.5 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.47 109.329 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -136.52 168.99 18.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 2.11 109.683 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.99 140.08 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.344 -0.848 . . . . 0.33 109.568 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.78 126.1 13.23 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.396 -0.815 . . . . 0.34 109.188 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.95 140.56 86.03 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.642 0.895 . . . . 0.42 110.237 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -58.97 -37.33 76.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 3.12 109.533 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -69.8 -1.64 9.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 3.82 110.242 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HG3' HH12 ' A' ' 228' ' ' ARG . 2.5 mptm? -118.32 17.04 13.93 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.681 -0.859 . . . . 2.08 108.681 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.85 175.14 9.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.421 -0.8 . . . . 0.32 109.724 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.8 128.46 21.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.316 -0.865 . . . . 1.79 109.127 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.7 mm -88.74 109.72 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.43 -0.794 . . . . 0.45 109.86 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.42 153.61 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.692 -0.855 . . . . 0.57 108.692 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.5 mtt-85 -94.78 136.98 34.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.272 -0.892 . . . . 3.63 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.078 -1.014 . . . . 2.05 109.626 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.564 -0.532 . . . . 3.83 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.38 138.54 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.799 -1.186 . . . . 2.08 107.799 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -82.26 -141.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.044 -1.035 . . . . 2.16 109.875 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.85 110.51 22.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.406 -0.809 . . . . 1.48 109.799 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.6 130.5 38.44 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.756 -0.831 . . . . 0.73 108.756 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 224' ' ' ARG . 20.2 mtm-85 -99.46 150.68 21.94 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 3.26 107.48 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.2 t -139.05 136.64 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.254 -0.904 . . . . 0.23 110.476 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.09 157.09 18.57 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.649 -1.241 . . . . 0.58 107.649 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.9 152.66 25.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.656 -1.278 . . . . 0.44 110.288 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.427 HH12 ' HG3' ' B' ' 264' ' ' LYS . 2.7 mtm-85 -93.38 144.39 25.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.374 -0.828 . . . . 2.76 109.853 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.79 175.21 6.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.382 -0.824 . . . . 2.23 109.316 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.39 -10.98 44.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.262 -0.899 . . . . 1.81 109.259 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -89.65 -15.2 33.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 3.64 109.702 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.2 m-20 -159.59 129.28 3.31 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.961 . . . . 2.16 109.249 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -65.03 8.35 0.22 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 120.882 1.055 . . . . 1.27 111.21 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.0 p -85.4 164.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.557 -1.34 . . . . 1.76 110.19 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.9 m95 -76.25 163.51 26.97 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' B' ' 237' ' ' GLY . 2.5 mtpp -118.53 165.15 14.27 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.644 -0.873 . . . . 1.44 108.644 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.15 164.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.184 -1.167 . . . . 0.4 110.184 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -64.9 160.0 43.3 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.488 1.459 . . . . 0.41 110.643 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.63 164.09 31.12 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.586 -0.894 . . . . 0.21 108.586 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.71 143.63 26.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.007 -1.058 . . . . 2.72 109.393 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.5 tp -90.04 128.45 36.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.594 -0.691 . . . . 0.3 110.4 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 32.8 mt -119.25 -70.55 0.78 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.573 -0.704 . . . . 0.45 110.102 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -92.01 137.86 32.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.152 -0.968 . . . . 0.33 110.7 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -144.05 115.83 8.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.8 . . . . 2.33 108.929 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -104.15 0.22 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.161 -1.176 . . . . 0.28 110.161 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.98 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 1.4 109.615 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.63 47.49 2.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.1 -1.6 . . . . 0.29 109.1 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.22 151.95 38.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.997 . . . . 0.29 108.865 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.79 134.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.31 109.502 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 89.9 t -95.48 138.04 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.155 -1.054 . . . . 0.3 108.155 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' B' ' 251' ' ' ILE . 12.8 pt -139.85 176.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.24 109.945 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.61 109.29 5.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.54 -0.911 . . . . 1.81 108.54 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.76 -77.35 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.304 -1.369 . . . . 1.18 107.304 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.19 -138.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.925 -1.509 . . . . 1.97 106.925 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.4 m -97.96 55.98 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.68 -1.23 . . . . 1.38 107.68 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.48 130.44 7.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.61 -0.681 . . . . 1.12 109.394 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 55.5 mt -95.8 135.61 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.48 109.307 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.71 169.03 18.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 2.13 109.574 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.93 140.02 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.34 109.611 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 53.3 t -138.69 126.05 13.31 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.34 109.221 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.81 140.48 85.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 120.616 0.877 . . . . 0.42 110.225 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -58.87 -37.33 76.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 3.11 109.449 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -69.96 -1.4 9.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.402 -0.811 . . . . 3.82 110.245 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.427 ' HG3' HH12 ' B' ' 228' ' ' ARG . 2.5 mptm? -118.41 16.87 13.86 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.717 -0.846 . . . . 2.08 108.717 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.82 175.29 9.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.413 -0.804 . . . . 0.32 109.742 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.9 128.47 21.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.438 -0.789 . . . . 1.79 109.122 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -88.78 109.57 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.501 -0.749 . . . . 0.45 109.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -105.22 153.59 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 108.742 -0.836 . . . . 0.57 108.742 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.6 mtt-85 -94.57 137.05 34.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.228 -0.92 . . . . 3.62 109.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.045 -1.034 . . . . 2.05 109.677 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 4.9 ptp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.373 -0.602 . . . . 3.82 109.373 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.6 HD11 ' CD2' ' A' ' 223' ' ' PHE . 6.6 tp -82.96 140.55 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 2.08 109.25 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.8 -140.9 0.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.167 -0.958 . . . . 2.17 109.686 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -92.75 104.62 16.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.268 -0.895 . . . . 1.48 109.273 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.6 ' CD2' HD11 ' A' ' 220' ' ' ILE . 41.0 m-85 -133.34 133.89 43.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.961 -0.755 . . . . 0.72 108.961 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.73 158.69 17.39 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.192 -1.04 . . . . 3.26 108.192 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.98 140.04 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.23 110.08 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.42 155.43 20.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.72 -1.215 . . . . 0.58 107.72 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.5 p90 -156.18 153.79 29.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.44 110.345 -179.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.93 141.16 29.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.76 . . . . 2.76 109.645 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 9.7 p30 -92.32 162.67 14.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.306 -0.871 . . . . 2.23 109.002 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.3 -2.71 36.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 1.8 109.842 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -89.91 -20.73 23.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.181 -0.949 . . . . 3.63 109.541 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 234' ' ' VAL . 14.5 m-20 -162.1 130.96 3.03 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.978 . . . . 2.16 108.969 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -63.57 8.44 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.751 0.968 . . . . 1.25 110.422 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.1 m -82.77 139.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.037 -1.04 . . . . 1.75 109.477 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -57.01 162.73 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.026 -1.046 . . . . 0.66 109.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 237' ' ' GLY . 39.3 tttp -119.18 165.0 14.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.483 -0.761 . . . . 1.43 109.091 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.45 166.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.111 -1.196 . . . . 0.39 110.111 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.51 162.18 43.06 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.641 1.561 . . . . 0.41 110.405 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.53 178.47 7.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.966 -0.753 . . . . 0.21 108.966 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.94 140.93 29.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.134 -0.979 . . . . 2.72 109.302 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.03 123.74 33.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.604 -0.685 . . . . 0.29 109.736 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 28.0 mt -113.45 -74.69 0.62 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.436 -0.79 . . . . 0.45 109.89 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.44 30.66 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.154 -0.966 . . . . 0.31 109.783 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.26 116.93 8.13 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.667 -0.864 . . . . 2.32 108.667 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -100.84 0.18 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.8 -1.191 . . . . 0.27 110.261 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.51 -157.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -1.096 . . . . 1.39 109.842 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.09 49.51 2.92 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.163 -1.575 . . . . 0.29 109.163 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.67 154.51 39.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -1.003 . . . . 0.29 108.499 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.11 131.95 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.085 -1.009 . . . . 0.31 109.862 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.6 t -93.84 135.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.29 107.828 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -138.53 177.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.328 -0.858 . . . . 0.23 110.289 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -145.07 111.5 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.581 -0.896 . . . . 1.81 108.581 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.83 -78.32 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.2 -1.408 . . . . 1.18 107.2 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -81.88 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.708 -1.59 . . . . 1.98 106.708 177.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 t -101.7 55.82 0.82 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.038 -1.097 . . . . 1.39 108.038 177.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -155.35 124.52 6.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.615 -0.678 . . . . 1.12 109.183 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.52 134.87 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.47 109.202 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -137.42 167.81 20.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 2.11 110.039 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 70.7 t -102.25 139.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.55 -0.719 . . . . 0.33 109.256 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.7 t -136.73 127.97 16.64 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.878 -0.786 . . . . 0.34 108.878 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.8 138.61 86.7 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.913 -0.841 . . . . 0.42 109.913 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.27 -32.27 66.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 3.12 109.428 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.485 HH11 ' HG3' ' A' ' 263' ' ' ARG . 5.1 ttm-85 -67.29 -8.77 34.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.433 -0.792 . . . . 3.82 110.204 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -120.25 18.31 12.26 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.384 -0.823 . . . . 2.08 109.187 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.26 168.6 19.4 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.65 -0.656 . . . . 0.32 109.4 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -141.6 130.99 23.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.79 109.169 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.97 114.77 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.45 109.946 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.66 154.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.69 -0.856 . . . . 0.57 108.69 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.4 mtt-85 -89.6 140.43 29.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 3.63 109.218 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 2.05 109.414 179.915 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 4.8 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.394 -0.595 . . . . 3.83 109.394 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' B' ' 223' ' ' PHE . 6.6 tp -82.99 140.52 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 2.08 109.252 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -85.76 -140.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 2.16 109.707 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -92.64 104.67 16.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 1.48 109.294 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 223' ' ' PHE . . . . . 0.596 ' CD2' HD11 ' B' ' 220' ' ' ILE . 41.0 m-85 -133.41 133.92 43.0 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.937 -0.764 . . . . 0.73 108.937 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -108.67 158.66 17.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.272 -1.01 . . . . 3.26 108.272 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.9 t -140.89 140.0 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.23 110.145 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.28 155.42 19.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.69 -1.226 . . . . 0.58 107.69 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.5 p90 -156.15 153.73 29.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.7 -1.25 . . . . 0.44 110.376 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.92 141.27 29.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.576 -0.703 . . . . 2.76 109.578 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 9.8 p30 -92.34 162.65 14.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.284 -0.885 . . . . 2.23 109.041 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.26 -2.76 36.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 1.81 109.812 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -89.82 -20.98 22.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.124 -0.985 . . . . 3.64 109.548 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' B' ' 234' ' ' VAL . 14.6 m-20 -161.82 130.98 3.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 2.16 108.98 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.51 8.37 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.712 0.941 . . . . 1.27 110.454 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.2 m -82.73 139.48 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 1.76 109.409 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.12 162.68 2.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.67 109.53 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -119.19 164.99 14.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.38 -0.825 . . . . 1.44 109.089 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.54 166.59 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.4 110.064 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.44 162.15 43.23 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.721 1.614 . . . . 0.41 110.426 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.47 178.44 7.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.926 -0.768 . . . . 0.21 108.926 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.85 141.02 29.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.14 -0.975 . . . . 2.72 109.368 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.01 123.7 33.57 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.568 -0.707 . . . . 0.3 109.701 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 28.2 mt -113.47 -74.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.414 -0.804 . . . . 0.45 109.859 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.28 30.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.264 -0.897 . . . . 0.33 109.776 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.14 116.98 8.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.657 -0.868 . . . . 2.33 108.657 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.83 -100.82 0.18 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.732 -1.223 . . . . 0.28 110.225 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.46 -157.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 1.4 109.816 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 49.81 3.01 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.42 39.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -1.037 . . . . 0.29 108.49 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.0 m -146.1 131.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.31 109.818 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.83 134.92 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.795 -1.187 . . . . 0.3 107.795 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -138.43 177.93 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.219 -0.926 . . . . 0.24 110.319 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -145.08 111.47 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.618 -0.882 . . . . 1.81 108.618 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.8 -78.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.15 -1.426 . . . . 1.18 107.15 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.84 -133.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.733 -1.58 . . . . 1.97 106.733 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.3 t -101.83 55.85 0.81 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -155.26 124.6 6.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 1.12 109.168 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.66 134.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.284 -0.885 . . . . 0.48 109.123 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -137.38 167.86 20.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.337 -0.852 . . . . 2.13 110.102 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 71.0 t -102.34 139.82 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.676 . . . . 0.34 109.274 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.67 128.07 16.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.914 -0.773 . . . . 0.34 108.914 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.89 138.58 86.52 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 N-CA-C 109.928 -0.835 . . . . 0.42 109.928 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.28 -32.22 66.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 3.11 109.443 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' B' ' 263' ' ' ARG . 5.2 ttm-85 -67.41 -8.76 35.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.478 -0.764 . . . . 3.82 110.12 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -120.2 18.23 12.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.312 -0.868 . . . . 2.08 109.162 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.23 168.44 19.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 0.32 109.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -141.51 130.9 23.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.286 -0.884 . . . . 1.79 109.175 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.81 114.75 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.243 -0.911 . . . . 0.45 109.917 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.67 154.49 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.713 -0.847 . . . . 0.57 108.713 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.4 mtt-85 -89.51 140.36 29.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.88 . . . . 3.62 109.211 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.089 -0.958 . . . . 2.05 109.382 179.892 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 219' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.363 0.601 . . . . 3.82 109.384 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.35 140.48 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.347 -0.846 . . . . 2.08 109.075 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.62 -117.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 2.17 109.883 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -98.94 111.36 23.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.906 . . . . 1.48 109.119 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -135.12 142.25 46.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.427 -0.796 . . . . 0.72 109.524 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -115.64 153.8 30.63 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.238 -1.393 . . . . 3.26 107.238 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.2 t -140.74 141.91 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.099 -1.001 . . . . 0.23 110.472 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -109.22 155.0 21.61 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.256 -1.387 . . . . 0.58 107.256 178.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -156.19 155.6 32.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.547 -1.346 . . . . 0.44 110.618 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -100.68 133.13 45.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.475 0.655 . . . . 2.76 109.358 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 22.2 p-10 -92.35 171.65 8.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.001 -0.741 . . . . 2.23 109.001 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 78.9 p -87.45 -9.15 55.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 1.8 109.661 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.32 -12.24 41.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.91 . . . . 3.63 109.365 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -161.27 128.54 2.65 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.296 -1.001 . . . . 2.16 108.296 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.53 -1.4 9.05 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 120.789 0.993 . . . . 1.25 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 137.89 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.745 -1.222 . . . . 1.75 110.005 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -50.35 166.98 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.089 -1.007 . . . . 0.66 109.219 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 237' ' ' GLY . 1.9 mtpp -119.65 166.37 13.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.67 -0.863 . . . . 1.43 108.67 179.278 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.31 168.78 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.823 -1.311 . . . . 0.39 109.823 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -66.96 158.87 54.58 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.685 1.59 . . . . 0.41 110.618 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.0 171.02 15.14 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.061 -0.718 . . . . 0.21 109.061 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -94.1 139.14 31.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.179 -0.951 . . . . 2.72 109.733 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.55 126.11 35.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.551 . . . . 0.29 109.515 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.89 -72.06 0.71 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.389 -0.819 . . . . 0.45 110.362 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.473 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.97 142.62 27.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.105 -0.997 . . . . 0.31 110.032 -178.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -148.68 118.59 7.13 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 2.32 109.459 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.22 0.17 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.842 -1.17 . . . . 0.27 110.21 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.6 -155.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -1.076 . . . . 1.39 109.931 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.87 48.71 3.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.689 -1.364 . . . . 0.29 109.689 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.88 154.96 41.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.379 -1.071 . . . . 0.29 108.612 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.39 128.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.075 -1.015 . . . . 0.31 109.787 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.06 132.69 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.955 -1.128 . . . . 0.29 107.955 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 251' ' ' ILE . 13.2 pt -135.64 177.68 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.911 . . . . 0.23 109.864 -179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -143.69 107.56 4.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.423 -0.798 . . . . 1.81 109.016 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.93 -76.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.748 -1.575 . . . . 1.18 106.748 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -163.32 0.55 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.999 -1.852 . . . . 1.98 105.999 177.134 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.1 p -79.47 48.79 0.94 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.599 -1.313 . . . . 1.39 108.288 178.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.31 126.7 11.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 1.12 109.175 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.503 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.9 mt -92.07 141.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.47 109.846 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -139.95 167.98 20.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -0.785 . . . . 2.11 109.796 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.19 137.45 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.358 -0.839 . . . . 0.33 109.241 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.2 130.56 19.31 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.461 -0.774 . . . . 0.34 109.038 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.16 137.11 80.35 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 N-CA-C 109.892 -0.849 . . . . 0.42 109.892 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.18 -35.35 69.49 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.202 -0.936 . . . . 3.12 109.427 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.82 -5.24 19.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.408 -0.807 . . . . 3.82 110.257 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.9 22.46 11.93 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.472 -0.936 . . . . 2.08 108.472 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.64 166.02 26.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.32 109.14 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.17 128.19 25.63 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.371 -0.831 . . . . 1.79 109.326 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.46 110.34 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.45 109.834 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.2 mm -105.31 156.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.452 -0.944 . . . . 0.57 108.452 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.98 138.83 31.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.06 -1.025 . . . . 3.63 109.229 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.038 -0.982 . . . . 2.05 109.506 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 219' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' B' ' 219' ' ' MET . 3.9 mpp? . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.315 0.579 . . . . 3.83 109.45 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.23 140.42 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.31 -0.869 . . . . 2.08 109.109 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -85.55 -117.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 2.16 109.964 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -98.97 111.37 23.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.302 -0.874 . . . . 1.48 109.111 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -135.04 142.21 46.31 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.419 -0.8 . . . . 0.73 109.496 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.3 OUTLIER -115.65 153.84 30.56 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.239 -1.393 . . . . 3.26 107.239 178.748 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.72 141.83 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.96 . . . . 0.23 110.571 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -109.24 155.01 21.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.162 -1.421 . . . . 0.58 107.162 178.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.1 p90 -156.12 155.69 32.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.604 -1.31 . . . . 0.44 110.63 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -100.94 132.99 46.09 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 2.76 109.442 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 22.3 p-10 -92.21 171.63 8.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 2.23 109.029 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 80.0 p -87.52 -9.09 55.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 1.81 109.633 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.2 -12.44 40.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.93 . . . . 3.64 109.348 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -161.17 128.47 2.66 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.305 -0.998 . . . . 2.16 108.305 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -70.41 -1.49 9.09 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 120.819 1.012 . . . . 1.27 111.065 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.02 137.85 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.749 -1.22 . . . . 1.76 109.933 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -50.49 166.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.073 -1.017 . . . . 0.67 109.182 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' B' ' 237' ' ' GLY . 1.9 mtpp -119.68 166.23 13.47 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.587 -0.894 . . . . 1.44 108.587 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.18 168.64 0.04 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.863 -1.295 . . . . 0.4 109.863 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.83 158.99 53.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.612 1.541 . . . . 0.41 110.749 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.16 170.84 15.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.048 -0.723 . . . . 0.21 109.048 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -93.87 139.06 31.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.077 -1.015 . . . . 2.72 109.77 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -89.48 126.05 35.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.749 -0.594 . . . . 0.3 109.531 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.75 -72.03 0.71 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.48 -0.762 . . . . 0.45 110.352 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.503 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.3 t90 -91.1 142.66 27.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.045 -1.034 . . . . 0.33 109.988 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -148.65 118.53 7.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.239 -0.913 . . . . 2.33 109.488 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.04 0.17 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.856 -1.164 . . . . 0.28 110.245 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.63 -155.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.377 -1.072 . . . . 1.4 109.974 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.94 48.59 3.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.727 -1.349 . . . . 0.29 109.727 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.79 155.07 41.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.29 108.59 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.44 128.73 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.134 -0.979 . . . . 0.31 109.728 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.1 132.71 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.967 -1.123 . . . . 0.3 107.967 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.24 109.848 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -143.65 107.64 4.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 1.81 109.079 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.05 -76.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.762 -1.57 . . . . 1.18 106.762 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -163.25 0.54 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.975 -1.861 . . . . 1.97 105.975 177.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 15.2 p -79.53 48.85 0.95 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.519 -1.363 . . . . 1.38 108.315 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.37 126.72 11.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.533 -0.729 . . . . 1.12 109.213 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.8 mt -92.07 141.57 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 0.48 109.824 -179.444 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -140.09 167.96 20.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.344 -0.848 . . . . 2.13 109.815 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.12 137.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.391 -0.818 . . . . 0.34 109.279 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.17 130.58 19.35 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.455 -0.778 . . . . 0.34 108.991 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.27 137.07 79.98 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 109.86 -0.862 . . . . 0.42 109.86 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -57.05 -35.54 69.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 3.11 109.433 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.81 -5.05 18.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.824 . . . . 3.82 110.372 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.87 22.22 12.06 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.542 -0.91 . . . . 2.08 108.542 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.4 166.16 25.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.535 -0.728 . . . . 0.32 109.133 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -138.21 128.1 25.41 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.361 -0.837 . . . . 1.79 109.396 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.43 110.31 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.45 109.888 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.3 mm -105.33 156.9 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.421 -0.955 . . . . 0.57 108.421 179.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.97 138.78 31.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.13 -0.981 . . . . 3.62 109.253 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.068 -1.02 . . . . 2.05 109.532 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.245 -0.65 . . . . 3.82 109.245 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.591 HD13 ' H ' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.3 113.16 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.436 -0.949 . . . . 2.08 108.436 -179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -86.13 -126.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 2.17 109.902 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -96.03 102.93 14.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.501 -0.75 . . . . 1.48 109.297 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.08 141.97 47.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.518 -0.739 . . . . 0.72 109.166 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -116.96 157.71 25.29 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.558 -1.275 . . . . 3.26 107.558 178.827 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.39 145.45 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.949 -1.094 . . . . 0.23 110.55 -179.184 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.79 161.97 15.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.017 -1.105 . . . . 0.58 108.017 178.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.84 149.54 23.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.87 -1.144 . . . . 0.44 110.231 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.73 159.03 15.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 2.76 109.881 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.9 OUTLIER -95.45 170.91 9.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.041 -0.726 . . . . 2.23 109.041 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.9 t -91.37 -15.05 29.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 1.8 108.982 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.3 mtt-85 -90.21 -15.07 32.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.857 . . . . 3.63 109.793 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.7 m-20 -161.19 128.8 2.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 2.16 109.173 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.77 17.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.813 1.008 . . . . 1.25 110.603 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 232' ' ' ASP . 32.7 m -80.9 130.93 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.785 -1.197 . . . . 1.75 109.834 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.78 174.82 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.66 109.398 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -122.62 -166.24 1.4 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.206 -1.035 . . . . 1.43 108.206 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.12 -179.31 51.75 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.287 -1.525 . . . . 0.39 109.287 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.4 149.01 49.72 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.695 1.596 . . . . 0.41 110.446 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.28 167.1 22.25 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.99 -0.744 . . . . 0.21 108.99 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -91.54 140.81 29.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.047 -1.033 . . . . 2.72 110.081 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.03 129.85 35.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.807 -0.558 . . . . 0.29 109.8 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.1 mt -118.03 -72.54 0.68 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.57 -0.707 . . . . 0.45 110.42 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.405 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.24 143.23 26.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.31 110.845 -178.04 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -143.89 112.6 6.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.839 -0.801 . . . . 2.32 108.839 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.67 -103.58 0.36 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.968 -1.253 . . . . 0.27 109.968 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.43 -154.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -1.162 . . . . 1.39 109.503 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.25 3.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.7 -1.76 . . . . 0.29 108.7 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.69 35.84 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.57 -0.959 . . . . 0.29 108.603 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.11 128.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.083 -1.011 . . . . 0.31 109.619 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 54.1 t -92.84 128.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.212 -1.032 . . . . 0.29 108.212 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.42 -179.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -0.793 . . . . 0.23 109.865 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -142.66 109.96 5.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.278 -1.008 . . . . 1.81 108.278 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -86.03 -81.02 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.298 -1.371 . . . . 1.18 107.298 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.837 -1.542 . . . . 1.98 106.837 177.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 35.0 t -100.58 53.71 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.052 -1.092 . . . . 1.39 108.052 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.53 124.23 5.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 1.12 109.375 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 22.2 mt -90.46 131.19 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.902 . . . . 0.47 109.257 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 258' ' ' LYS . 0.0 OUTLIER -131.64 167.99 18.5 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.446 -0.784 . . . . 2.11 109.74 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 142.06 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.33 109.446 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.16 130.09 17.19 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.485 -0.932 . . . . 0.34 108.485 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.19 141.99 90.18 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 N-CA-C 109.93 -0.834 . . . . 0.42 109.93 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.94 -31.15 66.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 3.12 109.101 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.08 -11.21 60.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.398 -0.814 . . . . 3.82 110.325 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.09 21.91 12.11 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 2.08 108.991 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.03 16.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.472 -0.767 . . . . 0.32 109.339 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -140.53 125.67 18.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 1.79 109.262 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.35 113.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.234 -0.917 . . . . 0.45 109.17 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.01 153.67 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.455 -0.778 . . . . 0.57 109.044 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 269' ' ' ARG . 18.4 mtm-85 -95.7 135.88 36.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.468 -0.77 . . . . 3.63 109.485 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 2.05 109.14 179.5 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 3.83 109.193 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.593 HD13 ' H ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.26 113.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 2.08 108.489 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -86.15 -126.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 2.16 109.899 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -95.97 102.94 14.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.767 . . . . 1.48 109.36 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -134.09 141.9 47.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.411 -0.806 . . . . 0.73 109.138 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -116.83 157.7 25.16 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.566 -1.272 . . . . 3.26 107.566 178.769 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.41 145.47 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.008 -1.057 . . . . 0.23 110.624 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.8 162.06 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.956 -1.127 . . . . 0.58 107.956 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.6 p90 -156.85 149.57 23.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.882 -1.136 . . . . 0.44 110.194 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -96.67 159.09 15.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 2.76 109.945 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -95.55 170.9 9.02 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.996 -0.742 . . . . 2.23 108.996 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.5 t -91.4 -15.09 29.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 1.81 108.827 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 231' ' ' ARG . 2.3 mtt-85 -90.23 -14.99 32.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 3.64 109.81 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.6 m-20 -161.15 128.9 2.76 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 2.16 109.114 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.93 17.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.844 1.03 . . . . 1.27 110.602 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' B' ' 232' ' ' ASP . 32.7 m -80.93 130.9 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.916 -1.115 . . . . 1.76 109.826 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.8 174.89 0.14 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -0.936 . . . . 0.67 109.532 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -122.66 -166.22 1.4 Allowed 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 108.157 -1.053 . . . . 1.44 108.157 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.1 -179.2 51.75 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.321 -1.512 . . . . 0.4 109.321 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.42 149.0 49.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.803 1.669 . . . . 0.41 110.421 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.35 167.12 22.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.944 -0.762 . . . . 0.21 108.944 179.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -91.57 140.76 29.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.0 -1.063 . . . . 2.72 110.069 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 tp -88.92 129.77 35.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.751 -0.593 . . . . 0.3 109.814 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.91 -72.58 0.68 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.363 -0.836 . . . . 0.45 110.416 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -90.27 143.06 27.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.33 110.887 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' B' ' 244' ' ' LYS . 0.9 OUTLIER -143.68 112.72 6.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.807 . . . . 2.33 108.938 179.172 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.65 -103.58 0.36 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.896 -1.281 . . . . 0.28 109.896 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.37 -154.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -1.119 . . . . 1.4 109.492 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.23 3.54 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.678 -1.769 . . . . 0.29 108.678 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.57 35.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.582 -0.952 . . . . 0.29 108.644 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.05 128.7 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.034 -1.041 . . . . 0.31 109.679 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.81 128.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.195 -1.039 . . . . 0.3 108.195 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.5 pt -134.31 -179.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.377 -0.827 . . . . 0.24 109.908 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -142.7 109.82 5.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.378 -0.971 . . . . 1.81 108.378 178.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -85.98 -81.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.281 -1.377 . . . . 1.18 107.281 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.48 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.823 -1.547 . . . . 1.97 106.823 177.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 34.9 t -100.6 53.73 0.87 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.046 -1.094 . . . . 1.38 108.046 178.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.54 124.42 5.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.604 -0.685 . . . . 1.12 109.327 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.405 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 21.9 mt -90.59 131.16 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.48 109.25 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 258' ' ' LYS . . . . . 0.593 ' HZ2' ' HB2' ' B' ' 258' ' ' LYS . 0.0 OUTLIER -131.63 168.0 18.48 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 2.13 109.743 -179.613 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.64 142.11 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.457 -0.777 . . . . 0.34 109.436 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 51.0 t -137.19 130.01 17.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.45 -0.944 . . . . 0.34 108.45 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 141.91 90.47 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.904 -0.845 . . . . 0.42 109.904 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.93 -31.15 66.54 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 3.11 109.132 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -70.13 -11.09 60.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 3.82 110.373 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.16 21.94 12.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.271 -0.893 . . . . 2.08 108.899 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.05 16.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.32 109.324 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -140.59 125.67 18.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 1.79 109.279 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.25 113.1 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -0.915 . . . . 0.45 109.235 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.92 153.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.57 109.093 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' B' ' 269' ' ' ARG . 18.5 mtm-85 -95.75 135.93 36.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 3.62 109.392 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.912 -1.042 . . . . 2.05 109.029 179.48 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.325 0.583 . . . . 3.82 109.428 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 220' ' ' ILE . 15.2 tt -82.64 129.79 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 2.08 109.383 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -87.29 -122.26 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.92 -1.112 . . . . 2.17 109.267 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -101.25 110.51 22.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.177 -0.952 . . . . 1.48 110.143 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -135.5 125.23 25.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.438 -0.789 . . . . 0.72 109.09 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -101.44 159.12 15.55 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.243 -1.021 . . . . 3.26 108.243 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.19 143.77 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.099 -1.001 . . . . 0.23 110.895 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.42 156.73 19.11 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.243 -1.391 . . . . 0.58 107.243 178.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.9 p90 -157.69 152.86 25.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.549 -1.345 . . . . 0.44 110.697 -179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -99.49 135.3 41.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.622 -0.674 . . . . 2.76 109.751 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -95.85 178.93 5.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.847 . . . . 2.23 109.185 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 73.9 p -91.21 -10.8 40.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.916 . . . . 1.8 109.429 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 232' ' ' ASP . 53.6 mtp180 -84.1 -19.05 34.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.205 -0.935 . . . . 3.63 109.481 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 231' ' ' ARG . 43.2 m-20 -159.37 129.04 3.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.323 -0.861 . . . . 2.16 109.152 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.41 1.83 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.76 0.974 . . . . 1.25 110.442 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.73 136.24 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.939 -1.101 . . . . 1.75 110.218 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.28 163.62 0.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.66 109.239 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.4 mtpt -119.85 166.74 12.89 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.459 -0.776 . . . . 1.43 109.561 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.16 166.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.457 -1.057 . . . . 0.39 110.457 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.61 159.73 39.51 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.591 1.528 . . . . 0.41 110.579 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.39 169.56 17.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.864 -0.791 . . . . 0.21 108.864 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -92.32 136.17 33.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.981 -1.074 . . . . 2.72 109.537 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.2 116.84 26.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.671 -0.643 . . . . 0.29 109.313 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.9 mt -104.82 -71.7 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.246 -0.908 . . . . 0.45 109.838 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -94.08 146.98 23.58 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.107 -0.996 . . . . 0.31 110.473 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.02 120.96 8.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.827 . . . . 2.32 109.017 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -108.58 0.3 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.78 -1.2 . . . . 0.27 110.332 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.76 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 1.39 109.69 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 47.91 2.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.994 -1.642 . . . . 0.29 108.994 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.29 146.85 30.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.976 . . . . 0.29 108.736 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.12 128.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.954 . . . . 0.31 109.247 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.8 t -89.13 140.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.198 -1.038 . . . . 0.29 108.198 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.38 179.28 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.919 . . . . 0.23 110.253 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -141.23 112.16 7.2 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.562 -0.903 . . . . 1.81 108.562 178.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.71 -81.08 0.29 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' SER . 32.7 t-20 -80.34 -129.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.783 -1.562 . . . . 1.98 106.783 177.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.6 t -104.19 53.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.245 -1.02 . . . . 1.39 108.245 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.12 129.72 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.02 -0.733 . . . . 1.12 109.02 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 67.9 mt -92.23 139.28 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.47 109.558 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.12 165.13 28.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 2.11 109.954 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.92 138.55 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.468 -0.77 . . . . 0.33 109.054 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -137.04 133.05 18.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.738 -0.838 . . . . 0.34 108.738 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.38 141.14 89.56 Favored 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 120.836 1.024 . . . . 0.42 110.512 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 3.12 109.448 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.422 ' HG2' ' NH1' ' A' ' 263' ' ' ARG . 0.6 OUTLIER -69.45 -8.18 44.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 3.82 110.526 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.77 20.74 12.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.127 -0.983 . . . . 2.08 109.282 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.9 16.95 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.01 -0.737 . . . . 0.32 109.01 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -139.71 122.59 16.59 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.219 -0.926 . . . . 1.79 108.977 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.82 107.42 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.145 -0.972 . . . . 0.45 109.997 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.04 151.11 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.451 -0.944 . . . . 0.57 108.451 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -90.55 143.77 26.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.343 -0.848 . . . . 3.63 109.726 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.053 -0.975 . . . . 2.05 109.416 179.662 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 219' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.416 -0.587 . . . . 3.83 109.416 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.492 ' O ' HG23 ' B' ' 220' ' ' ILE . 15.1 tt -82.83 129.87 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.308 -0.87 . . . . 2.08 109.261 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.19 -122.53 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.96 -1.087 . . . . 2.16 109.295 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -100.99 110.53 22.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.196 -0.94 . . . . 1.48 110.199 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -135.5 125.25 25.44 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.435 -0.791 . . . . 0.73 109.067 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -101.37 159.18 15.49 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.181 -1.044 . . . . 3.26 108.181 179.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 59.1 t -142.3 143.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.123 -0.985 . . . . 0.23 110.978 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -108.41 156.77 19.07 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.235 -1.394 . . . . 0.58 107.235 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.7 p90 -157.64 152.9 25.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.595 -1.316 . . . . 0.44 110.649 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -99.54 135.13 41.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.601 -0.687 . . . . 2.76 109.749 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -95.68 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 2.23 109.182 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.2 p -91.13 -10.84 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 1.81 109.492 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' B' ' 232' ' ' ASP . 53.5 mtp180 -84.08 -19.03 35.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 3.64 109.505 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' B' ' 231' ' ' ARG . 43.5 m-20 -159.5 129.03 3.24 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 2.16 109.053 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.28 1.7 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.792 0.995 . . . . 1.27 110.442 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -84.57 136.14 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.868 -1.145 . . . . 1.76 110.258 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -52.31 163.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.215 -0.928 . . . . 0.67 109.311 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mtpt -119.78 166.93 12.61 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.261 -0.899 . . . . 1.44 109.511 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.35 166.55 0.02 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.358 -1.097 . . . . 0.4 110.358 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.6 159.92 38.61 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.523 1.482 . . . . 0.41 110.54 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.45 169.53 17.54 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.922 -0.77 . . . . 0.21 108.922 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -92.32 136.2 33.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.11 -0.994 . . . . 2.72 109.596 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.27 116.79 26.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.644 . . . . 0.3 109.284 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -104.71 -71.74 0.73 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.271 -0.893 . . . . 0.45 109.872 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -94.12 146.98 23.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.179 -0.95 . . . . 0.33 110.415 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.09 121.08 8.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.375 -0.828 . . . . 2.33 108.931 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -108.65 0.3 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.785 -1.198 . . . . 0.28 110.335 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.68 -151.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -1.08 . . . . 1.4 109.761 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.18 47.98 2.7 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.918 -1.673 . . . . 0.29 108.918 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.35 146.88 30.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.491 -1.005 . . . . 0.29 108.745 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.2 128.06 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.31 109.277 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.07 139.96 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.219 -1.03 . . . . 0.3 108.219 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.37 179.27 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.24 110.299 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -141.25 112.21 7.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.468 -0.938 . . . . 1.81 108.468 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.7 -81.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' B' ' 255' ' ' SER . 32.6 t-20 -80.29 -129.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.866 -1.531 . . . . 1.97 106.866 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 8.7 t -104.32 53.27 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.106 -1.072 . . . . 1.38 108.106 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.15 129.8 8.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 1.12 108.982 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 68.1 mt -92.31 139.32 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.26 -0.9 . . . . 0.48 109.519 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.19 165.18 28.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.333 -0.855 . . . . 2.13 109.932 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.92 138.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.427 -0.795 . . . . 0.34 109.065 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.05 132.98 18.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.677 -0.86 . . . . 0.34 108.677 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.24 141.28 88.45 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.776 0.984 . . . . 0.42 110.599 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -59.71 -32.6 70.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 3.11 109.368 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.421 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 0.6 OUTLIER -69.35 -8.31 45.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.36 -0.838 . . . . 3.82 110.56 -179.195 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.65 20.66 12.85 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.225 -0.922 . . . . 2.08 109.274 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.72 17.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.32 109.101 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -139.53 122.57 16.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.228 -0.92 . . . . 1.79 108.981 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.76 107.4 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.252 -0.905 . . . . 0.45 109.977 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.06 151.23 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.39 -0.967 . . . . 0.57 108.39 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -90.69 143.66 26.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 3.62 109.724 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.948 -1.025 . . . . 2.05 109.484 179.655 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.396 -0.594 . . . . 3.82 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.83 109.82 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.456 -0.942 . . . . 2.08 108.456 -179.869 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -83.13 -112.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 2.17 109.629 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -100.31 102.01 13.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.31 -0.869 . . . . 1.48 109.532 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.27 130.41 38.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.72 109.191 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -105.57 156.32 18.35 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.456 -0.942 . . . . 3.26 108.456 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -139.1 142.86 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.361 -0.837 . . . . 0.23 110.098 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -109.22 152.07 25.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.312 -1.366 . . . . 0.58 107.312 178.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.03 157.59 36.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.555 -1.341 . . . . 0.44 110.724 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -100.05 140.04 34.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.59 -0.694 . . . . 2.76 109.291 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 232' ' ' ASP . 5.1 p-10 -93.33 176.78 6.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 2.23 109.467 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.6 t -89.02 -11.95 42.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 1.8 109.508 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 20.3 mmm180 -86.88 -11.97 49.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.088 -1.008 . . . . 3.63 109.417 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.5 ' N ' ' OD2' ' A' ' 229' ' ' ASP . 48.0 m-20 -161.95 129.52 2.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 2.16 108.95 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.6 4.83 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.64 0.893 . . . . 1.25 110.024 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.2 t -83.4 154.54 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.013 . . . . 1.75 110.024 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.41 163.6 22.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.66 109.071 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 4.9 mtpp -119.6 165.86 13.91 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.843 -0.799 . . . . 1.43 108.843 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -47.0 171.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.688 -1.365 . . . . 0.39 109.688 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.7 160.88 46.18 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.568 1.512 . . . . 0.41 110.522 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.07 13.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.489 -0.757 . . . . 0.21 109.053 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.49 134.67 34.45 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.165 -0.959 . . . . 2.72 109.344 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.37 124.68 34.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.576 -0.703 . . . . 0.29 109.225 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.83 -72.47 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.469 -0.769 . . . . 0.45 110.496 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.463 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.8 t90 -91.14 142.56 27.61 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.187 -0.946 . . . . 0.31 110.257 -178.481 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.406 ' HG3' HH22 ' A' ' 262' ' ' ARG . 8.1 ttpm? -147.07 121.14 9.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 2.32 109.607 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.65 -103.34 0.21 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.86 -1.162 . . . . 0.27 110.366 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.95 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -1.074 . . . . 1.39 110.111 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.73 47.95 2.56 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.25 -1.54 . . . . 0.29 109.25 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.86 37.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -1.082 . . . . 0.29 109.215 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.01 127.79 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.192 -0.942 . . . . 0.31 109.514 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.18 139.16 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.336 -0.987 . . . . 0.29 108.336 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 257' ' ' ILE . 19.6 pt -141.52 177.3 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.23 110.086 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -143.48 114.06 7.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 1.81 108.818 179.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -90.29 -82.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.316 -1.364 . . . . 1.18 107.316 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -80.28 -130.3 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.667 -1.605 . . . . 1.98 106.667 177.532 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.4 m -104.1 54.72 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.073 -1.084 . . . . 1.39 108.073 178.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -156.42 123.79 5.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.779 -0.823 . . . . 1.12 108.779 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' ILE . 11.5 mt -92.88 138.28 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.47 109.702 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.85 168.59 19.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.384 -0.822 . . . . 2.11 109.44 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.71 144.58 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.348 -0.845 . . . . 0.33 109.367 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 94.1 t -138.54 128.63 14.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 0.34 109.118 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.28 144.47 95.82 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 120.531 0.821 . . . . 0.42 110.06 179.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.406 HH22 ' HG3' ' A' ' 244' ' ' LYS . 11.9 tpp180 -60.11 -39.56 86.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 3.12 109.062 179.299 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -65.6 -7.48 15.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 3.82 110.344 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.82 22.44 11.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.233 -0.917 . . . . 2.08 109.307 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.67 169.35 17.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.32 109.529 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -141.28 128.45 20.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 1.79 109.254 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.4 112.85 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.101 -0.999 . . . . 0.45 109.789 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.3 144.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.914 -1.143 . . . . 0.57 107.914 179.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 269' ' ' ARG . 31.1 ptt180 -91.02 142.63 27.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 3.63 109.282 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 2.05 109.556 -179.852 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.287 -0.635 . . . . 3.83 109.287 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.551 HD13 ' H ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.72 109.85 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.427 -0.953 . . . . 2.08 108.427 -179.873 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -83.22 -112.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 2.16 109.566 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.31 102.06 13.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.293 -0.88 . . . . 1.48 109.55 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -133.31 130.36 38.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 0.73 109.222 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -105.43 156.44 18.19 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.515 -0.92 . . . . 3.26 108.515 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 87.3 t -139.09 142.9 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.23 110.112 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.26 152.16 25.59 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.339 -1.356 . . . . 0.58 107.339 178.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.6 p90 -156.14 157.51 36.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.609 -1.307 . . . . 0.44 110.726 -178.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -99.91 140.08 34.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 2.76 109.337 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' B' ' 232' ' ' ASP . 5.1 p-10 -93.41 176.78 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 2.23 109.401 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.7 t -88.99 -11.97 42.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 1.81 109.509 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 20.3 mmm180 -86.71 -12.1 49.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.143 -0.973 . . . . 3.64 109.462 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.501 ' N ' ' OD2' ' B' ' 229' ' ' ASP . 47.8 m-20 -161.92 129.57 2.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.171 -0.956 . . . . 2.16 108.887 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.59 4.8 1.53 Allowed 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 120.755 0.97 . . . . 1.27 109.959 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 7.3 t -83.44 154.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 1.76 110.031 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -68.32 163.62 22.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.67 109.085 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' B' ' 237' ' ' GLY . 4.9 mtpp -119.7 165.91 13.89 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -47.07 171.01 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.728 -1.349 . . . . 0.4 109.728 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.69 160.91 46.06 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.56 1.507 . . . . 0.41 110.486 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.68 172.02 13.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.553 -0.717 . . . . 0.21 109.084 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.43 134.65 34.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.973 . . . . 2.72 109.341 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.39 124.69 34.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.544 -0.722 . . . . 0.3 109.173 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.77 -72.52 0.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.41 -0.806 . . . . 0.45 110.609 -179.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.415 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.09 142.52 27.67 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.124 -0.985 . . . . 0.33 110.254 -178.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 244' ' ' LYS . . . . . 0.404 ' HG3' HH22 ' B' ' 262' ' ' ARG . 8.1 ttpm? -147.08 121.14 9.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.206 -0.934 . . . . 2.33 109.564 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.62 -103.29 0.21 Allowed Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.844 -1.17 . . . . 0.28 110.337 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -71.04 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.347 -1.09 . . . . 1.4 110.139 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.74 47.94 2.56 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.197 -1.561 . . . . 0.29 109.197 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.91 151.81 37.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.29 109.259 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.92 127.89 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.31 109.525 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.21 139.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.325 -0.991 . . . . 0.3 108.325 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 257' ' ' ILE . 19.7 pt -141.61 177.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.898 . . . . 0.24 110.138 -179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -143.56 114.06 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.817 -0.808 . . . . 1.81 108.817 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -90.29 -82.34 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.331 -1.359 . . . . 1.18 107.331 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -80.23 -130.21 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.716 -1.587 . . . . 1.97 106.716 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 64.8 m -104.24 54.71 0.73 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.983 -1.118 . . . . 1.38 107.983 178.106 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -156.45 123.81 5.39 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.829 -0.804 . . . . 1.12 108.829 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.463 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.4 mt -92.92 138.3 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.48 109.756 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.78 168.64 19.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 2.13 109.412 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.72 144.58 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 0.34 109.395 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.56 128.55 14.87 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.34 109.14 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.21 144.54 95.37 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 110.012 -0.803 . . . . 0.42 110.012 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' B' ' 244' ' ' LYS . 11.9 tpp180 -60.1 -39.7 87.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 3.11 108.956 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -65.47 -7.51 14.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 3.82 110.512 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.88 22.52 11.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.247 -0.908 . . . . 2.08 109.259 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.7 169.41 17.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.503 -0.748 . . . . 0.32 109.441 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -141.32 128.46 20.87 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.27 -0.894 . . . . 1.79 109.24 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.35 112.97 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.188 -0.945 . . . . 0.45 109.782 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.35 144.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 107.897 -1.149 . . . . 0.57 107.897 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -91.02 142.57 27.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 3.62 109.205 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.993 -1.003 . . . . 2.05 109.575 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.42 -0.585 . . . . 3.82 109.42 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.824 HD12 ' H ' ' A' ' 220' ' ' ILE . 0.1 OUTLIER -83.35 121.13 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.657 -0.868 . . . . 2.08 108.657 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -84.25 -117.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 2.17 109.656 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -97.78 104.26 16.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 1.48 109.819 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -136.37 131.6 34.46 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.015 -0.735 . . . . 0.72 109.015 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -105.21 158.09 16.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.353 -0.842 . . . . 3.26 109.014 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.5 t -139.05 140.76 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.23 109.877 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -107.51 156.33 19.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.508 -1.293 . . . . 0.58 107.508 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.79 151.63 25.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.704 -1.247 . . . . 0.44 110.729 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -98.22 148.5 23.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.738 . . . . 2.76 109.483 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 231' ' ' ARG . 25.0 t0 -94.89 -175.56 3.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.959 -0.756 . . . . 2.23 108.959 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.426 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 5.5 t -98.67 -14.77 19.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -0.956 . . . . 1.8 109.982 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 229' ' ' ASP . 15.3 mtm-85 -89.72 -11.75 41.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 3.63 109.981 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 231' ' ' ARG . 54.4 m-20 -161.01 129.02 2.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.928 -1.107 . . . . 2.16 109.478 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.57 6.84 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.731 0.954 . . . . 1.25 110.32 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.3 m -80.08 128.24 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.787 -1.195 . . . . 1.75 109.891 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.36 165.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.66 109.532 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 237' ' ' GLY . 28.6 mttm -118.41 166.41 12.7 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.633 -0.877 . . . . 1.43 108.633 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.73 177.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.932 -1.267 . . . . 0.39 109.932 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.86 160.28 48.25 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.663 1.575 . . . . 0.41 110.477 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.95 12.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.667 -0.864 . . . . 0.21 108.667 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.18 139.43 31.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.073 -1.017 . . . . 2.72 109.44 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.9 120.26 30.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 0.29 109.926 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.29 -72.91 0.68 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.427 -0.795 . . . . 0.45 110.231 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.204 -0.935 . . . . 0.31 110.129 -178.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.47 112.7 5.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.258 -0.901 . . . . 2.32 109.13 179.326 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -102.63 0.2 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.51 -1.328 . . . . 0.27 110.658 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.52 -159.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -1.081 . . . . 1.39 110.188 -179.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.99 44.86 1.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.028 -1.629 . . . . 0.29 109.028 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.3 152.51 37.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.445 -1.033 . . . . 0.29 108.975 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.62 126.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.31 109.325 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.38 137.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.971 -1.122 . . . . 0.29 107.971 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 260' ' ' VAL . 26.6 pt -140.17 -177.94 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.23 110.076 -179.013 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -143.94 109.07 5.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.401 -0.963 . . . . 1.81 108.401 178.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.81 -76.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.377 -1.342 . . . . 1.18 107.377 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -79.93 -134.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.697 -1.594 . . . . 1.98 106.697 177.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 15.3 p -103.9 54.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.981 -1.118 . . . . 1.39 107.981 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 65.0 m-20 -157.1 130.9 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.887 -0.783 . . . . 1.12 108.887 -179.308 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 73.8 mt -94.45 135.1 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.47 109.847 -179.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -137.45 176.67 8.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.445 -0.784 . . . . 2.11 109.922 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.31 137.9 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.663 -0.648 . . . . 0.33 109.602 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 251' ' ' ILE . 25.9 t -135.43 131.56 19.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.378 -0.826 . . . . 0.34 108.986 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.24 144.29 95.9 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 120.621 0.881 . . . . 0.42 109.946 179.044 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.46 -34.04 74.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 3.12 109.55 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 263' ' ' ARG . 35.4 mtm-85 -70.4 -5.68 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 3.82 110.846 -178.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -119.36 21.3 12.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.386 -0.821 . . . . 2.08 108.866 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.41 24.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.602 -0.686 . . . . 0.32 109.273 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.465 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.8 mtmp? -141.7 129.61 21.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 1.79 109.135 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.86 117.36 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.951 . . . . 0.45 109.978 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.86 150.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 108.795 -0.817 . . . . 0.57 108.795 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.38 146.11 23.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.404 -0.81 . . . . 3.63 108.856 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.495 1.799 0 O-C-N 120.956 -1.09 . . . . 2.05 109.49 179.863 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.328 0.585 . . . . 3.83 109.611 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.844 ' H ' HD12 ' B' ' 220' ' ' ILE . 0.1 OUTLIER -83.25 121.2 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.208 -0.933 . . . . 2.08 108.782 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.4 -117.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.03 -1.044 . . . . 2.16 109.673 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -97.6 104.01 16.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.249 -0.907 . . . . 1.48 109.905 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.14 131.49 34.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.572 -0.705 . . . . 0.73 109.126 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -105.15 158.01 16.88 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.334 -0.854 . . . . 3.26 109.011 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.95 140.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 0.23 109.977 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -107.56 156.53 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.469 -1.308 . . . . 0.58 107.469 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.4 p90 -156.9 151.63 25.74 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.584 -1.323 . . . . 0.44 110.67 -178.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -98.32 148.57 23.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.41 -0.806 . . . . 2.76 109.466 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.485 ' OD2' ' NH1' ' B' ' 231' ' ' ARG . 25.1 t0 -94.86 -175.46 3.57 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.345 -0.847 . . . . 2.23 108.902 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 230' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 5.4 t -98.7 -14.72 19.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.238 -0.914 . . . . 1.81 109.933 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.485 ' NH1' ' OD2' ' B' ' 229' ' ' ASP . 15.1 mtm-85 -89.96 -11.77 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 3.64 109.934 -179.409 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 231' ' ' ARG . 54.1 m-20 -160.97 128.9 2.81 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.14 -0.975 . . . . 2.16 109.494 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.4 6.83 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 120.705 0.937 . . . . 1.27 110.3 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.466 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.3 m -80.04 128.22 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 1.76 109.99 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.3 165.08 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.67 109.546 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' B' ' 237' ' ' GLY . 28.7 mttm -118.44 166.34 12.79 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.711 -0.848 . . . . 1.44 108.711 179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.72 177.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.978 -1.249 . . . . 0.4 109.978 -179.343 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -71.93 160.39 47.84 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.653 1.569 . . . . 0.41 110.506 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.1 173.09 11.99 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.723 -0.843 . . . . 0.21 108.723 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -95.35 139.2 31.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.996 -1.065 . . . . 2.72 109.464 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.81 120.16 30.82 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 0.3 109.855 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.23 -72.83 0.68 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.37 -0.831 . . . . 0.45 110.312 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.78 140.08 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.223 -0.923 . . . . 0.33 110.006 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -146.58 112.68 5.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.224 -0.923 . . . . 2.33 108.986 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.4 -102.47 0.2 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.496 -1.335 . . . . 0.28 110.644 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.65 -159.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.358 -1.083 . . . . 1.4 110.186 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.11 44.88 1.92 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.957 -1.657 . . . . 0.29 108.957 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 152.63 37.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.46 -1.023 . . . . 0.29 108.944 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.67 126.8 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.31 109.442 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.37 137.53 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.941 -1.133 . . . . 0.3 107.941 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 260' ' ' VAL . 26.2 pt -140.26 -178.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.24 110.119 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -143.76 109.27 5.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.394 -0.965 . . . . 1.81 108.394 178.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.97 -76.27 0.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.337 -1.357 . . . . 1.18 107.337 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.87 -134.8 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.763 -1.569 . . . . 1.97 106.763 177.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.406 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 15.4 p -103.93 54.41 0.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.897 -1.149 . . . . 1.38 107.897 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.6 m-20 -156.98 131.0 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.46 135.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.194 -0.941 . . . . 0.48 109.805 -179.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -137.52 176.68 8.49 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.435 -0.79 . . . . 2.13 109.891 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.32 137.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 0.34 109.553 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 260' ' ' VAL . . . . . 0.41 HG21 HD11 ' B' ' 251' ' ' ILE . 25.9 t -135.59 131.5 19.32 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.341 -0.849 . . . . 0.34 108.955 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.13 144.41 95.18 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.571 0.847 . . . . 0.42 109.913 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -61.43 -34.16 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 3.11 109.628 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' B' ' 263' ' ' ARG . 35.2 mtm-85 -70.47 -5.32 27.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 3.82 110.866 -178.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -119.71 21.13 12.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.355 -0.84 . . . . 2.08 108.799 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.77 166.49 24.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.653 . . . . 0.32 109.244 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.461 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.8 mtmp? -141.77 129.68 21.85 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.329 -0.857 . . . . 1.79 109.12 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.94 117.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.289 -0.882 . . . . 0.45 109.892 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.8 mm -117.14 150.71 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.48 146.2 23.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.734 -0.839 . . . . 3.62 108.734 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 120.975 -1.078 . . . . 2.05 109.377 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.509 -0.552 . . . . 3.82 109.509 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -82.17 134.44 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 2.08 109.449 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.57 -139.45 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.709 -0.849 . . . . 2.17 108.709 179.161 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -95.29 93.85 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.045 -1.035 . . . . 1.48 108.914 179.318 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -112.83 141.49 46.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.526 -0.734 . . . . 0.72 109.712 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -112.41 159.2 18.95 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.899 -1.148 . . . . 3.26 107.899 178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.03 142.29 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.187 -0.946 . . . . 0.23 110.154 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.26 154.46 23.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.517 -1.29 . . . . 0.58 107.517 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.6 p90 -155.74 154.8 32.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.8 -1.188 . . . . 0.44 110.199 -178.715 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.3 mtm-85 -91.98 153.39 19.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 2.76 109.364 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -95.35 169.66 9.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.319 -0.863 . . . . 2.23 109.484 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 37.1 t -87.93 -8.89 55.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -0.898 . . . . 1.8 109.381 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.66 32.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.313 -0.867 . . . . 3.63 109.636 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.0 m-20 -162.11 133.97 4.05 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.598 -0.89 . . . . 2.16 108.598 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.56 12.07 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.028 1.152 . . . . 1.25 111.125 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 235' ' ' TRP . 9.1 p -83.02 163.03 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.737 -1.227 . . . . 1.75 110.108 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.561 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.6 m95 -74.52 174.12 9.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.66 108.805 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.64 -164.91 1.46 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.311 -0.868 . . . . 1.43 108.81 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.89 52.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.706 -1.358 . . . . 0.39 109.706 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.26 159.89 48.49 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.694 1.596 . . . . 0.41 109.896 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.37 11.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.775 . . . . 0.21 109.19 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -95.29 136.35 35.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.186 -0.946 . . . . 2.72 109.45 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.46 121.49 29.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.662 . . . . 0.29 109.339 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.71 -68.94 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.412 -0.805 . . . . 0.45 110.039 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -94.19 146.96 23.63 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.18 -0.95 . . . . 0.31 109.697 -178.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -148.92 115.81 6.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.199 -0.938 . . . . 2.32 109.076 179.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.44 0.32 Allowed Glycine 0 N--CA 1.498 2.811 0 C-N-CA 119.611 -1.28 . . . . 0.27 110.722 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.38 -155.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 1.39 109.489 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 50.38 2.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.007 -1.637 . . . . 0.29 109.007 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.02 151.74 35.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.29 108.57 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -145.0 132.43 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 0.31 109.796 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.01 134.89 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.67 -1.233 . . . . 0.29 107.67 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.41 177.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 0.23 110.216 -178.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -141.75 109.65 5.79 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.891 -1.151 . . . . 1.81 107.891 178.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.28 -79.58 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.389 -1.338 . . . . 1.18 107.389 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 255' ' ' SER . 26.9 t-20 -80.78 -129.51 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.516 -1.661 . . . . 1.98 106.516 177.614 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.431 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 36.4 p -104.59 54.04 0.73 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.39 108.04 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -156.44 126.66 6.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.753 . . . . 1.12 109.195 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.3 135.06 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.47 109.444 -179.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.73 169.07 18.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.392 -0.818 . . . . 2.11 109.879 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.71 139.2 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.549 -0.719 . . . . 0.33 109.256 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 27.6 t -133.49 130.87 21.14 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.34 108.882 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.87 141.98 96.27 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.59 0.86 . . . . 0.42 110.192 179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.99 -36.03 67.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 3.12 109.008 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -65.7 -9.63 29.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 3.82 110.369 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -119.91 18.65 12.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.202 -0.936 . . . . 2.08 109.506 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.52 163.76 31.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.384 -0.823 . . . . 0.32 110.064 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.451 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.0 mtmp? -143.17 132.14 22.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.335 -0.853 . . . . 1.79 109.624 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.2 mm -89.06 113.58 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.295 -0.878 . . . . 0.45 109.811 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.1 mm -107.11 158.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.356 -0.84 . . . . 0.57 108.924 179.193 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER -90.74 142.62 27.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.229 -0.919 . . . . 3.63 109.145 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.949 -1.024 . . . . 2.05 109.425 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 18.9 mmt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.564 -0.532 . . . . 3.83 109.564 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -82.09 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 2.08 109.445 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.66 -139.35 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 2.16 108.745 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -95.53 93.85 7.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.035 . . . . 1.48 108.923 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -112.74 141.5 46.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.481 -0.762 . . . . 0.73 109.684 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -112.43 159.09 19.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 107.849 -1.167 . . . . 3.26 107.849 178.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 96.0 t -139.96 142.32 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.172 -0.955 . . . . 0.23 110.13 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.32 154.43 23.5 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.512 -1.292 . . . . 0.58 107.512 178.54 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.7 p90 -155.79 154.8 31.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.779 -1.201 . . . . 0.44 110.228 -178.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.478 ' HG3' HH11 ' B' ' 228' ' ' ARG . 2.3 mtm-85 -91.94 153.37 19.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 2.76 109.434 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.33 169.65 9.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 2.23 109.44 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 37.5 t -87.83 -8.98 55.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.933 . . . . 1.81 109.4 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.57 32.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 3.64 109.641 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.1 m-20 -162.23 133.95 3.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.16 108.596 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -64.55 12.06 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.006 1.137 . . . . 1.27 111.111 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 9.0 p -83.01 163.05 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.777 -1.202 . . . . 1.76 110.101 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.6 m95 -74.52 174.11 9.44 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.792 -0.818 . . . . 0.67 108.792 179.4 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.72 -165.07 1.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.238 -0.914 . . . . 1.44 108.804 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.4 175.81 52.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.28 159.82 48.62 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.688 1.592 . . . . 0.41 109.892 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.26 173.5 11.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.447 -0.783 . . . . 0.21 109.175 179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -95.41 136.36 35.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 2.72 109.385 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.44 121.41 29.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.589 -0.694 . . . . 0.3 109.31 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.69 -68.97 0.89 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.458 -0.776 . . . . 0.45 110.085 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -94.14 146.89 23.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.029 -1.045 . . . . 0.33 109.778 -179.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -148.92 115.76 5.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.132 -0.98 . . . . 2.33 109.131 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.53 0.32 Allowed Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.543 -1.313 . . . . 0.28 110.74 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.29 -155.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 1.4 109.573 -179.158 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 50.47 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.939 -1.664 . . . . 0.29 108.939 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.06 151.85 35.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.577 -0.955 . . . . 0.29 108.544 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.12 132.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.112 -0.992 . . . . 0.31 109.747 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.1 134.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.3 107.754 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.24 177.94 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.24 110.27 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -141.83 109.7 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.904 -1.147 . . . . 1.81 107.904 178.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -88.39 -79.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.382 -1.34 . . . . 1.18 107.382 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 254' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 255' ' ' SER . 26.8 t-20 -80.6 -129.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.614 -1.624 . . . . 1.97 106.614 177.518 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.432 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 36.5 p -104.52 54.08 0.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.116 -1.068 . . . . 1.38 108.116 177.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -156.42 126.59 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.462 -0.774 . . . . 1.12 109.166 -179.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 36.4 mt -93.21 135.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.48 109.394 -179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.78 169.07 18.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 2.13 109.832 -179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 t -101.62 139.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.537 -0.727 . . . . 0.34 109.219 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.4 t -133.33 130.9 21.32 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.34 108.954 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.92 141.89 95.94 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.592 0.861 . . . . 0.42 110.203 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.83 -36.2 67.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 3.11 108.948 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -65.6 -9.6 28.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.995 . . . . 3.82 110.461 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.98 18.67 12.44 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.191 -0.943 . . . . 2.08 109.484 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.82 31.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.32 110.075 -179.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.445 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 7.0 mtmp? -143.2 132.11 22.82 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.326 -0.859 . . . . 1.79 109.637 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.1 mm -89.09 113.59 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.331 -0.856 . . . . 0.45 109.833 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.0 mm -107.11 158.33 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.46 -0.775 . . . . 0.57 108.93 179.235 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -90.62 142.68 27.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.197 -0.94 . . . . 3.62 109.108 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' B' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.013 -0.994 . . . . 2.05 109.412 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.537 -0.542 . . . . 3.82 109.537 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.772 HD12 ' N ' ' A' ' 220' ' ' ILE . 2.2 mp -83.6 99.11 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 2.08 108.573 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -83.33 -108.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 2.17 109.419 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -97.57 96.7 8.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.222 -0.923 . . . . 1.48 109.427 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.77 126.47 27.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.365 -0.834 . . . . 0.72 108.845 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.1 OUTLIER -102.95 156.96 17.31 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.15 -0.968 . . . . 3.26 108.416 179.465 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.19 141.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.19 -0.943 . . . . 0.23 110.491 -179.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.41 156.41 18.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.621 -1.251 . . . . 0.58 107.621 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.7 p90 -155.02 151.56 28.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.686 -1.259 . . . . 0.44 110.809 -179.302 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -99.11 141.47 31.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.613 -0.679 . . . . 2.76 109.347 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 16.8 p30 -95.62 175.11 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 2.23 109.009 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.0 t -85.69 -6.24 59.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.8 109.19 179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -88.84 -18.34 27.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.302 -0.874 . . . . 3.63 109.688 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 234' ' ' VAL . 31.5 m-20 -161.95 129.1 2.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.978 . . . . 2.16 109.267 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.36 8.55 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 120.653 0.902 . . . . 1.25 110.252 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.2 t -83.58 158.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.877 -1.14 . . . . 1.75 109.827 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.401 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.5 m95 -74.72 159.9 31.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.66 109.327 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.1 mtpt -118.55 165.12 14.32 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.532 -0.914 . . . . 1.43 108.532 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.89 164.95 0.02 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.499 -1.04 . . . . 0.39 110.499 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.88 161.84 42.3 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.728 1.619 . . . . 0.41 110.302 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.82 178.39 7.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.456 -0.778 . . . . 0.21 109.067 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.75 138.76 33.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.221 -0.924 . . . . 2.72 108.923 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.07 123.49 32.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.548 -0.72 . . . . 0.29 109.751 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.3 mt -112.44 -76.13 0.6 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.444 -0.785 . . . . 0.45 110.289 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -89.17 143.84 26.55 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.156 -0.965 . . . . 0.31 110.29 -178.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.57 118.5 8.76 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.77 -0.826 . . . . 2.32 108.77 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -113.11 0.45 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.749 -1.215 . . . . 0.27 110.195 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.53 -154.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -1.057 . . . . 1.39 109.573 -179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.43 51.03 3.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.434 -1.466 . . . . 0.29 109.434 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 153.01 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.29 108.641 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.95 131.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.001 -1.062 . . . . 0.31 109.952 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.39 138.25 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.29 108.536 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 22.1 pt -140.37 178.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.874 . . . . 0.23 110.05 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -141.1 110.11 6.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.495 -0.928 . . . . 1.81 108.495 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.72 -79.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.402 -1.332 . . . . 1.18 107.402 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.21 -131.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.492 -1.669 . . . . 1.98 106.492 177.385 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.61 54.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.25 124.91 5.9 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.925 -0.769 . . . . 1.12 108.925 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.423 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 60.6 mt -90.92 136.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 0.47 109.624 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.26 172.67 12.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.285 -0.885 . . . . 2.11 109.911 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.15 136.96 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.502 -0.749 . . . . 0.33 109.688 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.93 123.34 18.04 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 108.426 -0.953 . . . . 0.34 108.426 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.23 139.12 85.45 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 109.854 -0.864 . . . . 0.42 109.854 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.6 -33.35 66.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.157 -0.964 . . . . 3.12 109.433 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -68.24 -6.07 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 3.82 109.95 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.15 17.67 11.59 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.485 -0.759 . . . . 2.08 109.429 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.71 168.31 20.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.467 -0.771 . . . . 0.32 109.263 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -141.44 131.69 24.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.28 -0.888 . . . . 1.79 109.197 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.2 mm -88.02 110.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.325 -0.859 . . . . 0.45 109.369 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.49 156.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.337 -0.852 . . . . 0.57 109.219 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.38 137.46 33.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.448 -0.783 . . . . 3.63 109.736 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.908 -1.044 . . . . 2.05 109.446 179.485 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.564 -0.532 . . . . 3.83 109.564 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.771 ' N ' HD12 ' B' ' 220' ' ' ILE . 2.2 mp -83.43 99.09 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 2.08 108.652 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -83.24 -108.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 2.16 109.463 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.7 96.75 8.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 1.48 109.367 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.72 126.37 27.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.73 108.909 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.1 OUTLIER -102.86 157.0 17.27 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.144 -0.973 . . . . 3.26 108.454 179.431 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.22 141.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.159 -0.963 . . . . 0.23 110.526 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.34 156.35 19.0 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.648 -1.241 . . . . 0.58 107.648 178.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -154.99 151.5 28.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.601 -1.312 . . . . 0.44 110.837 -179.353 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -98.95 141.3 31.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 2.76 109.426 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 17.0 p30 -95.5 175.19 6.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 2.23 109.008 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 35.9 t -85.68 -6.36 59.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 1.81 109.261 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -88.75 -18.34 28.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.233 -0.917 . . . . 3.64 109.711 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 31.6 m-20 -161.98 129.11 2.59 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 2.16 109.294 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -66.4 8.58 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.659 0.906 . . . . 1.27 110.211 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.3 t -83.54 158.12 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.806 -1.184 . . . . 1.76 109.844 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.402 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.5 m95 -74.85 159.83 31.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.67 109.352 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.2 mtpt -118.47 165.18 14.21 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.544 -0.91 . . . . 1.44 108.544 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.88 164.92 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.516 -1.033 . . . . 0.4 110.516 -179.064 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.92 161.88 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.639 1.559 . . . . 0.41 110.302 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 178.38 7.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.533 -0.729 . . . . 0.21 109.156 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.86 138.75 33.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.276 -0.89 . . . . 2.72 108.946 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -88.14 123.52 32.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.489 -0.757 . . . . 0.3 109.678 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 31.0 mt -112.42 -76.13 0.6 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.356 -0.84 . . . . 0.45 110.281 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.423 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -89.2 143.64 26.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.186 -0.946 . . . . 0.33 110.308 -178.739 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.51 118.47 8.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.794 -0.817 . . . . 2.33 108.794 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.23 -113.13 0.45 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.838 -1.172 . . . . 0.28 110.209 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.55 -154.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.416 -1.049 . . . . 1.4 109.545 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 51.12 3.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.29 109.483 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.07 38.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -1.098 . . . . 0.29 108.663 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 7.9 m -146.97 131.81 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.31 109.973 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 94.4 t -93.41 138.19 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.537 -0.912 . . . . 0.3 108.537 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 22.3 pt -140.31 178.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.176 -0.953 . . . . 0.24 110.111 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -141.09 110.1 6.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.459 -0.941 . . . . 1.81 108.459 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.75 -79.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.392 -1.336 . . . . 1.18 107.392 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.29 -131.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.432 -1.692 . . . . 1.97 106.432 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -104.58 54.72 0.72 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.182 -1.044 . . . . 1.38 108.182 177.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.22 124.97 5.94 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.06 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.48 109.571 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.19 172.58 12.7 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.346 -0.846 . . . . 2.13 109.96 -179.434 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.02 136.93 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.443 -0.786 . . . . 0.34 109.737 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.97 123.34 18.0 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.424 -0.954 . . . . 0.34 108.424 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.27 139.17 85.72 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.852 -0.865 . . . . 0.42 109.852 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.69 -33.14 66.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.9 . . . . 3.11 109.521 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.38 -6.04 22.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 3.82 109.996 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.12 17.8 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.465 -0.772 . . . . 2.08 109.463 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.85 168.41 19.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.32 109.227 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -141.47 131.61 24.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.896 . . . . 1.79 109.232 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.3 mm -88.08 110.5 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 0.45 109.299 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 29.3 mm -102.48 156.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.344 -0.848 . . . . 0.57 109.143 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.43 137.45 33.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 3.62 109.724 -179.709 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.003 -0.998 . . . . 2.05 109.317 179.469 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.27 -0.641 . . . . 3.82 109.27 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.503 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -84.93 107.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.218 -0.926 . . . . 2.08 108.981 -179.539 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.02 -128.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 2.17 109.69 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -93.57 105.32 17.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.358 -0.839 . . . . 1.48 109.716 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -134.14 145.64 49.47 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.428 -0.795 . . . . 0.72 109.767 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.493 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 11.2 mtp180 -118.95 152.9 35.5 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.567 -1.271 . . . . 3.26 107.567 178.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.6 t -139.25 142.0 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.121 -0.987 . . . . 0.23 110.431 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -108.39 158.34 17.59 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.684 -1.228 . . . . 0.58 107.684 178.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 15.8 p90 -156.64 152.38 27.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.722 -1.236 . . . . 0.44 110.509 -178.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -93.46 154.13 18.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.389 -0.819 . . . . 2.76 109.59 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.73 170.14 9.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.349 -0.844 . . . . 2.23 109.183 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.0 t -89.66 -13.45 37.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.89 . . . . 1.8 109.46 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 58.9 mtp180 -88.21 -14.6 38.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.16 -0.963 . . . . 3.63 109.373 179.746 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 234' ' ' VAL . 50.1 m-20 -162.22 130.04 2.76 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 2.16 108.718 179.747 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.57 19.37 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 120.759 0.973 . . . . 1.25 110.794 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.7 p -84.47 158.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.778 -1.201 . . . . 1.75 110.197 -179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.518 ' N ' HG22 ' A' ' 234' ' ' VAL . 96.8 m95 -76.66 165.9 24.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.709 -0.62 . . . . 0.66 109.937 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.72 -166.94 1.29 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.61 -0.885 . . . . 1.43 108.61 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.14 52.22 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.703 -1.359 . . . . 0.39 109.703 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.64 149.56 61.46 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.671 1.58 . . . . 0.41 109.862 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.63 169.21 17.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.87 -0.789 . . . . 0.21 108.87 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -92.75 138.73 31.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.088 -1.007 . . . . 2.72 109.502 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.8 tp -87.84 118.82 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.677 -0.64 . . . . 0.29 109.38 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.01 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.358 -0.839 . . . . 0.45 110.154 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.9 146.62 23.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.324 -0.86 . . . . 0.31 110.714 -178.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -150.29 117.01 5.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.452 -0.78 . . . . 2.32 109.14 179.127 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.87 -104.72 0.26 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.949 -1.261 . . . . 0.27 109.949 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -67.05 -155.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -1.112 . . . . 1.39 109.632 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.88 49.38 2.83 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.94 152.2 38.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -1.091 . . . . 0.29 108.542 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.0 m -144.21 132.67 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.31 109.677 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.05 133.81 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.812 -1.181 . . . . 0.29 107.812 178.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.14 -177.87 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.23 110.384 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -142.35 112.17 6.84 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.345 -0.983 . . . . 1.81 108.345 178.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.5 -84.55 0.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.596 -1.261 . . . . 1.18 107.596 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -78.16 -127.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.486 -1.672 . . . . 1.98 106.486 177.488 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.7 p -105.05 52.98 0.73 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.135 -0.978 . . . . 1.39 108.659 178.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -155.45 131.03 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 1.12 109.276 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.06 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.47 109.486 -179.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.04 165.26 26.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.377 -0.827 . . . . 2.11 109.75 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.44 136.77 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.489 -0.757 . . . . 0.33 108.978 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 26.7 t -134.36 132.08 20.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.435 -0.791 . . . . 0.34 108.892 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.25 148.65 85.13 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.641 0.894 . . . . 0.42 109.931 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.848 . . . . 3.12 109.075 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.29 -8.62 47.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -0.791 . . . . 3.82 110.249 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -119.24 19.17 12.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.428 -0.795 . . . . 2.08 108.94 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.54 164.01 31.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.32 109.463 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.5 mtmp? -140.41 130.95 25.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.329 -0.857 . . . . 1.79 109.44 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.02 111.54 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.366 -0.834 . . . . 0.45 110.101 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.0 mm -109.0 157.46 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.486 -0.759 . . . . 0.57 108.975 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 268' ' ' ILE . 83.8 mtm180 -91.44 140.72 29.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.845 . . . . 3.63 109.155 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 2.05 109.176 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.935 -0.765 . . . . 3.83 108.935 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.504 HD13 ' N ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -85.12 107.18 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.077 -1.014 . . . . 2.08 108.919 -179.462 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -84.81 -128.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 2.16 109.76 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -93.7 105.29 17.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 1.48 109.617 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -134.12 145.44 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.447 -0.783 . . . . 0.73 109.791 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.484 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 11.0 mtp180 -118.82 152.97 35.26 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.481 -1.303 . . . . 3.26 107.481 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.1 t -139.14 142.21 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.167 -0.958 . . . . 0.23 110.469 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -108.56 158.29 17.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.651 -1.24 . . . . 0.58 107.651 178.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.5 p90 -156.63 152.38 27.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.698 -1.251 . . . . 0.44 110.545 -178.687 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -93.33 153.91 18.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.243 -0.911 . . . . 2.76 109.608 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.63 170.13 9.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.25 -0.906 . . . . 2.23 109.154 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 26.8 t -89.69 -13.37 37.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 1.81 109.507 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 58.8 mtp180 -88.32 -14.5 38.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.138 -0.976 . . . . 3.64 109.319 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' B' ' 234' ' ' VAL . 50.6 m-20 -162.29 129.98 2.72 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 2.16 108.771 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.62 19.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 120.804 1.003 . . . . 1.27 110.697 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -84.35 158.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.869 -1.144 . . . . 1.76 110.243 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.523 ' N ' HG22 ' B' ' 234' ' ' VAL . 96.8 m95 -76.65 166.18 23.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 0.67 109.983 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.79 -166.98 1.3 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 1.44 108.689 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.07 52.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.713 -1.355 . . . . 0.4 109.713 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.69 149.52 61.11 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.762 1.641 . . . . 0.41 109.884 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.74 169.06 18.15 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.963 -0.754 . . . . 0.21 108.963 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.58 138.55 31.41 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.987 . . . . 2.72 109.52 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.75 118.96 27.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.724 -0.61 . . . . 0.3 109.414 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.25 -73.9 0.67 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.388 -0.82 . . . . 0.45 110.103 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -92.91 146.47 23.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.323 -0.861 . . . . 0.33 110.661 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -150.1 117.03 5.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.444 -0.785 . . . . 2.33 109.164 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.89 -104.69 0.26 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.948 -1.261 . . . . 0.28 109.948 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.03 -155.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -1.116 . . . . 1.4 109.612 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.94 49.42 2.86 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.276 -1.529 . . . . 0.29 109.276 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.42 38.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.389 -1.065 . . . . 0.29 108.494 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 m -144.46 132.68 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.023 . . . . 0.31 109.648 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.12 133.76 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.843 -1.169 . . . . 0.3 107.843 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.6 pt -138.13 -177.72 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.24 110.292 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -142.48 112.2 6.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.334 -0.987 . . . . 1.81 108.334 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -89.59 -84.54 0.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.552 -1.277 . . . . 1.18 107.552 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.12 -128.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.489 -1.671 . . . . 1.97 106.489 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 9.6 p -105.1 53.02 0.73 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.145 -0.972 . . . . 1.38 108.586 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -155.32 131.06 9.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.491 -0.756 . . . . 1.12 109.276 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.05 135.98 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.142 -0.974 . . . . 0.48 109.413 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -137.06 165.4 26.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.362 -0.836 . . . . 2.13 109.67 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.68 137.05 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.045 -0.724 . . . . 0.34 109.045 179.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.6 132.1 20.59 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.346 -0.846 . . . . 0.34 108.935 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.26 148.72 84.87 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 N-CA-C 109.911 -0.842 . . . . 0.42 109.911 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.84 73.39 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.282 -0.886 . . . . 3.11 108.997 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.33 -8.48 46.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 3.82 110.235 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -119.31 19.18 12.85 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.448 -0.782 . . . . 2.08 108.986 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.91 31.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.564 -0.71 . . . . 0.32 109.447 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.5 mtmp? -140.4 130.97 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.258 -0.901 . . . . 1.79 109.479 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.04 111.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.362 -0.836 . . . . 0.45 110.102 -179.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.418 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.1 mm -108.99 157.48 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.985 -0.746 . . . . 0.57 108.985 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.418 ' N ' HG22 ' B' ' 268' ' ' ILE . 83.8 mtm180 -91.43 140.69 29.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 3.62 109.159 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 2.05 109.064 179.495 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.275 -0.639 . . . . 3.82 109.275 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.762 HD12 ' N ' ' A' ' 220' ' ' ILE . 1.8 mp -84.67 136.89 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.257 -0.902 . . . . 2.08 109.181 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -82.67 -141.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 2.17 109.758 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -92.95 107.2 19.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 1.48 109.756 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.34 143.09 50.56 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.591 -0.693 . . . . 0.72 109.594 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 50.1 mtt180 -108.08 157.79 17.96 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.456 -1.313 . . . . 3.26 107.456 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.47 141.39 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.785 -1.197 . . . . 0.23 110.954 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.39 155.86 20.73 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.674 -1.602 . . . . 0.58 106.674 177.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -154.11 166.94 31.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.462 -1.399 . . . . 0.44 110.654 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -90.62 137.53 32.29 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.322 0.582 . . . . 2.76 109.453 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -94.39 160.97 14.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.545 -0.722 . . . . 2.23 109.432 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.9 m -86.81 -6.51 58.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 1.8 109.575 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -88.26 -20.36 25.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 3.63 109.628 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.4 m-20 -162.19 140.29 6.73 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 2.16 108.7 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.57 2.82 1.05 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.869 1.046 . . . . 1.25 110.378 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 235' ' ' TRP . 7.3 m -84.56 141.74 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.853 -1.155 . . . . 1.75 110.141 -179.514 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CZ2' ' NH1' ' A' ' 228' ' ' ARG . 97.2 m95 -52.32 -177.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.345 -0.847 . . . . 0.66 109.19 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.444 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 1.9 ttpp -131.77 -156.64 0.77 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.272 -0.893 . . . . 1.43 109.11 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.28 -178.6 52.46 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.59 -1.404 . . . . 0.39 109.59 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.64 159.84 47.83 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.571 1.514 . . . . 0.41 110.19 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.07 18.27 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.92 -0.77 . . . . 0.21 108.92 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -93.24 139.24 30.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.12 -0.987 . . . . 2.72 109.223 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.27 117.31 28.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.419 -0.801 . . . . 0.29 109.631 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.0 -73.61 0.68 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.291 -0.88 . . . . 0.45 110.005 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -90.77 141.56 28.68 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.31 110.531 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.73 113.95 5.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 2.32 109.361 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.01 -107.98 0.29 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.89 -1.284 . . . . 0.27 109.89 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -60.05 -158.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 1.39 109.833 -179.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.85 46.88 2.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.703 -1.359 . . . . 0.29 109.703 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.23 148.39 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -1.106 . . . . 0.29 108.867 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.0 m -142.19 129.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.912 . . . . 0.31 109.744 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.25 137.72 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.203 -1.036 . . . . 0.29 108.203 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -140.27 -179.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.192 -0.943 . . . . 0.23 110.452 -179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -144.19 110.29 5.42 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.81 -0.811 . . . . 1.81 108.81 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.42 -78.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.378 -1.342 . . . . 1.18 107.378 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -80.04 -134.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.445 -1.687 . . . . 1.98 106.445 177.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.9 p -102.15 54.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.48 126.43 7.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.705 . . . . 1.12 109.337 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.1 mt -92.61 137.84 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.339 -0.85 . . . . 0.47 109.61 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -140.73 170.63 15.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 2.11 109.643 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.42 139.77 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.33 109.605 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.19 130.22 19.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.76 141.47 95.68 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 N-CA-C 109.644 -0.945 . . . . 0.42 109.644 179.055 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.93 -34.7 73.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 3.12 109.727 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.01 -6.44 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 3.82 110.655 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.53 24.0 10.55 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.16 -0.962 . . . . 2.08 109.204 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.19 164.54 28.94 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.085 -0.709 . . . . 0.32 109.085 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -137.77 131.68 31.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.247 -0.908 . . . . 1.79 108.87 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.09 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 0.45 109.828 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.98 157.2 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.378 -0.827 . . . . 0.57 108.964 179.274 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.1 mtt-85 -90.84 143.77 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.158 -0.963 . . . . 3.63 109.198 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 18.4 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.104 -0.951 . . . . 2.05 109.448 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.315 -0.624 . . . . 3.83 109.315 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.767 ' N ' HD12 ' B' ' 220' ' ' ILE . 1.8 mp -84.79 137.0 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.92 . . . . 2.08 109.253 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -82.47 -141.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 2.16 109.789 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -93.08 107.28 19.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.48 109.705 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -130.54 142.94 50.47 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.694 -0.629 . . . . 0.73 109.48 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 49.9 mtt180 -108.1 157.76 17.99 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.401 -1.333 . . . . 3.26 107.401 178.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.51 141.17 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.952 -1.092 . . . . 0.23 110.979 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.16 155.8 20.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.907 -1.516 . . . . 0.58 106.907 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.7 p90 -154.2 166.92 31.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.56 -1.337 . . . . 0.44 110.761 -178.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' B' ' 228' ' ' ARG . 0.0 OUTLIER -90.47 137.41 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.706 -0.621 . . . . 2.76 109.556 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -94.36 161.02 14.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.416 -0.803 . . . . 2.23 109.333 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 68.7 m -86.79 -6.61 58.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 1.81 109.709 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.17 -20.37 25.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 3.64 109.532 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -162.29 140.11 6.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.984 . . . . 2.16 108.804 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.31 2.74 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 120.857 1.038 . . . . 1.27 110.624 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' B' ' 235' ' ' TRP . 7.5 m -84.54 141.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.965 -1.084 . . . . 1.76 110.111 -179.427 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.577 ' CZ2' ' NH1' ' B' ' 228' ' ' ARG . 97.0 m95 -52.2 -177.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 0.67 109.213 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.452 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 1.9 ttpp -131.82 -156.71 0.77 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.184 -0.947 . . . . 1.44 109.057 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.12 -178.43 52.39 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.81 159.78 47.6 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.543 1.495 . . . . 0.41 110.171 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 168.98 18.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.876 -0.787 . . . . 0.21 108.876 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -93.23 139.11 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 2.72 109.232 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.25 117.26 28.09 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.501 -0.749 . . . . 0.3 109.575 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.99 -73.55 0.68 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.314 -0.866 . . . . 0.45 110.034 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.73 141.53 28.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.33 110.528 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.63 114.04 5.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 2.33 109.255 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.24 -107.82 0.29 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.039 -1.224 . . . . 0.28 110.039 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.22 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -1.169 . . . . 1.4 109.704 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.61 46.77 2.02 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.753 -1.339 . . . . 0.29 109.753 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.13 148.35 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -1.19 . . . . 0.29 108.872 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.18 129.65 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.328 -0.857 . . . . 0.31 109.796 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -93.31 137.71 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.229 -1.026 . . . . 0.3 108.229 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.29 -179.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.19 -0.944 . . . . 0.24 110.507 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -144.13 110.14 5.37 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.835 -0.802 . . . . 1.81 108.835 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.24 -79.07 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.415 -1.328 . . . . 1.18 107.415 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.96 -134.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.485 -1.672 . . . . 1.97 106.485 177.388 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -102.04 54.27 0.8 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.994 -1.113 . . . . 1.38 107.994 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.55 126.32 6.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 1.12 109.336 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 30.0 mt -92.61 137.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.48 109.571 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -140.63 170.74 15.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 2.13 109.544 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.55 139.78 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.364 -0.835 . . . . 0.34 109.608 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.13 130.19 19.24 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 108.602 -0.888 . . . . 0.34 108.602 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 141.5 95.92 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.589 -0.966 . . . . 0.42 109.589 179.037 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.89 -34.6 73.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 3.11 109.782 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.07 -6.44 28.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 3.82 110.602 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.65 24.09 10.46 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.132 -0.98 . . . . 2.08 109.294 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 164.49 29.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.892 -0.781 . . . . 0.32 108.892 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -137.7 131.85 31.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.259 -0.9 . . . . 1.79 108.965 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.25 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.351 -0.843 . . . . 0.45 109.632 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.25 157.32 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.796 -0.816 . . . . 0.57 108.796 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.1 mtt-85 -91.02 143.76 26.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.241 -0.912 . . . . 3.62 109.176 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 18.3 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.03 -0.986 . . . . 2.05 109.464 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.444 -0.576 . . . . 3.82 109.444 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.02 139.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 2.08 109.228 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.35 -116.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 2.17 109.734 -179.339 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 -99.27 107.62 19.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.233 -0.917 . . . . 1.48 108.974 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -135.28 126.99 29.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.516 -0.74 . . . . 0.72 109.21 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -100.98 158.67 15.82 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.143 -1.058 . . . . 3.26 108.143 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.83 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.23 110.312 -179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -111.2 156.85 20.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.056 -1.091 . . . . 0.58 108.056 178.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.8 p90 -155.49 153.26 30.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.806 -1.184 . . . . 0.44 110.377 -179.044 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 233' ' ' PRO . 21.4 mtp180 -96.84 145.67 25.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 2.76 109.801 -179.704 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.52 163.94 12.83 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.42 -0.8 . . . . 2.23 108.928 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.2 m -82.65 -3.17 55.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 1.8 109.313 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.47 -17.26 30.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.865 . . . . 3.63 109.442 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 234' ' ' VAL . 22.5 m-20 -162.62 133.8 3.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 2.16 108.892 179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.632 ' CA ' HH21 ' A' ' 228' ' ' ARG . 6.8 Cg_endo -64.88 5.85 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.839 1.026 . . . . 1.25 110.458 179.871 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.4 m -83.34 154.16 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.94 -1.1 . . . . 1.75 109.786 -179.627 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.34 -171.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.66 108.782 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.48 -155.74 0.62 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.975 . . . . 1.43 109.251 179.727 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.17 173.97 52.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.874 -1.291 . . . . 0.39 109.874 -179.568 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.03 157.82 46.45 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.78 1.653 . . . . 0.41 110.297 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.59 174.3 10.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.21 109.194 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.44 142.76 27.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 2.72 109.463 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.23 124.48 34.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.318 -0.623 . . . . 0.29 109.318 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.8 mt -115.88 -74.12 0.62 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.499 -0.75 . . . . 0.45 110.207 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -92.25 142.08 27.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.284 -0.885 . . . . 0.31 110.396 -178.522 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.89 7.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.865 . . . . 2.32 109.231 179.265 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.82 -103.87 0.21 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.982 -1.247 . . . . 0.27 109.982 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.76 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 1.39 109.647 -179.658 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.19 50.57 3.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.279 -1.529 . . . . 0.29 109.279 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.26 152.93 36.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -1.02 . . . . 0.29 108.811 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.47 129.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 0.31 109.535 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.37 139.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.509 -0.923 . . . . 0.29 108.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.42 176.31 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.277 -0.889 . . . . 0.23 110.243 -179.234 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -144.96 113.33 6.6 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.85 -0.796 . . . . 1.81 108.85 178.93 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.09 -79.88 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.44 -1.319 . . . . 1.18 107.44 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.64 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.756 -1.572 . . . . 1.98 106.756 177.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.0 p -103.83 55.72 0.73 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.983 -1.117 . . . . 1.39 107.983 177.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -156.0 125.5 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.079 -0.712 . . . . 1.12 109.079 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 66.8 mt -91.78 136.97 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.238 -0.914 . . . . 0.47 109.611 -179.493 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.1 166.4 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 2.11 110.032 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.89 140.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.492 -0.755 . . . . 0.33 109.534 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.62 127.94 16.75 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.357 -0.84 . . . . 0.34 108.863 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.5 99.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.614 0.876 . . . . 0.42 110.363 179.637 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -59.02 -28.88 66.82 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.447 -0.946 . . . . 3.12 108.447 179.139 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.41 -13.58 62.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.468 -0.77 . . . . 3.82 110.805 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -120.65 23.99 10.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.317 -0.864 . . . . 2.08 109.644 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.97 163.07 33.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.32 109.634 -179.855 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.469 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 8.2 mtmp? -140.74 125.03 17.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.408 -0.807 . . . . 1.79 108.969 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.08 112.11 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.246 -0.909 . . . . 0.45 110.128 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.94 150.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.487 -0.931 . . . . 0.57 108.487 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -92.7 143.68 26.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.475 -0.766 . . . . 3.63 109.382 179.522 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.969 -1.015 . . . . 2.05 109.418 179.713 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.468 -0.567 . . . . 3.83 109.468 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.94 139.49 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.217 -0.927 . . . . 2.08 109.251 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.29 -116.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.432 -0.793 . . . . 2.16 109.776 -179.4 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.4 m-20 -99.21 107.74 20.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.326 -0.859 . . . . 1.48 109.011 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.3 127.04 29.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.73 109.16 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -100.98 158.68 15.82 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.124 -1.065 . . . . 3.26 108.124 179.16 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.23 110.284 -179.396 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.23 156.93 20.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.061 -1.089 . . . . 0.58 108.061 178.791 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -155.52 153.38 30.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.749 -1.219 . . . . 0.44 110.282 -178.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.646 HH21 ' CA ' ' B' ' 233' ' ' PRO . 21.5 mtp180 -97.01 145.62 25.77 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.6 -0.688 . . . . 2.76 109.754 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.5 163.95 12.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 2.23 108.997 179.58 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.1 m -82.68 -3.06 55.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 1.81 109.412 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.59 -17.21 30.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.39 -0.819 . . . . 3.64 109.41 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' B' ' 234' ' ' VAL . 22.7 m-20 -162.62 133.71 3.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 2.16 108.921 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.646 ' CA ' HH21 ' B' ' 228' ' ' ARG . 6.8 Cg_endo -64.79 5.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 120.858 1.039 . . . . 1.27 110.488 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.4 m -83.29 154.12 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.908 -1.12 . . . . 1.76 109.813 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.38 -171.48 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.67 108.759 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.45 -155.71 0.62 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.974 . . . . 1.44 109.264 179.759 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 174.04 52.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.914 -1.275 . . . . 0.4 109.914 -179.636 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.07 157.81 46.27 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.745 1.63 . . . . 0.41 110.297 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.65 174.24 10.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.488 -0.757 . . . . 0.21 109.163 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.34 142.62 27.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.02 . . . . 2.72 109.475 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -89.14 124.42 34.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.624 -0.672 . . . . 0.3 109.475 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 36.1 mt -115.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.388 -0.82 . . . . 0.45 110.156 -179.818 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.5 t90 -92.26 142.08 27.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.33 110.337 -178.492 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.85 7.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.309 -0.869 . . . . 2.33 109.223 179.244 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.77 -104.01 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.956 -1.257 . . . . 0.28 109.956 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.72 -156.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 1.4 109.632 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 50.58 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.272 -1.531 . . . . 0.29 109.272 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.28 152.87 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.443 -1.034 . . . . 0.29 108.867 179.94 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.41 129.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.139 -0.975 . . . . 0.31 109.525 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.39 139.65 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.084 -1.01 . . . . 0.3 108.543 179.531 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.5 pt -139.48 176.22 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.264 -0.897 . . . . 0.24 110.206 -179.131 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -144.95 113.46 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 1.81 108.811 178.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -91.1 -80.05 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.345 -1.354 . . . . 1.18 107.345 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.47 -131.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.737 -1.579 . . . . 1.97 106.737 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 86.9 p -103.76 55.57 0.74 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.051 -1.092 . . . . 1.38 108.051 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -155.96 125.53 6.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.023 -0.732 . . . . 1.12 109.023 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 67.0 mt -91.77 136.92 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.48 109.611 -179.489 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.14 166.41 23.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.398 -0.814 . . . . 2.13 109.985 -179.109 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.97 140.66 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.483 -0.761 . . . . 0.34 109.472 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.5 t -136.63 127.95 16.74 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.338 -0.852 . . . . 0.34 108.897 179.613 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.8 144.49 99.56 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 120.621 0.881 . . . . 0.42 110.253 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -58.91 -29.01 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.416 -0.957 . . . . 3.11 108.416 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -70.4 -13.55 62.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.462 -0.774 . . . . 3.82 110.76 -178.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -120.69 24.06 10.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.256 -0.902 . . . . 2.08 109.563 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.1 33.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.436 -0.79 . . . . 0.32 109.633 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 8.1 mtmp? -140.71 125.06 17.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 1.79 108.953 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 31.0 mm -89.04 112.1 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.285 -0.884 . . . . 0.45 110.135 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.88 150.08 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.513 -0.921 . . . . 0.57 108.513 179.098 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -92.8 143.63 26.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.406 -0.808 . . . . 3.62 109.316 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.044 -0.979 . . . . 2.05 109.49 179.734 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 57.9 mmm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.258 -0.645 . . . . 3.82 109.258 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.96 141.14 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.892 . . . . 2.08 109.829 -179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -87.57 -131.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 2.17 110.12 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -92.29 106.71 18.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 1.48 109.04 179.812 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.3 146.4 49.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.567 -0.708 . . . . 0.72 109.528 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -120.95 153.46 37.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.652 -1.24 . . . . 3.26 107.652 178.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.67 143.47 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.23 109.892 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.94 157.36 19.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.117 -1.438 . . . . 0.58 107.117 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 19.2 p90 -156.87 160.44 39.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.539 -1.35 . . . . 0.44 110.499 -179.354 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -97.72 153.78 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.648 -0.657 . . . . 2.76 109.953 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -96.39 175.16 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.505 -0.747 . . . . 2.23 109.351 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 83.6 p -91.55 -16.78 26.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 1.8 109.248 179.626 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -82.15 -12.55 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 3.63 109.581 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 46.1 m-20 -162.36 130.32 2.78 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 2.16 109.281 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -65.16 12.15 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.677 0.918 . . . . 1.25 110.041 179.201 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 41.0 t -84.62 160.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.022 . . . . 1.75 109.521 -179.746 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.46 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.4 m95 -75.09 168.68 19.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.735 . . . . 0.66 109.092 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.95 -165.16 1.31 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.1 -1.074 . . . . 1.43 108.1 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.36 178.14 47.83 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.385 -1.388 . . . . 0.39 109.882 -179.508 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.17 158.06 55.83 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.558 1.505 . . . . 0.41 109.904 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.11 169.22 18.16 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.743 -0.836 . . . . 0.21 108.743 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -91.74 139.0 31.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.025 -1.047 . . . . 2.72 109.398 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.17 123.7 33.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.654 -0.654 . . . . 0.29 109.71 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.6 mt -113.91 -73.56 0.65 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.493 -0.755 . . . . 0.45 109.768 -179.812 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -94.95 145.98 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.112 -0.993 . . . . 0.31 110.321 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.27 120.05 8.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.364 -0.835 . . . . 2.32 109.121 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -116.98 0.57 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.27 110.63 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.58 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.991 . . . . 1.39 110.041 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.95 52.54 2.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.695 -1.362 . . . . 0.29 109.695 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.55 146.46 21.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.961 -1.317 . . . . 0.29 110.508 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 262' ' ' ARG . 1.7 m -142.64 121.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.448 -0.945 . . . . 0.31 108.448 178.581 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 58.1 t -84.42 134.46 26.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.418 -0.956 . . . . 0.29 108.418 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -138.87 178.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.416 -0.802 . . . . 0.23 109.886 -179.117 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -140.96 109.78 6.06 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.328 -0.989 . . . . 1.81 108.328 178.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.61 -78.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.582 -1.266 . . . . 1.18 107.582 179.925 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -80.99 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.637 -1.616 . . . . 1.98 106.637 177.56 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.3 t -105.43 51.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.604 -0.887 . . . . 1.39 108.604 178.274 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -155.94 130.46 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.841 . . . . 1.12 109.402 -179.52 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 76.6 mt -92.5 136.92 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.47 109.455 -179.669 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -140.06 170.92 14.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 2.11 109.735 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.44 140.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.424 -0.797 . . . . 0.33 109.632 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.58 129.89 16.63 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.244 -0.91 . . . . 0.34 109.163 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.17 148.82 91.21 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 120.825 1.017 . . . . 0.42 109.637 179.132 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HG3' HH11 ' A' ' 262' ' ' ARG . 18.3 mmm-85 -56.66 -36.96 70.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.905 -1.122 . . . . 3.12 108.685 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -63.57 -8.1 8.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.886 -0.509 . . . . 3.82 110.537 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -122.61 14.1 10.16 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.3 -0.875 . . . . 2.08 108.712 179.309 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 159.53 41.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.32 109.275 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.66 131.88 38.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.356 -0.84 . . . . 1.79 109.005 179.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.53 108.97 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.45 109.954 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.95 151.99 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.624 -0.88 . . . . 0.57 108.624 178.961 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.8 OUTLIER -90.17 147.95 23.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 3.63 109.087 179.311 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.022 -0.989 . . . . 2.05 109.416 179.777 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 57.8 mmm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.202 -0.666 . . . . 3.83 109.202 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 3.2 pt -84.19 141.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 2.08 109.774 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.67 -131.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 2.16 109.94 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -92.6 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 1.48 109.041 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -134.29 146.52 50.09 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.601 -0.687 . . . . 0.73 109.493 -179.677 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -121.09 153.4 37.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.628 -1.249 . . . . 3.26 107.628 178.667 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.58 143.7 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.25 -0.906 . . . . 0.23 109.828 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.19 157.33 19.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.222 -1.399 . . . . 0.58 107.222 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 19.0 p90 -156.99 160.55 39.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.442 -1.411 . . . . 0.44 110.501 -179.276 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -97.78 153.72 18.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.691 . . . . 2.76 109.948 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -96.56 175.12 6.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.271 -0.893 . . . . 2.23 109.288 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 82.2 p -91.35 -16.57 27.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 1.81 109.223 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -82.27 -12.6 57.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 3.64 109.694 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' B' ' 234' ' ' VAL . 46.6 m-20 -162.27 130.16 2.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.049 -1.032 . . . . 2.16 109.307 -179.912 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.2 12.25 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 120.664 0.909 . . . . 1.27 109.957 179.291 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.9 t -84.84 160.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 1.76 109.501 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.459 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -75.06 168.43 19.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 0.67 109.108 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.71 -165.03 1.29 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.216 -1.031 . . . . 1.44 108.216 178.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.28 178.01 47.84 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.425 -1.369 . . . . 0.4 109.841 -179.51 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.88 158.17 56.23 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.602 1.535 . . . . 0.41 109.984 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.34 168.82 18.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.728 -0.841 . . . . 0.21 108.728 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -91.4 138.91 31.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.026 -1.046 . . . . 2.72 109.515 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.12 123.76 33.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.645 -0.66 . . . . 0.3 109.726 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.08 -73.71 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.507 -0.746 . . . . 0.45 109.722 -179.827 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.425 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 6.8 t90 -94.77 146.0 24.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.33 110.313 -179.139 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.4 120.29 8.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.332 -0.855 . . . . 2.33 109.145 178.947 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.5 -116.74 0.56 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.649 -1.262 . . . . 0.28 110.628 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -63.04 -145.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.997 . . . . 1.4 109.998 -179.041 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.91 52.36 2.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.64 -1.384 . . . . 0.29 109.64 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.57 146.4 20.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.994 -1.297 . . . . 0.29 110.591 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 249' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' B' ' 262' ' ' ARG . 1.7 m -142.58 121.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.492 -0.929 . . . . 0.31 108.492 178.714 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.39 134.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.464 -0.939 . . . . 0.3 108.464 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.9 pt -138.92 178.75 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.327 -0.858 . . . . 0.24 109.892 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -141.0 109.7 6.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.323 -0.992 . . . . 1.81 108.323 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.42 -78.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.619 -1.252 . . . . 1.18 107.619 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -80.87 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.677 -1.601 . . . . 1.97 106.677 177.626 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.4 t -105.42 52.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.267 -0.896 . . . . 1.38 108.584 178.285 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -156.06 130.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 1.12 109.293 -179.419 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 76.7 mt -92.74 136.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.48 109.413 -179.647 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.93 170.58 15.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.408 -0.808 . . . . 2.13 109.694 -178.992 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.16 140.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 0.34 109.654 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.2 t -137.76 129.77 16.37 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.297 -0.877 . . . . 0.34 109.119 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.93 148.76 91.61 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 120.828 1.019 . . . . 0.42 109.755 179.087 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' B' ' 262' ' ' ARG . 18.0 mmm-85 -56.49 -37.47 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 3.11 108.622 179.247 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -63.12 -8.21 7.3 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.099 -0.5 . . . . 3.82 110.492 -178.217 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -122.6 14.04 10.15 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.877 . . . . 2.08 108.688 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.82 159.87 41.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.32 109.323 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.89 131.92 37.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 1.79 109.021 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.64 109.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.45 109.976 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -107.09 152.07 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.594 -0.891 . . . . 0.57 108.594 178.979 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' B' ' 269' ' ' ARG . 0.8 OUTLIER -90.21 147.85 23.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 3.62 109.007 179.406 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.077 -0.964 . . . . 2.05 109.37 179.641 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.381 -0.6 . . . . 3.82 109.381 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.572 ' O ' HD12 ' A' ' 220' ' ' ILE . 0.9 OUTLIER -82.57 138.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.195 -0.941 . . . . 2.08 108.643 179.801 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -88.42 -126.42 0.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.965 -1.084 . . . . 2.17 109.772 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -94.92 99.99 11.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.276 -0.89 . . . . 1.48 109.147 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -135.5 128.9 32.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.72 109.301 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 224' ' ' ARG . 4.7 ptt-85 -109.65 162.59 14.28 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.141 -1.059 . . . . 3.26 108.141 178.461 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.214 -0.929 . . . . 0.23 110.814 -178.395 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -108.65 153.16 23.81 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.335 -1.357 . . . . 0.58 107.335 178.168 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.3 p90 -157.13 151.04 24.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.516 -1.365 . . . . 0.44 110.432 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.55 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 34.9 mtm180 -96.45 154.11 17.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 2.76 109.606 179.715 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 230' ' ' SER . 11.9 t70 -95.07 166.14 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 2.23 108.804 179.27 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 2.9 t -82.13 -7.26 59.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 1.8 109.171 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.73 -19.54 23.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 3.63 109.967 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.63 3.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.986 . . . . 2.16 109.173 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -64.69 15.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 120.842 1.028 . . . . 1.25 110.679 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 232' ' ' ASP . 26.0 m -82.51 131.84 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.927 -1.108 . . . . 1.75 109.82 -179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.9 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.66 109.465 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 237' ' ' GLY . 49.1 tttp -136.25 158.31 44.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.275 -0.891 . . . . 1.43 109.153 179.249 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.03 164.81 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.617 -0.993 . . . . 0.39 110.617 -179.326 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.56 159.44 50.74 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.614 1.543 . . . . 0.41 110.378 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.43 175.32 9.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.898 -0.779 . . . . 0.21 108.898 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.34 135.67 33.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.167 -0.958 . . . . 2.72 109.676 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.19 123.46 32.24 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.151 -0.685 . . . . 0.29 109.151 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -115.87 -72.27 0.7 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.416 -0.803 . . . . 0.45 110.125 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.78 137.46 32.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.221 -0.924 . . . . 0.31 110.067 -178.843 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.1 116.95 8.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.291 -0.881 . . . . 2.32 108.89 179.284 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.64 0.19 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.927 -1.269 . . . . 0.27 109.927 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.19 -157.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 1.39 109.671 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 48.94 2.68 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.364 -1.494 . . . . 0.29 109.364 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.42 152.04 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -1.112 . . . . 0.29 108.882 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.78 124.76 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.112 -0.993 . . . . 0.31 110.01 -179.716 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.0 136.51 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.179 -1.045 . . . . 0.29 108.179 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -139.47 178.64 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.3 -0.875 . . . . 0.23 110.118 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -143.53 112.42 6.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.538 -0.912 . . . . 1.81 108.538 179.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.78 -79.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.765 -1.198 . . . . 1.18 107.765 179.596 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.46 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.755 -1.572 . . . . 1.98 106.755 177.76 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.4 m -105.0 54.29 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.074 -1.084 . . . . 1.39 108.074 178.083 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -157.43 126.04 5.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.965 -0.754 . . . . 1.12 108.965 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.5 mt -92.46 140.73 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.279 -0.888 . . . . 0.47 109.589 -179.663 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.43 169.56 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.392 -0.818 . . . . 2.11 109.59 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.66 139.69 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 0.33 109.073 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.9 t -135.67 121.24 13.77 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.421 -0.8 . . . . 0.34 108.926 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.81 136.59 75.23 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 N-CA-C 109.934 -0.833 . . . . 0.42 109.934 179.588 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -56.04 -35.64 67.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 3.12 109.631 179.886 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.503 HH11 ' CG ' ' A' ' 263' ' ' ARG . 0.7 OUTLIER -69.34 -3.01 12.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 3.82 110.259 -179.417 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.55 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 19.3 mtpp -119.47 16.12 12.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.371 -0.831 . . . . 2.08 109.044 179.674 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.34 170.8 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.474 -0.767 . . . . 0.32 109.329 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.492 ' HZ1' HD11 ' A' ' 268' ' ' ILE . 6.3 mtmp? -140.79 132.12 26.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.27 -0.894 . . . . 1.79 109.457 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.96 117.25 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.264 -0.898 . . . . 0.45 109.922 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.492 HD11 ' HZ1' ' A' ' 266' ' ' LYS . 5.7 mm -116.21 148.84 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.556 -0.905 . . . . 0.57 108.556 179.15 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 141.93 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.476 -0.935 . . . . 3.63 108.476 179.46 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 118.008 -0.996 . . . . 2.05 109.505 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.371 -0.604 . . . . 3.83 109.371 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.577 ' O ' HD12 ' B' ' 220' ' ' ILE . 0.9 OUTLIER -82.54 138.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.158 -0.963 . . . . 2.08 108.763 179.738 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -88.34 -126.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.953 -1.092 . . . . 2.16 109.729 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -94.92 100.06 11.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -0.899 . . . . 1.48 109.144 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.58 128.84 31.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.492 -0.755 . . . . 0.73 109.33 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 224' ' ' ARG . 4.8 ptt-85 -109.64 162.51 14.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.207 -1.034 . . . . 3.26 108.207 178.515 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.1 t -138.03 146.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.165 -0.959 . . . . 0.23 110.839 -178.329 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -108.66 153.15 23.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.356 -1.35 . . . . 0.58 107.356 178.134 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.3 p90 -157.03 151.07 24.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.557 -1.34 . . . . 0.44 110.548 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.569 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 34.9 mtm180 -96.5 154.13 17.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 2.76 109.591 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 230' ' ' SER . 11.8 t70 -95.0 166.13 12.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.818 . . . . 2.23 108.831 179.254 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 2.9 t -82.11 -7.22 59.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -0.999 . . . . 1.81 109.209 179.803 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -90.66 -19.71 23.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.886 . . . . 3.64 109.952 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' B' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.61 3.06 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.056 -1.028 . . . . 2.16 109.139 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.71 15.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 120.86 1.04 . . . . 1.27 110.605 179.691 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' B' ' 232' ' ' ASP . 26.4 m -82.53 131.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.829 -1.169 . . . . 1.76 109.875 -179.656 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 0.67 109.463 179.895 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 237' ' ' GLY . 49.1 tttp -136.36 158.21 44.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.296 -0.877 . . . . 1.44 109.189 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.98 164.87 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.538 -1.025 . . . . 0.4 110.538 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.52 159.35 51.06 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.628 1.552 . . . . 0.41 110.406 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.34 175.34 9.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.983 -0.747 . . . . 0.21 108.983 179.371 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.38 135.64 33.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.053 -1.03 . . . . 2.72 109.671 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.17 123.51 32.28 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.166 -0.679 . . . . 0.3 109.166 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.96 -72.24 0.7 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.399 -0.813 . . . . 0.45 110.09 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -90.83 137.41 32.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.253 -0.904 . . . . 0.33 110.08 -178.836 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.03 116.94 8.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.87 . . . . 2.33 108.898 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.56 0.19 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.997 -1.241 . . . . 0.28 109.997 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.22 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -1.099 . . . . 1.4 109.606 -179.643 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 48.93 2.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.34 -1.504 . . . . 0.29 109.34 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.43 152.03 37.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 0.29 108.877 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.83 124.77 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 0.31 109.982 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.94 136.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.156 -1.053 . . . . 0.3 108.156 179.114 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.38 178.6 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 0.24 110.157 -179.127 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -143.48 112.45 6.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.603 -0.888 . . . . 1.81 108.603 178.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.77 -79.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.759 -1.2 . . . . 1.18 107.759 179.649 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.56 -130.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.654 -1.609 . . . . 1.97 106.654 177.794 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 35.3 m -104.98 54.17 0.71 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.089 -1.078 . . . . 1.38 108.089 178.207 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -157.39 126.0 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.024 -0.732 . . . . 1.12 109.024 -179.376 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 19.4 mt -92.37 140.75 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.929 . . . . 0.48 109.65 -179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.48 169.53 17.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 2.13 109.532 -179.598 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.6 139.61 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.34 109.1 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 75.5 t -135.58 121.24 13.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.477 -0.765 . . . . 0.34 108.964 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.79 136.43 74.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.965 -0.821 . . . . 0.42 109.965 179.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.55 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -55.99 -35.59 66.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 3.11 109.625 179.981 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.7 OUTLIER -69.33 -3.06 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 3.82 110.232 -179.393 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.569 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 19.4 mtpp -119.38 16.01 13.02 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.831 . . . . 2.08 109.004 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.27 170.84 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.712 . . . . 0.32 109.416 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.482 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.4 mtmp? -140.76 132.16 26.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.211 -0.931 . . . . 1.79 109.49 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.86 117.28 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.917 . . . . 0.45 109.941 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.484 HG21 ' NH2' ' B' ' 224' ' ' ARG . 5.7 mm -116.32 148.82 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.544 -0.909 . . . . 0.57 108.544 179.187 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 141.79 28.36 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.516 -0.92 . . . . 3.62 108.516 179.497 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 2.05 109.528 -179.862 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.504 -0.554 . . . . 3.82 109.504 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.91 141.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 2.08 109.516 -179.92 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -86.64 -132.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 2.17 109.858 -179.661 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -92.26 108.3 19.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.172 -0.955 . . . . 1.48 109.272 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -134.53 136.78 43.33 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.845 -0.798 . . . . 0.72 108.845 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -111.55 155.18 23.7 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.129 -1.063 . . . . 3.26 108.129 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.14 141.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 0.23 110.258 -179.399 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.12 157.65 18.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.456 -1.313 . . . . 0.58 107.456 178.582 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 10.5 p90 -156.47 150.12 24.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.653 -1.279 . . . . 0.44 110.28 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 228' ' ' ARG . 9.1 mtm-85 -94.69 154.43 17.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.461 -0.775 . . . . 2.76 109.66 179.774 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.81 166.44 11.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 2.23 108.841 179.362 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.0 t -85.83 -9.79 56.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 1.8 109.324 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -89.3 -16.09 31.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 3.63 109.56 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.5 m-20 -161.42 129.7 2.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.137 -0.977 . . . . 2.16 109.063 -179.846 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.38 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 120.781 0.987 . . . . 1.25 110.653 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 232' ' ' ASP . 11.6 m -82.69 133.41 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.73 -1.231 . . . . 1.75 109.848 -179.747 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -53.56 -177.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.26 -0.9 . . . . 0.66 109.124 179.635 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.742 ' HZ3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -136.79 -164.78 1.63 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.256 -0.903 . . . . 1.43 108.631 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.742 ' H ' ' HZ3' ' A' ' 236' ' ' LYS . . . -73.52 172.38 50.61 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.661 -1.257 . . . . 0.39 110.041 -179.441 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.35 158.76 55.21 Favored 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.633 1.555 . . . . 0.41 109.955 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.02 172.77 12.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.21 109.193 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -94.44 138.82 31.91 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.2 -0.938 . . . . 2.72 109.36 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.63 126.24 34.84 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.532 -0.73 . . . . 0.29 109.467 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 24.5 mt -119.59 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.752 . . . . 0.45 110.115 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.427 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.53 140.1 30.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.178 -0.951 . . . . 0.31 109.946 -178.76 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -147.82 119.5 8.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.258 -0.901 . . . . 2.32 109.163 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.14 -100.75 0.18 Allowed Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.788 -1.196 . . . . 0.27 110.28 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.33 -154.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -1.072 . . . . 1.39 109.804 -179.323 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.9 2.82 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.875 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.81 153.88 38.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -1.068 . . . . 0.29 109.009 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.34 132.92 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.31 109.825 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.5 t -94.39 139.32 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.206 -1.035 . . . . 0.29 108.206 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.5 pt -140.62 179.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.23 110.073 -179.207 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -142.54 115.03 8.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.469 -0.938 . . . . 1.81 108.469 179.013 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.26 -84.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.417 -1.327 . . . . 1.18 107.417 179.459 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.62 -126.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.629 -1.619 . . . . 1.98 106.629 177.62 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.2 t -105.7 53.9 0.71 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.025 -1.102 . . . . 1.39 108.025 177.891 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.08 8.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.12 109.196 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.6 mt -93.9 137.05 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.325 -0.859 . . . . 0.47 109.587 -179.611 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.5 167.39 22.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 2.11 109.681 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.04 143.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.381 -0.824 . . . . 0.33 109.351 179.596 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.2 t -137.92 126.01 14.16 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.352 -0.843 . . . . 0.34 109.047 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.82 143.4 99.2 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 N-CA-C 109.692 -0.926 . . . . 0.42 109.692 179.444 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.421 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -54.62 -41.17 69.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 3.12 109.293 179.606 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.431 HH11 ' HG3' ' A' ' 263' ' ' ARG . 29.6 mtm-85 -67.2 -2.48 5.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.85 . . . . 3.82 110.563 -178.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.74 14.64 12.6 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.355 -0.841 . . . . 2.08 109.112 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.28 169.06 18.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.32 109.832 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.21 130.07 24.61 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.446 -0.784 . . . . 1.79 109.068 179.629 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.41 110.54 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.237 -0.915 . . . . 0.45 109.515 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.42 155.27 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.749 -0.834 . . . . 0.57 108.749 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.38 140.79 29.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.372 -0.83 . . . . 3.63 109.621 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.007 -0.997 . . . . 2.05 109.449 179.661 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.509 -0.552 . . . . 3.83 109.509 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.89 141.19 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 2.08 109.542 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -86.58 -132.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 2.16 109.864 -179.651 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -92.33 108.28 19.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 1.48 109.276 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -134.51 136.88 43.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.848 -0.797 . . . . 0.73 108.848 179.966 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -111.63 155.22 23.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.063 -1.088 . . . . 3.26 108.063 179.095 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.17 141.12 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.285 -0.884 . . . . 0.23 110.185 -179.382 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.1 157.72 18.46 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.455 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.51 150.09 24.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.66 -1.275 . . . . 0.44 110.332 -179.012 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' B' ' 228' ' ' ARG . 9.1 mtm-85 -94.72 154.44 17.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 2.76 109.646 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.92 166.46 11.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 2.23 108.846 179.374 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.2 t -85.92 -9.67 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 1.81 109.283 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.25 -16.2 31.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 3.64 109.549 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.5 m-20 -161.43 129.81 2.93 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.223 -0.923 . . . . 2.16 109.073 -179.839 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.25 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.835 1.023 . . . . 1.27 110.594 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' B' ' 232' ' ' ASP . 11.5 m -82.59 133.56 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.782 -1.199 . . . . 1.76 109.806 -179.746 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -53.72 -177.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.09 -1.006 . . . . 0.67 109.094 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.77 ' HZ3' ' H ' ' B' ' 237' ' ' GLY . 0.1 OUTLIER -136.74 -164.73 1.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.23 -0.919 . . . . 1.44 108.685 179.241 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.77 ' H ' ' HZ3' ' B' ' 236' ' ' LYS . . . -73.75 172.38 51.04 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.625 -1.274 . . . . 0.4 110.053 -179.431 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.36 158.82 55.0 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.592 1.528 . . . . 0.41 109.996 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.79 12.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.21 109.163 179.471 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -94.47 138.71 32.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.161 -0.962 . . . . 2.72 109.406 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.4 tp -87.54 126.22 34.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.493 -0.754 . . . . 0.3 109.485 -179.829 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.56 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.737 . . . . 0.45 110.181 -179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -91.48 139.99 30.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.119 -0.988 . . . . 0.33 109.97 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -147.72 119.48 8.08 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.885 . . . . 2.33 109.134 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.11 -100.86 0.18 Allowed Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.828 -1.177 . . . . 0.28 110.334 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.23 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -1.063 . . . . 1.4 109.865 -179.342 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.99 2.84 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.355 -1.498 . . . . 0.29 109.355 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.86 153.92 38.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.113 . . . . 0.29 109.029 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.3 132.84 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.095 -1.003 . . . . 0.31 109.892 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.25 139.44 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.254 -1.017 . . . . 0.3 108.254 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.4 pt -140.77 179.3 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.24 110.117 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -142.48 114.9 8.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.507 -0.923 . . . . 1.81 108.507 179.101 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.17 -84.57 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.43 -1.322 . . . . 1.18 107.43 179.441 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -79.73 -125.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.589 -1.634 . . . . 1.97 106.589 177.68 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.3 t -105.79 53.91 0.7 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.995 -1.113 . . . . 1.38 107.995 177.946 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.22 8.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.542 -0.724 . . . . 1.12 109.164 -179.355 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.427 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 48.6 mt -94.01 137.06 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.48 109.587 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -138.51 167.36 22.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.299 -0.876 . . . . 2.13 109.711 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.96 143.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.391 -0.818 . . . . 0.34 109.408 179.615 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.97 125.97 14.08 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.418 -0.801 . . . . 0.34 108.973 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.77 143.34 99.05 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 N-CA-C 109.778 -0.893 . . . . 0.42 109.778 179.322 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.412 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -54.58 -41.24 69.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 3.11 109.324 179.64 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.438 HH11 ' HG3' ' B' ' 263' ' ' ARG . 29.6 mtm-85 -67.02 -2.63 5.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.248 -0.908 . . . . 3.82 110.597 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.65 14.63 12.67 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.344 -0.847 . . . . 2.08 109.127 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.14 169.08 18.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.313 -0.867 . . . . 0.32 109.839 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.16 130.15 24.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 1.79 109.077 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.38 110.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.244 -0.91 . . . . 0.45 109.595 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.38 155.28 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.737 -0.838 . . . . 0.57 108.737 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.36 140.86 29.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.313 -0.867 . . . . 3.62 109.607 179.831 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.923 -1.037 . . . . 2.05 109.405 179.702 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.337 -0.616 . . . . 3.82 109.337 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 220' ' ' ILE . 1.9 mp -83.01 109.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 2.08 108.843 -179.925 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -83.81 -121.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 2.17 109.435 179.853 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -96.49 100.2 11.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.262 -0.898 . . . . 1.48 109.773 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -135.86 135.26 39.62 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.803 . . . . 0.72 109.717 179.962 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 224' ' ' ARG . 12.0 mtm-85 -106.17 160.62 15.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.79 -1.189 . . . . 3.26 107.79 178.829 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.7 141.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.23 110.212 -179.256 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.81 154.7 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.363 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.8 p90 -157.15 152.2 26.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.643 -1.286 . . . . 0.44 110.11 -179.228 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.435 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 35.9 mtm180 -95.95 152.3 18.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.466 -0.771 . . . . 2.76 110.067 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -91.19 165.2 13.6 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 179.222 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 59.5 m -83.92 -13.07 54.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.994 -1.067 . . . . 1.8 108.873 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.81 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 3.63 109.588 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.7 p30 -156.95 128.87 3.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.954 -1.091 . . . . 2.16 109.414 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.76 7.08 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 121.059 1.173 . . . . 1.25 111.476 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 235' ' ' TRP . 13.9 p -83.29 161.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.459 -1.401 . . . . 1.75 110.208 -179.523 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.535 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.2 m95 -75.48 160.75 29.85 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.157 -0.683 . . . . 0.66 109.157 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.3 tttp -119.12 163.82 16.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.395 -0.816 . . . . 1.43 109.069 179.408 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.94 168.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.902 -1.279 . . . . 0.39 109.902 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.3 161.3 46.44 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.458 1.439 . . . . 0.41 110.64 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.61 173.9 11.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.992 -0.744 . . . . 0.21 108.992 179.252 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.75 139.59 31.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.092 -1.005 . . . . 2.72 109.21 179.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.18 123.85 33.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 0.29 109.455 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.15 -75.37 0.59 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.45 109.724 179.638 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.96 143.75 26.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 0.31 110.301 -179.062 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -149.54 118.72 6.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.477 -0.764 . . . . 2.32 108.955 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -100.99 0.18 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.618 -1.277 . . . . 0.27 110.157 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.35 -154.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -1.069 . . . . 1.39 109.751 -179.365 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.77 45.77 2.23 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.89 150.52 36.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.443 -1.034 . . . . 0.29 108.834 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 129.34 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.204 -0.935 . . . . 0.31 109.459 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.97 137.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.088 -1.078 . . . . 0.29 108.088 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.0 pt -140.11 -178.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.178 -0.951 . . . . 0.23 110.549 -178.747 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -145.99 112.15 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.93 -76.57 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.998 -1.482 . . . . 1.18 106.998 179.216 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.19 -136.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.822 -1.547 . . . . 1.98 106.822 177.586 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.74 55.42 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.344 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -157.69 127.06 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 1.12 109.097 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 38.3 mt -92.68 133.27 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.31 -0.869 . . . . 0.47 109.567 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.25 168.27 19.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.505 -0.747 . . . . 2.11 109.631 -179.661 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.48 138.48 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.439 -0.788 . . . . 0.33 109.658 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.5 133.07 19.0 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.473 -0.936 . . . . 0.34 108.473 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.39 140.64 95.3 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.663 0.909 . . . . 0.42 110.143 179.587 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -57.92 -35.5 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 3.12 109.209 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.4 mtt-85 -69.99 -1.95 11.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 3.82 110.464 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.435 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 5.3 mptp? -118.7 15.54 13.59 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.738 -0.838 . . . . 2.08 108.738 -179.672 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.17 173.34 11.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.524 -0.735 . . . . 0.32 109.445 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.55 129.04 22.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.336 -0.853 . . . . 1.79 108.997 179.545 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.2 mm -86.57 113.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.45 109.19 179.773 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.6 mm -112.6 148.65 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.514 -0.921 . . . . 0.57 108.514 179.364 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -91.39 149.99 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.554 -0.716 . . . . 3.63 109.518 179.917 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.972 -1.013 . . . . 2.05 109.24 179.647 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.271 -0.64 . . . . 3.83 109.271 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.695 ' N ' HD12 ' B' ' 220' ' ' ILE . 1.9 mp -82.97 109.47 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 2.08 108.901 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -83.81 -122.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 2.16 109.348 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -96.51 100.09 11.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.214 -0.928 . . . . 1.48 109.768 -179.652 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -135.86 135.25 39.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.426 -0.796 . . . . 0.73 109.665 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' B' ' 224' ' ' ARG . 11.9 mtm-85 -106.05 160.57 15.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.814 -1.18 . . . . 3.26 107.814 178.79 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 141.48 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.206 -0.934 . . . . 0.23 110.178 -179.24 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.75 154.75 22.49 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.447 -1.316 . . . . 0.58 107.447 178.369 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.21 152.16 25.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.653 -1.28 . . . . 0.44 110.096 -179.247 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.419 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 35.7 mtm180 -95.86 152.39 18.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.461 -0.775 . . . . 2.76 110.053 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -91.33 165.1 13.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 2.23 108.686 179.221 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 59.1 m -83.72 -13.19 54.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 1.81 108.943 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.66 40.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 3.64 109.59 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -157.12 128.8 3.88 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.115 -0.991 . . . . 2.16 109.322 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.8 7.27 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.988 1.125 . . . . 1.27 111.583 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.538 HG22 ' N ' ' B' ' 235' ' ' TRP . 13.9 p -83.33 161.65 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.347 -1.47 . . . . 1.76 110.241 -179.574 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.538 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.45 160.75 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.67 109.199 179.68 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.2 tttp -119.05 163.85 16.38 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.373 -0.829 . . . . 1.44 109.032 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.97 168.2 0.03 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.967 -1.253 . . . . 0.4 109.967 -179.486 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -69.34 161.31 46.39 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.479 1.453 . . . . 0.41 110.584 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.64 173.87 11.19 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.883 -0.784 . . . . 0.21 108.883 179.282 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.73 139.52 31.13 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.069 -1.019 . . . . 2.72 109.215 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.19 123.78 33.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.433 -0.792 . . . . 0.3 109.425 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.09 -75.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.476 -0.765 . . . . 0.45 109.744 179.655 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.97 143.8 26.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 0.33 110.274 -179.067 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -149.53 118.72 6.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.418 -0.801 . . . . 2.33 109.044 179.279 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.8 -100.97 0.18 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.577 -1.297 . . . . 0.28 110.191 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.32 -154.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -1.012 . . . . 1.4 109.807 -179.399 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 45.83 2.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.236 -1.545 . . . . 0.29 109.236 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.9 150.48 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -1.022 . . . . 0.29 108.789 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.96 129.36 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.92 . . . . 0.31 109.519 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.99 137.38 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.087 -1.079 . . . . 0.3 108.087 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.01 -178.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.286 -0.884 . . . . 0.24 110.618 -178.829 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -146.07 112.09 5.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.984 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.82 -76.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.063 -1.458 . . . . 1.18 107.063 179.213 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -82.08 -136.43 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.512 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.7 55.36 0.87 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.195 -1.039 . . . . 1.38 108.195 178.345 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -157.66 126.96 5.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.581 -0.699 . . . . 1.12 109.154 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 37.8 mt -92.56 133.25 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.48 109.586 -179.623 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.2 168.28 19.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.427 -0.796 . . . . 2.13 109.627 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.51 138.47 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 0.34 109.657 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 133.14 19.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.376 -0.972 . . . . 0.34 108.376 179.421 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.43 140.75 95.78 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 120.539 0.826 . . . . 0.42 110.162 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -57.95 -35.51 71.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.114 -0.991 . . . . 3.11 109.222 179.449 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' B' B ' 263' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.4 mtt-85 -70.01 -1.96 11.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 3.82 110.462 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.419 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 5.3 mptp? -118.72 15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.367 -0.833 . . . . 2.08 108.758 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 173.38 11.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.453 -0.78 . . . . 0.32 109.512 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.62 128.89 22.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 1.79 109.075 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.0 mm -86.43 113.29 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.158 -0.964 . . . . 0.45 109.233 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.71 148.61 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.471 -0.937 . . . . 0.57 108.471 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -91.33 150.01 21.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.541 -0.724 . . . . 3.62 109.581 179.908 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.219 179.704 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.594 -0.521 . . . . 3.82 109.594 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.0 pt -82.62 141.23 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 2.08 109.431 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -86.17 -135.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 2.17 109.475 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -93.92 110.81 22.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.203 -0.936 . . . . 1.48 109.057 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.64 138.62 46.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.582 -0.699 . . . . 0.72 109.381 -179.751 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.435 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 61.4 mtm180 -107.7 160.05 16.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.962 -1.125 . . . . 3.26 107.962 179.159 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 77.3 t -142.04 138.92 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.172 -0.955 . . . . 0.23 110.096 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -108.36 151.36 26.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.556 -1.276 . . . . 0.58 107.556 178.611 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -155.61 152.31 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.609 -1.307 . . . . 0.44 110.529 -179.076 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.45 ' HG3' HH11 ' A' ' 228' ' ' ARG . 8.8 mtm-85 -95.31 151.0 19.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 2.76 109.513 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.8 m-20 -96.52 167.15 11.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 2.23 108.892 179.34 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.2 t -83.33 -8.92 59.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.8 109.195 179.538 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -90.44 -16.17 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.352 -0.843 . . . . 3.63 109.764 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 234' ' ' VAL . 59.2 m-20 -160.69 129.74 3.14 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.139 -0.976 . . . . 2.16 109.232 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.39 10.91 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 120.862 1.041 . . . . 1.25 110.41 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.0 m -83.17 135.91 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 1.75 110.1 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.19 167.55 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.66 109.127 179.71 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 237' ' ' GLY . 36.8 tttp -125.5 157.92 35.79 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.383 -0.823 . . . . 1.43 109.34 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.05 166.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.349 -1.1 . . . . 0.39 110.349 -179.315 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -65.53 160.92 40.7 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.639 1.559 . . . . 0.41 110.58 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.824 -0.806 . . . . 0.21 108.824 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.9 137.93 34.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.118 -0.989 . . . . 2.72 109.216 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.89 125.41 35.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.563 -0.711 . . . . 0.29 109.765 -179.589 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.76 -72.89 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 0.45 109.912 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.24 28.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.234 -0.916 . . . . 0.31 110.341 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.84 118.74 7.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 2.32 108.896 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -100.24 0.18 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.787 -1.197 . . . . 0.27 110.151 -179.76 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.59 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 1.39 109.569 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.46 47.98 2.47 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.575 -1.41 . . . . 0.29 109.575 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.91 33.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -1.086 . . . . 0.29 108.854 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.21 125.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 0.31 109.489 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.99 139.52 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.368 -0.975 . . . . 0.29 108.368 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 251' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 260' ' ' VAL . 27.2 pt -141.73 178.51 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.117 -0.989 . . . . 0.23 110.257 -179.121 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -144.36 114.52 7.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.736 -0.839 . . . . 1.81 108.736 179.193 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.96 -78.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.453 -1.314 . . . . 1.18 107.453 179.241 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.57 -129.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.638 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.06 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.537 -0.727 . . . . 1.12 109.277 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 33.8 mt -92.74 135.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.807 . . . . 0.47 109.45 -179.629 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.09 14.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 2.11 109.776 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.35 138.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.466 -0.771 . . . . 0.33 109.475 179.802 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 251' ' ' ILE . 90.5 t -134.9 126.9 18.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.668 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 145.08 90.01 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 120.507 0.805 . . . . 0.42 110.47 179.822 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 262' ' ' ARG . 4.5 ttt-85 -65.16 -36.82 85.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.428 -0.795 . . . . 3.12 110.1 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -68.71 -4.91 17.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 3.82 110.174 -179.099 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -119.52 19.54 12.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.341 -0.849 . . . . 2.08 109.184 179.783 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.54 170.55 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.496 -0.752 . . . . 0.32 109.578 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -140.93 132.14 26.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.236 -0.915 . . . . 1.79 109.358 179.765 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.8 mm -88.78 106.03 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.27 -0.894 . . . . 0.45 109.593 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.47 155.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.374 -0.828 . . . . 0.57 109.208 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -91.34 147.91 22.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.801 . . . . 3.63 109.464 179.578 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.096 -1.002 . . . . 2.05 109.424 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 9.2 ptt? . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.599 -0.519 . . . . 3.83 109.599 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.0 pt -82.51 141.28 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 2.08 109.446 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -86.22 -135.44 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 2.16 109.471 -179.652 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -93.89 110.76 22.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.923 . . . . 1.48 109.03 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.66 138.58 45.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.69 . . . . 0.73 109.386 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.433 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 61.4 mtm180 -107.68 160.18 15.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.985 -1.117 . . . . 3.26 107.985 179.158 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 77.2 t -142.2 138.96 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.192 -0.943 . . . . 0.23 109.982 -179.57 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -108.42 151.31 26.21 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.62 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -155.51 152.47 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.44 110.541 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.8 mtm-85 -95.39 151.08 19.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 2.76 109.39 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.8 m-20 -96.61 167.17 11.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.355 -0.841 . . . . 2.23 108.89 179.316 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 43.5 t -83.26 -9.14 59.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 1.81 109.215 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -90.27 -16.15 29.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 3.64 109.821 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 59.1 m-20 -160.74 129.73 3.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 2.16 109.295 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.41 11.02 0.23 Allowed 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 120.79 0.994 . . . . 1.27 110.419 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.0 m -83.23 135.93 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.869 -1.144 . . . . 1.76 110.06 -179.48 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.2 167.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.227 -0.92 . . . . 0.67 109.107 179.663 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' B' ' 237' ' ' GLY . 36.8 tttp -125.48 157.92 35.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.373 -0.83 . . . . 1.44 109.272 179.447 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.11 166.11 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.361 -1.096 . . . . 0.4 110.361 -179.342 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -65.47 160.89 40.68 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.617 1.545 . . . . 0.41 110.585 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.805 . . . . 0.21 108.825 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.82 137.99 34.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.061 -1.024 . . . . 2.72 109.254 179.901 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.93 125.49 35.38 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.564 -0.71 . . . . 0.3 109.774 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.75 -72.93 0.66 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.45 -0.781 . . . . 0.45 110.002 179.872 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.16 28.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.23 -0.919 . . . . 0.33 110.251 -178.789 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.78 118.8 7.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.377 -0.827 . . . . 2.33 108.882 179.155 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -100.25 0.18 Allowed Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.096 -179.779 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.52 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 1.4 109.555 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.48 47.98 2.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.688 -1.365 . . . . 0.29 109.688 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.83 33.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -1.093 . . . . 0.29 108.82 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.12 125.87 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 0.31 109.501 179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.04 139.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.467 -0.938 . . . . 0.3 108.467 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 251' ' ' ILE . . . . . 0.427 HD11 HG21 ' B' ' 260' ' ' VAL . 27.1 pt -141.7 178.54 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.92 . . . . 0.24 110.265 -179.092 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -144.38 114.51 7.42 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.834 -0.802 . . . . 1.81 108.834 179.106 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.96 -78.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.436 -1.32 . . . . 1.18 107.436 179.33 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.51 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.78 -1.563 . . . . 1.97 106.78 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 17.7 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.105 -1.072 . . . . 1.38 108.105 178.081 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.07 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.628 -0.67 . . . . 1.12 109.257 -179.379 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 34.1 mt -92.76 135.92 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.355 -0.841 . . . . 0.48 109.436 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.02 15.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.822 . . . . 2.13 109.806 -179.432 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 138.32 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.388 -0.82 . . . . 0.34 109.542 179.795 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 260' ' ' VAL . . . . . 0.427 HG21 HD11 ' B' ' 251' ' ' ILE . 91.1 t -134.8 126.97 18.2 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.573 -0.899 . . . . 0.34 108.573 179.748 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.57 145.12 90.52 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 120.564 0.843 . . . . 0.42 110.355 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 262' ' ' ARG . 4.5 ttt-85 -65.14 -36.92 85.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.427 -0.796 . . . . 3.11 110.109 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -68.53 -4.95 16.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.109 -0.994 . . . . 3.82 110.325 -179.216 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -119.56 19.53 12.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.327 -0.858 . . . . 2.08 109.191 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 170.62 15.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.448 -0.783 . . . . 0.32 109.584 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -140.95 132.05 26.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 1.79 109.321 179.779 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.62 106.0 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.275 -0.891 . . . . 0.45 109.627 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -105.53 155.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.447 -0.783 . . . . 0.57 109.212 179.631 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -91.27 147.9 22.72 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 3.62 109.502 179.608 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.95 -1.024 . . . . 2.05 109.414 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.422 0.63 . . . . 3.82 109.332 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.9 mm -83.11 122.73 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 2.08 108.995 179.951 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' A' ' 222' ' ' ASN . 1.7 pm0 -81.54 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.04 . . . . 2.17 110.256 -179.425 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 222' ' ' ASN . 1.5 m-20 -96.96 103.79 15.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.242 -0.911 . . . . 1.48 110.925 -178.837 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.22 127.54 28.34 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.867 -0.79 . . . . 0.72 108.867 178.443 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.94 159.05 15.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.206 -1.035 . . . . 3.26 108.206 179.227 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.7 t -143.44 144.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.2 -0.938 . . . . 0.23 110.157 -179.731 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.53 157.02 20.84 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.555 -1.276 . . . . 0.58 107.555 178.626 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.0 p90 -157.78 149.26 21.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.258 . . . . 0.44 110.434 -178.943 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.464 ' NH1' ' CH2' ' A' ' 235' ' ' TRP . 24.0 mtm-85 -95.16 142.54 27.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.439 -0.788 . . . . 2.76 109.266 179.259 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.88 173.06 8.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 2.23 109.068 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.8 m -86.83 -8.1 57.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 1.8 109.527 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.46 -20.5 26.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 3.63 109.455 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.4 m-20 -162.42 132.34 3.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 2.16 108.95 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.35 14.64 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 120.724 0.949 . . . . 1.25 110.293 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 232' ' ' ASP . 44.5 t -80.91 155.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.798 -1.189 . . . . 1.75 109.577 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.464 ' CH2' ' NH1' ' A' ' 228' ' ' ARG . 98.8 m95 -75.89 160.71 29.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.66 109.573 -179.789 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.0 mttm -119.33 159.32 24.38 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.347 -0.845 . . . . 1.43 109.027 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.38 168.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.997 -1.241 . . . . 0.39 109.997 -179.565 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.74 159.09 54.3 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.585 1.523 . . . . 0.41 110.425 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.4 174.41 10.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.799 -0.815 . . . . 0.21 108.799 179.13 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 240' ' ' LYS . 11.5 mptt -92.71 136.62 33.07 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 2.72 109.373 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -87.07 122.9 31.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.327 -0.858 . . . . 0.29 109.403 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -113.78 -76.67 0.58 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.421 -0.8 . . . . 0.45 110.373 -179.958 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 21.3 t90 -97.35 137.86 35.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.018 -1.051 . . . . 0.31 110.772 -178.722 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.89 132.36 17.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.857 -0.794 . . . . 2.32 108.857 178.804 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -99.82 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.48 -1.448 . . . . 0.27 109.48 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.52 -149.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 1.39 109.154 179.829 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 48.32 3.09 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.231 -1.548 . . . . 0.29 109.231 179.66 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.61 149.15 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.971 . . . . 0.29 109.085 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.11 135.6 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.096 -1.003 . . . . 0.31 109.534 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 87.7 t -88.41 143.63 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.29 109.318 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.79 179.81 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.362 -0.836 . . . . 0.23 109.482 179.737 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -143.99 110.8 5.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 1.81 108.656 178.731 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -89.6 -78.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.67 -1.233 . . . . 1.18 107.67 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -81.13 -131.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.815 -1.55 . . . . 1.98 106.815 177.858 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -105.24 53.36 0.72 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.191 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -155.53 127.66 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.603 -0.686 . . . . 1.12 109.157 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.481 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 72.4 mt -93.0 132.97 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.47 109.861 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -134.99 170.62 15.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.449 -0.782 . . . . 2.11 109.493 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.3 t -100.89 139.87 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.415 -0.803 . . . . 0.33 109.498 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.75 121.56 14.99 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.441 -0.787 . . . . 0.34 109.201 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.99 139.35 89.63 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.486 0.791 . . . . 0.42 110.054 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -52.86 -43.1 65.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 3.12 109.555 179.658 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.26 -3.88 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.412 -0.805 . . . . 3.82 110.667 -178.783 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.426 ' CD ' ' NH2' ' A' ' 228' ' ' ARG . 7.2 mmmt -120.19 16.85 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.288 -0.883 . . . . 2.08 108.882 179.852 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.96 172.27 12.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.702 . . . . 0.32 109.749 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -137.4 126.96 25.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.783 -0.821 . . . . 1.79 108.783 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.97 107.11 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.45 109.516 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.45 147.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.61 -0.885 . . . . 0.57 108.61 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.65 145.8 24.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.352 -0.843 . . . . 3.63 109.367 179.682 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.994 -1.003 . . . . 2.05 109.594 179.746 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.34 -0.615 . . . . 3.83 109.34 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 15.9 mm -82.99 122.78 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.388 -0.82 . . . . 2.08 109.001 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 221' ' ' GLN . . . . . 0.465 ' CG ' ' H ' ' B' ' 222' ' ' ASN . 1.7 pm0 -81.63 -117.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 2.16 110.226 -179.442 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' B' ' 221' ' ' GLN . 1.5 m-20 -96.97 103.74 15.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.922 . . . . 1.48 110.873 -178.742 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.21 127.68 28.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.437 -0.789 . . . . 0.73 108.876 178.362 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.96 159.04 15.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.177 -1.045 . . . . 3.26 108.177 179.245 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.53 144.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.166 -0.958 . . . . 0.23 110.13 -179.84 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.45 157.01 20.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.626 -1.25 . . . . 0.58 107.626 178.6 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -157.75 149.28 21.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.241 . . . . 0.44 110.487 -178.948 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.465 ' NH1' ' CH2' ' B' ' 235' ' ' TRP . 24.1 mtm-85 -95.17 142.56 27.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.432 -0.792 . . . . 2.76 109.222 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.93 173.09 8.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.314 -0.866 . . . . 2.23 109.073 179.856 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -86.87 -8.1 57.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 1.81 109.509 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.44 -20.45 26.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 3.64 109.452 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.6 m-20 -162.47 132.32 3.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 2.16 108.976 179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.38 14.69 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 120.65 0.9 . . . . 1.27 110.321 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' B' ' 232' ' ' ASP . 44.3 t -80.94 155.09 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.836 -1.165 . . . . 1.76 109.579 -179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.465 ' CH2' ' NH1' ' B' ' 228' ' ' ARG . 98.8 m95 -75.96 160.7 29.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.67 109.609 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.0 mttm -119.31 159.33 24.34 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.415 -0.803 . . . . 1.44 108.917 179.574 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.27 168.81 0.03 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.971 -1.251 . . . . 0.4 109.971 -179.714 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.76 159.11 54.19 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.592 1.528 . . . . 0.41 110.424 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.37 174.38 10.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.835 -0.802 . . . . 0.21 108.835 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' B' ' 240' ' ' LYS . 11.5 mptt -92.64 136.6 33.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.132 -0.98 . . . . 2.72 109.416 -179.694 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.02 122.89 31.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.424 -0.797 . . . . 0.3 109.401 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.8 -76.66 0.58 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.45 110.442 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.411 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 21.5 t90 -97.48 137.9 35.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.057 -1.027 . . . . 0.33 110.76 -178.726 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.9 132.38 17.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.407 -0.808 . . . . 2.33 108.898 178.914 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -99.92 0.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.445 -1.462 . . . . 0.28 109.445 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.51 -149.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -1.178 . . . . 1.4 109.154 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.36 48.19 3.08 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.675 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.57 149.22 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -1.014 . . . . 0.29 108.981 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.15 135.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.142 -0.974 . . . . 0.31 109.594 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 250' ' ' VAL . . . . . 0.475 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 87.6 t -88.44 143.61 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.918 . . . . 0.3 109.339 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.73 179.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 0.24 109.61 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -144.04 110.73 5.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.701 -0.852 . . . . 1.81 108.701 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.53 -78.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.598 -1.26 . . . . 1.18 107.598 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -81.02 -131.13 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.875 -1.528 . . . . 1.97 106.875 177.884 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -105.25 53.35 0.72 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.189 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -155.56 127.59 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.154 -0.684 . . . . 1.12 109.154 -179.238 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 72.5 mt -92.96 132.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.48 109.899 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.95 170.7 15.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 2.13 109.456 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.06 139.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.386 -0.821 . . . . 0.34 109.501 179.79 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.69 121.55 15.06 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.504 -0.748 . . . . 0.34 109.253 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.97 139.36 89.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 110.138 -0.755 . . . . 0.42 110.138 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 262' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -52.87 -43.1 65.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 3.11 109.556 179.69 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.16 -4.0 4.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 3.82 110.669 -178.85 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 264' ' ' LYS . . . . . 0.419 ' CD ' ' NH2' ' B' ' 228' ' ' ARG . 7.3 mmmt -120.09 16.81 12.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.355 -0.841 . . . . 2.08 108.896 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.02 172.23 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.32 109.672 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -137.43 126.96 25.07 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.742 -0.836 . . . . 1.79 108.742 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.96 107.33 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.168 -0.957 . . . . 0.45 109.451 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.57 147.66 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.336 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.55 145.76 25.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.35 -0.844 . . . . 3.62 109.433 179.673 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.941 -1.028 . . . . 2.05 109.571 179.712 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 43.0 mtt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.363 0.601 . . . . 3.82 109.414 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt -82.73 141.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 2.08 109.374 179.916 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -86.37 -130.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 2.17 109.684 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.74 104.7 16.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 1.48 109.0 179.786 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -133.16 132.33 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.535 -0.728 . . . . 0.72 109.256 -179.545 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.632 ' NH2' ' CD2' ' A' ' 226' ' ' TYR . 0.2 OUTLIER -105.99 163.04 13.07 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.782 -1.192 . . . . 3.26 107.782 178.715 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.5 ' C ' HH22 ' A' ' 224' ' ' ARG . 96.2 t -141.47 139.66 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.021 -1.049 . . . . 0.23 110.491 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.632 ' CD2' ' NH2' ' A' ' 224' ' ' ARG . 47.5 m-85 -104.37 154.79 19.4 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.017 -1.475 . . . . 0.58 107.017 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.53 ' OH ' ' NZ ' ' A' ' 236' ' ' LYS . 23.7 p90 -158.71 163.39 36.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.372 -1.455 . . . . 0.44 110.983 -179.418 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -96.19 138.88 33.16 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.384 0.612 . . . . 2.76 109.527 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.38 -177.13 4.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.406 -0.809 . . . . 2.23 109.277 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.3 p -94.55 -11.72 28.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -0.929 . . . . 1.8 109.648 179.989 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 231' ' ' ARG . 2.9 mmp_? -79.51 -21.03 45.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.097 -1.002 . . . . 3.63 109.7 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.99 139.31 7.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 2.16 108.877 179.623 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.37 2.45 1.5 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 121.022 1.148 . . . . 1.25 111.304 -179.651 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.2 p -82.91 163.26 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.561 -1.337 . . . . 1.75 110.372 -179.361 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.573 ' N ' HG22 ' A' ' 234' ' ' VAL . 93.5 m95 -68.41 165.63 18.4 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.957 -0.757 . . . . 0.66 108.957 179.505 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.53 ' NZ ' ' OH ' ' A' ' 227' ' ' TYR . 5.6 ttpt -119.58 -163.17 0.96 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.226 -0.921 . . . . 1.43 109.328 -179.776 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.98 -179.05 32.25 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.699 -1.36 . . . . 0.39 109.699 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.05 158.94 45.24 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.777 1.651 . . . . 0.41 110.212 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.4 169.43 17.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.21 109.379 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -94.66 138.5 32.43 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.14 -0.975 . . . . 2.72 109.608 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.63 125.86 35.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.607 -0.683 . . . . 0.29 109.476 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.49 -72.95 0.66 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.447 -0.783 . . . . 0.45 110.108 179.925 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -93.04 145.4 24.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.31 110.129 -178.59 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -148.22 121.03 8.69 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.4 -0.812 . . . . 2.32 109.128 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.36 -102.41 0.2 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.734 -1.222 . . . . 0.27 110.324 -179.881 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.09 -153.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.221 -1.164 . . . . 1.39 109.803 -179.331 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.92 47.91 2.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.284 -1.527 . . . . 0.29 109.284 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.46 151.98 37.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.29 108.813 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.82 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.174 -0.954 . . . . 0.31 109.629 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.1 135.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.882 -1.155 . . . . 0.29 107.882 179.04 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -139.11 175.69 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.301 -0.874 . . . . 0.23 109.792 -179.02 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.86 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.746 -0.835 . . . . 1.81 108.746 179.216 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.75 -82.76 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.537 -1.282 . . . . 1.18 107.537 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 255' ' ' SER . 38.0 t-20 -78.96 -128.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.719 -1.586 . . . . 1.98 106.719 177.636 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.465 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 10.7 p -105.84 54.49 0.69 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.147 -1.056 . . . . 1.39 108.147 178.019 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 66.2 m-20 -155.05 123.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.55 -0.719 . . . . 1.12 109.099 -179.39 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.413 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 13.5 mt -94.23 136.54 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.47 109.58 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.52 169.8 17.09 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.11 109.622 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.24 142.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.33 109.027 179.389 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.49 131.38 19.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.34 109.164 -179.924 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.73 141.24 97.58 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.551 -0.98 . . . . 0.42 109.551 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -58.53 -35.63 72.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.209 -0.932 . . . . 3.12 109.512 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.58 -4.39 18.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 3.82 110.756 -179.157 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -118.96 21.27 12.47 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.124 -0.985 . . . . 2.08 108.819 179.429 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.18 16.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.32 109.591 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -141.64 124.79 16.36 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.294 -0.879 . . . . 1.79 109.142 179.802 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.77 101.53 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 0.45 109.701 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.467 ' HB ' HH11 ' A' ' 224' ' ' ARG . 5.7 mm -106.38 158.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.413 -0.958 . . . . 0.57 108.413 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.27 152.89 21.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.03 . . . . 3.63 109.444 179.555 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.984 -1.008 . . . . 2.05 109.42 179.774 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 43.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.372 -0.603 . . . . 3.83 109.372 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt -82.57 141.4 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 2.08 109.465 179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -86.3 -131.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 2.16 109.701 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -94.61 104.74 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.332 -0.855 . . . . 1.48 108.999 179.753 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.16 132.37 41.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 0.73 109.205 -179.532 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.636 ' NH2' ' CD2' ' B' ' 226' ' ' TYR . 0.2 OUTLIER -106.06 163.11 13.03 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.771 -1.196 . . . . 3.26 107.771 178.65 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.501 ' C ' HH22 ' B' ' 224' ' ' ARG . 95.6 t -141.6 139.5 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.23 110.52 -179.561 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 226' ' ' TYR . . . . . 0.636 ' CD2' ' NH2' ' B' ' 224' ' ' ARG . 47.3 m-85 -104.3 154.82 19.33 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.58 106.991 178.357 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' B' ' 236' ' ' LYS . 24.0 p90 -158.68 163.36 36.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.487 -1.383 . . . . 0.44 111.027 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.05 138.85 33.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.742 -0.599 . . . . 2.76 109.561 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.41 -177.09 4.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 2.23 109.249 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 29.1 p -94.59 -11.71 28.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.199 -0.938 . . . . 1.81 109.604 -179.921 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' N ' ' B' ' 231' ' ' ARG . 2.9 mmp_? -79.57 -21.15 45.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 3.64 109.606 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.87 139.36 7.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 2.16 108.9 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.39 2.45 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.086 1.191 . . . . 1.27 111.217 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.577 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.0 p -83.02 163.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.566 -1.334 . . . . 1.76 110.368 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.577 ' N ' HG22 ' B' ' 234' ' ' VAL . 93.4 m95 -68.42 165.7 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.996 -0.742 . . . . 0.67 108.996 179.588 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' B' ' 227' ' ' TYR . 5.6 ttpt -119.63 -163.16 0.97 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.308 -0.87 . . . . 1.44 109.345 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -72.07 -179.06 32.57 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.691 -1.364 . . . . 0.4 109.691 -179.694 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.1 159.09 44.88 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.639 1.559 . . . . 0.41 110.234 -179.697 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 169.33 17.87 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.436 -0.79 . . . . 0.21 109.48 179.461 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -94.48 138.49 32.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.124 -0.985 . . . . 2.72 109.786 179.74 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 tp -88.68 126.04 35.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.763 -0.586 . . . . 0.3 109.474 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.57 -73.17 0.65 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.451 -0.78 . . . . 0.45 110.019 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.4 t90 -92.91 145.37 24.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.311 -0.868 . . . . 0.33 110.257 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -148.14 120.96 8.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.361 -0.837 . . . . 2.33 109.132 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.31 -102.29 0.2 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.328 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.16 -153.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -1.159 . . . . 1.4 109.813 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 47.91 2.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.22 -1.552 . . . . 0.29 109.22 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.53 151.99 37.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.493 -1.004 . . . . 0.29 108.814 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.73 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.245 -0.909 . . . . 0.31 109.613 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.04 135.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.16 . . . . 0.3 107.869 179.017 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -138.94 175.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.24 109.861 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -143.87 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.726 -0.842 . . . . 1.81 108.726 179.105 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.72 -82.73 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.532 -1.284 . . . . 1.18 107.532 179.43 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 254' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 255' ' ' SER . 38.0 t-20 -78.92 -128.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.63 -1.619 . . . . 1.97 106.63 177.683 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.463 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 10.8 p -105.91 54.45 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.19 -1.041 . . . . 1.38 108.19 178.026 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 255' ' ' SER . 66.0 m-20 -155.04 123.93 6.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.585 -0.697 . . . . 1.12 109.167 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 13.3 mt -94.25 136.51 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.48 109.565 -179.686 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.49 169.84 17.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.263 -0.898 . . . . 2.13 109.604 -179.629 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.3 142.09 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.476 -0.765 . . . . 0.34 108.992 179.384 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.49 131.47 19.41 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.436 -0.79 . . . . 0.34 109.133 -179.992 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.71 141.24 97.53 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 N-CA-C 109.609 -0.958 . . . . 0.42 109.609 178.753 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -58.61 -35.58 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.211 -0.931 . . . . 3.11 109.516 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.53 -4.37 18.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 3.82 110.746 -179.149 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -119.12 21.34 12.36 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.227 -0.921 . . . . 2.08 108.887 179.454 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.74 170.16 16.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.53 -0.731 . . . . 0.32 109.658 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -141.72 124.71 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.238 -0.913 . . . . 1.79 109.165 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.74 101.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.25 -0.906 . . . . 0.45 109.668 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.477 ' HB ' HH11 ' B' ' 224' ' ' ARG . 5.8 mm -106.44 158.13 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.373 -0.973 . . . . 0.57 108.373 179.025 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.29 152.85 21.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 3.62 109.405 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 2.05 109.39 179.794 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.413 -0.588 . . . . 3.82 109.413 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 220' ' ' ILE . 6.1 tp -85.46 81.9 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.087 0.946 . . . . 2.08 109.122 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -86.03 -121.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 2.17 108.944 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -97.03 95.61 7.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.078 -1.014 . . . . 1.48 108.771 179.344 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -125.64 140.64 52.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.434 -0.791 . . . . 0.72 109.788 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.99 157.78 24.08 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.796 -1.187 . . . . 3.26 107.796 178.865 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 239' ' ' ALA . 78.3 t -139.3 141.03 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.172 -0.955 . . . . 0.23 110.309 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -107.32 150.35 26.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.506 -1.294 . . . . 0.58 107.506 178.138 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 14.5 p90 -155.78 156.44 34.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.753 -1.217 . . . . 0.44 110.03 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -93.87 150.01 20.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.49 -0.756 . . . . 2.76 109.829 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -93.51 159.19 15.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 2.23 108.886 179.524 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 46.9 t -76.89 2.58 14.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.061 -1.024 . . . . 1.8 109.189 179.796 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.9 mtt-85 -90.37 -25.5 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 3.63 109.831 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.0 m-20 -162.44 144.48 8.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.059 -1.026 . . . . 2.16 109.271 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -64.41 11.4 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.268 1.312 . . . . 1.25 110.706 179.834 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.6 m -84.86 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.872 -1.142 . . . . 1.75 109.823 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -66.59 161.5 23.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.66 109.244 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 237' ' ' GLY . 45.2 tttp -119.1 166.43 12.93 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.456 -0.777 . . . . 1.43 109.496 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.14 171.83 0.02 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.2 -1.16 . . . . 0.39 110.2 -179.534 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.22 164.58 27.43 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.729 1.619 . . . . 0.41 110.501 179.997 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -140.47 169.34 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.093 -0.706 . . . . 0.21 109.093 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -92.9 136.23 33.44 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.041 -1.037 . . . . 2.72 109.609 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.39 125.94 34.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.595 -0.69 . . . . 0.29 109.602 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.2 mt -118.37 -76.86 0.57 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.423 -0.798 . . . . 0.45 110.164 179.77 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -102.99 139.3 38.73 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 0.31 110.684 -178.529 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.22 134.68 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 2.32 109.205 179.05 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.75 -99.91 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.389 -1.484 . . . . 0.27 109.389 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -66.99 -150.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 1.39 108.985 179.781 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.77 48.15 2.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.951 -1.66 . . . . 0.29 108.951 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.13 147.76 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -1.043 . . . . 0.29 109.304 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.89 136.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.144 -0.973 . . . . 0.31 109.165 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.2 t -89.69 145.24 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.29 109.162 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.0 pt -143.82 178.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.245 -0.909 . . . . 0.23 109.998 -179.887 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -144.54 114.31 7.25 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.702 -0.851 . . . . 1.81 108.702 179.06 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.31 -80.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.269 -1.382 . . . . 1.18 107.269 179.188 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.23 -129.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.9 -1.518 . . . . 1.98 106.9 177.608 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.1 m -104.54 54.87 0.72 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.931 -1.137 . . . . 1.39 107.931 177.99 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.23 125.35 6.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 1.12 109.126 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 30.8 mt -93.82 137.24 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 0.47 109.657 -179.613 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -140.26 163.55 32.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.586 -179.711 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.38 134.04 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.853 . . . . 0.33 108.899 179.356 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.59 133.04 24.37 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.34 108.827 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.47 140.76 94.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.669 0.913 . . . . 0.42 110.323 179.505 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -56.04 -38.02 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 3.12 109.881 179.662 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -68.38 -2.36 8.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.228 -0.92 . . . . 3.82 110.705 -178.945 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -119.13 16.19 13.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.619 -0.882 . . . . 2.08 108.619 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.12 170.69 15.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.688 -0.632 . . . . 0.32 109.311 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -140.01 127.37 21.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.287 -0.883 . . . . 1.79 109.12 179.876 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.24 109.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 0.45 109.47 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.46 150.04 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.748 -0.834 . . . . 0.57 108.748 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -91.12 145.94 24.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 3.63 109.317 179.573 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.99 -1.005 . . . . 2.05 109.511 179.632 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.37 0.605 . . . . 3.83 109.453 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.6 ' O ' HG23 ' B' ' 220' ' ' ILE . 6.1 tp -85.47 81.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 2.08 109.089 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -86.03 -121.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 2.16 108.893 179.724 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -97.04 95.67 7.95 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.129 -0.982 . . . . 1.48 108.763 179.319 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.68 140.53 52.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.464 -0.773 . . . . 0.73 109.793 -179.452 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.89 157.7 24.1 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.87 -1.159 . . . . 3.26 107.87 178.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 225' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 239' ' ' ALA . 79.8 t -139.22 141.07 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 0.23 110.375 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -107.42 150.3 26.92 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.458 -1.312 . . . . 0.58 107.458 178.146 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.4 p90 -155.7 156.45 34.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.44 110.046 -179.547 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -93.84 150.04 20.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.473 -0.767 . . . . 2.76 109.832 -179.844 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -93.52 159.05 15.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 2.23 108.922 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 46.8 t -76.79 2.56 14.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.058 -1.026 . . . . 1.81 109.204 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 231' ' ' ARG . . . . . 0.625 HH11 ' CG ' ' B' ' 231' ' ' ARG . 2.9 mtt-85 -90.52 -25.35 20.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 3.64 109.794 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.0 m-20 -162.52 144.43 8.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.068 -1.02 . . . . 2.16 109.242 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -64.27 11.31 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.822 0 C-N-CA 121.302 1.335 . . . . 1.27 110.775 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.6 m -84.82 145.22 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.132 . . . . 1.76 109.841 -179.477 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -66.56 161.51 22.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.67 109.387 179.814 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' B' ' 237' ' ' GLY . 45.2 tttp -119.07 166.39 12.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 1.44 109.504 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.15 171.75 0.02 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.202 -1.159 . . . . 0.4 110.202 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.1 164.64 26.93 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.687 1.591 . . . . 0.41 110.461 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 225' ' ' VAL . . . -140.52 169.3 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.21 109.073 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -92.9 136.28 33.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.038 -1.039 . . . . 2.72 109.657 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.4 126.08 35.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.474 -0.766 . . . . 0.3 109.587 -179.752 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.55 -76.78 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.58 -0.7 . . . . 0.45 110.152 179.792 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -103.01 139.43 38.58 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.217 -0.927 . . . . 0.33 110.637 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.25 134.68 18.46 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.344 -0.848 . . . . 2.33 109.188 179.069 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.83 -99.9 0.18 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.308 -1.517 . . . . 0.28 109.308 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.2 -149.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -1.128 . . . . 1.4 108.96 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.72 48.1 2.88 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.952 -1.659 . . . . 0.29 108.952 179.603 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.08 147.76 27.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -1.028 . . . . 0.29 109.296 -179.673 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.86 136.45 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.31 109.088 179.31 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.73 145.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.3 109.156 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -143.8 178.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.24 110.024 -179.891 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -144.57 114.41 7.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.033 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.38 -80.04 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.26 -1.385 . . . . 1.18 107.26 179.173 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.25 -129.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.837 -1.542 . . . . 1.97 106.837 177.653 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.2 m -104.5 54.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.2 125.41 6.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 1.12 109.169 -179.251 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 31.1 mt -93.86 137.36 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.48 109.67 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -140.27 163.57 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 2.13 109.576 -179.712 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.4 134.04 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 0.34 108.927 179.306 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.6 133.03 24.37 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.893 -0.78 . . . . 0.34 108.893 -179.904 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.52 140.83 94.5 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.687 0.925 . . . . 0.42 110.234 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -56.1 -37.97 70.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.852 . . . . 3.11 109.86 179.64 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -68.46 -2.31 8.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.299 -0.876 . . . . 3.82 110.71 -178.877 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -119.1 16.14 13.25 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 2.08 108.6 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 170.57 15.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.639 -0.663 . . . . 0.32 109.319 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -139.95 127.37 21.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.312 -0.868 . . . . 1.79 109.111 179.874 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.14 109.06 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 0.45 109.481 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.46 150.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.779 -0.823 . . . . 0.57 108.779 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -91.25 145.87 24.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.375 -0.828 . . . . 3.62 109.395 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.991 -1.004 . . . . 2.05 109.535 179.751 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 32.6 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.449 -0.574 . . . . 3.82 109.449 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.674 HD13 ' H ' ' A' ' 220' ' ' ILE . 0.1 OUTLIER -80.39 136.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.072 -1.017 . . . . 2.08 109.165 179.519 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -86.91 -135.85 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.132 -0.692 . . . . 2.17 109.132 -179.821 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -92.83 116.33 28.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 1.48 108.655 179.426 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -134.3 149.56 50.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.409 -0.807 . . . . 0.72 109.538 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -120.68 155.39 33.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.882 -1.155 . . . . 3.26 107.882 179.344 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.61 141.06 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.098 -1.001 . . . . 0.23 110.635 -179.625 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.73 155.81 22.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.281 -1.377 . . . . 0.58 107.281 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.485 -1.384 . . . . 0.44 110.739 -179.175 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -100.52 140.02 35.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.591 -0.693 . . . . 2.76 109.671 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.64 170.05 9.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.866 . . . . 2.23 109.376 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.3 m -84.63 -9.48 58.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 1.8 109.137 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.42 -10.9 47.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 3.63 109.516 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.6 p30 -158.88 133.95 5.67 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.179 -0.95 . . . . 2.16 109.354 -179.242 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.13 -7.05 20.23 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 120.975 1.116 . . . . 1.25 111.396 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.569 HG22 ' N ' ' A' ' 235' ' ' TRP . 3.7 p -87.1 163.49 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.563 -1.336 . . . . 1.75 110.416 -179.398 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.569 ' N ' HG22 ' A' ' 234' ' ' VAL . 83.2 m95 -66.31 -175.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.646 -0.659 . . . . 0.66 109.514 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 4.0 ttpp -130.77 -156.38 0.75 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.589 -0.893 . . . . 1.43 108.589 179.326 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.28 54.22 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.57 -1.412 . . . . 0.39 109.57 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -71.46 154.26 60.56 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.677 1.585 . . . . 0.41 109.975 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.78 25.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.767 . . . . 0.21 109.215 179.446 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.02 141.44 28.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 2.72 109.846 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.63 123.93 34.65 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.829 -0.544 . . . . 0.29 109.565 -179.719 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.06 -73.2 0.65 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.334 -0.854 . . . . 0.45 111.017 -179.543 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.461 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 6.0 t90 -91.78 152.66 20.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.22 -0.925 . . . . 0.31 110.807 -177.97 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.46 128.34 21.93 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.523 -0.917 . . . . 2.32 108.523 178.934 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.4 -126.83 1.23 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.521 -1.323 . . . . 0.27 110.539 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.65 -144.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.589 -0.947 . . . . 1.39 109.342 -179.284 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.33 49.24 2.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.827 -1.709 . . . . 0.29 108.827 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.64 149.32 31.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.383 -1.069 . . . . 0.29 109.041 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.47 134.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.31 109.48 -179.826 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -91.9 140.84 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.287 -0.883 . . . . 0.29 109.077 179.816 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.98 176.7 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.88 . . . . 0.23 109.794 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -144.92 112.3 6.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.851 . . . . 1.81 109.018 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.41 -81.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.409 -1.33 . . . . 1.18 107.409 179.28 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.02 -131.42 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.651 -1.611 . . . . 1.98 106.651 177.585 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.5 t -104.34 57.07 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.7 -1.222 . . . . 1.39 107.7 177.82 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -155.73 122.43 5.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.142 -0.688 . . . . 1.12 109.142 -179.378 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.462 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 59.0 mt -93.05 134.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.258 -0.901 . . . . 0.47 109.331 -179.831 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.79 172.72 12.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.449 -0.782 . . . . 2.11 109.741 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.34 142.07 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.146 -0.687 . . . . 0.33 109.146 179.387 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.51 126.7 15.06 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.398 -0.964 . . . . 0.34 108.398 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.11 152.07 39.48 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 109.835 -0.871 . . . . 0.42 109.835 179.526 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.71 -34.59 77.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 3.12 109.742 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -70.93 -5.59 32.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.815 . . . . 3.82 111.329 -178.914 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -118.77 20.33 12.89 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.236 -0.915 . . . . 2.08 108.908 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.9 165.36 27.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.519 -0.738 . . . . 0.32 109.275 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.4 mtmp? -140.08 129.62 24.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.371 -0.831 . . . . 1.79 108.925 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.97 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.313 -0.867 . . . . 0.45 109.704 -179.35 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.45 150.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.055 -1.091 . . . . 0.57 108.055 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -92.05 142.27 27.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.187 -0.946 . . . . 3.63 109.216 179.652 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.978 . . . . 2.05 109.21 179.531 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 32.6 mtt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.566 -0.531 . . . . 3.83 109.566 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.675 HD13 ' H ' ' B' ' 220' ' ' ILE . 0.1 OUTLIER -80.38 136.69 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.217 -0.927 . . . . 2.08 109.225 179.554 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -86.72 -135.89 0.08 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.166 -0.679 . . . . 2.16 109.166 -179.829 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -92.83 116.32 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 1.48 108.608 179.483 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.23 149.54 50.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.73 109.491 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -120.67 155.33 34.07 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.902 -1.147 . . . . 3.26 107.902 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.53 141.14 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.146 -0.971 . . . . 0.23 110.652 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.84 155.78 23.06 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.181 -1.414 . . . . 0.58 107.181 178.363 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.487 -1.383 . . . . 0.44 110.808 -179.218 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -100.55 140.11 35.28 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.647 -0.658 . . . . 2.76 109.639 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.79 170.02 9.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.313 -0.867 . . . . 2.23 109.412 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -9.62 58.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 1.81 109.157 179.727 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.31 -10.85 48.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 3.64 109.536 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -158.94 133.9 5.62 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.181 -0.949 . . . . 2.16 109.335 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.99 -7.06 20.19 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 120.98 1.12 . . . . 1.27 111.349 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 234' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 235' ' ' TRP . 3.7 p -87.25 163.55 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.671 -1.268 . . . . 1.76 110.398 -179.391 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 235' ' ' TRP . . . . . 0.57 ' N ' HG22 ' B' ' 234' ' ' VAL . 83.2 m95 -66.34 -175.67 0.37 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.731 -0.605 . . . . 0.67 109.521 -179.956 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.445 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 4.0 ttpp -130.79 -156.55 0.76 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.598 -0.89 . . . . 1.44 108.598 179.378 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.8 177.2 54.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.604 -1.398 . . . . 0.4 109.604 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.38 154.24 60.98 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.593 1.528 . . . . 0.41 110.027 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 165.91 24.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.45 -0.782 . . . . 0.21 109.181 179.423 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.08 141.48 28.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.116 -0.99 . . . . 2.72 109.808 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.61 123.93 34.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.814 -0.554 . . . . 0.3 109.623 -179.82 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.97 -73.25 0.65 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.348 -0.845 . . . . 0.45 111.079 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.462 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 6.1 t90 -91.93 152.66 19.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.234 -0.916 . . . . 0.33 110.804 -177.943 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.31 128.28 22.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.588 -0.894 . . . . 2.33 108.588 179.014 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.38 -126.99 1.24 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.58 -1.295 . . . . 0.28 110.574 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.44 -144.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.954 . . . . 1.4 109.445 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.2 49.1 2.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.867 -1.693 . . . . 0.29 108.867 179.376 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.4 149.44 31.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -1.068 . . . . 0.29 109.001 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 134.76 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.246 -0.908 . . . . 0.31 109.455 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.97 140.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.828 . . . . 0.3 109.03 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.94 176.74 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.24 109.873 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -144.91 112.32 6.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.334 -0.854 . . . . 1.81 108.992 179.379 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.54 -81.13 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.398 -1.334 . . . . 1.18 107.398 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.98 -131.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.678 -1.601 . . . . 1.97 106.678 177.569 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 41.6 t -104.35 57.06 0.71 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.697 -1.223 . . . . 1.38 107.697 177.785 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -155.78 122.51 5.28 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.974 -0.75 . . . . 1.12 108.974 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.461 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 59.0 mt -93.05 134.62 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.153 -0.967 . . . . 0.48 109.375 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.83 172.71 12.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.502 -0.749 . . . . 2.13 109.721 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.33 142.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.114 -0.699 . . . . 0.34 109.114 179.5 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.55 126.69 15.0 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.443 -0.947 . . . . 0.34 108.443 179.349 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.03 152.1 38.73 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 N-CA-C 109.791 -0.888 . . . . 0.42 109.791 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.73 -34.55 77.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.385 -0.822 . . . . 3.11 109.684 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -71.06 -5.63 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.288 -0.883 . . . . 3.82 111.238 -178.805 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -118.8 20.34 12.87 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.019 -1.051 . . . . 2.08 108.922 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.91 165.33 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.32 109.269 179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 266' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.4 mtmp? -139.99 129.55 24.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.294 -0.879 . . . . 1.79 108.987 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.87 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.45 109.725 -179.34 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -105.35 150.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.141 -1.059 . . . . 0.57 108.141 178.954 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 269' ' ' ARG . . . . . 0.553 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.09 142.24 27.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 3.62 109.289 179.605 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.045 -0.979 . . . . 2.05 109.197 179.608 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.055 -0.72 . . . . 1.48 109.055 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.28 138.12 43.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.53 -0.731 . . . . 0.72 109.542 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.624 HH11 ' CG ' ' A' ' 224' ' ' ARG . 1.0 OUTLIER -108.62 157.31 18.62 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.699 -1.223 . . . . 3.26 107.699 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.85 140.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.09 -1.006 . . . . 0.23 110.418 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.79 153.17 23.87 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.593 -1.262 . . . . 0.58 107.593 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.6 p90 -156.48 152.82 27.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.699 -1.251 . . . . 0.44 110.156 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -95.32 156.4 16.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 2.76 109.653 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -93.07 172.55 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.661 -0.866 . . . . 2.23 108.661 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.24 -13.7 46.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 1.8 109.251 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -90.75 -14.79 31.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 3.63 109.954 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 12.1 m-20 -161.02 128.81 2.77 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.912 -1.118 . . . . 2.16 109.553 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.13 18.0 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 121.021 1.147 . . . . 1.25 110.882 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 31.5 m -83.24 135.06 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.829 -1.169 . . . . 1.75 109.55 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -58.9 161.24 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.66 109.496 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 237' ' ' GLY . 42.5 tttp -121.91 161.48 22.74 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.378 -0.826 . . . . 1.43 109.883 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.21 165.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.244 -1.142 . . . . 0.39 110.244 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.15 158.61 53.73 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.661 1.574 . . . . 0.41 110.699 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.01 172.55 12.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.851 -0.796 . . . . 0.21 108.851 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -92.75 135.75 33.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 2.72 110.026 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -88.14 125.37 34.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.29 109.558 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.86 -74.39 0.61 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.426 -0.796 . . . . 0.45 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.483 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 3.8 t90 -89.85 140.91 29.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.226 -0.921 . . . . 0.31 109.846 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.26 119.7 9.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 2.32 108.791 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -104.42 0.23 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.87 -1.157 . . . . 0.27 110.215 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.69 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -1.067 . . . . 1.39 109.735 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 49.0 2.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.55 151.28 36.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.29 108.522 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.15 126.54 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.31 109.909 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.86 135.16 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.025 -1.102 . . . . 0.29 108.025 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 257' ' ' ILE . 18.1 pt -139.31 179.27 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.871 . . . . 0.23 110.135 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.22 110.33 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 1.81 108.772 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.95 -81.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.467 -1.309 . . . . 1.18 107.467 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -78.6 -137.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.505 -1.665 . . . . 1.98 106.505 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.3 m -97.97 54.13 1.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.899 -1.149 . . . . 1.39 107.899 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.45 128.59 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.988 -0.745 . . . . 1.12 108.988 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.476 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 19.0 mt -92.74 140.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.121 -0.987 . . . . 0.47 109.604 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -138.44 168.22 20.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.406 -0.809 . . . . 2.11 109.774 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.75 138.34 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.508 -0.745 . . . . 0.33 109.228 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.72 131.93 18.35 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.363 -0.836 . . . . 0.34 109.137 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.43 139.75 91.85 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 N-CA-C 109.599 -0.962 . . . . 0.42 109.599 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.1 OUTLIER -59.96 -34.76 73.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 3.12 109.722 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.23 -4.96 19.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 3.82 110.988 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -119.29 17.51 13.07 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.254 -0.904 . . . . 2.08 108.873 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.77 17.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.014 -0.736 . . . . 0.32 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.6 131.37 27.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.303 -0.873 . . . . 1.79 109.094 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.7 mm -88.27 108.1 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.45 110.215 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.01 149.0 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.091 -1.078 . . . . 0.57 108.091 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.302 -0.874 . . . . 3.63 108.771 179.336 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.014 -0.735 . . . . 1.48 109.014 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -135.3 138.07 43.09 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.484 -0.76 . . . . 0.73 109.534 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 224' ' ' ARG . 1.0 OUTLIER -108.51 157.36 18.53 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.681 -1.229 . . . . 3.26 107.681 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.92 140.06 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.108 -0.995 . . . . 0.23 110.375 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.74 153.14 23.88 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.621 -1.252 . . . . 0.58 107.621 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.47 152.77 27.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.668 -1.27 . . . . 0.44 110.241 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -95.27 156.37 16.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.476 -0.765 . . . . 2.76 109.688 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -93.13 172.46 8.29 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.65 -0.87 . . . . 2.23 108.65 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.15 -13.75 46.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.81 109.183 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.71 -14.81 31.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 3.64 109.979 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' B' ' 234' ' ' VAL . 12.0 m-20 -161.03 128.83 2.78 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.949 -1.094 . . . . 2.16 109.521 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.28 18.16 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 120.97 1.114 . . . . 1.27 110.81 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' B' ' 232' ' ' ASP . 31.7 m -83.31 135.13 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.795 -1.191 . . . . 1.76 109.535 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -58.97 161.22 5.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.67 109.516 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 42.5 tttp -121.92 161.47 22.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.368 -0.832 . . . . 1.44 109.879 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.26 165.5 0.02 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.277 -1.129 . . . . 0.4 110.277 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.28 158.68 53.71 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.619 1.546 . . . . 0.41 110.644 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.99 172.59 12.71 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.856 -0.794 . . . . 0.21 108.856 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -92.8 135.73 33.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.009 -1.057 . . . . 2.72 110.007 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.18 125.38 34.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.642 -0.662 . . . . 0.3 109.603 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.86 -74.49 0.6 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.442 -0.786 . . . . 0.45 110.158 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.476 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 3.8 t90 -89.76 140.84 29.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.142 -0.974 . . . . 0.33 109.815 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.19 119.67 9.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 2.33 108.816 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -104.51 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.246 -1.142 . . . . 0.28 110.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -67.63 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -1.078 . . . . 1.4 109.686 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.83 2.74 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.514 -1.435 . . . . 0.29 109.514 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.29 151.29 36.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -1.077 . . . . 0.29 108.522 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.12 126.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.159 -0.963 . . . . 0.31 109.838 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.89 135.27 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.996 -1.113 . . . . 0.3 107.996 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 257' ' ' ILE . 18.2 pt -139.4 179.14 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.24 110.083 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.14 110.34 5.69 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.735 -0.839 . . . . 1.81 108.735 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 -81.83 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -78.61 -137.42 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.451 -1.685 . . . . 1.97 106.451 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 18.4 m -97.95 54.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.53 128.48 7.34 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.966 -0.753 . . . . 1.12 108.966 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.483 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.0 mt -92.68 140.04 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 0.48 109.67 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -138.5 168.14 20.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 2.13 109.757 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.65 138.33 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.512 -0.743 . . . . 0.34 109.268 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.7 131.98 18.39 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.432 -0.793 . . . . 0.34 109.134 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.44 139.65 91.44 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 109.713 -0.918 . . . . 0.42 109.713 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.1 OUTLIER -59.89 -34.77 73.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 3.11 109.664 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.19 -5.03 20.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.838 . . . . 3.82 110.955 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -119.28 17.51 13.07 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.192 -0.942 . . . . 2.08 108.848 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.34 169.7 17.34 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.094 -0.706 . . . . 0.32 109.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.51 131.35 27.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.25 -0.906 . . . . 1.79 109.099 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -88.2 108.09 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.897 . . . . 0.45 110.16 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.98 149.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.107 -1.072 . . . . 0.57 108.107 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.51 151.82 21.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 3.62 108.854 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.946 -1.026 . . . . 2.05 109.35 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.7 m120 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.091 -0.707 . . . . 1.48 109.091 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.21 142.27 45.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.72 109.473 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 28.5 mtp180 -108.63 156.67 19.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.536 -1.283 . . . . 3.26 107.536 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.1 t -141.54 143.99 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.072 -1.018 . . . . 0.23 110.794 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.96 155.87 22.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.599 -1.259 . . . . 0.58 107.599 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.8 151.88 26.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.44 110.224 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.6 mtm-85 -92.38 137.8 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 2.76 109.67 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.11 170.7 9.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.456 -0.777 . . . . 2.23 109.485 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.3 t -86.79 -9.13 56.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 1.8 109.513 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.39 43.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 3.63 110.055 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.479 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 26.0 p-10 -159.19 134.23 5.67 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.905 -1.122 . . . . 2.16 109.462 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.61 -7.96 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.027 1.152 . . . . 1.25 111.689 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.0 p -84.61 164.04 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.553 -1.342 . . . . 1.75 110.359 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.612 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.5 m95 -66.85 166.42 13.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.586 . . . . 0.66 109.595 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.11 166.37 13.01 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.349 -0.844 . . . . 1.43 109.383 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.0 164.08 0.06 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.115 -1.194 . . . . 0.39 110.115 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.15 164.4 30.4 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.543 1.496 . . . . 0.41 110.604 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.26 8.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.855 -0.794 . . . . 0.21 108.855 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.95 139.26 33.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.206 -0.934 . . . . 2.72 109.041 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -88.88 121.88 31.69 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.352 -0.842 . . . . 0.29 109.833 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.2 mt -110.19 -74.55 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.366 -0.834 . . . . 0.45 109.808 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.406 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.4 t90 -91.71 145.0 24.93 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.11 -0.994 . . . . 0.31 110.36 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.71 120.08 8.43 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.952 -0.758 . . . . 2.32 108.952 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -106.38 0.25 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.737 -1.22 . . . . 0.27 110.453 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.86 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -1.06 . . . . 1.39 109.871 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.69 49.1 2.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.29 109.469 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.2 150.0 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -1.066 . . . . 0.29 108.582 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.7 m -144.14 127.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.31 109.858 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 61.0 t -90.13 136.13 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.312 -0.995 . . . . 0.29 108.312 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.84 179.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.305 -0.872 . . . . 0.23 109.726 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' A' ' 257' ' ' ILE . 32.2 tt0 -141.8 111.94 6.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -81.54 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.57 -1.27 . . . . 1.18 107.57 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.65 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.467 -1.679 . . . . 1.98 106.467 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.5 p -105.6 54.29 0.7 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.048 -1.033 . . . . 1.39 108.344 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 255' ' ' SER . 63.0 m-20 -155.87 127.78 7.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.547 -0.721 . . . . 1.12 109.22 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' A' ' 252' ' ' GLN . 79.5 mt -91.65 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.05 -1.031 . . . . 0.47 109.355 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.23 168.91 18.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.921 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.66 138.92 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.519 -0.738 . . . . 0.33 109.348 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.3 t -133.4 131.46 21.51 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.38 137.87 81.78 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.546 0.831 . . . . 0.42 110.124 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -57.14 -36.23 70.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 3.12 109.611 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.67 -3.0 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 3.82 110.717 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -119.37 19.5 12.73 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.154 -0.966 . . . . 2.08 109.029 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.67 171.87 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.32 109.513 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -139.87 129.23 24.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 1.79 108.996 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.65 107.29 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.206 -0.934 . . . . 0.45 109.565 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -105.75 154.02 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.648 -0.871 . . . . 0.57 108.648 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 3.63 109.679 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m120 . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 108.98 -0.748 . . . . 1.48 108.98 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 142.25 46.25 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.442 -0.786 . . . . 0.73 109.541 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 28.4 mtp180 -108.59 156.58 19.37 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.525 -1.287 . . . . 3.26 107.525 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.5 144.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.075 -1.016 . . . . 0.23 110.662 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.1 155.77 22.34 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.71 151.96 26.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.741 -1.225 . . . . 0.44 110.238 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.7 mtm-85 -92.49 137.96 31.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.76 109.525 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.15 170.79 9.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 2.23 109.417 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 36.6 t -86.94 -8.94 56.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 1.81 109.429 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.41 43.85 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 3.64 110.004 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 25.8 p-10 -159.22 134.19 5.63 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.979 -1.076 . . . . 2.16 109.429 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.64 -7.96 20.92 Favored 'Trans proline' 0 N--CA 1.483 0.896 0 C-N-CA 121.001 1.134 . . . . 1.27 111.701 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.1 p -84.51 163.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.535 -1.353 . . . . 1.76 110.362 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.4 m95 -66.88 166.31 13.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.81 -0.556 . . . . 0.67 109.547 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.07 166.17 13.23 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.424 -0.797 . . . . 1.44 109.422 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.04 164.14 0.06 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.955 -1.258 . . . . 0.4 109.955 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -67.3 164.5 30.3 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.41 110.526 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.37 8.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.895 -0.78 . . . . 0.21 108.895 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.86 139.31 33.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.255 -0.903 . . . . 2.72 109.007 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -89.0 122.03 31.94 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.387 -0.821 . . . . 0.3 109.826 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.3 mt -110.25 -74.56 0.65 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.427 -0.796 . . . . 0.45 109.82 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -91.79 145.04 24.89 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.127 -0.983 . . . . 0.33 110.387 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -147.65 120.12 8.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.365 -0.834 . . . . 2.33 108.896 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -106.43 0.25 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.84 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -1.038 . . . . 1.4 109.855 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.7 49.23 2.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.06 33.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -1.06 . . . . 0.29 108.655 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -144.29 127.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.31 109.838 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.03 136.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.289 -1.004 . . . . 0.3 108.289 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.85 179.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 0.24 109.761 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' B' ' 257' ' ' ILE . 32.1 tt0 -141.81 111.76 6.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.32 -81.62 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.647 -1.242 . . . . 1.18 107.647 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.57 -129.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.538 -1.653 . . . . 1.97 106.538 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.5 p -105.63 54.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.344 -0.984 . . . . 1.38 108.344 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 255' ' ' SER . 62.7 m-20 -155.87 127.69 7.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 1.12 109.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' B' ' 252' ' ' GLN . 79.3 mt -91.66 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.143 -0.973 . . . . 0.48 109.312 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -137.37 168.89 18.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.13 109.839 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.72 138.74 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.493 -0.755 . . . . 0.34 109.352 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 23.1 t -133.26 131.68 21.76 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.46 137.85 81.98 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 120.566 0.844 . . . . 0.42 110.17 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -57.05 -36.42 70.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 3.11 109.618 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.51 -3.19 13.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.221 -0.924 . . . . 3.82 110.789 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -119.18 19.45 12.87 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.242 -0.911 . . . . 2.08 109.039 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.63 171.91 13.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.32 109.489 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -140.01 129.17 23.73 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.405 -0.809 . . . . 1.79 108.892 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.6 107.36 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.183 -0.948 . . . . 0.45 109.623 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.5 mm -105.77 154.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.582 -0.896 . . . . 0.57 108.582 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.7 OUTLIER -87.61 149.13 24.5 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.349 -0.844 . . . . 3.62 109.604 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.6 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.976 -1.011 . . . . 2.05 109.417 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 109.474 -0.565 . . . . 1.48 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -135.12 131.07 36.43 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.762 -0.829 . . . . 0.72 108.762 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -102.8 153.17 20.43 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 3.26 108.362 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.53 142.71 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 0.23 110.2 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.14 158.81 18.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.491 -1.299 . . . . 0.58 107.491 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.4 p90 -156.37 153.59 29.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.447 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.4 mtm-85 -95.88 147.49 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.531 -0.73 . . . . 2.76 110.115 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 14.5 p-10 -94.32 168.49 10.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -0.786 . . . . 2.23 109.203 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.5 t -84.92 -2.77 58.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 1.8 109.747 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -87.71 -23.79 24.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 3.63 109.834 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 234' ' ' VAL . 10.1 m-20 -163.15 142.39 6.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.99 . . . . 2.16 108.895 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.95 10.23 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.226 1.284 . . . . 1.25 110.826 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -82.75 156.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.644 -1.285 . . . . 1.75 110.415 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.488 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.2 m95 -75.69 -172.55 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.476 -0.564 . . . . 0.66 109.476 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.09 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 1.43 108.184 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.46 172.19 55.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.694 -1.362 . . . . 0.39 109.694 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.3 156.67 65.24 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.55 1.5 . . . . 0.41 110.166 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.02 166.23 25.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.21 109.093 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.42 140.5 29.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 2.72 109.547 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.42 125.24 34.63 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.462 -0.57 . . . . 0.29 109.462 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.9 mt -115.19 -69.97 0.82 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.84 . . . . 0.45 109.982 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.76 143.1 26.88 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.056 -1.027 . . . . 0.31 110.315 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.88 115.42 6.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.272 -0.892 . . . . 2.32 109.235 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.75 0.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.204 -1.158 . . . . 0.27 110.204 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -68.68 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.277 -1.131 . . . . 1.39 109.802 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 51.36 3.03 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.326 -1.509 . . . . 0.29 109.326 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.28 33.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.518 -0.989 . . . . 0.29 108.577 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.88 125.53 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.31 109.682 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.34 135.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.196 -1.038 . . . . 0.29 108.196 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.6 pt -137.66 -178.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.395 -0.816 . . . . 0.23 110.139 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.53 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.6 tt0 -143.48 111.63 6.2 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.37 -77.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.509 -1.293 . . . . 1.18 107.509 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.81 -132.27 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.944 -1.502 . . . . 1.98 106.944 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.9 p -104.26 53.04 0.75 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.958 -1.127 . . . . 1.39 107.958 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -156.1 127.29 7.05 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.986 -0.746 . . . . 1.12 108.986 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.53 ' CG1' HE21 ' A' ' 252' ' ' GLN . 55.9 mt -91.23 134.72 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.47 109.344 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -136.12 170.55 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.79 . . . . 2.11 109.857 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.73 139.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.33 109.826 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.73 124.03 14.28 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.626 -0.879 . . . . 0.34 108.626 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.75 139.37 90.06 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 N-CA-C 110.134 -0.756 . . . . 0.42 110.134 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -61.29 -30.48 70.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 3.12 109.407 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' A' ' 263' ' ' ARG . 0.0 OUTLIER -69.83 -9.91 56.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.41 -0.806 . . . . 3.82 110.06 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.45 22.96 11.48 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.242 -0.911 . . . . 2.08 109.11 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 169.57 17.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.081 -0.711 . . . . 0.32 109.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -137.11 127.89 27.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 1.79 108.783 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.44 109.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.45 109.893 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -103.34 152.63 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 3.63 109.353 179.903 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.208 0.528 . . . . 1.48 109.589 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 131.02 36.45 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.783 -0.821 . . . . 0.73 108.783 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -102.7 153.09 20.48 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.424 -0.954 . . . . 3.26 108.424 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.52 142.69 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -0.885 . . . . 0.23 110.156 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -111.2 158.74 18.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.496 -1.298 . . . . 0.58 107.496 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.3 p90 -156.21 153.69 29.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.586 -1.321 . . . . 0.44 110.45 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' B' ' 228' ' ' ARG . 10.5 mtm-85 -95.99 147.44 23.69 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.818 . . . . 2.76 110.094 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 14.7 p-10 -94.31 168.55 10.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.819 . . . . 2.23 109.268 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -85.02 -2.77 58.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 1.81 109.719 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -87.69 -23.73 24.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 3.64 109.767 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 9.9 m-20 -163.19 142.38 6.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.16 108.825 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -62.99 10.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.179 1.252 . . . . 1.27 110.895 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.501 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.7 p -82.69 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.657 -1.277 . . . . 1.76 110.372 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.501 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.3 m95 -75.77 -172.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.501 -0.555 . . . . 0.67 109.501 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.06 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.229 -1.026 . . . . 1.44 108.229 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.48 172.19 55.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.697 -1.361 . . . . 0.4 109.697 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.31 156.54 65.79 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.578 1.519 . . . . 0.41 110.205 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.49 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.21 109.124 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.55 140.57 29.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.092 -1.005 . . . . 2.72 109.495 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 17.8 tp -88.55 125.26 34.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.04 -70.08 0.82 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.281 -0.887 . . . . 0.45 110.082 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -91.72 143.17 26.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.096 -1.003 . . . . 0.33 110.269 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.92 115.39 6.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 2.33 109.184 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.65 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.914 -1.136 . . . . 0.28 110.301 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -68.76 -156.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 1.4 109.774 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.72 51.38 3.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.306 -1.518 . . . . 0.29 109.306 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.17 33.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.991 . . . . 0.29 108.575 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.86 125.66 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.31 109.598 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.42 135.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.194 -1.039 . . . . 0.3 108.194 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.5 pt -137.7 -178.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.309 -0.869 . . . . 0.24 110.206 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.534 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.4 tt0 -143.5 111.45 6.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.36 -77.39 0.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.519 -1.289 . . . . 1.18 107.519 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.8 -132.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.905 -1.517 . . . . 1.97 106.905 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 5.8 p -104.25 53.07 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -156.1 127.23 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.963 -0.754 . . . . 1.12 108.963 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.534 ' CG1' HE21 ' B' ' 252' ' ' GLN . 55.4 mt -91.08 134.77 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.48 109.369 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -136.15 170.57 15.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 2.13 109.845 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 8.8 t -99.76 139.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.455 -0.778 . . . . 0.34 109.821 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.9 t -136.75 123.92 14.18 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.6 139.46 90.29 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 110.006 -0.806 . . . . 0.42 110.006 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.41 -30.51 70.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 3.11 109.394 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.0 OUTLIER -69.78 -9.91 56.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.45 -0.781 . . . . 3.82 110.07 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.54 23.05 11.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.295 -0.878 . . . . 2.08 109.053 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.44 169.37 17.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.1 -0.704 . . . . 0.32 109.1 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -136.96 127.89 27.5 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.752 -0.833 . . . . 1.79 108.752 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.1 mm -88.48 109.55 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.91 . . . . 0.45 109.919 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.39 152.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.491 -0.929 . . . . 0.57 108.491 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -93.32 137.34 32.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.388 -0.82 . . . . 3.62 109.342 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.999 -1.001 . . . . 2.05 109.504 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 108.762 -0.829 . . . . 1.48 108.762 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -120.91 141.14 50.92 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.618 -0.676 . . . . 0.72 109.924 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -113.29 157.76 21.4 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.523 -1.288 . . . . 3.26 107.523 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.19 143.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.066 -1.021 . . . . 0.23 110.627 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -112.88 157.79 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.654 -1.239 . . . . 0.58 107.654 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 14.6 p90 -157.48 147.35 20.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.701 -1.25 . . . . 0.44 110.144 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.64 142.52 27.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.054 -1.029 . . . . 2.76 109.425 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.41 166.55 12.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 2.23 109.369 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.3 p -85.81 -10.15 55.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.921 . . . . 1.8 109.635 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.44 36.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.202 -0.936 . . . . 3.63 109.44 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 234' ' ' VAL . 3.3 p30 -159.23 128.04 3.05 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.31 -0.869 . . . . 2.16 109.105 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.62 9.22 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.805 1.004 . . . . 1.25 110.328 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 232' ' ' ASP . 4.4 t -84.06 156.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.013 -1.055 . . . . 1.75 109.764 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.05 169.75 16.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.66 109.611 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.3 mmtt -119.36 157.25 28.54 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.644 -0.873 . . . . 1.43 108.644 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.12 174.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.39 109.296 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.7 155.76 68.72 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.545 1.497 . . . . 0.41 110.693 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.67 171.91 13.79 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.925 -0.769 . . . . 0.21 108.925 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -93.91 137.39 33.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.049 -1.032 . . . . 2.72 109.707 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.12 121.4 31.41 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.594 -0.691 . . . . 0.29 109.28 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.16 -68.94 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.309 -0.87 . . . . 0.45 110.499 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -95.42 147.35 23.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.002 -1.061 . . . . 0.31 110.353 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.3 119.42 7.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.374 -0.829 . . . . 2.32 108.963 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.0 -109.2 0.32 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.784 -1.198 . . . . 0.27 110.397 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.88 -150.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -1.12 . . . . 1.39 109.488 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.5 56.18 2.47 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.196 -1.562 . . . . 0.29 109.196 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.49 146.72 22.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.364 -1.08 . . . . 0.29 109.643 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.05 121.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.672 -0.862 . . . . 0.31 108.672 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 59.4 t -84.73 132.16 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.375 -0.972 . . . . 0.29 108.375 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -137.96 178.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.23 109.977 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.44 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.1 tt0 -142.33 110.2 5.86 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -91.12 -78.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.357 -1.349 . . . . 1.18 107.357 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.59 -131.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.762 -1.569 . . . . 1.98 106.762 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 58.8 m -105.35 54.5 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.114 -1.069 . . . . 1.39 108.114 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.8 m-20 -157.08 127.33 6.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 1.12 109.312 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.44 ' CG1' HE21 ' A' ' 252' ' ' GLN . 79.8 mt -94.18 134.26 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.47 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.22 172.53 12.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 2.11 109.812 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.38 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.33 109.404 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.62 131.75 16.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.798 . . . . 0.34 108.909 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.49 142.98 92.36 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 N-CA-C 109.545 -0.983 . . . . 0.42 109.545 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -55.84 -34.69 65.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 3.12 108.641 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -65.35 -10.83 36.33 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.666 -0.697 . . . . 3.82 110.76 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.73 17.68 12.71 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.278 -1.008 . . . . 2.08 108.278 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.1 168.03 20.58 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.316 -0.624 . . . . 0.32 109.316 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -140.47 126.85 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.205 -0.934 . . . . 1.79 109.171 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.3 mm -87.54 108.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.242 -0.911 . . . . 0.45 109.486 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.18 152.92 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.524 -0.917 . . . . 0.57 108.524 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 3.63 109.934 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 108.708 -0.849 . . . . 1.48 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.03 141.06 51.1 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.63 -0.668 . . . . 0.73 109.796 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -113.31 157.75 21.41 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.559 -1.274 . . . . 3.26 107.559 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.1 143.83 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.022 -1.049 . . . . 0.23 110.776 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.83 157.77 20.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.667 -1.235 . . . . 0.58 107.667 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.0 p90 -157.4 147.38 20.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.292 . . . . 0.44 110.161 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.62 142.42 27.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.104 -0.997 . . . . 2.76 109.502 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -92.41 166.46 12.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.408 -0.808 . . . . 2.23 109.394 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.6 p -85.68 -10.25 55.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.219 -0.925 . . . . 1.81 109.651 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.37 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.099 -1.0 . . . . 3.64 109.442 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' B' ' 234' ' ' VAL . 3.3 p30 -159.23 127.88 3.0 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.083 -1.011 . . . . 2.16 109.195 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -67.56 9.34 0.34 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.74 0.96 . . . . 1.27 110.364 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' B' ' 232' ' ' ASP . 4.4 t -84.05 156.1 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.967 -1.083 . . . . 1.76 109.809 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -72.97 169.74 16.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.371 -0.83 . . . . 0.67 109.666 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mmtt -119.4 157.2 28.69 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.7 -0.852 . . . . 1.44 108.7 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.14 174.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.337 -1.505 . . . . 0.4 109.337 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -67.65 155.8 68.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.5 1.466 . . . . 0.41 110.648 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.61 171.95 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.902 -0.777 . . . . 0.21 108.902 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -93.94 137.44 33.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.133 -0.979 . . . . 2.72 109.684 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.22 121.39 31.47 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.542 -0.724 . . . . 0.3 109.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.17 -68.97 0.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.235 -0.916 . . . . 0.45 110.462 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -95.38 147.41 23.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.056 -1.027 . . . . 0.33 110.339 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.33 119.43 7.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.802 . . . . 2.33 109.004 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.05 -109.25 0.32 Allowed Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.738 -1.22 . . . . 0.28 110.336 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.9 -150.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -1.137 . . . . 1.4 109.497 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.47 56.23 2.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.274 -1.531 . . . . 0.29 109.274 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.5 146.82 22.74 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.342 -1.093 . . . . 0.29 109.559 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.12 121.13 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.601 -0.889 . . . . 0.31 108.601 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 60.3 t -84.81 132.06 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.3 108.416 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -137.8 178.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.454 -0.779 . . . . 0.24 110.035 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.442 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.1 tt0 -142.31 110.28 5.89 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.662 -0.866 . . . . 1.81 108.662 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -91.26 -78.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.307 -1.368 . . . . 1.18 107.307 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -80.53 -131.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.731 -1.581 . . . . 1.97 106.731 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 58.8 m -105.33 54.52 0.7 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.208 -1.034 . . . . 1.38 108.208 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.8 m-20 -157.06 127.33 6.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.474 -0.766 . . . . 1.12 109.242 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.442 ' CG1' HE21 ' B' ' 252' ' ' GLN . 79.4 mt -94.11 134.2 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.48 109.51 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.08 172.48 12.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.324 -0.86 . . . . 2.13 109.843 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.35 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.459 -0.776 . . . . 0.34 109.407 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.64 131.8 16.13 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 0.34 108.918 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.4 142.93 92.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 N-CA-C 109.506 -0.998 . . . . 0.42 109.506 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -55.8 -34.76 65.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.853 -1.155 . . . . 3.11 108.717 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -65.27 -10.92 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.649 -0.705 . . . . 3.82 110.724 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.7 17.76 12.72 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.257 -1.016 . . . . 2.08 108.257 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.07 168.1 20.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.259 -0.645 . . . . 0.32 109.259 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -140.55 126.82 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.249 -0.907 . . . . 1.79 109.154 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.1 mm -87.51 108.38 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.887 . . . . 0.45 109.556 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.23 152.8 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.49 -0.93 . . . . 0.57 108.49 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -91.4 143.67 26.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 3.62 109.94 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.541 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.001 -0.74 . . . . 1.48 109.001 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -128.18 132.77 48.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.105 -0.702 . . . . 0.72 109.105 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.37 159.47 15.7 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.382 -0.97 . . . . 3.26 108.382 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.83 141.68 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.156 -0.965 . . . . 0.23 110.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.68 151.28 27.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.55 -1.278 . . . . 0.58 107.55 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.0 p90 -156.43 151.21 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.651 -1.281 . . . . 0.44 110.441 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -92.72 141.68 28.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.589 -0.694 . . . . 2.76 109.577 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 5.0 p30 -93.79 165.72 12.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.423 -0.798 . . . . 2.23 109.044 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.99 -0.06 47.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 1.8 109.162 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 10.1 mmm180 -90.01 -20.96 22.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.387 -0.82 . . . . 3.63 109.205 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.7 m-20 -161.03 134.05 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.777 -0.823 . . . . 2.16 108.777 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.73 8.86 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 120.727 0.951 . . . . 1.25 110.208 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.2 t -84.06 159.18 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.034 -1.041 . . . . 1.75 109.921 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.435 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.9 m95 -75.09 164.88 26.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 0.66 108.959 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 237' ' ' GLY . 32.5 tttp -120.01 158.25 27.17 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.395 -0.816 . . . . 1.43 109.652 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.61 165.83 0.03 OUTLIER Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.283 -1.127 . . . . 0.39 110.283 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.97 163.25 36.42 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.705 1.603 . . . . 0.41 110.452 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.17 178.45 7.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.21 109.187 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.09 137.19 35.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.154 -0.966 . . . . 2.72 109.393 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.9 tp -87.88 124.64 33.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.413 -0.805 . . . . 0.29 109.238 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.58 -74.01 0.62 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.459 -0.776 . . . . 0.45 109.99 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.532 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.0 t90 -92.32 141.69 28.27 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.31 109.719 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.85 116.91 7.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.906 . . . . 2.32 109.138 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.13 -105.04 0.23 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.905 -1.14 . . . . 0.27 110.308 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -62.39 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.104 . . . . 1.39 109.877 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 49.86 2.79 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.773 -1.331 . . . . 0.29 109.773 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.76 154.11 39.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -1.126 . . . . 0.29 108.696 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.06 122.79 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.31 109.747 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.72 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.963 -1.125 . . . . 0.29 107.963 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.43 174.79 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.23 110.033 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.4 109.4 5.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.147 -1.057 . . . . 1.81 108.147 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.43 -79.75 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 1.18 107.574 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.5 -128.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 13.0 p -105.89 53.38 0.71 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.284 -1.006 . . . . 1.39 108.284 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.7 m-20 -155.69 129.85 8.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 1.12 109.487 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.418 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.6 mt -95.11 139.86 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.461 -0.774 . . . . 0.47 110.07 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -140.32 162.87 34.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.416 -0.802 . . . . 2.11 109.462 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.97 141.8 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.215 -0.928 . . . . 0.33 108.857 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.83 130.77 18.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.375 -0.828 . . . . 0.34 109.452 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.66 141.37 97.57 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.688 -0.928 . . . . 0.42 109.688 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.26 -29.48 69.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 3.12 109.727 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -70.04 -12.0 61.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.865 . . . . 3.82 111.042 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.83 28.06 8.15 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.153 -0.967 . . . . 2.08 109.273 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.09 168.87 18.81 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.801 -0.814 . . . . 0.32 108.801 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.07 126.94 19.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.224 -0.922 . . . . 1.79 109.392 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.52 109.73 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.343 -0.848 . . . . 0.45 109.67 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.31 149.41 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.394 -0.965 . . . . 0.57 108.394 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.856 . . . . 3.63 109.806 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.032 -0.729 . . . . 1.48 109.032 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -128.23 132.86 48.76 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.73 109.071 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -104.45 159.43 15.74 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.417 -0.957 . . . . 3.26 108.417 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.8 141.67 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.23 110.403 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.64 151.31 27.82 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.617 -1.253 . . . . 0.58 107.617 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.1 p90 -156.46 151.23 25.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.752 -1.218 . . . . 0.44 110.454 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -92.76 141.62 28.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.569 -0.707 . . . . 2.76 109.595 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 4.9 p30 -93.79 165.78 12.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.441 -0.787 . . . . 2.23 109.075 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.93 -0.24 47.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 1.81 109.182 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 10.1 mmm180 -89.93 -21.01 22.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 3.64 109.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.7 m-20 -161.08 134.05 4.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.787 -0.82 . . . . 2.16 108.787 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.61 8.69 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 120.765 0.977 . . . . 1.27 110.169 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.3 t -84.01 159.17 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.009 -1.057 . . . . 1.76 109.958 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.441 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.9 m95 -75.04 164.95 26.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.45 -0.781 . . . . 0.67 109.146 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' B' ' 237' ' ' GLY . 32.6 tttp -120.0 158.24 27.19 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.398 -0.814 . . . . 1.44 109.607 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.55 165.76 0.02 OUTLIER Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.296 -1.122 . . . . 0.4 110.296 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.95 163.26 36.38 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.658 1.572 . . . . 0.41 110.583 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.2 178.38 7.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.21 109.235 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.02 137.1 35.57 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 2.72 109.417 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.74 124.64 33.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.342 -0.849 . . . . 0.3 109.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.65 -73.93 0.63 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.465 -0.772 . . . . 0.45 109.983 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.418 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.0 t90 -92.28 141.6 28.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.2 -0.937 . . . . 0.33 109.844 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.76 117.04 7.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 2.33 109.047 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.17 -105.03 0.23 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.876 -1.155 . . . . 0.28 110.241 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -62.53 -158.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 1.4 109.819 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.56 49.85 2.78 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.859 -1.296 . . . . 0.29 109.859 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.04 38.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -1.086 . . . . 0.29 108.614 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.04 122.83 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.31 109.752 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.71 138.42 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.93 -1.137 . . . . 0.3 107.93 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.9 pt -141.54 174.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.24 109.956 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.38 109.32 5.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.235 -1.024 . . . . 1.81 108.235 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.4 -79.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.483 -1.303 . . . . 1.18 107.483 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.51 -128.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.592 -1.633 . . . . 1.97 106.592 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 13.0 p -105.8 53.21 0.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.267 -1.012 . . . . 1.38 108.267 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.6 m-20 -155.63 129.89 8.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.435 -0.79 . . . . 1.12 109.475 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.8 mt -95.13 139.83 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.434 -0.791 . . . . 0.48 110.076 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -140.29 162.87 34.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.417 -0.802 . . . . 2.13 109.491 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.93 141.84 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.34 108.916 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.79 130.78 18.84 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.34 109.444 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.72 141.39 97.7 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 N-CA-C 109.687 -0.928 . . . . 0.42 109.687 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.17 -29.62 69.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 3.11 109.68 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -69.96 -12.05 61.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 3.82 111.117 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.77 28.08 8.14 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.08 -1.012 . . . . 2.08 109.304 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.11 168.85 18.87 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.834 -0.802 . . . . 0.32 108.834 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.02 126.89 19.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.142 -0.974 . . . . 1.79 109.369 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.49 109.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.45 109.749 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.27 149.36 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.472 -0.936 . . . . 0.57 108.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -90.3 144.86 25.44 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.358 -0.839 . . . . 3.62 109.879 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.014 -0.993 . . . . 2.05 109.252 179.812 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.038 -0.727 . . . . 1.48 109.038 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.43 131.87 38.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.563 -0.711 . . . . 0.72 109.559 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.82 19.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.604 -1.258 . . . . 3.26 107.604 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -139.93 140.54 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 0.23 110.311 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.97 154.58 20.89 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.352 -1.351 . . . . 0.58 107.352 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.8 p90 -155.34 153.34 30.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.55 -1.344 . . . . 0.44 110.645 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -96.03 133.24 40.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.448 -0.783 . . . . 2.76 109.323 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -95.58 177.23 5.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 2.23 109.106 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 p -88.06 -11.63 46.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 1.8 108.932 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 231' ' ' ARG . 11.3 mpt_? -81.49 -13.37 58.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 3.63 109.124 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 15.6 p-10 -161.32 129.78 2.96 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.17 -0.956 . . . . 2.16 109.552 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.13 0.62 4.92 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 N-CA-C 109.574 -0.972 . . . . 1.25 109.574 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 235' ' ' TRP . 45.0 t -85.44 160.83 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 1.75 110.215 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.485 ' N ' HG12 ' A' ' 234' ' ' VAL . 98.5 m95 -67.46 163.35 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.523 -0.917 . . . . 0.66 108.523 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 40.7 tttp -119.95 164.79 15.54 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.267 -0.896 . . . . 1.43 109.748 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.02 169.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.458 -1.057 . . . . 0.39 110.458 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.15 161.02 47.53 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.985 1.79 . . . . 0.41 110.752 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.18 175.85 9.31 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.67 -0.863 . . . . 0.21 108.67 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -94.03 139.38 31.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.954 -1.091 . . . . 2.72 109.127 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.9 tp -89.33 125.17 35.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.898 . . . . 0.29 109.73 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.7 mt -117.49 -77.58 0.57 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.502 -0.749 . . . . 0.45 110.719 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -93.36 136.74 33.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.993 -1.067 . . . . 0.31 110.458 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.5 127.2 13.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.85 . . . . 2.32 109.249 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.64 -105.33 0.24 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.549 -1.42 . . . . 0.27 109.549 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 245' ' ' GLY . 25.5 mt-10 -60.09 -154.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 1.39 109.149 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.0 45.97 2.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.922 -1.671 . . . . 0.29 108.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.73 141.44 18.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.965 . . . . 0.29 108.867 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.29 144.26 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.116 -0.99 . . . . 0.31 108.931 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 147.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.101 -0.999 . . . . 0.29 109.993 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.26 178.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.749 . . . . 0.23 109.488 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.569 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.4 tt0 -144.72 110.86 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.241 -1.022 . . . . 1.81 108.241 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.94 -78.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.551 -1.277 . . . . 1.18 107.551 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -139.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.713 -1.588 . . . . 1.98 106.713 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 60.2 p -97.22 53.79 1.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 2.6 m-20 -155.14 126.22 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.949 -0.76 . . . . 1.12 108.949 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.569 ' CG1' HE21 ' A' ' 252' ' ' GLN . 41.3 mt -92.43 135.46 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.47 109.488 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.85 169.93 16.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.426 -0.797 . . . . 2.11 109.562 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.15 139.99 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.33 109.532 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.6 126.75 18.27 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.06 141.89 96.56 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 N-CA-C 110.039 -0.793 . . . . 0.42 110.039 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.48 -34.09 66.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.315 -0.866 . . . . 3.12 109.138 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -70.12 -8.2 47.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 3.82 110.496 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.48 22.29 11.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.293 -0.879 . . . . 2.08 109.113 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.16 33.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.54 -0.725 . . . . 0.32 109.067 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -139.06 132.01 29.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.309 -0.87 . . . . 1.79 108.957 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.5 107.36 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.372 -0.83 . . . . 0.45 109.579 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 269' ' ' ARG . 36.8 mm -103.79 160.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.466 -0.771 . . . . 0.57 109.275 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.438 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.768 . . . . 3.63 109.405 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.056 -0.72 . . . . 1.48 109.056 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.46 131.87 38.6 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.561 -0.712 . . . . 0.73 109.454 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.9 19.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.572 -1.27 . . . . 3.26 107.572 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -140.13 140.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.239 -0.913 . . . . 0.23 110.236 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.17 154.55 21.03 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.317 -1.364 . . . . 0.58 107.317 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -155.3 153.35 30.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.599 -1.313 . . . . 0.44 110.701 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -95.96 133.26 40.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.447 -0.783 . . . . 2.76 109.34 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -95.6 177.27 5.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 2.23 109.102 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 4.5 p -88.17 -11.69 46.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.077 -1.014 . . . . 1.81 108.857 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' B' ' 231' ' ' ARG . 11.3 mpt_? -81.32 -13.54 58.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 3.64 109.131 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 16.0 p-10 -161.24 129.57 2.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.196 -0.94 . . . . 2.16 109.555 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.9 0.45 4.99 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 N-CA-C 109.586 -0.967 . . . . 1.27 109.586 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.487 HG12 ' N ' ' B' ' 235' ' ' TRP . 45.1 t -85.44 160.81 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 1.76 110.255 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.487 ' N ' HG12 ' B' ' 234' ' ' VAL . 98.4 m95 -67.38 163.46 20.72 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.521 -0.918 . . . . 0.67 108.521 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 237' ' ' GLY . 40.9 tttp -119.94 164.65 15.75 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.306 -0.871 . . . . 1.44 109.705 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.14 169.53 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.447 -1.061 . . . . 0.4 110.447 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.29 161.08 47.3 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.893 1.729 . . . . 0.41 110.695 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 175.88 9.28 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.676 -0.861 . . . . 0.21 108.676 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -93.85 139.4 30.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.017 -1.052 . . . . 2.72 109.224 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.8 tp -89.46 125.15 35.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.182 -0.949 . . . . 0.3 109.724 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 23.5 mt -117.53 -77.53 0.57 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.486 -0.759 . . . . 0.45 110.747 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -93.4 136.66 33.46 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.16 -0.962 . . . . 0.33 110.408 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.33 127.27 13.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.228 -0.92 . . . . 2.33 109.274 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.66 -105.39 0.24 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.601 -1.4 . . . . 0.28 109.601 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 245' ' ' GLY . 25.6 mt-10 -60.03 -154.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -1.108 . . . . 1.4 109.121 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 45.93 2.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.961 -1.656 . . . . 0.29 108.961 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.5 19.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.969 . . . . 0.29 108.88 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.46 144.1 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -0.997 . . . . 0.31 108.925 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.46 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.3 110.008 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.27 178.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.24 109.507 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.57 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -144.56 110.76 5.5 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 1.81 108.31 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -88.91 -78.89 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.525 -1.287 . . . . 1.18 107.525 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' B' ' 254' ' ' ASN . 1.0 OUTLIER -81.82 -139.01 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 60.2 p -97.17 53.78 1.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.005 -1.109 . . . . 1.38 108.005 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' B' ' 255' ' ' SER . 2.6 m-20 -155.14 126.15 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.983 -0.747 . . . . 1.12 108.983 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.57 ' CG1' HE21 ' B' ' 252' ' ' GLN . 41.1 mt -92.33 135.48 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.48 109.508 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.93 169.88 17.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.586 -0.696 . . . . 2.13 109.485 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.17 140.07 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.419 -0.801 . . . . 0.34 109.466 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.64 126.86 18.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.73 -0.841 . . . . 0.34 108.73 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.22 141.97 97.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 110.035 -0.794 . . . . 0.42 110.035 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -56.47 -34.13 66.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.257 -0.902 . . . . 3.11 109.153 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.99 -8.29 47.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.43 -0.793 . . . . 3.82 110.514 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.3 22.12 11.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.285 -0.884 . . . . 2.08 109.137 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.63 163.21 33.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.089 -0.708 . . . . 0.32 109.089 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -139.16 131.98 29.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.281 -0.887 . . . . 1.79 108.92 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.48 107.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.45 109.487 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.442 HG22 ' N ' ' B' ' 269' ' ' ARG . 37.1 mm -103.84 160.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.57 109.16 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.442 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -93.74 141.54 28.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.487 -0.758 . . . . 3.62 109.438 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.01 -1.056 . . . . 2.05 109.389 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.3 m-20 . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.441 -0.577 . . . . 1.48 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -133.38 153.2 51.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.446 -0.783 . . . . 0.72 109.024 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -117.55 149.81 40.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.737 -1.208 . . . . 3.26 107.737 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.02 139.98 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.864 . . . . 0.23 110.085 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -109.22 154.45 22.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.499 -1.297 . . . . 0.58 107.499 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 16.3 p90 -157.01 160.24 38.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.613 -1.304 . . . . 0.44 110.399 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -93.2 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 2.76 109.844 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.72 171.88 8.71 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.833 -0.802 . . . . 2.23 108.833 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.9 p -89.45 -9.54 49.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 1.8 109.458 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -87.04 -16.81 34.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 3.63 109.632 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -162.5 134.1 3.91 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 2.16 108.782 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.84 12.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 120.988 1.125 . . . . 1.25 110.98 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 235' ' ' TRP . 8.6 p -84.64 161.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.699 -1.251 . . . . 1.75 110.029 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.539 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.0 m95 -75.57 163.34 27.46 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.42 -162.51 0.92 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.299 -0.875 . . . . 1.43 108.764 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.19 176.51 51.62 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.639 -1.385 . . . . 0.39 109.639 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -68.96 157.7 60.84 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.675 1.583 . . . . 0.41 110.528 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.96 170.29 16.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.746 -0.835 . . . . 0.21 108.746 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.58 142.44 27.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 2.72 109.702 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.27 119.32 30.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.73 -0.606 . . . . 0.29 109.926 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -109.71 -72.63 0.71 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.331 -0.856 . . . . 0.45 109.814 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.14 146.15 23.95 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.153 -0.967 . . . . 0.31 110.463 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -147.28 120.83 9.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.443 -0.785 . . . . 2.32 108.917 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -107.08 0.27 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.794 -1.194 . . . . 0.27 110.477 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -69.22 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 1.39 110.126 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.32 46.17 2.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.369 -1.493 . . . . 0.29 109.369 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.15 33.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.495 -1.003 . . . . 0.29 108.525 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.65 138.3 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.06 -1.025 . . . . 0.31 109.784 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.76 139.39 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.385 -0.968 . . . . 0.29 108.385 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.2 pt -141.53 178.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.23 110.059 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.36 111.18 5.73 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.779 -0.823 . . . . 1.81 108.779 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.78 -79.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.483 -1.302 . . . . 1.18 107.483 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -79.38 -131.33 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.914 -1.513 . . . . 1.98 106.914 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.432 ' N ' ' ND2' ' A' ' 254' ' ' ASN . 12.7 p -105.61 54.8 0.69 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.372 -0.973 . . . . 1.39 108.372 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -156.31 126.32 6.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 1.12 109.034 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -92.68 135.24 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.47 109.448 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.97 168.64 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 2.11 109.662 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.98 142.26 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.324 -0.86 . . . . 0.33 109.332 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 33.5 t -135.89 131.17 18.89 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.437 -0.789 . . . . 0.34 109.086 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.29 146.43 96.53 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 120.72 0.947 . . . . 0.42 110.458 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -59.25 -32.34 69.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.564 -0.902 . . . . 3.12 108.564 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.9 mtt-85 -70.68 -9.18 56.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.935 . . . . 3.82 110.853 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.56 21.09 12.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.176 -0.952 . . . . 2.08 109.776 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.25 22.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.412 -0.805 . . . . 0.32 109.959 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -140.5 124.93 17.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.58 -0.896 . . . . 1.79 108.58 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.53 112.47 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.133 -0.979 . . . . 0.45 110.159 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.94 147.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.74 -1.207 . . . . 0.57 107.74 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 3.63 109.767 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.413 -0.588 . . . . 1.48 109.413 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -133.34 153.23 51.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.773 . . . . 0.73 109.032 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -117.63 149.77 40.14 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.695 -1.224 . . . . 3.26 107.695 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.03 139.89 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.844 . . . . 0.23 110.062 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.19 154.43 22.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.543 -1.28 . . . . 0.58 107.543 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 16.0 p90 -156.93 160.22 38.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.804 -1.185 . . . . 0.44 110.387 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -93.16 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.744 . . . . 2.76 109.839 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.79 171.91 8.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 2.23 108.846 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 30.5 p -89.5 -9.56 49.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 1.81 109.436 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.94 -16.93 34.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 3.64 109.693 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.4 m-20 -162.41 134.0 3.91 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.93 . . . . 2.16 108.811 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.8 12.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 120.873 1.049 . . . . 1.27 110.957 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.532 HG22 ' N ' ' B' ' 235' ' ' TRP . 8.6 p -84.68 161.3 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.677 -1.264 . . . . 1.76 109.976 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.532 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.9 m95 -75.4 163.23 27.65 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.077 -0.712 . . . . 0.67 109.077 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.33 -162.63 0.92 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.289 -0.882 . . . . 1.44 108.819 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.04 176.55 51.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.76 -1.336 . . . . 0.4 109.76 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -69.12 157.6 61.02 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.74 1.627 . . . . 0.41 110.515 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.95 170.3 16.28 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.76 -0.83 . . . . 0.21 108.76 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.56 142.51 27.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.038 -1.039 . . . . 2.72 109.647 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.39 119.35 30.6 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.656 -0.653 . . . . 0.3 109.797 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.65 -72.69 0.71 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.317 -0.865 . . . . 0.45 109.851 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.17 146.17 23.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.158 -0.964 . . . . 0.33 110.411 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -147.29 120.83 9.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.398 -0.814 . . . . 2.33 108.866 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.79 -107.01 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.711 -1.233 . . . . 0.28 110.439 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.33 -153.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -1.027 . . . . 1.4 110.125 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.29 46.06 2.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.416 -1.473 . . . . 0.29 109.416 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.07 151.18 34.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.499 -1.0 . . . . 0.29 108.487 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.7 m -146.58 138.25 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 0.31 109.785 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.73 139.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.395 -0.965 . . . . 0.3 108.395 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.52 178.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.24 110.055 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.48 111.17 5.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.766 -0.828 . . . . 1.81 108.766 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.8 -79.84 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.47 -1.308 . . . . 1.18 107.47 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 255' ' ' SER . 0.3 OUTLIER -79.37 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.911 -1.514 . . . . 1.97 106.911 177.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.433 ' N ' ' ND2' ' B' ' 254' ' ' ASN . 12.8 p -105.52 54.82 0.69 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.335 -0.987 . . . . 1.38 108.335 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -156.31 126.33 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 1.12 109.064 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.6 mt -92.68 135.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.297 -0.877 . . . . 0.48 109.461 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -138.99 168.56 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.865 . . . . 2.13 109.677 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.94 142.36 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.397 -0.814 . . . . 0.34 109.283 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.92 131.17 18.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.373 -0.83 . . . . 0.34 109.179 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.3 146.53 96.32 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 120.692 0.928 . . . . 0.42 110.412 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -59.34 -32.29 69.96 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.61 -0.885 . . . . 3.11 108.61 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' B' ' 263' ' ' ARG . 2.9 mtt-85 -70.63 -9.18 56.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.271 -0.893 . . . . 3.82 110.812 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.47 20.91 12.34 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.243 -0.911 . . . . 2.08 109.769 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.15 167.25 22.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.439 -0.788 . . . . 0.32 109.9 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -140.56 124.89 17.67 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.61 -0.885 . . . . 1.79 108.61 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.46 112.37 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.235 -0.916 . . . . 0.45 110.22 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.95 147.12 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.638 -1.245 . . . . 0.57 107.638 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.62 140.79 29.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 3.62 109.741 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.997 -1.002 . . . . 2.05 109.353 179.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.988 -0.745 . . . . 1.48 108.988 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.2 135.28 40.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.389 -0.819 . . . . 0.72 109.299 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -103.47 157.98 16.66 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.839 -1.171 . . . . 3.26 107.839 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.33 138.68 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.026 -1.046 . . . . 0.23 110.646 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -111.03 151.87 27.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.724 -1.213 . . . . 0.58 107.724 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.0 p90 -158.3 154.65 27.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.671 -1.268 . . . . 0.44 110.376 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.05 152.24 18.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.534 -0.729 . . . . 2.76 109.651 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.67 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 2.23 108.82 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 58.0 m -79.25 -2.83 43.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.996 . . . . 1.8 109.333 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.89 20.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.299 -0.876 . . . . 3.63 109.844 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.3 m-20 -162.87 144.51 7.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.16 109.067 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.08 15.75 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.061 1.174 . . . . 1.25 110.643 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 232' ' ' ASP . 33.9 m -83.24 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.799 -1.188 . . . . 1.75 110.006 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -63.97 164.84 9.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.66 109.358 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.2 tttp -119.41 158.07 26.93 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.38 -0.825 . . . . 1.43 108.893 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.01 165.38 0.02 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.281 -1.127 . . . . 0.39 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.2 157.67 58.66 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.552 1.501 . . . . 0.41 110.289 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.32 169.02 18.53 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.927 -0.768 . . . . 0.21 108.927 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.22 142.72 26.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 2.72 109.334 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.0 tp -87.6 128.44 35.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.491 -0.756 . . . . 0.29 110.179 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.0 -76.15 0.58 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.36 -0.837 . . . . 0.45 109.749 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' A' ' 250' ' ' VAL . 5.3 t90 -93.07 142.6 27.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.154 -0.966 . . . . 0.31 110.121 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.66 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.285 -0.884 . . . . 2.32 108.744 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.35 -107.32 0.28 Allowed Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.792 -1.194 . . . . 0.27 110.184 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.8 -150.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 1.39 109.644 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 49.98 3.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.354 -1.498 . . . . 0.29 109.354 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.94 150.15 33.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.389 -1.065 . . . . 0.29 108.822 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.52 129.66 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.31 109.758 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 243' ' ' TRP . 95.4 t -93.41 134.18 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.45 -0.944 . . . . 0.29 108.45 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.98 178.63 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.23 109.583 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.2 tt0 -144.84 111.24 5.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.39 -0.819 . . . . 1.81 109.029 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.99 -82.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.108 -1.441 . . . . 1.18 107.108 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -78.85 -138.82 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.733 -1.58 . . . . 1.98 106.733 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.1 m -98.05 56.25 1.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.989 -1.07 . . . . 1.39 108.423 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -156.15 125.75 6.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.735 . . . . 1.12 109.038 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' A' ' 252' ' ' GLN . 80.6 mt -93.06 134.96 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.267 -0.896 . . . . 0.47 109.6 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.31 165.21 26.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.444 -0.785 . . . . 2.11 109.746 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.85 139.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.33 109.743 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.35 130.57 17.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 108.702 -0.851 . . . . 0.34 108.702 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.61 146.88 73.64 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.613 -0.957 . . . . 0.42 109.613 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -65.16 -32.88 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 3.12 109.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -69.97 -4.89 22.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 3.82 110.826 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.72 16.14 13.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.283 -0.885 . . . . 2.08 109.051 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.8 172.29 13.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.627 -0.671 . . . . 0.32 109.426 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -139.54 129.91 25.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.408 -0.808 . . . . 1.79 109.231 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.2 mm -88.49 106.61 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.45 109.727 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.01 156.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.339 -0.851 . . . . 0.57 108.849 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.289 -0.882 . . . . 3.63 109.219 179.406 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.999 -0.741 . . . . 1.48 108.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -135.2 135.17 40.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.421 -0.799 . . . . 0.73 109.329 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 84.4 mtt180 -103.3 157.94 16.67 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.834 -1.173 . . . . 3.26 107.834 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.4 t -142.3 138.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.106 -0.996 . . . . 0.23 110.622 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.98 151.99 27.32 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.723 -1.214 . . . . 0.58 107.723 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.2 p90 -158.39 154.68 27.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.709 -1.244 . . . . 0.44 110.344 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.0 152.16 18.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 2.76 109.706 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.71 13.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.372 -0.83 . . . . 2.23 108.771 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 57.7 m -79.35 -2.72 42.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 1.81 109.263 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.82 20.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 3.64 109.894 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.2 m-20 -162.93 144.43 7.75 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.044 -1.035 . . . . 2.16 109.065 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.9 15.54 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.236 1.291 . . . . 1.27 110.677 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' B' ' 232' ' ' ASP . 33.9 m -83.18 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 1.76 110.05 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -64.04 164.77 10.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.247 -0.908 . . . . 0.67 109.427 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.0 tttp -119.32 158.04 26.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.398 -0.814 . . . . 1.44 108.986 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.98 165.36 0.02 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.258 -1.137 . . . . 0.4 110.258 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.23 157.65 58.84 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 121.526 1.484 . . . . 0.41 110.225 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.35 169.05 18.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.21 108.96 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -93.31 142.71 27.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.064 -1.023 . . . . 2.72 109.282 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.62 128.46 35.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.416 -0.802 . . . . 0.3 110.232 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.03 -76.12 0.58 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.514 -0.741 . . . . 0.45 109.711 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' B' ' 250' ' ' VAL . 5.3 t90 -93.01 142.57 27.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.124 -0.985 . . . . 0.33 110.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.74 11.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.3 -0.875 . . . . 2.33 108.747 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -107.33 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.771 -1.204 . . . . 0.28 110.203 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.79 -150.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -1.041 . . . . 1.4 109.727 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.17 49.93 3.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.319 -1.513 . . . . 0.29 109.319 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.17 33.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -1.038 . . . . 0.29 108.799 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 12.0 m -145.58 129.74 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.31 109.827 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' B' ' 243' ' ' TRP . 95.9 t -93.47 134.17 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.439 -0.948 . . . . 0.3 108.439 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.2 pt -136.96 178.57 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.24 109.654 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.521 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.2 tt0 -144.83 111.24 5.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 1.81 109.039 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -88.98 -81.89 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.199 -1.408 . . . . 1.18 107.199 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -78.9 -138.9 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.674 -1.602 . . . . 1.97 106.674 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.2 m -97.94 56.22 1.23 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.954 -1.091 . . . . 1.38 108.494 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -156.16 125.75 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 1.12 109.102 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.521 ' CG1' HE21 ' B' ' 252' ' ' GLN . 80.5 mt -93.08 134.92 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.933 . . . . 0.48 109.617 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.26 165.32 26.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 2.13 109.749 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.92 139.96 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.424 -0.797 . . . . 0.34 109.696 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 83.9 t -137.43 130.57 17.07 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.47 146.91 71.93 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.597 -0.963 . . . . 0.42 109.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -65.36 -32.82 74.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 3.11 109.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -69.93 -4.86 22.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 3.82 110.867 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.84 16.33 13.49 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.258 -0.902 . . . . 2.08 109.013 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.89 172.23 13.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 0.32 109.426 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -139.51 129.86 25.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 1.79 109.288 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.44 106.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.277 -0.889 . . . . 0.45 109.778 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.02 156.33 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.385 -0.822 . . . . 0.57 108.909 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -91.02 147.4 23.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 3.62 109.196 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.6 m-20 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.048 -1.032 . . . . 2.05 109.477 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.393 -0.595 . . . . 1.48 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.54 121.7 20.21 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.508 -0.745 . . . . 0.72 109.213 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.17 165.29 12.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 3.26 108.294 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -143.39 143.02 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.138 -0.977 . . . . 0.23 110.676 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -113.02 148.29 35.44 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.631 -1.248 . . . . 0.58 107.631 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.7 p90 -156.91 151.99 26.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.729 -1.232 . . . . 0.44 110.288 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -93.19 139.25 30.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 2.76 109.456 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -94.19 166.79 11.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 2.23 109.224 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.4 p -79.76 -1.5 38.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 1.8 109.105 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -87.24 -22.6 25.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 3.63 109.531 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 234' ' ' VAL . 8.3 m-20 -163.07 135.05 3.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 2.16 109.073 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.82 10.95 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 120.813 1.009 . . . . 1.25 110.228 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 232' ' ' ASP . 25.0 t -85.63 160.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.905 -1.122 . . . . 1.75 109.821 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.461 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.2 m95 -74.52 162.17 29.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.66 108.765 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.3 tttm -119.44 153.06 35.83 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.296 -0.877 . . . . 1.43 109.385 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -41.26 163.57 0.01 OUTLIER Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.762 -0.935 . . . . 0.39 110.762 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -66.6 159.44 50.87 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 121.638 1.559 . . . . 0.41 110.612 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.78 177.18 8.08 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.008 -0.738 . . . . 0.21 109.008 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -94.39 136.49 34.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.029 -1.045 . . . . 2.72 109.194 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.74 124.01 33.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 0.29 109.619 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -113.3 -74.33 0.63 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.434 -0.791 . . . . 0.45 110.208 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -91.26 143.26 26.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.264 -0.897 . . . . 0.31 110.33 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.11 117.96 7.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.435 -0.791 . . . . 2.32 109.225 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.19 -108.7 0.3 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.944 -1.263 . . . . 0.27 109.944 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -63.56 -154.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -1.145 . . . . 1.39 109.416 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.37 52.02 3.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.603 -1.399 . . . . 0.29 109.603 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.69 150.44 34.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.396 -1.061 . . . . 0.29 108.967 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 122.85 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.31 109.701 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 52.8 t -87.22 135.36 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.991 -1.114 . . . . 0.29 107.991 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.63 178.33 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.23 110.52 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.473 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.7 tt0 -144.81 112.16 6.08 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.93 -78.5 0.39 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.612 -1.255 . . . . 1.18 107.612 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.766 HD22 ' H ' ' A' ' 255' ' ' SER . 8.7 t30 -80.53 -129.29 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.68 -1.6 . . . . 1.98 106.68 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.766 ' H ' HD22 ' A' ' 254' ' ' ASN . 68.5 m -105.41 54.3 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.106 -1.072 . . . . 1.39 108.106 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -156.19 128.41 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.519 -0.738 . . . . 1.12 109.519 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.473 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -94.61 137.59 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 0.47 109.488 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.32 166.65 23.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.386 -0.821 . . . . 2.11 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.94 142.5 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.33 109.112 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.2 t -139.28 129.52 14.5 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 0.34 109.168 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.406 ' HG2' ' HZ3' ' A' ' 264' ' ' LYS . 7.0 Cg_exo -54.37 160.66 6.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.939 -0.831 . . . . 0.42 109.939 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -84.8 -27.2 26.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 3.12 110.249 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.32 -18.82 65.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.893 . . . . 3.82 111.931 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.406 ' HZ3' ' HG2' ' A' ' 261' ' ' PRO . 2.0 ptpp? -119.43 29.24 7.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.897 -1.127 . . . . 2.08 109.616 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.4 164.41 25.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.517 -0.92 . . . . 0.32 108.517 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.12 124.62 19.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.248 -0.908 . . . . 1.79 109.293 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.7 mm -88.52 110.41 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 0.45 109.581 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.9 146.76 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 3.63 109.612 179.94 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.316 -0.624 . . . . 1.48 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -135.56 121.69 20.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.517 -0.739 . . . . 0.73 109.158 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.16 165.2 12.17 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.339 -0.986 . . . . 3.26 108.339 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.3 143.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.23 110.702 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -113.19 148.18 35.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.604 -1.258 . . . . 0.58 107.604 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.8 p90 -156.79 152.03 26.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.689 -1.257 . . . . 0.44 110.327 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -93.26 139.27 30.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.711 . . . . 2.76 109.405 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -94.25 166.76 11.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.357 -0.839 . . . . 2.23 109.226 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.1 p -79.68 -1.45 38.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 1.81 109.161 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -87.25 -22.62 25.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.64 109.536 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 8.3 m-20 -163.03 135.1 3.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 2.16 109.096 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.88 11.05 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.772 0.981 . . . . 1.27 110.233 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.488 ' H ' ' C ' ' B' ' 232' ' ' ASP . 25.2 t -85.73 160.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.939 -1.1 . . . . 1.76 109.907 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.467 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.2 m95 -74.34 162.17 29.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.67 108.787 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.3 tttm -119.41 153.02 35.87 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.345 -0.847 . . . . 1.44 109.439 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.27 163.55 0.01 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.73 -0.948 . . . . 0.4 110.73 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.53 159.39 50.92 Favored 'Trans proline' 0 N--CA 1.48 0.732 0 C-N-CA 121.654 1.569 . . . . 0.41 110.629 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.2 8.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.985 -0.746 . . . . 0.21 108.985 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -94.28 136.51 34.5 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.08 -1.013 . . . . 2.72 109.299 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.75 123.97 33.11 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.3 109.608 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.25 -74.52 0.62 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.338 -0.851 . . . . 0.45 110.206 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.16 143.29 26.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.197 -0.94 . . . . 0.33 110.414 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.1 118.01 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 2.33 109.214 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -108.71 0.3 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.962 -1.255 . . . . 0.28 109.962 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.68 -154.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 1.4 109.348 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.93 3.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.419 . . . . 0.29 109.551 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.67 150.44 34.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.392 -1.063 . . . . 0.29 108.948 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.66 122.79 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.209 -0.932 . . . . 0.31 109.762 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 52.9 t -87.26 135.33 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.032 -1.099 . . . . 0.3 108.032 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.58 178.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.21 -0.931 . . . . 0.24 110.606 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.473 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.6 tt0 -144.77 112.13 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.619 -0.882 . . . . 1.81 108.619 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.05 -78.43 0.39 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.571 -1.27 . . . . 1.18 107.571 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.759 HD22 ' H ' ' B' ' 255' ' ' SER . 8.8 t30 -80.54 -129.27 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.722 -1.584 . . . . 1.97 106.722 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.759 ' H ' HD22 ' B' ' 254' ' ' ASN . 68.7 m -105.41 54.29 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.131 -1.063 . . . . 1.38 108.131 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -156.12 128.43 7.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 1.12 109.524 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CG1' HE21 ' B' ' 252' ' ' GLN . 35.9 mt -94.56 137.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.259 -0.901 . . . . 0.48 109.536 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.31 166.65 23.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.323 -0.86 . . . . 2.13 109.701 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.0 142.43 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.34 109.119 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 78.8 t -139.22 129.4 14.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.366 -0.834 . . . . 0.34 109.258 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.3 160.54 6.49 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.616 0.877 . . . . 0.42 109.962 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -84.73 -27.1 27.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 3.11 110.313 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 3.82 111.893 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.401 ' HG2' ' HZ2' ' B' ' 264' ' ' LYS . 2.0 ptpp? -119.28 29.22 7.77 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.954 -1.091 . . . . 2.08 109.727 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.34 164.47 25.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.538 -0.912 . . . . 0.32 108.538 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.2 124.59 19.22 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.25 -0.906 . . . . 1.79 109.319 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.6 mm -88.6 110.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.45 109.56 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.88 146.64 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.546 -0.909 . . . . 0.57 108.546 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.24 141.17 28.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.649 -0.657 . . . . 3.62 109.605 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 2.05 109.429 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.3 m120 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.176 -0.676 . . . . 1.48 109.176 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.85 124.41 23.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.411 -0.806 . . . . 0.72 109.959 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -95.88 164.11 12.87 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.37 -1.345 . . . . 3.26 107.37 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.02 142.82 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.01 -1.056 . . . . 0.23 110.446 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -107.36 154.71 20.89 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.475 -1.306 . . . . 0.58 107.475 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.0 p90 -156.04 157.24 35.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.484 -1.385 . . . . 0.44 111.112 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -101.15 146.08 27.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.464 0.65 . . . . 2.76 109.421 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 230' ' ' SER . 37.0 t0 -98.74 -176.65 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 2.23 109.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 15.1 t -95.08 -14.14 24.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -0.808 . . . . 1.8 109.678 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.28 -16.93 31.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.19 -0.944 . . . . 3.63 109.857 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 234' ' ' VAL . 61.4 m-20 -160.4 128.82 2.94 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.147 -0.97 . . . . 2.16 109.351 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.95 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 120.786 0.991 . . . . 1.25 110.25 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.6 m -82.32 127.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.869 -1.144 . . . . 1.75 110.026 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.5 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.66 109.257 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 237' ' ' GLY . 31.3 mtpt -119.85 166.46 13.26 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.425 -0.797 . . . . 1.43 109.418 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.99 170.17 0.02 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.287 -1.125 . . . . 0.39 110.287 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -68.83 163.83 35.82 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 121.562 1.508 . . . . 0.41 110.66 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.58 177.86 7.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.21 109.347 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.56 137.45 34.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.197 -0.939 . . . . 2.72 109.39 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.408 HD21 ' NZ ' ' A' ' 244' ' ' LYS . 19.1 tp -88.67 123.86 33.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.565 -0.709 . . . . 0.29 109.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.14 -72.66 0.68 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.289 -0.882 . . . . 0.45 110.432 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.01 144.45 25.64 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.077 -1.014 . . . . 0.31 110.497 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.408 ' NZ ' HD21 ' A' ' 241' ' ' LEU . 16.0 ttmm -145.7 119.37 9.17 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.767 -0.827 . . . . 2.32 108.767 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.88 -104.88 0.26 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.209 -1.156 . . . . 0.27 110.209 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -73.04 -149.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -1.129 . . . . 1.39 109.736 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.54 3.95 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.136 -1.586 . . . . 0.29 109.136 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.49 150.95 34.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.29 108.425 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.36 123.31 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.971 -1.08 . . . . 0.31 109.827 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.94 133.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.399 -0.963 . . . . 0.29 108.399 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 260' ' ' VAL . 10.6 pt -138.81 178.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.348 -0.845 . . . . 0.23 109.987 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.7 tt0 -143.8 109.3 5.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.341 -0.985 . . . . 1.81 108.341 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.1 -77.23 0.4 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.499 -1.297 . . . . 1.18 107.499 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.87 -133.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.323 -1.732 . . . . 1.98 106.323 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.3 t -105.03 56.48 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.071 -1.085 . . . . 1.39 108.071 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -157.03 123.53 4.98 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.771 -0.826 . . . . 1.12 108.771 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' A' ' 252' ' ' GLN . 39.2 mt -91.64 134.29 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -0.998 . . . . 0.47 109.504 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.07 172.6 12.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.281 -0.887 . . . . 2.11 110.014 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.13 140.6 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.547 -0.72 . . . . 0.33 109.701 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 251' ' ' ILE . 58.1 t -134.19 124.93 17.65 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.16 139.55 90.89 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 120.584 0.856 . . . . 0.42 110.331 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.76 -36.26 69.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 3.12 109.758 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 263' ' ' ARG . 2.3 tpt180 -67.12 -9.58 41.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 3.82 110.693 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.545 ' HZ2' ' HB2' ' A' ' 264' ' ' LYS . 7.4 mtpm? -122.95 25.47 8.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.284 -0.885 . . . . 2.08 108.859 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.33 32.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.462 -0.94 . . . . 0.32 108.462 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -139.34 132.09 29.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.116 -0.99 . . . . 1.79 109.231 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.57 107.63 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 0.45 109.297 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.51 157.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.57 109.308 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 3.63 109.465 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 25.4 m120 . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.148 -0.686 . . . . 1.48 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.84 124.46 23.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.508 -0.745 . . . . 0.73 109.957 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 6.0 mpt_? -95.89 164.19 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.298 -1.371 . . . . 3.26 107.298 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 86.2 t -144.1 142.85 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.066 -1.021 . . . . 0.23 110.408 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -107.37 154.77 20.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.384 -1.339 . . . . 0.58 107.384 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.9 p90 -156.08 157.23 35.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.548 -1.345 . . . . 0.44 111.087 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -101.04 146.06 27.93 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.425 0.631 . . . . 2.76 109.516 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' B' ' 230' ' ' SER . 36.9 t0 -98.64 -176.67 3.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 2.23 109.879 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 15.2 t -95.17 -13.88 24.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.415 -0.803 . . . . 1.81 109.731 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.37 -16.97 31.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 3.64 109.847 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 234' ' ' VAL . 61.2 m-20 -160.39 128.82 2.95 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 2.16 109.339 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.94 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.776 0.984 . . . . 1.27 110.302 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.5 m -82.32 127.77 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.874 -1.141 . . . . 1.76 110.014 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.44 0.22 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.67 109.298 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' B' ' 237' ' ' GLY . 31.3 mtpt -119.71 166.44 13.21 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.371 -0.831 . . . . 1.44 109.431 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.15 170.3 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.303 -1.119 . . . . 0.4 110.303 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -68.92 163.8 36.13 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.55 1.5 . . . . 0.41 110.605 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.52 177.87 7.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.21 109.404 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.59 137.3 34.85 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.135 -0.978 . . . . 2.72 109.389 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.404 HD21 ' NZ ' ' B' ' 244' ' ' LYS . 19.3 tp -88.51 123.87 33.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.544 -0.723 . . . . 0.3 109.571 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.21 -72.53 0.69 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.381 -0.824 . . . . 0.45 110.488 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.18 144.47 25.58 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.051 -1.031 . . . . 0.33 110.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' HD21 ' B' ' 241' ' ' LEU . 16.0 ttmm -145.69 119.41 9.2 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.818 -0.808 . . . . 2.33 108.818 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.95 -104.92 0.26 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.148 -1.181 . . . . 0.28 110.148 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -72.98 -149.44 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -1.143 . . . . 1.4 109.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.61 3.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.19 -1.564 . . . . 0.29 109.19 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.96 34.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -1.023 . . . . 0.29 108.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.31 123.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.08 -1.012 . . . . 0.31 109.81 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.82 133.66 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.392 -0.966 . . . . 0.3 108.392 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.405 HD11 HG21 ' B' ' 260' ' ' VAL . 10.5 pt -138.86 178.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.24 110.066 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.521 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.6 tt0 -143.72 109.41 5.19 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.353 -0.981 . . . . 1.81 108.353 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.21 -77.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.538 -1.282 . . . . 1.18 107.538 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -80.96 -133.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.323 -1.732 . . . . 1.97 106.323 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.2 t -105.07 56.57 0.69 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -157.05 123.62 5.0 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.778 -0.823 . . . . 1.12 108.778 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.521 ' CG1' HE21 ' B' ' 252' ' ' GLN . 39.1 mt -91.66 134.31 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.48 109.435 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.11 172.59 12.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.368 -0.832 . . . . 2.13 110.05 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.13 140.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.461 -0.774 . . . . 0.34 109.745 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . 0.405 HG21 HD11 ' B' ' 251' ' ' ILE . 58.5 t -134.17 124.86 17.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.841 -0.8 . . . . 0.34 108.841 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.12 139.49 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 120.588 0.859 . . . . 0.42 110.325 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.81 -36.19 69.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 3.11 109.751 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.416 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 2.3 tpt180 -67.17 -9.47 40.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 3.82 110.733 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' B' ' 264' ' ' LYS . 7.4 mtpm? -123.03 25.53 8.5 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.21 -0.931 . . . . 2.08 108.833 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.493 -0.928 . . . . 0.32 108.493 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -139.32 131.9 28.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.113 -0.992 . . . . 1.79 109.318 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.44 107.62 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.231 -0.918 . . . . 0.45 109.311 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.44 157.55 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.41 -0.806 . . . . 0.57 109.269 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -91.69 137.23 32.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.308 -0.87 . . . . 3.62 109.487 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.105 -0.997 . . . . 2.05 109.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.6 m-20 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.227 -0.657 . . . . 1.48 109.227 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -135.66 134.08 38.83 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.72 109.374 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.1 18.89 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.925 -1.139 . . . . 3.26 107.925 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -140.99 140.23 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.103 -0.998 . . . . 0.23 110.983 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -109.28 154.28 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.141 -1.429 . . . . 0.58 107.141 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.9 p90 -156.53 150.12 24.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.593 -1.317 . . . . 0.44 110.55 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 228' ' ' ARG . 10.7 mtm-85 -94.22 134.97 36.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.513 -0.742 . . . . 2.76 109.463 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.36 175.24 6.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.366 -0.834 . . . . 2.23 109.591 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.2 t -85.88 -11.02 54.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 1.8 108.874 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -88.8 -9.31 52.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 3.63 109.414 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -158.07 128.52 3.51 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 2.16 109.04 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.69 -11.58 29.84 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 120.815 1.01 . . . . 1.25 110.44 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 1.5 p -84.59 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.043 . . . . 1.75 109.42 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 92.7 m95 -64.43 169.57 4.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.445 -0.784 . . . . 0.66 109.644 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 237' ' ' GLY . 44.9 tttp -118.95 165.35 14.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.512 -0.742 . . . . 1.43 109.223 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.22 167.37 0.02 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.119 -1.192 . . . . 0.39 110.119 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.4 160.25 50.52 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.448 1.432 . . . . 0.41 110.113 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.79 168.86 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 0.21 109.18 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.51 139.51 30.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.161 -0.962 . . . . 2.72 109.971 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.08 122.94 32.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -0.77 . . . . 0.29 109.428 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.66 -75.51 0.6 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.419 -0.801 . . . . 0.45 110.355 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -89.79 143.68 26.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.067 -1.021 . . . . 0.31 109.893 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.65 121.62 10.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.342 -0.849 . . . . 2.32 109.063 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.46 -104.93 0.23 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.812 -1.185 . . . . 0.27 110.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.38 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -1.053 . . . . 1.39 109.551 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 51.36 3.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.14 -1.584 . . . . 0.29 109.14 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.37 154.02 40.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.427 -1.043 . . . . 0.29 108.691 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -147.01 124.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.056 -1.027 . . . . 0.31 109.82 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.82 133.61 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.721 -1.214 . . . . 0.29 107.721 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.39 175.78 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.321 -0.862 . . . . 0.23 110.333 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -145.32 108.71 4.63 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.588 -0.893 . . . . 1.81 108.588 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.34 -77.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.421 -1.326 . . . . 1.18 107.421 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -80.28 -135.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.566 -1.642 . . . . 1.98 106.566 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 10.2 p -101.58 55.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.099 -1.074 . . . . 1.39 108.099 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 255' ' ' SER . 59.1 m-20 -156.75 123.71 5.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.143 -0.688 . . . . 1.12 109.143 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.428 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.3 mt -93.05 135.39 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.47 109.438 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.07 169.72 17.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.415 -0.803 . . . . 2.11 109.709 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.86 140.97 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.383 -0.823 . . . . 0.33 109.491 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.97 128.24 17.56 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.632 -0.877 . . . . 0.34 108.632 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.65 148.64 72.66 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.528 -0.989 . . . . 0.42 109.528 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -67.82 -30.3 69.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 3.12 109.452 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.68 -8.29 53.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 3.82 111.0 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.21 23.16 11.47 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.126 -0.983 . . . . 2.08 109.005 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.97 168.13 20.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.579 -0.701 . . . . 0.32 109.164 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -139.64 129.59 24.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.318 -0.864 . . . . 1.79 109.154 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.38 108.13 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 0.45 109.431 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -101.83 156.21 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 . . . . . 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 3.63 109.116 179.715 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 2.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.227 -0.657 . . . . 1.48 109.227 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.63 134.09 38.89 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.487 -0.758 . . . . 0.73 109.416 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.2 18.78 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.91 -1.144 . . . . 3.26 107.91 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -141.09 140.27 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.181 -0.95 . . . . 0.23 110.945 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -109.24 154.33 22.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.169 -1.419 . . . . 0.58 107.169 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -156.63 149.94 24.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.468 -1.395 . . . . 0.44 110.666 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.6 mtm-85 -94.07 135.05 35.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.523 -0.736 . . . . 2.76 109.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.45 175.18 6.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 2.23 109.629 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.1 t -85.79 -10.99 54.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 1.81 108.925 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -88.84 -9.2 52.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.443 -0.785 . . . . 3.64 109.433 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.17 128.37 3.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.16 109.147 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.64 -11.54 29.84 Favored 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 120.865 1.043 . . . . 1.27 110.433 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 1.5 p -84.52 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.037 . . . . 1.76 109.429 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.479 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 92.7 m95 -64.45 169.57 4.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.67 109.671 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 44.9 tttp -118.92 165.31 14.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.635 -0.666 . . . . 1.44 109.338 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.24 167.39 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.159 -1.176 . . . . 0.4 110.159 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.37 160.27 50.47 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 121.419 1.412 . . . . 0.41 110.122 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.88 168.88 18.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.21 109.071 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.4 139.48 30.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.227 -0.92 . . . . 2.72 109.971 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.1 122.88 32.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.704 . . . . 0.3 109.423 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -112.63 -75.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -0.828 . . . . 0.45 110.44 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.428 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.1 t90 -89.77 143.66 26.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.005 . . . . 0.33 109.889 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.75 121.64 10.63 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.315 -0.866 . . . . 2.33 109.044 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.41 -104.95 0.23 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.11 -1.196 . . . . 0.28 110.11 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -69.42 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -1.125 . . . . 1.4 109.516 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.43 3.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.05 -1.62 . . . . 0.29 109.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.11 40.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.467 -1.019 . . . . 0.29 108.72 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.99 124.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.126 -0.984 . . . . 0.31 109.943 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.78 133.77 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.703 -1.221 . . . . 0.3 107.703 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.51 175.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.296 -0.878 . . . . 0.24 110.278 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -145.3 108.75 4.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.593 -0.891 . . . . 1.81 108.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.43 -77.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.348 -1.353 . . . . 1.18 107.348 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.25 -135.73 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.54 -1.652 . . . . 1.97 106.54 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 10.1 p -101.63 56.06 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.964 -1.125 . . . . 1.38 107.964 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 59.1 m-20 -156.78 123.68 5.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 1.12 109.145 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.99 135.35 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.48 109.429 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.12 169.77 17.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 2.13 109.751 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 140.98 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.381 -0.824 . . . . 0.34 109.496 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.96 128.3 17.61 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.672 -0.862 . . . . 0.34 108.672 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.78 148.64 73.79 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.465 -1.013 . . . . 0.42 109.465 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.78 -30.37 69.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 3.11 109.489 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.58 -8.34 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.415 -0.803 . . . . 3.82 111.016 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.14 23.15 11.5 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.176 -0.952 . . . . 2.08 109.054 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.03 168.16 20.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.078 -0.712 . . . . 0.32 109.078 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.6 129.65 25.05 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.363 -0.836 . . . . 1.79 109.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.34 108.09 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.4 -0.812 . . . . 0.45 109.431 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.6 mm -101.88 156.08 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.319 -0.863 . . . . 0.57 108.683 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -94.5 135.36 36.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 3.62 109.183 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.042 -1.036 . . . . 2.05 109.555 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.178 -0.675 . . . . 1.48 109.178 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.95 122.68 22.25 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.817 -0.808 . . . . 0.72 108.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -100.99 161.16 13.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.289 -1.004 . . . . 3.26 108.289 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.6 141.91 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.324 -0.86 . . . . 0.23 110.093 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -107.21 155.21 20.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.299 -1.371 . . . . 0.58 107.299 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 8.3 p90 -154.86 153.29 30.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.716 -1.24 . . . . 0.44 110.456 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -95.29 157.15 16.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.495 -0.753 . . . . 2.76 109.978 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.55 176.46 6.28 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.9 -0.778 . . . . 2.23 108.9 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.41 -11.24 38.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -0.994 . . . . 1.8 109.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.63 -15.41 35.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.33 -0.856 . . . . 3.63 109.902 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.4 m-20 -161.38 132.34 3.77 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.142 -0.974 . . . . 2.16 109.282 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.5 18.28 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.023 1.149 . . . . 1.25 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.1 p -86.59 158.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.72 -1.238 . . . . 1.75 109.921 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.1 m95 -75.5 176.25 7.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.429 -0.582 . . . . 0.66 109.429 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -134.97 -150.6 0.39 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.234 -0.916 . . . . 1.43 109.141 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.17 174.95 49.63 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.093 -1.203 . . . . 0.39 110.093 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.12 158.95 45.0 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.78 1.653 . . . . 0.41 110.066 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 172.04 13.23 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 0.21 109.517 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.55 ' NZ ' HH22 ' A' ' 224' ' ' ARG . 66.7 mmtt -92.49 137.72 32.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.269 -0.895 . . . . 2.72 109.428 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.27 124.47 34.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.498 -0.752 . . . . 0.29 109.814 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.37 -73.71 0.63 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.377 -0.827 . . . . 0.45 110.27 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.85 140.33 29.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.26 -0.9 . . . . 0.31 109.956 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -147.24 115.11 6.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -0.897 . . . . 2.32 109.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -100.3 0.17 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.854 -1.165 . . . . 0.27 110.302 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.37 -156.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.357 -1.084 . . . . 1.39 109.888 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.21 48.16 2.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.061 -1.615 . . . . 0.29 109.061 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 152.34 36.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.437 -1.037 . . . . 0.29 108.999 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.58 125.2 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.31 109.413 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 50.5 t -87.85 135.02 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.109 -1.071 . . . . 0.29 108.109 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 260' ' ' VAL . 9.1 pt -139.75 -177.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.23 110.062 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.515 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.4 tt0 -143.14 109.41 5.32 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.359 -0.978 . . . . 1.81 108.359 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.62 -79.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.634 -1.247 . . . . 1.18 107.634 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -78.99 -135.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.481 -1.674 . . . . 1.98 106.481 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.7 m -101.02 53.72 0.84 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.167 -1.049 . . . . 1.39 108.167 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -157.35 132.13 8.7 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.051 -0.722 . . . . 1.12 109.051 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.515 ' CG1' HE21 ' A' ' 252' ' ' GLN . 37.3 mt -92.64 137.31 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.47 109.479 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.54 169.91 16.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 2.11 109.701 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.93 140.87 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.458 -0.777 . . . . 0.33 109.411 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 251' ' ' ILE . 43.0 t -134.56 134.03 21.96 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.678 -0.86 . . . . 0.34 108.678 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.42 140.96 96.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 120.715 0.944 . . . . 0.42 110.478 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.4 HH12 HG13 ' A' ' 267' ' ' ILE . 20.7 tpt180 -59.11 -38.95 80.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 3.12 109.271 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -66.96 -7.95 26.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 3.82 111.001 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.68 25.11 9.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.156 -0.965 . . . . 2.08 109.169 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.53 164.28 30.57 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.212 -0.662 . . . . 0.32 109.212 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.03 126.47 20.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 1.79 109.075 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . 0.4 HG13 HH12 ' A' ' 262' ' ' ARG . 18.4 mm -87.97 110.39 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.45 109.745 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.12 147.17 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.354 -0.98 . . . . 0.57 108.354 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 3.63 109.763 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.159 -0.682 . . . . 1.48 109.159 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.97 122.79 22.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.709 -0.849 . . . . 0.73 108.709 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -101.03 161.05 13.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.316 -0.994 . . . . 3.26 108.316 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.54 142.0 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 0.23 110.097 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.26 155.21 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.337 -1.357 . . . . 0.58 107.337 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -154.84 153.26 30.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.696 -1.253 . . . . 0.44 110.491 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -95.24 157.17 16.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.751 . . . . 2.76 109.975 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -94.52 176.48 6.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 2.23 108.962 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.44 -11.26 38.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 1.81 109.342 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.66 -15.4 35.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.331 -0.855 . . . . 3.64 109.857 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.7 m-20 -161.37 132.32 3.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 2.16 109.274 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.48 18.16 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.965 1.11 . . . . 1.27 110.838 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.2 p -86.41 158.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.774 -1.204 . . . . 1.76 109.922 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.498 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.66 176.28 7.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.381 -0.6 . . . . 0.67 109.381 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -135.0 -150.58 0.39 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.284 -0.885 . . . . 1.44 109.11 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.2 174.94 49.57 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.084 -1.207 . . . . 0.4 110.084 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.13 158.97 44.94 Favored 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 121.777 1.651 . . . . 0.41 110.077 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.11 172.15 13.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.392 -0.817 . . . . 0.21 109.5 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.552 ' NZ ' HH22 ' B' ' 224' ' ' ARG . 66.7 mmtt -92.52 137.7 32.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.233 -0.917 . . . . 2.72 109.422 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.29 124.48 34.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.3 109.783 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.35 -73.68 0.63 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.275 -0.891 . . . . 0.45 110.317 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.89 140.32 29.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.295 -0.878 . . . . 0.33 109.953 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -147.28 115.0 6.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.244 -0.91 . . . . 2.33 109.221 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.66 -100.36 0.18 Allowed Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.782 -1.199 . . . . 0.28 110.239 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.29 -157.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 1.4 109.863 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 48.06 2.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.27 36.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -1.067 . . . . 0.29 109.111 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.61 125.15 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.31 109.411 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.83 134.92 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.033 -1.099 . . . . 0.3 108.033 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 260' ' ' VAL . 9.2 pt -139.62 -177.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.24 110.105 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.4 tt0 -143.05 109.55 5.4 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.391 -0.966 . . . . 1.81 108.391 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.66 -79.15 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.629 -1.248 . . . . 1.18 107.629 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.94 -135.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.551 -1.648 . . . . 1.97 106.551 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.9 m -100.95 53.7 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.13 -1.063 . . . . 1.38 108.13 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -157.3 132.16 8.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.041 -0.726 . . . . 1.12 109.041 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.1 mt -92.63 137.25 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.235 -0.916 . . . . 0.48 109.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.49 169.81 17.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.402 -0.811 . . . . 2.13 109.746 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.88 140.89 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.409 -0.807 . . . . 0.34 109.458 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . 0.418 HG21 HD11 ' B' ' 251' ' ' ILE . 42.8 t -134.49 133.99 22.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.802 -0.814 . . . . 0.34 108.802 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.43 140.91 96.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.647 0.898 . . . . 0.42 110.522 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.1 -38.85 80.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 3.11 109.326 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -67.07 -7.83 25.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.465 -0.772 . . . . 3.82 110.997 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.75 25.08 9.93 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.151 -0.968 . . . . 2.08 109.192 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 164.24 30.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.224 -0.658 . . . . 0.32 109.224 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -140.04 126.47 20.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 1.79 109.097 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.94 110.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.267 -0.895 . . . . 0.45 109.742 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.1 147.16 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.329 -0.989 . . . . 0.57 108.329 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -95.93 141.65 29.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.45 -0.781 . . . . 3.62 109.758 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.02 -0.99 . . . . 2.05 109.612 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 222' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.304 0.573 . . . . 1.48 109.522 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.05 137.52 46.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.592 -0.693 . . . . 0.72 109.416 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.6 OUTLIER -104.85 157.81 16.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.41 -1.33 . . . . 3.26 107.41 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.0 t -141.53 142.91 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.077 -1.014 . . . . 0.23 110.642 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -110.63 154.81 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.303 -1.369 . . . . 0.58 107.303 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.76 151.91 26.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.534 -1.354 . . . . 0.44 110.529 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 228' ' ' ARG . 2.0 mtm-85 -92.5 149.27 21.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.739 . . . . 2.76 109.876 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -94.38 168.04 11.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 2.23 108.698 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.9 t -84.81 -9.38 58.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 1.8 109.084 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 231' ' ' ARG . 3.5 mtt-85 -90.83 -15.75 29.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 3.63 109.989 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 234' ' ' VAL . 38.0 m-20 -160.24 129.54 3.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 2.16 108.95 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.86 11.03 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 120.831 1.021 . . . . 1.25 110.827 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.8 p -81.62 158.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.697 -1.252 . . . . 1.75 109.886 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.6 m95 -75.33 162.15 28.66 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.213 -0.662 . . . . 0.66 109.213 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.7 tttp -118.38 158.13 25.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.462 -0.774 . . . . 1.43 109.162 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.16 171.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.551 -1.02 . . . . 0.39 110.551 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.37 158.25 57.89 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.691 1.594 . . . . 0.41 110.621 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.24 170.65 15.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.674 -0.861 . . . . 0.21 108.674 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -92.95 137.24 32.54 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.072 -1.017 . . . . 2.72 109.349 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.55 120.31 30.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.708 -0.62 . . . . 0.29 109.587 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.6 mt -111.15 -71.79 0.75 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.363 -0.836 . . . . 0.45 110.101 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.2 t90 -91.59 142.11 27.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.206 -0.934 . . . . 0.31 109.78 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.76 112.48 5.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.139 -0.976 . . . . 2.32 109.065 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.83 -104.17 0.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.814 -1.184 . . . . 0.27 110.251 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 245' ' ' GLY . 30.0 mt-10 -56.67 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.477 -1.014 . . . . 1.39 109.862 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.1 49.95 2.99 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.103 -1.599 . . . . 0.29 109.103 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.22 157.9 43.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -1.009 . . . . 0.29 108.569 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.38 132.44 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.31 109.552 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.79 133.93 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 15.3 pt -138.71 174.06 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.326 -0.859 . . . . 0.23 110.562 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -141.89 108.87 5.44 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.226 -1.027 . . . . 1.81 108.226 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.22 -75.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.514 -1.291 . . . . 1.18 107.514 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.25 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.615 -1.624 . . . . 1.98 106.615 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.98 52.23 0.74 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.854 -1.165 . . . . 1.39 107.854 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -156.35 129.0 7.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.521 -0.737 . . . . 1.12 109.29 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.1 mt -92.62 141.52 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.47 109.635 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.57 165.11 28.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 2.11 109.668 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.9 137.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.818 . . . . 0.33 109.404 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.72 131.53 20.21 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.361 -0.837 . . . . 0.34 109.189 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.64 146.98 93.84 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 N-CA-C 109.702 -0.922 . . . . 0.42 109.702 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.07 -33.07 75.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 3.12 109.716 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -68.99 -7.05 31.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.21 -0.931 . . . . 3.82 110.636 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -119.73 20.96 12.19 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.265 -0.897 . . . . 2.08 109.13 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.89 23.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.32 109.534 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -139.42 131.01 27.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.213 -0.93 . . . . 1.79 108.973 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.18 105.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 0.45 109.523 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 269' ' ' ARG . 8.1 mm -105.1 159.99 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.368 -0.833 . . . . 0.57 108.956 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 269' ' ' ARG . 24.7 mtm-85 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 3.63 109.376 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . 0.602 ' N ' HD22 ' B' ' 222' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.491 -0.559 . . . . 1.48 109.491 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -132.86 137.67 46.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.642 -0.661 . . . . 0.73 109.401 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.6 OUTLIER -104.96 157.82 16.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.403 -1.332 . . . . 3.26 107.403 178.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.55 143.03 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.111 -0.993 . . . . 0.23 110.601 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.66 154.8 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.77 151.98 26.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.513 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.0 mtm-85 -92.47 149.24 21.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 2.76 109.927 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -94.45 167.86 11.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.682 -0.858 . . . . 2.23 108.682 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 47.5 t -84.73 -9.26 58.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 1.81 109.139 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 231' ' ' ARG . 3.6 mtt-85 -90.89 -15.68 29.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 3.64 110.048 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 38.1 m-20 -160.31 129.59 3.2 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.159 -0.963 . . . . 2.16 108.965 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.04 11.16 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 120.775 0.983 . . . . 1.27 110.777 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.493 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.9 p -81.55 158.64 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.797 -1.189 . . . . 1.76 110.055 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.493 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.6 m95 -75.53 162.07 28.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.11 -0.7 . . . . 0.67 109.11 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.9 tttp -118.29 158.14 25.74 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.468 -0.77 . . . . 1.44 109.195 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.05 171.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.518 -1.033 . . . . 0.4 110.518 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.26 158.19 58.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.825 1.683 . . . . 0.41 110.667 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.23 170.81 15.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.678 -0.86 . . . . 0.21 108.678 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -93.14 137.16 32.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.022 -1.049 . . . . 2.72 109.339 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.8 tp -89.4 120.28 30.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.621 -0.675 . . . . 0.3 109.585 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.08 -71.9 0.74 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.314 -0.866 . . . . 0.45 110.095 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.1 t90 -91.58 142.18 27.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.33 109.805 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.84 112.55 5.67 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.205 -0.934 . . . . 2.33 109.109 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.88 -104.2 0.22 Allowed Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.783 -1.198 . . . . 0.28 110.301 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' B' ' 245' ' ' GLY . 30.3 mt-10 -56.68 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.032 . . . . 1.4 109.846 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.14 49.98 3.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.6 . . . . 0.29 109.101 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.18 158.0 43.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.589 -0.947 . . . . 0.29 108.527 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.36 132.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.31 109.544 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.79 133.95 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.936 -1.135 . . . . 0.3 107.936 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.77 173.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.24 110.565 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -141.74 108.77 5.46 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.311 -0.996 . . . . 1.81 108.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.23 -75.84 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.498 -1.297 . . . . 1.18 107.498 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.23 -132.07 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.566 -1.642 . . . . 1.97 106.566 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.94 52.06 0.75 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.952 -1.129 . . . . 1.38 107.952 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -156.2 129.0 7.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.643 -0.661 . . . . 1.12 109.335 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.2 mt -92.65 141.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.37 -0.831 . . . . 0.48 109.591 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.35 165.24 27.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 2.13 109.72 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.98 137.32 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.34 109.408 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.64 131.51 20.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.42 -0.8 . . . . 0.34 109.175 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.67 147.07 93.57 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 N-CA-C 109.734 -0.91 . . . . 0.42 109.734 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.06 -33.14 75.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 3.11 109.652 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.0 -7.03 31.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 3.82 110.559 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -119.7 20.96 12.21 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.29 -0.881 . . . . 2.08 109.134 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.62 166.81 23.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.32 109.524 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -139.41 130.91 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.354 -0.841 . . . . 1.79 109.092 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.8 mm -89.12 105.93 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 0.45 109.625 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' B' ' 269' ' ' ARG . 8.1 mm -105.08 160.13 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.383 -0.823 . . . . 0.57 109.026 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' B' ' 269' ' ' ARG . 24.6 mtm-85 -87.66 148.04 24.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 3.62 109.387 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.028 -0.987 . . . . 2.05 109.103 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.136 -0.691 . . . . 1.48 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.6 130.29 36.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.595 -0.691 . . . . 0.72 109.207 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.4 OUTLIER -105.68 159.48 15.94 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.293 -1.003 . . . . 3.26 108.293 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.13 140.8 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.044 -1.035 . . . . 0.23 110.59 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.06 152.48 23.95 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.252 -1.388 . . . . 0.58 107.252 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.57 151.5 26.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.537 -1.352 . . . . 0.44 110.615 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -95.06 143.63 26.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 2.76 109.88 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.77 173.25 7.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.392 -0.818 . . . . 2.23 108.997 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.24 -9.99 51.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.8 109.381 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.64 -13.0 43.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 3.63 109.55 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -158.43 128.43 3.38 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 2.16 108.707 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.32 2.04 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 120.875 1.05 . . . . 1.25 111.404 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.623 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.8 p -84.57 167.04 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.565 -1.334 . . . . 1.75 110.335 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.623 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.8 m95 -71.92 161.98 30.13 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.66 108.692 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.2 tttp -118.75 161.96 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.288 -0.883 . . . . 1.43 109.257 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.6 164.83 0.02 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.302 -1.119 . . . . 0.39 110.302 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.43 160.75 46.38 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.456 1.437 . . . . 0.41 110.127 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.66 175.32 9.67 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.836 -0.802 . . . . 0.21 108.836 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -95.89 138.73 33.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.126 -0.984 . . . . 2.72 109.795 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 tp -87.89 122.93 32.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.326 -0.859 . . . . 0.29 109.259 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.38 -72.94 0.67 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.352 -0.842 . . . . 0.45 110.326 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.528 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.7 t90 -90.07 139.95 30.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.091 -1.006 . . . . 0.31 110.387 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.62 7.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.374 -0.829 . . . . 2.32 109.008 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.33 -99.9 0.17 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.83 -1.308 . . . . 0.27 109.83 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.45 -155.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -1.149 . . . . 1.39 109.65 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.81 46.47 2.35 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.417 -1.473 . . . . 0.29 109.417 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.84 148.73 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -1.037 . . . . 0.29 108.564 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.76 126.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.297 -0.877 . . . . 0.31 109.697 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.19 139.42 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.156 -1.053 . . . . 0.29 108.156 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 257' ' ' ILE . 11.1 pt -141.2 178.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.23 110.408 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.407 HE21 HG12 ' A' ' 257' ' ' ILE . 29.3 tt0 -143.69 111.29 5.96 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.892 -1.151 . . . . 1.81 107.892 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.56 -78.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.851 -1.166 . . . . 1.18 107.851 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -80.39 -128.47 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.802 -1.555 . . . . 1.98 106.802 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 51.1 m -105.38 51.37 0.76 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.961 -1.126 . . . . 1.39 107.961 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.16 134.4 11.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.009 -0.737 . . . . 1.12 109.009 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.488 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 10.5 mt -93.52 144.89 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 0.47 109.306 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.06 162.88 34.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.318 -0.864 . . . . 2.11 110.056 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.77 131.3 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.536 -0.727 . . . . 0.33 109.212 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.09 133.26 20.69 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.698 -0.853 . . . . 0.34 108.698 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.8 147.46 80.75 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.521 0.814 . . . . 0.42 109.993 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.29 -37.52 77.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 3.12 109.359 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -70.84 1.81 5.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.791 . . . . 3.82 110.72 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -118.93 12.0 12.71 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.581 -0.896 . . . . 2.08 108.581 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.75 170.05 16.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.679 . . . . 0.32 109.657 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.47 130.11 27.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.339 -0.85 . . . . 1.79 108.984 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.76 115.2 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.416 -0.803 . . . . 0.45 109.749 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.9 mm -112.12 155.04 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.383 -0.823 . . . . 0.57 109.141 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.517 -0.739 . . . . 3.63 109.278 179.761 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.128 -0.693 . . . . 1.48 109.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -134.52 130.39 36.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.578 -0.701 . . . . 0.73 109.145 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.532 HH11 ' HG2' ' B' ' 224' ' ' ARG . 0.4 OUTLIER -105.69 159.53 15.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.347 -0.983 . . . . 3.26 108.347 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -142.28 140.72 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.23 110.581 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -106.95 152.55 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.241 -1.392 . . . . 0.58 107.241 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.8 p90 -156.71 151.47 25.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.595 -1.315 . . . . 0.44 110.562 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -95.09 143.53 26.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.641 -0.662 . . . . 2.76 109.847 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.66 173.35 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 2.23 109.066 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.36 -9.91 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.81 109.426 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.76 -12.95 43.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 3.64 109.505 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -158.37 128.44 3.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.115 -0.991 . . . . 2.16 108.732 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.29 1.99 2.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.948 1.099 . . . . 1.27 111.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.7 p -84.5 166.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.59 -1.319 . . . . 1.76 110.386 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.8 m95 -71.92 161.97 30.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.665 -0.865 . . . . 0.67 108.665 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.79 162.0 19.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.383 -0.823 . . . . 1.44 109.211 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.65 164.82 0.02 OUTLIER Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.376 -1.089 . . . . 0.4 110.376 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.39 160.67 46.68 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.484 1.456 . . . . 0.41 110.179 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.54 175.53 9.49 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.791 -0.818 . . . . 0.21 108.791 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -96.02 138.78 33.15 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.167 -0.958 . . . . 2.72 109.717 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.02 122.84 32.1 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.3 109.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.1 mt -116.4 -72.79 0.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.423 -0.798 . . . . 0.45 110.285 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.488 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.7 t90 -90.11 139.9 30.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.08 -1.013 . . . . 0.33 110.268 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.54 7.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.285 -0.885 . . . . 2.33 109.073 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.22 -99.76 0.17 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.901 -1.28 . . . . 0.28 109.901 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.44 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -1.103 . . . . 1.4 109.702 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 46.45 2.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.381 -1.488 . . . . 0.29 109.381 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.78 148.63 34.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.443 -1.034 . . . . 0.29 108.522 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.77 126.37 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.267 -0.896 . . . . 0.31 109.732 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.13 139.52 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.227 -1.027 . . . . 0.3 108.227 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.427 ' O ' HG23 ' B' ' 257' ' ' ILE . 11.1 pt -141.24 178.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.207 -0.933 . . . . 0.24 110.464 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.412 HE21 HG12 ' B' ' 257' ' ' ILE . 29.4 tt0 -143.65 111.31 5.98 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.985 -1.117 . . . . 1.81 107.985 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.62 -78.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.783 -1.192 . . . . 1.18 107.783 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.43 -128.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.767 -1.568 . . . . 1.97 106.767 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 51.0 m -105.42 51.34 0.76 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.972 -1.122 . . . . 1.38 107.972 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.09 134.43 11.51 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.053 -0.721 . . . . 1.12 109.053 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 10.7 mt -93.48 145.01 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.183 -0.948 . . . . 0.48 109.48 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.15 162.93 34.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 2.13 109.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.76 131.27 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 0.34 109.186 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.02 133.34 20.83 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.67 -0.863 . . . . 0.34 108.67 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.7 147.47 79.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.534 0.822 . . . . 0.42 110.027 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.47 -37.26 77.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 3.11 109.392 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -71.01 1.96 5.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 3.82 110.77 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -119.03 12.01 12.62 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.547 -0.909 . . . . 2.08 108.547 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.84 169.99 16.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.32 109.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.43 130.13 27.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.448 -0.783 . . . . 1.79 108.989 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.77 115.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.41 -0.806 . . . . 0.45 109.753 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -111.95 155.03 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.44 -0.788 . . . . 0.57 109.178 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -91.46 136.24 33.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.572 -0.705 . . . . 3.62 109.285 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.01 . . . . 2.05 109.555 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 109.588 -0.523 . . . . 1.48 109.588 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -136.07 135.46 39.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.525 -0.734 . . . . 0.72 109.466 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.53 156.94 20.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.215 -1.402 . . . . 3.26 107.215 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.14 141.79 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.008 -1.058 . . . . 0.23 110.716 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.44 152.55 25.23 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.406 -1.331 . . . . 0.58 107.406 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 17.6 p90 -155.91 158.58 38.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.44 110.673 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -102.02 143.72 31.51 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.425 0.631 . . . . 2.76 109.606 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 230' ' ' SER . 10.3 t70 -97.92 173.12 7.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.455 -0.778 . . . . 2.23 109.131 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 57.3 m -86.99 -5.67 59.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.8 109.406 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 231' ' ' ARG . 20.7 mtm-85 -88.59 -19.69 25.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.224 -0.923 . . . . 3.63 109.614 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -162.54 129.86 2.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 2.16 108.813 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -65.89 5.61 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 120.779 0.986 . . . . 1.25 110.698 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.4 m -83.0 127.51 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.821 -1.174 . . . . 1.75 109.993 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -48.28 164.4 0.05 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.25 -0.906 . . . . 0.66 109.551 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.8 mtpt -118.97 167.32 11.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.842 -0.799 . . . . 1.43 108.842 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -48.04 174.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.024 -1.231 . . . . 0.39 110.024 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.17 159.47 53.73 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.69 1.594 . . . . 0.41 110.502 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 172.17 13.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.101 -0.704 . . . . 0.21 109.101 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.61 33.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.112 -0.992 . . . . 2.72 109.573 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.78 125.32 34.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.52 -0.737 . . . . 0.29 109.493 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.0 mt -116.53 -74.54 0.6 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.397 -0.815 . . . . 0.45 110.209 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.71 141.55 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.31 109.988 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -145.94 118.72 8.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.831 . . . . 2.32 109.103 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.32 -104.77 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.723 -1.227 . . . . 0.27 110.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -68.85 -153.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 1.39 109.812 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.23 50.32 2.73 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.29 109.633 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.05 151.91 36.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -1.106 . . . . 0.29 108.917 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.24 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.97 . . . . 0.31 109.546 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -87.05 138.24 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.236 -1.024 . . . . 0.29 108.236 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.92 177.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -0.922 . . . . 0.23 110.095 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -144.69 110.3 5.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.687 -0.857 . . . . 1.81 108.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.57 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.577 -1.268 . . . . 1.18 107.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.8 -130.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 m -105.27 55.68 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.959 -1.126 . . . . 1.39 107.959 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.939 -0.763 . . . . 1.12 108.939 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.7 mt -92.65 139.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -0.872 . . . . 0.47 109.524 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.21 166.97 23.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 2.11 109.976 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.78 138.34 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.528 -0.916 . . . . 0.33 108.528 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.11 133.1 20.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.834 . . . . 0.34 109.35 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.43 139.12 89.35 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.798 -0.885 . . . . 0.42 109.798 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 262' ' ' ARG . 0.6 OUTLIER -58.9 -34.72 72.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 3.12 109.424 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 263' ' ' ARG . 18.8 ttm-85 -69.36 -2.87 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 3.82 109.731 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.46 17.09 13.8 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.335 -0.853 . . . . 2.08 109.095 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.18 170.92 14.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 0.32 109.903 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -140.39 131.51 26.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.243 -0.91 . . . . 1.79 109.17 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.73 107.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.139 -0.976 . . . . 0.45 109.508 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.96 150.63 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.172 -1.047 . . . . 0.57 108.172 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 269' ' ' ARG . 6.0 tpt180 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.427 -0.796 . . . . 3.63 109.127 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 109.539 -0.541 . . . . 1.48 109.539 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -136.04 135.51 39.47 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.432 -0.793 . . . . 0.73 109.508 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.48 156.88 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.292 -1.373 . . . . 3.26 107.292 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 91.7 t -141.07 141.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.995 -1.066 . . . . 0.23 110.661 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.41 152.52 25.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 17.4 p90 -155.84 158.65 38.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.633 -1.292 . . . . 0.44 110.602 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -102.04 143.77 31.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.405 0.621 . . . . 2.76 109.645 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 230' ' ' SER . 10.2 t70 -97.84 173.03 7.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.413 -0.804 . . . . 2.23 109.188 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 m -86.85 -5.73 59.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 1.81 109.499 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' B' ' 231' ' ' ARG . 20.7 mtm-85 -88.47 -19.89 25.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.924 . . . . 3.64 109.57 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.2 m-20 -162.46 129.84 2.63 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 2.16 108.906 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.93 5.69 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 120.8 1.0 . . . . 1.27 110.623 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.481 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.4 m -83.11 127.56 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.796 -1.19 . . . . 1.76 110.014 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -48.29 164.44 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.214 -0.929 . . . . 0.67 109.601 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.8 mtpt -119.0 167.23 11.95 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.863 -0.791 . . . . 1.44 108.863 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -48.06 174.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.997 -1.241 . . . . 0.4 109.997 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.24 159.49 53.59 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.697 1.598 . . . . 0.41 110.509 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.87 172.23 13.32 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.024 -0.732 . . . . 0.21 109.024 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.63 33.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.114 -0.991 . . . . 2.72 109.535 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.89 125.44 34.94 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.516 -0.74 . . . . 0.3 109.409 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.4 mt -116.65 -74.62 0.6 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.4 -0.812 . . . . 0.45 110.103 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.66 141.55 28.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.33 110.014 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -146.0 118.72 8.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.368 -0.833 . . . . 2.33 109.147 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -104.79 0.23 Allowed Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.195 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -68.83 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.297 -1.12 . . . . 1.4 109.816 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.24 50.27 2.73 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.373 . . . . 0.29 109.666 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.08 151.86 36.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -1.12 . . . . 0.29 108.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.11 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.125 -0.985 . . . . 0.31 109.586 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.97 138.16 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.244 -1.021 . . . . 0.3 108.244 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.89 177.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 0.24 110.099 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.63 110.3 5.31 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.65 -81.6 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.542 -1.281 . . . . 1.18 107.542 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.73 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.593 -1.632 . . . . 1.97 106.593 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.6 m -105.33 55.64 0.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.99 -1.115 . . . . 1.38 107.99 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 1.12 108.901 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 23.6 mt -92.57 139.15 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.48 109.574 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.22 166.87 23.51 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 2.13 110.023 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.76 138.4 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.19 133.08 20.43 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.34 109.312 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.38 139.16 89.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.769 -0.897 . . . . 0.42 109.769 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' B' ' 262' ' ' ARG . 0.7 OUTLIER -58.98 -34.83 72.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 3.11 109.351 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' B' ' 263' ' ' ARG . 18.9 ttm-85 -69.24 -2.81 11.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 3.82 109.793 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.53 17.16 13.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.318 -0.863 . . . . 2.08 109.116 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.3 170.86 14.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.32 109.943 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -140.36 131.49 26.4 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.356 -0.84 . . . . 1.79 109.188 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.76 107.5 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.114 -0.991 . . . . 0.45 109.51 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.8 150.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.267 -1.012 . . . . 0.57 108.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' B' ' 269' ' ' ARG . 6.0 tpt180 -90.98 145.21 24.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -0.785 . . . . 3.62 109.086 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.029 -0.986 . . . . 2.05 109.547 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 108.706 -0.85 . . . . 1.48 108.706 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -133.89 145.21 49.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 0.72 109.479 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.3 OUTLIER -119.71 154.03 34.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.851 -1.166 . . . . 3.26 107.851 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -138.87 146.45 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.079 -1.013 . . . . 0.23 111.012 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.17 155.78 24.39 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.261 -1.385 . . . . 0.58 107.261 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.8 p90 -157.43 150.86 23.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.578 -1.326 . . . . 0.44 110.465 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 228' ' ' ARG . 8.1 mtm-85 -93.04 146.44 23.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.476 -0.765 . . . . 2.76 109.306 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.84 167.41 11.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -0.9 . . . . 2.23 108.917 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.7 t -83.18 -10.54 58.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 1.8 109.24 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -89.96 -11.08 42.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 3.63 109.622 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.415 ' OD2' ' CG2' ' A' ' 234' ' ' VAL . 18.8 t0 -160.41 127.36 2.58 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 2.16 108.768 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.63 6.83 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.721 0.948 . . . . 1.25 110.269 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 235' ' ' TRP . 40.4 t -83.69 161.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 1.75 109.85 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.5 m95 -74.17 161.62 29.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.803 . . . . 0.66 109.076 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.3 tttp -118.92 160.86 21.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.383 -0.823 . . . . 1.43 109.25 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.0 167.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.6 -1.0 . . . . 0.39 110.6 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.37 157.91 57.85 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.681 1.588 . . . . 0.41 110.568 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.36 170.0 16.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.969 -0.752 . . . . 0.21 108.969 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -93.6 138.73 31.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.067 -1.02 . . . . 2.72 109.745 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.98 120.46 30.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.133 -0.691 . . . . 0.29 109.133 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.0 mt -111.12 -72.5 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.401 -0.812 . . . . 0.45 110.282 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.26 143.94 25.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.165 -0.959 . . . . 0.31 110.15 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.58 122.14 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.297 -0.877 . . . . 2.32 109.278 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.57 -103.78 0.21 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.081 -1.208 . . . . 0.27 110.081 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.62 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -1.124 . . . . 1.39 109.712 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 49.5 2.91 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.253 -1.539 . . . . 0.29 109.253 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.71 35.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -1.035 . . . . 0.29 108.704 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.03 124.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.991 . . . . 0.31 109.809 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.0 137.04 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.079 -1.082 . . . . 0.29 108.079 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.73 -179.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.861 . . . . 0.23 110.234 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.514 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -144.15 111.93 6.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.709 -0.848 . . . . 1.81 108.709 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.36 -78.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.491 -1.3 . . . . 1.18 107.491 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.64 -132.19 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.695 -1.594 . . . . 1.98 106.695 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.7 m -103.66 54.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.031 -1.1 . . . . 1.39 108.031 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.81 126.99 6.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 1.12 109.283 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.514 ' CG1' HE21 ' A' ' 252' ' ' GLN . 26.9 mt -92.71 137.0 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.47 109.286 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.49 171.86 13.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 2.11 109.743 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.92 137.47 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.372 -0.83 . . . . 0.33 109.359 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -136.94 125.22 14.8 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.401 -0.812 . . . . 0.34 108.974 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.46 143.75 93.54 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.527 0.818 . . . . 0.42 110.242 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.04 -32.54 72.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 3.12 109.387 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -68.71 -7.69 35.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.338 -0.851 . . . . 3.82 110.672 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -119.05 19.59 12.92 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.175 -0.953 . . . . 2.08 109.451 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.01 168.9 18.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.52 -0.737 . . . . 0.32 109.589 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.4 ' NZ ' ' CZ3' ' A' ' 235' ' ' TRP . 29.0 mtmm -137.62 127.27 25.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 1.79 109.049 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.4 mm -88.15 107.91 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.223 -0.923 . . . . 0.45 110.15 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.5 mm -105.7 151.51 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.398 -0.964 . . . . 0.57 108.398 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.303 -0.873 . . . . 3.63 109.053 179.349 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.696 -0.853 . . . . 1.48 108.696 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.03 145.14 49.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.522 -0.736 . . . . 0.73 109.449 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' B' ' 224' ' ' ARG . 0.3 OUTLIER -119.69 154.05 34.66 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.807 -1.183 . . . . 3.26 107.807 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.94 146.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.116 -0.99 . . . . 0.23 110.987 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -113.13 155.89 24.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.226 -1.398 . . . . 0.58 107.226 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.1 p90 -157.43 151.02 24.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.572 -1.33 . . . . 0.44 110.42 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.439 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.1 mtm-85 -93.14 146.54 23.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 2.76 109.291 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.89 167.38 11.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 2.23 108.931 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.8 t -83.16 -10.52 58.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 1.81 109.278 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -90.06 -10.96 42.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 3.64 109.592 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.413 ' OD2' ' CG2' ' B' ' 234' ' ' VAL . 18.7 t0 -160.44 127.31 2.56 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.16 108.782 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.49 6.72 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 120.814 1.009 . . . . 1.27 110.322 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.494 HG12 ' N ' ' B' ' 235' ' ' TRP . 40.3 t -83.74 161.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 1.76 109.893 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.494 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -74.06 161.55 29.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.67 109.063 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.91 160.86 21.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.41 -0.806 . . . . 1.44 109.285 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.86 166.98 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.578 -1.009 . . . . 0.4 110.578 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -66.33 157.91 57.77 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.767 1.644 . . . . 0.41 110.543 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.42 169.97 16.78 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.99 -0.745 . . . . 0.21 108.99 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -93.55 138.79 31.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.107 -0.996 . . . . 2.72 109.699 -179.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.3 tp -88.97 120.52 30.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.3 109.172 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.1 mt -111.23 -72.56 0.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.317 -0.864 . . . . 0.45 110.246 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.28 143.81 26.03 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.33 110.152 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -148.42 122.16 9.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 2.33 109.314 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.6 -103.71 0.21 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.096 -1.202 . . . . 0.28 110.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.61 -153.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -1.136 . . . . 1.4 109.7 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.16 49.48 2.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.234 -1.546 . . . . 0.29 109.234 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.75 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -1.061 . . . . 0.29 108.781 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.98 124.49 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.182 -0.949 . . . . 0.31 109.725 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.06 137.0 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.06 -1.089 . . . . 0.3 108.06 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.64 -179.77 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.221 -0.924 . . . . 0.24 110.252 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.525 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -144.18 111.86 6.12 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 1.81 108.705 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -90.21 -78.57 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.66 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.641 -1.614 . . . . 1.97 106.641 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.3 m -103.77 54.3 0.74 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.936 -1.135 . . . . 1.38 107.936 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.85 126.9 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.529 -0.732 . . . . 1.12 109.245 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.525 ' CG1' HE21 ' B' ' 252' ' ' GLN . 27.2 mt -92.65 137.03 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.48 109.272 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -137.45 171.84 13.87 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.406 -0.809 . . . . 2.13 109.728 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 137.51 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.374 -0.829 . . . . 0.34 109.396 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 55.1 t -136.97 125.2 14.75 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.374 -0.829 . . . . 0.34 108.931 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.48 143.72 93.69 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.48 0.787 . . . . 0.42 110.298 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 3.11 109.46 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -68.77 -7.63 35.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.227 -0.921 . . . . 3.82 110.705 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -119.17 19.78 12.79 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.191 -0.943 . . . . 2.08 109.436 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.1 168.85 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.32 109.559 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -137.55 127.35 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.341 -0.85 . . . . 1.79 109.024 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.18 107.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.207 -0.933 . . . . 0.45 110.201 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -105.59 151.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.482 -0.933 . . . . 0.57 108.482 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.13 149.36 21.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.374 -0.829 . . . . 3.62 109.147 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.05 109.49 179.872 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.366 0.603 . . . . 1.48 109.421 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.73 131.23 35.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.41 -0.806 . . . . 0.72 109.145 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.94 156.62 17.29 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.05 -1.093 . . . . 3.26 108.05 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.63 143.37 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.102 -0.999 . . . . 0.23 110.39 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 226' ' ' TYR . 22.6 m-85 -114.05 155.46 25.9 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.754 -1.202 . . . . 0.58 107.754 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.0 p90 -156.8 150.2 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.781 -1.199 . . . . 0.44 110.353 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -96.21 152.64 18.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 2.76 109.699 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.7 170.44 9.32 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.38 -0.97 . . . . 2.23 108.38 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.91 -12.44 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 1.8 109.225 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.68 -11.34 40.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.369 -0.832 . . . . 3.63 110.067 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 1.8 p30 -157.21 129.78 4.26 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.94 -1.1 . . . . 2.16 109.922 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.18 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 120.907 1.071 . . . . 1.25 110.659 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -82.53 142.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.779 -1.201 . . . . 1.75 109.74 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.93 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.66 108.981 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.36 -161.14 1.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.43 108.623 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.31 166.96 54.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.469 . . . . 0.39 109.429 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.92 159.35 53.62 Favored 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.408 1.405 . . . . 0.41 109.88 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.93 171.78 14.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.506 -0.746 . . . . 0.21 108.989 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.52 140.38 29.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.012 . . . . 2.72 109.212 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.97 125.14 34.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.672 -0.642 . . . . 0.29 109.718 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.3 -75.09 0.6 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.365 -0.834 . . . . 0.45 110.46 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 30.1 t90 -91.7 146.29 23.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.128 -0.982 . . . . 0.31 110.856 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.66 124.87 14.55 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.814 -0.809 . . . . 2.32 108.814 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.34 -116.13 0.54 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.087 -1.205 . . . . 0.27 110.087 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.59 -149.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -1.07 . . . . 1.39 109.449 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 52.92 3.43 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.312 -1.515 . . . . 0.29 109.312 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.44 147.45 27.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.957 . . . . 0.29 108.613 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.97 135.28 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.068 -1.02 . . . . 0.31 109.873 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.84 140.59 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.64 -0.874 . . . . 0.29 108.64 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.72 179.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.23 110.285 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.67 111.79 6.52 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.558 -0.905 . . . . 1.81 108.558 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.03 -77.65 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.41 -1.329 . . . . 1.18 107.41 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -81.77 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.72 -1.585 . . . . 1.98 106.72 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.93 54.49 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.41 130.43 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.492 -0.755 . . . . 1.12 109.328 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.448 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 97.9 mt -94.4 139.22 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.47 109.718 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.39 164.84 28.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 2.11 109.536 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.02 136.5 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.572 -0.899 . . . . 0.33 108.572 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.0 t -134.96 123.01 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 0.34 109.597 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -53.57 144.5 51.81 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.809 1.006 . . . . 0.42 110.839 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.54 -20.31 65.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.564 -0.71 . . . . 3.12 109.143 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -66.98 -17.89 65.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 3.82 111.64 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.89 28.67 5.55 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.979 -1.076 . . . . 2.08 109.702 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.11 159.52 40.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.841 -0.8 . . . . 0.32 108.841 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.436 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 6.3 mtmp? -139.31 130.29 26.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 1.79 109.635 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.83 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.45 109.593 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 269' ' ' ARG . 25.1 mm -105.26 160.39 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.0 mtt-85 . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.31 -0.868 . . . . 3.63 109.705 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 109.449 -0.574 . . . . 1.48 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . 0.408 ' CA ' ' OD1' ' B' ' 270' ' ' ASP . 39.8 m-85 -135.71 131.16 35.27 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.112 -0.699 . . . . 0.73 109.112 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.91 156.61 17.28 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.139 -1.06 . . . . 3.26 108.139 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 61.6 t -141.58 143.43 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.144 -0.972 . . . . 0.23 110.326 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 226' ' ' TYR . 22.0 m-85 -114.06 155.52 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.821 -1.178 . . . . 0.58 107.821 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.9 p90 -156.89 150.16 24.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.802 -1.186 . . . . 0.44 110.321 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -96.2 152.5 18.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.336 -0.853 . . . . 2.76 109.763 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.67 170.52 9.27 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.402 -0.962 . . . . 2.23 108.402 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.95 -12.44 53.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.981 -1.074 . . . . 1.81 109.198 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.72 -11.41 39.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.316 -0.865 . . . . 3.64 109.985 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 1.8 p30 -157.14 129.78 4.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.992 -1.067 . . . . 2.16 109.985 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.13 6.76 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 120.989 1.126 . . . . 1.27 110.627 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.57 142.69 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.762 -1.211 . . . . 1.76 109.688 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -60.93 -172.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.67 109.015 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.46 -161.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.214 -0.929 . . . . 1.44 108.604 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.25 166.96 54.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.433 -1.467 . . . . 0.4 109.433 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.94 159.35 53.6 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.402 1.401 . . . . 0.41 109.847 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.94 171.76 14.03 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.21 109.005 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.46 140.46 29.55 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.947 . . . . 2.72 109.184 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.3 tp -89.07 125.16 34.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.617 -0.677 . . . . 0.3 109.791 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.6 mt -114.32 -75.03 0.6 Allowed 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.302 -0.874 . . . . 0.45 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 29.8 t90 -91.78 146.3 23.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.223 -0.923 . . . . 0.33 110.887 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.62 124.86 14.57 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.89 -0.781 . . . . 2.33 108.89 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -116.15 0.54 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.029 -1.228 . . . . 0.28 110.029 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -67.45 -149.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.489 -1.007 . . . . 1.4 109.595 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.25 52.99 3.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.38 -1.488 . . . . 0.29 109.38 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.41 147.43 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.483 -1.01 . . . . 0.29 108.626 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 135.34 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.947 -1.095 . . . . 0.31 109.837 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.89 140.64 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.3 108.6 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.82 179.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.17 -0.956 . . . . 0.24 110.211 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.57 111.8 6.56 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.577 -0.898 . . . . 1.81 108.577 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.04 -77.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.482 -1.303 . . . . 1.18 107.482 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -81.65 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.788 -1.56 . . . . 1.97 106.788 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.99 54.5 0.71 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.062 -1.088 . . . . 1.38 108.062 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.39 130.37 7.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.12 109.347 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 97.9 mt -94.28 139.3 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.48 109.669 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -139.51 164.8 28.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.468 -0.77 . . . . 2.13 109.489 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.93 136.44 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.588 -0.893 . . . . 0.34 108.588 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 71.8 t -134.99 122.98 15.55 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.373 -0.83 . . . . 0.34 109.579 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -53.49 144.54 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.801 1.001 . . . . 0.42 110.927 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.59 -20.35 65.99 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.557 -0.714 . . . . 3.11 109.099 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.85 -18.07 65.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 3.82 111.631 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.82 28.65 5.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.005 -1.06 . . . . 2.08 109.68 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.04 159.6 40.3 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.803 -0.814 . . . . 0.32 108.803 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.435 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 6.3 mtmp? -139.3 130.3 26.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.169 -0.957 . . . . 1.79 109.675 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.86 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.45 109.627 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.439 HG22 ' N ' ' B' ' 269' ' ' ARG . 25.2 mm -105.37 160.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.644 -0.872 . . . . 0.57 108.644 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.32 26.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 3.62 109.719 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.408 ' OD1' ' CA ' ' B' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.043 -1.035 . . . . 2.05 108.965 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.003 -0.74 . . . . 1.48 109.003 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.54 125.67 26.15 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.235 -0.916 . . . . 0.72 109.788 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.02 164.46 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.756 -1.202 . . . . 3.26 107.756 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.02 141.65 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 0.23 109.972 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -108.83 151.98 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.523 -1.288 . . . . 0.58 107.523 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 8.2 p90 -153.73 152.23 30.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.77 -1.206 . . . . 0.44 110.332 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -94.13 153.14 18.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.76 110.245 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -92.3 171.09 9.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.2 t -87.77 -10.95 49.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.02 -1.05 . . . . 1.8 109.548 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -90.01 -14.51 33.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 3.63 109.611 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 234' ' ' VAL . 47.3 m-20 -161.3 130.57 3.19 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 2.16 109.29 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -65.93 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.804 1.003 . . . . 1.25 110.553 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 232' ' ' ASP . 21.7 m -83.48 140.37 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.846 -1.159 . . . . 1.75 109.736 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -60.68 167.21 2.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.66 109.516 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 237' ' ' GLY . 29.8 tttm -125.78 162.78 24.33 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.488 -0.757 . . . . 1.43 109.267 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.07 166.55 0.03 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.503 -1.039 . . . . 0.39 110.503 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.6 159.48 53.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.782 1.655 . . . . 0.41 110.458 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.22 5.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 0.21 109.164 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.95 138.95 34.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.029 -1.045 . . . . 2.72 109.835 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.7 tp -88.77 123.7 33.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.438 -0.788 . . . . 0.29 109.494 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.67 -74.51 0.61 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.474 -0.766 . . . . 0.45 110.286 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.36 143.62 26.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.139 -0.975 . . . . 0.31 110.191 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -147.53 118.53 7.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.875 . . . . 2.32 108.977 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.91 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.717 -1.23 . . . . 0.27 110.471 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -68.65 -153.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.269 -1.136 . . . . 1.39 109.917 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.46 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.139 -1.585 . . . . 0.29 109.139 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.83 155.15 40.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -1.099 . . . . 0.29 109.189 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.37 126.33 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.31 109.307 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.54 137.85 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 24.5 pt -141.97 179.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.23 110.344 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.492 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -142.17 114.04 8.03 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.19 -80.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.28 -1.378 . . . . 1.18 107.28 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 255' ' ' SER . 33.2 t30 -80.71 -130.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.572 -1.64 . . . . 1.98 106.572 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.587 ' H ' ' ND2' ' A' ' 254' ' ' ASN . 75.4 m -104.13 53.74 0.74 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.161 -0.962 . . . . 1.39 108.493 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.09 127.7 7.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.542 -0.723 . . . . 1.12 109.293 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.492 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.7 mt -92.66 136.38 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 0.47 109.493 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.1 172.15 13.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.234 -0.916 . . . . 2.11 109.873 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.91 137.29 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.479 -0.763 . . . . 0.33 109.935 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.05 130.21 19.32 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.423 -0.798 . . . . 0.34 108.95 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.48 142.25 97.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 109.706 -0.921 . . . . 0.42 109.706 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -63.63 -30.11 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.149 -0.97 . . . . 3.12 109.15 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.91 -10.77 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.38 -0.825 . . . . 3.82 109.873 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -119.48 25.44 10.06 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.382 -0.824 . . . . 2.08 108.883 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.494 -0.754 . . . . 0.32 109.833 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.444 ' HZ2' HD11 ' A' ' 268' ' ' ILE . 6.7 mtmp? -139.13 130.75 27.32 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.329 -0.857 . . . . 1.79 108.812 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.91 109.07 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.45 110.475 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.444 HD11 ' HZ2' ' A' ' 266' ' ' LYS . 23.5 mm -108.74 147.8 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.131 -1.062 . . . . 0.57 108.131 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 3.63 109.921 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.06 -0.718 . . . . 1.48 109.06 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.51 125.59 26.06 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.239 -0.913 . . . . 0.73 109.743 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.92 164.53 12.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.793 -1.188 . . . . 3.26 107.793 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.1 141.63 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.23 110.01 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.87 152.0 25.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.558 -1.275 . . . . 0.58 107.558 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.2 p90 -153.7 152.2 30.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 0.44 110.336 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -94.1 153.13 18.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.541 -0.724 . . . . 2.76 110.246 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.5 OUTLIER -92.35 171.06 9.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.438 -0.949 . . . . 2.23 108.438 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 44.3 t -87.65 -11.08 49.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.934 -1.104 . . . . 1.81 109.562 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -89.96 -14.46 34.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 3.64 109.67 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' B' ' 234' ' ' VAL . 47.1 m-20 -161.31 130.67 3.21 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.108 -0.995 . . . . 2.16 109.224 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.01 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 120.828 1.018 . . . . 1.27 110.459 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 232' ' ' ASP . 21.6 m -83.5 140.36 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.876 -1.14 . . . . 1.76 109.762 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -60.69 167.25 2.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.212 -0.93 . . . . 0.67 109.609 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' B' ' 237' ' ' GLY . 29.8 tttm -125.76 162.77 24.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.76 . . . . 1.44 109.246 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.14 166.61 0.03 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.477 -1.049 . . . . 0.4 110.477 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.66 159.54 53.11 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.691 1.594 . . . . 0.41 110.491 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.16 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.35 -0.844 . . . . 0.21 109.158 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -98.02 139.06 34.41 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.027 -1.046 . . . . 2.72 109.923 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -88.93 123.64 33.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.401 -0.812 . . . . 0.3 109.504 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.66 -74.44 0.61 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.413 -0.805 . . . . 0.45 110.298 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.34 143.61 26.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.174 -0.954 . . . . 0.33 110.217 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -147.62 118.57 7.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.258 -0.901 . . . . 2.33 108.816 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.95 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.679 -1.248 . . . . 0.28 110.518 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.65 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -1.172 . . . . 1.4 109.94 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.68 48.4 2.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.186 -1.565 . . . . 0.29 109.186 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.18 40.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.29 109.166 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 249' ' ' VAL . 26.6 m -146.32 126.33 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.31 109.296 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.59 137.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.938 -1.134 . . . . 0.3 107.938 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 24.4 pt -141.8 179.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.24 110.362 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.497 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -142.35 114.08 7.98 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.637 -0.875 . . . . 1.81 108.637 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -91.2 -80.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.188 -1.412 . . . . 1.18 107.188 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' B' ' 255' ' ' SER . 33.1 t30 -80.72 -130.06 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.612 -1.625 . . . . 1.97 106.612 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.599 ' H ' ' ND2' ' B' ' 254' ' ' ASN . 75.5 m -104.16 53.77 0.74 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.135 -0.978 . . . . 1.38 108.535 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.07 127.72 8.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.506 -0.746 . . . . 1.12 109.329 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.497 ' CG1' HE21 ' B' ' 252' ' ' GLN . 60.8 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.342 -0.849 . . . . 0.48 109.438 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.16 172.05 13.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.246 -0.909 . . . . 2.13 109.836 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.77 137.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 0.34 109.948 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.11 130.2 19.26 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.884 -0.784 . . . . 0.34 108.884 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.44 142.32 97.8 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 N-CA-C 109.739 -0.908 . . . . 0.42 109.739 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -63.71 -30.16 71.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 3.11 109.144 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.96 -10.63 51.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 3.82 109.895 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -119.53 25.46 10.03 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.347 -0.846 . . . . 2.08 108.825 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.85 161.11 39.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.577 -0.702 . . . . 0.32 109.905 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.442 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.7 mtmp? -139.17 130.76 27.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.327 -0.858 . . . . 1.79 108.784 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.0 mm -87.96 109.14 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.211 -0.93 . . . . 0.45 110.416 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.442 HD11 ' HZ1' ' B' ' 266' ' ' LYS . 23.6 mm -108.83 147.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.184 -1.043 . . . . 0.57 108.184 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.86 18.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.388 -0.82 . . . . 3.62 109.938 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 117.977 -1.011 . . . . 2.05 109.529 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.786 -0.82 . . . . 1.48 108.786 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -117.51 135.13 54.15 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.193 -0.669 . . . . 0.72 109.193 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -104.82 159.19 15.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.901 -1.148 . . . . 3.26 107.901 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.98 140.95 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.23 110.219 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.83 153.47 24.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.487 -1.301 . . . . 0.58 107.487 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.3 p90 -156.38 151.45 26.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.44 110.123 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -95.76 143.26 27.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.371 -0.831 . . . . 2.76 109.838 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.7 168.34 10.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.818 . . . . 2.23 108.989 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.86 8.82 7.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.984 . . . . 1.8 109.297 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.63 -39.22 15.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 3.63 109.523 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.3 p-10 -158.22 148.32 15.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.014 . . . . 2.16 109.306 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.88 10.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.172 1.248 . . . . 1.25 110.958 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.3 t -83.51 152.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.75 -1.219 . . . . 1.75 109.773 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.84 165.04 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.964 -0.754 . . . . 0.66 108.964 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.9 tttp -119.38 159.4 24.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.478 -0.764 . . . . 1.43 109.212 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.81 165.99 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.361 -1.095 . . . . 0.39 110.361 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.92 161.61 41.6 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.525 1.483 . . . . 0.41 110.405 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.23 173.4 11.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.862 -0.792 . . . . 0.21 108.862 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.06 137.01 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.095 -1.003 . . . . 2.72 109.608 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.38 123.07 31.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.635 -0.665 . . . . 0.29 109.366 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -115.76 -73.51 0.65 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.434 -0.791 . . . . 0.45 110.091 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.2 t90 -93.55 146.59 23.69 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.281 -0.887 . . . . 0.31 109.974 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -146.86 125.38 12.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 2.32 109.065 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -110.02 0.34 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.824 -1.179 . . . . 0.27 110.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.87 -150.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -1.1 . . . . 1.39 109.858 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.86 2.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.357 -1.497 . . . . 0.29 109.357 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.1 150.7 34.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.509 -0.995 . . . . 0.29 108.668 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.56 129.27 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.31 109.759 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.5 t -89.79 137.41 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.027 -1.101 . . . . 0.29 108.027 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.4 pt -141.22 177.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.301 -0.875 . . . . 0.23 109.929 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -144.09 110.75 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.472 -0.936 . . . . 1.81 108.472 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.01 -79.12 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.53 -1.285 . . . . 1.18 107.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.22 -130.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.48 -1.674 . . . . 1.98 106.48 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.9 t -105.26 54.93 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.992 -1.114 . . . . 1.39 107.992 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.56 125.48 5.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.166 -0.679 . . . . 1.12 109.166 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -92.36 138.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.887 . . . . 0.47 109.491 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -140.01 167.08 22.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.393 -0.817 . . . . 2.11 109.684 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.82 139.0 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.33 109.221 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -136.11 134.15 20.07 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.34 108.916 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.65 142.86 98.83 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 N-CA-C 109.85 -0.865 . . . . 0.42 109.85 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.417 ' HG2' ' NH1' ' A' ' 262' ' ' ARG . 6.4 tpt180 -60.69 -34.39 74.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 3.12 109.555 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -68.87 -7.1 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.241 -0.912 . . . . 3.82 110.846 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -119.0 19.0 13.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.073 -1.017 . . . . 2.08 108.839 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.36 168.71 19.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.897 -0.779 . . . . 0.32 108.897 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.43 129.72 23.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.977 . . . . 1.79 109.541 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.83 106.03 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.326 -0.859 . . . . 0.45 109.721 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.6 152.08 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.231 -0.918 . . . . 0.57 108.815 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.789 . . . . 3.63 109.642 179.773 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . 0.422 ' O ' ' OXT' ' B' ' 270' ' ' ASP . 19.3 m-20 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.774 -0.825 . . . . 1.48 108.774 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.35 135.24 54.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.573 -0.704 . . . . 0.73 109.189 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -104.97 159.11 16.07 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.897 -1.149 . . . . 3.26 107.897 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 81.1 t -140.96 140.99 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.185 -0.947 . . . . 0.23 110.22 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.79 153.45 24.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.509 -1.293 . . . . 0.58 107.509 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.5 p90 -156.36 151.39 26.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.68 -1.263 . . . . 0.44 110.114 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -95.78 143.26 27.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.485 -0.759 . . . . 2.76 109.857 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.72 168.32 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 2.23 109.059 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.83 8.79 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 1.81 109.301 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.56 -39.21 15.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 3.64 109.497 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.3 p-10 -158.34 148.27 15.34 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.147 -0.97 . . . . 2.16 109.294 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.85 10.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.222 1.281 . . . . 1.27 110.854 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.3 t -83.43 152.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.788 -1.195 . . . . 1.76 109.732 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.85 164.99 25.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.474 -0.766 . . . . 0.67 109.015 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.8 tttp -119.31 159.4 24.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.444 -0.785 . . . . 1.44 109.241 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.9 165.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.305 -1.118 . . . . 0.4 110.305 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.86 161.61 41.44 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.602 1.535 . . . . 0.41 110.41 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.31 173.48 11.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.811 -0.811 . . . . 0.21 108.811 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.07 137.06 34.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.124 -0.985 . . . . 2.72 109.559 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.56 123.09 32.08 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.7 . . . . 0.3 109.345 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.75 -73.5 0.65 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.414 -0.804 . . . . 0.45 109.996 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.45 146.61 23.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.91 . . . . 0.33 109.979 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -146.9 125.46 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.295 -0.878 . . . . 2.33 108.981 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -110.02 0.34 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.755 -1.212 . . . . 0.28 110.288 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.85 -150.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -1.062 . . . . 1.4 109.863 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 48.94 2.8 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.298 -1.521 . . . . 0.29 109.298 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.19 150.64 34.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.461 -1.023 . . . . 0.29 108.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.9 m -145.54 129.29 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.31 109.699 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.73 137.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.096 -1.076 . . . . 0.3 108.096 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.29 176.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.317 -0.864 . . . . 0.24 109.907 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -144.09 110.7 5.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.489 -0.93 . . . . 1.81 108.489 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.99 -79.17 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.536 -1.283 . . . . 1.18 107.536 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.12 -130.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.539 -1.652 . . . . 1.97 106.539 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.0 t -105.28 54.86 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.985 -1.117 . . . . 1.38 107.985 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.53 125.53 6.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.579 -0.701 . . . . 1.12 109.156 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.2 mt -92.41 137.93 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.375 -0.828 . . . . 0.48 109.519 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -139.9 167.22 22.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.432 -0.792 . . . . 2.13 109.704 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -103.95 138.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.412 -0.805 . . . . 0.34 109.203 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.03 134.13 20.16 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.34 108.966 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.57 142.83 98.58 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 120.597 0.865 . . . . 0.42 109.855 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' B' ' 262' ' ' ARG . 6.5 tpt180 -60.7 -34.32 74.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 3.11 109.569 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -68.89 -7.19 32.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.27 -0.894 . . . . 3.82 110.787 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -118.97 19.02 13.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.227 -0.921 . . . . 2.08 108.79 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 168.74 19.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.849 -0.797 . . . . 0.32 108.849 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.44 129.76 23.83 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.139 -0.976 . . . . 1.79 109.568 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.81 105.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.26 -0.9 . . . . 0.45 109.728 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.67 152.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.57 108.737 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 58.7 ttt180 -90.95 146.13 24.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.361 -0.837 . . . . 3.62 109.69 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.422 ' OXT' ' O ' ' B' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.933 -1.032 . . . . 2.05 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.27 0.557 . . . . 1.48 109.657 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.7 130.39 38.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.785 -0.82 . . . . 0.72 108.785 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -99.27 150.71 21.82 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.459 -1.311 . . . . 3.26 107.459 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.06 136.47 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.205 -0.935 . . . . 0.23 110.559 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -107.97 156.96 18.64 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.737 -1.209 . . . . 0.58 107.737 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.2 p90 -157.84 152.67 25.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.569 -1.332 . . . . 0.44 110.334 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.7 mtm-85 -93.37 144.36 25.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.44 -0.788 . . . . 2.76 109.837 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.75 175.4 6.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.405 -0.809 . . . . 2.23 109.328 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.68 -10.75 44.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.188 -0.945 . . . . 1.8 109.247 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -89.67 -15.23 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 3.63 109.617 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -159.55 129.28 3.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.143 -0.973 . . . . 2.16 109.204 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.06 8.57 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 120.8 1.0 . . . . 1.25 111.273 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.0 p -85.66 164.15 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.552 -1.342 . . . . 1.75 110.291 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.562 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.9 m95 -76.03 163.49 27.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.746 -0.596 . . . . 0.66 109.532 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 237' ' ' GLY . 2.5 mtpp -118.44 165.16 14.24 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 108.658 -0.867 . . . . 1.43 108.658 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.06 164.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.998 -1.241 . . . . 0.39 109.998 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.89 159.97 43.36 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.471 1.447 . . . . 0.41 110.659 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.56 164.22 30.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.508 -0.923 . . . . 0.21 108.508 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.67 143.52 26.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.023 -1.048 . . . . 2.72 109.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.86 128.36 36.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.45 -0.781 . . . . 0.29 110.563 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 mt -119.16 -70.61 0.78 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.515 -0.74 . . . . 0.45 110.137 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -91.96 137.85 32.02 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -144.07 115.72 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.985 -0.746 . . . . 2.32 108.985 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.71 -104.08 0.22 Allowed Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.839 -1.172 . . . . 0.27 110.293 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.97 -157.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 1.39 109.602 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 47.67 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.037 -1.625 . . . . 0.29 109.037 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.34 151.98 38.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.519 -0.989 . . . . 0.29 108.769 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.78 134.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.31 109.435 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -95.5 138.11 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.137 -1.06 . . . . 0.29 108.137 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.0 176.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.23 109.818 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.68 109.28 5.65 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.455 -0.943 . . . . 1.81 108.455 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.7 -77.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.37 -1.344 . . . . 1.18 107.37 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.23 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.937 -1.505 . . . . 1.98 106.937 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.6 m -97.97 56.06 1.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.681 -1.229 . . . . 1.39 107.681 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.56 130.37 7.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 1.12 109.46 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.91 135.5 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.47 109.329 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -136.52 168.99 18.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 2.11 109.683 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.99 140.08 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.344 -0.848 . . . . 0.33 109.568 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.78 126.1 13.23 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.396 -0.815 . . . . 0.34 109.188 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.95 140.56 86.03 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.642 0.895 . . . . 0.42 110.237 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -58.97 -37.33 76.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 3.12 109.533 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -69.8 -1.64 9.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 3.82 110.242 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HG3' HH12 ' A' ' 228' ' ' ARG . 2.5 mptm? -118.32 17.04 13.93 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.681 -0.859 . . . . 2.08 108.681 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.85 175.14 9.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.421 -0.8 . . . . 0.32 109.724 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.8 128.46 21.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.316 -0.865 . . . . 1.79 109.127 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.7 mm -88.74 109.72 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.43 -0.794 . . . . 0.45 109.86 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.42 153.61 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.692 -0.855 . . . . 0.57 108.692 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.5 mtt-85 . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.272 -0.892 . . . . 3.63 109.883 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.281 0.562 . . . . 1.48 109.799 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.6 130.5 38.44 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.756 -0.831 . . . . 0.73 108.756 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 224' ' ' ARG . 20.2 mtm-85 -99.46 150.68 21.94 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 3.26 107.48 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.2 t -139.05 136.64 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.254 -0.904 . . . . 0.23 110.476 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.09 157.09 18.57 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.649 -1.241 . . . . 0.58 107.649 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.9 152.66 25.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.656 -1.278 . . . . 0.44 110.288 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.427 HH12 ' HG3' ' B' ' 264' ' ' LYS . 2.7 mtm-85 -93.38 144.39 25.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.374 -0.828 . . . . 2.76 109.853 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.79 175.21 6.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.382 -0.824 . . . . 2.23 109.316 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.39 -10.98 44.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.262 -0.899 . . . . 1.81 109.259 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -89.65 -15.2 33.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 3.64 109.702 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.2 m-20 -159.59 129.28 3.31 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.961 . . . . 2.16 109.249 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -65.03 8.35 0.22 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 120.882 1.055 . . . . 1.27 111.21 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.0 p -85.4 164.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.557 -1.34 . . . . 1.76 110.19 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.9 m95 -76.25 163.51 26.97 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' B' ' 237' ' ' GLY . 2.5 mtpp -118.53 165.15 14.27 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.644 -0.873 . . . . 1.44 108.644 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.15 164.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.184 -1.167 . . . . 0.4 110.184 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -64.9 160.0 43.3 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.488 1.459 . . . . 0.41 110.643 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.63 164.09 31.12 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.586 -0.894 . . . . 0.21 108.586 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.71 143.63 26.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.007 -1.058 . . . . 2.72 109.393 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.5 tp -90.04 128.45 36.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.594 -0.691 . . . . 0.3 110.4 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 32.8 mt -119.25 -70.55 0.78 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.573 -0.704 . . . . 0.45 110.102 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -92.01 137.86 32.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.152 -0.968 . . . . 0.33 110.7 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -144.05 115.83 8.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.8 . . . . 2.33 108.929 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -104.15 0.22 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.161 -1.176 . . . . 0.28 110.161 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.98 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 1.4 109.615 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.63 47.49 2.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.1 -1.6 . . . . 0.29 109.1 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.22 151.95 38.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.997 . . . . 0.29 108.865 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.79 134.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.31 109.502 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 89.9 t -95.48 138.04 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.155 -1.054 . . . . 0.3 108.155 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' B' ' 251' ' ' ILE . 12.8 pt -139.85 176.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.24 109.945 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.61 109.29 5.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.54 -0.911 . . . . 1.81 108.54 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.76 -77.35 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.304 -1.369 . . . . 1.18 107.304 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.19 -138.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.925 -1.509 . . . . 1.97 106.925 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.4 m -97.96 55.98 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.68 -1.23 . . . . 1.38 107.68 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.48 130.44 7.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.61 -0.681 . . . . 1.12 109.394 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 55.5 mt -95.8 135.61 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.48 109.307 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.71 169.03 18.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 2.13 109.574 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.93 140.02 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.34 109.611 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 53.3 t -138.69 126.05 13.31 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.34 109.221 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.81 140.48 85.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 120.616 0.877 . . . . 0.42 110.225 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -58.87 -37.33 76.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 3.11 109.449 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -69.96 -1.4 9.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.402 -0.811 . . . . 3.82 110.245 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.427 ' HG3' HH12 ' B' ' 228' ' ' ARG . 2.5 mptm? -118.41 16.87 13.86 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.717 -0.846 . . . . 2.08 108.717 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.82 175.29 9.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.413 -0.804 . . . . 0.32 109.742 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.9 128.47 21.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.438 -0.789 . . . . 1.79 109.122 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -88.78 109.57 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.501 -0.749 . . . . 0.45 109.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -105.22 153.59 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 108.742 -0.836 . . . . 0.57 108.742 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.586 HH11 ' CG ' ' B' ' 269' ' ' ARG . 3.6 mtt-85 -94.57 137.05 34.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.228 -0.92 . . . . 3.62 109.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' B' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.045 -1.034 . . . . 2.05 109.677 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.273 -0.64 . . . . 1.48 109.273 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.34 133.89 43.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.961 -0.755 . . . . 0.72 108.961 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.73 158.69 17.39 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.192 -1.04 . . . . 3.26 108.192 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.98 140.04 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.23 110.08 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.42 155.43 20.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.72 -1.215 . . . . 0.58 107.72 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.5 p90 -156.18 153.79 29.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.44 110.345 -179.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.93 141.16 29.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.76 . . . . 2.76 109.645 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 9.7 p30 -92.32 162.67 14.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.306 -0.871 . . . . 2.23 109.002 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.3 -2.71 36.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 1.8 109.842 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -89.91 -20.73 23.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.181 -0.949 . . . . 3.63 109.541 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 234' ' ' VAL . 14.5 m-20 -162.1 130.96 3.03 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.978 . . . . 2.16 108.969 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -63.57 8.44 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.751 0.968 . . . . 1.25 110.422 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.1 m -82.77 139.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.037 -1.04 . . . . 1.75 109.477 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -57.01 162.73 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.026 -1.046 . . . . 0.66 109.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 237' ' ' GLY . 39.3 tttp -119.18 165.0 14.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.483 -0.761 . . . . 1.43 109.091 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.45 166.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.111 -1.196 . . . . 0.39 110.111 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.51 162.18 43.06 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.641 1.561 . . . . 0.41 110.405 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.53 178.47 7.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.966 -0.753 . . . . 0.21 108.966 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.94 140.93 29.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.134 -0.979 . . . . 2.72 109.302 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.03 123.74 33.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.604 -0.685 . . . . 0.29 109.736 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 28.0 mt -113.45 -74.69 0.62 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.436 -0.79 . . . . 0.45 109.89 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.44 30.66 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.154 -0.966 . . . . 0.31 109.783 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.26 116.93 8.13 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.667 -0.864 . . . . 2.32 108.667 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -100.84 0.18 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.8 -1.191 . . . . 0.27 110.261 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.51 -157.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -1.096 . . . . 1.39 109.842 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.09 49.51 2.92 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.163 -1.575 . . . . 0.29 109.163 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.67 154.51 39.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -1.003 . . . . 0.29 108.499 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.11 131.95 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.085 -1.009 . . . . 0.31 109.862 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.6 t -93.84 135.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.29 107.828 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -138.53 177.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.328 -0.858 . . . . 0.23 110.289 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.632 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.2 tt0 -145.07 111.5 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.581 -0.896 . . . . 1.81 108.581 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.83 -78.32 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.2 -1.408 . . . . 1.18 107.2 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -81.88 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.708 -1.59 . . . . 1.98 106.708 177.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 t -101.7 55.82 0.82 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.038 -1.097 . . . . 1.39 108.038 177.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -155.35 124.52 6.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.615 -0.678 . . . . 1.12 109.183 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.632 ' CG1' HE21 ' A' ' 252' ' ' GLN . 70.8 mt -93.52 134.87 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.47 109.202 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -137.42 167.81 20.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 2.11 110.039 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 70.7 t -102.25 139.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.55 -0.719 . . . . 0.33 109.256 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.7 t -136.73 127.97 16.64 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.878 -0.786 . . . . 0.34 108.878 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.8 138.61 86.7 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.913 -0.841 . . . . 0.42 109.913 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.27 -32.27 66.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 3.12 109.428 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.485 HH11 ' HG3' ' A' ' 263' ' ' ARG . 5.1 ttm-85 -67.29 -8.77 34.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.433 -0.792 . . . . 3.82 110.204 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -120.25 18.31 12.26 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.384 -0.823 . . . . 2.08 109.187 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.26 168.6 19.4 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.65 -0.656 . . . . 0.32 109.4 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -141.6 130.99 23.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.79 109.169 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.97 114.77 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.45 109.946 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.66 154.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.69 -0.856 . . . . 0.57 108.69 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.4 mtt-85 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 3.63 109.218 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.294 -0.632 . . . . 1.48 109.294 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -133.41 133.92 43.0 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.937 -0.764 . . . . 0.73 108.937 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -108.67 158.66 17.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.272 -1.01 . . . . 3.26 108.272 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.9 t -140.89 140.0 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.23 110.145 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.28 155.42 19.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.69 -1.226 . . . . 0.58 107.69 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.5 p90 -156.15 153.73 29.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.7 -1.25 . . . . 0.44 110.376 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.92 141.27 29.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.576 -0.703 . . . . 2.76 109.578 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 9.8 p30 -92.34 162.65 14.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.284 -0.885 . . . . 2.23 109.041 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.26 -2.76 36.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 1.81 109.812 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -89.82 -20.98 22.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.124 -0.985 . . . . 3.64 109.548 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' B' ' 234' ' ' VAL . 14.6 m-20 -161.82 130.98 3.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 2.16 108.98 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.51 8.37 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.712 0.941 . . . . 1.27 110.454 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.2 m -82.73 139.48 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 1.76 109.409 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.12 162.68 2.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.67 109.53 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -119.19 164.99 14.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.38 -0.825 . . . . 1.44 109.089 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.54 166.59 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.4 110.064 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.44 162.15 43.23 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.721 1.614 . . . . 0.41 110.426 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.47 178.44 7.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.926 -0.768 . . . . 0.21 108.926 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.85 141.02 29.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.14 -0.975 . . . . 2.72 109.368 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.01 123.7 33.57 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.568 -0.707 . . . . 0.3 109.701 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 28.2 mt -113.47 -74.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.414 -0.804 . . . . 0.45 109.859 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.28 30.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.264 -0.897 . . . . 0.33 109.776 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.14 116.98 8.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.657 -0.868 . . . . 2.33 108.657 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.83 -100.82 0.18 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.732 -1.223 . . . . 0.28 110.225 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.46 -157.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 1.4 109.816 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 49.81 3.01 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.42 39.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -1.037 . . . . 0.29 108.49 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.0 m -146.1 131.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.31 109.818 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.83 134.92 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.795 -1.187 . . . . 0.3 107.795 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -138.43 177.93 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.219 -0.926 . . . . 0.24 110.319 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.645 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.1 tt0 -145.08 111.47 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.618 -0.882 . . . . 1.81 108.618 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.8 -78.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.15 -1.426 . . . . 1.18 107.15 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.84 -133.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.733 -1.58 . . . . 1.97 106.733 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.3 t -101.83 55.85 0.81 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -155.26 124.6 6.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 1.12 109.168 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.645 ' CG1' HE21 ' B' ' 252' ' ' GLN . 71.2 mt -93.66 134.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.284 -0.885 . . . . 0.48 109.123 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -137.38 167.86 20.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.337 -0.852 . . . . 2.13 110.102 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 71.0 t -102.34 139.82 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.676 . . . . 0.34 109.274 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.67 128.07 16.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.914 -0.773 . . . . 0.34 108.914 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.89 138.58 86.52 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 N-CA-C 109.928 -0.835 . . . . 0.42 109.928 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.28 -32.22 66.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 3.11 109.443 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' B' ' 263' ' ' ARG . 5.2 ttm-85 -67.41 -8.76 35.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.478 -0.764 . . . . 3.82 110.12 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -120.2 18.23 12.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.312 -0.868 . . . . 2.08 109.162 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.23 168.44 19.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 0.32 109.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -141.51 130.9 23.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.286 -0.884 . . . . 1.79 109.175 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.81 114.75 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.243 -0.911 . . . . 0.45 109.917 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.67 154.49 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.713 -0.847 . . . . 0.57 108.713 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.4 mtt-85 -89.51 140.36 29.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.88 . . . . 3.62 109.211 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.089 -0.958 . . . . 2.05 109.382 179.892 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.119 -0.697 . . . . 1.48 109.119 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -135.12 142.25 46.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.427 -0.796 . . . . 0.72 109.524 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -115.64 153.8 30.63 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.238 -1.393 . . . . 3.26 107.238 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.2 t -140.74 141.91 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.099 -1.001 . . . . 0.23 110.472 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -109.22 155.0 21.61 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.256 -1.387 . . . . 0.58 107.256 178.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.447 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.0 p90 -156.19 155.6 32.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.547 -1.346 . . . . 0.44 110.618 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -100.68 133.13 45.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.475 0.655 . . . . 2.76 109.358 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 22.2 p-10 -92.35 171.65 8.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.001 -0.741 . . . . 2.23 109.001 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 78.9 p -87.45 -9.15 55.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 1.8 109.661 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.32 -12.24 41.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.91 . . . . 3.63 109.365 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -161.27 128.54 2.65 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.296 -1.001 . . . . 2.16 108.296 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.53 -1.4 9.05 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 120.789 0.993 . . . . 1.25 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 137.89 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.745 -1.222 . . . . 1.75 110.005 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -50.35 166.98 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.089 -1.007 . . . . 0.66 109.219 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 237' ' ' GLY . 1.9 mtpp -119.65 166.37 13.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.67 -0.863 . . . . 1.43 108.67 179.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.31 168.78 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.823 -1.311 . . . . 0.39 109.823 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -66.96 158.87 54.58 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.685 1.59 . . . . 0.41 110.618 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.0 171.02 15.14 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.061 -0.718 . . . . 0.21 109.061 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -94.1 139.14 31.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.179 -0.951 . . . . 2.72 109.733 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.55 126.11 35.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.551 . . . . 0.29 109.515 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.89 -72.06 0.71 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.389 -0.819 . . . . 0.45 110.362 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.473 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.97 142.62 27.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.105 -0.997 . . . . 0.31 110.032 -178.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -148.68 118.59 7.13 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 2.32 109.459 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.22 0.17 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.842 -1.17 . . . . 0.27 110.21 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.6 -155.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -1.076 . . . . 1.39 109.931 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.87 48.71 3.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.689 -1.364 . . . . 0.29 109.689 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.88 154.96 41.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.379 -1.071 . . . . 0.29 108.612 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.39 128.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.075 -1.015 . . . . 0.31 109.787 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.06 132.69 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.955 -1.128 . . . . 0.29 107.955 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 251' ' ' ILE . 13.2 pt -135.64 177.68 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.911 . . . . 0.23 109.864 -179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.43 HE21 HG12 ' A' ' 257' ' ' ILE . 37.5 tt0 -143.69 107.56 4.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.423 -0.798 . . . . 1.81 109.016 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.93 -76.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.748 -1.575 . . . . 1.18 106.748 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -163.32 0.55 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.999 -1.852 . . . . 1.98 105.999 177.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.1 p -79.47 48.79 0.94 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.599 -1.313 . . . . 1.39 108.288 178.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.31 126.7 11.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 1.12 109.175 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.503 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.9 mt -92.07 141.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.47 109.846 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -139.95 167.98 20.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -0.785 . . . . 2.11 109.796 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.19 137.45 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.358 -0.839 . . . . 0.33 109.241 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.2 130.56 19.31 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.461 -0.774 . . . . 0.34 109.038 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.16 137.11 80.35 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 N-CA-C 109.892 -0.849 . . . . 0.42 109.892 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.18 -35.35 69.49 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.202 -0.936 . . . . 3.12 109.427 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.82 -5.24 19.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.408 -0.807 . . . . 3.82 110.257 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.9 22.46 11.93 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.472 -0.936 . . . . 2.08 108.472 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.64 166.02 26.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.32 109.14 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.17 128.19 25.63 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.371 -0.831 . . . . 1.79 109.326 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.46 110.34 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.45 109.834 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.2 mm -105.31 156.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.452 -0.944 . . . . 0.57 108.452 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.06 -1.025 . . . . 3.63 109.229 179.65 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 1.48 109.111 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -135.04 142.21 46.31 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.419 -0.8 . . . . 0.73 109.496 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' B' ' 224' ' ' ARG . 0.3 OUTLIER -115.65 153.84 30.56 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.239 -1.393 . . . . 3.26 107.239 178.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.72 141.83 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.96 . . . . 0.23 110.571 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -109.24 155.01 21.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.162 -1.421 . . . . 0.58 107.162 178.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.1 p90 -156.12 155.69 32.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.604 -1.31 . . . . 0.44 110.63 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -100.94 132.99 46.09 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 2.76 109.442 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 22.3 p-10 -92.21 171.63 8.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 2.23 109.029 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 80.0 p -87.52 -9.09 55.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 1.81 109.633 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.2 -12.44 40.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.93 . . . . 3.64 109.348 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -161.17 128.47 2.66 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.305 -0.998 . . . . 2.16 108.305 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -70.41 -1.49 9.09 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 120.819 1.012 . . . . 1.27 111.065 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.02 137.85 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.749 -1.22 . . . . 1.76 109.933 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -50.49 166.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.073 -1.017 . . . . 0.67 109.182 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' B' ' 237' ' ' GLY . 1.9 mtpp -119.68 166.23 13.47 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.587 -0.894 . . . . 1.44 108.587 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.18 168.64 0.04 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.863 -1.295 . . . . 0.4 109.863 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.83 158.99 53.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.612 1.541 . . . . 0.41 110.749 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.16 170.84 15.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.048 -0.723 . . . . 0.21 109.048 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -93.87 139.06 31.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.077 -1.015 . . . . 2.72 109.77 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -89.48 126.05 35.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.749 -0.594 . . . . 0.3 109.531 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.75 -72.03 0.71 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.48 -0.762 . . . . 0.45 110.352 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.503 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.3 t90 -91.1 142.66 27.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.045 -1.034 . . . . 0.33 109.988 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -148.65 118.53 7.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.239 -0.913 . . . . 2.33 109.488 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.04 0.17 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.856 -1.164 . . . . 0.28 110.245 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.63 -155.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.377 -1.072 . . . . 1.4 109.974 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.94 48.59 3.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.727 -1.349 . . . . 0.29 109.727 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.79 155.07 41.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.29 108.59 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.44 128.73 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.134 -0.979 . . . . 0.31 109.728 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.1 132.71 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.967 -1.123 . . . . 0.3 107.967 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.24 109.848 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.433 HE21 HG12 ' B' ' 257' ' ' ILE . 37.4 tt0 -143.65 107.64 4.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 1.81 109.079 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.05 -76.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.762 -1.57 . . . . 1.18 106.762 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -163.25 0.54 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.975 -1.861 . . . . 1.97 105.975 177.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 15.2 p -79.53 48.85 0.95 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.519 -1.363 . . . . 1.38 108.315 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.37 126.72 11.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.533 -0.729 . . . . 1.12 109.213 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.8 mt -92.07 141.57 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 0.48 109.824 -179.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -140.09 167.96 20.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.344 -0.848 . . . . 2.13 109.815 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.12 137.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.391 -0.818 . . . . 0.34 109.279 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.17 130.58 19.35 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.455 -0.778 . . . . 0.34 108.991 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.27 137.07 79.98 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 109.86 -0.862 . . . . 0.42 109.86 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -57.05 -35.54 69.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 3.11 109.433 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.81 -5.05 18.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.824 . . . . 3.82 110.372 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.87 22.22 12.06 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.542 -0.91 . . . . 2.08 108.542 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.4 166.16 25.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.535 -0.728 . . . . 0.32 109.133 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -138.21 128.1 25.41 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.361 -0.837 . . . . 1.79 109.396 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.43 110.31 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.45 109.888 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.3 mm -105.33 156.9 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.421 -0.955 . . . . 0.57 108.421 179.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.97 138.78 31.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.13 -0.981 . . . . 3.62 109.253 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.068 -1.02 . . . . 2.05 109.532 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.6 m120 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.297 -0.631 . . . . 1.48 109.297 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.08 141.97 47.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.518 -0.739 . . . . 0.72 109.166 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -116.96 157.71 25.29 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.558 -1.275 . . . . 3.26 107.558 178.827 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.39 145.45 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.949 -1.094 . . . . 0.23 110.55 -179.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.79 161.97 15.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.017 -1.105 . . . . 0.58 108.017 178.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.84 149.54 23.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.87 -1.144 . . . . 0.44 110.231 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.73 159.03 15.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 2.76 109.881 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.9 OUTLIER -95.45 170.91 9.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.041 -0.726 . . . . 2.23 109.041 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.9 t -91.37 -15.05 29.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 1.8 108.982 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.3 mtt-85 -90.21 -15.07 32.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.857 . . . . 3.63 109.793 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.7 m-20 -161.19 128.8 2.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 2.16 109.173 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.77 17.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.813 1.008 . . . . 1.25 110.603 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 232' ' ' ASP . 32.7 m -80.9 130.93 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.785 -1.197 . . . . 1.75 109.834 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.78 174.82 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.66 109.398 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -122.62 -166.24 1.4 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.206 -1.035 . . . . 1.43 108.206 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.12 -179.31 51.75 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.287 -1.525 . . . . 0.39 109.287 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.4 149.01 49.72 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.695 1.596 . . . . 0.41 110.446 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.28 167.1 22.25 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.99 -0.744 . . . . 0.21 108.99 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -91.54 140.81 29.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.047 -1.033 . . . . 2.72 110.081 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.03 129.85 35.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.807 -0.558 . . . . 0.29 109.8 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.1 mt -118.03 -72.54 0.68 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.57 -0.707 . . . . 0.45 110.42 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.405 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.24 143.23 26.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.31 110.845 -178.04 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -143.89 112.6 6.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.839 -0.801 . . . . 2.32 108.839 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.67 -103.58 0.36 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.968 -1.253 . . . . 0.27 109.968 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.43 -154.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -1.162 . . . . 1.39 109.503 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.25 3.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.7 -1.76 . . . . 0.29 108.7 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.69 35.84 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.57 -0.959 . . . . 0.29 108.603 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.11 128.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.083 -1.011 . . . . 0.31 109.619 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 54.1 t -92.84 128.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.212 -1.032 . . . . 0.29 108.212 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.42 -179.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -0.793 . . . . 0.23 109.865 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.581 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.5 tt0 -142.66 109.96 5.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.278 -1.008 . . . . 1.81 108.278 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -86.03 -81.02 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.298 -1.371 . . . . 1.18 107.298 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.837 -1.542 . . . . 1.98 106.837 177.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 35.0 t -100.58 53.71 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.052 -1.092 . . . . 1.39 108.052 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.53 124.23 5.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 1.12 109.375 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.581 ' CG1' HE21 ' A' ' 252' ' ' GLN . 22.2 mt -90.46 131.19 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.902 . . . . 0.47 109.257 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 258' ' ' LYS . 0.0 OUTLIER -131.64 167.99 18.5 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.446 -0.784 . . . . 2.11 109.74 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 142.06 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.33 109.446 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.16 130.09 17.19 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.485 -0.932 . . . . 0.34 108.485 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.19 141.99 90.18 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 N-CA-C 109.93 -0.834 . . . . 0.42 109.93 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.94 -31.15 66.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 3.12 109.101 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.08 -11.21 60.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.398 -0.814 . . . . 3.82 110.325 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.09 21.91 12.11 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 2.08 108.991 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.03 16.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.472 -0.767 . . . . 0.32 109.339 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -140.53 125.67 18.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 1.79 109.262 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.35 113.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.234 -0.917 . . . . 0.45 109.17 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.01 153.67 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.455 -0.778 . . . . 0.57 109.044 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 269' ' ' ARG . 18.4 mtm-85 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.468 -0.77 . . . . 3.63 109.485 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 28.3 m120 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.36 -0.607 . . . . 1.48 109.36 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -134.09 141.9 47.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.411 -0.806 . . . . 0.73 109.138 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -116.83 157.7 25.16 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.566 -1.272 . . . . 3.26 107.566 178.769 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.41 145.47 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.008 -1.057 . . . . 0.23 110.624 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.8 162.06 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.956 -1.127 . . . . 0.58 107.956 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.6 p90 -156.85 149.57 23.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.882 -1.136 . . . . 0.44 110.194 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -96.67 159.09 15.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 2.76 109.945 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -95.55 170.9 9.02 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.996 -0.742 . . . . 2.23 108.996 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.5 t -91.4 -15.09 29.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 1.81 108.827 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 231' ' ' ARG . 2.3 mtt-85 -90.23 -14.99 32.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 3.64 109.81 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.6 m-20 -161.15 128.9 2.76 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 2.16 109.114 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.93 17.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.844 1.03 . . . . 1.27 110.602 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' B' ' 232' ' ' ASP . 32.7 m -80.93 130.9 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.916 -1.115 . . . . 1.76 109.826 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.8 174.89 0.14 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -0.936 . . . . 0.67 109.532 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -122.66 -166.22 1.4 Allowed 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 108.157 -1.053 . . . . 1.44 108.157 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.1 -179.2 51.75 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.321 -1.512 . . . . 0.4 109.321 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.42 149.0 49.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.803 1.669 . . . . 0.41 110.421 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.35 167.12 22.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.944 -0.762 . . . . 0.21 108.944 179.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -91.57 140.76 29.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.0 -1.063 . . . . 2.72 110.069 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 tp -88.92 129.77 35.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.751 -0.593 . . . . 0.3 109.814 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.91 -72.58 0.68 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.363 -0.836 . . . . 0.45 110.416 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -90.27 143.06 27.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.33 110.887 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' B' ' 244' ' ' LYS . 0.9 OUTLIER -143.68 112.72 6.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.807 . . . . 2.33 108.938 179.172 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.65 -103.58 0.36 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.896 -1.281 . . . . 0.28 109.896 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.37 -154.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -1.119 . . . . 1.4 109.492 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.23 3.54 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.678 -1.769 . . . . 0.29 108.678 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.57 35.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.582 -0.952 . . . . 0.29 108.644 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.05 128.7 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.034 -1.041 . . . . 0.31 109.679 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.81 128.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.195 -1.039 . . . . 0.3 108.195 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.5 pt -134.31 -179.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.377 -0.827 . . . . 0.24 109.908 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.583 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -142.7 109.82 5.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.378 -0.971 . . . . 1.81 108.378 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -85.98 -81.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.281 -1.377 . . . . 1.18 107.281 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.48 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.823 -1.547 . . . . 1.97 106.823 177.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 34.9 t -100.6 53.73 0.87 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.046 -1.094 . . . . 1.38 108.046 178.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.54 124.42 5.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.604 -0.685 . . . . 1.12 109.327 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.583 ' CG1' HE21 ' B' ' 252' ' ' GLN . 21.9 mt -90.59 131.16 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.48 109.25 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . 0.593 ' HZ2' ' HB2' ' B' ' 258' ' ' LYS . 0.0 OUTLIER -131.63 168.0 18.48 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 2.13 109.743 -179.613 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.64 142.11 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.457 -0.777 . . . . 0.34 109.436 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 51.0 t -137.19 130.01 17.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.45 -0.944 . . . . 0.34 108.45 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 141.91 90.47 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.904 -0.845 . . . . 0.42 109.904 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.93 -31.15 66.54 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 3.11 109.132 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -70.13 -11.09 60.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 3.82 110.373 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.16 21.94 12.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.271 -0.893 . . . . 2.08 108.899 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.05 16.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.32 109.324 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -140.59 125.67 18.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 1.79 109.279 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.25 113.1 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -0.915 . . . . 0.45 109.235 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.92 153.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.57 109.093 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' B' ' 269' ' ' ARG . 18.5 mtm-85 -95.75 135.93 36.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 3.62 109.392 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.912 -1.042 . . . . 2.05 109.029 179.48 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.218 0.533 . . . . 1.48 110.143 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -135.5 125.23 25.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.438 -0.789 . . . . 0.72 109.09 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -101.44 159.12 15.55 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.243 -1.021 . . . . 3.26 108.243 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.19 143.77 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.099 -1.001 . . . . 0.23 110.895 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.42 156.73 19.11 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.243 -1.391 . . . . 0.58 107.243 178.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.9 p90 -157.69 152.86 25.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.549 -1.345 . . . . 0.44 110.697 -179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -99.49 135.3 41.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.622 -0.674 . . . . 2.76 109.751 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -95.85 178.93 5.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.847 . . . . 2.23 109.185 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 73.9 p -91.21 -10.8 40.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.916 . . . . 1.8 109.429 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 232' ' ' ASP . 53.6 mtp180 -84.1 -19.05 34.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.205 -0.935 . . . . 3.63 109.481 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 231' ' ' ARG . 43.2 m-20 -159.37 129.04 3.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.323 -0.861 . . . . 2.16 109.152 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.41 1.83 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.76 0.974 . . . . 1.25 110.442 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.73 136.24 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.939 -1.101 . . . . 1.75 110.218 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.28 163.62 0.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.66 109.239 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.4 mtpt -119.85 166.74 12.89 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.459 -0.776 . . . . 1.43 109.561 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.16 166.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.457 -1.057 . . . . 0.39 110.457 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.61 159.73 39.51 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.591 1.528 . . . . 0.41 110.579 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.39 169.56 17.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.864 -0.791 . . . . 0.21 108.864 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -92.32 136.17 33.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.981 -1.074 . . . . 2.72 109.537 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.2 116.84 26.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.671 -0.643 . . . . 0.29 109.313 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.9 mt -104.82 -71.7 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.246 -0.908 . . . . 0.45 109.838 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -94.08 146.98 23.58 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.107 -0.996 . . . . 0.31 110.473 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.02 120.96 8.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.827 . . . . 2.32 109.017 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -108.58 0.3 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.78 -1.2 . . . . 0.27 110.332 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.76 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 1.39 109.69 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 47.91 2.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.994 -1.642 . . . . 0.29 108.994 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.29 146.85 30.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.976 . . . . 0.29 108.736 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.12 128.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.954 . . . . 0.31 109.247 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.8 t -89.13 140.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.198 -1.038 . . . . 0.29 108.198 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.38 179.28 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.919 . . . . 0.23 110.253 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.463 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.4 tt0 -141.23 112.16 7.2 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.562 -0.903 . . . . 1.81 108.562 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.71 -81.08 0.29 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' SER . 32.7 t-20 -80.34 -129.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.783 -1.562 . . . . 1.98 106.783 177.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.6 t -104.19 53.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.245 -1.02 . . . . 1.39 108.245 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.12 129.72 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.02 -0.733 . . . . 1.12 109.02 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.463 ' CG1' HE21 ' A' ' 252' ' ' GLN . 67.9 mt -92.23 139.28 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.47 109.558 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.12 165.13 28.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 2.11 109.954 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.92 138.55 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.468 -0.77 . . . . 0.33 109.054 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -137.04 133.05 18.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.738 -0.838 . . . . 0.34 108.738 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.38 141.14 89.56 Favored 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 120.836 1.024 . . . . 0.42 110.512 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 3.12 109.448 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.422 ' HG2' ' NH1' ' A' ' 263' ' ' ARG . 0.6 OUTLIER -69.45 -8.18 44.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 3.82 110.526 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.77 20.74 12.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.127 -0.983 . . . . 2.08 109.282 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.9 16.95 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.01 -0.737 . . . . 0.32 109.01 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -139.71 122.59 16.59 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.219 -0.926 . . . . 1.79 108.977 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.82 107.42 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.145 -0.972 . . . . 0.45 109.997 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.04 151.11 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.451 -0.944 . . . . 0.57 108.451 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.343 -0.848 . . . . 3.63 109.726 179.755 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 121.175 0.512 . . . . 1.48 110.199 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -135.5 125.25 25.44 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.435 -0.791 . . . . 0.73 109.067 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -101.37 159.18 15.49 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.181 -1.044 . . . . 3.26 108.181 179.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 59.1 t -142.3 143.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.123 -0.985 . . . . 0.23 110.978 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -108.41 156.77 19.07 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.235 -1.394 . . . . 0.58 107.235 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.7 p90 -157.64 152.9 25.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.595 -1.316 . . . . 0.44 110.649 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -99.54 135.13 41.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.601 -0.687 . . . . 2.76 109.749 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -95.68 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 2.23 109.182 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.2 p -91.13 -10.84 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 1.81 109.492 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' B' ' 232' ' ' ASP . 53.5 mtp180 -84.08 -19.03 35.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 3.64 109.505 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' B' ' 231' ' ' ARG . 43.5 m-20 -159.5 129.03 3.24 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 2.16 109.053 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.28 1.7 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.792 0.995 . . . . 1.27 110.442 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -84.57 136.14 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.868 -1.145 . . . . 1.76 110.258 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -52.31 163.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.215 -0.928 . . . . 0.67 109.311 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mtpt -119.78 166.93 12.61 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.261 -0.899 . . . . 1.44 109.511 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.35 166.55 0.02 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.358 -1.097 . . . . 0.4 110.358 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.6 159.92 38.61 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.523 1.482 . . . . 0.41 110.54 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.45 169.53 17.54 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.922 -0.77 . . . . 0.21 108.922 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -92.32 136.2 33.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.11 -0.994 . . . . 2.72 109.596 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.27 116.79 26.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.644 . . . . 0.3 109.284 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -104.71 -71.74 0.73 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.271 -0.893 . . . . 0.45 109.872 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -94.12 146.98 23.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.179 -0.95 . . . . 0.33 110.415 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.09 121.08 8.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.375 -0.828 . . . . 2.33 108.931 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -108.65 0.3 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.785 -1.198 . . . . 0.28 110.335 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.68 -151.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -1.08 . . . . 1.4 109.761 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.18 47.98 2.7 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.918 -1.673 . . . . 0.29 108.918 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.35 146.88 30.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.491 -1.005 . . . . 0.29 108.745 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.2 128.06 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.31 109.277 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.07 139.96 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.219 -1.03 . . . . 0.3 108.219 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.37 179.27 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.24 110.299 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.465 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.4 tt0 -141.25 112.21 7.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.468 -0.938 . . . . 1.81 108.468 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.7 -81.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' B' ' 255' ' ' SER . 32.6 t-20 -80.29 -129.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.866 -1.531 . . . . 1.97 106.866 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 8.7 t -104.32 53.27 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.106 -1.072 . . . . 1.38 108.106 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.15 129.8 8.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 1.12 108.982 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.465 ' CG1' HE21 ' B' ' 252' ' ' GLN . 68.1 mt -92.31 139.32 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.26 -0.9 . . . . 0.48 109.519 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.19 165.18 28.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.333 -0.855 . . . . 2.13 109.932 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.92 138.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.427 -0.795 . . . . 0.34 109.065 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.05 132.98 18.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.677 -0.86 . . . . 0.34 108.677 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.24 141.28 88.45 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.776 0.984 . . . . 0.42 110.599 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -59.71 -32.6 70.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 3.11 109.368 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.421 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 0.6 OUTLIER -69.35 -8.31 45.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.36 -0.838 . . . . 3.82 110.56 -179.195 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.65 20.66 12.85 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.225 -0.922 . . . . 2.08 109.274 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.72 17.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.32 109.101 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -139.53 122.57 16.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.228 -0.92 . . . . 1.79 108.981 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.76 107.4 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.252 -0.905 . . . . 0.45 109.977 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.06 151.23 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.39 -0.967 . . . . 0.57 108.39 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -90.69 143.66 26.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 3.62 109.724 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.948 -1.025 . . . . 2.05 109.484 179.655 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.532 -0.544 . . . . 1.48 109.532 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.27 130.41 38.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.72 109.191 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -105.57 156.32 18.35 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.456 -0.942 . . . . 3.26 108.456 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -139.1 142.86 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.361 -0.837 . . . . 0.23 110.098 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -109.22 152.07 25.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.312 -1.366 . . . . 0.58 107.312 178.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 13.4 p90 -156.03 157.59 36.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.555 -1.341 . . . . 0.44 110.724 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -100.05 140.04 34.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.59 -0.694 . . . . 2.76 109.291 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 232' ' ' ASP . 5.1 p-10 -93.33 176.78 6.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 2.23 109.467 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.6 t -89.02 -11.95 42.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 1.8 109.508 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 20.3 mmm180 -86.88 -11.97 49.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.088 -1.008 . . . . 3.63 109.417 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.5 ' N ' ' OD2' ' A' ' 229' ' ' ASP . 48.0 m-20 -161.95 129.52 2.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 2.16 108.95 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.6 4.83 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.64 0.893 . . . . 1.25 110.024 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.2 t -83.4 154.54 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.013 . . . . 1.75 110.024 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.41 163.6 22.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.66 109.071 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 4.9 mtpp -119.6 165.86 13.91 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.843 -0.799 . . . . 1.43 108.843 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -47.0 171.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.688 -1.365 . . . . 0.39 109.688 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.7 160.88 46.18 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.568 1.512 . . . . 0.41 110.522 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.07 13.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.489 -0.757 . . . . 0.21 109.053 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.49 134.67 34.45 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.165 -0.959 . . . . 2.72 109.344 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.37 124.68 34.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.576 -0.703 . . . . 0.29 109.225 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.83 -72.47 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.469 -0.769 . . . . 0.45 110.496 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.463 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.8 t90 -91.14 142.56 27.61 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.187 -0.946 . . . . 0.31 110.257 -178.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.406 ' HG3' HH22 ' A' ' 262' ' ' ARG . 8.1 ttpm? -147.07 121.14 9.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 2.32 109.607 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.65 -103.34 0.21 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.86 -1.162 . . . . 0.27 110.366 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.95 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -1.074 . . . . 1.39 110.111 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.73 47.95 2.56 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.25 -1.54 . . . . 0.29 109.25 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.86 37.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -1.082 . . . . 0.29 109.215 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.01 127.79 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.192 -0.942 . . . . 0.31 109.514 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.18 139.16 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.336 -0.987 . . . . 0.29 108.336 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 257' ' ' ILE . 19.6 pt -141.52 177.3 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.23 110.086 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.419 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.4 tt0 -143.48 114.06 7.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 1.81 108.818 179.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -90.29 -82.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.316 -1.364 . . . . 1.18 107.316 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -80.28 -130.3 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.667 -1.605 . . . . 1.98 106.667 177.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.4 m -104.1 54.72 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.073 -1.084 . . . . 1.39 108.073 178.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -156.42 123.79 5.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.779 -0.823 . . . . 1.12 108.779 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' ILE . 11.5 mt -92.88 138.28 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.47 109.702 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.85 168.59 19.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.384 -0.822 . . . . 2.11 109.44 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.71 144.58 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.348 -0.845 . . . . 0.33 109.367 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 94.1 t -138.54 128.63 14.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 0.34 109.118 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.28 144.47 95.82 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 120.531 0.821 . . . . 0.42 110.06 179.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.406 HH22 ' HG3' ' A' ' 244' ' ' LYS . 11.9 tpp180 -60.11 -39.56 86.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 3.12 109.062 179.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -65.6 -7.48 15.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 3.82 110.344 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.82 22.44 11.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.233 -0.917 . . . . 2.08 109.307 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.67 169.35 17.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.32 109.529 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -141.28 128.45 20.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 1.79 109.254 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.4 112.85 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.101 -0.999 . . . . 0.45 109.789 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.3 144.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.914 -1.143 . . . . 0.57 107.914 179.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 269' ' ' ARG . 31.1 ptt180 . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 3.63 109.282 179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.55 -0.537 . . . . 1.48 109.55 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -133.31 130.36 38.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 0.73 109.222 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -105.43 156.44 18.19 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.515 -0.92 . . . . 3.26 108.515 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 87.3 t -139.09 142.9 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.23 110.112 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.26 152.16 25.59 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.339 -1.356 . . . . 0.58 107.339 178.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.6 p90 -156.14 157.51 36.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.609 -1.307 . . . . 0.44 110.726 -178.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -99.91 140.08 34.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 2.76 109.337 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' B' ' 232' ' ' ASP . 5.1 p-10 -93.41 176.78 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 2.23 109.401 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.7 t -88.99 -11.97 42.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 1.81 109.509 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 20.3 mmm180 -86.71 -12.1 49.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.143 -0.973 . . . . 3.64 109.462 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.501 ' N ' ' OD2' ' B' ' 229' ' ' ASP . 47.8 m-20 -161.92 129.57 2.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.171 -0.956 . . . . 2.16 108.887 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.59 4.8 1.53 Allowed 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 120.755 0.97 . . . . 1.27 109.959 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 7.3 t -83.44 154.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 1.76 110.031 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -68.32 163.62 22.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.67 109.085 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' B' ' 237' ' ' GLY . 4.9 mtpp -119.7 165.91 13.89 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -47.07 171.01 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.728 -1.349 . . . . 0.4 109.728 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.69 160.91 46.06 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.56 1.507 . . . . 0.41 110.486 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.68 172.02 13.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.553 -0.717 . . . . 0.21 109.084 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.43 134.65 34.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.973 . . . . 2.72 109.341 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.39 124.69 34.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.544 -0.722 . . . . 0.3 109.173 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.77 -72.52 0.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.41 -0.806 . . . . 0.45 110.609 -179.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.415 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.09 142.52 27.67 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.124 -0.985 . . . . 0.33 110.254 -178.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . 0.404 ' HG3' HH22 ' B' ' 262' ' ' ARG . 8.1 ttpm? -147.08 121.14 9.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.206 -0.934 . . . . 2.33 109.564 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.62 -103.29 0.21 Allowed Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.844 -1.17 . . . . 0.28 110.337 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -71.04 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.347 -1.09 . . . . 1.4 110.139 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.74 47.94 2.56 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.197 -1.561 . . . . 0.29 109.197 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.91 151.81 37.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.29 109.259 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.92 127.89 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.31 109.525 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.21 139.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.325 -0.991 . . . . 0.3 108.325 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 257' ' ' ILE . 19.7 pt -141.61 177.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.898 . . . . 0.24 110.138 -179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.415 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.4 tt0 -143.56 114.06 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.817 -0.808 . . . . 1.81 108.817 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -90.29 -82.34 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.331 -1.359 . . . . 1.18 107.331 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -80.23 -130.21 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.716 -1.587 . . . . 1.97 106.716 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 64.8 m -104.24 54.71 0.73 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.983 -1.118 . . . . 1.38 107.983 178.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -156.45 123.81 5.39 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.829 -0.804 . . . . 1.12 108.829 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.463 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.4 mt -92.92 138.3 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.48 109.756 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.78 168.64 19.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 2.13 109.412 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.72 144.58 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 0.34 109.395 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.56 128.55 14.87 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.34 109.14 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.21 144.54 95.37 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 110.012 -0.803 . . . . 0.42 110.012 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' B' ' 244' ' ' LYS . 11.9 tpp180 -60.1 -39.7 87.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 3.11 108.956 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -65.47 -7.51 14.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 3.82 110.512 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.88 22.52 11.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.247 -0.908 . . . . 2.08 109.259 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.7 169.41 17.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.503 -0.748 . . . . 0.32 109.441 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -141.32 128.46 20.87 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.27 -0.894 . . . . 1.79 109.24 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.35 112.97 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.188 -0.945 . . . . 0.45 109.782 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.35 144.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 107.897 -1.149 . . . . 0.57 107.897 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -91.02 142.57 27.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 3.62 109.205 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.993 -1.003 . . . . 2.05 109.575 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 32.5 m120 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 121.285 0.564 . . . . 1.48 109.819 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -136.37 131.6 34.46 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.015 -0.735 . . . . 0.72 109.015 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -105.21 158.09 16.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.353 -0.842 . . . . 3.26 109.014 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.5 t -139.05 140.76 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.23 109.877 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -107.51 156.33 19.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.508 -1.293 . . . . 0.58 107.508 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.79 151.63 25.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.704 -1.247 . . . . 0.44 110.729 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -98.22 148.5 23.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.738 . . . . 2.76 109.483 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 231' ' ' ARG . 25.0 t0 -94.89 -175.56 3.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.959 -0.756 . . . . 2.23 108.959 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.426 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 5.5 t -98.67 -14.77 19.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -0.956 . . . . 1.8 109.982 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 229' ' ' ASP . 15.3 mtm-85 -89.72 -11.75 41.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 3.63 109.981 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 231' ' ' ARG . 54.4 m-20 -161.01 129.02 2.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.928 -1.107 . . . . 2.16 109.478 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.57 6.84 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.731 0.954 . . . . 1.25 110.32 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.3 m -80.08 128.24 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.787 -1.195 . . . . 1.75 109.891 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.36 165.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.66 109.532 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 237' ' ' GLY . 28.6 mttm -118.41 166.41 12.7 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.633 -0.877 . . . . 1.43 108.633 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.73 177.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.932 -1.267 . . . . 0.39 109.932 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.86 160.28 48.25 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.663 1.575 . . . . 0.41 110.477 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.95 12.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.667 -0.864 . . . . 0.21 108.667 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.18 139.43 31.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.073 -1.017 . . . . 2.72 109.44 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.9 120.26 30.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 0.29 109.926 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.29 -72.91 0.68 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.427 -0.795 . . . . 0.45 110.231 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.204 -0.935 . . . . 0.31 110.129 -178.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.47 112.7 5.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.258 -0.901 . . . . 2.32 109.13 179.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -102.63 0.2 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.51 -1.328 . . . . 0.27 110.658 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.52 -159.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -1.081 . . . . 1.39 110.188 -179.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.99 44.86 1.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.028 -1.629 . . . . 0.29 109.028 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.3 152.51 37.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.445 -1.033 . . . . 0.29 108.975 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.62 126.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.31 109.325 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.38 137.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.971 -1.122 . . . . 0.29 107.971 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 260' ' ' VAL . 26.6 pt -140.17 -177.94 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.23 110.076 -179.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.44 HE21 HG13 ' A' ' 257' ' ' ILE . 37.9 tt0 -143.94 109.07 5.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.401 -0.963 . . . . 1.81 108.401 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.81 -76.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.377 -1.342 . . . . 1.18 107.377 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -79.93 -134.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.697 -1.594 . . . . 1.98 106.697 177.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 15.3 p -103.9 54.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.981 -1.118 . . . . 1.39 107.981 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 65.0 m-20 -157.1 130.9 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.887 -0.783 . . . . 1.12 108.887 -179.308 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.44 HG13 HE21 ' A' ' 252' ' ' GLN . 73.8 mt -94.45 135.1 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.47 109.847 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -137.45 176.67 8.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.445 -0.784 . . . . 2.11 109.922 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.31 137.9 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.663 -0.648 . . . . 0.33 109.602 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 251' ' ' ILE . 25.9 t -135.43 131.56 19.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.378 -0.826 . . . . 0.34 108.986 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.24 144.29 95.9 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 120.621 0.881 . . . . 0.42 109.946 179.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.46 -34.04 74.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 3.12 109.55 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 263' ' ' ARG . 35.4 mtm-85 -70.4 -5.68 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 3.82 110.846 -178.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -119.36 21.3 12.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.386 -0.821 . . . . 2.08 108.866 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.41 24.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.602 -0.686 . . . . 0.32 109.273 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.465 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.8 mtmp? -141.7 129.61 21.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 1.79 109.135 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.86 117.36 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.951 . . . . 0.45 109.978 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.86 150.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 108.795 -0.817 . . . . 0.57 108.795 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.404 -0.81 . . . . 3.63 108.856 179.278 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 32.8 m120 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.128 0.489 . . . . 1.48 109.905 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.14 131.49 34.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.572 -0.705 . . . . 0.73 109.126 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -105.15 158.01 16.88 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.334 -0.854 . . . . 3.26 109.011 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.95 140.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 0.23 109.977 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -107.56 156.53 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.469 -1.308 . . . . 0.58 107.469 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.4 p90 -156.9 151.63 25.74 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.584 -1.323 . . . . 0.44 110.67 -178.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -98.32 148.57 23.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.41 -0.806 . . . . 2.76 109.466 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.485 ' OD2' ' NH1' ' B' ' 231' ' ' ARG . 25.1 t0 -94.86 -175.46 3.57 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.345 -0.847 . . . . 2.23 108.902 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 5.4 t -98.7 -14.72 19.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.238 -0.914 . . . . 1.81 109.933 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.485 ' NH1' ' OD2' ' B' ' 229' ' ' ASP . 15.1 mtm-85 -89.96 -11.77 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 3.64 109.934 -179.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 231' ' ' ARG . 54.1 m-20 -160.97 128.9 2.81 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.14 -0.975 . . . . 2.16 109.494 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.4 6.83 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 120.705 0.937 . . . . 1.27 110.3 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.466 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.3 m -80.04 128.22 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 1.76 109.99 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.3 165.08 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.67 109.546 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' B' ' 237' ' ' GLY . 28.7 mttm -118.44 166.34 12.79 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.711 -0.848 . . . . 1.44 108.711 179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.72 177.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.978 -1.249 . . . . 0.4 109.978 -179.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -71.93 160.39 47.84 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.653 1.569 . . . . 0.41 110.506 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.1 173.09 11.99 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.723 -0.843 . . . . 0.21 108.723 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -95.35 139.2 31.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.996 -1.065 . . . . 2.72 109.464 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.81 120.16 30.82 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 0.3 109.855 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.23 -72.83 0.68 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.37 -0.831 . . . . 0.45 110.312 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.78 140.08 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.223 -0.923 . . . . 0.33 110.006 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -146.58 112.68 5.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.224 -0.923 . . . . 2.33 108.986 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.4 -102.47 0.2 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.496 -1.335 . . . . 0.28 110.644 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.65 -159.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.358 -1.083 . . . . 1.4 110.186 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.11 44.88 1.92 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.957 -1.657 . . . . 0.29 108.957 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 152.63 37.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.46 -1.023 . . . . 0.29 108.944 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.67 126.8 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.31 109.442 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.37 137.53 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.941 -1.133 . . . . 0.3 107.941 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 260' ' ' VAL . 26.2 pt -140.26 -178.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.24 110.119 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.444 HE21 HG13 ' B' ' 257' ' ' ILE . 37.9 tt0 -143.76 109.27 5.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.394 -0.965 . . . . 1.81 108.394 178.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.97 -76.27 0.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.337 -1.357 . . . . 1.18 107.337 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.87 -134.8 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.763 -1.569 . . . . 1.97 106.763 177.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.406 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 15.4 p -103.93 54.41 0.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.897 -1.149 . . . . 1.38 107.897 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.6 m-20 -156.98 131.0 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.444 HG13 HE21 ' B' ' 252' ' ' GLN . 73.7 mt -94.46 135.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.194 -0.941 . . . . 0.48 109.805 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -137.52 176.68 8.49 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.435 -0.79 . . . . 2.13 109.891 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.32 137.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 0.34 109.553 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . 0.41 HG21 HD11 ' B' ' 251' ' ' ILE . 25.9 t -135.59 131.5 19.32 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.341 -0.849 . . . . 0.34 108.955 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.13 144.41 95.18 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.571 0.847 . . . . 0.42 109.913 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -61.43 -34.16 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 3.11 109.628 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' B' ' 263' ' ' ARG . 35.2 mtm-85 -70.47 -5.32 27.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 3.82 110.866 -178.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -119.71 21.13 12.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.355 -0.84 . . . . 2.08 108.799 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.77 166.49 24.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.653 . . . . 0.32 109.244 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.461 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.8 mtmp? -141.77 129.68 21.85 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.329 -0.857 . . . . 1.79 109.12 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.94 117.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.289 -0.882 . . . . 0.45 109.892 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.8 mm -117.14 150.71 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.48 146.2 23.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.734 -0.839 . . . . 3.62 108.734 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 120.975 -1.078 . . . . 2.05 109.377 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 108.914 -0.772 . . . . 1.48 108.914 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -112.83 141.49 46.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.526 -0.734 . . . . 0.72 109.712 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -112.41 159.2 18.95 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.899 -1.148 . . . . 3.26 107.899 178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.03 142.29 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.187 -0.946 . . . . 0.23 110.154 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.26 154.46 23.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.517 -1.29 . . . . 0.58 107.517 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.6 p90 -155.74 154.8 32.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.8 -1.188 . . . . 0.44 110.199 -178.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 228' ' ' ARG . 2.3 mtm-85 -91.98 153.39 19.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 2.76 109.364 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -95.35 169.66 9.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.319 -0.863 . . . . 2.23 109.484 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 37.1 t -87.93 -8.89 55.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -0.898 . . . . 1.8 109.381 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.66 32.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.313 -0.867 . . . . 3.63 109.636 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.0 m-20 -162.11 133.97 4.05 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.598 -0.89 . . . . 2.16 108.598 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.56 12.07 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.028 1.152 . . . . 1.25 111.125 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 235' ' ' TRP . 9.1 p -83.02 163.03 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.737 -1.227 . . . . 1.75 110.108 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.561 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.6 m95 -74.52 174.12 9.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.66 108.805 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.64 -164.91 1.46 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.311 -0.868 . . . . 1.43 108.81 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.89 52.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.706 -1.358 . . . . 0.39 109.706 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.26 159.89 48.49 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.694 1.596 . . . . 0.41 109.896 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.37 11.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.775 . . . . 0.21 109.19 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -95.29 136.35 35.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.186 -0.946 . . . . 2.72 109.45 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.46 121.49 29.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.662 . . . . 0.29 109.339 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.71 -68.94 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.412 -0.805 . . . . 0.45 110.039 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -94.19 146.96 23.63 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.18 -0.95 . . . . 0.31 109.697 -178.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -148.92 115.81 6.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.199 -0.938 . . . . 2.32 109.076 179.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.44 0.32 Allowed Glycine 0 N--CA 1.498 2.811 0 C-N-CA 119.611 -1.28 . . . . 0.27 110.722 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.38 -155.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 1.39 109.489 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 50.38 2.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.007 -1.637 . . . . 0.29 109.007 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.02 151.74 35.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.29 108.57 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -145.0 132.43 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 0.31 109.796 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.01 134.89 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.67 -1.233 . . . . 0.29 107.67 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.41 177.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 0.23 110.216 -178.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.545 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.0 tt0 -141.75 109.65 5.79 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.891 -1.151 . . . . 1.81 107.891 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.28 -79.58 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.389 -1.338 . . . . 1.18 107.389 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 255' ' ' SER . 26.9 t-20 -80.78 -129.51 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.516 -1.661 . . . . 1.98 106.516 177.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.431 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 36.4 p -104.59 54.04 0.73 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.39 108.04 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -156.44 126.66 6.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.753 . . . . 1.12 109.195 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.545 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -93.3 135.06 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.47 109.444 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.73 169.07 18.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.392 -0.818 . . . . 2.11 109.879 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.71 139.2 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.549 -0.719 . . . . 0.33 109.256 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 27.6 t -133.49 130.87 21.14 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.34 108.882 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.87 141.98 96.27 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.59 0.86 . . . . 0.42 110.192 179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.99 -36.03 67.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 3.12 109.008 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -65.7 -9.63 29.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 3.82 110.369 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -119.91 18.65 12.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.202 -0.936 . . . . 2.08 109.506 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.52 163.76 31.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.384 -0.823 . . . . 0.32 110.064 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.451 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.0 mtmp? -143.17 132.14 22.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.335 -0.853 . . . . 1.79 109.624 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.2 mm -89.06 113.58 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.295 -0.878 . . . . 0.45 109.811 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.1 mm -107.11 158.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.356 -0.84 . . . . 0.57 108.924 179.193 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 O-C-N 121.229 -0.919 . . . . 3.63 109.145 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 108.923 -0.769 . . . . 1.48 108.923 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -112.74 141.5 46.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.481 -0.762 . . . . 0.73 109.684 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -112.43 159.09 19.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 107.849 -1.167 . . . . 3.26 107.849 178.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 96.0 t -139.96 142.32 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.172 -0.955 . . . . 0.23 110.13 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.32 154.43 23.5 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.512 -1.292 . . . . 0.58 107.512 178.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.7 p90 -155.79 154.8 31.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.779 -1.201 . . . . 0.44 110.228 -178.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.478 ' HG3' HH11 ' B' ' 228' ' ' ARG . 2.3 mtm-85 -91.94 153.37 19.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 2.76 109.434 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.33 169.65 9.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 2.23 109.44 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 37.5 t -87.83 -8.98 55.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.933 . . . . 1.81 109.4 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.57 32.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 3.64 109.641 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.1 m-20 -162.23 133.95 3.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.16 108.596 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -64.55 12.06 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.006 1.137 . . . . 1.27 111.111 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 9.0 p -83.01 163.05 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.777 -1.202 . . . . 1.76 110.101 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.6 m95 -74.52 174.11 9.44 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.792 -0.818 . . . . 0.67 108.792 179.4 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.72 -165.07 1.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.238 -0.914 . . . . 1.44 108.804 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.4 175.81 52.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.28 159.82 48.62 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.688 1.592 . . . . 0.41 109.892 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.26 173.5 11.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.447 -0.783 . . . . 0.21 109.175 179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -95.41 136.36 35.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 2.72 109.385 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.44 121.41 29.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.589 -0.694 . . . . 0.3 109.31 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.69 -68.97 0.89 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.458 -0.776 . . . . 0.45 110.085 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -94.14 146.89 23.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.029 -1.045 . . . . 0.33 109.778 -179.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -148.92 115.76 5.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.132 -0.98 . . . . 2.33 109.131 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.53 0.32 Allowed Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.543 -1.313 . . . . 0.28 110.74 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.29 -155.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 1.4 109.573 -179.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 50.47 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.939 -1.664 . . . . 0.29 108.939 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.06 151.85 35.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.577 -0.955 . . . . 0.29 108.544 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.12 132.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.112 -0.992 . . . . 0.31 109.747 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.1 134.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.3 107.754 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.24 177.94 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.24 110.27 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.535 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.9 tt0 -141.83 109.7 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.904 -1.147 . . . . 1.81 107.904 178.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -88.39 -79.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.382 -1.34 . . . . 1.18 107.382 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 255' ' ' SER . 26.8 t-20 -80.6 -129.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.614 -1.624 . . . . 1.97 106.614 177.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.432 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 36.5 p -104.52 54.08 0.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.116 -1.068 . . . . 1.38 108.116 177.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -156.42 126.59 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.462 -0.774 . . . . 1.12 109.166 -179.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.535 ' CG1' HE21 ' B' ' 252' ' ' GLN . 36.4 mt -93.21 135.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.48 109.394 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.78 169.07 18.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 2.13 109.832 -179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 t -101.62 139.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.537 -0.727 . . . . 0.34 109.219 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.4 t -133.33 130.9 21.32 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.34 108.954 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.92 141.89 95.94 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.592 0.861 . . . . 0.42 110.203 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.83 -36.2 67.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 3.11 108.948 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -65.6 -9.6 28.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.995 . . . . 3.82 110.461 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.98 18.67 12.44 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.191 -0.943 . . . . 2.08 109.484 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.82 31.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.32 110.075 -179.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.445 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 7.0 mtmp? -143.2 132.11 22.82 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.326 -0.859 . . . . 1.79 109.637 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.1 mm -89.09 113.59 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.331 -0.856 . . . . 0.45 109.833 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.0 mm -107.11 158.33 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.46 -0.775 . . . . 0.57 108.93 179.235 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -90.62 142.68 27.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.197 -0.94 . . . . 3.62 109.108 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' B' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.013 -0.994 . . . . 2.05 109.412 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.427 -0.582 . . . . 1.48 109.427 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.77 126.47 27.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.365 -0.834 . . . . 0.72 108.845 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.1 OUTLIER -102.95 156.96 17.31 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.15 -0.968 . . . . 3.26 108.416 179.465 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.19 141.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.19 -0.943 . . . . 0.23 110.491 -179.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.41 156.41 18.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.621 -1.251 . . . . 0.58 107.621 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.7 p90 -155.02 151.56 28.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.686 -1.259 . . . . 0.44 110.809 -179.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -99.11 141.47 31.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.613 -0.679 . . . . 2.76 109.347 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 16.8 p30 -95.62 175.11 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 2.23 109.009 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.0 t -85.69 -6.24 59.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.8 109.19 179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -88.84 -18.34 27.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.302 -0.874 . . . . 3.63 109.688 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 234' ' ' VAL . 31.5 m-20 -161.95 129.1 2.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.978 . . . . 2.16 109.267 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.36 8.55 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 120.653 0.902 . . . . 1.25 110.252 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.2 t -83.58 158.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.877 -1.14 . . . . 1.75 109.827 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.401 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.5 m95 -74.72 159.9 31.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.66 109.327 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.1 mtpt -118.55 165.12 14.32 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.532 -0.914 . . . . 1.43 108.532 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.89 164.95 0.02 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.499 -1.04 . . . . 0.39 110.499 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.88 161.84 42.3 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.728 1.619 . . . . 0.41 110.302 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.82 178.39 7.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.456 -0.778 . . . . 0.21 109.067 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.75 138.76 33.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.221 -0.924 . . . . 2.72 108.923 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.07 123.49 32.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.548 -0.72 . . . . 0.29 109.751 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.3 mt -112.44 -76.13 0.6 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.444 -0.785 . . . . 0.45 110.289 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -89.17 143.84 26.55 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.156 -0.965 . . . . 0.31 110.29 -178.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.57 118.5 8.76 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.77 -0.826 . . . . 2.32 108.77 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -113.11 0.45 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.749 -1.215 . . . . 0.27 110.195 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.53 -154.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -1.057 . . . . 1.39 109.573 -179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.43 51.03 3.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.434 -1.466 . . . . 0.29 109.434 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 153.01 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.29 108.641 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.95 131.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.001 -1.062 . . . . 0.31 109.952 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.39 138.25 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.29 108.536 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 22.1 pt -140.37 178.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.874 . . . . 0.23 110.05 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.55 HE21 ' CG1' ' A' ' 257' ' ' ILE . 37.3 tt0 -141.1 110.11 6.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.495 -0.928 . . . . 1.81 108.495 179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.72 -79.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.402 -1.332 . . . . 1.18 107.402 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.21 -131.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.492 -1.669 . . . . 1.98 106.492 177.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.61 54.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.25 124.91 5.9 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.925 -0.769 . . . . 1.12 108.925 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.55 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.6 mt -90.92 136.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 0.47 109.624 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.26 172.67 12.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.285 -0.885 . . . . 2.11 109.911 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.15 136.96 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.502 -0.749 . . . . 0.33 109.688 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.93 123.34 18.04 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 108.426 -0.953 . . . . 0.34 108.426 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.23 139.12 85.45 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 109.854 -0.864 . . . . 0.42 109.854 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.6 -33.35 66.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.157 -0.964 . . . . 3.12 109.433 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -68.24 -6.07 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 3.82 109.95 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.15 17.67 11.59 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.485 -0.759 . . . . 2.08 109.429 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.71 168.31 20.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.467 -0.771 . . . . 0.32 109.263 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -141.44 131.69 24.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.28 -0.888 . . . . 1.79 109.197 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.2 mm -88.02 110.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.325 -0.859 . . . . 0.45 109.369 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.49 156.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.337 -0.852 . . . . 0.57 109.219 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.448 -0.783 . . . . 3.63 109.736 -179.674 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.367 -0.605 . . . . 1.48 109.367 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.72 126.37 27.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.73 108.909 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.1 OUTLIER -102.86 157.0 17.27 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.144 -0.973 . . . . 3.26 108.454 179.431 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.22 141.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.159 -0.963 . . . . 0.23 110.526 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.34 156.35 19.0 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.648 -1.241 . . . . 0.58 107.648 178.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -154.99 151.5 28.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.601 -1.312 . . . . 0.44 110.837 -179.353 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -98.95 141.3 31.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 2.76 109.426 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 17.0 p30 -95.5 175.19 6.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 2.23 109.008 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 35.9 t -85.68 -6.36 59.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 1.81 109.261 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -88.75 -18.34 28.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.233 -0.917 . . . . 3.64 109.711 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 31.6 m-20 -161.98 129.11 2.59 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 2.16 109.294 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -66.4 8.58 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.659 0.906 . . . . 1.27 110.211 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.3 t -83.54 158.12 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.806 -1.184 . . . . 1.76 109.844 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.402 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.5 m95 -74.85 159.83 31.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.67 109.352 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.2 mtpt -118.47 165.18 14.21 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.544 -0.91 . . . . 1.44 108.544 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.88 164.92 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.516 -1.033 . . . . 0.4 110.516 -179.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.92 161.88 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.639 1.559 . . . . 0.41 110.302 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 178.38 7.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.533 -0.729 . . . . 0.21 109.156 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.86 138.75 33.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.276 -0.89 . . . . 2.72 108.946 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -88.14 123.52 32.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.489 -0.757 . . . . 0.3 109.678 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 31.0 mt -112.42 -76.13 0.6 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.356 -0.84 . . . . 0.45 110.281 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.423 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -89.2 143.64 26.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.186 -0.946 . . . . 0.33 110.308 -178.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.51 118.47 8.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.794 -0.817 . . . . 2.33 108.794 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.23 -113.13 0.45 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.838 -1.172 . . . . 0.28 110.209 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.55 -154.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.416 -1.049 . . . . 1.4 109.545 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 51.12 3.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.29 109.483 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.07 38.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -1.098 . . . . 0.29 108.663 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 7.9 m -146.97 131.81 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.31 109.973 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 94.4 t -93.41 138.19 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.537 -0.912 . . . . 0.3 108.537 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 22.3 pt -140.31 178.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.176 -0.953 . . . . 0.24 110.111 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.534 HE21 ' CG1' ' B' ' 257' ' ' ILE . 37.4 tt0 -141.09 110.1 6.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.459 -0.941 . . . . 1.81 108.459 179.204 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.75 -79.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.392 -1.336 . . . . 1.18 107.392 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.29 -131.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.432 -1.692 . . . . 1.97 106.432 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -104.58 54.72 0.72 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.182 -1.044 . . . . 1.38 108.182 177.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.22 124.97 5.94 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.534 ' CG1' HE21 ' B' ' 252' ' ' GLN . 61.1 mt -91.06 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.48 109.571 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.19 172.58 12.7 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.346 -0.846 . . . . 2.13 109.96 -179.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.02 136.93 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.443 -0.786 . . . . 0.34 109.737 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.97 123.34 18.0 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.424 -0.954 . . . . 0.34 108.424 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.27 139.17 85.72 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.852 -0.865 . . . . 0.42 109.852 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.69 -33.14 66.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.9 . . . . 3.11 109.521 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.38 -6.04 22.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 3.82 109.996 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.12 17.8 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.465 -0.772 . . . . 2.08 109.463 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.85 168.41 19.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.32 109.227 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -141.47 131.61 24.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.896 . . . . 1.79 109.232 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.3 mm -88.08 110.5 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 0.45 109.299 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 29.3 mm -102.48 156.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.344 -0.848 . . . . 0.57 109.143 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.43 137.45 33.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 3.62 109.724 -179.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.003 -0.998 . . . . 2.05 109.317 179.469 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.223 0.535 . . . . 1.48 109.716 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -134.14 145.64 49.47 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.428 -0.795 . . . . 0.72 109.767 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -118.95 152.9 35.5 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.567 -1.271 . . . . 3.26 107.567 178.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.6 t -139.25 142.0 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.121 -0.987 . . . . 0.23 110.431 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -108.39 158.34 17.59 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.684 -1.228 . . . . 0.58 107.684 178.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 15.8 p90 -156.64 152.38 27.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.722 -1.236 . . . . 0.44 110.509 -178.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -93.46 154.13 18.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.389 -0.819 . . . . 2.76 109.59 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.73 170.14 9.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.349 -0.844 . . . . 2.23 109.183 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.0 t -89.66 -13.45 37.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.89 . . . . 1.8 109.46 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 58.9 mtp180 -88.21 -14.6 38.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.16 -0.963 . . . . 3.63 109.373 179.746 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 234' ' ' VAL . 50.1 m-20 -162.22 130.04 2.76 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 2.16 108.718 179.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.57 19.37 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 120.759 0.973 . . . . 1.25 110.794 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.7 p -84.47 158.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.778 -1.201 . . . . 1.75 110.197 -179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.518 ' N ' HG22 ' A' ' 234' ' ' VAL . 96.8 m95 -76.66 165.9 24.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.709 -0.62 . . . . 0.66 109.937 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.72 -166.94 1.29 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.61 -0.885 . . . . 1.43 108.61 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.14 52.22 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.703 -1.359 . . . . 0.39 109.703 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.64 149.56 61.46 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.671 1.58 . . . . 0.41 109.862 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.63 169.21 17.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.87 -0.789 . . . . 0.21 108.87 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -92.75 138.73 31.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.088 -1.007 . . . . 2.72 109.502 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.8 tp -87.84 118.82 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.677 -0.64 . . . . 0.29 109.38 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.01 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.358 -0.839 . . . . 0.45 110.154 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.9 146.62 23.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.324 -0.86 . . . . 0.31 110.714 -178.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -150.29 117.01 5.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.452 -0.78 . . . . 2.32 109.14 179.127 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.87 -104.72 0.26 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.949 -1.261 . . . . 0.27 109.949 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -67.05 -155.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -1.112 . . . . 1.39 109.632 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.88 49.38 2.83 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.94 152.2 38.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -1.091 . . . . 0.29 108.542 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.0 m -144.21 132.67 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.31 109.677 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.05 133.81 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.812 -1.181 . . . . 0.29 107.812 178.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.14 -177.87 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.23 110.384 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.577 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.1 tt0 -142.35 112.17 6.84 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.345 -0.983 . . . . 1.81 108.345 178.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.5 -84.55 0.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.596 -1.261 . . . . 1.18 107.596 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -78.16 -127.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.486 -1.672 . . . . 1.98 106.486 177.488 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.661 ' N ' HD22 ' A' ' 254' ' ' ASN . 9.7 p -105.05 52.98 0.73 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.135 -0.978 . . . . 1.39 108.659 178.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -155.45 131.03 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 1.12 109.276 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.577 ' CG1' HE21 ' A' ' 252' ' ' GLN . 58.1 mt -93.06 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.47 109.486 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.04 165.26 26.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.377 -0.827 . . . . 2.11 109.75 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.44 136.77 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.489 -0.757 . . . . 0.33 108.978 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 26.7 t -134.36 132.08 20.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.435 -0.791 . . . . 0.34 108.892 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.25 148.65 85.13 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.641 0.894 . . . . 0.42 109.931 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.848 . . . . 3.12 109.075 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.29 -8.62 47.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -0.791 . . . . 3.82 110.249 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -119.24 19.17 12.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.428 -0.795 . . . . 2.08 108.94 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.54 164.01 31.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.32 109.463 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.5 mtmp? -140.41 130.95 25.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.329 -0.857 . . . . 1.79 109.44 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.02 111.54 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.366 -0.834 . . . . 0.45 110.101 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.0 mm -109.0 157.46 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.486 -0.759 . . . . 0.57 108.975 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 268' ' ' ILE . 83.8 mtm180 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.845 . . . . 3.63 109.155 179.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.617 -0.512 . . . . 1.48 109.617 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -134.12 145.44 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.447 -0.783 . . . . 0.73 109.791 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.484 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 11.0 mtp180 -118.82 152.97 35.26 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.481 -1.303 . . . . 3.26 107.481 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.1 t -139.14 142.21 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.167 -0.958 . . . . 0.23 110.469 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -108.56 158.29 17.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.651 -1.24 . . . . 0.58 107.651 178.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.5 p90 -156.63 152.38 27.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.698 -1.251 . . . . 0.44 110.545 -178.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -93.33 153.91 18.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.243 -0.911 . . . . 2.76 109.608 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.63 170.13 9.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.25 -0.906 . . . . 2.23 109.154 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 26.8 t -89.69 -13.37 37.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 1.81 109.507 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 58.8 mtp180 -88.32 -14.5 38.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.138 -0.976 . . . . 3.64 109.319 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' B' ' 234' ' ' VAL . 50.6 m-20 -162.29 129.98 2.72 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 2.16 108.771 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.62 19.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 120.804 1.003 . . . . 1.27 110.697 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -84.35 158.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.869 -1.144 . . . . 1.76 110.243 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.523 ' N ' HG22 ' B' ' 234' ' ' VAL . 96.8 m95 -76.65 166.18 23.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 0.67 109.983 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.79 -166.98 1.3 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 1.44 108.689 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.07 52.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.713 -1.355 . . . . 0.4 109.713 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.69 149.52 61.11 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.762 1.641 . . . . 0.41 109.884 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.74 169.06 18.15 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.963 -0.754 . . . . 0.21 108.963 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.58 138.55 31.41 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.987 . . . . 2.72 109.52 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.75 118.96 27.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.724 -0.61 . . . . 0.3 109.414 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.25 -73.9 0.67 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.388 -0.82 . . . . 0.45 110.103 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -92.91 146.47 23.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.323 -0.861 . . . . 0.33 110.661 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -150.1 117.03 5.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.444 -0.785 . . . . 2.33 109.164 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.89 -104.69 0.26 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.948 -1.261 . . . . 0.28 109.948 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.03 -155.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -1.116 . . . . 1.4 109.612 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.94 49.42 2.86 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.276 -1.529 . . . . 0.29 109.276 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.42 38.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.389 -1.065 . . . . 0.29 108.494 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 m -144.46 132.68 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.023 . . . . 0.31 109.648 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.12 133.76 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.843 -1.169 . . . . 0.3 107.843 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.6 pt -138.13 -177.72 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.24 110.292 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.58 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.1 tt0 -142.48 112.2 6.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.334 -0.987 . . . . 1.81 108.334 178.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -89.59 -84.54 0.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.552 -1.277 . . . . 1.18 107.552 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.663 HD22 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -78.12 -128.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.489 -1.671 . . . . 1.97 106.489 177.561 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.663 ' N ' HD22 ' B' ' 254' ' ' ASN . 9.6 p -105.1 53.02 0.73 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.145 -0.972 . . . . 1.38 108.586 178.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -155.32 131.06 9.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.491 -0.756 . . . . 1.12 109.276 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.58 ' CG1' HE21 ' B' ' 252' ' ' GLN . 58.1 mt -93.05 135.98 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.142 -0.974 . . . . 0.48 109.413 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -137.06 165.4 26.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.362 -0.836 . . . . 2.13 109.67 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.68 137.05 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.045 -0.724 . . . . 0.34 109.045 179.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.6 132.1 20.59 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.346 -0.846 . . . . 0.34 108.935 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.26 148.72 84.87 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 N-CA-C 109.911 -0.842 . . . . 0.42 109.911 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.84 73.39 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.282 -0.886 . . . . 3.11 108.997 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.33 -8.48 46.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 3.82 110.235 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -119.31 19.18 12.85 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.448 -0.782 . . . . 2.08 108.986 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.91 31.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.564 -0.71 . . . . 0.32 109.447 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.5 mtmp? -140.4 130.97 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.258 -0.901 . . . . 1.79 109.479 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.04 111.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.362 -0.836 . . . . 0.45 110.102 -179.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.418 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.1 mm -108.99 157.48 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.985 -0.746 . . . . 0.57 108.985 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.418 ' N ' HG22 ' B' ' 268' ' ' ILE . 83.8 mtm180 -91.43 140.69 29.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 3.62 109.159 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 2.05 109.064 179.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.261 0.553 . . . . 1.48 109.756 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.34 143.09 50.56 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.591 -0.693 . . . . 0.72 109.594 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -108.08 157.79 17.96 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.456 -1.313 . . . . 3.26 107.456 178.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.47 141.39 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.785 -1.197 . . . . 0.23 110.954 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.39 155.86 20.73 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.674 -1.602 . . . . 0.58 106.674 177.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -154.11 166.94 31.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.462 -1.399 . . . . 0.44 110.654 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -90.62 137.53 32.29 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.322 0.582 . . . . 2.76 109.453 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -94.39 160.97 14.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.545 -0.722 . . . . 2.23 109.432 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.9 m -86.81 -6.51 58.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 1.8 109.575 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -88.26 -20.36 25.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 3.63 109.628 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.4 m-20 -162.19 140.29 6.73 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 2.16 108.7 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.57 2.82 1.05 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.869 1.046 . . . . 1.25 110.378 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 235' ' ' TRP . 7.3 m -84.56 141.74 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.853 -1.155 . . . . 1.75 110.141 -179.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CZ2' ' NH1' ' A' ' 228' ' ' ARG . 97.2 m95 -52.32 -177.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.345 -0.847 . . . . 0.66 109.19 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.444 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 1.9 ttpp -131.77 -156.64 0.77 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.272 -0.893 . . . . 1.43 109.11 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.28 -178.6 52.46 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.59 -1.404 . . . . 0.39 109.59 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.64 159.84 47.83 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.571 1.514 . . . . 0.41 110.19 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.07 18.27 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.92 -0.77 . . . . 0.21 108.92 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -93.24 139.24 30.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.12 -0.987 . . . . 2.72 109.223 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.27 117.31 28.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.419 -0.801 . . . . 0.29 109.631 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.0 -73.61 0.68 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.291 -0.88 . . . . 0.45 110.005 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -90.77 141.56 28.68 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.31 110.531 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.73 113.95 5.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 2.32 109.361 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.01 -107.98 0.29 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.89 -1.284 . . . . 0.27 109.89 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -60.05 -158.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 1.39 109.833 -179.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.85 46.88 2.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.703 -1.359 . . . . 0.29 109.703 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.23 148.39 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -1.106 . . . . 0.29 108.867 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.0 m -142.19 129.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.912 . . . . 0.31 109.744 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.25 137.72 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.203 -1.036 . . . . 0.29 108.203 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -140.27 -179.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.192 -0.943 . . . . 0.23 110.452 -179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.486 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.6 tt0 -144.19 110.29 5.42 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.81 -0.811 . . . . 1.81 108.81 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.42 -78.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.378 -1.342 . . . . 1.18 107.378 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -80.04 -134.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.445 -1.687 . . . . 1.98 106.445 177.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.9 p -102.15 54.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.48 126.43 7.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.705 . . . . 1.12 109.337 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.486 ' CG1' HE21 ' A' ' 252' ' ' GLN . 30.1 mt -92.61 137.84 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.339 -0.85 . . . . 0.47 109.61 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -140.73 170.63 15.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 2.11 109.643 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.42 139.77 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.33 109.605 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.19 130.22 19.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.76 141.47 95.68 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 N-CA-C 109.644 -0.945 . . . . 0.42 109.644 179.055 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.93 -34.7 73.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 3.12 109.727 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.01 -6.44 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 3.82 110.655 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.53 24.0 10.55 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.16 -0.962 . . . . 2.08 109.204 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.19 164.54 28.94 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.085 -0.709 . . . . 0.32 109.085 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -137.77 131.68 31.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.247 -0.908 . . . . 1.79 108.87 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.09 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 0.45 109.828 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.98 157.2 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.378 -0.827 . . . . 0.57 108.964 179.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.1 mtt-85 . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.158 -0.963 . . . . 3.63 109.198 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.288 0.566 . . . . 1.48 109.705 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -130.54 142.94 50.47 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.694 -0.629 . . . . 0.73 109.48 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 49.9 mtt180 -108.1 157.76 17.99 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.401 -1.333 . . . . 3.26 107.401 178.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.51 141.17 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.952 -1.092 . . . . 0.23 110.979 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.16 155.8 20.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.907 -1.516 . . . . 0.58 106.907 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.7 p90 -154.2 166.92 31.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.56 -1.337 . . . . 0.44 110.761 -178.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' B' ' 228' ' ' ARG . 0.0 OUTLIER -90.47 137.41 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.706 -0.621 . . . . 2.76 109.556 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -94.36 161.02 14.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.416 -0.803 . . . . 2.23 109.333 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 68.7 m -86.79 -6.61 58.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 1.81 109.709 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.17 -20.37 25.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 3.64 109.532 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -162.29 140.11 6.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.984 . . . . 2.16 108.804 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.31 2.74 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 120.857 1.038 . . . . 1.27 110.624 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' B' ' 235' ' ' TRP . 7.5 m -84.54 141.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.965 -1.084 . . . . 1.76 110.111 -179.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.577 ' CZ2' ' NH1' ' B' ' 228' ' ' ARG . 97.0 m95 -52.2 -177.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 0.67 109.213 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.452 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 1.9 ttpp -131.82 -156.71 0.77 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.184 -0.947 . . . . 1.44 109.057 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.12 -178.43 52.39 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.81 159.78 47.6 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.543 1.495 . . . . 0.41 110.171 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 168.98 18.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.876 -0.787 . . . . 0.21 108.876 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -93.23 139.11 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 2.72 109.232 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.25 117.26 28.09 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.501 -0.749 . . . . 0.3 109.575 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.99 -73.55 0.68 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.314 -0.866 . . . . 0.45 110.034 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.73 141.53 28.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.33 110.528 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.63 114.04 5.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 2.33 109.255 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.24 -107.82 0.29 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.039 -1.224 . . . . 0.28 110.039 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.22 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -1.169 . . . . 1.4 109.704 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.61 46.77 2.02 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.753 -1.339 . . . . 0.29 109.753 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.13 148.35 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -1.19 . . . . 0.29 108.872 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.18 129.65 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.328 -0.857 . . . . 0.31 109.796 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -93.31 137.71 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.229 -1.026 . . . . 0.3 108.229 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.29 -179.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.19 -0.944 . . . . 0.24 110.507 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.487 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -144.13 110.14 5.37 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.835 -0.802 . . . . 1.81 108.835 178.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.24 -79.07 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.415 -1.328 . . . . 1.18 107.415 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.96 -134.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.485 -1.672 . . . . 1.97 106.485 177.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -102.04 54.27 0.8 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.994 -1.113 . . . . 1.38 107.994 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.55 126.32 6.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 1.12 109.336 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.487 ' CG1' HE21 ' B' ' 252' ' ' GLN . 30.0 mt -92.61 137.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.48 109.571 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -140.63 170.74 15.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 2.13 109.544 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.55 139.78 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.364 -0.835 . . . . 0.34 109.608 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.13 130.19 19.24 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 108.602 -0.888 . . . . 0.34 108.602 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 141.5 95.92 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.589 -0.966 . . . . 0.42 109.589 179.037 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.89 -34.6 73.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 3.11 109.782 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.07 -6.44 28.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 3.82 110.602 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.65 24.09 10.46 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.132 -0.98 . . . . 2.08 109.294 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 164.49 29.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.892 -0.781 . . . . 0.32 108.892 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -137.7 131.85 31.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.259 -0.9 . . . . 1.79 108.965 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.25 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.351 -0.843 . . . . 0.45 109.632 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.25 157.32 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.796 -0.816 . . . . 0.57 108.796 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.1 mtt-85 -91.02 143.76 26.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.241 -0.912 . . . . 3.62 109.176 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 18.3 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.03 -0.986 . . . . 2.05 109.464 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 108.974 -0.75 . . . . 1.48 108.974 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -135.28 126.99 29.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.516 -0.74 . . . . 0.72 109.21 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -100.98 158.67 15.82 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.143 -1.058 . . . . 3.26 108.143 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.83 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.23 110.312 -179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -111.2 156.85 20.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.056 -1.091 . . . . 0.58 108.056 178.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.8 p90 -155.49 153.26 30.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.806 -1.184 . . . . 0.44 110.377 -179.044 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 233' ' ' PRO . 21.4 mtp180 -96.84 145.67 25.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 2.76 109.801 -179.704 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.52 163.94 12.83 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.42 -0.8 . . . . 2.23 108.928 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.2 m -82.65 -3.17 55.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 1.8 109.313 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.47 -17.26 30.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.865 . . . . 3.63 109.442 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 234' ' ' VAL . 22.5 m-20 -162.62 133.8 3.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 2.16 108.892 179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.632 ' CA ' HH21 ' A' ' 228' ' ' ARG . 6.8 Cg_endo -64.88 5.85 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.839 1.026 . . . . 1.25 110.458 179.871 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.4 m -83.34 154.16 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.94 -1.1 . . . . 1.75 109.786 -179.627 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.34 -171.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.66 108.782 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.48 -155.74 0.62 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.975 . . . . 1.43 109.251 179.727 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.17 173.97 52.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.874 -1.291 . . . . 0.39 109.874 -179.568 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.03 157.82 46.45 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.78 1.653 . . . . 0.41 110.297 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.59 174.3 10.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.21 109.194 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.44 142.76 27.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 2.72 109.463 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.23 124.48 34.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.318 -0.623 . . . . 0.29 109.318 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.8 mt -115.88 -74.12 0.62 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.499 -0.75 . . . . 0.45 110.207 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -92.25 142.08 27.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.284 -0.885 . . . . 0.31 110.396 -178.522 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.89 7.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.865 . . . . 2.32 109.231 179.265 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.82 -103.87 0.21 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.982 -1.247 . . . . 0.27 109.982 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.76 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 1.39 109.647 -179.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.19 50.57 3.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.279 -1.529 . . . . 0.29 109.279 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.26 152.93 36.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -1.02 . . . . 0.29 108.811 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.47 129.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 0.31 109.535 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.37 139.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.509 -0.923 . . . . 0.29 108.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.42 176.31 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.277 -0.889 . . . . 0.23 110.243 -179.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.558 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.5 tt0 -144.96 113.33 6.6 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.85 -0.796 . . . . 1.81 108.85 178.93 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.09 -79.88 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.44 -1.319 . . . . 1.18 107.44 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.64 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.756 -1.572 . . . . 1.98 106.756 177.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.0 p -103.83 55.72 0.73 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.983 -1.117 . . . . 1.39 107.983 177.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -156.0 125.5 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.079 -0.712 . . . . 1.12 109.079 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.558 ' CG1' HE21 ' A' ' 252' ' ' GLN . 66.8 mt -91.78 136.97 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.238 -0.914 . . . . 0.47 109.611 -179.493 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.1 166.4 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 2.11 110.032 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.89 140.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.492 -0.755 . . . . 0.33 109.534 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.62 127.94 16.75 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.357 -0.84 . . . . 0.34 108.863 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.5 99.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.614 0.876 . . . . 0.42 110.363 179.637 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -59.02 -28.88 66.82 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.447 -0.946 . . . . 3.12 108.447 179.139 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.41 -13.58 62.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.468 -0.77 . . . . 3.82 110.805 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -120.65 23.99 10.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.317 -0.864 . . . . 2.08 109.644 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.97 163.07 33.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.32 109.634 -179.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.469 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 8.2 mtmp? -140.74 125.03 17.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.408 -0.807 . . . . 1.79 108.969 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.08 112.11 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.246 -0.909 . . . . 0.45 110.128 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.94 150.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.487 -0.931 . . . . 0.57 108.487 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.475 -0.766 . . . . 3.63 109.382 179.522 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.4 m-20 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.011 -0.737 . . . . 1.48 109.011 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.3 127.04 29.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.73 109.16 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -100.98 158.68 15.82 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.124 -1.065 . . . . 3.26 108.124 179.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.23 110.284 -179.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.23 156.93 20.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.061 -1.089 . . . . 0.58 108.061 178.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -155.52 153.38 30.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.749 -1.219 . . . . 0.44 110.282 -178.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.646 HH21 ' CA ' ' B' ' 233' ' ' PRO . 21.5 mtp180 -97.01 145.62 25.77 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.6 -0.688 . . . . 2.76 109.754 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.5 163.95 12.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 2.23 108.997 179.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.1 m -82.68 -3.06 55.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 1.81 109.412 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.59 -17.21 30.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.39 -0.819 . . . . 3.64 109.41 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' B' ' 234' ' ' VAL . 22.7 m-20 -162.62 133.71 3.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 2.16 108.921 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . 0.646 ' CA ' HH21 ' B' ' 228' ' ' ARG . 6.8 Cg_endo -64.79 5.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 120.858 1.039 . . . . 1.27 110.488 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.4 m -83.29 154.12 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.908 -1.12 . . . . 1.76 109.813 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.38 -171.48 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.67 108.759 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.45 -155.71 0.62 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.974 . . . . 1.44 109.264 179.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 174.04 52.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.914 -1.275 . . . . 0.4 109.914 -179.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.07 157.81 46.27 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.745 1.63 . . . . 0.41 110.297 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.65 174.24 10.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.488 -0.757 . . . . 0.21 109.163 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.34 142.62 27.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.02 . . . . 2.72 109.475 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -89.14 124.42 34.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.624 -0.672 . . . . 0.3 109.475 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 36.1 mt -115.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.388 -0.82 . . . . 0.45 110.156 -179.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.5 t90 -92.26 142.08 27.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.33 110.337 -178.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.85 7.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.309 -0.869 . . . . 2.33 109.223 179.244 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.77 -104.01 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.956 -1.257 . . . . 0.28 109.956 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.72 -156.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 1.4 109.632 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 50.58 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.272 -1.531 . . . . 0.29 109.272 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.28 152.87 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.443 -1.034 . . . . 0.29 108.867 179.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.41 129.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.139 -0.975 . . . . 0.31 109.525 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.39 139.65 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.084 -1.01 . . . . 0.3 108.543 179.531 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.5 pt -139.48 176.22 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.264 -0.897 . . . . 0.24 110.206 -179.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.567 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.5 tt0 -144.95 113.46 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 1.81 108.811 178.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -91.1 -80.05 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.345 -1.354 . . . . 1.18 107.345 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.47 -131.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.737 -1.579 . . . . 1.97 106.737 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 86.9 p -103.76 55.57 0.74 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.051 -1.092 . . . . 1.38 108.051 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -155.96 125.53 6.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.023 -0.732 . . . . 1.12 109.023 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.567 ' CG1' HE21 ' B' ' 252' ' ' GLN . 67.0 mt -91.77 136.92 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.48 109.611 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.14 166.41 23.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.398 -0.814 . . . . 2.13 109.985 -179.109 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.97 140.66 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.483 -0.761 . . . . 0.34 109.472 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.5 t -136.63 127.95 16.74 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.338 -0.852 . . . . 0.34 108.897 179.613 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.8 144.49 99.56 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 120.621 0.881 . . . . 0.42 110.253 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -58.91 -29.01 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.416 -0.957 . . . . 3.11 108.416 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -70.4 -13.55 62.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.462 -0.774 . . . . 3.82 110.76 -178.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -120.69 24.06 10.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.256 -0.902 . . . . 2.08 109.563 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.1 33.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.436 -0.79 . . . . 0.32 109.633 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 8.1 mtmp? -140.71 125.06 17.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 1.79 108.953 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 31.0 mm -89.04 112.1 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.285 -0.884 . . . . 0.45 110.135 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.88 150.08 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.513 -0.921 . . . . 0.57 108.513 179.098 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -92.8 143.63 26.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.406 -0.808 . . . . 3.62 109.316 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.044 -0.979 . . . . 2.05 109.49 179.734 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.04 -0.726 . . . . 1.48 109.04 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.3 146.4 49.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.567 -0.708 . . . . 0.72 109.528 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -120.95 153.46 37.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.652 -1.24 . . . . 3.26 107.652 178.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.67 143.47 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.23 109.892 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.94 157.36 19.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.117 -1.438 . . . . 0.58 107.117 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 19.2 p90 -156.87 160.44 39.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.539 -1.35 . . . . 0.44 110.499 -179.354 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -97.72 153.78 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.648 -0.657 . . . . 2.76 109.953 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -96.39 175.16 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.505 -0.747 . . . . 2.23 109.351 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 83.6 p -91.55 -16.78 26.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 1.8 109.248 179.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -82.15 -12.55 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 3.63 109.581 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 46.1 m-20 -162.36 130.32 2.78 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 2.16 109.281 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -65.16 12.15 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.677 0.918 . . . . 1.25 110.041 179.201 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 41.0 t -84.62 160.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.022 . . . . 1.75 109.521 -179.746 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.46 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.4 m95 -75.09 168.68 19.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.735 . . . . 0.66 109.092 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.95 -165.16 1.31 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.1 -1.074 . . . . 1.43 108.1 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.36 178.14 47.83 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.385 -1.388 . . . . 0.39 109.882 -179.508 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.17 158.06 55.83 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.558 1.505 . . . . 0.41 109.904 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.11 169.22 18.16 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.743 -0.836 . . . . 0.21 108.743 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -91.74 139.0 31.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.025 -1.047 . . . . 2.72 109.398 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.17 123.7 33.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.654 -0.654 . . . . 0.29 109.71 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.6 mt -113.91 -73.56 0.65 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.493 -0.755 . . . . 0.45 109.768 -179.812 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -94.95 145.98 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.112 -0.993 . . . . 0.31 110.321 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.27 120.05 8.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.364 -0.835 . . . . 2.32 109.121 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -116.98 0.57 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.27 110.63 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.58 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.991 . . . . 1.39 110.041 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.95 52.54 2.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.695 -1.362 . . . . 0.29 109.695 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.55 146.46 21.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.961 -1.317 . . . . 0.29 110.508 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 262' ' ' ARG . 1.7 m -142.64 121.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.448 -0.945 . . . . 0.31 108.448 178.581 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 58.1 t -84.42 134.46 26.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.418 -0.956 . . . . 0.29 108.418 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -138.87 178.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.416 -0.802 . . . . 0.23 109.886 -179.117 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -140.96 109.78 6.06 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.328 -0.989 . . . . 1.81 108.328 178.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.61 -78.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.582 -1.266 . . . . 1.18 107.582 179.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.856 HD22 ' H ' ' A' ' 255' ' ' SER . 8.2 t30 -80.99 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.637 -1.616 . . . . 1.98 106.637 177.56 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.856 ' H ' HD22 ' A' ' 254' ' ' ASN . 15.3 t -105.43 51.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.604 -0.887 . . . . 1.39 108.604 178.274 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -155.94 130.46 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.841 . . . . 1.12 109.402 -179.52 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 76.6 mt -92.5 136.92 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.47 109.455 -179.669 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -140.06 170.92 14.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 2.11 109.735 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.44 140.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.424 -0.797 . . . . 0.33 109.632 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.58 129.89 16.63 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.244 -0.91 . . . . 0.34 109.163 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.17 148.82 91.21 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 120.825 1.017 . . . . 0.42 109.637 179.132 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HG3' HH11 ' A' ' 262' ' ' ARG . 18.3 mmm-85 -56.66 -36.96 70.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.905 -1.122 . . . . 3.12 108.685 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -63.57 -8.1 8.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.886 -0.509 . . . . 3.82 110.537 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -122.61 14.1 10.16 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.3 -0.875 . . . . 2.08 108.712 179.309 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 159.53 41.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.32 109.275 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.66 131.88 38.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.356 -0.84 . . . . 1.79 109.005 179.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.53 108.97 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.45 109.954 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.95 151.99 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.624 -0.88 . . . . 0.57 108.624 178.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 3.63 109.087 179.311 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 31.5 m120 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.041 -0.726 . . . . 1.48 109.041 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -134.29 146.52 50.09 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.601 -0.687 . . . . 0.73 109.493 -179.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -121.09 153.4 37.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.628 -1.249 . . . . 3.26 107.628 178.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.58 143.7 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.25 -0.906 . . . . 0.23 109.828 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.19 157.33 19.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.222 -1.399 . . . . 0.58 107.222 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 19.0 p90 -156.99 160.55 39.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.442 -1.411 . . . . 0.44 110.501 -179.276 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -97.78 153.72 18.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.691 . . . . 2.76 109.948 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -96.56 175.12 6.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.271 -0.893 . . . . 2.23 109.288 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 82.2 p -91.35 -16.57 27.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 1.81 109.223 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -82.27 -12.6 57.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 3.64 109.694 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' B' ' 234' ' ' VAL . 46.6 m-20 -162.27 130.16 2.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.049 -1.032 . . . . 2.16 109.307 -179.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.2 12.25 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 120.664 0.909 . . . . 1.27 109.957 179.291 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.9 t -84.84 160.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 1.76 109.501 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.459 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -75.06 168.43 19.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 0.67 109.108 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.71 -165.03 1.29 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.216 -1.031 . . . . 1.44 108.216 178.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.28 178.01 47.84 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.425 -1.369 . . . . 0.4 109.841 -179.51 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.88 158.17 56.23 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.602 1.535 . . . . 0.41 109.984 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.34 168.82 18.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.728 -0.841 . . . . 0.21 108.728 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -91.4 138.91 31.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.026 -1.046 . . . . 2.72 109.515 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.12 123.76 33.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.645 -0.66 . . . . 0.3 109.726 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.08 -73.71 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.507 -0.746 . . . . 0.45 109.722 -179.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.425 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 6.8 t90 -94.77 146.0 24.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.33 110.313 -179.139 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.4 120.29 8.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.332 -0.855 . . . . 2.33 109.145 178.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.5 -116.74 0.56 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.649 -1.262 . . . . 0.28 110.628 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -63.04 -145.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.997 . . . . 1.4 109.998 -179.041 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.91 52.36 2.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.64 -1.384 . . . . 0.29 109.64 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.57 146.4 20.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.994 -1.297 . . . . 0.29 110.591 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' B' ' 262' ' ' ARG . 1.7 m -142.58 121.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.492 -0.929 . . . . 0.31 108.492 178.714 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.39 134.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.464 -0.939 . . . . 0.3 108.464 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.9 pt -138.92 178.75 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.327 -0.858 . . . . 0.24 109.892 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -141.0 109.7 6.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.323 -0.992 . . . . 1.81 108.323 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.42 -78.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.619 -1.252 . . . . 1.18 107.619 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.839 HD22 ' H ' ' B' ' 255' ' ' SER . 8.3 t30 -80.87 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.677 -1.601 . . . . 1.97 106.677 177.626 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.839 ' H ' HD22 ' B' ' 254' ' ' ASN . 16.4 t -105.42 52.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.267 -0.896 . . . . 1.38 108.584 178.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -156.06 130.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 1.12 109.293 -179.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 76.7 mt -92.74 136.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.48 109.413 -179.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.93 170.58 15.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.408 -0.808 . . . . 2.13 109.694 -178.992 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.16 140.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 0.34 109.654 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.2 t -137.76 129.77 16.37 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.297 -0.877 . . . . 0.34 109.119 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.93 148.76 91.61 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 120.828 1.019 . . . . 0.42 109.755 179.087 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' B' ' 262' ' ' ARG . 18.0 mmm-85 -56.49 -37.47 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 3.11 108.622 179.247 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -63.12 -8.21 7.3 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.099 -0.5 . . . . 3.82 110.492 -178.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -122.6 14.04 10.15 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.877 . . . . 2.08 108.688 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.82 159.87 41.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.32 109.323 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.89 131.92 37.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 1.79 109.021 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.64 109.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.45 109.976 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -107.09 152.07 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.594 -0.891 . . . . 0.57 108.594 178.979 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.535 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.8 OUTLIER -90.21 147.85 23.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 3.62 109.007 179.406 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.077 -0.964 . . . . 2.05 109.37 179.641 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.147 -0.686 . . . . 1.48 109.147 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -135.5 128.9 32.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.72 109.301 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 224' ' ' ARG . 4.7 ptt-85 -109.65 162.59 14.28 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.141 -1.059 . . . . 3.26 108.141 178.461 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.214 -0.929 . . . . 0.23 110.814 -178.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -108.65 153.16 23.81 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.335 -1.357 . . . . 0.58 107.335 178.168 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.3 p90 -157.13 151.04 24.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.516 -1.365 . . . . 0.44 110.432 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.55 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 34.9 mtm180 -96.45 154.11 17.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 2.76 109.606 179.715 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 230' ' ' SER . 11.9 t70 -95.07 166.14 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 2.23 108.804 179.27 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 2.9 t -82.13 -7.26 59.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 1.8 109.171 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.73 -19.54 23.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 3.63 109.967 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.63 3.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.986 . . . . 2.16 109.173 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -64.69 15.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 120.842 1.028 . . . . 1.25 110.679 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 232' ' ' ASP . 26.0 m -82.51 131.84 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.927 -1.108 . . . . 1.75 109.82 -179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.9 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.66 109.465 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 237' ' ' GLY . 49.1 tttp -136.25 158.31 44.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.275 -0.891 . . . . 1.43 109.153 179.249 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.03 164.81 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.617 -0.993 . . . . 0.39 110.617 -179.326 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.56 159.44 50.74 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.614 1.543 . . . . 0.41 110.378 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.43 175.32 9.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.898 -0.779 . . . . 0.21 108.898 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.34 135.67 33.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.167 -0.958 . . . . 2.72 109.676 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.19 123.46 32.24 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.151 -0.685 . . . . 0.29 109.151 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -115.87 -72.27 0.7 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.416 -0.803 . . . . 0.45 110.125 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.78 137.46 32.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.221 -0.924 . . . . 0.31 110.067 -178.843 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.1 116.95 8.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.291 -0.881 . . . . 2.32 108.89 179.284 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.64 0.19 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.927 -1.269 . . . . 0.27 109.927 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.19 -157.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 1.39 109.671 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 48.94 2.68 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.364 -1.494 . . . . 0.29 109.364 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.42 152.04 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -1.112 . . . . 0.29 108.882 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.78 124.76 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.112 -0.993 . . . . 0.31 110.01 -179.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.0 136.51 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.179 -1.045 . . . . 0.29 108.179 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -139.47 178.64 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.3 -0.875 . . . . 0.23 110.118 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.496 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.5 tt0 -143.53 112.42 6.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.538 -0.912 . . . . 1.81 108.538 179.034 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.78 -79.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.765 -1.198 . . . . 1.18 107.765 179.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.46 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.755 -1.572 . . . . 1.98 106.755 177.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.4 m -105.0 54.29 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.074 -1.084 . . . . 1.39 108.074 178.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -157.43 126.04 5.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.965 -0.754 . . . . 1.12 108.965 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.496 ' CG1' HE21 ' A' ' 252' ' ' GLN . 19.5 mt -92.46 140.73 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.279 -0.888 . . . . 0.47 109.589 -179.663 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.43 169.56 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.392 -0.818 . . . . 2.11 109.59 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.66 139.69 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 0.33 109.073 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.9 t -135.67 121.24 13.77 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.421 -0.8 . . . . 0.34 108.926 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.81 136.59 75.23 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 N-CA-C 109.934 -0.833 . . . . 0.42 109.934 179.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -56.04 -35.64 67.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 3.12 109.631 179.886 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.503 HH11 ' CG ' ' A' ' 263' ' ' ARG . 0.7 OUTLIER -69.34 -3.01 12.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 3.82 110.259 -179.417 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.55 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 19.3 mtpp -119.47 16.12 12.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.371 -0.831 . . . . 2.08 109.044 179.674 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.34 170.8 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.474 -0.767 . . . . 0.32 109.329 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.492 ' HZ1' HD11 ' A' ' 268' ' ' ILE . 6.3 mtmp? -140.79 132.12 26.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.27 -0.894 . . . . 1.79 109.457 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.96 117.25 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.264 -0.898 . . . . 0.45 109.922 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.492 HD11 ' HZ1' ' A' ' 266' ' ' LYS . 5.7 mm -116.21 148.84 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.556 -0.905 . . . . 0.57 108.556 179.15 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 108.476 -0.935 . . . . 3.63 108.476 179.46 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.144 -0.687 . . . . 1.48 109.144 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.58 128.84 31.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.492 -0.755 . . . . 0.73 109.33 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 224' ' ' ARG . 4.8 ptt-85 -109.64 162.51 14.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.207 -1.034 . . . . 3.26 108.207 178.515 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.1 t -138.03 146.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.165 -0.959 . . . . 0.23 110.839 -178.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -108.66 153.15 23.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.356 -1.35 . . . . 0.58 107.356 178.134 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.3 p90 -157.03 151.07 24.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.557 -1.34 . . . . 0.44 110.548 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.569 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 34.9 mtm180 -96.5 154.13 17.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 2.76 109.591 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 230' ' ' SER . 11.8 t70 -95.0 166.13 12.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.818 . . . . 2.23 108.831 179.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 2.9 t -82.11 -7.22 59.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -0.999 . . . . 1.81 109.209 179.803 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -90.66 -19.71 23.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.886 . . . . 3.64 109.952 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' B' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.61 3.06 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.056 -1.028 . . . . 2.16 109.139 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.71 15.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 120.86 1.04 . . . . 1.27 110.605 179.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' B' ' 232' ' ' ASP . 26.4 m -82.53 131.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.829 -1.169 . . . . 1.76 109.875 -179.656 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 0.67 109.463 179.895 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 237' ' ' GLY . 49.1 tttp -136.36 158.21 44.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.296 -0.877 . . . . 1.44 109.189 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.98 164.87 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.538 -1.025 . . . . 0.4 110.538 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.52 159.35 51.06 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.628 1.552 . . . . 0.41 110.406 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.34 175.34 9.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.983 -0.747 . . . . 0.21 108.983 179.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.38 135.64 33.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.053 -1.03 . . . . 2.72 109.671 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.17 123.51 32.28 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.166 -0.679 . . . . 0.3 109.166 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.96 -72.24 0.7 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.399 -0.813 . . . . 0.45 110.09 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -90.83 137.41 32.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.253 -0.904 . . . . 0.33 110.08 -178.836 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.03 116.94 8.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.87 . . . . 2.33 108.898 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.56 0.19 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.997 -1.241 . . . . 0.28 109.997 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.22 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -1.099 . . . . 1.4 109.606 -179.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 48.93 2.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.34 -1.504 . . . . 0.29 109.34 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.43 152.03 37.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 0.29 108.877 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.83 124.77 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 0.31 109.982 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.94 136.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.156 -1.053 . . . . 0.3 108.156 179.114 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.38 178.6 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 0.24 110.157 -179.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.486 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -143.48 112.45 6.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.603 -0.888 . . . . 1.81 108.603 178.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.77 -79.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.759 -1.2 . . . . 1.18 107.759 179.649 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.56 -130.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.654 -1.609 . . . . 1.97 106.654 177.794 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 35.3 m -104.98 54.17 0.71 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.089 -1.078 . . . . 1.38 108.089 178.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -157.39 126.0 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.024 -0.732 . . . . 1.12 109.024 -179.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.486 ' CG1' HE21 ' B' ' 252' ' ' GLN . 19.4 mt -92.37 140.75 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.929 . . . . 0.48 109.65 -179.673 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.48 169.53 17.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 2.13 109.532 -179.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.6 139.61 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.34 109.1 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 75.5 t -135.58 121.24 13.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.477 -0.765 . . . . 0.34 108.964 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.79 136.43 74.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.965 -0.821 . . . . 0.42 109.965 179.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.55 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -55.99 -35.59 66.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 3.11 109.625 179.981 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.7 OUTLIER -69.33 -3.06 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 3.82 110.232 -179.393 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.569 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 19.4 mtpp -119.38 16.01 13.02 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.831 . . . . 2.08 109.004 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.27 170.84 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.712 . . . . 0.32 109.416 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.482 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.4 mtmp? -140.76 132.16 26.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.211 -0.931 . . . . 1.79 109.49 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.86 117.28 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.917 . . . . 0.45 109.941 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.484 HG21 ' NH2' ' B' ' 224' ' ' ARG . 5.7 mm -116.32 148.82 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.544 -0.909 . . . . 0.57 108.544 179.187 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 141.79 28.36 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.516 -0.92 . . . . 3.62 108.516 179.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 2.05 109.528 -179.862 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.272 -0.64 . . . . 1.48 109.272 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -134.53 136.78 43.33 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.845 -0.798 . . . . 0.72 108.845 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -111.55 155.18 23.7 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.129 -1.063 . . . . 3.26 108.129 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.14 141.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 0.23 110.258 -179.399 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.12 157.65 18.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.456 -1.313 . . . . 0.58 107.456 178.582 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.47 150.12 24.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.653 -1.279 . . . . 0.44 110.28 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.1 mtm-85 -94.69 154.43 17.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.461 -0.775 . . . . 2.76 109.66 179.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.81 166.44 11.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 2.23 108.841 179.362 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.0 t -85.83 -9.79 56.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 1.8 109.324 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -89.3 -16.09 31.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 3.63 109.56 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.5 m-20 -161.42 129.7 2.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.137 -0.977 . . . . 2.16 109.063 -179.846 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.38 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 120.781 0.987 . . . . 1.25 110.653 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 232' ' ' ASP . 11.6 m -82.69 133.41 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.73 -1.231 . . . . 1.75 109.848 -179.747 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -53.56 -177.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.26 -0.9 . . . . 0.66 109.124 179.635 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.742 ' HZ3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -136.79 -164.78 1.63 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.256 -0.903 . . . . 1.43 108.631 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.742 ' H ' ' HZ3' ' A' ' 236' ' ' LYS . . . -73.52 172.38 50.61 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.661 -1.257 . . . . 0.39 110.041 -179.441 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.35 158.76 55.21 Favored 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.633 1.555 . . . . 0.41 109.955 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.02 172.77 12.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.21 109.193 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -94.44 138.82 31.91 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.2 -0.938 . . . . 2.72 109.36 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.63 126.24 34.84 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.532 -0.73 . . . . 0.29 109.467 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 24.5 mt -119.59 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.752 . . . . 0.45 110.115 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.427 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.53 140.1 30.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.178 -0.951 . . . . 0.31 109.946 -178.76 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -147.82 119.5 8.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.258 -0.901 . . . . 2.32 109.163 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.14 -100.75 0.18 Allowed Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.788 -1.196 . . . . 0.27 110.28 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.33 -154.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -1.072 . . . . 1.39 109.804 -179.323 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.9 2.82 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.81 153.88 38.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -1.068 . . . . 0.29 109.009 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.34 132.92 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.31 109.825 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.5 t -94.39 139.32 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.206 -1.035 . . . . 0.29 108.206 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.5 pt -140.62 179.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.23 110.073 -179.207 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.489 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.7 tt0 -142.54 115.03 8.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.469 -0.938 . . . . 1.81 108.469 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.26 -84.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.417 -1.327 . . . . 1.18 107.417 179.459 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.707 HD22 ' H ' ' A' ' 255' ' ' SER . 10.2 t30 -79.62 -126.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.629 -1.619 . . . . 1.98 106.629 177.62 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.707 ' H ' HD22 ' A' ' 254' ' ' ASN . 14.2 t -105.7 53.9 0.71 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.025 -1.102 . . . . 1.39 108.025 177.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.08 8.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.12 109.196 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.489 ' CG1' HE21 ' A' ' 252' ' ' GLN . 48.6 mt -93.9 137.05 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.325 -0.859 . . . . 0.47 109.587 -179.611 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.5 167.39 22.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 2.11 109.681 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.04 143.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.381 -0.824 . . . . 0.33 109.351 179.596 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.2 t -137.92 126.01 14.16 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.352 -0.843 . . . . 0.34 109.047 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.82 143.4 99.2 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 N-CA-C 109.692 -0.926 . . . . 0.42 109.692 179.444 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.421 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -54.62 -41.17 69.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 3.12 109.293 179.606 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 263' ' ' ARG . 29.6 mtm-85 -67.2 -2.48 5.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.85 . . . . 3.82 110.563 -178.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.74 14.64 12.6 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.355 -0.841 . . . . 2.08 109.112 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.28 169.06 18.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.32 109.832 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.21 130.07 24.61 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.446 -0.784 . . . . 1.79 109.068 179.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.41 110.54 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.237 -0.915 . . . . 0.45 109.515 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.42 155.27 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.749 -0.834 . . . . 0.57 108.749 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.372 -0.83 . . . . 3.63 109.621 179.792 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.276 -0.639 . . . . 1.48 109.276 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -134.51 136.88 43.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.848 -0.797 . . . . 0.73 108.848 179.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -111.63 155.22 23.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.063 -1.088 . . . . 3.26 108.063 179.095 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.17 141.12 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.285 -0.884 . . . . 0.23 110.185 -179.382 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.1 157.72 18.46 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.455 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.51 150.09 24.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.66 -1.275 . . . . 0.44 110.332 -179.012 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.1 mtm-85 -94.72 154.44 17.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 2.76 109.646 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.92 166.46 11.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 2.23 108.846 179.374 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.2 t -85.92 -9.67 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 1.81 109.283 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.25 -16.2 31.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 3.64 109.549 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.5 m-20 -161.43 129.81 2.93 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.223 -0.923 . . . . 2.16 109.073 -179.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.25 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.835 1.023 . . . . 1.27 110.594 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' B' ' 232' ' ' ASP . 11.5 m -82.59 133.56 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.782 -1.199 . . . . 1.76 109.806 -179.746 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -53.72 -177.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.09 -1.006 . . . . 0.67 109.094 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.77 ' HZ3' ' H ' ' B' ' 237' ' ' GLY . 0.1 OUTLIER -136.74 -164.73 1.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.23 -0.919 . . . . 1.44 108.685 179.241 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.77 ' H ' ' HZ3' ' B' ' 236' ' ' LYS . . . -73.75 172.38 51.04 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.625 -1.274 . . . . 0.4 110.053 -179.431 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.36 158.82 55.0 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.592 1.528 . . . . 0.41 109.996 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.79 12.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.21 109.163 179.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -94.47 138.71 32.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.161 -0.962 . . . . 2.72 109.406 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.4 tp -87.54 126.22 34.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.493 -0.754 . . . . 0.3 109.485 -179.829 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.56 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.737 . . . . 0.45 110.181 -179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -91.48 139.99 30.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.119 -0.988 . . . . 0.33 109.97 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -147.72 119.48 8.08 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.885 . . . . 2.33 109.134 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.11 -100.86 0.18 Allowed Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.828 -1.177 . . . . 0.28 110.334 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.23 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -1.063 . . . . 1.4 109.865 -179.342 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.99 2.84 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.355 -1.498 . . . . 0.29 109.355 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.86 153.92 38.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.113 . . . . 0.29 109.029 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.3 132.84 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.095 -1.003 . . . . 0.31 109.892 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.25 139.44 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.254 -1.017 . . . . 0.3 108.254 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.4 pt -140.77 179.3 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.24 110.117 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.494 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.7 tt0 -142.48 114.9 8.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.507 -0.923 . . . . 1.81 108.507 179.101 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.17 -84.57 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.43 -1.322 . . . . 1.18 107.43 179.441 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.714 HD22 ' H ' ' B' ' 255' ' ' SER . 10.2 t30 -79.73 -125.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.589 -1.634 . . . . 1.97 106.589 177.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.714 ' H ' HD22 ' B' ' 254' ' ' ASN . 14.3 t -105.79 53.91 0.7 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.995 -1.113 . . . . 1.38 107.995 177.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.22 8.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.542 -0.724 . . . . 1.12 109.164 -179.355 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.494 ' CG1' HE21 ' B' ' 252' ' ' GLN . 48.6 mt -94.01 137.06 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.48 109.587 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -138.51 167.36 22.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.299 -0.876 . . . . 2.13 109.711 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.96 143.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.391 -0.818 . . . . 0.34 109.408 179.615 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.97 125.97 14.08 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.418 -0.801 . . . . 0.34 108.973 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.77 143.34 99.05 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 N-CA-C 109.778 -0.893 . . . . 0.42 109.778 179.322 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.412 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -54.58 -41.24 69.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 3.11 109.324 179.64 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' B' ' 263' ' ' ARG . 29.6 mtm-85 -67.02 -2.63 5.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.248 -0.908 . . . . 3.82 110.597 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.65 14.63 12.67 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.344 -0.847 . . . . 2.08 109.127 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.14 169.08 18.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.313 -0.867 . . . . 0.32 109.839 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.16 130.15 24.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 1.79 109.077 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.38 110.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.244 -0.91 . . . . 0.45 109.595 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.38 155.28 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.737 -0.838 . . . . 0.57 108.737 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.36 140.86 29.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.313 -0.867 . . . . 3.62 109.607 179.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.923 -1.037 . . . . 2.05 109.405 179.702 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 m120 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 121.067 0.46 . . . . 1.48 109.773 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -135.86 135.26 39.62 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.803 . . . . 0.72 109.717 179.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 224' ' ' ARG . 12.0 mtm-85 -106.17 160.62 15.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.79 -1.189 . . . . 3.26 107.79 178.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.7 141.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.23 110.212 -179.256 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.81 154.7 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.363 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.8 p90 -157.15 152.2 26.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.643 -1.286 . . . . 0.44 110.11 -179.228 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.435 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 35.9 mtm180 -95.95 152.3 18.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.466 -0.771 . . . . 2.76 110.067 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -91.19 165.2 13.6 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 179.222 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 59.5 m -83.92 -13.07 54.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.994 -1.067 . . . . 1.8 108.873 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.81 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 3.63 109.588 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.7 p30 -156.95 128.87 3.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.954 -1.091 . . . . 2.16 109.414 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.76 7.08 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 121.059 1.173 . . . . 1.25 111.476 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 235' ' ' TRP . 13.9 p -83.29 161.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.459 -1.401 . . . . 1.75 110.208 -179.523 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.535 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.2 m95 -75.48 160.75 29.85 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.157 -0.683 . . . . 0.66 109.157 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.3 tttp -119.12 163.82 16.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.395 -0.816 . . . . 1.43 109.069 179.408 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.94 168.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.902 -1.279 . . . . 0.39 109.902 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.3 161.3 46.44 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.458 1.439 . . . . 0.41 110.64 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.61 173.9 11.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.992 -0.744 . . . . 0.21 108.992 179.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.75 139.59 31.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.092 -1.005 . . . . 2.72 109.21 179.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.18 123.85 33.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 0.29 109.455 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.15 -75.37 0.59 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.45 109.724 179.638 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.96 143.75 26.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 0.31 110.301 -179.062 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -149.54 118.72 6.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.477 -0.764 . . . . 2.32 108.955 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -100.99 0.18 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.618 -1.277 . . . . 0.27 110.157 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.35 -154.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -1.069 . . . . 1.39 109.751 -179.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.77 45.77 2.23 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.89 150.52 36.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.443 -1.034 . . . . 0.29 108.834 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 129.34 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.204 -0.935 . . . . 0.31 109.459 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.97 137.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.088 -1.078 . . . . 0.29 108.088 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.0 pt -140.11 -178.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.178 -0.951 . . . . 0.23 110.549 -178.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.559 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -145.99 112.15 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.93 -76.57 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.998 -1.482 . . . . 1.18 106.998 179.216 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.19 -136.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.822 -1.547 . . . . 1.98 106.822 177.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.74 55.42 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.344 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -157.69 127.06 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 1.12 109.097 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.559 ' CG1' HE21 ' A' ' 252' ' ' GLN . 38.3 mt -92.68 133.27 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.31 -0.869 . . . . 0.47 109.567 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.25 168.27 19.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.505 -0.747 . . . . 2.11 109.631 -179.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.48 138.48 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.439 -0.788 . . . . 0.33 109.658 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.5 133.07 19.0 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.473 -0.936 . . . . 0.34 108.473 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.39 140.64 95.3 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.663 0.909 . . . . 0.42 110.143 179.587 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -57.92 -35.5 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 3.12 109.209 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.4 mtt-85 -69.99 -1.95 11.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 3.82 110.464 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.435 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 5.3 mptp? -118.7 15.54 13.59 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.738 -0.838 . . . . 2.08 108.738 -179.672 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.17 173.34 11.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.524 -0.735 . . . . 0.32 109.445 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.55 129.04 22.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.336 -0.853 . . . . 1.79 108.997 179.545 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.2 mm -86.57 113.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.45 109.19 179.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.6 mm -112.6 148.65 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.514 -0.921 . . . . 0.57 108.514 179.364 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.554 -0.716 . . . . 3.63 109.518 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.135 0.493 . . . . 1.48 109.768 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -135.86 135.25 39.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.426 -0.796 . . . . 0.73 109.665 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' B' ' 224' ' ' ARG . 11.9 mtm-85 -106.05 160.57 15.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.814 -1.18 . . . . 3.26 107.814 178.79 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 141.48 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.206 -0.934 . . . . 0.23 110.178 -179.24 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.75 154.75 22.49 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.447 -1.316 . . . . 0.58 107.447 178.369 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.21 152.16 25.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.653 -1.28 . . . . 0.44 110.096 -179.247 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.419 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 35.7 mtm180 -95.86 152.39 18.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.461 -0.775 . . . . 2.76 110.053 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -91.33 165.1 13.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 2.23 108.686 179.221 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 59.1 m -83.72 -13.19 54.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 1.81 108.943 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.66 40.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 3.64 109.59 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -157.12 128.8 3.88 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.115 -0.991 . . . . 2.16 109.322 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.8 7.27 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.988 1.125 . . . . 1.27 111.583 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.538 HG22 ' N ' ' B' ' 235' ' ' TRP . 13.9 p -83.33 161.65 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.347 -1.47 . . . . 1.76 110.241 -179.574 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.538 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.45 160.75 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.67 109.199 179.68 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.2 tttp -119.05 163.85 16.38 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.373 -0.829 . . . . 1.44 109.032 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.97 168.2 0.03 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.967 -1.253 . . . . 0.4 109.967 -179.486 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -69.34 161.31 46.39 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.479 1.453 . . . . 0.41 110.584 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.64 173.87 11.19 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.883 -0.784 . . . . 0.21 108.883 179.282 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.73 139.52 31.13 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.069 -1.019 . . . . 2.72 109.215 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.19 123.78 33.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.433 -0.792 . . . . 0.3 109.425 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.09 -75.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.476 -0.765 . . . . 0.45 109.744 179.655 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.97 143.8 26.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 0.33 110.274 -179.067 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -149.53 118.72 6.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.418 -0.801 . . . . 2.33 109.044 179.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.8 -100.97 0.18 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.577 -1.297 . . . . 0.28 110.191 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.32 -154.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -1.012 . . . . 1.4 109.807 -179.399 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 45.83 2.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.236 -1.545 . . . . 0.29 109.236 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.9 150.48 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -1.022 . . . . 0.29 108.789 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.96 129.36 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.92 . . . . 0.31 109.519 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.99 137.38 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.087 -1.079 . . . . 0.3 108.087 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.01 -178.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.286 -0.884 . . . . 0.24 110.618 -178.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.561 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -146.07 112.09 5.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.82 -76.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.063 -1.458 . . . . 1.18 107.063 179.213 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -82.08 -136.43 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.512 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.7 55.36 0.87 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.195 -1.039 . . . . 1.38 108.195 178.345 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -157.66 126.96 5.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.581 -0.699 . . . . 1.12 109.154 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.561 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.8 mt -92.56 133.25 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.48 109.586 -179.623 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.2 168.28 19.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.427 -0.796 . . . . 2.13 109.627 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.51 138.47 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 0.34 109.657 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 133.14 19.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.376 -0.972 . . . . 0.34 108.376 179.421 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.43 140.75 95.78 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 120.539 0.826 . . . . 0.42 110.162 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -57.95 -35.51 71.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.114 -0.991 . . . . 3.11 109.222 179.449 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.4 mtt-85 -70.01 -1.96 11.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 3.82 110.462 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.419 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 5.3 mptp? -118.72 15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.367 -0.833 . . . . 2.08 108.758 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 173.38 11.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.453 -0.78 . . . . 0.32 109.512 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.62 128.89 22.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 1.79 109.075 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.0 mm -86.43 113.29 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.158 -0.964 . . . . 0.45 109.233 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.71 148.61 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.471 -0.937 . . . . 0.57 108.471 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -91.33 150.01 21.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.541 -0.724 . . . . 3.62 109.581 179.908 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.219 179.704 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.057 -0.72 . . . . 1.48 109.057 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.64 138.62 46.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.582 -0.699 . . . . 0.72 109.381 -179.751 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -107.7 160.05 16.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.962 -1.125 . . . . 3.26 107.962 179.159 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 77.3 t -142.04 138.92 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.172 -0.955 . . . . 0.23 110.096 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -108.36 151.36 26.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.556 -1.276 . . . . 0.58 107.556 178.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -155.61 152.31 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.609 -1.307 . . . . 0.44 110.529 -179.076 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.45 ' HG3' HH11 ' A' ' 228' ' ' ARG . 8.8 mtm-85 -95.31 151.0 19.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 2.76 109.513 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.8 m-20 -96.52 167.15 11.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 2.23 108.892 179.34 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.2 t -83.33 -8.92 59.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.8 109.195 179.538 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -90.44 -16.17 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.352 -0.843 . . . . 3.63 109.764 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 234' ' ' VAL . 59.2 m-20 -160.69 129.74 3.14 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.139 -0.976 . . . . 2.16 109.232 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.39 10.91 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 120.862 1.041 . . . . 1.25 110.41 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.0 m -83.17 135.91 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 1.75 110.1 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.19 167.55 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.66 109.127 179.71 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 237' ' ' GLY . 36.8 tttp -125.5 157.92 35.79 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.383 -0.823 . . . . 1.43 109.34 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.05 166.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.349 -1.1 . . . . 0.39 110.349 -179.315 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -65.53 160.92 40.7 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.639 1.559 . . . . 0.41 110.58 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.824 -0.806 . . . . 0.21 108.824 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.9 137.93 34.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.118 -0.989 . . . . 2.72 109.216 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.89 125.41 35.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.563 -0.711 . . . . 0.29 109.765 -179.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.76 -72.89 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 0.45 109.912 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.24 28.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.234 -0.916 . . . . 0.31 110.341 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.84 118.74 7.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 2.32 108.896 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -100.24 0.18 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.787 -1.197 . . . . 0.27 110.151 -179.76 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.59 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 1.39 109.569 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.46 47.98 2.47 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.575 -1.41 . . . . 0.29 109.575 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.91 33.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -1.086 . . . . 0.29 108.854 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.21 125.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 0.31 109.489 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.99 139.52 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.368 -0.975 . . . . 0.29 108.368 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 260' ' ' VAL . 27.2 pt -141.73 178.51 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.117 -0.989 . . . . 0.23 110.257 -179.121 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.539 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.1 tt0 -144.36 114.52 7.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.736 -0.839 . . . . 1.81 108.736 179.193 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.96 -78.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.453 -1.314 . . . . 1.18 107.453 179.241 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.57 -129.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.06 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.537 -0.727 . . . . 1.12 109.277 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.539 ' CG1' HE21 ' A' ' 252' ' ' GLN . 33.8 mt -92.74 135.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.807 . . . . 0.47 109.45 -179.629 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.09 14.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 2.11 109.776 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.35 138.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.466 -0.771 . . . . 0.33 109.475 179.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 251' ' ' ILE . 90.5 t -134.9 126.9 18.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.668 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 145.08 90.01 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 120.507 0.805 . . . . 0.42 110.47 179.822 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 262' ' ' ARG . 4.5 ttt-85 -65.16 -36.82 85.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.428 -0.795 . . . . 3.12 110.1 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -68.71 -4.91 17.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 3.82 110.174 -179.099 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -119.52 19.54 12.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.341 -0.849 . . . . 2.08 109.184 179.783 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.54 170.55 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.496 -0.752 . . . . 0.32 109.578 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -140.93 132.14 26.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.236 -0.915 . . . . 1.79 109.358 179.765 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.8 mm -88.78 106.03 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.27 -0.894 . . . . 0.45 109.593 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.47 155.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.374 -0.828 . . . . 0.57 109.208 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.801 . . . . 3.63 109.464 179.578 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.03 -0.729 . . . . 1.48 109.03 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.66 138.58 45.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.69 . . . . 0.73 109.386 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.433 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 61.4 mtm180 -107.68 160.18 15.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.985 -1.117 . . . . 3.26 107.985 179.158 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 77.2 t -142.2 138.96 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.192 -0.943 . . . . 0.23 109.982 -179.57 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -108.42 151.31 26.21 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.62 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -155.51 152.47 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.44 110.541 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.8 mtm-85 -95.39 151.08 19.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 2.76 109.39 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.8 m-20 -96.61 167.17 11.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.355 -0.841 . . . . 2.23 108.89 179.316 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 43.5 t -83.26 -9.14 59.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 1.81 109.215 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -90.27 -16.15 29.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 3.64 109.821 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 59.1 m-20 -160.74 129.73 3.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 2.16 109.295 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.41 11.02 0.23 Allowed 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 120.79 0.994 . . . . 1.27 110.419 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.0 m -83.23 135.93 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.869 -1.144 . . . . 1.76 110.06 -179.48 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.2 167.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.227 -0.92 . . . . 0.67 109.107 179.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' B' ' 237' ' ' GLY . 36.8 tttp -125.48 157.92 35.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.373 -0.83 . . . . 1.44 109.272 179.447 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.11 166.11 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.361 -1.096 . . . . 0.4 110.361 -179.342 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -65.47 160.89 40.68 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.617 1.545 . . . . 0.41 110.585 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.805 . . . . 0.21 108.825 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.82 137.99 34.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.061 -1.024 . . . . 2.72 109.254 179.901 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.93 125.49 35.38 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.564 -0.71 . . . . 0.3 109.774 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.75 -72.93 0.66 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.45 -0.781 . . . . 0.45 110.002 179.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.16 28.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.23 -0.919 . . . . 0.33 110.251 -178.789 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.78 118.8 7.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.377 -0.827 . . . . 2.33 108.882 179.155 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -100.25 0.18 Allowed Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.096 -179.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.52 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 1.4 109.555 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.48 47.98 2.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.688 -1.365 . . . . 0.29 109.688 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.83 33.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -1.093 . . . . 0.29 108.82 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.12 125.87 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 0.31 109.501 179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.04 139.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.467 -0.938 . . . . 0.3 108.467 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . 0.427 HD11 HG21 ' B' ' 260' ' ' VAL . 27.1 pt -141.7 178.54 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.92 . . . . 0.24 110.265 -179.092 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.544 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.1 tt0 -144.38 114.51 7.42 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.834 -0.802 . . . . 1.81 108.834 179.106 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.96 -78.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.436 -1.32 . . . . 1.18 107.436 179.33 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.51 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.78 -1.563 . . . . 1.97 106.78 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 17.7 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.105 -1.072 . . . . 1.38 108.105 178.081 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.07 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.628 -0.67 . . . . 1.12 109.257 -179.379 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.544 ' CG1' HE21 ' B' ' 252' ' ' GLN . 34.1 mt -92.76 135.92 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.355 -0.841 . . . . 0.48 109.436 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.02 15.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.822 . . . . 2.13 109.806 -179.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 138.32 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.388 -0.82 . . . . 0.34 109.542 179.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . 0.427 HG21 HD11 ' B' ' 251' ' ' ILE . 91.1 t -134.8 126.97 18.2 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.573 -0.899 . . . . 0.34 108.573 179.748 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.57 145.12 90.52 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 120.564 0.843 . . . . 0.42 110.355 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 262' ' ' ARG . 4.5 ttt-85 -65.14 -36.92 85.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.427 -0.796 . . . . 3.11 110.109 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -68.53 -4.95 16.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.109 -0.994 . . . . 3.82 110.325 -179.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -119.56 19.53 12.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.327 -0.858 . . . . 2.08 109.191 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 170.62 15.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.448 -0.783 . . . . 0.32 109.584 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -140.95 132.05 26.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 1.79 109.321 179.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.62 106.0 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.275 -0.891 . . . . 0.45 109.627 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -105.53 155.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.447 -0.783 . . . . 0.57 109.212 179.631 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -91.27 147.9 22.72 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 3.62 109.502 179.608 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.95 -1.024 . . . . 2.05 109.414 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 222' ' ' ASN . 1.5 m-20 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 121.353 0.597 . . . . 1.48 110.925 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.22 127.54 28.34 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.867 -0.79 . . . . 0.72 108.867 178.443 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.94 159.05 15.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.206 -1.035 . . . . 3.26 108.206 179.227 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.7 t -143.44 144.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.2 -0.938 . . . . 0.23 110.157 -179.731 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.53 157.02 20.84 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.555 -1.276 . . . . 0.58 107.555 178.626 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.0 p90 -157.78 149.26 21.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.258 . . . . 0.44 110.434 -178.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.464 ' NH1' ' CH2' ' A' ' 235' ' ' TRP . 24.0 mtm-85 -95.16 142.54 27.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.439 -0.788 . . . . 2.76 109.266 179.259 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.88 173.06 8.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 2.23 109.068 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.8 m -86.83 -8.1 57.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 1.8 109.527 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.46 -20.5 26.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 3.63 109.455 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.4 m-20 -162.42 132.34 3.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 2.16 108.95 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.35 14.64 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 120.724 0.949 . . . . 1.25 110.293 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 232' ' ' ASP . 44.5 t -80.91 155.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.798 -1.189 . . . . 1.75 109.577 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.464 ' CH2' ' NH1' ' A' ' 228' ' ' ARG . 98.8 m95 -75.89 160.71 29.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.66 109.573 -179.789 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.0 mttm -119.33 159.32 24.38 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.347 -0.845 . . . . 1.43 109.027 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.38 168.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.997 -1.241 . . . . 0.39 109.997 -179.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.74 159.09 54.3 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.585 1.523 . . . . 0.41 110.425 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.4 174.41 10.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.799 -0.815 . . . . 0.21 108.799 179.13 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 240' ' ' LYS . 11.5 mptt -92.71 136.62 33.07 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 2.72 109.373 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -87.07 122.9 31.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.327 -0.858 . . . . 0.29 109.403 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -113.78 -76.67 0.58 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.421 -0.8 . . . . 0.45 110.373 -179.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 21.3 t90 -97.35 137.86 35.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.018 -1.051 . . . . 0.31 110.772 -178.722 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.89 132.36 17.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.857 -0.794 . . . . 2.32 108.857 178.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -99.82 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.48 -1.448 . . . . 0.27 109.48 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.52 -149.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 1.39 109.154 179.829 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 48.32 3.09 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.231 -1.548 . . . . 0.29 109.231 179.66 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.61 149.15 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.971 . . . . 0.29 109.085 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.11 135.6 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.096 -1.003 . . . . 0.31 109.534 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 87.7 t -88.41 143.63 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.29 109.318 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.79 179.81 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.362 -0.836 . . . . 0.23 109.482 179.737 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.419 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.6 tt0 -143.99 110.8 5.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 1.81 108.656 178.731 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -89.6 -78.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.67 -1.233 . . . . 1.18 107.67 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.647 HD22 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -81.13 -131.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.815 -1.55 . . . . 1.98 106.815 177.858 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.647 ' N ' HD22 ' A' ' 254' ' ' ASN . 14.6 m -105.24 53.36 0.72 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.191 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -155.53 127.66 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.603 -0.686 . . . . 1.12 109.157 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.481 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 72.4 mt -93.0 132.97 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.47 109.861 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -134.99 170.62 15.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.449 -0.782 . . . . 2.11 109.493 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.3 t -100.89 139.87 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.415 -0.803 . . . . 0.33 109.498 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.75 121.56 14.99 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.441 -0.787 . . . . 0.34 109.201 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.99 139.35 89.63 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.486 0.791 . . . . 0.42 110.054 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -52.86 -43.1 65.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 3.12 109.555 179.658 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.26 -3.88 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.412 -0.805 . . . . 3.82 110.667 -178.783 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.426 ' CD ' ' NH2' ' A' ' 228' ' ' ARG . 7.2 mmmt -120.19 16.85 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.288 -0.883 . . . . 2.08 108.882 179.852 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.96 172.27 12.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.702 . . . . 0.32 109.749 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -137.4 126.96 25.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.783 -0.821 . . . . 1.79 108.783 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.97 107.11 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.45 109.516 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.45 147.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.61 -0.885 . . . . 0.57 108.61 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.352 -0.843 . . . . 3.63 109.367 179.682 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' B' ' 222' ' ' ASN . 1.5 m-20 . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.315 0.579 . . . . 1.48 110.873 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.21 127.68 28.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.437 -0.789 . . . . 0.73 108.876 178.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.96 159.04 15.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.177 -1.045 . . . . 3.26 108.177 179.245 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.53 144.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.166 -0.958 . . . . 0.23 110.13 -179.84 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.45 157.01 20.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.626 -1.25 . . . . 0.58 107.626 178.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -157.75 149.28 21.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.241 . . . . 0.44 110.487 -178.948 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . 0.465 ' NH1' ' CH2' ' B' ' 235' ' ' TRP . 24.1 mtm-85 -95.17 142.56 27.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.432 -0.792 . . . . 2.76 109.222 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.93 173.09 8.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.314 -0.866 . . . . 2.23 109.073 179.856 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -86.87 -8.1 57.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 1.81 109.509 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.44 -20.45 26.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 3.64 109.452 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.6 m-20 -162.47 132.32 3.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 2.16 108.976 179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.38 14.69 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 120.65 0.9 . . . . 1.27 110.321 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' B' ' 232' ' ' ASP . 44.3 t -80.94 155.09 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.836 -1.165 . . . . 1.76 109.579 -179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.465 ' CH2' ' NH1' ' B' ' 228' ' ' ARG . 98.8 m95 -75.96 160.7 29.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.67 109.609 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.0 mttm -119.31 159.33 24.34 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.415 -0.803 . . . . 1.44 108.917 179.574 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.27 168.81 0.03 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.971 -1.251 . . . . 0.4 109.971 -179.714 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.76 159.11 54.19 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.592 1.528 . . . . 0.41 110.424 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.37 174.38 10.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.835 -0.802 . . . . 0.21 108.835 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' B' ' 240' ' ' LYS . 11.5 mptt -92.64 136.6 33.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.132 -0.98 . . . . 2.72 109.416 -179.694 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.02 122.89 31.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.424 -0.797 . . . . 0.3 109.401 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.8 -76.66 0.58 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.45 110.442 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.411 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 21.5 t90 -97.48 137.9 35.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.057 -1.027 . . . . 0.33 110.76 -178.726 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.9 132.38 17.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.407 -0.808 . . . . 2.33 108.898 178.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -99.92 0.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.445 -1.462 . . . . 0.28 109.445 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.51 -149.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -1.178 . . . . 1.4 109.154 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.36 48.19 3.08 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.675 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.57 149.22 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -1.014 . . . . 0.29 108.981 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.15 135.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.142 -0.974 . . . . 0.31 109.594 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . 0.475 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 87.6 t -88.44 143.61 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.918 . . . . 0.3 109.339 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.73 179.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 0.24 109.61 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.419 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.5 tt0 -144.04 110.73 5.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.701 -0.852 . . . . 1.81 108.701 178.776 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.53 -78.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.598 -1.26 . . . . 1.18 107.598 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.649 HD22 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -81.02 -131.13 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.875 -1.528 . . . . 1.97 106.875 177.884 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.649 ' N ' HD22 ' B' ' 254' ' ' ASN . 14.6 m -105.25 53.35 0.72 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.189 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -155.56 127.59 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.154 -0.684 . . . . 1.12 109.154 -179.238 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 72.5 mt -92.96 132.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.48 109.899 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.95 170.7 15.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 2.13 109.456 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.06 139.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.386 -0.821 . . . . 0.34 109.501 179.79 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.69 121.55 15.06 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.504 -0.748 . . . . 0.34 109.253 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.97 139.36 89.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 110.138 -0.755 . . . . 0.42 110.138 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -52.87 -43.1 65.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 3.11 109.556 179.69 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.16 -4.0 4.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 3.82 110.669 -178.85 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . 0.419 ' CD ' ' NH2' ' B' ' 228' ' ' ARG . 7.3 mmmt -120.09 16.81 12.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.355 -0.841 . . . . 2.08 108.896 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.02 172.23 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.32 109.672 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -137.43 126.96 25.07 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.742 -0.836 . . . . 1.79 108.742 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.96 107.33 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.168 -0.957 . . . . 0.45 109.451 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.57 147.66 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.336 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.55 145.76 25.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.35 -0.844 . . . . 3.62 109.433 179.673 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.941 -1.028 . . . . 2.05 109.571 179.712 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.0 -0.741 . . . . 1.48 109.0 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -133.16 132.33 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.535 -0.728 . . . . 0.72 109.256 -179.545 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . 0.632 ' NH2' ' CD2' ' A' ' 226' ' ' TYR . 0.2 OUTLIER -105.99 163.04 13.07 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.782 -1.192 . . . . 3.26 107.782 178.715 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.5 ' C ' HH22 ' A' ' 224' ' ' ARG . 96.2 t -141.47 139.66 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.021 -1.049 . . . . 0.23 110.491 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.632 ' CD2' ' NH2' ' A' ' 224' ' ' ARG . 47.5 m-85 -104.37 154.79 19.4 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.017 -1.475 . . . . 0.58 107.017 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.53 ' OH ' ' NZ ' ' A' ' 236' ' ' LYS . 23.7 p90 -158.71 163.39 36.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.372 -1.455 . . . . 0.44 110.983 -179.418 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -96.19 138.88 33.16 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.384 0.612 . . . . 2.76 109.527 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.38 -177.13 4.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.406 -0.809 . . . . 2.23 109.277 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.3 p -94.55 -11.72 28.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -0.929 . . . . 1.8 109.648 179.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 231' ' ' ARG . 2.9 mmp_? -79.51 -21.03 45.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.097 -1.002 . . . . 3.63 109.7 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.99 139.31 7.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 2.16 108.877 179.623 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.37 2.45 1.5 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 121.022 1.148 . . . . 1.25 111.304 -179.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.2 p -82.91 163.26 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.561 -1.337 . . . . 1.75 110.372 -179.361 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.573 ' N ' HG22 ' A' ' 234' ' ' VAL . 93.5 m95 -68.41 165.63 18.4 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.957 -0.757 . . . . 0.66 108.957 179.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.53 ' NZ ' ' OH ' ' A' ' 227' ' ' TYR . 5.6 ttpt -119.58 -163.17 0.96 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.226 -0.921 . . . . 1.43 109.328 -179.776 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.98 -179.05 32.25 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.699 -1.36 . . . . 0.39 109.699 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.05 158.94 45.24 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.777 1.651 . . . . 0.41 110.212 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.4 169.43 17.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.21 109.379 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -94.66 138.5 32.43 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.14 -0.975 . . . . 2.72 109.608 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.63 125.86 35.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.607 -0.683 . . . . 0.29 109.476 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.49 -72.95 0.66 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.447 -0.783 . . . . 0.45 110.108 179.925 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -93.04 145.4 24.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.31 110.129 -178.59 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -148.22 121.03 8.69 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.4 -0.812 . . . . 2.32 109.128 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.36 -102.41 0.2 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.734 -1.222 . . . . 0.27 110.324 -179.881 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.09 -153.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.221 -1.164 . . . . 1.39 109.803 -179.331 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.92 47.91 2.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.284 -1.527 . . . . 0.29 109.284 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.46 151.98 37.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.29 108.813 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.82 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.174 -0.954 . . . . 0.31 109.629 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.1 135.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.882 -1.155 . . . . 0.29 107.882 179.04 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -139.11 175.69 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.301 -0.874 . . . . 0.23 109.792 -179.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.422 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.0 tt0 -143.86 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.746 -0.835 . . . . 1.81 108.746 179.216 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.75 -82.76 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.537 -1.282 . . . . 1.18 107.537 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 255' ' ' SER . 38.0 t-20 -78.96 -128.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.719 -1.586 . . . . 1.98 106.719 177.636 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.465 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 10.7 p -105.84 54.49 0.69 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.147 -1.056 . . . . 1.39 108.147 178.019 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 66.2 m-20 -155.05 123.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.55 -0.719 . . . . 1.12 109.099 -179.39 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.422 ' CG1' HE21 ' A' ' 252' ' ' GLN . 13.5 mt -94.23 136.54 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.47 109.58 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.52 169.8 17.09 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.11 109.622 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.24 142.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.33 109.027 179.389 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.49 131.38 19.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.34 109.164 -179.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.73 141.24 97.58 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.551 -0.98 . . . . 0.42 109.551 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -58.53 -35.63 72.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.209 -0.932 . . . . 3.12 109.512 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.58 -4.39 18.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 3.82 110.756 -179.157 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -118.96 21.27 12.47 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.124 -0.985 . . . . 2.08 108.819 179.429 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.18 16.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.32 109.591 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -141.64 124.79 16.36 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.294 -0.879 . . . . 1.79 109.142 179.802 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.77 101.53 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 0.45 109.701 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.467 ' HB ' HH11 ' A' ' 224' ' ' ARG . 5.7 mm -106.38 158.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.413 -0.958 . . . . 0.57 108.413 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.03 . . . . 3.63 109.444 179.555 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 108.999 -0.741 . . . . 1.48 108.999 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.16 132.37 41.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 0.73 109.205 -179.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . 0.636 ' NH2' ' CD2' ' B' ' 226' ' ' TYR . 0.2 OUTLIER -106.06 163.11 13.03 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.771 -1.196 . . . . 3.26 107.771 178.65 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.501 ' C ' HH22 ' B' ' 224' ' ' ARG . 95.6 t -141.6 139.5 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.23 110.52 -179.561 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . 0.636 ' CD2' ' NH2' ' B' ' 224' ' ' ARG . 47.3 m-85 -104.3 154.82 19.33 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.58 106.991 178.357 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' B' ' 236' ' ' LYS . 24.0 p90 -158.68 163.36 36.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.487 -1.383 . . . . 0.44 111.027 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.05 138.85 33.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.742 -0.599 . . . . 2.76 109.561 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.41 -177.09 4.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 2.23 109.249 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 29.1 p -94.59 -11.71 28.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.199 -0.938 . . . . 1.81 109.604 -179.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' N ' ' B' ' 231' ' ' ARG . 2.9 mmp_? -79.57 -21.15 45.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 3.64 109.606 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.87 139.36 7.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 2.16 108.9 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.39 2.45 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.086 1.191 . . . . 1.27 111.217 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.577 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.0 p -83.02 163.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.566 -1.334 . . . . 1.76 110.368 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.577 ' N ' HG22 ' B' ' 234' ' ' VAL . 93.4 m95 -68.42 165.7 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.996 -0.742 . . . . 0.67 108.996 179.588 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' B' ' 227' ' ' TYR . 5.6 ttpt -119.63 -163.16 0.97 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.308 -0.87 . . . . 1.44 109.345 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -72.07 -179.06 32.57 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.691 -1.364 . . . . 0.4 109.691 -179.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.1 159.09 44.88 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.639 1.559 . . . . 0.41 110.234 -179.697 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 169.33 17.87 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.436 -0.79 . . . . 0.21 109.48 179.461 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -94.48 138.49 32.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.124 -0.985 . . . . 2.72 109.786 179.74 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 tp -88.68 126.04 35.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.763 -0.586 . . . . 0.3 109.474 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.57 -73.17 0.65 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.451 -0.78 . . . . 0.45 110.019 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.4 t90 -92.91 145.37 24.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.311 -0.868 . . . . 0.33 110.257 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -148.14 120.96 8.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.361 -0.837 . . . . 2.33 109.132 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.31 -102.29 0.2 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.328 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.16 -153.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -1.159 . . . . 1.4 109.813 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 47.91 2.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.22 -1.552 . . . . 0.29 109.22 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.53 151.99 37.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.493 -1.004 . . . . 0.29 108.814 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.73 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.245 -0.909 . . . . 0.31 109.613 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.04 135.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.16 . . . . 0.3 107.869 179.017 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -138.94 175.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.24 109.861 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.418 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.1 tt0 -143.87 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.726 -0.842 . . . . 1.81 108.726 179.105 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.72 -82.73 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.532 -1.284 . . . . 1.18 107.532 179.43 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 255' ' ' SER . 38.0 t-20 -78.92 -128.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.63 -1.619 . . . . 1.97 106.63 177.683 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . 0.463 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 10.8 p -105.91 54.45 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.19 -1.041 . . . . 1.38 108.19 178.026 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 255' ' ' SER . 66.0 m-20 -155.04 123.93 6.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.585 -0.697 . . . . 1.12 109.167 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.418 ' CG1' HE21 ' B' ' 252' ' ' GLN . 13.3 mt -94.25 136.51 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.48 109.565 -179.686 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.49 169.84 17.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.263 -0.898 . . . . 2.13 109.604 -179.629 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.3 142.09 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.476 -0.765 . . . . 0.34 108.992 179.384 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.49 131.47 19.41 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.436 -0.79 . . . . 0.34 109.133 -179.992 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.71 141.24 97.53 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 N-CA-C 109.609 -0.958 . . . . 0.42 109.609 178.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -58.61 -35.58 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.211 -0.931 . . . . 3.11 109.516 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.53 -4.37 18.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 3.82 110.746 -179.149 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -119.12 21.34 12.36 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.227 -0.921 . . . . 2.08 108.887 179.454 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.74 170.16 16.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.53 -0.731 . . . . 0.32 109.658 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -141.72 124.71 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.238 -0.913 . . . . 1.79 109.165 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.74 101.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.25 -0.906 . . . . 0.45 109.668 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . 0.477 ' HB ' HH11 ' B' ' 224' ' ' ARG . 5.8 mm -106.44 158.13 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.373 -0.973 . . . . 0.57 108.373 179.025 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.29 152.85 21.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 3.62 109.405 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 2.05 109.39 179.794 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.771 -0.826 . . . . 1.48 108.771 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -125.64 140.64 52.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.434 -0.791 . . . . 0.72 109.788 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.99 157.78 24.08 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.796 -1.187 . . . . 3.26 107.796 178.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 239' ' ' ALA . 78.3 t -139.3 141.03 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.172 -0.955 . . . . 0.23 110.309 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -107.32 150.35 26.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.506 -1.294 . . . . 0.58 107.506 178.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 14.5 p90 -155.78 156.44 34.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.753 -1.217 . . . . 0.44 110.03 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -93.87 150.01 20.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.49 -0.756 . . . . 2.76 109.829 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -93.51 159.19 15.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 2.23 108.886 179.524 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 46.9 t -76.89 2.58 14.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.061 -1.024 . . . . 1.8 109.189 179.796 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.9 mtt-85 -90.37 -25.5 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 3.63 109.831 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.0 m-20 -162.44 144.48 8.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.059 -1.026 . . . . 2.16 109.271 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -64.41 11.4 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.268 1.312 . . . . 1.25 110.706 179.834 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.6 m -84.86 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.872 -1.142 . . . . 1.75 109.823 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -66.59 161.5 23.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.66 109.244 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 237' ' ' GLY . 45.2 tttp -119.1 166.43 12.93 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.456 -0.777 . . . . 1.43 109.496 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.14 171.83 0.02 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.2 -1.16 . . . . 0.39 110.2 -179.534 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.22 164.58 27.43 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.729 1.619 . . . . 0.41 110.501 179.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -140.47 169.34 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.093 -0.706 . . . . 0.21 109.093 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -92.9 136.23 33.44 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.041 -1.037 . . . . 2.72 109.609 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.39 125.94 34.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.595 -0.69 . . . . 0.29 109.602 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.2 mt -118.37 -76.86 0.57 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.423 -0.798 . . . . 0.45 110.164 179.77 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -102.99 139.3 38.73 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 0.31 110.684 -178.529 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.22 134.68 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 2.32 109.205 179.05 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.75 -99.91 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.389 -1.484 . . . . 0.27 109.389 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -66.99 -150.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 1.39 108.985 179.781 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.77 48.15 2.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.951 -1.66 . . . . 0.29 108.951 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.13 147.76 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -1.043 . . . . 0.29 109.304 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.89 136.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.144 -0.973 . . . . 0.31 109.165 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.2 t -89.69 145.24 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.29 109.162 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.0 pt -143.82 178.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.245 -0.909 . . . . 0.23 109.998 -179.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.407 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.8 tt0 -144.54 114.31 7.25 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.702 -0.851 . . . . 1.81 108.702 179.06 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.31 -80.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.269 -1.382 . . . . 1.18 107.269 179.188 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.23 -129.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.9 -1.518 . . . . 1.98 106.9 177.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.1 m -104.54 54.87 0.72 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.931 -1.137 . . . . 1.39 107.931 177.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.23 125.35 6.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 1.12 109.126 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.407 ' CG1' HE21 ' A' ' 252' ' ' GLN . 30.8 mt -93.82 137.24 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 0.47 109.657 -179.613 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -140.26 163.55 32.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.586 -179.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.38 134.04 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.853 . . . . 0.33 108.899 179.356 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.59 133.04 24.37 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.34 108.827 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.47 140.76 94.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.669 0.913 . . . . 0.42 110.323 179.505 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -56.04 -38.02 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 3.12 109.881 179.662 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -68.38 -2.36 8.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.228 -0.92 . . . . 3.82 110.705 -178.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -119.13 16.19 13.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.619 -0.882 . . . . 2.08 108.619 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.12 170.69 15.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.688 -0.632 . . . . 0.32 109.311 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -140.01 127.37 21.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.287 -0.883 . . . . 1.79 109.12 179.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.24 109.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 0.45 109.47 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.46 150.04 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.748 -0.834 . . . . 0.57 108.748 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 3.63 109.317 179.573 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 108.763 -0.829 . . . . 1.48 108.763 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.68 140.53 52.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.464 -0.773 . . . . 0.73 109.793 -179.452 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.89 157.7 24.1 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.87 -1.159 . . . . 3.26 107.87 178.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 239' ' ' ALA . 79.8 t -139.22 141.07 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 0.23 110.375 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -107.42 150.3 26.92 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.458 -1.312 . . . . 0.58 107.458 178.146 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.4 p90 -155.7 156.45 34.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.44 110.046 -179.547 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -93.84 150.04 20.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.473 -0.767 . . . . 2.76 109.832 -179.844 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -93.52 159.05 15.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 2.23 108.922 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 46.8 t -76.79 2.56 14.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.058 -1.026 . . . . 1.81 109.204 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . 0.625 HH11 ' CG ' ' B' ' 231' ' ' ARG . 2.9 mtt-85 -90.52 -25.35 20.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 3.64 109.794 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.0 m-20 -162.52 144.43 8.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.068 -1.02 . . . . 2.16 109.242 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -64.27 11.31 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.822 0 C-N-CA 121.302 1.335 . . . . 1.27 110.775 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.6 m -84.82 145.22 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.132 . . . . 1.76 109.841 -179.477 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -66.56 161.51 22.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.67 109.387 179.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' B' ' 237' ' ' GLY . 45.2 tttp -119.07 166.39 12.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 1.44 109.504 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.15 171.75 0.02 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.202 -1.159 . . . . 0.4 110.202 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.1 164.64 26.93 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.687 1.591 . . . . 0.41 110.461 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 225' ' ' VAL . . . -140.52 169.3 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.21 109.073 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -92.9 136.28 33.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.038 -1.039 . . . . 2.72 109.657 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.4 126.08 35.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.474 -0.766 . . . . 0.3 109.587 -179.752 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.55 -76.78 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.58 -0.7 . . . . 0.45 110.152 179.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -103.01 139.43 38.58 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.217 -0.927 . . . . 0.33 110.637 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.25 134.68 18.46 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.344 -0.848 . . . . 2.33 109.188 179.069 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.83 -99.9 0.18 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.308 -1.517 . . . . 0.28 109.308 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.2 -149.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -1.128 . . . . 1.4 108.96 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.72 48.1 2.88 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.952 -1.659 . . . . 0.29 108.952 179.603 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.08 147.76 27.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -1.028 . . . . 0.29 109.296 -179.673 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.86 136.45 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.31 109.088 179.31 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.73 145.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.3 109.156 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -143.8 178.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.24 110.024 -179.891 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . 0.418 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.8 tt0 -144.57 114.41 7.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.033 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.38 -80.04 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.26 -1.385 . . . . 1.18 107.26 179.173 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.25 -129.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.837 -1.542 . . . . 1.97 106.837 177.653 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.2 m -104.5 54.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.2 125.41 6.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 1.12 109.169 -179.251 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.418 ' CG1' HE21 ' B' ' 252' ' ' GLN . 31.1 mt -93.86 137.36 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.48 109.67 -179.582 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -140.27 163.57 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 2.13 109.576 -179.712 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.4 134.04 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 0.34 108.927 179.306 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.6 133.03 24.37 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.893 -0.78 . . . . 0.34 108.893 -179.904 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.52 140.83 94.5 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.687 0.925 . . . . 0.42 110.234 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -56.1 -37.97 70.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.852 . . . . 3.11 109.86 179.64 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -68.46 -2.31 8.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.299 -0.876 . . . . 3.82 110.71 -178.877 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -119.1 16.14 13.25 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 2.08 108.6 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 170.57 15.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.639 -0.663 . . . . 0.32 109.319 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -139.95 127.37 21.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.312 -0.868 . . . . 1.79 109.111 179.874 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.14 109.06 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 0.45 109.481 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.46 150.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.779 -0.823 . . . . 0.57 108.779 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -91.25 145.87 24.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.375 -0.828 . . . . 3.62 109.395 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.991 -1.004 . . . . 2.05 109.535 179.751 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.655 -0.868 . . . . 1.48 108.655 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -134.3 149.56 50.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.409 -0.807 . . . . 0.72 109.538 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -120.68 155.39 33.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.882 -1.155 . . . . 3.26 107.882 179.344 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.61 141.06 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.098 -1.001 . . . . 0.23 110.635 -179.625 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.73 155.81 22.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.281 -1.377 . . . . 0.58 107.281 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.485 -1.384 . . . . 0.44 110.739 -179.175 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -100.52 140.02 35.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.591 -0.693 . . . . 2.76 109.671 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.64 170.05 9.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.866 . . . . 2.23 109.376 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.3 m -84.63 -9.48 58.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 1.8 109.137 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.42 -10.9 47.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 3.63 109.516 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.6 p30 -158.88 133.95 5.67 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.179 -0.95 . . . . 2.16 109.354 -179.242 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.13 -7.05 20.23 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 120.975 1.116 . . . . 1.25 111.396 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.569 HG22 ' N ' ' A' ' 235' ' ' TRP . 3.7 p -87.1 163.49 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.563 -1.336 . . . . 1.75 110.416 -179.398 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.569 ' N ' HG22 ' A' ' 234' ' ' VAL . 83.2 m95 -66.31 -175.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.646 -0.659 . . . . 0.66 109.514 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 4.0 ttpp -130.77 -156.38 0.75 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.589 -0.893 . . . . 1.43 108.589 179.326 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.28 54.22 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.57 -1.412 . . . . 0.39 109.57 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -71.46 154.26 60.56 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.677 1.585 . . . . 0.41 109.975 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.78 25.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.767 . . . . 0.21 109.215 179.446 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.02 141.44 28.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 2.72 109.846 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.63 123.93 34.65 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.829 -0.544 . . . . 0.29 109.565 -179.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.06 -73.2 0.65 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.334 -0.854 . . . . 0.45 111.017 -179.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 243' ' ' TRP . . . . . 0.461 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 6.0 t90 -91.78 152.66 20.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.22 -0.925 . . . . 0.31 110.807 -177.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.46 128.34 21.93 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.523 -0.917 . . . . 2.32 108.523 178.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.4 -126.83 1.23 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.521 -1.323 . . . . 0.27 110.539 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.65 -144.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.589 -0.947 . . . . 1.39 109.342 -179.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.33 49.24 2.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.827 -1.709 . . . . 0.29 108.827 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.64 149.32 31.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.383 -1.069 . . . . 0.29 109.041 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.47 134.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.31 109.48 -179.826 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -91.9 140.84 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.287 -0.883 . . . . 0.29 109.077 179.816 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.98 176.7 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.88 . . . . 0.23 109.794 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.92 112.3 6.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.851 . . . . 1.81 109.018 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.41 -81.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.409 -1.33 . . . . 1.18 107.409 179.28 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.02 -131.42 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.651 -1.611 . . . . 1.98 106.651 177.585 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.5 t -104.34 57.07 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.7 -1.222 . . . . 1.39 107.7 177.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -155.73 122.43 5.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.142 -0.688 . . . . 1.12 109.142 -179.378 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.462 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 59.0 mt -93.05 134.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.258 -0.901 . . . . 0.47 109.331 -179.831 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.79 172.72 12.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.449 -0.782 . . . . 2.11 109.741 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.34 142.07 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.146 -0.687 . . . . 0.33 109.146 179.387 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.51 126.7 15.06 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.398 -0.964 . . . . 0.34 108.398 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.11 152.07 39.48 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 109.835 -0.871 . . . . 0.42 109.835 179.526 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.71 -34.59 77.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 3.12 109.742 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -70.93 -5.59 32.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.815 . . . . 3.82 111.329 -178.914 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -118.77 20.33 12.89 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.236 -0.915 . . . . 2.08 108.908 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.9 165.36 27.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.519 -0.738 . . . . 0.32 109.275 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.4 mtmp? -140.08 129.62 24.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.371 -0.831 . . . . 1.79 108.925 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.97 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.313 -0.867 . . . . 0.45 109.704 -179.35 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.45 150.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.055 -1.091 . . . . 0.57 108.055 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.187 -0.946 . . . . 3.63 109.216 179.652 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.608 -0.886 . . . . 1.48 108.608 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.23 149.54 50.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.73 109.491 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -120.67 155.33 34.07 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.902 -1.147 . . . . 3.26 107.902 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.53 141.14 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.146 -0.971 . . . . 0.23 110.652 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.84 155.78 23.06 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.181 -1.414 . . . . 0.58 107.181 178.363 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.487 -1.383 . . . . 0.44 110.808 -179.218 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -100.55 140.11 35.28 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.647 -0.658 . . . . 2.76 109.639 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.79 170.02 9.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.313 -0.867 . . . . 2.23 109.412 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -9.62 58.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 1.81 109.157 179.727 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.31 -10.85 48.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 3.64 109.536 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -158.94 133.9 5.62 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.181 -0.949 . . . . 2.16 109.335 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.99 -7.06 20.19 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 120.98 1.12 . . . . 1.27 111.349 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 234' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 235' ' ' TRP . 3.7 p -87.25 163.55 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.671 -1.268 . . . . 1.76 110.398 -179.391 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 235' ' ' TRP . . . . . 0.57 ' N ' HG22 ' B' ' 234' ' ' VAL . 83.2 m95 -66.34 -175.67 0.37 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.731 -0.605 . . . . 0.67 109.521 -179.956 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 236' ' ' LYS . . . . . 0.445 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 4.0 ttpp -130.79 -156.55 0.76 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.598 -0.89 . . . . 1.44 108.598 179.378 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.8 177.2 54.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.604 -1.398 . . . . 0.4 109.604 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.38 154.24 60.98 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.593 1.528 . . . . 0.41 110.027 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 165.91 24.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.45 -0.782 . . . . 0.21 109.181 179.423 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.08 141.48 28.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.116 -0.99 . . . . 2.72 109.808 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.61 123.93 34.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.814 -0.554 . . . . 0.3 109.623 -179.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.97 -73.25 0.65 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.348 -0.845 . . . . 0.45 111.079 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 243' ' ' TRP . . . . . 0.462 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 6.1 t90 -91.93 152.66 19.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.234 -0.916 . . . . 0.33 110.804 -177.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.31 128.28 22.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.588 -0.894 . . . . 2.33 108.588 179.014 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.38 -126.99 1.24 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.58 -1.295 . . . . 0.28 110.574 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.44 -144.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.954 . . . . 1.4 109.445 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.2 49.1 2.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.867 -1.693 . . . . 0.29 108.867 179.376 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.4 149.44 31.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -1.068 . . . . 0.29 109.001 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 134.76 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.246 -0.908 . . . . 0.31 109.455 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.97 140.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.828 . . . . 0.3 109.03 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.94 176.74 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.24 109.873 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -144.91 112.32 6.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.334 -0.854 . . . . 1.81 108.992 179.379 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.54 -81.13 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.398 -1.334 . . . . 1.18 107.398 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.98 -131.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.678 -1.601 . . . . 1.97 106.678 177.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 41.6 t -104.35 57.06 0.71 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.697 -1.223 . . . . 1.38 107.697 177.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -155.78 122.51 5.28 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.974 -0.75 . . . . 1.12 108.974 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 257' ' ' ILE . . . . . 0.461 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 59.0 mt -93.05 134.62 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.153 -0.967 . . . . 0.48 109.375 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.83 172.71 12.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.502 -0.749 . . . . 2.13 109.721 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.33 142.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.114 -0.699 . . . . 0.34 109.114 179.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.55 126.69 15.0 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.443 -0.947 . . . . 0.34 108.443 179.349 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.03 152.1 38.73 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 N-CA-C 109.791 -0.888 . . . . 0.42 109.791 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.73 -34.55 77.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.385 -0.822 . . . . 3.11 109.684 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -71.06 -5.63 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.288 -0.883 . . . . 3.82 111.238 -178.805 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -118.8 20.34 12.87 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.019 -1.051 . . . . 2.08 108.922 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.91 165.33 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.32 109.269 179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 266' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.4 mtmp? -139.99 129.55 24.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.294 -0.879 . . . . 1.79 108.987 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.87 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.45 109.725 -179.34 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -105.35 150.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.141 -1.059 . . . . 0.57 108.141 178.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 269' ' ' ARG . . . . . 0.553 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.09 142.24 27.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 3.62 109.289 179.605 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.045 -0.979 . . . . 2.05 109.197 179.608 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 52.3 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.508 -0.553 . . . . 3.82 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 220' ' ' ILE . 2.0 mp -83.59 104.98 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 2.08 109.109 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -84.75 -119.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.864 . . . . 2.17 109.182 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -96.52 102.98 14.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 1.48 109.055 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -135.28 138.12 43.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.53 -0.731 . . . . 0.72 109.542 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.624 HH11 ' CG ' ' A' ' 224' ' ' ARG . 1.0 OUTLIER -108.62 157.31 18.62 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 107.699 -1.223 . . . . 3.26 107.699 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 93.6 t -141.85 140.06 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.09 -1.006 . . . . 0.23 110.418 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.79 153.17 23.87 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.593 -1.262 . . . . 0.58 107.593 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.6 p90 -156.48 152.82 27.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.699 -1.251 . . . . 0.44 110.156 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -95.32 156.4 16.34 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.771 . . . . 2.76 109.653 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -93.07 172.55 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.661 -0.866 . . . . 2.23 108.661 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.24 -13.7 46.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 1.8 109.251 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -90.75 -14.79 31.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 3.63 109.954 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 12.1 m-20 -161.02 128.81 2.77 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.912 -1.118 . . . . 2.16 109.553 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.13 18.0 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.814 0 C-N-CA 121.021 1.147 . . . . 1.25 110.882 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 31.5 m -83.24 135.06 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.829 -1.169 . . . . 1.75 109.55 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -58.9 161.24 5.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.66 109.496 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 237' ' ' GLY . 42.5 tttp -121.91 161.48 22.74 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.378 -0.826 . . . . 1.43 109.883 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.21 165.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.244 -1.142 . . . . 0.39 110.244 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.15 158.61 53.73 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 121.661 1.574 . . . . 0.41 110.699 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.01 172.55 12.76 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.851 -0.796 . . . . 0.21 108.851 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -92.75 135.75 33.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 2.72 110.026 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -88.14 125.37 34.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.29 109.558 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.86 -74.39 0.61 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.426 -0.796 . . . . 0.45 110.215 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.483 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 3.8 t90 -89.85 140.91 29.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.226 -0.921 . . . . 0.31 109.846 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.26 119.7 9.04 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 2.32 108.791 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -104.42 0.23 Allowed Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.87 -1.157 . . . . 0.27 110.215 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -67.69 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.387 -1.067 . . . . 1.39 109.735 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 49.0 2.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.55 151.28 36.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.29 108.522 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.15 126.54 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.105 -0.997 . . . . 0.31 109.909 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.86 135.16 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.025 -1.102 . . . . 0.29 108.025 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 257' ' ' ILE . 18.1 pt -139.31 179.27 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.871 . . . . 0.23 110.135 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.22 110.33 5.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.361 -0.837 . . . . 1.81 108.772 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.95 -81.81 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.467 -1.309 . . . . 1.18 107.467 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -78.6 -137.36 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.505 -1.665 . . . . 1.98 106.505 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.3 m -97.97 54.13 1.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.899 -1.149 . . . . 1.39 107.899 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.45 128.59 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.988 -0.745 . . . . 1.12 108.988 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.476 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 19.0 mt -92.74 140.0 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.121 -0.987 . . . . 0.47 109.604 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -138.44 168.22 20.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.406 -0.809 . . . . 2.11 109.774 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.75 138.34 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.508 -0.745 . . . . 0.33 109.228 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.72 131.93 18.35 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.363 -0.836 . . . . 0.34 109.137 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.43 139.75 91.85 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 N-CA-C 109.599 -0.962 . . . . 0.42 109.599 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.1 OUTLIER -59.96 -34.76 73.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 3.12 109.722 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.23 -4.96 19.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.313 -0.867 . . . . 3.82 110.988 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -119.29 17.51 13.07 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.254 -0.904 . . . . 2.08 108.873 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.35 169.77 17.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.014 -0.736 . . . . 0.32 109.014 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.6 131.37 27.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.303 -0.873 . . . . 1.79 109.094 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.7 mm -88.27 108.1 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.45 110.215 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.01 149.0 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.091 -1.078 . . . . 0.57 108.091 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.47 151.85 21.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.302 -0.874 . . . . 3.63 108.771 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.99 -1.005 . . . . 2.05 109.312 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.48 -0.563 . . . . 3.83 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.734 ' N ' HD12 ' B' ' 220' ' ' ILE . 2.0 mp -83.51 105.0 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 2.08 109.11 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -84.78 -119.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.322 -0.861 . . . . 2.16 109.127 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -96.53 102.96 14.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.857 . . . . 1.48 109.014 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -135.3 138.07 43.09 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.484 -0.76 . . . . 0.73 109.534 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 224' ' ' ARG . 1.0 OUTLIER -108.51 157.36 18.53 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.681 -1.229 . . . . 3.26 107.681 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.2 t -141.92 140.06 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.108 -0.995 . . . . 0.23 110.375 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -108.74 153.14 23.88 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.621 -1.252 . . . . 0.58 107.621 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.47 152.77 27.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.668 -1.27 . . . . 0.44 110.241 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -95.27 156.37 16.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.476 -0.765 . . . . 2.76 109.688 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.3 OUTLIER -93.13 172.46 8.29 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.65 -0.87 . . . . 2.23 108.65 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 33.4 t -86.15 -13.75 46.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.177 -0.952 . . . . 1.81 109.183 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.71 -14.81 31.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 3.64 109.979 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' B' ' 234' ' ' VAL . 12.0 m-20 -161.03 128.83 2.78 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.949 -1.094 . . . . 2.16 109.521 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.28 18.16 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 120.97 1.114 . . . . 1.27 110.81 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' B' ' 232' ' ' ASP . 31.7 m -83.31 135.13 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.795 -1.191 . . . . 1.76 109.535 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -58.97 161.22 5.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.225 -0.922 . . . . 0.67 109.516 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 42.5 tttp -121.92 161.47 22.78 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.368 -0.832 . . . . 1.44 109.879 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.26 165.5 0.02 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.277 -1.129 . . . . 0.4 110.277 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -66.28 158.68 53.71 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.619 1.546 . . . . 0.41 110.644 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.99 172.59 12.71 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.856 -0.794 . . . . 0.21 108.856 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -92.8 135.73 33.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.009 -1.057 . . . . 2.72 110.007 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.18 125.38 34.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.642 -0.662 . . . . 0.3 109.603 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.86 -74.49 0.6 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.442 -0.786 . . . . 0.45 110.158 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.476 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 3.8 t90 -89.76 140.84 29.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.142 -0.974 . . . . 0.33 109.815 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -146.19 119.67 9.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 2.33 108.816 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -104.51 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.246 -1.142 . . . . 0.28 110.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -67.63 -155.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -1.078 . . . . 1.4 109.686 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.83 2.74 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.514 -1.435 . . . . 0.29 109.514 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.29 151.29 36.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -1.077 . . . . 0.29 108.522 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 19.0 m -144.12 126.54 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.159 -0.963 . . . . 0.31 109.838 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.9 t -88.89 135.27 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.996 -1.113 . . . . 0.3 107.996 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.423 ' O ' HG23 ' B' ' 257' ' ' ILE . 18.2 pt -139.4 179.14 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.24 110.083 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -143.14 110.34 5.69 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.735 -0.839 . . . . 1.81 108.735 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.97 -81.83 0.24 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -78.61 -137.42 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.451 -1.685 . . . . 1.97 106.451 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 18.4 m -97.95 54.25 1.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.53 128.48 7.34 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.966 -0.753 . . . . 1.12 108.966 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.483 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.0 mt -92.68 140.04 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.212 -0.93 . . . . 0.48 109.67 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -138.5 168.14 20.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.394 -0.816 . . . . 2.13 109.757 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.65 138.33 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.512 -0.743 . . . . 0.34 109.268 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.7 131.98 18.39 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.432 -0.793 . . . . 0.34 109.134 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.44 139.65 91.44 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 109.713 -0.918 . . . . 0.42 109.713 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.1 OUTLIER -59.89 -34.77 73.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 3.11 109.664 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -69.19 -5.03 20.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.838 . . . . 3.82 110.955 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -119.28 17.51 13.07 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.192 -0.942 . . . . 2.08 108.848 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.34 169.7 17.34 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.094 -0.706 . . . . 0.32 109.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -139.51 131.35 27.58 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.25 -0.906 . . . . 1.79 109.099 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -88.2 108.09 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.897 . . . . 0.45 110.16 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.98 149.06 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.107 -1.072 . . . . 0.57 108.107 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -89.51 151.82 21.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.293 -0.879 . . . . 3.62 108.854 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.946 -1.026 . . . . 2.05 109.35 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.464 -0.569 . . . . 3.82 109.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 223' ' ' PHE . 6.6 tp -83.14 137.21 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 2.08 109.192 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.46 -146.82 0.14 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -0.93 . . . . 2.17 109.179 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -92.41 113.34 25.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.111 -0.993 . . . . 1.48 109.091 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.45 ' CD2' HD11 ' A' ' 220' ' ' ILE . 41.0 m-85 -135.21 142.27 45.99 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.72 109.473 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.472 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 28.5 mtp180 -108.63 156.67 19.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.536 -1.283 . . . . 3.26 107.536 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.1 t -141.54 143.99 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.072 -1.018 . . . . 0.23 110.794 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.96 155.87 22.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.599 -1.259 . . . . 0.58 107.599 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.8 151.88 26.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.758 -1.214 . . . . 0.44 110.224 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.6 mtm-85 -92.38 137.8 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.426 -0.796 . . . . 2.76 109.67 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.11 170.7 9.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.456 -0.777 . . . . 2.23 109.485 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.3 t -86.79 -9.13 56.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.885 . . . . 1.8 109.513 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.39 43.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -0.882 . . . . 3.63 110.055 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.479 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 26.0 p-10 -159.19 134.23 5.67 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 120.905 -1.122 . . . . 2.16 109.462 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.61 -7.96 20.89 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 121.027 1.152 . . . . 1.25 111.689 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.612 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.0 p -84.61 164.04 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.553 -1.342 . . . . 1.75 110.359 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.612 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.5 m95 -66.85 166.42 13.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.763 -0.586 . . . . 0.66 109.595 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.11 166.37 13.01 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.349 -0.844 . . . . 1.43 109.383 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.0 164.08 0.06 OUTLIER Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.115 -1.194 . . . . 0.39 110.115 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.15 164.4 30.4 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.543 1.496 . . . . 0.41 110.604 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.26 8.9 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.855 -0.794 . . . . 0.21 108.855 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.95 139.26 33.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.206 -0.934 . . . . 2.72 109.041 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -88.88 121.88 31.69 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.352 -0.842 . . . . 0.29 109.833 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.2 mt -110.19 -74.55 0.65 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.366 -0.834 . . . . 0.45 109.808 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.406 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.4 t90 -91.71 145.0 24.93 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.11 -0.994 . . . . 0.31 110.36 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -147.71 120.08 8.43 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.952 -0.758 . . . . 2.32 108.952 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -106.38 0.25 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.737 -1.22 . . . . 0.27 110.453 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.86 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -1.06 . . . . 1.39 109.871 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.69 49.1 2.72 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.29 109.469 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.2 150.0 32.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -1.066 . . . . 0.29 108.582 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.7 m -144.14 127.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.31 109.858 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 61.0 t -90.13 136.13 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.312 -0.995 . . . . 0.29 108.312 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.84 179.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.305 -0.872 . . . . 0.23 109.726 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' A' ' 257' ' ' ILE . 32.2 tt0 -141.8 111.94 6.89 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.57 -0.9 . . . . 1.81 108.57 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -81.54 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.57 -1.27 . . . . 1.18 107.57 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.65 -129.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.467 -1.679 . . . . 1.98 106.467 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.5 p -105.6 54.29 0.7 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.048 -1.033 . . . . 1.39 108.344 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 255' ' ' SER . 63.0 m-20 -155.87 127.78 7.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.547 -0.721 . . . . 1.12 109.22 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' A' ' 252' ' ' GLN . 79.5 mt -91.65 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.05 -1.031 . . . . 0.47 109.355 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -137.23 168.91 18.69 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.921 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.66 138.92 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.519 -0.738 . . . . 0.33 109.348 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.3 t -133.4 131.46 21.51 Favored Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.38 137.87 81.78 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.546 0.831 . . . . 0.42 110.124 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -57.14 -36.23 70.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 3.12 109.611 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.67 -3.0 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.241 -0.912 . . . . 3.82 110.717 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -119.37 19.5 12.73 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.154 -0.966 . . . . 2.08 109.029 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.67 171.87 13.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.599 -0.688 . . . . 0.32 109.513 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -139.87 129.23 24.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.378 -0.826 . . . . 1.79 108.996 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.65 107.29 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.206 -0.934 . . . . 0.45 109.565 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -105.75 154.02 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.648 -0.871 . . . . 0.57 108.648 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.6 OUTLIER -87.65 149.03 24.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.348 -0.845 . . . . 3.63 109.679 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 7.5 m-20 . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.025 -0.988 . . . . 2.05 109.372 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.467 -0.568 . . . . 3.83 109.467 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' B' ' 223' ' ' PHE . 6.6 tp -83.22 137.19 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.306 -0.871 . . . . 2.08 109.162 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -87.49 -146.75 0.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.179 -0.95 . . . . 2.16 109.217 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -92.51 113.33 25.57 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.144 -0.973 . . . . 1.48 108.98 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' B' ' 220' ' ' ILE . 41.0 m-85 -135.08 142.25 46.25 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.442 -0.786 . . . . 0.73 109.541 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.474 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 28.4 mtp180 -108.59 156.58 19.37 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.525 -1.287 . . . . 3.26 107.525 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.5 144.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.075 -1.016 . . . . 0.23 110.662 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.1 155.77 22.34 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.5 p90 -156.71 151.96 26.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.741 -1.225 . . . . 0.44 110.238 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.454 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.7 mtm-85 -92.49 137.96 31.92 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.438 -0.789 . . . . 2.76 109.525 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -94.15 170.79 9.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.366 -0.834 . . . . 2.23 109.417 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 36.6 t -86.94 -8.94 56.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 1.81 109.429 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -88.22 -12.41 43.85 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.277 -0.889 . . . . 3.64 110.004 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 25.8 p-10 -159.22 134.19 5.63 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.979 -1.076 . . . . 2.16 109.429 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.64 -7.96 20.92 Favored 'Trans proline' 0 N--CA 1.483 0.896 0 C-N-CA 121.001 1.134 . . . . 1.27 111.701 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.1 p -84.51 163.99 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 120.535 -1.353 . . . . 1.76 110.362 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.4 m95 -66.88 166.31 13.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.81 -0.556 . . . . 0.67 109.547 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 42.5 tttt -119.07 166.17 13.23 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.424 -0.797 . . . . 1.44 109.422 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.04 164.14 0.06 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.955 -1.258 . . . . 0.4 109.955 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -67.3 164.5 30.3 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.517 1.478 . . . . 0.41 110.526 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.92 176.37 8.8 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.895 -0.78 . . . . 0.21 108.895 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -96.86 139.31 33.08 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.255 -0.903 . . . . 2.72 109.007 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -89.0 122.03 31.94 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.387 -0.821 . . . . 0.3 109.826 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.3 mt -110.25 -74.56 0.65 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.427 -0.796 . . . . 0.45 109.82 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -91.79 145.04 24.89 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.127 -0.983 . . . . 0.33 110.387 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -147.65 120.12 8.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.365 -0.834 . . . . 2.33 108.896 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -106.43 0.25 Allowed Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.345 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -67.84 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.436 -1.038 . . . . 1.4 109.855 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.7 49.23 2.74 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 150.06 33.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -1.06 . . . . 0.29 108.655 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -144.29 127.83 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.31 109.838 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.03 136.23 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.289 -1.004 . . . . 0.3 108.289 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.0 pt -139.85 179.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.894 . . . . 0.24 109.761 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' B' ' 257' ' ' ILE . 32.1 tt0 -141.81 111.76 6.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -91.32 -81.62 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.647 -1.242 . . . . 1.18 107.647 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.57 -129.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.538 -1.653 . . . . 1.97 106.538 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.43 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.5 p -105.63 54.32 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.344 -0.984 . . . . 1.38 108.344 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 255' ' ' SER . 62.7 m-20 -155.87 127.69 7.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.43 -0.794 . . . . 1.12 109.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' B' ' 252' ' ' GLN . 79.3 mt -91.66 133.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.143 -0.973 . . . . 0.48 109.312 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -137.37 168.89 18.75 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.467 -0.77 . . . . 2.13 109.839 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.72 138.74 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.493 -0.755 . . . . 0.34 109.352 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 23.1 t -133.26 131.68 21.76 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -56.46 137.85 81.98 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 120.566 0.844 . . . . 0.42 110.17 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -57.05 -36.42 70.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 3.11 109.618 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -69.51 -3.19 13.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.221 -0.924 . . . . 3.82 110.789 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -119.18 19.45 12.87 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.242 -0.911 . . . . 2.08 109.039 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.63 171.91 13.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.593 -0.692 . . . . 0.32 109.489 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -140.01 129.17 23.73 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.405 -0.809 . . . . 1.79 108.892 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.6 107.36 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.183 -0.948 . . . . 0.45 109.623 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.5 mm -105.77 154.06 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.582 -0.896 . . . . 0.57 108.582 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.7 OUTLIER -87.61 149.13 24.5 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.349 -0.844 . . . . 3.62 109.604 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.6 m-20 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 117.976 -1.011 . . . . 2.05 109.417 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.364 -0.606 . . . . 3.82 109.364 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.77 140.5 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 2.08 108.329 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -84.14 -136.77 0.05 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.977 -1.077 . . . . 2.17 110.023 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -96.3 108.59 21.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.315 -0.865 . . . . 1.48 109.474 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -135.12 131.07 36.43 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.762 -0.829 . . . . 0.72 108.762 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -102.8 153.17 20.43 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 3.26 108.362 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.7 t -138.53 142.71 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.304 -0.872 . . . . 0.23 110.2 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.14 158.81 18.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.491 -1.299 . . . . 0.58 107.491 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.4 p90 -156.37 153.59 29.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.447 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 228' ' ' ARG . 10.4 mtm-85 -95.88 147.49 23.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.531 -0.73 . . . . 2.76 110.115 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 14.5 p-10 -94.32 168.49 10.87 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.442 -0.786 . . . . 2.23 109.203 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.5 t -84.92 -2.77 58.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 1.8 109.747 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -87.71 -23.79 24.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.199 -0.938 . . . . 3.63 109.834 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 234' ' ' VAL . 10.1 m-20 -163.15 142.39 6.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.99 . . . . 2.16 108.895 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.95 10.23 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.226 1.284 . . . . 1.25 110.826 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 232' ' ' ASP . 7.7 p -82.75 156.96 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.644 -1.285 . . . . 1.75 110.415 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.488 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.2 m95 -75.69 -172.55 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.476 -0.564 . . . . 0.66 109.476 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.09 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.184 -1.043 . . . . 1.43 108.184 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.46 172.19 55.14 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.694 -1.362 . . . . 0.39 109.694 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -67.3 156.67 65.24 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.55 1.5 . . . . 0.41 110.166 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.02 166.23 25.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.518 -0.739 . . . . 0.21 109.093 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.42 140.5 29.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.114 -0.991 . . . . 2.72 109.547 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.42 125.24 34.63 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.462 -0.57 . . . . 0.29 109.462 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.9 mt -115.19 -69.97 0.82 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.84 . . . . 0.45 109.982 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.404 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.76 143.1 26.88 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.056 -1.027 . . . . 0.31 110.315 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.88 115.42 6.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.272 -0.892 . . . . 2.32 109.235 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.75 0.2 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.204 -1.158 . . . . 0.27 110.204 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -68.68 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.277 -1.131 . . . . 1.39 109.802 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 51.36 3.03 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.326 -1.509 . . . . 0.29 109.326 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.58 151.28 33.56 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.518 -0.989 . . . . 0.29 108.577 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.88 125.53 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.141 -0.975 . . . . 0.31 109.682 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.34 135.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.196 -1.038 . . . . 0.29 108.196 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.6 pt -137.66 -178.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.395 -0.816 . . . . 0.23 110.139 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.53 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.6 tt0 -143.48 111.63 6.2 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.37 -77.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.509 -1.293 . . . . 1.18 107.509 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.81 -132.27 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.944 -1.502 . . . . 1.98 106.944 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.9 p -104.26 53.04 0.75 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.958 -1.127 . . . . 1.39 107.958 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -156.1 127.29 7.05 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.986 -0.746 . . . . 1.12 108.986 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.53 ' CG1' HE21 ' A' ' 252' ' ' GLN . 55.9 mt -91.23 134.72 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.47 109.344 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -136.12 170.55 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.79 . . . . 2.11 109.857 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.73 139.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -0.785 . . . . 0.33 109.826 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.73 124.03 14.28 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.626 -0.879 . . . . 0.34 108.626 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.75 139.37 90.06 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 N-CA-C 110.134 -0.756 . . . . 0.42 110.134 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -61.29 -30.48 70.51 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -0.834 . . . . 3.12 109.407 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' A' ' 263' ' ' ARG . 0.0 OUTLIER -69.83 -9.91 56.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.41 -0.806 . . . . 3.82 110.06 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.45 22.96 11.48 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.242 -0.911 . . . . 2.08 109.11 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 169.57 17.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.081 -0.711 . . . . 0.32 109.081 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -137.11 127.89 27.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.331 -0.855 . . . . 1.79 108.783 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.44 109.54 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.45 109.893 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -103.34 152.63 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -93.4 137.38 32.75 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.34 -0.85 . . . . 3.63 109.353 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.02 -0.99 . . . . 2.05 109.519 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 34.4 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.425 -0.583 . . . . 3.83 109.425 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.73 140.55 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.421 -0.955 . . . . 2.08 108.421 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -84.24 -136.77 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.96 -1.088 . . . . 2.16 110.011 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -96.27 108.49 20.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.349 -0.844 . . . . 1.48 109.589 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -135.08 131.02 36.45 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.783 -0.821 . . . . 0.73 108.783 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -102.7 153.09 20.48 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.424 -0.954 . . . . 3.26 108.424 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.4 t -138.52 142.69 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -0.885 . . . . 0.23 110.156 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -111.2 158.74 18.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.496 -1.298 . . . . 0.58 107.496 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.3 p90 -156.21 153.69 29.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.586 -1.321 . . . . 0.44 110.45 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' B' ' 228' ' ' ARG . 10.5 mtm-85 -95.99 147.44 23.69 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.392 -0.818 . . . . 2.76 110.094 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 14.7 p-10 -94.31 168.55 10.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.389 -0.819 . . . . 2.23 109.268 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 22.6 t -85.02 -2.77 58.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 1.81 109.719 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -87.69 -23.73 24.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 3.64 109.767 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 9.9 m-20 -163.19 142.38 6.64 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.136 -0.977 . . . . 2.16 108.825 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -62.99 10.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.179 1.252 . . . . 1.27 110.895 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.501 HG22 ' N ' ' B' ' 235' ' ' TRP . 7.7 p -82.69 156.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.657 -1.277 . . . . 1.76 110.372 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.501 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.3 m95 -75.77 -172.56 1.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.501 -0.555 . . . . 0.67 109.501 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -137.06 -164.97 1.67 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.229 -1.026 . . . . 1.44 108.229 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -77.48 172.19 55.14 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.697 -1.361 . . . . 0.4 109.697 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.31 156.54 65.79 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.578 1.519 . . . . 0.41 110.205 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.49 24.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.577 -0.702 . . . . 0.21 109.124 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -92.55 140.57 29.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.092 -1.005 . . . . 2.72 109.495 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 17.8 tp -88.55 125.26 34.7 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.04 -70.08 0.82 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.281 -0.887 . . . . 0.45 110.082 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -91.72 143.17 26.82 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.096 -1.003 . . . . 0.33 110.269 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -146.92 115.39 6.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 2.33 109.184 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -102.65 0.2 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.914 -1.136 . . . . 0.28 110.301 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -68.76 -156.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -1.124 . . . . 1.4 109.774 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.72 51.38 3.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.306 -1.518 . . . . 0.29 109.306 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.17 33.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.991 . . . . 0.29 108.575 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.4 m -143.86 125.66 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.994 . . . . 0.31 109.598 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.2 t -88.42 135.27 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.194 -1.039 . . . . 0.3 108.194 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.5 pt -137.7 -178.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.309 -0.869 . . . . 0.24 110.206 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.534 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.4 tt0 -143.5 111.45 6.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.682 -0.859 . . . . 1.81 108.682 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.36 -77.39 0.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.519 -1.289 . . . . 1.18 107.519 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.8 -132.31 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.905 -1.517 . . . . 1.97 106.905 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 5.8 p -104.25 53.07 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -156.1 127.23 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.963 -0.754 . . . . 1.12 108.963 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.534 ' CG1' HE21 ' B' ' 252' ' ' GLN . 55.4 mt -91.08 134.77 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.48 109.369 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -136.15 170.57 15.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 2.13 109.845 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 8.8 t -99.76 139.05 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.455 -0.778 . . . . 0.34 109.821 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.9 t -136.75 123.92 14.18 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.627 -0.879 . . . . 0.34 108.627 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.6 139.46 90.29 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 110.006 -0.806 . . . . 0.42 110.006 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.41 -30.51 70.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 3.11 109.394 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.0 OUTLIER -69.78 -9.91 56.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.45 -0.781 . . . . 3.82 110.07 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -119.54 23.05 11.4 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.295 -0.878 . . . . 2.08 109.053 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.44 169.37 17.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.1 -0.704 . . . . 0.32 109.1 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -136.96 127.89 27.5 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.752 -0.833 . . . . 1.79 108.752 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.1 mm -88.48 109.55 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.243 -0.91 . . . . 0.45 109.919 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.39 152.57 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.491 -0.929 . . . . 0.57 108.491 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -93.32 137.34 32.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.388 -0.82 . . . . 3.62 109.342 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.999 -1.001 . . . . 2.05 109.504 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.44 -0.578 . . . . 3.82 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 220' ' ' ILE . 14.4 tt -81.29 132.62 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 2.08 109.38 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -89.26 -142.9 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.689 -0.856 . . . . 2.17 108.689 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -90.51 100.07 12.98 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.008 -1.058 . . . . 1.48 108.762 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -120.91 141.14 50.92 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.618 -0.676 . . . . 0.72 109.924 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -113.29 157.76 21.4 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 107.523 -1.288 . . . . 3.26 107.523 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.19 143.89 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.066 -1.021 . . . . 0.23 110.627 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -112.88 157.79 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.654 -1.239 . . . . 0.58 107.654 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 14.6 p90 -157.48 147.35 20.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.701 -1.25 . . . . 0.44 110.144 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.64 142.52 27.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.054 -1.029 . . . . 2.76 109.425 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.41 166.55 12.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 2.23 109.369 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.3 p -85.81 -10.15 55.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.227 -0.921 . . . . 1.8 109.635 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.44 36.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.202 -0.936 . . . . 3.63 109.44 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 234' ' ' VAL . 3.3 p30 -159.23 128.04 3.05 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.31 -0.869 . . . . 2.16 109.105 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -67.62 9.22 0.35 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.805 1.004 . . . . 1.25 110.328 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 232' ' ' ASP . 4.4 t -84.06 156.22 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.013 -1.055 . . . . 1.75 109.764 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.05 169.75 16.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.66 109.611 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.3 mmtt -119.36 157.25 28.54 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.644 -0.873 . . . . 1.43 108.644 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.12 174.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.296 -1.522 . . . . 0.39 109.296 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.7 155.76 68.72 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.545 1.497 . . . . 0.41 110.693 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.67 171.91 13.79 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.925 -0.769 . . . . 0.21 108.925 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -93.91 137.39 33.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.049 -1.032 . . . . 2.72 109.707 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.12 121.4 31.41 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.594 -0.691 . . . . 0.29 109.28 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.16 -68.94 0.9 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.309 -0.87 . . . . 0.45 110.499 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -95.42 147.35 23.61 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.002 -1.061 . . . . 0.31 110.353 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.3 119.42 7.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.374 -0.829 . . . . 2.32 108.963 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.0 -109.2 0.32 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.784 -1.198 . . . . 0.27 110.397 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.88 -150.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.297 -1.12 . . . . 1.39 109.488 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.5 56.18 2.47 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.196 -1.562 . . . . 0.29 109.196 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.49 146.72 22.67 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.364 -1.08 . . . . 0.29 109.643 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.05 121.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.672 -0.862 . . . . 0.31 108.672 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.421 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 59.4 t -84.73 132.16 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.375 -0.972 . . . . 0.29 108.375 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -137.96 178.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.358 -0.839 . . . . 0.23 109.977 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.44 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.1 tt0 -142.33 110.2 5.86 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.631 -0.877 . . . . 1.81 108.631 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -91.12 -78.49 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.357 -1.349 . . . . 1.18 107.357 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.59 -131.31 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.762 -1.569 . . . . 1.98 106.762 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 58.8 m -105.35 54.5 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.114 -1.069 . . . . 1.39 108.114 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.8 m-20 -157.08 127.33 6.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.495 -0.753 . . . . 1.12 109.312 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.44 ' CG1' HE21 ' A' ' 252' ' ' GLN . 79.8 mt -94.18 134.26 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.47 109.551 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.22 172.53 12.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.287 -0.883 . . . . 2.11 109.812 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.38 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.33 109.404 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.62 131.75 16.14 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.798 . . . . 0.34 108.909 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.49 142.98 92.36 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 N-CA-C 109.545 -0.983 . . . . 0.42 109.545 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -55.84 -34.69 65.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 3.12 108.641 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -65.35 -10.83 36.33 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.666 -0.697 . . . . 3.82 110.76 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.73 17.68 12.71 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.278 -1.008 . . . . 2.08 108.278 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.1 168.03 20.58 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.316 -0.624 . . . . 0.32 109.316 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -140.47 126.85 19.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.205 -0.934 . . . . 1.79 109.171 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.3 mm -87.54 108.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.242 -0.911 . . . . 0.45 109.486 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.18 152.92 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.524 -0.917 . . . . 0.57 108.524 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.4 ' O ' ' OD1' ' A' ' 270' ' ' ASP . 57.3 ttt180 -91.54 143.65 26.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 3.63 109.934 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 269' ' ' ARG . 3.5 m-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.024 -0.989 . . . . 2.05 109.484 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.4 -0.593 . . . . 3.83 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.441 ' O ' HG23 ' B' ' 220' ' ' ILE . 14.4 tt -81.07 132.56 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.936 . . . . 2.08 109.472 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -89.16 -142.73 0.14 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.74 -0.837 . . . . 2.16 108.74 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -90.73 100.15 13.06 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.016 -1.052 . . . . 1.48 108.708 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.03 141.06 51.1 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.63 -0.668 . . . . 0.73 109.796 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -113.31 157.75 21.41 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 107.559 -1.274 . . . . 3.26 107.559 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 76.9 t -140.1 143.83 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.022 -1.049 . . . . 0.23 110.776 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -112.83 157.77 20.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.667 -1.235 . . . . 0.58 107.667 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.0 p90 -157.4 147.38 20.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.633 -1.292 . . . . 0.44 110.161 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -93.62 142.42 27.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.104 -0.997 . . . . 2.76 109.502 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -92.41 166.46 12.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.408 -0.808 . . . . 2.23 109.394 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.6 p -85.68 -10.25 55.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.219 -0.925 . . . . 1.81 109.651 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -89.85 -13.37 36.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.099 -1.0 . . . . 3.64 109.442 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' B' ' 234' ' ' VAL . 3.3 p30 -159.23 127.88 3.0 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.083 -1.011 . . . . 2.16 109.195 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -67.56 9.34 0.34 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 120.74 0.96 . . . . 1.27 110.364 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' B' ' 232' ' ' ASP . 4.4 t -84.05 156.1 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.967 -1.083 . . . . 1.76 109.809 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -72.97 169.74 16.3 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.371 -0.83 . . . . 0.67 109.666 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mmtt -119.4 157.2 28.69 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.7 -0.852 . . . . 1.44 108.7 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.14 174.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.337 -1.505 . . . . 0.4 109.337 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -67.65 155.8 68.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.5 1.466 . . . . 0.41 110.648 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.61 171.95 13.74 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.902 -0.777 . . . . 0.21 108.902 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -93.94 137.44 33.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.133 -0.979 . . . . 2.72 109.684 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -89.22 121.39 31.47 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.542 -0.724 . . . . 0.3 109.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.0 mt -112.17 -68.97 0.89 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.235 -0.916 . . . . 0.45 110.462 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -95.38 147.41 23.54 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.056 -1.027 . . . . 0.33 110.339 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -149.33 119.43 7.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.418 -0.802 . . . . 2.33 109.004 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.05 -109.25 0.32 Allowed Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.738 -1.22 . . . . 0.28 110.336 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.9 -150.31 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -1.137 . . . . 1.4 109.497 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.47 56.23 2.46 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.274 -1.531 . . . . 0.29 109.274 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -155.5 146.82 22.74 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.342 -1.093 . . . . 0.29 109.559 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.12 121.13 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.601 -0.889 . . . . 0.31 108.601 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 60.3 t -84.81 132.06 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.3 108.416 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -137.8 178.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.454 -0.779 . . . . 0.24 110.035 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.442 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.1 tt0 -142.31 110.28 5.89 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.662 -0.866 . . . . 1.81 108.662 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -91.26 -78.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.307 -1.368 . . . . 1.18 107.307 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -80.53 -131.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.731 -1.581 . . . . 1.97 106.731 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 58.8 m -105.33 54.52 0.7 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.208 -1.034 . . . . 1.38 108.208 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.8 m-20 -157.06 127.33 6.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.474 -0.766 . . . . 1.12 109.242 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.442 ' CG1' HE21 ' B' ' 252' ' ' GLN . 79.4 mt -94.11 134.2 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.48 109.51 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.08 172.48 12.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.324 -0.86 . . . . 2.13 109.843 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.09 141.35 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.459 -0.776 . . . . 0.34 109.407 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 22.2 t -138.64 131.8 16.13 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 0.34 108.918 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.4 142.93 92.59 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 N-CA-C 109.506 -0.998 . . . . 0.42 109.506 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -55.8 -34.76 65.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.853 -1.155 . . . . 3.11 108.717 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -65.27 -10.92 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.649 -0.705 . . . . 3.82 110.724 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -119.7 17.76 12.72 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 108.257 -1.016 . . . . 2.08 108.257 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.07 168.1 20.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.259 -0.645 . . . . 0.32 109.259 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -140.55 126.82 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.249 -0.907 . . . . 1.79 109.154 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.1 mm -87.51 108.38 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.887 . . . . 0.45 109.556 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.23 152.8 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.49 -0.93 . . . . 0.57 108.49 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -91.4 143.67 26.38 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.902 . . . . 3.62 109.94 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.541 179.551 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' A' ' 219' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.255 0.55 . . . . 3.82 109.527 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.92 104.48 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.278 -0.889 . . . . 2.08 108.799 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -85.02 -125.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 2.17 109.468 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -93.48 104.27 16.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.236 -0.915 . . . . 1.48 109.001 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -128.18 132.77 48.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.105 -0.702 . . . . 0.72 109.105 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -104.37 159.47 15.7 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.382 -0.97 . . . . 3.26 108.382 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.83 141.68 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.156 -0.965 . . . . 0.23 110.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.68 151.28 27.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.55 -1.278 . . . . 0.58 107.55 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.0 p90 -156.43 151.21 25.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.651 -1.281 . . . . 0.44 110.441 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -92.72 141.68 28.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.589 -0.694 . . . . 2.76 109.577 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 5.0 p30 -93.79 165.72 12.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.423 -0.798 . . . . 2.23 109.044 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.99 -0.06 47.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 1.8 109.162 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 10.1 mmm180 -90.01 -20.96 22.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.387 -0.82 . . . . 3.63 109.205 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.7 m-20 -161.03 134.05 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.777 -0.823 . . . . 2.16 108.777 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.73 8.86 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 120.727 0.951 . . . . 1.25 110.208 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.2 t -84.06 159.18 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.034 -1.041 . . . . 1.75 109.921 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.435 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.9 m95 -75.09 164.88 26.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.476 -0.765 . . . . 0.66 108.959 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 237' ' ' GLY . 32.5 tttp -120.01 158.25 27.17 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.395 -0.816 . . . . 1.43 109.652 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.61 165.83 0.03 OUTLIER Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.283 -1.127 . . . . 0.39 110.283 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.97 163.25 36.42 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.705 1.603 . . . . 0.41 110.452 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.17 178.45 7.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.21 109.187 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.09 137.19 35.51 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.154 -0.966 . . . . 2.72 109.393 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.9 tp -87.88 124.64 33.87 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.413 -0.805 . . . . 0.29 109.238 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.58 -74.01 0.62 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.459 -0.776 . . . . 0.45 109.99 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.532 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.0 t90 -92.32 141.69 28.27 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 0.31 109.719 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.85 116.91 7.28 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.251 -0.906 . . . . 2.32 109.138 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.13 -105.04 0.23 Allowed Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.905 -1.14 . . . . 0.27 110.308 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -62.39 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.104 . . . . 1.39 109.877 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 49.86 2.79 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.773 -1.331 . . . . 0.29 109.773 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.76 154.11 39.11 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -1.126 . . . . 0.29 108.696 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.06 122.79 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.16 -0.962 . . . . 0.31 109.747 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.72 138.28 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.963 -1.125 . . . . 0.29 107.963 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.43 174.79 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.23 110.033 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.4 109.4 5.03 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.147 -1.057 . . . . 1.81 108.147 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.43 -79.75 0.3 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.574 -1.269 . . . . 1.18 107.574 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.5 -128.56 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 13.0 p -105.89 53.38 0.71 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.284 -1.006 . . . . 1.39 108.284 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 255' ' ' SER . 67.7 m-20 -155.69 129.85 8.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -0.783 . . . . 1.12 109.487 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.418 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.6 mt -95.11 139.86 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.461 -0.774 . . . . 0.47 110.07 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -140.32 162.87 34.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.416 -0.802 . . . . 2.11 109.462 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.0 t -97.97 141.8 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.215 -0.928 . . . . 0.33 108.857 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.83 130.77 18.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.375 -0.828 . . . . 0.34 109.452 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.66 141.37 97.57 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 N-CA-C 109.688 -0.928 . . . . 0.42 109.688 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.26 -29.48 69.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.882 . . . . 3.12 109.727 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -70.04 -12.0 61.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.865 . . . . 3.82 111.042 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.83 28.06 8.15 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.153 -0.967 . . . . 2.08 109.273 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.09 168.87 18.81 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.801 -0.814 . . . . 0.32 108.801 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.07 126.94 19.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.224 -0.922 . . . . 1.79 109.392 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.9 mm -87.52 109.73 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.343 -0.848 . . . . 0.45 109.67 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.31 149.41 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.394 -0.965 . . . . 0.57 108.394 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -90.41 144.91 25.37 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.33 -0.856 . . . . 3.63 109.806 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 2.05 109.339 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . 0.571 ' N ' ' SD ' ' B' ' 219' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.502 -0.555 . . . . 3.83 109.502 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.98 104.51 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.329 -0.857 . . . . 2.08 108.837 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -85.08 -125.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.988 . . . . 2.16 109.415 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -93.54 104.26 16.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.189 -0.944 . . . . 1.48 109.032 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -128.23 132.86 48.76 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.73 109.071 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -104.45 159.43 15.74 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.417 -0.957 . . . . 3.26 108.417 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.1 t -141.8 141.67 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.164 -0.96 . . . . 0.23 110.403 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -110.64 151.31 27.82 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.617 -1.253 . . . . 0.58 107.617 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.1 p90 -156.46 151.23 25.93 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.752 -1.218 . . . . 0.44 110.454 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -92.76 141.62 28.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.569 -0.707 . . . . 2.76 109.595 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 4.9 p30 -93.79 165.78 12.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.441 -0.787 . . . . 2.23 109.075 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.4 m -82.93 -0.24 47.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 1.81 109.182 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.431 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 10.1 mmm180 -89.93 -21.01 22.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.196 -0.94 . . . . 3.64 109.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.7 m-20 -161.08 134.05 4.61 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.787 -0.82 . . . . 2.16 108.787 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -63.61 8.69 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 120.765 0.977 . . . . 1.27 110.169 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.3 t -84.01 159.17 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.009 -1.057 . . . . 1.76 109.958 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.441 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.9 m95 -75.04 164.95 26.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.45 -0.781 . . . . 0.67 109.146 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' B' ' 237' ' ' GLY . 32.6 tttp -120.0 158.24 27.19 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.398 -0.814 . . . . 1.44 109.607 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.55 165.76 0.02 OUTLIER Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.296 -1.122 . . . . 0.4 110.296 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -67.95 163.26 36.38 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.658 1.572 . . . . 0.41 110.583 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.2 178.38 7.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.466 -0.771 . . . . 0.21 109.235 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -96.02 137.1 35.57 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.139 -0.975 . . . . 2.72 109.417 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.74 124.64 33.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.342 -0.849 . . . . 0.3 109.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.65 -73.93 0.63 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.465 -0.772 . . . . 0.45 109.983 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.418 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.0 t90 -92.28 141.6 28.38 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.2 -0.937 . . . . 0.33 109.844 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -146.76 117.04 7.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 2.33 109.047 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.17 -105.03 0.23 Allowed Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.876 -1.155 . . . . 0.28 110.241 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -62.53 -158.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 1.4 109.819 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.56 49.85 2.78 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.859 -1.296 . . . . 0.29 109.859 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.04 38.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -1.086 . . . . 0.29 108.614 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.04 122.83 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.31 109.752 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 46.3 t -85.71 138.42 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.93 -1.137 . . . . 0.3 107.93 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.9 pt -141.54 174.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.24 109.956 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -144.38 109.32 5.0 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.235 -1.024 . . . . 1.81 108.235 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -88.4 -79.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.483 -1.303 . . . . 1.18 107.483 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.51 -128.64 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.592 -1.633 . . . . 1.97 106.592 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 13.0 p -105.8 53.21 0.71 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.267 -1.012 . . . . 1.38 108.267 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 67.6 m-20 -155.63 129.89 8.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.435 -0.79 . . . . 1.12 109.475 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.532 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.8 mt -95.13 139.83 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.434 -0.791 . . . . 0.48 110.076 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -140.29 162.87 34.24 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.417 -0.802 . . . . 2.13 109.491 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 t -97.93 141.84 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.23 -0.919 . . . . 0.34 108.916 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.79 130.78 18.84 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.34 109.444 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.72 141.39 97.7 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 N-CA-C 109.687 -0.928 . . . . 0.42 109.687 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -66.17 -29.62 69.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.32 -0.862 . . . . 3.11 109.68 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -69.96 -12.05 61.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 3.82 111.117 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -120.77 28.08 8.14 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.08 -1.012 . . . . 2.08 109.304 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.11 168.85 18.87 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.834 -0.802 . . . . 0.32 108.834 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -141.02 126.89 19.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.142 -0.974 . . . . 1.79 109.369 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.8 mm -87.49 109.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.45 109.749 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -104.27 149.36 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.472 -0.936 . . . . 0.57 108.472 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -90.3 144.86 25.44 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.358 -0.839 . . . . 3.62 109.879 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.014 -0.993 . . . . 2.05 109.252 179.812 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.31 0.576 . . . . 3.82 109.461 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 33.5 mm -85.26 140.02 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 2.08 109.038 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -84.14 -137.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.084 -1.01 . . . . 2.17 109.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -91.35 98.44 11.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 1.48 109.038 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.43 131.87 38.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.563 -0.711 . . . . 0.72 109.559 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.82 19.89 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.604 -1.258 . . . . 3.26 107.604 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -139.93 140.54 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.204 -0.935 . . . . 0.23 110.311 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -106.97 154.58 20.89 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.352 -1.351 . . . . 0.58 107.352 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.8 p90 -155.34 153.34 30.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.55 -1.344 . . . . 0.44 110.645 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -96.03 133.24 40.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.448 -0.783 . . . . 2.76 109.323 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -95.58 177.23 5.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.199 -0.938 . . . . 2.23 109.106 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.4 p -88.06 -11.63 46.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.129 -0.982 . . . . 1.8 108.932 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' A' ' 231' ' ' ARG . 11.3 mpt_? -81.49 -13.37 58.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 3.63 109.124 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 15.6 p-10 -161.32 129.78 2.96 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.17 -0.956 . . . . 2.16 109.552 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.13 0.62 4.92 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 N-CA-C 109.574 -0.972 . . . . 1.25 109.574 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 235' ' ' TRP . 45.0 t -85.44 160.83 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 1.75 110.215 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.485 ' N ' HG12 ' A' ' 234' ' ' VAL . 98.5 m95 -67.46 163.35 21.15 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.523 -0.917 . . . . 0.66 108.523 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 40.7 tttp -119.95 164.79 15.54 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.267 -0.896 . . . . 1.43 109.748 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.02 169.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.458 -1.057 . . . . 0.39 110.458 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -69.15 161.02 47.53 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.985 1.79 . . . . 0.41 110.752 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.18 175.85 9.31 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.67 -0.863 . . . . 0.21 108.67 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -94.03 139.38 31.02 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.954 -1.091 . . . . 2.72 109.127 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.9 tp -89.33 125.17 35.01 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.898 . . . . 0.29 109.73 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.7 mt -117.49 -77.58 0.57 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.502 -0.749 . . . . 0.45 110.719 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -93.36 136.74 33.34 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.993 -1.067 . . . . 0.31 110.458 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.5 127.2 13.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.85 . . . . 2.32 109.249 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.64 -105.33 0.24 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.549 -1.42 . . . . 0.27 109.549 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 245' ' ' GLY . 25.5 mt-10 -60.09 -154.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -1.128 . . . . 1.39 109.149 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.0 45.97 2.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.922 -1.671 . . . . 0.29 108.922 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.73 141.44 18.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.56 -0.965 . . . . 0.29 108.867 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.29 144.26 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.116 -0.99 . . . . 0.31 108.931 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 147.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.101 -0.999 . . . . 0.29 109.993 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.26 178.1 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.502 -0.749 . . . . 0.23 109.488 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.569 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.4 tt0 -144.72 110.86 5.49 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.241 -1.022 . . . . 1.81 108.241 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.94 -78.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.551 -1.277 . . . . 1.18 107.551 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.83 -139.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.713 -1.588 . . . . 1.98 106.713 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 60.2 p -97.22 53.79 1.19 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 2.6 m-20 -155.14 126.22 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.949 -0.76 . . . . 1.12 108.949 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.569 ' CG1' HE21 ' A' ' 252' ' ' GLN . 41.3 mt -92.43 135.46 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.881 . . . . 0.47 109.488 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.85 169.93 16.93 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.426 -0.797 . . . . 2.11 109.562 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.15 139.99 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.33 109.532 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.6 126.75 18.27 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.06 141.89 96.56 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 N-CA-C 110.039 -0.793 . . . . 0.42 110.039 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.48 -34.09 66.59 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.315 -0.866 . . . . 3.12 109.138 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -70.12 -8.2 47.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 3.82 110.496 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.48 22.29 11.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.293 -0.879 . . . . 2.08 109.113 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.16 33.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.54 -0.725 . . . . 0.32 109.067 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -139.06 132.01 29.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.309 -0.87 . . . . 1.79 108.957 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.5 107.36 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.372 -0.83 . . . . 0.45 109.579 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 269' ' ' ARG . 36.8 mm -103.79 160.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.466 -0.771 . . . . 0.57 109.275 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.438 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER -93.62 141.58 28.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.472 -0.768 . . . . 3.63 109.405 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 9.5 m-20 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 2.05 109.446 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.219 0.533 . . . . 3.83 109.632 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 33.5 mm -85.16 140.06 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.322 -0.861 . . . . 2.08 109.019 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -84.19 -137.74 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.079 -1.013 . . . . 2.16 109.642 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -91.33 98.53 11.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 1.48 109.056 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -134.46 131.87 38.6 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.561 -0.712 . . . . 0.73 109.454 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.8 OUTLIER -105.61 154.9 19.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.572 -1.27 . . . . 3.26 107.572 179.101 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 84.5 t -140.13 140.62 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.239 -0.913 . . . . 0.23 110.236 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -107.17 154.55 21.03 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.317 -1.364 . . . . 0.58 107.317 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -155.3 153.35 30.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.599 -1.313 . . . . 0.44 110.701 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -95.96 133.26 40.38 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.447 -0.783 . . . . 2.76 109.34 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -95.6 177.27 5.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 2.23 109.102 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 4.5 p -88.17 -11.69 46.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.077 -1.014 . . . . 1.81 108.857 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.44 ' N ' ' CD ' ' B' ' 231' ' ' ARG . 11.3 mpt_? -81.32 -13.54 58.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.3 -0.875 . . . . 3.64 109.131 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 16.0 p-10 -161.24 129.57 2.92 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.196 -0.94 . . . . 2.16 109.555 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.9 0.45 4.99 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 N-CA-C 109.586 -0.967 . . . . 1.27 109.586 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.487 HG12 ' N ' ' B' ' 235' ' ' TRP . 45.1 t -85.44 160.81 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.301 -0.874 . . . . 1.76 110.255 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.487 ' N ' HG12 ' B' ' 234' ' ' VAL . 98.4 m95 -67.38 163.46 20.72 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.521 -0.918 . . . . 0.67 108.521 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' B' ' 237' ' ' GLY . 40.9 tttp -119.94 164.65 15.75 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.306 -0.871 . . . . 1.44 109.705 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.14 169.53 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.447 -1.061 . . . . 0.4 110.447 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.29 161.08 47.3 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.893 1.729 . . . . 0.41 110.695 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 175.88 9.28 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.676 -0.861 . . . . 0.21 108.676 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -93.85 139.4 30.92 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.017 -1.052 . . . . 2.72 109.224 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.8 tp -89.46 125.15 35.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.182 -0.949 . . . . 0.3 109.724 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 23.5 mt -117.53 -77.53 0.57 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.486 -0.759 . . . . 0.45 110.747 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -93.4 136.66 33.46 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.16 -0.962 . . . . 0.33 110.408 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -147.33 127.27 13.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.228 -0.92 . . . . 2.33 109.274 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.66 -105.39 0.24 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.601 -1.4 . . . . 0.28 109.601 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 245' ' ' GLY . 25.6 mt-10 -60.03 -154.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -1.108 . . . . 1.4 109.121 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 45.93 2.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.961 -1.656 . . . . 0.29 108.961 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -154.69 141.5 19.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.552 -0.969 . . . . 0.29 108.88 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -142.46 144.1 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -0.997 . . . . 0.31 108.925 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.46 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.3 110.008 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.27 178.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.425 -0.797 . . . . 0.24 109.507 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.57 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -144.56 110.76 5.5 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.31 -0.996 . . . . 1.81 108.31 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -88.91 -78.89 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.525 -1.287 . . . . 1.18 107.525 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' B' ' 254' ' ' ASN . 1.0 OUTLIER -81.82 -139.01 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.403 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 60.2 p -97.17 53.78 1.2 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.005 -1.109 . . . . 1.38 108.005 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' B' ' 255' ' ' SER . 2.6 m-20 -155.14 126.15 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.983 -0.747 . . . . 1.12 108.983 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.57 ' CG1' HE21 ' B' ' 252' ' ' GLN . 41.1 mt -92.33 135.48 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -0.924 . . . . 0.48 109.508 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -136.93 169.88 17.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.586 -0.696 . . . . 2.13 109.485 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.17 140.07 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.419 -0.801 . . . . 0.34 109.466 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.64 126.86 18.29 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.73 -0.841 . . . . 0.34 108.73 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -58.22 141.97 97.0 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 110.035 -0.794 . . . . 0.42 110.035 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -56.47 -34.13 66.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.257 -0.902 . . . . 3.11 109.153 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -69.99 -8.29 47.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.43 -0.793 . . . . 3.82 110.514 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -120.3 22.12 11.46 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.285 -0.884 . . . . 2.08 109.137 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.63 163.21 33.43 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.089 -0.708 . . . . 0.32 109.089 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -139.16 131.98 29.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.281 -0.887 . . . . 1.79 108.92 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.48 107.44 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.45 109.487 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.442 HG22 ' N ' ' B' ' 269' ' ' ARG . 37.1 mm -103.84 160.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.507 -0.746 . . . . 0.57 109.16 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.442 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -93.74 141.54 28.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.487 -0.758 . . . . 3.62 109.438 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 9.4 m-20 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.01 -1.056 . . . . 2.05 109.389 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.46 -0.57 . . . . 3.82 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.69 107.24 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.079 0.942 . . . . 2.08 108.476 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -92.02 -131.85 0.12 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.594 -1.316 . . . . 2.17 109.744 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.3 m-20 -95.37 109.85 21.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.202 -0.936 . . . . 1.48 109.441 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -133.38 153.2 51.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.446 -0.783 . . . . 0.72 109.024 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -117.55 149.81 40.02 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.737 -1.208 . . . . 3.26 107.737 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.02 139.98 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.318 -0.864 . . . . 0.23 110.085 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -109.22 154.45 22.39 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.499 -1.297 . . . . 0.58 107.499 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 16.3 p90 -157.01 160.24 38.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.613 -1.304 . . . . 0.44 110.399 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -93.2 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.495 -0.753 . . . . 2.76 109.844 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.72 171.88 8.71 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.833 -0.802 . . . . 2.23 108.833 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.9 p -89.45 -9.54 49.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.076 -1.015 . . . . 1.8 109.458 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -87.04 -16.81 34.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 3.63 109.632 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -162.5 134.1 3.91 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 2.16 108.782 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.84 12.55 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 120.988 1.125 . . . . 1.25 110.98 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 235' ' ' TRP . 8.6 p -84.64 161.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.699 -1.251 . . . . 1.75 110.029 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.539 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.0 m95 -75.57 163.34 27.46 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.019 -0.734 . . . . 0.66 109.019 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.42 -162.51 0.92 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.299 -0.875 . . . . 1.43 108.764 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.19 176.51 51.62 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.639 -1.385 . . . . 0.39 109.639 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -68.96 157.7 60.84 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.675 1.583 . . . . 0.41 110.528 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.96 170.29 16.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.746 -0.835 . . . . 0.21 108.746 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.58 142.44 27.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 2.72 109.702 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.27 119.32 30.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.73 -0.606 . . . . 0.29 109.926 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -109.71 -72.63 0.71 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.331 -0.856 . . . . 0.45 109.814 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.14 146.15 23.95 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.153 -0.967 . . . . 0.31 110.463 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -147.28 120.83 9.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.443 -0.785 . . . . 2.32 108.917 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -107.08 0.27 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.794 -1.194 . . . . 0.27 110.477 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -69.22 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.503 -0.998 . . . . 1.39 110.126 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.32 46.17 2.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.369 -1.493 . . . . 0.29 109.369 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.16 151.15 33.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.495 -1.003 . . . . 0.29 108.525 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.65 138.3 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.06 -1.025 . . . . 0.31 109.784 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.76 139.39 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.385 -0.968 . . . . 0.29 108.385 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.2 pt -141.53 178.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.268 -0.895 . . . . 0.23 110.059 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.36 111.18 5.73 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.779 -0.823 . . . . 1.81 108.779 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.78 -79.81 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.483 -1.302 . . . . 1.18 107.483 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.432 ' ND2' ' N ' ' A' ' 255' ' ' SER . 0.3 OUTLIER -79.38 -131.33 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.914 -1.513 . . . . 1.98 106.914 177.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.432 ' N ' ' ND2' ' A' ' 254' ' ' ASN . 12.7 p -105.61 54.8 0.69 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.372 -0.973 . . . . 1.39 108.372 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -156.31 126.32 6.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.492 -0.755 . . . . 1.12 109.034 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 61.7 mt -92.68 135.24 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 0.47 109.448 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.97 168.64 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 2.11 109.662 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.98 142.26 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.324 -0.86 . . . . 0.33 109.332 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 33.5 t -135.89 131.17 18.89 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.437 -0.789 . . . . 0.34 109.086 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.29 146.43 96.53 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 120.72 0.947 . . . . 0.42 110.458 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -59.25 -32.34 69.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.564 -0.902 . . . . 3.12 108.564 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.9 mtt-85 -70.68 -9.18 56.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.203 -0.935 . . . . 3.82 110.853 -179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.56 21.09 12.23 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.176 -0.952 . . . . 2.08 109.776 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.25 22.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.412 -0.805 . . . . 0.32 109.959 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -140.5 124.93 17.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.58 -0.896 . . . . 1.79 108.58 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.53 112.47 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.133 -0.979 . . . . 0.45 110.159 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.94 147.06 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.74 -1.207 . . . . 0.57 107.74 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.58 140.72 29.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 3.63 109.767 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.069 -0.967 . . . . 2.05 109.478 179.706 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 3.83 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.617 ' O ' HG23 ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.7 107.19 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.49 -0.93 . . . . 2.08 108.49 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -91.96 -131.87 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.668 -1.27 . . . . 2.16 109.712 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -95.4 109.82 21.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.23 -0.919 . . . . 1.48 109.413 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -133.34 153.23 51.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.773 . . . . 0.73 109.032 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -117.63 149.77 40.14 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.695 -1.224 . . . . 3.26 107.695 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.4 t -139.03 139.89 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.844 . . . . 0.23 110.062 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -109.19 154.43 22.39 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.543 -1.28 . . . . 0.58 107.543 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 16.0 p90 -156.93 160.22 38.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.804 -1.185 . . . . 0.44 110.387 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -93.16 150.36 20.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.509 -0.744 . . . . 2.76 109.839 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -92.79 171.91 8.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.387 -0.821 . . . . 2.23 108.846 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 30.5 p -89.5 -9.56 49.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 1.81 109.436 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -86.94 -16.93 34.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 3.64 109.693 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.4 m-20 -162.41 134.0 3.91 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.211 -0.93 . . . . 2.16 108.811 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.8 12.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 120.873 1.049 . . . . 1.27 110.957 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.532 HG22 ' N ' ' B' ' 235' ' ' TRP . 8.6 p -84.68 161.3 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.677 -1.264 . . . . 1.76 109.976 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.532 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.9 m95 -75.4 163.23 27.65 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.077 -0.712 . . . . 0.67 109.077 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -119.33 -162.63 0.92 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.289 -0.882 . . . . 1.44 108.819 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.04 176.55 51.29 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.76 -1.336 . . . . 0.4 109.76 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -69.12 157.6 61.02 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.74 1.627 . . . . 0.41 110.515 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.95 170.3 16.28 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.76 -0.83 . . . . 0.21 108.76 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -94.56 142.51 27.35 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.038 -1.039 . . . . 2.72 109.647 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.39 119.35 30.6 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.656 -0.653 . . . . 0.3 109.797 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.65 -72.69 0.71 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.317 -0.865 . . . . 0.45 109.851 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -92.17 146.17 23.93 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.158 -0.964 . . . . 0.33 110.411 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -147.29 120.83 9.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.398 -0.814 . . . . 2.33 108.866 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.79 -107.01 0.26 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.711 -1.233 . . . . 0.28 110.439 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.33 -153.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.455 -1.027 . . . . 1.4 110.125 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.29 46.06 2.14 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.416 -1.473 . . . . 0.29 109.416 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.07 151.18 34.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.499 -1.0 . . . . 0.29 108.487 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.7 m -146.58 138.25 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 0.31 109.785 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.73 139.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.395 -0.965 . . . . 0.3 108.395 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -141.52 178.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.24 110.055 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -144.48 111.17 5.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.766 -0.828 . . . . 1.81 108.766 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.8 -79.84 0.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.47 -1.308 . . . . 1.18 107.47 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 255' ' ' SER . 0.3 OUTLIER -79.37 -131.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.911 -1.514 . . . . 1.97 106.911 177.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.433 ' N ' ' ND2' ' B' ' 254' ' ' ASN . 12.8 p -105.52 54.82 0.69 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.335 -0.987 . . . . 1.38 108.335 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -156.31 126.33 6.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 1.12 109.064 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 61.6 mt -92.68 135.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.297 -0.877 . . . . 0.48 109.461 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -138.99 168.56 19.57 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.315 -0.865 . . . . 2.13 109.677 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.94 142.36 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.397 -0.814 . . . . 0.34 109.283 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 32.8 t -135.92 131.17 18.86 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.373 -0.83 . . . . 0.34 109.179 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.3 146.53 96.32 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 120.692 0.928 . . . . 0.42 110.412 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -59.34 -32.29 69.96 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.61 -0.885 . . . . 3.11 108.61 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.9 mtt-85 -70.63 -9.18 56.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.271 -0.893 . . . . 3.82 110.812 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -119.47 20.91 12.34 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.243 -0.911 . . . . 2.08 109.769 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.15 167.25 22.48 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.439 -0.788 . . . . 0.32 109.9 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -140.56 124.89 17.67 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.61 -0.885 . . . . 1.79 108.61 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 7.4 mm -89.46 112.37 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.235 -0.916 . . . . 0.45 110.22 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -107.95 147.12 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 107.638 -1.245 . . . . 0.57 107.638 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -89.62 140.79 29.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 3.62 109.741 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.997 -1.002 . . . . 2.05 109.353 179.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.305 0.574 . . . . 3.82 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -84.88 130.13 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 2.08 108.994 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -84.63 -134.41 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.063 . . . . 2.17 109.42 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -95.02 113.82 25.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.339 -0.851 . . . . 1.48 108.988 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.2 135.28 40.88 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.389 -0.819 . . . . 0.72 109.299 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 84.6 mtt180 -103.47 157.98 16.66 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.839 -1.171 . . . . 3.26 107.839 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.33 138.68 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.026 -1.046 . . . . 0.23 110.646 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -111.03 151.87 27.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.724 -1.213 . . . . 0.58 107.724 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.0 p90 -158.3 154.65 27.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.671 -1.268 . . . . 0.44 110.376 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.05 152.24 18.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.534 -0.729 . . . . 2.76 109.651 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.67 13.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 2.23 108.82 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 58.0 m -79.25 -2.83 43.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.996 . . . . 1.8 109.333 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.89 20.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.299 -0.876 . . . . 3.63 109.844 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.3 m-20 -162.87 144.51 7.85 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.068 -1.02 . . . . 2.16 109.067 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.08 15.75 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.061 1.174 . . . . 1.25 110.643 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 232' ' ' ASP . 33.9 m -83.24 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.799 -1.188 . . . . 1.75 110.006 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -63.97 164.84 9.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.26 -0.9 . . . . 0.66 109.358 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.2 tttp -119.41 158.07 26.93 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.38 -0.825 . . . . 1.43 108.893 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.01 165.38 0.02 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.281 -1.127 . . . . 0.39 110.281 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.2 157.67 58.66 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.552 1.501 . . . . 0.41 110.289 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.32 169.02 18.53 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.927 -0.768 . . . . 0.21 108.927 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -93.22 142.72 26.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.014 -1.054 . . . . 2.72 109.334 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.0 tp -87.6 128.44 35.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.491 -0.756 . . . . 0.29 110.179 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.5 mt -115.0 -76.15 0.58 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.36 -0.837 . . . . 0.45 109.749 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' A' ' 250' ' ' VAL . 5.3 t90 -93.07 142.6 27.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.154 -0.966 . . . . 0.31 110.121 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.66 11.33 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.285 -0.884 . . . . 2.32 108.744 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.35 -107.32 0.28 Allowed Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.792 -1.194 . . . . 0.27 110.184 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.8 -150.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 1.39 109.644 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 49.98 3.04 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.354 -1.498 . . . . 0.29 109.354 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.94 150.15 33.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.389 -1.065 . . . . 0.29 108.822 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.52 129.66 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.31 109.758 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 243' ' ' TRP . 95.4 t -93.41 134.18 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.45 -0.944 . . . . 0.29 108.45 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.98 178.63 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.23 109.583 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.2 tt0 -144.84 111.24 5.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.39 -0.819 . . . . 1.81 109.029 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.99 -82.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.108 -1.441 . . . . 1.18 107.108 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -78.85 -138.82 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.733 -1.58 . . . . 1.98 106.733 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.1 m -98.05 56.25 1.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.989 -1.07 . . . . 1.39 108.423 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -156.15 125.75 6.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.524 -0.735 . . . . 1.12 109.038 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' A' ' 252' ' ' GLN . 80.6 mt -93.06 134.96 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.267 -0.896 . . . . 0.47 109.6 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.31 165.21 26.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.444 -0.785 . . . . 2.11 109.746 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.85 139.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.487 -0.758 . . . . 0.33 109.743 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 84.5 t -137.35 130.57 17.17 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 108.702 -0.851 . . . . 0.34 108.702 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.61 146.88 73.64 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.613 -0.957 . . . . 0.42 109.613 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -65.16 -32.88 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 3.12 109.98 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -69.97 -4.89 22.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 3.82 110.826 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.72 16.14 13.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.283 -0.885 . . . . 2.08 109.051 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.8 172.29 13.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.627 -0.671 . . . . 0.32 109.426 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -139.54 129.91 25.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.408 -0.808 . . . . 1.79 109.231 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.2 mm -88.49 106.61 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.45 109.727 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.01 156.42 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.339 -0.851 . . . . 0.57 108.849 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -91.08 147.42 23.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.289 -0.882 . . . . 3.63 109.219 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 5.7 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.946 -1.026 . . . . 2.05 109.466 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.368 0.604 . . . . 3.83 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.52 ' O ' HD12 ' B' ' 220' ' ' ILE . 0.8 OUTLIER -84.87 130.11 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.316 -0.865 . . . . 2.08 109.001 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.61 -134.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.01 -1.056 . . . . 2.16 109.394 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -94.99 113.76 25.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.348 -0.845 . . . . 1.48 108.999 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -135.2 135.17 40.79 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.421 -0.799 . . . . 0.73 109.329 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 84.4 mtt180 -103.3 157.94 16.67 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 107.834 -1.173 . . . . 3.26 107.834 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.4 t -142.3 138.63 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.106 -0.996 . . . . 0.23 110.622 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.98 151.99 27.32 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 107.723 -1.214 . . . . 0.58 107.723 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.2 p90 -158.39 154.68 27.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.709 -1.244 . . . . 0.44 110.344 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -95.0 152.16 18.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.606 -0.684 . . . . 2.76 109.706 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -92.83 164.71 13.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.372 -0.83 . . . . 2.23 108.771 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 57.7 m -79.35 -2.72 42.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 1.81 109.263 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -90.56 -24.82 20.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 3.64 109.894 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.2 m-20 -162.93 144.43 7.75 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.044 -1.035 . . . . 2.16 109.065 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.9 15.54 0.12 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.236 1.291 . . . . 1.27 110.677 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' B' ' 232' ' ' ASP . 33.9 m -83.18 137.5 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 1.76 110.05 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -64.04 164.77 10.03 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.247 -0.908 . . . . 0.67 109.427 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.0 tttp -119.32 158.04 26.9 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.398 -0.814 . . . . 1.44 108.986 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.98 165.36 0.02 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.258 -1.137 . . . . 0.4 110.258 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.23 157.65 58.84 Favored 'Trans proline' 0 C--N 1.321 -0.877 0 C-N-CA 121.526 1.484 . . . . 0.41 110.225 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.35 169.05 18.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.479 -0.763 . . . . 0.21 108.96 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -93.31 142.71 27.01 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.064 -1.023 . . . . 2.72 109.282 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.62 128.46 35.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.416 -0.802 . . . . 0.3 110.232 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -115.03 -76.12 0.58 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.514 -0.741 . . . . 0.45 109.711 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.416 ' H ' ' HB ' ' B' ' 250' ' ' VAL . 5.3 t90 -93.01 142.57 27.14 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.124 -0.985 . . . . 0.33 110.126 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 122.74 11.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.3 -0.875 . . . . 2.33 108.747 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -107.33 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.771 -1.204 . . . . 0.28 110.203 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.79 -150.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -1.041 . . . . 1.4 109.727 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.17 49.93 3.01 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.319 -1.513 . . . . 0.29 109.319 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.9 150.17 33.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.435 -1.038 . . . . 0.29 108.799 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 12.0 m -145.58 129.74 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.201 -0.937 . . . . 0.31 109.827 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' B' ' 243' ' ' TRP . 95.9 t -93.47 134.17 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.439 -0.948 . . . . 0.3 108.439 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.2 pt -136.96 178.57 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.24 109.654 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.521 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.2 tt0 -144.83 111.24 5.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 1.81 109.039 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -88.98 -81.89 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.199 -1.408 . . . . 1.18 107.199 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -78.9 -138.9 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.674 -1.602 . . . . 1.97 106.674 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 75.2 m -97.94 56.22 1.23 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.954 -1.091 . . . . 1.38 108.494 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -156.16 125.75 6.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 1.12 109.102 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.521 ' CG1' HE21 ' B' ' 252' ' ' GLN . 80.5 mt -93.08 134.92 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.933 . . . . 0.48 109.617 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -136.26 165.32 26.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 2.13 109.749 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.92 139.96 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.424 -0.797 . . . . 0.34 109.696 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 83.9 t -137.43 130.57 17.07 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.47 146.91 71.93 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.597 -0.963 . . . . 0.42 109.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -65.36 -32.82 74.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 3.11 109.925 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -69.93 -4.86 22.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.19 -0.944 . . . . 3.82 110.867 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -118.84 16.33 13.49 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.258 -0.902 . . . . 2.08 109.013 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.89 172.23 13.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 0.32 109.426 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -139.51 129.86 25.46 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.834 . . . . 1.79 109.288 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.0 mm -88.44 106.59 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.277 -0.889 . . . . 0.45 109.778 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.02 156.33 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.385 -0.822 . . . . 0.57 108.909 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -91.02 147.4 23.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 3.62 109.196 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.6 m-20 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.048 -1.032 . . . . 2.05 109.477 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.342 0.591 . . . . 3.82 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 220' ' ' ILE . 1.7 mp -82.45 124.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -0.951 . . . . 2.08 108.932 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -83.73 -129.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 2.17 109.488 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.36 98.75 11.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 1.48 109.393 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.54 121.7 20.21 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.508 -0.745 . . . . 0.72 109.213 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.17 165.29 12.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.087 -1.008 . . . . 3.26 108.294 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -143.39 143.02 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.138 -0.977 . . . . 0.23 110.676 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -113.02 148.29 35.44 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.631 -1.248 . . . . 0.58 107.631 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.7 p90 -156.91 151.99 26.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.729 -1.232 . . . . 0.44 110.288 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -93.19 139.25 30.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 2.76 109.456 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -94.19 166.79 11.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 2.23 109.224 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.4 p -79.76 -1.5 38.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 1.8 109.105 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -87.24 -22.6 25.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 3.63 109.531 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 234' ' ' VAL . 8.3 m-20 -163.07 135.05 3.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.965 . . . . 2.16 109.073 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.82 10.95 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 120.813 1.009 . . . . 1.25 110.228 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 232' ' ' ASP . 25.0 t -85.63 160.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.905 -1.122 . . . . 1.75 109.821 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.461 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.2 m95 -74.52 162.17 29.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.66 108.765 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.3 tttm -119.44 153.06 35.83 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.296 -0.877 . . . . 1.43 109.385 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -41.26 163.57 0.01 OUTLIER Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.762 -0.935 . . . . 0.39 110.762 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -66.6 159.44 50.87 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 121.638 1.559 . . . . 0.41 110.612 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.78 177.18 8.08 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.008 -0.738 . . . . 0.21 109.008 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -94.39 136.49 34.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.029 -1.045 . . . . 2.72 109.194 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.74 124.01 33.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 0.29 109.619 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -113.3 -74.33 0.63 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.434 -0.791 . . . . 0.45 110.208 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -91.26 143.26 26.83 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.264 -0.897 . . . . 0.31 110.33 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.11 117.96 7.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.435 -0.791 . . . . 2.32 109.225 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.19 -108.7 0.3 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.944 -1.263 . . . . 0.27 109.944 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -63.56 -154.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.253 -1.145 . . . . 1.39 109.416 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.37 52.02 3.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.603 -1.399 . . . . 0.29 109.603 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.69 150.44 34.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.396 -1.061 . . . . 0.29 108.967 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.64 122.85 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.191 -0.943 . . . . 0.31 109.701 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 52.8 t -87.22 135.36 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.991 -1.114 . . . . 0.29 107.991 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.63 178.33 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.23 110.52 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.473 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.7 tt0 -144.81 112.16 6.08 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.93 -78.5 0.39 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.612 -1.255 . . . . 1.18 107.612 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.766 HD22 ' H ' ' A' ' 255' ' ' SER . 8.7 t30 -80.53 -129.29 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.68 -1.6 . . . . 1.98 106.68 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.766 ' H ' HD22 ' A' ' 254' ' ' ASN . 68.5 m -105.41 54.3 0.7 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.106 -1.072 . . . . 1.39 108.106 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -156.19 128.41 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.519 -0.738 . . . . 1.12 109.519 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.473 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -94.61 137.59 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.24 -0.913 . . . . 0.47 109.488 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.32 166.65 23.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.386 -0.821 . . . . 2.11 109.683 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.94 142.5 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.33 109.112 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 78.2 t -139.28 129.52 14.5 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 0.34 109.168 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.406 ' HG2' ' HZ3' ' A' ' 264' ' ' LYS . 7.0 Cg_exo -54.37 160.66 6.43 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.939 -0.831 . . . . 0.42 109.939 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -84.8 -27.2 26.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 3.12 110.249 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.32 -18.82 65.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.893 . . . . 3.82 111.931 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.406 ' HZ3' ' HG2' ' A' ' 261' ' ' PRO . 2.0 ptpp? -119.43 29.24 7.73 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.897 -1.127 . . . . 2.08 109.616 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.4 164.41 25.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.517 -0.92 . . . . 0.32 108.517 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.12 124.62 19.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.248 -0.908 . . . . 1.79 109.293 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 35.7 mm -88.52 110.41 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 0.45 109.581 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.9 146.76 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.54 -0.911 . . . . 0.57 108.54 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.38 141.13 29.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.522 -0.736 . . . . 3.63 109.612 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.953 -1.022 . . . . 2.05 109.48 179.799 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.292 0.568 . . . . 3.83 109.504 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.693 ' N ' HD12 ' B' ' 220' ' ' ILE . 1.7 mp -82.4 124.73 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 2.08 108.891 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -83.83 -129.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -0.922 . . . . 2.16 109.474 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -93.47 98.83 11.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.275 -0.891 . . . . 1.48 109.316 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -135.56 121.69 20.18 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.517 -0.739 . . . . 0.73 109.158 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -97.16 165.2 12.17 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.339 -0.986 . . . . 3.26 108.339 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.3 143.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.23 110.702 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -113.19 148.18 35.96 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.604 -1.258 . . . . 0.58 107.604 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.8 p90 -156.79 152.03 26.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.689 -1.257 . . . . 0.44 110.327 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 24.8 mtm-85 -93.26 139.27 30.81 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.563 -0.711 . . . . 2.76 109.405 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -94.25 166.76 11.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.357 -0.839 . . . . 2.23 109.226 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.1 p -79.68 -1.45 38.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 1.81 109.161 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -87.25 -22.62 25.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -0.857 . . . . 3.64 109.536 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' B' ' 234' ' ' VAL . 8.3 m-20 -163.03 135.1 3.98 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 2.16 109.096 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -64.88 11.05 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 120.772 0.981 . . . . 1.27 110.233 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.488 ' H ' ' C ' ' B' ' 232' ' ' ASP . 25.2 t -85.73 160.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.939 -1.1 . . . . 1.76 109.907 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.467 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.2 m95 -74.34 162.17 29.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.359 -0.838 . . . . 0.67 108.787 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.3 tttm -119.41 153.02 35.87 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.345 -0.847 . . . . 1.44 109.439 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.27 163.55 0.01 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.73 -0.948 . . . . 0.4 110.73 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.53 159.39 50.92 Favored 'Trans proline' 0 N--CA 1.48 0.732 0 C-N-CA 121.654 1.569 . . . . 0.41 110.629 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.2 8.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.985 -0.746 . . . . 0.21 108.985 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -94.28 136.51 34.5 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.08 -1.013 . . . . 2.72 109.299 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -87.75 123.97 33.11 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.361 -0.837 . . . . 0.3 109.608 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 21.8 mt -113.25 -74.52 0.62 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.338 -0.851 . . . . 0.45 110.206 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -91.16 143.29 26.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.197 -0.94 . . . . 0.33 110.414 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.1 118.01 7.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 2.33 109.214 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.27 -108.71 0.3 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.962 -1.255 . . . . 0.28 109.962 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -63.68 -154.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 1.4 109.348 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.93 3.33 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.551 -1.419 . . . . 0.29 109.551 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.67 150.44 34.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.392 -1.063 . . . . 0.29 108.948 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -144.66 122.79 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.209 -0.932 . . . . 0.31 109.762 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 52.9 t -87.26 135.33 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.032 -1.099 . . . . 0.3 108.032 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.58 178.35 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.21 -0.931 . . . . 0.24 110.606 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.473 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.6 tt0 -144.77 112.13 6.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.619 -0.882 . . . . 1.81 108.619 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -91.05 -78.43 0.39 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.571 -1.27 . . . . 1.18 107.571 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.759 HD22 ' H ' ' B' ' 255' ' ' SER . 8.8 t30 -80.54 -129.27 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.722 -1.584 . . . . 1.97 106.722 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.759 ' H ' HD22 ' B' ' 254' ' ' ASN . 68.7 m -105.41 54.29 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.131 -1.063 . . . . 1.38 108.131 178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -156.12 128.43 7.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 1.12 109.524 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CG1' HE21 ' B' ' 252' ' ' GLN . 35.9 mt -94.56 137.57 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.259 -0.901 . . . . 0.48 109.536 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -139.31 166.65 23.99 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.323 -0.86 . . . . 2.13 109.701 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.0 142.43 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.34 109.119 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 78.8 t -139.22 129.4 14.51 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.366 -0.834 . . . . 0.34 109.258 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -54.3 160.54 6.49 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.616 0.877 . . . . 0.42 109.962 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -84.73 -27.1 27.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.486 -0.759 . . . . 3.11 110.313 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -67.31 -18.99 65.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 3.82 111.893 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.401 ' HG2' ' HZ2' ' B' ' 264' ' ' LYS . 2.0 ptpp? -119.28 29.22 7.77 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.954 -1.091 . . . . 2.08 109.727 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -131.34 164.47 25.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.538 -0.912 . . . . 0.32 108.538 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -139.2 124.59 19.22 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.25 -0.906 . . . . 1.79 109.319 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.6 mm -88.6 110.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.45 109.56 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.88 146.64 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.546 -0.909 . . . . 0.57 108.546 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -90.24 141.17 28.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.649 -0.657 . . . . 3.62 109.605 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.96 -1.019 . . . . 2.05 109.429 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.44 -0.578 . . . . 3.82 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 220' ' ' ILE . 0.8 OUTLIER -85.22 120.0 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.403 -0.811 . . . . 2.08 108.928 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -84.33 -132.99 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.016 -1.053 . . . . 2.17 109.506 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.79 108.27 19.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.134 -0.979 . . . . 1.48 109.176 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -135.85 124.41 23.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.411 -0.806 . . . . 0.72 109.959 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 6.0 mpt_? -95.88 164.11 12.87 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.37 -1.345 . . . . 3.26 107.37 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.5 t -144.02 142.82 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.01 -1.056 . . . . 0.23 110.446 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -107.36 154.71 20.89 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.475 -1.306 . . . . 0.58 107.475 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.0 p90 -156.04 157.24 35.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.484 -1.385 . . . . 0.44 111.112 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -101.15 146.08 27.96 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.464 0.65 . . . . 2.76 109.421 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 230' ' ' SER . 37.0 t0 -98.74 -176.65 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.421 -0.799 . . . . 2.23 109.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 15.1 t -95.08 -14.14 24.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -0.808 . . . . 1.8 109.678 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.28 -16.93 31.85 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.19 -0.944 . . . . 3.63 109.857 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 234' ' ' VAL . 61.4 m-20 -160.4 128.82 2.94 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.147 -0.97 . . . . 2.16 109.351 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.95 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 120.786 0.991 . . . . 1.25 110.25 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.6 m -82.32 127.83 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.869 -1.144 . . . . 1.75 110.026 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.5 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.66 109.257 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 237' ' ' GLY . 31.3 mtpt -119.85 166.46 13.26 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.425 -0.797 . . . . 1.43 109.418 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.99 170.17 0.02 OUTLIER Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.287 -1.125 . . . . 0.39 110.287 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -68.83 163.83 35.82 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 C-N-CA 121.562 1.508 . . . . 0.41 110.66 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.58 177.86 7.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.21 109.347 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.56 137.45 34.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.197 -0.939 . . . . 2.72 109.39 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.408 HD21 ' NZ ' ' A' ' 244' ' ' LYS . 19.1 tp -88.67 123.86 33.53 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.565 -0.709 . . . . 0.29 109.459 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.14 -72.66 0.68 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.289 -0.882 . . . . 0.45 110.432 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.01 144.45 25.64 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.077 -1.014 . . . . 0.31 110.497 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.408 ' NZ ' HD21 ' A' ' 241' ' ' LEU . 16.0 ttmm -145.7 119.37 9.17 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.767 -0.827 . . . . 2.32 108.767 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.88 -104.88 0.26 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.209 -1.156 . . . . 0.27 110.209 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -73.04 -149.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.281 -1.129 . . . . 1.39 109.736 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.54 3.95 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.136 -1.586 . . . . 0.29 109.136 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.49 150.95 34.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.29 108.425 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.36 123.31 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.971 -1.08 . . . . 0.31 109.827 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.94 133.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.399 -0.963 . . . . 0.29 108.399 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 260' ' ' VAL . 10.6 pt -138.81 178.64 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.348 -0.845 . . . . 0.23 109.987 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.7 tt0 -143.8 109.3 5.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.341 -0.985 . . . . 1.81 108.341 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.1 -77.23 0.4 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.499 -1.297 . . . . 1.18 107.499 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.87 -133.72 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.323 -1.732 . . . . 1.98 106.323 177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.3 t -105.03 56.48 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.071 -1.085 . . . . 1.39 108.071 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -157.03 123.53 4.98 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.771 -0.826 . . . . 1.12 108.771 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' A' ' 252' ' ' GLN . 39.2 mt -91.64 134.29 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.103 -0.998 . . . . 0.47 109.504 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.07 172.6 12.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.281 -0.887 . . . . 2.11 110.014 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.13 140.6 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.547 -0.72 . . . . 0.33 109.701 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 251' ' ' ILE . 58.1 t -134.19 124.93 17.65 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.826 -0.805 . . . . 0.34 108.826 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.16 139.55 90.89 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 120.584 0.856 . . . . 0.42 110.331 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.76 -36.26 69.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 3.12 109.758 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 263' ' ' ARG . 2.3 tpt180 -67.12 -9.58 41.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 3.82 110.693 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.545 ' HZ2' ' HB2' ' A' ' 264' ' ' LYS . 7.4 mtpm? -122.95 25.47 8.57 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.284 -0.885 . . . . 2.08 108.859 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.33 32.69 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.462 -0.94 . . . . 0.32 108.462 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -139.34 132.09 29.07 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.116 -0.99 . . . . 1.79 109.231 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.57 107.63 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.918 . . . . 0.45 109.297 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.51 157.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.43 -0.794 . . . . 0.57 109.308 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -91.7 137.31 32.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 3.63 109.465 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.03 -0.986 . . . . 2.05 109.451 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.2 ptt? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.17 -0.678 . . . . 3.83 109.17 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.468 ' O ' HD12 ' B' ' 220' ' ' ILE . 0.8 OUTLIER -85.3 120.13 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.288 -0.883 . . . . 2.08 108.933 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -84.25 -133.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.966 -1.084 . . . . 2.16 109.534 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -92.93 108.3 19.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.173 -0.955 . . . . 1.48 109.148 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -135.84 124.46 23.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.508 -0.745 . . . . 0.73 109.957 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 6.0 mpt_? -95.89 164.19 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.298 -1.371 . . . . 3.26 107.298 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 86.2 t -144.1 142.85 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.066 -1.021 . . . . 0.23 110.408 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -107.37 154.77 20.82 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.384 -1.339 . . . . 0.58 107.384 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.9 p90 -156.08 157.23 35.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.548 -1.345 . . . . 0.44 111.087 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -101.04 146.06 27.93 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.425 0.631 . . . . 2.76 109.516 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' B' ' 230' ' ' SER . 36.9 t0 -98.64 -176.67 3.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 2.23 109.879 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 15.2 t -95.17 -13.88 24.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.415 -0.803 . . . . 1.81 109.731 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -88.37 -16.97 31.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.199 -0.938 . . . . 3.64 109.847 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 234' ' ' VAL . 61.2 m-20 -160.39 128.82 2.95 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 2.16 109.339 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.94 7.63 0.58 Allowed 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.776 0.984 . . . . 1.27 110.302 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.492 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.5 m -82.32 127.77 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.874 -1.141 . . . . 1.76 110.014 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -50.25 162.44 0.22 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.67 109.298 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' B' ' 237' ' ' GLY . 31.3 mtpt -119.71 166.44 13.21 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.371 -0.831 . . . . 1.44 109.431 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.15 170.3 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.303 -1.119 . . . . 0.4 110.303 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -68.92 163.8 36.13 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.55 1.5 . . . . 0.41 110.605 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.52 177.87 7.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.21 109.404 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -95.59 137.3 34.85 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.135 -0.978 . . . . 2.72 109.389 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.404 HD21 ' NZ ' ' B' ' 244' ' ' LYS . 19.3 tp -88.51 123.87 33.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.544 -0.723 . . . . 0.3 109.571 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -115.21 -72.53 0.69 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.381 -0.824 . . . . 0.45 110.488 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.18 144.47 25.58 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.051 -1.031 . . . . 0.33 110.469 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' HD21 ' B' ' 241' ' ' LEU . 16.0 ttmm -145.69 119.41 9.2 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.818 -0.808 . . . . 2.33 108.818 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.95 -104.92 0.26 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.148 -1.181 . . . . 0.28 110.148 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -72.98 -149.44 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.256 -1.143 . . . . 1.4 109.725 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.61 3.97 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.19 -1.564 . . . . 0.29 109.19 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.96 34.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -1.023 . . . . 0.29 108.447 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.31 123.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.08 -1.012 . . . . 0.31 109.81 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 56.4 t -85.82 133.66 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.392 -0.966 . . . . 0.3 108.392 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.405 HD11 HG21 ' B' ' 260' ' ' VAL . 10.5 pt -138.86 178.59 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.315 -0.866 . . . . 0.24 110.066 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.521 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.6 tt0 -143.72 109.41 5.19 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.353 -0.981 . . . . 1.81 108.353 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.21 -77.1 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.538 -1.282 . . . . 1.18 107.538 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -80.96 -133.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.323 -1.732 . . . . 1.97 106.323 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 16.2 t -105.07 56.57 0.69 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -157.05 123.62 5.0 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.778 -0.823 . . . . 1.12 108.778 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.521 ' CG1' HE21 ' B' ' 252' ' ' GLN . 39.1 mt -91.66 134.31 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.48 109.435 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -139.11 172.59 12.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.368 -0.832 . . . . 2.13 110.05 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.13 140.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.461 -0.774 . . . . 0.34 109.745 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . 0.405 HG21 HD11 ' B' ' 251' ' ' ILE . 58.5 t -134.17 124.86 17.64 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.841 -0.8 . . . . 0.34 108.841 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -58.12 139.49 90.65 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 120.588 0.859 . . . . 0.42 110.325 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.81 -36.19 69.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 3.11 109.751 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.416 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 2.3 tpt180 -67.17 -9.47 40.42 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 3.82 110.733 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.496 ' NZ ' ' CB ' ' B' ' 264' ' ' LYS . 7.4 mtpm? -123.03 25.53 8.5 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.21 -0.931 . . . . 2.08 108.833 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.07 163.31 32.74 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.493 -0.928 . . . . 0.32 108.493 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -139.32 131.9 28.8 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.113 -0.992 . . . . 1.79 109.318 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 21.8 mm -89.44 107.62 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.231 -0.918 . . . . 0.45 109.311 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.44 157.55 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.41 -0.806 . . . . 0.57 109.269 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -91.69 137.23 32.53 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.308 -0.87 . . . . 3.62 109.487 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 1.8 m-20 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.105 -0.997 . . . . 2.05 109.425 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.415 -0.587 . . . . 3.82 109.415 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 220' ' ' ILE . 1.9 mp -84.0 114.27 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 2.08 108.958 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -83.49 -124.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 2.17 109.792 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 2.6 m-20 -94.75 99.01 11.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 1.48 109.227 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -135.66 134.08 38.83 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.72 109.374 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.1 18.89 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 107.925 -1.139 . . . . 3.26 107.925 178.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.6 t -140.99 140.23 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.103 -0.998 . . . . 0.23 110.983 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -109.28 154.28 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.141 -1.429 . . . . 0.58 107.141 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.9 p90 -156.53 150.12 24.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.593 -1.317 . . . . 0.44 110.55 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 228' ' ' ARG . 10.7 mtm-85 -94.22 134.97 36.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.513 -0.742 . . . . 2.76 109.463 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.36 175.24 6.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.366 -0.834 . . . . 2.23 109.591 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.2 t -85.88 -11.02 54.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 1.8 108.874 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -88.8 -9.31 52.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.504 -0.748 . . . . 3.63 109.414 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -158.07 128.52 3.51 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.222 -0.924 . . . . 2.16 109.04 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.69 -11.58 29.84 Favored 'Trans proline' 0 N--CA 1.48 0.72 0 C-N-CA 120.815 1.01 . . . . 1.25 110.44 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 235' ' ' TRP . 1.5 p -84.59 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.043 . . . . 1.75 109.42 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.477 ' N ' ' CG2' ' A' ' 234' ' ' VAL . 92.7 m95 -64.43 169.57 4.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.445 -0.784 . . . . 0.66 109.644 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.44 ' O ' ' O ' ' A' ' 237' ' ' GLY . 44.9 tttp -118.95 165.35 14.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.512 -0.742 . . . . 1.43 109.223 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.22 167.37 0.02 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.119 -1.192 . . . . 0.39 110.119 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.4 160.25 50.52 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.448 1.432 . . . . 0.41 110.113 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.79 168.86 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 0.21 109.18 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.51 139.51 30.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.161 -0.962 . . . . 2.72 109.971 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -89.08 122.94 32.9 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.469 -0.77 . . . . 0.29 109.428 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 21.9 mt -112.66 -75.51 0.6 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.419 -0.801 . . . . 0.45 110.355 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -89.79 143.68 26.6 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.067 -1.021 . . . . 0.31 109.893 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.65 121.62 10.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.342 -0.849 . . . . 2.32 109.063 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.46 -104.93 0.23 Allowed Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.812 -1.185 . . . . 0.27 110.147 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -69.38 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.411 -1.053 . . . . 1.39 109.551 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.23 51.36 3.24 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.14 -1.584 . . . . 0.29 109.14 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.37 154.02 40.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.427 -1.043 . . . . 0.29 108.691 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -147.01 124.61 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.056 -1.027 . . . . 0.31 109.82 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.82 133.61 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.721 -1.214 . . . . 0.29 107.721 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.39 175.78 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.321 -0.862 . . . . 0.23 110.333 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -145.32 108.71 4.63 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.588 -0.893 . . . . 1.81 108.588 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.34 -77.84 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.421 -1.326 . . . . 1.18 107.421 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -80.28 -135.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.566 -1.642 . . . . 1.98 106.566 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.421 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 10.2 p -101.58 55.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.099 -1.074 . . . . 1.39 108.099 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 255' ' ' SER . 59.1 m-20 -156.75 123.71 5.2 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.143 -0.688 . . . . 1.12 109.143 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.428 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 11.3 mt -93.05 135.39 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.866 . . . . 0.47 109.438 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.07 169.72 17.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.415 -0.803 . . . . 2.11 109.709 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.86 140.97 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.383 -0.823 . . . . 0.33 109.491 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.97 128.24 17.56 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.632 -0.877 . . . . 0.34 108.632 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.65 148.64 72.66 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.528 -0.989 . . . . 0.42 109.528 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -67.82 -30.3 69.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.332 -0.855 . . . . 3.12 109.452 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.68 -8.29 53.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 3.82 111.0 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.21 23.16 11.47 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.126 -0.983 . . . . 2.08 109.005 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.97 168.13 20.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.579 -0.701 . . . . 0.32 109.164 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -139.64 129.59 24.89 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.318 -0.864 . . . . 1.79 109.154 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.38 108.13 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.403 -0.811 . . . . 0.45 109.431 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -101.83 156.21 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -94.57 135.37 36.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 3.63 109.116 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.082 -1.011 . . . . 2.05 109.516 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.461 -0.57 . . . . 3.83 109.461 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.762 ' N ' HD12 ' B' ' 220' ' ' ILE . 1.9 mp -83.91 114.3 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 2.08 108.96 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -83.45 -125.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.091 -1.006 . . . . 2.16 109.853 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 2.6 m-20 -94.7 98.95 11.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.329 -0.857 . . . . 1.48 109.227 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -135.63 134.09 38.89 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.487 -0.758 . . . . 0.73 109.416 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.537 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -110.51 158.2 18.78 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 107.91 -1.144 . . . . 3.26 107.91 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.7 t -141.09 140.27 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.181 -0.95 . . . . 0.23 110.945 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -109.24 154.33 22.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.169 -1.419 . . . . 0.58 107.169 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -156.63 149.94 24.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.468 -1.395 . . . . 0.44 110.666 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.432 HH11 ' HG3' ' B' ' 228' ' ' ARG . 10.6 mtm-85 -94.07 135.05 35.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.523 -0.736 . . . . 2.76 109.51 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.45 175.18 6.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.359 -0.838 . . . . 2.23 109.629 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.1 t -85.79 -10.99 54.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 1.81 108.925 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -88.84 -9.2 52.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.443 -0.785 . . . . 3.64 109.433 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -158.17 128.37 3.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.196 -0.94 . . . . 2.16 109.147 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -70.64 -11.54 29.84 Favored 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 120.865 1.043 . . . . 1.27 110.433 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' B' ' 235' ' ' TRP . 1.5 p -84.52 163.62 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.042 -1.037 . . . . 1.76 109.429 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.479 ' N ' ' CG2' ' B' ' 234' ' ' VAL . 92.7 m95 -64.45 169.57 4.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.481 -0.762 . . . . 0.67 109.671 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 44.9 tttp -118.92 165.31 14.22 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.635 -0.666 . . . . 1.44 109.338 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.24 167.39 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.159 -1.176 . . . . 0.4 110.159 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.37 160.27 50.47 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 121.419 1.412 . . . . 0.41 110.122 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.88 168.88 18.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.477 -0.764 . . . . 0.21 109.071 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -92.4 139.48 30.56 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.227 -0.92 . . . . 2.72 109.971 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.1 tp -89.1 122.88 32.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.573 -0.704 . . . . 0.3 109.423 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -112.63 -75.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.375 -0.828 . . . . 0.45 110.44 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.428 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.1 t90 -89.77 143.66 26.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.005 . . . . 0.33 109.889 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -145.75 121.64 10.63 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.315 -0.866 . . . . 2.33 109.044 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.41 -104.95 0.23 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.11 -1.196 . . . . 0.28 110.11 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -69.42 -153.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -1.125 . . . . 1.4 109.516 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.28 51.43 3.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.05 -1.62 . . . . 0.29 109.05 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.11 40.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.467 -1.019 . . . . 0.29 108.72 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.99 124.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.126 -0.984 . . . . 0.31 109.943 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.78 133.77 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 107.703 -1.221 . . . . 0.3 107.703 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -138.51 175.79 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.296 -0.878 . . . . 0.24 110.278 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -145.3 108.75 4.64 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.593 -0.891 . . . . 1.81 108.593 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.43 -77.86 0.37 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.348 -1.353 . . . . 1.18 107.348 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.25 -135.73 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.54 -1.652 . . . . 1.97 106.54 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 10.1 p -101.63 56.06 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.964 -1.125 . . . . 1.38 107.964 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' B' ' 255' ' ' SER . 59.1 m-20 -156.78 123.68 5.17 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.145 -0.687 . . . . 1.12 109.145 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.99 135.35 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.48 109.429 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -139.12 169.77 17.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.332 -0.855 . . . . 2.13 109.751 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 140.98 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.381 -0.824 . . . . 0.34 109.496 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.96 128.3 17.61 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.672 -0.862 . . . . 0.34 108.672 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.78 148.64 73.79 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 N-CA-C 109.465 -1.013 . . . . 0.42 109.465 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -67.78 -30.37 69.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 3.11 109.489 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -71.58 -8.34 53.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.415 -0.803 . . . . 3.82 111.016 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -119.14 23.15 11.5 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.176 -0.952 . . . . 2.08 109.054 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.03 168.16 20.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.078 -0.712 . . . . 0.32 109.078 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -139.6 129.65 25.05 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.363 -0.836 . . . . 1.79 109.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.8 mm -89.34 108.09 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.4 -0.812 . . . . 0.45 109.431 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.6 mm -101.88 156.08 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.319 -0.863 . . . . 0.57 108.683 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -94.5 135.36 36.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 3.62 109.183 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.042 -1.036 . . . . 2.05 109.555 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 36.1 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.269 0.557 . . . . 3.82 109.525 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -86.11 120.18 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.364 -0.976 . . . . 2.08 108.364 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -82.68 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.031 -1.043 . . . . 2.17 109.808 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -92.55 99.71 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.281 -0.887 . . . . 1.48 109.178 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.95 122.68 22.25 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.817 -0.808 . . . . 0.72 108.817 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.609 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -100.99 161.16 13.79 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.289 -1.004 . . . . 3.26 108.289 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.6 141.91 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.324 -0.86 . . . . 0.23 110.093 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -107.21 155.21 20.16 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.299 -1.371 . . . . 0.58 107.299 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 8.3 p90 -154.86 153.29 30.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.716 -1.24 . . . . 0.44 110.456 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -95.29 157.15 16.02 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.495 -0.753 . . . . 2.76 109.978 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -94.55 176.46 6.28 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.9 -0.778 . . . . 2.23 108.9 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.41 -11.24 38.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.109 -0.994 . . . . 1.8 109.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.63 -15.41 35.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.33 -0.856 . . . . 3.63 109.902 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.4 m-20 -161.38 132.34 3.77 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.142 -0.974 . . . . 2.16 109.282 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.5 18.28 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.023 1.149 . . . . 1.25 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.1 p -86.59 158.54 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.72 -1.238 . . . . 1.75 109.921 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.508 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.1 m95 -75.5 176.25 7.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.429 -0.582 . . . . 0.66 109.429 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -134.97 -150.6 0.39 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.234 -0.916 . . . . 1.43 109.141 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.17 174.95 49.63 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.093 -1.203 . . . . 0.39 110.093 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -74.12 158.95 45.0 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.78 1.653 . . . . 0.41 110.066 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.12 172.04 13.23 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.345 -0.847 . . . . 0.21 109.517 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.55 ' NZ ' HH22 ' A' ' 224' ' ' ARG . 66.7 mmtt -92.49 137.72 32.13 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.269 -0.895 . . . . 2.72 109.428 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.27 124.47 34.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.498 -0.752 . . . . 0.29 109.814 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.37 -73.71 0.63 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.377 -0.827 . . . . 0.45 110.27 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.85 140.33 29.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.26 -0.9 . . . . 0.31 109.956 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -147.24 115.11 6.47 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.265 -0.897 . . . . 2.32 109.209 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.74 -100.3 0.17 Allowed Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.854 -1.165 . . . . 0.27 110.302 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.37 -156.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.357 -1.084 . . . . 1.39 109.888 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.21 48.16 2.74 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.061 -1.615 . . . . 0.29 109.061 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 152.34 36.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.437 -1.037 . . . . 0.29 108.999 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.58 125.2 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.31 109.413 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 50.5 t -87.85 135.02 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.109 -1.071 . . . . 0.29 108.109 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 260' ' ' VAL . 9.1 pt -139.75 -177.89 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.352 -0.843 . . . . 0.23 110.062 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.515 HE21 ' CG1' ' A' ' 257' ' ' ILE . 34.4 tt0 -143.14 109.41 5.32 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.359 -0.978 . . . . 1.81 108.359 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.62 -79.09 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.634 -1.247 . . . . 1.18 107.634 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -78.99 -135.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.481 -1.674 . . . . 1.98 106.481 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.7 m -101.02 53.72 0.84 Allowed 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.167 -1.049 . . . . 1.39 108.167 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -157.35 132.13 8.7 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.051 -0.722 . . . . 1.12 109.051 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.515 ' CG1' HE21 ' A' ' 252' ' ' GLN . 37.3 mt -92.64 137.31 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.47 109.479 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.54 169.91 16.88 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 2.11 109.701 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 23.1 t -103.93 140.87 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.458 -0.777 . . . . 0.33 109.411 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 251' ' ' ILE . 43.0 t -134.56 134.03 21.96 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 108.678 -0.86 . . . . 0.34 108.678 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.42 140.96 96.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 120.715 0.944 . . . . 0.42 110.478 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.4 HH12 HG13 ' A' ' 267' ' ' ILE . 20.7 tpt180 -59.11 -38.95 80.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.45 -0.781 . . . . 3.12 109.271 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -66.96 -7.95 26.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -0.797 . . . . 3.82 111.001 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.68 25.11 9.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.156 -0.965 . . . . 2.08 109.169 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.53 164.28 30.57 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.212 -0.662 . . . . 0.32 109.212 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -140.03 126.47 20.2 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.252 -0.905 . . . . 1.79 109.075 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.4 HG13 HH12 ' A' ' 262' ' ' ARG . 18.4 mm -87.97 110.39 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.45 109.745 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.12 147.17 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.354 -0.98 . . . . 0.57 108.354 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -95.99 141.6 29.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.412 -0.805 . . . . 3.63 109.763 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.007 -0.997 . . . . 2.05 109.492 179.431 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 36.2 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.425 -0.583 . . . . 3.83 109.425 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.406 ' N ' HD13 ' B' ' 220' ' ' ILE . 0.4 OUTLIER -86.12 120.15 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.455 -0.943 . . . . 2.08 108.455 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -82.56 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.009 -1.057 . . . . 2.16 109.868 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -92.55 99.71 12.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.223 -0.923 . . . . 1.48 109.159 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.97 122.79 22.38 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.709 -0.849 . . . . 0.73 108.709 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.594 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -101.03 161.05 13.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.316 -0.994 . . . . 3.26 108.316 179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.54 142.0 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.265 -0.897 . . . . 0.23 110.097 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.26 155.21 20.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.337 -1.357 . . . . 0.58 107.337 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -154.84 153.26 30.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.696 -1.253 . . . . 0.44 110.491 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -95.24 157.17 16.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.751 . . . . 2.76 109.975 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -94.52 176.48 6.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 2.23 108.962 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -91.44 -11.26 38.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 1.81 109.342 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.66 -15.4 35.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.331 -0.855 . . . . 3.64 109.857 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.7 m-20 -161.37 132.32 3.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 2.16 109.274 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.48 18.16 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.965 1.11 . . . . 1.27 110.838 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.2 p -86.41 158.56 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.774 -1.204 . . . . 1.76 109.922 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.498 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.66 176.28 7.83 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.381 -0.6 . . . . 0.67 109.381 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -135.0 -150.58 0.39 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.284 -0.885 . . . . 1.44 109.11 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -85.2 174.94 49.57 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.084 -1.207 . . . . 0.4 110.084 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.13 158.97 44.94 Favored 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 121.777 1.651 . . . . 0.41 110.077 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.11 172.15 13.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.392 -0.817 . . . . 0.21 109.5 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.552 ' NZ ' HH22 ' B' ' 224' ' ' ARG . 66.7 mmtt -92.52 137.7 32.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.233 -0.917 . . . . 2.72 109.422 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.29 124.48 34.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.568 -0.707 . . . . 0.3 109.783 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.7 mt -117.35 -73.68 0.63 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.275 -0.891 . . . . 0.45 110.317 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.89 140.32 29.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.295 -0.878 . . . . 0.33 109.953 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -147.28 115.0 6.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.244 -0.91 . . . . 2.33 109.221 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.66 -100.36 0.18 Allowed Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.782 -1.199 . . . . 0.28 110.239 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -66.29 -157.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 1.4 109.863 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 48.06 2.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.27 36.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -1.067 . . . . 0.29 109.111 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.61 125.15 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.31 109.411 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.83 134.92 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.033 -1.099 . . . . 0.3 108.033 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 260' ' ' VAL . 9.2 pt -139.62 -177.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.24 110.105 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.522 HE21 ' CG1' ' B' ' 257' ' ' ILE . 34.4 tt0 -143.05 109.55 5.4 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.391 -0.966 . . . . 1.81 108.391 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -89.66 -79.15 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.629 -1.248 . . . . 1.18 107.629 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -78.94 -135.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.551 -1.648 . . . . 1.97 106.551 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.9 m -100.95 53.7 0.85 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.13 -1.063 . . . . 1.38 108.13 178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -157.3 132.16 8.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.041 -0.726 . . . . 1.12 109.041 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.522 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.1 mt -92.63 137.25 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.235 -0.916 . . . . 0.48 109.477 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -139.49 169.81 17.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.402 -0.811 . . . . 2.13 109.746 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.88 140.89 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.409 -0.807 . . . . 0.34 109.458 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . 0.418 HG21 HD11 ' B' ' 251' ' ' ILE . 42.8 t -134.49 133.99 22.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 108.802 -0.814 . . . . 0.34 108.802 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.43 140.91 96.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.647 0.898 . . . . 0.42 110.522 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.1 -38.85 80.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.378 -0.826 . . . . 3.11 109.326 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -67.07 -7.83 25.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.465 -0.772 . . . . 3.82 110.997 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -120.75 25.08 9.93 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.151 -0.968 . . . . 2.08 109.192 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 164.24 30.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.224 -0.658 . . . . 0.32 109.224 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -140.04 126.47 20.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.304 -0.873 . . . . 1.79 109.097 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.4 mm -87.94 110.36 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.267 -0.895 . . . . 0.45 109.742 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.4 mm -103.1 147.16 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.329 -0.989 . . . . 0.57 108.329 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -95.93 141.65 29.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.45 -0.781 . . . . 3.62 109.758 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.02 -0.99 . . . . 2.05 109.612 179.385 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.356 0.598 . . . . 3.82 109.53 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.0 136.09 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.967 -1.083 . . . . 2.08 108.204 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.12 -142.33 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.928 -1.107 . . . . 2.17 109.779 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 222' ' ' ASN . 0.9 OUTLIER -92.22 109.65 21.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.312 -0.867 . . . . 1.48 109.522 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.05 137.52 46.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.592 -0.693 . . . . 0.72 109.416 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.6 OUTLIER -104.85 157.81 16.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.41 -1.33 . . . . 3.26 107.41 178.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.0 t -141.53 142.91 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.077 -1.014 . . . . 0.23 110.642 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -110.63 154.81 23.27 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.303 -1.369 . . . . 0.58 107.303 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.76 151.91 26.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.534 -1.354 . . . . 0.44 110.529 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 228' ' ' ARG . 2.0 mtm-85 -92.5 149.27 21.48 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.739 . . . . 2.76 109.876 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -94.38 168.04 11.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -0.858 . . . . 2.23 108.698 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 47.9 t -84.81 -9.38 58.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.0 . . . . 1.8 109.084 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.587 HH11 ' CG ' ' A' ' 231' ' ' ARG . 3.5 mtt-85 -90.83 -15.75 29.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.348 -0.845 . . . . 3.63 109.989 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 234' ' ' VAL . 38.0 m-20 -160.24 129.54 3.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.056 -1.027 . . . . 2.16 108.95 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -65.86 11.03 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 120.831 1.021 . . . . 1.25 110.827 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.8 p -81.62 158.49 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.697 -1.252 . . . . 1.75 109.886 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.6 m95 -75.33 162.15 28.66 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.213 -0.662 . . . . 0.66 109.213 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.7 tttp -118.38 158.13 25.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.462 -0.774 . . . . 1.43 109.162 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.16 171.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.551 -1.02 . . . . 0.39 110.551 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.37 158.25 57.89 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.691 1.594 . . . . 0.41 110.621 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.24 170.65 15.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.674 -0.861 . . . . 0.21 108.674 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -92.95 137.24 32.54 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.072 -1.017 . . . . 2.72 109.349 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.9 tp -89.55 120.31 30.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.708 -0.62 . . . . 0.29 109.587 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.6 mt -111.15 -71.79 0.75 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.363 -0.836 . . . . 0.45 110.101 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.2 t90 -91.59 142.11 27.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.206 -0.934 . . . . 0.31 109.78 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.76 112.48 5.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.139 -0.976 . . . . 2.32 109.065 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.413 ' O ' ' O ' ' A' ' 246' ' ' GLU . . . -155.83 -104.17 0.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.814 -1.184 . . . . 0.27 110.251 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 245' ' ' GLY . 30.0 mt-10 -56.67 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.477 -1.014 . . . . 1.39 109.862 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.1 49.95 2.99 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.103 -1.599 . . . . 0.29 109.103 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.22 157.9 43.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.485 -1.009 . . . . 0.29 108.569 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.38 132.44 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.082 -1.011 . . . . 0.31 109.552 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.79 133.93 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 15.3 pt -138.71 174.06 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.326 -0.859 . . . . 0.23 110.562 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -141.89 108.87 5.44 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.226 -1.027 . . . . 1.81 108.226 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.22 -75.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.514 -1.291 . . . . 1.18 107.514 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.25 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.615 -1.624 . . . . 1.98 106.615 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.98 52.23 0.74 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.854 -1.165 . . . . 1.39 107.854 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -156.35 129.0 7.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.521 -0.737 . . . . 1.12 109.29 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.1 mt -92.62 141.52 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.39 -0.819 . . . . 0.47 109.635 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.57 165.11 28.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.356 -0.84 . . . . 2.11 109.668 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.9 137.46 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.39 -0.818 . . . . 0.33 109.404 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.72 131.53 20.21 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.361 -0.837 . . . . 0.34 109.189 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -59.64 146.98 93.84 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 N-CA-C 109.702 -0.922 . . . . 0.42 109.702 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.07 -33.07 75.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.311 -0.868 . . . . 3.12 109.716 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -68.99 -7.05 31.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.21 -0.931 . . . . 3.82 110.636 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -119.73 20.96 12.19 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.265 -0.897 . . . . 2.08 109.13 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.89 23.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.32 109.534 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -139.42 131.01 27.18 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.213 -0.93 . . . . 1.79 108.973 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.18 105.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 0.45 109.523 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 269' ' ' ARG . 8.1 mm -105.1 159.99 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.368 -0.833 . . . . 0.57 108.956 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 269' ' ' ARG . 24.7 mtm-85 -87.54 148.19 25.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.2 -0.938 . . . . 3.63 109.376 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 8.5 m-20 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.1 -1.0 . . . . 2.05 109.067 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.326 0.584 . . . . 3.83 109.466 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 8.4 mm -83.98 136.05 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.005 -1.059 . . . . 2.08 108.205 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -84.06 -142.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.989 -1.069 . . . . 2.16 109.726 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.602 ' N ' HD22 ' B' ' 222' ' ' ASN . 0.9 OUTLIER -92.39 109.51 20.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 1.48 109.491 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -132.86 137.67 46.77 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.642 -0.661 . . . . 0.73 109.401 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.6 OUTLIER -104.96 157.82 16.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.403 -1.332 . . . . 3.26 107.403 178.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.55 143.03 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.111 -0.993 . . . . 0.23 110.601 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -110.66 154.8 23.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.77 151.98 26.38 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.605 -1.309 . . . . 0.44 110.513 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.447 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.0 mtm-85 -92.47 149.24 21.5 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.445 -0.784 . . . . 2.76 109.927 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -94.45 167.86 11.24 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.682 -0.858 . . . . 2.23 108.682 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 47.5 t -84.73 -9.26 58.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 1.81 109.139 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' B' ' 231' ' ' ARG . 3.6 mtt-85 -90.89 -15.68 29.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 3.64 110.048 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 38.1 m-20 -160.31 129.59 3.2 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.159 -0.963 . . . . 2.16 108.965 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -66.04 11.16 0.16 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 120.775 0.983 . . . . 1.27 110.777 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.493 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.9 p -81.55 158.64 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.797 -1.189 . . . . 1.76 110.055 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.493 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.6 m95 -75.53 162.07 28.62 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.11 -0.7 . . . . 0.67 109.11 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.9 tttp -118.29 158.14 25.74 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.468 -0.77 . . . . 1.44 109.195 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.05 171.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.518 -1.033 . . . . 0.4 110.518 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.26 158.19 58.14 Favored 'Trans proline' 0 C--N 1.319 -0.978 0 C-N-CA 121.825 1.683 . . . . 0.41 110.667 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.23 170.81 15.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.678 -0.86 . . . . 0.21 108.678 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -93.14 137.16 32.74 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.022 -1.049 . . . . 2.72 109.339 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.8 tp -89.4 120.28 30.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.621 -0.675 . . . . 0.3 109.585 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.08 -71.9 0.74 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.314 -0.866 . . . . 0.45 110.095 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.505 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.1 t90 -91.58 142.18 27.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.33 109.805 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -146.84 112.55 5.67 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.205 -0.934 . . . . 2.33 109.109 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' B' ' 246' ' ' GLU . . . -155.88 -104.2 0.22 Allowed Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.783 -1.198 . . . . 0.28 110.301 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' B' ' 245' ' ' GLY . 30.3 mt-10 -56.68 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.445 -1.032 . . . . 1.4 109.846 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.14 49.98 3.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.101 -1.6 . . . . 0.29 109.101 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.18 158.0 43.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.589 -0.947 . . . . 0.29 108.527 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.36 132.36 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.31 109.544 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.1 t -93.79 133.95 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.936 -1.135 . . . . 0.3 107.936 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.77 173.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.24 110.565 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -141.74 108.77 5.46 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.311 -0.996 . . . . 1.81 108.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.23 -75.84 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.498 -1.297 . . . . 1.18 107.498 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.23 -132.07 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.566 -1.642 . . . . 1.97 106.566 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 11.0 t -104.94 52.06 0.75 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.952 -1.129 . . . . 1.38 107.952 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -156.2 129.0 7.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.643 -0.661 . . . . 1.12 109.335 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.505 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.2 mt -92.65 141.48 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.37 -0.831 . . . . 0.48 109.591 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -140.35 165.24 27.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 2.13 109.72 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.98 137.32 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.34 109.408 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.9 t -134.64 131.51 20.28 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.42 -0.8 . . . . 0.34 109.175 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.67 147.07 93.57 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 N-CA-C 109.734 -0.91 . . . . 0.42 109.734 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -65.06 -33.14 75.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.255 -0.903 . . . . 3.11 109.652 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.0 -7.03 31.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.271 -0.893 . . . . 3.82 110.559 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -119.7 20.96 12.21 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.29 -0.881 . . . . 2.08 109.134 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.62 166.81 23.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.666 -0.646 . . . . 0.32 109.524 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -139.41 130.91 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.354 -0.841 . . . . 1.79 109.092 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.8 mm -89.12 105.93 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -0.846 . . . . 0.45 109.625 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.437 HG22 ' N ' ' B' ' 269' ' ' ARG . 8.1 mm -105.08 160.13 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.383 -0.823 . . . . 0.57 109.026 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' B' ' 269' ' ' ARG . 24.6 mtm-85 -87.66 148.04 24.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.266 -0.896 . . . . 3.62 109.387 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.028 -0.987 . . . . 2.05 109.103 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.494 -0.558 . . . . 3.82 109.494 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.69 127.39 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.028 -1.101 . . . . 2.08 108.028 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.35 -126.71 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.935 . . . . 2.17 109.429 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -93.38 106.71 18.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.119 -0.988 . . . . 1.48 109.136 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -134.6 130.29 36.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.595 -0.691 . . . . 0.72 109.207 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.4 OUTLIER -105.68 159.48 15.94 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.293 -1.003 . . . . 3.26 108.293 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.1 t -142.13 140.8 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.044 -1.035 . . . . 0.23 110.59 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.06 152.48 23.95 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.252 -1.388 . . . . 0.58 107.252 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.57 151.5 26.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.537 -1.352 . . . . 0.44 110.615 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -95.06 143.63 26.37 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 2.76 109.88 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.77 173.25 7.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.392 -0.818 . . . . 2.23 108.997 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.24 -9.99 51.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.8 109.381 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.64 -13.0 43.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.214 -0.929 . . . . 3.63 109.55 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -158.43 128.43 3.38 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 2.16 108.707 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -67.32 2.04 2.58 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 120.875 1.05 . . . . 1.25 111.404 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.623 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.8 p -84.57 167.04 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.565 -1.334 . . . . 1.75 110.335 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.623 ' N ' HG22 ' A' ' 234' ' ' VAL . 98.8 m95 -71.92 161.98 30.13 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.692 -0.855 . . . . 0.66 108.692 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.2 tttp -118.75 161.96 19.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.288 -0.883 . . . . 1.43 109.257 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.6 164.83 0.02 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.302 -1.119 . . . . 0.39 110.302 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -67.43 160.75 46.38 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.456 1.437 . . . . 0.41 110.127 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.66 175.32 9.67 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.836 -0.802 . . . . 0.21 108.836 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -95.89 138.73 33.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.126 -0.984 . . . . 2.72 109.795 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.9 tp -87.89 122.93 32.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.326 -0.859 . . . . 0.29 109.259 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 mt -116.38 -72.94 0.67 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.352 -0.842 . . . . 0.45 110.326 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.528 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.7 t90 -90.07 139.95 30.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.091 -1.006 . . . . 0.31 110.387 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.62 7.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.374 -0.829 . . . . 2.32 109.008 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.33 -99.9 0.17 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.83 -1.308 . . . . 0.27 109.83 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.45 -155.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -1.149 . . . . 1.39 109.65 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.81 46.47 2.35 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.417 -1.473 . . . . 0.29 109.417 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.84 148.73 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -1.037 . . . . 0.29 108.564 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.76 126.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.297 -0.877 . . . . 0.31 109.697 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.19 139.42 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.156 -1.053 . . . . 0.29 108.156 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 257' ' ' ILE . 11.1 pt -141.2 178.48 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.23 110.408 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.407 HE21 HG12 ' A' ' 257' ' ' ILE . 29.3 tt0 -143.69 111.29 5.96 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.892 -1.151 . . . . 1.81 107.892 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.56 -78.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.851 -1.166 . . . . 1.18 107.851 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -80.39 -128.47 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.802 -1.555 . . . . 1.98 106.802 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 51.1 m -105.38 51.37 0.76 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.961 -1.126 . . . . 1.39 107.961 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -156.16 134.4 11.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.009 -0.737 . . . . 1.12 109.009 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.488 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 10.5 mt -93.52 144.89 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 0.47 109.306 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.06 162.88 34.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.318 -0.864 . . . . 2.11 110.056 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.77 131.3 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.536 -0.727 . . . . 0.33 109.212 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.09 133.26 20.69 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 108.698 -0.853 . . . . 0.34 108.698 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.8 147.46 80.75 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 120.521 0.814 . . . . 0.42 109.993 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.29 -37.52 77.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 3.12 109.359 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -70.84 1.81 5.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.791 . . . . 3.82 110.72 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -118.93 12.0 12.71 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.581 -0.896 . . . . 2.08 108.581 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.75 170.05 16.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.679 . . . . 0.32 109.657 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.47 130.11 27.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.339 -0.85 . . . . 1.79 108.984 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.76 115.2 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.416 -0.803 . . . . 0.45 109.749 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.9 mm -112.12 155.04 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.383 -0.823 . . . . 0.57 109.141 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -91.57 136.29 33.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.517 -0.739 . . . . 3.63 109.278 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.979 -1.01 . . . . 2.05 109.55 179.844 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 53.2 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.2 0.524 . . . . 3.83 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.521 HD13 ' N ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.58 127.38 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.999 -1.112 . . . . 2.08 107.999 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -84.38 -126.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 2.16 109.479 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -93.31 106.65 18.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.2 -0.938 . . . . 1.48 109.128 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -134.52 130.39 36.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.578 -0.701 . . . . 0.73 109.145 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.532 HH11 ' HG2' ' B' ' 224' ' ' ARG . 0.4 OUTLIER -105.69 159.53 15.91 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.347 -0.983 . . . . 3.26 108.347 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.5 t -142.28 140.72 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.122 -0.986 . . . . 0.23 110.581 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -106.95 152.55 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.241 -1.392 . . . . 0.58 107.241 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.8 p90 -156.71 151.47 25.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.595 -1.315 . . . . 0.44 110.562 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -95.09 143.53 26.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.641 -0.662 . . . . 2.76 109.847 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.66 173.35 7.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.412 -0.805 . . . . 2.23 109.066 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.0 m -88.36 -9.91 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 1.81 109.426 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -87.76 -12.95 43.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.185 -0.947 . . . . 3.64 109.505 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -158.37 128.44 3.4 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.115 -0.991 . . . . 2.16 108.732 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.29 1.99 2.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.948 1.099 . . . . 1.27 111.46 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.618 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.7 p -84.5 166.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.59 -1.319 . . . . 1.76 110.386 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.618 ' N ' HG22 ' B' ' 234' ' ' VAL . 98.8 m95 -71.92 161.97 30.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.665 -0.865 . . . . 0.67 108.665 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.79 162.0 19.19 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.383 -0.823 . . . . 1.44 109.211 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.65 164.82 0.02 OUTLIER Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.376 -1.089 . . . . 0.4 110.376 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -67.39 160.67 46.68 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.484 1.456 . . . . 0.41 110.179 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.54 175.53 9.49 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.791 -0.818 . . . . 0.21 108.791 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -96.02 138.78 33.15 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.167 -0.958 . . . . 2.72 109.717 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.02 122.84 32.1 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.473 -0.767 . . . . 0.3 109.274 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 14.1 mt -116.4 -72.79 0.67 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.423 -0.798 . . . . 0.45 110.285 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.488 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.7 t90 -90.11 139.9 30.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.08 -1.013 . . . . 0.33 110.268 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -147.07 117.54 7.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.285 -0.885 . . . . 2.33 109.073 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.22 -99.76 0.17 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.901 -1.28 . . . . 0.28 109.901 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.44 -155.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -1.103 . . . . 1.4 109.702 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.75 46.45 2.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.381 -1.488 . . . . 0.29 109.381 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -144.78 148.63 34.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.443 -1.034 . . . . 0.29 108.522 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.77 126.37 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.267 -0.896 . . . . 0.31 109.732 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.13 139.52 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.227 -1.027 . . . . 0.3 108.227 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.427 ' O ' HG23 ' B' ' 257' ' ' ILE . 11.1 pt -141.24 178.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.207 -0.933 . . . . 0.24 110.464 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.412 HE21 HG12 ' B' ' 257' ' ' ILE . 29.4 tt0 -143.65 111.31 5.98 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.985 -1.117 . . . . 1.81 107.985 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.62 -78.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.783 -1.192 . . . . 1.18 107.783 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.43 -128.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.767 -1.568 . . . . 1.97 106.767 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 51.0 m -105.42 51.34 0.76 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.972 -1.122 . . . . 1.38 107.972 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -156.09 134.43 11.51 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.053 -0.721 . . . . 1.12 109.053 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.528 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 10.7 mt -93.48 145.01 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.183 -0.948 . . . . 0.48 109.48 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -140.15 162.93 34.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.332 -0.855 . . . . 2.13 109.993 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.76 131.27 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.589 -0.694 . . . . 0.34 109.186 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 48.5 t -135.02 133.34 20.83 Favored Pre-proline 0 N--CA 1.496 1.871 0 N-CA-C 108.67 -0.863 . . . . 0.34 108.67 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.7 147.47 79.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.534 0.822 . . . . 0.42 110.027 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -59.47 -37.26 77.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 3.11 109.392 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -71.01 1.96 5.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 3.82 110.77 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -119.03 12.01 12.62 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.547 -0.909 . . . . 2.08 108.547 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.84 169.99 16.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.641 -0.662 . . . . 0.32 109.657 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -138.43 130.13 27.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.448 -0.783 . . . . 1.79 108.989 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 17.6 mm -88.77 115.14 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.41 -0.806 . . . . 0.45 109.753 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -111.95 155.03 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.44 -0.788 . . . . 0.57 109.178 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -91.46 136.24 33.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.572 -0.705 . . . . 3.62 109.285 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.01 . . . . 2.05 109.555 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.504 ' O ' ' CE2' ' A' ' 223' ' ' PHE . 53.1 mtt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.533 0.682 . . . . 3.82 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 8.7 pt -83.3 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.125 0.965 . . . . 2.08 109.268 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -78.82 -107.46 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 109.489 -0.56 . . . . 2.17 109.489 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 -97.35 91.07 5.31 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.098 -1.001 . . . . 1.48 109.588 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 219' ' ' MET . 38.1 m-85 -136.07 135.46 39.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.525 -0.734 . . . . 0.72 109.466 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.53 156.94 20.18 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.215 -1.402 . . . . 3.26 107.215 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.14 141.79 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.008 -1.058 . . . . 0.23 110.716 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.44 152.55 25.23 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.406 -1.331 . . . . 0.58 107.406 178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 17.6 p90 -155.91 158.58 38.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.44 110.673 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -102.02 143.72 31.51 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.425 0.631 . . . . 2.76 109.606 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 230' ' ' SER . 10.3 t70 -97.92 173.12 7.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.455 -0.778 . . . . 2.23 109.131 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 57.3 m -86.99 -5.67 59.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.8 109.406 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 231' ' ' ARG . 20.7 mtm-85 -88.59 -19.69 25.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.224 -0.923 . . . . 3.63 109.614 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -162.54 129.86 2.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 2.16 108.813 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -65.89 5.61 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 120.779 0.986 . . . . 1.25 110.698 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.4 m -83.0 127.51 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 120.821 -1.174 . . . . 1.75 109.993 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -48.28 164.4 0.05 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.25 -0.906 . . . . 0.66 109.551 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 25.8 mtpt -118.97 167.32 11.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.842 -0.799 . . . . 1.43 108.842 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -48.04 174.78 0.02 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.024 -1.231 . . . . 0.39 110.024 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.17 159.47 53.73 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.69 1.594 . . . . 0.41 110.502 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 172.17 13.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.101 -0.704 . . . . 0.21 109.101 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.61 33.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.112 -0.992 . . . . 2.72 109.573 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.78 125.32 34.84 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.52 -0.737 . . . . 0.29 109.493 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.0 mt -116.53 -74.54 0.6 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.397 -0.815 . . . . 0.45 110.209 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.71 141.55 28.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.31 109.988 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -145.94 118.72 8.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.371 -0.831 . . . . 2.32 109.103 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.32 -104.77 0.23 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.723 -1.227 . . . . 0.27 110.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -68.85 -153.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -1.112 . . . . 1.39 109.812 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.23 50.32 2.73 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.633 -1.387 . . . . 0.29 109.633 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.05 151.91 36.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -1.106 . . . . 0.29 108.917 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.24 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.97 . . . . 0.31 109.546 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 51.3 t -87.05 138.24 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.236 -1.024 . . . . 0.29 108.236 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.92 177.79 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -0.922 . . . . 0.23 110.095 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -144.69 110.3 5.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.687 -0.857 . . . . 1.81 108.687 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.57 -81.61 0.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.577 -1.268 . . . . 1.18 107.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.8 -130.77 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.636 -1.616 . . . . 1.98 106.636 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.9 m -105.27 55.68 0.69 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.959 -1.126 . . . . 1.39 107.959 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.939 -0.763 . . . . 1.12 108.939 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.7 mt -92.65 139.26 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -0.872 . . . . 0.47 109.524 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.21 166.97 23.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 2.11 109.976 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.9 t -102.78 138.34 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.528 -0.916 . . . . 0.33 108.528 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.11 133.1 20.54 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.366 -0.834 . . . . 0.34 109.35 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.43 139.12 89.35 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 N-CA-C 109.798 -0.885 . . . . 0.42 109.798 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 262' ' ' ARG . 0.6 OUTLIER -58.9 -34.72 72.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.905 . . . . 3.12 109.424 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 263' ' ' ARG . 18.8 ttm-85 -69.36 -2.87 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 3.82 109.731 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.46 17.09 13.8 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.335 -0.853 . . . . 2.08 109.095 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.18 170.92 14.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 0.32 109.903 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -140.39 131.51 26.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.243 -0.91 . . . . 1.79 109.17 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.73 107.57 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.139 -0.976 . . . . 0.45 109.508 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.96 150.63 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.172 -1.047 . . . . 0.57 108.172 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 269' ' ' ARG . 6.0 tpt180 -90.9 145.19 24.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.427 -0.796 . . . . 3.63 109.127 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.914 -1.041 . . . . 2.05 109.54 179.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . 0.504 ' O ' ' CE2' ' B' ' 223' ' ' PHE . 53.0 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.439 0.638 . . . . 3.83 109.432 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 8.7 pt -83.24 35.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 122.116 0.96 . . . . 2.08 109.218 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -78.79 -107.37 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.789 -0.569 . . . . 2.16 109.556 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.3 m-20 -97.42 91.07 5.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.013 . . . . 1.48 109.539 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' B' ' 219' ' ' MET . 38.2 m-85 -136.04 135.51 39.47 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.432 -0.793 . . . . 0.73 109.508 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -110.48 156.88 20.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.292 -1.373 . . . . 3.26 107.292 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 91.7 t -141.07 141.84 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.995 -1.066 . . . . 0.23 110.661 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -109.41 152.52 25.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.353 -1.351 . . . . 0.58 107.353 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 17.4 p90 -155.84 158.65 38.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.633 -1.292 . . . . 0.44 110.602 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.5 mtp180 -102.04 143.77 31.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.405 0.621 . . . . 2.76 109.645 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' B' ' 230' ' ' SER . 10.2 t70 -97.84 173.03 7.29 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.413 -0.804 . . . . 2.23 109.188 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 56.5 m -86.85 -5.73 59.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 1.81 109.499 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.474 ' HG3' HH11 ' B' ' 231' ' ' ARG . 20.7 mtm-85 -88.47 -19.89 25.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.222 -0.924 . . . . 3.64 109.57 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.2 m-20 -162.46 129.84 2.63 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.173 -0.954 . . . . 2.16 108.906 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.93 5.69 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 120.8 1.0 . . . . 1.27 110.623 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.481 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.4 m -83.11 127.56 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.796 -1.19 . . . . 1.76 110.014 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -48.29 164.44 0.05 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.214 -0.929 . . . . 0.67 109.601 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' B' ' 237' ' ' GLY . 25.8 mtpt -119.0 167.23 11.95 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.863 -0.791 . . . . 1.44 108.863 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -48.06 174.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.997 -1.241 . . . . 0.4 109.997 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.24 159.49 53.59 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.697 1.598 . . . . 0.41 110.509 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.87 172.23 13.32 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.024 -0.732 . . . . 0.21 109.024 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -92.64 136.63 33.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.114 -0.991 . . . . 2.72 109.535 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 39.9 tp -88.89 125.44 34.94 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.516 -0.74 . . . . 0.3 109.409 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.4 mt -116.65 -74.62 0.6 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.4 -0.812 . . . . 0.45 110.103 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -89.66 141.55 28.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.237 -0.914 . . . . 0.33 110.014 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -146.0 118.72 8.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.368 -0.833 . . . . 2.33 109.147 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -104.79 0.23 Allowed Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.195 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -68.83 -153.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.297 -1.12 . . . . 1.4 109.816 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.24 50.27 2.73 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.666 -1.373 . . . . 0.29 109.666 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.08 151.86 36.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -1.12 . . . . 0.29 108.903 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.67 122.11 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.125 -0.985 . . . . 0.31 109.586 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 51.9 t -86.97 138.16 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.244 -1.021 . . . . 0.3 108.244 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 10.9 pt -140.89 177.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.196 -0.94 . . . . 0.24 110.099 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.63 110.3 5.31 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.65 -81.6 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.542 -1.281 . . . . 1.18 107.542 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -78.73 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.593 -1.632 . . . . 1.97 106.593 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.6 m -105.33 55.64 0.69 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 107.99 -1.115 . . . . 1.38 107.99 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -155.83 123.6 5.63 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 1.12 108.901 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 23.6 mt -92.57 139.15 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.297 -0.877 . . . . 0.48 109.574 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -140.22 166.87 23.51 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 2.13 110.023 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.76 138.4 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.569 -0.9 . . . . 0.34 108.569 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.5 t -135.19 133.08 20.43 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 0.34 109.312 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.38 139.16 89.51 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.769 -0.897 . . . . 0.42 109.769 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' B' ' 262' ' ' ARG . 0.7 OUTLIER -58.98 -34.83 72.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 3.11 109.351 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' B' ' 263' ' ' ARG . 18.9 ttm-85 -69.24 -2.81 11.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 3.82 109.793 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -118.53 17.16 13.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.318 -0.863 . . . . 2.08 109.116 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.3 170.86 14.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.495 -0.753 . . . . 0.32 109.943 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -140.36 131.49 26.4 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.356 -0.84 . . . . 1.79 109.188 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.76 107.5 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.114 -0.991 . . . . 0.45 109.51 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.8 150.62 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.267 -1.012 . . . . 0.57 108.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' B' ' 269' ' ' ARG . 6.0 tpt180 -90.98 145.21 24.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -0.785 . . . . 3.62 109.086 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 118.029 -0.986 . . . . 2.05 109.547 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.384 -0.599 . . . . 3.82 109.384 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.3 135.34 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.176 -0.953 . . . . 2.08 109.485 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -88.5 -139.81 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 2.17 108.925 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -93.25 110.87 22.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.136 -0.978 . . . . 1.48 108.706 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -133.89 145.21 49.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.499 -0.75 . . . . 0.72 109.479 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 224' ' ' ARG . 0.3 OUTLIER -119.71 154.03 34.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 107.851 -1.166 . . . . 3.26 107.851 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 99.6 t -138.87 146.45 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.079 -1.013 . . . . 0.23 111.012 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -113.17 155.78 24.39 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.261 -1.385 . . . . 0.58 107.261 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.8 p90 -157.43 150.86 23.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.578 -1.326 . . . . 0.44 110.465 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.44 ' HG3' HH11 ' A' ' 228' ' ' ARG . 8.1 mtm-85 -93.04 146.44 23.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.476 -0.765 . . . . 2.76 109.306 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.84 167.41 11.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -0.9 . . . . 2.23 108.917 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.7 t -83.18 -10.54 58.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 1.8 109.24 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -89.96 -11.08 42.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 3.63 109.622 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.415 ' OD2' ' CG2' ' A' ' 234' ' ' VAL . 18.8 t0 -160.41 127.36 2.58 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 2.16 108.768 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.63 6.83 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.721 0.948 . . . . 1.25 110.269 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 235' ' ' TRP . 40.4 t -83.69 161.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.928 -1.108 . . . . 1.75 109.85 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.495 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.5 m95 -74.17 161.62 29.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.416 -0.803 . . . . 0.66 109.076 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 237' ' ' GLY . 37.3 tttp -118.92 160.86 21.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.383 -0.823 . . . . 1.43 109.25 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.0 167.06 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.6 -1.0 . . . . 0.39 110.6 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.37 157.91 57.85 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 121.681 1.588 . . . . 0.41 110.568 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.36 170.0 16.74 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.969 -0.752 . . . . 0.21 108.969 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -93.6 138.73 31.55 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.067 -1.02 . . . . 2.72 109.745 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.98 120.46 30.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.133 -0.691 . . . . 0.29 109.133 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.0 mt -111.12 -72.5 0.72 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.401 -0.812 . . . . 0.45 110.282 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.26 143.94 25.91 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.165 -0.959 . . . . 0.31 110.15 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -148.58 122.14 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.297 -0.877 . . . . 2.32 109.278 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.57 -103.78 0.21 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.081 -1.208 . . . . 0.27 110.081 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.62 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.288 -1.124 . . . . 1.39 109.712 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 49.5 2.91 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.253 -1.539 . . . . 0.29 109.253 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.71 35.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -1.035 . . . . 0.29 108.704 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.03 124.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.991 . . . . 0.31 109.809 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.0 137.04 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.079 -1.082 . . . . 0.29 108.079 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.73 -179.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.861 . . . . 0.23 110.234 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.514 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -144.15 111.93 6.16 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.709 -0.848 . . . . 1.81 108.709 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.36 -78.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.491 -1.3 . . . . 1.18 107.491 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -80.64 -132.19 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.695 -1.594 . . . . 1.98 106.695 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 66.7 m -103.66 54.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.031 -1.1 . . . . 1.39 108.031 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.81 126.99 6.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 1.12 109.283 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.514 ' CG1' HE21 ' A' ' 252' ' ' GLN . 26.9 mt -92.71 137.0 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.47 109.286 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -137.49 171.86 13.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 2.11 109.743 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.92 137.47 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.372 -0.83 . . . . 0.33 109.359 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -136.94 125.22 14.8 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.401 -0.812 . . . . 0.34 108.974 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.46 143.75 93.54 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 120.527 0.818 . . . . 0.42 110.242 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.04 -32.54 72.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 3.12 109.387 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -68.71 -7.69 35.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.338 -0.851 . . . . 3.82 110.672 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -119.05 19.59 12.92 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.175 -0.953 . . . . 2.08 109.451 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.01 168.9 18.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.52 -0.737 . . . . 0.32 109.589 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.4 ' NZ ' ' CZ3' ' A' ' 235' ' ' TRP . 29.0 mtmm -137.62 127.27 25.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 1.79 109.049 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.4 mm -88.15 107.91 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.223 -0.923 . . . . 0.45 110.15 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.5 mm -105.7 151.51 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.398 -0.964 . . . . 0.57 108.398 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.18 149.35 21.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.303 -0.873 . . . . 3.63 109.053 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.927 -1.035 . . . . 2.05 109.446 179.832 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.435 -0.58 . . . . 3.83 109.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.27 135.4 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.145 -0.972 . . . . 2.08 109.453 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -88.58 -139.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.889 . . . . 2.16 108.834 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -93.2 110.91 22.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.176 -0.952 . . . . 1.48 108.696 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -134.03 145.14 49.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.522 -0.736 . . . . 0.73 109.449 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' B' ' 224' ' ' ARG . 0.3 OUTLIER -119.69 154.05 34.66 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 107.807 -1.183 . . . . 3.26 107.807 179.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.94 146.5 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.116 -0.99 . . . . 0.23 110.987 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -113.13 155.89 24.15 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.226 -1.398 . . . . 0.58 107.226 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.1 p90 -157.43 151.02 24.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.572 -1.33 . . . . 0.44 110.42 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.439 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.1 mtm-85 -93.14 146.54 23.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 2.76 109.291 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.89 167.38 11.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.247 -0.908 . . . . 2.23 108.931 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.8 t -83.16 -10.52 58.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 1.81 109.278 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -90.06 -10.96 42.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 3.64 109.592 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.413 ' OD2' ' CG2' ' B' ' 234' ' ' VAL . 18.7 t0 -160.44 127.31 2.56 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 2.16 108.782 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.49 6.72 0.85 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 120.814 1.009 . . . . 1.27 110.322 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.494 HG12 ' N ' ' B' ' 235' ' ' TRP . 40.3 t -83.74 161.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 1.76 109.893 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.494 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -74.06 161.55 29.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.401 -0.812 . . . . 0.67 109.063 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' B' ' 237' ' ' GLY . 37.3 tttp -118.91 160.86 21.18 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.41 -0.806 . . . . 1.44 109.285 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.86 166.98 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.578 -1.009 . . . . 0.4 110.578 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -66.33 157.91 57.77 Favored 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.767 1.644 . . . . 0.41 110.543 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.42 169.97 16.78 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.99 -0.745 . . . . 0.21 108.99 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.499 ' HB2' ' HZ2' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -93.55 138.79 31.47 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.107 -0.996 . . . . 2.72 109.699 -179.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 15.3 tp -88.97 120.52 30.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.598 -0.689 . . . . 0.3 109.172 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.1 mt -111.23 -72.56 0.71 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.317 -0.864 . . . . 0.45 110.246 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -92.28 143.81 26.03 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.163 -0.96 . . . . 0.33 110.152 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -148.42 122.16 9.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 2.33 109.314 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.6 -103.71 0.21 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.096 -1.202 . . . . 0.28 110.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.61 -153.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -1.136 . . . . 1.4 109.7 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.16 49.48 2.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.234 -1.546 . . . . 0.29 109.234 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.18 150.75 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -1.061 . . . . 0.29 108.781 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.98 124.49 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.182 -0.949 . . . . 0.31 109.725 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.06 137.0 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.06 -1.089 . . . . 0.3 108.06 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.3 pt -140.64 -179.77 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.221 -0.924 . . . . 0.24 110.252 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.525 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -144.18 111.86 6.12 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 1.81 108.705 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -90.21 -78.57 0.37 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.484 -1.302 . . . . 1.18 107.484 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.66 -132.09 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.641 -1.614 . . . . 1.97 106.641 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 66.3 m -103.77 54.3 0.74 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.936 -1.135 . . . . 1.38 107.936 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -156.85 126.9 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.529 -0.732 . . . . 1.12 109.245 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.525 ' CG1' HE21 ' B' ' 252' ' ' GLN . 27.2 mt -92.65 137.03 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.48 109.272 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -137.45 171.84 13.87 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.406 -0.809 . . . . 2.13 109.728 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.93 137.51 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.374 -0.829 . . . . 0.34 109.396 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 55.1 t -136.97 125.2 14.75 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.374 -0.829 . . . . 0.34 108.931 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -57.48 143.72 93.69 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.48 0.787 . . . . 0.42 110.298 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 3.11 109.46 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -68.77 -7.63 35.79 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.227 -0.921 . . . . 3.82 110.705 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -119.17 19.78 12.79 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.191 -0.943 . . . . 2.08 109.436 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -136.1 168.85 18.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.591 -0.693 . . . . 0.32 109.559 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -137.55 127.35 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.341 -0.85 . . . . 1.79 109.024 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.18 107.79 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.207 -0.933 . . . . 0.45 110.201 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.4 mm -105.59 151.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.482 -0.933 . . . . 0.57 108.482 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -91.13 149.36 21.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.374 -0.829 . . . . 3.62 109.147 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.046 -1.034 . . . . 2.05 109.49 179.872 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.58 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.487 -0.56 . . . . 3.82 109.487 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.2 pt -82.9 139.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.342 -0.849 . . . . 2.08 109.278 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -85.11 -126.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 2.17 109.793 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.69 116.54 28.88 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.161 -0.962 . . . . 1.48 109.421 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.41 ' CA ' ' OD1' ' A' ' 270' ' ' ASP . 39.6 m-85 -135.73 131.23 35.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.41 -0.806 . . . . 0.72 109.145 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.94 156.62 17.29 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.05 -1.093 . . . . 3.26 108.05 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.7 t -141.63 143.37 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.102 -0.999 . . . . 0.23 110.39 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 226' ' ' TYR . 22.6 m-85 -114.05 155.46 25.9 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.754 -1.202 . . . . 0.58 107.754 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.0 p90 -156.8 150.2 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.781 -1.199 . . . . 0.44 110.353 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -96.21 152.64 18.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 2.76 109.699 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.7 170.44 9.32 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.38 -0.97 . . . . 2.23 108.38 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.91 -12.44 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 1.8 109.225 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.68 -11.34 40.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.369 -0.832 . . . . 3.63 110.067 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.8 p30 -157.21 129.78 4.26 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.94 -1.1 . . . . 2.16 109.922 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.18 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 120.907 1.071 . . . . 1.25 110.659 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -82.53 142.66 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.779 -1.201 . . . . 1.75 109.74 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.93 -172.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.66 108.981 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.36 -161.14 1.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.215 -0.928 . . . . 1.43 108.623 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.31 166.96 54.48 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.429 -1.469 . . . . 0.39 109.429 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.92 159.35 53.62 Favored 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 121.408 1.405 . . . . 0.41 109.88 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.93 171.78 14.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.506 -0.746 . . . . 0.21 108.989 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.52 140.38 29.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.012 . . . . 2.72 109.212 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.4 tp -88.97 125.14 34.84 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.672 -0.642 . . . . 0.29 109.718 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.3 -75.09 0.6 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.365 -0.834 . . . . 0.45 110.46 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 30.1 t90 -91.7 146.29 23.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.128 -0.982 . . . . 0.31 110.856 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.66 124.87 14.55 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.814 -0.809 . . . . 2.32 108.814 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.34 -116.13 0.54 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.087 -1.205 . . . . 0.27 110.087 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.59 -149.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -1.07 . . . . 1.39 109.449 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 52.92 3.43 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.312 -1.515 . . . . 0.29 109.312 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.44 147.45 27.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.573 -0.957 . . . . 0.29 108.613 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.1 m -145.97 135.28 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.068 -1.02 . . . . 0.31 109.873 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.84 140.59 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.64 -0.874 . . . . 0.29 108.64 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.72 179.71 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.148 -0.97 . . . . 0.23 110.285 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.67 111.79 6.52 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.558 -0.905 . . . . 1.81 108.558 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.03 -77.65 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.41 -1.329 . . . . 1.18 107.41 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -81.77 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.72 -1.585 . . . . 1.98 106.72 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.93 54.49 0.71 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.41 130.43 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.492 -0.755 . . . . 1.12 109.328 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.448 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 97.9 mt -94.4 139.22 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.126 -0.984 . . . . 0.47 109.718 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.39 164.84 28.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 2.11 109.536 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.02 136.5 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.572 -0.899 . . . . 0.33 108.572 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.0 t -134.96 123.01 15.61 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 0.34 109.597 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -53.57 144.5 51.81 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.809 1.006 . . . . 0.42 110.839 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.54 -20.31 65.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.564 -0.71 . . . . 3.12 109.143 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -66.98 -17.89 65.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.486 -0.759 . . . . 3.82 111.64 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.89 28.67 5.55 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.979 -1.076 . . . . 2.08 109.702 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.11 159.52 40.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.841 -0.8 . . . . 0.32 108.841 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.436 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 6.3 mtmp? -139.31 130.29 26.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 1.79 109.635 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.83 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.45 109.593 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 269' ' ' ARG . 25.1 mm -105.26 160.39 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.661 -0.866 . . . . 0.57 108.661 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.27 26.47 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.31 -0.868 . . . . 3.63 109.705 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.41 ' OD1' ' CA ' ' A' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.058 -1.026 . . . . 2.05 108.977 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.422 -0.585 . . . . 3.83 109.422 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.2 pt -83.01 139.6 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 2.08 109.28 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -85.16 -126.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 2.16 109.782 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.69 116.58 28.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.177 -0.952 . . . . 1.48 109.449 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . 0.408 ' CA ' ' OD1' ' B' ' 270' ' ' ASP . 39.8 m-85 -135.71 131.16 35.27 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.112 -0.699 . . . . 0.73 109.112 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -100.91 156.61 17.28 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.139 -1.06 . . . . 3.26 108.139 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 61.6 t -141.58 143.43 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.144 -0.972 . . . . 0.23 110.326 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' B' ' 226' ' ' TYR . 22.0 m-85 -114.06 155.52 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.821 -1.178 . . . . 0.58 107.821 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.9 p90 -156.89 150.16 24.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.802 -1.186 . . . . 0.44 110.321 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 36.2 mtm180 -96.2 152.5 18.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.336 -0.853 . . . . 2.76 109.763 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -95.67 170.52 9.27 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.402 -0.962 . . . . 2.23 108.402 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 60.2 p -84.95 -12.44 53.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.981 -1.074 . . . . 1.81 109.198 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -90.72 -11.41 39.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.316 -0.865 . . . . 3.64 109.985 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.8 p30 -157.14 129.78 4.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 120.992 -1.067 . . . . 2.16 109.985 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -70.61 0.13 6.76 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 120.989 1.126 . . . . 1.27 110.627 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.57 142.69 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.762 -1.211 . . . . 1.76 109.688 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -60.93 -172.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.202 -0.936 . . . . 0.67 109.015 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -138.46 -161.22 1.15 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.214 -0.929 . . . . 1.44 108.604 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -73.25 166.96 54.46 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.433 -1.467 . . . . 0.4 109.433 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.94 159.35 53.6 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.402 1.401 . . . . 0.41 109.847 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.94 171.76 14.03 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.21 109.005 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -92.46 140.46 29.55 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.947 . . . . 2.72 109.184 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.3 tp -89.07 125.16 34.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.617 -0.677 . . . . 0.3 109.791 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.6 mt -114.32 -75.03 0.6 Allowed 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.302 -0.874 . . . . 0.45 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.448 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 29.8 t90 -91.78 146.3 23.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.223 -0.923 . . . . 0.33 110.887 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -143.62 124.86 14.57 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.89 -0.781 . . . . 2.33 108.89 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -116.15 0.54 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.029 -1.228 . . . . 0.28 110.029 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -67.45 -149.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.489 -1.007 . . . . 1.4 109.595 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.25 52.99 3.45 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.38 -1.488 . . . . 0.29 109.38 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -150.41 147.43 27.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.483 -1.01 . . . . 0.29 108.626 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.0 m -146.0 135.34 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.947 -1.095 . . . . 0.31 109.837 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.89 140.64 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.6 -0.889 . . . . 0.3 108.6 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.8 pt -142.82 179.65 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.17 -0.956 . . . . 0.24 110.211 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -142.57 111.8 6.56 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.577 -0.898 . . . . 1.81 108.577 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.04 -77.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.482 -1.303 . . . . 1.18 107.482 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -81.65 -130.91 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.788 -1.56 . . . . 1.97 106.788 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 14.4 t -104.99 54.5 0.71 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.062 -1.088 . . . . 1.38 108.062 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -157.39 130.37 7.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.485 -0.759 . . . . 1.12 109.347 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.421 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 97.9 mt -94.28 139.3 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.48 109.669 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -139.51 164.8 28.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.468 -0.77 . . . . 2.13 109.489 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.93 136.44 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.588 -0.893 . . . . 0.34 108.588 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 71.8 t -134.99 122.98 15.55 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.373 -0.83 . . . . 0.34 109.579 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -53.49 144.54 50.73 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.801 1.001 . . . . 0.42 110.927 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -66.59 -20.35 65.99 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.557 -0.714 . . . . 3.11 109.099 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.85 -18.07 65.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.499 -0.751 . . . . 3.82 111.631 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -127.82 28.65 5.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.005 -1.06 . . . . 2.08 109.68 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -134.04 159.6 40.3 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.803 -0.814 . . . . 0.32 108.803 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.435 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 6.3 mtmp? -139.3 130.3 26.42 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.169 -0.957 . . . . 1.79 109.675 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.4 mm -91.04 111.86 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.45 109.627 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.439 HG22 ' N ' ' B' ' 269' ' ' ARG . 25.2 mm -105.37 160.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.644 -0.872 . . . . 0.57 108.644 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 269' ' ' ARG . 2.0 mtt-85 -93.64 143.32 26.42 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 3.62 109.719 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.408 ' OD1' ' CA ' ' B' ' 223' ' ' PHE . 1.4 m-20 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.043 -1.035 . . . . 2.05 108.965 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 219' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.488 -0.56 . . . . 3.82 109.488 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.23 129.36 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.005 . . . . 2.08 108.731 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -97.02 -109.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.105 -0.997 . . . . 2.17 110.001 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.82 104.03 12.93 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.003 -0.74 . . . . 1.48 109.003 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.54 125.67 26.15 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.235 -0.916 . . . . 0.72 109.788 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.02 164.46 12.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.756 -1.202 . . . . 3.26 107.756 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.9 t -143.02 141.65 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 0.23 109.972 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -108.83 151.98 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.523 -1.288 . . . . 0.58 107.523 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 8.2 p90 -153.73 152.23 30.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.77 -1.206 . . . . 0.44 110.332 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -94.13 153.14 18.26 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.76 110.245 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -92.3 171.09 9.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.487 -0.931 . . . . 2.23 108.487 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 44.2 t -87.77 -10.95 49.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.02 -1.05 . . . . 1.8 109.548 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -90.01 -14.51 33.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.129 -0.982 . . . . 3.63 109.611 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 234' ' ' VAL . 47.3 m-20 -161.3 130.57 3.19 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 2.16 109.29 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -65.93 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.804 1.003 . . . . 1.25 110.553 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 232' ' ' ASP . 21.7 m -83.48 140.37 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.846 -1.159 . . . . 1.75 109.736 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -60.68 167.21 2.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.66 109.516 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 237' ' ' GLY . 29.8 tttm -125.78 162.78 24.33 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.488 -0.757 . . . . 1.43 109.267 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.07 166.55 0.03 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.503 -1.039 . . . . 0.39 110.503 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -69.6 159.48 53.36 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.782 1.655 . . . . 0.41 110.458 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.22 5.39 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.341 -0.849 . . . . 0.21 109.164 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -97.95 138.95 34.52 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.029 -1.045 . . . . 2.72 109.835 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.7 tp -88.77 123.7 33.44 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.438 -0.788 . . . . 0.29 109.494 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.2 mt -115.67 -74.51 0.61 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.474 -0.766 . . . . 0.45 110.286 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.36 143.62 26.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.139 -0.975 . . . . 0.31 110.191 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -147.53 118.53 7.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.299 -0.875 . . . . 2.32 108.977 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.91 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 119.717 -1.23 . . . . 0.27 110.471 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -68.65 -153.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.269 -1.136 . . . . 1.39 109.917 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 48.46 2.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.139 -1.585 . . . . 0.29 109.139 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.83 155.15 40.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -1.099 . . . . 0.29 109.189 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.37 126.33 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.31 109.307 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.54 137.85 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.004 -1.11 . . . . 0.29 108.004 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 24.5 pt -141.97 179.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.216 -0.928 . . . . 0.23 110.344 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.492 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -142.17 114.04 8.03 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.654 -0.869 . . . . 1.81 108.654 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -91.19 -80.42 0.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.28 -1.378 . . . . 1.18 107.28 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 255' ' ' SER . 33.2 t30 -80.71 -130.05 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.572 -1.64 . . . . 1.98 106.572 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.587 ' H ' ' ND2' ' A' ' 254' ' ' ASN . 75.4 m -104.13 53.74 0.74 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.161 -0.962 . . . . 1.39 108.493 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.09 127.7 7.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.542 -0.723 . . . . 1.12 109.293 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.492 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.7 mt -92.66 136.38 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 0.47 109.493 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.1 172.15 13.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.234 -0.916 . . . . 2.11 109.873 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.91 137.29 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.479 -0.763 . . . . 0.33 109.935 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.6 t -135.05 130.21 19.32 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.423 -0.798 . . . . 0.34 108.95 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.48 142.25 97.84 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 N-CA-C 109.706 -0.921 . . . . 0.42 109.706 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -63.63 -30.11 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.149 -0.97 . . . . 3.12 109.15 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -66.91 -10.77 52.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.38 -0.825 . . . . 3.82 109.873 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -119.48 25.44 10.06 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.382 -0.824 . . . . 2.08 108.883 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.494 -0.754 . . . . 0.32 109.833 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.444 ' HZ2' HD11 ' A' ' 268' ' ' ILE . 6.7 mtmp? -139.13 130.75 27.32 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.329 -0.857 . . . . 1.79 108.812 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.91 109.07 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.125 -0.984 . . . . 0.45 110.475 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.444 HD11 ' HZ2' ' A' ' 266' ' ' LYS . 23.5 mm -108.74 147.8 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 108.131 -1.062 . . . . 0.57 108.131 178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.77 18.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.351 -0.843 . . . . 3.63 109.921 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.055 -0.974 . . . . 2.05 109.623 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' B' ' 219' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.499 -0.556 . . . . 3.83 109.499 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.14 129.37 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.192 -0.943 . . . . 2.08 108.694 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -97.12 -109.54 0.16 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.045 -1.034 . . . . 2.16 109.877 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.81 103.92 12.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.783 . . . . 1.48 109.06 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.51 125.59 26.06 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.239 -0.913 . . . . 0.73 109.743 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.92 164.53 12.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.793 -1.188 . . . . 3.26 107.793 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.2 t -143.1 141.63 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.23 110.01 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -108.87 152.0 25.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.558 -1.275 . . . . 0.58 107.558 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.2 p90 -153.7 152.2 30.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.646 -1.284 . . . . 0.44 110.336 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -94.1 153.13 18.29 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.541 -0.724 . . . . 2.76 110.246 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.5 OUTLIER -92.35 171.06 9.3 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.438 -0.949 . . . . 2.23 108.438 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 44.3 t -87.65 -11.08 49.51 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.934 -1.104 . . . . 1.81 109.562 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -89.96 -14.46 34.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.18 -0.95 . . . . 3.64 109.67 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' B' ' 234' ' ' VAL . 47.1 m-20 -161.31 130.67 3.21 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.108 -0.995 . . . . 2.16 109.224 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.01 16.05 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 120.828 1.018 . . . . 1.27 110.459 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 232' ' ' ASP . 21.6 m -83.5 140.36 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.876 -1.14 . . . . 1.76 109.762 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -60.69 167.25 2.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.212 -0.93 . . . . 0.67 109.609 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' B' ' 237' ' ' GLY . 29.8 tttm -125.76 162.77 24.34 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.483 -0.76 . . . . 1.44 109.246 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.14 166.61 0.03 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.477 -1.049 . . . . 0.4 110.477 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.66 159.54 53.11 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.691 1.594 . . . . 0.41 110.491 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.41 -178.16 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.35 -0.844 . . . . 0.21 109.158 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -98.02 139.06 34.41 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.027 -1.046 . . . . 2.72 109.923 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.6 tp -88.93 123.64 33.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.401 -0.812 . . . . 0.3 109.504 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -115.66 -74.44 0.61 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.413 -0.805 . . . . 0.45 110.298 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -93.34 143.61 26.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.174 -0.954 . . . . 0.33 110.217 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -147.62 118.57 7.65 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.258 -0.901 . . . . 2.33 108.816 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.95 -101.59 0.19 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.679 -1.248 . . . . 0.28 110.518 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.65 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.208 -1.172 . . . . 1.4 109.94 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.68 48.4 2.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.186 -1.565 . . . . 0.29 109.186 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.18 40.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.29 109.166 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 249' ' ' VAL . 26.6 m -146.32 126.33 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.31 109.296 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.59 137.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.938 -1.134 . . . . 0.3 107.938 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 24.4 pt -141.8 179.35 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.24 110.362 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.497 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -142.35 114.08 7.98 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.637 -0.875 . . . . 1.81 108.637 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -91.2 -80.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.188 -1.412 . . . . 1.18 107.188 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.599 ' ND2' ' H ' ' B' ' 255' ' ' SER . 33.1 t30 -80.72 -130.06 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.612 -1.625 . . . . 1.97 106.612 177.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.599 ' H ' ' ND2' ' B' ' 254' ' ' ASN . 75.5 m -104.16 53.77 0.74 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.135 -0.978 . . . . 1.38 108.535 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -155.07 127.72 8.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.506 -0.746 . . . . 1.12 109.329 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.497 ' CG1' HE21 ' B' ' 252' ' ' GLN . 60.8 mt -92.6 136.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.342 -0.849 . . . . 0.48 109.438 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -139.16 172.05 13.4 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.246 -0.909 . . . . 2.13 109.836 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.77 137.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 0.34 109.948 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.3 t -135.11 130.2 19.26 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.884 -0.784 . . . . 0.34 108.884 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.44 142.32 97.8 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 N-CA-C 109.739 -0.908 . . . . 0.42 109.739 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -63.71 -30.16 71.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 3.11 109.144 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -66.96 -10.63 51.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.447 -0.783 . . . . 3.82 109.895 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -119.53 25.46 10.03 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.347 -0.846 . . . . 2.08 108.825 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.85 161.11 39.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.577 -0.702 . . . . 0.32 109.905 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.442 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.7 mtmp? -139.17 130.76 27.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.327 -0.858 . . . . 1.79 108.784 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 35.0 mm -87.96 109.14 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.211 -0.93 . . . . 0.45 110.416 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.442 HD11 ' HZ1' ' B' ' 266' ' ' LYS . 23.6 mm -108.83 147.77 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 108.184 -1.043 . . . . 0.57 108.184 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.24 154.86 18.37 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.388 -0.82 . . . . 3.62 109.938 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 1.5 m-20 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 117.977 -1.011 . . . . 2.05 109.529 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.507 -0.553 . . . . 3.82 109.507 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 pt -82.9 140.28 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.191 -0.943 . . . . 2.08 109.465 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -89.06 -133.92 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 2.17 109.794 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.423 ' O ' ' OXT' ' A' ' 270' ' ' ASP . 19.3 m-20 -92.5 98.24 11.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.285 -0.885 . . . . 1.48 108.786 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -117.51 135.13 54.15 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.193 -0.669 . . . . 0.72 109.193 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -104.82 159.19 15.99 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.901 -1.148 . . . . 3.26 107.901 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 82.2 t -140.98 140.95 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.213 -0.929 . . . . 0.23 110.219 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.83 153.47 24.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.487 -1.301 . . . . 0.58 107.487 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 11.3 p90 -156.38 151.45 26.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.706 -1.246 . . . . 0.44 110.123 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -95.76 143.26 27.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.371 -0.831 . . . . 2.76 109.838 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.7 168.34 10.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.818 . . . . 2.23 108.989 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.86 8.82 7.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.984 . . . . 1.8 109.297 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.63 -39.22 15.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 3.63 109.523 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 234' ' ' VAL . 36.3 p-10 -158.22 148.32 15.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.014 . . . . 2.16 109.306 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.88 10.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 121.172 1.248 . . . . 1.25 110.958 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.3 t -83.51 152.09 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.75 -1.219 . . . . 1.75 109.773 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.84 165.04 24.93 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.964 -0.754 . . . . 0.66 108.964 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.9 tttp -119.38 159.4 24.25 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.478 -0.764 . . . . 1.43 109.212 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.81 165.99 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.361 -1.095 . . . . 0.39 110.361 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.92 161.61 41.6 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.525 1.483 . . . . 0.41 110.405 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.23 173.4 11.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.862 -0.792 . . . . 0.21 108.862 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.06 137.01 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.095 -1.003 . . . . 2.72 109.608 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -87.38 123.07 31.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.635 -0.665 . . . . 0.29 109.366 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -115.76 -73.51 0.65 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.434 -0.791 . . . . 0.45 110.091 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 5.2 t90 -93.55 146.59 23.69 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.281 -0.887 . . . . 0.31 109.974 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -146.86 125.38 12.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 2.32 109.065 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -110.02 0.34 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 119.824 -1.179 . . . . 0.27 110.367 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.87 -150.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.33 -1.1 . . . . 1.39 109.858 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.86 2.78 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.357 -1.497 . . . . 0.29 109.357 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.1 150.7 34.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.509 -0.995 . . . . 0.29 108.668 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.56 129.27 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.31 109.759 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.5 t -89.79 137.41 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.027 -1.101 . . . . 0.29 108.027 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.4 pt -141.22 177.04 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.301 -0.875 . . . . 0.23 109.929 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -144.09 110.75 5.61 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.472 -0.936 . . . . 1.81 108.472 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -90.01 -79.12 0.35 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.53 -1.285 . . . . 1.18 107.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.22 -130.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.48 -1.674 . . . . 1.98 106.48 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.9 t -105.26 54.93 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.992 -1.114 . . . . 1.39 107.992 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.56 125.48 5.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.166 -0.679 . . . . 1.12 109.166 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 19.0 mt -92.36 138.01 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.887 . . . . 0.47 109.491 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -140.01 167.08 22.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.393 -0.817 . . . . 2.11 109.684 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.82 139.0 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.746 . . . . 0.33 109.221 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -136.11 134.15 20.07 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.34 108.916 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.65 142.86 98.83 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 N-CA-C 109.85 -0.865 . . . . 0.42 109.85 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.417 ' HG2' ' NH1' ' A' ' 262' ' ' ARG . 6.4 tpt180 -60.69 -34.39 74.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.271 -0.893 . . . . 3.12 109.555 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -68.87 -7.1 31.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.241 -0.912 . . . . 3.82 110.846 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -119.0 19.0 13.1 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.073 -1.017 . . . . 2.08 108.839 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.36 168.71 19.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.897 -0.779 . . . . 0.32 108.897 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.43 129.72 23.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.977 . . . . 1.79 109.541 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.83 106.03 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.326 -0.859 . . . . 0.45 109.721 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.6 152.08 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.231 -0.918 . . . . 0.57 108.815 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.416 ' O ' ' OD1' ' A' ' 270' ' ' ASP . 58.7 ttt180 -91.03 146.19 24.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.437 -0.789 . . . . 3.63 109.642 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.423 ' OXT' ' O ' ' A' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.935 -1.031 . . . . 2.05 109.429 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.523 -0.547 . . . . 3.83 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 pt -82.71 140.21 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.262 -0.899 . . . . 2.08 109.48 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -89.05 -133.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 2.16 109.831 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.422 ' O ' ' OXT' ' B' ' 270' ' ' ASP . 19.3 m-20 -92.59 98.19 11.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 1.48 108.774 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.35 135.24 54.0 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.573 -0.704 . . . . 0.73 109.189 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -104.97 159.11 16.07 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.897 -1.149 . . . . 3.26 107.897 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 81.1 t -140.96 140.99 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.185 -0.947 . . . . 0.23 110.22 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -109.79 153.45 24.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.509 -1.293 . . . . 0.58 107.509 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.5 p90 -156.36 151.39 26.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.68 -1.263 . . . . 0.44 110.114 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -95.78 143.26 27.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.485 -0.759 . . . . 2.76 109.857 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -95.72 168.32 10.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.759 . . . . 2.23 109.059 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 23.7 t -80.83 8.79 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 1.81 109.301 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.56 -39.21 15.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 3.64 109.497 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' B' ' 234' ' ' VAL . 36.3 p-10 -158.34 148.27 15.34 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.147 -0.97 . . . . 2.16 109.294 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.85 10.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.222 1.281 . . . . 1.27 110.854 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.3 t -83.43 152.07 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.788 -1.195 . . . . 1.76 109.732 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.85 164.99 25.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.474 -0.766 . . . . 0.67 109.015 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.8 tttp -119.31 159.4 24.2 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.444 -0.785 . . . . 1.44 109.241 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.9 165.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.305 -1.118 . . . . 0.4 110.305 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -66.86 161.61 41.44 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.602 1.535 . . . . 0.41 110.41 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.31 173.48 11.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.811 -0.811 . . . . 0.21 108.811 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -95.07 137.06 34.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.124 -0.985 . . . . 2.72 109.559 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.56 123.09 32.08 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.58 -0.7 . . . . 0.3 109.345 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.5 mt -115.75 -73.5 0.65 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.414 -0.804 . . . . 0.45 109.996 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -93.45 146.61 23.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.243 -0.91 . . . . 0.33 109.979 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -146.9 125.46 12.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.295 -0.878 . . . . 2.33 108.981 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -110.02 0.34 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.755 -1.212 . . . . 0.28 110.288 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -69.85 -150.11 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -1.062 . . . . 1.4 109.863 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 48.94 2.8 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.298 -1.521 . . . . 0.29 109.298 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.19 150.64 34.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.461 -1.023 . . . . 0.29 108.684 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.9 m -145.54 129.29 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.31 109.699 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.73 137.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.096 -1.076 . . . . 0.3 108.096 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.6 pt -141.29 176.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.317 -0.864 . . . . 0.24 109.907 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -144.09 110.7 5.59 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.489 -0.93 . . . . 1.81 108.489 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.99 -79.17 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.536 -1.283 . . . . 1.18 107.536 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.12 -130.88 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.539 -1.652 . . . . 1.97 106.539 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.0 t -105.28 54.86 0.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.985 -1.117 . . . . 1.38 107.985 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.53 125.53 6.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.579 -0.701 . . . . 1.12 109.156 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.45 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 19.2 mt -92.41 137.93 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.375 -0.828 . . . . 0.48 109.519 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -139.9 167.22 22.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.432 -0.792 . . . . 2.13 109.704 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 53.8 t -103.95 138.9 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.412 -0.805 . . . . 0.34 109.203 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.03 134.13 20.16 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.34 108.966 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -58.57 142.83 98.58 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 120.597 0.865 . . . . 0.42 109.855 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.408 ' NH1' ' HG2' ' B' ' 262' ' ' ARG . 6.5 tpt180 -60.7 -34.32 74.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.89 . . . . 3.11 109.569 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -68.89 -7.19 32.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.27 -0.894 . . . . 3.82 110.787 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -118.97 19.02 13.12 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.227 -0.921 . . . . 2.08 108.79 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 168.74 19.12 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.849 -0.797 . . . . 0.32 108.849 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -140.44 129.76 23.83 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.139 -0.976 . . . . 1.79 109.568 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.5 mm -88.81 105.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.26 -0.9 . . . . 0.45 109.728 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.67 152.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.307 -0.871 . . . . 0.57 108.737 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' B' ' 270' ' ' ASP . 58.7 ttt180 -90.95 146.13 24.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.361 -0.837 . . . . 3.62 109.69 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.422 ' OXT' ' O ' ' B' ' 222' ' ' ASN . 2.8 m-20 . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 117.933 -1.032 . . . . 2.05 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.46 -0.57 . . . . 3.82 109.46 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.41 138.54 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.898 -1.149 . . . . 2.08 107.898 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -82.41 -141.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 2.17 109.805 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -93.99 110.63 22.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 1.48 109.657 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.7 130.39 38.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.785 -0.82 . . . . 0.72 108.785 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -99.27 150.71 21.82 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.459 -1.311 . . . . 3.26 107.459 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 97.2 t -139.06 136.47 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.205 -0.935 . . . . 0.23 110.559 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -107.97 156.96 18.64 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.737 -1.209 . . . . 0.58 107.737 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.2 p90 -157.84 152.67 25.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.569 -1.332 . . . . 0.44 110.334 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' A' ' 228' ' ' ARG . 2.7 mtm-85 -93.37 144.36 25.41 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.44 -0.788 . . . . 2.76 109.837 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.75 175.4 6.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.405 -0.809 . . . . 2.23 109.328 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.68 -10.75 44.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.188 -0.945 . . . . 1.8 109.247 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -89.67 -15.23 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.329 -0.857 . . . . 3.63 109.617 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 234' ' ' VAL . 32.2 m-20 -159.55 129.28 3.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.143 -0.973 . . . . 2.16 109.204 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -65.06 8.57 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 120.8 1.0 . . . . 1.25 111.273 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 235' ' ' TRP . 14.0 p -85.66 164.15 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.552 -1.342 . . . . 1.75 110.291 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.562 ' N ' HG22 ' A' ' 234' ' ' VAL . 94.9 m95 -76.03 163.49 27.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.746 -0.596 . . . . 0.66 109.532 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 237' ' ' GLY . 2.5 mtpp -118.44 165.16 14.24 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 108.658 -0.867 . . . . 1.43 108.658 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.06 164.62 0.02 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.998 -1.241 . . . . 0.39 109.998 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -64.89 159.97 43.36 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.471 1.447 . . . . 0.41 110.659 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.56 164.22 30.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.508 -0.923 . . . . 0.21 108.508 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.67 143.52 26.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.023 -1.048 . . . . 2.72 109.422 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.9 tp -89.86 128.36 36.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.45 -0.781 . . . . 0.29 110.563 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 33.6 mt -119.16 -70.61 0.78 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.515 -0.74 . . . . 0.45 110.137 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -91.96 137.85 32.02 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.31 110.634 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -144.07 115.72 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.985 -0.746 . . . . 2.32 108.985 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.71 -104.08 0.22 Allowed Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.839 -1.172 . . . . 0.27 110.293 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -64.97 -157.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 1.39 109.602 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 47.67 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.037 -1.625 . . . . 0.29 109.037 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.34 151.98 38.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.519 -0.989 . . . . 0.29 108.769 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.78 134.22 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.244 -0.91 . . . . 0.31 109.435 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -95.5 138.11 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.137 -1.06 . . . . 0.29 108.137 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.0 176.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.23 109.818 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.68 109.28 5.65 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.455 -0.943 . . . . 1.81 108.455 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.7 -77.25 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.37 -1.344 . . . . 1.18 107.37 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.23 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.937 -1.505 . . . . 1.98 106.937 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.6 m -97.97 56.06 1.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.681 -1.229 . . . . 1.39 107.681 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.56 130.37 7.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.575 -0.703 . . . . 1.12 109.46 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.91 135.5 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.47 109.329 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -136.52 168.99 18.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.581 -0.699 . . . . 2.11 109.683 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.99 140.08 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.344 -0.848 . . . . 0.33 109.568 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.78 126.1 13.23 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.396 -0.815 . . . . 0.34 109.188 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.95 140.56 86.03 Favored 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.642 0.895 . . . . 0.42 110.237 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -58.97 -37.33 76.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 3.12 109.533 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -69.8 -1.64 9.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.468 -0.77 . . . . 3.82 110.242 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HG3' HH12 ' A' ' 228' ' ' ARG . 2.5 mptm? -118.32 17.04 13.93 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.681 -0.859 . . . . 2.08 108.681 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.85 175.14 9.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.421 -0.8 . . . . 0.32 109.724 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.8 128.46 21.54 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.316 -0.865 . . . . 1.79 109.127 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.7 mm -88.74 109.72 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.43 -0.794 . . . . 0.45 109.86 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.42 153.61 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.692 -0.855 . . . . 0.57 108.692 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.5 mtt-85 -94.78 136.98 34.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.272 -0.892 . . . . 3.63 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.078 -1.014 . . . . 2.05 109.626 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.564 -0.532 . . . . 3.83 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.38 138.54 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.799 -1.186 . . . . 2.08 107.799 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -82.26 -141.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.044 -1.035 . . . . 2.16 109.875 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -93.85 110.51 22.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.406 -0.809 . . . . 1.48 109.799 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -133.6 130.5 38.44 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.756 -0.831 . . . . 0.73 108.756 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 224' ' ' ARG . 20.2 mtm-85 -99.46 150.68 21.94 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.48 -1.304 . . . . 3.26 107.48 178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.2 t -139.05 136.64 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.254 -0.904 . . . . 0.23 110.476 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -108.09 157.09 18.57 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.649 -1.241 . . . . 0.58 107.649 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.9 152.66 25.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.656 -1.278 . . . . 0.44 110.288 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.427 HH12 ' HG3' ' B' ' 264' ' ' LYS . 2.7 mtm-85 -93.38 144.39 25.38 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.374 -0.828 . . . . 2.76 109.853 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -91.79 175.21 6.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.382 -0.824 . . . . 2.23 109.316 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.6 m -89.39 -10.98 44.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.262 -0.899 . . . . 1.81 109.259 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -89.65 -15.2 33.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.391 -0.818 . . . . 3.64 109.702 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' B' ' 234' ' ' VAL . 32.2 m-20 -159.59 129.28 3.31 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.162 -0.961 . . . . 2.16 109.249 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -65.03 8.35 0.22 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 120.882 1.055 . . . . 1.27 111.21 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 14.0 p -85.4 164.44 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.557 -1.34 . . . . 1.76 110.19 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 94.9 m95 -76.25 163.51 26.97 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.436 -0.579 . . . . 0.67 109.436 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' B' ' 237' ' ' GLY . 2.5 mtpp -118.53 165.15 14.27 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.644 -0.873 . . . . 1.44 108.644 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.15 164.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.184 -1.167 . . . . 0.4 110.184 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -64.9 160.0 43.3 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.488 1.459 . . . . 0.41 110.643 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.63 164.09 31.12 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.586 -0.894 . . . . 0.21 108.586 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -92.71 143.63 26.11 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.007 -1.058 . . . . 2.72 109.393 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.5 tp -90.04 128.45 36.29 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.594 -0.691 . . . . 0.3 110.4 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 32.8 mt -119.25 -70.55 0.78 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.573 -0.704 . . . . 0.45 110.102 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -92.01 137.86 32.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.152 -0.968 . . . . 0.33 110.7 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -144.05 115.83 8.24 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.8 . . . . 2.33 108.929 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.52 -104.15 0.22 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.161 -1.176 . . . . 0.28 110.161 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -64.98 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.301 -1.117 . . . . 1.4 109.615 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.63 47.49 2.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.1 -1.6 . . . . 0.29 109.1 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.22 151.95 38.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.997 . . . . 0.29 108.865 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 5.5 m -144.79 134.28 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.31 109.502 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 89.9 t -95.48 138.04 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.155 -1.054 . . . . 0.3 108.155 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' B' ' 251' ' ' ILE . 12.8 pt -139.85 176.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.304 -0.872 . . . . 0.24 109.945 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.61 109.29 5.68 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.54 -0.911 . . . . 1.81 108.54 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.76 -77.35 0.37 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.304 -1.369 . . . . 1.18 107.304 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.19 -138.27 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.925 -1.509 . . . . 1.97 106.925 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.4 m -97.96 55.98 1.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.68 -1.23 . . . . 1.38 107.68 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -157.48 130.44 7.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.61 -0.681 . . . . 1.12 109.394 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 55.5 mt -95.8 135.61 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.48 109.307 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -136.71 169.03 18.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 2.13 109.574 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.93 140.02 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.478 -0.764 . . . . 0.34 109.611 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 53.3 t -138.69 126.05 13.31 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.34 109.221 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.81 140.48 85.09 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 120.616 0.877 . . . . 0.42 110.225 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -58.87 -37.33 76.29 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 3.11 109.449 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -69.96 -1.4 9.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.402 -0.811 . . . . 3.82 110.245 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.427 ' HG3' HH12 ' B' ' 228' ' ' ARG . 2.5 mptm? -118.41 16.87 13.86 Favored 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.717 -0.846 . . . . 2.08 108.717 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.82 175.29 9.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.413 -0.804 . . . . 0.32 109.742 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -140.9 128.47 21.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.438 -0.789 . . . . 1.79 109.122 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -88.78 109.57 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.501 -0.749 . . . . 0.45 109.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.7 mm -105.22 153.59 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 108.742 -0.836 . . . . 0.57 108.742 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.6 mtt-85 -94.57 137.05 34.16 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.228 -0.92 . . . . 3.62 109.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.045 -1.034 . . . . 2.05 109.677 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 4.9 ptp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.373 -0.602 . . . . 3.82 109.373 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.6 HD11 ' CD2' ' A' ' 223' ' ' PHE . 6.6 tp -82.96 140.55 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 2.08 109.25 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.8 -140.9 0.09 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.167 -0.958 . . . . 2.17 109.686 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -92.75 104.62 16.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.268 -0.895 . . . . 1.48 109.273 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.6 ' CD2' HD11 ' A' ' 220' ' ' ILE . 41.0 m-85 -133.34 133.89 43.08 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.961 -0.755 . . . . 0.72 108.961 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.73 158.69 17.39 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.192 -1.04 . . . . 3.26 108.192 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.98 140.04 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.23 110.08 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.42 155.43 20.03 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.72 -1.215 . . . . 0.58 107.72 178.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 9.5 p90 -156.18 153.79 29.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.44 110.345 -179.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.93 141.16 29.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.485 -0.76 . . . . 2.76 109.645 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 9.7 p30 -92.32 162.67 14.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.306 -0.871 . . . . 2.23 109.002 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.3 -2.71 36.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 1.8 109.842 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -89.91 -20.73 23.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.181 -0.949 . . . . 3.63 109.541 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 234' ' ' VAL . 14.5 m-20 -162.1 130.96 3.03 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.978 . . . . 2.16 108.969 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -63.57 8.44 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.751 0.968 . . . . 1.25 110.422 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.1 m -82.77 139.38 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.037 -1.04 . . . . 1.75 109.477 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -57.01 162.73 2.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.026 -1.046 . . . . 0.66 109.588 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 237' ' ' GLY . 39.3 tttp -119.18 165.0 14.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.483 -0.761 . . . . 1.43 109.091 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.45 166.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.111 -1.196 . . . . 0.39 110.111 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.51 162.18 43.06 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.641 1.561 . . . . 0.41 110.405 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.53 178.47 7.19 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.966 -0.753 . . . . 0.21 108.966 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.94 140.93 29.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.134 -0.979 . . . . 2.72 109.302 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.03 123.74 33.63 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.604 -0.685 . . . . 0.29 109.736 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 28.0 mt -113.45 -74.69 0.62 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.436 -0.79 . . . . 0.45 109.89 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.44 30.66 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.154 -0.966 . . . . 0.31 109.783 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.26 116.93 8.13 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.667 -0.864 . . . . 2.32 108.667 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.81 -100.84 0.18 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.8 -1.191 . . . . 0.27 110.261 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.51 -157.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -1.096 . . . . 1.39 109.842 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.09 49.51 2.92 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.163 -1.575 . . . . 0.29 109.163 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.67 154.51 39.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.494 -1.003 . . . . 0.29 108.499 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.11 131.95 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.085 -1.009 . . . . 0.31 109.862 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.6 t -93.84 135.0 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.29 107.828 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -138.53 177.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.328 -0.858 . . . . 0.23 110.289 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.632 HE21 ' CG1' ' A' ' 257' ' ' ILE . 30.2 tt0 -145.07 111.5 5.7 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.581 -0.896 . . . . 1.81 108.581 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.83 -78.32 0.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.2 -1.408 . . . . 1.18 107.2 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -81.88 -133.7 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.708 -1.59 . . . . 1.98 106.708 177.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 t -101.7 55.82 0.82 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.038 -1.097 . . . . 1.39 108.038 177.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -155.35 124.52 6.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.615 -0.678 . . . . 1.12 109.183 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.632 ' CG1' HE21 ' A' ' 252' ' ' GLN . 70.8 mt -93.52 134.87 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.194 -0.941 . . . . 0.47 109.202 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -137.42 167.81 20.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.366 -0.834 . . . . 2.11 110.039 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 70.7 t -102.25 139.86 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.55 -0.719 . . . . 0.33 109.256 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.7 t -136.73 127.97 16.64 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.878 -0.786 . . . . 0.34 108.878 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.8 138.61 86.7 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 N-CA-C 109.913 -0.841 . . . . 0.42 109.913 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.27 -32.27 66.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 3.12 109.428 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.485 HH11 ' HG3' ' A' ' 263' ' ' ARG . 5.1 ttm-85 -67.29 -8.77 34.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.433 -0.792 . . . . 3.82 110.204 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -120.25 18.31 12.26 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.384 -0.823 . . . . 2.08 109.187 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.26 168.6 19.4 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.65 -0.656 . . . . 0.32 109.4 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -141.6 130.99 23.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.79 109.169 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.97 114.77 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.225 -0.922 . . . . 0.45 109.946 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.66 154.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.69 -0.856 . . . . 0.57 108.69 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' A' ' 269' ' ' ARG . 2.4 mtt-85 -89.6 140.43 29.56 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.243 -0.911 . . . . 3.63 109.218 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 2.05 109.414 179.915 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 4.8 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.394 -0.595 . . . . 3.83 109.394 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' B' ' 223' ' ' PHE . 6.6 tp -82.99 140.52 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 2.08 109.252 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -85.76 -140.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 2.16 109.707 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -92.64 104.67 16.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.215 -0.928 . . . . 1.48 109.294 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . 0.596 ' CD2' HD11 ' B' ' 220' ' ' ILE . 41.0 m-85 -133.41 133.92 43.0 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.937 -0.764 . . . . 0.73 108.937 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -108.67 158.66 17.4 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.272 -1.01 . . . . 3.26 108.272 178.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 97.9 t -140.89 140.0 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.158 -0.964 . . . . 0.23 110.145 -179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -107.28 155.42 19.97 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.69 -1.226 . . . . 0.58 107.69 178.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.5 p90 -156.15 153.73 29.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.7 -1.25 . . . . 0.44 110.376 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -95.92 141.27 29.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.576 -0.703 . . . . 2.76 109.578 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 9.8 p30 -92.34 162.65 14.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.284 -0.885 . . . . 2.23 109.041 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 14.7 t -77.26 -2.76 36.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 1.81 109.812 -179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -89.82 -20.98 22.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.124 -0.985 . . . . 3.64 109.548 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' B' ' 234' ' ' VAL . 14.6 m-20 -161.82 130.98 3.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 2.16 108.98 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.51 8.37 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.712 0.941 . . . . 1.27 110.454 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.2 m -82.73 139.48 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 1.76 109.409 -179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -57.12 162.68 2.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.67 109.53 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -119.19 164.99 14.77 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.38 -0.825 . . . . 1.44 109.089 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -45.54 166.59 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.064 -1.215 . . . . 0.4 110.064 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.44 162.15 43.23 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.721 1.614 . . . . 0.41 110.426 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.47 178.44 7.21 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.926 -0.768 . . . . 0.21 108.926 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -94.85 141.02 29.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.14 -0.975 . . . . 2.72 109.368 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.7 tp -89.01 123.7 33.57 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.568 -0.707 . . . . 0.3 109.701 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 28.2 mt -113.47 -74.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.414 -0.804 . . . . 0.45 109.859 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -91.92 139.28 30.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.264 -0.897 . . . . 0.33 109.776 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -145.14 116.98 8.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.657 -0.868 . . . . 2.33 108.657 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.83 -100.82 0.18 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.732 -1.223 . . . . 0.28 110.225 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -67.46 -157.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.303 -1.116 . . . . 1.4 109.816 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.22 49.81 3.01 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.09 -1.604 . . . . 0.29 109.09 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.42 39.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.436 -1.037 . . . . 0.29 108.49 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 14.0 m -146.1 131.94 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 0.31 109.818 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.83 134.92 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.795 -1.187 . . . . 0.3 107.795 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -138.43 177.93 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.219 -0.926 . . . . 0.24 110.319 -178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.645 HE21 ' CG1' ' B' ' 257' ' ' ILE . 30.1 tt0 -145.08 111.47 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.618 -0.882 . . . . 1.81 108.618 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.8 -78.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.15 -1.426 . . . . 1.18 107.15 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.84 -133.66 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.733 -1.58 . . . . 1.97 106.733 177.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.3 t -101.83 55.85 0.81 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.977 -1.12 . . . . 1.38 107.977 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -155.26 124.6 6.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 1.12 109.168 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.645 ' CG1' HE21 ' B' ' 252' ' ' GLN . 71.2 mt -93.66 134.89 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.284 -0.885 . . . . 0.48 109.123 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -137.38 167.86 20.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.337 -0.852 . . . . 2.13 110.102 -179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 71.0 t -102.34 139.82 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.619 -0.676 . . . . 0.34 109.274 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 37.3 t -136.67 128.07 16.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.914 -0.773 . . . . 0.34 108.914 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.89 138.58 86.52 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 N-CA-C 109.928 -0.835 . . . . 0.42 109.928 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -57.28 -32.22 66.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 3.11 109.443 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' B' ' 263' ' ' ARG . 5.2 ttm-85 -67.41 -8.76 35.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.478 -0.764 . . . . 3.82 110.12 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -120.2 18.23 12.31 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.312 -0.868 . . . . 2.08 109.162 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.23 168.44 19.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.618 -0.677 . . . . 0.32 109.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -141.51 130.9 23.71 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.286 -0.884 . . . . 1.79 109.175 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 18.2 mm -87.81 114.75 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.243 -0.911 . . . . 0.45 109.917 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.67 154.49 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.713 -0.847 . . . . 0.57 108.713 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' B' ' 269' ' ' ARG . 2.4 mtt-85 -89.51 140.36 29.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.88 . . . . 3.62 109.211 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.089 -0.958 . . . . 2.05 109.382 179.892 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 219' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.363 0.601 . . . . 3.82 109.384 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.35 140.48 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.347 -0.846 . . . . 2.08 109.075 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -85.62 -117.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.265 -0.897 . . . . 2.17 109.883 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -98.94 111.36 23.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.906 . . . . 1.48 109.119 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -135.12 142.25 46.17 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.427 -0.796 . . . . 0.72 109.524 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.3 OUTLIER -115.64 153.8 30.63 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.238 -1.393 . . . . 3.26 107.238 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 60.2 t -140.74 141.91 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.099 -1.001 . . . . 0.23 110.472 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -109.22 155.0 21.61 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.256 -1.387 . . . . 0.58 107.256 178.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -156.19 155.6 32.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.547 -1.346 . . . . 0.44 110.618 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -100.68 133.13 45.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.475 0.655 . . . . 2.76 109.358 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 22.2 p-10 -92.35 171.65 8.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.001 -0.741 . . . . 2.23 109.001 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 78.9 p -87.45 -9.15 55.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.945 . . . . 1.8 109.661 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.32 -12.24 41.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.91 . . . . 3.63 109.365 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 229' ' ' ASP . 0.4 OUTLIER -161.27 128.54 2.65 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.296 -1.001 . . . . 2.16 108.296 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -70.53 -1.4 9.05 Favored 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 120.789 0.993 . . . . 1.25 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 137.89 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.745 -1.222 . . . . 1.75 110.005 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -50.35 166.98 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.089 -1.007 . . . . 0.66 109.219 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 237' ' ' GLY . 1.9 mtpp -119.65 166.37 13.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.67 -0.863 . . . . 1.43 108.67 179.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.31 168.78 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.823 -1.311 . . . . 0.39 109.823 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -66.96 158.87 54.58 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.685 1.59 . . . . 0.41 110.618 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.0 171.02 15.14 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.061 -0.718 . . . . 0.21 109.061 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -94.1 139.14 31.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.179 -0.951 . . . . 2.72 109.733 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.55 126.11 35.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.819 -0.551 . . . . 0.29 109.515 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.89 -72.06 0.71 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.389 -0.819 . . . . 0.45 110.362 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.473 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.97 142.62 27.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.105 -0.997 . . . . 0.31 110.032 -178.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -148.68 118.59 7.13 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 2.32 109.459 179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.22 0.17 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.842 -1.17 . . . . 0.27 110.21 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.6 -155.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -1.076 . . . . 1.39 109.931 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.87 48.71 3.33 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.689 -1.364 . . . . 0.29 109.689 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.88 154.96 41.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.379 -1.071 . . . . 0.29 108.612 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.39 128.72 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.075 -1.015 . . . . 0.31 109.787 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.06 132.69 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.955 -1.128 . . . . 0.29 107.955 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 251' ' ' ILE . 13.2 pt -135.64 177.68 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.243 -0.911 . . . . 0.23 109.864 -179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.43 HE21 HG12 ' A' ' 257' ' ' ILE . 37.5 tt0 -143.69 107.56 4.68 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.423 -0.798 . . . . 1.81 109.016 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.93 -76.76 0.43 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.748 -1.575 . . . . 1.18 106.748 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -163.32 0.55 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.999 -1.852 . . . . 1.98 105.999 177.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.1 p -79.47 48.79 0.94 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.599 -1.313 . . . . 1.39 108.288 178.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.31 126.7 11.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 1.12 109.175 -179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.503 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 9.9 mt -92.07 141.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.47 109.846 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -139.95 167.98 20.86 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -0.785 . . . . 2.11 109.796 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.19 137.45 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.358 -0.839 . . . . 0.33 109.241 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.0 t -135.2 130.56 19.31 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.461 -0.774 . . . . 0.34 109.038 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.16 137.11 80.35 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 N-CA-C 109.892 -0.849 . . . . 0.42 109.892 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.18 -35.35 69.49 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.202 -0.936 . . . . 3.12 109.427 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.82 -5.24 19.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.408 -0.807 . . . . 3.82 110.257 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.9 22.46 11.93 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.472 -0.936 . . . . 2.08 108.472 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.64 166.02 26.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.548 -0.72 . . . . 0.32 109.14 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.17 128.19 25.63 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.371 -0.831 . . . . 1.79 109.326 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.46 110.34 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.291 -0.88 . . . . 0.45 109.834 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.2 mm -105.31 156.88 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.452 -0.944 . . . . 0.57 108.452 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.98 138.83 31.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.06 -1.025 . . . . 3.63 109.229 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.038 -0.982 . . . . 2.05 109.506 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' B' ' 219' ' ' MET . 3.9 mpp? . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.315 0.579 . . . . 3.83 109.45 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 2.4 pp -81.23 140.42 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.31 -0.869 . . . . 2.08 109.109 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -85.55 -117.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 2.16 109.964 -179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -98.97 111.37 23.79 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.302 -0.874 . . . . 1.48 109.111 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -135.04 142.21 46.31 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.419 -0.8 . . . . 0.73 109.496 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.3 OUTLIER -115.65 153.84 30.56 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.239 -1.393 . . . . 3.26 107.239 178.748 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 60.6 t -140.72 141.83 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.96 . . . . 0.23 110.571 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -109.24 155.01 21.62 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.162 -1.421 . . . . 0.58 107.162 178.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.1 p90 -156.12 155.69 32.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.604 -1.31 . . . . 0.44 110.63 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -100.94 132.99 46.09 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 2.76 109.442 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 22.3 p-10 -92.21 171.63 8.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 2.23 109.029 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 80.0 p -87.52 -9.09 55.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 1.81 109.633 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -89.2 -12.44 40.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.93 . . . . 3.64 109.348 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' B' ' 229' ' ' ASP . 0.4 OUTLIER -161.17 128.47 2.66 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.305 -0.998 . . . . 2.16 108.305 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -70.41 -1.49 9.09 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 120.819 1.012 . . . . 1.27 111.065 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.02 137.85 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.749 -1.22 . . . . 1.76 109.933 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -50.49 166.94 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.073 -1.017 . . . . 0.67 109.182 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' B' ' 237' ' ' GLY . 1.9 mtpp -119.68 166.23 13.47 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.587 -0.894 . . . . 1.44 108.587 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.18 168.64 0.04 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.863 -1.295 . . . . 0.4 109.863 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.83 158.99 53.64 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.612 1.541 . . . . 0.41 110.749 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.16 170.84 15.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.048 -0.723 . . . . 0.21 109.048 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -93.87 139.06 31.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.077 -1.015 . . . . 2.72 109.77 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -89.48 126.05 35.43 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.749 -0.594 . . . . 0.3 109.531 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.6 mt -119.75 -72.03 0.71 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.48 -0.762 . . . . 0.45 110.352 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.503 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.3 t90 -91.1 142.66 27.51 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.045 -1.034 . . . . 0.33 109.988 -178.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -148.65 118.53 7.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.239 -0.913 . . . . 2.33 109.488 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.96 -100.04 0.17 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.856 -1.164 . . . . 0.28 110.245 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -67.63 -155.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.377 -1.072 . . . . 1.4 109.974 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.94 48.59 3.32 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.727 -1.349 . . . . 0.29 109.727 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.79 155.07 41.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -1.081 . . . . 0.29 108.59 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 6.9 m -143.44 128.73 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.134 -0.979 . . . . 0.31 109.728 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.1 132.71 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.967 -1.123 . . . . 0.3 107.967 179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.3 pt -135.77 177.64 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.24 109.848 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.433 HE21 HG12 ' B' ' 257' ' ' ILE . 37.4 tt0 -143.65 107.64 4.71 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 1.81 109.079 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.05 -76.56 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.762 -1.57 . . . . 1.18 106.762 178.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -163.25 0.54 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.975 -1.861 . . . . 1.97 105.975 177.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 15.2 p -79.53 48.85 0.95 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.519 -1.363 . . . . 1.38 108.315 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -149.37 126.72 11.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.533 -0.729 . . . . 1.12 109.213 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.473 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 9.8 mt -92.07 141.57 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 0.48 109.824 -179.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -140.09 167.96 20.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.344 -0.848 . . . . 2.13 109.815 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.12 137.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.391 -0.818 . . . . 0.34 109.279 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.17 130.58 19.35 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.455 -0.778 . . . . 0.34 108.991 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -57.27 137.07 79.98 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 N-CA-C 109.86 -0.862 . . . . 0.42 109.86 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -57.05 -35.54 69.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.226 -0.921 . . . . 3.11 109.433 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -68.81 -5.05 18.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.382 -0.824 . . . . 3.82 110.372 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -118.87 22.22 12.06 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.542 -0.91 . . . . 2.08 108.542 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -143.4 166.16 25.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.535 -0.728 . . . . 0.32 109.133 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -138.21 128.1 25.41 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.361 -0.837 . . . . 1.79 109.396 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 26.1 mm -87.43 110.31 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.345 -0.847 . . . . 0.45 109.888 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.3 mm -105.33 156.9 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.421 -0.955 . . . . 0.57 108.421 179.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.97 138.78 31.7 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.13 -0.981 . . . . 3.62 109.253 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 5.4 m-20 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.068 -1.02 . . . . 2.05 109.532 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.245 -0.65 . . . . 3.82 109.245 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.591 HD13 ' H ' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.3 113.16 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.436 -0.949 . . . . 2.08 108.436 -179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -86.13 -126.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 2.17 109.902 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -96.03 102.93 14.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.501 -0.75 . . . . 1.48 109.297 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.08 141.97 47.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.518 -0.739 . . . . 0.72 109.166 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.0 OUTLIER -116.96 157.71 25.29 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 107.558 -1.275 . . . . 3.26 107.558 178.827 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.39 145.45 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.949 -1.094 . . . . 0.23 110.55 -179.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.79 161.97 15.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.017 -1.105 . . . . 0.58 108.017 178.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 11.8 p90 -156.84 149.54 23.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.87 -1.144 . . . . 0.44 110.231 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -96.73 159.03 15.15 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.198 -0.939 . . . . 2.76 109.881 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.9 OUTLIER -95.45 170.91 9.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.041 -0.726 . . . . 2.23 109.041 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.9 t -91.37 -15.05 29.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 1.8 108.982 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.3 mtt-85 -90.21 -15.07 32.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.33 -0.857 . . . . 3.63 109.793 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.7 m-20 -161.19 128.8 2.73 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.052 -1.03 . . . . 2.16 109.173 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.77 17.39 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 120.813 1.008 . . . . 1.25 110.603 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 232' ' ' ASP . 32.7 m -80.9 130.93 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.785 -1.197 . . . . 1.75 109.834 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.78 174.82 0.14 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.197 -0.939 . . . . 0.66 109.398 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -122.62 -166.24 1.4 Allowed 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.206 -1.035 . . . . 1.43 108.206 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.12 -179.31 51.75 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.287 -1.525 . . . . 0.39 109.287 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.4 149.01 49.72 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 121.695 1.596 . . . . 0.41 110.446 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.28 167.1 22.25 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.99 -0.744 . . . . 0.21 108.99 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -91.54 140.81 29.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.047 -1.033 . . . . 2.72 110.081 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.03 129.85 35.59 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.807 -0.558 . . . . 0.29 109.8 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.1 mt -118.03 -72.54 0.68 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.57 -0.707 . . . . 0.45 110.42 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.405 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.4 t90 -90.24 143.23 26.96 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.415 -0.803 . . . . 0.31 110.845 -178.04 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 244' ' ' LYS . 0.9 OUTLIER -143.89 112.6 6.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.839 -0.801 . . . . 2.32 108.839 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.67 -103.58 0.36 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.968 -1.253 . . . . 0.27 109.968 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.43 -154.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.224 -1.162 . . . . 1.39 109.503 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.25 3.54 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.7 -1.76 . . . . 0.29 108.7 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.69 35.84 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.57 -0.959 . . . . 0.29 108.603 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.11 128.77 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.083 -1.011 . . . . 0.31 109.619 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 54.1 t -92.84 128.51 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.212 -1.032 . . . . 0.29 108.212 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 7.4 pt -134.42 -179.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.432 -0.793 . . . . 0.23 109.865 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.581 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.5 tt0 -142.66 109.96 5.67 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.278 -1.008 . . . . 1.81 108.278 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -86.03 -81.02 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.298 -1.371 . . . . 1.18 107.298 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.53 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.837 -1.542 . . . . 1.98 106.837 177.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 35.0 t -100.58 53.71 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.052 -1.092 . . . . 1.39 108.052 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.53 124.23 5.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.597 -0.689 . . . . 1.12 109.375 -179.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.581 ' CG1' HE21 ' A' ' 252' ' ' GLN . 22.2 mt -90.46 131.19 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.258 -0.902 . . . . 0.47 109.257 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 258' ' ' LYS . 0.0 OUTLIER -131.64 167.99 18.5 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.446 -0.784 . . . . 2.11 109.74 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 142.06 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.436 -0.79 . . . . 0.33 109.446 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 50.2 t -137.16 130.09 17.19 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.485 -0.932 . . . . 0.34 108.485 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.19 141.99 90.18 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 N-CA-C 109.93 -0.834 . . . . 0.42 109.93 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.94 -31.15 66.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.289 -0.882 . . . . 3.12 109.101 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.08 -11.21 60.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.398 -0.814 . . . . 3.82 110.325 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.09 21.91 12.11 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 2.08 108.991 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.03 16.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.472 -0.767 . . . . 0.32 109.339 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -140.53 125.67 18.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 1.79 109.262 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.35 113.23 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.234 -0.917 . . . . 0.45 109.17 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -108.01 153.67 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.455 -0.778 . . . . 0.57 109.044 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' A' ' 269' ' ' ARG . 18.4 mtm-85 -95.7 135.88 36.83 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.468 -0.77 . . . . 3.63 109.485 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 2.05 109.14 179.5 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 3.83 109.193 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.593 HD13 ' H ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.26 113.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 2.08 108.489 179.981 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -86.15 -126.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 2.16 109.899 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -95.97 102.94 14.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.474 -0.767 . . . . 1.48 109.36 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -134.09 141.9 47.32 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.411 -0.806 . . . . 0.73 109.138 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.0 OUTLIER -116.83 157.7 25.16 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 107.566 -1.272 . . . . 3.26 107.566 178.769 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 40.2 t -143.41 145.47 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.008 -1.057 . . . . 0.23 110.624 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -111.8 162.06 15.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.956 -1.127 . . . . 0.58 107.956 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.6 p90 -156.85 149.57 23.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.882 -1.136 . . . . 0.44 110.194 -179.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -96.67 159.09 15.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.298 -0.876 . . . . 2.76 109.945 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 0.9 OUTLIER -95.55 170.9 9.02 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.996 -0.742 . . . . 2.23 108.996 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.5 t -91.4 -15.09 29.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 1.81 108.827 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' B' ' 231' ' ' ARG . 2.3 mtt-85 -90.23 -14.99 32.26 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.225 -0.922 . . . . 3.64 109.81 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.6 m-20 -161.15 128.9 2.76 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 2.16 109.114 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -65.93 17.45 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.844 1.03 . . . . 1.27 110.602 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' B' ' 232' ' ' ASP . 32.7 m -80.93 130.9 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.916 -1.115 . . . . 1.76 109.826 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -56.8 174.89 0.14 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -0.936 . . . . 0.67 109.532 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -122.66 -166.22 1.4 Allowed 'General case' 0 N--CA 1.504 2.253 0 N-CA-C 108.157 -1.053 . . . . 1.44 108.157 179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -84.1 -179.2 51.75 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.321 -1.512 . . . . 0.4 109.321 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.42 149.0 49.6 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.803 1.669 . . . . 0.41 110.421 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.35 167.12 22.22 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.944 -0.762 . . . . 0.21 108.944 179.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -91.57 140.76 29.42 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.0 -1.063 . . . . 2.72 110.069 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 tp -88.92 129.77 35.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.751 -0.593 . . . . 0.3 109.814 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 35.2 mt -117.91 -72.58 0.68 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.363 -0.836 . . . . 0.45 110.416 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -90.27 143.06 27.11 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.42 -0.8 . . . . 0.33 110.887 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' B' ' 244' ' ' LYS . 0.9 OUTLIER -143.68 112.72 6.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.807 . . . . 2.33 108.938 179.172 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -146.65 -103.58 0.36 Allowed Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.896 -1.281 . . . . 0.28 109.896 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -73.37 -154.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -1.119 . . . . 1.4 109.492 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.06 55.23 3.54 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.678 -1.769 . . . . 0.29 108.678 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.63 152.57 35.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.582 -0.952 . . . . 0.29 108.644 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.4 m -145.05 128.7 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.034 -1.041 . . . . 0.31 109.679 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.81 128.45 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.195 -1.039 . . . . 0.3 108.195 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 7.5 pt -134.31 -179.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.377 -0.827 . . . . 0.24 109.908 -178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.583 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -142.7 109.82 5.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.378 -0.971 . . . . 1.81 108.378 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -85.98 -81.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.281 -1.377 . . . . 1.18 107.281 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -81.34 -132.48 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.823 -1.547 . . . . 1.97 106.823 177.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 34.9 t -100.6 53.73 0.87 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.046 -1.094 . . . . 1.38 108.046 178.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -156.54 124.42 5.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.604 -0.685 . . . . 1.12 109.327 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.583 ' CG1' HE21 ' B' ' 252' ' ' GLN . 21.9 mt -90.59 131.16 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.48 109.25 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . 0.593 ' HZ2' ' HB2' ' B' ' 258' ' ' LYS . 0.0 OUTLIER -131.63 168.0 18.48 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 2.13 109.743 -179.613 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.64 142.11 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.457 -0.777 . . . . 0.34 109.436 179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 51.0 t -137.19 130.01 17.12 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.45 -0.944 . . . . 0.34 108.45 179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.07 141.91 90.47 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 N-CA-C 109.904 -0.845 . . . . 0.42 109.904 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -57.93 -31.15 66.54 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 3.11 109.132 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -70.13 -11.09 60.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 3.82 110.373 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -119.16 21.94 12.06 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.271 -0.893 . . . . 2.08 108.899 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.05 16.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.547 -0.721 . . . . 0.32 109.324 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -140.59 125.67 18.47 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.375 -0.828 . . . . 1.79 109.279 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 14.3 mm -86.25 113.1 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.237 -0.915 . . . . 0.45 109.235 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.1 mm -107.92 153.74 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.57 109.093 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' B' ' 269' ' ' ARG . 18.5 mtm-85 -95.75 135.93 36.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 3.62 109.392 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.912 -1.042 . . . . 2.05 109.029 179.48 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 219' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.325 0.583 . . . . 3.82 109.428 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 220' ' ' ILE . 15.2 tt -82.64 129.79 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 2.08 109.383 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -87.29 -122.26 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.92 -1.112 . . . . 2.17 109.267 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -101.25 110.51 22.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.177 -0.952 . . . . 1.48 110.143 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -135.5 125.23 25.4 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.438 -0.789 . . . . 0.72 109.09 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -101.44 159.12 15.55 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.243 -1.021 . . . . 3.26 108.243 179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.0 t -142.19 143.77 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.099 -1.001 . . . . 0.23 110.895 -179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.42 156.73 19.11 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.243 -1.391 . . . . 0.58 107.243 178.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 12.9 p90 -157.69 152.86 25.8 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.549 -1.345 . . . . 0.44 110.697 -179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -99.49 135.3 41.11 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.622 -0.674 . . . . 2.76 109.751 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -95.85 178.93 5.28 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.847 . . . . 2.23 109.185 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 73.9 p -91.21 -10.8 40.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.234 -0.916 . . . . 1.8 109.429 179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.404 ' O ' ' CG ' ' A' ' 232' ' ' ASP . 53.6 mtp180 -84.1 -19.05 34.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.205 -0.935 . . . . 3.63 109.481 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 231' ' ' ARG . 43.2 m-20 -159.37 129.04 3.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.323 -0.861 . . . . 2.16 109.152 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.41 1.83 3.3 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 120.76 0.974 . . . . 1.25 110.442 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.73 136.24 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.939 -1.101 . . . . 1.75 110.218 -179.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -52.28 163.62 0.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.129 -0.982 . . . . 0.66 109.239 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 237' ' ' GLY . 34.4 mtpt -119.85 166.74 12.89 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.459 -0.776 . . . . 1.43 109.561 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.16 166.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.457 -1.057 . . . . 0.39 110.457 -179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.61 159.73 39.51 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.591 1.528 . . . . 0.41 110.579 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.39 169.56 17.47 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.864 -0.791 . . . . 0.21 108.864 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -92.32 136.17 33.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.981 -1.074 . . . . 2.72 109.537 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.2 116.84 26.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.671 -0.643 . . . . 0.29 109.313 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.9 mt -104.82 -71.7 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.246 -0.908 . . . . 0.45 109.838 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 7.5 t90 -94.08 146.98 23.58 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.107 -0.996 . . . . 0.31 110.473 -179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.02 120.96 8.76 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.376 -0.827 . . . . 2.32 109.017 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -108.58 0.3 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.78 -1.2 . . . . 0.27 110.332 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -67.76 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -1.126 . . . . 1.39 109.69 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.99 47.91 2.64 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.994 -1.642 . . . . 0.29 108.994 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.29 146.85 30.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.541 -0.976 . . . . 0.29 108.736 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 4.1 m -143.12 128.13 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.173 -0.954 . . . . 0.31 109.247 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 78.8 t -89.13 140.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.198 -1.038 . . . . 0.29 108.198 179.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.38 179.28 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.919 . . . . 0.23 110.253 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.463 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.4 tt0 -141.23 112.16 7.2 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.562 -0.903 . . . . 1.81 108.562 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.71 -81.08 0.29 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 255' ' ' SER . 32.7 t-20 -80.34 -129.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.783 -1.562 . . . . 1.98 106.783 177.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 8.6 t -104.19 53.16 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.245 -1.02 . . . . 1.39 108.245 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.12 129.72 8.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.02 -0.733 . . . . 1.12 109.02 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.463 ' CG1' HE21 ' A' ' 252' ' ' GLN . 67.9 mt -92.23 139.28 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.47 109.558 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.12 165.13 28.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.304 -0.873 . . . . 2.11 109.954 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.92 138.55 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.468 -0.77 . . . . 0.33 109.054 179.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -137.04 133.05 18.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.738 -0.838 . . . . 0.34 108.738 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.38 141.14 89.56 Favored 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 120.836 1.024 . . . . 0.42 110.512 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -59.61 -32.48 70.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 3.12 109.448 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.422 ' HG2' ' NH1' ' A' ' 263' ' ' ARG . 0.6 OUTLIER -69.45 -8.18 44.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 3.82 110.526 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.77 20.74 12.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.127 -0.983 . . . . 2.08 109.282 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.9 16.95 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.01 -0.737 . . . . 0.32 109.01 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -139.71 122.59 16.59 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.219 -0.926 . . . . 1.79 108.977 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.82 107.42 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.145 -0.972 . . . . 0.45 109.997 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.04 151.11 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 108.451 -0.944 . . . . 0.57 108.451 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -90.55 143.77 26.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.343 -0.848 . . . . 3.63 109.726 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.053 -0.975 . . . . 2.05 109.416 179.662 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' B' ' 219' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.416 -0.587 . . . . 3.83 109.416 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.492 ' O ' HG23 ' B' ' 220' ' ' ILE . 15.1 tt -82.83 129.87 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.308 -0.87 . . . . 2.08 109.261 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.19 -122.53 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.96 -1.087 . . . . 2.16 109.295 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -100.99 110.53 22.57 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.196 -0.94 . . . . 1.48 110.199 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -135.5 125.25 25.44 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.435 -0.791 . . . . 0.73 109.067 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -101.37 159.18 15.49 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.181 -1.044 . . . . 3.26 108.181 179.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 59.1 t -142.3 143.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.123 -0.985 . . . . 0.23 110.978 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -108.41 156.77 19.07 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.235 -1.394 . . . . 0.58 107.235 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.475 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.7 p90 -157.64 152.9 25.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.595 -1.316 . . . . 0.44 110.649 -179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -99.54 135.13 41.41 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.601 -0.687 . . . . 2.76 109.749 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -95.68 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 2.23 109.182 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 74.2 p -91.13 -10.84 40.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.196 -0.94 . . . . 1.81 109.492 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' B' ' 232' ' ' ASP . 53.5 mtp180 -84.08 -19.03 35.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 3.64 109.505 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' B' ' 231' ' ' ARG . 43.5 m-20 -159.5 129.03 3.24 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 2.16 109.053 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.28 1.7 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.792 0.995 . . . . 1.27 110.442 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 3.6 m -84.57 136.14 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.868 -1.145 . . . . 1.76 110.258 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -52.31 163.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.215 -0.928 . . . . 0.67 109.311 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' B' ' 237' ' ' GLY . 34.3 mtpt -119.78 166.93 12.61 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.261 -0.899 . . . . 1.44 109.511 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.35 166.55 0.02 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.358 -1.097 . . . . 0.4 110.358 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -63.6 159.92 38.61 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.523 1.482 . . . . 0.41 110.54 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.45 169.53 17.54 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.922 -0.77 . . . . 0.21 108.922 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -92.32 136.2 33.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.11 -0.994 . . . . 2.72 109.596 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 12.7 tp -88.27 116.79 26.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.669 -0.644 . . . . 0.3 109.284 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -104.71 -71.74 0.73 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.271 -0.893 . . . . 0.45 109.872 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -94.12 146.98 23.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.179 -0.95 . . . . 0.33 110.415 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -148.09 121.08 8.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.375 -0.828 . . . . 2.33 108.931 179.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -108.65 0.3 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.785 -1.198 . . . . 0.28 110.335 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.68 -151.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -1.08 . . . . 1.4 109.761 -179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.18 47.98 2.7 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.918 -1.673 . . . . 0.29 108.918 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.35 146.88 30.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.491 -1.005 . . . . 0.29 108.745 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 4.2 m -143.2 128.06 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.31 109.277 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.07 139.96 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.219 -1.03 . . . . 0.3 108.219 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.37 179.27 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.24 110.299 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.465 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.4 tt0 -141.25 112.21 7.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.468 -0.938 . . . . 1.81 108.468 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -89.7 -81.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.549 -1.278 . . . . 1.18 107.549 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' B' ' 255' ' ' SER . 32.6 t-20 -80.29 -129.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.866 -1.531 . . . . 1.97 106.866 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.494 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 8.7 t -104.32 53.27 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.106 -1.072 . . . . 1.38 108.106 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -156.15 129.8 8.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.982 -0.747 . . . . 1.12 108.982 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.465 ' CG1' HE21 ' B' ' 252' ' ' GLN . 68.1 mt -92.31 139.32 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.26 -0.9 . . . . 0.48 109.519 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -141.19 165.18 28.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.333 -0.855 . . . . 2.13 109.932 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.92 138.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.427 -0.795 . . . . 0.34 109.065 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.05 132.98 18.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.677 -0.86 . . . . 0.34 108.677 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.24 141.28 88.45 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.776 0.984 . . . . 0.42 110.599 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -59.71 -32.6 70.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 3.11 109.368 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.421 ' NH1' ' HG2' ' B' ' 263' ' ' ARG . 0.6 OUTLIER -69.35 -8.31 45.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.36 -0.838 . . . . 3.82 110.56 -179.195 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -118.65 20.66 12.85 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.225 -0.922 . . . . 2.08 109.274 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 169.72 17.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.572 -0.705 . . . . 0.32 109.101 179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -139.53 122.57 16.77 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.228 -0.92 . . . . 1.79 108.981 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.76 107.4 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.252 -0.905 . . . . 0.45 109.977 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.06 151.23 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.39 -0.967 . . . . 0.57 108.39 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -90.69 143.66 26.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.303 -0.873 . . . . 3.62 109.724 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.948 -1.025 . . . . 2.05 109.484 179.655 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.396 -0.594 . . . . 3.82 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -83.83 109.82 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.456 -0.942 . . . . 2.08 108.456 -179.869 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -83.13 -112.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 2.17 109.629 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -100.31 102.01 13.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.31 -0.869 . . . . 1.48 109.532 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -133.27 130.41 38.93 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.387 -0.821 . . . . 0.72 109.191 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -105.57 156.32 18.35 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.456 -0.942 . . . . 3.26 108.456 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 86.7 t -139.1 142.86 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.361 -0.837 . . . . 0.23 110.098 -179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -109.22 152.07 25.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.312 -1.366 . . . . 0.58 107.312 178.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.03 157.59 36.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.555 -1.341 . . . . 0.44 110.724 -178.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -100.05 140.04 34.84 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.59 -0.694 . . . . 2.76 109.291 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 232' ' ' ASP . 5.1 p-10 -93.33 176.78 6.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 2.23 109.467 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.6 t -89.02 -11.95 42.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 1.8 109.508 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 20.3 mmm180 -86.88 -11.97 49.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.088 -1.008 . . . . 3.63 109.417 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.5 ' N ' ' OD2' ' A' ' 229' ' ' ASP . 48.0 m-20 -161.95 129.52 2.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.098 -1.001 . . . . 2.16 108.95 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.6 4.83 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.64 0.893 . . . . 1.25 110.024 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 7.2 t -83.4 154.54 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.013 . . . . 1.75 110.024 -179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -68.41 163.6 22.84 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.66 109.071 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 237' ' ' GLY . 4.9 mtpp -119.6 165.86 13.91 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.843 -0.799 . . . . 1.43 108.843 179.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -47.0 171.03 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.688 -1.365 . . . . 0.39 109.688 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.7 160.88 46.18 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.568 1.512 . . . . 0.41 110.522 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.57 172.07 13.52 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.489 -0.757 . . . . 0.21 109.053 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.49 134.67 34.45 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.165 -0.959 . . . . 2.72 109.344 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.37 124.68 34.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.576 -0.703 . . . . 0.29 109.225 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.83 -72.47 0.69 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.469 -0.769 . . . . 0.45 110.496 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.463 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 4.8 t90 -91.14 142.56 27.61 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.187 -0.946 . . . . 0.31 110.257 -178.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.406 ' HG3' HH22 ' A' ' 262' ' ' ARG . 8.1 ttpm? -147.07 121.14 9.43 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 2.32 109.607 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.65 -103.34 0.21 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.86 -1.162 . . . . 0.27 110.366 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.95 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -1.074 . . . . 1.39 110.111 -179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.73 47.95 2.56 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.25 -1.54 . . . . 0.29 109.25 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.86 37.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -1.082 . . . . 0.29 109.215 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.01 127.79 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.192 -0.942 . . . . 0.31 109.514 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.18 139.16 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.336 -0.987 . . . . 0.29 108.336 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 257' ' ' ILE . 19.6 pt -141.52 177.3 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.23 110.086 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.419 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.4 tt0 -143.48 114.06 7.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.818 -0.808 . . . . 1.81 108.818 179.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -90.29 -82.36 0.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.316 -1.364 . . . . 1.18 107.316 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -80.28 -130.3 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.667 -1.605 . . . . 1.98 106.667 177.532 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.4 m -104.1 54.72 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.073 -1.084 . . . . 1.39 108.073 178.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -156.42 123.79 5.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.779 -0.823 . . . . 1.12 108.779 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' ILE . 11.5 mt -92.88 138.28 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.21 -0.931 . . . . 0.47 109.702 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.85 168.59 19.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.384 -0.822 . . . . 2.11 109.44 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.71 144.58 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.348 -0.845 . . . . 0.33 109.367 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 94.1 t -138.54 128.63 14.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 0.34 109.118 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.28 144.47 95.82 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 120.531 0.821 . . . . 0.42 110.06 179.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.406 HH22 ' HG3' ' A' ' 244' ' ' LYS . 11.9 tpp180 -60.11 -39.56 86.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 3.12 109.062 179.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -65.6 -7.48 15.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 3.82 110.344 -178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.82 22.44 11.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.233 -0.917 . . . . 2.08 109.307 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.67 169.35 17.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.32 109.529 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -141.28 128.45 20.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 1.79 109.254 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 16.8 mm -88.4 112.85 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.101 -0.999 . . . . 0.45 109.789 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.3 144.92 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.914 -1.143 . . . . 0.57 107.914 179.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 269' ' ' ARG . 31.1 ptt180 -91.02 142.63 27.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 3.63 109.282 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.995 -1.002 . . . . 2.05 109.556 -179.852 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.287 -0.635 . . . . 3.83 109.287 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.551 HD13 ' H ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -83.72 109.85 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.427 -0.953 . . . . 2.08 108.427 -179.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -83.22 -112.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 2.16 109.566 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -100.31 102.06 13.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.293 -0.88 . . . . 1.48 109.55 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -133.31 130.36 38.78 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 0.73 109.222 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -105.43 156.44 18.19 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.515 -0.92 . . . . 3.26 108.515 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 87.3 t -139.09 142.9 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.23 110.112 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.26 152.16 25.59 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.339 -1.356 . . . . 0.58 107.339 178.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.6 p90 -156.14 157.51 36.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.609 -1.307 . . . . 0.44 110.726 -178.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -99.91 140.08 34.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.666 -0.646 . . . . 2.76 109.337 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' B' ' 232' ' ' ASP . 5.1 p-10 -93.41 176.78 6.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 2.23 109.401 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 10.7 t -88.99 -11.97 42.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 1.81 109.509 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.432 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 20.3 mmm180 -86.71 -12.1 49.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.143 -0.973 . . . . 3.64 109.462 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.501 ' N ' ' OD2' ' B' ' 229' ' ' ASP . 47.8 m-20 -161.92 129.57 2.72 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.171 -0.956 . . . . 2.16 108.887 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.59 4.8 1.53 Allowed 'Trans proline' 0 C--O 1.214 -0.718 0 C-N-CA 120.755 0.97 . . . . 1.27 109.959 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 7.3 t -83.44 154.63 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.097 -1.002 . . . . 1.76 110.031 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -68.32 163.62 22.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.67 109.085 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' B' ' 237' ' ' GLY . 4.9 mtpp -119.7 165.91 13.89 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.771 -0.826 . . . . 1.44 108.771 179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -47.07 171.01 0.04 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.728 -1.349 . . . . 0.4 109.728 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -67.69 160.91 46.06 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 121.56 1.507 . . . . 0.41 110.486 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.68 172.02 13.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.553 -0.717 . . . . 0.21 109.084 179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -91.43 134.65 34.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.144 -0.973 . . . . 2.72 109.341 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.39 124.69 34.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.544 -0.722 . . . . 0.3 109.173 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.77 -72.52 0.68 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.41 -0.806 . . . . 0.45 110.609 -179.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.415 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.8 t90 -91.09 142.52 27.67 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.124 -0.985 . . . . 0.33 110.254 -178.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . 0.404 ' HG3' HH22 ' B' ' 262' ' ' ARG . 8.1 ttpm? -147.08 121.14 9.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.206 -0.934 . . . . 2.33 109.564 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.62 -103.29 0.21 Allowed Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.844 -1.17 . . . . 0.28 110.337 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -71.04 -152.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.347 -1.09 . . . . 1.4 110.139 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.74 47.94 2.56 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.197 -1.561 . . . . 0.29 109.197 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.91 151.81 37.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.29 109.259 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.9 m -145.92 127.89 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.31 109.525 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.21 139.23 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.325 -0.991 . . . . 0.3 108.325 179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 257' ' ' ILE . 19.7 pt -141.61 177.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.264 -0.898 . . . . 0.24 110.138 -179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.415 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.4 tt0 -143.56 114.06 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.817 -0.808 . . . . 1.81 108.817 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -90.29 -82.34 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.331 -1.359 . . . . 1.18 107.331 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -80.23 -130.21 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.716 -1.587 . . . . 1.97 106.716 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 64.8 m -104.24 54.71 0.73 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.983 -1.118 . . . . 1.38 107.983 178.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -156.45 123.81 5.39 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.829 -0.804 . . . . 1.12 108.829 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.463 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 11.4 mt -92.92 138.3 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.281 -0.887 . . . . 0.48 109.756 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -137.78 168.64 19.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.533 -0.729 . . . . 2.13 109.412 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.72 144.58 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.27 -0.894 . . . . 0.34 109.395 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.56 128.55 14.87 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.47 -0.769 . . . . 0.34 109.14 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.21 144.54 95.37 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 N-CA-C 110.012 -0.803 . . . . 0.42 110.012 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' B' ' 244' ' ' LYS . 11.9 tpp180 -60.1 -39.7 87.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 3.11 108.956 179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -65.47 -7.51 14.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 3.82 110.512 -178.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -118.88 22.52 11.91 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.247 -0.908 . . . . 2.08 109.259 179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.7 169.41 17.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.503 -0.748 . . . . 0.32 109.441 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -141.32 128.46 20.87 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.27 -0.894 . . . . 1.79 109.24 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 16.7 mm -88.35 112.97 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.188 -0.945 . . . . 0.45 109.782 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.35 144.88 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 107.897 -1.149 . . . . 0.57 107.897 179.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -91.02 142.57 27.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 3.62 109.205 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.993 -1.003 . . . . 2.05 109.575 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 90.1 mtp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.42 -0.585 . . . . 3.82 109.42 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.824 HD12 ' H ' ' A' ' 220' ' ' ILE . 0.1 OUTLIER -83.35 121.13 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.657 -0.868 . . . . 2.08 108.657 -179.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -84.25 -117.72 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 2.17 109.656 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -97.78 104.26 16.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 1.48 109.819 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -136.37 131.6 34.46 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.015 -0.735 . . . . 0.72 109.015 179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -105.21 158.09 16.84 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.353 -0.842 . . . . 3.26 109.014 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.5 t -139.05 140.76 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.23 109.877 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -107.51 156.33 19.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.508 -1.293 . . . . 0.58 107.508 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 13.4 p90 -156.79 151.63 25.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.704 -1.247 . . . . 0.44 110.729 -178.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -98.22 148.5 23.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.738 . . . . 2.76 109.483 179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 231' ' ' ARG . 25.0 t0 -94.89 -175.56 3.59 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.959 -0.756 . . . . 2.23 108.959 179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.426 ' H ' ' CG ' ' A' ' 229' ' ' ASP . 5.5 t -98.67 -14.77 19.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -0.956 . . . . 1.8 109.982 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 229' ' ' ASP . 15.3 mtm-85 -89.72 -11.75 41.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 3.63 109.981 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 231' ' ' ARG . 54.4 m-20 -161.01 129.02 2.83 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.928 -1.107 . . . . 2.16 109.478 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -68.57 6.84 0.83 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 120.731 0.954 . . . . 1.25 110.32 179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 234' ' ' VAL . 5.3 m -80.08 128.24 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.787 -1.195 . . . . 1.75 109.891 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.36 165.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.534 -0.729 . . . . 0.66 109.532 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 237' ' ' GLY . 28.6 mttm -118.41 166.41 12.7 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.633 -0.877 . . . . 1.43 108.633 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -49.73 177.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.932 -1.267 . . . . 0.39 109.932 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.86 160.28 48.25 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.663 1.575 . . . . 0.41 110.477 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.95 12.16 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.667 -0.864 . . . . 0.21 108.667 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.18 139.43 31.51 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.073 -1.017 . . . . 2.72 109.44 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.9 120.26 30.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 0.29 109.926 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.29 -72.91 0.68 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.427 -0.795 . . . . 0.45 110.231 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.204 -0.935 . . . . 0.31 110.129 -178.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -146.47 112.7 5.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.258 -0.901 . . . . 2.32 109.13 179.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.39 -102.63 0.2 Allowed Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.51 -1.328 . . . . 0.27 110.658 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.52 -159.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -1.081 . . . . 1.39 110.188 -179.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.99 44.86 1.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.028 -1.629 . . . . 0.29 109.028 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.3 152.51 37.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.445 -1.033 . . . . 0.29 108.975 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.62 126.97 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.262 -0.899 . . . . 0.31 109.325 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 59.7 t -86.38 137.4 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.971 -1.122 . . . . 0.29 107.971 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.408 HD11 HG21 ' A' ' 260' ' ' VAL . 26.6 pt -140.17 -177.94 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.23 110.076 -179.013 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.44 HE21 HG13 ' A' ' 257' ' ' ILE . 37.9 tt0 -143.94 109.07 5.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.401 -0.963 . . . . 1.81 108.401 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.81 -76.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.377 -1.342 . . . . 1.18 107.377 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -79.93 -134.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.697 -1.594 . . . . 1.98 106.697 177.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 15.3 p -103.9 54.42 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.981 -1.118 . . . . 1.39 107.981 178.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 255' ' ' SER . 65.0 m-20 -157.1 130.9 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.887 -0.783 . . . . 1.12 108.887 -179.308 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.44 HG13 HE21 ' A' ' 252' ' ' GLN . 73.8 mt -94.45 135.1 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.262 -0.899 . . . . 0.47 109.847 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -137.45 176.67 8.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.445 -0.784 . . . . 2.11 109.922 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.31 137.9 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.663 -0.648 . . . . 0.33 109.602 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 251' ' ' ILE . 25.9 t -135.43 131.56 19.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.378 -0.826 . . . . 0.34 108.986 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.24 144.29 95.9 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 120.621 0.881 . . . . 0.42 109.946 179.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.46 -34.04 74.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 3.12 109.55 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 263' ' ' ARG . 35.4 mtm-85 -70.4 -5.68 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.352 -0.842 . . . . 3.82 110.846 -178.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -119.36 21.3 12.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.386 -0.821 . . . . 2.08 108.866 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.87 166.41 24.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.602 -0.686 . . . . 0.32 109.273 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.465 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.8 mtmp? -141.7 129.61 21.85 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.253 -0.904 . . . . 1.79 109.135 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 27.5 mm -86.86 117.36 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.179 -0.951 . . . . 0.45 109.978 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.86 150.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 108.795 -0.817 . . . . 0.57 108.795 179.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.38 146.11 23.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.404 -0.81 . . . . 3.63 108.856 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.495 1.799 0 O-C-N 120.956 -1.09 . . . . 2.05 109.49 179.863 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.328 0.585 . . . . 3.83 109.611 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.844 ' H ' HD12 ' B' ' 220' ' ' ILE . 0.1 OUTLIER -83.25 121.2 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.208 -0.933 . . . . 2.08 108.782 -179.835 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -84.4 -117.76 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.03 -1.044 . . . . 2.16 109.673 -179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -97.6 104.01 16.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.249 -0.907 . . . . 1.48 109.905 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -136.14 131.49 34.79 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.572 -0.705 . . . . 0.73 109.126 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -105.15 158.01 16.88 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.334 -0.854 . . . . 3.26 109.011 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.95 140.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.427 -0.796 . . . . 0.23 109.977 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -107.56 156.53 18.91 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.469 -1.308 . . . . 0.58 107.469 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 13.4 p90 -156.9 151.63 25.74 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.584 -1.323 . . . . 0.44 110.67 -178.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -98.32 148.57 23.52 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.41 -0.806 . . . . 2.76 109.466 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.485 ' OD2' ' NH1' ' B' ' 231' ' ' ARG . 25.1 t0 -94.86 -175.46 3.57 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.345 -0.847 . . . . 2.23 108.902 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . 0.425 ' H ' ' CG ' ' B' ' 229' ' ' ASP . 5.4 t -98.7 -14.72 19.67 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.238 -0.914 . . . . 1.81 109.933 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.485 ' NH1' ' OD2' ' B' ' 229' ' ' ASP . 15.1 mtm-85 -89.96 -11.77 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.134 -0.979 . . . . 3.64 109.934 -179.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 231' ' ' ARG . 54.1 m-20 -160.97 128.9 2.81 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.14 -0.975 . . . . 2.16 109.494 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -68.4 6.83 0.8 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 120.705 0.937 . . . . 1.27 110.3 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.466 ' O ' HG23 ' B' ' 234' ' ' VAL . 5.3 m -80.04 128.22 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.89 -1.131 . . . . 1.76 109.99 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -50.3 165.08 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.67 109.546 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' B' ' 237' ' ' GLY . 28.7 mttm -118.44 166.34 12.79 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.711 -0.848 . . . . 1.44 108.711 179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -49.72 177.95 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.978 -1.249 . . . . 0.4 109.978 -179.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -71.93 160.39 47.84 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.653 1.569 . . . . 0.41 110.506 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.1 173.09 11.99 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.723 -0.843 . . . . 0.21 108.723 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -95.35 139.2 31.99 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.996 -1.065 . . . . 2.72 109.464 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.81 120.16 30.82 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.471 -0.768 . . . . 0.3 109.855 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.0 mt -114.23 -72.83 0.68 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.37 -0.831 . . . . 0.45 110.312 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -92.78 140.08 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.223 -0.923 . . . . 0.33 110.006 -178.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -146.58 112.68 5.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.224 -0.923 . . . . 2.33 108.986 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.4 -102.47 0.2 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.496 -1.335 . . . . 0.28 110.644 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -61.65 -159.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.358 -1.083 . . . . 1.4 110.186 -179.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.11 44.88 1.92 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.957 -1.657 . . . . 0.29 108.957 179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 152.63 37.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.46 -1.023 . . . . 0.29 108.944 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.4 m -144.67 126.8 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.143 -0.973 . . . . 0.31 109.442 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.0 t -86.37 137.53 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.941 -1.133 . . . . 0.3 107.941 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.41 HD11 HG21 ' B' ' 260' ' ' VAL . 26.2 pt -140.26 -178.09 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.24 110.119 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.444 HE21 HG13 ' B' ' 257' ' ' ILE . 37.9 tt0 -143.76 109.27 5.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.394 -0.965 . . . . 1.81 108.394 178.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -89.97 -76.27 0.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.337 -1.357 . . . . 1.18 107.337 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.87 -134.8 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.763 -1.569 . . . . 1.97 106.763 177.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.406 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 15.4 p -103.93 54.41 0.74 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.897 -1.149 . . . . 1.38 107.897 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.6 m-20 -156.98 131.0 8.34 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.444 HG13 HE21 ' B' ' 252' ' ' GLN . 73.7 mt -94.46 135.07 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.194 -0.941 . . . . 0.48 109.805 -179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -137.52 176.68 8.49 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.435 -0.79 . . . . 2.13 109.891 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.32 137.98 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 0.34 109.553 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . 0.41 HG21 HD11 ' B' ' 251' ' ' ILE . 25.9 t -135.59 131.5 19.32 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.341 -0.849 . . . . 0.34 108.955 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.13 144.41 95.18 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 120.571 0.847 . . . . 0.42 109.913 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -61.43 -34.16 74.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 3.11 109.628 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.408 ' NH1' ' HG3' ' B' ' 263' ' ' ARG . 35.2 mtm-85 -70.47 -5.32 27.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 3.82 110.866 -178.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -119.71 21.13 12.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.355 -0.84 . . . . 2.08 108.799 179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.77 166.49 24.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.656 -0.653 . . . . 0.32 109.244 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.461 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.8 mtmp? -141.77 129.68 21.85 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.329 -0.857 . . . . 1.79 109.12 179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.94 117.6 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.289 -0.882 . . . . 0.45 109.892 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.8 mm -117.14 150.71 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -92.48 146.2 23.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.734 -0.839 . . . . 3.62 108.734 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 120.975 -1.078 . . . . 2.05 109.377 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.509 -0.552 . . . . 3.82 109.509 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -82.17 134.44 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 2.08 109.449 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.57 -139.45 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.709 -0.849 . . . . 2.17 108.709 179.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -95.29 93.85 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.045 -1.035 . . . . 1.48 108.914 179.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -112.83 141.49 46.58 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.526 -0.734 . . . . 0.72 109.712 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -112.41 159.2 18.95 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.899 -1.148 . . . . 3.26 107.899 178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -140.03 142.29 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.187 -0.946 . . . . 0.23 110.154 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.26 154.46 23.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.517 -1.29 . . . . 0.58 107.517 178.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.6 p90 -155.74 154.8 32.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.8 -1.188 . . . . 0.44 110.199 -178.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 228' ' ' ARG . 2.3 mtm-85 -91.98 153.39 19.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 2.76 109.364 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -95.35 169.66 9.91 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.319 -0.863 . . . . 2.23 109.484 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 37.1 t -87.93 -8.89 55.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.264 -0.898 . . . . 1.8 109.381 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.66 32.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.313 -0.867 . . . . 3.63 109.636 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.0 m-20 -162.11 133.97 4.05 Favored Pre-proline 0 N--CA 1.492 1.653 0 N-CA-C 108.598 -0.89 . . . . 2.16 108.598 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.56 12.07 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.028 1.152 . . . . 1.25 111.125 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 235' ' ' TRP . 9.1 p -83.02 163.03 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.737 -1.227 . . . . 1.75 110.108 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.561 ' N ' HG22 ' A' ' 234' ' ' VAL . 97.6 m95 -74.52 174.12 9.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.805 -0.813 . . . . 0.66 108.805 179.378 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.64 -164.91 1.46 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.311 -0.868 . . . . 1.43 108.81 179.567 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.89 52.71 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.706 -1.358 . . . . 0.39 109.706 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.26 159.89 48.49 Favored 'Trans proline' 0 C--N 1.318 -1.037 0 C-N-CA 121.694 1.596 . . . . 0.41 109.896 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.37 11.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.775 . . . . 0.21 109.19 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -95.29 136.35 35.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.186 -0.946 . . . . 2.72 109.45 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 13.4 tp -87.46 121.49 29.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.642 -0.662 . . . . 0.29 109.339 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.71 -68.94 0.89 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.412 -0.805 . . . . 0.45 110.039 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -94.19 146.96 23.63 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.18 -0.95 . . . . 0.31 109.697 -178.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -148.92 115.81 6.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.199 -0.938 . . . . 2.32 109.076 179.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.44 0.32 Allowed Glycine 0 N--CA 1.498 2.811 0 C-N-CA 119.611 -1.28 . . . . 0.27 110.722 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.38 -155.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -1.122 . . . . 1.39 109.489 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.87 50.38 2.98 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.007 -1.637 . . . . 0.29 109.007 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.02 151.74 35.05 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.29 108.57 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 9.6 m -145.0 132.43 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 0.31 109.796 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.01 134.89 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.67 -1.233 . . . . 0.29 107.67 179.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.41 177.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.313 -0.867 . . . . 0.23 110.216 -178.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.545 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.0 tt0 -141.75 109.65 5.79 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.891 -1.151 . . . . 1.81 107.891 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.28 -79.58 0.3 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.389 -1.338 . . . . 1.18 107.389 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 255' ' ' SER . 26.9 t-20 -80.78 -129.51 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.516 -1.661 . . . . 1.98 106.516 177.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.431 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 36.4 p -104.59 54.04 0.73 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.39 108.04 178.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -156.44 126.66 6.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.496 -0.753 . . . . 1.12 109.195 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.545 ' CG1' HE21 ' A' ' 252' ' ' GLN . 36.1 mt -93.3 135.06 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.47 109.444 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.73 169.07 18.4 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.392 -0.818 . . . . 2.11 109.879 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.71 139.2 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.549 -0.719 . . . . 0.33 109.256 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 27.6 t -133.49 130.87 21.14 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.34 108.882 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.87 141.98 96.27 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.59 0.86 . . . . 0.42 110.192 179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.99 -36.03 67.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.431 -0.793 . . . . 3.12 109.008 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -65.7 -9.63 29.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 3.82 110.369 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -119.91 18.65 12.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.202 -0.936 . . . . 2.08 109.506 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.52 163.76 31.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.384 -0.823 . . . . 0.32 110.064 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.451 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.0 mtmp? -143.17 132.14 22.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.335 -0.853 . . . . 1.79 109.624 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 20.2 mm -89.06 113.58 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.295 -0.878 . . . . 0.45 109.811 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.1 mm -107.11 158.37 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.356 -0.84 . . . . 0.57 108.924 179.193 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' A' ' 268' ' ' ILE . 0.2 OUTLIER -90.74 142.62 27.57 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.229 -0.919 . . . . 3.63 109.145 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.949 -1.024 . . . . 2.05 109.425 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 18.9 mmt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.564 -0.532 . . . . 3.83 109.564 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -82.09 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 2.08 109.445 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.66 -139.35 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.249 -0.907 . . . . 2.16 108.745 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -95.53 93.85 7.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.035 . . . . 1.48 108.923 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -112.74 141.5 46.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.481 -0.762 . . . . 0.73 109.684 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -112.43 159.09 19.08 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 107.849 -1.167 . . . . 3.26 107.849 178.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 96.0 t -139.96 142.32 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.172 -0.955 . . . . 0.23 110.13 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.32 154.43 23.5 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.512 -1.292 . . . . 0.58 107.512 178.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.7 p90 -155.79 154.8 31.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.779 -1.201 . . . . 0.44 110.228 -178.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.478 HH11 ' HG3' ' B' ' 228' ' ' ARG . 2.3 mtm-85 -91.94 153.37 19.53 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 2.76 109.434 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.33 169.65 9.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.342 -0.849 . . . . 2.23 109.44 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 37.5 t -87.83 -8.98 55.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.933 . . . . 1.81 109.4 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -88.47 -16.57 32.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 3.64 109.641 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' B' ' 234' ' ' VAL . 24.1 m-20 -162.23 133.95 3.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.16 108.596 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -64.55 12.06 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 121.006 1.137 . . . . 1.27 111.111 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.563 HG22 ' N ' ' B' ' 235' ' ' TRP . 9.0 p -83.01 163.05 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.777 -1.202 . . . . 1.76 110.101 -179.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.563 ' N ' HG22 ' B' ' 234' ' ' VAL . 97.6 m95 -74.52 174.11 9.44 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.792 -0.818 . . . . 0.67 108.792 179.4 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -129.72 -165.07 1.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.238 -0.914 . . . . 1.44 108.804 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.4 175.81 52.61 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.28 159.82 48.62 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.688 1.592 . . . . 0.41 109.892 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.26 173.5 11.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.447 -0.783 . . . . 0.21 109.175 179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -95.41 136.36 35.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.246 -0.909 . . . . 2.72 109.385 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.44 121.41 29.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.589 -0.694 . . . . 0.3 109.31 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -112.69 -68.97 0.89 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.458 -0.776 . . . . 0.45 110.085 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -94.14 146.89 23.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.029 -1.045 . . . . 0.33 109.778 -179.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -148.92 115.76 5.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.132 -0.98 . . . . 2.33 109.131 179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -151.74 -106.53 0.32 Allowed Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.543 -1.313 . . . . 0.28 110.74 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.29 -155.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -1.122 . . . . 1.4 109.573 -179.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.98 50.47 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.939 -1.664 . . . . 0.29 108.939 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.06 151.85 35.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.577 -0.955 . . . . 0.29 108.544 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.12 132.57 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.112 -0.992 . . . . 0.31 109.747 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.1 134.79 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.754 -1.202 . . . . 0.3 107.754 179.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.24 177.94 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.24 110.27 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.535 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.9 tt0 -141.83 109.7 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.904 -1.147 . . . . 1.81 107.904 178.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -88.39 -79.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.382 -1.34 . . . . 1.18 107.382 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' B' ' 255' ' ' SER . 26.8 t-20 -80.6 -129.62 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.614 -1.624 . . . . 1.97 106.614 177.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.432 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 36.5 p -104.52 54.08 0.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.116 -1.068 . . . . 1.38 108.116 177.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -156.42 126.59 6.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.462 -0.774 . . . . 1.12 109.166 -179.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.535 ' CG1' HE21 ' B' ' 252' ' ' GLN . 36.4 mt -93.21 135.08 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.48 109.394 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -139.78 169.07 18.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 2.13 109.832 -179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.7 t -101.62 139.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.537 -0.727 . . . . 0.34 109.219 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.4 t -133.33 130.9 21.32 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.34 108.954 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.92 141.89 95.94 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.592 0.861 . . . . 0.42 110.203 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -55.83 -36.2 67.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 3.11 108.948 179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -65.6 -9.6 28.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -0.995 . . . . 3.82 110.461 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -119.98 18.67 12.44 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.191 -0.943 . . . . 2.08 109.484 179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.55 163.82 31.83 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.455 -0.778 . . . . 0.32 110.075 -179.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.445 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.0 mtmp? -143.2 132.11 22.82 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.326 -0.859 . . . . 1.79 109.637 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 20.1 mm -89.09 113.59 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.331 -0.856 . . . . 0.45 109.833 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.435 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.0 mm -107.11 158.33 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.46 -0.775 . . . . 0.57 108.93 179.235 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.435 ' N ' HG22 ' B' ' 268' ' ' ILE . 0.2 OUTLIER -90.62 142.68 27.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.197 -0.94 . . . . 3.62 109.108 179.642 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' B' ' 269' ' ' ARG . 2.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.013 -0.994 . . . . 2.05 109.412 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.537 -0.542 . . . . 3.82 109.537 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.772 HD12 ' N ' ' A' ' 220' ' ' ILE . 2.2 mp -83.6 99.11 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 2.08 108.573 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -83.33 -108.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 2.17 109.419 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -97.57 96.7 8.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.222 -0.923 . . . . 1.48 109.427 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.77 126.47 27.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.365 -0.834 . . . . 0.72 108.845 179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 224' ' ' ARG . 0.1 OUTLIER -102.95 156.96 17.31 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.15 -0.968 . . . . 3.26 108.416 179.465 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.19 141.52 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.19 -0.943 . . . . 0.23 110.491 -179.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -107.41 156.41 18.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.621 -1.251 . . . . 0.58 107.621 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 9.7 p90 -155.02 151.56 28.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.686 -1.259 . . . . 0.44 110.809 -179.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -99.11 141.47 31.83 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.613 -0.679 . . . . 2.76 109.347 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 232' ' ' ASP . 16.8 p30 -95.62 175.11 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.276 -0.89 . . . . 2.23 109.009 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.0 t -85.69 -6.24 59.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.312 -0.867 . . . . 1.8 109.19 179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtm180 -88.84 -18.34 27.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.302 -0.874 . . . . 3.63 109.688 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 234' ' ' VAL . 31.5 m-20 -161.95 129.1 2.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.134 -0.978 . . . . 2.16 109.267 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.36 8.55 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 120.653 0.902 . . . . 1.25 110.252 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 232' ' ' ASP . 14.2 t -83.58 158.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.877 -1.14 . . . . 1.75 109.827 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.401 ' N ' HG12 ' A' ' 234' ' ' VAL . 97.5 m95 -74.72 159.9 31.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.66 109.327 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.1 mtpt -118.55 165.12 14.32 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.532 -0.914 . . . . 1.43 108.532 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.89 164.95 0.02 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.499 -1.04 . . . . 0.39 110.499 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -67.88 161.84 42.3 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.728 1.619 . . . . 0.41 110.302 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.82 178.39 7.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.456 -0.778 . . . . 0.21 109.067 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.75 138.76 33.82 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.221 -0.924 . . . . 2.72 108.923 179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.07 123.49 32.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.548 -0.72 . . . . 0.29 109.751 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 31.3 mt -112.44 -76.13 0.6 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.444 -0.785 . . . . 0.45 110.289 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -89.17 143.84 26.55 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.156 -0.965 . . . . 0.31 110.29 -178.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.57 118.5 8.76 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.77 -0.826 . . . . 2.32 108.77 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -113.11 0.45 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.749 -1.215 . . . . 0.27 110.195 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.53 -154.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -1.057 . . . . 1.39 109.573 -179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.43 51.03 3.27 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.434 -1.466 . . . . 0.29 109.434 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.14 153.01 38.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.29 108.641 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 7.7 m -146.95 131.84 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.001 -1.062 . . . . 0.31 109.952 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.8 t -93.39 138.25 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.536 -0.912 . . . . 0.29 108.536 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 22.1 pt -140.37 178.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.302 -0.874 . . . . 0.23 110.05 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.55 HE21 ' CG1' ' A' ' 257' ' ' ILE . 37.3 tt0 -141.1 110.11 6.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.495 -0.928 . . . . 1.81 108.495 179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.72 -79.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.402 -1.332 . . . . 1.18 107.402 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.21 -131.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.492 -1.669 . . . . 1.98 106.492 177.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 75.4 m -104.61 54.67 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.133 -1.062 . . . . 1.39 108.133 177.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.25 124.91 5.9 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.925 -0.769 . . . . 1.12 108.925 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.55 ' CG1' HE21 ' A' ' 252' ' ' GLN . 60.6 mt -90.92 136.02 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.884 . . . . 0.47 109.624 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.26 172.67 12.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.285 -0.885 . . . . 2.11 109.911 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.15 136.96 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.502 -0.749 . . . . 0.33 109.688 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.93 123.34 18.04 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 108.426 -0.953 . . . . 0.34 108.426 179.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.23 139.12 85.45 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 109.854 -0.864 . . . . 0.42 109.854 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -56.6 -33.35 66.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.157 -0.964 . . . . 3.12 109.433 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -68.24 -6.07 21.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 3.82 109.95 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.15 17.67 11.59 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.485 -0.759 . . . . 2.08 109.429 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.71 168.31 20.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.467 -0.771 . . . . 0.32 109.263 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -141.44 131.69 24.98 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.28 -0.888 . . . . 1.79 109.197 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.2 mm -88.02 110.47 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.325 -0.859 . . . . 0.45 109.369 -179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.49 156.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.337 -0.852 . . . . 0.57 109.219 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.38 137.46 33.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.448 -0.783 . . . . 3.63 109.736 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.908 -1.044 . . . . 2.05 109.446 179.485 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.564 -0.532 . . . . 3.83 109.564 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.771 ' N ' HD12 ' B' ' 220' ' ' ILE . 2.2 mp -83.43 99.09 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 2.08 108.652 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -83.24 -108.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 2.16 109.463 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -97.7 96.75 8.47 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.297 -0.877 . . . . 1.48 109.367 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -135.72 126.37 27.16 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.73 108.909 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' B' ' 224' ' ' ARG . 0.1 OUTLIER -102.86 157.0 17.27 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.144 -0.973 . . . . 3.26 108.454 179.431 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.22 141.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.159 -0.963 . . . . 0.23 110.526 -179.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -107.34 156.35 19.0 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 107.648 -1.241 . . . . 0.58 107.648 178.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -154.99 151.5 28.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.601 -1.312 . . . . 0.44 110.837 -179.353 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -98.95 141.3 31.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 2.76 109.426 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 17.0 p30 -95.5 175.19 6.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.157 -0.965 . . . . 2.23 109.008 179.47 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 35.9 t -85.68 -6.36 59.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 1.81 109.261 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -88.75 -18.34 28.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.233 -0.917 . . . . 3.64 109.711 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 31.6 m-20 -161.98 129.11 2.59 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 2.16 109.294 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -66.4 8.58 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 120.659 0.906 . . . . 1.27 110.211 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 14.3 t -83.54 158.12 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.806 -1.184 . . . . 1.76 109.844 -179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.402 ' N ' HG12 ' B' ' 234' ' ' VAL . 97.5 m95 -74.85 159.83 31.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.535 -0.728 . . . . 0.67 109.352 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.2 mtpt -118.47 165.18 14.21 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.544 -0.91 . . . . 1.44 108.544 179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -42.88 164.92 0.02 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.516 -1.033 . . . . 0.4 110.516 -179.064 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.92 161.88 42.17 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.639 1.559 . . . . 0.41 110.302 179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 178.38 7.19 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.533 -0.729 . . . . 0.21 109.156 179.443 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -96.86 138.75 33.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.276 -0.89 . . . . 2.72 108.946 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.6 tp -88.14 123.52 32.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.489 -0.757 . . . . 0.3 109.678 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 31.0 mt -112.42 -76.13 0.6 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.356 -0.84 . . . . 0.45 110.281 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.423 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.2 t90 -89.2 143.64 26.69 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.186 -0.946 . . . . 0.33 110.308 -178.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -145.51 118.47 8.77 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.794 -0.817 . . . . 2.33 108.794 179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.23 -113.13 0.45 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.838 -1.172 . . . . 0.28 110.209 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.55 -154.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.416 -1.049 . . . . 1.4 109.545 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 51.12 3.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.29 109.483 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.13 153.07 38.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -1.098 . . . . 0.29 108.663 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 7.9 m -146.97 131.81 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.31 109.973 -179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 94.4 t -93.41 138.19 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.537 -0.912 . . . . 0.3 108.537 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 22.3 pt -140.31 178.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.176 -0.953 . . . . 0.24 110.111 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.534 HE21 ' CG1' ' B' ' 257' ' ' ILE . 37.4 tt0 -141.09 110.1 6.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.459 -0.941 . . . . 1.81 108.459 179.204 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.75 -79.52 0.33 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.392 -1.336 . . . . 1.18 107.392 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.29 -131.97 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.432 -1.692 . . . . 1.97 106.432 177.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -104.58 54.72 0.72 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.182 -1.044 . . . . 1.38 108.182 177.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -156.22 124.97 5.94 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.931 -0.766 . . . . 1.12 108.931 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.534 ' CG1' HE21 ' B' ' 252' ' ' GLN . 61.1 mt -91.06 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.48 109.571 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -138.19 172.58 12.7 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.346 -0.846 . . . . 2.13 109.96 -179.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.8 t -102.02 136.93 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.443 -0.786 . . . . 0.34 109.737 179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.97 123.34 18.0 Favored Pre-proline 0 N--CA 1.493 1.714 0 N-CA-C 108.424 -0.954 . . . . 0.34 108.424 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.27 139.17 85.72 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 N-CA-C 109.852 -0.865 . . . . 0.42 109.852 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -56.69 -33.14 66.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.9 . . . . 3.11 109.521 179.837 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.38 -6.04 22.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.257 -0.902 . . . . 3.82 109.996 -179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -121.12 17.8 11.61 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.465 -0.772 . . . . 2.08 109.463 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.85 168.41 19.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 0.32 109.227 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -141.47 131.61 24.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.267 -0.896 . . . . 1.79 109.232 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.3 mm -88.08 110.5 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.333 -0.854 . . . . 0.45 109.299 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 29.3 mm -102.48 156.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.344 -0.848 . . . . 0.57 109.143 179.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -94.43 137.45 33.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.522 -0.736 . . . . 3.62 109.724 -179.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.003 -0.998 . . . . 2.05 109.317 179.469 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.27 -0.641 . . . . 3.82 109.27 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.503 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -84.93 107.3 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.218 -0.926 . . . . 2.08 108.981 -179.539 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -85.02 -128.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 2.17 109.69 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -93.57 105.32 17.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.358 -0.839 . . . . 1.48 109.716 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -134.14 145.64 49.47 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.428 -0.795 . . . . 0.72 109.767 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.493 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 11.2 mtp180 -118.95 152.9 35.5 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.567 -1.271 . . . . 3.26 107.567 178.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 70.6 t -139.25 142.0 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.121 -0.987 . . . . 0.23 110.431 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -108.39 158.34 17.59 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.684 -1.228 . . . . 0.58 107.684 178.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 15.8 p90 -156.64 152.38 27.07 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.722 -1.236 . . . . 0.44 110.509 -178.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -93.46 154.13 18.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.389 -0.819 . . . . 2.76 109.59 179.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -94.73 170.14 9.67 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.349 -0.844 . . . . 2.23 109.183 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.0 t -89.66 -13.45 37.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.89 . . . . 1.8 109.46 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 58.9 mtp180 -88.21 -14.6 38.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.16 -0.963 . . . . 3.63 109.373 179.746 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 234' ' ' VAL . 50.1 m-20 -162.22 130.04 2.76 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 2.16 108.718 179.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.57 19.37 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 120.759 0.973 . . . . 1.25 110.794 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 235' ' ' TRP . 7.7 p -84.47 158.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.778 -1.201 . . . . 1.75 110.197 -179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.518 ' N ' HG22 ' A' ' 234' ' ' VAL . 96.8 m95 -76.66 165.9 24.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.709 -0.62 . . . . 0.66 109.937 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.72 -166.94 1.29 Allowed 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.61 -0.885 . . . . 1.43 108.61 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.14 52.22 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.703 -1.359 . . . . 0.39 109.703 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.64 149.56 61.46 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.671 1.58 . . . . 0.41 109.862 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.63 169.21 17.89 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.87 -0.789 . . . . 0.21 108.87 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -92.75 138.73 31.24 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.088 -1.007 . . . . 2.72 109.502 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 16.8 tp -87.84 118.82 27.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.677 -0.64 . . . . 0.29 109.38 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 20.3 mt -107.01 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.358 -0.839 . . . . 0.45 110.154 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -92.9 146.62 23.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.324 -0.86 . . . . 0.31 110.714 -178.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -150.29 117.01 5.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.452 -0.78 . . . . 2.32 109.14 179.127 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.87 -104.72 0.26 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.949 -1.261 . . . . 0.27 109.949 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -67.05 -155.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -1.112 . . . . 1.39 109.632 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.88 49.38 2.83 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.94 152.2 38.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -1.091 . . . . 0.29 108.542 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 10.0 m -144.21 132.67 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.31 109.677 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.05 133.81 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.812 -1.181 . . . . 0.29 107.812 178.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.14 -177.87 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.325 -0.859 . . . . 0.23 110.384 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.577 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.1 tt0 -142.35 112.17 6.84 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.345 -0.983 . . . . 1.81 108.345 178.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.5 -84.55 0.22 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.596 -1.261 . . . . 1.18 107.596 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -78.16 -127.96 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.486 -1.672 . . . . 1.98 106.486 177.488 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.661 ' N ' HD22 ' A' ' 254' ' ' ASN . 9.7 p -105.05 52.98 0.73 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.135 -0.978 . . . . 1.39 108.659 178.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -155.45 131.03 9.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 1.12 109.276 -179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.577 ' CG1' HE21 ' A' ' 252' ' ' GLN . 58.1 mt -93.06 135.91 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.47 109.486 -179.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.04 165.26 26.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.377 -0.827 . . . . 2.11 109.75 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.44 136.77 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.489 -0.757 . . . . 0.33 108.978 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 26.7 t -134.36 132.08 20.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.435 -0.791 . . . . 0.34 108.892 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.25 148.65 85.13 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.641 0.894 . . . . 0.42 109.931 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.344 -0.848 . . . . 3.12 109.075 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.29 -8.62 47.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.434 -0.791 . . . . 3.82 110.249 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -119.24 19.17 12.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.428 -0.795 . . . . 2.08 108.94 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.54 164.01 31.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.487 -0.758 . . . . 0.32 109.463 -179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.5 mtmp? -140.41 130.95 25.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.329 -0.857 . . . . 1.79 109.44 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 25.1 mm -89.02 111.54 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.366 -0.834 . . . . 0.45 110.101 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 269' ' ' ARG . 7.0 mm -109.0 157.46 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.486 -0.759 . . . . 0.57 108.975 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 268' ' ' ILE . 83.8 mtm180 -91.44 140.72 29.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.845 . . . . 3.63 109.155 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 2.05 109.176 179.523 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.935 -0.765 . . . . 3.83 108.935 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.504 HD13 ' N ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -85.12 107.18 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.077 -1.014 . . . . 2.08 108.919 -179.462 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -84.81 -128.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 2.16 109.76 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -93.7 105.29 17.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 1.48 109.617 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -134.12 145.44 49.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.447 -0.783 . . . . 0.73 109.791 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.484 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 11.0 mtp180 -118.82 152.97 35.26 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.481 -1.303 . . . . 3.26 107.481 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.1 t -139.14 142.21 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.167 -0.958 . . . . 0.23 110.469 -178.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -108.56 158.29 17.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.651 -1.24 . . . . 0.58 107.651 178.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 15.5 p90 -156.63 152.38 27.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.698 -1.251 . . . . 0.44 110.545 -178.687 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -93.33 153.91 18.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.243 -0.911 . . . . 2.76 109.608 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -94.63 170.13 9.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.25 -0.906 . . . . 2.23 109.154 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 26.8 t -89.69 -13.37 37.1 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 1.81 109.507 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' B' ' 232' ' ' ASP . 58.8 mtp180 -88.32 -14.5 38.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.138 -0.976 . . . . 3.64 109.319 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' B' ' 234' ' ' VAL . 50.6 m-20 -162.29 129.98 2.72 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 2.16 108.771 179.714 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.62 19.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 120.804 1.003 . . . . 1.27 110.697 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' B' ' 232' ' ' ASP . 7.7 p -84.35 158.79 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.869 -1.144 . . . . 1.76 110.243 -179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.523 ' N ' HG22 ' B' ' 234' ' ' VAL . 96.8 m95 -76.65 166.18 23.74 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.806 -0.559 . . . . 0.67 109.983 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -118.79 -166.98 1.3 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.689 -0.856 . . . . 1.44 108.689 179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.07 52.18 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.713 -1.355 . . . . 0.4 109.713 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.69 149.52 61.11 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.762 1.641 . . . . 0.41 109.884 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -135.74 169.06 18.15 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.963 -0.754 . . . . 0.21 108.963 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.58 138.55 31.41 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.987 . . . . 2.72 109.52 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.75 118.96 27.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.724 -0.61 . . . . 0.3 109.414 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.25 -73.9 0.67 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.388 -0.82 . . . . 0.45 110.103 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -92.91 146.47 23.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.323 -0.861 . . . . 0.33 110.661 -178.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -150.1 117.03 5.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.444 -0.785 . . . . 2.33 109.164 179.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.89 -104.69 0.26 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.948 -1.261 . . . . 0.28 109.948 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.03 -155.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.303 -1.116 . . . . 1.4 109.612 -179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.94 49.42 2.86 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.276 -1.529 . . . . 0.29 109.276 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.42 38.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.389 -1.065 . . . . 0.29 108.494 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 9.9 m -144.46 132.68 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.064 -1.023 . . . . 0.31 109.648 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.6 t -96.12 133.76 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.843 -1.169 . . . . 0.3 107.843 178.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 18.6 pt -138.13 -177.72 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 0.24 110.292 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.58 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.1 tt0 -142.48 112.2 6.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.334 -0.987 . . . . 1.81 108.334 178.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -89.59 -84.54 0.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.552 -1.277 . . . . 1.18 107.552 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.663 HD22 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -78.12 -128.03 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.489 -1.671 . . . . 1.97 106.489 177.561 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.663 ' N ' HD22 ' B' ' 254' ' ' ASN . 9.6 p -105.1 53.02 0.73 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.145 -0.972 . . . . 1.38 108.586 178.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -155.32 131.06 9.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.491 -0.756 . . . . 1.12 109.276 -179.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.58 ' CG1' HE21 ' B' ' 252' ' ' GLN . 58.1 mt -93.05 135.98 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.142 -0.974 . . . . 0.48 109.413 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -137.06 165.4 26.12 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.362 -0.836 . . . . 2.13 109.67 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.68 137.05 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.045 -0.724 . . . . 0.34 109.045 179.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.6 132.1 20.59 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.346 -0.846 . . . . 0.34 108.935 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.26 148.72 84.87 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 N-CA-C 109.911 -0.842 . . . . 0.42 109.911 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -62.03 -32.84 73.39 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.282 -0.886 . . . . 3.11 108.997 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -69.33 -8.48 46.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.384 -0.823 . . . . 3.82 110.235 -179.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -119.31 19.18 12.85 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.448 -0.782 . . . . 2.08 108.986 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.91 31.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.564 -0.71 . . . . 0.32 109.447 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.5 mtmp? -140.4 130.97 25.49 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.258 -0.901 . . . . 1.79 109.479 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 24.9 mm -89.04 111.46 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.362 -0.836 . . . . 0.45 110.102 -179.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.418 HG22 ' N ' ' B' ' 269' ' ' ARG . 7.1 mm -108.99 157.48 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.985 -0.746 . . . . 0.57 108.985 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.418 ' N ' HG22 ' B' ' 268' ' ' ILE . 83.8 mtm180 -91.43 140.69 29.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 3.62 109.159 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 8.6 m-20 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.009 -1.057 . . . . 2.05 109.064 179.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.275 -0.639 . . . . 3.82 109.275 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.762 HD12 ' N ' ' A' ' 220' ' ' ILE . 1.8 mp -84.67 136.89 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.257 -0.902 . . . . 2.08 109.181 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -82.67 -141.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 2.17 109.758 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -92.95 107.2 19.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.279 -0.888 . . . . 1.48 109.756 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.34 143.09 50.56 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.591 -0.693 . . . . 0.72 109.594 179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 50.1 mtt180 -108.08 157.79 17.96 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.456 -1.313 . . . . 3.26 107.456 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.47 141.39 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.785 -1.197 . . . . 0.23 110.954 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.39 155.86 20.73 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.674 -1.602 . . . . 0.58 106.674 177.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -154.11 166.94 31.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.462 -1.399 . . . . 0.44 110.654 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 228' ' ' ARG . 0.0 OUTLIER -90.62 137.53 32.29 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.322 0.582 . . . . 2.76 109.453 179.786 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -94.39 160.97 14.42 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.545 -0.722 . . . . 2.23 109.432 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 68.9 m -86.81 -6.51 58.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.102 -0.999 . . . . 1.8 109.575 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -88.26 -20.36 25.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 3.63 109.628 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 234' ' ' VAL . 24.4 m-20 -162.19 140.29 6.73 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 2.16 108.7 179.506 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -64.57 2.82 1.05 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.869 1.046 . . . . 1.25 110.378 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 235' ' ' TRP . 7.3 m -84.56 141.74 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.853 -1.155 . . . . 1.75 110.141 -179.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CZ2' ' NH1' ' A' ' 228' ' ' ARG . 97.2 m95 -52.32 -177.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.345 -0.847 . . . . 0.66 109.19 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.444 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 1.9 ttpp -131.77 -156.64 0.77 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.272 -0.893 . . . . 1.43 109.11 179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.28 -178.6 52.46 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.59 -1.404 . . . . 0.39 109.59 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.64 159.84 47.83 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 C-N-CA 121.571 1.514 . . . . 0.41 110.19 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 169.07 18.27 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.92 -0.77 . . . . 0.21 108.92 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -93.24 139.24 30.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.12 -0.987 . . . . 2.72 109.223 179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 14.4 tp -89.27 117.31 28.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.419 -0.801 . . . . 0.29 109.631 -179.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 mt -107.0 -73.61 0.68 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.291 -0.88 . . . . 0.45 110.005 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -90.77 141.56 28.68 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.31 110.531 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.73 113.95 5.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.33 -0.856 . . . . 2.32 109.361 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.01 -107.98 0.29 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.89 -1.284 . . . . 0.27 109.89 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -60.05 -158.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 1.39 109.833 -179.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.85 46.88 2.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.703 -1.359 . . . . 0.29 109.703 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.23 148.39 32.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -1.106 . . . . 0.29 108.867 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 13.0 m -142.19 129.61 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.912 . . . . 0.31 109.744 -179.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.25 137.72 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.203 -1.036 . . . . 0.29 108.203 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 14.7 pt -140.27 -179.22 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.192 -0.943 . . . . 0.23 110.452 -179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.486 HE21 ' CG1' ' A' ' 257' ' ' ILE . 39.6 tt0 -144.19 110.29 5.42 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.81 -0.811 . . . . 1.81 108.81 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.42 -78.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.378 -1.342 . . . . 1.18 107.378 179.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -80.04 -134.54 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.445 -1.687 . . . . 1.98 106.445 177.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 12.9 p -102.15 54.36 0.8 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.009 -1.108 . . . . 1.39 108.009 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.48 126.43 7.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.705 . . . . 1.12 109.337 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.486 ' CG1' HE21 ' A' ' 252' ' ' GLN . 30.1 mt -92.61 137.84 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.339 -0.85 . . . . 0.47 109.61 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -140.73 170.63 15.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.404 -0.81 . . . . 2.11 109.643 -179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.42 139.77 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.33 109.605 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.19 130.22 19.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.645 -0.872 . . . . 0.34 108.645 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.76 141.47 95.68 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 N-CA-C 109.644 -0.945 . . . . 0.42 109.644 179.055 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -59.93 -34.7 73.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.185 -0.947 . . . . 3.12 109.727 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.01 -6.44 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 3.82 110.655 -178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.53 24.0 10.55 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.16 -0.962 . . . . 2.08 109.204 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.19 164.54 28.94 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.085 -0.709 . . . . 0.32 109.085 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.9 mttm -137.77 131.68 31.59 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.247 -0.908 . . . . 1.79 108.87 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.09 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 0.45 109.828 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.98 157.2 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.378 -0.827 . . . . 0.57 108.964 179.274 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 269' ' ' ARG . 3.1 mtt-85 -90.84 143.77 26.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.158 -0.963 . . . . 3.63 109.198 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 18.4 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.104 -0.951 . . . . 2.05 109.448 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 51.1 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.315 -0.624 . . . . 3.83 109.315 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.767 ' N ' HD12 ' B' ' 220' ' ' ILE . 1.8 mp -84.79 137.0 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.227 -0.92 . . . . 2.08 109.253 -179.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -82.47 -141.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 2.16 109.789 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -93.08 107.28 19.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.48 109.705 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -130.54 142.94 50.47 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.694 -0.629 . . . . 0.73 109.48 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.526 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 49.9 mtt180 -108.1 157.76 17.99 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.401 -1.333 . . . . 3.26 107.401 178.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.51 141.17 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.952 -1.092 . . . . 0.23 110.979 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -109.16 155.8 20.6 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.907 -1.516 . . . . 0.58 106.907 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.7 p90 -154.2 166.92 31.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.56 -1.337 . . . . 0.44 110.761 -178.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' B' ' 228' ' ' ARG . 0.0 OUTLIER -90.47 137.41 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.706 -0.621 . . . . 2.76 109.556 179.935 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -94.36 161.02 14.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.416 -0.803 . . . . 2.23 109.333 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 68.7 m -86.79 -6.61 58.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 1.81 109.709 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.17 -20.37 25.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.272 -0.893 . . . . 3.64 109.532 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -162.29 140.11 6.56 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.125 -0.984 . . . . 2.16 108.804 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -64.31 2.74 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 120.857 1.038 . . . . 1.27 110.624 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' B' ' 235' ' ' TRP . 7.5 m -84.54 141.73 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.965 -1.084 . . . . 1.76 110.111 -179.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.577 ' CZ2' ' NH1' ' B' ' 228' ' ' ARG . 97.0 m95 -52.2 -177.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.279 -0.888 . . . . 0.67 109.213 179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.452 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 1.9 ttpp -131.82 -156.71 0.77 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.184 -0.947 . . . . 1.44 109.057 179.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -82.12 -178.43 52.39 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.652 -1.379 . . . . 0.4 109.652 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.81 159.78 47.6 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.543 1.495 . . . . 0.41 110.171 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -142.17 168.98 18.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.876 -0.787 . . . . 0.21 108.876 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -93.23 139.11 30.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 2.72 109.232 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 14.5 tp -89.25 117.26 28.09 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.501 -0.749 . . . . 0.3 109.575 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.99 -73.55 0.68 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.314 -0.866 . . . . 0.45 110.034 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -90.73 141.53 28.7 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.187 -0.946 . . . . 0.33 110.528 -178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -148.63 114.04 5.59 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.372 -0.83 . . . . 2.33 109.255 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.24 -107.82 0.29 Allowed Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.039 -1.224 . . . . 0.28 110.039 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.22 -158.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -1.169 . . . . 1.4 109.704 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.61 46.77 2.02 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.753 -1.339 . . . . 0.29 109.753 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -146.13 148.35 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -1.19 . . . . 0.29 108.872 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.18 129.65 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.328 -0.857 . . . . 0.31 109.796 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.0 t -93.31 137.71 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.229 -1.026 . . . . 0.3 108.229 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 14.8 pt -140.29 -179.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.19 -0.944 . . . . 0.24 110.507 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.487 HE21 ' CG1' ' B' ' 257' ' ' ILE . 39.5 tt0 -144.13 110.14 5.37 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.835 -0.802 . . . . 1.81 108.835 178.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.24 -79.07 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.415 -1.328 . . . . 1.18 107.415 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.96 -134.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.485 -1.672 . . . . 1.97 106.485 177.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 12.8 p -102.04 54.27 0.8 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.994 -1.113 . . . . 1.38 107.994 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -155.55 126.32 6.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.504 -0.748 . . . . 1.12 109.336 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.487 ' CG1' HE21 ' B' ' 252' ' ' GLN . 30.0 mt -92.61 137.82 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.48 109.571 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -140.63 170.74 15.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 2.13 109.544 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.6 t -100.55 139.78 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.364 -0.835 . . . . 0.34 109.608 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 99.7 t -135.13 130.19 19.24 Favored Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 108.602 -0.888 . . . . 0.34 108.602 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 141.5 95.92 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.589 -0.966 . . . . 0.42 109.589 179.037 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.89 -34.6 73.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 3.11 109.782 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -69.07 -6.44 28.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.208 -0.933 . . . . 3.82 110.602 -179.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.65 24.09 10.46 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.132 -0.98 . . . . 2.08 109.294 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.38 164.49 29.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.892 -0.781 . . . . 0.32 108.892 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -137.7 131.85 31.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.259 -0.9 . . . . 1.79 108.965 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 15.3 mm -88.5 107.25 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.351 -0.843 . . . . 0.45 109.632 -179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.25 157.32 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.796 -0.816 . . . . 0.57 108.796 179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' B' ' 269' ' ' ARG . 3.1 mtt-85 -91.02 143.76 26.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.241 -0.912 . . . . 3.62 109.176 179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 18.3 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.03 -0.986 . . . . 2.05 109.464 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.444 -0.576 . . . . 3.82 109.444 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.02 139.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.263 -0.898 . . . . 2.08 109.228 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.35 -116.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 2.17 109.734 -179.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.3 m-20 -99.27 107.62 19.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.233 -0.917 . . . . 1.48 108.974 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -135.28 126.99 29.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.516 -0.74 . . . . 0.72 109.21 179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -100.98 158.67 15.82 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.143 -1.058 . . . . 3.26 108.143 179.183 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.83 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.208 -0.933 . . . . 0.23 110.312 -179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -111.2 156.85 20.82 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.056 -1.091 . . . . 0.58 108.056 178.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 8.8 p90 -155.49 153.26 30.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.806 -1.184 . . . . 0.44 110.377 -179.044 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.632 HH21 ' CA ' ' A' ' 233' ' ' PRO . 21.4 mtp180 -96.84 145.67 25.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 2.76 109.801 -179.704 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.52 163.94 12.83 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.42 -0.8 . . . . 2.23 108.928 179.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 20.2 m -82.65 -3.17 55.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 1.8 109.313 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.47 -17.26 30.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.865 . . . . 3.63 109.442 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 234' ' ' VAL . 22.5 m-20 -162.62 133.8 3.73 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.266 -0.897 . . . . 2.16 108.892 179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.632 ' CA ' HH21 ' A' ' 228' ' ' ARG . 6.8 Cg_endo -64.88 5.85 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 120.839 1.026 . . . . 1.25 110.458 179.871 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' A' ' 232' ' ' ASP . 6.4 m -83.34 154.16 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.94 -1.1 . . . . 1.75 109.786 -179.627 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.34 -171.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.66 108.782 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.48 -155.74 0.62 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.141 -0.975 . . . . 1.43 109.251 179.727 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.17 173.97 52.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.874 -1.291 . . . . 0.39 109.874 -179.568 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.03 157.82 46.45 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.78 1.653 . . . . 0.41 110.297 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.59 174.3 10.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.21 109.194 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.44 142.76 27.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.168 -0.958 . . . . 2.72 109.463 179.747 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -89.23 124.48 34.42 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.318 -0.623 . . . . 0.29 109.318 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 35.8 mt -115.88 -74.12 0.62 Allowed 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.499 -0.75 . . . . 0.45 110.207 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -92.25 142.08 27.86 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.284 -0.885 . . . . 0.31 110.396 -178.522 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.89 7.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.865 . . . . 2.32 109.231 179.265 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.82 -103.87 0.21 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.982 -1.247 . . . . 0.27 109.982 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.76 -156.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -1.08 . . . . 1.39 109.647 -179.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.19 50.57 3.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.279 -1.529 . . . . 0.29 109.279 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.26 152.93 36.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.466 -1.02 . . . . 0.29 108.811 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.47 129.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 0.31 109.535 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.0 t -90.37 139.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.509 -0.923 . . . . 0.29 108.509 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 16.6 pt -139.42 176.31 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.277 -0.889 . . . . 0.23 110.243 -179.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.558 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.5 tt0 -144.96 113.33 6.6 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.85 -0.796 . . . . 1.81 108.85 178.93 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -91.09 -79.88 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.44 -1.319 . . . . 1.18 107.44 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.64 -131.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.756 -1.572 . . . . 1.98 106.756 177.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.0 p -103.83 55.72 0.73 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.983 -1.117 . . . . 1.39 107.983 177.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -156.0 125.5 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.079 -0.712 . . . . 1.12 109.079 -179.433 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.558 ' CG1' HE21 ' A' ' 252' ' ' GLN . 66.8 mt -91.78 136.97 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.238 -0.914 . . . . 0.47 109.611 -179.493 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.1 166.4 23.46 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 2.11 110.032 -179.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.89 140.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.492 -0.755 . . . . 0.33 109.534 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.62 127.94 16.75 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.357 -0.84 . . . . 0.34 108.863 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.68 144.5 99.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.614 0.876 . . . . 0.42 110.363 179.637 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -59.02 -28.88 66.82 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.447 -0.946 . . . . 3.12 108.447 179.139 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -70.41 -13.58 62.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.468 -0.77 . . . . 3.82 110.805 -179.031 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -120.65 23.99 10.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.317 -0.864 . . . . 2.08 109.644 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.97 163.07 33.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.443 -0.786 . . . . 0.32 109.634 -179.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.469 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 8.2 mtmp? -140.74 125.03 17.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.408 -0.807 . . . . 1.79 108.969 179.664 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 31.1 mm -89.08 112.11 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.246 -0.909 . . . . 0.45 110.128 -179.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.94 150.08 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 108.487 -0.931 . . . . 0.57 108.487 179.149 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -92.7 143.68 26.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.475 -0.766 . . . . 3.63 109.382 179.522 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.969 -1.015 . . . . 2.05 109.418 179.713 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.468 -0.567 . . . . 3.83 109.468 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.94 139.49 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.217 -0.927 . . . . 2.08 109.251 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -85.29 -116.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.432 -0.793 . . . . 2.16 109.776 -179.4 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' B' ' 222' ' ' ASN . 1.4 m-20 -99.21 107.74 20.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.326 -0.859 . . . . 1.48 109.011 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -135.3 127.04 29.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.45 -0.781 . . . . 0.73 109.16 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -100.98 158.68 15.82 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.124 -1.065 . . . . 3.26 108.124 179.16 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 58.5 t -143.1 141.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.23 110.284 -179.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -111.23 156.93 20.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.061 -1.089 . . . . 0.58 108.061 178.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 8.7 p90 -155.52 153.38 30.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.749 -1.219 . . . . 0.44 110.282 -178.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.646 HH21 ' CA ' ' B' ' 233' ' ' PRO . 21.5 mtp180 -97.01 145.62 25.77 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.6 -0.688 . . . . 2.76 109.754 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.5 163.95 12.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 2.23 108.997 179.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 20.1 m -82.68 -3.06 55.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 1.81 109.412 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -88.59 -17.21 30.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.39 -0.819 . . . . 3.64 109.41 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' B' ' 234' ' ' VAL . 22.7 m-20 -162.62 133.71 3.7 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 2.16 108.921 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.646 ' CA ' HH21 ' B' ' 228' ' ' ARG . 6.8 Cg_endo -64.79 5.75 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 120.858 1.039 . . . . 1.27 110.488 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' B' ' 232' ' ' ASP . 6.4 m -83.29 154.12 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.908 -1.12 . . . . 1.76 109.813 -179.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.38 -171.48 0.26 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.67 108.759 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -138.45 -155.71 0.62 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.142 -0.974 . . . . 1.44 109.264 179.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -83.14 174.04 52.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.914 -1.275 . . . . 0.4 109.914 -179.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.07 157.81 46.27 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 121.745 1.63 . . . . 0.41 110.297 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -141.65 174.24 10.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.488 -0.757 . . . . 0.21 109.163 179.154 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -95.34 142.62 27.51 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.069 -1.02 . . . . 2.72 109.475 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -89.14 124.42 34.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.624 -0.672 . . . . 0.3 109.475 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 36.1 mt -115.89 -74.14 0.62 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.388 -0.82 . . . . 0.45 110.156 -179.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.45 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 4.5 t90 -92.26 142.08 27.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.33 110.337 -178.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -147.41 117.85 7.44 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.309 -0.869 . . . . 2.33 109.223 179.244 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.77 -104.01 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.956 -1.257 . . . . 0.28 109.956 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -64.72 -156.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 1.4 109.632 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.13 50.58 3.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.272 -1.531 . . . . 0.29 109.272 179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -149.28 152.87 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.443 -1.034 . . . . 0.29 108.867 179.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.41 129.52 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.139 -0.975 . . . . 0.31 109.525 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.39 139.65 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.084 -1.01 . . . . 0.3 108.543 179.531 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 16.5 pt -139.48 176.22 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.264 -0.897 . . . . 0.24 110.206 -179.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.567 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.5 tt0 -144.95 113.46 6.66 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 1.81 108.811 178.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -91.1 -80.05 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.345 -1.354 . . . . 1.18 107.345 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.47 -131.41 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.737 -1.579 . . . . 1.97 106.737 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 86.9 p -103.76 55.57 0.74 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.051 -1.092 . . . . 1.38 108.051 177.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -155.96 125.53 6.33 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.023 -0.732 . . . . 1.12 109.023 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.567 ' CG1' HE21 ' B' ' 252' ' ' GLN . 67.0 mt -91.77 136.92 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.289 -0.882 . . . . 0.48 109.611 -179.489 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -136.14 166.41 23.47 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.398 -0.814 . . . . 2.13 109.985 -179.109 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.97 140.66 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.483 -0.761 . . . . 0.34 109.472 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 64.5 t -136.63 127.95 16.74 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.338 -0.852 . . . . 0.34 108.897 179.613 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.8 144.49 99.56 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 120.621 0.881 . . . . 0.42 110.253 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -58.91 -29.01 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.416 -0.957 . . . . 3.11 108.416 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -70.4 -13.55 62.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.462 -0.774 . . . . 3.82 110.76 -178.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -120.69 24.06 10.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.256 -0.902 . . . . 2.08 109.563 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.1 33.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.436 -0.79 . . . . 0.32 109.633 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' B' ' 266' ' ' LYS . 8.1 mtmp? -140.71 125.06 17.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 1.79 108.953 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 31.0 mm -89.04 112.1 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.285 -0.884 . . . . 0.45 110.135 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.4 mm -105.88 150.08 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 108.513 -0.921 . . . . 0.57 108.513 179.098 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -92.8 143.63 26.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.406 -0.808 . . . . 3.62 109.316 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.044 -0.979 . . . . 2.05 109.49 179.734 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 57.9 mmm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.258 -0.645 . . . . 3.82 109.258 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.3 pt -83.96 141.14 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.892 . . . . 2.08 109.829 -179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -87.57 -131.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 2.17 110.12 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -92.29 106.71 18.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.433 -0.792 . . . . 1.48 109.04 179.812 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.3 146.4 49.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.567 -0.708 . . . . 0.72 109.528 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -120.95 153.46 37.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.652 -1.24 . . . . 3.26 107.652 178.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.67 143.47 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.247 -0.908 . . . . 0.23 109.892 -179.772 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.94 157.36 19.34 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.117 -1.438 . . . . 0.58 107.117 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 19.2 p90 -156.87 160.44 39.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.539 -1.35 . . . . 0.44 110.499 -179.354 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -97.72 153.78 18.02 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.648 -0.657 . . . . 2.76 109.953 179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -96.39 175.16 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.505 -0.747 . . . . 2.23 109.351 179.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 83.6 p -91.55 -16.78 26.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 1.8 109.248 179.626 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -82.15 -12.55 58.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 3.63 109.581 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 234' ' ' VAL . 46.1 m-20 -162.36 130.32 2.78 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.142 -0.974 . . . . 2.16 109.281 -179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -65.16 12.15 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 120.677 0.918 . . . . 1.25 110.041 179.201 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' A' ' 232' ' ' ASP . 41.0 t -84.62 160.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.064 -1.022 . . . . 1.75 109.521 -179.746 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.46 ' N ' HG12 ' A' ' 234' ' ' VAL . 99.4 m95 -75.09 168.68 19.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.524 -0.735 . . . . 0.66 109.092 179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.95 -165.16 1.31 Allowed 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.1 -1.074 . . . . 1.43 108.1 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.36 178.14 47.83 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.385 -1.388 . . . . 0.39 109.882 -179.508 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.17 158.06 55.83 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.558 1.505 . . . . 0.41 109.904 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.11 169.22 18.16 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.743 -0.836 . . . . 0.21 108.743 179.3 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -91.74 139.0 31.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.025 -1.047 . . . . 2.72 109.398 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.17 123.7 33.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.654 -0.654 . . . . 0.29 109.71 -179.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 23.6 mt -113.91 -73.56 0.65 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.493 -0.755 . . . . 0.45 109.768 -179.812 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -94.95 145.98 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.112 -0.993 . . . . 0.31 110.321 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.27 120.05 8.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.364 -0.835 . . . . 2.32 109.121 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.45 -116.98 0.57 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.27 110.63 -179.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -62.58 -145.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.516 -0.991 . . . . 1.39 110.041 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.95 52.54 2.89 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.695 -1.362 . . . . 0.29 109.695 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.55 146.46 21.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.961 -1.317 . . . . 0.29 110.508 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 262' ' ' ARG . 1.7 m -142.64 121.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.448 -0.945 . . . . 0.31 108.448 178.581 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 58.1 t -84.42 134.46 26.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.418 -0.956 . . . . 0.29 108.418 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 13.4 pt -138.87 178.88 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.416 -0.802 . . . . 0.23 109.886 -179.117 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -140.96 109.78 6.06 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.328 -0.989 . . . . 1.81 108.328 178.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -90.61 -78.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.582 -1.266 . . . . 1.18 107.582 179.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.856 HD22 ' H ' ' A' ' 255' ' ' SER . 8.2 t30 -80.99 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.637 -1.616 . . . . 1.98 106.637 177.56 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.856 ' H ' HD22 ' A' ' 254' ' ' ASN . 15.3 t -105.43 51.99 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.604 -0.887 . . . . 1.39 108.604 178.274 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -155.94 130.46 8.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.841 . . . . 1.12 109.402 -179.52 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.425 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 76.6 mt -92.5 136.92 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.47 109.455 -179.669 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -140.06 170.92 14.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.358 -0.839 . . . . 2.11 109.735 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.44 140.75 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.424 -0.797 . . . . 0.33 109.632 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.58 129.89 16.63 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.244 -0.91 . . . . 0.34 109.163 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -64.17 148.82 91.21 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 120.825 1.017 . . . . 0.42 109.637 179.132 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HG3' HH11 ' A' ' 262' ' ' ARG . 18.3 mmm-85 -56.66 -36.96 70.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.905 -1.122 . . . . 3.12 108.685 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -63.57 -8.1 8.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.886 -0.509 . . . . 3.82 110.537 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -122.61 14.1 10.16 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.3 -0.875 . . . . 2.08 108.712 179.309 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.02 159.53 41.92 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.32 109.275 179.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.66 131.88 38.27 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.356 -0.84 . . . . 1.79 109.005 179.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.53 108.97 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.306 -0.871 . . . . 0.45 109.954 -179.604 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.6 mm -106.95 151.99 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.624 -0.88 . . . . 0.57 108.624 178.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.538 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.8 OUTLIER -90.17 147.95 23.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 3.63 109.087 179.311 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.022 -0.989 . . . . 2.05 109.416 179.777 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 57.8 mmm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.202 -0.666 . . . . 3.83 109.202 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 3.2 pt -84.19 141.18 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.393 -0.817 . . . . 2.08 109.774 -179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -87.67 -131.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 2.16 109.94 -179.736 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -92.6 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.399 -0.813 . . . . 1.48 109.041 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -134.29 146.52 50.09 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.601 -0.687 . . . . 0.73 109.493 -179.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -121.09 153.4 37.5 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.628 -1.249 . . . . 3.26 107.628 178.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.58 143.7 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.25 -0.906 . . . . 0.23 109.828 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -110.19 157.33 19.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.222 -1.399 . . . . 0.58 107.222 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 19.0 p90 -156.99 160.55 39.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.442 -1.411 . . . . 0.44 110.501 -179.276 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -97.78 153.72 18.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.691 . . . . 2.76 109.948 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -96.56 175.12 6.51 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.271 -0.893 . . . . 2.23 109.288 179.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 82.2 p -91.35 -16.57 27.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.142 -0.974 . . . . 1.81 109.223 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -82.27 -12.6 57.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 3.64 109.694 179.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' B' ' 234' ' ' VAL . 46.6 m-20 -162.27 130.16 2.77 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.049 -1.032 . . . . 2.16 109.307 -179.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.2 12.25 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 120.664 0.909 . . . . 1.27 109.957 179.291 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.527 ' H ' ' C ' ' B' ' 232' ' ' ASP . 40.9 t -84.84 160.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -0.978 . . . . 1.76 109.501 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.459 ' N ' HG12 ' B' ' 234' ' ' VAL . 99.5 m95 -75.06 168.43 19.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 0.67 109.108 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -123.71 -165.03 1.29 Allowed 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.216 -1.031 . . . . 1.44 108.216 178.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -75.28 178.01 47.84 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.425 -1.369 . . . . 0.4 109.841 -179.51 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.88 158.17 56.23 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 121.602 1.535 . . . . 0.41 109.984 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.34 168.82 18.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.728 -0.841 . . . . 0.21 108.728 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -91.4 138.91 31.21 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.026 -1.046 . . . . 2.72 109.515 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.12 123.76 33.1 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.645 -0.66 . . . . 0.3 109.726 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.08 -73.71 0.65 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.507 -0.746 . . . . 0.45 109.722 -179.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.425 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 6.8 t90 -94.77 146.0 24.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.181 -0.949 . . . . 0.33 110.313 -179.139 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -147.4 120.29 8.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.332 -0.855 . . . . 2.33 109.145 178.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.5 -116.74 0.56 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.649 -1.262 . . . . 0.28 110.628 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -63.04 -145.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.997 . . . . 1.4 109.998 -179.041 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -75.91 52.36 2.85 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.64 -1.384 . . . . 0.29 109.64 -179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -156.57 146.4 20.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.994 -1.297 . . . . 0.29 110.591 -179.44 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . 0.404 HG13 ' HD2' ' B' ' 262' ' ' ARG . 1.7 m -142.58 121.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.492 -0.929 . . . . 0.31 108.492 178.714 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.39 134.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.464 -0.939 . . . . 0.3 108.464 179.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 13.9 pt -138.92 178.75 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.327 -0.858 . . . . 0.24 109.892 -179.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -141.0 109.7 6.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.323 -0.992 . . . . 1.81 108.323 178.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -90.42 -78.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.619 -1.252 . . . . 1.18 107.619 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.839 HD22 ' H ' ' B' ' 255' ' ' SER . 8.3 t30 -80.87 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.677 -1.601 . . . . 1.97 106.677 177.626 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.839 ' H ' HD22 ' B' ' 254' ' ' ASN . 16.4 t -105.42 52.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.267 -0.896 . . . . 1.38 108.584 178.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -156.06 130.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 1.12 109.293 -179.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . . . . . . . . . 76.7 mt -92.74 136.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.48 109.413 -179.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.93 170.58 15.6 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.408 -0.808 . . . . 2.13 109.694 -178.992 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.16 140.9 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 0.34 109.654 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.2 t -137.76 129.77 16.37 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.297 -0.877 . . . . 0.34 109.119 179.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.93 148.76 91.61 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 120.828 1.019 . . . . 0.42 109.755 179.087 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' B' ' 262' ' ' ARG . 18.0 mmm-85 -56.49 -37.47 70.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 3.11 108.622 179.247 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -63.12 -8.21 7.3 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 116.099 -0.5 . . . . 3.82 110.492 -178.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -122.6 14.04 10.15 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.296 -0.877 . . . . 2.08 108.688 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -138.82 159.87 41.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.552 -0.717 . . . . 0.32 109.323 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -134.89 131.92 37.89 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 1.79 109.021 179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.2 mm -88.64 109.14 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.321 -0.862 . . . . 0.45 109.976 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.8 mm -107.09 152.07 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 108.594 -0.891 . . . . 0.57 108.594 178.979 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.535 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.8 OUTLIER -90.21 147.85 23.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.377 -0.827 . . . . 3.62 109.007 179.406 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 118.077 -0.964 . . . . 2.05 109.37 179.641 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.381 -0.6 . . . . 3.82 109.381 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.572 ' O ' HD12 ' A' ' 220' ' ' ILE . 0.9 OUTLIER -82.57 138.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.195 -0.941 . . . . 2.08 108.643 179.801 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -88.42 -126.42 0.05 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.965 -1.084 . . . . 2.17 109.772 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -94.92 99.99 11.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.276 -0.89 . . . . 1.48 109.147 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -135.5 128.9 32.24 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.505 -0.747 . . . . 0.72 109.301 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 224' ' ' ARG . 4.7 ptt-85 -109.65 162.59 14.28 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.141 -1.059 . . . . 3.26 108.141 178.461 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.214 -0.929 . . . . 0.23 110.814 -178.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -108.65 153.16 23.81 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.335 -1.357 . . . . 0.58 107.335 178.168 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.3 p90 -157.13 151.04 24.61 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.516 -1.365 . . . . 0.44 110.432 -179.276 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.55 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 34.9 mtm180 -96.45 154.11 17.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.53 -0.731 . . . . 2.76 109.606 179.715 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 230' ' ' SER . 11.9 t70 -95.07 166.14 12.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 2.23 108.804 179.27 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 2.9 t -82.13 -7.26 59.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 1.8 109.171 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.73 -19.54 23.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 3.63 109.967 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.63 3.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.123 -0.986 . . . . 2.16 109.173 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -64.69 15.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 120.842 1.028 . . . . 1.25 110.679 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 232' ' ' ASP . 26.0 m -82.51 131.84 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.927 -1.108 . . . . 1.75 109.82 -179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.9 0.1 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.233 -0.917 . . . . 0.66 109.465 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 237' ' ' GLY . 49.1 tttp -136.25 158.31 44.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.275 -0.891 . . . . 1.43 109.153 179.249 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -42.03 164.81 0.02 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.617 -0.993 . . . . 0.39 110.617 -179.326 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -66.56 159.44 50.74 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.614 1.543 . . . . 0.41 110.378 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.43 175.32 9.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.898 -0.779 . . . . 0.21 108.898 179.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.34 135.67 33.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.167 -0.958 . . . . 2.72 109.676 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.19 123.46 32.24 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.151 -0.685 . . . . 0.29 109.151 -179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.8 mt -115.87 -72.27 0.7 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.416 -0.803 . . . . 0.45 110.125 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.78 137.46 32.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.221 -0.924 . . . . 0.31 110.067 -178.843 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.1 116.95 8.22 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.291 -0.881 . . . . 2.32 108.89 179.284 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.64 0.19 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.927 -1.269 . . . . 0.27 109.927 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.19 -157.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 1.39 109.671 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.64 48.94 2.68 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.364 -1.494 . . . . 0.29 109.364 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.42 152.04 37.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -1.112 . . . . 0.29 108.882 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.78 124.76 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.112 -0.993 . . . . 0.31 110.01 -179.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.0 136.51 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.179 -1.045 . . . . 0.29 108.179 179.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 11.9 pt -139.47 178.64 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.3 -0.875 . . . . 0.23 110.118 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.496 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.5 tt0 -143.53 112.42 6.61 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.538 -0.912 . . . . 1.81 108.538 179.034 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.78 -79.16 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.765 -1.198 . . . . 1.18 107.765 179.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.46 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.755 -1.572 . . . . 1.98 106.755 177.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.4 m -105.0 54.29 0.71 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.074 -1.084 . . . . 1.39 108.074 178.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -157.43 126.04 5.68 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.965 -0.754 . . . . 1.12 108.965 -179.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.496 ' CG1' HE21 ' A' ' 252' ' ' GLN . 19.5 mt -92.46 140.73 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.279 -0.888 . . . . 0.47 109.589 -179.663 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.43 169.56 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.392 -0.818 . . . . 2.11 109.59 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.66 139.69 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 0.33 109.073 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.9 t -135.67 121.24 13.77 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.421 -0.8 . . . . 0.34 108.926 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.81 136.59 75.23 Favored 'Trans proline' 0 C--O 1.214 -0.725 0 N-CA-C 109.934 -0.833 . . . . 0.42 109.934 179.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.3 OUTLIER -56.04 -35.64 67.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 3.12 109.631 179.886 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.503 HH11 ' CG ' ' A' ' 263' ' ' ARG . 0.7 OUTLIER -69.34 -3.01 12.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 3.82 110.259 -179.417 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.55 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 19.3 mtpp -119.47 16.12 12.94 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.371 -0.831 . . . . 2.08 109.044 179.674 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.34 170.8 15.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.474 -0.767 . . . . 0.32 109.329 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.492 ' HZ1' HD11 ' A' ' 268' ' ' ILE . 6.3 mtmp? -140.79 132.12 26.7 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.27 -0.894 . . . . 1.79 109.457 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.96 117.25 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.264 -0.898 . . . . 0.45 109.922 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.492 HD11 ' HZ1' ' A' ' 266' ' ' LYS . 5.7 mm -116.21 148.84 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.556 -0.905 . . . . 0.57 108.556 179.15 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 141.93 28.22 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.476 -0.935 . . . . 3.63 108.476 179.46 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 118.008 -0.996 . . . . 2.05 109.505 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.371 -0.604 . . . . 3.83 109.371 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.577 ' O ' HD12 ' B' ' 220' ' ' ILE . 0.9 OUTLIER -82.54 138.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.158 -0.963 . . . . 2.08 108.763 179.738 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -88.34 -126.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.953 -1.092 . . . . 2.16 109.729 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -94.92 100.06 11.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -0.899 . . . . 1.48 109.144 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -135.58 128.84 31.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.492 -0.755 . . . . 0.73 109.33 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' B' ' 224' ' ' ARG . 4.8 ptt-85 -109.64 162.51 14.35 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.207 -1.034 . . . . 3.26 108.207 178.515 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.1 t -138.03 146.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.165 -0.959 . . . . 0.23 110.839 -178.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -108.66 153.15 23.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.356 -1.35 . . . . 0.58 107.356 178.134 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.3 p90 -157.03 151.07 24.82 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.557 -1.34 . . . . 0.44 110.548 -179.309 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.569 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 34.9 mtm180 -96.5 154.13 17.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 2.76 109.591 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 230' ' ' SER . 11.8 t70 -95.0 166.13 12.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.818 . . . . 2.23 108.831 179.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . 0.476 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 2.9 t -82.11 -7.22 59.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -0.999 . . . . 1.81 109.209 179.803 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -90.66 -19.71 23.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.283 -0.886 . . . . 3.64 109.952 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' B' ' 234' ' ' VAL . 7.9 m-20 -161.72 130.61 3.06 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.056 -1.028 . . . . 2.16 109.139 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.71 15.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 120.86 1.04 . . . . 1.27 110.605 179.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' B' ' 232' ' ' ASP . 26.4 m -82.53 131.86 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.829 -1.169 . . . . 1.76 109.875 -179.656 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -55.23 173.91 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 0.67 109.463 179.895 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 237' ' ' GLY . 49.1 tttp -136.36 158.21 44.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.296 -0.877 . . . . 1.44 109.189 179.242 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -41.98 164.87 0.02 OUTLIER Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.538 -1.025 . . . . 0.4 110.538 -179.182 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -66.52 159.35 51.06 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.628 1.552 . . . . 0.41 110.406 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.34 175.34 9.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.983 -0.747 . . . . 0.21 108.983 179.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -92.38 135.64 33.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.053 -1.03 . . . . 2.72 109.671 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.3 tp -87.17 123.51 32.28 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.166 -0.679 . . . . 0.3 109.166 -179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.96 -72.24 0.7 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.399 -0.813 . . . . 0.45 110.09 -179.657 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -90.83 137.41 32.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.253 -0.904 . . . . 0.33 110.08 -178.836 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -145.03 116.94 8.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.309 -0.87 . . . . 2.33 108.898 179.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.7 -101.56 0.19 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.997 -1.241 . . . . 0.28 109.997 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.22 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -1.099 . . . . 1.4 109.606 -179.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.58 48.93 2.66 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.34 -1.504 . . . . 0.29 109.34 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.43 152.03 37.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -1.087 . . . . 0.29 108.877 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.83 124.77 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 0.31 109.982 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 62.0 t -87.94 136.4 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.156 -1.053 . . . . 0.3 108.156 179.114 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 12.0 pt -139.38 178.6 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 0.24 110.157 -179.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.486 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.4 tt0 -143.48 112.45 6.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.603 -0.888 . . . . 1.81 108.603 178.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.77 -79.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.759 -1.2 . . . . 1.18 107.759 179.649 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -80.56 -130.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.654 -1.609 . . . . 1.97 106.654 177.794 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 35.3 m -104.98 54.17 0.71 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.089 -1.078 . . . . 1.38 108.089 178.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -157.39 126.0 5.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.024 -0.732 . . . . 1.12 109.024 -179.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.486 ' CG1' HE21 ' B' ' 252' ' ' GLN . 19.4 mt -92.37 140.75 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.213 -0.929 . . . . 0.48 109.65 -179.673 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -140.48 169.53 17.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.439 -0.788 . . . . 2.13 109.532 -179.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.6 139.61 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.34 109.1 179.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 75.5 t -135.58 121.24 13.87 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.477 -0.765 . . . . 0.34 108.964 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.79 136.43 74.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 N-CA-C 109.965 -0.821 . . . . 0.42 109.965 179.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.55 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.3 OUTLIER -55.99 -35.59 66.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 3.11 109.625 179.981 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' B' ' 263' ' ' ARG . 0.7 OUTLIER -69.33 -3.06 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 3.82 110.232 -179.393 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.569 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 19.4 mtpp -119.38 16.01 13.02 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.371 -0.831 . . . . 2.08 109.004 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.27 170.84 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.56 -0.712 . . . . 0.32 109.416 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.482 ' HZ1' HD11 ' B' ' 268' ' ' ILE . 6.4 mtmp? -140.76 132.16 26.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.211 -0.931 . . . . 1.79 109.49 179.664 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.86 117.28 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.232 -0.917 . . . . 0.45 109.941 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.484 HG21 ' NH2' ' B' ' 224' ' ' ARG . 5.7 mm -116.32 148.82 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.544 -0.909 . . . . 0.57 108.544 179.187 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 141.79 28.36 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.516 -0.92 . . . . 3.62 108.516 179.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 2.8 m-20 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 2.05 109.528 -179.862 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.504 -0.554 . . . . 3.82 109.504 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.91 141.28 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 2.08 109.516 -179.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -86.64 -132.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 2.17 109.858 -179.661 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -92.26 108.3 19.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.172 -0.955 . . . . 1.48 109.272 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -134.53 136.78 43.33 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.845 -0.798 . . . . 0.72 108.845 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -111.55 155.18 23.7 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.129 -1.063 . . . . 3.26 108.129 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.14 141.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 0.23 110.258 -179.399 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.12 157.65 18.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.456 -1.313 . . . . 0.58 107.456 178.582 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.5 p90 -156.47 150.12 24.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.653 -1.279 . . . . 0.44 110.28 -179.068 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 228' ' ' ARG . 9.1 mtm-85 -94.69 154.43 17.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.461 -0.775 . . . . 2.76 109.66 179.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.81 166.44 11.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 2.23 108.841 179.362 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 13.0 t -85.83 -9.79 56.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.146 -0.971 . . . . 1.8 109.324 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -89.3 -16.09 31.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.23 -0.919 . . . . 3.63 109.56 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 234' ' ' VAL . 51.5 m-20 -161.42 129.7 2.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.137 -0.977 . . . . 2.16 109.063 -179.846 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.38 0.17 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 120.781 0.987 . . . . 1.25 110.653 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 232' ' ' ASP . 11.6 m -82.69 133.41 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.73 -1.231 . . . . 1.75 109.848 -179.747 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -53.56 -177.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.26 -0.9 . . . . 0.66 109.124 179.635 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.742 ' HZ3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -136.79 -164.78 1.63 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.256 -0.903 . . . . 1.43 108.631 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.742 ' H ' ' HZ3' ' A' ' 236' ' ' LYS . . . -73.52 172.38 50.61 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.661 -1.257 . . . . 0.39 110.041 -179.441 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.35 158.76 55.21 Favored 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.633 1.555 . . . . 0.41 109.955 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.02 172.77 12.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.21 109.193 179.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -94.44 138.82 31.91 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.2 -0.938 . . . . 2.72 109.36 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.5 tp -87.63 126.24 34.84 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.532 -0.73 . . . . 0.29 109.467 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 24.5 mt -119.59 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.752 . . . . 0.45 110.115 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.427 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.3 t90 -91.53 140.1 30.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.178 -0.951 . . . . 0.31 109.946 -178.76 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -147.82 119.5 8.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.258 -0.901 . . . . 2.32 109.163 179.463 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.14 -100.75 0.18 Allowed Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.788 -1.196 . . . . 0.27 110.28 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.33 -154.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -1.072 . . . . 1.39 109.804 -179.323 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.9 2.82 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.453 -1.459 . . . . 0.29 109.453 179.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.81 153.88 38.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -1.068 . . . . 0.29 109.009 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.34 132.92 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.31 109.825 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.5 t -94.39 139.32 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.206 -1.035 . . . . 0.29 108.206 179.313 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.5 pt -140.62 179.38 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.218 -0.926 . . . . 0.23 110.073 -179.207 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.489 HE21 ' CG1' ' A' ' 257' ' ' ILE . 33.7 tt0 -142.54 115.03 8.5 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.469 -0.938 . . . . 1.81 108.469 179.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.26 -84.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.417 -1.327 . . . . 1.18 107.417 179.459 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.707 HD22 ' H ' ' A' ' 255' ' ' SER . 10.2 t30 -79.62 -126.11 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.629 -1.619 . . . . 1.98 106.629 177.62 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.707 ' H ' HD22 ' A' ' 254' ' ' ASN . 14.2 t -105.7 53.9 0.71 Allowed 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.025 -1.102 . . . . 1.39 108.025 177.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.08 8.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.596 -0.69 . . . . 1.12 109.196 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.489 ' CG1' HE21 ' A' ' 252' ' ' GLN . 48.6 mt -93.9 137.05 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.325 -0.859 . . . . 0.47 109.587 -179.611 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.5 167.39 22.01 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 2.11 109.681 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.04 143.62 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.381 -0.824 . . . . 0.33 109.351 179.596 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.2 t -137.92 126.01 14.16 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.352 -0.843 . . . . 0.34 109.047 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.82 143.4 99.2 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 N-CA-C 109.692 -0.926 . . . . 0.42 109.692 179.444 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.421 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -54.62 -41.17 69.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 3.12 109.293 179.606 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 263' ' ' ARG . 29.6 mtm-85 -67.2 -2.48 5.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.339 -0.85 . . . . 3.82 110.563 -178.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.74 14.64 12.6 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.355 -0.841 . . . . 2.08 109.112 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.28 169.06 18.28 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.249 -0.907 . . . . 0.32 109.832 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.21 130.07 24.61 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.446 -0.784 . . . . 1.79 109.068 179.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.41 110.54 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.237 -0.915 . . . . 0.45 109.515 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.42 155.27 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 108.749 -0.834 . . . . 0.57 108.749 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.38 140.79 29.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.372 -0.83 . . . . 3.63 109.621 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.007 -0.997 . . . . 2.05 109.449 179.661 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.509 -0.552 . . . . 3.83 109.509 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.1 pt -82.89 141.19 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 2.08 109.542 -179.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -86.58 -132.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 2.16 109.864 -179.651 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -92.33 108.28 19.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 1.48 109.276 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -134.51 136.88 43.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.848 -0.797 . . . . 0.73 108.848 179.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -111.63 155.22 23.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.063 -1.088 . . . . 3.26 108.063 179.095 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.17 141.12 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.285 -0.884 . . . . 0.23 110.185 -179.382 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -109.1 157.72 18.46 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.561 -1.274 . . . . 0.58 107.561 178.455 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.7 p90 -156.51 150.09 24.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.66 -1.275 . . . . 0.44 110.332 -179.012 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' B' ' 228' ' ' ARG . 9.1 mtm-85 -94.72 154.44 17.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 2.76 109.646 179.812 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.92 166.46 11.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.418 -0.801 . . . . 2.23 108.846 179.374 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 13.2 t -85.92 -9.67 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -0.976 . . . . 1.81 109.283 179.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -89.25 -16.2 31.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 3.64 109.549 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' B' ' 234' ' ' VAL . 51.5 m-20 -161.43 129.81 2.93 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.223 -0.923 . . . . 2.16 109.073 -179.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.57 10.25 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.835 1.023 . . . . 1.27 110.594 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' B' ' 232' ' ' ASP . 11.5 m -82.59 133.56 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.782 -1.199 . . . . 1.76 109.806 -179.746 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -53.72 -177.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.09 -1.006 . . . . 0.67 109.094 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.77 ' HZ3' ' H ' ' B' ' 237' ' ' GLY . 0.1 OUTLIER -136.74 -164.73 1.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.23 -0.919 . . . . 1.44 108.685 179.241 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.77 ' H ' ' HZ3' ' B' ' 236' ' ' LYS . . . -73.75 172.38 51.04 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.625 -1.274 . . . . 0.4 110.053 -179.431 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.36 158.82 55.0 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.592 1.528 . . . . 0.41 109.996 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.08 172.79 12.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.569 -0.707 . . . . 0.21 109.163 179.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -94.47 138.71 32.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.161 -0.962 . . . . 2.72 109.406 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.4 tp -87.54 126.22 34.8 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.493 -0.754 . . . . 0.3 109.485 -179.829 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.56 -74.91 0.59 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.737 . . . . 0.45 110.181 -179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -91.48 139.99 30.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.119 -0.988 . . . . 0.33 109.97 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -147.72 119.48 8.08 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.285 -0.885 . . . . 2.33 109.134 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.11 -100.86 0.18 Allowed Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.828 -1.177 . . . . 0.28 110.334 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.23 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -1.063 . . . . 1.4 109.865 -179.342 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 47.99 2.84 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.355 -1.498 . . . . 0.29 109.355 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.86 153.92 38.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.113 . . . . 0.29 109.029 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 16.6 m -146.3 132.84 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.095 -1.003 . . . . 0.31 109.892 -179.9 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 60.7 t -94.25 139.44 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.254 -1.017 . . . . 0.3 108.254 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.4 pt -140.77 179.3 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.223 -0.923 . . . . 0.24 110.117 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.494 HE21 ' CG1' ' B' ' 257' ' ' ILE . 33.7 tt0 -142.48 114.9 8.44 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.507 -0.923 . . . . 1.81 108.507 179.101 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.17 -84.57 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.43 -1.322 . . . . 1.18 107.43 179.441 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.714 HD22 ' H ' ' B' ' 255' ' ' SER . 10.2 t30 -79.73 -125.97 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.589 -1.634 . . . . 1.97 106.589 177.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.714 ' H ' HD22 ' B' ' 254' ' ' ASN . 14.3 t -105.79 53.91 0.7 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.995 -1.113 . . . . 1.38 107.995 177.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -154.54 128.22 8.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.542 -0.724 . . . . 1.12 109.164 -179.355 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.494 ' CG1' HE21 ' B' ' 252' ' ' GLN . 48.6 mt -94.01 137.06 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.296 -0.877 . . . . 0.48 109.587 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -138.51 167.36 22.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.299 -0.876 . . . . 2.13 109.711 -179.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.96 143.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.391 -0.818 . . . . 0.34 109.408 179.615 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.97 125.97 14.08 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.418 -0.801 . . . . 0.34 108.973 179.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.77 143.34 99.05 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 N-CA-C 109.778 -0.893 . . . . 0.42 109.778 179.322 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.412 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -54.58 -41.24 69.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 3.11 109.324 179.64 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.438 ' HG3' HH11 ' B' ' 263' ' ' ARG . 29.6 mtm-85 -67.02 -2.63 5.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.248 -0.908 . . . . 3.82 110.597 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -119.65 14.63 12.67 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.344 -0.847 . . . . 2.08 109.127 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -142.14 169.08 18.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.313 -0.867 . . . . 0.32 109.839 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -140.16 130.15 24.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 1.79 109.077 179.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 23.4 mm -88.38 110.42 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.244 -0.91 . . . . 0.45 109.595 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 7.0 mm -103.38 155.28 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.737 -0.838 . . . . 0.57 108.737 179.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -92.36 140.86 29.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.313 -0.867 . . . . 3.62 109.607 179.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.923 -1.037 . . . . 2.05 109.405 179.702 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.337 -0.616 . . . . 3.82 109.337 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 220' ' ' ILE . 1.9 mp -83.01 109.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 2.08 108.843 -179.925 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -83.81 -121.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 2.17 109.435 179.853 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -96.49 100.2 11.8 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.262 -0.898 . . . . 1.48 109.773 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -135.86 135.26 39.62 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.803 . . . . 0.72 109.717 179.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 224' ' ' ARG . 12.0 mtm-85 -106.17 160.62 15.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.79 -1.189 . . . . 3.26 107.79 178.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.7 141.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.23 110.212 -179.256 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.81 154.7 22.61 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.363 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.8 p90 -157.15 152.2 26.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.643 -1.286 . . . . 0.44 110.11 -179.228 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.435 HH21 ' NZ ' ' A' ' 264' ' ' LYS . 35.9 mtm180 -95.95 152.3 18.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.466 -0.771 . . . . 2.76 110.067 -179.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.1 m-20 -91.19 165.2 13.6 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 179.222 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 59.5 m -83.92 -13.07 54.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.994 -1.067 . . . . 1.8 108.873 179.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.81 40.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.495 -0.753 . . . . 3.63 109.588 179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.7 p30 -156.95 128.87 3.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.954 -1.091 . . . . 2.16 109.414 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.76 7.08 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.91 0 C-N-CA 121.059 1.173 . . . . 1.25 111.476 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 235' ' ' TRP . 13.9 p -83.29 161.71 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.459 -1.401 . . . . 1.75 110.208 -179.523 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.535 ' N ' HG22 ' A' ' 234' ' ' VAL . 99.2 m95 -75.48 160.75 29.85 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.157 -0.683 . . . . 0.66 109.157 179.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 237' ' ' GLY . 41.3 tttp -119.12 163.82 16.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.395 -0.816 . . . . 1.43 109.069 179.408 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -44.94 168.1 0.03 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.902 -1.279 . . . . 0.39 109.902 -179.449 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -69.3 161.3 46.44 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.458 1.439 . . . . 0.41 110.64 -179.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.61 173.9 11.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.992 -0.744 . . . . 0.21 108.992 179.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.75 139.59 31.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.092 -1.005 . . . . 2.72 109.21 179.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.18 123.85 33.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 0.29 109.455 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.15 -75.37 0.59 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.45 109.724 179.638 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.96 143.75 26.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.156 -0.965 . . . . 0.31 110.301 -179.062 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -149.54 118.72 6.78 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.477 -0.764 . . . . 2.32 108.955 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.78 -100.99 0.18 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.618 -1.277 . . . . 0.27 110.157 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.35 -154.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -1.069 . . . . 1.39 109.751 -179.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.77 45.77 2.23 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.89 150.52 36.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.443 -1.034 . . . . 0.29 108.834 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.02 129.34 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.204 -0.935 . . . . 0.31 109.459 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 60.3 t -90.97 137.39 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.088 -1.078 . . . . 0.29 108.088 179.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.0 pt -140.11 -178.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.178 -0.951 . . . . 0.23 110.549 -178.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.559 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.0 tt0 -145.99 112.15 5.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -90.93 -76.57 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.998 -1.482 . . . . 1.18 106.998 179.216 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.19 -136.34 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.822 -1.547 . . . . 1.98 106.822 177.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.74 55.42 0.87 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.344 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -157.69 127.06 5.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.499 -0.751 . . . . 1.12 109.097 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.559 ' CG1' HE21 ' A' ' 252' ' ' GLN . 38.3 mt -92.68 133.27 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.31 -0.869 . . . . 0.47 109.567 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.25 168.27 19.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.505 -0.747 . . . . 2.11 109.631 -179.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.48 138.48 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.439 -0.788 . . . . 0.33 109.658 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 38.8 t -136.5 133.07 19.0 Favored Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 108.473 -0.936 . . . . 0.34 108.473 179.449 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.39 140.64 95.3 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 120.663 0.909 . . . . 0.42 110.143 179.587 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -57.92 -35.5 71.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 3.12 109.209 179.444 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 263' ' ' ARG . 2.4 mtt-85 -69.99 -1.95 11.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 3.82 110.464 -179.409 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.435 ' NZ ' HH21 ' A' ' 228' ' ' ARG . 5.3 mptp? -118.7 15.54 13.59 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.738 -0.838 . . . . 2.08 108.738 -179.672 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.17 173.34 11.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.524 -0.735 . . . . 0.32 109.445 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.55 129.04 22.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.336 -0.853 . . . . 1.79 108.997 179.545 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 30.2 mm -86.57 113.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.45 109.19 179.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.6 mm -112.6 148.65 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.514 -0.921 . . . . 0.57 108.514 179.364 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -91.39 149.99 21.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.554 -0.716 . . . . 3.63 109.518 179.917 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.972 -1.013 . . . . 2.05 109.24 179.647 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.271 -0.64 . . . . 3.83 109.271 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.695 ' N ' HD12 ' B' ' 220' ' ' ILE . 1.9 mp -82.97 109.47 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 2.08 108.901 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -83.81 -122.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 2.16 109.348 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -96.51 100.09 11.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.214 -0.928 . . . . 1.48 109.768 -179.652 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -135.86 135.25 39.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.426 -0.796 . . . . 0.73 109.665 179.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' B' ' 224' ' ' ARG . 11.9 mtm-85 -106.05 160.57 15.2 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 107.814 -1.18 . . . . 3.26 107.814 178.79 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 48.4 t -142.68 141.48 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.206 -0.934 . . . . 0.23 110.178 -179.24 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -109.75 154.75 22.49 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.447 -1.316 . . . . 0.58 107.447 178.369 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 12.8 p90 -157.21 152.16 25.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.653 -1.28 . . . . 0.44 110.096 -179.247 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.419 HH21 ' NZ ' ' B' ' 264' ' ' LYS . 35.7 mtm180 -95.86 152.39 18.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.461 -0.775 . . . . 2.76 110.053 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.1 m-20 -91.33 165.1 13.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 2.23 108.686 179.221 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 59.1 m -83.72 -13.19 54.61 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 1.81 108.943 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -90.16 -11.66 40.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 3.64 109.59 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -157.12 128.8 3.88 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.115 -0.991 . . . . 2.16 109.322 -179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.8 7.27 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 120.988 1.125 . . . . 1.27 111.583 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.538 HG22 ' N ' ' B' ' 235' ' ' TRP . 13.9 p -83.33 161.65 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.347 -1.47 . . . . 1.76 110.241 -179.574 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.538 ' N ' HG22 ' B' ' 234' ' ' VAL . 99.2 m95 -75.45 160.75 29.88 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.199 -0.667 . . . . 0.67 109.199 179.68 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' B' ' 237' ' ' GLY . 41.2 tttp -119.05 163.85 16.38 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.373 -0.829 . . . . 1.44 109.032 179.376 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -44.97 168.2 0.03 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.967 -1.253 . . . . 0.4 109.967 -179.486 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -69.34 161.31 46.39 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 121.479 1.453 . . . . 0.41 110.584 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.64 173.87 11.19 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.883 -0.784 . . . . 0.21 108.883 179.282 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.73 139.52 31.13 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.069 -1.019 . . . . 2.72 109.215 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -89.19 123.78 33.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.433 -0.792 . . . . 0.3 109.425 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.6 mt -115.09 -75.34 0.59 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.476 -0.765 . . . . 0.45 109.744 179.655 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -89.97 143.8 26.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.197 -0.939 . . . . 0.33 110.274 -179.067 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -149.53 118.72 6.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.418 -0.801 . . . . 2.33 109.044 179.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.8 -100.97 0.18 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.577 -1.297 . . . . 0.28 110.191 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -69.32 -154.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.48 -1.012 . . . . 1.4 109.807 -179.399 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.84 45.83 2.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.236 -1.545 . . . . 0.29 109.236 179.774 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -145.9 150.48 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.463 -1.022 . . . . 0.29 108.789 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.96 129.36 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.92 . . . . 0.31 109.519 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 59.9 t -90.99 137.38 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.087 -1.079 . . . . 0.3 108.087 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.01 -178.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.286 -0.884 . . . . 0.24 110.618 -178.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.561 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.0 tt0 -146.07 112.09 5.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.632 -0.877 . . . . 1.81 108.632 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.82 -76.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.063 -1.458 . . . . 1.18 107.063 179.213 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -82.08 -136.43 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.812 -1.551 . . . . 1.97 106.812 177.512 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 10.5 t -100.7 55.36 0.87 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.195 -1.039 . . . . 1.38 108.195 178.345 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -157.66 126.96 5.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.581 -0.699 . . . . 1.12 109.154 -179.358 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.561 ' CG1' HE21 ' B' ' 252' ' ' GLN . 37.8 mt -92.56 133.25 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -0.911 . . . . 0.48 109.586 -179.623 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -135.2 168.28 19.45 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.427 -0.796 . . . . 2.13 109.627 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.1 t -101.51 138.47 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.409 -0.807 . . . . 0.34 109.657 179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 133.14 19.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.376 -0.972 . . . . 0.34 108.376 179.421 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.43 140.75 95.78 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 120.539 0.826 . . . . 0.42 110.162 179.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -57.95 -35.51 71.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.114 -0.991 . . . . 3.11 109.222 179.449 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' B' ' 263' ' ' ARG . 2.4 mtt-85 -70.01 -1.96 11.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 3.82 110.462 -179.421 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.419 ' NZ ' HH21 ' B' ' 228' ' ' ARG . 5.3 mptp? -118.72 15.53 13.57 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.367 -0.833 . . . . 2.08 108.758 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 173.38 11.57 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.453 -0.78 . . . . 0.32 109.512 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -140.62 128.89 22.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 1.79 109.075 179.49 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 30.0 mm -86.43 113.29 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.158 -0.964 . . . . 0.45 109.233 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 8.7 mm -112.71 148.61 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.471 -0.937 . . . . 0.57 108.471 179.43 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -91.33 150.01 21.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.541 -0.724 . . . . 3.62 109.581 179.908 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.966 -1.016 . . . . 2.05 109.219 179.704 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.594 -0.521 . . . . 3.82 109.594 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.0 pt -82.62 141.23 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.928 . . . . 2.08 109.431 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -86.17 -135.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.14 -0.975 . . . . 2.17 109.475 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -93.92 110.81 22.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.203 -0.936 . . . . 1.48 109.057 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -133.64 138.62 46.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.582 -0.699 . . . . 0.72 109.381 -179.751 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.435 ' N ' ' OD1' ' A' ' 270' ' ' ASP . 61.4 mtm180 -107.7 160.05 16.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.962 -1.125 . . . . 3.26 107.962 179.159 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 77.3 t -142.04 138.92 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.172 -0.955 . . . . 0.23 110.096 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -108.36 151.36 26.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.556 -1.276 . . . . 0.58 107.556 178.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 12.0 p90 -155.61 152.31 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.609 -1.307 . . . . 0.44 110.529 -179.076 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.45 ' HG3' HH11 ' A' ' 228' ' ' ARG . 8.8 mtm-85 -95.31 151.0 19.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.466 -0.771 . . . . 2.76 109.513 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 1.8 m-20 -96.52 167.15 11.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.388 -0.82 . . . . 2.23 108.892 179.34 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 43.2 t -83.33 -8.92 59.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.127 -0.983 . . . . 1.8 109.195 179.538 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -90.44 -16.17 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.352 -0.843 . . . . 3.63 109.764 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 234' ' ' VAL . 59.2 m-20 -160.69 129.74 3.14 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.139 -0.976 . . . . 2.16 109.232 -179.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.39 10.91 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 120.862 1.041 . . . . 1.25 110.41 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 232' ' ' ASP . 12.0 m -83.17 135.91 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 1.75 110.1 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.19 167.55 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.66 109.127 179.71 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 237' ' ' GLY . 36.8 tttp -125.5 157.92 35.79 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.383 -0.823 . . . . 1.43 109.34 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.05 166.16 0.02 OUTLIER Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.349 -1.1 . . . . 0.39 110.349 -179.315 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -65.53 160.92 40.7 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.639 1.559 . . . . 0.41 110.58 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.824 -0.806 . . . . 0.21 108.824 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.9 137.93 34.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.118 -0.989 . . . . 2.72 109.216 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.89 125.41 35.34 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.563 -0.711 . . . . 0.29 109.765 -179.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.76 -72.89 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 0.45 109.912 179.906 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.24 28.66 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.234 -0.916 . . . . 0.31 110.341 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.84 118.74 7.62 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.354 -0.841 . . . . 2.32 108.896 179.262 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.26 -100.24 0.18 Allowed Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.787 -1.197 . . . . 0.27 110.151 -179.76 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.59 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -1.104 . . . . 1.39 109.569 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.46 47.98 2.47 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.575 -1.41 . . . . 0.29 109.575 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.91 33.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -1.086 . . . . 0.29 108.854 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.21 125.85 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 0.31 109.489 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.99 139.52 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.368 -0.975 . . . . 0.29 108.368 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 260' ' ' VAL . 27.2 pt -141.73 178.51 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.117 -0.989 . . . . 0.23 110.257 -179.121 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.539 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.1 tt0 -144.36 114.52 7.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.736 -0.839 . . . . 1.81 108.736 179.193 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.96 -78.95 0.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.453 -1.314 . . . . 1.18 107.453 179.241 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.57 -129.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.732 -1.581 . . . . 1.98 106.732 177.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.4 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.206 -1.035 . . . . 1.39 108.206 178.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.06 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.537 -0.727 . . . . 1.12 109.277 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.539 ' CG1' HE21 ' A' ' 252' ' ' GLN . 33.8 mt -92.74 135.87 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.807 . . . . 0.47 109.45 -179.629 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.09 14.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 2.11 109.776 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.35 138.4 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.466 -0.771 . . . . 0.33 109.475 179.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 251' ' ' ILE . 90.5 t -134.9 126.9 18.06 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.592 -0.892 . . . . 0.34 108.592 179.668 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 145.08 90.01 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 120.507 0.805 . . . . 0.42 110.47 179.822 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 262' ' ' ARG . 4.5 ttt-85 -65.16 -36.82 85.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.428 -0.795 . . . . 3.12 110.1 -179.985 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -68.71 -4.91 17.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 3.82 110.174 -179.099 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -119.52 19.54 12.62 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.341 -0.849 . . . . 2.08 109.184 179.783 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.54 170.55 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.496 -0.752 . . . . 0.32 109.578 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -140.93 132.14 26.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.236 -0.915 . . . . 1.79 109.358 179.765 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 22.8 mm -88.78 106.03 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.27 -0.894 . . . . 0.45 109.593 -179.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.47 155.73 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.374 -0.828 . . . . 0.57 109.208 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -91.34 147.91 22.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.801 . . . . 3.63 109.464 179.578 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.096 -1.002 . . . . 2.05 109.424 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 9.2 ptt? . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.599 -0.519 . . . . 3.83 109.599 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 4.0 pt -82.51 141.28 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 2.08 109.446 179.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -86.22 -135.44 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 2.16 109.471 -179.652 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -93.89 110.76 22.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.224 -0.923 . . . . 1.48 109.03 179.701 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.66 138.58 45.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.69 . . . . 0.73 109.386 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.433 ' N ' ' OD1' ' B' ' 270' ' ' ASP . 61.4 mtm180 -107.68 160.18 15.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.985 -1.117 . . . . 3.26 107.985 179.158 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 77.2 t -142.2 138.96 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.192 -0.943 . . . . 0.23 109.982 -179.57 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -108.42 151.31 26.21 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.474 -1.306 . . . . 0.58 107.474 178.62 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 11.9 p90 -155.51 152.47 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.44 110.541 -179.22 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' B' ' 228' ' ' ARG . 8.8 mtm-85 -95.39 151.08 19.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 2.76 109.39 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' B' ' 229' ' ' ASP . 1.8 m-20 -96.61 167.17 11.3 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.355 -0.841 . . . . 2.23 108.89 179.316 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 43.5 t -83.26 -9.14 59.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 1.81 109.215 179.567 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -90.27 -16.15 29.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.31 -0.869 . . . . 3.64 109.821 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' B' ' 234' ' ' VAL . 59.1 m-20 -160.74 129.73 3.12 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 2.16 109.295 -179.83 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.41 11.02 0.23 Allowed 'Trans proline' 0 N--CA 1.481 0.759 0 C-N-CA 120.79 0.994 . . . . 1.27 110.419 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' B' ' 232' ' ' ASP . 12.0 m -83.23 135.93 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.869 -1.144 . . . . 1.76 110.06 -179.48 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -55.2 167.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.227 -0.92 . . . . 0.67 109.107 179.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' B' ' 237' ' ' GLY . 36.8 tttp -125.48 157.92 35.76 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.373 -0.83 . . . . 1.44 109.272 179.447 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.11 166.11 0.02 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.361 -1.096 . . . . 0.4 110.361 -179.342 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -65.47 160.89 40.68 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.617 1.545 . . . . 0.41 110.585 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.84 176.88 8.31 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.805 . . . . 0.21 108.825 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -95.82 137.99 34.1 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.061 -1.024 . . . . 2.72 109.254 179.901 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 20.5 tp -89.93 125.49 35.38 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.564 -0.71 . . . . 0.3 109.774 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 19.6 mt -118.75 -72.93 0.66 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.45 -0.781 . . . . 0.45 110.002 179.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -92.82 141.16 28.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.23 -0.919 . . . . 0.33 110.251 -178.789 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -147.78 118.8 7.68 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.377 -0.827 . . . . 2.33 108.882 179.155 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.28 -100.25 0.18 Allowed Glycine 0 N--CA 1.496 2.65 0 C-N-CA 119.726 -1.226 . . . . 0.28 110.096 -179.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -70.52 -154.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 1.4 109.555 -179.428 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.48 47.98 2.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.688 -1.365 . . . . 0.29 109.688 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.86 149.83 33.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -1.093 . . . . 0.29 108.82 179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 18.2 m -143.12 125.87 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 0.31 109.501 179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.04 139.6 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.467 -0.938 . . . . 0.3 108.467 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . 0.427 HD11 HG21 ' B' ' 260' ' ' VAL . 27.1 pt -141.7 178.54 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.92 . . . . 0.24 110.265 -179.092 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.544 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.1 tt0 -144.38 114.51 7.42 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.834 -0.802 . . . . 1.81 108.834 179.106 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.96 -78.94 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.436 -1.32 . . . . 1.18 107.436 179.33 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.51 -129.14 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.78 -1.563 . . . . 1.97 106.78 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 17.7 m -105.19 54.8 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.105 -1.072 . . . . 1.38 108.105 178.081 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -156.07 125.73 6.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.628 -0.67 . . . . 1.12 109.257 -179.379 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.544 ' CG1' HE21 ' B' ' 252' ' ' GLN . 34.1 mt -92.76 135.92 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.355 -0.841 . . . . 0.48 109.436 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -137.47 171.02 15.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.822 . . . . 2.13 109.806 -179.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.32 138.32 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.388 -0.82 . . . . 0.34 109.542 179.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . 0.427 HG21 HD11 ' B' ' 251' ' ' ILE . 91.1 t -134.8 126.97 18.2 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 108.573 -0.899 . . . . 0.34 108.573 179.748 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.57 145.12 90.52 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 120.564 0.843 . . . . 0.42 110.355 179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' B' ' 262' ' ' ARG . 4.5 ttt-85 -65.14 -36.92 85.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.427 -0.796 . . . . 3.11 110.109 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -68.53 -4.95 16.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.109 -0.994 . . . . 3.82 110.325 -179.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -119.56 19.53 12.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.327 -0.858 . . . . 2.08 109.191 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.48 170.62 15.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.448 -0.783 . . . . 0.32 109.584 -179.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -140.95 132.05 26.31 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.268 -0.895 . . . . 1.79 109.321 179.779 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.62 106.0 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.275 -0.891 . . . . 0.45 109.627 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 23.5 mm -105.53 155.79 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.447 -0.783 . . . . 0.57 109.212 179.631 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -91.27 147.9 22.72 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.39 -0.819 . . . . 3.62 109.502 179.608 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 224' ' ' ARG . 7.2 m-20 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.95 -1.024 . . . . 2.05 109.414 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 4.4 ptp . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.422 0.63 . . . . 3.82 109.332 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.9 mm -83.11 122.73 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 2.08 108.995 179.951 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.822 ' H ' HE21 ' A' ' 221' ' ' GLN . 0.0 OUTLIER -81.54 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.04 . . . . 2.17 110.256 -179.425 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.484 ' N ' ' OD1' ' A' ' 222' ' ' ASN . 1.5 m-20 -96.96 103.79 15.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.242 -0.911 . . . . 1.48 110.925 -178.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.22 127.54 28.34 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.867 -0.79 . . . . 0.72 108.867 178.443 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.94 159.05 15.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.206 -1.035 . . . . 3.26 108.206 179.227 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 98.7 t -143.44 144.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.2 -0.938 . . . . 0.23 110.157 -179.731 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.53 157.02 20.84 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.555 -1.276 . . . . 0.58 107.555 178.626 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.0 p90 -157.78 149.26 21.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.688 -1.258 . . . . 0.44 110.434 -178.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.464 ' NH1' ' CH2' ' A' ' 235' ' ' TRP . 24.0 mtm-85 -95.16 142.54 27.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.439 -0.788 . . . . 2.76 109.266 179.259 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.88 173.06 8.18 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 2.23 109.068 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.8 m -86.83 -8.1 57.62 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.341 -0.849 . . . . 1.8 109.527 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.46 -20.5 26.51 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 3.63 109.455 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 234' ' ' VAL . 42.4 m-20 -162.42 132.34 3.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 2.16 108.95 179.896 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.35 14.64 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 120.724 0.949 . . . . 1.25 110.293 179.531 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 232' ' ' ASP . 44.5 t -80.91 155.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.798 -1.189 . . . . 1.75 109.577 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.464 ' CH2' ' NH1' ' A' ' 228' ' ' ARG . 98.8 m95 -75.89 160.71 29.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.66 109.573 -179.789 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 237' ' ' GLY . 35.0 mttm -119.33 159.32 24.38 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.347 -0.845 . . . . 1.43 109.027 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -45.38 168.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.997 -1.241 . . . . 0.39 109.997 -179.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.74 159.09 54.3 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.585 1.523 . . . . 0.41 110.425 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.4 174.41 10.63 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.799 -0.815 . . . . 0.21 108.799 179.13 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 240' ' ' LYS . 11.5 mptt -92.71 136.62 33.07 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 2.72 109.373 -179.633 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.1 tp -87.07 122.9 31.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.327 -0.858 . . . . 0.29 109.403 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 22.3 mt -113.78 -76.67 0.58 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.421 -0.8 . . . . 0.45 110.373 -179.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.424 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 21.3 t90 -97.35 137.86 35.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.018 -1.051 . . . . 0.31 110.772 -178.722 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.89 132.36 17.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.857 -0.794 . . . . 2.32 108.857 178.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -99.82 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.48 -1.448 . . . . 0.27 109.48 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -68.52 -149.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -1.148 . . . . 1.39 109.154 179.829 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 48.32 3.09 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.231 -1.548 . . . . 0.29 109.231 179.66 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.61 149.15 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.971 . . . . 0.29 109.085 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.11 135.6 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.096 -1.003 . . . . 0.31 109.534 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 257' ' ' ILE . 87.7 t -88.41 143.63 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -0.884 . . . . 0.29 109.318 179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.79 179.81 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.362 -0.836 . . . . 0.23 109.482 179.737 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.419 HE21 ' CG1' ' A' ' 257' ' ' ILE . 35.6 tt0 -143.99 110.8 5.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.298 -0.876 . . . . 1.81 108.656 178.731 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -89.6 -78.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.67 -1.233 . . . . 1.18 107.67 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.647 HD22 ' N ' ' A' ' 255' ' ' SER . 0.2 OUTLIER -81.13 -131.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.815 -1.55 . . . . 1.98 106.815 177.858 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.647 ' N ' HD22 ' A' ' 254' ' ' ASN . 14.6 m -105.24 53.36 0.72 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.079 -1.082 . . . . 1.39 108.079 178.191 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -155.53 127.66 7.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.603 -0.686 . . . . 1.12 109.157 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.481 ' CG2' ' CG1' ' A' ' 250' ' ' VAL . 72.4 mt -93.0 132.97 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.359 -0.838 . . . . 0.47 109.861 -179.632 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -134.99 170.62 15.61 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.449 -0.782 . . . . 2.11 109.493 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.3 t -100.89 139.87 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.415 -0.803 . . . . 0.33 109.498 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.75 121.56 14.99 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.441 -0.787 . . . . 0.34 109.201 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -56.99 139.35 89.63 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 120.486 0.791 . . . . 0.42 110.054 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.579 HH11 ' CG ' ' A' ' 262' ' ' ARG . 0.0 OUTLIER -52.86 -43.1 65.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 3.12 109.555 179.658 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.26 -3.88 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.412 -0.805 . . . . 3.82 110.667 -178.783 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.426 ' CD ' ' NH2' ' A' ' 228' ' ' ARG . 7.2 mmmt -120.19 16.85 12.37 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.288 -0.883 . . . . 2.08 108.882 179.852 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.96 172.27 12.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.702 . . . . 0.32 109.749 179.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -137.4 126.96 25.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.783 -0.821 . . . . 1.79 108.783 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.97 107.11 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.08 -1.012 . . . . 0.45 109.516 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.45 147.72 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.61 -0.885 . . . . 0.57 108.61 179.31 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.65 145.8 24.98 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.352 -0.843 . . . . 3.63 109.367 179.682 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.994 -1.003 . . . . 2.05 109.594 179.746 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.34 -0.615 . . . . 3.83 109.34 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 15.9 mm -82.99 122.78 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.388 -0.82 . . . . 2.08 109.001 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . 0.818 ' H ' HE21 ' B' ' 221' ' ' GLN . 0.0 OUTLIER -81.63 -117.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 2.16 110.226 -179.442 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' B' ' 221' ' ' GLN . 1.5 m-20 -96.97 103.74 15.69 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.922 . . . . 1.48 110.873 -178.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -136.21 127.68 28.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.437 -0.789 . . . . 0.73 108.876 178.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -100.96 159.04 15.54 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.177 -1.045 . . . . 3.26 108.177 179.245 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.53 144.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.166 -0.958 . . . . 0.23 110.13 -179.84 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -111.45 157.01 20.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.626 -1.25 . . . . 0.58 107.626 178.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 9.9 p90 -157.75 149.28 21.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.715 -1.241 . . . . 0.44 110.487 -178.948 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.465 ' NH1' ' CH2' ' B' ' 235' ' ' TRP . 24.1 mtm-85 -95.17 142.56 27.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.432 -0.792 . . . . 2.76 109.222 179.333 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -90.93 173.09 8.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.314 -0.866 . . . . 2.23 109.073 179.856 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -86.87 -8.1 57.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 1.81 109.509 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.44 -20.45 26.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 3.64 109.452 179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' B' ' 234' ' ' VAL . 42.6 m-20 -162.47 132.32 3.31 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 2.16 108.976 179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -66.38 14.69 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 120.65 0.9 . . . . 1.27 110.321 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' B' ' 232' ' ' ASP . 44.3 t -80.94 155.09 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.836 -1.165 . . . . 1.76 109.579 -179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.465 ' CH2' ' NH1' ' B' ' 228' ' ' ARG . 98.8 m95 -75.96 160.7 29.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.565 -0.709 . . . . 0.67 109.609 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' B' ' 237' ' ' GLY . 35.0 mttm -119.31 159.33 24.34 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.415 -0.803 . . . . 1.44 108.917 179.574 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -45.27 168.81 0.03 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.971 -1.251 . . . . 0.4 109.971 -179.714 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -67.76 159.11 54.19 Favored 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.592 1.528 . . . . 0.41 110.424 179.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.37 174.38 10.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.835 -0.802 . . . . 0.21 108.835 179.159 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' B' ' 240' ' ' LYS . 11.5 mptt -92.64 136.6 33.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.132 -0.98 . . . . 2.72 109.416 -179.694 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.02 122.89 31.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.424 -0.797 . . . . 0.3 109.401 -179.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 22.1 mt -113.8 -76.66 0.58 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.45 110.442 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.411 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 21.5 t90 -97.48 137.9 35.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.057 -1.027 . . . . 0.33 110.76 -178.726 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -147.9 132.38 17.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.407 -0.808 . . . . 2.33 108.898 178.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.48 -99.92 0.17 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.445 -1.462 . . . . 0.28 109.445 179.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.51 -149.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -1.178 . . . . 1.4 109.154 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.36 48.19 3.08 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.217 -1.553 . . . . 0.29 109.217 179.675 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -152.57 149.22 28.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.475 -1.014 . . . . 0.29 108.981 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 20.1 m -148.15 135.55 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.142 -0.974 . . . . 0.31 109.594 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . 0.475 ' CG1' ' CG2' ' B' ' 257' ' ' ILE . 87.6 t -88.44 143.61 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.918 . . . . 0.3 109.339 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 19.1 pt -141.73 179.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.472 -0.768 . . . . 0.24 109.61 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.419 HE21 ' CG1' ' B' ' 257' ' ' ILE . 35.5 tt0 -144.04 110.73 5.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.701 -0.852 . . . . 1.81 108.701 178.776 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.53 -78.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.598 -1.26 . . . . 1.18 107.598 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.649 HD22 ' N ' ' B' ' 255' ' ' SER . 0.2 OUTLIER -81.02 -131.13 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.875 -1.528 . . . . 1.97 106.875 177.884 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.649 ' N ' HD22 ' B' ' 254' ' ' ASN . 14.6 m -105.25 53.35 0.72 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.055 -1.091 . . . . 1.38 108.055 178.189 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -155.56 127.59 7.58 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.154 -0.684 . . . . 1.12 109.154 -179.238 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.475 ' CG2' ' CG1' ' B' ' 250' ' ' VAL . 72.5 mt -92.96 132.94 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.48 109.899 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -134.95 170.7 15.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.801 . . . . 2.13 109.456 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.06 139.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.386 -0.821 . . . . 0.34 109.501 179.79 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.69 121.55 15.06 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.504 -0.748 . . . . 0.34 109.253 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.97 139.36 89.6 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 110.138 -0.755 . . . . 0.42 110.138 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' B' ' 262' ' ' ARG . 0.0 OUTLIER -52.87 -43.1 65.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 3.11 109.556 179.69 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -65.16 -4.0 4.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.194 -0.941 . . . . 3.82 110.669 -178.85 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . 0.419 ' CD ' ' NH2' ' B' ' 228' ' ' ARG . 7.3 mmmt -120.09 16.81 12.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.355 -0.841 . . . . 2.08 108.896 179.869 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -141.02 172.23 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.51 -0.744 . . . . 0.32 109.672 -179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -137.43 126.96 25.07 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.742 -0.836 . . . . 1.79 108.742 179.342 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 8.1 mm -88.96 107.33 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.168 -0.957 . . . . 0.45 109.451 179.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -104.57 147.66 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.59 -0.893 . . . . 0.57 108.59 179.336 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -89.55 145.76 25.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.35 -0.844 . . . . 3.62 109.433 179.673 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.941 -1.028 . . . . 2.05 109.571 179.712 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 43.0 mtt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.363 0.601 . . . . 3.82 109.414 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt -82.73 141.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 2.08 109.374 179.916 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -86.37 -130.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 2.17 109.684 -179.547 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -94.74 104.7 16.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 1.48 109.0 179.786 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -133.16 132.33 41.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.535 -0.728 . . . . 0.72 109.256 -179.545 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.632 ' NH2' ' CD2' ' A' ' 226' ' ' TYR . 0.2 OUTLIER -105.99 163.04 13.07 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.782 -1.192 . . . . 3.26 107.782 178.715 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.5 ' C ' HH22 ' A' ' 224' ' ' ARG . 96.2 t -141.47 139.66 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.021 -1.049 . . . . 0.23 110.491 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.632 ' CD2' ' NH2' ' A' ' 224' ' ' ARG . 47.5 m-85 -104.37 154.79 19.4 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.017 -1.475 . . . . 0.58 107.017 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.53 ' OH ' ' NZ ' ' A' ' 236' ' ' LYS . 23.7 p90 -158.71 163.39 36.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.372 -1.455 . . . . 0.44 110.983 -179.418 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -96.19 138.88 33.16 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.384 0.612 . . . . 2.76 109.527 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.38 -177.13 4.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.406 -0.809 . . . . 2.23 109.277 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 29.3 p -94.55 -11.72 28.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.214 -0.929 . . . . 1.8 109.648 179.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HE ' ' N ' ' A' ' 231' ' ' ARG . 2.9 mmp_? -79.51 -21.03 45.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.097 -1.002 . . . . 3.63 109.7 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.99 139.31 7.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 2.16 108.877 179.623 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.37 2.45 1.5 Allowed 'Trans proline' 0 N--CA 1.482 0.816 0 C-N-CA 121.022 1.148 . . . . 1.25 111.304 -179.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.573 HG22 ' N ' ' A' ' 235' ' ' TRP . 12.2 p -82.91 163.26 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.561 -1.337 . . . . 1.75 110.372 -179.361 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.573 ' N ' HG22 ' A' ' 234' ' ' VAL . 93.5 m95 -68.41 165.63 18.4 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.957 -0.757 . . . . 0.66 108.957 179.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.53 ' NZ ' ' OH ' ' A' ' 227' ' ' TYR . 5.6 ttpt -119.58 -163.17 0.96 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.226 -0.921 . . . . 1.43 109.328 -179.776 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -71.98 -179.05 32.25 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.699 -1.36 . . . . 0.39 109.699 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.05 158.94 45.24 Favored 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.777 1.651 . . . . 0.41 110.212 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.4 169.43 17.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.21 109.379 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -94.66 138.5 32.43 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.14 -0.975 . . . . 2.72 109.608 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.63 125.86 35.02 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.607 -0.683 . . . . 0.29 109.476 179.978 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.49 -72.95 0.66 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.447 -0.783 . . . . 0.45 110.108 179.925 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -93.04 145.4 24.41 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.31 110.129 -178.59 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -148.22 121.03 8.69 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.4 -0.812 . . . . 2.32 109.128 179.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.36 -102.41 0.2 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.734 -1.222 . . . . 0.27 110.324 -179.881 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.09 -153.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.221 -1.164 . . . . 1.39 109.803 -179.331 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.92 47.91 2.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.284 -1.527 . . . . 0.29 109.284 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.46 151.98 37.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.29 108.813 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.82 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.174 -0.954 . . . . 0.31 109.629 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.1 135.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.882 -1.155 . . . . 0.29 107.882 179.04 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -139.11 175.69 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.301 -0.874 . . . . 0.23 109.792 -179.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.422 HE21 ' CG1' ' A' ' 257' ' ' ILE . 40.0 tt0 -143.86 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.746 -0.835 . . . . 1.81 108.746 179.216 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.75 -82.76 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.537 -1.282 . . . . 1.18 107.537 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 255' ' ' SER . 38.0 t-20 -78.96 -128.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.719 -1.586 . . . . 1.98 106.719 177.636 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.465 ' N ' ' OD1' ' A' ' 254' ' ' ASN . 10.7 p -105.84 54.49 0.69 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.147 -1.056 . . . . 1.39 108.147 178.019 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 255' ' ' SER . 66.2 m-20 -155.05 123.9 6.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.55 -0.719 . . . . 1.12 109.099 -179.39 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.422 ' CG1' HE21 ' A' ' 252' ' ' GLN . 13.5 mt -94.23 136.54 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 0.47 109.58 -179.742 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.52 169.8 17.09 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.254 -0.904 . . . . 2.11 109.622 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.24 142.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.438 -0.789 . . . . 0.33 109.027 179.389 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.49 131.38 19.37 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.461 -0.774 . . . . 0.34 109.164 -179.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.73 141.24 97.58 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 N-CA-C 109.551 -0.98 . . . . 0.42 109.551 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -58.53 -35.63 72.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.209 -0.932 . . . . 3.12 109.512 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.58 -4.39 18.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 3.82 110.756 -179.157 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -118.96 21.27 12.47 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.124 -0.985 . . . . 2.08 108.819 179.429 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.76 170.18 16.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.32 109.591 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -141.64 124.79 16.36 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.294 -0.879 . . . . 1.79 109.142 179.802 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.77 101.53 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 0.45 109.701 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.467 ' HB ' HH11 ' A' ' 224' ' ' ARG . 5.7 mm -106.38 158.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.413 -0.958 . . . . 0.57 108.413 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.27 152.89 21.91 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.051 -1.03 . . . . 3.63 109.444 179.555 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.984 -1.008 . . . . 2.05 109.42 179.774 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 43.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.372 -0.603 . . . . 3.83 109.372 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . . . . . . . . . 1.9 pt -82.57 141.4 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 2.08 109.465 179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -86.3 -131.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 2.16 109.701 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -94.61 104.74 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.332 -0.855 . . . . 1.48 108.999 179.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.16 132.37 41.51 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 0.73 109.205 -179.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.636 ' NH2' ' CD2' ' B' ' 226' ' ' TYR . 0.2 OUTLIER -106.06 163.11 13.03 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.771 -1.196 . . . . 3.26 107.771 178.65 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.501 ' C ' HH22 ' B' ' 224' ' ' ARG . 95.6 t -141.6 139.5 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.23 110.52 -179.561 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . 0.636 ' CD2' ' NH2' ' B' ' 224' ' ' ARG . 47.3 m-85 -104.3 154.82 19.33 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.58 106.991 178.357 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.532 ' OH ' ' NZ ' ' B' ' 236' ' ' LYS . 24.0 p90 -158.68 163.36 36.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.487 -1.383 . . . . 0.44 111.027 -179.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 -96.05 138.85 33.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.742 -0.599 . . . . 2.76 109.561 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -92.41 -177.09 4.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.385 -0.822 . . . . 2.23 109.249 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 29.1 p -94.59 -11.71 28.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.199 -0.938 . . . . 1.81 109.604 -179.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.459 ' HE ' ' N ' ' B' ' 231' ' ' ARG . 2.9 mmp_? -79.57 -21.15 45.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 3.64 109.606 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -160.87 139.36 7.41 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.953 . . . . 2.16 108.9 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -65.39 2.45 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.086 1.191 . . . . 1.27 111.217 -179.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.577 HG22 ' N ' ' B' ' 235' ' ' TRP . 12.0 p -83.02 163.31 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.566 -1.334 . . . . 1.76 110.368 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.577 ' N ' HG22 ' B' ' 234' ' ' VAL . 93.4 m95 -68.42 165.7 18.29 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.996 -0.742 . . . . 0.67 108.996 179.588 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.532 ' NZ ' ' OH ' ' B' ' 227' ' ' TYR . 5.6 ttpt -119.63 -163.16 0.97 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.308 -0.87 . . . . 1.44 109.345 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -72.07 -179.06 32.57 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.691 -1.364 . . . . 0.4 109.691 -179.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.1 159.09 44.88 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.639 1.559 . . . . 0.41 110.234 -179.697 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -140.39 169.33 17.87 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.436 -0.79 . . . . 0.21 109.48 179.461 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -94.48 138.49 32.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.124 -0.985 . . . . 2.72 109.786 179.74 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.0 tp -88.68 126.04 35.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.763 -0.586 . . . . 0.3 109.474 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 18.2 mt -118.57 -73.17 0.65 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.451 -0.78 . . . . 0.45 110.019 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.413 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 5.4 t90 -92.91 145.37 24.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.311 -0.868 . . . . 0.33 110.257 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -148.14 120.96 8.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.361 -0.837 . . . . 2.33 109.132 179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.31 -102.29 0.2 Allowed Glycine 0 N--CA 1.496 2.67 0 C-N-CA 119.805 -1.188 . . . . 0.28 110.328 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -72.16 -153.09 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.229 -1.159 . . . . 1.4 109.813 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.95 47.91 2.63 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.22 -1.552 . . . . 0.29 109.22 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -147.53 151.99 37.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.493 -1.004 . . . . 0.29 108.814 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.87 129.73 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.245 -0.909 . . . . 0.31 109.613 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 48.8 t -90.04 135.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.869 -1.16 . . . . 0.3 107.869 179.017 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 20.8 pt -138.94 175.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.288 -0.883 . . . . 0.24 109.861 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.418 HE21 ' CG1' ' B' ' 257' ' ' ILE . 40.1 tt0 -143.87 112.27 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.726 -0.842 . . . . 1.81 108.726 179.105 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.72 -82.73 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.532 -1.284 . . . . 1.18 107.532 179.43 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' B' ' 255' ' ' SER . 38.0 t-20 -78.92 -128.61 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.63 -1.619 . . . . 1.97 106.63 177.683 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.463 ' N ' ' OD1' ' B' ' 254' ' ' ASN . 10.8 p -105.91 54.45 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.19 -1.041 . . . . 1.38 108.19 178.026 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' B' ' 255' ' ' SER . 66.0 m-20 -155.04 123.93 6.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.585 -0.697 . . . . 1.12 109.167 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.418 ' CG1' HE21 ' B' ' 252' ' ' GLN . 13.3 mt -94.25 136.51 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.292 -0.88 . . . . 0.48 109.565 -179.686 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -139.49 169.84 17.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.263 -0.898 . . . . 2.13 109.604 -179.629 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 t -101.3 142.09 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.476 -0.765 . . . . 0.34 108.992 179.384 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.49 131.47 19.41 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.436 -0.79 . . . . 0.34 109.133 -179.992 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.71 141.24 97.53 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 N-CA-C 109.609 -0.958 . . . . 0.42 109.609 178.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -58.61 -35.58 72.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.211 -0.931 . . . . 3.11 109.516 179.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -69.53 -4.37 18.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -0.879 . . . . 3.82 110.746 -179.149 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -119.12 21.34 12.36 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.227 -0.921 . . . . 2.08 108.887 179.454 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.74 170.16 16.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.53 -0.731 . . . . 0.32 109.658 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -141.72 124.71 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.238 -0.913 . . . . 1.79 109.165 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 28.4 mm -90.74 101.66 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.25 -0.906 . . . . 0.45 109.668 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.477 ' HB ' HH11 ' B' ' 224' ' ' ARG . 5.8 mm -106.44 158.13 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.373 -0.973 . . . . 0.57 108.373 179.025 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -87.29 152.85 21.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 3.62 109.405 179.549 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 117.986 -1.007 . . . . 2.05 109.39 179.794 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.413 -0.588 . . . . 3.82 109.413 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 220' ' ' ILE . 6.1 tp -85.46 81.9 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 122.087 0.946 . . . . 2.08 109.122 179.971 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -86.03 -121.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 2.17 108.944 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -97.03 95.61 7.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.078 -1.014 . . . . 1.48 108.771 179.344 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -125.64 140.64 52.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.434 -0.791 . . . . 0.72 109.788 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.99 157.78 24.08 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.796 -1.187 . . . . 3.26 107.796 178.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 239' ' ' ALA . 78.3 t -139.3 141.03 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.172 -0.955 . . . . 0.23 110.309 -179.155 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -107.32 150.35 26.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.506 -1.294 . . . . 0.58 107.506 178.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 14.5 p90 -155.78 156.44 34.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.753 -1.217 . . . . 0.44 110.03 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -93.87 150.01 20.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.49 -0.756 . . . . 2.76 109.829 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -93.51 159.19 15.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 2.23 108.886 179.524 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 46.9 t -76.89 2.58 14.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.061 -1.024 . . . . 1.8 109.189 179.796 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.619 HH11 ' CG ' ' A' ' 231' ' ' ARG . 2.9 mtt-85 -90.37 -25.5 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 3.63 109.831 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 234' ' ' VAL . 4.0 m-20 -162.44 144.48 8.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.059 -1.026 . . . . 2.16 109.271 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -64.41 11.4 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.268 1.312 . . . . 1.25 110.706 179.834 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 232' ' ' ASP . 22.6 m -84.86 145.26 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.872 -1.142 . . . . 1.75 109.823 -179.45 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -66.59 161.5 23.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.66 109.244 179.836 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 237' ' ' GLY . 45.2 tttp -119.1 166.43 12.93 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.456 -0.777 . . . . 1.43 109.496 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -46.14 171.83 0.02 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.2 -1.16 . . . . 0.39 110.2 -179.534 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -66.22 164.58 27.43 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.729 1.619 . . . . 0.41 110.501 179.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -140.47 169.34 17.83 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.093 -0.706 . . . . 0.21 109.093 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -92.9 136.23 33.44 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.041 -1.037 . . . . 2.72 109.609 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.39 125.94 34.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.595 -0.69 . . . . 0.29 109.602 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.2 mt -118.37 -76.86 0.57 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.423 -0.798 . . . . 0.45 110.164 179.77 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -102.99 139.3 38.73 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.188 -0.945 . . . . 0.31 110.684 -178.529 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.22 134.68 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 2.32 109.205 179.05 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.75 -99.91 0.18 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.389 -1.484 . . . . 0.27 109.389 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -66.99 -150.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 1.39 108.985 179.781 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.77 48.15 2.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.951 -1.66 . . . . 0.29 108.951 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.13 147.76 27.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.427 -1.043 . . . . 0.29 109.304 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.89 136.4 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.144 -0.973 . . . . 0.31 109.165 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 44.2 t -89.69 145.24 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.29 109.162 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 27.0 pt -143.82 178.0 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.245 -0.909 . . . . 0.23 109.998 -179.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.407 HE21 ' CG1' ' A' ' 257' ' ' ILE . 36.8 tt0 -144.54 114.31 7.25 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.702 -0.851 . . . . 1.81 108.702 179.06 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.31 -80.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.269 -1.382 . . . . 1.18 107.269 179.188 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.23 -129.87 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.9 -1.518 . . . . 1.98 106.9 177.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 58.1 m -104.54 54.87 0.72 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.931 -1.137 . . . . 1.39 107.931 177.99 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.23 125.35 6.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 1.12 109.126 -179.197 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.407 ' CG1' HE21 ' A' ' 252' ' ' GLN . 30.8 mt -93.82 137.24 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.358 -0.839 . . . . 0.47 109.657 -179.613 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -140.26 163.55 32.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.37 -0.831 . . . . 2.11 109.586 -179.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.38 134.04 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.853 . . . . 0.33 108.899 179.356 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.59 133.04 24.37 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.34 108.827 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.47 140.76 94.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.669 0.913 . . . . 0.42 110.323 179.505 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -56.04 -38.02 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 3.12 109.881 179.662 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -68.38 -2.36 8.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.228 -0.92 . . . . 3.82 110.705 -178.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -119.13 16.19 13.23 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.619 -0.882 . . . . 2.08 108.619 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.12 170.69 15.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.688 -0.632 . . . . 0.32 109.311 179.911 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -140.01 127.37 21.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.287 -0.883 . . . . 1.79 109.12 179.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 6.9 mm -89.24 109.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 0.45 109.47 -179.852 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 5.6 mm -106.46 150.04 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.748 -0.834 . . . . 0.57 108.748 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -91.12 145.94 24.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 3.63 109.317 179.573 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.99 -1.005 . . . . 2.05 109.511 179.632 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.37 0.605 . . . . 3.83 109.453 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.6 ' O ' HG23 ' B' ' 220' ' ' ILE . 6.1 tp -85.47 81.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.191 -0.943 . . . . 2.08 109.089 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -86.03 -121.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 2.16 108.893 179.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -97.04 95.67 7.95 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.129 -0.982 . . . . 1.48 108.763 179.319 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -125.68 140.53 52.63 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.464 -0.773 . . . . 0.73 109.793 -179.452 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -115.89 157.7 24.1 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.87 -1.159 . . . . 3.26 107.87 178.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 239' ' ' ALA . 79.8 t -139.22 141.07 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 0.23 110.375 -179.229 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -107.42 150.3 26.92 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.458 -1.312 . . . . 0.58 107.458 178.146 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 14.4 p90 -155.7 156.45 34.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.747 -1.221 . . . . 0.44 110.046 -179.547 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtt180 -93.84 150.04 20.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.473 -0.767 . . . . 2.76 109.832 -179.844 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -93.52 159.05 15.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 2.23 108.922 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 46.8 t -76.79 2.56 14.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.058 -1.026 . . . . 1.81 109.204 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . 0.625 HH11 ' CG ' ' B' ' 231' ' ' ARG . 2.9 mtt-85 -90.52 -25.35 20.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.279 -0.888 . . . . 3.64 109.794 -179.768 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' B' ' 234' ' ' VAL . 4.0 m-20 -162.52 144.43 8.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.068 -1.02 . . . . 2.16 109.242 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -64.27 11.31 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.822 0 C-N-CA 121.302 1.335 . . . . 1.27 110.775 179.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' B' ' 232' ' ' ASP . 22.6 m -84.82 145.22 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.132 . . . . 1.76 109.841 -179.477 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -66.56 161.51 22.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.67 109.387 179.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' B' ' 237' ' ' GLY . 45.2 tttp -119.07 166.39 12.96 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 1.44 109.504 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -46.15 171.75 0.02 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.202 -1.159 . . . . 0.4 110.202 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.1 164.64 26.93 Favored 'Trans proline' 0 C--N 1.322 -0.856 0 C-N-CA 121.687 1.591 . . . . 0.41 110.461 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' B' ' 225' ' ' VAL . . . -140.52 169.3 17.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.546 -0.721 . . . . 0.21 109.073 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -92.9 136.28 33.39 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.038 -1.039 . . . . 2.72 109.657 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 21.2 tp -88.4 126.08 35.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.474 -0.766 . . . . 0.3 109.587 -179.752 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.55 -76.78 0.57 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.58 -0.7 . . . . 0.45 110.152 179.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -103.01 139.43 38.58 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.217 -0.927 . . . . 0.33 110.637 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -149.25 134.68 18.46 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.344 -0.848 . . . . 2.33 109.188 179.069 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.83 -99.9 0.18 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.308 -1.517 . . . . 0.28 109.308 179.809 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.2 -149.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -1.128 . . . . 1.4 108.96 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.72 48.1 2.88 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.952 -1.659 . . . . 0.29 108.952 179.603 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -151.08 147.76 27.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -1.028 . . . . 0.29 109.296 -179.673 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.86 136.45 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.31 109.088 179.31 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.73 145.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.3 109.156 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 27.2 pt -143.8 178.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.24 110.024 -179.891 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.418 HE21 ' CG1' ' B' ' 257' ' ' ILE . 36.8 tt0 -144.57 114.41 7.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.683 -0.858 . . . . 1.81 108.683 179.033 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.38 -80.04 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.26 -1.385 . . . . 1.18 107.26 179.173 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -82.25 -129.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.837 -1.542 . . . . 1.97 106.837 177.653 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 58.2 m -104.5 54.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.913 -1.143 . . . . 1.38 107.913 178.024 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -155.2 125.41 6.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 1.12 109.169 -179.251 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.418 ' CG1' HE21 ' B' ' 252' ' ' GLN . 31.1 mt -93.86 137.36 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.48 109.67 -179.582 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -140.27 163.57 32.4 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.375 -0.828 . . . . 2.13 109.576 -179.712 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.4 134.04 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 0.34 108.927 179.306 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.6 133.03 24.37 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.893 -0.78 . . . . 0.34 108.893 -179.904 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.52 140.83 94.5 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.687 0.925 . . . . 0.42 110.234 179.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -56.1 -37.97 70.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.852 . . . . 3.11 109.86 179.64 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -68.46 -2.31 8.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.299 -0.876 . . . . 3.82 110.71 -178.877 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -119.1 16.14 13.25 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.6 -0.889 . . . . 2.08 108.6 179.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.13 170.57 15.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.639 -0.663 . . . . 0.32 109.319 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -139.95 127.37 21.42 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.312 -0.868 . . . . 1.79 109.111 179.874 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 6.8 mm -89.14 109.06 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.23 -0.919 . . . . 0.45 109.481 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 5.5 mm -106.46 150.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 108.779 -0.823 . . . . 0.57 108.779 179.359 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -91.25 145.87 24.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.375 -0.828 . . . . 3.62 109.395 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.991 -1.004 . . . . 2.05 109.535 179.751 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 32.6 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.449 -0.574 . . . . 3.82 109.449 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.674 HD13 ' H ' ' A' ' 220' ' ' ILE . 0.1 OUTLIER -80.39 136.78 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.072 -1.017 . . . . 2.08 109.165 179.519 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -86.91 -135.85 0.08 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.132 -0.692 . . . . 2.17 109.132 -179.821 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -92.83 116.33 28.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.124 -0.985 . . . . 1.48 108.655 179.426 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -134.3 149.56 50.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.409 -0.807 . . . . 0.72 109.538 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -120.68 155.39 33.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.882 -1.155 . . . . 3.26 107.882 179.344 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 57.6 t -141.61 141.06 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.098 -1.001 . . . . 0.23 110.635 -179.625 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.73 155.81 22.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.281 -1.377 . . . . 0.58 107.281 178.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.485 -1.384 . . . . 0.44 110.739 -179.175 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -100.52 140.02 35.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.591 -0.693 . . . . 2.76 109.671 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.64 170.05 9.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.866 . . . . 2.23 109.376 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.3 m -84.63 -9.48 58.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 1.8 109.137 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.42 -10.9 47.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.386 -0.821 . . . . 3.63 109.516 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 232' ' ' ASP . 1.6 p30 -158.88 133.95 5.67 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.179 -0.95 . . . . 2.16 109.354 -179.242 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.13 -7.05 20.23 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 120.975 1.116 . . . . 1.25 111.396 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.569 HG22 ' N ' ' A' ' 235' ' ' TRP . 3.7 p -87.1 163.49 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.563 -1.336 . . . . 1.75 110.416 -179.398 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.569 ' N ' HG22 ' A' ' 234' ' ' VAL . 83.2 m95 -66.31 -175.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.646 -0.659 . . . . 0.66 109.514 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' CE ' ' OH ' ' A' ' 227' ' ' TYR . 4.0 ttpp -130.77 -156.38 0.75 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.589 -0.893 . . . . 1.43 108.589 179.326 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.28 54.22 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.57 -1.412 . . . . 0.39 109.57 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -71.46 154.26 60.56 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.677 1.585 . . . . 0.41 109.975 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.78 25.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.767 . . . . 0.21 109.215 179.446 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.02 141.44 28.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 2.72 109.846 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.63 123.93 34.65 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.829 -0.544 . . . . 0.29 109.565 -179.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -117.06 -73.2 0.65 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.334 -0.854 . . . . 0.45 111.017 -179.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.461 ' CZ3' ' CD1' ' B' ' 257' ' ' ILE . 6.0 t90 -91.78 152.66 20.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.22 -0.925 . . . . 0.31 110.807 -177.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.46 128.34 21.93 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.523 -0.917 . . . . 2.32 108.523 178.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.4 -126.83 1.23 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.521 -1.323 . . . . 0.27 110.539 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.65 -144.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.589 -0.947 . . . . 1.39 109.342 -179.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.33 49.24 2.61 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.827 -1.709 . . . . 0.29 108.827 179.471 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.64 149.32 31.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.383 -1.069 . . . . 0.29 109.041 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.47 134.84 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.31 109.48 -179.826 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 58.5 t -91.9 140.84 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.287 -0.883 . . . . 0.29 109.077 179.816 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.98 176.7 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.293 -0.88 . . . . 0.23 109.794 -179.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -144.92 112.3 6.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.339 -0.851 . . . . 1.81 109.018 179.312 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.41 -81.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.409 -1.33 . . . . 1.18 107.409 179.28 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.02 -131.42 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.651 -1.611 . . . . 1.98 106.651 177.585 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.5 t -104.34 57.07 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.7 -1.222 . . . . 1.39 107.7 177.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -155.73 122.43 5.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.142 -0.688 . . . . 1.12 109.142 -179.378 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.462 ' CD1' ' CZ3' ' B' ' 243' ' ' TRP . 59.0 mt -93.05 134.76 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.258 -0.901 . . . . 0.47 109.331 -179.831 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.79 172.72 12.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.449 -0.782 . . . . 2.11 109.741 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.34 142.07 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 109.146 -0.687 . . . . 0.33 109.146 179.387 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.51 126.7 15.06 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.398 -0.964 . . . . 0.34 108.398 179.391 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.11 152.07 39.48 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 N-CA-C 109.835 -0.871 . . . . 0.42 109.835 179.526 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.71 -34.59 77.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 3.12 109.742 179.899 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -70.93 -5.59 32.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.815 . . . . 3.82 111.329 -178.914 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -118.77 20.33 12.89 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.236 -0.915 . . . . 2.08 108.908 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.9 165.36 27.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.519 -0.738 . . . . 0.32 109.275 179.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.415 ' NZ ' ' CB ' ' A' ' 266' ' ' LYS . 7.4 mtmp? -140.08 129.62 24.23 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.371 -0.831 . . . . 1.79 108.925 179.821 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.97 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.313 -0.867 . . . . 0.45 109.704 -179.35 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.0 mm -105.45 150.02 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.055 -1.091 . . . . 0.57 108.055 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER -92.05 142.27 27.7 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.187 -0.946 . . . . 3.63 109.216 179.652 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.136 -0.978 . . . . 2.05 109.21 179.531 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 32.6 mtt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.566 -0.531 . . . . 3.83 109.566 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.675 HD13 ' H ' ' B' ' 220' ' ' ILE . 0.1 OUTLIER -80.38 136.69 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.217 -0.927 . . . . 2.08 109.225 179.554 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -86.72 -135.89 0.08 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.166 -0.679 . . . . 2.16 109.166 -179.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -92.83 116.32 28.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 1.48 108.608 179.483 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.23 149.54 50.97 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.508 -0.745 . . . . 0.73 109.491 -179.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -120.67 155.33 34.07 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.902 -1.147 . . . . 3.26 107.902 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 57.8 t -141.53 141.14 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.146 -0.971 . . . . 0.23 110.652 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -111.84 155.78 23.06 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.181 -1.414 . . . . 0.58 107.181 178.363 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.9 p90 -156.23 159.26 38.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.487 -1.383 . . . . 0.44 110.808 -179.218 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -100.55 140.11 35.28 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.647 -0.658 . . . . 2.76 109.639 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.79 170.02 9.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.313 -0.867 . . . . 2.23 109.412 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 16.6 m -84.56 -9.62 58.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 1.81 109.157 179.727 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -88.31 -10.85 48.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 3.64 109.536 179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' B' ' 232' ' ' ASP . 1.6 p30 -158.94 133.9 5.62 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.181 -0.949 . . . . 2.16 109.335 -179.231 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.99 -7.06 20.19 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 120.98 1.12 . . . . 1.27 111.349 -179.669 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . 0.57 HG22 ' N ' ' B' ' 235' ' ' TRP . 3.7 p -87.25 163.55 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 120.671 -1.268 . . . . 1.76 110.398 -179.391 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . 0.57 ' N ' HG22 ' B' ' 234' ' ' VAL . 83.2 m95 -66.34 -175.67 0.37 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.731 -0.605 . . . . 0.67 109.521 -179.956 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.445 ' CE ' ' OH ' ' B' ' 227' ' ' TYR . 4.0 ttpp -130.79 -156.55 0.76 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.598 -0.89 . . . . 1.44 108.598 179.378 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . . . . . . . . . . . -78.8 177.2 54.18 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.604 -1.398 . . . . 0.4 109.604 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.38 154.24 60.98 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.593 1.528 . . . . 0.41 110.027 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.86 165.91 24.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.45 -0.782 . . . . 0.21 109.181 179.423 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -94.08 141.48 28.49 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.116 -0.99 . . . . 2.72 109.808 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 18.0 tp -90.61 123.93 34.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.814 -0.554 . . . . 0.3 109.623 -179.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.97 -73.25 0.65 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.348 -0.845 . . . . 0.45 111.079 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.462 ' CZ3' ' CD1' ' A' ' 257' ' ' ILE . 6.1 t90 -91.93 152.66 19.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.234 -0.916 . . . . 0.33 110.804 -177.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -140.31 128.28 22.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.588 -0.894 . . . . 2.33 108.588 179.014 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.38 -126.99 1.24 Allowed Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.58 -1.295 . . . . 0.28 110.574 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.44 -144.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.578 -0.954 . . . . 1.4 109.445 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.2 49.1 2.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.867 -1.693 . . . . 0.29 108.867 179.376 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.4 149.44 31.74 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.385 -1.068 . . . . 0.29 109.001 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 134.76 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.246 -0.908 . . . . 0.31 109.455 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 58.7 t -91.97 140.87 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.828 . . . . 0.3 109.03 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.94 176.74 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.24 109.873 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -144.91 112.32 6.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.334 -0.854 . . . . 1.81 108.992 179.379 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.54 -81.13 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.398 -1.334 . . . . 1.18 107.398 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.98 -131.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.678 -1.601 . . . . 1.97 106.678 177.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . . . . . . . . . 41.6 t -104.35 57.06 0.71 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.697 -1.223 . . . . 1.38 107.697 177.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -155.78 122.51 5.28 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.974 -0.75 . . . . 1.12 108.974 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.461 ' CD1' ' CZ3' ' A' ' 243' ' ' TRP . 59.0 mt -93.05 134.62 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.153 -0.967 . . . . 0.48 109.375 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -136.83 172.71 12.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.502 -0.749 . . . . 2.13 109.721 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.33 142.05 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.114 -0.699 . . . . 0.34 109.114 179.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.55 126.69 15.0 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.443 -0.947 . . . . 0.34 108.443 179.349 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -56.03 152.1 38.73 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 N-CA-C 109.791 -0.888 . . . . 0.42 109.791 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -67.73 -34.55 77.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.385 -0.822 . . . . 3.11 109.684 179.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -71.06 -5.63 32.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.288 -0.883 . . . . 3.82 111.238 -178.805 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -118.8 20.34 12.87 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.019 -1.051 . . . . 2.08 108.922 179.584 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -140.91 165.33 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.32 109.269 179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . 0.423 ' NZ ' ' CB ' ' B' ' 266' ' ' LYS . 7.4 mtmp? -139.99 129.55 24.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.294 -0.879 . . . . 1.79 108.987 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.7 mm -87.98 112.87 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.236 -0.915 . . . . 0.45 109.725 -179.34 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.1 mm -105.35 150.07 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.141 -1.059 . . . . 0.57 108.141 178.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . 0.553 ' CG ' HH11 ' B' ' 269' ' ' ARG . 0.0 OUTLIER -92.09 142.24 27.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 3.62 109.289 179.605 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.045 -0.979 . . . . 2.05 109.197 179.608 . . . . . . . . 0 0 . 1 stop_ save_